Citrus Sinensis ID: 007455
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 603 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGF4 | 591 | LRR receptor-like serine/ | no | no | 0.933 | 0.952 | 0.516 | 1e-174 | |
| C0LGL9 | 589 | LRR receptor-like serine/ | no | no | 0.932 | 0.954 | 0.516 | 1e-169 | |
| Q0WVM4 | 634 | Probable LRR receptor-lik | no | no | 0.940 | 0.894 | 0.359 | 8e-93 | |
| Q94AG2 | 625 | Somatic embryogenesis rec | no | no | 0.903 | 0.872 | 0.364 | 1e-92 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.817 | 0.413 | 0.385 | 3e-92 | |
| Q93ZS4 | 632 | Protein NSP-INTERACTING K | no | no | 0.878 | 0.838 | 0.373 | 5e-91 | |
| Q8RY65 | 635 | Protein NSP-INTERACTING K | no | no | 0.880 | 0.836 | 0.373 | 6e-90 | |
| C0LGX1 | 607 | Probable LRR receptor-lik | no | no | 0.915 | 0.909 | 0.366 | 1e-89 | |
| C0LGU5 | 614 | Probable LRR receptor-lik | no | no | 0.875 | 0.859 | 0.357 | 2e-88 | |
| Q9LFS4 | 638 | Protein NSP-INTERACTING K | no | no | 0.880 | 0.832 | 0.347 | 5e-88 |
| >sp|C0LGF4|FEI1_ARATH LRR receptor-like serine/threonine-protein kinase FEI 1 OS=Arabidopsis thaliana GN=FEI1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 613 bits (1581), Expect = e-174, Method: Compositional matrix adjust.
Identities = 298/577 (51%), Positives = 407/577 (70%), Gaps = 14/577 (2%)
Query: 25 ALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGG 84
A++ DG LL ++++ S + + W+ + PC W G++C +RV ++NL Y ++ G
Sbjct: 29 AISPDGEALLSFRNAVTRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYHKIMG 88
Query: 85 IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144
+ P IG+LD L+ L LH N+L+G+IP + NCT L ++L++NY G IPA +G+L L
Sbjct: 89 PLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGDLPGL 148
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
LD+SSN+L G IP+SLG+L L N+S NF G+IP G LS F SFIGNL+LCG
Sbjct: 149 QKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNLNLCG 208
Query: 205 RQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLWI 264
+ V C+ G P+ + ++ K++S + LI A +T+G L+V L W
Sbjct: 209 KHVDVVCQDDSGNPSSHSQSGQNQ-----KKNSGKL---LISASATVGALLLVALMCFWG 260
Query: 265 CLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGF 324
C L KK V+ + + D ++ FHGD+PY S +II+KLE L+EE ++G GGF
Sbjct: 261 CFLYKKLGKVEIKSLAK---DVGGGASIVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGF 317
Query: 325 GTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384
GTVY++ M+D FA+KRI + EG D+ FERELEILGSIKH LVNLRGYC P +KLL
Sbjct: 318 GTVYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 377
Query: 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSN 444
+YDYL GSLD+ LHE GE L+W +R+ I +G+A+GL+YLHHDC P+IIHRDIKSSN
Sbjct: 378 LYDYLPGGSLDEALHERGEQ---LDWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSN 434
Query: 445 ILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVL 504
ILLD NLE VSDFGLAKLL DEE+H+TT+VAGTFGYLAPEY+QSGRATEK+DVYSFGVL
Sbjct: 435 ILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVL 494
Query: 505 LLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAAR 564
+LE+++GKRPTD +F+++GLNVVGW+ L+ E R D++D C ME+++A+L IA +
Sbjct: 495 VLEVLSGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQ 554
Query: 565 CTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHSD 601
C +P++RP+M++V+QLLE EVM+PCPS+FY+S SD
Sbjct: 555 CVSPSPEERPTMHRVVQLLESEVMTPCPSEFYDSSSD 591
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGL9|FEI2_ARATH LRR receptor-like serine/threonine-protein kinase FEI 2 OS=Arabidopsis thaliana GN=FEI2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 593 bits (1530), Expect = e-169, Method: Compositional matrix adjust.
Identities = 298/577 (51%), Positives = 407/577 (70%), Gaps = 15/577 (2%)
Query: 25 ALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGG 84
A++ DG LL ++ + S ++G W+ + PC W G++C +RV +++L Y +L G
Sbjct: 28 AISPDGEALLSFRNGVLASDGVIGLWRPEDPDPCNWKGVTCDAKTKRVIALSLTYHKLRG 87
Query: 85 IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144
+ P +G+LD+L+ L LH N+L+ SIP + NCT L +YL+ NY+ G IP+ IGNL L
Sbjct: 88 PLPPELGKLDQLRLLMLHNNALYQSIPASLGNCTALEGIYLQNNYITGTIPSEIGNLSGL 147
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
LDLS+N+L GAIP+SLG+L L N+S NF G+IP G L+ SF GN +LCG
Sbjct: 148 KNLDLSNNNLNGAIPASLGQLKRLTKFNVSNNFLVGKIPSDGLLARLSRDSFNGNRNLCG 207
Query: 205 RQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLWI 264
+Q+ C S +S PT + + K +LI A +T+G L+V L W
Sbjct: 208 KQIDIVCNDS---------GNSTASGSPTGQGGNNPKRLLISASATVGGLLLVALMCFWG 258
Query: 265 CLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGF 324
C L KK V+ + V +D ++ FHGD+PY S +II+KLE+L+EE ++G GGF
Sbjct: 259 CFLYKKLGRVESKSLV---IDVGGGASIVMFHGDLPYASKDIIKKLESLNEEHIIGCGGF 315
Query: 325 GTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384
GTVY++ M+D FA+KRI + EG D+ FERELEILGSIKH LVNLRGYC P +KLL
Sbjct: 316 GTVYKLSMDDGNVFALKRIVKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 375
Query: 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSN 444
+YDYL GSLD+ LH+ GE L+W +R+ I +G+A+GLAYLHHDC P+IIHRDIKSSN
Sbjct: 376 LYDYLPGGSLDEALHKRGE---QLDWDSRVNIIIGAAKGLAYLHHDCSPRIIHRDIKSSN 432
Query: 445 ILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVL 504
ILLD NLE VSDFGLAKLL DEE+H+TT+VAGTFGYLAPEY+QSGRATEK+DVYSFGVL
Sbjct: 433 ILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVL 492
Query: 505 LLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAAR 564
+LE+++GK PTD +F+++G N+VGW+N L+ ENR ++++D C + E+++A+L IA +
Sbjct: 493 VLEVLSGKLPTDASFIEKGFNIVGWLNFLISENRAKEIVDLSCEGVERESLDALLSIATK 552
Query: 565 CTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHSD 601
C ++PD+RP+M++V+QLLE EVM+PCPSDFY+S SD
Sbjct: 553 CVSSSPDERPTMHRVVQLLESEVMTPCPSDFYDSSSD 589
|
Involved in the signaling pathway that regulates cell wall function, including cellulose biosynthesis, likely via an 1-aminocyclopropane-1-carboxylic acid (ACC)-mediated signal (a precursor of ethylene). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0WVM4|Y2239_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g23950 OS=Arabidopsis thaliana GN=At2g23950 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 341 bits (875), Expect = 8e-93, Method: Compositional matrix adjust.
Identities = 219/610 (35%), Positives = 333/610 (54%), Gaps = 43/610 (7%)
Query: 9 ILTVIFAATLFSSCCLA---LTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISC 65
I +V+ F +C L+ + L+ IK+ L+D + NW PC WT ISC
Sbjct: 11 IFSVLLLLCFFVTCSLSSEPRNPEVEALINIKNELHDPHGVFKNWDEFSVDPCSWTMISC 70
Query: 66 HTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYL 125
+ D V + P L G +S SIG L L++++L N++ G IP EI + +L+ L L
Sbjct: 71 SS-DNLVIGLGAPSQSLSGTLSGSIGNLTNLRQVSLQNNNISGKIPPEICSLPKLQTLDL 129
Query: 126 RANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDF 185
N G IP ++ L L L L++NSL G P+SL ++ HL +L+LS N G +P F
Sbjct: 130 SNNRFSGEIPGSVNQLSNLQYLRLNNNSLSGPFPASLSQIPHLSFLDLSYNNLRGPVPKF 189
Query: 186 GALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLI 245
A + + GN +C + + C S+ S+ ++V + SS +L
Sbjct: 190 PARTF----NVAGNPLICKNSLPEICSGSI---------SASPLSVSLRSSSGRRTNILA 236
Query: 246 GAMS-TMGLALVVLLA--FLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYP 302
A+ ++G A+ V+L+ F+W KK+R R T +R QE L+ +
Sbjct: 237 VALGVSLGFAVSVILSLGFIW---YRKKQR---RLTMLRISDKQEEG--LLGLGNLRSFT 288
Query: 303 SCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRI-DRSREGSDQVFERELEIL 361
E+ + + ++G+GGFG VYR D AVKR+ D + + F ELE++
Sbjct: 289 FRELHVATDGFSSKSILGAGGFGNVYRGKFGDGTVVAVKRLKDVNGTSGNSQFRTELEMI 348
Query: 362 GSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA 421
H NL+ L GYC + +LL+Y Y+S GS+ L + + L+W+ R KIA+G+A
Sbjct: 349 SLAVHRNLLRLIGYCASSSERLLVYPYMSNGSVASRL----KAKPALDWNTRKKIAIGAA 404
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
RGL YLH C PKIIHRD+K++NILLDE E V DFGLAKLL E++HVTT V GT G+
Sbjct: 405 RGLFYLHEQCDPKIIHRDVKAANILLDEYFEAVVGDFGLAKLLNHEDSHVTTAVRGTVGH 464
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTD--PTFVKRGLNVVGWMNTLLKENRL 539
+APEYL +G+++EK+DV+ FG+LLLEL+TG R + + ++G ++ W+ L KE ++
Sbjct: 465 IAPEYLSTGQSSEKTDVFGFGILLLELITGMRALEFGKSVSQKGA-MLEWVRKLHKEMKV 523
Query: 540 EDVIDKRCADA-DMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE------VMSPCP 592
E+++D+ D V +L++A CT P RP M++V+Q+LE + S
Sbjct: 524 EELVDRELGTTYDRIEVGEMLQVALLCTQFLPAHRPKMSEVVQMLEGDGLAERWAASHDH 583
Query: 593 SDFYESHSDY 602
S FY ++ Y
Sbjct: 584 SHFYHANMSY 593
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94AG2|SERK1_ARATH Somatic embryogenesis receptor kinase 1 OS=Arabidopsis thaliana GN=SERK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 341 bits (874), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 204/560 (36%), Positives = 315/560 (56%), Gaps = 15/560 (2%)
Query: 29 DGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISP 88
+G L ++ +L D N+L +W T +PC W ++C+ + +R ++L +L G + P
Sbjct: 29 EGDALHTLRVTLVDPNNVLQSWDPTLVNPCTWFHVTCNNENSVIR-VDLGNAELSGHLVP 87
Query: 89 SIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148
+G L LQ L L+ N++ G IP+ + N T L +L L N G IP ++G L L L
Sbjct: 88 ELGVLKNLQYLELYSNNITGPIPSNLGNLTNLVSLDLYLNSFSGPIPESLGKLSKLRFLR 147
Query: 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVH 208
L++NSL G+IP SL +T L L+LS N SG +PD G+ S F SF NLDLCG
Sbjct: 148 LNNNSLTGSIPMSLTNITTLQVLDLSNNRLSGSVPDNGSFSLFTPISFANNLDLCGPVTS 207
Query: 209 KPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLWICLLS 268
PC S F P V+ P+ + A + + A + W
Sbjct: 208 HPCPGSPPFSPPPPFIQPPPVSTPSGYGITGAIAGGVAAGAALLFAAPAIAFAWW----- 262
Query: 269 KKERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVY 328
++ + + + +V + D E + + E+ + ++++G GGFG VY
Sbjct: 263 RRRKPLDIFFDVPAEEDPEVHLGQLKR-----FSLRELQVASDGFSNKNILGRGGFGKVY 317
Query: 329 RMVMNDCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387
+ + D AVKR+ R G + F+ E+E++ H NL+ LRG+C P +LL+Y
Sbjct: 318 KGRLADGTLVAVKRLKEERTPGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 377
Query: 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL 447
Y++ GS+ L E Q L+W R +IALGSARGL+YLH C PKIIHRD+K++NILL
Sbjct: 378 YMANGSVASCLRERPPSQPPLDWPTRKRIALGSARGLSYLHDHCDPKIIHRDVKAANILL 437
Query: 448 DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLE 507
DE E V DFGLAKL+ ++ HVTT V GT G++APEYL +G+++EK+DV+ +G++LLE
Sbjct: 438 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLE 497
Query: 508 LVTGKRPTDPTFVKRGLNV--VGWMNTLLKENRLEDVIDKRC-ADADMETVEAILEIAAR 564
L+TG+R D + +V + W+ LLKE +LE ++D + + +E ++++A
Sbjct: 498 LITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEMLVDPDLQTNYEERELEQVIQVALL 557
Query: 565 CTDANPDDRPSMNQVLQLLE 584
CT +P +RP M++V+++LE
Sbjct: 558 CTQGSPMERPKMSEVVRMLE 577
|
Dual specificity kinase acting on both serine/threonine-and tyrosine-containing substrates. Phosphorylates BRI1 on 'Ser-887' and CDC48 on at least one threonine residue and on 'Ser-41'. Confers embryogenic competence. Acts redundantly with SERK2 as a control point for sporophytic development controlling male gametophyte production. Involved in the brassinolide signaling pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (871), Expect = 3e-92, Method: Compositional matrix adjust.
Identities = 204/529 (38%), Positives = 295/529 (55%), Gaps = 36/529 (6%)
Query: 75 INLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGI 134
+NL +L G + S+G L +L + L N+L G + +E++ +L LY+ N G I
Sbjct: 681 LNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEI 740
Query: 135 PANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNK 194
P+ +GNL L LD+S N L G IP+ + L +L +LNL+ N GE+P G
Sbjct: 741 PSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKA 800
Query: 195 SFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMGLA 254
GN +LCGR V C+ + RS+ + G+++G T+ +
Sbjct: 801 LLSGNKELCGRVVGSDCK----------------IEGTKLRSAWGIAGLMLGF--TIIVF 842
Query: 255 LVVLLAFLWICLLSKKERA-VKRYTEVRKQ--VDQET------------STKLITFHGDM 299
+ V W K+R +R E R + VDQ S + F +
Sbjct: 843 VFVFSLRRWAMTKRVKQRDDPERMEESRLKGFVDQNLYFLSGSRSREPLSINIAMFEQPL 902
Query: 300 -PYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFEREL 358
+I+E + +++++G GGFGTVY+ + T AVK++ ++ ++ F E+
Sbjct: 903 LKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEM 962
Query: 359 EILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIAL 418
E LG +KH NLV+L GYC KLL+Y+Y+ GSLD +L ++L+WS RLKIA+
Sbjct: 963 ETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAV 1022
Query: 419 GSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT 478
G+ARGLA+LHH P IIHRDIK+SNILLD + EP V+DFGLA+L+ E+HV+TV+AGT
Sbjct: 1023 GAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGT 1082
Query: 479 FGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVK-RGLNVVGWMNTLLKEN 537
FGY+ PEY QS RAT K DVYSFGV+LLELVTGK PT P F + G N+VGW + +
Sbjct: 1083 FGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQG 1142
Query: 538 RLEDVIDKRCADADMETVE-AILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ DVID ++ + +L+IA C P RP+M VL+ L++
Sbjct: 1143 KAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKE 1191
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93ZS4|NIK3_ARATH Protein NSP-INTERACTING KINASE 3 OS=Arabidopsis thaliana GN=NIK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 335 bits (860), Expect = 5e-91, Method: Compositional matrix adjust.
Identities = 209/559 (37%), Positives = 315/559 (56%), Gaps = 29/559 (5%)
Query: 33 LLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGR 92
L+ +K+ LND +L NW PC W +SC D V S++LP L G +SP IG
Sbjct: 39 LVAVKNELNDPYKVLENWDVNSVDPCSWRMVSCT--DGYVSSLDLPSQSLSGTLSPRIGN 96
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
L LQ + L N++ G IP I +L++L L N G IPA++G L L L L++N
Sbjct: 97 LTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNNSFTGEIPASLGELKNLNYLRLNNN 156
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCR 212
SL G P SL ++ L +++S N SG +P A + IGN +CG + C
Sbjct: 157 SLIGTCPESLSKIEGLTLVDISYNNLSGSLPKVSARTF----KVIGNALICGPKAVSNC- 211
Query: 213 TSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLWICLLSKKER 272
+++ P LP DE T+ + H++ + S FLW + R
Sbjct: 212 SAVPEPLTLPQDGPDESG--TRTNGHHVALAFAASFSAAFFVFFTSGMFLWW----RYRR 265
Query: 273 AVKRYTEVRKQVDQETST---KLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYR 329
+ + +V +Q D E S K TF E+ + ++++G GG+G VY+
Sbjct: 266 NKQIFFDVNEQYDPEVSLGHLKRYTFK--------ELRSATNHFNSKNILGRGGYGIVYK 317
Query: 330 MVMNDCGTFAVKRI-DRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388
+ND AVKR+ D + G + F+ E+E + H NL+ LRG+C ++L+Y Y
Sbjct: 318 GHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALHRNLLRLRGFCSSNQERILVYPY 377
Query: 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD 448
+ GS+ L ++ G+ L+WS R KIA+G+ARGL YLH C PKIIHRD+K++NILLD
Sbjct: 378 MPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVYLHEQCDPKIIHRDVKAANILLD 437
Query: 449 ENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLEL 508
E+ E V DFGLAKLL ++HVTT V GT G++APEYL +G+++EK+DV+ FG+LLLEL
Sbjct: 438 EDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 497
Query: 509 VTGKRPTD--PTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA-DMETVEAILEIAARC 565
+TG++ D + ++G+ ++ W+ L +E +L+ +IDK D D +E I+++A C
Sbjct: 498 ITGQKALDFGRSAHQKGV-MLDWVKKLHQEGKLKQLIDKDLNDKFDRVELEEIVQVALLC 556
Query: 566 TDANPDDRPSMNQVLQLLE 584
T NP RP M++V+++LE
Sbjct: 557 TQFNPSHRPKMSEVMKMLE 575
|
Involved in defense response to geminivirus infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RY65|NIK2_ARATH Protein NSP-INTERACTING KINASE 2 OS=Arabidopsis thaliana GN=NIK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (851), Expect = 6e-90, Method: Compositional matrix adjust.
Identities = 210/562 (37%), Positives = 307/562 (54%), Gaps = 31/562 (5%)
Query: 31 MTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSI 90
+ L+ IKSSL D +L NW T PC W I+C D V + P L G +S SI
Sbjct: 44 VALIGIKSSLTDPHGVLMNWDDTAVDPCSWNMITCS--DGFVIRLEAPSQNLSGTLSSSI 101
Query: 91 GRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150
G L LQ + L N + G+IP+EI +L+ L L N G IP + L L ++
Sbjct: 102 GNLTNLQTVLLQNNYITGNIPHEIGKLMKLKTLDLSTNNFTGQIPFTLSYSKNLQYLRVN 161
Query: 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSF--IGNLDLCGRQVH 208
+NSL G IPSSL +T L +L+LS N SG +P A K+F +GN +C
Sbjct: 162 NNSLTGTIPSSLANMTQLTFLDLSYNNLSGPVPRSLA------KTFNVMGNSQICPTGTE 215
Query: 209 KPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLWICLLS 268
K C + P + SS K S K I + + L V LL + LL
Sbjct: 216 KDCNGTQPKPMSITLNSSQ-----NKSSDGGTKNRKIAVVFGVSLTCVCLLIIGFGFLLW 270
Query: 269 KKERAVKR--YTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGT 326
+ R K+ + ++ +Q +E + + E+ +++VG GGFG
Sbjct: 271 WRRRHNKQVLFFDINEQNKEE-----MCLGNLRRFNFKELQSATSNFSSKNLVGKGGFGN 325
Query: 327 VYRMVMNDCGTFAVKRIDRSREGSDQV-FERELEILGSIKHINLVNLRGYCRLPATKLLI 385
VY+ ++D AVKR+ G +V F+ ELE++ H NL+ L G+C + +LL+
Sbjct: 326 VYKGCLHDGSIIAVKRLKDINNGGGEVQFQTELEMISLAVHRNLLRLYGFCTTSSERLLV 385
Query: 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNI 445
Y Y+S GS+ L + + +L+W R +IALG+ RGL YLH C PKIIHRD+K++NI
Sbjct: 386 YPYMSNGSVASRL----KAKPVLDWGTRKRIALGAGRGLLYLHEQCDPKIIHRDVKAANI 441
Query: 446 LLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLL 505
LLD+ E V DFGLAKLL EE+HVTT V GT G++APEYL +G+++EK+DV+ FG+LL
Sbjct: 442 LLDDYFEAVVGDFGLAKLLDHEESHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILL 501
Query: 506 LELVTGKRPTD--PTFVKRGLNVVGWMNTLLKENRLEDVIDKRC-ADADMETVEAILEIA 562
LEL+TG R + +RG ++ W+ L +E +LE ++DK ++ D VE ++++A
Sbjct: 502 LELITGLRALEFGKAANQRGA-ILDWVKKLQQEKKLEQIVDKDLKSNYDRIEVEEMVQVA 560
Query: 563 ARCTDANPDDRPSMNQVLQLLE 584
CT P RP M++V+++LE
Sbjct: 561 LLCTQYLPIHRPKMSEVVRMLE 582
|
Involved in defense response to geminivirus infection (By similarity). Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX1|Y5524_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g65240 OS=Arabidopsis thaliana GN=At5g65240 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 331 bits (848), Expect = 1e-89, Method: Compositional matrix adjust.
Identities = 215/587 (36%), Positives = 327/587 (55%), Gaps = 35/587 (5%)
Query: 12 VIFAATLFSSCCLALTED--GMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHD 69
+I A +FSS +++ D G L ++SSL S L +W + PC W+ + C
Sbjct: 4 LIITALVFSSLWSSVSPDAQGDALFALRSSLRASPEQLSDWNQNQVDPCTWSQVICDDK- 62
Query: 70 QRVRSINLPYMQLG-GIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN 128
+ V S+ L YM G +S IG L L+ L L N + G IP I N + L +L L N
Sbjct: 63 KHVTSVTLSYMNFSSGTLSSGIGILTTLKTLTLKGNGIMGGIPESIGNLSSLTSLDLEDN 122
Query: 129 YLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
+L IP+ +GNL L L LS N+L G+IP SL L+ L + L +N SGEIP +L
Sbjct: 123 HLTDRIPSTLGNLKNLQFLTLSRNNLNGSIPDSLTGLSKLINILLDSNNLSGEIPQ--SL 180
Query: 189 SAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAM 248
+F N CG +PC T + G++ G +
Sbjct: 181 FKIPKYNFTANNLSCGGTFPQPCVTESSPSGDSSSRKT---------------GIIAGVV 225
Query: 249 STMGLALVVLLAFLWICLLSKKERAVKR--YTEVRKQVDQETSTKLITFHGDMPYPSCEI 306
S G+A V+LL F + K + KR + +V +VD+ I F + E+
Sbjct: 226 S--GIA-VILLGFFFFFFCKDKHKGYKRDVFVDVAGEVDRR-----IAFGQLRRFAWREL 277
Query: 307 IEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRI-DRSREGSDQVFERELEILGSIK 365
+ E++V+G GGFG VY+ +++D AVKR+ D R G D+ F+RE+E++
Sbjct: 278 QLATDEFSEKNVLGQGGFGKVYKGLLSDGTKVAVKRLTDFERPGGDEAFQREVEMISVAV 337
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLA 425
H NL+ L G+C +LL+Y ++ S+ L E G +L+W R +IALG+ARGL
Sbjct: 338 HRNLLRLIGFCTTQTERLLVYPFMQNLSVAYCLREIKPGDPVLDWFRRKQIALGAARGLE 397
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
YLH C PKIIHRD+K++N+LLDE+ E V DFGLAKL+ +VTT V GT G++APE
Sbjct: 398 YLHEHCNPKIIHRDVKAANVLLDEDFEAVVGDFGLAKLVDVRRTNVTTQVRGTMGHIAPE 457
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNV--VGWMNTLLKENRLEDVI 543
+ +G+++EK+DV+ +G++LLELVTG+R D + ++ +V + + L +E RLED++
Sbjct: 458 CISTGKSSEKTDVFGYGIMLLELVTGQRAIDFSRLEEEDDVLLLDHVKKLEREKRLEDIV 517
Query: 544 DKRC-ADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589
DK+ D E VE ++++A CT A P++RP+M++V+++LE E ++
Sbjct: 518 DKKLDEDYIKEEVEMMIQVALLCTQAAPEERPAMSEVVRMLEGEGLA 564
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU5|Y5457_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g45780 OS=Arabidopsis thaliana GN=At5g45780 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 327 bits (837), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 199/557 (35%), Positives = 307/557 (55%), Gaps = 29/557 (5%)
Query: 32 TLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIG 91
L+ +K+ + D + +L W PC W + C + + V S+ + L GI+S SIG
Sbjct: 42 ALMSVKNKMKDEKEVLSGWDINSVDPCTWNMVGCSS-EGFVVSLEMASKGLSGILSTSIG 100
Query: 92 RLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSS 151
L L L L N L G IP+E+ +EL L L N G IPA++G L L L LS
Sbjct: 101 ELTHLHTLLLQNNQLTGPIPSELGQLSELETLDLSGNRFSGEIPASLGFLTHLNYLRLSR 160
Query: 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPC 211
N L G +P + L+ L +L+LS N SG P+ A + +GN LCG + C
Sbjct: 161 NLLSGQVPHLVAGLSGLSFLDLSFNNLSGPTPNISA----KDYRIVGNAFLCGPASQELC 216
Query: 212 RTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLWICLLSKKE 271
+ + + K +S + VL A + +A ++ L FL+ +L +
Sbjct: 217 SDAT--------PVRNATGLSEKDNSKHHSLVLSFAFGIV-VAFIISLMFLFFWVLWHRS 267
Query: 272 RAVKRYTEVRKQVDQETS-TKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRM 330
R + + V++ + E K +F EI ++++G GGFG VY+
Sbjct: 268 RLSR--SHVQQDYEFEIGHLKRFSFR--------EIQTATSNFSPKNILGQGGFGMVYKG 317
Query: 331 VMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390
+ + AVKR+ + F+ E+E++G H NL+ L G+C P ++L+Y Y+
Sbjct: 318 YLPNGTVVAVKRLKDPIYTGEVQFQTEVEMIGLAVHRNLLRLFGFCMTPEERMLVYPYMP 377
Query: 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN 450
GS+ D L ++ + L+W+ R+ IALG+ARGL YLH C PKIIHRD+K++NILLDE+
Sbjct: 378 NGSVADRLRDNYGEKPSLDWNRRISIALGAARGLVYLHEQCNPKIIHRDVKAANILLDES 437
Query: 451 LEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT 510
E V DFGLAKLL ++HVTT V GT G++APEYL +G+++EK+DV+ FGVL+LEL+T
Sbjct: 438 FEAIVGDFGLAKLLDQRDSHVTTAVRGTIGHIAPEYLSTGQSSEKTDVFGFGVLILELIT 497
Query: 511 GKRPTDPTF--VKRGLNVVGWMNTLLKENRLEDVIDKRC-ADADMETVEAILEIAARCTD 567
G + D V++G+ ++ W+ TL E R +++D+ + D +E ++E+A CT
Sbjct: 498 GHKMIDQGNGQVRKGM-ILSWVRTLKAEKRFAEMVDRDLKGEFDDLVLEEVVELALLCTQ 556
Query: 568 ANPDDRPSMNQVLQLLE 584
+P+ RP M+QVL++LE
Sbjct: 557 PHPNLRPRMSQVLKVLE 573
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFS4|NIK1_ARATH Protein NSP-INTERACTING KINASE 1 OS=Arabidopsis thaliana GN=NIK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 325 bits (834), Expect = 5e-88, Method: Compositional matrix adjust.
Identities = 195/561 (34%), Positives = 310/561 (55%), Gaps = 30/561 (5%)
Query: 33 LLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGR 92
L++IK+SL+D +L NW PC WT ++C + + V + P L G +SPSI
Sbjct: 45 LMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSS-ENFVIGLGTPSQNLSGTLSPSITN 103
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
L L+ + L N++ G IP EI T L L L N+ G IP ++G L L L L++N
Sbjct: 104 LTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNN 163
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCR 212
SL G P SL +T L +L+LS N SG +P F A + S +GN +C C
Sbjct: 164 SLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAAKTF----SIVGNPLICPTGTEPDCN 219
Query: 213 TSMGFPAVLPHASSDEVAVPT---KRSSHYMKGVLIGAMSTMGLALVVLLAFLWICLLSK 269
+ P + + ++ VP +H M + ++ T+ L + + FLW +
Sbjct: 220 GTTLIPMSM---NLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWW----R 272
Query: 270 KERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYR 329
+ + +V+ E ++ + E+ ++++G GG+G VY+
Sbjct: 273 QRHNQNTFFDVKDGNHHEE----VSLGNLRRFGFRELQIATNNFSSKNLLGKGGYGNVYK 328
Query: 330 MVMNDCGTFAVKRI-DRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388
++ D AVKR+ D G + F+ E+E++ H NL+ L G+C KLL+Y Y
Sbjct: 329 GILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPY 388
Query: 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD 448
+S GS+ + + + +L+WS R +IA+G+ARGL YLH C PKIIHRD+K++NILLD
Sbjct: 389 MSNGSVASRM----KAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLD 444
Query: 449 ENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLEL 508
+ E V DFGLAKLL +++HVTT V GT G++APEYL +G+++EK+DV+ FG+LLLEL
Sbjct: 445 DYCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLEL 504
Query: 509 VTGKRPTD--PTFVKRGLNVVGWMNTLLKENRLEDVIDK---RCADADMETVEAILEIAA 563
VTG+R + ++G+ ++ W+ + +E +LE ++DK + D ++ ++ +A
Sbjct: 505 VTGQRAFEFGKAANQKGV-MLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVAL 563
Query: 564 RCTDANPDDRPSMNQVLQLLE 584
CT P RP M++V+++LE
Sbjct: 564 LCTQYLPGHRPKMSEVVRMLE 584
|
Involved in defense response to geminivirus infection via regulation of the nuclear trafficking of RPL10A. Phosphorylates RPL10A in vitro. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 603 | ||||||
| 225456649 | 604 | PREDICTED: LRR receptor-like serine/thre | 1.0 | 0.998 | 0.852 | 0.0 | |
| 118484080 | 603 | unknown [Populus trichocarpa] | 1.0 | 1.0 | 0.850 | 0.0 | |
| 255540893 | 604 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.966 | 0.965 | 0.872 | 0.0 | |
| 224121550 | 598 | predicted protein [Populus trichocarpa] | 0.991 | 1.0 | 0.842 | 0.0 | |
| 356516754 | 599 | PREDICTED: LRR receptor-like serine/thre | 0.993 | 1.0 | 0.806 | 0.0 | |
| 356507172 | 594 | PREDICTED: LOW QUALITY PROTEIN: LRR rece | 0.985 | 1.0 | 0.798 | 0.0 | |
| 449469665 | 601 | PREDICTED: LRR receptor-like serine/thre | 0.963 | 0.966 | 0.810 | 0.0 | |
| 357477395 | 605 | LRR receptor-like serine/threonine-prote | 0.995 | 0.991 | 0.789 | 0.0 | |
| 356513557 | 595 | PREDICTED: LRR receptor-like serine/thre | 0.980 | 0.993 | 0.795 | 0.0 | |
| 297793859 | 604 | leucine-rich repeat family protein [Arab | 0.990 | 0.988 | 0.78 | 0.0 |
| >gi|225456649|ref|XP_002270994.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1 [Vitis vinifera] gi|297734035|emb|CBI15282.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1082 bits (2797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/604 (85%), Positives = 555/604 (91%), Gaps = 1/604 (0%)
Query: 1 MKMHELVLILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKW 60
MKM + + I TL CCLAL+EDG+TLLEIKS LNDSRN LGNW+ ++E PCKW
Sbjct: 1 MKMGLWIWFFSAILGGTLLGPCCLALSEDGVTLLEIKSRLNDSRNFLGNWRDSDEFPCKW 60
Query: 61 TGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTEL 120
TG+SC+ HD RVRSINLPYMQLGGIISPSIG+L+KLQRLALHQNSLHGSIPNEI NC EL
Sbjct: 61 TGVSCYHHDHRVRSINLPYMQLGGIISPSIGKLNKLQRLALHQNSLHGSIPNEIANCAEL 120
Query: 121 RALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG 180
RALYLRANYLQGGIP+++GNL +LTILD SSNSLKGAIPSSLGRL L YLNLSTNF SG
Sbjct: 121 RALYLRANYLQGGIPSDLGNLSYLTILDFSSNSLKGAIPSSLGRLKRLRYLNLSTNFLSG 180
Query: 181 EIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYM 240
EIPD G LS F NKSFIGNLDLCG+QVHKPCRTS+GFPAVLPHA SDE AVP KRS+H+
Sbjct: 181 EIPDVGVLSTFDNKSFIGNLDLCGQQVHKPCRTSLGFPAVLPHAESDEAAVPVKRSAHFT 240
Query: 241 KGVLIGAMSTMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMP 300
KGVLIGAMSTM L LV+LLAFLWIC LSKKERA ++YTEV+KQV QE STKLITFHGD+P
Sbjct: 241 KGVLIGAMSTMALVLVMLLAFLWICFLSKKERASRKYTEVKKQVHQEPSTKLITFHGDLP 300
Query: 301 YPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEI 360
YPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSD+VFERELEI
Sbjct: 301 YPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDKVFERELEI 360
Query: 361 LGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEH-GEGQQLLNWSARLKIALG 419
LGSIKHINLVNLRGYCRLP +KLLIYDYL++GSLDDFLHEH G+ ++ LNWSARL IALG
Sbjct: 361 LGSIKHINLVNLRGYCRLPTSKLLIYDYLALGSLDDFLHEHGGQDERSLNWSARLNIALG 420
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF 479
SARGLAYLHHDC P+I+HRDIKSSNILLDENLEPHVSDFGLAKLLVDE+AH+TTVVAGTF
Sbjct: 421 SARGLAYLHHDCSPRIVHRDIKSSNILLDENLEPHVSDFGLAKLLVDEDAHITTVVAGTF 480
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539
GYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL
Sbjct: 481 GYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 540
Query: 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESH 599
EDV+DKRC DA++ETVEAIL+IA RCTDANPDDRPSM+QVLQLLEQEVMSPCPSDFYESH
Sbjct: 541 EDVVDKRCRDAEVETVEAILDIAGRCTDANPDDRPSMSQVLQLLEQEVMSPCPSDFYESH 600
Query: 600 SDYC 603
SDYC
Sbjct: 601 SDYC 604
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|118484080|gb|ABK93925.1| unknown [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1082 bits (2797), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 513/603 (85%), Positives = 555/603 (92%)
Query: 1 MKMHELVLILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKW 60
MKM L+ I +VI + TL S+C LAL+EDG+TLLEI S+ NDSRN+L NWQAT+ESPCKW
Sbjct: 1 MKMVLLLWIFSVISSVTLLSTCSLALSEDGLTLLEIMSTWNDSRNILTNWQATDESPCKW 60
Query: 61 TGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTEL 120
TGISCH DQRV SINLPYM+LGGIISPSIG+L +LQRLALHQNSLHG IP EI+NCTEL
Sbjct: 61 TGISCHPQDQRVTSINLPYMELGGIISPSIGKLSRLQRLALHQNSLHGIIPYEISNCTEL 120
Query: 121 RALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG 180
RA+YL ANYLQGGIPA+IGNL L ILDLSSN LKGAIPSS+GRLT L +LNLSTN FSG
Sbjct: 121 RAIYLMANYLQGGIPADIGNLSHLNILDLSSNLLKGAIPSSIGRLTRLRHLNLSTNSFSG 180
Query: 181 EIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYM 240
EIPDFG+LS FGN SFIGN DLCGRQVHKPCRTS+GFPAVLPHA+SDE AVP KRSSHY+
Sbjct: 181 EIPDFGSLSTFGNNSFIGNSDLCGRQVHKPCRTSLGFPAVLPHAASDEAAVPPKRSSHYI 240
Query: 241 KGVLIGAMSTMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMP 300
KG+LIG MSTM + L+VLL FLWICL+SKKERA K+YTEV+KQVDQE S KLITFHGD+P
Sbjct: 241 KGLLIGVMSTMAITLLVLLIFLWICLVSKKERAAKKYTEVKKQVDQEASAKLITFHGDLP 300
Query: 301 YPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEI 360
YPSCEIIEKLE+LDEEDVVGSGGFGTV+RMVMNDCGTFAVKRIDRSREGSDQVFERELEI
Sbjct: 301 YPSCEIIEKLESLDEEDVVGSGGFGTVFRMVMNDCGTFAVKRIDRSREGSDQVFERELEI 360
Query: 361 LGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS 420
LGSI HINLVNLRGYCRLP +KLLIYDYL+MGSLDDFLHEHG+ ++LLNWSARL+IALGS
Sbjct: 361 LGSINHINLVNLRGYCRLPMSKLLIYDYLAMGSLDDFLHEHGQEERLLNWSARLRIALGS 420
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480
ARGLAYLHHDCCPKI+HRDIKSSNILLDENLEPHVSDFGLAKLLVDE+AHVTTVVAGTFG
Sbjct: 421 ARGLAYLHHDCCPKIVHRDIKSSNILLDENLEPHVSDFGLAKLLVDEDAHVTTVVAGTFG 480
Query: 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540
YLAPEYLQSG ATEKSDVYSFGVLLLELVTGKRPTDP FVKRGLNVVGWMNTLL+ENRLE
Sbjct: 481 YLAPEYLQSGIATEKSDVYSFGVLLLELVTGKRPTDPAFVKRGLNVVGWMNTLLRENRLE 540
Query: 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHS 600
DV+D RC D DMET+E ILEIA RCTDANPDDRP+MNQ LQLLEQEVMSPCPSDFYESHS
Sbjct: 541 DVVDTRCKDTDMETLEVILEIATRCTDANPDDRPTMNQALQLLEQEVMSPCPSDFYESHS 600
Query: 601 DYC 603
DYC
Sbjct: 601 DYC 603
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255540893|ref|XP_002511511.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223550626|gb|EEF52113.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1079 bits (2791), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 514/589 (87%), Positives = 551/589 (93%), Gaps = 6/589 (1%)
Query: 14 FAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVR 73
+ATLFS+ LALTEDG+TLLEIKS+LNDSRN+LGNWQA +ESPCKWTGISCH+HDQRV
Sbjct: 21 LSATLFSTSSLALTEDGLTLLEIKSTLNDSRNVLGNWQAADESPCKWTGISCHSHDQRVS 80
Query: 74 SINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGG 133
SINLPYMQLGGIIS SIG+L +LQR+ALHQNSLHG IPNEITNCTELRA+YLRANYLQGG
Sbjct: 81 SINLPYMQLGGIISTSIGKLSRLQRIALHQNSLHGIIPNEITNCTELRAVYLRANYLQGG 140
Query: 134 IPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGN 193
IP++IGNL LTILD+SSN LKGAIPSS+GRLT L +LNLSTNFFSGEIPDFGALS FGN
Sbjct: 141 IPSDIGNLSHLTILDVSSNMLKGAIPSSIGRLTRLRHLNLSTNFFSGEIPDFGALSTFGN 200
Query: 194 KSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMGL 253
SFIGNLDLCGRQVH+PCRTSMGFPAVLPHA A+PTKRSSHY+KGVLIG M+TM L
Sbjct: 201 NSFIGNLDLCGRQVHRPCRTSMGFPAVLPHA-----AIPTKRSSHYIKGVLIGVMATMAL 255
Query: 254 ALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEAL 313
L VLLAFLWICLLSKKERA K+YTEV+KQVDQE STKLITFHGD+PYPSCEIIEKLE+L
Sbjct: 256 TLAVLLAFLWICLLSKKERAAKKYTEVKKQVDQEASTKLITFHGDLPYPSCEIIEKLESL 315
Query: 314 DEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLR 373
DEEDVVG+GGFGTVYRMVMNDCGTFAVKRIDRSREGSDQ FERELEILGSIKHINLVNLR
Sbjct: 316 DEEDVVGAGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQGFERELEILGSIKHINLVNLR 375
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
GYCRLP +KLLIYDYL+MGSLDD LHE G+ +Q LNWSARL+IALGSARGLAYLHHDC P
Sbjct: 376 GYCRLPMSKLLIYDYLAMGSLDDILHERGQ-EQPLNWSARLRIALGSARGLAYLHHDCSP 434
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
KI+HRDIKSSNILLDEN EPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT
Sbjct: 435 KIVHRDIKSSNILLDENFEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 494
Query: 494 EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADME 553
EKSDVYSFGVLLLELVTGKRPTDP FVKRGLNVVGWMNTLL+EN LEDV+DKRC+DAD+E
Sbjct: 495 EKSDVYSFGVLLLELVTGKRPTDPAFVKRGLNVVGWMNTLLRENLLEDVVDKRCSDADLE 554
Query: 554 TVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHSDY 602
+VEAILEIAARCTDANPDDRP+MNQ LQLLEQEVMSPCPSDFYES SDY
Sbjct: 555 SVEAILEIAARCTDANPDDRPTMNQALQLLEQEVMSPCPSDFYESQSDY 603
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121550|ref|XP_002318612.1| predicted protein [Populus trichocarpa] gi|222859285|gb|EEE96832.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1065 bits (2753), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 508/603 (84%), Positives = 550/603 (91%), Gaps = 5/603 (0%)
Query: 1 MKMHELVLILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKW 60
MKM L+ I +VI + TL S+C LAL+EDG+TLLEI S+ NDSRN+L NWQAT+ESPCKW
Sbjct: 1 MKMVLLLWIFSVISSVTLLSTCSLALSEDGLTLLEIMSTWNDSRNILTNWQATDESPCKW 60
Query: 61 TGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTEL 120
TGISCH DQRV SINLPYM+LGGIISPSIG+L +LQRLALHQNSLHG IP EI+NCTEL
Sbjct: 61 TGISCHPQDQRVTSINLPYMELGGIISPSIGKLSRLQRLALHQNSLHGIIPYEISNCTEL 120
Query: 121 RALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG 180
RA+YL ANYLQGGIPA+IGNL L ILDLSSN LKGAIPSS+GRLT L +LNLSTN FSG
Sbjct: 121 RAIYLMANYLQGGIPADIGNLSHLNILDLSSNLLKGAIPSSIGRLTRLRHLNLSTNSFSG 180
Query: 181 EIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYM 240
EIPDFG+LS FGN SFIGN DLCGRQVHKPCRTS+GFPAVLPHA A+P KRSSHY+
Sbjct: 181 EIPDFGSLSTFGNNSFIGNSDLCGRQVHKPCRTSLGFPAVLPHA-----AIPPKRSSHYI 235
Query: 241 KGVLIGAMSTMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMP 300
KG+LIG MSTM + L+VLL FLWICL+SKKERA K+YTEV+KQVDQE S KLITFHGD+P
Sbjct: 236 KGLLIGVMSTMAITLLVLLIFLWICLVSKKERAAKKYTEVKKQVDQEASAKLITFHGDLP 295
Query: 301 YPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEI 360
Y SCEIIEKLE+LDEEDVVGSGGFGTV+RMVMNDCGTFAVKRIDRSREGSDQVFERELEI
Sbjct: 296 YHSCEIIEKLESLDEEDVVGSGGFGTVFRMVMNDCGTFAVKRIDRSREGSDQVFERELEI 355
Query: 361 LGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS 420
LGSI HINLVNLRGYCRLP +KLLIYDYL+MGSLDDFLHEHG+ ++LLNWSARL+IALGS
Sbjct: 356 LGSINHINLVNLRGYCRLPMSKLLIYDYLAMGSLDDFLHEHGQEERLLNWSARLRIALGS 415
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480
ARGLAYLHHDCCPKI+HRDIKSSNILLDENLEPHVSDFGLAKLLVDE+AHVTTVVAGTFG
Sbjct: 416 ARGLAYLHHDCCPKIVHRDIKSSNILLDENLEPHVSDFGLAKLLVDEDAHVTTVVAGTFG 475
Query: 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540
YLAPEYLQSG ATEKSDVYSFGVLLLELVTGKRPTDP FVKRGLNVVGWMNTLL+ENRLE
Sbjct: 476 YLAPEYLQSGIATEKSDVYSFGVLLLELVTGKRPTDPAFVKRGLNVVGWMNTLLRENRLE 535
Query: 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHS 600
DV+D RC D DMET+E ILEIA RCTDANPDDRP+MNQ LQLLEQEVMSPCPSDFYESHS
Sbjct: 536 DVVDTRCKDTDMETLEVILEIATRCTDANPDDRPTMNQALQLLEQEVMSPCPSDFYESHS 595
Query: 601 DYC 603
DYC
Sbjct: 596 DYC 598
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356516754|ref|XP_003527058.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1021 bits (2641), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 485/601 (80%), Positives = 536/601 (89%), Gaps = 2/601 (0%)
Query: 3 MHELVLILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTG 62
M VLIL V+ ++ + LALT+DG+TLLE+KS+LND+RN L NW+ + E+ C WTG
Sbjct: 1 MGHAVLILVVVISSIVLCPSSLALTQDGLTLLEVKSTLNDTRNFLSNWRKSGETHCTWTG 60
Query: 63 ISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRA 122
I+CH +QRVRSINLPYMQLGGIISPSIG+L +L RLALHQN LHG IPNEI+NCTELRA
Sbjct: 61 ITCHPGEQRVRSINLPYMQLGGIISPSIGKLSRLHRLALHQNGLHGIIPNEISNCTELRA 120
Query: 123 LYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEI 182
LYLRANYLQGGIP+NIGNL FL +LDLSSNSLKGAIPSS+GRLT L LNLSTNFFSGEI
Sbjct: 121 LYLRANYLQGGIPSNIGNLSFLHVLDLSSNSLKGAIPSSIGRLTQLRVLNLSTNFFSGEI 180
Query: 183 PDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKG 242
PD G LS FGN +FIGNLDLCGRQV KPCRTS+GFP VLPHA SDE VP KRSSHY+K
Sbjct: 181 PDIGVLSTFGNNAFIGNLDLCGRQVQKPCRTSLGFPVVLPHAESDEAEVPDKRSSHYVKW 240
Query: 243 VLIGAMSTMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYP 302
VL+GA++ MGLALV+ L+ LWICLLSKKERA +RY EV+ Q++ E+STKLITFHGD+PY
Sbjct: 241 VLVGAITIMGLALVMTLSLLWICLLSKKERAARRYIEVKDQINPESSTKLITFHGDLPYT 300
Query: 303 SCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILG 362
S EIIEKLE+LDE+DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQ FERELEILG
Sbjct: 301 SLEIIEKLESLDEDDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQGFERELEILG 360
Query: 363 SIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSAR 422
SIKHINLVNLRGYCRLP+TKLLIYDYL+MGSLDD LHE+ E Q LNWS RLKIALGSAR
Sbjct: 361 SIKHINLVNLRGYCRLPSTKLLIYDYLAMGSLDDLLHENTE--QSLNWSTRLKIALGSAR 418
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
GL YLHHDCCPKI+HRDIKSSNILLDEN+EP VSDFGLAKLLVDE+AHVTTVVAGTFGYL
Sbjct: 419 GLTYLHHDCCPKIVHRDIKSSNILLDENMEPRVSDFGLAKLLVDEDAHVTTVVAGTFGYL 478
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542
APEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDP+F RG+NVVGWMNT LKENRLEDV
Sbjct: 479 APEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPSFASRGVNVVGWMNTFLKENRLEDV 538
Query: 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHSDY 602
+DKRC DAD+E+VE ILE+AA CTDAN D+RPSMNQVLQ+LEQEVMSPCPSDFYES SD+
Sbjct: 539 VDKRCIDADLESVEVILELAASCTDANADERPSMNQVLQILEQEVMSPCPSDFYESQSDH 598
Query: 603 C 603
C
Sbjct: 599 C 599
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356507172|ref|XP_003522344.1| PREDICTED: LOW QUALITY PROTEIN: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1009 bits (2610), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 480/601 (79%), Positives = 535/601 (89%), Gaps = 7/601 (1%)
Query: 3 MHELVLILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTG 62
M +VL+L V+ + T+ LALT DG+ LLE+KS+LND+RN L NW+ ++ES C WTG
Sbjct: 1 MGLVVLMLMVVISTTVLCPSSLALTLDGLALLEVKSTLNDTRNFLSNWRKSDESHCTWTG 60
Query: 63 ISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRA 122
I+CH +QRVRSINLPYMQLGGIISPSIG+L +L RLALHQN LHG IPNEI+NCTELRA
Sbjct: 61 ITCHLGEQRVRSINLPYMQLGGIISPSIGKLSRLHRLALHQNGLHGVIPNEISNCTELRA 120
Query: 123 LYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEI 182
LYLRANYLQGGIP+NIGNL FL +LDLSSNSLKGAIPSS+GRLT L LNLSTNFFSGEI
Sbjct: 121 LYLRANYLQGGIPSNIGNLSFLHVLDLSSNSLKGAIPSSIGRLTQLRVLNLSTNFFSGEI 180
Query: 183 PDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKG 242
PD G LS FG+ +FIGNLDLCGRQV KPCRTS+GFP VLPHA +P KRSSHY+K
Sbjct: 181 PDIGVLSTFGSNAFIGNLDLCGRQVQKPCRTSLGFPVVLPHAE-----IPNKRSSHYVKW 235
Query: 243 VLIGAMSTMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYP 302
VL+GA++ MGLALV+ L+ LWIC+LSKKERAV RY EV+ QV+ E+STKLITFHGDMPY
Sbjct: 236 VLVGAITLMGLALVITLSLLWICMLSKKERAVMRYIEVKDQVNPESSTKLITFHGDMPYT 295
Query: 303 SCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILG 362
S EIIEKLE++DE+DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQ FERELEILG
Sbjct: 296 SLEIIEKLESVDEDDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQGFERELEILG 355
Query: 363 SIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSAR 422
SIKHINLVNLRGYC LP+TKLLIYDYL+MGSLDD LHE+ E Q LNWS RLKIALGSAR
Sbjct: 356 SIKHINLVNLRGYCSLPSTKLLIYDYLAMGSLDDLLHENTE--QSLNWSTRLKIALGSAR 413
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
GLAYLHHDCCPK++HRDIKSSNILLDEN+EP VSDFGLAKLLVDE+AHVTTVVAGTFGYL
Sbjct: 414 GLAYLHHDCCPKVVHRDIKSSNILLDENMEPRVSDFGLAKLLVDEDAHVTTVVAGTFGYL 473
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542
APEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDP+F +RG+NVVGWMNT L+ENRLEDV
Sbjct: 474 APEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPSFARRGVNVVGWMNTFLRENRLEDV 533
Query: 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHSDY 602
+DKRC DAD+E+VE ILE+AA CTDAN D+RPSMNQVLQ+LEQEVMSPCPSDFYESHSD+
Sbjct: 534 VDKRCTDADLESVEVILELAASCTDANADERPSMNQVLQILEQEVMSPCPSDFYESHSDH 593
Query: 603 C 603
C
Sbjct: 594 C 594
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449469665|ref|XP_004152539.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1002 bits (2590), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 471/581 (81%), Positives = 532/581 (91%)
Query: 22 CCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQ 81
C ALT DG+TLLEI+ + NDS+NLLG+W+A++E PCKW GISCH DQRV SINLPYMQ
Sbjct: 20 CTFALTPDGLTLLEIRRAFNDSKNLLGDWEASDEFPCKWPGISCHPEDQRVSSINLPYMQ 79
Query: 82 LGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNL 141
LGGIISPSIG+L +LQRLALH+N LHG+IP+EIT CT+LRALYLR+NYLQGGIP++IG+L
Sbjct: 80 LGGIISPSIGKLSRLQRLALHENGLHGNIPSEITKCTQLRALYLRSNYLQGGIPSDIGSL 139
Query: 142 LFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLD 201
LTILDLSSN+LKGAIPSS+G+L+ L +LNLSTNFFSGEIPDFG LS FG+ SFIGNLD
Sbjct: 140 SALTILDLSSNALKGAIPSSIGQLSLLRHLNLSTNFFSGEIPDFGVLSTFGSNSFIGNLD 199
Query: 202 LCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAF 261
LCG QV+K CRTS+GFPAVLPHA SDE +VP K+SSHY+KGVLIGAMSTMG+ALVVL+ F
Sbjct: 200 LCGHQVNKACRTSLGFPAVLPHAESDEASVPMKKSSHYIKGVLIGAMSTMGVALVVLVPF 259
Query: 262 LWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGS 321
LWI LSKKERAVKRYTEV+KQV E STKLITFHGD+PYPSCEIIEKLE+LDEEDVVGS
Sbjct: 260 LWIRWLSKKERAVKRYTEVKKQVVHEPSTKLITFHGDLPYPSCEIIEKLESLDEEDVVGS 319
Query: 322 GGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPAT 381
GGFG VYRMVMNDCGTFAVK+ID SR+GSDQVFERELEILG IKHINLVNLRGYC LP +
Sbjct: 320 GGFGIVYRMVMNDCGTFAVKKIDGSRKGSDQVFERELEILGCIKHINLVNLRGYCSLPTS 379
Query: 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIK 441
KLLIYD+L+MGSLDDFLHEHG +Q L+W ARL+IA GSARG+AYLHHDCCPKI+HRDIK
Sbjct: 380 KLLIYDFLAMGSLDDFLHEHGPERQPLDWRARLRIAFGSARGIAYLHHDCCPKIVHRDIK 439
Query: 442 SSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSF 501
SSNILLDENL PHVSDFGLAKLLVD++AHVTTVVAGTFGYLAP+YLQSGRATEKSD+YSF
Sbjct: 440 SSNILLDENLVPHVSDFGLAKLLVDDDAHVTTVVAGTFGYLAPKYLQSGRATEKSDIYSF 499
Query: 502 GVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEI 561
GVLLLELVTGKRPTDP+FVKRGLNVVGWM+ LL EN++++++DKRC D D +TVEAILEI
Sbjct: 500 GVLLLELVTGKRPTDPSFVKRGLNVVGWMHILLGENKMDEIVDKRCKDVDADTVEAILEI 559
Query: 562 AARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHSDY 602
AA+CTDA+PD+RPSM+QVLQ LEQEVMSPCPSDFYES SDY
Sbjct: 560 AAKCTDADPDNRPSMSQVLQFLEQEVMSPCPSDFYESQSDY 600
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357477395|ref|XP_003608983.1| LRR receptor-like serine/threonine-protein kinase FEI [Medicago truncatula] gi|355510038|gb|AES91180.1| LRR receptor-like serine/threonine-protein kinase FEI [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1001 bits (2587), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 479/607 (78%), Positives = 538/607 (88%), Gaps = 7/607 (1%)
Query: 1 MKMHELVLILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKW 60
MK+ + ++F TLF+S LALT+DG TLLEIKS+LND++N+L NWQ + S C W
Sbjct: 1 MKITIVACTFLLVFT-TLFNSSSLALTQDGQTLLEIKSTLNDTKNVLSNWQEFDASHCAW 59
Query: 61 TGISCHTHD-QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTE 119
TGISCH D QRVRSINLPYMQLGGIISPSIG+L +LQRLA HQN LHG IP EITNCTE
Sbjct: 60 TGISCHPGDEQRVRSINLPYMQLGGIISPSIGKLSRLQRLAFHQNGLHGIIPTEITNCTE 119
Query: 120 LRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
LRALYLRANY QGGIP+ IGNL FL ILD+SSNSLKGAIPSS+GRL+HL LNLSTNFFS
Sbjct: 120 LRALYLRANYFQGGIPSGIGNLSFLNILDVSSNSLKGAIPSSIGRLSHLQVLNLSTNFFS 179
Query: 180 GEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSS-- 237
GEIPD G LS F SFIGNLDLCGRQ+ KPCRTS+GFP V+PHA SDE AVP K+SS
Sbjct: 180 GEIPDIGVLSTFQKNSFIGNLDLCGRQIEKPCRTSLGFPVVIPHAESDEAAVPPKKSSQS 239
Query: 238 HYMKGVLIGAMSTMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQETS--TKLITF 295
HY+K VLIGA++T+GLAL++ L+ LW+ L SKKERAV++YTEV+KQVD S KLITF
Sbjct: 240 HYLKAVLIGAVATLGLALIITLSLLWVRLSSKKERAVRKYTEVKKQVDPSASKSAKLITF 299
Query: 296 HGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFE 355
HGDMPY S EIIEKLE+LDEED+VGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFE
Sbjct: 300 HGDMPYTSSEIIEKLESLDEEDIVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFE 359
Query: 356 RELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK 415
RELEILGSIKHINLVNLRGYCRLP ++LLIYDY+++GSLDD LHE+ E +Q LNW+ RLK
Sbjct: 360 RELEILGSIKHINLVNLRGYCRLPTSRLLIYDYVALGSLDDLLHENTE-RQPLNWNDRLK 418
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
I LGSARGLAYLHH+CCPKI+HRDIKSSNILL+EN+EPH+SDFGLAKLLVDE+AHVTTVV
Sbjct: 419 ITLGSARGLAYLHHECCPKIVHRDIKSSNILLNENMEPHISDFGLAKLLVDEDAHVTTVV 478
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535
AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDP+FVKRGLNVVGWMNTLLK
Sbjct: 479 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPSFVKRGLNVVGWMNTLLK 538
Query: 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDF 595
ENRLEDV+D++C+D + ET+E ILE+AARCTD+N DDRPSMNQVLQLLEQEVMSPCPS+F
Sbjct: 539 ENRLEDVVDRKCSDVNAETLEVILELAARCTDSNADDRPSMNQVLQLLEQEVMSPCPSEF 598
Query: 596 YESHSDY 602
YESHSD+
Sbjct: 599 YESHSDH 605
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513557|ref|XP_003525479.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FEI 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1001 bits (2587), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 475/597 (79%), Positives = 532/597 (89%), Gaps = 6/597 (1%)
Query: 7 VLILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCH 66
V + ++ T F LALT+DGM LLEIKS+LND++N+L NWQ +ESPC WTGISCH
Sbjct: 4 VAWIFLVIMVTFFCPSSLALTQDGMALLEIKSTLNDTKNVLSNWQEFDESPCAWTGISCH 63
Query: 67 THD-QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYL 125
D QRVRSINLPYMQLGGIISPSIG+L +LQRLALHQNSLHG+IPNE+TNCTELRALYL
Sbjct: 64 PGDEQRVRSINLPYMQLGGIISPSIGKLSRLQRLALHQNSLHGTIPNELTNCTELRALYL 123
Query: 126 RANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDF 185
R NY QGGIP+NIGNL +L ILDLSSNSLKGAIPSS+GRL+HL +NLSTNFFSGEIPD
Sbjct: 124 RGNYFQGGIPSNIGNLSYLNILDLSSNSLKGAIPSSIGRLSHLQIMNLSTNFFSGEIPDI 183
Query: 186 GALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLI 245
G LS F SFIGN+DLCGRQV KPCRTS GFP VLPHA S PTKR SHYMKGVLI
Sbjct: 184 GVLSTFDKSSFIGNVDLCGRQVQKPCRTSFGFPVVLPHAES-----PTKRPSHYMKGVLI 238
Query: 246 GAMSTMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCE 305
GAM+ +GL LV++L+FLW LLSKKERA KRYTEV+KQVD + STKLITFHGD+PY S E
Sbjct: 239 GAMAILGLVLVIILSFLWTRLLSKKERAAKRYTEVKKQVDPKASTKLITFHGDLPYTSSE 298
Query: 306 IIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIK 365
IIEKLE+LDEE++VGSGGFGTVYRMVMNDCGTFAVK+IDRS EGSDQVFERELEILGSIK
Sbjct: 299 IIEKLESLDEENLVGSGGFGTVYRMVMNDCGTFAVKQIDRSCEGSDQVFERELEILGSIK 358
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLA 425
HINLVNLRGYCRLP+++LLIYDY+++GSLDD LHE+ + +QLLNW+ RLKIALGSA+GLA
Sbjct: 359 HINLVNLRGYCRLPSSRLLIYDYVALGSLDDLLHENTQQRQLLNWNDRLKIALGSAQGLA 418
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
YLHH+C PK++H +IKSSNILLDEN+EPH+SDFGLAKLLVDE AHVTTVVAGTFGYLAPE
Sbjct: 419 YLHHECSPKVVHCNIKSSNILLDENMEPHISDFGLAKLLVDENAHVTTVVAGTFGYLAPE 478
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545
YLQSGRATEKSDVYSFGVLLLELVTGKRPTDP+FVKRGLNVVGWMNTLL+ENR+EDV+DK
Sbjct: 479 YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPSFVKRGLNVVGWMNTLLRENRMEDVVDK 538
Query: 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHSDY 602
RC DAD T+E ILE+AARCTD N DDRPSMNQVLQLLEQEVMSPCPS++YESHSD+
Sbjct: 539 RCTDADAGTLEVILELAARCTDGNADDRPSMNQVLQLLEQEVMSPCPSEYYESHSDH 595
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793859|ref|XP_002864814.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297310649|gb|EFH41073.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 983 bits (2542), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 468/600 (78%), Positives = 528/600 (88%), Gaps = 3/600 (0%)
Query: 7 VLILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCH 66
+ + +VI AATLF SC ALT DG LLE+KS ND+RN L NW+ ++ESPC WTG+SC+
Sbjct: 5 IWVFSVISAATLFVSCSSALTPDGFALLELKSGFNDTRNSLENWKDSDESPCSWTGVSCN 64
Query: 67 THDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLR 126
DQRV SINLPYMQLGGIISPSIG+L +LQRLALHQNSLHG IPNEITNCTELRA+YLR
Sbjct: 65 PQDQRVVSINLPYMQLGGIISPSIGKLSRLQRLALHQNSLHGIIPNEITNCTELRAMYLR 124
Query: 127 ANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFG 186
AN+LQGGIP N+GNL FLTILDLSSN+LKG IPSS+ RLT L LNLSTNFFSGEIPD G
Sbjct: 125 ANFLQGGIPPNLGNLTFLTILDLSSNTLKGPIPSSISRLTRLRSLNLSTNFFSGEIPDIG 184
Query: 187 ALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIG 246
LS FG ++F GNLDLCGRQ+ KPCR+SMGFP VLPHA +D+ + P KRSS +KG+LIG
Sbjct: 185 VLSRFGVETFTGNLDLCGRQIRKPCRSSMGFPVVLPHAETDDESDPPKRSSRLIKGILIG 244
Query: 247 AMSTMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVD-QETSTKLITFHGDMPYPSCE 305
AMSTM LA +V+ FLWI +LSKKER VK+YTEV+KQ D ETS KLITFHGD+PY S E
Sbjct: 245 AMSTMALAFIVIFVFLWIWMLSKKERTVKKYTEVKKQKDPSETSKKLITFHGDLPYSSTE 304
Query: 306 IIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIK 365
+IEKLE+LDEED+VGSGGFGTVYRMVMND GTFAVK+IDRSREGSD+VFERE+EILGS+K
Sbjct: 305 LIEKLESLDEEDIVGSGGFGTVYRMVMNDLGTFAVKKIDRSREGSDRVFEREVEILGSVK 364
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLA 425
HINLVNLRGYCRLP+++LLIYDYL++GSLDD LHE + LLNW+ARL+IALGSARGLA
Sbjct: 365 HINLVNLRGYCRLPSSRLLIYDYLTLGSLDDLLHERAQEDGLLNWNARLRIALGSARGLA 424
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
YLHHDC PKI+HRDIKSSNILL++ LEP VSDFGLAKLLVDE+AHVTTVVAGTFGYLAPE
Sbjct: 425 YLHHDCSPKIVHRDIKSSNILLNDKLEPRVSDFGLAKLLVDEDAHVTTVVAGTFGYLAPE 484
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545
YLQ+GRATEKSDVYSFGVLLLELVTGKRPTDP FVKRGLNVVGWMNT+LKENRLEDVIDK
Sbjct: 485 YLQNGRATEKSDVYSFGVLLLELVTGKRPTDPIFVKRGLNVVGWMNTVLKENRLEDVIDK 544
Query: 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPS-DFY-ESHSDYC 603
RC D D ++VEA+LEIAARCTDANP+DRP+MNQV QLLEQEVMSP D+Y +SHSDYC
Sbjct: 545 RCTDVDEDSVEALLEIAARCTDANPEDRPAMNQVAQLLEQEVMSPSSGIDYYDDSHSDYC 604
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 603 | ||||||
| TAIR|locus:2170668 | 604 | AT5G62710 [Arabidopsis thalian | 0.985 | 0.983 | 0.781 | 3.7e-254 | |
| TAIR|locus:2206179 | 592 | FEI1 "FEI 1" [Arabidopsis thal | 0.935 | 0.952 | 0.521 | 4.1e-159 | |
| TAIR|locus:2058759 | 589 | FEI2 "FEI 2" [Arabidopsis thal | 0.930 | 0.952 | 0.519 | 1.1e-158 | |
| TAIR|locus:2026097 | 628 | SERK2 "somatic embryogenesis r | 0.941 | 0.904 | 0.373 | 9.7e-96 | |
| TAIR|locus:2013021 | 625 | SERK1 "somatic embryogenesis r | 0.943 | 0.910 | 0.366 | 2.6e-95 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.466 | 0.235 | 0.484 | 4.3e-90 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.781 | 0.403 | 0.384 | 1.1e-89 | |
| TAIR|locus:2092810 | 1164 | BRL3 "BRI1-like 3" [Arabidopsi | 0.802 | 0.415 | 0.376 | 2.2e-89 | |
| TAIR|locus:2146102 | 638 | NIK1 "NSP-interacting kinase 1 | 0.882 | 0.833 | 0.351 | 1e-84 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.825 | 0.787 | 0.376 | 3.4e-84 |
| TAIR|locus:2170668 AT5G62710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2447 (866.4 bits), Expect = 3.7e-254, P = 3.7e-254
Identities = 468/599 (78%), Positives = 527/599 (87%)
Query: 9 ILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTH 68
+ +VI ATLF SC ALT DG LLE+KS ND+RN L NW+ ++ESPC WTG+SC+
Sbjct: 7 VFSVISVATLFVSCSFALTLDGFALLELKSGFNDTRNSLENWKDSDESPCSWTGVSCNPQ 66
Query: 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN 128
DQRV SINLPYMQLGGIISPSIG+L +LQRLALHQNSLHG+IPNEITNCTELRA+YLRAN
Sbjct: 67 DQRVVSINLPYMQLGGIISPSIGKLSRLQRLALHQNSLHGNIPNEITNCTELRAMYLRAN 126
Query: 129 YLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
+LQGGIP ++GNL FLTILDLSSN+LKGAIPSS+ RLT L LNLSTNFFSGEIPD G L
Sbjct: 127 FLQGGIPPDLGNLTFLTILDLSSNTLKGAIPSSISRLTRLRSLNLSTNFFSGEIPDIGVL 186
Query: 189 SAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHA-SSDEVAVPTKRSSHYMKGVLIGA 247
S FG ++F GNLDLCGRQ+ KPCR+SMGFP VLPHA S+DE P KRSS +KG+LIGA
Sbjct: 187 SRFGVETFTGNLDLCGRQIRKPCRSSMGFPVVLPHAESADESDSP-KRSSRLIKGILIGA 245
Query: 248 MSTMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVD-QETSTKLITFHGDMPYPSCEI 306
MSTM LA +V+ FLWI +LSKKER VK+YTEV+KQ D ETS KLITFHGD+PY S E+
Sbjct: 246 MSTMALAFIVIFVFLWIWMLSKKERKVKKYTEVKKQKDPSETSKKLITFHGDLPYSSTEL 305
Query: 307 IEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKH 366
IEKLE+LDEED+VGSGGFGTVYRMVMND GTFAVK+IDRSR+GSD+VFERE+EILGS+KH
Sbjct: 306 IEKLESLDEEDIVGSGGFGTVYRMVMNDLGTFAVKKIDRSRQGSDRVFEREVEILGSVKH 365
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
INLVNLRGYCRLP+++LLIYDYL++GSLDD LHE + LLNW+ARLKIALGSARGLAY
Sbjct: 366 INLVNLRGYCRLPSSRLLIYDYLTLGSLDDLLHERAQEDGLLNWNARLKIALGSARGLAY 425
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
LHHDC PKI+HRDIKSSNILL++ LEP VSDFGLAKLLVDE+AHVTTVVAGTFGYLAPEY
Sbjct: 426 LHHDCSPKIVHRDIKSSNILLNDKLEPRVSDFGLAKLLVDEDAHVTTVVAGTFGYLAPEY 485
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546
LQ+GRATEKSDVYSFGVLLLELVTGKRPTDP FVKRGLNVVGWMNT+LKENRLEDVIDKR
Sbjct: 486 LQNGRATEKSDVYSFGVLLLELVTGKRPTDPIFVKRGLNVVGWMNTVLKENRLEDVIDKR 545
Query: 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPS-DFYE-SHSDYC 603
C D D E+VEA+LEIA RCTDANP++RP+MNQV QLLEQEVMSP D+Y+ SHSDYC
Sbjct: 546 CTDVDEESVEALLEIAERCTDANPENRPAMNQVAQLLEQEVMSPSSGIDYYDDSHSDYC 604
|
|
| TAIR|locus:2206179 FEI1 "FEI 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1550 (550.7 bits), Expect = 4.1e-159, P = 4.1e-159
Identities = 301/577 (52%), Positives = 409/577 (70%)
Query: 25 ALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGG 84
A++ DG LL ++++ S + + W+ + PC W G++C +RV ++NL Y ++ G
Sbjct: 29 AISPDGEALLSFRNAVTRSDSFIHQWRPEDPDPCNWNGVTCDAKTKRVITLNLTYHKIMG 88
Query: 85 IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144
+ P IG+LD L+ L LH N+L+G+IP + NCT L ++L++NY G IPA +G+L L
Sbjct: 89 PLPPDIGKLDHLRLLMLHNNALYGAIPTALGNCTALEEIHLQSNYFTGPIPAEMGDLPGL 148
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
LD+SSN+L G IP+SLG+L L N+S NF G+IP G LS F SFIGNL+LCG
Sbjct: 149 QKLDMSSNTLSGPIPASLGQLKKLSNFNVSNNFLVGQIPSDGVLSGFSKNSFIGNLNLCG 208
Query: 205 RQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLWI 264
+ V C+ G P+ H+ S + K++S + LI A +T+G L+V L W
Sbjct: 209 KHVDVVCQDDSGNPS--SHSQSGQ---NQKKNSGKL---LISASATVGALLLVALMCFWG 260
Query: 265 CLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGF 324
C L KK V+ + K V S ++ FHGD+PY S +II+KLE L+EE ++G GGF
Sbjct: 261 CFLYKKLGKVE-IKSLAKDVGGGAS--IVMFHGDLPYSSKDIIKKLEMLNEEHIIGCGGF 317
Query: 325 GTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384
GTVY++ M+D FA+KRI + EG D+ FERELEILGSIKH LVNLRGYC P +KLL
Sbjct: 318 GTVYKLAMDDGKVFALKRILKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKLL 377
Query: 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSN 444
+YDYL GSLD+ LH G+QL +W +R+ I +G+A+GL+YLHHDC P+IIHRDIKSSN
Sbjct: 378 LYDYLPGGSLDEALHVE-RGEQL-DWDSRVNIIIGAAKGLSYLHHDCSPRIIHRDIKSSN 435
Query: 445 ILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVL 504
ILLD NLE VSDFGLAKLL DEE+H+TT+VAGTFGYLAPEY+QSGRATEK+DVYSFGVL
Sbjct: 436 ILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGVL 495
Query: 505 LLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAAR 564
+LE+++GKRPTD +F+++GLNVVGW+ L+ E R D++D C ME+++A+L IA +
Sbjct: 496 VLEVLSGKRPTDASFIEKGLNVVGWLKFLISEKRPRDIVDPNCEGMQMESLDALLSIATQ 555
Query: 565 CTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHSD 601
C +P++RP+M++V+QLLE EVM+PCPS+FY+S SD
Sbjct: 556 CVSPSPEERPTMHRVVQLLESEVMTPCPSEFYDSSSD 592
|
|
| TAIR|locus:2058759 FEI2 "FEI 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1546 (549.3 bits), Expect = 1.1e-158, P = 1.1e-158
Identities = 300/578 (51%), Positives = 409/578 (70%)
Query: 25 ALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGG 84
A++ DG LL ++ + S ++G W+ + PC W G++C +RV +++L Y +L G
Sbjct: 28 AISPDGEALLSFRNGVLASDGVIGLWRPEDPDPCNWKGVTCDAKTKRVIALSLTYHKLRG 87
Query: 85 IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144
+ P +G+LD+L+ L LH N+L+ SIP + NCT L +YL+ NY+ G IP+ IGNL L
Sbjct: 88 PLPPELGKLDQLRLLMLHNNALYQSIPASLGNCTALEGIYLQNNYITGTIPSEIGNLSGL 147
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
LDLS+N+L GAIP+SLG+L L N+S NF G+IP G L+ SF GN +LCG
Sbjct: 148 KNLDLSNNNLNGAIPASLGQLKRLTKFNVSNNFLVGKIPSDGLLARLSRDSFNGNRNLCG 207
Query: 205 RQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMG-LALVVLLAFLW 263
+Q+ C S +S PT + + K +LI A +T+G L LV L+ F W
Sbjct: 208 KQIDIVCNDS---------GNSTASGSPTGQGGNNPKRLLISASATVGGLLLVALMCF-W 257
Query: 264 ICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGG 323
C L KK V+ + V +D ++ FHGD+PY S +II+KLE+L+EE ++G GG
Sbjct: 258 GCFLYKKLGRVESKSLV---IDVGGGASIVMFHGDLPYASKDIIKKLESLNEEHIIGCGG 314
Query: 324 FGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383
FGTVY++ M+D FA+KRI + EG D+ FERELEILGSIKH LVNLRGYC P +KL
Sbjct: 315 FGTVYKLSMDDGNVFALKRIVKLNEGFDRFFERELEILGSIKHRYLVNLRGYCNSPTSKL 374
Query: 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSS 443
L+YDYL GSLD+ LH+ GE L+W +R+ I +G+A+GLAYLHHDC P+IIHRDIKSS
Sbjct: 375 LLYDYLPGGSLDEALHKRGEQ---LDWDSRVNIIIGAAKGLAYLHHDCSPRIIHRDIKSS 431
Query: 444 NILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGV 503
NILLD NLE VSDFGLAKLL DEE+H+TT+VAGTFGYLAPEY+QSGRATEK+DVYSFGV
Sbjct: 432 NILLDGNLEARVSDFGLAKLLEDEESHITTIVAGTFGYLAPEYMQSGRATEKTDVYSFGV 491
Query: 504 LLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAA 563
L+LE+++GK PTD +F+++G N+VGW+N L+ ENR ++++D C + E+++A+L IA
Sbjct: 492 LVLEVLSGKLPTDASFIEKGFNIVGWLNFLISENRAKEIVDLSCEGVERESLDALLSIAT 551
Query: 564 RCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHSD 601
+C ++PD+RP+M++V+QLLE EVM+PCPSDFY+S SD
Sbjct: 552 KCVSSSPDERPTMHRVVQLLESEVMTPCPSDFYDSSSD 589
|
|
| TAIR|locus:2026097 SERK2 "somatic embryogenesis receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 952 (340.2 bits), Expect = 9.7e-96, P = 9.7e-96
Identities = 221/592 (37%), Positives = 336/592 (56%)
Query: 2 KMHELVLILTVIFAATLFSSCCLALTE-DGMTLLEIKSSLNDSRNLLGNWQATEESPCKW 60
K E + +I LF+S LA + +G L ++++L D N+L +W T +PC W
Sbjct: 4 KKFEAFGFVCLISLLLLFNSLWLASSNMEGDALHSLRANLVDPNNVLQSWDPTLVNPCTW 63
Query: 61 TGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTEL 120
++C+ + +R ++L L G + P +G+L LQ L L+ N++ G +P+++ N T L
Sbjct: 64 FHVTCNNENSVIR-VDLGNADLSGQLVPQLGQLKNLQYLELYSNNITGPVPSDLGNLTNL 122
Query: 121 RALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG 180
+L L N G IP ++G L L L L++NSL G IP SL + L L+LS N SG
Sbjct: 123 VSLDLYLNSFTGPIPDSLGKLFKLRFLRLNNNSLTGPIPMSLTNIMTLQVLDLSNNRLSG 182
Query: 181 EIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYM 240
+PD G+ S F SF NLDLCG +PC S F P V P S+
Sbjct: 183 SVPDNGSFSLFTPISFANNLDLCGPVTSRPCPGSPPFSPPPPFIPPPIVPTPGGYSA--- 239
Query: 241 KGVLIGAMSTMGLALVVL---LAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHG 297
G + G ++ G AL+ LAF W ++ + + + +V + D E G
Sbjct: 240 TGAIAGGVAA-GAALLFAAPALAFAWW----RRRKPQEFFFDVPAEEDPEVHL------G 288
Query: 298 DMPYPSC-EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE-GSDQVFE 355
+ S E+ ++ ++++G GGFG VY+ + D AVKR+ R G + F+
Sbjct: 289 QLKRFSLRELQVATDSFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQ 348
Query: 356 RELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK 415
E+E++ H NL+ LRG+C P +LL+Y Y++ GS+ L E Q L WS R +
Sbjct: 349 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQLPLAWSIRQQ 408
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
IALGSARGL+YLH C PKIIHRD+K++NILLDE E V DFGLA+L+ ++ HVTT V
Sbjct: 409 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLARLMDYKDTHVTTAV 468
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVV--GWMNTL 533
GT G++APEYL +G+++EK+DV+ +G++LLEL+TG+R D + +V+ W+ L
Sbjct: 469 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 528
Query: 534 LKENRLEDVIDKRCADADMET-VEAILEIAARCTDANPDDRPSMNQVLQLLE 584
LKE +LE ++D E VE ++++A CT ++P +RP M++V+++LE
Sbjct: 529 LKEKKLEMLVDPDLQSNYTEAEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 580
|
|
| TAIR|locus:2013021 SERK1 "somatic embryogenesis receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 948 (338.8 bits), Expect = 2.6e-95, P = 2.6e-95
Identities = 217/592 (36%), Positives = 333/592 (56%)
Query: 1 MKMHELVLILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKW 60
M+ +V IL + S + +G L ++ +L D N+L +W T +PC W
Sbjct: 1 MESSYVVFILLSLILLPNHSLWLASANLEGDALHTLRVTLVDPNNVLQSWDPTLVNPCTW 60
Query: 61 TGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTEL 120
++C+ + +R ++L +L G + P +G L LQ L L+ N++ G IP+ + N T L
Sbjct: 61 FHVTCNNENSVIR-VDLGNAELSGHLVPELGVLKNLQYLELYSNNITGPIPSNLGNLTNL 119
Query: 121 RALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG 180
+L L N G IP ++G L L L L++NSL G+IP SL +T L L+LS N SG
Sbjct: 120 VSLDLYLNSFSGPIPESLGKLSKLRFLRLNNNSLTGSIPMSLTNITTLQVLDLSNNRLSG 179
Query: 181 EIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYM 240
+PD G+ S F SF NLDLCG PC S F P V+ P S + +
Sbjct: 180 SVPDNGSFSLFTPISFANNLDLCGPVTSHPCPGSPPFSPPPPFIQPPPVSTP---SGYGI 236
Query: 241 KGVLIGAMSTMGLALVVL---LAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHG 297
G + G ++ G AL+ +AF W ++ + + + +V + D E G
Sbjct: 237 TGAIAGGVAA-GAALLFAAPAIAFAWW----RRRKPLDIFFDVPAEEDPEVHL------G 285
Query: 298 DMPYPSC-EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE-GSDQVFE 355
+ S E+ + ++++G GGFG VY+ + D AVKR+ R G + F+
Sbjct: 286 QLKRFSLRELQVASDGFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTPGGELQFQ 345
Query: 356 RELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK 415
E+E++ H NL+ LRG+C P +LL+Y Y++ GS+ L E Q L+W R +
Sbjct: 346 TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPPSQPPLDWPTRKR 405
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
IALGSARGL+YLH C PKIIHRD+K++NILLDE E V DFGLAKL+ ++ HVTT V
Sbjct: 406 IALGSARGLSYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 465
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVV--GWMNTL 533
GT G++APEYL +G+++EK+DV+ +G++LLEL+TG+R D + +V+ W+ L
Sbjct: 466 RGTIGHIAPEYLSTGKSSEKTDVFGYGIMLLELITGQRAFDLARLANDDDVMLLDWVKGL 525
Query: 534 LKENRLEDVIDKRC-ADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
LKE +LE ++D + + +E ++++A CT +P +RP M++V+++LE
Sbjct: 526 LKEKKLEMLVDPDLQTNYEERELEQVIQVALLCTQGSPMERPKMSEVVRMLE 577
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 4.3e-90, Sum P(2) = 4.3e-90
Identities = 137/283 (48%), Positives = 190/283 (67%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSI 364
+I+E + +++++G GGFGTVY+ + T AVK++ ++ ++ F E+E LG +
Sbjct: 909 DIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKV 968
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
KH NLV+L GYC KLL+Y+Y+ GSLD +L ++L+WS RLKIA+G+ARGL
Sbjct: 969 KHPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGL 1028
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
A+LHH P IIHRDIK+SNILLD + EP V+DFGLA+L+ E+HV+TV+AGTFGY+ P
Sbjct: 1029 AFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPP 1088
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVK-RGLNVVGWMNTLLKENRLEDVI 543
EY QS RAT K DVYSFGV+LLELVTGK PT P F + G N+VGW + + + DVI
Sbjct: 1089 EYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVI 1148
Query: 544 DKRCADADMETVEA-ILEIAARCTDANPDDRPSMNQVLQLLEQ 585
D ++ + +L+IA C P RP+M VL+ L++
Sbjct: 1149 DPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALKE 1191
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 810 (290.2 bits), Expect = 1.1e-89, Sum P(2) = 1.1e-89
Identities = 192/499 (38%), Positives = 279/499 (55%)
Query: 104 NSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLG 163
N++ G IP N L+ L L N + G IP + G L + +LDLS N+L+G +P SLG
Sbjct: 649 NAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLG 708
Query: 164 RLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLP- 222
L+ L L++S N +G IP G L+ F + N LCG + +PC ++ P
Sbjct: 709 SLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPL-RPCGSAPRRPITSRI 767
Query: 223 HASSDEVAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLWICLLSKKERAVKRYTEVR- 281
HA VA + G+ A S M ++V+ A + + KKE+ ++Y E
Sbjct: 768 HAKKQTVATAV------IAGI---AFSFMCFVMLVM-ALYRVRKVQKKEQKREKYIESLP 817
Query: 282 ---------KQVDQETSTKLITFHGDM-PYPSCEIIEKLEALDEEDVVGSGGFGTVYRMV 331
V + S + TF + ++E E +VGSGGFG VY+
Sbjct: 818 TSGSCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQ 877
Query: 332 MNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391
+ D A+K++ R D+ F E+E +G IKH NLV L GYC++ +LL+Y+Y+
Sbjct: 878 LRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKW 937
Query: 392 GSLDDFLHEHG--EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE 449
GSL+ LHE +G LNW+AR KIA+G+ARGLA+LHH C P IIHRD+KSSN+LLDE
Sbjct: 938 GSLETVLHEKSSKKGGIYLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDE 997
Query: 450 NLEPHVSDFGLAKLLVDEEAHVT-TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLEL 508
+ E VSDFG+A+L+ + H++ + +AGT GY+ PEY QS R T K DVYS+GV+LLEL
Sbjct: 998 DFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLEL 1057
Query: 509 VTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAI--LEIAARCT 566
++GK+P DP N+VGW L +E R +++D VE L+IA++C
Sbjct: 1058 LSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKIASQCL 1117
Query: 567 DANPDDRPSMNQVLQLLEQ 585
D P RP+M Q++ + ++
Sbjct: 1118 DDRPFKRPTMIQLMAMFKE 1136
|
|
| TAIR|locus:2092810 BRL3 "BRI1-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 803 (287.7 bits), Expect = 2.2e-89, Sum P(2) = 2.2e-89
Identities = 193/512 (37%), Positives = 284/512 (55%)
Query: 99 LALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAI 158
L L N++ GSIP L+ L L N L G IP + G L + +LDLS N L+G +
Sbjct: 644 LDLSYNAVSGSIPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFL 703
Query: 159 PSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFP 218
P SLG L+ L L++S N +G IP G L+ F + N LCG + PC S G
Sbjct: 704 PGSLGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPLTRYANNSGLCGVPL-PPC--SSGSR 760
Query: 219 AVLPHASSDEVAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLWICL-LSKKERAVKRY 277
HA + ++ T S+ G++ M +V+L+ L+ + KKE+ ++Y
Sbjct: 761 PTRSHAHPKKQSIATGMSA----GIVFSFM-----CIVMLIMALYRARKVQKKEKQREKY 811
Query: 278 TEVR----------KQVDQETSTKLITFHGDM-PYPSCEIIEKLEALDEEDVVGSGGFGT 326
E V + S + TF + ++E + ++GSGGFG
Sbjct: 812 IESLPTSGSSSWKLSSVHEPLSINVATFEKPLRKLTFAHLLEATNGFSADSMIGSGGFGD 871
Query: 327 VYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386
VY+ + D A+K++ + D+ F E+E +G IKH NLV L GYC++ +LL+Y
Sbjct: 872 VYKAKLADGSVVAIKKLIQVTGQGDREFMAEMETIGKIKHRNLVPLLGYCKIGEERLLVY 931
Query: 387 DYLSMGSLDDFLHEHGE-GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNI 445
+Y+ GSL+ LHE + G L+WSAR KIA+G+ARGLA+LHH C P IIHRD+KSSN+
Sbjct: 932 EYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNV 991
Query: 446 LLDENLEPHVSDFGLAKLLVDEEAHVT-TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVL 504
LLD++ VSDFG+A+L+ + H++ + +AGT GY+ PEY QS R T K DVYS+GV+
Sbjct: 992 LLDQDFVARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGVI 1051
Query: 505 LLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAI--LEIA 562
LLEL++GK+P DP N+VGW L +E R +++D VE + L+IA
Sbjct: 1052 LLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELLHYLKIA 1111
Query: 563 ARCTDANPDDRPSMNQVLQLLEQEVMSPCPSD 594
++C D P RP+M QV+ + ++ V +D
Sbjct: 1112 SQCLDDRPFKRPTMIQVMTMFKELVQVDTEND 1143
|
|
| TAIR|locus:2146102 NIK1 "NSP-interacting kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 848 (303.6 bits), Expect = 1.0e-84, P = 1.0e-84
Identities = 197/560 (35%), Positives = 312/560 (55%)
Query: 33 LLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGR 92
L++IK+SL+D +L NW PC WT ++C + + V + P L G +SPSI
Sbjct: 45 LMDIKASLHDPHGVLDNWDRDAVDPCSWTMVTCSS-ENFVIGLGTPSQNLSGTLSPSITN 103
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
L L+ + L N++ G IP EI T L L L N+ G IP ++G L L L L++N
Sbjct: 104 LTNLRIVLLQNNNIKGKIPAEIGRLTRLETLDLSDNFFHGEIPFSVGYLQSLQYLRLNNN 163
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCR 212
SL G P SL +T L +L+LS N SG +P F A F S +GN +C C
Sbjct: 164 SLSGVFPLSLSNMTQLAFLDLSYNNLSGPVPRFAA-KTF---SIVGNPLICPTGTEPDCN 219
Query: 213 TSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGA-MSTMGLALVVLLAFLWICLLSKKE 271
+ P + + + V + S ++ + +G+ + T+ L + + FLW ++
Sbjct: 220 GTTLIPMSM-NLNQTGVPLYAGGSRNHKMAIAVGSSVGTVSLIFIAVGLFLWW----RQR 274
Query: 272 RAVKRYTEVRK-QVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRM 330
+ +V+ +E S + G + +I ++++G GG+G VY+
Sbjct: 275 HNQNTFFDVKDGNHHEEVSLGNLRRFG---FRELQIATN--NFSSKNLLGKGGYGNVYKG 329
Query: 331 VMNDCGTFAVKRI-DRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389
++ D AVKR+ D G + F+ E+E++ H NL+ L G+C KLL+Y Y+
Sbjct: 330 ILGDSTVVAVKRLKDGGALGGEIQFQTEVEMISLAVHRNLLRLYGFCITQTEKLLVYPYM 389
Query: 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE 449
S GS+ + + + +L+WS R +IA+G+ARGL YLH C PKIIHRD+K++NILLD+
Sbjct: 390 SNGSVASRM----KAKPVLDWSIRKRIAIGAARGLVYLHEQCDPKIIHRDVKAANILLDD 445
Query: 450 NLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELV 509
E V DFGLAKLL +++HVTT V GT G++APEYL +G+++EK+DV+ FG+LLLELV
Sbjct: 446 YCEAVVGDFGLAKLLDHQDSHVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELV 505
Query: 510 TGKRPTD--PTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA---DMETVEAILEIAAR 564
TG+R + ++G+ ++ W+ + +E +LE ++DK D ++ ++ +A
Sbjct: 506 TGQRAFEFGKAANQKGV-MLDWVKKIHQEKKLELLVDKELLKKKSYDEIELDEMVRVALL 564
Query: 565 CTDANPDDRPSMNQVLQLLE 584
CT P RP M++V+++LE
Sbjct: 565 CTQYLPGHRPKMSEVVRMLE 584
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 3.4e-84, P = 3.4e-84
Identities = 196/521 (37%), Positives = 298/521 (57%)
Query: 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN 128
D V S++LP L G +SP IG L LQ + L N++ G IP I +L++L L N
Sbjct: 73 DGYVSSLDLPSQSLSGTLSPRIGNLTYLQSVVLQNNAITGPIPETIGRLEKLQSLDLSNN 132
Query: 129 YLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
G IPA++G L L L L++NSL G P SL ++ L +++S N SG +P A
Sbjct: 133 SFTGEIPASLGELKNLNYLRLNNNSLIGTCPESLSKIEGLTLVDISYNNLSGSLPKVSAR 192
Query: 189 SAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAM 248
+ F IGN +CG + C +++ P LP DE T+ + H++ +
Sbjct: 193 T-F---KVIGNALICGPKAVSNC-SAVPEPLTLPQDGPDESG--TRTNGHHVALAFAASF 245
Query: 249 STMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMP-YPSCEII 307
S FLW + R + + +V +Q D E S G + Y E+
Sbjct: 246 SAAFFVFFTSGMFLWW----RYRRNKQIFFDVNEQYDPEVSL------GHLKRYTFKELR 295
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRI-DRSREGSDQVFERELEILGSIKH 366
+ ++++G GG+G VY+ +ND AVKR+ D + G + F+ E+E + H
Sbjct: 296 SATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVETISLALH 355
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
NL+ LRG+C ++L+Y Y+ GS+ L ++ G+ L+WS R KIA+G+ARGL Y
Sbjct: 356 RNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVGTARGLVY 415
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
LH C PKIIHRD+K++NILLDE+ E V DFGLAKLL ++HVTT V GT G++APEY
Sbjct: 416 LHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTVGHIAPEY 475
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRPTD--PTFVKRGLNVVGWMNTLLKENRLEDVID 544
L +G+++EK+DV+ FG+LLLEL+TG++ D + ++G+ ++ W+ L +E +L+ +ID
Sbjct: 476 LSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGV-MLDWVKKLHQEGKLKQLID 534
Query: 545 KRCADA-DMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
K D D +E I+++A CT NP RP M++V+++LE
Sbjct: 535 KDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLE 575
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00000078001 | SubName- Full=Chromosome chr17 scaffold_101, whole genome shotgun sequence; (602 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 603 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-59 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-44 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-37 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-34 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-31 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-30 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-28 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-28 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-28 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-27 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-27 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-27 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-26 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-25 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-25 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-25 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-25 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-24 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-23 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-23 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-22 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-20 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-20 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-20 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-19 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-19 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-18 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 8e-16 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-15 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-15 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-15 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-15 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-14 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-14 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 9e-14 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-13 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-13 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-13 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-13 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-12 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-12 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 6e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-10 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-10 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-10 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-08 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 7e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 8e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 9e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-05 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 6e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 7e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 211 bits (539), Expect = 9e-59
Identities = 156/520 (30%), Positives = 247/520 (47%), Gaps = 50/520 (9%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+R+ +++L Q G + +G L +L +L L +N L G IP+E+++C +L +L L N
Sbjct: 475 KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
L G IPA+ + L+ LDLS N L G IP +LG + L +N+S N G +P GA
Sbjct: 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFL 594
Query: 190 AFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAMS 249
A + GN+DLCG T+ G P P KR +
Sbjct: 595 AINASAVAGNIDLCGGD------TTSGLP-------------PCKRVRKTPSWWFYITCT 635
Query: 250 TMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEK 309
++ L+AF ++ + + +KR V+ E T + F S I +
Sbjct: 636 LGAFLVLALVAFGFVFIRGRNNLELKR-------VENEDGTWELQFFDSKVSKSITINDI 688
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHIN 368
L +L EE+V+ G G Y+ G F VK I+ + + E+ +G ++H N
Sbjct: 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIND----VNSIPSSEIADMGKLQHPN 744
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH 428
+V L G CR LI++Y+ +L + L L+W R KIA+G A+ L +LH
Sbjct: 745 IVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLH 797
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTFGYLAPEYL 487
C P ++ ++ I++D EPH+ L LL D + +++ Y+APE
Sbjct: 798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETR 850
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID--- 544
++ TEKSD+Y FG++L+EL+TGK P D F G ++V W + L+ ID
Sbjct: 851 ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSI 909
Query: 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
+ + + ++ +A CT +P RP N VL+ LE
Sbjct: 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 1e-52
Identities = 82/278 (29%), Positives = 131/278 (47%), Gaps = 28/278 (10%)
Query: 313 LDEEDVVGSGGFGTVYRMVMNDCGTF-----AVKRIDRSREGSDQV-FERELEILGSIKH 366
L +G G FG VY+ + G AVK + F RE I+ + H
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
N+V L G C ++ +Y+ G L +L ++ L+ S L AL ARG+ Y
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFALQIARGMEY 117
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
L IHRD+ + N L+ ENL +SDFGL++ L D++ + ++APE
Sbjct: 118 LESKNF---IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES 174
Query: 487 LQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545
L+ G+ T KSDV+SFGVLL E+ T G++P G++ + L RL
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYP------GMSNEEVLEYLKNGYRLP--QPP 226
Query: 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
C + ++ +C +P+DRP+ ++++++L
Sbjct: 227 NCPP-------ELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 2e-52
Identities = 85/281 (30%), Positives = 138/281 (49%), Gaps = 33/281 (11%)
Query: 313 LDEEDVVGSGGFGTVYRMVMNDCGTF-----AVKRIDRSREGSDQV----FERELEILGS 363
L +G G FG VY+ + G AVK + +E + + F RE I+
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL---KEDASEQQIEEFLREARIMRK 57
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARG 423
+ H N+V L G C +++ +Y+ G L D+L ++ + L+ S L AL ARG
Sbjct: 58 LDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFALQIARG 115
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
+ YL IHRD+ + N L+ ENL +SDFGL++ L D++ + ++A
Sbjct: 116 MEYLESKNF---IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMA 172
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542
PE L+ G+ T KSDV+SFGVLL E+ T G+ P G++ + L K RL
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYP------GMSNAEVLEYLKKGYRLP-- 224
Query: 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
C + ++ +C +P+DRP+ ++++++L
Sbjct: 225 KPPNCPP-------ELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 2e-49
Identities = 93/268 (34%), Positives = 127/268 (47%), Gaps = 21/268 (7%)
Query: 318 VVGSGGFGTVYRMV-MNDCGTFAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLRG 374
+GSG FGTVY+ AVK + + E S DQ RE+ IL + H N+V L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
L+ +Y G L D+L G L+ KIAL RGL YLH +
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR-AT 493
IIHRD+K NILLDEN ++DFGLAK L + + T GT Y+APE L G
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 494 EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADME 553
K DV+S GV+L EL+TGK P G N++ L++ +
Sbjct: 178 PKVDVWSLGVILYELLTGKPP------FSGENILD-QLQLIRRILGPPLEFDE--PKWSS 228
Query: 554 TVEAILEIAARCTDANPDDRPSMNQVLQ 581
E ++ +C + +P RP+ ++LQ
Sbjct: 229 GSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 4e-48
Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 38/284 (13%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTF----AVKRIDRSREGSDQV-FERELEILGSIKHINLVN 371
+G G FG VY+ + AVK + ++ F +E ++ + H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEH-----GEGQQLLNWSARLKIALGSARGLAY 426
L G C L+ +Y+ G L D+L + + L+ L A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV-----VAGTFGY 481
L K +HRD+ + N L+ E+L +SDFGL++ + D++ + + +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540
+APE L+ G T KSDV+SFGVLL E+ T G P GL+ + L K RL
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYP------GLSNEEVLEYLRKGYRLP 227
Query: 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
+ C D + E+ C +P+DRP+ +++++ LE
Sbjct: 228 --KPEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-47
Identities = 88/269 (32%), Positives = 124/269 (46%), Gaps = 58/269 (21%)
Query: 319 VGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSD-QVFERELEILGSIKHINLVNLRGYC 376
+G GGFGTVY G A+K I + S + RE+EIL + H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 377 RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKII 436
L+ +Y GSL D L E+ L+ L+I L GL YLH + II
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQILEGLEYLHSN---GII 114
Query: 437 HRDIKSSNILLDE-NLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATE 494
HRD+K NILLD N + ++DFGL+KLL +++ + T+V GT Y+APE L G +E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 495 KSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554
KSD++S GV+L EL L+D+I
Sbjct: 174 KSDIWSLGVILYEL----------------------------PELKDLIR---------- 195
Query: 555 VEAILEIAARCTDANPDDRPSMNQVLQLL 583
+ +P+ RPS ++L+ L
Sbjct: 196 ---------KMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 3e-47
Identities = 78/267 (29%), Positives = 117/267 (43%), Gaps = 23/267 (8%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQV-FERELEILGSIKHINLVNLRG 374
+ +G G FG VY G A+K I + + D+ RE++IL +KH N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
L+ +Y G L D L + G L+ L YLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDEARFYLRQILSALEYLHSK---G 117
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATE 494
I+HRD+K NILLDE+ ++DFGLA+ L D +TT V GT Y+APE L +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTFV-GTPEYMAPEVLLGKGYGK 175
Query: 495 KSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554
D++S GV+L EL+TGK P F ++ + K + + +
Sbjct: 176 AVDIWSLGVILYELLTGKPP----F-PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDL 230
Query: 555 VEAILEIAARCTDANPDDRPSMNQVLQ 581
+ +L +P+ R + + LQ
Sbjct: 231 IRKLLVK-------DPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-44
Identities = 84/279 (30%), Positives = 136/279 (48%), Gaps = 39/279 (13%)
Query: 318 VVGSGGFGTVYRMVMNDCGTF-----AVKRIDRSREGSDQV-FERELEILGSIKHINLVN 371
+G G FG VY+ + G AVK + ++ F E I+ + H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC 431
L G C ++ +Y+ G L DFL +HG + L L++AL A+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYLESK- 121
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG---YLAPEYLQ 488
+HRD+ + N L+ ENL +SDFGL++ + +++ + G ++APE L+
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLK 177
Query: 489 SGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547
G+ T KSDV+SFGVLL E+ T G++P G N + E LED R
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP-----------YPGMSNEEVLE-LLED--GYRL 223
Query: 548 A---DADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
+ E + E+ +C +P+DRP+ +++++ L
Sbjct: 224 PRPENCPDE----LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 72/213 (33%), Positives = 109/213 (51%), Gaps = 33/213 (15%)
Query: 318 VVGSGGFGTVYR-MVMNDCGTFAVKRIDRSREGSDQV--FERELEILGSIKHINLVNLRG 374
++G G FG+VY + + AVK ++ S + +++ ERE+ IL S++H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 375 YCRLPATK-LLIY-DYLSMGSLDDFLHEHG---EGQ------QLLNWSARLKIALGSARG 423
R L I+ +Y+S GSL L + G E Q+L G
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-------------EG 113
Query: 424 LAYLH-HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE-AHVTTVVAGTFGY 481
LAYLH + I+HRDIK +NIL+D + ++DFG AK L D E T V GT +
Sbjct: 114 LAYLHSN----GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+APE ++ +D++S G ++E+ TGK P
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 80/286 (27%), Positives = 119/286 (41%), Gaps = 56/286 (19%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQV--FERELEILGSIKHINLVNLR 373
+G G FG VY + G + +K ID S + E++IL + H N++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 374 GYCRLPATKLLI-YDYLSMGSLDDFLHEHGEGQQL------LNWSARLKIALGSARGLAY 426
KL I +Y G L + + + + L+W +L +AL Y
Sbjct: 66 E-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL------KY 118
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
LH KI+HRDIK NI L N + DFG++K+L TVV GT YL+PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPEL 174
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN--------- 537
Q+ KSD++S G +L EL T K P F G N++ +LK
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHP----F--EGENLLELALKILKGQYPPIPSQYS 228
Query: 538 -RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582
L +++ +P++RPS+ Q+LQ
Sbjct: 229 SELRNLVSS-------------------LLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 78/269 (28%), Positives = 125/269 (46%), Gaps = 28/269 (10%)
Query: 317 DVVGSGGFGTVYRM--VMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRG 374
+ +G GGFG VY+ A+K I + + E++IL KH N+V G
Sbjct: 6 EKIGKGGFGEVYKARHKRTGK-EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 375 YCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
L +L ++ ++ S GSL D L Q L S + +GL YLH +
Sbjct: 65 -SYLKKDELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN--- 117
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
IIHRDIK++NILL + E + DFGL+ L D +A T V GT ++APE +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV--GTPYWMAPEVINGKPYD 175
Query: 494 EKSDVYSFGVLLLELVTGKRP-TDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADM 552
K+D++S G+ +EL GK P ++ +K + + ++ +D
Sbjct: 176 YKADIWSLGITAIELAEGKPPYSELPPMKA-------LFKIATNGPPGLRNPEKWSDEFK 228
Query: 553 ETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ ++ +C NP+ RP+ Q+L+
Sbjct: 229 DFLK-------KCLQKNPEKRPTAEQLLK 250
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-34
Identities = 88/289 (30%), Positives = 137/289 (47%), Gaps = 36/289 (12%)
Query: 319 VGSGGFGTVY--RMVMNDCGTF---AVKRIDRSREGSDQV-FERELEILGSIKHINLVNL 372
+G G FG V R T AVK ++ S E + FERE+EIL ++ H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 373 RGYCRLPATK--LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
+G C P + LI +YL GSL D+L H + +N L + +G+ YL
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ 128
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG---TFGYLAPEYL 487
+ IHRD+ + NIL++ +SDFGLAK+L +++ + G F Y APE L
Sbjct: 129 ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRPTD---PTFVKRGLNVVGWMNTLLKENRLEDVID 544
++ + + SDV+SFGV L EL T P+ F++ G M L++
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE--G 242
Query: 545 KR------CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587
+R C D + ++ C +A P DRPS ++ ++++
Sbjct: 243 ERLPRPPSCPD-------EVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-32
Identities = 71/236 (30%), Positives = 121/236 (51%), Gaps = 28/236 (11%)
Query: 306 IIEKLEALDEEDVVGSGGFGTVYRMVM-----NDCGTFAVKRI-DRSREGSDQVFERELE 359
I K L++ V+GSG FGTVY+ V A+K + + + +++ E
Sbjct: 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAY 61
Query: 360 ILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGE---GQQLLNWSARLKI 416
++ S+ H ++V L G C L + LI + +G L D++ H + Q LLNW ++
Sbjct: 62 VMASVDHPHVVRLLGIC-LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI-- 118
Query: 417 ALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVV 475
A+G++YL +++HRD+ + N+L+ ++DFGLAKLL VDE+ +
Sbjct: 119 ----AKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGG 171
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTD-------PTFVKRG 523
++A E + T KSDV+S+GV + EL+T G +P + P +++G
Sbjct: 172 KVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (314), Expect = 2e-31
Identities = 82/277 (29%), Positives = 124/277 (44%), Gaps = 22/277 (7%)
Query: 318 VVGSGGFGTVYRMVMNDCGTFAVKRIDR---SREGSDQVFERELEILGSIKH-INLVNLR 373
+G G FG VY D A+K + + S+ + F RE++IL S+ H N+V L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
+ + + L+ +Y+ GSL+D L + G L S L I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE-SEALFILAQILSALEYLHSKG-- 121
Query: 434 KIIHRDIKSSNILLDENL-EPHVSDFGLAKLLVDEEAHV-----TTVVAGTFGYLAPEYL 487
IIHRDIK NILLD + + DFGLAKLL D + + GT GY+APE L
Sbjct: 122 -IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 488 QS---GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544
A+ SD++S G+ L EL+TG P + ++ + ++ E +
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEG---EKNSSATSQTLKIILELPTPSLAS 237
Query: 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+A ++ + +P +R S + L
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 76/271 (28%), Positives = 121/271 (44%), Gaps = 28/271 (10%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRI--DRSREGSDQVFERELEILGSIKHINLVNLR 373
V+G G G VY++ G +A+K+I D E Q+ REL+ L S + +V
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL-LRELKTLRSCESPYVVKCY 65
Query: 374 G-YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
G + + ++ +Y+ GSL D L + G + IA +GL YLH
Sbjct: 66 GAFYK-EGEISIVLEYMDGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTK-- 118
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
IIHRDIK SN+L++ E ++DFG++K+L + T V GT Y++PE +Q
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESY 177
Query: 493 TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI--DKRCADA 550
+ +D++S G+ LLE GK P P + L++
Sbjct: 178 SYAADIWSLGLTLLECALGKFPFLP------PGQPSFF-ELMQAICDGPPPSLPAEEFSP 230
Query: 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ + + C +P RPS ++LQ
Sbjct: 231 EFR------DFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 63/202 (31%), Positives = 110/202 (54%), Gaps = 13/202 (6%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQV--FERELEILGSIKHINLVNLR 373
D++G G FG VY+ + + G F A+K+I + + + +E+++L ++KH N+V
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR-LKIALGSARGLAYLHHDCC 432
G + +I +Y GSL + + G + L A + L +GLAYLH
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL--VAVYVYQVL---QGLAYLHEQ-- 118
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
+IHRDIK++NIL ++ ++DFG+A +++ + V GT ++APE ++ A
Sbjct: 119 -GVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176
Query: 493 TEKSDVYSFGVLLLELVTGKRP 514
+ SD++S G ++EL+TG P
Sbjct: 177 STASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-30
Identities = 73/213 (34%), Positives = 105/213 (49%), Gaps = 19/213 (8%)
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE----RELEILGSI 364
LE L E +G+G G V +++ G AVK I R ++ + REL+IL
Sbjct: 3 LEYLGE---LGAGNSGVVSKVLHRPTGKIMAVKTI---RLEINEAIQKQILRELDILHKC 56
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
+V G + +Y+ GSLD L E Q + KIA+ +GL
Sbjct: 57 NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKE---VQGRIPERILGKIAVAVLKGL 113
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
YLH KIIHRD+K SNIL++ + + DFG++ LV+ A GT Y+AP
Sbjct: 114 TYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF---VGTSSYMAP 168
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRPTDP 517
E +Q + KSD++S G+ L+EL TG+ P P
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 76/289 (26%), Positives = 124/289 (42%), Gaps = 53/289 (18%)
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTF-----AVKRIDRSREGSDQVFERELEILGSI 364
+ L +G G FG V G + AVK + + F E ++ ++
Sbjct: 5 SKELKLGATIGKGEFGDVML------GDYRGQKVAVKCLKDDSTAAQA-FLAEASVMTTL 57
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
+H NLV L G ++ +Y++ GSL D+L G+ ++ + +L AL G+
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGM 115
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF--GYL 482
YL +HRD+ + N+L+ E+L VSDFGLAK + + G +
Sbjct: 116 EYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDS---GKLPVKWT 166
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKR---PTDPTFVKRGLNVVGWMNTLLKENRL 539
APE L+ + + KSDV+SFG+LL E+ + R P P L
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---------------------L 205
Query: 540 EDVIDKRCADADMETVE----AILEIAARCTDANPDDRPSMNQVLQLLE 584
+DV+ ME E + ++ C + +P RP+ Q+ + L
Sbjct: 206 KDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 89/279 (31%), Positives = 134/279 (48%), Gaps = 46/279 (16%)
Query: 320 GSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCR 377
G+G FG V+ N AVK + + G S + F +E +I+ ++H LV L C
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 378 LPATKLLIYDYLSMGSLDDFLHEHGEG-----QQLLNWSARLKIALGSARGLAYLHHDCC 432
++ +Y+S GSL DFL GEG QL++ +A++ A G+AYL
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQI------AEGMAYLESR-- 122
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF--GYLAPEYLQSG 490
IHRD+ + NIL+ ENL ++DFGLA+L+ D+E T F + APE G
Sbjct: 123 -NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE--YTAREGAKFPIKWTAPEAANYG 179
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
R T KSDV+SFG+LL E+VT R P R +V+++
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------------------EVLEQVERGY 221
Query: 551 DM----ETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
M E + ++ +C D +P++RP+ + LE
Sbjct: 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (284), Expect = 4e-28
Identities = 73/206 (35%), Positives = 97/206 (47%), Gaps = 24/206 (11%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRIDRS----REGSDQVFERELEILGSIKHINLVNLR 373
+G G FG V + D G +A+K + + R+ + E IL I H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLT-ERNILSRINHPFIVKLH 59
Query: 374 GYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLH-HD 430
Y KL L+ +Y G L L + G + AR A + A L YLH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEG---RFSEERARFYAAEIVLA--LEYLHSLG 113
Query: 431 CCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
II+RD+K NILLD + H+ +DFGLAK L E + T GT YLAPE L
Sbjct: 114 ----IIYRDLKPENILLDA--DGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLL 166
Query: 489 SGRATEKSDVYSFGVLLLELVTGKRP 514
+ D +S GVLL E++TGK P
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 75/209 (35%), Positives = 105/209 (50%), Gaps = 24/209 (11%)
Query: 319 VGSGGFGTVYRMVMNDCGT-FAVK--RIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+G G FG VY V D G AVK RI + + + E+++L +KH NLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66
Query: 376 CRLPATKLLIY-DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
+ K+ I+ +Y S G+L++ L EHG L GLAYLH
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLL---EGLAYLHSH---G 119
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV------AGTFGYLAPEYLQ 488
I+HRDIK +NI LD N + DFG A L + + TT+ AGT Y+APE +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN---NTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 489 SGRATEK---SDVYSFGVLLLELVTGKRP 514
G+ +D++S G ++LE+ TGKRP
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-28
Identities = 80/284 (28%), Positives = 131/284 (46%), Gaps = 42/284 (14%)
Query: 316 EDVVGSGGFGTVYRMVMN----DCGTFAVKRIDRSREGSDQV-FERELEILGSIKHINLV 370
E V+G G FG V R + A+K + ++ F E I+G H N++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
L G ++I +Y+ GSLD FL E+ +G+ + + G A G+ YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLREN-DGK--FTVGQLVGMLRGIASGMKYLSEM 125
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG---TFGYLAPEYL 487
+HRD+ + NIL++ NL VSDFGL++ L D EA TT G + APE +
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT--KGGKIPIRWTAPEAI 180
Query: 488 QSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK- 545
+ T SDV+SFG+++ E+++ G+RP N +DVI
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYW-----------DMSN--------QDVIKAV 221
Query: 546 ----RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
R M+ A+ ++ C + ++RP+ +Q++ L++
Sbjct: 222 EDGYRLP-PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 80/272 (29%), Positives = 124/272 (45%), Gaps = 30/272 (11%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVK--RIDRSREGSDQVFERELEILGSIKHINLVNLRGYC 376
+G G FG VY+ V+ AVK R + + F +E EIL H N+V L G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPD-LKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 377 RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKII 436
++ + + GSL FL + + L+++L +A G+ YL C I
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK---LLQMSLDAAAGMEYLESKNC---I 115
Query: 437 HRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT----FGYLAPEYLQSGRA 492
HRD+ + N L+ EN +SDFG+++ +EE + TV G + APE L GR
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 493 TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADM 552
T +SDV+S+G+LL E + P G N +E R+E
Sbjct: 173 TSESDVWSYGILLWETFSLGDTPYP----------GMSNQQTRE-RIESGYRMPAPQL-- 219
Query: 553 ETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
E I + +C +P++RPS +++ L+
Sbjct: 220 -CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 76/271 (28%), Positives = 128/271 (47%), Gaps = 33/271 (12%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYC 376
+GSG FG V+ + A+K I REG S++ F E +++ + H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 377 RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKII 436
+ L+++++ G L D+L + + L + L G+AYL +I
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 437 HRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKS 496
HRD+ + N L+ EN VSDFG+ + ++D++ +T + +PE + + KS
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 497 DVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNT---LLKENRLEDVIDKRCADADM 552
DV+SFGVL+ E+ + GK P + + VV +N L K + +
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYEN---RSNSEVVETINAGFRLYKP--------RLAS---- 227
Query: 553 ETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
+++ E+ C P+DRPS + +L L
Sbjct: 228 ---QSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 86/280 (30%), Positives = 136/280 (48%), Gaps = 33/280 (11%)
Query: 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLV 370
E+L + +G G FG V+ N A+K + + + F +E +I+ ++H LV
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLV 64
Query: 371 NLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQ-----QLLNWSARLKIALGSARGL 424
L Y + + ++ +++ GSL DFL E G+G+ QL++ +A++ A G+
Sbjct: 65 PL--YAVVSEEPIYIVTEFMGKGSLLDFLKE-GDGKYLKLPQLVDMAAQI------ADGM 115
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
AY+ IHRD++++NIL+ +NL ++DFGLA+L+ D E + AP
Sbjct: 116 AYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544
E GR T KSDV+SFG+LL ELVT R P V R + LE V
Sbjct: 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV--------------LEQVER 218
Query: 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
E++ E+ C +PD+RP+ + LE
Sbjct: 219 GYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 85/275 (30%), Positives = 136/275 (49%), Gaps = 23/275 (8%)
Query: 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLV 370
E+L E +G G FG V+ N A+K + + S + F +E +++ ++H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 64
Query: 371 NLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429
L Y + + ++ +Y+S GSL DFL GE + L + +A A G+AY+
Sbjct: 65 QL--YAVVSEEPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS 489
+HRD++++NIL+ ENL V+DFGLA+L+ D E + APE
Sbjct: 121 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 177
Query: 490 GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549
GR T KSDV+SFG+LL EL T R P V R + ++ + + R+ C
Sbjct: 178 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQVERGYRMP------CPP 226
Query: 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
E E++ ++ +C P++RP+ + LE
Sbjct: 227 ---ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 63/199 (31%), Positives = 102/199 (51%), Gaps = 11/199 (5%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQV--FERELEILGSIKHINLVNLRGYC 376
+G+G FG V+ + N+ AVK + + G+ F E +I+ ++H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 377 RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKII 436
L ++ + + GSL ++L G G+ L + +A A G+AYL I
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQ-GGAGRAL-KLPQLIDMAAQVASGMAYLEAQ---NYI 125
Query: 437 HRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKS 496
HRD+ + N+L+ EN V+DFGLA+++ ++ + APE R + KS
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185
Query: 497 DVYSFGVLLLELVT-GKRP 514
DV+SFG+LL E+VT G+ P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 8e-27
Identities = 78/304 (25%), Positives = 128/304 (42%), Gaps = 68/304 (22%)
Query: 319 VGSGGFGTVYRMVMNDCGT-FAVKRI--DRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+G G +G VY+ G A+K+I + +EG RE+++L ++H N+V L+
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 376 CRLPATK--LLIYDYLS---MGSLDDFLHEHGEGQ------QLLNWSARLKIALGSARGL 424
++++Y+ G LD + E Q QLL GL
Sbjct: 67 VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE-------------GL 113
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT--VVAGTFGYL 482
YLH + I+HRDIK SNIL++ + ++DFGLA+ + T V+ T Y
Sbjct: 114 QYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYR 168
Query: 483 APEYL-QSGRATEKSDVYSFGVLLLELVTGK--------------------RPTDPTFVK 521
PE L + R + D++S G +L EL GK PTD +
Sbjct: 169 PPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENW-- 226
Query: 522 RGLNVVGWMNTL----LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMN 577
G++ + W L + RL + + ++ ++ +L + +P R S +
Sbjct: 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTL-------DPKKRISAD 279
Query: 578 QVLQ 581
Q LQ
Sbjct: 280 QALQ 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 80/272 (29%), Positives = 121/272 (44%), Gaps = 34/272 (12%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE--RELEILGSIKHINLVNLRGY 375
+G G FG V+++V +A+K+ID S+ + E E +L + ++ R Y
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII--RYY 65
Query: 376 -CRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQL---LNWSARLKIALGSARGLAYLHHD 430
L KL ++ +Y G L L G+ L W ++I LG LA+LH
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLG----LAHLHSK 120
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
KI+HRDIKS N+ LD + D G+AKLL D T+V GT YL+PE +
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPELCEDK 176
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
EKSDV++ GV+L E TGK P D N + +++ V
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDAN------NQGALILKIIR-GVFPPVSQMYSQQ- 228
Query: 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQL 582
+ ++ +C + RP Q+L+
Sbjct: 229 -------LAQLIDQCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 92/295 (31%), Positives = 144/295 (48%), Gaps = 46/295 (15%)
Query: 298 DMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERE 357
++P S ++I+KL G+G FG V+ N AVK + + S + F E
Sbjct: 2 EIPRESLQLIKKL---------GNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEE 51
Query: 358 LEILGSIKHINLVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQ-----QLLNWS 411
+I+ ++H LV L Y + + ++ +Y+S GSL DFL + GEG+ L++ +
Sbjct: 52 AQIMKKLRHDKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKD-GEGRALKLPNLVDMA 108
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471
A++ A G+AY+ IHRD++S+NIL+ + L ++DFGLA+L+ D E
Sbjct: 109 AQV------AAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159
Query: 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN 531
+ APE GR T KSDV+SFG+LL ELVT R P G+N
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP-----GMN------ 208
Query: 532 TLLKENR--LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
NR LE V + ++ E+ +C +P++RP+ + LE
Sbjct: 209 -----NREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 80/267 (29%), Positives = 123/267 (46%), Gaps = 16/267 (5%)
Query: 320 GSGGFGTVYRMVMNDCGT-FAVKRI--DRSREGSDQVFERELEILGSIKHINLVNLRGYC 376
G G G+V + + + G FA+K I D + + Q+ RELEI S K +V G
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQIL-RELEINKSCKSPYIVKYYGAF 68
Query: 377 RLPATKLL--IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
++ + +Y GSLD + + + KIA +GL+YLH K
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---K 125
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATE 494
IIHRDIK SNILL + + DFG++ LV+ A T GT Y+APE +Q +
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKPYSI 182
Query: 495 KSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554
SDV+S G+ LLE+ + P F G +G + L + + K ++
Sbjct: 183 TSDVWSLGLTLLEVAQNRFP----FPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238
Query: 555 VEAILEIAARCTDANPDDRPSMNQVLQ 581
E + +C + +P RP+ +L+
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 88/290 (30%), Positives = 139/290 (47%), Gaps = 42/290 (14%)
Query: 319 VGSGGFGTV----YRMVMNDCGTF-AVKRIDRSREGSDQVFERELEILGSIKHINLVNLR 373
+G G FG+V Y + ++ G AVK++ S + FERE+EIL S++H N+V +
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 374 GYCRLPATK--LLIYDYLSMGSLDDFLHEHGE---GQQLLNWSARLKIALGSARGLAYLH 428
G C + L+ +YL GSL D+L +H E ++LL +++++ +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQI------CKGMEYLG 125
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG---TFGYLAPE 485
+HRD+ + NIL++ + DFGL K+L ++ + G F Y APE
Sbjct: 126 SKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APE 181
Query: 486 YLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFV--------KRGLNVVGWMNTLLKE 536
L + + SDV+SFGV+L EL T + P K+G +V + LLK
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 537 N-RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
N RL C I I C + +P RPS +++ +E
Sbjct: 242 NGRLPAPPG--CPA-------EIYAIMKECWNNDPSQRPSFSELALQVEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-25
Identities = 86/292 (29%), Positives = 138/292 (47%), Gaps = 40/292 (13%)
Query: 298 DMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFE 355
++P + ++++KL G+G FG V+ N A+K + ++G S + F
Sbjct: 2 EVPRETLKLVKKL---------GAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSPEAFL 49
Query: 356 RELEILGSIKHINLVNLRGYCRLPATKLLIY---DYLSMGSLDDFLHEHGEGQQLLNWSA 412
E ++ ++H LV L T+ IY +Y+ GSL DFL + EG +L +
Sbjct: 50 AEANLMKQLQHPRLVRLYAV----VTQEPIYIITEYMENGSLVDFL-KTPEGIKL-TINK 103
Query: 413 RLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472
+ +A A G+A++ IHRD++++NIL+ E L ++DFGLA+L+ D E
Sbjct: 104 LIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160
Query: 473 TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT 532
+ APE + G T KSDV+SFG+LL E+VT R P G N
Sbjct: 161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP----------GMTNP 210
Query: 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
+ +N LE D E + E+ C P++RP+ + +LE
Sbjct: 211 EVIQN-LERGYRMPRPDN---CPEELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 75/280 (26%), Positives = 123/280 (43%), Gaps = 50/280 (17%)
Query: 319 VGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSD-----QVFERELEILGSIKHINLVNL 372
+GSG FG+VY + D G F AVK + + +G + E+E+ +L ++H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGE---------GQQLLNWSARLKIALGSARG 423
G R + + + GSL L ++G +Q+L G
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-------------G 114
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
L YLH +HRDIK +NIL+D N ++DFG+AK +V E G+ ++A
Sbjct: 115 LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMA 169
Query: 484 PEYL-QSGRATEKSDVYSFGVLLLELVTGKRP-TDPTFVKRGLNVVGWMNTLLKENRLED 541
PE + Q G +D++S G +LE+ TGK P + V + + L
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG-------RSKELPP 222
Query: 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ D +A + +C +P RP+ ++L+
Sbjct: 223 IPDHLSDEAK--------DFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 77/272 (28%), Positives = 123/272 (45%), Gaps = 35/272 (12%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYC 376
+GSG FG V+ A+K I REG S+ F E +++ + H NLV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 377 RLPATKLLIYDYLSMGSLDDFL--HEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
++ +Y++ G L ++L + G + L L + + YL +
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL-----LDMCSDVCEAMEYLESNG--- 120
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF--GYLAPEYLQSGRA 492
IHRD+ + N L+ E+ VSDFGLA+ ++D++ T+ F + PE R
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--YTSSQGTKFPVKWAPPEVFDYSRF 178
Query: 493 TEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551
+ KSDV+SFGVL+ E+ + GK P + + N+ + E+ R A
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYE-----------RFSNSEVVESVSAGYRLYRPKLAP 227
Query: 552 METVEAILEIAARCTDANPDDRPSMNQVLQLL 583
E + I C P+DRP+ ++L L
Sbjct: 228 TE----VYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 71/206 (34%), Positives = 96/206 (46%), Gaps = 23/206 (11%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLR 373
V+G G FG V + D FA+K +++ +GS + E IL + H LVNL
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66
Query: 374 GYCRLPATKL-LIYDYLSMGSLDDFLHEHG---EGQQLLNWSARLKIA-LGSARGLAYLH 428
Y + L+ D L G L L + E Q + I + A L YLH
Sbjct: 67 -YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ------VKFWICEIVLA--LEYLH 117
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
IIHRDIK NILLDE H++DF +A + + +TT +GT GY+APE L
Sbjct: 118 SK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLC 172
Query: 489 SGRATEKSDVYSFGVLLLELVTGKRP 514
+ D +S GV E + GKRP
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 78/258 (30%), Positives = 129/258 (50%), Gaps = 22/258 (8%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRL 378
+GSG FG V+ + + A+K + Q F++E++ L ++H +L++L C +
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 379 PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHR 438
+I + + GSL FL EGQ L ++ + +A A G+AYL IHR
Sbjct: 74 GEPVYIITELMEKGSLLAFLRS-PEGQVL-PVASLIDMACQVAEGMAYLEEQ---NSIHR 128
Query: 439 DIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDV 498
D+ + NIL+ E+L V+DFGLA+L+ E+ ++++ + + APE G + KSDV
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDV 187
Query: 499 YSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEA 557
+SFG+LL E+ T G+ P G+N + + R+ + +
Sbjct: 188 WSFGILLYEMFTYGQVPYP------GMNNHEVYDQITAGYRMP---------CPAKCPQE 232
Query: 558 ILEIAARCTDANPDDRPS 575
I +I C A P+DRPS
Sbjct: 233 IYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 83/292 (28%), Positives = 145/292 (49%), Gaps = 39/292 (13%)
Query: 298 DMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERE 357
++P S ++++KL G+G FG V+ N+ AVK + + S Q F E
Sbjct: 2 EIPRESIKLVKKL---------GAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEE 51
Query: 358 LEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQ----QLLNWSAR 413
++ +++H LV L +I +Y++ GSL DFL G+ +L+++SA+
Sbjct: 52 ANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ 111
Query: 414 LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT 473
+ A G+AY+ IHRD++++N+L+ E+L ++DFGLA+++ D E
Sbjct: 112 I------AEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 162
Query: 474 VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNT 532
+ APE + G T KSDV+SFG+LL E+VT GK P G++ M+
Sbjct: 163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP------GMSNSDVMSA 216
Query: 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
L + R+ + + C D + +I C ++RP+ + + +L+
Sbjct: 217 LQRGYRMPRM--ENCPD-------ELYDIMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 38/292 (13%)
Query: 311 EALDEEDVVGSGGFGTVY--RMVMNDCGT----FAVKRID-RSREGSDQVFERELEILGS 363
L E +G G FG V+ + + VK + E F REL++
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFL-----HEHGEGQQLLNWSARLKIAL 418
+ H N+V L G CR +I +Y +G L FL + L+ ++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 419 GSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT 478
A G+ +L + + +HRD+ + N L+ E VS L+K + + E +
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 479 FGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP----TDPTFVKRGLNVVGWMNTL 533
+LAPE +Q + KSDV+SFGVL+ E+ T G+ P +D + R
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR----------- 230
Query: 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
L+ +LE + + C + ++ RC NP DRPS ++++ L +
Sbjct: 231 LQAGKLELPVPEGCP-------SRLYKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 4e-25
Identities = 67/181 (37%), Positives = 94/181 (51%), Gaps = 7/181 (3%)
Query: 4 HELVLILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGI 63
++ ++F L S A E+ LL KSS+ND L NW ++ + C W GI
Sbjct: 7 QHCPYLIFMLFFLFLNFSMLHA--EELELLLSFKSSINDPLKYLSNWNSSADV-CLWQGI 63
Query: 64 SCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRA 122
+C + RV SI+L + G IS +I RL +Q + L N L G IP++I T + LR
Sbjct: 64 TC-NNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRY 122
Query: 123 LYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEI 182
L L N G IP G++ L LDLS+N L G IP+ +G + L L+L N G+I
Sbjct: 123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 183 P 183
P
Sbjct: 181 P 181
|
Length = 968 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-25
Identities = 85/277 (30%), Positives = 126/277 (45%), Gaps = 41/277 (14%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQV--FERELEILGSIKHINLVNLRGY 375
+G G +G VY V T AVK + +E + +V F +E ++ IKH NLV L G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 376 CRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKI 435
C +I ++++ G+L D+L E Q +N L +A + + YL
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NF 125
Query: 436 IHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT---FGYLAPEYLQSGRA 492
IHRD+ + N L+ EN V+DFGL++L+ + T AG + APE L +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 493 TEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551
+ KSDV++FGVLL E+ T G P G++ L V +
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYP------GID-------------LSQVYELLEKGYR 223
Query: 552 METVEA----ILEIAARCTDANPDDRPSMNQVLQLLE 584
ME E + E+ C NP DRPS ++ Q E
Sbjct: 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 83/281 (29%), Positives = 138/281 (49%), Gaps = 35/281 (12%)
Query: 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLV 370
E+L E +G+G FG V+ N AVK + + S + F E ++ +++H LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 371 NLRGYCRLPATKLLIY---DYLSMGSLDDFLH-EHGEGQQL---LNWSARLKIALGSARG 423
L TK IY ++++ GSL DFL + G Q L +++SA++ A G
Sbjct: 65 KLHAV----VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEG 114
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
+A++ IHRD++++NIL+ +L ++DFGLA+++ D E + A
Sbjct: 115 MAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 171
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543
PE + G T KSDV+SFG+LL+E+VT R P G++ + L + R+
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP-----GMSNPEVIRALERGYRMPRP- 225
Query: 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
+ C E + I RC P++RP+ + +L+
Sbjct: 226 -ENCP-------EELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 22/214 (10%)
Query: 313 LDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQV-FERELE-ILGSIKHINL 369
L + +G G FGTV +M+ GT AVKRI + + +Q +L+ ++ S +
Sbjct: 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDF---LHEHGEG---QQLLNWSARLKIALGSARG 423
V G + + + + SLD F ++E + +++L KIA+ + +
Sbjct: 66 VKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILG-----KIAVATVKA 119
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
L YL + KIIHRD+K SNILLD N + DFG++ LVD A T AG Y+A
Sbjct: 120 LNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMA 175
Query: 484 PEYLQSGRATE---KSDVYSFGVLLLELVTGKRP 514
PE + +SDV+S G+ L E+ TGK P
Sbjct: 176 PERIDPSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 76/279 (27%), Positives = 131/279 (46%), Gaps = 29/279 (10%)
Query: 315 EEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRS-REGSDQVFERELEILGSIKHINL 369
++ V+G+G FG V+R ++ G A+K + E Q F E I+G H N+
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429
+ L G ++I +Y+ G+LD +L +H L+ G A G+ YL
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSD 125
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG--YLAPEYL 487
+HRD+ + NIL++ NLE VSDFGL+++L D+ T G + APE +
Sbjct: 126 ---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAI 182
Query: 488 QSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546
+ T SDV+SFG+++ E+++ G+RP W + ++ + D
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPY-------------W--DMSNHEVMKAINDGF 227
Query: 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
A M+ A+ ++ +C + RP ++ LL++
Sbjct: 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGS 363
+I+EKL G G +G+VY+ + + G A+K + E Q +E+ IL
Sbjct: 6 DILEKL---------GEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQ 54
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARG 423
+V G ++ +Y GS+ D + + L I + +G
Sbjct: 55 CDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKG 111
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
L YLH + K IHRDIK+ NILL+E + ++DFG++ L D A TV+ GT ++A
Sbjct: 112 LEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMA 167
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
PE +Q K+D++S G+ +E+ GK P
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 3e-23
Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 40/220 (18%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVK--RIDRSREGSDQVFERELEILGSI 364
EKLE L E G +G VY+ G A+K R+D EG RE+ +L +
Sbjct: 2 EKLEKLGE------GTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL 55
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG----------QQLLNWSARL 414
KH N+V L L+++Y M L +L + QLL
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLL------ 108
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTT 473
RGLAY H +I+HRD+K NIL++ + ++DFGLA+ + +
Sbjct: 109 -------RGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158
Query: 474 VVAGTFGYLAPEYLQSGRATEKS-DVYSFGVLLLELVTGK 512
VV T Y APE L + + D++S G + E++TGK
Sbjct: 159 VV--TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 72/236 (30%), Positives = 121/236 (51%), Gaps = 30/236 (12%)
Query: 307 IEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-----FAVKRI-DRSREGSDQVFERELEI 360
I K L + ++GSG FGTV++ + G A+K I DRS + Q +
Sbjct: 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62
Query: 361 LGSIKHINLVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKI 416
+GS+ H +V L G C P L L+ +GSL D + +H + Q+LLNW ++
Sbjct: 63 MGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI-- 118
Query: 417 ALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV-DEEAHVTTVV 475
A+G+ YL ++HR++ + NILL + ++DFG+A LL D++ + +
Sbjct: 119 ----AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH 171
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-------GKRPTD-PTFVKRG 523
++A E + GR T +SDV+S+GV + E+++ G RP + P +++G
Sbjct: 172 KTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 7e-23
Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSD-----QVFERELEILGSIKHINLVNL 372
+G G FG VY D G AVK++ + + E E+++L +++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
G R T + +Y+ GS+ D L +G L + K G+ YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHSN-- 123
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV--VAGTFGYLAPEYLQSG 490
I+HRDIK +NIL D + DFG +K L + T + V GT +++PE +
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182
Query: 491 RATEKSDVYSFGVLLLELVTGKRP 514
K+DV+S G ++E++T K P
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-22
Identities = 89/293 (30%), Positives = 134/293 (45%), Gaps = 43/293 (14%)
Query: 311 EALDEEDVVGSGGFGTVYRMVMNDCG---TFAVKRI-DRSREGSDQVFERELEILGSI-K 365
E + EDV+G G FG V R ++ G A+K + + + E + F ELE+L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLH-------------EHGEGQQLLNWSA 412
H N++NL G C + +Y G+L DFL EHG L +
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS-QQ 120
Query: 413 RLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472
L+ A A G+ YL + IHRD+ + N+L+ ENL ++DFGL++ EE +V
Sbjct: 121 LLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVK 174
Query: 473 TVVAG-TFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWM 530
+ ++A E L T KSDV+SFGVLL E+V+ G P G+
Sbjct: 175 KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPY------CGMTCAELY 228
Query: 531 NTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQV-LQL 582
L + R+E + C D + E+ +C P +RP Q+ +QL
Sbjct: 229 EKLPQGYRMEK--PRNCDD-------EVYELMRQCWRDRPYERPPFAQISVQL 272
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 71/280 (25%), Positives = 126/280 (45%), Gaps = 33/280 (11%)
Query: 317 DVVGSGGFGTVYRMVMN-DCG-TFAVKRIDRSREGSDQVFER----------ELEILGSI 364
+++G G +G VY + +N G AVK+++ + + R E+E L +
Sbjct: 7 ELIGKGTYGRVY-LALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
H+N+V G+ + +Y+ GS+ L +G ++ L ++ GL
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL----EGL 121
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV-TTVVAGTFGYLA 483
AYLH I+HRD+K+ N+L+D + +SDFG++K D + + G+ ++A
Sbjct: 122 AYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 484 PEYLQSGRA--TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541
PE + S + K D++S G ++LE+ G+RP + M L +
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS------DEEAIAAMFKLGNKRSAPP 232
Query: 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ D M L+ C NPD+RP+ ++LQ
Sbjct: 233 IPP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 82/287 (28%), Positives = 124/287 (43%), Gaps = 36/287 (12%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYR-MVMNDCGTFAVKRIDRSR--EGSDQVFERELEIL 361
E++E + G G FGTV + +D K ID E Q E+ IL
Sbjct: 3 EVLETI---------GKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNIL 53
Query: 362 GSIKHINLVNLRGYCRL---PATKLLIY-DYLSMGSLDDFLHEHGEGQQLLNWSARLKIA 417
+KH N+V R Y R+ L I +Y G L + + + ++ + +I
Sbjct: 54 RELKHPNIV--RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRIL 111
Query: 418 LGSARGLAYLHH--DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
L H+ D ++HRD+K +NI LD N + DFGLAK+L + + T V
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV 171
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535
GT Y++PE L EKSD++S G L+ EL P F R + + +K
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP----FTARNQLQ---LASKIK 223
Query: 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582
E + I R + + E+ + +PD RPS ++LQL
Sbjct: 224 EGKFRR-IPYRYSS-------ELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 85/282 (30%), Positives = 132/282 (46%), Gaps = 39/282 (13%)
Query: 318 VVGSGGFGTVYRMVMND-------CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLV 370
V+G G FG VY + D C ++ RI E F +E I+ H N++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ--FLKEGIIMKDFSHPNVL 59
Query: 371 NLRGYCRLP--ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALG--SARGLAY 426
+L G C LP + L++ Y+ G L +F+ N + + I G A+G+ Y
Sbjct: 60 SLLGIC-LPSEGSPLVVLPYMKHGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEY 113
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE---AHVTTVVAGTFGYLA 483
L K +HRD+ + N +LDE+ V+DFGLA+ + D+E H T ++A
Sbjct: 114 LASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543
E LQ+ + T KSDV+SFGVLL EL+T P P ++ LL+ RL
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VDSFDITVYLLQGRRLLQ-- 223
Query: 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ C D + E+ C P+ RP+ ++++ +EQ
Sbjct: 224 PEYCPD-------PLYEVMLSCWHPKPEMRPTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 84/293 (28%), Positives = 136/293 (46%), Gaps = 38/293 (12%)
Query: 313 LDEEDVVGSGGFGTV--YRMVMNDCGT---FAVKRIDRS-----REGSDQVFERELEILG 362
L + V+G G FG V Y + GT AVK + R G +++E+ IL
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSG----WKKEINILK 61
Query: 363 SIKHINLVNLRGYCRLPATK--LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS 420
++ H N+V +G C K LI +Y+ +GSL D+L +H LN + L A
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-----LNLAQLLLFAQQI 116
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG--- 477
G+AYLH IHRD+ + N+LLD + + DFGLAK + + + G
Sbjct: 117 CEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 173
Query: 478 TFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPT-DPTFVKRGLNVVGWMNTLLKE 536
F Y A E L+ + + SDV+SFGV L EL+T P K+ ++G +
Sbjct: 174 VFWY-AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP--KKFEEMIGPKQGQMTV 230
Query: 537 NRLEDVIDKR----CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
RL +++++ C + V +++ C + RP+ ++ +L++
Sbjct: 231 VRLIELLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPILKE 280
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 7e-22
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 35/277 (12%)
Query: 319 VGSGGFGTV----YRMVMNDCGTFAVKRIDRSREGSDQV-FERELEILGSIKHINLVNLR 373
+G G FG+V Y M AVK + + + + F RE ++ + H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQ--QLLNWSARLKIALGSARGLAYLHHDC 431
G C+ +L+ + +G L +L + E L A A G+AYL
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK- 114
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF--GYLAPEYLQS 489
+HRD+ + N+LL + +SDFG+++ L + AG + + APE +
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 490 GRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548
G+ + KSDV+S+GV L E + G +P + + L RL
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPY------GEMKGAEVIAMLESGERLP------RP 220
Query: 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ E + I I C P+DRP+ +++ +
Sbjct: 221 E---ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 68/216 (31%), Positives = 113/216 (52%), Gaps = 30/216 (13%)
Query: 318 VVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSD---------QVFERELEILGSIKHI 367
++GSG FG+VY + G AVK+++ + RE+ +L ++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 368 NLVNLRGYCRLPATKLLIY-DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
N+V G L A L I+ +Y+ GS+ L+ +G ++ L + +I +GL Y
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNY 121
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV--------VAGT 478
LH+ IIHRDIK +NIL+D +SDFG++K L EA+ + + G+
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGARPSLQGS 175
Query: 479 FGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
++APE ++ T K+D++S G L++E++TGK P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 1e-21
Identities = 83/289 (28%), Positives = 128/289 (44%), Gaps = 47/289 (16%)
Query: 317 DVVGSGGFGTVYRMVMNDCG---TFAVKRI-DRSREGSDQVFERELEILGSI-KHINLVN 371
DV+G G FG V + + G A+KR+ + + + + F ELE+L + H N++N
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLH-------------EHGEGQQLLNWSAR--LKI 416
L G C L +Y G+L DFL + L S++ L
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL---SSQQLLHF 117
Query: 417 ALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA 476
A ARG+ YL + IHRD+ + NIL+ EN ++DFGL++ +E +V +
Sbjct: 118 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 171
Query: 477 G-TFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLL 534
++A E L T SDV+S+GVLL E+V+ G P G+ L
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY------CGMTCAELYEKLP 225
Query: 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQV-LQL 582
+ RLE C D + ++ +C P +RPS Q+ + L
Sbjct: 226 QGYRLEK--PLNCDD-------EVYDLMRQCWREKPYERPSFAQILVSL 265
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 1e-21
Identities = 70/215 (32%), Positives = 112/215 (52%), Gaps = 23/215 (10%)
Query: 313 LDEEDV-----VGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS---DQVFERELEILGSI 364
+D +D+ +G+G FG V A+K I +EGS D+ E E +++ +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIE-EAKVMMKL 56
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
H LV L G C ++ +Y+S G L ++L EHG+ Q S L++ G+
Sbjct: 57 SHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDVCEGM 113
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF--GYL 482
AYL + IHRD+ + N L+D+ VSDFGL++ ++D+E T+ V F +
Sbjct: 114 AYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWS 168
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTD 516
PE L + + KSDV++FGVL+ E+ + GK P +
Sbjct: 169 PPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 90/322 (27%), Positives = 146/322 (45%), Gaps = 34/322 (10%)
Query: 279 EVRKQVDQETSTKLITFHGDMPYPSCEIIE-KLEALDEEDVVGSGGFG-----TVYRMVM 332
EVR +V + + + P E L +G+G FG T Y +
Sbjct: 2 EVRWKVIESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSK 61
Query: 333 NDCG-TFAVKRIDRSREGSD-QVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYL 389
+D AVK + + S+ + EL+I+ + H N+VNL G C + L+I +Y
Sbjct: 62 SDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYC 121
Query: 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE 449
G L +FL E L L + A+G+A+L C IHRD+ + N+LL
Sbjct: 122 CYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNVLLTH 176
Query: 450 NLEPHVSDFGLAKLLVDEEAHVTTVVAGTF---GYLAPEYLQSGRATEKSDVYSFGVLLL 506
+ DFGLA+ ++++ +V V ++APE + + T +SDV+S+G+LL
Sbjct: 177 GKIVKICDFGLARDIMNDSNYV--VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLW 234
Query: 507 ELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARC 565
E+ + G P G+ V L+KE R A + E I +I C
Sbjct: 235 EIFSLGSNPYP------GMPVDSKFYKLIKEGY-------RMAQPEHAPAE-IYDIMKTC 280
Query: 566 TDANPDDRPSMNQVLQLLEQEV 587
DA+P RP+ Q++QL+ +++
Sbjct: 281 WDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 76/266 (28%), Positives = 120/266 (45%), Gaps = 25/266 (9%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQV-FERELEILGSIKHINLVNLRGY 375
+++G G FG V++ + D AVK ++ F E IL H N+V L G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 376 C--RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
C R P IY + + DFL + + L +K AL +A G+AYL C
Sbjct: 61 CTQRQP-----IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC- 114
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
IHRD+ + N L+ EN +SDFG+++ D + + + APE L GR +
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 494 EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADME 553
+SDV+S+G+LL E TF L V + ++ R E V +
Sbjct: 173 SESDVWSYGILLWE----------TF---SLGVCPYPGMTNQQAR-EQVEKGYRMSCPQK 218
Query: 554 TVEAILEIAARCTDANPDDRPSMNQV 579
+ + ++ RC D P++RP +++
Sbjct: 219 CPDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 318 VVGSGGFGTVYR------MVMNDCGTFAVKRI-DRSREGSDQVFERELEILGSIKHINLV 370
+G G FG V+ ND AVK + + + + + FERE E+L + +H N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG--------EGQ--QLLNWSARLKIALGS 420
G C +++++Y+ G L+ FL HG L S L+IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT-- 478
A G+ YL +HRD+ + N L+ +L + DFG+++ + + + V G
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY---RVGGHTM 185
Query: 479 --FGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP 514
++ PE + + T +SDV+SFGV+L E+ T GK+P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 2e-21
Identities = 80/282 (28%), Positives = 124/282 (43%), Gaps = 35/282 (12%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHI 367
++ L +G G FG V M+ + G AVK I + + Q F E ++ ++H
Sbjct: 4 NMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHS 59
Query: 368 NLVNLRGYCRLPATKLLIY-DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
NLV L G L I +Y++ GSL D+L G+ +L LK +L + Y
Sbjct: 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEY 117
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG-TFGYLAPE 485
L + +HRD+ + N+L+ E+ VSDFGL K EA T + APE
Sbjct: 118 LEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPE 169
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE--NRLEDVI 543
L+ + + KSDV+SFG+LL E+ + R V + LK+ R+E
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGR-------------VPYPRIPLKDVVPRVEKGY 216
Query: 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
D + ++ +C + RPS Q+ + LE
Sbjct: 217 KMDAPDG---CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-21
Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 24/214 (11%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKR---IDRSREGSDQVFERELEILGSI 364
E LE + + +G+G G+V ++ GT K+ I Q+ REL+I+
Sbjct: 5 EDLETISD---LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQIL-RELQIMHEC 60
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQ-QLLNWSARLKIALGSARG 423
+ +V+ G + +++ GSLD + G ++L KIA+ G
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEG 115
Query: 424 LAYL---HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480
L YL H I+HRDIK SNIL++ + + DFG++ L++ A T V GT
Sbjct: 116 LTYLYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFV-GTST 167
Query: 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
Y++PE +Q G+ T KSDV+S G+ ++EL GK P
Sbjct: 168 YMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 6e-21
Identities = 72/221 (32%), Positives = 114/221 (51%), Gaps = 21/221 (9%)
Query: 307 IEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-----FAVKRIDRSREGSDQV-FERELEI 360
I K L V+GSG FGTVY+ + G A+K ++ + V F E I
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 62
Query: 361 LGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGE---GQQLLNWSARLKIA 417
+ S+ H +LV L G C P +L + + G L D++HEH + Q LLNW ++
Sbjct: 63 MASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI--- 118
Query: 418 LGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV-DEEAHVTTVVA 476
A+G+ YL +++HRD+ + N+L+ ++DFGLA+LL DE+ +
Sbjct: 119 ---AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 172
Query: 477 GTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTD 516
++A E + + T +SDV+S+GV + EL+T G +P D
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 6e-21
Identities = 70/229 (30%), Positives = 110/229 (48%), Gaps = 38/229 (16%)
Query: 302 PSCEIIEKLEALDEEDVVGSGGFGTV---------YRMVMNDCGTFAVKRIDRSREGSDQ 352
SC IEK V+G+G FG V R + T ++ R
Sbjct: 3 ASCIKIEK--------VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD--- 51
Query: 353 VFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQ----QLL 408
F E I+G H N+++L G +++ +Y+ GSLD FL +H +GQ QL+
Sbjct: 52 -FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLV 109
Query: 409 NWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468
+ G A G+ YL +HRD+ + NIL++ NL VSDFGL+++L D+
Sbjct: 110 G------MLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160
Query: 469 AHVTTVVAGTFG--YLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP 514
T G + APE + + T SDV+S+G+++ E+++ G+RP
Sbjct: 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 6e-21
Identities = 74/256 (28%), Positives = 108/256 (42%), Gaps = 40/256 (15%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFER--------ELEILGSIKHINL 369
+G GGFG V + + TFA+K + + + E E EIL H +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKK-----RHIVETGQQEHIFSEKEILEECNHPFI 55
Query: 370 VNLRGYCRLPATKLLIY---DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
V L + K IY +Y G L L + G ++AR IA Y
Sbjct: 56 VKLYRTFK---DKKYIYMLMEYCLGGELWTILRDRG---LFDEYTARFYIA-CVVLAFEY 108
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
LH+ II+RD+K N+LLD N + DFG AK L + T GT Y+APE
Sbjct: 109 LHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC--GTPEYVAPEI 163
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRP-----TDP----TFVKRGLNVVGWMNTLLKEN 537
+ + D +S G+LL EL+TG+ P DP + +G + + N + K
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAA 223
Query: 538 RLEDVIDKRCADADME 553
+ D+I + E
Sbjct: 224 K--DLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 82/283 (28%), Positives = 135/283 (47%), Gaps = 39/283 (13%)
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTF-----AVKRIDRSREGSDQVFERELEILGSI 364
L+ L +++G G FG V + G + AVK I + + Q F E ++ +
Sbjct: 5 LQKLTLGEIIGEGEFGAVLQ------GEYTGQKVAVKNI--KCDVTAQAFLEETAVMTKL 56
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
H NLV L G L ++ + +S G+L +FL G+ L++ L+ +L A G+
Sbjct: 57 HHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGM 113
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
YL K++HRD+ + NIL+ E+ VSDFGLA+ V + + + AP
Sbjct: 114 EYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLP--VKWTAP 166
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543
E L+ + + KSDV+S+GVLL E+ + G+ P + K L V + K R+E
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAP----YPKMSLKEVK--ECVEKGYRMEP-- 218
Query: 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586
+ V ++ C + P RPS +++ + LE+E
Sbjct: 219 ----PEGCPADVYVLM---TSCWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 63/226 (27%), Positives = 109/226 (48%), Gaps = 30/226 (13%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYR------MVMNDCGTFAVKRIDRSREGSDQV-FERE 357
+ + L+E +G G FG VY+ + A+K + + E Q F +E
Sbjct: 2 IPLSAVRFLEE---LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 358 LEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEH------------GEGQ 405
E++ ++H N+V L G C ++++YL+ G L +FL + +
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 406 QLLNWSARLKIALGSARGLAYL--HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463
L+ S L IA+ A G+ YL HH +HRD+ + N L+ E L +SDFGL++
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRD 173
Query: 464 LVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLEL 508
+ + + V + ++ PE + G+ T +SD++SFGV+L E+
Sbjct: 174 IYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 18/209 (8%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFAVKRID------RSREGSDQVFERELEILGSIKHINLV 370
+V+G G +GTVY + N AVK+++ + E + + E+++L S+KH+N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
G C T + +++ GS+ L+ G + + +I G+AYLH++
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL----DGVAYLHNN 121
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT-----TVVAGTFGYLAPE 485
C ++HRDIK +N++L N + DFG A+ L H T + GT ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+ KSD++S G + E+ TGK P
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 23/211 (10%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-----FAVK--RIDRSREGSDQVFERELEILGSIKHINLV 370
V+GSG FGTVY+ + G A+K R S + + ++ + E ++ S+ + ++
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD-EAYVMASVDNPHVC 72
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGE---GQQLLNWSARLKIALGSARGLAYL 427
L G C L +T LI + G L D++ EH + Q LLNW ++ A+G+ YL
Sbjct: 73 RLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 125
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTFGYLAPEY 486
+++HRD+ + N+L+ ++DFGLAKLL DE+ + ++A E
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 487 LQSGRATEKSDVYSFGVLLLELVT-GKRPTD 516
+ T +SDV+S+GV + EL+T G +P D
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRS---REG-SDQVFERELEILGSIK-HINL 369
++G G F TV + +A+K +D+ +E V E E+L + H +
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVK-IEKEVLTRLNGHPGI 64
Query: 370 VNLRGYCRLP-ATKL-LIYDYLSMGSLDDFLHEHG--EGQQLLNWSARLKIALGSARGLA 425
+ L Y L + +Y G L ++ ++G + + ++A + +AL
Sbjct: 65 IKL--YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLAL------E 116
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA--------- 476
YLH IIHRD+K NILLD+++ ++DFG AK+L + +
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 477 ----------GTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
GT Y++PE L A + SD+++ G ++ +++TGK P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 2e-20
Identities = 79/300 (26%), Positives = 127/300 (42%), Gaps = 53/300 (17%)
Query: 318 VVGSGGFGTVYRMVMNDCG------TFAVKRIDRSREGSDQVFER----ELEILGSIKHI 367
+G G FG V + T AVK + +E + R E +L + H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENASSSELRDLLSEFNLLKQVNHP 63
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEH--------------------GEGQQL 407
+++ L G C LLI +Y GSL FL E ++
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467
L + A +RG+ YL K++HRD+ + N+L+ E + +SDFGL++ + +E
Sbjct: 124 LTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 468 EAHVTTVVAGT-FGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLN 525
+++V ++A E L T +SDV+SFGVLL E+VT G P +R N
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240
Query: 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ + T + R E+ C+ E + + C PD RP+ + + LE+
Sbjct: 241 L---LKTGYRMERPEN-----CS-------EEMYNLMLTCWKQEPDKRPTFADISKELEK 285
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE--RELEILGSIKHINLVNL 372
+ +G G FG VY+ + A+K ID E D++ + +E++ L + +
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLE-EAEDEIEDIQQEIQFLSQCRSPYITKY 64
Query: 373 RGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC 431
G L +KL +I +Y GS D L + + + I GL YLH +
Sbjct: 65 YG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-----ILREVLLGLEYLHEE- 117
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR 491
IHRDIK++NILL E + ++DFG++ L + T V GT ++APE ++
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSG 174
Query: 492 ATEKSDVYSFGVLLLELVTGKRP 514
EK+D++S G+ +EL G+ P
Sbjct: 175 YDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 80/267 (29%), Positives = 119/267 (44%), Gaps = 32/267 (11%)
Query: 319 VGSGGFGTVYRMV-MNDCGTF---AVK--RIDRSREGSDQVFERELEILGSIKHINLVNL 372
+G G FG V R G AVK + D+ + D F +E I+ S+ H NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDD-FLKEAAIMHSLDHENLIRL 61
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
G + + + +GSL D L + G L+ S A+ A G+ YL
Sbjct: 62 YGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLI--STLCDYAVQIANGMRYLESK-- 116
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT--FGYLAPEYLQSG 490
+ IHRD+ + NILL + + + DFGL + L E H F + APE L++
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 491 RATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKE-NRLEDVIDKRCA 548
+ SDV+ FGV L E+ T G+ P + GL+ + + KE RLE + C
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP----WA--GLSGSQILKKIDKEGERLER--PEACP 227
Query: 549 DADMETVEAILEIAARCTDANPDDRPS 575
+ I + +C NP DRP+
Sbjct: 228 -------QDIYNVMLQCWAHNPADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 311 EALDEEDVVGSGGFGTVYR-MVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINL 369
E + +G G G VY+ A+K++ R R+ + ++ E+ I+ KH N+
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNI 77
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG----EGQQLLNWSARLKIALGSARGLA 425
V+ + ++ +Y+ GSL D + ++ E Q A + +GL
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ-----IAY--VCREVLQGLE 130
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
YLH +IHRDIKS NILL ++ ++DFG A L E++ +VV GT ++APE
Sbjct: 131 YLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPE 186
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRP 514
++ K D++S G++ +E+ G+ P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 14/206 (6%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSD-QVFERELEILGSIKHINLVNLRG 374
+V+G G VY + A+KRID + + +E++ + H N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-- 64
Query: 375 YCRLPATKLL--IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
Y L + YLS GSL D + + + L+ + + +GL YLH +
Sbjct: 65 YTSFVVGDELWLVMPYLSGGSLLDIM-KSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLL---VDEEAHVTTVVAGTFGYLAPEYLQS 489
IHRDIK+ NILL E+ ++DFG++ L D V GT ++APE ++
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 490 GRA-TEKSDVYSFGVLLLELVTGKRP 514
K+D++SFG+ +EL TG P
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-20
Identities = 71/284 (25%), Positives = 128/284 (45%), Gaps = 47/284 (16%)
Query: 318 VVGSGGFGTVY--RMVMNDCGTF-AVKRIDRSREGS---DQVFE---RELEILGSIKHIN 368
+G+G F + Y R V GT AVK++ R S ++V E +E+ ++ + H +
Sbjct: 7 QLGTGAFSSCYQARDVKT--GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH 428
++ + G + L ++++ GS+ L ++G ++ + + RGL+YLH
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE----AVIINYTEQLLRGLSYLH 120
Query: 429 HDCCPKIIHRDIKSSNILLDENLEP-HVSDFGLAKLLVDEEAHVTTV------VAGTFGY 481
+ +IIHRD+K +N+L+D + ++DFG A L A T + GT +
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA---AKGTGAGEFQGQLLGTIAF 174
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541
+APE L+ + DV+S G +++E+ T K P W N L
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP--------------WNAEKH-SNHLAL 219
Query: 542 VIDKRCADADMETVE----AILEIAARCTDANPDDRPSMNQVLQ 581
+ A E + ++ RC + P+DRP ++L+
Sbjct: 220 IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 84/301 (27%), Positives = 137/301 (45%), Gaps = 46/301 (15%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGS--DQVFERELEILGSI 364
EK E L +VG G +G V + + G A+K+ S + ++ RE+ +L +
Sbjct: 1 EKYENLG---LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL 57
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLH-EHGEGQQLLNWSARLKIALGSARG 423
+H NLVNL R L+++++ LDD +G + + K RG
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR-----KYLFQILRG 112
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
+ + H IIHRDIK NIL+ ++ + DFG A+ L T VA T Y A
Sbjct: 113 IEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRA 168
Query: 484 PEYL----QSGRATEKSDVYSFGVLLLELVTGKRPTDPTF------------VKRGLNVV 527
PE L + GRA D+++ G L+ E++TG +P F +K N++
Sbjct: 169 PELLVGDTKYGRAV---DIWAVGCLVTEMLTG----EPLFPGDSDIDQLYHIIKCLGNLI 221
Query: 528 GWMNTLLKEN------RLEDVIDKRCADADMETVEAI-LEIAARCTDANPDDRPSMNQVL 580
+ ++N RL +V + + + + L++A +C +PDDRPS +Q+L
Sbjct: 222 PRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
Query: 581 Q 581
Sbjct: 282 H 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-20
Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 35/202 (17%)
Query: 26 LTEDGMTLLEIKSSLNDSRNLLG-----NWQATEESPC-----KWTGISCHTHDQRVRSI 75
+T + TLLE S+L ++ LG W PC W+G C + +
Sbjct: 363 ITAESKTLLEEVSALQTLKSSLGLPLRFGWNG---DPCVPQQHPWSGADCQFDSTKGKWF 419
Query: 76 NLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIP 135
+ L L L G IPN+I+ L+++ L N ++G IP
Sbjct: 420 --------------------IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIP 459
Query: 136 ANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNK 194
++G++ L +LDLS NS G+IP SLG+LT L LNL+ N SG +P G
Sbjct: 460 PSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRAS 519
Query: 195 -SFIGNLDLCGRQVHKPCRTSM 215
+F N LCG + C +
Sbjct: 520 FNFTDNAGLCGIPGLRACGPHL 541
|
Length = 623 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 4e-20
Identities = 84/290 (28%), Positives = 133/290 (45%), Gaps = 52/290 (17%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG---TFAVKRI-DRSREGSDQVFERELEILGSI-KHINLV 370
+DV+G G FG V + + G A+KR+ + + + + F ELE+L + H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG------------------EGQQLLNWSA 412
NL G C L +Y G+L DFL + QQLL+++A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 413 RLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472
+ ARG+ YL + IHRD+ + NIL+ EN ++DFGL++ +E +V
Sbjct: 132 DV------ARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVK 179
Query: 473 TVVAG-TFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWM 530
+ ++A E L T SDV+S+GVLL E+V+ G P G+
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY------CGMTCAELY 233
Query: 531 NTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVL 580
L + RLE ++ C D + ++ +C P +RPS Q+L
Sbjct: 234 EKLPQGYRLEKPLN--CDD-------EVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 5e-20
Identities = 56/132 (42%), Positives = 67/132 (50%), Gaps = 10/132 (7%)
Query: 76 NLPYMQLGG-----IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYL 130
+L + LGG I S+ L L+ L L N L G IP E+ L+ +YL N L
Sbjct: 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224
Query: 131 QGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
G IP IG L L LDL N+L G IPSSLG L +L YL L N SG IP S
Sbjct: 225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP----SI 280
Query: 191 FGNKSFIGNLDL 202
F + I +LDL
Sbjct: 281 FSLQKLI-SLDL 291
|
Length = 968 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 6e-20
Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 40/276 (14%)
Query: 317 DVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS----REGSDQVFERELEILGSIKHINLVN 371
+G G +G+VY++ D +A+K +D +E D V E+ IL S+ H N+++
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV--NEIRILASVNHPNIIS 63
Query: 372 -----LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
L G +L ++ +Y G L + + + ++L+ +I + RGL
Sbjct: 64 YKEAFLDG-NKL----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
LH KI+HRD+KS+NILL N + D G++K+L A GT Y+APE
Sbjct: 119 LHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEV 172
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRPTDP-TFVKRGLNVVGWMNTLLKENRLEDVIDK 545
+ + KSD++S G LL E+ T P + + V + +D+
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQ-- 230
Query: 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
P RP+ +++L
Sbjct: 231 --------------NFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 8e-20
Identities = 66/217 (30%), Positives = 113/217 (52%), Gaps = 32/217 (14%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG----TFAVKRI-----DRSREGSDQVFERELEILGSIKH 366
E+V+G+G FG V R + G A+K + ++ R F E I+G H
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD----FLSEASIMGQFDH 64
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQ----QLLNWSARLKIALGSAR 422
N+++L G ++I +++ G+LD FL ++ +GQ QL+ + G A
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVG------MLRGIAA 117
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH--VTTVVAGTFG 480
G+ YL +HRD+ + NIL++ NL VSDFGL++ L D+ + T+ + G
Sbjct: 118 GMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174
Query: 481 --YLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP 514
+ APE + + T SDV+S+G+++ E+++ G+RP
Sbjct: 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 84/295 (28%), Positives = 129/295 (43%), Gaps = 54/295 (18%)
Query: 319 VGSGGFGTVYRM------VMNDCGTFAVKRIDRS---REGSDQVFERELEILGSI-KHIN 368
+G G FG V + N+ T AVK + ++ SD V E+E++ I KH N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV--SEMEMMKMIGKHKN 77
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKI------------ 416
++NL G C ++ +Y + G+L DFL + +
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 417 ALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA 476
A ARG+ +L K IHRD+ + N+L+ E+ ++DFGLA+ + + + T
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT--- 191
Query: 477 GTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWM 530
T G L APE L T +SDV+SFGVLL E+ T G P P V +
Sbjct: 192 -TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY-PGI------PVEEL 243
Query: 531 NTLLKEN-RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
LLKE R+E + + E + + C P RP+ Q+++ L+
Sbjct: 244 FKLLKEGYRME-----KPQNCTQE----LYHLMRDCWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 52/281 (18%)
Query: 320 GSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFERELEILGSIKHINLVNL-RGYCR 377
G G FG VY+ + G F A K I E + F E++IL KH N+V L Y
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73
Query: 378 LPATKLLIY-DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKII 436
KL I ++ G+LD + E G L + L +LH K+I
Sbjct: 74 EN--KLWILIEFCDGGALDSIMLELERG---LTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 437 HRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATE-- 494
HRD+K+ NILL + + ++DFG++ T + GT ++APE + A E
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVV----ACETF 180
Query: 495 -------KSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547
K+D++S G+ L+EL + P M LLK I K
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNP---------MRVLLK-------ILK-- 222
Query: 548 ADADMETVEA-------ILEIAARCTDANPDDRPSMNQVLQ 581
++ T++ + C +PDDRP+ ++L+
Sbjct: 223 --SEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 28/218 (12%)
Query: 319 VGSGGFGTVYRMVMNDCGTF---------AVKRIDRSREGSDQVFERELEILGSIKHINL 369
+G G FG V+ + +C AVK + + E + Q F+RE E+L ++H ++
Sbjct: 13 LGEGAFGKVF---LAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLN-----------WSARLKIAL 418
V G C L++++Y+ G L+ FL HG ++L L IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 419 GSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH-VTTVVAG 477
A G+ YL +HRD+ + N L+ + L + DFG+++ + + + V
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186
Query: 478 TFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP 514
++ PE + + T +SD++SFGV+L E+ T GK+P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 37/276 (13%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQV--FERELEILGSIKHINLVNLR 373
+++G G +G VYR G A+K I+ D V +RE+ +L ++ N+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 374 GY--CRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIAL---GSARGLAYL 427
Y L +L +I +Y GS+ + + + A I++ L Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPI----AEKYISVIIREVLVALKYI 117
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
H +IHRDIK++NIL+ + DFG+A LL + +T V GT ++APE +
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVI 173
Query: 488 QSGRATE-KSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546
G+ + K+D++S G+ + E+ TG P R + ++ K RLED
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS----KPPRLED----N 225
Query: 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582
+ E A C D P +R S ++L+
Sbjct: 226 GYSKLLR------EFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 67/221 (30%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 302 PSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVK--RIDRSREGSDQVFEREL 358
C + + E L+ +G G +G VYR G A+K R+D R+G RE+
Sbjct: 1 GRCRSVTEFEKLNR---IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREI 57
Query: 359 EILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK--- 415
+L +++H N+V L+ + K L +L M E L N
Sbjct: 58 TLLLNLRHPNIVELK---EVVVGKHLDSIFLVMEYC-----EQDLASLLDNMPTPFSESQ 109
Query: 416 ---IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472
+ L RGL YLH + IIHRD+K SN+LL + ++DFGLA+ +T
Sbjct: 110 VKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
Query: 473 TVVAGTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTGK 512
V T Y APE L T D+++ G +L EL+ K
Sbjct: 167 PKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 6e-19
Identities = 74/302 (24%), Positives = 130/302 (43%), Gaps = 56/302 (18%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDC------GTFAVKRIDRSREGSDQV-FERELEI 360
EK+ + E +G G FG VY + A+K ++ + +++ F E +
Sbjct: 6 EKITLIRE---LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV 62
Query: 361 LGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG------------QQLL 408
+ ++V L G L++ + ++ G L +L Q+ +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 409 NWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468
+A + A G+AYL K +HRD+ + N ++ E+L + DFG+ + + + +
Sbjct: 123 QMAAEI------ADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
Query: 469 AHVTTVVAGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKR 522
+ G G L APE L+ G T KSDV+SFGV+L E+ T ++P +
Sbjct: 174 YYRK----GGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY------Q 223
Query: 523 GLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582
GL+ E L+ VID D + +LE+ C NP RP+ +++
Sbjct: 224 GLS---------NEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274
Query: 583 LE 584
L+
Sbjct: 275 LK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 30/219 (13%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSD-QVFERELEILGS 363
E+I++ +GSG +G VY+ G ++ + G D ++ ++E+ +L
Sbjct: 6 ELIQR---------IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE 56
Query: 364 IKHINLVNLRG-YCRLPATKLLI-YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIAL--- 418
+H N+V G Y R KL I +Y GSL D + L+IA
Sbjct: 57 CRHPNIVAYFGSYLRR--DKLWIVMEYCGGGSLQDIYQ------VTRGPLSELQIAYVCR 108
Query: 419 GSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT 478
+ +GLAYLH IHRDIK +NILL E+ + ++DFG++ L A + + GT
Sbjct: 109 ETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GT 164
Query: 479 FGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRP 514
++APE G K D+++ G+ +EL + P
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 319 VGSGGFGTVYRM------VMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNL 372
+G G FG V+ D AVK + + + F+RE E+L +++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHG-------EGQQL-----LNWSARLKIALGS 420
G C +++++Y+ G L+ FL HG +GQ L S L IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTF 479
A G+ YL +HRD+ + N L+ NL + DFG+++ + + + V
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP 514
++ PE + + T +SDV+SFGV+L E+ T GK+P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 62/216 (28%), Positives = 105/216 (48%), Gaps = 26/216 (12%)
Query: 319 VGSGGFGTVYRMVMNDCGTF---------AVKRIDRSREGSDQVFERELEILGSIKHINL 369
+G G FG V+ + +C AVK + + + + + F RE E+L +++H ++
Sbjct: 13 LGEGAFGKVF---LAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQL---------LNWSARLKIALGS 420
V G C +++++Y+ G L+ FL HG L L S L IA
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTF 479
A G+ YL +HRD+ + N L+ ENL + DFG+++ + + + V
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP 514
++ PE + + T +SDV+S GV+L E+ T GK+P
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 69/205 (33%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 319 VGSGGFGTVY--RMVMNDCGTFAVKRIDRSREGSDQVFE---RELEILGSIKHINLVNLR 373
+G G FG VY R V + A+K++ S + S++ ++ +E+ L ++H N + +
Sbjct: 23 IGHGSFGAVYFARDVRTN-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 374 GYCRL-PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
G C L T L+ +Y +GS D L H + Q + +A I G+ +GLAYLH
Sbjct: 82 G-CYLREHTAWLVMEY-CLGSASDILEVHKKPLQEVEIAA---ICHGALQGLAYLHSHE- 135
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY---LQS 489
IHRDIK+ NILL E ++DFG A L+ + V GT ++APE +
Sbjct: 136 --RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDE 188
Query: 490 GRATEKSDVYSFGVLLLELVTGKRP 514
G+ K DV+S G+ +EL K P
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 1e-18
Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQV--FERELEILGSIKHI 367
E + + +G G FG V++ + N A+K ID E D++ ++E+ +L
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-EEAEDEIEDIQQEITVLSQCDSP 62
Query: 368 NLVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
+ G L TKL +I +YL GS D L + + LK L +GL Y
Sbjct: 63 YVTKYYG-SYLKGTKLWIIMEYLGGGSALDLLRAGPFDE--FQIATMLKEIL---KGLDY 116
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
LH + K IHRDIK++N+LL E + ++DFG+A L D + T V F ++APE
Sbjct: 117 LHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEV 172
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRP 514
+Q K+D++S G+ +EL G+ P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 79/282 (28%), Positives = 127/282 (45%), Gaps = 34/282 (12%)
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER---ELEI-LGSI 364
LE ++E +G G +G V +M GT AVKRI + +Q +R +L+I + S+
Sbjct: 3 LEVIEE---LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ--KRLLMDLDISMRSV 57
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
V G + I + SLD F + + + KIA+ + L
Sbjct: 58 DCPYTVTFYG-ALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKAL 116
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
YLH +IHRD+K SN+L++ N + + DFG++ LVD A T+ AG Y+AP
Sbjct: 117 EYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTIDAGCKPYMAP 172
Query: 485 EYLQSGRATE----KSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540
E + + KSDV+S G+ ++EL TG+ P D W +L+
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SWKTPF---QQLK 218
Query: 541 DVIDKRCADADMETVEA-ILEIAARCTDANPDDRPSMNQVLQ 581
V+++ E + +C N +RP+ ++LQ
Sbjct: 219 QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 319 VGSGGFGTVYRMVMNDCGT-FAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRG 374
+G GGFG V + G +A K++D+ R +Q+ E +IL + +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEG----QQLLNWSARLKIALGSARGLAYLHHD 430
L+ ++ G L ++ GE + + ++A++ GL +LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQI------ICGLEHLHQR 114
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
+I++RD+K N+LLD++ +SD GLA L + AGT GY+APE LQ
Sbjct: 115 ---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGE 169
Query: 491 RATEKSDVYSFGVLLLELVTGKRP 514
D ++ G L E++ G+ P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 3e-18
Identities = 58/153 (37%), Positives = 76/153 (49%), Gaps = 10/153 (6%)
Query: 35 EIKSSLNDSRNL----LGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSI 90
+I L ++L LG + E P + G++ H ++L Y L G I S+
Sbjct: 203 QIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNH------LDLVYNNLTGPIPSSL 256
Query: 91 GRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150
G L LQ L L+QN L G IP I + +L +L L N L G IP + L L IL L
Sbjct: 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLF 316
Query: 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP 183
SN+ G IP +L L L L L +N FSGEIP
Sbjct: 317 SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIP 349
|
Length = 968 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 74/276 (26%), Positives = 132/276 (47%), Gaps = 37/276 (13%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT--FAVKRID----------RSREGSDQVFERELEILG-S 363
+ +GSG FG VY++ + G A+K I+ R R+ S E+ I+
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 364 IKHINLVNLRGYCRLPATKL-LIYDYLSMGSLDDFL------HEHGEGQQLLNWSARLKI 416
++H N+V L +L ++ D + L + + +++ W+ +++
Sbjct: 66 LRHPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI--WNIFVQM 122
Query: 417 ALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA 476
L L YLH + +I+HRD+ +NI+L E+ + ++DFGLAK E+ +T+VV
Sbjct: 123 VLA----LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK-QKQPESKLTSVV- 174
Query: 477 GTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPT-FVKRGLNVVGWMNTLLK 535
GT Y PE +++ EK+DV++FG +L ++ T + P T + +V + L
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234
Query: 536 E----NRLEDVIDKRCADADMETVEAILEIAARCTD 567
E + DVI C D E I++++A +D
Sbjct: 235 EGMYSEDVTDVI-TSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 40/287 (13%)
Query: 318 VVGSGGFGTVYRMVMN-DCGTF---AVK--RIDRSREGSDQVFERELEILGSIKHINLVN 371
++G G FG+V ++ D G+ AVK ++D + F E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 372 LRGYC------RLPATKLLIYDYLSMGSLDDFL--HEHGEGQQLLNWSARLKIALGSARG 423
L G C + ++I ++ G L FL G + L LK + A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT-FGYL 482
+ YL + IHRD+ + N +L E++ V+DFGL+K + + + +A ++
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRL-- 539
A E L T KSDV++FGV + E+ T G+ P G+ + L NRL
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP------GVENHEIYDYLRHGNRLKQ 236
Query: 540 -EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
ED +D+ + ++ C A+P DRP+ ++ ++LE
Sbjct: 237 PEDCLDE------------LYDLMYSCWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 21/204 (10%)
Query: 319 VGSGGFGTVY--RMVMNDCGTFAVKRIDRSREGSDQVFE---RELEILGSIKHINLVNLR 373
+G G FG VY R V N A+K++ S + S++ ++ +E+ L ++H N + R
Sbjct: 23 IGHGSFGAVYFARDVRNS-EVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
G T L+ +Y +GS D L H + Q + +A + G+ +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHSH--- 134
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY---LQSG 490
+IHRD+K+ NILL E + DFG A ++ V GT ++APE + G
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEG 189
Query: 491 RATEKSDVYSFGVLLLELVTGKRP 514
+ K DV+S G+ +EL K P
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 4e-18
Identities = 70/267 (26%), Positives = 121/267 (45%), Gaps = 26/267 (9%)
Query: 318 VVGSGGFG--TVYRMVMNDCGTFAVKRIDRSREGSDQVFE--RELEILGSIKHINLVNLR 373
V+G G FG T+YR D K ++ +R + + E+ IL ++H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
+ T L+ +Y + G+L D + + QL L ++Y+H
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVR--QKGQLFEEEMVLWYLFQIVSAVSYIHKA--- 120
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
I+HRDIK+ NI L + + DFG++K+L E + TVV GT Y++PE Q +
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKYN 179
Query: 494 EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADME 553
KSD+++ G +L EL+T KR D T N + + +++ N
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDAT------NPLNLVVKIVQGNY---------TPVVSV 224
Query: 554 TVEAILEIAARCTDANPDDRPSMNQVL 580
++ + +P+ RP+ ++VL
Sbjct: 225 YSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 79/303 (26%), Positives = 142/303 (46%), Gaps = 44/303 (14%)
Query: 307 IEKLEALDEEDVVGSGGFGTVYRMVMNDCG-------TFAVKRIDRSREGSDQVFERELE 359
I K L + V+GSG FGTVY+ + G V R + S + + ++ + E
Sbjct: 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD-EAY 61
Query: 360 ILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGE---GQQLLNWSARLKI 416
++ + + L G C L +T L+ + G L D++ E+ + Q LLNW ++
Sbjct: 62 VMAGVGSPYVCRLLGIC-LTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI-- 118
Query: 417 ALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVV 475
A+G++YL +++HRD+ + N+L+ ++DFGLA+LL +DE +
Sbjct: 119 ----AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGG 171
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLL 534
++A E + R T +SDV+S+GV + EL+T G +P D +
Sbjct: 172 KVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG----------------I 215
Query: 535 KENRLEDVIDK--RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCP 592
+ D+++K R + T++ + I +C + + RP +++ E M+ P
Sbjct: 216 PAREIPDLLEKGERLPQPPICTIDVYM-IMVKCWMIDSECRPRFRELVD--EFSRMARDP 272
Query: 593 SDF 595
S F
Sbjct: 273 SRF 275
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 8e-18
Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 23/205 (11%)
Query: 319 VGSGGFGTVYRMVMNDCGT---FAVKRIDRSREGSDQVFE---RELEILGSIKHINLVNL 372
+G G FG VY D T A+K++ S + S++ ++ +E++ L IKH N +
Sbjct: 33 IGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
+G T L+ +Y +GS D L H + Q + +A I G+ +GLAYLH
Sbjct: 91 KGCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSH-- 144
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY---LQS 489
+IHRDIK+ NILL E + ++DFG A + + V GT ++APE +
Sbjct: 145 -NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAMDE 198
Query: 490 GRATEKSDVYSFGVLLLELVTGKRP 514
G+ K DV+S G+ +EL K P
Sbjct: 199 GQYDGKVDVWSLGITCIELAERKPP 223
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 73/228 (32%), Positives = 105/228 (46%), Gaps = 40/228 (17%)
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVK--RIDRSREGSDQVFERELEILGSIKH 366
++ D +G G +G VY+ D G A+K R+D +EG RE++IL + H
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH 65
Query: 367 INLVNLRGYC--RLPATKL--------LIYDYLS---MGSLD----DFLHEHGEG--QQL 407
N+VNL+ + A L+++Y+ MG L+ F +H + +QL
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467
L GL Y H +HRDIK SNILL+ + ++DFGLA+L E
Sbjct: 126 LE-------------GLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
Query: 468 EAHVTTVVAGTFGYLAPE-YLQSGRATEKSDVYSFGVLLLELVTGKRP 514
E+ T T Y PE L R DV+S G +L EL T K+P
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE---RELEILGSIKHINLVNLRG 374
+G G FG VY + AVK++ S + +++ ++ +E++ L +KH N + +G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
T L+ +Y +GS D L H + Q + +A I G+ +GLAYLH
Sbjct: 89 CYLKEHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHSHN--- 141
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY---LQSGR 491
+IHRDIK+ NILL E + ++DFG A + V GT ++APE + G+
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 492 ATEKSDVYSFGVLLLELVTGKRP 514
K DV+S G+ +EL K P
Sbjct: 197 YDGKVDVWSLGITCIELAERKPP 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 68/213 (31%), Positives = 105/213 (49%), Gaps = 19/213 (8%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQV--FERELEILG 362
E+ KLE +G G FG V++ + N +I E D++ ++E+ +L
Sbjct: 4 ELFTKLEK------IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 57
Query: 363 SIKHINLVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA 421
+ G L TKL +I +YL GS D L E G L+ + I
Sbjct: 58 QCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSALDLL-EPGP----LDETQIATILREIL 111
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
+GL YLH + K IHRDIK++N+LL E+ E ++DFG+A L D + T V F +
Sbjct: 112 KGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-W 167
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+APE ++ K+D++S G+ +EL G+ P
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 69/225 (30%), Positives = 117/225 (52%), Gaps = 28/225 (12%)
Query: 305 EIIEKLEAL----------DEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV 353
EI+EKL + + +G G GTVY + G A+K+++ ++ ++
Sbjct: 3 EILEKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL 62
Query: 354 FERELEILGSIKHINLVN-LRGYCRLPATKL-LIYDYLSMGSLDDFLHE--HGEGQQLLN 409
E+ ++ KH N+VN L Y L +L ++ +YL+ GSL D + E EGQ
Sbjct: 63 IINEILVMRENKHPNIVNYLDSY--LVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---- 116
Query: 410 WSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469
+A + L + L +LH + ++IHRDIKS NILL + ++DFG + E++
Sbjct: 117 IAAVCRECL---QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170
Query: 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+T+V GT ++APE + K D++S G++ +E+V G+ P
Sbjct: 171 KRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (207), Expect = 2e-17
Identities = 67/229 (29%), Positives = 101/229 (44%), Gaps = 65/229 (28%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---------RELEILGSIKHI 367
+GSG +G V V G A+K+I VF+ RE+++L ++H
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHE 59
Query: 368 NLVNLRGYCRLPATK-----LLIYDYL---------SMGSLDD-----FLHEHGEGQQLL 408
N++ L R P+ + ++ + + S L D FL+ Q+L
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLY------QIL 113
Query: 409 NWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468
RGL YLH +IHRD+K SNIL++ N + + DFGLA+ + +E
Sbjct: 114 -------------RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
Query: 469 AHVTT----VVAGTFGYLAPE-YLQSGRATEKSDVYSFGVLLLELVTGK 512
VV T Y APE L S R T+ D++S G + EL+T K
Sbjct: 158 DEKGFLTEYVV--TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 51/200 (25%), Positives = 87/200 (43%), Gaps = 16/200 (8%)
Query: 319 VGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE----RELEILGSIKHINLVNLR 373
+G G +G VY+ G A+K+I E + RE+++L + H N++ L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
R L+++++ D + Q+ L S +GLA+ H
Sbjct: 65 DVFRHKGDLYLVFEFMDT----DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL-QSGRA 492
I+HRD+K N+L++ ++DFGLA+ T V T Y APE L
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGY 176
Query: 493 TEKSDVYSFGVLLLELVTGK 512
+ D++S G + EL++ +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 77/274 (28%), Positives = 119/274 (43%), Gaps = 35/274 (12%)
Query: 319 VGSGGFGTVYR-MVMNDCGTFAVK--RIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+G G FG V+ + D AVK R + + F +E IL H N+V L G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGV 61
Query: 376 CRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKI 435
C ++ + + G FL G L +++ +A G+ YL C
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYLESKHC--- 115
Query: 436 IHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT----FGYLAPEYLQSGR 491
IHRD+ + N L+ E +SDFG+++ +EE V G + APE L GR
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 492 ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR--LEDVIDKRCAD 549
+ +SDV+SFG+LL E + L V + N ++ R +E + C +
Sbjct: 173 YSSESDVWSFGILLWEAFS-------------LGAVPYANLSNQQTREAIEQGVRLPCPE 219
Query: 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
+ V ++E RC + +P RPS + V Q L
Sbjct: 220 LCPDAVYRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 49/132 (37%), Positives = 76/132 (57%), Gaps = 11/132 (8%)
Query: 387 DYLSMGSLDDFLHEHGE-GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNI 445
+++ GSLD L + G + +L KI++ RGL YL KI+HRD+K SNI
Sbjct: 79 EHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLREK--HKIMHRDVKPSNI 131
Query: 446 LLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLL 505
L++ E + DFG++ L+D A+ + V GT Y++PE LQ T +SD++S G+ L
Sbjct: 132 LVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSPERLQGTHYTVQSDIWSLGLSL 188
Query: 506 LELVTGKRPTDP 517
+E+ G+ P P
Sbjct: 189 VEMAIGRYPIPP 200
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 70/271 (25%), Positives = 121/271 (44%), Gaps = 31/271 (11%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRI--DRSREGSDQVFERELEILGSIKHINLVNL 372
++++G G GTVY+ AVK I D + E Q+ ELEIL ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMS-ELEILYKCDSPYIIGF 64
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDF--LHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
G + + +++ GSLD + + EH G +IA+ +GL YL
Sbjct: 65 YGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG----------RIAVAVVKGLTYLWS- 113
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
KI+HRD+K SN+L++ + + DFG++ LV+ + GT Y+APE +
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYMAPERISGE 168
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD- 549
+ SDV+S G+ +EL G+ P +G +L+ L+ ++D+
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPYPQIQKNQG--------SLMPLQLLQCIVDEDPPVL 220
Query: 550 ADMETVEAILEIAARCTDANPDDRPSMNQVL 580
+ E + +C P +RP+ ++
Sbjct: 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 74/258 (28%), Positives = 108/258 (41%), Gaps = 63/258 (24%)
Query: 295 FHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV 353
F Y + IE +GSG +G V + G A+K+I + D
Sbjct: 1 FDVGSRY---KPIEN---------IGSGAYGVVCSAIDTRSGKKVAIKKIPHA---FDVP 45
Query: 354 FE-----RELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHE--HGEGQ- 405
REL+IL KH N++ +R R P Y+ M ++ LH H +
Sbjct: 46 TLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDVYVVMDLMESDLHHIIHSDQPL 104
Query: 406 ----------QLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455
QLL RGL Y+H +IHRD+K SN+L++E+ E +
Sbjct: 105 TEEHIRYFLYQLL-------------RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRI 148
Query: 456 SDFGLAKLL----VDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVT 510
DFG+A+ L + + +T VA T Y APE L S T D++S G + E++
Sbjct: 149 GDFGMARGLSSSPTEHKYFMTEYVA-TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML- 206
Query: 511 GKRPTDPTFVKRGLNVVG 528
G+R P G N V
Sbjct: 207 GRRQLFP-----GKNYVH 219
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQV--FERELEILGSIKHINLVNLRG 374
+ +G G FG VY+ + N +I E D++ ++E+ +L + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 375 YCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
L TKL +I +YL GS D L + + R + +GL YLH +
Sbjct: 70 -SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-----KGLDYLHSE--- 120
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
+ IHRDIK++N+LL E + ++DFG+A L D + T V F ++APE ++
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYD 179
Query: 494 EKSDVYSFGVLLLELVTGKRP 514
K+D++S G+ +EL G+ P
Sbjct: 180 FKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 5e-17
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQ-----VFERELEILGSIKHINLVN 371
++G GGFG VY D G +A+K +D+ R Q + ER + L S +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 372 LRGYCRLPATKL-LIYDYLSMGSLDDFLHEHG--EGQQLLNWSARLKIALGSARGLAYLH 428
Y KL I D ++ G L L +HG ++ ++A + + GL ++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL------GLEHMH 114
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
+ +++RD+K +NILLDE+ +SD GLA ++ H + GT GY+APE LQ
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQ 168
Query: 489 SGRATEKS-DVYSFGVLLLELVTGKRP 514
G A + S D +S G +L +L+ G P
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 26/210 (12%)
Query: 318 VVGSGGFGTVYRMVMN---DCG-TFAVKRIDRS---REGSDQVFER-ELEILGSIKHINL 369
V+G GG+G V+++ D G FA+K + ++ R D + E IL ++KH +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 370 VNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLN----WSARLKIALGSARGL 424
V+L Y KL LI +YLS G L F+H EG + + + + + +AL
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALE----- 114
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
+LH II+RD+K NILLD ++DFGL K + E VT GT Y+AP
Sbjct: 115 -HLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESI-HEGTVTHTFCGTIEYMAP 169
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
E L + D +S G L+ +++TG P
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 29/209 (13%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRID-----RSREGSDQVFERELEILGSIKHINLV 370
+G+G FG V + G +A+K + + ++ + V E IL SI+H LV
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHV-LNEKRILQSIRHPFLV 64
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG--EGQQLLNWSARLKIALGSARGLAYLH 428
NL G + + L+ +Y+ G L L + G ++A++ +AL YLH
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALE------YLH 118
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
I++RD+K N+LLD + ++DFG AK + T + GT YLAPE +
Sbjct: 119 SL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG----RTYTLCGTPEYLAPEIIL 171
Query: 489 S---GRATEKSDVYSFGVLLLELVTGKRP 514
S G+A D ++ G+L+ E++ G P
Sbjct: 172 SKGYGKA---VDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 8e-17
Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 34/271 (12%)
Query: 319 VGSGGFGTVYRMVMN--DCGTFAVKRIDRSREGSDQVFE--RELEILGSIKHINLVNLRG 374
+G G FG +V + D + +K I+ S+ + E +E+ +L ++KH N+V +
Sbjct: 8 IGEGSFGKAI-LVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHG----EGQQLLNWSARLKIALGSARGLAYLHHD 430
++ DY G L ++ Q+L+W ++ +AL HD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHV-------HD 119
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
KI+HRDIKS NI L ++ + DFG+A++L + + GT YL+PE ++
Sbjct: 120 --RKILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYLSPEICENR 176
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
KSD+++ G +L E+ T K + +K N +LK +I
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---------NLVLK------IIRGSYPPV 221
Query: 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ + ++ NP DRPS+N +L+
Sbjct: 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 48/114 (42%), Positives = 62/114 (54%), Gaps = 5/114 (4%)
Query: 76 NLPYM-----QLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYL 130
NL Y+ +L G I PSI L KL L L NSL G IP + L L+L +N
Sbjct: 261 NLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF 320
Query: 131 QGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
G IP + +L L +L L SN G IP +LG+ +L L+LSTN +GEIP+
Sbjct: 321 TGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
|
Length = 968 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 72/268 (26%), Positives = 120/268 (44%), Gaps = 27/268 (10%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYC 376
+GSG FG V+ A+K I EG S++ F E +++ + H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 377 RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKII 436
++ +++ G L ++L + Q L+ L + G+ YL + I
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFI 122
Query: 437 HRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKS 496
HRD+ + N L+ VSDFG+ + ++D+E ++ + PE + + KS
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182
Query: 497 DVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETV 555
DV+SFGVL+ E+ T GK P + K VV + + RL R A M
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEK---KSNYEVV---EMISRGFRL-----YRPKLASM--- 228
Query: 556 EAILEIAARCTDANPDDRPSMNQVLQLL 583
+ E+ C P+ RP+ ++L+ +
Sbjct: 229 -TVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 78/282 (27%), Positives = 122/282 (43%), Gaps = 33/282 (11%)
Query: 319 VGSGGFGTVYRMVMNDCGTF---AVK--RIDRSREGSDQVFERELEILGSIKHINLVNLR 373
+G G FG+V +N + AVK +I + F E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 374 GYC-------RLPATKLLIYDYLSMGSLDDFL--HEHGEGQQLLNWSARLKIALGSARGL 424
G C P+ ++I ++ G L FL G+ Q L +K A G+
Sbjct: 67 GVCLQTVESEGYPS-PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT-FGYLA 483
YL IHRD+ + N +L+EN+ V+DFGL+K + + + + +A ++A
Sbjct: 126 EYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543
E L T KSDV+SFGV + E+ T + P G+ + L + NRL+
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP-----GVENSEIYDYLRQGNRLKQPP 237
Query: 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
D C D + + + C NP DRPS + LE+
Sbjct: 238 D--CLD-------GLYSLMSSCWLLNPKDRPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 74/280 (26%), Positives = 133/280 (47%), Gaps = 22/280 (7%)
Query: 319 VGSGGFGTV----YRMVMNDCGTF-AVKRID-RSREGSDQVFERELEILGSIKHINLVNL 372
+G G FG V Y ++ G AVK + S ++E+EIL ++ H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 373 RGYCRLPATK--LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
+G C LI ++L GSL ++L + + +N +LK A+ +G+ YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT---VVAGTFGYLAPEYL 487
+ +HRD+ + N+L++ + + DFGL K + ++ + T + + F Y APE L
Sbjct: 129 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECL 184
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID--K 545
+ SDV+SFGV L EL+T ++ + + L ++G + + RL V++ K
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243
Query: 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
R E + ++ +C + P R + +++ E
Sbjct: 244 RLPRPP-NCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQ-----VFERELEILGSIKHINLVN 371
++G GGFG VY D G +A+K +D+ R Q + ER + L S +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 372 LRGYCRLPATKL-LIYDYLSMGSLDDFLHEHG--EGQQLLNWSARLKIALGSARGLAYLH 428
Y KL I D ++ G L L +HG +++ ++ + + GL ++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMH 114
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
+ +++RD+K +NILLDE+ +SD GLA ++ H + GT GY+APE LQ
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQ 168
Query: 489 SGRATEKS-DVYSFGVLLLELVTGKRP 514
G A + S D +S G +L +L+ G P
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 11/163 (6%)
Query: 356 RELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGE-GQQLLNWSARL 414
REL++L +V G + +++ GSLD L E +++L
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG----- 106
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
K+++ RGLAYL +I+HRD+K SNIL++ E + DFG++ L+D A+
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS--- 161
Query: 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDP 517
GT Y++PE LQ + +SD++S G+ L+EL G+ P P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 55/291 (18%)
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV---FERELEILGSIK 365
L L+ + +GSG GTVY+++ G +A+K I + E D V RE+EIL +
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVN 130
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLA 425
H N+V ++ +++ GSL EG + + +A G+A
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSL--------EGTHIADEQFLADVARQILSGIA 182
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
YLH I+HRDIK SN+L++ ++DFG++++L + V GT Y++PE
Sbjct: 183 YLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE 238
Query: 486 YLQS--------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537
+ + G A D++S GV +LE G+ P G+ G +L+
Sbjct: 239 RINTDLNHGAYDGYA---GDIWSLGVSILEFYLGRFPF-------GVGRQGDWASLM--- 285
Query: 538 RLEDVIDKRCADADMETVEA-------ILEIAARCTDANPDDRPSMNQVLQ 581
CA + EA + C P R S Q+LQ
Sbjct: 286 ---------CAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT----FAVKRIDRSREGSDQV-FERELEILGSIKHINLV 370
E ++G+G FG + R + A+ + + F E LG H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
L G T +++ +Y+S G+LD FL +H EGQ L + + G A G+ YL
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQ--LVAGQLMGMLPGLASGMKYLSE- 125
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL--APEYLQ 488
+H+ + + +L++ +L +S F +L D+ + T ++G L APE +Q
Sbjct: 126 --MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 489 SGRATEKSDVYSFGVLLLELVT-GKRP 514
+ SDV+SFG+++ E+++ G+RP
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVKRI---DRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+G+G G V+++ G +++ + +Q+ REL++L +V G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII-RELQVLHECNSPYIVGFYGA 71
Query: 376 CRLPATKLLIYDYLSMGSLDDFLHEHGE-GQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
+ +++ GSLD L + G +Q+L K+++ +GL YL K
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREK--HK 124
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATE 494
I+HRD+K SNIL++ E + DFG++ L+D A+ GT Y++PE LQ +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSV 181
Query: 495 KSDVYSFGVLLLELVTGKRPTDP 517
+SD++S G+ L+E+ G+ P P
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 3e-16
Identities = 58/221 (26%), Positives = 111/221 (50%), Gaps = 20/221 (9%)
Query: 305 EIIEKLEAL----------DEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV 353
EI+EKL + + +G G GTV+ + G A+K+I+ ++ ++
Sbjct: 3 EIMEKLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL 62
Query: 354 FERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR 413
E+ ++ +K+ N+VN + ++ +YL+ GSL D + E ++ +
Sbjct: 63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQI 117
Query: 414 LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT 473
+ + L +LH + ++IHRDIKS N+LL + ++DFG + E++ +T
Sbjct: 118 AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174
Query: 474 VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+V GT ++APE + K D++S G++ +E+V G+ P
Sbjct: 175 MV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 67/207 (32%), Positives = 103/207 (49%), Gaps = 22/207 (10%)
Query: 318 VVGSGGFGTVY--RMVMN-DCGT-FAVKRIDRSREGSDQVFER-----ELEILGSIKHIN 368
V+G G FG V+ R + D G +A+K + ++ + +V +R E +IL + H
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVL---KKATLKVRDRVRTKMERDILAEVNHPF 59
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS-ARGLAYL 427
+V L + LI D+L G L L ++++ +K L A L +L
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAELALALDHL 114
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
H II+RD+K NILLDE ++DFGL+K +D E GT Y+APE +
Sbjct: 115 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVEYMAPEVV 170
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRP 514
T+ +D +SFGVL+ E++TG P
Sbjct: 171 NRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRG- 374
+V+G G +G VY+ G +I E ++ + E IL H N+ G
Sbjct: 12 EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71
Query: 375 -YCRLPATK----LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK------IALGSARG 423
+ P L+ + GS+ D + + L RLK I + RG
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRG 125
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
LAYLH + K+IHRDIK NILL +N E + DFG++ L T + GT ++A
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMA 181
Query: 484 PEYL---QSGRAT--EKSDVYSFGVLLLELVTGKRP 514
PE + + A+ +SDV+S G+ +EL GK P
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 26/209 (12%)
Query: 318 VVGSGGFGTVY-RMVMNDCGTFAVKRID------RSREGSDQVFERELEILGSIKHINLV 370
+G G FG +Y +D +K ID + +E S ++E+ +L +KH N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS----KKEVILLAKMKHPNIV 62
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLH-EHG---EGQQLLNWSARLKIALGSARGLAY 426
+ ++ +Y G L ++ + G Q+L+W ++I+LG L +
Sbjct: 63 TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF--VQISLG----LKH 116
Query: 427 LHHDCCPKIIHRDIKSSNILLDEN-LEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
+H KI+HRDIKS NI L +N + + DFG+A+ L D T V GT YL+PE
Sbjct: 117 IHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPE 172
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRP 514
Q+ K+D++S G +L EL T K P
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 73/275 (26%), Positives = 109/275 (39%), Gaps = 36/275 (13%)
Query: 318 VVGSGGFGTVYRMVMNDCGT---FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRG 374
V+G G +G VY D T A+K I Q E+ + +KH N+V G
Sbjct: 15 VLGKGTYGIVY--AARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
+ + + GSL L G N + GL YLH + +
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---Q 128
Query: 435 IIHRDIKSSNILLDE-NLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG-RA 492
I+HRDIK N+L++ + +SDFG +K L T GT Y+APE + G R
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRG 187
Query: 493 TEK-SDVYSFGVLLLELVTGKRPTDPTFVKRG-----LNVVGWMNTLLKENRLEDVIDKR 546
+D++S G ++E+ TGK P F++ G + VG K
Sbjct: 188 YGAPADIWSLGCTIVEMATGK----PPFIELGEPQAAMFKVGMF--------------KI 229
Query: 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ RC + +PD R S + +LQ
Sbjct: 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 319 VGSGGFGTVYR------MVMNDCGTFAVKRIDRSREGSDQV---FERELEILGSIKHINL 369
+G G FG V++ + AVK + E S + F+RE ++ H N+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDHPNI 70
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHE------------------HGEGQQLLNWS 411
V L G C + L+++Y++ G L++FL G L+ +
Sbjct: 71 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA-KLLVDEEAH 470
+L IA A G+AYL K +HRD+ + N L+ EN+ ++DFGL+ + +
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187
Query: 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLEL 508
+ A ++ PE + R T +SDV+++GV+L E+
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 8e-16
Identities = 77/291 (26%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 305 EIIEKLEAL----------DEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV 353
EI+EKL ++ + +G G GTVY + G A+K+++ ++ ++
Sbjct: 3 EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL 62
Query: 354 FERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHE--HGEGQQLLNWS 411
E+ ++ K+ N+VN + ++ +YL+ GSL D + E EGQ +
Sbjct: 63 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ----IA 118
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471
A + L + L +LH + ++IHRDIKS NILL + ++DFG + E++
Sbjct: 119 AVCRECL---QALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 172
Query: 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN 531
+T+V GT ++APE + K D++S G++ +E+V G+ P R L ++
Sbjct: 173 STMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231
Query: 532 TLLKENRLEDVIDKRCADADMETVEAIL-EIAARCTDANPDDRPSMNQVLQ 581
T +N E + A+ + RC + + D R S ++LQ
Sbjct: 232 TPELQNP--------------ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 65/219 (29%), Positives = 112/219 (51%), Gaps = 19/219 (8%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGS--DQVFERELEILGSI 364
+++E LDE +G G +G+VY+++ G T A+K I + S +Q+ EL+IL
Sbjct: 1 DEIEVLDE---LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII-MELDILHKA 56
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
+V+ G + + +Y+ GSLD L+ G + + +I +GL
Sbjct: 57 VSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGL 115
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
+L + IIHRD+K +N+L++ N + + DFG++ LV A + G Y+AP
Sbjct: 116 KFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTNIGCQSYMAP 170
Query: 485 EYLQSGRATE------KSDVYSFGVLLLELVTGKRPTDP 517
E ++SG + +SDV+S G+ +LE+ G+ P P
Sbjct: 171 ERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRID-----RSREGSDQVFERELEILGSIKHIN-LVN 371
+G G FG VY++ D +A+K + +E + + ER + + + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH-HD 430
L+ + + L+ DY+S G L F H EG+ A+ IA L +LH +D
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGR-FSEDRAKFYIA-ELVLALEHLHKYD 116
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
I++RD+K NILLD + DFGL+K + + T GT YLAPE L
Sbjct: 117 ----IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDE 171
Query: 491 RA-TEKSDVYSFGVLLLELVTGKRP 514
+ T+ D +S GVL+ E+ G P
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 28/220 (12%)
Query: 307 IEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRS--REGSDQVFERELEI-LG 362
+ LE L E +GSG G VY+M G AVK++ R+ +E + ++ +L++ L
Sbjct: 14 LNDLENLGE---IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRIL-MDLDVVLK 69
Query: 363 SIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLH--EHGEGQQLLNWSARLKIALGS 420
S +V G + + + I L LD L + + +L K+ +
Sbjct: 70 SHDCPYIVKCYG-YFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMTVAI 123
Query: 421 ARGLAYL--HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT 478
+ L YL H +IHRD+K SNILLD + + DFG++ LVD +A T AG
Sbjct: 124 VKALHYLKEKHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGC 177
Query: 479 FGYLAPEYLQSGRATEK----SDVYSFGVLLLELVTGKRP 514
Y+APE + K +DV+S G+ L+EL TG+ P
Sbjct: 178 AAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 36/284 (12%)
Query: 318 VVGSGGFGTVYRMVMN-DCGTF---AVKRIDRSREGSDQV--FERELEILGSIKHINLVN 371
++G G FG+V + + G+F AVK + S + F RE + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 372 L-------RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR--LKIALGSAR 422
L R RLP ++I ++ G L FL G++ + ++ + A
Sbjct: 66 LIGVSLRSRAKGRLP-IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG-TFGY 481
G+ YL IHRD+ + N +L+EN+ V+DFGL+K + + + + +
Sbjct: 125 GMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540
LA E L T SDV++FGV + E++T G+ P G+ N L+K NRL+
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY------AGVENSEIYNYLIKGNRLK 235
Query: 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
+ +E + E+ +C P RPS + LE
Sbjct: 236 Q---------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 78/308 (25%), Positives = 135/308 (43%), Gaps = 68/308 (22%)
Query: 317 DVVGSGGFGTVYRMVMND-----CGTFAVKRI-DRSREGSDQVFERELEILGSIKHINLV 370
D++ G FG ++ ++ D VK + D + E + +E +L + H N++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 371 NLRGYC-RLPATKLLIYDYLSMGSLDDFLHE--HGEGQQLLNWSARLKIALGS--ARGLA 425
+ C ++Y Y++ G+L FL + GE S + + + A G++
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG----- 480
YLH +IH+DI + N ++DE L+ ++D L++ L + H G
Sbjct: 132 YLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH-------CLGDNENR 181
Query: 481 ---YLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP---TDP----TFVKRGLNVVGW 529
++A E L + + SDV+SFGVLL EL+T G+ P DP ++K G
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY----- 236
Query: 530 MNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589
RL I+ C D + + A C +P++RPS +Q++Q
Sbjct: 237 --------RLAQPIN--CPD-------ELFAVMACCWALDPEERPSFSQLVQ-------- 271
Query: 590 PCPSDFYE 597
C +DF+
Sbjct: 272 -CLTDFHA 278
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 57/153 (37%), Positives = 74/153 (48%), Gaps = 19/153 (12%)
Query: 369 LVNLRGYCRLPATKL-LIYDYLSMGSLDDFLH----EHGEGQQLLNWSARLKIALGSARG 423
LV L Y TKL LI DY++ G L F H EH ++ + A + +AL
Sbjct: 67 LVTLH-YAFQTDTKLHLILDYVNGGEL--FTHLYQREHFTESEVRVYIAEIVLALDH--- 120
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
LH II+RDIK NILLD ++DFGL+K + EE GT Y+A
Sbjct: 121 ---LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 484 PEYLQSGRATEKS--DVYSFGVLLLELVTGKRP 514
PE ++ G D +S GVL EL+TG P
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 78/287 (27%), Positives = 129/287 (44%), Gaps = 42/287 (14%)
Query: 319 VGSGGFGTVYRMVMND---CGT----FAVKRIDRSREGSDQV-FERELEILGSIKHINLV 370
+GSG FG VY D G+ AVK + + ++ F +E ++ + H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHE---HGEGQQLLNWSARLKIALGSARGLAYL 427
L G C L + +I + + G L +L + G LL L I L A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEP-----HVSDFGLAKLLVDEEAHVTTVVAGT---- 478
IHRD+ + N L+ E + DFGLA+ + + + G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR---KEGEGLLP 176
Query: 479 FGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKEN 537
++APE L G+ T +SDV+SFGVL+ E++T G++P LN + +
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP------ALNNQEVLQHVTAGG 230
Query: 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
RL+ + C D I ++ C +P +RP+ +++ ++L+
Sbjct: 231 RLQK--PENCPD-------KIYQLMTNCWAQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 2e-15
Identities = 78/303 (25%), Positives = 141/303 (46%), Gaps = 39/303 (12%)
Query: 305 EIIEKLEAL----------DEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV 353
EI+EKL ++ + +G G GTVY + G A+++++ ++ ++
Sbjct: 4 EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63
Query: 354 FERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHE--HGEGQQLLNWS 411
E+ ++ K+ N+VN + ++ +YL+ GSL D + E EGQ +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ----IA 119
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471
A + L + L +LH + ++IHRDIKS NILL + ++DFG + E++
Sbjct: 120 AVCRECL---QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN 531
+T+V GT ++APE + K D++S G++ +E++ G+ P R L ++
Sbjct: 174 STMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232
Query: 532 TLLKENRLEDVIDKRCADADMETVEAIL-EIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
T +N E + AI + RC D + + R S ++LQ ++ P
Sbjct: 233 TPELQNP--------------EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
Query: 591 CPS 593
S
Sbjct: 279 LSS 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 318 VVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE---RELEILGSIKHINLVNLR 373
VVG G +G V + G A+K+ + E + V + RE+++L ++H N+VNL+
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
R L+++Y+ L+ L G L A + +AY H
Sbjct: 67 EAFRRKGRLYLVFEYVERTLLEL-LEASPGG---LPPDAVRSYIWQLLQAIAYCHSH--- 119
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE-EAHVTTVVAGTFGYLAPEYLQSGRA 492
IIHRDIK NIL+ E+ + DFG A+ L + +T VA T Y APE L
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178
Query: 493 TEKS-DVYSFGVLLLELVTGKRPTDP 517
K DV++ G ++ EL+ G P P
Sbjct: 179 YGKPVDVWAIGCIMAELLDG-EPLFP 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRID---RSREGSDQV--FERELEILGSIKHINLVN 371
++G G FG VY D G A K++ S E S +V E E+++L +++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 372 LRGYCRLPATKLL--IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429
G R A K L +Y+ GS+ D L +G L S K G++YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEGMSYLHS 124
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV--VAGTFGYLAPEYL 487
+ I+HRDIK +NIL D + DFG +K L T + V GT +++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVI 181
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRP 514
K+DV+S G ++E++T K P
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 319 VGSGGFGTVYRMVMNDCGT-FAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRG 374
+G GGFG V + + + G +A K++D+ R + +++ E EIL + +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 375 YCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
Y T L L+ ++ G L H + G++ L + + G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
I++RD+K N+LLD+ +SD GLA L ++ T AGT GY+APE L+ +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVEL--KDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 494 EKSDVYSFGVLLLELVTGKRP 514
D ++ G + E+V G+ P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 56/245 (22%), Positives = 106/245 (43%), Gaps = 42/245 (17%)
Query: 353 VFERELEILGSIKHINLVNLRGY--------CRLPATKLLIYDYLSMGSLDDFLHEHGEG 404
+ E E++ L I N++ + G+ RL LI +Y + G L + L +
Sbjct: 64 ITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL----SLILEYCTRGYLREVLDK---- 115
Query: 405 QQLLNWSARLKIALGSARGLAYLH-HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463
++ L++ +L +A+ +GL L+ + P ++++ S + L+ EN + + GL K+
Sbjct: 116 EKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKI 172
Query: 464 L-VDEEAHVTTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRPTDPTFV 520
L +V +V Y + + L T K D+YS GV+L E+ TGK P +
Sbjct: 173 LSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE---- 223
Query: 521 KRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVL 580
L + ++ +N + ++ I I CT + RP++ ++L
Sbjct: 224 --NLTTKEIYDLIINKNNSLKL--------PLDCPLEIKCIVEACTSHDSIKRPNIKEIL 273
Query: 581 QLLEQ 585
L
Sbjct: 274 YNLSL 278
|
Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 68/203 (33%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 318 VVGSGGFGTVYRMVMNDCGTF-AVK-----RIDRSREGSDQVFERELEILGSIKHINLVN 371
V+G G FG V G+F AVK I + +E + + ER + +L ++KH LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLVG 60
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC 431
L + + DY++ G L F H E + L AR A A + YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGEL--FFHLQRE-RCFLEPRARF-YAAEVASAIGYLH--- 113
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR 491
II+RD+K NILLD ++DFGL K V+ E T+ GT YLAPE L+
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-TTSTFCGTPEYLAPEVLRKEP 172
Query: 492 ATEKSDVYSFGVLLLELVTGKRP 514
D + G +L E++ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-15
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 25/224 (11%)
Query: 318 VVGSGGFGTVYRMV-MNDCGTFAVKRIDRSREGSD-QVFERELEILGSIKHINLVNLRGY 375
VVG G FG + +N +A+K I + S + +E +L +KH N+V +
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 376 CRLPATKLLIYDYLSMGSL-DDFLHEHGE---GQQLLNWSARLKIALGSARGLAYLHHDC 431
++ +Y G L + G+ +L W ++ + G+ ++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK- 119
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR 491
+++HRDIKS NI L +N + + DFG A+LL A+ T V GT Y+ PE ++
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 492 ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535
KSD++S G +L EL T K P W N +LK
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHP---------FQANSWKNLILK 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-15
Identities = 46/104 (44%), Positives = 58/104 (55%)
Query: 81 QLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGN 140
QL G I +G++ L+ + L N+L G IP EI T L L L N L G IP+++GN
Sbjct: 199 QLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGN 258
Query: 141 LLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
L L L L N L G IP S+ L L L+LS N SGEIP+
Sbjct: 259 LKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
|
Length = 968 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 73/256 (28%), Positives = 118/256 (46%), Gaps = 45/256 (17%)
Query: 350 SDQVFEREL-EILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG---- 404
SD + E E+ +++G KH N++NL G C +I +Y S G+L ++L
Sbjct: 68 SDLISEMEMMKMIG--KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY 125
Query: 405 --------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS 456
++ L++ + A ARG+ YL C IHRD+ + N+L+ E+ ++
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIA 182
Query: 457 DFGLAKLLVDEEAHVTTVVAGTFG-----YLAPEYLQSGRATEKSDVYSFGVLLLELVT- 510
DFGLA+ + H+ T G ++APE L T +SDV+SFGVLL E+ T
Sbjct: 183 DFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238
Query: 511 GKRPTDPTFVKRGLNVVGWMNTLLKE-NRLEDVIDKRCADADMETVEAILEIAARCTDAN 569
G P V+ + LLKE +R+ D + + C A
Sbjct: 239 GGSPYPGVPVEE-------LFKLLKEGHRM---------DKPSNCTNELYMMMRDCWHAV 282
Query: 570 PDDRPSMNQVLQLLEQ 585
P RP+ Q+++ L++
Sbjct: 283 PSQRPTFKQLVEDLDR 298
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 17/207 (8%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRID---RSREGSDQV--FERELEILGSIKHINLVN 371
++G G FG VY D G AVK++ S+E S +V E E+++L +++H +V
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 372 LRGYCRLPAT-KLLIY-DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429
G R P KL I+ +Y+ GS+ D L +G L + + +G++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQGVSYLHS 124
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV--VAGTFGYLAPEYL 487
+ I+HRDIK +NIL D + DFG +K + T + V GT +++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRP 514
K+DV+S ++E++T K P
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 6e-15
Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRID---RSREGSDQV--FERELEILGSIKHINLVN 371
++G G FG VY D G AVK++ S E S +V E E+++L ++ H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 372 LRGYCRLPATKLL--IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429
G R P + L +++ GS+ D L +G L + K G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA----LTENVTRKYTRQILEGVSYLHS 124
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV--VAGTFGYLAPEYL 487
+ I+HRDIK +NIL D + DFG +K L T + V GT +++PE +
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRP 514
K+D++S G ++E++T K P
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 80/293 (27%), Positives = 135/293 (46%), Gaps = 46/293 (15%)
Query: 319 VGSGGFGTVYRMVM--------NDCGTFAVKRIDRS---REGSDQVFEREL-EILGSIKH 366
+G G FG V R + T AVK + + ++ +D + E EL +++G KH
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG--KH 77
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGE------------GQQLLNWSARL 414
N++NL G C +I +Y + G+L +FL ++ L++ +
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
A ARG+ YL C IHRD+ + N+L+ E+ ++DFGLA+ + D + + T
Sbjct: 138 SCAYQVARGMEYLESRRC---IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS 194
Query: 475 VAGT-FGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNT 532
++APE L T +SDV+SFG+L+ E+ T G P V+ +
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-------LFK 247
Query: 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
LL+E D + ++ E + E C A P RP+ Q+++ L++
Sbjct: 248 LLREGHRMD----KPSNCTHELYMLMRE----CWHAVPTQRPTFKQLVEALDK 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 7e-15
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE----RELEILG 362
EK E L + +G G +G V++ + G A+K+ S + D V + RE+ +L
Sbjct: 1 EKYEKLSK---IGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLK 55
Query: 363 SIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDF-LHEHGEGQQLLNWSARLKIALGSA 421
+KH NLVNL R L+++Y L++ + G + L+ KI +
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQTL 110
Query: 422 RGLAYLH-HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480
+ + + H H+C IHRD+K NIL+ + + + DFG A++L T VA T
Sbjct: 111 QAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRW 165
Query: 481 YLAPEYL----QSGRATEKSDVYSFGVLLLELVTG 511
Y APE L Q G DV++ G + EL+TG
Sbjct: 166 YRAPELLVGDTQYGPPV---DVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 319 VGSGGFGTVYRMVMNDCGT-FAVKRIDR---SREGSDQVFERELEILGSIKHINLVNLRG 374
VGSG +G V G A+K++ R S + + + REL +L + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLD 81
Query: 375 YCRLPATKLLIYD--YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
PA+ L + YL + L+ + Q+L + + + RGL Y+H
Sbjct: 82 -VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYIH---S 136
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE-YLQSGR 491
IIHRD+K SNI ++E+ E + DFGLA+ DE +T VA T Y APE L
Sbjct: 137 AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVA-TRWYRAPEIMLNWMH 192
Query: 492 ATEKSDVYSFGVLLLELVTGK---RPTDPTF-VKRGLNVVG 528
+ D++S G ++ EL+TGK +D +KR +N+VG
Sbjct: 193 YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 75/285 (26%), Positives = 111/285 (38%), Gaps = 39/285 (13%)
Query: 318 VVGSGGFGTVY----RMVMNDCGTFAVKRIDR---SREGSDQVFERELEILGSIKHINLV 370
+G G FG VY R D V E + F E I+ H N+V
Sbjct: 13 ALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72
Query: 371 NLRGYC--RLPATKLLIYDYLSMGSLDDFLHE---HGEGQQLLNWSARLKIALGSARGLA 425
L G RLP + ++ + ++ G L FL E E L L A A+G
Sbjct: 73 RLIGVSFERLP--RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCK 130
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHV---SDFGLAKLLVDEEAHVTTVVAG-TFGY 481
YL + IHRDI + N LL V +DFG+A+ + + A +
Sbjct: 131 YLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR--L 539
+ PE G T K+DV+SFGVLL E+ + +G+M + N+ +
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS----------------LGYMPYPGRTNQEVM 231
Query: 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
E V D + I C P+DRP+ +L+ ++
Sbjct: 232 EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 9e-15
Identities = 53/207 (25%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 318 VVGSGGFGTVYRMV-MNDCGTFAVKRI--DRSREGSDQVFERELEILGSIKHINLVNLRG 374
VVG G FG V+ D +K+I ++ + + E ++L + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHG----EGQQLLNWSARLKIALGSARGLAYLHHD 430
+++ +Y G+L +++ + + +L++ ++ +AL HH
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL---------HHV 117
Query: 431 CCPKIIHRDIKSSNILLDEN-LEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS 489
I+HRD+K+ NILLD++ + + DFG++K+L + T V GT Y++PE +
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEG 175
Query: 490 GRATEKSDVYSFGVLLLELVTGKRPTD 516
+KSD+++ G +L EL + KR +
Sbjct: 176 KPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 1e-14
Identities = 87/308 (28%), Positives = 139/308 (45%), Gaps = 55/308 (17%)
Query: 319 VGSGGFGTVYRMVM-----------NDCGTFAVKRID---RSREGSDQVFEREL-EILGS 363
+G G FG V VM N T AVK + ++ SD V E E+ +++G
Sbjct: 20 LGEGCFGQV---VMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG- 75
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG------------QQLLNWS 411
KH N++NL G C ++ +Y S G+L ++L ++ L +
Sbjct: 76 -KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471
+ A ARG+ YL C IHRD+ + N+L+ E+ ++DFGLA+ + + + +
Sbjct: 135 DLVSCAYQVARGMEYLASQKC---IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYK 191
Query: 472 TTVVAG-TFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGW 529
T ++APE L T +SDV+SFGVLL E+ T G P V+
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------- 244
Query: 530 MNTLLKE-NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588
+ LLKE +R+ D + I C A P RP+ Q+++ L++ V+
Sbjct: 245 LFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDR-VL 294
Query: 589 SPCPSDFY 596
+ +D Y
Sbjct: 295 TVTSTDEY 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 44/114 (38%), Positives = 62/114 (54%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
Q++ S++L L G I + +L L+ L L N+ G IP +T+ L+ L L +N
Sbjct: 284 QKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP 183
G IP N+G LT+LDLS+N+L G IP L +L L L +N GEIP
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIP 397
|
Length = 968 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 67/214 (31%), Positives = 103/214 (48%), Gaps = 16/214 (7%)
Query: 309 KLEALDEEDVVGSGGFGTVY--RMVMNDCGTFAVKRID-RSREGSDQVFERELEILGSIK 365
KLE + D +G G + TVY R + D A+K I EG+ RE+ +L +K
Sbjct: 4 KLETYIKLDKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLA 425
H N+V L + L+++YL L +L + G + N L L RGL
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLL---RGLN 118
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL-LVDEEAHVTTVVAGTFGYLAP 484
Y H K++HRD+K N+L++E E ++DFGLA+ + + + VV T Y P
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPP 173
Query: 485 E-YLQSGRATEKSDVYSFGVLLLELVTGKRPTDP 517
+ L S + + D++ G + E+ TG RP P
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 72/299 (24%), Positives = 133/299 (44%), Gaps = 44/299 (14%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDC------GTFAVKRIDRSREGSDQV-FERELEI 360
EK+ L E +G G FG VY D AVK ++ S +++ F E +
Sbjct: 6 EKITLLRE---LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 62
Query: 361 LGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLH------EHGEGQQLLNWSARL 414
+ ++V L G L++ + ++ G L +L E+ G+ +
Sbjct: 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMI 122
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
++A A G+AYL+ K +HRD+ + N ++ + + DFG+ + + + + +
Sbjct: 123 QMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRK-- 177
Query: 475 VAGTFG-----YLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVG 528
G G ++APE L+ G T SD++SFGV+L E+ + ++P +GL+
Sbjct: 178 --GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY------QGLS--- 226
Query: 529 WMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587
E L+ V+D D E + ++ C NP RP+ +++ LL+ ++
Sbjct: 227 ------NEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 66/210 (31%), Positives = 102/210 (48%), Gaps = 32/210 (15%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSD-QVFERELEILGSIKHINLVNLRGYCR 377
VGSG +G VY+ G A +I + G D + ++E+ ++ KH N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG-SY 75
Query: 378 LPATKLLI-YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIAL---GSARGLAYLHHDCCP 433
L KL I +Y GSL D H G + L+IA + +GLAYLH
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGP-------LSELQIAYVCRETLQGLAYLHSK--- 125
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA------GTFGYLAPEYL 487
+HRDIK +NILL +N + ++DFG+A A +T +A GT ++APE
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKSFIGTPYWMAPEVA 178
Query: 488 ---QSGRATEKSDVYSFGVLLLELVTGKRP 514
++G + D+++ G+ +EL + P
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 319 VGSGGFGTVYRMVMNDCGTF------AVKRIDRSREGSDQVFERELEILGSIKHINLVNL 372
VG+G FG V+ + + A+ + R ++ +Q E +L + H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ--EQHVHNEKRVLKEVSHPFIIRL 66
Query: 373 RGYCRLPATKLL--IYDYLSMGSLDDFLHEHGE--GQQLLNWSARLKIALGSARGLAYLH 428
+ + L + +Y+ G L +L G L +++ + AL YLH
Sbjct: 67 --FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL------EYLH 118
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
+I++RD+K NILLD+ ++DFG AK L D T + GT YLAPE +Q
Sbjct: 119 SK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----TWTLCGTPEYLAPEVIQ 171
Query: 489 SGRATEKSDVYSFGVLLLELVTGKRP 514
S + D ++ G+L+ E++ G P
Sbjct: 172 SKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 74/265 (27%), Positives = 120/265 (45%), Gaps = 34/265 (12%)
Query: 337 TFAVKRI-DRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSMGSL 394
T AVK + D + E E+E++ I KH N++NL G C +I +Y S G+L
Sbjct: 49 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 108
Query: 395 DDFLHEHGE------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKS 442
++L + + + + ARG+ YL C IHRD+ +
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC---IHRDLAA 165
Query: 443 SNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG-TFGYLAPEYLQSGRATEKSDVYSF 501
N+L+ EN ++DFGLA+ + + + + T ++APE L T +SDV+SF
Sbjct: 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 225
Query: 502 GVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILE 560
GVL+ E+ T G P V+ + LLKE D + A+ E +
Sbjct: 226 GVLMWEIFTLGGSPYPGIPVEE-------LFKLLKEGHRMD----KPANCTNE----LYM 270
Query: 561 IAARCTDANPDDRPSMNQVLQLLEQ 585
+ C A P RP+ Q+++ L++
Sbjct: 271 MMRDCWHAIPSHRPTFKQLVEDLDR 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 72/227 (31%), Positives = 112/227 (49%), Gaps = 21/227 (9%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRID-RSREGSDQVFERELEILGSIKH 366
KLE + D +G G + TV++ A+K I EG+ RE+ +L ++KH
Sbjct: 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH 62
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA-RGLA 425
N+V L L+++YL L +L G + N +KI + RGL+
Sbjct: 63 ANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHN----VKIFMFQLLRGLS 117
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL-LVDEEAHVTTVVAGTFGYLAP 484
Y H KI+HRD+K N+L++E E ++DFGLA+ V + + VV T Y P
Sbjct: 118 YCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPP 172
Query: 485 EYLQSGRATEKS---DVYSFGVLLLELVTGKRPTDP-TFVKRGLNVV 527
+ L +TE S D++ G +L E+ TG RP P + VK L+++
Sbjct: 173 DVLLG--STEYSTPIDMWGVGCILYEMATG-RPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 43/213 (20%)
Query: 319 VGSGGFGTVYRMV-MNDCGTFAVK--RIDRSREGSDQVFERELEILGSIK---HINLVNL 372
+G G +GTVY+ +N A+K R+ S EG RE+ +L ++ H N+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 373 RGYCRLPATK-----LLIYDYLSMGSLDDFLHEHGEG-----------QQLLNWSARLKI 416
C P T L+++++ L +L + + +QLL
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL-------- 117
Query: 417 ALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA 476
RG+ +LH +I+HRD+K NIL+ + + ++DFGLA++ E +T+VV
Sbjct: 118 -----RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTSVVV 168
Query: 477 GTFGYLAPEYL-QSGRATEKSDVYSFGVLLLEL 508
T Y APE L QS AT D++S G + EL
Sbjct: 169 -TLWYRAPEVLLQSSYAT-PVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 32/214 (14%)
Query: 319 VGSGGFGTVY---RMVMNDCGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNL 372
+ G +G V+ + D +A+K I ++ R+ E +IL + +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 373 RGYCRLPATK--LLIYDYLSMGSLDDFLHEHG--EGQQLLNWSARLKIALGSARGLAYLH 428
Y K L+ +YL G L L G + + A + +AL YLH
Sbjct: 59 --YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLAL------EYLH 110
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL--------LVDEEAHVTTVVAGTFG 480
+ IIHRD+K NIL+D N ++DFGL+K+ L D+E +V GT
Sbjct: 111 SN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIV-GTPD 166
Query: 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
Y+APE + ++ D +S G +L E + G P
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 66/236 (27%), Positives = 109/236 (46%), Gaps = 47/236 (19%)
Query: 301 YPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRI--DRSREGSDQVFERE 357
+P C+ + K E L + +G G FG V++ A+K++ + +EG RE
Sbjct: 5 FPFCDEVSKYEKLAK---IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE 61
Query: 358 LEILGSIKHINLVNLRGYCRLPATK--------LLIYDY--------LSMGSLDDFLHEH 401
++IL +KH N+VNL CR AT L++++ LS ++ L E
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEI 121
Query: 402 GE-GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460
+ + LLN GL Y+H + KI+HRD+K++NIL+ ++ ++DFGL
Sbjct: 122 KKVMKMLLN-------------GLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165
Query: 461 AKLLVDEEA-----HVTTVVAGTFGYLAPEYLQSGRATEKS-DVYSFGVLLLELVT 510
A+ + + VV T Y PE L R D++ G ++ E+ T
Sbjct: 166 ARAFSLSKNSKPNRYTNRVV--TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 69/216 (31%), Positives = 105/216 (48%), Gaps = 20/216 (9%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRID-RSREGSDQVFERELEILGSIKH 366
KLE + D +G G + TVY+ G A+K I EG+ RE +L +KH
Sbjct: 3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH 62
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS-ARGLA 425
N+V L T L+++YL L ++ + G G + N +++ L RGLA
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHN----VRLFLFQLLRGLA 117
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL-LVDEEAHVTTVVAGTFGYLAP 484
Y H +++HRD+K N+L+ E E ++DFGLA+ V + + VV T Y P
Sbjct: 118 YCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPP 172
Query: 485 EYLQSGRATEKS---DVYSFGVLLLELVTGKRPTDP 517
+ L +TE S D++ G + E+ TG RP P
Sbjct: 173 DVLLG--STEYSTSLDMWGVGCIFYEMATG-RPLFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 71/286 (24%), Positives = 127/286 (44%), Gaps = 61/286 (21%)
Query: 318 VVGSGGFGTVYRMVMN--DCGTFAVKRID------RSREGSDQVFERELEILGSIKHINL 369
VVG G +G V +V + D + +K+++ R R+ ++Q E ++L +KH N+
Sbjct: 7 VVGKGSYGEV-SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ----EAQLLSQLKHPNI 61
Query: 370 VNLR-----GYCRLPATKLLIYDYLSMGSLD--DFLHEHGEGQ-------QLLNWSARLK 415
V R L Y+ MG + D H+ E + Q++ W ++
Sbjct: 62 VAYRESWEGEDGLL---------YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIA 112
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
+AL YLH I+HRD+K+ N+ L V D G+A++L ++ +T++
Sbjct: 113 MAL------QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI 163
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535
GT Y++PE + KSDV++ G + E+ T +K N MN+L+
Sbjct: 164 -GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT---------LKHAFNAKD-MNSLVY 212
Query: 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+I+ + + + E+ A P+ RPS+ +L+
Sbjct: 213 R-----IIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 66/286 (23%), Positives = 128/286 (44%), Gaps = 41/286 (14%)
Query: 319 VGSGGFGTVYR-----MVMNDCGT-FAVKRIDRSREGSDQV-FERELEILGSIKHINLVN 371
+G G FG VY +V ++ T A+K ++ + +++ F E ++ ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLH------EHGEGQQLLNWSARLKIALGSARGLA 425
L G L+I + ++ G L +L E+ Q + +++A A G+A
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG----- 480
YL+ + K +HRD+ + N ++ E+ + DFG+ + + + + + G G
Sbjct: 134 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK----GGKGLLPVR 186
Query: 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRL 539
+++PE L+ G T SDV+SFGV+L E+ T ++P + E L
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------YQGMSNEQVL 231
Query: 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
V++ D + + E+ C NP RPS +++ +++
Sbjct: 232 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 15/216 (6%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVM----NDCGTFAVKRIDRSREGSD-QVFERELE 359
EI + L +G G FG VY+ V N+ AVK S + F +E
Sbjct: 2 EIQREDITLGR--CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 360 ILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALG 419
I+ H ++V L G ++ + +G L +L + + L+ ++ + +
Sbjct: 60 IMRQFDHPHIVKLIGVITENPV-WIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQ 115
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF 479
+ LAYL + +HRDI + N+L+ + DFGL++ L DE + +
Sbjct: 116 LSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI 172
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLE-LVTGKRP 514
++APE + R T SDV+ FGV + E L+ G +P
Sbjct: 173 KWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 56/243 (23%)
Query: 303 SCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRI--DRSREGSDQVFERELE 359
S + EKL ++E G +G VYR G A+K++ ++ +EG RE+
Sbjct: 3 SVDEYEKLNRIEE------GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREIN 56
Query: 360 ILGSIKHINLVNLR----GYCRLPATKL----LIYDYLSMGSLDDFLHEHGEG------- 404
IL ++H N+V ++ G + L ++ +Y+ L + +
Sbjct: 57 ILLKLQHPNIVTVKEVVVG------SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVK 109
Query: 405 ---QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461
QLL G+A+LH + I+HRD+K+SN+LL+ + DFGLA
Sbjct: 110 CLMLQLL-------------SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLA 153
Query: 462 KLLVDEEAHVTTVVAGTFGYLAPE-YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFV 520
+ T +V T Y APE L + + D++S G + EL+T P F
Sbjct: 154 REYGSPLKPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK----KPLFP 208
Query: 521 KRG 523
+
Sbjct: 209 GKS 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 318 VVGSGGFGTVY---RMVMNDCGT-FAVKRIDRS----REGSDQVFERELEILGSIKHINL 369
V+G+G +G V+ ++ +D G +A+K + ++ + + + E ++L I+
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 370 VNLRGYCRLPATKL-LIYDYLSMGSLDDFLH----EHGEGQQLLNWSARLKIALGSARGL 424
+ Y TKL LI DY++ G L F H E + Q++ +S + +AL L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
II+RDIK NILLD N ++DFGL+K ++E GT Y+AP
Sbjct: 125 G---------IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 485 EYLQSGRATEKS--DVYSFGVLLLELVTGKRP 514
+ ++ G D +S GVL+ EL+TG P
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 61/241 (25%), Positives = 114/241 (47%), Gaps = 24/241 (9%)
Query: 356 RELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK 415
REL++L ++H N+++L P + L L L +Q + +
Sbjct: 58 RELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY----- 112
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
RGL Y+H ++HRD+K SNIL++EN + + DFGLA++ ++ +T V
Sbjct: 113 FLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGYV 166
Query: 476 AGTFGYLAPE-YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFV-KRGLNVVGWMNTL 533
+ + Y APE L + + D++S G + E++ GK P F K +N + L
Sbjct: 167 STRY-YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK----PLFPGKDHVNQFSIITDL 221
Query: 534 LKENRLEDVIDKRCADADMETVEAI-----LEIAARCTDANPDDRPSMNQVLQLLEQEVM 588
L +DVI+ C++ + V+++ + + + +A+P + ++L Q+ +
Sbjct: 222 LG-TPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280
Query: 589 S 589
S
Sbjct: 281 S 281
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 21/209 (10%)
Query: 318 VVGSGGFGTVY---RMVMNDCGT-FAVKRIDRS----REGSDQVFERELEILGSIKHINL 369
V+G+G +G V+ ++ +D G +A+K + ++ + + + E +L ++
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 370 VNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWS-ARLKIALGSA-RGLAY 426
+ Y KL LI DY+S G + F H + Q N+S ++ G L +
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEM--FTHLY----QRDNFSEDEVRFYSGEIILALEH 120
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
LH I++RDIK NILLD ++DFGL+K + EE T GT Y+APE
Sbjct: 121 LHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 487 LQSGRATEKS-DVYSFGVLLLELVTGKRP 514
++ K+ D +S G+L+ EL+TG P
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 319 VGSGGFGTVYRMVMNDCGTF-AVK--RIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+G G +G VY+ G A+K R++ EG RE+ +L ++H N+V L+
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 376 CRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS-ARGLAYLHHDCCPK 434
+ LI+++LSM L +L +GQ + + +K L +G+ + H +
Sbjct: 68 LMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMD--AELVKSYLYQILQGILFCHSR---R 121
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTFGYLAPEYL-QSGRA 492
++HRD+K N+L+D ++DFGLA+ + + VV T Y APE L S R
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGSPRY 179
Query: 493 TEKSDVYSFGVLLLELVTGKRP 514
+ D++S G + E+ T K+P
Sbjct: 180 STPVDIWSIGTIFAEMAT-KKP 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 18/215 (8%)
Query: 309 KLEALDEEDVVGSGGFGTVY--RMVMNDCGTFAVKRID-RSREGSDQVFERELEILGSIK 365
K+E + + +G G + TV+ R + + A+K I EG+ RE+ +L +K
Sbjct: 4 KMETYIKLEKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA-RGL 424
H N+V L + L+++YL L ++ + G + N +KI L RGL
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHN----VKIFLYQILRGL 117
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL-LVDEEAHVTTVVAGTFGYLA 483
AY H K++HRD+K N+L++E E ++DFGLA+ V + + VV T Y
Sbjct: 118 AYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRP 172
Query: 484 PE-YLQSGRATEKSDVYSFGVLLLELVTGKRPTDP 517
P+ L S + + D++ G + E+ +G RP P
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRI--DRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+G G G V++ + G T A+K++ R G RE++ L + +H +V L
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 376 CRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKI 435
+ +L+ +Y+ L + L + E + L + +G+AY+H + I
Sbjct: 68 FPHGSGFVLVMEYM-PSDLSEVLRD--EERPLPEAQVK-SYMRMLLKGVAYMHAN---GI 120
Query: 436 IHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA-TE 494
+HRD+K +N+L+ + ++DFGLA+L +EE + + T Y APE L R
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDP 180
Query: 495 KSDVYSFGVLLLELVTG 511
D+++ G + EL+ G
Sbjct: 181 GVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 311 EALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINL 369
E LD +G G G V G AVK++D ++ ++ E+ I+ H N+
Sbjct: 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFL-HEHGEGQQLLNWSARLKIALGSARGLAYLH 428
V++ + ++ ++L G+L D + H +Q+ + L R L+YLH
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRALSYLH 135
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
+ +IHRDIKS +ILL + +SDFG V +E + GT ++APE +
Sbjct: 136 NQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCA-QVSKEVPKRKSLVGTPYWMAPEVIS 191
Query: 489 SGRATEKSDVYSFGVLLLELVTGKRP 514
+ D++S G++++E++ G+ P
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 71/205 (34%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 318 VVGSGGFGTVYRMVMNDCGTF-AVK-----RIDRSREGSDQVFERELEILGSIKHINLVN 371
V+G G FG V G F AVK I + +E + ER + +L ++KH LV
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 372 LRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHH 429
L Y A KL + DY++ G L F H E + AR A + SA L YLH
Sbjct: 61 LH-YSFQTADKLYFVLDYVNGGEL--FFHLQRE-RSFPEPRARFYAAEIASA--LGYLHS 114
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS 489
II+RD+K NILLD ++DFGL K ++ T+ GT YLAPE L+
Sbjct: 115 ---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK-TTSTFCGTPEYLAPEVLRK 170
Query: 490 GRATEKSDVYSFGVLLLELVTGKRP 514
D + G +L E++ G P
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 43/121 (35%), Positives = 61/121 (50%), Gaps = 6/121 (4%)
Query: 82 LGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNL 141
L G I + L +L L NSL G IP + C LR + L+ N G +P+ L
Sbjct: 368 LTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKL 427
Query: 142 LFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLD 201
+ LD+S+N+L+G I S + L L+L+ N F G +PD FG+K + NLD
Sbjct: 428 PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS-----FGSKR-LENLD 481
Query: 202 L 202
L
Sbjct: 482 L 482
|
Length = 968 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 23/207 (11%)
Query: 318 VVGSGGFGTVYRMVMNDCGT---FAVK--RIDRSREGSD---QVFERELEILGSIKHINL 369
V+G G FG V M+ GT FA+K + D E D + ER + L +H L
Sbjct: 2 VLGKGSFGKV--MLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFL 58
Query: 370 VNLRGYCRLPATKLLIY--DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYL 427
+L +C + L + +YL+ G D + + AR A GL +L
Sbjct: 59 THL--FCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARF-YAAEIICGLQFL 112
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
H II+RD+K N+LLD++ ++DFG+ K ++ E +T GT Y+APE L
Sbjct: 113 HKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF-CGTPDYIAPEIL 168
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRP 514
+ + E D +SFGVLL E++ G+ P
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 37/274 (13%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSD-QVFERELEILGSIKHINLVNLRGYCR 377
+GSG +G VY+ + G A ++ + G D V ++E+ ++ KH N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG-SY 75
Query: 378 LPATKLLI-YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKII 436
L KL I ++ GSL D H G L+ S ++ + +GL YLH +
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSK---GKM 128
Query: 437 HRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA------GTFGYLAPEYL--- 487
HRDIK +NILL +N ++DFG++ A +T +A GT ++APE
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMAPEVAAVE 181
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547
+ G + D+++ G+ +EL + P R L ++ N + +L+D
Sbjct: 182 RKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN--FQPPKLKD------ 233
Query: 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
M+ + NP RP+ ++LQ
Sbjct: 234 ---KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLR 373
V+G GGFG V + G +A KR+++ R + + E +IL + +VNL
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHG----EGQQLLNWSARLKIALGSARGLAYLHH 429
L+ ++ G L ++ G E ++ L ++A + GL LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILC------GLEDLHR 120
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS 489
+ ++RD+K NILLD+ +SD GLA + + E+ V GT GY+APE L +
Sbjct: 121 E---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV--GTVGYMAPEVLNN 175
Query: 490 GRATEKSDVYSFGVLLLELVTGKRP 514
R T D + G L+ E++ G+ P
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 54/228 (23%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---------RELEILGSIKH 366
+G G +G V G A+K+I FE RE++IL KH
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKI--------SPFEHQTFCQRTLREIKILRRFKH 62
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDF-------------LHEHGEGQQLLNWSAR 413
N++ I D + S + F L++ + Q L N +
Sbjct: 63 ENIIG-------------ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQ 109
Query: 414 LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH--- 470
+ RGL Y+H ++HRD+K SN+LL+ N + + DFGLA++ E H
Sbjct: 110 YFL-YQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF 165
Query: 471 VTTVVAGTFGYLAPEYLQSGRATEKS-DVYSFGVLLLELVTGKRPTDP 517
+T VA T Y APE + + + K+ D++S G +L E+++ RP P
Sbjct: 166 LTEYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFP 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 43/194 (22%)
Query: 405 QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464
+ LL++S ++ A+G+++L C IHRD+ + NILL + DFGLA+ +
Sbjct: 214 EDLLSFSYQV------AKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDI 264
Query: 465 VDEEAHVTTVVAGT----FGYLAPEYLQSGRATEKSDVYSFGVLLLELVT------GKRP 514
++ +V V G ++APE + + T +SDV+S+G+LL E+ + P
Sbjct: 265 RNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321
Query: 515 TDPTFVKRGLNVVGWMNTLLKEN-RLEDVIDKRCADADMETVEAILEIAARCTDANPDDR 573
D F K ++KE R+ CA ++M +I C DA+P R
Sbjct: 322 VDSKFYK-----------MIKEGYRMLS---PECAPSEM------YDIMKSCWDADPLKR 361
Query: 574 PSMNQVLQLLEQEV 587
P+ Q++QL+EQ++
Sbjct: 362 PTFKQIVQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 73/249 (29%), Positives = 110/249 (44%), Gaps = 19/249 (7%)
Query: 319 VGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER---ELEILGSIKHINLVNLRG 374
+G GGFG V M G +A K++++ R + +E E IL + +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 375 YCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
Y T L L+ ++ G L ++ E GL +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
+II+RD+K N+LLD + +SD GLA L D ++ T AGT G++APE LQ
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175
Query: 494 EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID--KRCADAD 551
D ++ GV L E++ + P F RG V N LK+ L D + + + A
Sbjct: 176 FSVDYFALGVTLYEMIAARGP----FRARGEKV---ENKELKQRILNDSVTYPDKFSPAS 228
Query: 552 METVEAILE 560
EA+L
Sbjct: 229 KSFCEALLA 237
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 55/165 (33%), Positives = 83/165 (50%), Gaps = 26/165 (15%)
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG--- 480
L +HH +IHRDIKS+NILL N + DFG +K+ A V+ V TF
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY---AATVSDDVGRTFCGTP 209
Query: 481 -YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL--KEN 537
Y+APE + ++K+D++S GVLL EL+T KRP D G N+ M+ L + +
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD------GENMEEVMHKTLAGRYD 263
Query: 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582
L I +M+ + L ++P RPS +++L +
Sbjct: 264 PLPPSISP-----EMQEIVTAL------LSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 29/210 (13%)
Query: 318 VVGSGGFGTV----YRMV--MNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVN 371
V+G GGFG V R M C KRI + R+G E +IL + +V+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGESMALN-EKQILEKVNSRFVVS 64
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC 431
L L+ ++ G L ++ GE R + Y C
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA------------GFEEGRAVFYAAEIC 112
Query: 432 C-------PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
C +I++RD+K NILLD++ +SD GLA + V E + V GT GY+AP
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-GTVGYMAP 170
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
E +++ R T D ++ G LL E++ G+ P
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 313 LDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFERELEILGSIKHINLVN 371
LD +G G G V + G AVK++D ++ ++ E+ I+ +H N+V
Sbjct: 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVE 81
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFL-HEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
+ + ++ ++L G+L D + H +Q+ + L + L+ LH
Sbjct: 82 MYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA------VCLAVLKALSVLHAQ 135
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
+IHRDIKS +ILL + +SDFG V +E + GT ++APE +
Sbjct: 136 ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQ-VSKEVPRRKSLVGTPYWMAPELISRL 191
Query: 491 RATEKSDVYSFGVLLLELVTGKRP 514
+ D++S G++++E+V G+ P
Sbjct: 192 PYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 6e-13
Identities = 59/210 (28%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKH-INLVNLRGY 375
+VVG+G +G VY+ G A ++ E ++ + E+ +L H N+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 376 C--RLPATK----LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429
+ P L+ ++ GS+ D + +W A I RGLA+LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLH- 138
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS 489
K+IHRDIK N+LL EN E + DFG++ L D GT ++APE +
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIAC 195
Query: 490 GRATE-----KSDVYSFGVLLLELVTGKRP 514
+ +SD++S G+ +E+ G P
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 23/207 (11%)
Query: 318 VVGSGGFGTV----YRMV--MNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVN 371
V+G GGFG V R M C KRI + R+G E +IL + +V+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK-RKGEAMALN-EKQILEKVNSRFVVS 64
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG----QQLLNWSARLKIALGSARGLAYL 427
L L+ ++ G L ++ G ++ + ++A + GL L
Sbjct: 65 LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC------GLEDL 118
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
H + +I++RD+K NILLD+ +SD GLA + + E V GT GY+APE +
Sbjct: 119 HRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVV 173
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRP 514
++ R T D + G L+ E++ GK P
Sbjct: 174 KNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 64/219 (29%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE----GSDQVFERELEILGSI 364
KL + + +G+G FG V G + + + RE Q +E IL +
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 365 KHINLVN-LRGYC---RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLN-----WSARLK 415
H +VN + + R+ + +++ G L F H G+ N + A L
Sbjct: 76 SHPFIVNMMCSFQDENRV----YFLLEFVVGGEL--FTHLRKAGR-FPNDVAKFYHAELV 128
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
+A YLH II+RD+K N+LLD V+DFG AK + D T +
Sbjct: 129 LAF------EYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTL 175
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
GT YLAPE +QS + D ++ GVLL E + G P
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 8e-13
Identities = 71/244 (29%), Positives = 107/244 (43%), Gaps = 33/244 (13%)
Query: 318 VVGSGGFGTVYRMVMNDCGTF-AVKRIDRS-----REGSDQVFERELEILGSIKHINLVN 371
V+G G FG V G AVK + + +E + ER + +L ++KH LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNV-LLKNVKHPFLVG 60
Query: 372 LRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
L Y KL + D+++ G L F H E + AR A A L YLH
Sbjct: 61 LH-YSFQTTEKLYFVLDFVNGGEL--FFHLQRE-RSFPEPRARFYAA-EIASALGYLH-- 113
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
I++RD+K NILLD ++DFGL K + ++ TT GT YLAPE ++
Sbjct: 114 -SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 491 RATEKSDVYSFGVLLLELVTGKRP--------------TDPTFVKRGLNVVGW--MNTLL 534
D + G +L E++ G P P ++ G ++ W + LL
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELL 231
Query: 535 KENR 538
+++R
Sbjct: 232 EKDR 235
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 61/225 (27%), Positives = 95/225 (42%), Gaps = 54/225 (24%)
Query: 319 VGSGGFGTVYRMVM---NDCGTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNL 372
+G G +G VY+ D +A+K+ +E G Q RE+ +L +KH N+V+L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 373 RGYCRLPATKL--LIYDYLSMGSLDDFLH---EHGEGQ--------------QLLNWSAR 413
A K L++DY + D H + + Q+LN
Sbjct: 68 VEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN---- 119
Query: 414 LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH----VSDFGLAKLLVD--- 466
G+ YLH + ++HRD+K +NIL+ + D GLA+L
Sbjct: 120 ---------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167
Query: 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKS-DVYSFGVLLLELVT 510
A + VV T Y APE L R K+ D+++ G + EL+T
Sbjct: 168 PLADLDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 46/176 (26%), Positives = 88/176 (50%), Gaps = 9/176 (5%)
Query: 339 AVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFL 398
AVK++D ++ ++ E+ I+ +H N+V + + ++ ++L G+L D +
Sbjct: 48 AVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV 107
Query: 399 HEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458
+N + L + L++LH +IHRDIKS +ILL + +SDF
Sbjct: 108 -----THTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDF 159
Query: 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
G + E ++V GT ++APE + + D++S G++++E+V G+ P
Sbjct: 160 GFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 58/226 (25%), Positives = 105/226 (46%), Gaps = 24/226 (10%)
Query: 310 LEALDEEDVVGSGGFGTVYR-----MVMNDCGTFAVKRI-DRSREGSDQVFERELEILGS 363
L A+ + +G FG +Y+ M+ A+K + D + F++E ++
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE 63
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFL-------------HEHGEGQQLLNW 410
+ H N+V L G ++++YL+ G L +FL E G + L+
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 411 SARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470
L IA+ A G+ YL +H+D+ + NIL+ E L +SD GL++ + + +
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY 180
Query: 471 -VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP 514
V ++ PE + G+ + SD++SFGV+L E+ + G +P
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 64/240 (26%), Positives = 94/240 (39%), Gaps = 58/240 (24%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRI--DRSREGSDQVFERELEIL 361
EI+ KL G G FG VY+ G A+K+I ++G RE++IL
Sbjct: 11 EILGKL---------GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKIL 61
Query: 362 GSIKHINLVNL--RGYCRLPA---TKLLIY------DYLSMGSLDD----FLHEHGEG-- 404
+KH N+V L R + +Y D+ G L++ +
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 405 QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464
QLL G+ YLH I+HRDIK++NIL+D ++DFGLA+
Sbjct: 122 LQLLE-------------GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPY 165
Query: 465 VDE-----------EAHVTTVVAGTFGYLAPEY-LQSGRATEKSDVYSFGVLLLELVTGK 512
T +V T Y PE L R T D++ G + E+ T +
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVV-TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 73/273 (26%), Positives = 121/273 (44%), Gaps = 34/273 (12%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAV-KRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCR 377
+G G FG VY+ + G A K I+ E + + E+EIL + H +V L G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 378 LPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIH 437
++ ++ G++D + E G + L L YLH KIIH
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML---EALQYLH---SMKIIH 133
Query: 438 RDIKSSNILLDENLEPHVSDFGLA----KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
RD+K+ N+LL + + ++DFG++ K L ++ + GT ++APE +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETMK 188
Query: 494 E-----KSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548
+ K+D++S G+ L+E+ + P LN M LLK + E + +
Sbjct: 189 DTPYDYKADIWSLGITLIEMAQIEPP------HHELNP---MRVLLKIAKSEPPTLSQPS 239
Query: 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
ME L+ A D +P+ RPS Q+L+
Sbjct: 240 KWSME-FRDFLKTA---LDKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRI---DRS--REGSDQVFERELEILGSIKHINL 369
+G G + VY+ + G A+K+I +R ++G + RE+++L +KH N+
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 370 VNLRG-YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK------IALGSAR 422
+ L + L +++++ L+ + + S L L + R
Sbjct: 65 IGLLDVFGHKSNINL-VFEFME-TDLEKVIK---------DKSIVLTPADIKSYMLMTLR 113
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
GL YLH + I+HRD+K +N+L+ + ++DFGLA+ +T V T Y
Sbjct: 114 GLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYR 169
Query: 483 APEYLQSGRA-TEKSDVYSFGVLLLELVTGK 512
APE L R D++S G + EL+
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 34/112 (30%), Positives = 49/112 (43%), Gaps = 13/112 (11%)
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
G+ LH IIHRDIK N+L+D+ ++DFGL++ GT YL
Sbjct: 109 GVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYL 160
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRP-----TDPTFVKRGLNVVGW 529
APE + + SD +S G ++ E + G P D F + W
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRID-RSREGSDQVFERELEILGSIKH 366
+LE L G G + TVY+ G A+K I + EG+ RE+ ++ +KH
Sbjct: 4 QLEKL------GEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH 57
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQL-LNWSARLKIALGSARGLA 425
N+V L +L+++Y+ L ++ HG L N L +G+A
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIA 114
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTFGYLAP 484
+ H + +++HRD+K N+L+++ E ++DFGLA+ + VV T Y AP
Sbjct: 115 FCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAP 169
Query: 485 EYLQSGRATEKS-DVYSFGVLLLELVTGK 512
+ L R S D++S G ++ E++TG+
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (162), Expect = 3e-12
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKH-INLVNLRG- 374
++VG+G +G VY+ G A ++ ++ ++E+ +L H N+ G
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 375 YCRLPATKL-----LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429
+ + + L+ ++ GS+ D + W A I RGL++LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQ 129
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS 489
K+IHRDIK N+LL EN E + DFG++ L D GT ++APE +
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFIGTPYWMAPEVIAC 185
Query: 490 GRATE-----KSDVYSFGVLLLELVTGKRP 514
+ KSD++S G+ +E+ G P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 35/210 (16%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVK--RIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+G G +G VY+ G A+K R+D EG RE+ +L + H N+V L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 376 CRLPATKLLIYDYLSMGSLDDFLHEHGEG-----------QQLLNWSARLKIALGSARGL 424
L++++L L F+ QLL GL
Sbjct: 68 IHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQ-------------GL 113
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTFGYLA 483
A+ H +++HRD+K N+L++ ++DFGLA+ V + VV T Y A
Sbjct: 114 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 168
Query: 484 PEYLQSGR-ATEKSDVYSFGVLLLELVTGK 512
PE L + + D++S G + E+VT +
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 47/176 (26%), Positives = 86/176 (48%), Gaps = 9/176 (5%)
Query: 339 AVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFL 398
AVK +D ++ ++ E+ I+ +H N+V + + ++ ++L G+L D +
Sbjct: 50 AVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV 109
Query: 399 HEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458
Q LN + + L YLH +IHRDIKS +ILL + +SDF
Sbjct: 110 -----SQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDF 161
Query: 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
G + + ++V GT ++APE + + D++S G++++E+V G+ P
Sbjct: 162 GFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 54/189 (28%), Positives = 91/189 (48%), Gaps = 22/189 (11%)
Query: 339 AVK--RIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDD 396
AVK R D ++ + F +E++IL +K N++ L G C +I +Y+ G L+
Sbjct: 50 AVKILRPDANKNARND-FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 397 FLHEH-------------GEGQQLL--NWSARLKIALGSARGLAYLHHDCCPKIIHRDIK 441
FL H L ++S+ L +AL A G+ YL +HRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 442 SSNILLDENLEPHVSDFGLAK-LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYS 500
+ N L+ ENL ++DFG+++ L + + ++A E + G+ T SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 501 FGVLLLELV 509
FGV L E++
Sbjct: 226 FGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 64/218 (29%), Positives = 107/218 (49%), Gaps = 23/218 (10%)
Query: 310 LEALDEEDVVGSGGFGTVYRM---VMNDCGTFAVK--RIDRSREGSDQVFERELEILGSI 364
++ ++ + +G G +G VY+ V N+ T A+K R+++ EG RE+ +L +
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNE--TIALKKIRLEQEDEGVPSTAIREISLLKEM 58
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARL-KIALGSA-R 422
+H N+V L+ L+++YL LD L +H + + RL K L R
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEYLD---LD--LKKHMDSSPDFAKNPRLIKTYLYQILR 113
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEP-HVSDFGLAKLL-VDEEAHVTTVVAGTFG 480
G+AY H +++HRD+K N+L+D ++DFGLA+ + VV T
Sbjct: 114 GIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLW 168
Query: 481 YLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDP 517
Y APE L R + D++S G + E+V ++P P
Sbjct: 169 YRAPEILLGSRHYSTPVDIWSVGCIFAEMVN-QKPLFP 205
|
Length = 294 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-12
Identities = 68/214 (31%), Positives = 100/214 (46%), Gaps = 43/214 (20%)
Query: 319 VGSGGFGTVYRMVMNDCGTF--------AVKRIDRSREG---SDQVFERELEILGSIKHI 367
VGSG +G+V C F AVK++ R + + + + REL +L +KH
Sbjct: 25 VGSGAYGSV-------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHE 76
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA------ 421
N++ L PA L ++ D +L H G L N K+
Sbjct: 77 NVIGLLDVFT-PARSLEEFN-------DVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 128
Query: 422 --RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF 479
RGL Y+H IIHRD+K SN+ ++E+ E + DFGLA+ DE +T VA T
Sbjct: 129 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE---MTGYVA-TR 181
Query: 480 GYLAPE-YLQSGRATEKSDVYSFGVLLLELVTGK 512
Y APE L + D++S G ++ EL+TG+
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 65/209 (31%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 318 VVGSGGFGTV----YRMVMNDCGTFAVKR---IDRSREGSDQVFERELEILGSIKHINLV 370
V+G G FG V Y+ A+K+ I R S +R E S +H LV
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
NL + + +Y + G L +H H + A A GL YLH +
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDL--MMHIHTD--VFSEPRAVFYAAC-VVLGLQYLHEN 120
Query: 431 CCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEE---AHVTTVVAGTFGYLAPE 485
KI++RD+K N+LLD E V +DFGL K E T+ GT +LAPE
Sbjct: 121 ---KIVYRDLKLDNLLLD--TEGFVKIADFGLCK----EGMGFGDRTSTFCGTPEFLAPE 171
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRP 514
L T D + GVL+ E++ G+ P
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 52/170 (30%), Positives = 79/170 (46%), Gaps = 29/170 (17%)
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG-TF 479
ARG+ +L C IHRD+ + NILL EN + DFGLA+ + + +V A
Sbjct: 183 ARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP-----TDPTFVKRGLNVVGWMNTL 533
++APE + T +SDV+SFGVLL E+ + G P D F
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC------------- 286
Query: 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
RL++ R + I I C NP+DRP+ ++++++L
Sbjct: 287 ---RRLKEGTRMRAPE---YATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 66/226 (29%), Positives = 104/226 (46%), Gaps = 24/226 (10%)
Query: 300 PYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELE 359
P + EIIE +G G +G VY++ G+ A +I D+ E E
Sbjct: 20 PTDTWEIIE---------TIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYN 70
Query: 360 ILGSI-KHINLVNLRGYC----RLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSAR 413
IL S+ H N+V G +L +L L+ + + GS+ + + Q L+ +
Sbjct: 71 ILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMI 130
Query: 414 LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT 473
I G+ GL +LH++ +IIHRD+K +NILL + DFG++ L T
Sbjct: 131 SYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187
Query: 474 VVAGTFGYLAPEYLQSGRATEKS-----DVYSFGVLLLELVTGKRP 514
V GT ++APE + + + S DV+S G+ +EL G P
Sbjct: 188 SV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 37/92 (40%), Positives = 54/92 (58%), Gaps = 4/92 (4%)
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
GL +LH II+RD+K N++LD + ++DFG+ K V + +T GT Y+
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF-CGTPDYI 163
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
APE LQ + T D +SFGVLL E++ G+ P
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFE--RELEILGSIK 365
EKLE L G G + TVY+ G ++ R +E F RE +L +K
Sbjct: 8 EKLEKL------GEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK 61
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLA 425
H N+V L T L+++Y+ L ++ +H G N L L RGL+
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLL---RGLS 117
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL-LVDEEAHVTTVVAGTFGYLAP 484
Y+H I+HRD+K N+L+ + E ++DFGLA+ V + VV T Y P
Sbjct: 118 YIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPP 172
Query: 485 EYLQSGRATEKS---DVYSFGVLLLELVTG 511
+ L +TE S D++ G + +E++ G
Sbjct: 173 DVLLG--STEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 57/211 (27%), Positives = 97/211 (45%), Gaps = 44/211 (20%)
Query: 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE 449
S S D+ E E L+ L+ + A+G+ +L C IHRD+ + N+LL +
Sbjct: 194 SSDSKDE---EDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNC---IHRDVAARNVLLTD 247
Query: 450 NLEPHVSDFGLAKLLVDEEAHVTTVVAGT----FGYLAPEYLQSGRATEKSDVYSFGVLL 505
+ DFGLA+ ++++ + VV G ++APE + T +SDV+S+G+LL
Sbjct: 248 GRVAKICDFGLARDIMNDSNY---VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 304
Query: 506 LELVT-GKRP-----TDPTF---VKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVE 556
E+ + GK P + F VKRG + + D E
Sbjct: 305 WEIFSLGKSPYPGILVNSKFYKMVKRGYQM---------------------SRPDFAPPE 343
Query: 557 AILEIAARCTDANPDDRPSMNQVLQLLEQEV 587
I I C + P +RP+ +Q+ QL+++++
Sbjct: 344 -IYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 24/243 (9%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNL----- 372
+G G G V+ V +DC AVK+I + S + RE++I+ + H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 373 RGYCRLPATKLLIYD----YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH 428
L + + Y+ ++ L E L ARL RGL Y+H
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARL-FMYQLLRGLKYIH 131
Query: 429 HDCCPKIIHRDIKSSNILLD-ENLEPHVSDFGLAKLLVDEEAHVTTVVAG--TFGYLAPE 485
++HRD+K +N+ ++ E+L + DFGLA+++ +H + G T Y +P
Sbjct: 132 ---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR 188
Query: 486 YLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544
L S T+ D+++ G + E++TGK P F G + + M +L+ + D
Sbjct: 189 LLLSPNNYTKAIDMWAAGCIFAEMLTGK----PLFA--GAHELEQMQLILESVPVVREED 242
Query: 545 KRC 547
+
Sbjct: 243 RNE 245
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 319 VGSGGFGTV----YRMVMNDCGTFAVKRIDRSREGSDQ-VFERELEILGSIKHINLVNLR 373
+GSG FG V Y+M A+K + E S + RE EI+ + + +V +
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
G C A +L+ + S G L+ FL + + S +++ + G+ YL
Sbjct: 62 GVCEAEAL-MLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGK--- 114
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF--GYLAPEYLQSGR 491
+HRD+ + N+LL +SDFGL+K L ++++ AG + + APE + +
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174
Query: 492 ATEKSDVYSFGVLLLELVT-GKRP 514
+ +SDV+S+G+ + E + G++P
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 75/242 (30%), Positives = 118/242 (48%), Gaps = 38/242 (15%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF--------AVKRIDRSREG---SDQV 353
E+ E+ + L VGSG +G+V C + AVK++ R + + +
Sbjct: 12 EVPERYQNLTP---VGSGAYGSV-------CSAYDTRLRQKVAVKKLSRPFQSLIHARRT 61
Query: 354 FERELEILGSIKHINLVNLRGYCRLPATKLLIYD--YLSMGSLDDFLHEHGEGQQLLNWS 411
+ REL +L +KH N++ L PAT + ++ YL + L+ + Q+L +
Sbjct: 62 Y-RELRLLKHMKHENVIGLLDVFT-PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEH 119
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471
+ I RGL Y+H IIHRD+K SN+ ++E+ E + DFGLA+ DE +
Sbjct: 120 VQFLI-YQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE---M 172
Query: 472 TTVVAGTFGYLAPE-YLQSGRATEKSDVYSFGVLLLELVTGKR--PTDPTF--VKRGLNV 526
T VA T Y APE L + D++S G ++ EL+ GK P + +KR + V
Sbjct: 173 TGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV 231
Query: 527 VG 528
VG
Sbjct: 232 VG 233
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTFG 480
RGL YLH I+HRDIK N+L++ N + DFGLA++ DE H+T V +
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 481 YLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGK 512
Y APE L R T D++S G + EL+ +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 71/255 (27%), Positives = 109/255 (42%), Gaps = 39/255 (15%)
Query: 318 VVGSGGFGTV----YRMV--MNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVN 371
V+G GGFG V R M C KRI + R+G E IL + +V+
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRI-KKRKGEAMALN-EKRILEKVNSRFVVS 64
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHG----EGQQLLNWSARLKIALGSARGLAYL 427
L L+ ++ G L ++ G + Q+ + ++A L GL L
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAEL------CCGLEDL 118
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
+ +I++RD+K NILLD+ +SD GLA + + E V GT GY+APE +
Sbjct: 119 QRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV--GTVGYMAPEVI 173
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547
+ + T D + G L+ E++ G+ P F KR KE + +D+R
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP----FRKR------------KERVKREEVDRRV 217
Query: 548 ADADMETVEAILEIA 562
+ E E E A
Sbjct: 218 KEDQEEYSEKFSEDA 232
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 65/203 (32%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 318 VVGSGGFGTVYRMV-MNDCGTFAVK-----RIDRSREGSDQVFERELEILGSIKHINLVN 371
V+G G FG V + +AVK I + +E + ER + +L ++KH LV
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVG 60
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC 431
L + + DY++ G L F H E + L AR A A L YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGEL--FYHLQRE-RCFLEPRARF-YAAEIASALGYLHS-- 114
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR 491
I++RD+K NILLD ++DFGL K + E T+ GT YLAPE L
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI-EHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 492 ATEKSDVYSFGVLLLELVTGKRP 514
D + G +L E++ G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 22/207 (10%)
Query: 319 VGSGGFGTV----YRMVMNDCGTFAVK--RIDRSREGSDQVFERELEILGSIKHINLVNL 372
+GSG FGTV Y+M T AVK + D + RE ++ + + +V +
Sbjct: 3 LGSGNFGTVKKGMYKM-KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHE--HGEGQQLLNWSARLKIALGSARGLAYLHHD 430
G C + +L+ + +G L+ FL + H + + ++ + G+ YL
Sbjct: 62 IGICEAESW-MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM------GMKYLEET 114
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF--GYLAPEYLQ 488
+HRD+ + N+LL +SDFGL+K L +E + G + + APE +
Sbjct: 115 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 489 SGRATEKSDVYSFGVLLLELVT-GKRP 514
+ + KSDV+SFGVL+ E + G++P
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 318 VVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFE---RELEILGSIKHINLVNLRG 374
VVG G +G V + + + + E +++V E REL++L ++K N+V L+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALGSARGLAYLHHDC 431
R L+++Y+ L+ L E G +++ ++ +L + + + H +
Sbjct: 68 AFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYIYQL------IKAIHWCHKN- 119
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD-EEAHVTTVVAGTFGYLAPEYLQSG 490
I+HRDIK N+L+ N + DFG A+ L + A+ T VA T Y +PE L
Sbjct: 120 --DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSPELLLGA 176
Query: 491 RATEKSDVYSFGVLLLELVTGK 512
+ D++S G +L EL G+
Sbjct: 177 PYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 60/285 (21%), Positives = 116/285 (40%), Gaps = 42/285 (14%)
Query: 316 EDVVGSGGFGTVYR-MVMNDCGTFAVKRIDRSREGSDQVFE-----------RELEILGS 363
E +G G F VYR + D A+K++ Q+FE +E+++L
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKV--------QIFEMMDAKARQDCVKEIDLLKQ 58
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARG 423
+ H N++ ++ + G L + + ++L+ K +
Sbjct: 59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
+ ++H +++HRDIK +N+ + + D GL + + ++V GT Y++
Sbjct: 119 VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543
PE + KSD++S G LL E+ + P F +N+ +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLFSLCQKI---------- 220
Query: 544 DKRCADADMET---VEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
++C + T E + E+ + C +PD RP + V Q+ +Q
Sbjct: 221 -EQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQ 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 67/252 (26%), Positives = 108/252 (42%), Gaps = 48/252 (19%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVKRIDRSRE---GSDQVFE-----RELEILGSIKHINLV 370
+G G FGTVY ++ D A +R+ +E G E +E ++L + H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQ------QLLNWSARLKIALGSARGL 424
+I +Y LD L E Q+ W +L + G+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------GV 119
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
Y+H +I+HRD+K+ NI L NL + DFG+++LL+ + T GT Y++P
Sbjct: 120 HYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGS-CDLATTFTGTPYYMSP 174
Query: 485 EYLQSGRATEKSDVYSFGVLLLEL-------------------VTGKRPTDPTFVKRGLN 525
E L+ KSD++S G +L E+ V G P+ P R LN
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN 234
Query: 526 VVGWMNTLLKEN 537
+ M ++L ++
Sbjct: 235 SI--MQSMLNKD 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 17/200 (8%)
Query: 319 VGSGGFGTVYRMVMNDCGTF-AVKRID-RSREGSDQVFERELEILGSIKHINLVNLRGYC 376
+G G + TVY+ + G A+K I ++ EG RE +L +KH N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 377 RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKII 436
T +++Y+ L ++ +H G L ++ RL RGLAY+H I+
Sbjct: 73 HTKETLTFVFEYMHT-DLAQYMIQHPGG--LHPYNVRL-FMFQLLRGLAYIHGQ---HIL 125
Query: 437 HRDIKSSNILLDENLEPHVSDFGLAKL-LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEK 495
HRD+K N+L+ E ++DFGLA+ + + + + VV T Y P+ L AT+
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLG--ATDY 181
Query: 496 S---DVYSFGVLLLELVTGK 512
S D++ G + +E++ G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 21/206 (10%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAV-KRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCR 377
+G G FG VY+ + G A K ID E + + E++IL S H N+V L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 378 LPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIH 437
++ ++ + G++D + E ++ L + + L YLH + KIIH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 438 RDIKSSNILLDENLEPHVSDFGLA----KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
RD+K+ NIL + + ++DFG++ + + ++ + GT ++APE + +
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCETSK 181
Query: 494 E-----KSDVYSFGVLLLELVTGKRP 514
+ K+DV+S G+ L+E+ + P
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 43/166 (25%), Positives = 82/166 (49%), Gaps = 12/166 (7%)
Query: 354 FERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHE--------HGEGQ 405
F +E++I+ +K+ N++ L G C +I +Y+ G L+ FL + H
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 406 QLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465
++ + L +A+ A G+ YL +HRD+ + N L+ + ++DFG+++ L
Sbjct: 124 PSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLY 180
Query: 466 DEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT 510
+ + + ++A E + G+ T SDV++FGV L E+ T
Sbjct: 181 SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 5e-11
Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 19/171 (11%)
Query: 354 FERELEILGSIKHINLVNL--RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWS 411
F RE + + H N+V L G P +++Y+ +L + L G L
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAP-PGLLFAVFEYVPGRTLREVLAADG----ALPAG 79
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-NLEPH--VSDFGLAKLLVD-E 467
++ L LA H+ I+HRD+K NI++ + + PH V DFG+ LL
Sbjct: 80 ETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVR 136
Query: 468 EAHVTTV-----VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKR 513
+A V T+ V GT Y APE L+ T SD+Y++G++ LE +TG+R
Sbjct: 137 DADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 29/170 (17%)
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG-TF 479
ARG+ +L C IHRD+ + NILL EN + DFGLA+ + + +V A
Sbjct: 184 ARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP-----TDPTFVKRGLNVVGWMNTL 533
++APE + T +SDV+SFGVLL E+ + G P + F +
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ------------ 288
Query: 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
RL+D R + I I C +P +RP+ + ++++L
Sbjct: 289 ----RLKDGTRMRAPE---NATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 21/206 (10%)
Query: 319 VGSGGFGTVYRMVMNDCGTF-AVK--RIDRSREGSDQVFERELEILGSIK---HINLVNL 372
+G G +GTVY+ G F A+K R+ + +G RE+ +L ++ H N+V L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGE-----GQQLLNWSARLKIALGSARGLAYL 427
C T L +D L + + G ++ L RGL +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL---RGLDFL 124
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE-Y 486
H +C I+HRD+K NIL+ + ++DFGLA++ + A VV T Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVL 179
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGK 512
LQS AT D++S G + E+ K
Sbjct: 180 LQSTYAT-PVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 22/205 (10%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE---------RELEILGSIKHIN 368
+G G +G V ++ A+K+I F+ RE+++L + H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIA-------NAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH 428
++ ++ P + Y+ +D LH+ Q L+ RGL Y+H
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE-YL 487
++HRD+K SN+LL+ N + + DFGLA+ ++ +T V T Y APE L
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLL 181
Query: 488 QSGRATEKSDVYSFGVLLLELVTGK 512
T DV+S G + EL+ K
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 20/215 (9%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRI--DRSREGSDQVFERELEILGSI 364
EKLE + G G +GTV++ + A+KR+ D EG RE+ +L +
Sbjct: 3 EKLEKI------GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL 56
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
KH N+V L L+++Y F +G+ + S ++ +GL
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLL----KGL 112
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTFGYLA 483
A+ H ++HRD+K N+L+++N E ++DFGLA+ + + VV T Y
Sbjct: 113 AFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRP 167
Query: 484 PEYLQSGRATEKS-DVYSFGVLLLELVTGKRPTDP 517
P+ L + S D++S G + EL RP P
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-11
Identities = 31/88 (35%), Positives = 50/88 (56%), Gaps = 5/88 (5%)
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
GL YLH +IIHRD+K+ NI +++ + + D G A+ V A + +AGT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVET 222
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELV 509
APE L + K+D++S G++L E++
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 70/307 (22%), Positives = 123/307 (40%), Gaps = 65/307 (21%)
Query: 320 GSGGFGTVY---------------RMVMNDCGT--FAVKRIDRSREGSD----QVFEREL 358
G G FG V+ N AVK + R + + F +E+
Sbjct: 14 GEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL---RPDASDNAREDFLKEV 70
Query: 359 EILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEH-------GEGQQLLNWS 411
+IL + N+ L G C + +I +Y+ G L+ FL +H + L++S
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471
L +A A G+ YL +HRD+ + N L+ +N ++DFG+++ L +
Sbjct: 131 TLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY---SSD 184
Query: 472 TTVVAGT----FGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNV 526
V G ++A E + G+ T KSDV++FGV L E++T + P
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ--P--------- 233
Query: 527 VGWMNTLLKENRLEDVIDKRCADADMETV--------EAILEIAARCTDANPDDRPSMNQ 578
L + +E+ D + + I E+ C + +DRP+ +
Sbjct: 234 ---YEHLTDQQVIENAGHFFR-DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE 289
Query: 579 VLQLLEQ 585
+ L++
Sbjct: 290 IHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 65/292 (22%), Positives = 121/292 (41%), Gaps = 44/292 (15%)
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE-----------RE 357
L E +G G F VY+ + G A+K++ Q+FE +E
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKV--------QIFEMMDAKARQDCLKE 52
Query: 358 LEILGSIKHINLVNLRGYCRLPATKLLI--YDYLSMGSLDDFLHEHGEGQQLLNWSARLK 415
+++L + H N++ + L + G L + + ++L+ K
Sbjct: 53 IDLLKQLDHPNVI--KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE--EAHVTT 473
+ L ++H +I+HRDIK +N+ + + D GL + + AH
Sbjct: 111 YFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-- 165
Query: 474 VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533
+ GT Y++PE + KSD++S G LL E+ + P F +N+ +
Sbjct: 166 -LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCKKI 220
Query: 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
K D AD + E + ++ +RC + +P+ RP ++ VLQ+ ++
Sbjct: 221 EK-------CDYPPLPADHYS-EELRDLVSRCINPDPEKRPDISYVLQVAKE 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
GL +LH I++RD+K NILLD + ++DFG+ K + +A T GT Y+
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYI 163
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
APE L + D +SFGVLL E++ G+ P
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 25/216 (11%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFA---VKRIDRSREGSDQV-FERELEILGSIKHINLVNL 372
D +G+G FG V + + A VK + S +Q+ F +E++ + H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFL-----HEHGEGQQLLNWSARLKIALGSARGLAYL 427
G C LL+ ++ +G L ++L Q+ + ++A A GL +L
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV----LQRMACEVASGLLWL 116
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT-VVAGTFGYLAPEY 486
H IH D+ N L +L + D+GLA E+ ++T A +LAPE
Sbjct: 117 HQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 487 LQS-------GRATEKSDVYSFGVLLLELVT-GKRP 514
++ T+KS+++S GV + EL T +P
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 35/96 (36%), Positives = 51/96 (53%), Gaps = 8/96 (8%)
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFG 480
GL +LH II+RD+K N+LLD E H+ +DFG+ K + T+ GT
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDS--EGHIKIADFGMCKEGILGGV-TTSTFCGTPD 161
Query: 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTD 516
Y+APE L D ++ GVLL E++ G+ P +
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRIDR----SREGSDQVFERELEILGSIKHINLVNLR 373
+G G FG V ++ D +A+K I + SR E +L + +V L+
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLA-ERTVLAQVNCPFIVPLK 59
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLN----WSARLKIALGSARGLAYLHH 429
+ P L+ +++ G L F H EG+ L+ ++A L AL +
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL--FHHLQREGRFDLSRARFYTAELLCALENLHKF----- 112
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS 489
+I+RD+K NILLD + DFGL KL + ++ T GT YLAPE L
Sbjct: 113 ----NVIYRDLKPENILLDYQGHIALCDFGLCKLNM-KDDDKTNTFCGTPEYLAPELLLG 167
Query: 490 GRATEKSDVYSFGVLLLELVTGKRP 514
T+ D ++ GVLL E++TG P
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 22/214 (10%)
Query: 309 KLEALDEEDVVGSGGFGTVY--RMVMNDCGTFAVKRIDRSR----EGSDQVFERELEILG 362
K E + +G+G FG V D A+KR ++S+ + D VF E +IL
Sbjct: 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILN 86
Query: 363 SIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLN--WSARLKIALGS 420
I H VNL G + + L+ +++ G FL + + ++A++ +
Sbjct: 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480
+ L I++RD+K N+LLD++ ++DFG AK +VD T + GT
Sbjct: 147 LQSL---------NIVYRDLKPENLLLDKDGFIKMTDFGFAK-VVDTR---TYTLCGTPE 193
Query: 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
Y+APE L + + +D ++ G+ + E++ G P
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDR---SREGSDQVFERELEILGSIKHINLVNLR 373
V+G G FG V + + + FA+K +++ + F E ++L + + + L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGE---GQQLLNWSARLKIALGSARGLAYLHHD 430
+ L+ DY G L L + + + A + IA+ S L Y
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS- 489
+HRDIK NIL+D N ++DFG L+++ ++V GT Y++PE LQ+
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 490 ----GRATEKSDVYSFGVLLLELVTGKRP 514
G+ + D +S GV + E++ G+ P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 53/163 (32%), Positives = 77/163 (47%), Gaps = 12/163 (7%)
Query: 357 ELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLD----DFLHEHGEGQQLLNWSA 412
EL L + H +V + LLI +Y S G L+ L EH Q+
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 413 RLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA-HV 471
+I L L +H ++HRD+KS+NI L + DFG +K D + V
Sbjct: 175 FYQIVLA----LDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV 227
Query: 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+ GT YLAPE + R ++K+D++S GV+L EL+T RP
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 386 YDYLSMGSLDDFLHEHG-EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSN 444
Y + + + L + G EG L+ L ARG+ +L C +HRD+ + N
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL---LSFTYQVARGMEFLASKNC---VHRDLAARN 267
Query: 445 ILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF---GYLAPEYLQSGRATEKSDVYSF 501
+LL + + DFGLA+ ++ + +V+ TF ++APE + T SDV+S+
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSK--GSTFLPVKWMAPESIFDNLYTTLSDVWSY 325
Query: 502 GVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEI 561
G+LL E+ F G G + N+++ R A D T E + +I
Sbjct: 326 GILLWEI----------FSLGGTPYPGMIVDSTFYNKIKS--GYRMAKPDHATQE-VYDI 372
Query: 562 AARCTDANPDDRPSMNQVLQLLE 584
+C ++ P+ RPS + ++E
Sbjct: 373 MVKCWNSEPEKRPSFLHLSDIVE 395
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 54/177 (30%), Positives = 80/177 (45%), Gaps = 27/177 (15%)
Query: 357 ELEILGSIKHINLVNLRG---YCR-----LPATKLLIYDYLSMGSLDDFLHEHGEGQQLL 408
E IL +I H +++ L+G Y + LP K +Y YL+ ++ +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLA-------------AKRNI 179
Query: 409 NWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468
L I R + YLH + +IIHRDIK+ NI ++ + + DFG A VD
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236
Query: 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLN 525
A+ AGT APE L D++S G++L E+ T D F K GL+
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH---DSLFEKDGLD 290
|
Length = 391 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 30/217 (13%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRI--DRSREGSDQVFERELEILGSI 364
+K+E +G G +G VY+ G A+K+I + EG RE+ +L +
Sbjct: 2 QKVEK------IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL 55
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLD-----DFLHEHGEGQQLLNWSARLKIALG 419
H N+V L L++++L + D D G L+
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLDL---DLKKYMDSSPLTGLDPPLIK-----SYLYQ 107
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGT 478
+G+AY H +++HRD+K N+L+D ++DFGLA+ V + VV T
Sbjct: 108 LLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--T 162
Query: 479 FGYLAPEYLQSGRATEKS-DVYSFGVLLLELVTGKRP 514
Y APE L R D++S G + E+V +RP
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 40/119 (33%), Positives = 64/119 (53%), Gaps = 15/119 (12%)
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL----VDEEAHVTTVVAG 477
GL Y+H ++HRD+K N+L++ + E + DFGLA+ + +T VA
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA- 171
Query: 478 TFGYLAPEYLQSGRATEKS-DVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535
T Y APE + S ++ K+ DV+S G +L EL+ K P F +G + V +N +L+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK----PVF--KGKDYVDQLNQILQ 224
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (148), Expect = 4e-10
Identities = 63/297 (21%), Positives = 116/297 (39%), Gaps = 58/297 (19%)
Query: 319 VGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE-RELEILGSIK-HINLVNLRGY 375
+G G FG+VY + G A+K++ + ++ RE++ L + H N+V L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKL--- 63
Query: 376 CRLPATKLLIYD----YLSMGSLDDFLHE---HGEGQQLLNWSARLKIALGSARGLAYLH 428
K + + Y ++ L++ +G+ R I +GLA++H
Sbjct: 64 ------KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIR-SIIYQILQGLAHIH 116
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE-YL 487
HRD+K N+L+ ++DFGLA+ + + V T Y APE L
Sbjct: 117 KH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV--STRWYRAPEILL 171
Query: 488 QSGRATEKSDVYSFGVLLLELVTGK--------------------RPTDPTFVKRGLNVV 527
+S + D+++ G ++ EL T + PT + G +
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW-PEGYKLA 230
Query: 528 GWMN---TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ L +I +A ++ ++ +L +P RP+ +Q LQ
Sbjct: 231 SKLGFRFPQFAPTSLHQLIPNASPEA-IDLIKDMLRW-------DPKKRPTASQALQ 279
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 4e-10
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 21/203 (10%)
Query: 319 VGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE----RELEILGSIKHINLVNLR 373
VGSG +GTV + G A+K++ R + ++F REL +L +KH N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ--SELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 374 GYCRLPATKLLIYD--YLSMGSLDDFLHEHGEGQQLLNWSARLK-IALGSARGLAYLHHD 430
P L + YL M + L + + ++L R++ + +GL Y+H
Sbjct: 81 DVFT-PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL--SEDRIQFLVYQMLKGLKYIH-- 135
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
IIHRD+K N+ ++E+ E + DFGLA+ ++ +T V T Y APE + +
Sbjct: 136 -AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWYRAPEVILNW 190
Query: 491 -RATEKSDVYSFGVLLLELVTGK 512
T+ D++S G ++ E++TGK
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 27/211 (12%)
Query: 319 VGSGGFGTVYRMV-MNDCGTF-AVKRI--DRSREGSDQVFERELEIL---GSIKHINLVN 371
+G G +G V++ + + G F A+KR+ EG RE+ +L + +H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 372 LRGYCRLP----ATKL-LIYDYLS--MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
L C + TKL L+++++ + + D + E G + + + RGL
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK-----DMMFQLLRGL 123
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
+LH +++HRD+K NIL+ + + ++DFGLA++ + A T V T Y AP
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAP 178
Query: 485 E-YLQSGRATEKSDVYSFGVLLLELVTGKRP 514
E LQS AT D++S G + E+ ++P
Sbjct: 179 EVLLQSSYAT-PVDLWSVGCIFAEMFR-RKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 7e-10
Identities = 39/97 (40%), Positives = 57/97 (58%), Gaps = 10/97 (10%)
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH-----VTTVVA 476
+ L Y+H +IHRD+K SNILL+ + ++DFGLA+ L + E + +T VA
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 477 GTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTGK 512
T Y APE L S R T+ D++S G +L E++ GK
Sbjct: 175 -TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 24/211 (11%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQ---VFERELEILGSIKHINLVNLR 373
+VG G FG V + G +A+K + +S + + FE E +IL + L+
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLN----WSARLKIALGSARGLAYLHH 429
+ L+ +Y G L L+ + E Q + + A L +A+ S + Y
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGY--- 123
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS 489
+HRDIK N+L+D ++DFG A L + + + GT Y+APE L +
Sbjct: 124 ------VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 490 GRATEKS------DVYSFGVLLLELVTGKRP 514
K D +S GV+ E++ G+ P
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 19/205 (9%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+++G+G FG VY + D A+K++ + Q REL I+ ++ HIN++ L+ Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDY 127
Query: 376 CRLPATKLL---IYDYLSMGSLDDFLHEHGEGQQLLNWS-ARLKIALGS---ARGLAYLH 428
K I+ + M + +H++ + N + + L S R LAY+H
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187
Query: 429 HDCCPKIIHRDIKSSNILLDENLEP-HVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE-Y 486
I HRD+K N+L+D N + DFG AK L+ + V+ + + Y APE
Sbjct: 188 SKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF--YRAPELM 242
Query: 487 LQSGRATEKSDVYSFGVLLLELVTG 511
L + T D++S G ++ E++ G
Sbjct: 243 LGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (144), Expect = 1e-09
Identities = 46/152 (30%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
+ N + L +LI DY+ G L D L + G+ L+ + KI L
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK----LSEAEVKKIIRQLVEAL 122
Query: 425 AYLH-HDCCPKIIHRDIKSSNILLDENLEP-HVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
LH H IIH DIK N+L D + ++ D+GL K+ + GT Y
Sbjct: 123 NDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI-----IGTPSCYDGTLDYF 173
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+PE ++ D ++ GVL EL+TGK P
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 12/201 (5%)
Query: 318 VVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE--GSDQVFER--ELEILGSIKHINLVNLR 373
++G G FG V + G + +I + D+V E +L + +H L +L+
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
+ + +Y++ G L F H E + + + SA L YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSA--LDYLHSG--- 114
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
KI++RD+K N++LD++ ++DFGL K + + A + T GT YLAPE L+
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYG 173
Query: 494 EKSDVYSFGVLLLELVTGKRP 514
D + GV++ E++ G+ P
Sbjct: 174 RAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 66/241 (27%), Positives = 107/241 (44%), Gaps = 60/241 (24%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE---------RELEILGSIK 365
++V+G G +G V + G A+K+I+ VFE RE+++L ++
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-------DVFEHVSDATRILREIKLLRLLR 57
Query: 366 HINLVNLRGYCRLPATKLLIYD------------YLSMGSLDDFLHEHGEG--QQLLNWS 411
H ++V ++ + LP ++ D + + + DD EH + QLL
Sbjct: 58 HPDIVEIK-HIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLL--- 113
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471
R L Y+H + HRD+K NIL + + + + DFGLA++ ++
Sbjct: 114 ----------RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160
Query: 472 ---TTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNV 526
T VA T Y APE S + T D++S G + E++TGK P F G NV
Sbjct: 161 IFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK----PLF--PGKNV 213
Query: 527 V 527
V
Sbjct: 214 V 214
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 63/208 (30%), Positives = 96/208 (46%), Gaps = 32/208 (15%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE----RELEILGSIKHINLVNLR 373
VGSG +G+V + G A+K++ SR ++F REL +L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80
Query: 374 GYCRLPATKLL-IYD-YLSMGSLDDFL-----HEHGEGQ-QLLNWSARLKIALGSARGLA 425
A D YL M + L H E + Q L + GL
Sbjct: 81 D-VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQ--------MLCGLK 131
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
Y+H IIHRD+K N+ ++E+ E + DFGLA+ +A +T V T Y APE
Sbjct: 132 YIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWYRAPE 184
Query: 486 Y-LQSGRATEKSDVYSFGVLLLELVTGK 512
L + D++S G ++ E++TGK
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 63/298 (21%), Positives = 107/298 (35%), Gaps = 50/298 (16%)
Query: 320 GSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQV--FERELEILGSIKHINLVNLRGYC 376
+ + T AVK+I+ + + ++E+ ++H N++
Sbjct: 11 EDLMIVHLAKH--KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TS 67
Query: 377 RLPATKL-LIYDYLSMGSLDDFLHEH-GEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
+ ++L ++ ++ GS +D L H EG L A I L Y+H
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEG---LPELAIAFILKDVLNALDYIHSKGF-- 122
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG------YLAPEYLQ 488
IHR +K+S+ILL + + +S + ++ V +L+PE LQ
Sbjct: 123 -IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 489 ---SGRATEKSDVYSFGVLLLELVTGKRP---TDPTFV---KRGLNVVGWMNTLLKENRL 539
G EKSD+YS G+ EL G P T + K V G + LL ++
Sbjct: 182 QNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEK----VRGTVPCLLDKSTY 236
Query: 540 EDVIDKRCADADMETVEAILE----------------IAARCTDANPDDRPSMNQVLQ 581
D + C +P+ RPS +Q+L
Sbjct: 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 10/99 (10%)
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480
A GL +LH II+RD+K N++LD ++DFG+ K + T GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK-TTRTFCGTPD 166
Query: 481 YLAPE---YLQSGRATEKSDVYSFGVLLLELVTGKRPTD 516
Y+APE Y G++ D ++FGVLL E++ G+ P D
Sbjct: 167 YIAPEIIAYQPYGKSV---DWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 70/242 (28%), Positives = 105/242 (43%), Gaps = 33/242 (13%)
Query: 289 STKLITFHGDMPYPS--CEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRS 346
S K I F P PS EIIE +G G +G V++++ G+ A +I
Sbjct: 4 SGKTIIFD-SFPDPSDTWEIIE---------TIGKGTYGKVFKVLNKKNGSKAAVKILDP 53
Query: 347 REGSDQVFERELEILGSIK-HINLVNLRGYCRLPATK-----LLIYDYLSMGSLDDFLH- 399
D+ E E IL ++ H N+V G K L+ + + GS+ D +
Sbjct: 54 IHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG 113
Query: 400 --EHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSD 457
+ GE + + L AL GL +LH + K IHRD+K +NILL + D
Sbjct: 114 FLKRGERMEEPIIAYILHEAL---MGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVD 167
Query: 458 FGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA-----TEKSDVYSFGVLLLELVTGK 512
FG++ L T V GT ++APE + + + DV+S G+ +EL G
Sbjct: 168 FGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGD 226
Query: 513 RP 514
P
Sbjct: 227 PP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 78/303 (25%), Positives = 119/303 (39%), Gaps = 97/303 (32%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER--------ELEILGSIKHIN 368
V+G G FG V + D G +A+K++ +S ++ E+ E +IL +
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKLRKS-----EMLEKEQVAHVRAERDILAEADNPW 62
Query: 369 LVNLRGYCRL--PATKLLIYDYLSMGSL-------DDFLHEHGEGQQLLNWSARLKIALG 419
+V L Y LI +YL G + D F E + + A +A+
Sbjct: 63 VVKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-----ETRFYIAETILAID 115
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV----- 474
S L Y IHRDIK N+LLD +SDFGL L +++H T
Sbjct: 116 SIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILS 164
Query: 475 ----------------------------------VAGTFGYLAPE-YLQSGRATEKSDVY 499
GT Y+APE +LQ+G E D +
Sbjct: 165 HALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWW 223
Query: 500 SFGVLLLELVTGKRP---TDP--TFVKRGLNVVGWMNTLLK--ENRL----EDVIDKRCA 548
S GV++ E++ G P +P T+ K ++ W TL E L +D+I + C
Sbjct: 224 SLGVIMYEMLVGYPPFCSDNPQETYRK----IINWKETLQFPDEVPLSPEAKDLIKRLCC 279
Query: 549 DAD 551
+A+
Sbjct: 280 EAE 282
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 33/91 (36%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
L +LH +I+RD+K NILLD ++DFG+ K + TT GT Y+A
Sbjct: 109 LMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTTFCGTPDYIA 164
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
PE LQ D ++ GVL+ E++ G+ P
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 4/91 (4%)
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
L YLH +++RDIK N++LD++ ++DFGL K + + A + T GT YLA
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
PE L+ D + GV++ E++ G+ P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 68/289 (23%), Positives = 117/289 (40%), Gaps = 59/289 (20%)
Query: 320 GSGGFGTVYRMVMNDCGTFAVKRIDRSRE--------GSDQV----FERELEILGSIKHI 367
G G F +Y+ V+ + +E GSD F ++ + H
Sbjct: 4 GQGTFTNIYKGVLRVQSDL--DIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHK 61
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYL 427
+LV L G C +++ +Y+ G LD FLH ++ +L +A A L YL
Sbjct: 62 HLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNN---VSLHWKLDVAKQLASALHYL 117
Query: 428 HHDCCPKIIHRDIKSSNILL-----DENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFG 480
K++H ++ NIL+ +E P + SD G+ ++ E V +
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----P 169
Query: 481 YLAPEYLQSGRA--TEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKEN 537
++APE +++G+A T +D +SFG LLE+ + G+ P ++TL
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEP---------------LSTLSSSE 214
Query: 538 RLEDVIDKRCADADMETVEAILEIAA---RCTDANPDDRPSMNQVLQLL 583
+ D + E+A +C +P RPS +L+ L
Sbjct: 215 KER-----FYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 29/170 (17%)
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG-TF 479
A+G+ +L C IHRD+ + NILL EN + DFGLA+ + + +V A
Sbjct: 189 AKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP-----TDPTFVKRGLNVVGWMNTL 533
++APE + T +SDV+SFGVLL E+ + G P D F +R
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----------- 294
Query: 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
LKE R D T E + + C P RP+ +++++ L
Sbjct: 295 LKEG-------TRMRAPDYTTPE-MYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 66/237 (27%), Positives = 91/237 (38%), Gaps = 53/237 (22%)
Query: 318 VVGSGGFGTVYRMVMNDCGT---FAVKRIDRS----REGSDQVFERELEILGSIKHINLV 370
++G G G V+ ++ GT FA+K +D+ R +V E EIL ++ H L
Sbjct: 8 LLGKGDVGRVF--LVRLKGTGKLFALKVLDKKEMIKRNKVKRV-LTEQEILATLDHPFLP 64
Query: 371 NLRGYCRLPATKLLIY--DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH 428
L Y L DY G L L G+ L AR A L YLH
Sbjct: 65 TL--YASFQTETYLCLVMDYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLL-ALEYLH 120
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVT-------------- 472
I++RD+K NILL E+ H+ SDF L+K D E
Sbjct: 121 ---LLGIVYRDLKPENILLHES--GHIMLSDFDLSKQS-DVEPPPVSKALRKGSRRSSVN 174
Query: 473 -----TVVA----------GTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
T GT Y+APE + D ++ G+LL E++ G P
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 26/219 (11%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCG--TFAVK---RIDRSREGSDQVFERELEILGS 363
K E D V+G G FG V ++V + +A+K + + + F E +I+
Sbjct: 41 KAEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99
Query: 364 IKHINLVNLRGYCRLPATKLL--IYDYLSMGSLDDFLHEHGEGQQLLN-WSARLKIALGS 420
+V L +C K L + +Y+ G L + + + ++ ++A + +AL +
Sbjct: 100 ANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA 157
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA-GTF 479
+ +IHRD+K N+LLD++ ++DFG + +DE V A GT
Sbjct: 158 IHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTP 207
Query: 480 GYLAPEYLQS----GRATEKSDVYSFGVLLLELVTGKRP 514
Y++PE L+S G + D +S GV L E++ G P
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 436 IHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-----G 490
+HRDIK N+LLD N ++DFG + + ++V GT Y++PE LQ+ G
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183
Query: 491 RATEKSDVYSFGVLLLELVTGKRP 514
+ + D +S GV + E++ G+ P
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 27/212 (12%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDR---SREGSDQVF--ERELEILGSIKHINLVN 371
V+G G FG V + M + G +A+K +++ + F ER++ + G + I N
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWIT--N 65
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGE---GQQLLNWSARLKIALGSARGLAYLH 428
L + L+ DY G L L + + + A + +A+ S L Y
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY-- 123
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA-GTFGYLAPEYL 487
+HRDIK N+LLD+N ++DFG + L + + V + VA GT Y++PE L
Sbjct: 124 -------VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEIL 175
Query: 488 QS-----GRATEKSDVYSFGVLLLELVTGKRP 514
Q+ GR + D +S GV + E++ G+ P
Sbjct: 176 QAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 3/92 (3%)
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
L YLH + +++RD+K N++LD++ ++DFGL K + + A + T GT YL
Sbjct: 107 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYL 163
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
APE L+ D + GV++ E++ G+ P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 34/94 (36%), Positives = 54/94 (57%), Gaps = 10/94 (10%)
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
L YLH +++RD+K N++LD++ ++DFGL K + + A + T GT YLA
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163
Query: 484 PEYLQS---GRATEKSDVYSFGVLLLELVTGKRP 514
PE L+ GRA D + GV++ E++ G+ P
Sbjct: 164 PEVLEDNDYGRAV---DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 318 VVGSGGFGTVY--RMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHIN------- 368
V+G G + V R+ ND +A+K + + D+ +++ + + KH+
Sbjct: 2 VIGRGSYAKVLLVRLKKND-QIYAMKVVKKELVHDDE----DIDWVQTEKHVFEQASSNP 56
Query: 369 -LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYL 427
LV L + + L+ +Y++ G D + ++L AR A L +L
Sbjct: 57 FLVGLHSCFQTTSRLFLVIEYVNGG---DLMFHMQRQRKLPEEHARF-YAAEICIALNFL 112
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
H II+RD+K N+LLD + ++D+G+ K + T+ GT Y+APE L
Sbjct: 113 HER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPEIL 168
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRPTD 516
+ D ++ GVL+ E++ G+ P D
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 33/109 (30%), Positives = 51/109 (46%), Gaps = 20/109 (18%)
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE-------------- 468
+ Y+H ++HRD+K NILL E + D+G A EE
Sbjct: 125 TIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 469 AHVTTV---VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
T+ + GT Y+APE L A+E +D+Y+ GV+L +++T P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 45/203 (22%), Positives = 87/203 (42%), Gaps = 8/203 (3%)
Query: 316 EDVVGSGGFGTVYRMV-MNDCGTFAVKRI---DRSREGSDQVFERELEILGSIKHINLVN 371
E +G G F VYR + D A+K++ D + +E+++L + H N++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC 431
++ + G L + + ++L+ K + L ++H
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR- 125
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR 491
+++HRDIK +N+ + + D GL + + ++V GT Y++PE +
Sbjct: 126 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 182
Query: 492 ATEKSDVYSFGVLLLELVTGKRP 514
KSD++S G LL E+ + P
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 10/94 (10%)
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH---VTTVVAGTFG 480
L +LH II+RD+K N+LLD ++DFG+ K E T+ GT
Sbjct: 109 LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK----EGIFNGKTTSTFCGTPD 161
Query: 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
Y+APE LQ D ++ GVLL E++ G P
Sbjct: 162 YIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 35/107 (32%), Positives = 55/107 (51%), Gaps = 10/107 (9%)
Query: 410 WSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469
+SA + +AL YLH II+RD+K N+LLD ++D+G+ K +
Sbjct: 101 YSAEISLALN------YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-RPG 150
Query: 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTD 516
T+ GT Y+APE L+ D ++ GVL+ E++ G+ P D
Sbjct: 151 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 38/135 (28%), Positives = 70/135 (51%), Gaps = 12/135 (8%)
Query: 384 LIYDYLSMGSLDDFLHEHGEGQ--QLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIK 441
+ +Y++ G L + + G+ + Q + ++A + + GL +LH II+RD+K
Sbjct: 78 FVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GLFFLHRR---GIIYRDLK 128
Query: 442 SSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSF 501
N++LD ++DFG+ K + + T GT Y+APE + + D +++
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKEHM-VDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAY 187
Query: 502 GVLLLELVTGKRPTD 516
GVLL E++ G+ P D
Sbjct: 188 GVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 69/234 (29%), Positives = 101/234 (43%), Gaps = 44/234 (18%)
Query: 319 VGSGGFGTVYRMVMNDCGTF-AVKRIDRSR-EGSDQV--FERELEILGSIKHINLVNLRG 374
VG GG+G V+ D G A+KR+ +S ++V E +IL + K LV L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-- 66
Query: 375 YCRLPATKLLIYDYLSM-----GSLDDFLHEHGEGQQLLNWSARLKI-----ALGSARGL 424
L A + Y YL+M G L+ G L AR + A+ + L
Sbjct: 67 ---LYAFQDDEYLYLAMEYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL 120
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
Y IHRD+K N L+D + ++DFGL+K +V A+ V G+ Y+AP
Sbjct: 121 GY---------IHRDLKPENFLIDASGHIKLTDFGLSKGIV-TYAN---SVVGSPDYMAP 167
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRP-----TDPTFVKRGLNVVGWMNTL 533
E L+ D +S G +L E + G P + T+ N+ W TL
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE----NLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 66/259 (25%), Positives = 99/259 (38%), Gaps = 58/259 (22%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNL 372
V+G G FG V+ + D G +A+K + +S + E +IL +V L
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL 66
Query: 373 RGYCRLPATKLL--IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKI-----ALGSARGLA 425
Y + L + +Y+ G L + L +AR I AL S L
Sbjct: 67 --YYSFQDEEHLYLVMEYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG 121
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAK-----------------LLVD 466
+ IHRDIK NIL+D + H+ +DFGL K LL
Sbjct: 122 F---------IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 467 EEAHVTT-----------VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP- 514
+ V GT Y+APE L+ + D +S GV+L E++ G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 515 TDPTFVKRGLNVVGWMNTL 533
T + ++ W +L
Sbjct: 231 YSDTLQETYNKIINWKESL 249
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 42/165 (25%), Positives = 82/165 (49%), Gaps = 11/165 (6%)
Query: 354 FERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQL------ 407
F +E++I+ +K N++ L C +I +Y+ G L+ FL H +
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 408 -LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466
+++S + +A A G+ YL +HRD+ + N L+ +N ++DFG+++ L
Sbjct: 126 TISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 467 EEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT 510
+ + + +++ E + G+ T SDV++FGV L E++T
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 7e-08
Identities = 17/41 (41%), Positives = 23/41 (56%), Gaps = 1/41 (2%)
Query: 26 LTEDGMTLLEIKSSLNDSRN-LLGNWQATEESPCKWTGISC 65
L +D LL KSSLN + L +W + PC WTG++C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTC 41
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480
A GL +LH II+RD+K N++LD ++DFG+ K + + T GT
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENM-WDGVTTKTFCGTPD 166
Query: 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTD 516
Y+APE + + D ++FGVLL E++ G+ P +
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 47/177 (26%), Positives = 81/177 (45%), Gaps = 39/177 (22%)
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF- 479
A G+ +L C +HRD+ + N+L+ E + DFGLA+ ++ + +++ TF
Sbjct: 249 ANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GSTFL 303
Query: 480 --GYLAPEYLQSGRATEKSDVYSFGVLLLELVT------GKRPTDPTF---VKRGLNVVG 528
++APE + + T SDV+SFG+LL E+ T + P + F +KRG +
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM-- 361
Query: 529 WMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ A A E I EI +C + + RP +Q++ L+
Sbjct: 362 ----------------AKPAHASDE----IYEIMQKCWEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 436 IHRDIKSSNILLDENLEPHVSDFGLA-KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT- 493
IHRD+K N+LLD++ ++DFG K+ + T V GT Y++PE L+S
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 494 ---EKSDVYSFGVLLLELVTGKRP 514
+ D +S GV L E++ G P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLN------WSARLKIALGSAR 422
LV L + + + +++S G L H + Q+ L +SA + +AL
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDL----MFHMQRQRKLPEEHARFYSAEISLALN--- 110
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
+LH II+RD+K N+LLD ++D+G+ K + T+ GT Y+
Sbjct: 111 ---FLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI-RPGDTTSTFCGTPNYI 163
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRPTD 516
APE L+ D ++ GVL+ E++ G+ P D
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 44/166 (26%), Positives = 64/166 (38%), Gaps = 49/166 (29%)
Query: 436 IHRDIKSSNILLDENLEPHVSDFGL----------------------------------- 460
IHRDIK NIL+D + ++DFGL
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 461 AKLLVDEEAHV---TTVVA----GTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKR 513
+L E +A GT Y+APE L T+ D +S GV+L E++ G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 514 P-TDPTFVKRGLNVVGWMNTL--LKENRLE----DVIDKRCADADM 552
P T + L V+ W TL + +L D+I + C A+
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAED 288
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 319 VGSGGFGTVYRMVMNDCGT---FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
VG G +G VY+ D +A+K+I+ + G RE+ +L +KH N+++L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKV 66
Query: 376 CRLPATK--LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY-----LH 428
A + L++DY D H + +++ G + L Y +H
Sbjct: 67 FLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 429 HDCCPKIIHRDIKSSNILL----DENLEPHVSDFGLAKLL---VDEEAHVTTVVAGTFGY 481
+ ++HRD+K +NIL+ E ++D G A+L + A + VV TF Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 181
Query: 482 LAPEYLQSGRATEKS-DVYSFGVLLLELVTGKRPTDPTF 519
APE L R K+ D+++ G + EL+T ++P F
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT----SEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 319 VGSGGFGTVYRMVMNDCGTFA---VKRIDRSREGSDQV-FERELEILGSIKHINLVNLRG 374
+G+G FG V +N T A VK + S +Q+ F E + S++H NL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARL-KIALGSARGLAYLHHDCCP 433
C LL+ ++ +G L +L + + + L ++A A GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT-VVAGTFGYLAPEYLQSGRA 492
IH D+ N LL +L + D+GL+ E+ +VT + ++APE +
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 493 -------TEKSDVYSFGVLLLEL 508
T++S+V+S GV + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 354 FERELEILGSIKHINLVNLRGYCRLPATKLLI---YDYLSMGSLDDFLHEHG---EGQQL 407
E E+ LG + H N++ + R A +I YD+ L F+++ + + L
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPL 265
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467
L + + L A + Y+H K+IHRDIK NI L+ + + + DFG A E
Sbjct: 266 LKQTRAIMKQLLCA--VEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT 510
GT +PE L E +D++S G++LL++++
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 52/218 (23%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 309 KLEALDEE--DVVGSGGFGTVYRMVMNDCGT--FAVK---RIDRSREGSDQVFERELEIL 361
+++A D E V+G G FG V ++V + +A+K + + + F E +I+
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 362 GSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG-EGQQLLNWSARLKIALGS 420
+V L + ++ +Y+ G L + + + + ++A + +AL +
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 157
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480
+ + IHRD+K N+LLD++ ++DFG + E GT
Sbjct: 158 IHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 481 YLAPEYLQS----GRATEKSDVYSFGVLLLELVTGKRP 514
Y++PE L+S G + D +S GV L E++ G P
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 32/221 (14%)
Query: 319 VGSGGFGTVYRMVM------NDCGTFAVKRIDRSREGS-DQVFERELEILGSIKHINLVN 371
+G FG VY+ + A+K + EG + F+ E + ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFL---HEHGEG---------QQLLNWSARLKIALG 419
L G +I+ Y S L +FL H + + L + + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 420 SARGLAYL--HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG 477
A G+ +L HH ++H+D+ + N+L+ + L +SD GL + + A ++
Sbjct: 133 IAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVY--AADYYKLMGN 185
Query: 478 TF---GYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRP 514
+ +++PE + G+ + SD++S+GV+L E+ + G +P
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 50/165 (30%), Positives = 72/165 (43%), Gaps = 17/165 (10%)
Query: 355 ERELEILGSIKHINLVNL-RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR 413
RE++IL +I H ++NL Y +++ Y D F + G L
Sbjct: 134 GREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY----KCDLFTYVDRSGPLPLE--QA 187
Query: 414 LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT 473
+ I LAYLH IIHRD+K+ NI LDE + DFG A L +AH T
Sbjct: 188 ITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL---DAHPDT 241
Query: 474 VV----AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+GT +PE L K+D++S G++L E+
Sbjct: 242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 27/218 (12%)
Query: 319 VGSGGFGTVYRMVMNDCG---TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
VG G +G VY+ D +A+K+I+ + G RE+ +L +KH N++ L+
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKV 66
Query: 376 CRLPATK--LLIYDYLS--MGSLDDFLHEHGEGQQLLNWSARLKIAL--GSARGLAYLHH 429
+ + L++DY + + F ++ + + +L G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 430 DCCPKIIHRDIKSSNILL----DENLEPHVSDFGLAKLL---VDEEAHVTTVVAGTFGYL 482
+ ++HRD+K +NIL+ E ++D G A+L + A + VV TF Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYR 182
Query: 483 APEYLQSGRATEKS-DVYSFGVLLLELVTGKRPTDPTF 519
APE L R K+ D+++ G + EL+T ++P F
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLT----SEPIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 55/232 (23%)
Query: 319 VGSGGFGTVYR-MVMNDCGTFAVKR---------IDRSREGSDQV---FE--RELEILGS 363
+G G +G V + A+K+ + + R+ F REL+I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 364 IKHINLVNLRG-YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK------I 416
IKH N++ L Y L++ D + + +++++ RL I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVM-DIM-----------ASDLKKVVDRKIRLTESQVKCI 124
Query: 417 ALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK-----LLVDE---- 467
L GL LH +HRD+ +NI ++ ++DFGLA+ D
Sbjct: 125 LLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 468 ------EAHVTTVVAGTFGYLAPEYLQ-SGRATEKSDVYSFGVLLLELVTGK 512
E + VV T Y APE L + + D++S G + EL+TGK
Sbjct: 182 ETMQRREEMTSKVV--TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 38/111 (34%), Positives = 56/111 (50%), Gaps = 19/111 (17%)
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE----------NLEPHVSDFGLAKLLV 465
I G+ RGL YLH + IHR+IK+S+IL+ +L V + AK++
Sbjct: 106 ILFGALRGLNYLHQNGY---IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 466 DEEAHVTTVVAGTFGYLAPEYLQSGRA--TEKSDVYSFGVLLLELVTGKRP 514
D T+V+ +L+PE L+ KSD+YS G+ EL TG+ P
Sbjct: 163 DFPQFSTSVLP----WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 31/93 (33%), Positives = 44/93 (47%), Gaps = 3/93 (3%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT 145
+ + L L+ L L N L +P ++N + L L L N + +P I L L
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALE 212
Query: 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFF 178
LDLS+NS+ + SSL L +L L LS N
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL 244
|
Length = 394 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 58/199 (29%), Positives = 85/199 (42%), Gaps = 15/199 (7%)
Query: 319 VGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE--RELEILGSIKHINLVNLRGY 375
+GSG G V G AVK++ R + REL +L + H N+++L
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV 88
Query: 376 CRLPATKLLIYD-YLSMGSLDDFLHE--HGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
+ D YL M +D L + H E L+ + G+ +LH
Sbjct: 89 FTPQKSLEEFQDVYLVMELMDANLCQVIHME----LDHERMSYLLYQMLCGIKHLH---S 141
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
IIHRD+K SNI++ + + DFGLA+ VV T Y APE +
Sbjct: 142 AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGMGY 199
Query: 493 TEKSDVYSFGVLLLELVTG 511
E D++S G ++ ELV G
Sbjct: 200 KENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
G+ +LH IIHRD+K SNI++ + + DFGLA+ VV T Y
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 184
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGK 512
APE + E D++S G ++ E++ G
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 53/220 (24%), Positives = 93/220 (42%), Gaps = 31/220 (14%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVK--RIDRSREGSDQVFERELEILGSI 364
EKLE +G G +G VY+ + G A+K R++ EG RE+ +L +
Sbjct: 4 EKLE------KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQML 57
Query: 365 KH-INLVNLRGYCRLPATK--------LLIYDYLSMGSLDDFLHEHGEGQ-QLLNWSARL 414
I +V L + + L+++YL L F+ +G G + L
Sbjct: 58 SESIYIVRL---LDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEP-HVSDFGLAK-LLVDEEAHVT 472
+G+A+ H ++HRD+K N+L+D+ ++D GL + + +++
Sbjct: 114 SFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 473 TVVAGTFGYLAPEYLQSGRATEKS-DVYSFGVLLLELVTG 511
+V T Y APE L D++S G + E+
Sbjct: 171 EIV--TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 69/292 (23%), Positives = 109/292 (37%), Gaps = 68/292 (23%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVKRIDRSRE--GSDQV--FERELEILGSIKHINLVNLRG 374
+G G FG V D + R ++ +QV + E +IL + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLN--WSARLKIALGSARGLAYLHHDCC 432
+ + DY+ G + L ++L + A L +A+ S + +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF------ 122
Query: 433 PKIIHRDIKSSNILLD---------------------------------ENLEPH----- 454
IHRDIK NIL+D +++EP
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 455 VSDFGLAKLLVDEEAHVTT--------VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLL 506
VS+ L E T + GT Y+APE L T+ D +S GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 507 ELVTGKRP-TDPTFVKRGLNVVGWMNTLLKENRLE------DVIDKRCADAD 551
E++ G+ P PT + L V+ W NTL +++ D+I K C A+
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAE 291
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 15/200 (7%)
Query: 319 VGSGGFGTV---YRMVMNDCGTFAVKRIDRSREGSDQVFE--RELEILGSIKHINLVNLR 373
+GSG G V Y V++ A+K++ R + REL ++ + H N+++L
Sbjct: 25 IGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 374 GYCRLPATKLLIYD-YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
+ D YL M +D L + Q L+ + G+ +LH
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQ--VIQMELDHERMSYLLYQMLCGIKHLHS--- 137
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
IIHRD+K SNI++ + + DFGLA+ + + T T Y APE +
Sbjct: 138 AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGY 195
Query: 493 TEKSDVYSFGVLLLELVTGK 512
E D++S G ++ E+V K
Sbjct: 196 KENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 62/283 (21%), Positives = 126/283 (44%), Gaps = 46/283 (16%)
Query: 319 VGSGGFGTVYRMVMNDCGTFA--------VKRIDRSREGSDQVFERELEILGSIKHINLV 370
+G G F +++ + + G + +K +D+S + F ++ + H +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY-LHH 429
G C +++ +Y+ GSLD +L ++ L+N S +L++ A+ LA+ LH
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK---NLINISWKLEV----AKQLAWALHF 115
Query: 430 DCCPKIIHRDIKSSNILL-----DENLEP---HVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
+ H ++ + N+LL + P +SD G++ ++ +E + + +
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI-----PW 170
Query: 482 LAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540
+ PE +++ + + +D +SFG L E+ +G P ++ L + +L+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGG--DKP------------LSALDSQKKLQ 216
Query: 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
D+ A T A L +C D PD RPS +++ L
Sbjct: 217 FYEDRHQLPAPKWTELANL--INQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRS----REGSDQVFERELEILGSIKHINLVNL 372
++ +G +G VY + + FA+K+I++ R QVF E +IL ++ +V++
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAENPFVVSM 66
Query: 373 RGYCRLPATKLL--IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
+C + L + +Y+ G L G L AR+ A + L YLH+
Sbjct: 67 --FCSFETKRHLCMVMEYVEGGDCATLLKNIGA---LPVDMARMYFA-ETVLALEYLHN- 119
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAK--------------LLVDEEAHVTTVVA 476
I+HRD+K N+L+ ++DFGL+K + D + V
Sbjct: 120 --YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177
Query: 477 GTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
GT Y+APE + + D ++ G++L E + G P
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 48/198 (24%), Positives = 90/198 (45%), Gaps = 18/198 (9%)
Query: 320 GSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE-RELEILGSIK-HINLVNLRG-- 374
G G F V + G + A+K + + + +QV RE++ L + H N++ L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVL 67
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQ-QLLNWSARLKIALGSARGLAYLHHDCCP 433
+ R L+++ + M L+E +G+ + L + L ++H +
Sbjct: 68 FDRKTGRLALVFELMDMN-----LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN--- 119
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE-YLQSGRA 492
I HRDIK NIL+ +++ ++DFG + + + + T T Y APE L G
Sbjct: 120 GIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPY--TEYISTRWYRAPECLLTDGYY 176
Query: 493 TEKSDVYSFGVLLLELVT 510
K D+++ G + E+++
Sbjct: 177 GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
G+ +LH IIHRD+K SNI++ + + DFGLA+ VV T Y
Sbjct: 138 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYR 192
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGK 512
APE + E D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 21/158 (13%)
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEH----GEGQQLLNWSARLKIALG 419
++H N++ G C LL+++Y +G L +L + Q LL ++A
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACE 107
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT--VVAG 477
A G+ ++H +H D+ N L +L V D+G+ E+ ++ T
Sbjct: 108 IAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCV 163
Query: 478 TFGYLAPEY-------LQSGRATEKSDVYSFGVLLLEL 508
+LAPE L + T+ S+V++ GV L EL
Sbjct: 164 PLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 32/96 (33%), Positives = 44/96 (45%), Gaps = 9/96 (9%)
Query: 318 VVGSGGFGTVYRMVM------NDCGTFAVKRIDRSREGSDQ-VFERELEILGSI-KHINL 369
V+G G FG V + C T AVK + S+ EL+IL I H+N+
Sbjct: 14 VLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV 73
Query: 370 VNLRGYCRLPATKLL-IYDYLSMGSLDDFLHEHGEG 404
VNL G C P L+ I ++ G+L +FL E
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREF 109
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 7e-05
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 39/236 (16%)
Query: 313 LDEEDVV---GSGGFGTVY-----RMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSI 364
L+E +V+ G+G FG V+ R C R + RE S V E + ++ +
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIE--VNVMREL 69
Query: 365 KHINLVN-LRGYCRLPATKLLI-YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSAR 422
KH N+V + + KL I ++ G L + + + + A + I
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 423 GLAYLHH----DCCPKIIHRDIKSSNILLDENLE-----------------PHVSDFGLA 461
LAY H+ +++HRD+K NI L + + DFGL+
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 462 KLL-VDEEAHVTTVVAGTFGYLAPEYL--QSGRATEKSDVYSFGVLLLELVTGKRP 514
K + ++ AH GT Y +PE L ++ +KSD+++ G ++ EL +GK P
Sbjct: 190 KNIGIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 44/177 (24%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 340 VKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLH 399
+K +D S F ++ + HI+L + G C + +++ +++ G LD L
Sbjct: 49 LKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLR 108
Query: 400 EHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNIL-----LDENLEPH 454
+ +G+ + W + L SA L+YL ++H ++ + NIL L E P
Sbjct: 109 KE-KGRVPVAWKITVAQQLASA--LSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPF 162
Query: 455 V--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLEL 508
+ SD G++ + E V + ++APE + G + + +D +SFG LLE+
Sbjct: 163 IKLSDPGVSFTALSREERVERI-----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 9e-05
Identities = 44/162 (27%), Positives = 66/162 (40%), Gaps = 51/162 (31%)
Query: 436 IHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV--------------------- 474
IHRDIK N+LLD +SDFGL L ++AH T
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGL--KKAHRTEFYRNLTHNPPSDFSFQNMNSKR 180
Query: 475 ---------------VAGTFGYLAPE-YLQSGRATEKSDVYSFGVLLLELVTGKRP---T 515
GT Y+APE ++Q+G + D +S GV++ E++ G P
Sbjct: 181 KAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 516 DPTFVKRGLNVVGWMNTLL------KENRLEDVIDKRCADAD 551
P R V+ W TL+ + +D+I + C D++
Sbjct: 240 TPQETYR--KVMNWKETLVFPPEVPISEKAKDLILRFCTDSE 279
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 36/106 (33%), Positives = 50/106 (47%), Gaps = 8/106 (7%)
Query: 76 NLPYMQLGGI----ISPSIGRLD-KLQRLALHQNSLHGSIPNEITNCTELRALYLRANYL 130
NL + L I P IG L L+ L L N + S+P+ + N L+ L L N L
Sbjct: 117 NLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESLPSPLRNLPNLKNLDLSFNDL 175
Query: 131 QGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+P + NL L LDLS N + +P + L+ L L+LS N
Sbjct: 176 SD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNN 219
|
Length = 394 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 65/269 (24%), Positives = 98/269 (36%), Gaps = 58/269 (21%)
Query: 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE--GSDQV--FERELEILGSIKH 366
E + V+G G FG V + D G +I R + +QV E +IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG----EGQQLLNWSARLKIALGSAR 422
+ +V + + LI ++L G + L + E Q + A +A+ S
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF--YIAETVLAIDSIH 118
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV-------- 474
L + IHRDIK N+LLD +SDFGL L ++AH T
Sbjct: 119 QLGF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGL--KKAHRTEFYRNLNHSL 167
Query: 475 ----------------------------VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLL 506
GT Y+APE + D +S GV++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 507 ELVTGKRP-TDPTFVKRGLNVVGWMNTLL 534
E++ G P T + V+ W TL+
Sbjct: 228 EMLIGYPPFCSETPQETYKKVMNWKETLI 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 8/89 (8%)
Query: 318 VVGSGGFG-----TVYRMVMNDCG-TFAVKRIDRSREGSD-QVFERELEILGSI-KHINL 369
+G+G FG T Y + +D T AVK + S ++ + EL++L + HIN+
Sbjct: 42 TLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINI 101
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFL 398
VNL G C + L+I +Y G L +FL
Sbjct: 102 VNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 41/177 (23%), Positives = 80/177 (45%), Gaps = 19/177 (10%)
Query: 340 VKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLH 399
+K +D S F ++ + H ++V L G C +++ +++ G LD F+H
Sbjct: 37 LKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH 96
Query: 400 EHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL-----DENLEPH 454
+ +L + K+A A L+YL ++H ++ + NILL D P
Sbjct: 97 RKSD---VLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPF 150
Query: 455 V--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLEL 508
+ SD G+ ++ + V + ++APE ++ + + +D +SFG L E+
Sbjct: 151 IKLSDPGIPITVLSRQECVERI-----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 48/195 (24%), Positives = 84/195 (43%), Gaps = 33/195 (16%)
Query: 339 AVKRIDRSREGSDQV--FERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDD 396
V+RI+ ++ V + EL + H N+V R ++ +++ GS D
Sbjct: 29 TVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD 88
Query: 397 FLHEHGEGQQLLNWSARLKIA---LGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEP 453
+ H ++ + L IA G + L Y+HH +HR +K+S+IL+ + +
Sbjct: 89 LICTH-----FMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKV 140
Query: 454 HVSDFGL------------AKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA--TEKSDVY 499
++S GL +++ D + V+ +L+PE LQ KSD+Y
Sbjct: 141 YLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLP----WLSPEVLQQNLQGYDAKSDIY 194
Query: 500 SFGVLLLELVTGKRP 514
S G+ EL G P
Sbjct: 195 SVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 27/83 (32%), Positives = 41/83 (49%), Gaps = 4/83 (4%)
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAP 484
Y+H IIHRDIK+ N+L++ + + DFG A + +AGT AP
Sbjct: 275 YIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 485 EYLQSGRATEKSDVYSFGVLLLE 507
E L T D++S G+++ E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 6e-04
Identities = 20/57 (35%), Positives = 26/57 (45%)
Query: 120 LRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L++L L N L L L +LDLS N+L P + L L L+LS N
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 47/179 (26%), Positives = 78/179 (43%), Gaps = 20/179 (11%)
Query: 336 GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLD 395
TF +K + +S E S ER I + + +V L Y + L+ + G L
Sbjct: 19 QTFILKGLRKSSEYSR---ERLTIIPHCVPN--MVCLHKYIVSEDSVFLVLQHAEGGKLW 73
Query: 396 DFLHE--HGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEP 453
+ + + + + W+A + +AL + LH + I+ RD+ +NILLD+
Sbjct: 74 SHISKFLNIPEECVKRWAAEMVVALDA------LHRE---GIVCRDLNPNNILLDDRGHI 124
Query: 454 HVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGK 512
++ F + E++ V Y APE TE D +S G +L EL+TGK
Sbjct: 125 QLTYFSRWSEV--EDSCDGEAVENM--YCAPEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 33/116 (28%), Positives = 46/116 (39%), Gaps = 15/116 (12%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT 145
+ S+ L L L L N L +P I N + L L L N Q +++G+L L
Sbjct: 224 LLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNN--QISSISSLGSLTNLR 280
Query: 146 ILDLSSNSLKGAIP------------SSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
LDLS NSL A+P +L L L++ + I G S
Sbjct: 281 ELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGETS 336
|
Length = 394 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 46/212 (21%), Positives = 71/212 (33%), Gaps = 51/212 (24%)
Query: 392 GSLDDFLHEHGEG---QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD 448
SL D L G +++ W+ + L L LH R KS NILL
Sbjct: 1 VSLADILEVRGRPLNEEEI--WA----VCLQCLGALRELH---------RQAKSGNILLT 45
Query: 449 ENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLEL 508
+ + G E++ +APE +Q TEK+D+YS G+ L E
Sbjct: 46 WDG--LLKLDGSVAFKTPEQSRPDPYF------MAPEVIQGQSYTEKADIYSLGITLYEA 97
Query: 509 VTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA-----DMETVEAILEIAA 563
+ + P + LE +++ AD ++E V A
Sbjct: 98 LDYELPYN--------------EERELSAILEILLNGMPADDPRDRSNLEGVSAARSFED 143
Query: 564 ---RCTDANPDDRPSMNQ---VLQLLEQEVMS 589
C P R + N + L E +
Sbjct: 144 FMRLCASRLPQRREAANHYLAHCRALFAETLE 175
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 15/153 (9%)
Query: 322 GGFGTVYRMVMNDCGT-FAVKRIDRS----REGSDQVFERELEILGSIKHINLVNLRGYC 376
G FG VY + +AVK + ++ + QV + E + L K +V+L Y
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQV-QAERDALALSKSPFIVHLY-YS 72
Query: 377 RLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKI 435
A + L+ +YL G + LH +G + + A I+ A L YLH I
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEM---AVKYIS-EVALALDYLHRH---GI 125
Query: 436 IHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468
IHRD+K N+L+ ++DFGL+K+ ++ E
Sbjct: 126 IHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 30/97 (30%), Positives = 45/97 (46%), Gaps = 9/97 (9%)
Query: 311 EALDEEDVVGSGGFGTVYRMVM------NDCGTFAVKRI-DRSREGSDQVFERELEILGS 363
+ L +G G FG V + C T AVK + + + + EL+IL
Sbjct: 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIH 66
Query: 364 I-KHINLVNLRGYCRLPATKLL-IYDYLSMGSLDDFL 398
I H+N+VNL G C P L+ I +Y G+L ++L
Sbjct: 67 IGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 35.6 bits (83), Expect = 0.004
Identities = 17/60 (28%), Positives = 27/60 (45%)
Query: 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYL 130
++S++L +L I + L L+ L L N+L P + LR+L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 603 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.86 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.44 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.42 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.36 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.35 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.35 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.35 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.33 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.32 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.32 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.31 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.2 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.18 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.15 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.08 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.07 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.04 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.02 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.99 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 98.97 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.96 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.96 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.95 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.95 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 98.94 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.94 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.93 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.86 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.85 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 98.84 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.8 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.76 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 98.75 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.75 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.72 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.72 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 98.71 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.69 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.59 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.59 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.58 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.57 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.48 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.39 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.38 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.32 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.3 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.29 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.25 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.25 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-59 Score=546.70 Aligned_cols=474 Identities=31% Similarity=0.552 Sum_probs=294.8
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
+++.|+|++|++++.+|..+.++++|+.|+|++|++.+.+|..+.++++|++|+|++|+++|.+|..|.++++|+.|+|+
T Consensus 476 ~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 555 (968)
T PLN00113 476 RLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555 (968)
T ss_pred cceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECC
Confidence 34445555555544444444455555555555555554455445555555555555555555555555555555555555
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCcccCCCCCCCCCCCCCCCCCCCCCCCCCCcc
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSDEVA 230 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~~~~~~c~~~~~~~~~~~~~~~~~~~ 230 (603)
+|+++|.+|..+.++++|+.|++++|++++.+|..+.+..+....+.+|+.+|+.+... +.++ .
T Consensus 556 ~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~------~~~~---------c- 619 (968)
T PLN00113 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTS------GLPP---------C- 619 (968)
T ss_pred CCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCcccc------CCCC---------C-
Confidence 55555555555555555555555555555444443333344444444444444322100 0000 0
Q ss_pred cCCCCCCcccccchhhhhHhHHHHHHHHHHHHHHhhhhcccccccchhhhhhccccccccceeeccCCCCCChHHHHHHh
Q 007455 231 VPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKL 310 (603)
Q Consensus 231 ~~~~~~~~~~~~~vi~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (603)
.........++++++++ ++++++++++++++++++|++...++. ... ........+..... ......+..
T Consensus 620 --~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~~~~~~-~~~~~~~~~ 689 (968)
T PLN00113 620 --KRVRKTPSWWFYITCTL-GAFLVLALVAFGFVFIRGRNNLELKRV---ENE---DGTWELQFFDSKVS-KSITINDIL 689 (968)
T ss_pred --ccccccceeeeehhHHH-HHHHHHHHHHHHHHHHHhhhccccccc---ccc---cccccccccccccc-hhhhHHHHH
Confidence 00001111222333322 222333333333333333322111111 000 00000001111110 111223334
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
..++..++||+|+||.||+|.+. ++..||||++...... ..+|++.+++++||||+++++++.+++..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 56788899999999999999985 5667999988644322 235688999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.++++. ++|.++.+++.|+++||+|||..+.++|+||||||+||+++.++..++. ||........
T Consensus 766 ~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 766 EGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 99999999963 7899999999999999999997666699999999999999999888875 6655433211
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
....+++.|+|||++.+..++.++|||||||++|||+||+.||+.... .......|.+...........+++....
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 123578999999999999999999999999999999999999965432 2345667776655444444445544322
Q ss_pred ---cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 550 ---ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 550 ---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
.+.....++.+++.+||+.+|++||||+|+++.|+++..
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 334566788999999999999999999999999998754
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=426.85 Aligned_cols=285 Identities=47% Similarity=0.822 Sum_probs=250.9
Q ss_pred CCChHHHHHHhhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecC
Q 007455 300 PYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLP 379 (603)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 379 (603)
.|++.++..++++|...++||+|+||.||+|...++..||||++........++|..|+.++.+++|||+|+++|||.+.
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEG 143 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecC
Confidence 47899999999999999999999999999999999989999988665433145599999999999999999999999999
Q ss_pred C-ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 380 A-TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 380 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
+ +.++|||||++|+|.+++...... +++|..+++||.++|+||+|||+.+.++||||||||+|||+|+++++||+||
T Consensus 144 ~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 144 GEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred CceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 8 599999999999999999975543 6899999999999999999999998889999999999999999999999999
Q ss_pred ccccccCC-CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 459 GLAKLLVD-EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 459 G~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
|+|+.... ........ .||.+|+|||+...+..+.|+|||||||+++||+||+.|.+.........+..|....+...
T Consensus 222 GLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred cCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99976543 22211111 79999999999999999999999999999999999999988765445556899999999988
Q ss_pred cchhhhcccCC--CcCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 538 RLEDVIDKRCA--DADM-ETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 538 ~~~~~~~~~~~--~~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.+.+++|+.+. .++. .....+..++.+|++.+|.+||+|.||+++|+...
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 99999999976 3343 57788999999999999999999999999996644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=375.80 Aligned_cols=252 Identities=33% Similarity=0.498 Sum_probs=212.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCC-CCChHHHHHHHHHHHhhCCCCeeeecceeeecCC-ccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRS-REGSDQVFERELEILGSIKHINLVNLRGYCRLPA-TKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 387 (603)
.+++..+.||+|..|+|||+.++.++. +|+|++... .....+++.+|++++++.+||+||++||.|..+. ...++||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 345567899999999999999997766 899999543 3445678999999999999999999999999998 4999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
||++|||++++...+. +++...-+++.++++||.|||+.. +||||||||+|||++..|+|||||||.++.+.+.
T Consensus 159 YMDgGSLd~~~k~~g~----i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 159 YMDGGSLDDILKRVGR----IPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hcCCCCHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 9999999999987644 899999999999999999999632 8999999999999999999999999999887554
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
....+.||..|||||.+.+..|+.++||||||++++|+.+|+.||.+.... ..+|..- +..+.+...
T Consensus 233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~----~~~~~~L------l~~Iv~~pp 299 (364)
T KOG0581|consen 233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP----YLDIFEL------LCAIVDEPP 299 (364)
T ss_pred ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC----CCCHHHH------HHHHhcCCC
Confidence 456788999999999999999999999999999999999999999775111 1112211 222233333
Q ss_pred CCcCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 548 ADADME-TVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 548 ~~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+..+.. .+.++..++..||++||.+||+++|+++
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 444443 7889999999999999999999999986
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=382.22 Aligned_cols=257 Identities=37% Similarity=0.579 Sum_probs=211.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCCh--HHHHHHHHHHHhhCCCCeeeecceeeecCC-ccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLRGYCRLPA-TKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e 387 (603)
..+...+.||+|+||+||+|.+++...||||++....... .+.|.+|+.+|++++|||||+++|+|.++. ...+|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 3445566799999999999999987669999997654333 458999999999999999999999999887 7899999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEecCCCCCeEECCCC-CeEEeecccccccC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK-IIHRDIKSSNILLDENL-EPHVSDFGLAKLLV 465 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~~~ 465 (603)
|+++|+|.+++... ....+++..++.+|.|||+|+.|||++ + ||||||||+|||++.++ ++||+|||+++...
T Consensus 121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999999999874 233499999999999999999999999 6 99999999999999997 99999999998765
Q ss_pred CCCcceeecccccccccCccccc--cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQ--SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
... ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||..... ..-+.... .
T Consensus 196 ~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~--------~ 260 (362)
T KOG0192|consen 196 ISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVV--------V 260 (362)
T ss_pred ccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHH--------h
Confidence 432 2223367999999999999 56899999999999999999999999976432 11111111 1
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
....+..+...+..+..++.+||..||+.||++.+++..|+.+.
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~ 304 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM 304 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence 11222333446678999999999999999999999999998643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=382.90 Aligned_cols=255 Identities=35% Similarity=0.522 Sum_probs=214.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
.+...+.||+|.||.||.|.+++...||+|.++... ...+.|.+|+++|.+|+|+|||+++|+|..++.+|||||||+.
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 345568899999999999999998899999997653 4456688999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.++++.. ++..+...+.+.++.|||+|++||+++ ++|||||.++|||++++..+||+|||+|+...++....
T Consensus 286 GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 286 GSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred CcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999982 334489999999999999999999999 89999999999999999999999999999665555444
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCc
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (603)
.....-...|.|||.+..+.++.|||||||||+||||+| |+.||.... ..+-+..+.+..++ ..
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms------n~ev~~~le~GyRl---------p~ 425 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS------NEEVLELLERGYRL---------PR 425 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC------HHHHHHHHhccCcC---------CC
Confidence 444445568999999999999999999999999999999 777765431 12222222222221 23
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 551 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
|..++.++.++|..||..+|++|||++.+...|++..
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 4567789999999999999999999999999888754
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-46 Score=379.05 Aligned_cols=247 Identities=26% Similarity=0.426 Sum_probs=212.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEE-CCCCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVM-NDCGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
..|...+.||+|||+.||.+++ ..+..||+|++.+. .....+.+.+|+++.++|+|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688999999999999999999 56667999999763 3445567899999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
|+|..|+|.++++..+. +++.++..++.||+.||.|||++ +|+|||||..|+|++++.++||+|||+|..+..
T Consensus 98 ELC~~~sL~el~Krrk~----ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKP----LTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhcCC----CCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999986544 99999999999999999999999 899999999999999999999999999998865
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
++. .....+|||-|+|||++....++..+||||+||++|.|++|++||+....++.. ..+...
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety----------------~~Ik~~ 233 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY----------------NKIKLN 233 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH----------------HHHHhc
Confidence 433 345678999999999999888999999999999999999999999864322111 111111
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
-...|...+.+..+||.++|+.+|.+|||+++|+.
T Consensus 234 ~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12233455678999999999999999999999995
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=361.06 Aligned_cols=200 Identities=30% Similarity=0.485 Sum_probs=180.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
..+|...+.||+|+||+||+|++++ +..||||.+... .....+.+..|+++|+.++|||||++++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 4678888899999999999999875 456999999766 3445566899999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC------CCeEEeeccc
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN------LEPHVSDFGL 460 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~------~~~kl~DfG~ 460 (603)
|||+||+|.+|++..+. +++..+..++.|+|.||++||++ +||||||||+|||++.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~~~----l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR----LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999998764 89999999999999999999999 89999999999999765 4589999999
Q ss_pred ccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcc
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPT 518 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~ 518 (603)
|+.+.+.. .....+|++.|||||++...+|+.|+|+||+|+++|++++|+.||+..
T Consensus 162 AR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 162 ARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred hhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99986433 345678999999999999999999999999999999999999999854
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=360.53 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=203.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC-------hHHHHHHHHHHHhhCCCCeeeecceeeecCCc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG-------SDQVFERELEILGSIKHINLVNLRGYCRLPAT 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 381 (603)
.+.|.+.+.||+|+||.|-+|..+. ++.||||.+.+.... .....++|+++|++++|||||+++++|..++.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4567778999999999999999775 456999999543111 12235799999999999999999999999999
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC---CCeEEeec
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN---LEPHVSDF 458 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~Df 458 (603)
.|+||||++||+|.+.+-.++. +.+.....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk~----l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANKY----LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhccc----cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999987654 66777788999999999999999 99999999999999766 67999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccCCC---CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA---TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (603)
|+|+..+ +.......+||+.|.|||++.+... ..++|+||+||++|-+++|.+||....... ++. ..+.
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~----eQI~ 395 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK----EQIL 395 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH----HHHh
Confidence 9999876 3445677899999999999975533 347899999999999999999997643211 111 1111
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.++.. ..+......+++..++|.+||..||++|||++|+++
T Consensus 396 ~G~y~-----f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYA-----FGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCccc-----ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 11111 012234567889999999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=347.44 Aligned_cols=259 Identities=23% Similarity=0.370 Sum_probs=212.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecce-eeecCCc-cEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRG-YCRLPAT-KLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~l 384 (603)
..+|.+.++||+|+||+|||+.+. ++..+|.|.++-.. .........|+.+|++++|||||++++ .+.++++ .++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 356777889999999999999976 55569999987432 233456889999999999999999998 5555555 899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK--IIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
||||++.|+|...++......+.+++..+|+++.|+++||.++|+.. ++ |+||||||.||+++.+|.||++|||+++
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999988888888999999999999999999999942 24 9999999999999999999999999999
Q ss_pred ccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
.+..... .....+|||.||+||.+.+..|+.||||||+||++|||+.-.+||.+. .+.+..+++..
T Consensus 177 ~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~q------- 242 (375)
T KOG0591|consen 177 FLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQ------- 242 (375)
T ss_pred HhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHc-------
Confidence 8865443 345678999999999999999999999999999999999999999764 22221111111
Q ss_pred hcccCCCcC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 543 IDKRCADAD-METVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 543 ~~~~~~~~~-~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
...+..+ .-++..+..|+..|+..||+.||+.-.+++.+..
T Consensus 243 --gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 --GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred --CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1122223 5678899999999999999999996666555544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=388.31 Aligned_cols=263 Identities=28% Similarity=0.458 Sum_probs=218.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC------CEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC------GTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
..+....+.||+|+||+||+|...+. .-||||.++..... ...+|++|+++++.++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 34556678999999999999986432 24999999876655 677899999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCC------CCc----cCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC
Q 007455 383 LLIYDYLSMGSLDDFLHEHGE------GQQ----LLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE 452 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~------~~~----~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 452 (603)
++|+|||..|||.++|+.+.+ +++ +++..+.+.||.|||.|+.||-++ .+|||||..+|+|+.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 999999999999999986542 122 388999999999999999999999 8999999999999999999
Q ss_pred eEEeecccccccCCCCcceee-cccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHH
Q 007455 453 PHVSDFGLAKLLVDEEAHVTT-VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWM 530 (603)
Q Consensus 453 ~kl~DfG~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 530 (603)
|||+|||+++..-..++++.. ...-..+|||||.+..++++++||||||||+|||+++ |+.||.....
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---------- 711 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---------- 711 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----------
Confidence 999999999876444443332 3334579999999999999999999999999999999 8888865321
Q ss_pred HHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCC
Q 007455 531 NTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590 (603)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 590 (603)
++.++.+-+..+-+.+..++.+++.||..||+..|++||+++||-..|+.....+
T Consensus 712 -----~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 712 -----QEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred -----HHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 1112222233444567788889999999999999999999999999998855443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=350.54 Aligned_cols=242 Identities=29% Similarity=0.401 Sum_probs=205.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.+.|++.++||+|+||.||.++.+++++ ||+|++++.. ....+...+|..++.+++||+||+++-.|++++..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 5789999999999999999999887665 8999997543 23345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
+||+.||.|...++..+. +++..+.-++.+|+.||.|||+. +||||||||+|||+|.+|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~~eg~----F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR----FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhcCC----cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999997655 89999999999999999999999 89999999999999999999999999998643
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. ...+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||..... ..+...... .
T Consensus 177 ~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~---------~ 240 (357)
T KOG0598|consen 177 KD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILK---------G 240 (357)
T ss_pred cC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhc---------C
Confidence 33 2345568999999999999999999999999999999999999999976432 222222222 1
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCC
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRP 574 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP 574 (603)
..+..+.-.+.+..+++.+++..+|++|.
T Consensus 241 k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 241 KLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred cCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 22333333556799999999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=335.21 Aligned_cols=261 Identities=26% Similarity=0.357 Sum_probs=203.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
+.|+...++|+|+||+|||++++++++ ||||++..+.+. ..+-..||+++|++++|||+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467778899999999999999998776 999999655442 34567899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|++. ++.+-+...+.+ ++.....+++.|+++|+.|+|++ ++|||||||+|||++.+|.+||||||+|+.+..+
T Consensus 82 ~~dh-TvL~eLe~~p~G---~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNG---VPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHhccCC---CCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9998 666666666544 88899999999999999999999 8999999999999999999999999999998754
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHH----------HHhhh
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN----------TLLKE 536 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~----------~~~~~ 536 (603)
... .+..+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+-|.+...- ..++.... .++..
T Consensus 155 gd~-YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDi--DQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 155 GDN-YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDI--DQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred cch-hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchH--HHHHHHHHHHcccCHHHHHHhcc
Confidence 333 344568999999999977 68999999999999999999999877653211 11111110 11111
Q ss_pred C-cchhhhcccCCC------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 N-RLEDVIDKRCAD------ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ~-~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+ .+..+.-+.... --...+.-+.++++.|+..||++|++.+|++.
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 111110011100 01123346899999999999999999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=355.85 Aligned_cols=249 Identities=24% Similarity=0.367 Sum_probs=209.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 384 (603)
..+|..++.||+|+|++|++|+..++ ++||||++.+.. +...+.+.+|-.+|.+| .||.|++++..|++...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 46889999999999999999998765 469999986532 22234567888999999 89999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
|+||+++|+|.+++++.+. +++.....++.+|+.||+|||++ |||||||||+|||+|+||+++|.|||.|+.+
T Consensus 152 vLe~A~nGdll~~i~K~Gs----fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYGS----FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEecCCCcHHHHHHHhCc----chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999999876 99999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCcc----------e--eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHH
Q 007455 465 VDEEAH----------V--TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT 532 (603)
Q Consensus 465 ~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 532 (603)
.+.... . ...++||..|++||++.....+..+|+|+|||++|+|+.|.+||.+..+ ..-+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-----yliF--- 296 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-----YLIF--- 296 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-----HHHH---
Confidence 643221 1 1458899999999999999999999999999999999999999976421 1111
Q ss_pred HhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+.|.......+...++.+.+|+.+.|..||.+|+|.++|.+
T Consensus 297 --------qkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 297 --------QKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred --------HHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 11111222344455578999999999999999999999886
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=369.14 Aligned_cols=258 Identities=28% Similarity=0.484 Sum_probs=216.3
Q ss_pred CCCCCeeeecCCeEEEEEEECCCC----EEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 313 LDEEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
..+.++||.|.||.||+|+++-.+ .||||.++....+ ....|..|+.||.+++||||+++.|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 345689999999999999987332 4999999876543 45679999999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
||++|+|+.+|+.+... +.+.+...+.++||.|+.||-+. ++|||||.++|||++.+..+|++|||+++.+.++
T Consensus 711 yMENGsLDsFLR~~DGq---ftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDGQ---FTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred hhhCCcHHHHHhhcCCc---eEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccC
Confidence 99999999999987532 88999999999999999999999 8999999999999999999999999999988665
Q ss_pred Ccceeeccccc--ccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 468 EAHVTTVVAGT--FGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 468 ~~~~~~~~~gt--~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
.....+...|. .+|.|||.+.-+.++.+|||||||++|||.++ |..||.....+ +-++.+....
T Consensus 785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ------dVIkaIe~gy------- 851 (996)
T KOG0196|consen 785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------DVIKAIEQGY------- 851 (996)
T ss_pred CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH------HHHHHHHhcc-------
Confidence 53333333343 58999999999999999999999999999888 99998653211 1111111111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCC
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPC 591 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 591 (603)
....++.++..+.+|+..||++|-.+||++.|++..|.++...|.
T Consensus 852 --RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 852 --RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred --CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 123567888999999999999999999999999999999887654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=346.02 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=203.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCC--ccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPA--TKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e 387 (603)
.++...+.||+|+||+||++...+ +...|||.+........+.+++|+.+|++++|||||+.+|...... .+++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456778999999999999999886 5669999986653333566899999999999999999999855444 5889999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-CCCeEEeecccccccCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-NLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~~~~~~~ 466 (603)
|+++|+|.+++...+. .+++..+..++.||++||.|||++ +||||||||+|||++. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 9999999999998653 389999999999999999999998 9999999999999999 79999999999987653
Q ss_pred --CCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 467 --EEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 467 --~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
..........||+.|||||++..+ ....++||||+||++.||+||+.||... .....+.-....
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~-------- 237 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGR-------- 237 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhc--------
Confidence 222234457799999999999853 3345999999999999999999998642 111111111111
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+..+...+.+..+++.+|+..+|++||||+++++
T Consensus 238 ~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 238 EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 11223445556778999999999999999999999997
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=351.40 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=206.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecC--CccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLP--ATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 384 (603)
.+.|+..++||+|.||.||+|++..++ .||+|++... ..+......+||.+|++|+||||+++.+...+. ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 355677789999999999999987655 5999999654 355667788999999999999999999998876 68999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
|+|||+. +|.-++...+ ..++..++..++.|++.||+|+|++ +|+|||||.+|||+|.+|.+||+|||+|+++
T Consensus 196 VFeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999998 9988887633 2389999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCcc----------HhHHHHHH
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLN----------VVGWMNTL 533 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~----------~~~~~~~~ 533 (603)
........+..+-|.+|.|||.+.+. .|+.++|+||.|||+.||+.|++.|.+...-+... ...|....
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 77766656677789999999998765 79999999999999999999999887543211000 00121000
Q ss_pred hhhCcchhhhc------ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 LKENRLEDVID------KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+. ....+. +.+.+.....+....+|+..+|..||.+|.|+.++++
T Consensus 349 LP---~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LP---HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CC---cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 00 000000 0000011123456889999999999999999999986
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=350.40 Aligned_cols=247 Identities=24% Similarity=0.389 Sum_probs=211.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
..|+.-++||+|+.|.||.|.... +..||||++........+-+..|+.+|+..+|+|||++++.|...++.++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 456677899999999999998764 4569999998887777888999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
+||+|.+.+.... +++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999988654 89999999999999999999999 899999999999999999999999999988766544
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC-
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA- 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 548 (603)
.....+||+.|||||+.....|++|+||||||++++||+-|.+||--+.+-. .+.-+.....+
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr---------------AlyLIa~ng~P~ 488 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---------------ALYLIATNGTPK 488 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH---------------HHHHHhhcCCCC
Confidence 3455679999999999999999999999999999999999999986422110 01111111111
Q ss_pred -CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 -DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 -~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+..+.+++.+||+.|+++|+++.|+|+
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 134566778999999999999999999999997
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=347.22 Aligned_cols=260 Identities=23% Similarity=0.357 Sum_probs=207.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHH-HHHHHHHHHhhCC-CCeeeecceeeecCC-ccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQ-VFERELEILGSIK-HINLVNLRGYCRLPA-TKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l 384 (603)
-.++|...++||.|.||.||+|+... +..||||++++.....++ .-.||++.|+++. ||||+++.+++.+.+ .+|+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 35678889999999999999999764 456999999876655544 3468999999998 999999999999888 8999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
|||||+. +|.++++.+ +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+.....+||+|||+||..
T Consensus 88 VfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence 9999988 999999875 45699999999999999999999999 9999999999999998889999999999987
Q ss_pred CCCCcceeecccccccccCcccc-ccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCC-ccHh---------HHHHHH
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG-LNVV---------GWMNTL 533 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~-~~~~---------~~~~~~ 533 (603)
.... ..+..+.|.+|.|||++ ..+.|+.+.|+||+|||++|+.+-++-|.+....+. ..+. .|...
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg- 237 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG- 237 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH-
Confidence 5433 34566789999999987 567899999999999999999998887765432110 0010 11111
Q ss_pred hhhCcchhhhcccCCC--------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 LKENRLEDVIDKRCAD--------ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ~~~~~~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+.-..+. .-...+.+..+++.+|+.+||.+||||+|+++
T Consensus 238 ---~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 238 ---YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred ---HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 0111111111111 11235678999999999999999999999997
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.49 Aligned_cols=246 Identities=27% Similarity=0.403 Sum_probs=211.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCCCCh--HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|.+.+.||+|+||.||||+.+.+.. ||+|.+.+..... -+.+.+|+++++.++||||+.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 578888999999999999999887655 8999986654333 3568999999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+.| +|..++...+. +++..+..++.+++.||.|||++ +|.|||+||.|||++..|.+|++|||+++.+...
T Consensus 82 ~a~g-~L~~il~~d~~----lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK----LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9988 99999998766 99999999999999999999999 9999999999999999999999999999988664
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
. ...+...|||-|||||...++.|+..+|.||+||++||+++|++||.... +...++.+ ...-
T Consensus 154 t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I----------~~d~ 216 (808)
T KOG0597|consen 154 T-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSI----------LKDP 216 (808)
T ss_pred c-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHH----------hcCC
Confidence 3 34456779999999999999999999999999999999999999996531 22222222 2222
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..++...+..+..++...+.+||.+|.|..+++.
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 2344577788999999999999999999999985
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=348.87 Aligned_cols=249 Identities=29% Similarity=0.413 Sum_probs=207.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC----CC-ChHHHHHHHHHHHhhCC-CCeeeecceeeecCCc
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS----RE-GSDQVFERELEILGSIK-HINLVNLRGYCRLPAT 381 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 381 (603)
....|.+.+.||+|+||+|+.|.+.. +..||+|.+.+. .. ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 34688999999999999999998764 467999977553 11 23456789999999999 9999999999999999
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC-CCeEEeeccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN-LEPHVSDFGL 460 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~ 460 (603)
.|+||||+.||+|.+++...+. +.+..+..++.|++.|++|||++ +|+||||||+|||+|.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~g~----l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNKGR----LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHcCC----CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999998544 78899999999999999999999 89999999999999999 9999999999
Q ss_pred ccccCCCCcceeecccccccccCccccccCC-CC-cccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR-AT-EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.... ..
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~---------- 230 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PN---------- 230 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HH----------
Confidence 99874 2233456678999999999999877 75 789999999999999999999986321 11
Q ss_pred chhhhcccCCCcCHHH-HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCADADMET-VEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+...+.......+... +.++..++.+|+..+|.+|+|+.+++.
T Consensus 231 l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 231 LYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred HHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1111222222233333 678999999999999999999999993
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=316.74 Aligned_cols=237 Identities=26% Similarity=0.364 Sum_probs=203.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChH---HHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSD---QVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+++|+..+.||.|+||.|..++.+.++ .+|+|++++...... +...+|..+|+.+.||+++++++.+.+....|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 567888999999999999999987554 599999976543332 3466899999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||++||-|..++++.+. +++..+.-+|.||+.||+|||+. +|++|||||+|||+|.+|.+||.|||+|+...
T Consensus 123 meyv~GGElFS~Lrk~~r----F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGR----FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred EeccCCccHHHHHHhcCC----CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 999999999999998665 99999999999999999999999 89999999999999999999999999999875
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. +...+|||.|+|||++.+..+..++|.|||||++|||+.|..||...... . +.+.|-.
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---~-------------iY~KI~~ 255 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---Q-------------IYEKILE 255 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH---H-------------HHHHHHh
Confidence 43 67789999999999999999999999999999999999999999765321 1 1111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCC
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDR 573 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~R 573 (603)
.-...|.-.+.++.+|+.++++.|-.+|
T Consensus 256 ~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1222445556789999999999999999
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=329.48 Aligned_cols=261 Identities=24% Similarity=0.337 Sum_probs=205.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCCh-HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGS-DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.+.|++.++||.|..++||+|+... +..||||++.-..-.. -..+.+|+..|+.++||||++++..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3678899999999999999999764 3569999996543333 3678999999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
||.+||+.+.++...+.+ +++..+..|.+++++||.|||.+ |.||||||+.|||++.+|.|||+|||.+..+.+.
T Consensus 105 fMa~GS~ldIik~~~~~G--l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDG--LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHcccc--ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999998865544 89999999999999999999999 8999999999999999999999999987665443
Q ss_pred Ccc---eeecccccccccCccccc--cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 468 EAH---VTTVVAGTFGYLAPEYLQ--SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 468 ~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
... ....+.||++|||||++. -..|+.|+||||||++..||.+|..||....+ +..-............
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP-----mkvLl~tLqn~pp~~~- 253 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP-----MKVLLLTLQNDPPTLL- 253 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh-----HHHHHHHhcCCCCCcc-
Confidence 221 115578999999999953 34689999999999999999999999974321 1111111110000000
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....-.+........+.+++..|+.+||++|||++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000001122344568999999999999999999999985
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=311.12 Aligned_cols=260 Identities=22% Similarity=0.343 Sum_probs=202.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|...++||+|.||.||+|++..+ +.||||+++... ++......||++.|+.++|+||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677788999999999999998754 469999997543 3345678999999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
||+. +|+..++.. ...++-.+..+++.++++|++|||++ .|+||||||.|+|++.+|.+||+|||+++.+...
T Consensus 82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9998 999998864 34588899999999999999999999 7999999999999999999999999999998876
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh---hCcc----
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK---ENRL---- 539 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~---- 539 (603)
....+.. +-|.+|.|||.+.+ ..|+..+|+||.||++.||+-|.+-|.+...- ..+....+ .+. ++.+
T Consensus 155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi--dQL~~If~-~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI--DQLSKIFR-ALGTPTPDQWPEMT 230 (318)
T ss_pred Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH--HHHHHHHH-HcCCCCcccCcccc
Confidence 5544433 67999999998865 46899999999999999999988655432110 00000000 000 0000
Q ss_pred --hhhhc------ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 540 --EDVID------KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 540 --~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+..+ +.....-...+.+..+++..|+..||.+|.|++|+++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 00000 0000011234456799999999999999999999997
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=347.18 Aligned_cols=261 Identities=30% Similarity=0.492 Sum_probs=203.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhC-CCCeeeecceeeecCC-
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSRE-GSDQVFERELEILGSI-KHINLVNLRGYCRLPA- 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~- 380 (603)
.++|++.+.||+|+||.||+|.+. .+..||+|++..... .....+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 367889999999999999999752 234699999865432 2335688999999999 8999999999887644
Q ss_pred ccEEEEEecCCCCccccccccCCC--------------------------------------------------------
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEG-------------------------------------------------------- 404 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 404 (603)
..++||||+++|+|.+++......
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 578999999999999988753210
Q ss_pred --CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc-eeecccccccc
Q 007455 405 --QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGY 481 (603)
Q Consensus 405 --~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y 481 (603)
...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........ ......++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 23478889999999999999999998 8999999999999999999999999999865432221 12233456789
Q ss_pred cCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHH
Q 007455 482 LAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILE 560 (603)
Q Consensus 482 ~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 560 (603)
+|||++.+..++.++||||||+++|||++ |..||...... ...... ..... ....+...+..+.+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-----~~~~~~-~~~~~--------~~~~~~~~~~~l~~ 308 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-----EEFCQR-LKDGT--------RMRAPENATPEIYR 308 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-----HHHHHH-HhcCC--------CCCCCCCCCHHHHH
Confidence 99999988899999999999999999997 99998653211 001111 11110 11112234567999
Q ss_pred HHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 561 IAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 561 li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
++.+||+.+|++|||+.|+++.|++..
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=373.27 Aligned_cols=268 Identities=29% Similarity=0.453 Sum_probs=215.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC--CC----EEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND--CG----TFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.++.+..+.||+|+||.||.|...+ +. .||||.+.+.. .+....|.+|..+|++++|||||+++|++.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 3456677899999999999998653 32 38999997653 44556799999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCC---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGE---GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
++++|||++|+|..++++... ....+...+.+.++.|||+|+.||+++ ++|||||.++|+|++....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999997522 234588999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCcceeecc-cccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 460 LAKLLVDEEAHVTTVV-AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
+|+...+.+....... .-..+|||||.+..+.++.|+|||||||++||++| |..||..... .++ +.......
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---~~v---~~~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---FEV---LLDVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch---HHH---HHHHHhCC
Confidence 9996544443332222 33469999999999999999999999999999999 6677754321 111 11111222
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCCCccc
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDF 595 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~ 595 (603)
..+.+..++..++++|..||+.+|++||++..+++.+..+.....+.+|
T Consensus 922 ---------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~~ 970 (1025)
T KOG1095|consen 922 ---------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTIY 970 (1025)
T ss_pred ---------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCcc
Confidence 2234566778899999999999999999999999988876655444433
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.24 Aligned_cols=265 Identities=29% Similarity=0.424 Sum_probs=210.3
Q ss_pred HHHHHHhhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCCh--HHHHHHHHHHHhhCCCCeeeecceeeecCCc
Q 007455 304 CEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLRGYCRLPAT 381 (603)
Q Consensus 304 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 381 (603)
.++....+++.+.+.||+|+||+||+|.+.+ .||||++....... -+.|+.|+.++++-+|.||+=+.|+|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 3444455677889999999999999999974 89999997654443 3569999999999999999999999998877
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.||+-+++|-+|+.+++.... .++..+.+.||.|+++|+.|||.. +|||||||..||++.+++.|||+|||++
T Consensus 463 -AIiTqwCeGsSLY~hlHv~et---kfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQET---KFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred -eeeehhccCchhhhhccchhh---hhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence 999999999999999997543 388999999999999999999999 8999999999999999999999999998
Q ss_pred cccCCC-CcceeecccccccccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 462 KLLVDE-EAHVTTVVAGTFGYLAPEYLQS---GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 462 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
.....- ........-|...|||||++.. ..|+.++||||||+|+|||++|..||.........-.+ ..+
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV-------GrG 608 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV-------GRG 608 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-------ccc
Confidence 754321 1111223347778999999854 46789999999999999999999999732211111000 000
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
...+.........+.++.+|+..||..++++||.+.+++..|+....
T Consensus 609 ----~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 609 ----YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ----ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 00111112234566789999999999999999999999998887665
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=335.46 Aligned_cols=247 Identities=29% Similarity=0.434 Sum_probs=208.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
..|+..+.||+|+||.||+|.++.+++ ||+|++...... ..+.+++|+.++..++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 456777999999999999999987665 899999755433 346789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+.||++.+.++.... +++....-++.++..|+.|||++ +.+|||||+.|||+..+|.+|++|||.+..+....
T Consensus 93 ~~gGsv~~lL~~~~~----~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI----LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhccCCC----CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999987543 46777777889999999999999 89999999999999999999999999998776554
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
... ..++||+.|||||++++..|+.|+||||||++.+||.+|.+|+....+ .++...|.+..+
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~P 228 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAP 228 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCC
Confidence 443 678899999999999988999999999999999999999999865332 112222222222
Q ss_pred -CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 -DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 -~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......+..+.+++..||.++|+.||+|.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 233466678999999999999999999999985
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=348.01 Aligned_cols=261 Identities=28% Similarity=0.421 Sum_probs=208.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC----CE-EEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC----GT-FAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
++....++||+|+||.||+|..... .. ||||..+... ......+.+|+++|++++|||||++||++.....+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 4556669999999999999987642 23 8999887522 33456799999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++|||+++||+|.+++++.+. .++..++..++.+.|.||+|||+. +++||||.++|+|++.++.+||+|||+++
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~---~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK---SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccccc
Confidence 999999999999999998764 389999999999999999999999 89999999999999999999999999987
Q ss_pred ccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
......... ....-..+|+|||.+....++.++|||||||++||+++ |..||.+.... .+..+ +...+ .
T Consensus 311 ~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~k---I~~~~-~-- 380 (474)
T KOG0194|consen 311 AGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAK---IVKNG-Y-- 380 (474)
T ss_pred CCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHH---HHhcC-c--
Confidence 643111111 01124568999999999999999999999999999999 78888754321 11111 10111 0
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCCC
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCP 592 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 592 (603)
....+...+.++..++.+||..+|++||+|.++.+.++........
T Consensus 381 -----r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 381 -----RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred -----cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 1112335567889999999999999999999999999987655444
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=342.83 Aligned_cols=244 Identities=26% Similarity=0.358 Sum_probs=206.1
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCcc
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATK 382 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 382 (603)
...++|....+||+|+||+|++|..+.+.+ ||||++++.. ...-+..+.|.+++... +||.+++++..|+.++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 456889999999999999999999886554 8999998754 33345677888888777 599999999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|+||||+.||++..+.+.. .+++..+.-++..++.||+|||++ +||+||||.+|||+|.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~~~~-----~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTD-----VFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEecc-----cccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999965555432 289999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
.... ....++.++||+.|||||++.+..|+.++|.|||||+||||+.|..||.++.. +.+-+.
T Consensus 517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE----------------ee~Fds 579 (694)
T KOG0694|consen 517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE----------------EEVFDS 579 (694)
T ss_pred ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH----------------HHHHHH
Confidence 6432 23357889999999999999999999999999999999999999999986532 122222
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSM 576 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 576 (603)
|-..-..+|...+.+...++++++.++|++|.-+
T Consensus 580 I~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2233344666777899999999999999999665
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=344.03 Aligned_cols=246 Identities=27% Similarity=0.385 Sum_probs=211.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.-|.+++.||.|+.|.|..|++..++ .+|||.+.+.... ....+++|+-+|+-+.|||++++|+++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 45678899999999999999987655 5899988654222 2345899999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|-|.+++-..+. +++.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+++||+|||+|....+
T Consensus 92 Eyv~gGELFdylv~kG~----l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP----LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHhhCC----CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999988766 89999999999999999999999 899999999999999999999999999986543
Q ss_pred CCcceeecccccccccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRAT-EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
+. .....+|++.|.+||++.+..|. .++||||.|||||.|+||+.||+++..+ .+...+..
T Consensus 165 gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir----------------~LLlKV~~ 226 (786)
T KOG0588|consen 165 GK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR----------------VLLLKVQR 226 (786)
T ss_pred Cc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH----------------HHHHHHHc
Confidence 32 33456899999999999999885 6899999999999999999999864321 12223344
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+.+...+.++++|+++|+.+||++|.|++||++
T Consensus 227 G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 227 GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 455566788889999999999999999999999997
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=325.20 Aligned_cols=271 Identities=28% Similarity=0.423 Sum_probs=204.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHh--hCCCCeeeecceeeecCC----ccE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILG--SIKHINLVNLRGYCRLPA----TKL 383 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~l~~~~~~~~----~~~ 383 (603)
....+..++||+|.||.||||.+.+ +.||||++.. ...+.|+.|-++++ .++|+||+++++.-...+ +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 4556677899999999999999987 8899998853 23445777777766 458999999999876555 789
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC------CCCCeEEecCCCCCeEECCCCCeEEee
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD------CCPKIIHRDIKSSNILLDENLEPHVSD 457 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~Dlkp~NIll~~~~~~kl~D 457 (603)
+|+||.+.|+|.+|++.+- ++|....+|+..+++||+|||+. ..|+|+|||||.+|||+..|+++.|+|
T Consensus 285 LVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999999999753 89999999999999999999986 357899999999999999999999999
Q ss_pred cccccccCCCCc-ceeecccccccccCccccccCCCC------cccchHhHHHHHHHHHhCCCCCC--------cccc--
Q 007455 458 FGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRAT------EKSDVYSFGVLLLELVTGKRPTD--------PTFV-- 520 (603)
Q Consensus 458 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~------~~~Dv~slG~vl~elltg~~p~~--------~~~~-- 520 (603)
||+|..+..... ......+||.+|||||++.+...- .+.||||+|.|+|||+++..-++ ..+.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 999988764322 233457899999999999764322 36899999999999999664332 1111
Q ss_pred -cCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCCC
Q 007455 521 -KRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCP 592 (603)
Q Consensus 521 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 592 (603)
.....+ +-++..+-..+.+..+..... ....+..+.+.+..||..||+.|.|+.=+-+.+.++.+..+.
T Consensus 440 vG~hPt~-e~mq~~VV~kK~RP~~p~~W~--~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 440 VGNHPTL-EEMQELVVRKKQRPKIPDAWR--KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred hcCCCCH-HHHHHHHHhhccCCCChhhhh--cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 111111 112222111111111111111 124456789999999999999999999999999887765543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=330.39 Aligned_cols=246 Identities=22% Similarity=0.341 Sum_probs=198.7
Q ss_pred CCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCCh---HHHHHHHHHHHhhCCCCeeeecceeeec----CCccEEEEEe
Q 007455 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS---DQVFERELEILGSIKHINLVNLRGYCRL----PATKLLIYDY 388 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 388 (603)
...||+|++|.||+|.++ ++.||||++....... .+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 367999999999999984 5789999997654333 3567899999999999999999999876 3467899999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++.... .+++.....++.+++.||.|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhCC----CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999998643 3889999999999999999999842 68899999999999999999999999998654322
Q ss_pred cceeecccccccccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 469 AHVTTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||..... ............
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~------~~~~~~i~~~~~-------- 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT------KEIYDLIINKNN-------- 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCC--------
Confidence 23457889999999975 6789999999999999999999999975321 111111111110
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
....+...+.++.+++.+||+.||++|||++|+++.|+..
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 0112223566899999999999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=334.60 Aligned_cols=252 Identities=24% Similarity=0.349 Sum_probs=205.4
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
..++|+.+.+||+|+||.||.|+-++++. +|+|+++++... ..+.+..|-.+|...++|.||+++-.|++.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 35789999999999999999999887765 899999876433 33457889999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||++||++..+|...+. +++..+...+.+++-|+.-+|+. |+|||||||+|+|||..|++||+|||++.-+
T Consensus 219 iMEylPGGD~mTLL~~~~~----L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDT----LTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHHhcCc----CchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999987655 89999999999999999999999 9999999999999999999999999998532
Q ss_pred CC----------------------CCcc------------------------eeecccccccccCccccccCCCCcccch
Q 007455 465 VD----------------------EEAH------------------------VTTVVAGTFGYLAPEYLQSGRATEKSDV 498 (603)
Q Consensus 465 ~~----------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv 498 (603)
.. .+.. .....+|||.|+|||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 0000 0122569999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCcccccCCc-cHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCC---
Q 007455 499 YSFGVLLLELVTGKRPTDPTFVKRGL-NVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRP--- 574 (603)
Q Consensus 499 ~slG~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP--- 574 (603)
||+|||+|||+.|.+||..+.+.... .+..|...... ......+.+..+||.+|+. ||++|.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-------------P~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-------------PEEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-------------CCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 99999999999999999876543322 22223211110 1112233689999999999 999995
Q ss_pred CHHHHHH
Q 007455 575 SMNQVLQ 581 (603)
Q Consensus 575 s~~evl~ 581 (603)
.++||.+
T Consensus 438 G~~EIK~ 444 (550)
T KOG0605|consen 438 GAEEIKK 444 (550)
T ss_pred cHHHHhc
Confidence 5777764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=327.05 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=203.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC----CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN----DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.+|++.+.||+|+||.||+|.++ .+..||+|.++.... .....+.+|+.++++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 56888999999999999999864 234699998875432 2335688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +++||||||+||+++.++.++++|||.+....
T Consensus 85 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 99999999999987643 2388999999999999999999998 89999999999999999999999999876543
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
...........++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ....... ...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~------~~~~~~~-~~~------- 224 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG------QDVIKAV-EDG------- 224 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHH-HCC-------
Confidence 222111222335678999999998899999999999999999875 9999864321 1111111 111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
.....+...+..+.+++.+||+.+|++||+++++++.|++.
T Consensus 225 -~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112234556799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=304.93 Aligned_cols=249 Identities=26% Similarity=0.375 Sum_probs=210.0
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++++|++++.||+|-||.||.|+.+.+. -||+|++.++. .....++.+|+++-+.++||||+++|++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3578999999999999999999987655 48999997653 3345679999999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
++||...|++...++..... .+++.....++.|+|.||.|+|.. +|+||||||+|+|++.++..||+|||-+...
T Consensus 100 ilEya~~gel~k~L~~~~~~--~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMK--RFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhcccc--cccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999854332 278888899999999999999998 8999999999999999999999999998754
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
. .......+||..|.+||...+..++..+|+|++|++.||++.|.+||+.... .+.+ ..+.
T Consensus 175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---~etY-------------krI~ 235 (281)
T KOG0580|consen 175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---SETY-------------KRIR 235 (281)
T ss_pred C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---HHHH-------------HHHH
Confidence 3 3345667899999999999999999999999999999999999999976431 1111 1111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..-...+...+.++.++|.+|+..+|.+|.+..|++.
T Consensus 236 k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 236 KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred HccccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 1111233566678999999999999999999999876
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=323.56 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=203.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||.||+|.++++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4678889999999999999999887789999876433 334568899999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++..... .+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||.++........
T Consensus 83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQG---KLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999875322 378999999999999999999998 8999999999999999999999999998865433222
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ........... ...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~------~~~~~~i~~~~---------~~~ 221 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN------YEVVEMISRGF---------RLY 221 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHCCC---------CCC
Confidence 2222335568999999988889999999999999999999 8889864321 11111111111 011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 583 (603)
.+...+.++.+++.+||+.+|++||+++++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1222345789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=333.56 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=200.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||+|.+. .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999987 45679999986432 123456889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++..... +++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRNSGR----FSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999976543 88899999999999999999998 899999999999999999999999999986543
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.. ....|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......... .
T Consensus 154 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~------~~~~~~i~~----------~ 213 (291)
T cd05612 154 RT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP------FGIYEKILA----------G 213 (291)
T ss_pred Cc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh----------C
Confidence 21 234689999999999988899999999999999999999999865321 111111111 1
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
....+...+..+.+++.+||+.||.+||+ ++|+++
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 214 KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 11122233567899999999999999995 888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=325.36 Aligned_cols=252 Identities=25% Similarity=0.363 Sum_probs=197.8
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC---------C-----hHHHHHHHHHHHhhCCCCeeeec
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE---------G-----SDQVFERELEILGSIKHINLVNL 372 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---------~-----~~~~~~~E~~~l~~l~h~niv~l 372 (603)
..+++|++.+.||+|.||.|-+|++.. +..||||++.+... . ..+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 346889999999999999999999874 45699999964321 1 12467899999999999999999
Q ss_pred ceeeecC--CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC
Q 007455 373 RGYCRLP--ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN 450 (603)
Q Consensus 373 ~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 450 (603)
+++..++ +.+|+|+||+..|.+...-.... .+...++++++.++..||+|||.+ +||||||||+|+|++++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~----els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP----ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcc----cccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCC
Confidence 9999765 56899999999988765433222 288999999999999999999999 89999999999999999
Q ss_pred CCeEEeecccccccCCCCc----ceeecccccccccCccccccCC----CCcccchHhHHHHHHHHHhCCCCCCcccccC
Q 007455 451 LEPHVSDFGLAKLLVDEEA----HVTTVVAGTFGYLAPEYLQSGR----ATEKSDVYSFGVLLLELVTGKRPTDPTFVKR 522 (603)
Q Consensus 451 ~~~kl~DfG~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~vl~elltg~~p~~~~~~~~ 522 (603)
|+|||+|||.+........ .......|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||-+.+..
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~- 325 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL- 325 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH-
Confidence 9999999999987633211 1123367999999999987633 256789999999999999999999765321
Q ss_pred CccHhHHHHHHhhhCcchhhhcccCC-CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 523 GLNVVGWMNTLLKENRLEDVIDKRCA-DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+ ..+ ++...+. ....+..+.+.+||.++|++||++|.+..+|..
T Consensus 326 --~l---~~K---------Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 326 --EL---FDK---------IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred --HH---HHH---------HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 11 111 1111111 112245678999999999999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=330.10 Aligned_cols=264 Identities=25% Similarity=0.385 Sum_probs=202.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-----------------CEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-----------------GTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNL 372 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-----------------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l 372 (603)
.+|.+.+.||+|+||.||+|.++++ ..||+|.+...... ....+.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 4678889999999999999986432 25999988654322 34568899999999999999999
Q ss_pred ceeeecCCccEEEEEecCCCCccccccccCC---------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 007455 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGE---------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIH 437 (603)
Q Consensus 373 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 437 (603)
++++...+..++||||+++|+|.+++..... ....+++...++++.|++.||.|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 9999999999999999999999998865321 112468889999999999999999998 8999
Q ss_pred ecCCCCCeEECCCCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh--CCCC
Q 007455 438 RDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT--GKRP 514 (603)
Q Consensus 438 ~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt--g~~p 514 (603)
|||||+|||++.++.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999865433221 1223345778999999988889999999999999999997 4566
Q ss_pred CCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 515 TDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
|..... ................. .....+...+..+.+++.+||+.+|++|||++|+.+.|++
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGRQ-----VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhcccc-----ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 653211 11222222111111000 0011122345679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=310.09 Aligned_cols=275 Identities=23% Similarity=0.302 Sum_probs=207.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeec--CCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRL--PATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 384 (603)
.++|+..+.|++|+||.||+|+++.+.+ ||+|+++... .+..-...||+.+|.+.+|||||.+..+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 5678888999999999999999986665 8999996543 3334457899999999999999999988753 467899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||++. +|..++...+ +.+...++.-++.|+++|++|||.+ .|+|||||++|+|+...|.+||+|||+|+.+
T Consensus 155 VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999998 9999998765 4488999999999999999999999 7999999999999999999999999999998
Q ss_pred CCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
+.+-.. .+..+-|.+|.|||.+.+ ..|++++|+||+|||+.||+++++-|.+...-+. +...+. . -+.-.+.+
T Consensus 228 gsp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ--l~~If~-l--lGtPte~i 301 (419)
T KOG0663|consen 228 GSPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ--LDKIFK-L--LGTPSEAI 301 (419)
T ss_pred cCCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH--HHHHHH-H--hCCCcccc
Confidence 776433 344567999999998865 4689999999999999999999988765432111 000000 0 00000000
Q ss_pred ccc-----------CCC---------cCH-HHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcccCCCCcccccc
Q 007455 544 DKR-----------CAD---------ADM-ETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQEVMSPCPSDFYES 598 (603)
Q Consensus 544 ~~~-----------~~~---------~~~-~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~~~~~~~~~~~~ 598 (603)
.+. .+. ... ..++.-.+|+..++..||.+|.|++|.++ .+. +...|.++++...
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~-e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFR-ETPLPIDPSMFPT 378 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccc-cCCCCCChhhcCC
Confidence 000 000 000 13467889999999999999999999986 232 2334444444333
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=329.12 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=200.5
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.|+..+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3667889999999999999975 55679999886432 2223457889999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999888764322 2388999999999999999999998 8999999999999999999999999999875432
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
. ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... ...-... .+....
T Consensus 156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~---------~~~~~~ 221 (285)
T cd05631 156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV---KREEVDR---------RVKEDQ 221 (285)
T ss_pred C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch---hHHHHHH---------Hhhccc
Confidence 2 2234568999999999998899999999999999999999999997542211 0000000 011111
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
...+...+.++.+|+.+||+.+|++||+ ++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1223345568999999999999999997 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=323.12 Aligned_cols=255 Identities=29% Similarity=0.452 Sum_probs=206.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.++|++.++||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 367888999999999999999988888899998865432 3567899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.......
T Consensus 84 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999876432 2378889999999999999999998 899999999999999999999999999987654332
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ............ .
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~------~~~~~~~~~~~~---------~ 223 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN------SDVMSALQRGYR---------M 223 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH------HHHHHHHHcCCC---------C
Confidence 22223345678999999988889999999999999999998 8999864211 011111111100 0
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
......+.++.+++.+|+..+|++||+++++.+.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=336.07 Aligned_cols=240 Identities=31% Similarity=0.527 Sum_probs=200.7
Q ss_pred CCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCc
Q 007455 315 EEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 315 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
.++-||.|+.|.||.|+..+ .+||||+++.-. +.+++-|++|+||||+.+.|+|....-++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~n-etVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHN-ETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeeccC-ceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 35779999999999999886 789999875332 3468889999999999999999999889999999999999
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeec
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 474 (603)
.+.++.... +.-.....+..+||.|+.|||.+ .|||||||.-||||..+..|||+|||-++...+. .....
T Consensus 200 ~~VLka~~~----itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMS 270 (904)
T KOG4721|consen 200 YEVLKAGRP----ITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMS 270 (904)
T ss_pred HHHHhccCc----cCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhh
Confidence 999986543 78888899999999999999999 8999999999999999999999999999876544 23356
Q ss_pred ccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHH
Q 007455 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554 (603)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (603)
++||..|||||++.....++|+||||||||||||+||..||....... +-| -+..+.+. ...+..+
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----IIw---GVGsNsL~-------LpvPstc 336 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----IIW---GVGSNSLH-------LPVPSTC 336 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----eEE---eccCCccc-------ccCcccC
Confidence 889999999999999999999999999999999999999986432110 000 00011111 1245577
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 555 VEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 555 ~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
+..+.-|++.||+-.|..||++++++.-|+-
T Consensus 337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred chHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 7889999999999999999999999987753
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=339.08 Aligned_cols=260 Identities=30% Similarity=0.461 Sum_probs=202.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhC-CCCeeeecceeeecCCc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSRE-GSDQVFERELEILGSI-KHINLVNLRGYCRLPAT 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 381 (603)
.++|++.+.||+|+||.||+|.+. .+..||||+++.... ...+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 457889999999999999999742 234699999865432 2345688999999999 89999999999999999
Q ss_pred cEEEEEecCCCCccccccccCC----------------------------------------------------------
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGE---------------------------------------------------------- 403 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 403 (603)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999998864321
Q ss_pred -------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 404 -------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 404 -------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
....+++..+.+++.|+++||+|||+. +++||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 112478889999999999999999998 8999999999999999999999999999866443221
Q ss_pred e-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 471 V-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 471 ~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....+ ..... ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~----~~~~~--------~~ 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKM----IKEGY--------RM 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHH----HHhCc--------cC
Confidence 1 112334567999999998899999999999999999998 88887643211 011111 11110 00
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
..+...+.++.+++.+||+.+|++|||++|+++.|++.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11122346799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=329.76 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=200.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|++.+.||+|+||.||+|.++++ ..+|+|++.... ....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3688899999999999999998754 569999986532 2234567899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|++++.+..+.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99997776554332 2388999999999999999999998 8999999999999999999999999999876443
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHh---------HHHHHHhhhCc
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVV---------GWMNTLLKENR 538 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~---------~~~~~~~~~~~ 538 (603)
.........|++.|+|||++.+..++.++||||+||++|||++|+.||............ .+.........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 332233456899999999998888999999999999999999999999753211100000 00000000000
Q ss_pred chhhhcccCCC-------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCAD-------ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......+.... .....+.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 01124567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=337.43 Aligned_cols=245 Identities=24% Similarity=0.307 Sum_probs=200.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+.. ++.||+|.+.... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 4678889999999999999999875 4579999986432 22335688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGR----FPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999986543 78888999999999999999999 89999999999999999999999999998764
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
... ....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ..
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~-~~-------- 230 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKIL-AG-------- 230 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH------HHHHHHHh-cC--------
Confidence 332 234689999999999988899999999999999999999999864321 11111111 11
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
....+...+..+.+++.+||+.||.+||+ ++++++
T Consensus 231 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 231 -RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred -CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 11122234467899999999999999987 677763
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=318.99 Aligned_cols=245 Identities=25% Similarity=0.415 Sum_probs=206.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEE-CCCCEEEEEEeCCCCCChHH---HHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVM-NDCGTFAVKRIDRSREGSDQ---VFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.+|++.+.||+|.||.|-+|+. ..++.||||.+++....+.+ .+.+|+++|+.++||||+.++++|...+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 4677788899999999999986 57788999999776554443 4789999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||..+|.|++|+...+. +++.++..++.||..|+.|+|.+ +++|||||.+|||+|+++++||+|||++..+.+
T Consensus 133 EYaS~GeLYDYiSer~~----LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS----LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHHhcc----ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998665 99999999999999999999999 999999999999999999999999999988765
Q ss_pred CCcceeecccccccccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRAT-EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. ....++|++-|.+||++.+..|. +.+|-||+||+||.|+.|.-||++.... ..++ .+..+...
T Consensus 206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------~lvr-QIs~GaYr----- 271 (668)
T KOG0611|consen 206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------RLVR-QISRGAYR----- 271 (668)
T ss_pred cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH------HHHH-Hhhccccc-----
Confidence 43 35678999999999999998884 6799999999999999999999864211 1111 11111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+.+....-||+.||..+|++|.|+.+|..
T Consensus 272 -----EP~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 272 -----EPETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred -----CCCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 1122345778999999999999999999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=335.67 Aligned_cols=241 Identities=20% Similarity=0.278 Sum_probs=195.9
Q ss_pred CeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCC
Q 007455 317 DVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
+.||+|+||.||+|.+. +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999986 45679999986532 222345778999999999999999999999999999999999999
Q ss_pred CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCccee
Q 007455 393 SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472 (603)
Q Consensus 393 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 472 (603)
+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSRERV----FSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99998876443 88999999999999999999999 89999999999999999999999999987542221 122
Q ss_pred ecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCH
Q 007455 473 TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADM 552 (603)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (603)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......... .....+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~~~~----------~~~~~p~ 216 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILM----------EEIRFPR 216 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH------HHHHHHHHc----------CCCCCCC
Confidence 345699999999999988999999999999999999999999864321 011111110 1111233
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 553 ETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 553 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
..+.++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 4556799999999999999999 7999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=326.97 Aligned_cols=264 Identities=25% Similarity=0.398 Sum_probs=211.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
+.+.+.++||+|-||.|..+.......||||.++..... ....|.+|+++|.+++||||++++|+|..++.+++++|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 456678999999999999999988889999999865544 3478999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++..+.... +......+|+.||+.|++||.+- ++|||||.++|+|+|.++++||+|||+++-+-..+.
T Consensus 618 EnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred hcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 9999999999874322 45566778999999999999998 899999999999999999999999999986544444
Q ss_pred ce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh--CCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 470 HV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT--GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 470 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
+. .....-..+|||||.+..+++++++|||+||+++||+++ ...||...... ..++-........... .
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~-----~ 764 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQ-----V 764 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCcc-----e
Confidence 33 333445679999999999999999999999999999876 66787542111 1111111111111111 1
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
....+.-++..+++++.+||+.+.++||+++++...|.+..
T Consensus 765 ~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 765 VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 12234556778999999999999999999999999887754
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=332.85 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=213.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCc-cEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPAT-KLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv 385 (603)
.++|..++++|+|+||.++.++++ +...+++|.+..... ..++....|+.++++++|||||.+.+.+.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 467888999999999999999876 445699999864433 334468899999999999999999999999988 8999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|+|++||++.+.+.+.. +..+++..++.++.|++.|+.|||+. .|+|||||+.|||++.++.|+|+|||+|+.+.
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999998765 34589999999999999999999988 89999999999999999999999999999987
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.... ......||+.|+.||.+.+..|..|+||||+||++|||++-+++|.+.... .-+. .+...
T Consensus 158 ~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~------~Li~---------ki~~~ 221 (426)
T KOG0589|consen 158 PEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS------ELIL---------KINRG 221 (426)
T ss_pred Cchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH------HHHH---------HHhhc
Confidence 6652 345577999999999999999999999999999999999999999764211 1111 11111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
.....+..++.++..++..|++.+|+.||++.+++..
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 2234556777889999999999999999999999974
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=318.95 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=206.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||.||+|.+++++.||+|.++.... ..+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 56888899999999999999988878899999865432 35668999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+++|.+++.... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++........
T Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 85 YGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred CCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999997643 23489999999999999999999998 8999999999999999999999999999876533222
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
.......+..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ... .... ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~---~~~-~~~~--------~~~~ 224 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA---EV---LQQ-VDQG--------YRMP 224 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH---HH---HHH-HHcC--------CCCC
Confidence 1122223457999999998889999999999999999999 99898643210 00 001 1100 0011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.+...+..+.+++.+|++.+|++||+++++.+.|++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 222345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=319.32 Aligned_cols=252 Identities=28% Similarity=0.420 Sum_probs=203.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++......++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577889999999999999998877789999886443 334668999999999999999999999998889999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++..... .+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||.++........
T Consensus 83 ~~~l~~~i~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHGK---RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 9999999876432 389999999999999999999998 8999999999999999999999999998866443322
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||...+..++.++||||||+++|||++ |..||..... ........... ...
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~~---------~~~ 221 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN------SETVEKVSQGL---------RLY 221 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHhcCC---------CCC
Confidence 2222335678999999988889999999999999999999 9999864221 01111111110 111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
.+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12223567999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.03 Aligned_cols=260 Identities=28% Similarity=0.471 Sum_probs=203.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecCCc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLPAT 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 381 (603)
.++|++.+.||+|+||.||+|.+.. +..||+|+++..... ....+.+|+++++.+ +|+||+++++++...+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 4678999999999999999998532 236999998654322 335688999999999 89999999999999999
Q ss_pred cEEEEEecCCCCccccccccCC----------------------------------------------------------
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGE---------------------------------------------------------- 403 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 403 (603)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998854211
Q ss_pred --------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce-eec
Q 007455 404 --------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV-TTV 474 (603)
Q Consensus 404 --------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~-~~~ 474 (603)
....+++..+++++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 112478888999999999999999998 89999999999999999999999999997654332211 122
Q ss_pred ccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHH
Q 007455 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADME 553 (603)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (603)
..++..|+|||++.+..++.++||||||+++|||++ |+.||....... .+.. ..... . . ...+..
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-----~~~~-~~~~~-~----~---~~~~~~ 339 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-----KFYK-MVKRG-Y----Q---MSRPDF 339 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-----HHHH-HHHcc-c----C---ccCCCC
Confidence 334568999999988899999999999999999997 999986532110 0101 11100 0 0 011112
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 554 TVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 554 ~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
.+.++.+++.+||+.+|++|||+.++++.|+++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 346799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.12 Aligned_cols=245 Identities=22% Similarity=0.280 Sum_probs=200.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC--CEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC--GTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
.++|++.+.||+|+||.||+|.+.++ ..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 46788999999999999999986543 469999885432 2234568899999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++..... +++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 109 v~Ey~~~g~L~~~i~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKR----FPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999976543 88999999999999999999998 8999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~i~~--------- 242 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------LIYQKILE--------- 242 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------HHHHHHhc---------
Confidence 432 23356899999999998888999999999999999999999999653210 00111111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
.....+...+..+.+++.+|++.+|++|+ +++++++
T Consensus 243 -~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 243 -GIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11112223445788999999999999995 8998875
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=348.51 Aligned_cols=252 Identities=24% Similarity=0.277 Sum_probs=204.2
Q ss_pred CCCCCCeeeecCCeEEEEEEECCC--CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDC--GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.|.+.+.||+|+||.||+|....+ ..||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 478889999999999999987643 468888775554444556788999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998865433344588999999999999999999998 899999999999999999999999999987654322
Q ss_pred -ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 -HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... ....
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~---------~~~~ 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLY---------GKYD 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh---------CCCC
Confidence 123445699999999999988999999999999999999999999864321 111111111 1111
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+.++.+++.+||..+|++||+++++++
T Consensus 290 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 122234567999999999999999999999874
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=333.06 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=202.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|+..+.||+|+||.||++.+..+ ..+|+|.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 5788899999999999999998854 4588888865422 2345689999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++..... +++..+..++.|++.||.|||+.. +|+||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 85 MDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred CCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999976433 789999999999999999999863 69999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh------------
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE------------ 536 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 536 (603)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||...... .+..........
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---ELEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhcccccccccCCccccCcc
Confidence 23346899999999999888999999999999999999999999643211 000000000000
Q ss_pred ----------------------CcchhhhcccCCC-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 ----------------------NRLEDVIDKRCAD-ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ----------------------~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...........+. .....+.++.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000011 11234567999999999999999999999986
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=323.34 Aligned_cols=257 Identities=26% Similarity=0.460 Sum_probs=206.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC------CEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC------GTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
++|.+.+.||+|+||.||+|.+.++ ..+|+|.+...... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 5678889999999999999987543 56999998765443 3467999999999999999999999999999999
Q ss_pred EEEEecCCCCccccccccCC----------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCe
Q 007455 384 LIYDYLSMGSLDDFLHEHGE----------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEP 453 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 453 (603)
+||||+++|+|.+++...+. ....+++.++..++.|++.|+.|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 99999999999999976432 223478899999999999999999998 89999999999999999999
Q ss_pred EEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHH
Q 007455 454 HVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 454 kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 531 (603)
+|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... .....
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~------~~~~~ 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN------EEVIE 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Confidence 9999999876533221 11223345678999999998999999999999999999998 9999854321 11111
Q ss_pred HHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 532 TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.. . .......+...+..+.+++.+||+.+|++||+++|+++.|++
T Consensus 236 ~~-~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 236 CI-T--------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HH-H--------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11 1 111112223455779999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=319.76 Aligned_cols=255 Identities=30% Similarity=0.462 Sum_probs=209.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
..+|++.+.||+|+||.||+|.+.++..+++|.+..........+.+|+.+++.++|+||+++++++......++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 35688889999999999999999988889999987665545667899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++.... ...+++.++..++.|++.||+|||++ +++||||+|+||++++++.+||+|||.+........
T Consensus 85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 85 EKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999998643 23478999999999999999999998 899999999999999999999999999977644322
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... .... ..... ....
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~---~~~~~---------~~~~ 223 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVY---DQITA---------GYRM 223 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHH---HHHHh---------CCcC
Confidence 1 123345678999999988889999999999999999998 8889864321 1111 11111 0011
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
..+...+..+.+++.+||+.+|++|||++++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1223445679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=331.12 Aligned_cols=239 Identities=26% Similarity=0.336 Sum_probs=193.2
Q ss_pred eeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCc
Q 007455 319 VGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 319 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
||+|+||.||+|.+.+ +..||+|.+.... ......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 6999999999999875 4569999986432 22335678899999999999999999999999999999999999999
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeec
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 474 (603)
.+++..... +++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||+++...... .....
T Consensus 81 ~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQREGR----FDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 999876433 88999999999999999999998 89999999999999999999999999987543222 22334
Q ss_pred ccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHH
Q 007455 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554 (603)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (603)
..||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......... .....+...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~------~~~~~~~~~~----------~~~~~~~~~ 216 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN------VNEMYRKILQ----------EPLRFPDGF 216 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC------HHHHHHHHHc----------CCCCCCCcC
Confidence 568999999999998899999999999999999999999986432 1111111111 111122344
Q ss_pred HHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 007455 555 VEAILEIAARCTDANPDDRPS---MNQVLQ 581 (603)
Q Consensus 555 ~~~l~~li~~cl~~~P~~RPs---~~evl~ 581 (603)
+.++.+++.+||+.||++||+ +.|+++
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 567899999999999999975 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=316.70 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=197.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCc---c--EE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPAT---K--LL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~--~l 384 (603)
-.|...+++|.|+||.||+|....+ +.||||++-..... -.+|+++|+.++|||||++.-+|....+ . .+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3566678999999999999998755 67999998554433 2468999999999999999888854332 2 48
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC-CCeEEeecccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN-LEPHVSDFGLAKL 463 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~~~ 463 (603)
|||||+. +|.++++.....++.++...+.-+..||++||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999998 99999987544555688888999999999999999998 99999999999999987 8999999999999
Q ss_pred cCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh------
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE------ 536 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 536 (603)
+..++...+ ...|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....+ .+...++ ++..
T Consensus 176 L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik-~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIK-VLGTPTREDI 250 (364)
T ss_pred eccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHH-HhCCCCHHHH
Confidence 877665533 346889999998865 479999999999999999999999887643211 1111111 1100
Q ss_pred ---------CcchhhhcccCCC-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 ---------NRLEDVIDKRCAD-ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ---------~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....++....... .....+.+..+++.+++..+|.+|.++.|++.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0001111111001 22344578999999999999999999999985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.84 Aligned_cols=250 Identities=23% Similarity=0.299 Sum_probs=201.9
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
+|++.+.||+|+||.||+|.+.+ +..||+|++.... ......+.+|++++..++||||+++++++...+..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 68889999999999999999875 5679999986432 2233567889999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++..... +++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLGV----LSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred CCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999976443 88999999999999999999998 899999999999999999999999999976543
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc-cc
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID-KR 546 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 546 (603)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....... . ....... ...+. +.
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~---~~~i~~~---~~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE---T---WENLKYW---KETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH---H---HHHHHhc---cccccCCC
Confidence 2234568999999999998899999999999999999999999997532111 0 0111000 00000 00
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+.++.+++.+||..+|.+||+++++++
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 01111234567999999999999999999999996
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=321.66 Aligned_cols=258 Identities=27% Similarity=0.496 Sum_probs=206.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC------CEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC------GTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
..+|++.+.||+|+||.||+|..... ..+++|.+..... .....+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 35688899999999999999987543 3589998864432 2345688999999999999999999999998999
Q ss_pred EEEEEecCCCCccccccccCCC------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEG------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN 450 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 450 (603)
+++|||+++|+|.+++...... ...+++...+.++.|++.||.|||+. +++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCC
Confidence 9999999999999998764221 13478899999999999999999998 89999999999999999
Q ss_pred CCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhH
Q 007455 451 LEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVG 528 (603)
Q Consensus 451 ~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~ 528 (603)
+.++|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... ..
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~-- 235 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EV-- 235 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH--
Confidence 9999999999976543322 12233456788999999988889999999999999999998 99998653211 11
Q ss_pred HHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 529 WMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
... +. .......+...+.++.+++.+||+.+|.+||+++|+++.|++
T Consensus 236 -~~~-i~--------~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 -IEM-IR--------SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHH-HH--------cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111 11 111122334556789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=322.81 Aligned_cols=249 Identities=35% Similarity=0.578 Sum_probs=192.6
Q ss_pred CCCeeeecCCeEEEEEEEC-----CCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 315 EEDVVGSGGFGTVYRMVMN-----DCGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 315 ~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+.+.||.|+||.||+|.+. .+..|+||.+...... ..+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999988 2245999999654332 356799999999999999999999999988889999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++.... ...+++..+..++.|+++||+|||+. +++||||+++||+++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~~--~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN--KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHTC--TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999998861 22389999999999999999999998 89999999999999999999999999998763222
Q ss_pred c-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 469 A-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 469 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
. ...........|+|||.+....++.++||||||+++||+++ |+.||... ....+.... ....
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~------~~~~~~~~~-~~~~-------- 222 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY------DNEEIIEKL-KQGQ-------- 222 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS------CHHHHHHHH-HTTE--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccc-cccc--------
Confidence 2 22233446778999999988889999999999999999999 67887532 111222222 1111
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 583 (603)
....+...+..+.+++.+||..+|++|||++++++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1112223456799999999999999999999999976
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=325.52 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=198.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
+++|+..+.||+|+||.||+|.+.. +..||+|.++... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 4678999999999999999999874 4569999886433 2234567899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++ +|.+++...+ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 84 YLDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CCCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 9986 8988886543 2378899999999999999999998 8999999999999999999999999998764332
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccH----------hHHHHHHhhh
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNV----------VGWMNTLLKE 536 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~----------~~~~~~~~~~ 536 (603)
.. ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||........... ..|.. ....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 234 (288)
T cd07871 157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG-ITSN 234 (288)
T ss_pred Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc-cccc
Confidence 21 1233457899999998865 5688999999999999999999999965422110000 00000 0000
Q ss_pred CcchhhhcccCCC-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 NRLEDVIDKRCAD-----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+.... .....+.++.+++.+|++.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 01123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=315.56 Aligned_cols=253 Identities=31% Similarity=0.466 Sum_probs=204.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56888999999999999999988888899999865443 3456899999999999999999999875 456899999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+++|.+++..... ..+++.+++.++.|++.||+|||+. +++||||||+||++++++.++|+|||++..+......
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999876432 2378999999999999999999998 8999999999999999999999999999876543322
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||...+..++.++||||||+++|||++ |..||..... .......... ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~---------~~~~ 223 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN------REVLEQVERG---------YRMP 223 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcC---------CCCC
Confidence 2222335568999999988889999999999999999999 8888854211 1111111110 0111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.+...+..+.+++.+|+..+|++|||++++.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 223445679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=330.36 Aligned_cols=241 Identities=21% Similarity=0.292 Sum_probs=194.6
Q ss_pred CeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCC
Q 007455 317 DVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
+.||+|+||.||++.+. ++..||+|++.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999986 45679999986532 223345778999999999999999999999999999999999999
Q ss_pred CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCccee
Q 007455 393 SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472 (603)
Q Consensus 393 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 472 (603)
+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSRER----VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 9998887643 388999999999999999999998 89999999999999999999999999987532221 112
Q ss_pred ecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCH
Q 007455 473 TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADM 552 (603)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (603)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ .....+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~~~~----------~~~~~p~ 216 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILM----------EEIRFPR 216 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHhc----------CCCCCCC
Confidence 3356899999999999889999999999999999999999998643211 00111110 0111223
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 553 ETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 553 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
..+.++.+++.+||+.+|++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 4456789999999999999998 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=316.31 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=202.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
.+|++.+.||+|+||.||+|.++.+..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 35778899999999999999988777899998864433 34568889999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+++|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++...+....
T Consensus 83 ~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 83 NGCLLNYLRERKG---KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 9999999875432 388999999999999999999998 8999999999999999999999999999765433222
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . ..... ... . ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~---~~~~~-~~~-----~---~~~ 221 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS---E---VVESV-SAG-----Y---RLY 221 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH---H---HHHHH-HcC-----C---cCC
Confidence 2222224457999999988889999999999999999999 78888643111 0 11111 000 0 011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 583 (603)
.+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1223456899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=316.12 Aligned_cols=253 Identities=31% Similarity=0.477 Sum_probs=203.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
.+|++.++||+|+||.||+|.+.++..+|+|++.... ...+.+.+|+++++.++||||+++++++. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4688899999999999999998887789999986533 23457899999999999999999999874 456799999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++..... ..+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||.++........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 84 KGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999976422 2378999999999999999999998 8999999999999999999999999999876544332
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||+..+..++.++||||||+++|||++ |..||...... ........ .....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~~~---------~~~~~ 223 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVER---------GYRMP 223 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhc---------CCCCC
Confidence 2223446678999999988889999999999999999999 77787643211 00111100 00111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.+...+..+.+++.+|++.+|++||+++++++.|++
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 224 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 223456779999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=329.86 Aligned_cols=241 Identities=21% Similarity=0.294 Sum_probs=195.4
Q ss_pred CeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCC
Q 007455 317 DVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
+.||+|+||.||++.+.. +..||+|++.... ......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999864 5679999986532 223356788999999999999999999999999999999999999
Q ss_pred CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCccee
Q 007455 393 SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472 (603)
Q Consensus 393 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 472 (603)
+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 9998887543 388999999999999999999998 89999999999999999999999999987543221 122
Q ss_pred ecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCH
Q 007455 473 TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADM 552 (603)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (603)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......... .....+.
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~------~~~~~~~~~----------~~~~~p~ 216 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILM----------EDIKFPR 216 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH------HHHHHHhcc----------CCccCCC
Confidence 345689999999999988899999999999999999999999864321 111111110 1111223
Q ss_pred HHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 553 ETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 553 ~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
..+.++.+++.+||+.+|++|| ++.|+++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 4456799999999999999997 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=331.16 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=199.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEC----CCCEEEEEEeCCC----CCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCcc
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN----DCGTFAVKRIDRS----REGSDQVFERELEILGSI-KHINLVNLRGYCRLPATK 382 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 382 (603)
+|++.+.||+|+||.||++... .+..||+|++... .....+.+.+|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998863 4567999998642 122335578899999999 599999999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++||||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDN----FSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999876433 88999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
.+............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .........
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~------- 224 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRIL------- 224 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHh-------
Confidence 7644433334456799999999998765 478899999999999999999999964322111 111111111
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
...+..+...+..+.+++.+||+.||++|| +++++++
T Consensus 225 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 225 ---KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111122233456789999999999999999 7777774
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=316.58 Aligned_cols=255 Identities=30% Similarity=0.436 Sum_probs=204.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.+|+..+.||+|+||.||+|.+.+ +..+|+|.+.... .....+.+|+++++.++|+||+++++++......+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 357778899999999999999875 4569999886432 33456889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++..... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 99999999875432 3378999999999999999999998 899999999999999999999999999987654332
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||.... ............ ..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~------~~~~~~~~~~~~---------~~ 224 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEKGY---------RM 224 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC------HHHHHHHHHCCC---------CC
Confidence 22222334568999999988899999999999999999998 888876421 111111111110 11
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
..+...+.++.+++.+||+.+|++||++.+++++|++.
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 12223456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.68 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=204.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC----CEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC----GTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
++|+..+.||+|+||.||+|.+... ..+|+|.+...... ....+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 5688899999999999999998532 35899988654332 345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++++|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||++++++.++|+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999999876432 388999999999999999999998 89999999999999999999999999998775
Q ss_pred CCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 466 DEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 466 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~------~~~~~~~~~~------- 224 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN------QDVIKAVEDG------- 224 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH------HHHHHHHHcC-------
Confidence 22221 2222334578999999988889999999999999999998 9999854211 1111111110
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
.....+...+..+.+++.+||+.+|++||+++|+++.|++.
T Consensus 225 --~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 --YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=312.53 Aligned_cols=263 Identities=23% Similarity=0.326 Sum_probs=200.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCC--CCCChHHHHHHHHHHHhhCCCCeeeecceeeec-----CCcc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDR--SREGSDQVFERELEILGSIKHINLVNLRGYCRL-----PATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~ 382 (603)
..|...+.||+|+||.|++|.++.+ ..||||++.. ......++..+|+++++.++|+||+.+++++.. -...
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 4555578999999999999998754 5699999973 333445678899999999999999999998855 3567
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|+|+|+|+. +|...++.+.. ++...+..++.|+++||.|+|+. +|+||||||+|++++.+..+||+|||+|+
T Consensus 102 YiV~elMet-DL~~iik~~~~----L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 102 YLVFELMET-DLHQIIKSQQD----LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred EEehhHHhh-HHHHHHHcCcc----ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 999999965 99999887544 88999999999999999999998 89999999999999999999999999999
Q ss_pred ccCCC-CcceeecccccccccCcccc-ccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhH--------HHHH
Q 007455 463 LLVDE-EAHVTTVVAGTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVG--------WMNT 532 (603)
Q Consensus 463 ~~~~~-~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~--------~~~~ 532 (603)
..... .....+..+.|.+|.|||++ ....|+.+.||||.|||+.||++|+.-|.+...-....++. ..-.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 87542 12223556789999999987 45689999999999999999999999887543211000000 0000
Q ss_pred HhhhCcchhhhcccC--CCcC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 533 LLKENRLEDVIDKRC--ADAD-----METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~--~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+........+.... +..+ ........+|+.+||..||.+|+|++|.++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 111111111111110 1111 123457899999999999999999999996
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=296.04 Aligned_cols=261 Identities=24% Similarity=0.310 Sum_probs=210.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecC-----CccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLP-----ATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~l 384 (603)
++|.+.+.+|+|||+-||.+..- .++.||+|++.-......+..++|++..++++|||+++++++...+ .+.|+
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 57899999999999999999854 4456999999877767778899999999999999999999887443 34899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
+++|...|+|.+.++....++..+++.+.+.++.++++||++||+.. ++++||||||.|||+.+++.+++.|||.++..
T Consensus 101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 99999999999999987777777999999999999999999999973 45999999999999999999999999998764
Q ss_pred CCCC--cc------eeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH
Q 007455 465 VDEE--AH------VTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 465 ~~~~--~~------~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
.-.- .. .......|..|.|||.+. +...++++|||||||++|+|+.|..||+....+ +.++
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~-GgSl------- 251 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ-GGSL------- 251 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-CCeE-------
Confidence 3210 00 112234678899999885 445688999999999999999999999875442 2111
Q ss_pred hhhCcchhhhcccC--CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 534 LKENRLEDVIDKRC--ADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 534 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
.-.+.... ......+++.+.+++++|++.||.+||++.+++..+++.
T Consensus 252 ------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 ------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111100 011223678899999999999999999999999988764
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=312.41 Aligned_cols=266 Identities=23% Similarity=0.301 Sum_probs=202.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCe-eeecceeeecCC-----
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR--EGSDQVFERELEILGSIKHIN-LVNLRGYCRLPA----- 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 380 (603)
...|+..++||+|+||+||+|+...+ ..||+|++.... ++......+|+.++++++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34566678899999999999998754 479999996543 345566899999999999999 999999998877
Q ss_pred -ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 381 -TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 381 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
..++|+||++. +|..++.......+.++...+..++.||++||+|||++ +|+||||||+|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 78899999988 99999998764334477788999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHH--Hhhh
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT--LLKE 536 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~--~~~~ 536 (603)
+|+.+.-+... .+...+|.+|.|||++.+. .|++..||||+||+++||++++.-|.+....+ .+....+. ...+
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFRIFRLLGTPNE 242 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHHHcCCCCc
Confidence 99976533322 3445689999999998776 78999999999999999999998887643211 00000000 0000
Q ss_pred Ccchhhh---------ccc--CCCcCHHH---HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 537 NRLEDVI---------DKR--CADADMET---VEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 537 ~~~~~~~---------~~~--~~~~~~~~---~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
..+..+. ... ........ .....+++.+|++.+|.+|.|++.+++.
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111110 000 00000111 1368999999999999999999999974
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=321.13 Aligned_cols=260 Identities=25% Similarity=0.440 Sum_probs=207.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
.++|.+.+.||+|+||.||++...+ ...+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 3578889999999999999998532 2348999887655455567899999999999999999999999999999
Q ss_pred EEEEecCCCCccccccccCC---------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeE
Q 007455 384 LIYDYLSMGSLDDFLHEHGE---------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH 454 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 454 (603)
+||||+++++|.+++...+. ....+++.+++.++.|++.||+|||+. +++||||||+||++++++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999999875432 123489999999999999999999998 899999999999999999999
Q ss_pred EeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHH
Q 007455 455 VSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNT 532 (603)
Q Consensus 455 l~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 532 (603)
|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||...... .....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~------~~~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIEC 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 9999999765432211 1122335678999999988889999999999999999999 88887543211 01111
Q ss_pred HhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
. ... .....+...+.++.+++.+||+.+|.+|||++++.+.|+++.
T Consensus 235 i-~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 I-TQG--------RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred H-HcC--------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1 111 111112234467999999999999999999999999998866
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=334.29 Aligned_cols=257 Identities=23% Similarity=0.287 Sum_probs=195.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.+|++.+.||+|+||.||+|.+..+ +.||+|... ...+.+|++++++++||||+++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 5799999999999999999998754 568999643 234688999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
. ++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 166 K-TDLYCYLAAKR----NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred C-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 6 58888876543 278999999999999999999998 899999999999999999999999999976433322
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCC-ccHhHHHHHHhhh------------
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG-LNVVGWMNTLLKE------------ 536 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~------------ 536 (603)
.......||+.|+|||++.+..++.++||||+||++|||++|+.|+.......+ .............
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 233445799999999999988999999999999999999999988643211100 0000000000000
Q ss_pred -Ccchhhh----c--ccCCC------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 -NRLEDVI----D--KRCAD------ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 -~~~~~~~----~--~~~~~------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....... . ...+. .....+.++.+++.+||+.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000 0 00000 01134567899999999999999999999995
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=333.93 Aligned_cols=258 Identities=28% Similarity=0.466 Sum_probs=209.6
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCC-----EEEEEEeCCC-CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRS-REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.+...++||+|+||+||+|.+-..+ +||+|++... ...+..++.+|+.+|.+++|||++|++|+|.... ..||
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3455789999999999999975323 4899988543 3445677999999999999999999999998766 8899
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
++||+.|+|.++++.+.. .+.-...+.+..|||+|+.|||++ ++|||||.++|||+..-..+||.|||+++...
T Consensus 776 tq~mP~G~LlDyvr~hr~---~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD---NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHhcccchHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 999999999999998644 377888999999999999999999 99999999999999999999999999999886
Q ss_pred CCCcceeec-ccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 466 DEEAHVTTV-VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 466 ~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
..+...... ..-.+.|||-|.+....++.++|||||||++||++| |..|++.....+ +...++.+
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~g------ 916 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKG------ 916 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhcc------
Confidence 654433322 233458999999999999999999999999999999 888987543221 11111111
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCC
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPC 591 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 591 (603)
.+ ...+...+.+++.++.+||..|+..||+++++...+.++...|.
T Consensus 917 -eR-LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 917 -ER-LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred -cc-CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 11 22345667789999999999999999999999999988775543
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.15 Aligned_cols=241 Identities=27% Similarity=0.370 Sum_probs=194.5
Q ss_pred CeeeecCCeEEEEEEEC----CCCEEEEEEeCCCC----CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 317 DVVGSGGFGTVYRMVMN----DCGTFAVKRIDRSR----EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+.||+|+||.||++... .++.||+|.++... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999863 45679999986432 22234578899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++...+. +.+..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLEREGI----FMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999876543 77888899999999999999998 89999999999999999999999999987543222
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......... . ..
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~------~~~~~~~~~---------~-~~ 217 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR------KKTIDKILK---------G-KL 217 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH------HHHHHHHHc---------C-CC
Confidence 2 22345689999999999888899999999999999999999999975321 111111111 1 11
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
..+...+..+.+++.+||+.+|++|| +++++++
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 12223456789999999999999999 7888875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=326.23 Aligned_cols=240 Identities=24% Similarity=0.362 Sum_probs=191.1
Q ss_pred CeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+.++ ..||+|.++... ....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999998754 569999986432 22233456677777654 899999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSSGR----FDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999998876433 88999999999999999999998 89999999999999999999999999997653322 22
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....... ....+..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~------~~~~~~i----------~~~~~~~~ 216 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE------DELFDSI----------LNDRPHFP 216 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH------HHHHHHH----------HcCCCCCC
Confidence 3445689999999999988899999999999999999999999975321 1111111 11112223
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSMN-QVL 580 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl 580 (603)
...+.++.+++.+||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 34456789999999999999999875 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=318.09 Aligned_cols=258 Identities=23% Similarity=0.389 Sum_probs=202.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.++|++.+.||+|+||.||+|.+.+ +..+|+|++..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 4678999999999999999998642 24599998854322 2334688999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCCC------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEe
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEG------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS 456 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 456 (603)
++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999998753221 23367888999999999999999998 89999999999999999999999
Q ss_pred ecccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHh
Q 007455 457 DFGLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 457 DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... ........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~------~~~~~~~~ 235 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------EQVLRFVM 235 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHH
Confidence 999987654322211 112345678999999988889999999999999999999 6788754311 11111111
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.......+...+..+.+++.+||+.+|++|||+.|+++.|++
T Consensus 236 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 ---------EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred ---------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111112223345679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=313.17 Aligned_cols=261 Identities=21% Similarity=0.341 Sum_probs=209.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||+|... ++..||||.+.... ......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57889999999999999999976 55679999875432 223346889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++.........++...+..++.|+++||.|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998865443344578899999999999999999998 899999999999999999999999999887643
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
... ......|++.|+|||.+.+..++.++|+||+|+++|||++|+.||.... .....+........ .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~----~~~~~~~~~~~~~~--------~ 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLFSLCQKIEQCD--------Y 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc----ccHHHHHHHHhcCC--------C
Confidence 322 1123457889999999988888999999999999999999999985432 11122221111100 0
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.+......+..+.+++.+||..+|++||++.++++.++++.
T Consensus 226 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01112345577999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=320.42 Aligned_cols=259 Identities=25% Similarity=0.451 Sum_probs=207.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
.+|.+.+.||+|+||.||+|.+.+ ...+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 457788999999999999998542 23488898876555555679999999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCC------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC
Q 007455 385 IYDYLSMGSLDDFLHEHGE------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE 452 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 452 (603)
||||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999976432 112378999999999999999999998 8999999999999999999
Q ss_pred eEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHH
Q 007455 453 PHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWM 530 (603)
Q Consensus 453 ~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~ 530 (603)
++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... . ..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~---~---~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT---E---VI 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---H---HH
Confidence 99999999976543322 11223446788999999988889999999999999999999 99998543211 1 11
Q ss_pred HHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 531 NTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.. ... ......+...+..+.+++.+||+.+|++|||+++++++|++..
T Consensus 236 ~~-~~~--------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 236 EC-ITQ--------GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred HH-HhC--------CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11 111 1111122234567999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=323.82 Aligned_cols=258 Identities=26% Similarity=0.420 Sum_probs=203.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-----EEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
.+|+..+.||+|+||.||+|.+..++ .||+|.+.... ....+.+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999875333 38999886433 23346788999999999999999999998764 5789
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
++||+++|+|.+++..... .+++...+.++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 9999999999999886432 378899999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCccee-ecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAHVT-TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
........ ....++..|+|||.+.+..++.++||||||+++|||++ |+.||+.... ..+.. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~------~~~~~-~~~~~----- 227 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------SEISS-ILEKG----- 227 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HHHHH-HHhCC-----
Confidence 54332221 22234668999999998899999999999999999998 9999864311 11111 11110
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCC
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 590 (603)
.....+...+.++.+++.+||..+|++||++.+++..+......+
T Consensus 228 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 228 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 001112233457899999999999999999999999998766443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=329.19 Aligned_cols=248 Identities=26% Similarity=0.420 Sum_probs=193.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|+..+.||+|+||.||+|.+. ++..||||.+..... .....+.+|+++++.++|+||+++++++...+..++|||
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 345667789999999999999987 456799999864432 234568899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+... ..+..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 153 ~~~~~~L~~~~~--------~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 153 FMDGGSLEGTHI--------ADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred cCCCCccccccc--------CCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 999999865322 45677889999999999999998 8999999999999999999999999999865432
Q ss_pred CcceeecccccccccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-----GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
.. ......||..|+|||++.. ...+.++|||||||++|||++|+.||...... .|.......
T Consensus 222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~------~~~~~~~~~------ 288 (353)
T PLN00034 222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASLMCAI------ 288 (353)
T ss_pred cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc------cHHHHHHHH------
Confidence 21 1234568999999998743 23346899999999999999999999732211 121111100
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+...+.++.+++.+||..+|++|||++|+++
T Consensus 289 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 289 CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000111122344567999999999999999999999997
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=302.49 Aligned_cols=246 Identities=27% Similarity=0.370 Sum_probs=201.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCC--CCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDR--SREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|++.+.||+|.|+.||++.+..+ +.+|+|.+.. ......+.+.+|+++-+.++||||+++.+.+.+....|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 5677788999999999999987654 4588887742 233456779999999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC---CCCeEEeeccccccc
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE---NLEPHVSDFGLAKLL 464 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~~~~~ 464 (603)
+|.||+|..-+-.. ...++..+-..+.||+.+|.|+|.+ +|||||+||+|+++-. ...+|++|||++..+
T Consensus 91 ~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999997655443 2377888899999999999999999 8999999999999953 346999999999988
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
. +........|||.|||||++...+|+..+|||+.||+||-|+.|..||.++... ++.+.|.
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~----------------rlye~I~ 225 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH----------------RLYEQIK 225 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH----------------HHHHHHh
Confidence 7 334456788999999999999999999999999999999999999999863211 1111111
Q ss_pred ccCCC----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCAD----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..-.+ .....+++..+|+++||..||++|.|+.|.++
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11111 22355678999999999999999999999875
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=312.99 Aligned_cols=253 Identities=30% Similarity=0.457 Sum_probs=204.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.++||+|+||.||+|...++..+|+|.+..... ....+.+|+.++++++|+||+++++++. .+..+++|||+.
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYME 83 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCC
Confidence 57888999999999999999998888999999865443 3457899999999999999999999874 467899999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+++|.+++..... ..+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 84 NGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999875432 3488999999999999999999998 8999999999999999999999999999776533222
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||.+.+..++.++||||||+++||+++ |+.||..... ........... ...
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~---------~~~ 223 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN------PEVIQNLERGY---------RMP 223 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh------HHHHHHHHcCC---------CCC
Confidence 2223345678999999988889999999999999999999 9999864321 11111110000 011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.+...+.++.+++.+|++.+|++||+++++++.|+.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 122344679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=327.29 Aligned_cols=262 Identities=25% Similarity=0.377 Sum_probs=200.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence 6789999999999999999998754 4588887765422 2345688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++...+. +++..+..++.|++.||.|||+.. +++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 85 MDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred CCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999976433 788899999999999999999853 69999999999999999999999999987653321
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhH-----HHHH-----------
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVG-----WMNT----------- 532 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~-----~~~~----------- 532 (603)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||............+ +...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 223468899999999998889999999999999999999999987532110000000 0000
Q ss_pred ----Hhhh-----Cc---chh-hhcccCCCc-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 533 ----LLKE-----NR---LED-VIDKRCADA-DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 533 ----~~~~-----~~---~~~-~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... .. ..+ ......+.. ....+.++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 0000 00 000 000000010 1123467899999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=331.58 Aligned_cols=261 Identities=26% Similarity=0.447 Sum_probs=204.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCC-CCeeeecceeeecCCc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSRE-GSDQVFERELEILGSIK-HINLVNLRGYCRLPAT 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 381 (603)
.++|.+.+.||+|+||.||+|.+.. ...||||++..... ...+.+.+|+++++++. ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678889999999999999998642 12599999965433 23456899999999996 9999999999999999
Q ss_pred cEEEEEecCCCCccccccccCC----------------------------------------------------------
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGE---------------------------------------------------------- 403 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 403 (603)
.++||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988764311
Q ss_pred ----------------------------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC
Q 007455 404 ----------------------------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE 449 (603)
Q Consensus 404 ----------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 449 (603)
....+++..++.++.|+++||.|||+. +++||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 012477888999999999999999998 8999999999999999
Q ss_pred CCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHh
Q 007455 450 NLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVV 527 (603)
Q Consensus 450 ~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~ 527 (603)
++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~--~-- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS--T-- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH--H--
Confidence 999999999999865433221 1223346778999999988889999999999999999997 889986432110 0
Q ss_pred HHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 528 GWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
........ .....+...+.++.+++.+||+.+|++||++.++.++|++..
T Consensus 349 --~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 --FYNKIKSG--------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHhcC--------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 00111111 001122344567999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.47 Aligned_cols=255 Identities=27% Similarity=0.333 Sum_probs=204.4
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCC-----
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPA----- 380 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 380 (603)
..++|.+.+.||+|+||+||+|.+. ++..||||.+..... .....+.+|+..+..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 3468999999999999999999876 556799999865432 23356789999999999999999987765432
Q ss_pred ---ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEee
Q 007455 381 ---TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSD 457 (603)
Q Consensus 381 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 457 (603)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 25799999999999999976554445689999999999999999999998 899999999999999999999999
Q ss_pred cccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh
Q 007455 458 FGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE 536 (603)
Q Consensus 458 fG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 536 (603)
||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ..........
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~~~~- 259 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHKTLA- 259 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHhc-
Confidence 999987643221 22234569999999999998899999999999999999999999996532 1112221111
Q ss_pred CcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......+...+.++.+++.+||+.+|++||++.++++
T Consensus 260 --------~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 260 --------GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred --------CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 1111122344567999999999999999999999986
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=311.48 Aligned_cols=253 Identities=31% Similarity=0.480 Sum_probs=202.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..+++|||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4578889999999999999999887789999876543 33456889999999999999999998875 456899999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||.++........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999976432 2378999999999999999999998 8999999999999999999999999999766443322
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||...+..++.++||||||+++|||++ |+.||...... ....+ ... . ....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~---~~~-~--------~~~~ 223 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQ---VER-G--------YRMP 223 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH---HHc-C--------CCCC
Confidence 2222345678999999988889999999999999999999 88888643211 11111 100 0 0011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.+...+..+.+++.+||..+|++||+++++++.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 223445779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=317.19 Aligned_cols=258 Identities=23% Similarity=0.420 Sum_probs=203.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-----CCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-----DCGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
+++|++.+.||+|+||.||+|.+. .+..+++|.+...... ....+.+|++++++++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 356788899999999999999852 3356999998653332 2356889999999999999999999999999999
Q ss_pred EEEEecCCCCccccccccCC-------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC
Q 007455 384 LIYDYLSMGSLDDFLHEHGE-------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN 450 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~ 450 (603)
+||||+++|+|.+++..... ....+++.+...++.|++.||+|||++ +++||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCC
Confidence 99999999999999853221 123478899999999999999999998 89999999999999999
Q ss_pred CCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhH
Q 007455 451 LEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVG 528 (603)
Q Consensus 451 ~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~ 528 (603)
+.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ..
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~------~~ 234 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN------QE 234 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH------HH
Confidence 9999999999986543322 12233445678999999988889999999999999999999 8888854211 01
Q ss_pred HHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 529 WMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.... .... .....+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus 235 ~~~~-~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEM-VRKR--------QLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH-HHcC--------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111 1111 1111223345679999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=318.54 Aligned_cols=247 Identities=24% Similarity=0.297 Sum_probs=195.7
Q ss_pred eeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCc
Q 007455 319 VGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 319 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
||+|+||+||++.+. +++.+|+|++...... ..+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999987 4557999998643222 224567899999999999999999999999999999999999999
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeec
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 474 (603)
.+++.........+++..++.++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988754333334589999999999999999999998 899999999999999999999999999976644322 1233
Q ss_pred ccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHH
Q 007455 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554 (603)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (603)
..|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ........ ... .....+...
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~---------~~~-~~~~~~~~~ 224 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELKQR---------ILN-DSVTYPDKF 224 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch--hHHHHHHh---------hcc-cCCCCcccC
Confidence 568999999999999999999999999999999999999997532110 00000000 000 111123345
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 555 VEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 555 ~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
+..+.+++.+||+.+|++|| +++++++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 67799999999999999999 7788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=311.47 Aligned_cols=259 Identities=21% Similarity=0.372 Sum_probs=209.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||+|... ++..+|+|.++... ....+.+.+|++++++++|+|++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999987 56679999885322 223457889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++.........+++.+++.++.++++||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999876544445589999999999999999999998 899999999999999999999999999876543
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.... ............ ..
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~---------~~ 224 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEK---------CD 224 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC----ccHHHHHhhhhc---------CC
Confidence 3221 223457889999999988889999999999999999999999985432 111111111110 01
Q ss_pred CCCcC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 547 CADAD-METVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 547 ~~~~~-~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
....+ ...+..+.+++.+||..+|++|||+.+++++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11112 24556799999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=326.79 Aligned_cols=258 Identities=29% Similarity=0.438 Sum_probs=214.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.+.....+||.|.||.||.|.|+... .||||.++... ..-++|..|+.+|+.++|||+|+++|+|..+..+|||+|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 45666789999999999999998655 59999986544 34567999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
.+|+|.+|++.... +.++....+.+|.||+.|++||... .+|||||.++|+|+.++..|||+|||+++.+..+..
T Consensus 346 ~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred cCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 99999999998643 3477778899999999999999998 899999999999999999999999999999877655
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......-...|.|||-+....++.|+|||+|||+|||+.| |..||.+.. +.+-..-..+..++
T Consensus 421 TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~LLEkgyRM--------- 485 (1157)
T KOG4278|consen 421 TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYGLLEKGYRM--------- 485 (1157)
T ss_pred ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHHHhccccc---------
Confidence 44444445678999999998899999999999999999999 778875432 11111111111111
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
+.+..++..+++||+.||++.|.+||++.|+-+.++.+-..
T Consensus 486 ~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 486 DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 23456677899999999999999999999999999876543
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=326.21 Aligned_cols=244 Identities=25% Similarity=0.336 Sum_probs=193.6
Q ss_pred CCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHH---hhCCCCeeeecceeeecCCccEEE
Q 007455 313 LDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEIL---GSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
|++.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5667899999999999999874 5679999986432 22234566676655 566899999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|..++... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHTD-----VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 9999999998887642 289999999999999999999998 89999999999999999999999999987543
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... .........
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~------~~~~~~i~~---------- 215 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE------EEVFDSIVN---------- 215 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh----------
Confidence 222 122345689999999999988999999999999999999999999865321 111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
.....+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 216 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 216 DEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 11112233456789999999999999999 5677665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=325.74 Aligned_cols=236 Identities=24% Similarity=0.332 Sum_probs=190.6
Q ss_pred CeeeecCCeEEEEEEECC-CCEEEEEEeCCC---CCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMND-CGTFAVKRIDRS---REGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.++. ++.||+|.+... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999875 457999998643 223344567888888876 699999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~i~~~~~----l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~ 152 (320)
T cd05590 81 GDLMFHIQKSRR----FDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-T 152 (320)
T ss_pred chHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-c
Confidence 999998876543 88999999999999999999998 899999999999999999999999999875432221 2
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ......... .....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~----------~~~~~~ 216 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILN----------DEVVYP 216 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhc----------CCCCCC
Confidence 2345689999999999988899999999999999999999999975321 111111111 111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH
Q 007455 552 METVEAILEIAARCTDANPDDRPSM 576 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~ 576 (603)
...+.++.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2345678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=315.47 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=201.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-----EEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|++.+.||+|+||.||+|.+..++ .+++|.+..... .....+..|+..+++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 56788899999999999999985433 377787753322 22356778888999999999999999875 455789
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
++||+++|+|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD---SLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999975432 388999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||...... .. ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~---~~----~~~~~~~~---- 228 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH---EV----PDLLEKGE---- 228 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HH----HHHHHCCC----
Confidence 443222 1223446778999999988899999999999999999998 99998653211 11 11111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCC
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 590 (603)
....+...+..+.+++.+||..+|++|||+.|+++.|..+...|
T Consensus 229 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 229 ----RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 00111123456888999999999999999999999998866554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=328.53 Aligned_cols=241 Identities=20% Similarity=0.278 Sum_probs=194.0
Q ss_pred CeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCC
Q 007455 317 DVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
+.||+|+||.||++.+. .+..||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999976 45579999986432 222345778999999999999999999999999999999999999
Q ss_pred CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 393 SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH-DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 393 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 9998887543 38899999999999999999997 5 899999999999999999999999999875432221 2
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....... .......+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~------~~~~~~i----------~~~~~~~p 216 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELI----------LMEEIRFP 216 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH------HHHHHHH----------hcCCCCCC
Confidence 2335689999999999988999999999999999999999999864321 1111111 11111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 552 METVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
...+.++.+++.+||+.||++|+ +++++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 33456789999999999999996 8999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=325.09 Aligned_cols=241 Identities=22% Similarity=0.312 Sum_probs=193.5
Q ss_pred CCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCC-eeeecceeeecCCccEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSIKHI-NLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 386 (603)
+|++.+.||+|+||.||+|.+.++ +.||+|++.... ....+.+..|.+++..+.|+ +|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999998754 469999986432 23345678899999999764 6888999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGK----FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999998876543 78999999999999999999998 899999999999999999999999999875322
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .-.... ...
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i----------~~~ 216 (324)
T cd05587 154 GGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQSI----------MEH 216 (324)
T ss_pred CCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHH----------HcC
Confidence 211 233456899999999999888999999999999999999999999753211 001111 111
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSM 576 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 576 (603)
....+...+.++.+++.+||..+|.+|++.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 112223445678999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=331.94 Aligned_cols=251 Identities=23% Similarity=0.339 Sum_probs=202.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||+|.+. .+..||+|++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36888999999999999999987 45679999986432 233456889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRKD----VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 9999999999998653 388999999999999999999998 899999999999999999999999999987654
Q ss_pred CC----------------------------cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcc
Q 007455 467 EE----------------------------AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPT 518 (603)
Q Consensus 467 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~ 518 (603)
.. ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 33 11223456899999999999889999999999999999999999999754
Q ss_pred cccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 007455 519 FVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPS-MNQVLQ 581 (603)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~ 581 (603)
... ......... .... ..+. ....+.++.+++.+|+. +|.+||+ ++++++
T Consensus 234 ~~~------~~~~~i~~~---~~~~--~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 234 TLQ------ETYNKIINW---KESL--RFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CHH------HHHHHHhcc---CCcc--cCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 211 111111110 0000 0111 11145779999999997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=319.21 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=194.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC--CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhC---CCCeeeecceeee-----c
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN--DCGTFAVKRIDRSR--EGSDQVFERELEILGSI---KHINLVNLRGYCR-----L 378 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 378 (603)
++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888999999999999999874 34569999886432 22234566788777766 6999999999885 2
Q ss_pred CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 379 PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
....++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 455789999997 589998876432 2378999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh---
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK--- 535 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 535 (603)
|+++..... .......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... ...........
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~---~~~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLPG 229 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCC
Confidence 999865433 2233456899999999998888999999999999999999999999753211 11111111000
Q ss_pred hCcch-------hhhcccCCC----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 536 ENRLE-------DVIDKRCAD----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 536 ~~~~~-------~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+. ......... .....+..+.+++.+|++.+|++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000000 01123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=318.03 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=200.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
+|+..++||+|+||.||++.+. ++..||+|++..... .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999986 456799999864322 223457789999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999988865322 3388999999999999999999998 8999999999999999999999999999875432
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
.. .....|++.|+|||++.+..++.++||||+|+++|||++|+.||...... ..... +...+....
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~~---------~~~~~~~~~ 221 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKREE---------VERRVKEDQ 221 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHHH---------HHHHhhhcc
Confidence 21 22346889999999998888999999999999999999999999753211 00000 111111112
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
...+...+..+.+++.+||..||++|| +++++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 223344567799999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=327.72 Aligned_cols=261 Identities=22% Similarity=0.361 Sum_probs=194.0
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCC-----ccE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPA-----TKL 383 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 383 (603)
+|++.+.||+|+||.||+|.+.. +..||||++.... ......+.+|++++++++||||+++++++.... ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47788999999999999999874 5679999986432 223346889999999999999999999875432 479
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+. ++|.+++..... +++..+..++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKANDD----LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhccc----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 589888875433 88999999999999999999999 899999999999999999999999999976
Q ss_pred cCCCCc--ceeecccccccccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCcc---------HhHHH
Q 007455 464 LVDEEA--HVTTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLN---------VVGWM 530 (603)
Q Consensus 464 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~---------~~~~~ 530 (603)
...... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ...+.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 532211 11234568999999999865 578899999999999999999999996532110000 00000
Q ss_pred HHHhhhCcchhhh---cccCCCc----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 531 NTLLKENRLEDVI---DKRCADA----DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 531 ~~~~~~~~~~~~~---~~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... .......+ ....+.. ....+..+.+++.+||+.+|++|||++|+++
T Consensus 233 ~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVR-NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhh-hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000 00000000 0000000 0112456889999999999999999999996
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=310.94 Aligned_cols=255 Identities=32% Similarity=0.491 Sum_probs=206.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.++|.+.+.||+|+||.||+|.++++..+|+|.+.... ...+.+.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 36788899999999999999998887889999987543 34567899999999999999999999999889999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++.... ...+++..+..++.|++.|+.|||++ +++||||||+||++++++.++++|||.++.......
T Consensus 84 ~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 84 SKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999997643 23389999999999999999999998 899999999999999999999999999987654222
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......++..|+|||.+.+..++.++|+||+|+++||+++ |+.||..... ........... ..
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~------~~~~~~~~~~~---------~~ 223 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN------REVLEQVERGY---------RM 223 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCC---------CC
Confidence 21222234568999999988889999999999999999999 9999854211 11111111100 00
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
..+...+.++.+++.+|++.+|++||+++++.+.|++
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1112235679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.19 Aligned_cols=241 Identities=24% Similarity=0.336 Sum_probs=193.7
Q ss_pred CeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
++||+|+||.||+|.+.++ ..||+|++.... ......+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999998754 579999986532 22334577888888866 799999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|..++..... +++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++........ .
T Consensus 81 ~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 999988876443 88999999999999999999999 899999999999999999999999999875433222 2
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .......... ....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~------~~~~~~i~~~----------~~~~p 216 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE------DDLFESILHD----------DVLYP 216 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH------HHHHHHHHcC----------CCCCC
Confidence 2345689999999999988999999999999999999999999975321 1111111111 11112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 007455 552 METVEAILEIAARCTDANPDDRP-------SMNQVLQ 581 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RP-------s~~evl~ 581 (603)
...+.++.+++.+||+.+|++|| +++++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 23446789999999999999999 7888874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=322.43 Aligned_cols=241 Identities=24% Similarity=0.339 Sum_probs=191.9
Q ss_pred CeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+.++ ..||+|.++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999998754 569999986532 22334566788888764 899999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +++.++..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQSCHK----FDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999999876433 78899999999999999999998 899999999999999999999999999875322221 2
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........ ...+..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~i~----------~~~~~~~ 216 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE------EELFQSIR----------MDNPCYP 216 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH------HHHHHHHH----------hCCCCCC
Confidence 2345689999999999988899999999999999999999999965321 11111110 0011122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSMN-QVLQ 581 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl~ 581 (603)
...+.++.+++.+||+.+|++||++. ++++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 23456789999999999999999997 6643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=315.37 Aligned_cols=262 Identities=23% Similarity=0.389 Sum_probs=204.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.++|++.+.||+|+||.||+|..++ +..||+|.+...... ....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 4688999999999999999997642 336999987644322 234578899999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCC------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEe
Q 007455 383 LLIYDYLSMGSLDDFLHEHGE------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS 456 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 456 (603)
++||||+++|+|.+++..... .....++..+..++.|++.||.|||++ +++||||||+||++++++.++|+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEEC
Confidence 999999999999999975322 123356778899999999999999998 89999999999999999999999
Q ss_pred ecccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHh
Q 007455 457 DFGLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 457 DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... .+......
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~ 235 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------EQVLKFVM 235 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHH
Confidence 999987654322211 122234678999999988889999999999999999999 6778754211 11111111
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
+......+...+..+.+++.+|++.+|++|||+.++++.|++...+
T Consensus 236 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 236 ---------DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred ---------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 1111112223346799999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=309.54 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=195.1
Q ss_pred CeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCc
Q 007455 317 DVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
+.||+|+||.||+|.+. +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46899999999999986 55679999875433 22345689999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCccee-e
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT-T 473 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~-~ 473 (603)
.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99987533 2378999999999999999999998 899999999999999999999999999876543211111 1
Q ss_pred cccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCH
Q 007455 474 VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADM 552 (603)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 552 (603)
....+..|+|||.+.+..++.++||||+|+++|||++ |..||...... . ....... ......+.
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~------~-~~~~~~~--------~~~~~~~~ 219 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ------Q-TREAIEQ--------GVRLPCPE 219 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH------H-HHHHHHc--------CCCCCCcc
Confidence 1123456999999988889999999999999999998 88887542111 0 0000100 00111223
Q ss_pred HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 553 ETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 553 ~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
..+..+.+++.+|++.+|++|||+++++++|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 44567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=317.68 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=196.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999987 456799999864432 233457889999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+. ++|.+++..... .++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHPG---GLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 588777765422 378889999999999999999998 8999999999999999999999999998754322
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC---cch---
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN---RLE--- 540 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 540 (603)
. .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... .............. .+.
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhhccchh
Confidence 2 12233557899999998865 45788999999999999999999999753210 00000000000000 000
Q ss_pred ---hhhcccC----CCc------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 ---DVIDKRC----ADA------DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ---~~~~~~~----~~~------~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....... +.. ....+..+.+++.+|++.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 000 0012356889999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=315.03 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=204.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC------CEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC------GTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.++|++.+.||+|+||.||+|.+.+. ..+|+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 35788899999999999999987642 4699999864432 2334688999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCCC------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEe
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEG------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS 456 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 456 (603)
++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 9999999999999998754321 22378899999999999999999998 89999999999999999999999
Q ss_pred ecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHh
Q 007455 457 DFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 457 DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
|||+++....... .......++..|+|||.+.+..++.++||||||+++||+++ |..||..... .....+ .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~---~- 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKF---V- 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHH---H-
Confidence 9999876544322 12223446788999999988889999999999999999998 8888854211 111111 1
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
. .......+...+.++.+++.+||+.+|++|||+.++++.|++
T Consensus 235 ~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 I--------DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred h--------cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 111111222346789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=331.44 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=200.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 5678899999999999999999875 4569999985422 22334578899999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++.... ++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~~~-----l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 122 MEYMPGGDLVNLMSNYD-----IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999886532 77888889999999999999998 89999999999999999999999999998764
Q ss_pred CCCcceeecccccccccCccccccC----CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSG----RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
...........||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ............ .
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~~--~ 265 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMDHKN--S 265 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCCC--c
Confidence 4333233446799999999988643 478899999999999999999999975321 111111111000 0
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDD--RPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~ 581 (603)
...+ .....+.++.+++.+|++.+|++ |++++|+++
T Consensus 266 ---~~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 266 ---LTFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred ---CCCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 0001 11134578999999999999987 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=319.45 Aligned_cols=258 Identities=29% Similarity=0.459 Sum_probs=201.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC---EEEEEEeCCCC-CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG---TFAVKRIDRSR-EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 384 (603)
+++|++.+.||+|+||.||+|.+.+++ .+++|.+.... ......+.+|++++.++ +|+||+++++++...+..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 567888999999999999999976433 36777765432 23345688999999999 89999999999999999999
Q ss_pred EEEecCCCCccccccccCC------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC
Q 007455 385 IYDYLSMGSLDDFLHEHGE------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE 452 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 452 (603)
|+||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999875431 123478999999999999999999998 8999999999999999999
Q ss_pred eEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHH
Q 007455 453 PHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 453 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 531 (603)
+||+|||++...... .......++..|+|||.+.+..++.++||||||+++|||+| |..||..... .....
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYE 234 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh------HHHHH
Confidence 999999998643211 11112224567999999988888999999999999999998 9999864321 11111
Q ss_pred HHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 532 TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..... .....+...+.++.+++.+||+.+|++||+++++++.|+++.
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 235 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11100 001112234467899999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=323.04 Aligned_cols=240 Identities=24% Similarity=0.342 Sum_probs=191.5
Q ss_pred CeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+.. +..||+|.++... ......+..|..++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999875 4569999986532 22334567788888754 899999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++...... ..
T Consensus 81 g~L~~~i~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQDKGR----FDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999998876433 78999999999999999999998 89999999999999999999999999987532211 12
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ....... ....+..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~------~~~~~~~----------~~~~~~~~ 216 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE------DELFESI----------RVDTPHYP 216 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHH----------HhCCCCCC
Confidence 3345689999999999988999999999999999999999999965321 1111111 11111222
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSMN-QVL 580 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~-evl 580 (603)
...+.++.+++.+||+.||++||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23456789999999999999999984 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=329.17 Aligned_cols=262 Identities=23% Similarity=0.290 Sum_probs=196.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCC-----ccE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPA-----TKL 383 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 383 (603)
+|+..+.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+++++.++|+||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999975 566799999864322 23456889999999999999999999998776 789
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+|+||+.+ +|.+++.... .+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~~-~l~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQ----PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeecccc-CHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99999974 7877775433 389999999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCcc----------HhHHHH-
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLN----------VVGWMN- 531 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~----------~~~~~~- 531 (603)
.............+++.|+|||.+.+. .++.++||||+||++|||++|+.||.......... ...+..
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 544333333344678899999998764 47899999999999999999999997543211000 000000
Q ss_pred -----HHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 532 -----TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 532 -----~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.......................+.++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000000000000000011123567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=323.65 Aligned_cols=248 Identities=21% Similarity=0.325 Sum_probs=195.8
Q ss_pred CeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
++||+|+||.||+|.+.. +..||+|.++... ......+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999874 4569999996532 22234578899999988 799999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~~~----l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQRQRK----LPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 999988875433 89999999999999999999998 89999999999999999999999999987532211 12
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccC--CccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKR--GLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||+...... ......+........ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 223 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK---------QIR 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC---------CCC
Confidence 234568999999999998899999999999999999999999997432111 111122222222111 111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPS------MNQVLQ 581 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs------~~evl~ 581 (603)
.+...+.++.+++.+||+.+|.+||+ ++++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 22334567899999999999999997 567763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=307.66 Aligned_cols=247 Identities=28% Similarity=0.434 Sum_probs=197.6
Q ss_pred CeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCcc
Q 007455 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLD 395 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (603)
++||+|+||.||+|...++..+|+|.+...... ....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 468999999999999888888999988654322 2346889999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeecc
Q 007455 396 DFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475 (603)
Q Consensus 396 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~ 475 (603)
+++..... .+++..+..++.|++.||.|+|++ +++||||||+||+++.++.++++|||++..............
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKKD---ELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 98865432 378999999999999999999998 899999999999999999999999999875433222111222
Q ss_pred cccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHH
Q 007455 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554 (603)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (603)
.++..|+|||++.+..++.++||||||+++||+++ |..||...... .......... ....+...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~~~~~~~~~~---------~~~~~~~~ 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------QAREQVEKGY---------RMSCPQKC 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHHcCC---------CCCCCCCC
Confidence 34567999999998889999999999999999998 88898643211 0111111100 01112234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 555 VEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 555 ~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
+..+.+++.+|+..+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=317.75 Aligned_cols=258 Identities=30% Similarity=0.450 Sum_probs=202.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC---EEEEEEeCCCC-CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG---TFAVKRIDRSR-EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 385 (603)
++|++.+.||+|+||.||+|.+.+++ .+++|.++... ....+.+.+|++++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888999999999999999986543 36888776432 22345688999999999 799999999999999999999
Q ss_pred EEecCCCCccccccccCC------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCe
Q 007455 386 YDYLSMGSLDDFLHEHGE------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEP 453 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 453 (603)
+||+++|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999875421 112478899999999999999999998 89999999999999999999
Q ss_pred EEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHH
Q 007455 454 HVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNT 532 (603)
Q Consensus 454 kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 532 (603)
||+|||++...... ........+..|+|||...+..++.++||||||+++|||++ |..||..... ......
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~------~~~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC------AELYEK 230 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHH
Confidence 99999998643211 11111223457999999988889999999999999999998 9999864321 111111
Q ss_pred HhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
... ......+...+..+.+++.+||+.+|.+||+++++++.|+++..
T Consensus 231 ~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 231 LPQ---------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred Hhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 110 00111222345679999999999999999999999999887664
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=323.56 Aligned_cols=241 Identities=22% Similarity=0.319 Sum_probs=193.7
Q ss_pred CCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 386 (603)
+|++.+.||+|+||.||+|.+..+ ..||+|.+.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477889999999999999998754 469999986532 22234466788888777 5899999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVGR----FKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998876443 88999999999999999999998 899999999999999999999999999875432
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........ .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~i~~----------~ 216 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIME----------H 216 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHHHHh----------C
Confidence 22 1223456899999999999999999999999999999999999999753211 11111111 1
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSM 576 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 576 (603)
....+...+.++.+++.+|++.+|++|++.
T Consensus 217 ~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 112233455678999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=323.85 Aligned_cols=260 Identities=31% Similarity=0.501 Sum_probs=201.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecC-Cc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLP-AT 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 381 (603)
++|++.+.||+|+||.||+|.+.+ ++.||+|++...... ..+.+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 478889999999999999997543 246999988644322 234578899999999 799999999988654 56
Q ss_pred cEEEEEecCCCCccccccccCCC---------------------------------------------------------
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEG--------------------------------------------------------- 404 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 404 (603)
.++++||+++|+|.+++......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999988642210
Q ss_pred CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce-eecccccccccC
Q 007455 405 QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV-TTVVAGTFGYLA 483 (603)
Q Consensus 405 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~a 483 (603)
...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+++.+....... .....++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 12578999999999999999999998 89999999999999999999999999998764332221 222345678999
Q ss_pred ccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHH
Q 007455 484 PEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIA 562 (603)
Q Consensus 484 PE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 562 (603)
||++.+..++.++|||||||++|||++ |..||....... .......... ....+...+.++.+++
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~--------~~~~~~~~~~~~~~l~ 309 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGT--------RMRAPEYATPEIYSIM 309 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccC--------CCCCCccCCHHHHHHH
Confidence 999998999999999999999999998 999986432110 0111111110 0111223446799999
Q ss_pred HHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 563 ARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 563 ~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.+||+.+|++||++.|+++.|++..
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999999999998755
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.52 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=198.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||+|.+.. ++.||||++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 368889999999999999999874 5679999986432 223345788999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++...+. +++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKKDT----FTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999876443 89999999999999999999999 899999999999999999999999999875432
Q ss_pred CCcc-------------------------------------eeecccccccccCccccccCCCCcccchHhHHHHHHHHH
Q 007455 467 EEAH-------------------------------------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELV 509 (603)
Q Consensus 467 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell 509 (603)
.... ......||+.|+|||++....++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 011245899999999998888999999999999999999
Q ss_pred hCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 007455 510 TGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPS---MNQVLQ 581 (603)
Q Consensus 510 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 581 (603)
+|..||...... .......... ..+ ........+.++.+++.+|+. +|.+|++ ++|+++
T Consensus 234 ~G~~Pf~~~~~~------~~~~~i~~~~---~~~---~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 234 VGYPPFCSDNPQ------ETYRKIINWK---ETL---QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred cCCCCCCCCCHH------HHHHHHHcCC---Ccc---CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999753211 1111111100 000 000111234678899999996 9999997 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=323.86 Aligned_cols=243 Identities=21% Similarity=0.326 Sum_probs=191.8
Q ss_pred CeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+..+ ..+|+|.++... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999998754 569999986532 22334577889888877 799999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~~----l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 999988875433 88999999999999999999998 899999999999999999999999999875422211 2
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccC--CccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKR--GLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+........ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------~~~ 223 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------QIR 223 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC---------CCC
Confidence 234568999999999999899999999999999999999999996422111 111122222211111 112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSM 576 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~ 576 (603)
.+...+..+.+++.+||+.||++||++
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 233445678999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=311.33 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=197.9
Q ss_pred CCCCCeeeecCCeEEEEEEECCCC---EEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecC------Cc
Q 007455 313 LDEEDVVGSGGFGTVYRMVMNDCG---TFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLP------AT 381 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 381 (603)
|.+.+.||+|+||.||+|.+.++. .+|+|.++... ....+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356789999999999999987654 48999886542 22345688999999999999999999987432 24
Q ss_pred cEEEEEecCCCCccccccccC--CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHG--EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
.++++||+++|+|.+++.... .....+++.....++.|++.||+|||++ +|+||||||+||++++++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 689999999999998874322 2223488999999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 460 LAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 460 ~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
+++......... .....+++.|+|||...+..++.++||||||+++|||++ |+.||..... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------SEIYDYLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCC
Confidence 998764432211 122345678999999998889999999999999999999 7888754211 11111111111
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
....+...+..+.+++.+||+.+|++|||++++++.|++.
T Consensus 232 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 ---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111223456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=331.15 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=194.7
Q ss_pred CCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.|+..+.||+|+||+||+|.+.++ ..||+|++.... ......+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999998754 569999986532 2233468899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRMEV----FPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999876543 78888999999999999999998 8999999999999999999999999997543110
Q ss_pred Cc----------------------------------------------ceeecccccccccCccccccCCCCcccchHhH
Q 007455 468 EA----------------------------------------------HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSF 501 (603)
Q Consensus 468 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 501 (603)
.. .......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123469999999999988889999999999
Q ss_pred HHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHH--cccCCCCCCCCHHHH
Q 007455 502 GVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAAR--CTDANPDDRPSMNQV 579 (603)
Q Consensus 502 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~P~~RPs~~ev 579 (603)
||++|||++|+.||...... ........... .. ..+ .....+.++.+++.+ |+..+|..||+++|+
T Consensus 235 G~il~elltG~~Pf~~~~~~------~~~~~i~~~~~---~~--~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPT------ETQLKVINWEN---TL--HIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHH------HHHHHHHcccc---cc--CCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999999753211 00011110000 00 000 111234678888888 445566679999999
Q ss_pred HH
Q 007455 580 LQ 581 (603)
Q Consensus 580 l~ 581 (603)
++
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=316.55 Aligned_cols=257 Identities=21% Similarity=0.360 Sum_probs=202.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
.+|.+.+.||+|+||.||+|.+.+ +..||+|++...... ....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 346667889999999999998753 346999998754332 2356889999999999999999999999999999
Q ss_pred EEEEecCCCCccccccccC------------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC
Q 007455 384 LIYDYLSMGSLDDFLHEHG------------EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL 451 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 451 (603)
+++||+.+++|.+++.... .....+++..+..++.|++.||+|+|++ +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence 9999999999999985321 1123478889999999999999999998 899999999999999999
Q ss_pred CeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHH
Q 007455 452 EPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGW 529 (603)
Q Consensus 452 ~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 529 (603)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||+|+++|||++ |..||.... ..++
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~------~~~~ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS------NQDV 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC------HHHH
Confidence 999999999886543322 11223345778999999988889999999999999999998 777875421 1112
Q ss_pred HHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 530 MNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
...... ......+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus 236 ~~~i~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRN---------RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHc---------CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 111111 11112233455679999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=315.10 Aligned_cols=265 Identities=28% Similarity=0.433 Sum_probs=199.9
Q ss_pred CCCCCeeeecCCeEEEEEEE-----CCCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecC--CccEE
Q 007455 313 LDEEDVVGSGGFGTVYRMVM-----NDCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLP--ATKLL 384 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 384 (603)
|+..+.||+|+||+||++.. .++..+|+|.+..... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 47889999999999988653 2455799998865432 2345688999999999999999999987654 35789
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
+|||+++|+|.+++.... +++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~~~-----l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK-----LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 999999999999987532 89999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcce--eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAHV--TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
....... .....++..|+|||.+.+..++.++||||||+++|||++|..|+....... .....+.........+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhh
Confidence 4432211 122335567999999988889999999999999999999999976432110 0000000000000011111
Q ss_pred hccc-CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 543 IDKR-CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 543 ~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
.+.. ....+...+.++.+++.+||+.+|++|||++++++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 1111 1112234457899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=314.31 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=203.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|+..++||+|+||.||++... .+..+++|.+..........+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56778899999999999999743 234588998876555555679999999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCC-----------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCe
Q 007455 385 IYDYLSMGSLDDFLHEHGEG-----------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEP 453 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 453 (603)
+|||+++|+|.+++...... ...+++..++.++.|++.|++|||+. +++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 99999999999998764321 12478999999999999999999998 89999999999999999999
Q ss_pred EEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHH
Q 007455 454 HVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 454 kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 531 (603)
+|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ....
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT------EAIE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH------HHHH
Confidence 9999999876543221 11122335678999999988889999999999999999998 88887542211 0111
Q ss_pred HHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 532 TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
... .......+...+..+.+++.+||+.+|.+||+++|+++.|+.
T Consensus 236 ~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CIT---------QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHH---------cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111 111111222345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=309.51 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=201.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC-----hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG-----SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|+..+.||+|++|.||+|.+. .+..+++|.+...... ....+.+|++++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888999999999999999976 4567999988643221 12458889999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
|+||+++++|.+++..... ++...+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGA----LTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999876543 78889999999999999999998 8999999999999999999999999998765
Q ss_pred CCCCccee--ecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAHVT--TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
........ ....++..|+|||.+.+..++.++||||+|+++|||++|+.||..... ... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~~------- 221 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-----MAA-IFKIAT------- 221 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-----HHH-HHHHhc-------
Confidence 43221111 234577899999999988899999999999999999999999864311 000 000000
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.......+...+..+.+++.+||..+|.+|||+.|+++
T Consensus 222 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 222 -QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred -cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 00111223345567999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=311.20 Aligned_cols=260 Identities=19% Similarity=0.328 Sum_probs=208.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||+|.+. ++..++||.+..... .....+.+|+.+++.++|+||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46788899999999999999975 666799998764322 23356889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++++|.+++.........+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998875433344589999999999999999999998 899999999999999999999999999876643
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.... .....++..|+|||.+.+..++.++|+||||+++|||++|..||..... ....+..... ....+
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~------~~~~~- 226 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIE------QCDYP- 226 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc----hHHHHhhhhh------cCCCC-
Confidence 3221 2234588899999999888899999999999999999999999864311 1111111110 00000
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
+......+..+.+++.+||..+|++|||+.+|+++++++
T Consensus 227 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 -PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 011224566899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=328.57 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=194.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|+..+.||+|+||+||+|.+.. +..||+|++.... ......+.+|+.++.+++|+||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468889999999999999999875 4579999986432 222346788999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++...+. +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKKDT----LTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999976543 89999999999999999999998 899999999999999999999999999875432
Q ss_pred CCc----------------------------------ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCC
Q 007455 467 EEA----------------------------------HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGK 512 (603)
Q Consensus 467 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~ 512 (603)
... .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012356999999999999889999999999999999999999
Q ss_pred CCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHccc--CCCCCCCCHHHHHH
Q 007455 513 RPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTD--ANPDDRPSMNQVLQ 581 (603)
Q Consensus 513 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~P~~RPs~~evl~ 581 (603)
.||...... .......... ....+ +. ....+.++.+++.+++. .++..||+++|+++
T Consensus 234 ~Pf~~~~~~------~~~~~i~~~~-~~~~~----p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~ 292 (363)
T cd05628 234 PPFCSETPQ------ETYKKVMNWK-ETLIF----PP-EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKT 292 (363)
T ss_pred CCCCCCCHH------HHHHHHHcCc-CcccC----CC-cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence 999753211 1111111100 00000 11 11234567778877554 23445689999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=304.95 Aligned_cols=267 Identities=27% Similarity=0.375 Sum_probs=207.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhh--CCCCeeeecceeeecC----Ccc
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGS--IKHINLVNLRGYCRLP----ATK 382 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~ 382 (603)
.-.+..+.+.||+|.||.||+|.+++ +.||||++...+ +....+|.++++. ++|+||+.+++.-..+ .+.
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wrG-e~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWRG-EDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhheeEEEEEecCccccceeeccccC-CceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 34677888999999999999999986 789999986443 3346777777775 5999999998865333 357
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEecCCCCCeEECCCCCeEEee
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD-----CCPKIIHRDIKSSNILLDENLEPHVSD 457 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~D 457 (603)
++|++|.+.|||.||+..+. ++....++++..+|.||+|||.. +.|.|+|||||+.|||+..++.+.|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r~t-----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRNT-----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhhcc-----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 89999999999999998743 88999999999999999999975 678999999999999999999999999
Q ss_pred cccccccCCCCcc---eeecccccccccCccccccCCC------CcccchHhHHHHHHHHHhCC----------CCCCcc
Q 007455 458 FGLAKLLVDEEAH---VTTVVAGTFGYLAPEYLQSGRA------TEKSDVYSFGVLLLELVTGK----------RPTDPT 518 (603)
Q Consensus 458 fG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~------~~~~Dv~slG~vl~elltg~----------~p~~~~ 518 (603)
+|+|......... ..+..+||.+|||||++...-. -..+||||||.|+||+.... .||...
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999776544221 2355789999999999964321 23689999999999998732 466543
Q ss_pred cccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 519 FVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
.+. ..-++-++.++-..++...++++... .+....+.++|+.||..+|.-|-|+-.+.+.|.++..
T Consensus 440 Vp~--DPs~eeMrkVVCv~~~RP~ipnrW~s--~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 440 VPS--DPSFEEMRKVVCVQKLRPNIPNRWKS--DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCC--CCCHHHHhcceeecccCCCCCccccc--CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 221 22233344444444444444443333 4566789999999999999999999999999988764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=313.81 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=193.6
Q ss_pred eeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCc
Q 007455 319 VGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 319 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
||+|+||.||++.... ++.||+|.+.... ......+..|++++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 6999999999999764 5679999986432 12234466799999999999999999999999999999999999999
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeec
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 474 (603)
.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNVGE--RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 988865432 3378999999999999999999998 89999999999999999999999999987664332 2233
Q ss_pred ccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHH
Q 007455 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554 (603)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (603)
..|+..|+|||++.+..++.++||||+||++|||++|+.||...... ........... ...........
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~--~~~~~~~~~~~---------~~~~~~~~~~~ 222 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK--VAKEELKRRTL---------EDEVKFEHQNF 222 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch--hhHHHHHHHhh---------ccccccccccC
Confidence 56889999999998888999999999999999999999998643211 01111111111 11111111234
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 555 VEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 555 ~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
+.++.+++.+||+.+|++||+++|+++.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 5679999999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=322.18 Aligned_cols=241 Identities=24% Similarity=0.334 Sum_probs=194.3
Q ss_pred CeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999875 4579999986432 22334567888998888 699999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++....... .
T Consensus 81 ~~L~~~~~~~~~----l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 999988876533 89999999999999999999998 899999999999999999999999999875322221 2
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......... .....+
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~------~~~~~~i~~----------~~~~~~ 216 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE------DELFQSILE----------DEVRYP 216 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH------HHHHHHHHc----------CCCCCC
Confidence 2335689999999999988999999999999999999999999964321 111111111 111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSM-----NQVLQ 581 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 581 (603)
...+.++.+++.+||..||.+||++ .++++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 3345678999999999999999999 88864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=310.62 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=200.5
Q ss_pred CCCCCeeeecCCeEEEEEEECCC----CEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCc-----
Q 007455 313 LDEEDVVGSGGFGTVYRMVMNDC----GTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPAT----- 381 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 381 (603)
|++.+.||+|+||.||+|.+..+ ..+|+|.++..... ....+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 56788999999999999987532 45999998654322 23468899999999999999999998866554
Q ss_pred -cEEEEEecCCCCccccccccC--CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 382 -KLLIYDYLSMGSLDDFLHEHG--EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 382 -~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
.++++||+++|+|.+++.... .....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999885532 1223589999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhh
Q 007455 459 GLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKE 536 (603)
Q Consensus 459 G~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 536 (603)
|+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||..... .........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~------~~~~~~~~~- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------HEIYDYLRH- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHc-
Confidence 9998764432221 122234668999999988889999999999999999999 8888754221 111111111
Q ss_pred CcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
......+...+.++.+++.+||+.+|++|||+.|+++.|++.
T Consensus 231 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 --------GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --------CCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111112334556899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=336.40 Aligned_cols=257 Identities=26% Similarity=0.347 Sum_probs=208.3
Q ss_pred CCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CCeeeeccee-eec------CCcc
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRGY-CRL------PATK 382 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------~~~~ 382 (603)
++++.+.|.+|||+.||.|.+.++ .+||+|++....+..-+...+|+++|+.|. |+|||.+++. ... ..++
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Ev 117 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEV 117 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEE
Confidence 456678999999999999999887 889999998777777788999999999996 9999999993 211 2357
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
+|.||||.||.|-+++..+...+ +++.++++|+.|+++|+++||.. .++|||||||-+|||+..+|+.||||||.+.
T Consensus 118 llLmEyC~gg~Lvd~mn~Rlq~~--lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 118 LLLMEYCKGGSLVDFMNTRLQTR--LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EeehhhccCCcHHHHHHHHHhcc--CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 89999999999999998754433 99999999999999999999997 4679999999999999999999999999986
Q ss_pred ccCCCC-cc-------eeecccccccccCcccc---ccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHH
Q 007455 463 LLVDEE-AH-------VTTVVAGTFGYLAPEYL---QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 463 ~~~~~~-~~-------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 531 (603)
...... .. ......-|+.|+|||.+ .+...++|+|||||||+||-|+....||+.....
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 532221 11 01123468899999977 5677899999999999999999999999864211
Q ss_pred HHhhhCcchhhhcccCC-CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCC
Q 007455 532 TLLKENRLEDVIDKRCA-DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590 (603)
Q Consensus 532 ~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 590 (603)
.++..... .....++..+.+||+.||+.+|.+||++-+++..+-.+.-.+
T Consensus 265 ---------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ---------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 11111111 122477889999999999999999999999999888766433
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.93 Aligned_cols=245 Identities=24% Similarity=0.390 Sum_probs=194.9
Q ss_pred eeeecCCeEEEEEEEC---CCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCC
Q 007455 318 VVGSGGFGTVYRMVMN---DCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 318 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
.||+|+||.||+|.+. ++..+|+|.++..... ..+.+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 3456999988644322 3456889999999999999999999875 45678999999999
Q ss_pred CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCccee
Q 007455 393 SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472 (603)
Q Consensus 393 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 472 (603)
+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.++|+|||+++..........
T Consensus 81 ~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 9999987543 388999999999999999999998 899999999999999999999999999987654332211
Q ss_pred --ecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 473 --TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 473 --~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
....++..|+|||.+....++.++||||||+++|||++ |..||..... ..+...... . ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~i~~-~--------~~~~ 218 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG------NEVTQMIES-G--------ERME 218 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHC-C--------CCCC
Confidence 12234578999999988888999999999999999998 9999865321 111111111 1 0111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.+...+.++.+++.+||+.+|++||++++|.+.|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 223455679999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.94 Aligned_cols=252 Identities=22% Similarity=0.297 Sum_probs=201.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||+|.+. .+..||+|+++.... ...+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36888999999999999999987 455799999865322 23456889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYED---QFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 99999999999986522 388999999999999999999998 899999999999999999999999999987654
Q ss_pred CCcceeecccccccccCccccc------cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQ------SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||..... ..............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~ 228 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS------AKTYNNIMNFQRFL 228 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence 4433334456899999999986 45678899999999999999999999965321 11111111111100
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. .+ .....+.++.+++.+|++ +|++|||++++++
T Consensus 229 ~-----~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 229 K-----FP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred C-----CC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 01 111345678999999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=312.51 Aligned_cols=261 Identities=23% Similarity=0.385 Sum_probs=205.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-C----EEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-G----TFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
.++|+..+.||+|+||+||+|.+... . .||+|.+..... .....+.+|+.+++.+.|+||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35788899999999999999986533 2 379998864332 334568899999999999999999999875 4578
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+++||+++|+|.+++.... ..+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999987542 2388999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 464 LVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 464 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
........ .....+++.|+|||...+..++.++||||||+++|||++ |..||..... .....+. ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~----~~~---- 227 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLL----EKG---- 227 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HCC----
Confidence 64332211 112234678999999988889999999999999999998 8888864321 1111111 110
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCCC
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCP 592 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 592 (603)
.....+...+.++.+++.+||..+|++||++.++++.|+.+...|++
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~ 274 (279)
T cd05109 228 ----ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPSR 274 (279)
T ss_pred ----CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcC
Confidence 00111223456789999999999999999999999999988766644
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.79 Aligned_cols=258 Identities=29% Similarity=0.451 Sum_probs=202.6
Q ss_pred CCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
+|++.+.||+|+||.||+|.... ...+++|.+...... ....+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778999999999999998642 235888887644322 23568899999999999999999999999999999
Q ss_pred EEEecCCCCccccccccC--------------------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 007455 385 IYDYLSMGSLDDFLHEHG--------------------EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSN 444 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~--------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 444 (603)
++||+.+|+|.+++.... .....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999876421 1123478999999999999999999998 89999999999
Q ss_pred eEECCCCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccC
Q 007455 445 ILLDENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKR 522 (603)
Q Consensus 445 Ill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~ 522 (603)
|++++++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~- 236 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE- 236 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence 99999999999999999765432221 1122345678999999988889999999999999999999 99898643211
Q ss_pred CccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 523 GLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.... ..... . ....+...+.++.+++.+||+.+|++||+++|+++.|+++.
T Consensus 237 -----~~~~-~~~~~-~-------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 237 -----RLFN-LLKTG-Y-------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred -----HHHH-HHhCC-C-------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 1111 11110 0 01112234567999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=310.69 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=200.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++|++.+.||+|+||.||+|.+. ++..+|+|++..........+.+|+.++++++||||+++++++...+..++|+||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357899999999999999999986 4456999988755444556688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++..... +++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHVTGP----LSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999998875432 78999999999999999999998 89999999999999999999999999998654321
Q ss_pred cceeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 469 AHVTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
. ......|+..|+|||.+. ...++.++||||+|+++|||++|+.||......... ..+ ...... ..
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~--~~~-----~~~~~~---~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--FLM-----SKSNFQ---PP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh--eee-----ecCCCC---CC
Confidence 1 123345888999999874 345778999999999999999999998532211000 000 000000 00
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
.. ......+..+.+++.+||..+|++|||++++++.
T Consensus 230 ~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 230 KL-KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CC-ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 01 1112345679999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.22 Aligned_cols=252 Identities=21% Similarity=0.299 Sum_probs=198.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+.. ++.+|+|.+... .......+.+|+.+++.++||||+++++++..+...++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 4678999999999999999999875 456999988542 222344578999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++.... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 122 ~Ey~~gg~L~~~l~~~~-----~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 122 MEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999986532 78888999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCccccccC----CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSG----RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
...........||+.|+|||++.+. .++.++||||+||++|||++|+.||..... .............
T Consensus 194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~-- 265 (370)
T cd05621 194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNS-- 265 (370)
T ss_pred cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCcc--
Confidence 4333233456799999999998653 377899999999999999999999975321 1111111111000
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDD--RPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~ 581 (603)
... ......+..+.+++.+|+..++.+ |++++|+++
T Consensus 266 ---~~~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 266 ---LNF-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred ---cCC-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 000 111234567889999999855543 899999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=315.97 Aligned_cols=260 Identities=29% Similarity=0.432 Sum_probs=204.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC------CEEEEEEeCCCCC-ChHHHHHHHHHHHhhC-CCCeeeecceeeecCCc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC------GTFAVKRIDRSRE-GSDQVFERELEILGSI-KHINLVNLRGYCRLPAT 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 381 (603)
.++|+..+.||+|+||.||+|...+. ..+|+|.+..... .....+.+|+.++.++ +|+||+++++++...+.
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 45788889999999999999987532 3589998865322 2234588999999999 79999999999999999
Q ss_pred cEEEEEecCCCCccccccccC------------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC
Q 007455 382 KLLIYDYLSMGSLDDFLHEHG------------EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE 449 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 449 (603)
.+++|||+++|+|.++++... .....+++..++.++.|++.||.|||+. +++||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 999999999999999986532 1234588999999999999999999998 8999999999999999
Q ss_pred CCCeEEeecccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHh
Q 007455 450 NLEPHVSDFGLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVV 527 (603)
Q Consensus 450 ~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~ 527 (603)
++.+||+|||+++.+....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..... .
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~ 241 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV------E 241 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH------H
Confidence 9999999999998765432211 122234568999999988889999999999999999998 8888754211 0
Q ss_pred HHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 528 GWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..... ... ......+...+..+.+++.+|+..+|++|||++|+++.|++..
T Consensus 242 ~~~~~-~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ELFKL-LKE--------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHH-HHc--------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111 111 0111122344567999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.42 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=202.8
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|+..+.||+|++|.||+|.+.. +..|++|.+... .......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 46778899999999999999864 567999988643 233445688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++.... ...+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997642 23488999999999999999999998 89999999999999999999999999988765432
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.. .....|++.|+|||+..+..++.++|+||||+++|||++|+.||..... ....... .....+
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~---------~~~~~~ 219 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKI---------IRGVFP 219 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHH---------HcCCCC
Confidence 21 2334578899999999988899999999999999999999999864321 0011111 111112
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+..+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 222245567999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.06 Aligned_cols=238 Identities=28% Similarity=0.335 Sum_probs=192.5
Q ss_pred CeeeecCCeEEEEEEEC----CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 317 DVVGSGGFGTVYRMVMN----DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
+.||+|+||.||++... .+..+|+|++..... .....+.+|++++++++||||+++++++..++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 57999999999998763 456799999865322 223457789999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 999999987543 389999999999999999999998 899999999999999999999999999876543322
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCc
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (603)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ......... .....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~------~~~~~~i~~----------~~~~~ 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR------KETMTMILK----------AKLGM 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH------HHHHHHHHc----------CCCCC
Confidence 23345689999999999888889999999999999999999999865321 111111111 11112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007455 551 DMETVEAILEIAARCTDANPDDRPSMNQ 578 (603)
Q Consensus 551 ~~~~~~~l~~li~~cl~~~P~~RPs~~e 578 (603)
+...+..+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2334567899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=320.56 Aligned_cols=252 Identities=24% Similarity=0.426 Sum_probs=210.2
Q ss_pred CCCCCeeeecCCeEEEEEEECCC---C--EEEEEEeCCC-CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 313 LDEEDVVGSGGFGTVYRMVMNDC---G--TFAVKRIDRS-REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~~---~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.+..+.||+|.||.||+|...+- . .||||.-+.. .....+.|..|+.+|++++||||++++|+|.+ ...++||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 44567899999999999986532 2 2899988763 33445679999999999999999999999975 5689999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
|.++.|.|.+|++.++.. ++......++.||+.||+|||+. ++|||||.++|||+....-||++|||+++.+.+
T Consensus 470 EL~~~GELr~yLq~nk~s---L~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDS---LPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ecccchhHHHHHHhcccc---chHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999986543 88899999999999999999998 899999999999999999999999999999988
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhc-
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID- 544 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 544 (603)
......+...-...|||||.+.-.+++.++|||.|||.+||++. |..||..-... .+-..+.
T Consensus 544 ~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs----------------DVI~~iEn 607 (974)
T KOG4257|consen 544 DAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS----------------DVIGHIEN 607 (974)
T ss_pred cchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc----------------ceEEEecC
Confidence 87776665556679999999999999999999999999999887 88898653211 1111111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
......+..++..++.|+.+||.++|.+||++.++...|++..
T Consensus 608 GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 608 GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 1122345677788999999999999999999999998877644
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=309.40 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=203.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-C---EEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-G---TFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
++|+..+.||+|+||.||+|.+..+ + .+++|.+.... ....+.+..|++++++++|+||+++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 4677889999999999999997632 2 58999886543 22345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 85 TEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 99999999999987532 2378999999999999999999998 89999999999999999999999999997664
Q ss_pred CCCcceee--cccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 466 DEEAHVTT--VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 466 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
........ ....+..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+........
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~------~~~~~~i~~~~----- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN------HEVMKAINDGF----- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH------HHHHHHHhcCC-----
Confidence 33221111 1223457999999988889999999999999999998 9999864321 11211111110
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
........+.++.+++.+||..+|++||++.++++.|+++
T Consensus 228 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 228 ----RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111223456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=306.10 Aligned_cols=250 Identities=28% Similarity=0.457 Sum_probs=204.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.++|++.+.||+|+||.||+|... ++.+|+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999976 57899999976544 4567899999999999999999999999889999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 99999999876432 2489999999999999999999998 899999999999999999999999999987633211
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
....+..|+|||.+.+..++.++||||||+++||+++ |..||...... ......... ...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~--------~~~ 218 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPHVEKG--------YRM 218 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhcC--------CCC
Confidence 2234567999999988889999999999999999997 99998643211 011111110 001
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
..+...+..+.+++.+||..+|++|||++|++++|++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1122345779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.50 Aligned_cols=263 Identities=29% Similarity=0.457 Sum_probs=200.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-----CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecC--CccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-----DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLP--ATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 383 (603)
..|++.+.||+|+||.||+|... .+..||+|.+........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 36778899999999999999743 4567999998766555556789999999999999999999987543 4578
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+|+||+++|+|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||++++++.++|+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999987542 2378999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCccee--ecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC----
Q 007455 464 LVDEEAHVT--TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN---- 537 (603)
Q Consensus 464 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 537 (603)
......... ....++..|+|||.+.+..++.++||||||+++|||++|..|+..... .+........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 230 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA-------EFMRMMGNDKQGQM 230 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch-------hhhhhccccccccc
Confidence 654322111 112234569999999888899999999999999999998876543210 0000000000
Q ss_pred ---cchhhhccc-CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 538 ---RLEDVIDKR-CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 538 ---~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
.+.+.+... ....+...+.++.+++.+||..+|++|||++|+++.|+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000011100 1111223456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.16 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=206.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-----CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeec-CCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-----CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRL-PATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 382 (603)
.++|++.+.||+|+||.||+|.+.+ +..+++|.+..... ...+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678889999999999999999876 56689998864332 234568899999999999999999998765 5678
Q ss_pred EEEEEecCCCCccccccccCCC----CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEG----QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
++++||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998764322 14589999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhh
Q 007455 459 GLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKE 536 (603)
Q Consensus 459 G~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 536 (603)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+.......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~ 235 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP------FEMAAYLKDG 235 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH------HHHHHHHHcC
Confidence 9998764433221 122345678999999988889999999999999999999 9999864321 1121111111
Q ss_pred CcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
... ......+.++.+++.+||+.+|++|||+.++++.|++..
T Consensus 236 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 236 YRL---------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred CCC---------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 110 111223467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=307.57 Aligned_cols=253 Identities=29% Similarity=0.467 Sum_probs=203.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||.||+|.++++..+++|.+.... .....+.+|+++++.++|+||+++++++.. ...+++|||++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~ 83 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMA 83 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCC
Confidence 5788899999999999999998887889999886543 234568899999999999999999999887 77899999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+.........
T Consensus 84 ~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 84 KGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999976432 2378889999999999999999998 8999999999999999999999999999766443322
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||.+....++.++|+||||+++|++++ |+.||..... .....+ .... ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~----~~~~--------~~~~ 223 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRA----LERG--------YRMP 223 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHH----HhCC--------CCCC
Confidence 2222345677999999988889999999999999999999 8888864311 111111 1110 0011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.....+.++.+++.+|++.+|++||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 122345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=306.95 Aligned_cols=251 Identities=28% Similarity=0.475 Sum_probs=202.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
.+|++.+.||+|+||.||+|.+.+++.+|+|.+..... ....+.+|++++++++|||++++++++......++|+||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46778899999999999999988778899998864433 34568999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+++|.+++..... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+++........
T Consensus 83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhCcc---CCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 9999999875432 378899999999999999999998 8999999999999999999999999998765433222
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||.+.+..++.++||||+|+++|||++ |+.||..... ............ ..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~~---------~~ 221 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN------SEVVETINAGFR---------LY 221 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH------HHHHHHHhCCCC---------CC
Confidence 2222335578999999988889999999999999999998 8999864321 111111111000 00
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 583 (603)
.+...+..+.+++.+||+.+|++|||++|+++.|
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1112346799999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=330.16 Aligned_cols=251 Identities=21% Similarity=0.283 Sum_probs=195.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||+|.+. .+..||||++.... ....+.+.+|++++++++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 36888999999999999999986 44569999885432 223356788999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~~~----~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKYDT----FSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999876433 78889999999999999999998 899999999999999999999999999864321
Q ss_pred CCcc----------------------------------------------eeecccccccccCccccccCCCCcccchHh
Q 007455 467 EEAH----------------------------------------------VTTVVAGTFGYLAPEYLQSGRATEKSDVYS 500 (603)
Q Consensus 467 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s 500 (603)
.... ......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 001246899999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCC---CCHH
Q 007455 501 FGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDR---PSMN 577 (603)
Q Consensus 501 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~ 577 (603)
+||++|||++|..||...... ......... ...+ ..+ .....+.++.+++.+|+. +|.+| +++.
T Consensus 234 lGvil~elltG~~Pf~~~~~~------~~~~~i~~~---~~~~--~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSH------ETYRKIINW---RETL--YFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHH------HHHHHHHcc---CCcc--CCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999999653211 111111110 0000 001 111234678899999997 66665 6999
Q ss_pred HHHH
Q 007455 578 QVLQ 581 (603)
Q Consensus 578 evl~ 581 (603)
|+++
T Consensus 301 ~~l~ 304 (377)
T cd05629 301 EIKS 304 (377)
T ss_pred HHhc
Confidence 9886
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=310.85 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=201.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.++|++.+.||+|+||.||+|.+.+ ...|++|.+..... .....+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678889999999999999999865 33588888754332 2345688999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCCC---CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC---CeEEe
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL---EPHVS 456 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 456 (603)
++||||+++++|.+++...... ...+++.++..++.||+.||+|||+. +++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 9999999999999998764321 23488999999999999999999998 899999999999998765 59999
Q ss_pred ecccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHh
Q 007455 457 DFGLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 457 DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||...... .......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~------~~~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ------EVMEFVT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHH
Confidence 999998763322111 112223467999999988889999999999999999997 98998643211 1111111
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
... ....+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 236 ~~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111 11122334567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.87 Aligned_cols=262 Identities=26% Similarity=0.416 Sum_probs=204.8
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCC-CCeeeecceeeecC
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREG-SDQVFERELEILGSIK-HINLVNLRGYCRLP 379 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 379 (603)
...++|.+.+.||+|+||.||+|.+.+ +..||+|+++..... ....+.+|++++.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 345678889999999999999998643 246999999754322 2346889999999997 99999999999999
Q ss_pred CccEEEEEecCCCCccccccccCC--------------------------------------------------------
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHGE-------------------------------------------------------- 403 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 403 (603)
+..++|+||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999865321
Q ss_pred --------------------------------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCe
Q 007455 404 --------------------------------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNI 445 (603)
Q Consensus 404 --------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 445 (603)
....+++.....++.|++.||.|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 112467788899999999999999998 899999999999
Q ss_pred EECCCCCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCC
Q 007455 446 LLDENLEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRG 523 (603)
Q Consensus 446 ll~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~ 523 (603)
|+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--- 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--- 347 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc---
Confidence 999999999999999986533221 11122346788999999988889999999999999999998 8888754211
Q ss_pred ccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 524 LNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
............ ....+...+.++.+++.+||..+|.+||+++|+++.|++.
T Consensus 348 ---~~~~~~~~~~~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 ---NEQFYNAIKRGY--------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ---hHHHHHHHHcCC--------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 001111111110 0111223456799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=308.63 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=202.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC----CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND----CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.+|++.+.||+|+||.||+|.+.. ...+|+|.++.... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 467888999999999999998752 22589998865432 2345789999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++++|.+++..... .+++.+++.++.|++.||+|||+. +++||||||+||+++.++.++++|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG---QFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999976432 378999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcceee--cccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 466 DEEAHVTT--VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 466 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
........ ...++..|+|||.+.+..++.++|+||||+++||+++ |..||..... ..... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~---~~~~~~----- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIK---AIEEGY----- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHH---HHhCCC-----
Confidence 43322211 1223568999999998889999999999999999887 9999864311 01111 111100
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
....+...+..+.+++.+|++.+|.+||++.++++.|++.
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=322.89 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=189.6
Q ss_pred CeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHH-HHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFEREL-EILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+..+ ..||+|.+.... ......+.+|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999998754 469999986432 12223344444 456788999999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +....+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~~~----~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQRERC----FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 999999876433 77888889999999999999998 899999999999999999999999999875432221 2
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... .....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~----------~~~~~ 216 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK----------PLQLK 216 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH------HHHHHHHHhC----------CcCCC
Confidence 3345689999999999988999999999999999999999999964321 1111111110 01112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
...+..+.+++.+|++.+|.+||++.+.+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 2345678999999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=304.16 Aligned_cols=251 Identities=24% Similarity=0.330 Sum_probs=206.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.+.|+..+.||+|.-|+||.+..+++ ..+|+|++.+.... ...+++.|-+||+.++||.++.+|+.++.++..++|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 34566678899999999999999876 45999999765433 335678899999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
||||+||+|..+.+++.. ..+++..+.-++.+++-||+|||-. |||.|||||+|||+.++|++.|+||.++....
T Consensus 156 meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 999999999999988654 3489999999999999999999999 99999999999999999999999999875431
Q ss_pred C---------------------------------C-C---------------------cceeecccccccccCccccccC
Q 007455 466 D---------------------------------E-E---------------------AHVTTVVAGTFGYLAPEYLQSG 490 (603)
Q Consensus 466 ~---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~ 490 (603)
. . . ...+..++||..|+|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 1 0 0 0112346799999999999999
Q ss_pred CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc--CCCcCHHHHHHHHHHHHHcccC
Q 007455 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR--CADADMETVEAILEIAARCTDA 568 (603)
Q Consensus 491 ~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~ 568 (603)
..+.++|.|+|||++|||+.|..||.+..... .+..++.+. .++. ...+..+.+||+++|.+
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvK 374 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEE-PEVSSAAKDLIRKLLVK 374 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCC-CcchhHHHHHHHHHhcc
Confidence 99999999999999999999999997653221 122222211 1222 25667899999999999
Q ss_pred CCCCCCC----HHHHHH
Q 007455 569 NPDDRPS----MNQVLQ 581 (603)
Q Consensus 569 ~P~~RPs----~~evl~ 581 (603)
||.+|.. +.||.+
T Consensus 375 dP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 375 DPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ChhhhhccccchHHhhc
Confidence 9999988 888876
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=305.36 Aligned_cols=246 Identities=24% Similarity=0.395 Sum_probs=193.6
Q ss_pred eeeecCCeEEEEEEEC--C-CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCC
Q 007455 318 VVGSGGFGTVYRMVMN--D-CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGS 393 (603)
Q Consensus 318 ~ig~G~~g~Vy~~~~~--~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (603)
.||+|+||.||+|.+. + +..+|+|.+...... ..+.+.+|+.++++++||||+++++++. ....++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999865 2 335899988654332 3356889999999999999999999875 457899999999999
Q ss_pred ccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCccee-
Q 007455 394 LDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT- 472 (603)
Q Consensus 394 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~- 472 (603)
|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999987532 2389999999999999999999998 899999999999999999999999999976544322211
Q ss_pred -ecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCc
Q 007455 473 -TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550 (603)
Q Consensus 473 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (603)
....++..|+|||.+.+..++.++||||||+++||+++ |..||..... ..+....... .....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~---------~~~~~ 219 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG------PEVMSFIEQG---------KRLDC 219 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH------HHHHHHHHCC---------CCCCC
Confidence 11223568999999988889999999999999999996 9999864321 1111111111 11122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 551 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
+...+.++.+++.+||..+|++||++.++.+.|+.
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 23445789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.78 Aligned_cols=261 Identities=26% Similarity=0.433 Sum_probs=201.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-----CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecC--Ccc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-----DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLP--ATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 382 (603)
..|++.+.||+|+||.||.+... .+..||+|.++... ......+.+|+.+++.++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34677899999999999999743 34569999986543 22345789999999999999999999998775 567
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++||||+++++|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 899999999999999865432 378999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcc--eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccccc--------CC-ccHhHHHH
Q 007455 463 LLVDEEAH--VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVK--------RG-LNVVGWMN 531 (603)
Q Consensus 463 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~--------~~-~~~~~~~~ 531 (603)
........ ......++..|+|||.+.+..++.++||||||+++|||++++.|....... .. .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 76543321 112344667899999998888999999999999999999988764322110 00 00001111
Q ss_pred HHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 532 TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
..... .....+...+..+.+++.+||+.+|++|||++++++.|+++
T Consensus 238 -~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 -VLEEG--------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHHcC--------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11100 01111223557899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=318.91 Aligned_cols=243 Identities=21% Similarity=0.313 Sum_probs=192.6
Q ss_pred CeeeecCCeEEEEEEECCC-CEEEEEEeCCCCC---ChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSRE---GSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+..+ ..+|+|++..... ...+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999998754 5699999965322 2234578899999888 699999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~~~~----l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQRQRK----LPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 999988875433 89999999999999999999998 89999999999999999999999999987532221 12
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||.............+........ ....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~p 223 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK---------PIRIP 223 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC---------CCCCC
Confidence 234568999999999998899999999999999999999999996432221112222222211111 11122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCH
Q 007455 552 METVEAILEIAARCTDANPDDRPSM 576 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~ 576 (603)
...+..+.+++.+||+.||++|+++
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 3345678999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=321.98 Aligned_cols=237 Identities=25% Similarity=0.326 Sum_probs=187.8
Q ss_pred CeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHH-HHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELE-ILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||+||+|.+. ++..||+|.+.... ......+.+|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999987 45679999986432 122234445544 56789999999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQRERS----FPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999998876433 88899999999999999999998 89999999999999999999999999987543222 12
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ........... ....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~------~~~~~~~i~~~----------~~~~~ 216 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------TAEMYDNILNK----------PLRLK 216 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC------HHHHHHHHHcC----------CCCCC
Confidence 334568999999999998899999999999999999999999986532 11111111111 11112
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSMN 577 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~ 577 (603)
...+..+.+++.+|++.+|++||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 23356799999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=330.63 Aligned_cols=250 Identities=21% Similarity=0.283 Sum_probs=195.4
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
+|++.+.||+|+||.||+|.+.. ++.||+|.+.... ......+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68889999999999999999875 4569999985432 2234567899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++...+. ++...+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~g~L~~~i~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRLGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999976533 78888899999999999999998 8999999999999999999999999997533100
Q ss_pred C------------------------------------------cceeecccccccccCccccccCCCCcccchHhHHHHH
Q 007455 468 E------------------------------------------AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLL 505 (603)
Q Consensus 468 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl 505 (603)
. ........||+.|+|||++.+..++.++||||+||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001134699999999999988999999999999999
Q ss_pred HHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCC---CHHHHHH
Q 007455 506 LELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRP---SMNQVLQ 581 (603)
Q Consensus 506 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP---s~~evl~ 581 (603)
|||++|+.||...... .+......... .. .. ......+.++.+++.+|+ .+|.+|+ ++.|+++
T Consensus 235 yell~G~~Pf~~~~~~------~~~~~i~~~~~---~~--~~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPA------ETQLKVINWET---TL--HI-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHH------HHHHHHhccCc---cc--cC-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999999754211 11111111000 00 00 011133456788888876 5999999 8899885
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=304.91 Aligned_cols=247 Identities=26% Similarity=0.437 Sum_probs=196.5
Q ss_pred CeeeecCCeEEEEEEECCC----CEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMNDC----GTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
++||+|+||.||+|.+... ..+|+|.+..... ...+.+.+|+++++.++|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 4699999999999986432 4699998875543 24457889999999999999999999875 4567999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999998654 388999999999999999999998 89999999999999999999999999998764433221
Q ss_pred ee--cccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 472 TT--VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 472 ~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.. ...++..|+|||.+.+..++.++||||||+++|||++ |..||..... .....+.. ... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~----~~~--------~~ 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLE----SGE--------RL 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHH----cCC--------cC
Confidence 11 1223467999999988889999999999999999998 9999864321 11111111 110 01
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
..+...+..+.+++.+||..+|++||++.++++.|++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 12223456799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=329.65 Aligned_cols=250 Identities=21% Similarity=0.276 Sum_probs=193.6
Q ss_pred CCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.|+..+.||+|+||.||+|.+..+ ..||+|++.... ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 577889999999999999998654 569999986432 2233468899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~~----~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRMG----IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 999999999987643 278888999999999999999998 8999999999999999999999999997533110
Q ss_pred C----------------------------------------------cceeecccccccccCccccccCCCCcccchHhH
Q 007455 468 E----------------------------------------------AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSF 501 (603)
Q Consensus 468 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~sl 501 (603)
. ........||+.|+|||++.+..++.++||||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000122468999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC---HHH
Q 007455 502 GVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPS---MNQ 578 (603)
Q Consensus 502 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~e 578 (603)
||++|||++|+.||...... ........... ....+ .....+.++.+++.+|+ .+|++|++ +++
T Consensus 235 Gvil~elltG~~Pf~~~~~~------~~~~~i~~~~~-----~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPL------ETQMKVINWQT-----SLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHH------HHHHHHHccCC-----CcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 99999999999999753211 01111110000 00001 11233466788888875 59999987 888
Q ss_pred HHH
Q 007455 579 VLQ 581 (603)
Q Consensus 579 vl~ 581 (603)
+++
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=306.62 Aligned_cols=248 Identities=25% Similarity=0.426 Sum_probs=199.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCCh---------HHHHHHHHHHHhhCCCCeeeecceeeecCCc
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGS---------DQVFERELEILGSIKHINLVNLRGYCRLPAT 381 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 381 (603)
+|.+...||+|+||.||+|.+. ++..+|+|.+....... .+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3677889999999999999976 45679999886543221 1457899999999999999999999999999
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.++|+||+++++|.+++...+. +++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGA----FEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccC----ccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999976543 78889999999999999999998 8999999999999999999999999998
Q ss_pred cccCCCCcc-----eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh
Q 007455 462 KLLVDEEAH-----VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE 536 (603)
Q Consensus 462 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 536 (603)
+........ ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... . ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~---~~--- 221 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL------Q---AI--- 221 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH------H---HH---
Confidence 876532111 112234788999999998888899999999999999999999998643110 0 00
Q ss_pred CcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+..+...+..+.+++.+||+.+|.+||++.|+++
T Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 222 ---FKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---HHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000011112223345577999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=313.90 Aligned_cols=260 Identities=29% Similarity=0.435 Sum_probs=204.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC--------CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhC-CCCeeeecceeeecC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN--------DCGTFAVKRIDRSR-EGSDQVFERELEILGSI-KHINLVNLRGYCRLP 379 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 379 (603)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467888999999999999999742 22358999886432 23345688999999999 899999999999999
Q ss_pred CccEEEEEecCCCCccccccccCCC------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHGEG------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL 447 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 447 (603)
...++||||+++|+|.+++...... ...+++.++..++.|+++||+|||++ +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 9999999999999999998764321 23478889999999999999999998 89999999999999
Q ss_pred CCCCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCcc
Q 007455 448 DENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLN 525 (603)
Q Consensus 448 ~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~ 525 (603)
++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||... .
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------~ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------P 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC------C
Confidence 99999999999999876443222 1222345678999999988889999999999999999998 77777532 1
Q ss_pred HhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
...+......... ...+...+..+.+++.+||..+|++|||+.|+++.|++..
T Consensus 245 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 245 VEELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 1222221111111 1112234567999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=314.92 Aligned_cols=259 Identities=30% Similarity=0.433 Sum_probs=203.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC--------CCEEEEEEeCCCC-CChHHHHHHHHHHHhhC-CCCeeeecceeeecCC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND--------CGTFAVKRIDRSR-EGSDQVFERELEILGSI-KHINLVNLRGYCRLPA 380 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 380 (603)
++|.+.+.||+|+||.||+|.+.+ ...+|+|.+.... ......+.+|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 578999999999999999998632 2359999887542 22334688899999999 7999999999999999
Q ss_pred ccEEEEEecCCCCccccccccCCC------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEG------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD 448 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 448 (603)
..++||||+++|+|.+++...... ...+++.+++.++.|++.||+|||++ +++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEc
Confidence 999999999999999999764321 23488999999999999999999998 899999999999999
Q ss_pred CCCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccH
Q 007455 449 ENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNV 526 (603)
Q Consensus 449 ~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~ 526 (603)
.++.++|+|||.++........ ......++..|+|||.+.+..++.++||||+|+++|||++ |..||.... .
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------~ 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------V 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------H
Confidence 9999999999998765432211 1112224568999999988889999999999999999998 888875421 1
Q ss_pred hHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 527 VGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
....... ... .....+...+.++.+++.+||..+|++|||+.++++.|++..
T Consensus 249 ~~~~~~~-~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 249 EELFKLL-KEG--------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred HHHHHHH-HcC--------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1111111 111 011122334568999999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=304.91 Aligned_cols=250 Identities=30% Similarity=0.487 Sum_probs=203.2
Q ss_pred CeeeecCCeEEEEEEECC----CCEEEEEEeCCCCCCh-HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMND----CGTFAVKRIDRSREGS-DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+.+ +..+++|.+....... .+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999875 5679999987654433 56789999999999999999999999999999999999999
Q ss_pred CCccccccccCCC-----CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 392 GSLDDFLHEHGEG-----QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 392 gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
++|.+++...... ...+++..++.++.|+++||+|||++ +++||||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875221 24489999999999999999999998 899999999999999999999999999987654
Q ss_pred CCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 467 EEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 467 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
... .......++..|+|||.+....++.++||||+|+++|||++ |..||.... ..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~------~~~~~~~~~~--------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS------NEEVLEYLRK--------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC------HHHHHHHHHc---------
Confidence 321 12233457889999999988889999999999999999999 588886531 1111111111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
......+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111223344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=311.53 Aligned_cols=258 Identities=25% Similarity=0.446 Sum_probs=202.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.++|+..+.||+|+||.||+|.+. .+..+|+|.+..... .....+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357888999999999999999874 345699998865432 2245688999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCC------------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 007455 383 LLIYDYLSMGSLDDFLHEHGE------------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSN 444 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 444 (603)
++|+||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999875321 123478889999999999999999998 89999999999
Q ss_pred eEECCCCCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccC
Q 007455 445 ILLDENLEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKR 522 (603)
Q Consensus 445 Ill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~ 522 (603)
|++++++.++|+|||++........ ........+..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999875533221 11122234567999999988899999999999999999998 7788753211
Q ss_pred CccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 523 GLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
..+...... ......+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 239 ----~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ----EEVIYYVRD---------GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ----HHHHHHHhc---------CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111111 11111122345679999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=308.74 Aligned_cols=255 Identities=27% Similarity=0.491 Sum_probs=201.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC----EEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
..|++.+.||+|+||.||+|.+...+ .||+|.+.... ......+..|+.+++.++||||+++++++..+...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35677899999999999999976433 49999886542 22345789999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++..... .+++.+++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 999999999999876432 378999999999999999999998 89999999999999999999999999987654
Q ss_pred CCCccee--eccc--ccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 466 DEEAHVT--TVVA--GTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 466 ~~~~~~~--~~~~--gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
....... .... .+..|+|||.+.+..++.++||||+|+++||+++ |..||...... ....+. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i---~~~~--- 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI---EQDY--- 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH---HcCC---
Confidence 3322111 1111 2357999999998899999999999999999887 99998643211 111111 1000
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
. ...+...+..+.+++.+||+.+|.+||+++++++.|++.
T Consensus 229 -----~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 -----R-LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----c-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 011223456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.46 Aligned_cols=249 Identities=23% Similarity=0.378 Sum_probs=203.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.+|+..+.||+|+||.||+|.+. .+..+++|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888899999999999999975 45679999987665555677899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999988643 278899999999999999999998 899999999999999999999999999876543221
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||....... .+ ........ ....
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~-~~~~~~~~-------~~~~ 237 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----AL-YLIATNGT-------PELQ 237 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hH-HHHhcCCC-------CCCC
Confidence 1223458889999999988888999999999999999999999996542210 01 00000000 0011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+...+..+.+++.+||..+|++||+++++++
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 12344567899999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=312.39 Aligned_cols=264 Identities=23% Similarity=0.375 Sum_probs=200.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC---------------CEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecce
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC---------------GTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRG 374 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~---------------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~ 374 (603)
.+|.+.+.||+|+||.||++.+.+. ..||+|.+..... .....+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5788899999999999999886532 2389998865422 23356889999999999999999999
Q ss_pred eeecCCccEEEEEecCCCCccccccccCC--------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeE
Q 007455 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGE--------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNIL 446 (603)
Q Consensus 375 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 446 (603)
++......++||||+++++|.+++..... ....+++..++.++.|+++||+|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 99999999999999999999999865321 112368899999999999999999998 8999999999999
Q ss_pred ECCCCCeEEeecccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh--CCCCCCcccccCC
Q 007455 447 LDENLEPHVSDFGLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT--GKRPTDPTFVKRG 523 (603)
Q Consensus 447 l~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt--g~~p~~~~~~~~~ 523 (603)
+++++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 9999999999999997654332211 122335678999999988889999999999999999998 55676542211
Q ss_pred ccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 524 LNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
................ .....+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 240 -~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 -QVIENTGEFFRNQGRQ-----IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred -HHHHHHHHhhhhcccc-----ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111111100000 0011122344679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.34 Aligned_cols=249 Identities=25% Similarity=0.333 Sum_probs=209.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG---SDQVFERELEILGSIK-HINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 385 (603)
..|++.+.||+|.||.||+++.+. ++.+|+|.+.+.... +...+.+|+.+|+++. |||||.+++.|.+....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 467888999999999999999887 567999999765443 3357899999999998 99999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC----CCeEEeecccc
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN----LEPHVSDFGLA 461 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~~ 461 (603)
||++.||.|.+.+... . +++..+..++.|++.++.|||+. +|+||||||+|+|+... +.+|++|||++
T Consensus 115 mEL~~GGeLfd~i~~~----~-~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK----H-YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EEecCCchHHHHHHHc----c-CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 9999999999999876 1 89999999999999999999998 99999999999999643 47999999999
Q ss_pred cccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||......... ... .....
T Consensus 187 ~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~------~~i-~~~~~-- 255 (382)
T KOG0032|consen 187 KFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF------LAI-LRGDF-- 255 (382)
T ss_pred eEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH------HHH-HcCCC--
Confidence 98766 44566788999999999999999999999999999999999999999875321110 011 11111
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.-..+.....+..+.+++++++..||.+|+|+.++++
T Consensus 256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 0111233455678999999999999999999999998
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=307.18 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=196.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|+..+.||+|+||.||+|.+. .+..+|+|.+.... ......+.+|++++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35778899999999999999976 44569999886542 22345688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|..+. .+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~ 149 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI 149 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc
Confidence 9999986542 167888899999999999999998 89999999999999999999999999997654321
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCc-cHhHHHHHHhhhCcchhhhcccC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL-NVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||......... ....+........ ....
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 220 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL 220 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC
Confidence 23356889999999999888999999999999999999999998753321111 1111111111000 0011
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+.++.+++.+|++.+|++||+++|+++
T Consensus 221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 11224467899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=307.05 Aligned_cols=251 Identities=30% Similarity=0.471 Sum_probs=195.6
Q ss_pred CeeeecCCeEEEEEEECCCC---EEEEEEeCCCC-CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMNDCG---TFAVKRIDRSR-EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+.+++ .+++|.++... ......+.+|++++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46899999999999987544 36888876432 23345688999999999 799999999999999999999999999
Q ss_pred CCccccccccCC------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 392 GSLDDFLHEHGE------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 392 gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
|+|.+++..... ....+++.++..++.|++.||+|||+. +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999875431 123478999999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||..... ...........
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~------~~~~~~~~~~~- 228 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEKLPQGY- 228 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH------HHHHHHHhCCC-
Confidence 98632211 11111223567999999988889999999999999999997 9999854211 11111111100
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
....+...+.++.+++.+||..+|.+|||+.++++.|+++.
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 --------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 01112234467899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=312.70 Aligned_cols=258 Identities=29% Similarity=0.478 Sum_probs=203.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhC-CCCeeeecceeeecCCc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSRE-GSDQVFERELEILGSI-KHINLVNLRGYCRLPAT 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 381 (603)
.++|.+.+.||+|+||.||+|.+. .+..+|+|.++.... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 467889999999999999999752 223599998865432 2335688999999999 79999999999999999
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.++||||+++|+|.+++..... ..+++.++..++.|++.||+|||++ +++|+||||+||+++.++.++++|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999875332 2378999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 462 KLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 462 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
+........ ......++..|+|||.+.+..++.++||||+|+++|||++ |..||....... . ........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~--~----~~~~~~~~-- 260 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS--K----FYKLIKEG-- 260 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH--H----HHHHHHcC--
Confidence 866443221 1122345678999999988889999999999999999998 999986432110 0 00111110
Q ss_pred hhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
.....+...+.++.+++.+|+..+|++|||+.|+++.|++.
T Consensus 261 ------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00111123346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=325.80 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=198.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
..++|++.+.||+|+||.||+|.+..+ ..+|+|.+.... ......+.+|+.+++.++||||+++++.+..+...++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 457899999999999999999998754 468999885422 2233457889999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++.... ++...+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 121 v~Ey~~gg~L~~~~~~~~-----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 121 VMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred EEcCCCCCcHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 999999999999986532 78888899999999999999999 8999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCccccccC----CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSG----RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
............||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ..............
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~ 266 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKNSL 266 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCcc
Confidence 54433333456799999999998653 378899999999999999999999975321 11111111110000
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDD--RPSMNQVLQ 581 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~ 581 (603)
..+ .....+..+.+++.+|+..++.+ |++++|+++
T Consensus 267 -----~~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 267 -----TFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred -----cCC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 001 11234567899999999844433 789999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=289.72 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=201.7
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC-----ChH---HHHHHHHHHHhhC-CCCeeeecceeeec
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE-----GSD---QVFERELEILGSI-KHINLVNLRGYCRL 378 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-----~~~---~~~~~E~~~l~~l-~h~niv~l~~~~~~ 378 (603)
-..+|...++||+|..++|.++..+. ++++|+|++..... ... +.-.+|+.+|+++ .||+|+++.++|..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 35678888999999999999988775 45699999854321 111 2345799999998 69999999999999
Q ss_pred CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 379 PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
+...++|+|.|+.|.|.+++...-. +++....+|+.|+..|++|||.. .||||||||+|||+|++.++||+||
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~Vt----lSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKVT----LSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhee----ecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence 9999999999999999999986543 89999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccc------cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHH
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ------SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT 532 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 532 (603)
|+++.+.+++ +....+|||+|+|||.+. ...|+..+|+||+||++|.|+.|.+||..... ..+-.
T Consensus 168 GFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR 238 (411)
T KOG0599|consen 168 GFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLR 238 (411)
T ss_pred ceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHH
Confidence 9999886654 346688999999999884 24567889999999999999999999853210 00111
Q ss_pred HhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
++-++... -..+ ....++....+|+.+||+.||.+|.|++|+++
T Consensus 239 ~ImeGkyq----F~sp-eWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 239 MIMEGKYQ----FRSP-EWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHhcccc----cCCc-chhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11111110 0111 12345677999999999999999999999985
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=307.40 Aligned_cols=255 Identities=24% Similarity=0.379 Sum_probs=202.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC----CEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC----GTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
++|++.+.||+|+||.||+|.+.+. ..+++|...... ....+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577889999999999999987543 358999876544 2334578999999999999999999998865 567899
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++..... .+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVNKY---SLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 999999999999976432 389999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
...........++..|+|||.+....++.++||||||+++||+++ |..||...... ....+ .....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~---~~~~~------- 225 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGR---IENGE------- 225 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH---HHcCC-------
Confidence 443222223334568999999988889999999999999999996 99998653211 11111 10000
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
....+...+..+.+++.+|+..+|++|||+.++++.|++..
T Consensus 226 --~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 226 --RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred --cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 01112334567999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=305.35 Aligned_cols=240 Identities=21% Similarity=0.409 Sum_probs=188.5
Q ss_pred CeeeecCCeEEEEEEECCC-------------CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 317 DVVGSGGFGTVYRMVMNDC-------------GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~-------------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
+.||+|+||.||+|+.... ..+++|.+..........+.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 4689999999999985421 148888876655555567889999999999999999999999999999
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC-------eEEe
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE-------PHVS 456 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-------~kl~ 456 (603)
+||||+++|+|..++.... ..+++..+++++.|+++||+|||+. +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999998876532 2388999999999999999999998 8999999999999987664 8999
Q ss_pred ecccccccCCCCcceeecccccccccCccccc-cCCCCcccchHhHHHHHHHHH-hCCCCCCcccccCCccHhHHHHHHh
Q 007455 457 DFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ-SGRATEKSDVYSFGVLLLELV-TGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 457 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
|||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+...... .. ....
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~-~~~~ 222 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA------EK-ERFY 222 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh------HH-HHHH
Confidence 99998755322 2245778899999886 466889999999999999998 577776532110 00 0000
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
. . .. ........++.+++.+||+.||.+||++.++++.++
T Consensus 223 ~-~--------~~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 E-G--------QC-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred h-c--------Cc-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0 00 011122457899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.87 Aligned_cols=241 Identities=22% Similarity=0.321 Sum_probs=192.8
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIK-HINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 386 (603)
+|+..+.||+|+||.||+|.+.. +..||+|++.... ....+.+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36778899999999999999874 5579999986432 223345778889988885 577888999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++..... +++.++..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVGK----FKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999876543 88999999999999999999998 899999999999999999999999999875432
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ........ .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~----------~ 216 (323)
T cd05615 154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIME----------H 216 (323)
T ss_pred CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh----------C
Confidence 22 1223456899999999999888999999999999999999999999753211 11111111 1
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSM 576 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 576 (603)
....+...+.++.+++.+||+.+|.+|++.
T Consensus 217 ~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111223345678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=309.52 Aligned_cols=265 Identities=25% Similarity=0.420 Sum_probs=204.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-----------------CEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeee
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-----------------GTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVN 371 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-----------------~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 371 (603)
..+|++.+.||+|+||.||+|.+.+. ..+|+|.+..... ...+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 35788999999999999999987542 2478998865432 23456889999999999999999
Q ss_pred cceeeecCCccEEEEEecCCCCccccccccCC-------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 007455 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGE-------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSN 444 (603)
Q Consensus 372 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 444 (603)
+++++..+...++++||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999876541 122489999999999999999999998 89999999999
Q ss_pred eEECCCCCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh--CCCCCCccccc
Q 007455 445 ILLDENLEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT--GKRPTDPTFVK 521 (603)
Q Consensus 445 Ill~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt--g~~p~~~~~~~ 521 (603)
|+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999876543322 12223446778999999988889999999999999999998 6667653211
Q ss_pred CCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 522 RGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.................. ....+...+.++.+++.+|++.+|++|||+.|+++.|++
T Consensus 240 --~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 240 --QQVIENAGHFFRDDGRQI-----YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HHHHHHHHhccccccccc-----cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111111110000 011122344689999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=305.29 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=201.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
+|++.+.||+|+||.||++.+. .+..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999987 45579999885432 233456889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++.... ...++......++.|++.||.|||++ +++|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999886532 23378899999999999999999998 899999999999999999999999999976643322
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......|++.|+|||++.+..++.++|+||||+++|+|++|+.||..... ........ . .....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~------~~~~~~~~-~--------~~~~~ 219 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW------KNLILKVC-Q--------GSYKP 219 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH------HHHHHHHh-c--------CCCCC
Confidence 22335688899999999888899999999999999999999999975321 11111111 0 11111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
.+...+..+.+++.+||+.+|++||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 222345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=302.99 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=199.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeee-cCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCR-LPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~ 388 (603)
.++|++.+.||+|+||.||+|... +..+++|.+.... ..+.+.+|+.++++++|+|++++++++. .....++++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 457888999999999999999876 4679999885432 3456889999999999999999999764 45678999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999876432 3478999999999999999999998 89999999999999999999999999987543322
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
....++..|+|||++.+..++.++||||||+++|||++ |+.||.... ............ .
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~~---------~ 217 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------LKDVVPRVEKGY---------K 217 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCC---------C
Confidence 12234568999999988889999999999999999998 898875321 111111111100 0
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
...+...+..+.+++.+|++.+|++|||++++++.|++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11122345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=318.63 Aligned_cols=237 Identities=26% Similarity=0.327 Sum_probs=187.0
Q ss_pred CeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHH-HHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELE-ILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
++||+|+||.||+|.+.. +..||+|.+.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999874 4569999986432 122334555554 57889999999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+.+.... .++...+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~~----~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (321)
T cd05603 81 GELFFHLQRER----CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE-T 152 (321)
T ss_pred CCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC-c
Confidence 99988886543 278888999999999999999998 899999999999999999999999999875432221 2
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||.... .......... .....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~i~~----------~~~~~~ 216 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD------VSQMYDNILH----------KPLQLP 216 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC------HHHHHHHHhc----------CCCCCC
Confidence 234568999999999988889999999999999999999999996532 1111111111 111122
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSMN 577 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~ 577 (603)
...+..+.+++.+|++.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23456789999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.76 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=191.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecC--------Cc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLP--------AT 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------~~ 381 (603)
.+|++.+.||+|+||.||+|.+.+ +..||||++.... ....+|+.+++.++||||+++++++... ..
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 578899999999999999999864 4579999885432 2345799999999999999998876432 23
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-CeEEeeccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-EPHVSDFGL 460 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~ 460 (603)
.++||||+++ +|.+++.........+++..+..++.|++.||+|||+. +|+||||||+|||++.++ .+||+|||+
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGl 217 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGS 217 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecccc
Confidence 5689999986 77777765433344589999999999999999999998 899999999999999665 699999999
Q ss_pred ccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
++.+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|..||....... .+.. ..........
T Consensus 218 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~-i~~~~~~p~~ 292 (440)
T PTZ00036 218 AKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVR-IIQVLGTPTE 292 (440)
T ss_pred chhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHhCCCCH
Confidence 987643322 223468999999998865 468999999999999999999999997532110 0000 0000000000
Q ss_pred ----------hhhhcccCC------CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 540 ----------EDVIDKRCA------DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 540 ----------~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....-+... ..+...+.++.+|+.+||+.+|.+|||+.|+++
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000000000 011223467999999999999999999999984
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=315.80 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=196.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||++.... ++.||+|++.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999999875 567999998642 2223455888999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++..... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999975322 378899999999999999999999 899999999999999999999999999876654
Q ss_pred CCcceeecccccccccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQS-----GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
..........||+.|+|||++.. ..++.++||||+||++|||++|+.||..... ..............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~- 227 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHF- 227 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcc-
Confidence 33333334568999999999863 4577899999999999999999999865321 11111111111000
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCC--CCCCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANP--DDRPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P--~~RPs~~evl~ 581 (603)
..+......+..+.+++.+|+..++ ..||+++++++
T Consensus 228 ----~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 228 ----QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred ----cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 0111112245678889999876533 34789998886
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=320.76 Aligned_cols=240 Identities=25% Similarity=0.306 Sum_probs=188.5
Q ss_pred CeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHH-HHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELE-ILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+.. +..+|+|++.... ......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999864 5679999986432 222334555554 46778999999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|..++..... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQRERS----FPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 999988875433 88999999999999999999998 89999999999999999999999999987532221 12
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||..... .......... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~------~~~~~~~~~~---------~~-~~~ 216 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV------AEMYDNILHK---------PL-VLR 216 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH------HHHHHHHHcC---------Cc-cCC
Confidence 2345689999999999988999999999999999999999999865321 1111111111 10 111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSMNQVL 580 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~evl 580 (603)
...+..+.+++.+|++.+|.+||++.+.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 23446788999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=310.40 Aligned_cols=264 Identities=22% Similarity=0.373 Sum_probs=201.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-----------------CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-----------------CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNL 372 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l 372 (603)
++|++.+.||+|+||.||++.+.+ ...+|+|.+..... .....+.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 468889999999999999986432 22489998865432 234578999999999999999999
Q ss_pred ceeeecCCccEEEEEecCCCCccccccccCCC-------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCe
Q 007455 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG-------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNI 445 (603)
Q Consensus 373 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 445 (603)
++++...+..++||||+++|+|.+++...... ...+++.++..++.|++.||+|||+. +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 99999999999999999999999998764321 12477889999999999999999998 899999999999
Q ss_pred EECCCCCeEEeecccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh--CCCCCCcccccC
Q 007455 446 LLDENLEPHVSDFGLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT--GKRPTDPTFVKR 522 (603)
Q Consensus 446 ll~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt--g~~p~~~~~~~~ 522 (603)
+++.++.++|+|||+++.+....... .....++..|+|||...++.++.++||||||+++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 99999999999999997654332211 122334578999999888889999999999999999998 66787542211
Q ss_pred CccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 523 GLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
................. ....+...+..+.+++.+||+.+|.+||++.++.+.|++
T Consensus 241 --~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 --QVIENTGEFFRDQGRQV-----YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHHhhccccc-----cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111111110000 011122344679999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=315.01 Aligned_cols=263 Identities=22% Similarity=0.376 Sum_probs=197.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|...+.||+|+||.||+|.+.. +..+|+|.+.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 3678889999999999999999874 4569999986443 2233457889999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 85 YLDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CCCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 9986 8888776543 2378899999999999999999998 8999999999999999999999999998764332
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccH----------hHHHHHHhhh
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNV----------VGWMNTLLKE 536 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~----------~~~~~~~~~~ 536 (603)
.. ......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+.... ..|.. ....
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 235 (309)
T cd07872 158 TK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG-ISSN 235 (309)
T ss_pred cc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh-hcch
Confidence 21 1223457889999998864 4678999999999999999999999965322110000 00100 0000
Q ss_pred CcchhhhcccC-C----CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 NRLEDVIDKRC-A----DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ~~~~~~~~~~~-~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......-.+.. + ......+.++.+++.+|++.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 0 001123457889999999999999999999997
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=339.88 Aligned_cols=261 Identities=25% Similarity=0.329 Sum_probs=202.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.+|++.++||+|+||.||+|.+.. ++.||+|++...... ..+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578889999999999999999875 567999998653222 2456889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCC-------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 387 DYLSMGSLDDFLHEHGE-------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
||++||+|.+++..... .....++..+++++.|+++||+|||+. +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998864211 112356778899999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCc-----------------ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccC
Q 007455 460 LAKLLVDEEA-----------------HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKR 522 (603)
Q Consensus 460 ~~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~ 522 (603)
+++....... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 00112468999999999998899999999999999999999999986532110
Q ss_pred CccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHhhcc
Q 007455 523 GLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDR-PSMNQVLQLLEQEV 587 (603)
Q Consensus 523 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-Ps~~evl~~L~~~~ 587 (603)
. .+. .... .+.........+..+.+++.+|++.+|++| ++++++.+.|+...
T Consensus 239 ---i-~~~------~~i~---~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 ---I-SYR------DVIL---SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred ---h-hhh------hhcc---ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 000 0000 000000112345678999999999999999 56777777777643
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=309.42 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=198.5
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.|+..+.||+|+||.||++.+.. ++.||+|.+...... ....+.+|+.++++++|+||+++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 36677899999999999999875 456999988643222 23457789999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++++|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999998865332 2388999999999999999999998 8999999999999999999999999998765432
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
.. .....|+..|+|||.+.+..++.++||||+|+++|||++|+.||........ .. -...... ...
T Consensus 156 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~--~~-~~~~~~~---------~~~ 221 (285)
T cd05630 156 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--RE-EVERLVK---------EVQ 221 (285)
T ss_pred cc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch--HH-HHHhhhh---------hhh
Confidence 21 1234689999999999988899999999999999999999999975321100 00 0000000 000
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
...+...+.++.+++.+||+.||++||| ++|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112234567899999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=313.21 Aligned_cols=260 Identities=26% Similarity=0.422 Sum_probs=199.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||.||+|.+..++ .+|+|.+...... ....+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999987544 5788877644222 235688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++..... +++..+..++.|+++||.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAGR----IPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999976533 789999999999999999999842 79999999999999999999999999987653321
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC-----------
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN----------- 537 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 537 (603)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+........
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccC
Confidence 233468899999999988889999999999999999999999986432110 000000000000
Q ss_pred -------------cchhhhcccCCCc-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 538 -------------RLEDVIDKRCADA-DMETVEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 538 -------------~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
..........+.. ....+.++.+++.+||..+|++|||++|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000110 11245679999999999999999999999973
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=303.17 Aligned_cols=248 Identities=29% Similarity=0.427 Sum_probs=199.4
Q ss_pred CeeeecCCeEEEEEEECC-CC---EEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMND-CG---TFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~-~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|++|.||+|.+.. ++ .+|+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998754 22 489999876655 455678999999999999999999999988 888999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... ..+++...+.++.|++.||+|||+. +++||||+|+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987542 3489999999999999999999998 89999999999999999999999999998765432221
Q ss_pred --eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 472 --TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 472 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ........... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~--------~~~ 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG------SQILKKIDKEG--------ERL 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhcC--------CcC
Confidence 112446778999999988889999999999999999999 9999854311 11111111100 011
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
..+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112234567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=300.48 Aligned_cols=247 Identities=29% Similarity=0.435 Sum_probs=197.6
Q ss_pred CeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCcc
Q 007455 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLD 395 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (603)
++||+|+||.||+|.+.+++.|++|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999888788999988654433 4457899999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCccee-ec
Q 007455 396 DFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT-TV 474 (603)
Q Consensus 396 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~-~~ 474 (603)
+++..... .+++..+..++.+++.||+|||++ +++||||+|+||+++.++.++|+|||++........... ..
T Consensus 81 ~~l~~~~~---~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 99875422 378899999999999999999998 899999999999999999999999999876542221111 11
Q ss_pred ccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHH
Q 007455 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADME 553 (603)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (603)
..++..|+|||.+.+..++.++|+||||+++|||++ |..||..... ........... ....+..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~------~~~~~~~~~~~---------~~~~~~~ 219 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN------QQTRERIESGY---------RMPAPQL 219 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH------HHHHHHHhcCC---------CCCCCcc
Confidence 223567999999988889999999999999999999 7888754321 11111110000 0111223
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 554 TVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 554 ~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
.+.++.+++.+|++.+|++|||+.|+++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=309.60 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=204.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
..+|++.+.||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 367888999999999999999975 5678999999766555567788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++... .+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999998653 278889999999999999999998 89999999999999999999999999987654332
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.. .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......... ..... .....
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~-------~~~~~ 235 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATN-------GTPEL 235 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccC-------CCCCC
Confidence 21 223457889999999988889999999999999999999999996532111000 00000 00001
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+..+.+++.+||..+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122344567889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=314.63 Aligned_cols=260 Identities=29% Similarity=0.416 Sum_probs=203.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC--------CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhC-CCCeeeecceeeecCC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND--------CGTFAVKRIDRSRE-GSDQVFERELEILGSI-KHINLVNLRGYCRLPA 380 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 380 (603)
.+|++.+.||+|+||.||+|.+.+ ...+|+|.+..... ...+.+.+|+++++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468889999999999999997532 12589998764332 2345688999999999 7999999999999999
Q ss_pred ccEEEEEecCCCCccccccccCC------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGE------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD 448 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 448 (603)
..++++||+++|+|.+++..... ....+++.++..++.|++.||.|||++ +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 99999999999999999875421 123478899999999999999999998 899999999999999
Q ss_pred CCCCeEEeecccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccH
Q 007455 449 ENLEPHVSDFGLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNV 526 (603)
Q Consensus 449 ~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~ 526 (603)
.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------V 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------H
Confidence 99999999999997654322111 112234567999999988889999999999999999998 788875421 1
Q ss_pred hHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 527 VGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
..+........ ....+...+.++.+++.+||+.+|++||++.|+++.|++...
T Consensus 243 ~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 EELFKLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 22222111111 111122345679999999999999999999999999997663
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.35 Aligned_cols=252 Identities=35% Similarity=0.533 Sum_probs=199.3
Q ss_pred CCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChHH--HHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 313 LDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQ--VFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
|++.+.||+|+||+||++.+..++ .+|+|.+......... ...+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999998766 6999999766443332 2356999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++..... +++..++.++.|+++||.+||+. +++||||||+||+++.++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNKP----LSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NN 152 (260)
T ss_dssp TTEBHHHHHHHHSS----BBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TT
T ss_pred cccccccccccccc----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence 99999999984333 89999999999999999999999 899999999999999999999999999976422 22
Q ss_pred ceeecccccccccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQ-SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......++..|+|||++. +..++.++||||+|+++|+|++|..||...... ............ .. .....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~---~~~~~~~~~~~~-~~----~~~~~ 224 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD---DQLEIIEKILKR-PL----PSSSQ 224 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH---HHHHHHHHHHHT-HH----HHHTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccch---hhhhhhhhcccc-cc----ccccc
Confidence 2344566889999999998 888999999999999999999999998754110 111111111000 00 00000
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ......++.+++.+||+.+|++||++.++++
T Consensus 225 ~-~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 225 Q-SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp S-HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c-cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0011268999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=302.41 Aligned_cols=249 Identities=27% Similarity=0.432 Sum_probs=202.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
++|+..+.||+|+||.||+|.+.+ +..+++|.+..... .+.+.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578889999999999999999876 56799998865432 567999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 9999999987533 3489999999999999999999998 899999999999999999999999999887654322
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||++.+..++.++||||||+++|+|++|+.||........ . .. .... ......
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-----~-~~-~~~~------~~~~~~ 220 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-----I-FM-IPNK------PPPTLS 220 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-----h-hh-hccC------CCCCCC
Confidence 22334578899999999888899999999999999999999999864321100 0 00 0000 000011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+.....++.+++.+||+.+|++|||++|+++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12234567999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=312.06 Aligned_cols=260 Identities=29% Similarity=0.440 Sum_probs=202.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC--------CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhC-CCCeeeecceeeecC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN--------DCGTFAVKRIDRSRE-GSDQVFERELEILGSI-KHINLVNLRGYCRLP 379 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 379 (603)
.++|.+.+.||+|+||.||+|... ....+|+|.+..... .....+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357888999999999999999753 223589998864332 2234678999999999 699999999999998
Q ss_pred CccEEEEEecCCCCccccccccCC------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHGE------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL 447 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 447 (603)
...++||||+++|+|.+++..... ....+++.++..++.|++.||.|||++ +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999976421 123488999999999999999999998 89999999999999
Q ss_pred CCCCCeEEeecccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCcc
Q 007455 448 DENLEPHVSDFGLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLN 525 (603)
Q Consensus 448 ~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~ 525 (603)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----- 242 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----- 242 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-----
Confidence 999999999999998664322211 112224467999999988889999999999999999999 8888754211
Q ss_pred HhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
....... ... .....+...+.++.+++.+||..+|++|||+.|+++.|++..
T Consensus 243 -~~~~~~~-~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 243 -EELFKLL-REG--------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred -HHHHHHH-HcC--------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111111 111 001112234567889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=316.90 Aligned_cols=261 Identities=24% Similarity=0.303 Sum_probs=194.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCC-----
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPA----- 380 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 380 (603)
..++|++.+.||+|+||.||+|.+.. +..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 35789999999999999999999864 5679999986432 233456789999999999999999999886543
Q ss_pred -ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 381 -TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 381 -~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
..|+||||+++ +|.+.+.. .++...+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999986 56655532 177888999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCC---------ccHhHHH
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG---------LNVVGWM 530 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~---------~~~~~~~ 530 (603)
+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||........ .....+.
T Consensus 169 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 246 (359)
T cd07876 169 LARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM 246 (359)
T ss_pred CccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence 997643321 12335688999999999988999999999999999999999999975321000 0000000
Q ss_pred HH-------HhhhC------cchhhhccc----CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 531 NT-------LLKEN------RLEDVIDKR----CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 531 ~~-------~~~~~------~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. ..... ...+.+... ........+.++.+++.+||..||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 00000 000000000 00011122456899999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.38 Aligned_cols=250 Identities=27% Similarity=0.422 Sum_probs=200.4
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC------hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG------SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+|+..+.||+|+||.||+|...+++.+|+|.+...... ....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999999888788999988643211 124588999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
+||+++++|.+++..... +++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRFGP----LPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999976433 78899999999999999999998 89999999999999999999999999987653
Q ss_pred CCC-----cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 466 DEE-----AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 466 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
... ........|+..|+|||.+.+..++.++||||+|+++|||++|+.||..... ...... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~-~~~~---- 223 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-----LAAMFY-IGAH---- 223 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-----HHHHHH-hhhc----
Confidence 211 1112234588899999999888899999999999999999999999864211 000000 0000
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+..+...+.++.+++.+||..+|++||++.|+++
T Consensus 224 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 ---RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111222345567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=310.01 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=203.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.+|+..+.||.|+||.||+|.+. +++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888899999999999999975 55679999987655555677899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 999999988653 278999999999999999999999 899999999999999999999999999876543322
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......... .....
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~------~~~~~~~~~~-------~~~~~ 236 (296)
T cd06655 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL------RALYLIATNG-------TPELQ 236 (296)
T ss_pred c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhcC-------CcccC
Confidence 1 22345888999999998888999999999999999999999998754221 1111110000 00011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+...+..+.+++.+||..+|++||++.++++
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 22334567899999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=304.38 Aligned_cols=256 Identities=26% Similarity=0.345 Sum_probs=199.9
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.+++++.....||+|+||.||+|.+.+ +..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 345666677899999999999999765 4569999887665555667899999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-CCCeEEeecccccccC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-NLEPHVSDFGLAKLLV 465 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~~~~~~ 465 (603)
||+++++|.+++...... ...++..+..++.|++.||+|||+. +++||||||+||+++. ++.++|+|||.+....
T Consensus 85 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 85 EQVPGGSLSALLRSKWGP-LKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred ecCCCCCHHHHHHHhccc-CCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999998754211 1127788889999999999999998 8999999999999986 6799999999987654
Q ss_pred CCCcceeecccccccccCccccccCC--CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGR--ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
.... ......|++.|+|||.+.+.. ++.++||||+|+++|+|++|+.||..... .....+... .
T Consensus 161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~---~~~~~~~~~----------~ 226 (268)
T cd06624 161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE---PQAAMFKVG----------M 226 (268)
T ss_pred cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC---hhhhHhhhh----------h
Confidence 3222 122345788999999986543 78899999999999999999999864211 000111000 0
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+..+.....++.+++.+||+.+|++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 01111223344567999999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=307.73 Aligned_cols=250 Identities=25% Similarity=0.325 Sum_probs=197.5
Q ss_pred CCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 313 LDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
|+..+.||+|+||+||+|.+.. ++.+|+|.+..... .....+.+|++++++++|+||+++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 5667889999999999999864 55799998864322 2234578899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++...+. ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 999999988865332 2489999999999999999999998 89999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
. .....|+..|+|||++.+..++.++|+||+|+++|||++|+.||....... ....+... +.....
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~~----------~~~~~~ 222 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDRR----------VLETEE 222 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHh----------hhcccc
Confidence 1 233468999999999988889999999999999999999999996532110 00001000 000111
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
..+...+.++.+++.+|++.+|++||+ ++++++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 122334567899999999999999999 667765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=312.01 Aligned_cols=197 Identities=27% Similarity=0.392 Sum_probs=159.8
Q ss_pred CCeeeecCCeEEEEEEECC---CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeec--CCccEEEEEecC
Q 007455 316 EDVVGSGGFGTVYRMVMND---CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRL--PATKLLIYDYLS 390 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 390 (603)
..+||+|+||.||+|.+.+ +..+|+|.+.... ....+.+|+.++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 4689999999999999753 3569999986543 23457889999999999999999998854 455789999987
Q ss_pred CCCccccccccC-----CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE----CCCCCeEEeecccc
Q 007455 391 MGSLDDFLHEHG-----EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL----DENLEPHVSDFGLA 461 (603)
Q Consensus 391 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~~ 461 (603)
+ +|.+++.... .....+++..+..++.|++.||+|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 8877765322 1123488899999999999999999998 89999999999999 45678999999999
Q ss_pred cccCCCCcc--eeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcc
Q 007455 462 KLLVDEEAH--VTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPT 518 (603)
Q Consensus 462 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~ 518 (603)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 876433221 2234568999999999876 45889999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=301.88 Aligned_cols=254 Identities=25% Similarity=0.389 Sum_probs=190.6
Q ss_pred CeeeecCCeEEEEEEECCC---CEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCC
Q 007455 317 DVVGSGGFGTVYRMVMNDC---GTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
+.||+|+||.||+|...++ ..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 3589999999999987543 3589998865433 23356889999999999999999999999999999999999999
Q ss_pred CccccccccCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 393 SLDDFLHEHGE-GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 393 sL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
+|.+++..... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432 122356778889999999999999998 89999999999999999999999999987543322211
Q ss_pred -eecccccccccCccccccC-------CCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 472 -TTVVAGTFGYLAPEYLQSG-------RATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 472 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||...... ....+ ...... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---~~~~~---~~~~~~-~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE---QVLTY---TVREQQ-LKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH---HHHHH---Hhhccc-CCC
Confidence 1234567889999988532 35789999999999999996 99998643211 00000 011110 000
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
.. +......+..+.+++.+|+ .+|++|||++||++.|+
T Consensus 231 ~~---~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PK---PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CC---CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 01 1111123456888999999 68999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=307.54 Aligned_cols=262 Identities=31% Similarity=0.479 Sum_probs=204.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-----CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeec--CCcc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-----CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRL--PATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 382 (603)
+.|+..+.||+|+||.||+|.+.. +..+|+|.+...... ..+.+.+|+++++.+.|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 456778999999999999998652 356999998765443 45679999999999999999999999877 5578
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++||||+++++|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc---ccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 999999999999999976542 389999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCccee--ecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCc--------cHhHHHHH
Q 007455 463 LLVDEEAHVT--TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL--------NVVGWMNT 532 (603)
Q Consensus 463 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~--------~~~~~~~~ 532 (603)
.......... ....++..|+|||...+..++.++||||||+++|||++|+.|+......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 7653322111 1223456799999998888999999999999999999999997643211100 00111111
Q ss_pred HhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
..... .....+...+.++.+++.+||+.+|++|||+.|++++|+++
T Consensus 238 ~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEG--------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcC--------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11100 00111223446799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.75 Aligned_cols=260 Identities=28% Similarity=0.457 Sum_probs=199.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecC-Cc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLP-AT 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~~ 381 (603)
++|++.+.||+|+||.||+|.+. .++.||||+++..... ....+.+|+.++.++ +||||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 57889999999999999999753 3456999998654322 234688999999999 689999999988654 45
Q ss_pred cEEEEEecCCCCccccccccCC----------------------------------------------------------
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGE---------------------------------------------------------- 403 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 403 (603)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999998864321
Q ss_pred -----CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc-eeecccc
Q 007455 404 -----GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH-VTTVVAG 477 (603)
Q Consensus 404 -----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~g 477 (603)
....+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++......... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 012367888999999999999999998 8999999999999999999999999999765332211 1122335
Q ss_pred cccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHH
Q 007455 478 TFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVE 556 (603)
Q Consensus 478 t~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 556 (603)
+..|+|||.+.+..++.++||||||+++|||++ |..||...... ... ........ ....+...+.
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~~-~~~~~~~~--------~~~~~~~~~~ 309 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEF-CRRLKEGT--------RMRAPDYTTP 309 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-----HHH-HHHHhccC--------CCCCCCCCCH
Confidence 667999999988889999999999999999997 88888543111 001 11111110 0111112345
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 557 AILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 557 ~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
++.+++.+||+.+|++|||+.|+++.|+...
T Consensus 310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 7899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=319.13 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=203.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECC--CC--EEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND--CG--TFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
+....++||+|+||.|++|.|.. ++ .||||.+...... ....|.+|+.+|.+|+|||++++||+..+ ....+|+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34456889999999999999873 33 4899999766554 55679999999999999999999999987 6788999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
|.++.|+|.+.+++ ..+..+.....+.++.|||.|+.||.++ ++|||||.++|+++-....|||+|||+.+.++.
T Consensus 190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 99999999999998 2334478889999999999999999999 899999999999999999999999999999887
Q ss_pred CCcceeec--ccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 467 EEAHVTTV--VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 467 ~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
.+.+.... ..-.+.|+|||.+....++.++|||+|||++|||+| |..||-+-. -.... +.+
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~------g~qIL----------~~i 328 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR------GIQIL----------KNI 328 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC------HHHHH----------Hhc
Confidence 66554322 223458999999999999999999999999999999 556765421 11111 111
Q ss_pred c-ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 D-KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~-~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
| ......+..+++.++++++.||..+|++|||+..+.+
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 1 1122245567889999999999999999999999974
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=314.18 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=197.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.++||+|+||.||++.++++ ..+|+|.+.+. .......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 3688899999999999999998754 45899988532 1222345788999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++..... .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFED---RLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999976322 378889999999999999999998 899999999999999999999999999876544
Q ss_pred CCcceeecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||.... ..............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~-- 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKER-- 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCcc--
Confidence 3333334457999999999886 3457889999999999999999999996532 11111221111100
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDD--RPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~ 581 (603)
...+......+.++.+++.+|+..++.+ |++++|+++
T Consensus 227 ---~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 227 ---FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred ---ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 0111112234567899999988654443 689999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=304.55 Aligned_cols=256 Identities=26% Similarity=0.419 Sum_probs=203.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-----EEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
.+|++.+.||+|+||.||+|.+.+.+ .+|+|.+...... ....+.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788899999999999999976432 4899987655432 33568899999999999999999999887 78899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
|+||+++|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD---NIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999876432 288999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCccee-ecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAHVT-TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
........ ....++..|+|||.+....++.++|+||||+++||+++ |+.||+.... .++.......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~------ 227 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA------VEIPDLLEKG------ 227 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhCC------
Confidence 53322211 11223568999999988889999999999999999999 9999865321 1111111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
.....+...+..+.+++.+||..+|.+||++.++++.|++...
T Consensus 228 ---~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ---ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0111122234568899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=305.84 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=198.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
++|.+.+.||+|+||.||+|.+.+ +..||+|.++.........+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 466777889999999999999764 5569999887654444556889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++...+. +++.+++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999999876543 88999999999999999999999 89999999999999999999999999987654321
Q ss_pred ceeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 470 HVTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.......|+..|+|||.+. ...++.++||||+||++|||++|+.||....... .. ....... .. ...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~----~~~~~~~-~~---~~~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--AL----FLMTKSN-FQ---PPK 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hH----HhhhccC-CC---CCc
Confidence 1223456889999999874 4557889999999999999999999985432110 00 0000000 00 000
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ......+..+.+++.+|+..+|++||+++++++
T Consensus 231 ~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 L-KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred c-cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 011123456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=303.82 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=203.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
++|+..+.||+|+||.||+|+.+. ...+++|.+...... ....+.+|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578888999999999999999753 235899987654433 3467899999999999999999999999989999
Q ss_pred EEEEecCCCCccccccccCCCC-----ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQ-----QLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
+||||+++|+|.+++....... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997654221 2489999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
|++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||..... ....... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~------~~~~~~~-~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD------EEVLNRL-QAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch------HHHHHHH-HcC
Confidence 9987543332222333456778999999988888999999999999999999 7778753211 1111111 111
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
.... ..+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 235 ~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLEL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1100 012234567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=315.93 Aligned_cols=254 Identities=21% Similarity=0.298 Sum_probs=197.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||++.+..+ +.||+|.+.... ......+.+|..++..++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688899999999999999998754 569999886421 222345788999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFED---RLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999976322 378889999999999999999998 899999999999999999999999999987654
Q ss_pred CCcceeecccccccccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQS-----GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
..........|++.|+|||++.+ +.++.++||||+|+++|||++|+.||..... .............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~-- 226 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEER-- 226 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCc--
Confidence 43333344569999999999865 4678899999999999999999999965321 1111111111000
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDD--RPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~ 581 (603)
...+......+.++.+++.+|+..++++ |++++++++
T Consensus 227 ---~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 227 ---FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred ---ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0011111234567899999999865544 468888874
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=322.89 Aligned_cols=251 Identities=21% Similarity=0.313 Sum_probs=195.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|+..+.||+|+||.||+|...+ +..||+|++.... ......+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 367888999999999999999875 4569999986432 223456788999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+|||++.++.++|+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMKKDT----LSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999876433 88999999999999999999998 899999999999999999999999999875432
Q ss_pred CCc----------------------------------ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCC
Q 007455 467 EEA----------------------------------HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGK 512 (603)
Q Consensus 467 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~ 512 (603)
... .......||+.|+|||++.+..++.++||||+||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0012346999999999999889999999999999999999999
Q ss_pred CCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 007455 513 RPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPS---MNQVLQ 581 (603)
Q Consensus 513 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 581 (603)
.||...... .......... ..+ ..+ .....+.++.+++.+++ .+|.+|++ ++|+++
T Consensus 234 ~Pf~~~~~~------~~~~~i~~~~---~~~--~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 234 PPFCSETPQ------ETYRKVMNWK---ETL--VFP-PEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCCHH------HHHHHHHcCC---Cce--ecC-CCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 999653211 1111111100 000 001 01123457888888876 49999985 566664
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=301.69 Aligned_cols=249 Identities=31% Similarity=0.456 Sum_probs=191.1
Q ss_pred CeeeecCCeEEEEEEECC----CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeee-cCCccEEEEEecC
Q 007455 317 DVVGSGGFGTVYRMVMND----CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCR-LPATKLLIYDYLS 390 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 390 (603)
+.||+|+||.||+|.+.+ ...+|+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 2358999885432 223456888999999999999999999775 4556789999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++..... ..++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSETH---NPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 9999999875432 257788899999999999999998 8999999999999999999999999999765432211
Q ss_pred ---eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCC-CCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 471 ---VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKR-PTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 471 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
......++..|+|||.+.+..++.++||||||+++|||++|+. ||... ............ .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~------~~~~~~~~~~~~---------~ 219 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------DSFDITVYLLQG---------R 219 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC------CHHHHHHHHhcC---------C
Confidence 1112345678999999988889999999999999999999654 44321 111111111111 1
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
....+...+..+.+++.+||..+|++||++.|+++.|++.
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 1111223346799999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=304.27 Aligned_cols=251 Identities=28% Similarity=0.504 Sum_probs=197.1
Q ss_pred CeeeecCCeEEEEEEECCC-------CEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 317 DVVGSGGFGTVYRMVMNDC-------GTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+.||+|+||.||+|...+. ..+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 3689999999999987642 358999875433 23455788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCC---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-----CeEEeeccc
Q 007455 389 LSMGSLDDFLHEHGE---GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-----EPHVSDFGL 460 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfG~ 460 (603)
+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975322 123478899999999999999999998 899999999999999887 899999999
Q ss_pred ccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 461 AKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 461 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
+........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ... .... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~---~~~~-~~-- 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEV---LQHV-TA-- 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHH---HHHH-hc--
Confidence 876543221 11122345678999999998899999999999999999998 9999864211 111 1111 00
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
......+...+..+.+++.+||+.+|.+||+++++++.|++
T Consensus 229 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 ------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 01112223456789999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=303.09 Aligned_cols=256 Identities=25% Similarity=0.390 Sum_probs=201.8
Q ss_pred CCCCCCeeeecCCeEEEEEEECC--CCEEEEEEeCCCC----------CChHHHHHHHHHHHhh-CCCCeeeecceeeec
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND--CGTFAVKRIDRSR----------EGSDQVFERELEILGS-IKHINLVNLRGYCRL 378 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 378 (603)
+|++.+.||+|+||.||+|.+.. +..+|+|.+.... ......+.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999876 4569999875321 1122446778888875 799999999999999
Q ss_pred CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 379 PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
.+..+++|||+++++|.+++.........+++..++.++.|++.||.|||+.. +++||||+|+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999988654333445899999999999999999999642 7999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.... .......... ..
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~------~~~~~~~~~~-~~ 229 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN------MLSLATKIVE-AV 229 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC------HHHHHHHHhh-cc
Confidence 9998765433 2334568889999999998889999999999999999999999986432 1111111111 10
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.. +......+..+.+++.+||+.+|++||++.|+..++++
T Consensus 230 ~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 230 YE-------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CC-------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 00 00111344679999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=306.59 Aligned_cols=239 Identities=21% Similarity=0.354 Sum_probs=185.7
Q ss_pred eeeecCCeEEEEEEECC-----------------------C--CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeec
Q 007455 318 VVGSGGFGTVYRMVMND-----------------------C--GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNL 372 (603)
Q Consensus 318 ~ig~G~~g~Vy~~~~~~-----------------------~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 372 (603)
.||+|+||.||+|.... + ..+++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997521 1 1388888865544444568889999999999999999
Q ss_pred ceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-
Q 007455 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL- 451 (603)
Q Consensus 373 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~- 451 (603)
++++......++||||+++|+|..++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 999999999999999999999999886532 2378999999999999999999998 899999999999997654
Q ss_pred ------CeEEeecccccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHH-hCCCCCCcccccCC
Q 007455 452 ------EPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELV-TGKRPTDPTFVKRG 523 (603)
Q Consensus 452 ------~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~ell-tg~~p~~~~~~~~~ 523 (603)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-- 228 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-- 228 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH--
Confidence 3899999988654322 12346788999998865 56789999999999999995 688888643211
Q ss_pred ccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 524 LNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
....+ ... .... +......+.+++.+||+.+|++|||++++++.|.
T Consensus 229 -~~~~~----~~~-------~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 -EKERF----YEK-------KHRL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHH----HHh-------ccCC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11011 000 0001 1112346899999999999999999999999773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=306.01 Aligned_cols=240 Identities=22% Similarity=0.419 Sum_probs=189.3
Q ss_pred CeeeecCCeEEEEEEECCC--------CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 317 DVVGSGGFGTVYRMVMNDC--------GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+.||+|+||.||+|..... ..+++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 4689999999999987532 23788877654444456788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC--------eEEeeccc
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE--------PHVSDFGL 460 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~kl~DfG~ 460 (603)
+++|+|.+++..... .+++..++.++.|++.||+|||+. +++||||||+||+++.++. ++++|||.
T Consensus 81 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNKN---LINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999976432 378999999999999999999998 8999999999999988765 69999998
Q ss_pred ccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCC-CCCCcccccCCccHhHHHHHHhhhCc
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGK-RPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
+...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+..... ...... . ..
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~------~~~~~~-~-~~- 220 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS------QKKLQF-Y-ED- 220 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH------HHHHHH-H-Hc-
Confidence 8654332 22457889999999876 45788999999999999999995 45432211 000000 0 00
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01112223457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=299.75 Aligned_cols=251 Identities=32% Similarity=0.511 Sum_probs=201.5
Q ss_pred CCCCCeeeecCCeEEEEEEECC-----CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 313 LDEEDVVGSGGFGTVYRMVMND-----CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
+++.+.||+|+||.||++.+.+ ...+|+|.+...... ..+.+.+|+.++..++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999999875 256999998655433 4567899999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++++|.+++...... .+++.++..++.|++.||+|||+. +++||||+|+||++++++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK--ELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhhc--cCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 999999999998764321 178999999999999999999999 899999999999999999999999999987654
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
..........+++.|+|||.+.+..++.++||||+|+++|||++ |..||.... ............
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~------~~~~~~~~~~~~-------- 221 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS------NEEVLEYLKKGY-------- 221 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHhcCC--------
Confidence 42222222336789999999988889999999999999999998 777875421 111111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 583 (603)
....+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1112223567799999999999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=299.40 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=203.3
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|+..+.||+|+||.||.+.... +..+++|.+.... ......+.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47788999999999999998764 5569999876432 33345688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++.... ...+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997653 23478999999999999999999998 89999999999999999999999999998764433
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
. ......+++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ......... ....
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~---------~~~~ 219 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIVQ---------GNYT 219 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHc---------CCCC
Confidence 2 22345688999999999888889999999999999999999999865321 111111111 1111
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
..+...+.++.+++.+||+.+|++||+++|+++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1223445679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.91 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=203.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
++|+..+.||+|+||.||+|.+.. +..+++|.+........+.+.+|++++++++||||+++++++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 578888999999999999999864 4569999987655555677899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++.... ..++...+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||.+.......
T Consensus 83 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 83 GGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 9999999887642 2388999999999999999999998 89999999999999999999999999987654322
Q ss_pred ceeecccccccccCccccccC---CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 470 HVTTVVAGTFGYLAPEYLQSG---RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.||....... -... ...... ...
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~~~~-~~~~~~----~~~ 224 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------ALFL-ISKSNF----PPP 224 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHH-HHhccC----CCc
Confidence 122334578899999998776 78899999999999999999999986432110 0000 000000 000
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+.++.+++.+||..+|.+|||+++++.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11122345678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=305.26 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=198.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
+.|++.+.||+|+||.||+|.+.. +..+++|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 567888999999999999999875 4569999887655455567889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|..++.... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 92 ~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 92 PGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 9999988776432 2388999999999999999999998 89999999999999999999999999987543221
Q ss_pred ceeecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 470 HVTTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
.......+++.|+|||++. ...++.++||||||+++|||++|+.||..... ........... .
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~------~ 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE------P 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC------C
Confidence 1123345788999999884 34567899999999999999999999864311 11111111100 0
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+ ....+...+.++.+++.+||+.+|++||+++|+++
T Consensus 233 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 P-TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred c-cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 00112234567899999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.27 Aligned_cols=261 Identities=21% Similarity=0.265 Sum_probs=195.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecC------
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLP------ 379 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 379 (603)
..++|.+.+.||+|+||.||+|.+.. +..||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 35789999999999999999999764 4569999986532 22345678999999999999999999987543
Q ss_pred CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
...|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 346999999976 67766643 277888999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCc---------cHhHHH
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL---------NVVGWM 530 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~---------~~~~~~ 530 (603)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......... ....+.
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 997653321 223456899999999999889999999999999999999999999753211000 000000
Q ss_pred HHH-------hhhC------cchhhhcccC----CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 531 NTL-------LKEN------RLEDVIDKRC----ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 531 ~~~-------~~~~------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... .... .......... .........++.+++.+|++.||.+|||++|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000 0000 0000000000 0011112356899999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=303.39 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=201.0
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
+|+..+.||.|+||.||+|.+.. +..+++|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 57788899999999999999874 4569999886543 233456889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++... .+++..+..++.|++.|+.|||++ +++||||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999998764 389999999999999999999998 899999999999999999999999999987654321
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||...... ....... .. ..+.
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~~~~~~~-~~--------~~~~ 217 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------RVLFLIP-KN--------NPPS 217 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------HHHHHhh-hc--------CCCC
Confidence 223345788999999998888999999999999999999999998643211 0110000 00 0111
Q ss_pred cCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 550 ADME-TVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 550 ~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... .+..+.+++.+||..+|++|||++++++
T Consensus 218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111 4567999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=307.21 Aligned_cols=259 Identities=24% Similarity=0.317 Sum_probs=191.9
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhC---CCCeeeecceeeec-----CC
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSI---KHINLVNLRGYCRL-----PA 380 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 380 (603)
+|++.+.||+|+||.||+|.+.+ ++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47788999999999999999875 4569999886432 22234466777777665 69999999998754 24
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 47899999985 88888875432 2388999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh---C
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE---N 537 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 537 (603)
++...... ......|+..|+|||++.+..++.++||||+||++|||++|+.||....... ........... .
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~ 229 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIGLPPED 229 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHHHHHHhCCCChh
Confidence 98664322 1233457899999999988889999999999999999999999986432110 00000000000 0
Q ss_pred cchh-------hhcccCC----CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 RLED-------VIDKRCA----DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 ~~~~-------~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+.. ....... ......+..+.+++.+|++.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 0000000 011123467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.64 Aligned_cols=253 Identities=26% Similarity=0.450 Sum_probs=200.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||.||+|.+. .+..+|+|.+..... .....+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788899999999999999987 556799998865322 2235688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++..... ...+++..+..++.|++.||.|||+.. +++||||||+||+++.++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 999999988875321 224899999999999999999999743 89999999999999999999999999987653321
Q ss_pred cceeecccccccccCccccccCC------CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGR------ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
.....++..|+|||.+.+.. ++.++|+||+||++|||++|+.||...... . +... ....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~---~~~~------~~~~ 222 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---N---IFAQ------LSAI 222 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---h---HHHH------HHHH
Confidence 22345788999999985543 478999999999999999999998643211 1 1100 1111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+..+...+.++.+++.+||+.+|++||+++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111122233346678999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=315.79 Aligned_cols=262 Identities=21% Similarity=0.256 Sum_probs=195.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecC-----
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLP----- 379 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 379 (603)
...++|+..+.||+|+||.||+|.+.. +..+|||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 346789999999999999999999764 45699999865432 2335678899999999999999999988643
Q ss_pred -CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 380 -ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 380 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
...++||||+++ ++.+.+.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 346899999976 66666543 278888999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCc---------cHhHH
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL---------NVVGW 529 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~---------~~~~~ 529 (603)
|+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||......... ....+
T Consensus 164 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred cccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9998653321 223456899999999999888999999999999999999999999753211000 00000
Q ss_pred H-------HHHhhhC-cc-----hhhhcccCC----CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 530 M-------NTLLKEN-RL-----EDVIDKRCA----DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 530 ~-------~~~~~~~-~~-----~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ....... .. ......... ........++.+++.+|++.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0 0000000 00 000000000 011123457899999999999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=340.76 Aligned_cols=260 Identities=22% Similarity=0.326 Sum_probs=199.7
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeec--CCccE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRL--PATKL 383 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 383 (603)
...+|.+.+.||+|+||+||+|.+..+. .+|+|.+.... ......+..|+.+++.++||||++++++|.. ....|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 4578999999999999999999987655 58888876432 2234568899999999999999999998854 35689
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEecCCCCCeEECC----------
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC----PKIIHRDIKSSNILLDE---------- 449 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~----~~ivH~Dlkp~NIll~~---------- 449 (603)
+||||+++|+|.+++.........+++..++.|+.||+.||.|||+.+. .+||||||||+|||++.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999997643333458999999999999999999998521 25999999999999964
Q ss_pred -------CCCeEEeecccccccCCCCcceeecccccccccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCcccc
Q 007455 450 -------NLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRPTDPTFV 520 (603)
Q Consensus 450 -------~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~p~~~~~~ 520 (603)
.+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~- 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN- 247 (1021)
T ss_pred cccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC-
Confidence 23489999999986643321 234568999999999854 457899999999999999999999996421
Q ss_pred cCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 007455 521 KRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQ 585 (603)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~ 585 (603)
........... . +.. .....+.++.+||..||..+|.+||++.|+++ .+..
T Consensus 248 ----~~~qli~~lk~-~-------p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 248 ----NFSQLISELKR-G-------PDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred ----cHHHHHHHHhc-C-------CCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 11111111111 0 000 11123467999999999999999999999994 4543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=299.40 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=199.8
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecC-CccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLP-ATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 387 (603)
+|++.+.||+|++|.||++.+.. +..+|+|++..... ...+.+.+|++++++++|+|++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47888999999999999999874 45699999864332 2345688999999999999999999887643 45789999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++++|.+++.... ...+++.++..++.+++.|+++||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999987632 23489999999999999999999998 8999999999999999999999999999766432
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
.. ......+++.|+|||...+..++.++||||+|++++||++|+.||.... ...+..... ....
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~---------~~~~ 219 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRII---------EGKL 219 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHH---------hcCC
Confidence 22 2233457889999999998889999999999999999999999986431 111111111 1111
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+..+...+.++.+++.+|++.+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 2223345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=305.40 Aligned_cols=262 Identities=24% Similarity=0.324 Sum_probs=196.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|++.+.||+|++|.||+|.+. .+..||+|++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999986 45679999886432 22345688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
++ ++|.+++..... ...+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 98 588888865432 23488999999999999999999998 89999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH-----------hhh
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL-----------LKE 536 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~ 536 (603)
.......+++.|+|||.+.+. .++.++||||+|+++|||+||+.||....... ......... ...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSL 232 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhh
Confidence 112233568899999988654 46889999999999999999999987532110 000000000 000
Q ss_pred Ccchhhhcc----cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 NRLEDVIDK----RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......+.. .........+.++.+++.+||..||++|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000 000011124567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=304.13 Aligned_cols=249 Identities=25% Similarity=0.352 Sum_probs=196.5
Q ss_pred CCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 313 LDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
|++.+.||+|+||.||+|.+..++ .+++|.+........+.+.+|+++++.++||||+++++++......++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 456788999999999999988644 5788888655444456688999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
++|.+++.... ..+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||++....... ..
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 99988876422 2389999999999999999999998 89999999999999999999999999987653321 12
Q ss_pred eecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 472 TTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.....++..|+|||++. +..++.++||||+||++|||++|+.||..... ............ ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~~------~~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEP------PT 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH------HHHHHHHhhcCC------CC
Confidence 23356889999999873 34567899999999999999999999864321 111111111000 00
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+...+.++.+++.+||+.+|.+||+++++++
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 -LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0112234567999999999999999999999886
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=299.22 Aligned_cols=247 Identities=27% Similarity=0.416 Sum_probs=200.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC-----ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE-----GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+|+..+.||+|+||.||+|... ++..|++|.+..... ...+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677899999999999999987 667899998854331 2345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
+||+++++|.+++..... +++..+..++.|+++||+|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKKYGS----FPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999976533 78999999999999999999998 89999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGR-ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ..........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~-------- 217 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRS-------- 217 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhc--------
Confidence 332 223455888999999987666 88999999999999999999999865321 1111110000
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+..+......+.+++.+||+.+|.+||+++++++
T Consensus 218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111222234567899999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=305.84 Aligned_cols=254 Identities=26% Similarity=0.414 Sum_probs=202.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||+||+|.+.. +..+|+|.+.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 567778899999999999999874 4568999875433 23356789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++...+. +++..+..++.+++.||.|||+.. +++||||+|+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999998876432 889999999999999999999742 79999999999999999999999999986543221
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccC-----CccHhHHHHHHhhhCcchhhh
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKR-----GLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 543 (603)
.....|+..|+|||++.+..++.++|||||||++||+++|+.||....... ......+......
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 227 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-------- 227 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh--------
Confidence 223468899999999988889999999999999999999999997543211 0111122222111
Q ss_pred cccCCCc-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 544 DKRCADA-DMETVEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 544 ~~~~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
...+.. ....+.++.+++.+|++.+|++|||++|+++.
T Consensus 228 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 228 -EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred -ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111111 12355679999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=301.42 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=200.4
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.|+..+.||+|+||.||+|.+.. +..+|+|.+.... ......+.+|+.++++++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 46667889999999999999875 5569999886443 233456889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++... .+++.+...++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 999999988753 278889999999999999999998 899999999999999999999999999976644322
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||.+.+..++.++|+||||+++|||++|..||....... .... ......+.
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~------~~~~---------~~~~~~~~ 220 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR------VLFL---------IPKNNPPT 220 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh------Hhhh---------hhcCCCCC
Confidence 1233457889999999988889999999999999999999999986432110 0000 00011122
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+..+.+++.+||+.+|++||+++++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 221 LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred CchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 33456678999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=297.94 Aligned_cols=247 Identities=24% Similarity=0.387 Sum_probs=205.2
Q ss_pred CCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 313 LDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
|++.++||+|+||+||+|.++..+ .+|||++... ..-+++..|+.+|++.+.|++|++||.|.....+++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 456788999999999999988655 5899988543 3456689999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|++.+.++... .++.+.++..++..-++||+|||.. .-+|||||+.|||++.+|.+|++|||.+..+.+. ..+
T Consensus 113 GSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAK 185 (502)
T KOG0574|consen 113 GSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAK 185 (502)
T ss_pred CcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHh
Confidence 99999998643 3489999999999999999999998 7899999999999999999999999999776543 334
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|||||++..-.|+.++||||+|++..||..|++||....+-+...++ .. -.+....-+
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------PT------~PPPTF~KP 252 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------PT------KPPPTFKKP 252 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------cC------CCCCCCCCh
Confidence 56678999999999999989999999999999999999999998754332111000 00 001111134
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+.++-+++++||-++|++|.|+.++++
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 566778999999999999999999998875
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=310.18 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=197.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|...+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 5678899999999999999999874 4579999886433 2334567889999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++ +|.+++..... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 85 ~~~~-~l~~~l~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 85 YLDK-DLKQYLDDCGN---SINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cccc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 9984 89888865432 378899999999999999999998 8999999999999999999999999998764332
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH------------h
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL------------L 534 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~------------~ 534 (603)
.. ......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||....... ........ .
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCChhhchhhh
Confidence 21 1223456889999998865 357889999999999999999999986532110 00000000 0
Q ss_pred hhCcchhhhcccC-----CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 KENRLEDVIDKRC-----ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 ~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..........+.. .......+..+.+++.+|++.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000000000 0011123457899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=314.42 Aligned_cols=242 Identities=29% Similarity=0.425 Sum_probs=197.9
Q ss_pred CCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCCh---HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 313 LDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGS---DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
|...+.||.|+||.||-|++..+. .||||++..+...+ ...+..|+.+|++++|||++.+.|+|..+.+.++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 444577999999999999987655 48999997554433 24688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
|-| +-.|++..+.+ ++.+..+..|..+.++||+|||++ +.||||||+.|||+++.|.||++|||.+....+.
T Consensus 108 ClG-SAsDlleVhkK---plqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKK---PLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred Hhc-cHHHHHHHHhc---cchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 976 88888876543 378888999999999999999999 8999999999999999999999999999776443
Q ss_pred cceeecccccccccCcccc---ccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 469 AHVTTVVAGTFGYLAPEYL---QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
..++|||.|||||++ ..+.|+-++||||+|++..||.-.++|+-.. .-+ . .+..+..+
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-----NAM----S------ALYHIAQN 240 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAM----S------ALYHIAQN 240 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-----hHH----H------HHHHHHhc
Confidence 457899999999987 4678999999999999999999999985321 000 0 01111111
Q ss_pred cCCC-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCAD-ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+. ...+.+..+..++..||++-|.+|||.+++++
T Consensus 241 esPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 1121 23456678999999999999999999999986
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=305.09 Aligned_cols=245 Identities=26% Similarity=0.411 Sum_probs=197.5
Q ss_pred CCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 313 LDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
|+..+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 4556789999999999999865 4569999886443 2334568899999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+++|.+++... .+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++++|||++........
T Consensus 86 ~~~L~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 86 GGSALDLLKPG-----PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999988642 278899999999999999999998 899999999999999999999999999876543321
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCc
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (603)
......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... . +... .. ....+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~---~~~~-~~--------~~~~~~~ 221 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM---R---VLFL-IP--------KNSPPTL 221 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh---h---HHhh-hh--------cCCCCCC
Confidence 122345788999999999888999999999999999999999998643211 0 0000 00 0111112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 551 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+.++.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 2344567999999999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.57 Aligned_cols=257 Identities=27% Similarity=0.459 Sum_probs=200.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-----EEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|+..+.||+|+||.||+|.+..++ .+|+|.+...... ....+.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 56778899999999999999875433 3788887654322 234688999999999999999999998654 4679
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
++||+++|+|.+++..... .+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 9999999999999876432 378899999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ....+ .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~~~---- 228 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDL----LEKGE---- 228 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHCCC----
Confidence 4332211 122335678999999988889999999999999999998 88998643211 11111 11110
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
....+...+..+.+++.+||..+|++||+++++++.|+.....
T Consensus 229 ----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 229 ----RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 0111122345789999999999999999999999999886543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=300.62 Aligned_cols=238 Identities=23% Similarity=0.415 Sum_probs=189.2
Q ss_pred CeeeecCCeEEEEEEECCCC-----------EEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 317 DVVGSGGFGTVYRMVMNDCG-----------TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+.||+|+||.||+|.+.++. .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46899999999999987654 3677776544333 5678999999999999999999999988 778999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-------CeEEeec
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-------EPHVSDF 458 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-------~~kl~Df 458 (603)
|||+++|+|.+++..... .+++..+..++.|++.||+|||++ +++||||||+||+++.++ .++|+||
T Consensus 79 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN---NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 999999999999986542 388999999999999999999998 899999999999999887 7999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccC--CCCcccchHhHHHHHHHHHhC-CCCCCcccccCCccHhHHHHHHhh
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG--RATEKSDVYSFGVLLLELVTG-KRPTDPTFVKRGLNVVGWMNTLLK 535 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~ 535 (603)
|++..... .....++..|+|||++.+. .++.++||||||+++|||++| ..|+...... .+......
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~------~~~~~~~~ 221 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS------EKERFYQD 221 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch------hHHHHHhc
Confidence 99876543 1223466789999998776 788999999999999999994 6666442110 11111100
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
.. ..+. .....+.+++.+||..+|.+|||+.++++.|+
T Consensus 222 ~~--------~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QH--------RLPM---PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CC--------CCCC---CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0111 11267899999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=298.51 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=201.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|+..+.||+|+||.||++... +++.|++|.+.... ....+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999976 45679999886432 23345788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+.+++|.+++..... ..+++.++..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 999999998875322 2378899999999999999999998 89999999999999999999999999997654332
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
. ......|++.|+|||+..+..++.++|+||||+++++|++|+.||.... ......... ....+
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~------~~~~~~~~~---------~~~~~ 219 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN------MKNLVLKII---------RGSYP 219 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC------HHHHHHHHh---------cCCCC
Confidence 1 1223457889999999988889999999999999999999999986431 111111111 11111
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+.++.+++.+||+.+|++||+++|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 223344567999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=300.25 Aligned_cols=253 Identities=21% Similarity=0.362 Sum_probs=188.7
Q ss_pred eeeecCCeEEEEEEECCCC---EEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCC
Q 007455 318 VVGSGGFGTVYRMVMNDCG---TFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGS 393 (603)
Q Consensus 318 ~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (603)
.||+|+||.||+|...++. .+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5899999999999765443 35667665433 2345678999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC-ccee
Q 007455 394 LDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE-AHVT 472 (603)
Q Consensus 394 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~-~~~~ 472 (603)
|.+++..........++.....++.|+++||+|||+. +++||||||+|||++.++.++|+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986543333467778889999999999999998 89999999999999999999999999986432211 1112
Q ss_pred ecccccccccCcccccc-------CCCCcccchHhHHHHHHHHHhC-CCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 473 TVVAGTFGYLAPEYLQS-------GRATEKSDVYSFGVLLLELVTG-KRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 473 ~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
....++..|+|||++.. ..++.++||||||+++|||+++ ..||.... ............. ....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~------~~~~~~~~~~~~~-~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS------DREVLNHVIKDQQ-VKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHhhcc-cccCC
Confidence 33457889999998743 2457789999999999999975 55764321 1112222222111 11111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
+.. .......+.+++..|| .+|++||+++++++.|.
T Consensus 232 ~~~---~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQL---ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred Ccc---CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 111 1224467888999999 67999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=304.55 Aligned_cols=251 Identities=25% Similarity=0.353 Sum_probs=200.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
++|++.+.||+|+||.||+|.+. ++..+|+|.+........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56788889999999999999986 45679999987655445567889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999987643 2389999999999999999999999 899999999999999999999999999876543222
Q ss_pred ceeecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 470 HVTTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
......+++.|+|||.+. ...++.++|+||||+++|||++|+.||..... ............
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~------ 225 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP------MRVLLKILKSEP------ 225 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH------HHHHHHHhcCCC------
Confidence 223345889999999874 34467799999999999999999999864321 111111111000
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+...+.++.+++.+||+.+|.+||+++++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 -PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 001112234567899999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=300.16 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=188.1
Q ss_pred CeeeecCCeEEEEEEECCC---CEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCC
Q 007455 317 DVVGSGGFGTVYRMVMNDC---GTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
+.||+|+||.||+|...++ ..+++|.+..... .....+.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 3589999999999976543 2478887654332 23356789999999999999999999999999999999999999
Q ss_pred CccccccccCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 393 SLDDFLHEHGEG-QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 393 sL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
+|.+++...... ....++.....++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999765422 22356778889999999999999999 89999999999999999999999999987543322111
Q ss_pred -eecccccccccCcccccc-------CCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 472 -TTVVAGTFGYLAPEYLQS-------GRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 472 -~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
.....++..|+|||++.. ..++.++||||+|+++|||++ |..||...... .-..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~~~~--- 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE------QVLKQVVREQDI--- 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhhccCc---
Confidence 122345678999998742 356789999999999999999 67777542110 011111111110
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 583 (603)
....+..+...+..+.+++..|+ .||++|||+++|++.|
T Consensus 229 -~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 229 -KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred -cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 00111122344566788889998 5999999999999987
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=318.70 Aligned_cols=258 Identities=23% Similarity=0.271 Sum_probs=196.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC---CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND---CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.+|.+.+.||+|+||.||++...+ +..|++|.+... ....+|++++++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 478899999999999999998653 345899987543 235689999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
++. ++|.+++.... .+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++|+|||+++.....
T Consensus 167 ~~~-~~l~~~l~~~~----~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 167 KYK-CDLFTYVDRSG----PLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hcC-CCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 996 58888885432 389999999999999999999998 8999999999999999999999999999766443
Q ss_pred Ccc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc-------
Q 007455 468 EAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL------- 539 (603)
Q Consensus 468 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------- 539 (603)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.............-+.........
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 221 223456899999999999889999999999999999999999998654322111000000000000000
Q ss_pred -------hhhh---ccc--CCC--cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 540 -------EDVI---DKR--CAD--ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 540 -------~~~~---~~~--~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... .+. .+. .......++.+++.+||..+|++|||+.|++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000 000 000 00122456889999999999999999999997
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=298.83 Aligned_cols=248 Identities=27% Similarity=0.379 Sum_probs=193.7
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC-----ChHHHHHHHHHHHhhCCCCeeeecceeeecC--CccE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE-----GSDQVFERELEILGSIKHINLVNLRGYCRLP--ATKL 383 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 383 (603)
+|+..+.||+|+||.||+|.+.+ +..|++|++..... .....+.+|+.++++++||||+++++++... ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 68889999999999999999864 56799998854321 1224588899999999999999999988653 5678
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+++||+++++|.+++..... +++...+.++.|++.||+|||+. +++||||+|+||+++.++.++|+|||+++.
T Consensus 83 l~~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGA----LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 99999999999999876433 78899999999999999999998 899999999999999999999999999876
Q ss_pred cCCCCc--ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 464 LVDEEA--HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 464 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
...... .......++..|+|||.+.+..++.++||||+|+++|||++|+.||..... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~------ 223 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIAT------ 223 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhc------
Confidence 532111 111234578899999999888899999999999999999999999864311 011111100
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+..+......+.+++ +||..+|++||+++|+++
T Consensus 224 --~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 224 --QPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0011222334455677777 677789999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=297.41 Aligned_cols=247 Identities=29% Similarity=0.449 Sum_probs=197.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||.||++... +..+|+|.+.... ....+.+|+.++++++|||++++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEecccC-CCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 56888999999999999999754 4679999885432 345688999999999999999999998654 4799999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+++|.+++..... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 9999999976432 2378999999999999999999998 89999999999999999999999999987543221
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
.....+..|+|||.+.+..++.++|+||||+++|||++ |+.||..... ........... ...
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------~~~~~~~~~~~---------~~~ 217 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL------KEVKECVEKGY---------RME 217 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH------HHHHHHHhCCC---------CCC
Confidence 11224567999999988889999999999999999998 8888864321 11111111100 011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=299.00 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=201.4
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeec--CCccEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRL--PATKLLIY 386 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 386 (603)
+|++.+.||.|+||.||+|.+.. +..+|+|.+..... ...+.+.+|+++++.++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47788999999999999999764 45699998864332 234568889999999999999999998754 34578999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH-----HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-----~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
||+++++|.+++.........+++..++.++.|++.||.||| +. +++||||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765444455899999999999999999999 65 8999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
......... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ...... ..
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~-~~------ 223 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ------LQLASK-IK------ 223 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH------HHHHHH-Hh------
Confidence 876543321 2334588999999999888899999999999999999999999875321 111111 11
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+..+...+..+.+++.+|++.+|++||+++++++
T Consensus 224 --~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 224 --EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred --cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11112233455678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=306.24 Aligned_cols=197 Identities=27% Similarity=0.396 Sum_probs=159.2
Q ss_pred CCeeeecCCeEEEEEEECCC---CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeec--CCccEEEEEecC
Q 007455 316 EDVVGSGGFGTVYRMVMNDC---GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRL--PATKLLIYDYLS 390 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 390 (603)
+.+||+|+||.||+|...++ ..||+|.+.... ....+.+|++++++++||||+++++++.. +...++|+||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 36899999999999997643 469999886543 23457899999999999999999998853 456789999987
Q ss_pred CCCccccccccC-----CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE----CCCCCeEEeecccc
Q 007455 391 MGSLDDFLHEHG-----EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL----DENLEPHVSDFGLA 461 (603)
Q Consensus 391 ~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~~ 461 (603)
+ +|.+++.... .....+++..+..++.|++.||.|||+. +++||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 6 7777764321 1123478899999999999999999998 89999999999999 56678999999999
Q ss_pred cccCCCCcc--eeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcc
Q 007455 462 KLLVDEEAH--VTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPT 518 (603)
Q Consensus 462 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~ 518 (603)
+........ ......||+.|+|||++.+ ..++.++||||+|+++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876443221 1234568899999999876 45789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.68 Aligned_cols=195 Identities=27% Similarity=0.340 Sum_probs=169.7
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChHHHHHHHHHHHhhCC-CC-----eeeecceeeecCCccEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIK-HI-----NLVNLRGYCRLPATKLL 384 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~l 384 (603)
+|.+.++||+|+||.|.+|.+.+++ .||||+++.... ...+...|+.+|..++ |. |+|+++++|...++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7889999999999999999998755 499999876443 3445678999999997 43 89999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC--CeEEeeccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL--EPHVSDFGLAK 462 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~~~ 462 (603)
|+|.++. +|.++++.+... .++...+..++.||+.||..||+. +|||+||||+|||+.+-+ .+||+|||.|+
T Consensus 266 VfELL~~-NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhhh-hHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999987 999999986543 389999999999999999999998 899999999999997543 69999999998
Q ss_pred ccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCc
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDP 517 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~ 517 (603)
...+.- .....+..|.|||++.+.+|+.+.||||||||++||++|.+-|.+
T Consensus 340 ~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 340 FESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred ccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 754332 245678899999999999999999999999999999999876654
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=303.65 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=198.3
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeee-----cC
Q 007455 307 IEKLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCR-----LP 379 (603)
Q Consensus 307 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~ 379 (603)
....++|++.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++++ +||||+++++++. ..
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 3456789999999999999999999864 4568999875432 3345688999999999 6999999999874 34
Q ss_pred CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
+..++||||+++++|.+++.........+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCC
Confidence 568999999999999998764333334588999999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-----GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
+++....... ......|++.|+|||++.. ..++.++||||+||++|||++|+.||...... ... .
T Consensus 170 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-----~~~----~ 239 (286)
T cd06638 170 VSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-----RAL----F 239 (286)
T ss_pred ceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----HHH----h
Confidence 9876643221 2233458899999998753 44788999999999999999999998643211 000 0
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... ...... ..+...+..+.+++.+||+.+|++|||+.|+++
T Consensus 240 ~~~~---~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 240 KIPR---NPPPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred hccc---cCCCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0000 000000 011123456999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=301.64 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=196.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecC------C
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLP------A 380 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~ 380 (603)
+...|+..+.||+|+||.||+|...+ +..+|+|.+.... .....+.+|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 34567788899999999999999875 4568999886543 3345688999999998 699999999998653 4
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 5789999999999999987643 23488999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (603)
+....... .......|+..|+|||++. ...++.++||||+||++|||++|+.||...... ..... ..
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~~--~~ 229 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFL--IP 229 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHH--Hh
Confidence 87653322 1223456889999999885 335778999999999999999999998643211 11100 00
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... .........+.++.+++.+||..+|.+|||++|+++
T Consensus 230 ~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNP-------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCC-------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 000111233457899999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.82 Aligned_cols=258 Identities=25% Similarity=0.321 Sum_probs=193.2
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecC-----
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLP----- 379 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 379 (603)
+..++|+..+.||+|+||.||+|.+.. +..||||++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 345789999999999999999999864 45799999865322 2234577899999999999999999887543
Q ss_pred -CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 380 -ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 380 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
...++++|++ +++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ-----KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999987 66998877542 288999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH----
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL---- 533 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~---- 533 (603)
|+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .+..+....
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 236 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPS 236 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 999865432 233468999999999876 568899999999999999999999986532110 000000000
Q ss_pred ------hhhCcchhhhcccCCCcC--------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 ------LKENRLEDVIDKRCADAD--------METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ------~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.........+. ..+..+ ......+.+++.+|+..||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 237 PEVLKKISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHHhcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 000000 012345789999999999999999999995
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.65 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=191.8
Q ss_pred CCCeeeec--CCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 315 EEDVVGSG--GFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 315 ~~~~ig~G--~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
+.++||+| +||+||++.+.. +..||+|++..... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 789999999875 45699999865432 23356788999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++..+.. ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.++++|||..........
T Consensus 82 ~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 99999999875432 2388999999999999999999998 899999999999999999999999986543322111
Q ss_pred c------eeecccccccccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh-------
Q 007455 470 H------VTTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL------- 534 (603)
Q Consensus 470 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 534 (603)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCcccccccc
Confidence 0 0122346678999999865 458899999999999999999999996421100 0000000000
Q ss_pred --hhCc-------------chhhhc----------ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 --KENR-------------LEDVID----------KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 --~~~~-------------~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+. ...... ..........+.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 000000 0000011234567999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=315.14 Aligned_cols=240 Identities=25% Similarity=0.302 Sum_probs=185.6
Q ss_pred eeecCCeEEEEEEECC-CCEEEEEEeCCCCC---ChHHHHHHHHHHHhhC---CCCeeeecceeeecCCccEEEEEecCC
Q 007455 319 VGSGGFGTVYRMVMND-CGTFAVKRIDRSRE---GSDQVFERELEILGSI---KHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 319 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
||+|+||+||+|.+.. +..||+|++..... .....+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999999874 56799999854321 1223345566776655 699999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +++..+..++.|+++||+|||++ +|+||||||+|||++.++.++|+|||+++....... .
T Consensus 81 g~L~~~l~~~~~----~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQKEGR----FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 999998876433 88999999999999999999998 899999999999999999999999999875432221 2
Q ss_pred eecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCc
Q 007455 472 TTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (603)
.....||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ......... .. ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~-~~--------~~~~ 217 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAF-GK--------VRFP 217 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHc-CC--------CCCC
Confidence 2345689999999998654 478999999999999999999999865321 111111110 00 0011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 007455 551 DMETVEAILEIAARCTDANPDDRP----SMNQVLQ 581 (603)
Q Consensus 551 ~~~~~~~l~~li~~cl~~~P~~RP----s~~evl~ 581 (603)
....+.++.+++.+||+.+|++|| ++.++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 112356788999999999999998 5666654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=305.15 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=201.7
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 313 LDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
|.....||+|+||.||++.+. .+..||+|.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 333467999999999999976 4567999998665555556788999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
++|.+++... .+++.++..++.|++.||.|||++ +++||||||+||++++++.++|+|||++........ .
T Consensus 104 ~~L~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~ 174 (292)
T cd06658 104 GALTDIVTHT-----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-K 174 (292)
T ss_pred CcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-c
Confidence 9999987542 278899999999999999999998 899999999999999999999999999876533221 1
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||...... . -.... ...+..... ..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~---~~~~~------~~~~~~~~~-~~ 241 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL---Q---AMRRI------RDNLPPRVK-DS 241 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---H---HHHHH------HhcCCCccc-cc
Confidence 23345888999999998888999999999999999999999998643210 0 00000 001111111 11
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HhhcccCCC
Q 007455 552 METVEAILEIAARCTDANPDDRPSMNQVLQL--LEQEVMSPC 591 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~~~~~ 591 (603)
...+..+.+++.+|+..+|.+|||++|+++. ++....+..
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~ 283 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSC 283 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccc
Confidence 2334578899999999999999999999973 443333333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=313.48 Aligned_cols=244 Identities=30% Similarity=0.430 Sum_probs=201.3
Q ss_pred eeeecCCeEEEEEEECCCCE-EEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCccc
Q 007455 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDD 396 (603)
Q Consensus 318 ~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 396 (603)
+||+|.||+||.|++.+++. +|||-+........+-+.+|+.+-++++|.|||+++|.+.+++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999988764 89999876655555668899999999999999999999999999999999999999999
Q ss_pred cccccCCCCccC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC-CCCCeEEeecccccccCCCCcceee
Q 007455 397 FLHEHGEGQQLL--NWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD-ENLEPHVSDFGLAKLLVDEEAHVTT 473 (603)
Q Consensus 397 ~l~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~~~~~~~~~~~~~~ 473 (603)
+++.... ++ ++.+.-.+..||++||.|||++ .|||||||-+|||++ ..|.+||+|||-++++..-+ ..+.
T Consensus 662 LLrskWG---PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TE 734 (1226)
T KOG4279|consen 662 LLRSKWG---PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTE 734 (1226)
T ss_pred HHHhccC---CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-cccc
Confidence 9987432 24 5667777889999999999999 899999999999995 57899999999998775432 2345
Q ss_pred cccccccccCccccccC--CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 474 VVAGTFGYLAPEYLQSG--RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 474 ~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.+.||..|||||++..+ .|..++|||||||++.||.||++||...... ...+++-+.. +.-+..+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--------qAAMFkVGmy-----KvHP~iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--------QAAMFKVGMY-----KVHPPIP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--------hHhhhhhcce-----ecCCCCc
Confidence 57799999999999654 5788999999999999999999999643210 0111111111 1234467
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+.+.+...+|.+|+..+|.+||++.++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 788889999999999999999999999996
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=296.29 Aligned_cols=251 Identities=29% Similarity=0.457 Sum_probs=200.3
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|+..+.||+|+||.||+|.+. ++..+++|.+...... ..+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778899999999999999976 5567999998655443 456789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++.... .+++..+..++.++++||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHGR----ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhcC----CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 99999999987643 278889999999999999999998 89999999999999999999999999998765433
Q ss_pred ccee---ecccccccccCccccccCC---CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 469 AHVT---TVVAGTFGYLAPEYLQSGR---ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 469 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
.... ....++..|+|||.+.+.. .+.++||||||+++||+++|+.||..... .|..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~--- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-------EFQIMFHVGAGH--- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-------hHHHHHHHhcCC---
Confidence 2221 1345788999999997766 78899999999999999999999864321 011100000000
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+. ....+..+.+++.+||+.+|.+|||+.|++.
T Consensus 224 -~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 -KPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 001111 1123567889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=297.35 Aligned_cols=252 Identities=23% Similarity=0.427 Sum_probs=200.4
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC------hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG------SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
+|+..+.||+|+||.||+|... ++..+|+|.+...... ..+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4778899999999999999975 4567999988643311 23568899999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-CeEEeecccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-EPHVSDFGLAKL 463 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~ 463 (603)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG----AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 999999999999987643 378999999999999999999998 899999999999998876 599999999877
Q ss_pred cCCCCcc---eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 464 LVDEEAH---VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 464 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
....... ......++..|+|||.+.+..++.++||||+|+++|+|++|..||....... ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~----- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFKIAS----- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHHHhc-----
Confidence 6543211 1223457889999999988889999999999999999999999986432111 1111110000
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+..+...+.++.+++.+|+..+|++||++.|+++
T Consensus 226 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 ---ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01112233445678999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=301.18 Aligned_cols=246 Identities=24% Similarity=0.335 Sum_probs=208.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
-|++.+.||+|.|+.|-.|++-- |..||||++++.... +...+..|++.|+-++|||||++|++......+|+|.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 46777889999999999998764 456999999766433 446789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC-CCCCeEEeecccccccCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD-ENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~~~~~~~~ 467 (603)
-++|+|.+|+.++..+ +.+.-+.+++.||+.|+.|+|+. .+|||||||+||.+- .-|-||+.|||++..+.++
T Consensus 99 GD~GDl~DyImKHe~G---l~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEG---LNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred cCCchHHHHHHhhhcc---ccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999987665 88999999999999999999998 799999999998775 5688999999999887655
Q ss_pred CcceeecccccccccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRAT-EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.. ....+|+..|.|||++.+..|+ +++||||+|||||-|++|+.||...... +.+..++|-
T Consensus 173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------ETLTmImDC- 234 (864)
T KOG4717|consen 173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------ETLTMIMDC- 234 (864)
T ss_pred ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------hhhhhhhcc-
Confidence 43 4567899999999999998886 5789999999999999999999754221 112222222
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+...+.+..+||.+||..||++|.+.+||..
T Consensus 235 KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 23356677889999999999999999999999985
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=310.58 Aligned_cols=192 Identities=23% Similarity=0.315 Sum_probs=163.0
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
...+|.+.+.||+|+||.||+|.+..+ ..||+|..... ....|+.++++++||||+++++++......++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 345799999999999999999998754 46888864322 23568999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+. ++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 996 48888876532 2389999999999999999999998 8999999999999999999999999998753322
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPT 515 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~ 515 (603)
. ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 123356899999999999889999999999999999999966554
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=296.25 Aligned_cols=250 Identities=29% Similarity=0.451 Sum_probs=205.4
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
+|++.+.||+|++|.||+|.+.+ +..+++|++..... .....+.+|+..+.+++|+||+++++++......++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 57888999999999999999885 66799999876543 34567899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH-DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
++++|.+++.... .++...++.++.|+++|++|||+ . +++||||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~l~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKKVG----KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999997653 38999999999999999999999 8 89999999999999999999999999998764433
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ........ ......+
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~---------~~~~~~~ 221 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELMQA---------ICDGPPP 221 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHHHH---------HhcCCCC
Confidence 22 22345788999999998888999999999999999999999998654321 11111111 1111112
Q ss_pred CcCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADME-TVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+.. .+..+.+++.+|+..+|++||++.|+++
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 22223 5678999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=316.28 Aligned_cols=258 Identities=19% Similarity=0.208 Sum_probs=193.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
..|.+.+.||+|+||.||+|.+... ..||||.... ..+.+|++++++++|+||+++++++...+..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 4688889999999999999998754 5699995321 23678999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
. ++|.+++.... ..+++.+++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 243 ~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 243 R-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred C-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 6 58888876532 2489999999999999999999998 899999999999999999999999999986543222
Q ss_pred c-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccccc-CCccHhHHHHHHhhhCc-----ch--
Q 007455 470 H-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVK-RGLNVVGWMNTLLKENR-----LE-- 540 (603)
Q Consensus 470 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~-----~~-- 540 (603)
. ......||+.|+|||++.+..++.++|||||||++|||++|..|+-..... .......-....+.... ..
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 223456999999999999989999999999999999999988764321110 00000000111111000 00
Q ss_pred ------hhh-----cccCCC---cC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 ------DVI-----DKRCAD---AD----METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ------~~~-----~~~~~~---~~----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... ....+. .. ......+.+|+.+||+.||.+|||+.|+++
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 000000 00 012346889999999999999999999997
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=300.85 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=203.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367888999999999999999875 4567999998655555566789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++.... +++..+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~~~-----l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 98 LAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCCcHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999999987532 78889999999999999999999 89999999999999999999999999987654433
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
. ......+++.|+|||.+....++.++||||||+++|++++|+.||.......... ...... ....
T Consensus 170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~-------~~~~ 235 (293)
T cd06647 170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG-------TPEL 235 (293)
T ss_pred c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCC-------CCCC
Confidence 2 1223458889999999988888999999999999999999999997542211000 000000 0001
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+..+.+++.+||..+|++||++++++.
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112234567899999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=300.07 Aligned_cols=261 Identities=23% Similarity=0.320 Sum_probs=198.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|+..+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 368888999999999999999874 5679999886432 2234567899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++++|..+...... +++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhCCCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888887654332 89999999999999999999998 8999999999999999999999999999876543
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHH----------Hhhh
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT----------LLKE 536 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~----------~~~~ 536 (603)
.. ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+ ........ ....
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD--QLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChHHhhhccc
Confidence 32 1223457789999998865 457889999999999999999999986432110 00000000 0000
Q ss_pred Ccchhhh-cccCC-C-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 NRLEDVI-DKRCA-D-----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ~~~~~~~-~~~~~-~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....... .+... . .....+..+.+++.+||+.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000 00000 0 00123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=314.78 Aligned_cols=241 Identities=30% Similarity=0.454 Sum_probs=191.4
Q ss_pred CCCeeeecCCeEEEEEEECCCCE-EE---EEEeCCC-CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCc--cEEEEE
Q 007455 315 EEDVVGSGGFGTVYRMVMNDCGT-FA---VKRIDRS-REGSDQVFERELEILGSIKHINLVNLRGYCRLPAT--KLLIYD 387 (603)
Q Consensus 315 ~~~~ig~G~~g~Vy~~~~~~~~~-va---vK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 387 (603)
..++||+|+|-+||||.+..++. || ||.-+.. .....++|..|+++|+.|+||||+++|.++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 45789999999999999976543 32 2211111 12233679999999999999999999999987665 668999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC-CCeEEeecccccccCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN-LEPHVSDFGLAKLLVD 466 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~~~~~~ 466 (603)
.+..|+|..|.++++. ++.....+|++||++||.|||++ .|+|+|||||-+||+++.+ |.|||+|+|+|+....
T Consensus 124 L~TSGtLr~Y~kk~~~----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHhcc----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 9999999999998876 88899999999999999999998 4789999999999999764 8999999999998754
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh---hhCcchhhh
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL---KENRLEDVI 543 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 543 (603)
.. .....|||.|||||... ..|++.+||||||+.++||+|+..||.. .......-+++. +...+..+
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE-----C~n~AQIYKKV~SGiKP~sl~kV- 268 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE-----CTNPAQIYKKVTSGIKPAALSKV- 268 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh-----hCCHHHHHHHHHcCCCHHHhhcc-
Confidence 32 23478999999999998 6899999999999999999999999852 111111111111 11111111
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...++.+||.+|+.. .++|||+.|+|+
T Consensus 269 ----------~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 269 ----------KDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ----------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 125799999999999 999999999996
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.07 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=199.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|++.+.||+|+||.||+|.+. ++..|++|++.... ......+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999986 45679999986543 33346789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+ +++|.+++.... ..+++.+++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999987543 3489999999999999999999998 89999999999999999999999999998765443
Q ss_pred cceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC----------
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN---------- 537 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------- 537 (603)
........++..|+|||.+.+. .++.++||||+|+++|||++|..||..... .....+........
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence 2223345688999999988654 468899999999999999999877754321 01111111100000
Q ss_pred --cchhhhcccCC-----CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 --RLEDVIDKRCA-----DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 --~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........... .........+.+++.+|+..+|++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 001123478999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=303.12 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=199.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||++.+.. +..+|+|.+.... ....+.+.+|++++++++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 367888999999999999999874 5679999886432 223456889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++++|.+++..... ++...+..++.|++.||.|||+. +++||||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~~----l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKSGR----FPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999876533 88999999999999999999998 899999999999999999999999999987644
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
. .....+++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ..-..... ..
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~--------- 213 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKIL-EG--------- 213 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHh-cC---------
Confidence 3 2334588999999999888889999999999999999999999864321 00000000 00
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
....+...+..+.+++.+||..+|.+|+ +++|+++
T Consensus 214 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 214 KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 1112223356789999999999999998 7777763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=299.41 Aligned_cols=260 Identities=28% Similarity=0.380 Sum_probs=200.0
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecC--CccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLP--ATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 387 (603)
+|+..+.||.|++|.||+|.+.+ +..+|+|.+..... .....+.+|++++++++||||+++++++... ...++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 57778899999999999999865 45689998864432 3345689999999999999999999988654 46799999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++++|.+++.........++......++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999988765333334578899999999999999999998 8999999999999999999999999998755332
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
.. ....++..|+|||.+.+..++.++||||+|+++|||++|+.||....... ............. .... +.. .
T Consensus 159 ~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~-~~~~-~~~-~ 231 (287)
T cd06621 159 LA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNM-PNPE-LKD-E 231 (287)
T ss_pred cc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhcC-Cchh-hcc-C
Confidence 21 23457788999999988889999999999999999999999997652211 1111111111110 0000 000 0
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.......+..+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111234567999999999999999999999997
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=301.53 Aligned_cols=263 Identities=27% Similarity=0.410 Sum_probs=197.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|+..+.||+|+||.||+|.+.+ +..+|+|++...... ..+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 367888999999999999999874 567999987543322 34568899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++++|.++...... +++..++.++.|+++||.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKYPNG----LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999998887654322 88999999999999999999998 8999999999999999999999999998765443
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCc-cHhHH-------HHHHhhhCc
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL-NVVGW-------MNTLLKENR 538 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~-~~~~~-------~~~~~~~~~ 538 (603)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......... ....+ .........
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 154 GE-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred cc-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 32 2233457889999998865 45678999999999999999999988643210000 00000 000000000
Q ss_pred ch-hhhcccCC------CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LE-DVIDKRCA------DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~-~~~~~~~~------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. ....+... ......+..+.+++.+||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 00000000 001133567999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=296.62 Aligned_cols=249 Identities=25% Similarity=0.343 Sum_probs=195.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--C---ChHHHHHHHHHHHhhCCCCeeeecceeeecC--Ccc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--E---GSDQVFERELEILGSIKHINLVNLRGYCRLP--ATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 382 (603)
.+|++.+.||+|+||.||+|.+.+ +..||+|.+.... . ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 468889999999999999999865 5679999875322 1 1234678899999999999999999988664 457
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
+++|||+++++|.+++..... +++.....++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGA----LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999876433 78888999999999999999998 89999999999999999999999999987
Q ss_pred ccCCCCc--ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 463 LLVDEEA--HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 463 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~------ 222 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAA-IFKIA------ 222 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHH-HHHHh------
Confidence 6532211 112234588899999999888889999999999999999999999864211 000 00000
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+..+......+.+++.+|+. +|++||+++|+++
T Consensus 223 --~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 --TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred --cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0111122334555678899999995 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=297.24 Aligned_cols=253 Identities=27% Similarity=0.439 Sum_probs=196.9
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC----------hHHHHHHHHHHHhhCCCCeeeecceeeecCC
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG----------SDQVFERELEILGSIKHINLVNLRGYCRLPA 380 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 380 (603)
+|...+.||+|+||.||+|... ++..+|+|.++..... ..+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999876 4567999987532111 1235788999999999999999999999999
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..++||||+++|+|.+++...+ .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++++|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 9999999999999999998753 388899999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcc-eeecccccccccCccccccCC--CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 461 AKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGR--ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 461 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
++........ ......|+..|+|||.+.... ++.++|+||+|+++||+++|..||..... ..... .... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~-~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMF-KLGN-K 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHH-Hhhc-c
Confidence 9765432211 123345788999999987654 78899999999999999999999853211 11110 0000 0
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+.. ......+.++.+++.+||..+|++||+++++++
T Consensus 228 ~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 228 RSAPPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccCCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000111 111234578999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=303.82 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=199.6
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|++.+.||+|+||.||+|.+.+ +..|++|.++... ....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 67888999999999999999875 4569999886432 23346789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
++++.+..+..... .+++..+..++.|++.||.|||++ +++||||+|+||++++++.++|+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEASPG----GLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99877766554432 278999999999999999999998 89999999999999999999999999998765544
Q ss_pred cceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh------------
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK------------ 535 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------ 535 (603)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||...... +..........
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLYLIQKCLGPLPPSHQELFSS 231 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHhhhccc
Confidence 3233345678899999999877 7889999999999999999999998643211 00000000000
Q ss_pred hCcchh--hhcccCC-----CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 536 ENRLED--VIDKRCA-----DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 536 ~~~~~~--~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...... ..+.... ..+...+.++.+++++||..+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000000 0000000 011123677999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=304.19 Aligned_cols=245 Identities=22% Similarity=0.365 Sum_probs=197.3
Q ss_pred CCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCC
Q 007455 315 EEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGS 393 (603)
Q Consensus 315 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (603)
....||+|+||.||+|.+. ++..||+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999976 566799999865555556678899999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceee
Q 007455 394 LDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT 473 (603)
Q Consensus 394 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~ 473 (603)
|.+++... .+++..++.++.|++.||+|||++ +++||||+|+||+++.++.++|+|||++........ ...
T Consensus 105 L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 175 (297)
T cd06659 105 LTDIVSQT-----RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRK 175 (297)
T ss_pred HHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-ccc
Confidence 99877542 278999999999999999999998 899999999999999999999999999875543221 223
Q ss_pred cccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHH
Q 007455 474 VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADME 553 (603)
Q Consensus 474 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (603)
...|+..|+|||.+.+..++.++||||||+++|||++|+.||..... ... .... .... . ........
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~---~~~~-~~~~-~-----~~~~~~~~ 242 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQA---MKRL-RDSP-P-----PKLKNAHK 242 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHH---HHHH-hccC-C-----CCccccCC
Confidence 35688999999999888899999999999999999999999864321 011 1110 0000 0 00011122
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 554 TVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 554 ~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+..+.+++.+||+.+|++||+++++++
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 3456899999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=299.12 Aligned_cols=251 Identities=29% Similarity=0.421 Sum_probs=202.3
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
+|+..+.||+|+||.||+|.+.. +..+++|.+..... ...+.+.+|++++++++||||+++++.+......++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 56778899999999999999874 56799998865532 34456889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH-DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
++++|.+++.... ..++......++.|++.|++|||+ . +++||||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999987643 338889999999999999999999 7 89999999999999999999999999987653322
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.. ...++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ............. ...+
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~---------~~~~ 222 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVN---------EPPP 222 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhc---------CCCC
Confidence 11 156888999999998889999999999999999999999998654211 1111112211111 1111
Q ss_pred CcCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADME-TVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+.. .+.++.+++.+||..+|++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11222 5667999999999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=294.81 Aligned_cols=248 Identities=23% Similarity=0.384 Sum_probs=199.3
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|+..+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+++++.++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 47788999999999999999864 4569999886542 22345788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-CeEEeecccccccCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-EPHVSDFGLAKLLVDE 467 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~~~~~ 467 (603)
+++++|.+++.... ...+++..+..++.++++||+|||++ +++||||+|+||++++++ .++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997643 23478999999999999999999998 899999999999998654 5899999999876543
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... ...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~------~~~~~~~~~---------~~~ 218 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL------PALVLKIMS---------GTF 218 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch------HHHHHHHHh---------cCC
Confidence 22 2234578899999999888889999999999999999999999865321 111111111 111
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+...+..+.+++.+||..+|++|||++|+++
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112234567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=304.29 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=200.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|+..+.||+|+||.||+|...+ +..+|+|.+...... ..+.+.+|+++++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 367888999999999999999875 567999998754332 3356889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+.+++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 9999999999987542 23488999999999999999999998 899999999999999999999999999875432
Q ss_pred CCcc----------------------------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcc
Q 007455 467 EEAH----------------------------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPT 518 (603)
Q Consensus 467 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~ 518 (603)
.... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 111235788999999998888999999999999999999999998643
Q ss_pred cccCCccHhHHHHHHhhhCcchhhhcccCC-CcCHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 007455 519 FVKRGLNVVGWMNTLLKENRLEDVIDKRCA-DADMETVEAILEIAARCTDANPDDRPS----MNQVLQ 581 (603)
Q Consensus 519 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs----~~evl~ 581 (603)
... ..+. ........ ......+..+.+++.+||..+|++||| ++|+++
T Consensus 236 ~~~-----~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRD-----ETFS----------NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chH-----HHHH----------HHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 211 0010 01111110 111124678999999999999999999 777776
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=295.02 Aligned_cols=255 Identities=27% Similarity=0.405 Sum_probs=202.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||.|+||+||+|...+ +..+++|++.... ......+.+|++.++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 468889999999999999999764 4569999886433 22456789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++..... ...+++..+..++.|++.||+|||++ +++||||+|+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976432 12378999999999999999999998 89999999999999999999999999987765433
Q ss_pred cc---eeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 469 AH---VTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 469 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
.. ......|+..|+|||.+... .++.++|+||||+++|||++|+.||....... . .. ...... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~---~~-~~~~~~------~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--V---LM-LTLQND------P 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--h---HH-HHhcCC------C
Confidence 22 22334588899999998766 78899999999999999999999986432110 0 00 001100 0
Q ss_pred ccCCCc--CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADA--DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~--~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...... ....+..+.+++.+||..+|++||+++++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 011111 1244577899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.85 Aligned_cols=256 Identities=27% Similarity=0.412 Sum_probs=196.1
Q ss_pred CCCCCeeeecCCeEEEEEEECC----CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCC------
Q 007455 313 LDEEDVVGSGGFGTVYRMVMND----CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPA------ 380 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 380 (603)
|.+.+.||+|+||.||+|.+.. +..+|+|.+...... ..+.+.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 5667899999999999998642 356999988654322 3456889999999999999999999886532
Q ss_pred ccEEEEEecCCCCccccccccC--CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHG--EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
..++++||+.+|+|.+++.... .....+++...+.++.|++.||+|||+. +++||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999988875322 1223478899999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhh
Q 007455 459 GLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKE 536 (603)
Q Consensus 459 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 536 (603)
|.++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||..... .... ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~---~~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIY---NYLIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHH---HHHHcC
Confidence 998865433211 1122335578999999988888999999999999999999 7888754311 1111 111111
Q ss_pred CcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
.. ...+...+..+.+++.+|++.+|++||++.++++.|++.
T Consensus 232 ~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 111123446799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=301.03 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=199.7
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecC---
Q 007455 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLP--- 379 (603)
Q Consensus 305 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--- 379 (603)
++..+.++|++.+.||+|+||.||+|...+ +..+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 344456789999999999999999999864 5569999886433 2345678899999999 799999999998654
Q ss_pred --CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEee
Q 007455 380 --ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSD 457 (603)
Q Consensus 380 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 457 (603)
+..++|+||+++|+|.++++........+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~d 171 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVD 171 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEee
Confidence 357999999999999998865333334488999999999999999999998 899999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCccccccC-----CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHH
Q 007455 458 FGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG-----RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT 532 (603)
Q Consensus 458 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 532 (603)
||++........ ......|+..|+|||.+... .++.++||||+|+++|||++|+.||...... ... ..
T Consensus 172 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~--~~~----~~ 244 (291)
T cd06639 172 FGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV--KTL----FK 244 (291)
T ss_pred cccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH--HHH----HH
Confidence 999876543221 12234578899999987543 2578999999999999999999998643210 000 00
Q ss_pred HhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... .... .. ..+......+.+++.+||+.+|++||++.|+++
T Consensus 245 ~~~-~~~~-----~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 IPR-NPPP-----TL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred Hhc-CCCC-----CC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 0000 00 112234457999999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=299.27 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=194.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC-ChHHHHHHHHHH-HhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE-GSDQVFERELEI-LGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|++.+.||+|+||.||+|.+.. +..||+|++..... .....+..|+.. ++..+||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 367888999999999999999874 56799999865432 233455666665 566789999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|++ |+|.+++.........+++..++.++.|++.||+|||++. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 5888887654333345899999999999999999999863 7999999999999999999999999998765432
Q ss_pred CcceeecccccccccCcccccc----CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS----GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
. ......++..|+|||.+.+ ..++.++|+||+|+++|||++|+.||..... .. ...... .
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~-~~~~~~---------~ 221 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----PF-QQLKQV---------V 221 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----CH-HHHHHH---------H
Confidence 1 1123457889999998864 4467899999999999999999999864211 00 011111 1
Q ss_pred cccCCCc-CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADA-DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~-~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+.. ....+.++.+++.+||..+|++||+++++++
T Consensus 222 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 222 EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111111 1234567999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=302.97 Aligned_cols=255 Identities=20% Similarity=0.322 Sum_probs=200.2
Q ss_pred CCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
+|+..+.||+|+||.||++.+... +.|++|.+..... .....+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 678889999999999999998754 5699998865432 223467899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++++|.+++...+ .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||+++.....
T Consensus 82 ~~~g~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 82 YVEGGDCATLLKNIG----ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred cCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999997643 288999999999999999999998 8999999999999999999999999988642110
Q ss_pred C--------------cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH
Q 007455 468 E--------------AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 468 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
. ........++..|+|||.+....++.++|+||||+++|||++|..||.... ...+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~------~~~~~~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT------PEELFGQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH
Confidence 0 001112357788999999988889999999999999999999999986421 11111111
Q ss_pred hhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
.... . ..+......+.++.+++.+||+.+|++||++.++.+.|+.-
T Consensus 229 ~~~~-~------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 229 ISDD-I------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred Hhcc-c------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 1110 0 00111113456789999999999999999987777777663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=312.23 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=200.7
Q ss_pred CCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCC
Q 007455 314 DEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 314 ~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
.++..||.|+||.||+|..++++. .|.|++.......-+.+.-|+++|+..+||+||++++.|...+.++++.|||.||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 345668999999999999987665 5778887666666677899999999999999999999999999999999999999
Q ss_pred CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCccee
Q 007455 393 SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472 (603)
Q Consensus 393 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 472 (603)
-++..+-.-+ .++.+.++..++.|++.||.|||++ .|||||||+.|||++-+|.++++|||.+..... .....
T Consensus 115 AVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR 187 (1187)
T KOG0579|consen 115 AVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR 187 (1187)
T ss_pred hHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence 9988776543 3489999999999999999999999 899999999999999999999999998854321 22344
Q ss_pred ecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 473 TVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 473 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
..+.|||+|||||+.. ..+|+.++||||||++|.||..+.+|..... . ++..++-.. -++..
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------p---MRVllKiaK----SePPT 254 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------P---MRVLLKIAK----SEPPT 254 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------h---HHHHHHHhh----cCCCc
Confidence 5688999999999873 5688999999999999999999999965321 1 111111000 00111
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.-.+...+..+.+++.+||.++|..||++.++++
T Consensus 255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1134556678999999999999999999999986
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=296.89 Aligned_cols=247 Identities=28% Similarity=0.331 Sum_probs=200.9
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
+|++.+.||+|+||.||+|.+.. +..+|+|.+..... ...+.+.+|++++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47788999999999999999874 56799998864332 234678899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+.+++|.+++.... .++...+..++.|+++||.|||++ +++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~~L~~~l~~~~----~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQKV----KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 999999999987652 388999999999999999999998 8999999999999999999999999998776443
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
. ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||...... ...+....... ..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~---------~~ 218 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET---------AD 218 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc---------cc
Confidence 2 123355788999999998888999999999999999999999998754321 11111111110 11
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSM--NQVL 580 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~--~evl 580 (603)
...+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 12233445789999999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=296.15 Aligned_cols=247 Identities=25% Similarity=0.387 Sum_probs=197.6
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCC---CCeeeecceeeecCCccEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-EGSDQVFERELEILGSIK---HINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 386 (603)
.|+..+.||+|+||.||+|.+. ++..+++|.+.... ......+.+|+.+++.++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677889999999999999975 45679999886543 233456889999999996 999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++++|.++++.. .+++..++.++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999988653 388999999999999999999998 899999999999999999999999999987654
Q ss_pred CCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
... ......|+..|+|||.+.++ .++.++|+||||+++|+|++|..||...... .+.... ... ..+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~------~~~~~~-~~~-----~~~ 220 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF------RAMMLI-PKS-----KPP 220 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh------hhhhcc-ccC-----CCC
Confidence 432 22334688899999988654 4688999999999999999999998653211 111000 000 000
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... ....+.++.+++.+||+.+|++||++.|+++
T Consensus 221 ~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 221 RLE--DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111 1124567999999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=298.80 Aligned_cols=259 Identities=23% Similarity=0.323 Sum_probs=197.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC-----hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG-----SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+|+..+.||+|+||.||+|.+. +++.|++|.+...... ....+..|++++++++|+||+++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999976 4668999999654322 234577899999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+ +|+|.+++.... ..+++..+..++.|+++||.|||++ +++||||+|+||+++.++.++|+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 889999997643 2489999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh---------
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK--------- 535 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 535 (603)
..... .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||...... ...........
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI---DQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH---HHHHHHHHHcCCCchhhhhh
Confidence 43221 222346788999998854 45788999999999999999998777543210 00000000000
Q ss_pred hCcchhhhccc-CCC-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 536 ENRLEDVIDKR-CAD-----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 536 ~~~~~~~~~~~-~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........... ... .....+..+.+++.+||+.+|++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000 000 11223567899999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=294.21 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=200.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|+..+.||+|+||.||+|.++. +..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 46778899999999999999875 5679999886432 22345688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC-eEEeecccccccCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE-PHVSDFGLAKLLVDE 467 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfG~~~~~~~~ 467 (603)
+++++|.+++..... ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 999999999876432 2478999999999999999999998 8999999999999998864 699999998776443
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
.. ......|++.|+|||...+..++.++|+||||+++|||++|+.||.... ...+...... ...
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~---------~~~ 219 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ---------GYF 219 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc---------ccC
Confidence 22 2233458889999999988889999999999999999999999986432 1122221111 111
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.......+.++.+++.+|+..+|++|||+.|+++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112234467999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=294.72 Aligned_cols=246 Identities=26% Similarity=0.417 Sum_probs=198.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
-|+..+.||+|+||.||+|.+. ++..+|+|.+..... .....+.+|+.++++++||||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4667789999999999999876 456799998754332 23356889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999988643 278999999999999999999998 899999999999999999999999999876543221
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ..+.... .. ...+.
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~-~~--------~~~~~ 220 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP------MKVLFLI-PK--------NNPPT 220 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch------HHHHHHH-hc--------CCCCC
Confidence 12234578899999999888889999999999999999999999864211 1111111 00 01111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+.++.+++.+||+.+|.+||++.++++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 22334567999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.75 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=194.7
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|+..+.||+|++|.||+|++. .+..||||++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999986 45679999886433 22335688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+. ++|.+++..... ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 588888865432 3488999999999999999999998 89999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh-----------
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGR-ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE----------- 536 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------- 536 (603)
. ......++..|+|||.+.+.. ++.++||||||+++|||+||+.||...... ..........-..
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHH
Confidence 1 122234678899999886544 588999999999999999999998643211 0010000000000
Q ss_pred CcchhhhcccCC----CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 NRLEDVIDKRCA----DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......+..... ........++.+++.+|++.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 001123456889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=299.65 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=193.5
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|+..+.||+|+||.||+|.+.. +..+|+|.+.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 47778899999999999999874 5579999886432 22234578899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++ +|.+++.... ..+++..++.++.|+++||.|||+. +++||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CDQ-DLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 975 7877776432 2389999999999999999999998 89999999999999999999999999987654322
Q ss_pred cceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh---hCc------
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK---ENR------ 538 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~------ 538 (603)
. ......++..|+|||.+.+. .++.++||||+|+++|||++|+.|+..... .......... ...
T Consensus 154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-----VDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC-----HHHHHHHHHHHhCCCChHHhHH
Confidence 1 12234578899999988664 468899999999999999999998643211 0011110000 000
Q ss_pred chhhhc----ccCC------CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVID----KRCA------DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~----~~~~------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+ .... ......+.++.+++.+||+.||.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0000 011123467889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=296.89 Aligned_cols=255 Identities=26% Similarity=0.377 Sum_probs=199.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCC------
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPA------ 380 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------ 380 (603)
..++|++.+.||+|++|.||+|.+.. +..+++|.+..... ....+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45789999999999999999999864 45699998865443 346689999999999 7999999999997644
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 47999999999999999876442234589999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQS-----GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (603)
+....... .......|+..|+|||.+.. ..++.++||||+|+++|+|++|+.||...... . -.....
T Consensus 160 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~-~~~~~~- 231 (275)
T cd06608 160 SAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-----R-ALFKIP- 231 (275)
T ss_pred ceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-----H-HHHHhh-
Confidence 87654322 22233558889999998753 34677899999999999999999998643110 0 000000
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... .... ..+...+.++.+++.+||..||++|||++|+++
T Consensus 232 ~~~-----~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNP-----PPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccC-----CCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 0001 112235568999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=296.58 Aligned_cols=248 Identities=25% Similarity=0.358 Sum_probs=206.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.+.|..-++||+|+||.||-+..+.++. ||.|++.+.. ...+.....|-.++.++..+.||.+--.|...+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 3567778999999999999998887666 8999885432 23345678899999999999999998889999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
+..|.||+|.-++...+. ..+++..+.-.+.+|+.||++||.. +||.||+||+|||+|+.|+++|+|.|+|..+.
T Consensus 264 LtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999999987664 4499999999999999999999999 89999999999999999999999999999887
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
+.... ...+||.+|||||+++++.|+...|.||+||++|||+.|+.||.....+ .+.+.+.+.+..
T Consensus 339 ~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK------------vk~eEvdrr~~~ 404 (591)
T KOG0986|consen 339 EGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK------------VKREEVDRRTLE 404 (591)
T ss_pred CCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh------------hhHHHHHHHHhc
Confidence 65543 3447999999999999999999999999999999999999998643211 112223333333
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSM 576 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~ 576 (603)
....++...+++..++.+..|..||++|...
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 3334556777889999999999999999543
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=296.71 Aligned_cols=247 Identities=23% Similarity=0.351 Sum_probs=199.3
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 313 LDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
|...+.||+|++|.||+|.+. ++..+++|++........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444579999999999999975 5567999988655545556788999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
++|.+++... .+++..+..++.|++.||+|||++ +++||||+|+||+++.++.++|+|||.+........ .
T Consensus 101 ~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVTHT-----RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 9999988762 278899999999999999999998 899999999999999999999999998875543221 2
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....|++.|+|||...+..++.++||||||+++|||++|+.||..... ........... ... ....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~~------~~~-~~~~ 238 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDNL------PPK-LKNL 238 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhcC------CCC-Cccc
Confidence 2334588999999999888899999999999999999999999864221 11111111110 000 0111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+..+.+++.+||..+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 224567999999999999999999999996
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=297.30 Aligned_cols=256 Identities=26% Similarity=0.365 Sum_probs=197.1
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeec----
Q 007455 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRL---- 378 (603)
Q Consensus 305 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 378 (603)
++......|++.+.||+|+||.||+|.+.+ +..+|+|.+.... .....+..|+.++.++ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 333456788889999999999999999864 4568999875543 2335688899999998 69999999998853
Q ss_pred --CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEe
Q 007455 379 --PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS 456 (603)
Q Consensus 379 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 456 (603)
....+++|||+++|+|.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEe
Confidence 4567999999999999999876432 2377888999999999999999998 89999999999999999999999
Q ss_pred ecccccccCCCCcceeecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHH
Q 007455 457 DFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 457 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 531 (603)
|||++........ ......|++.|+|||.+. ...++.++||||||+++|||++|+.||..........
T Consensus 164 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~------ 236 (282)
T cd06636 164 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF------ 236 (282)
T ss_pred eCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh------
Confidence 9999876532211 123345888999999875 3457789999999999999999999986432110000
Q ss_pred HHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 532 TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ..... . ........+.++.+++.+||+.+|.+||++.|+++
T Consensus 237 ~-~~~~~-----~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 L-IPRNP-----P--PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h-HhhCC-----C--CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00000 0 00011234567999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=296.38 Aligned_cols=260 Identities=25% Similarity=0.373 Sum_probs=194.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|+..+.||+|++|.||+|.+. ++..||+|.+..... .....+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 467888999999999999999987 456799999864332 223456789999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+.+ +|.+++..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++.....
T Consensus 84 ~~~~-~L~~~~~~~~~---~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 84 YLDT-DLKQYMDDCGG---GLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred cCCC-CHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9985 99988875432 378999999999999999999998 8999999999999999999999999998754322
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh---hCcchhh-
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK---ENRLEDV- 542 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 542 (603)
.. ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ............ .......
T Consensus 157 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07844 157 SK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV--EDQLHKIFRVLGTPTEETWPGVS 233 (291)
T ss_pred Cc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHhcCCCChhhhhhhh
Confidence 11 1122346788999998865 45788999999999999999999998643210 000000000000 0000000
Q ss_pred -----------------hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 -----------------IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 -----------------~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+..... .......+.+++.+|++.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 234 SNPEFKPYSFPFYPPRPLINHAP--RLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hccccccccccccCChhHHHhCc--CCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000 0011256889999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=288.32 Aligned_cols=249 Identities=29% Similarity=0.448 Sum_probs=203.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
.|+..+.||+|++|.||++.+. ++..+++|++..........+.+|+++++.++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999987 556799999876655456679999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+++|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999987653 2389999999999999999999998 899999999999999999999999999987654432
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCc
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (603)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... . .......
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~------~~~~~~~ 219 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP------MKALFKIAT-N------GPPGLRN 219 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch------HHHHHHHHh-c------CCCCcCc
Confidence 2345678899999999888889999999999999999999999864311 011111000 0 0000011
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 551 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+..+.+++.+||+.+|++|||+.|+++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122567999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=290.63 Aligned_cols=251 Identities=27% Similarity=0.398 Sum_probs=205.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|++.+.||+|+||.||++.+. ++..+++|++..... .....+.+|+++++.++|+|++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999987 456799999876543 3456788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999987543334589999999999999999999998 89999999999999999999999999998765433
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......|++.|+|||...+..++.++|+||+|+++++|++|+.||.... ......... .....
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~------~~~~~~~~~---------~~~~~ 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN------LLELALKIL---------KGQYP 221 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc------HHHHHHHHh---------cCCCC
Confidence 22334568889999999988889999999999999999999999986432 111111111 11112
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+..+.+++.+||..+|++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 222344567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=320.36 Aligned_cols=260 Identities=18% Similarity=0.245 Sum_probs=188.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhCCC------CeeeecceeeecC-C
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSIKH------INLVNLRGYCRLP-A 380 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~~-~ 380 (603)
...+|++.++||+|+||+||+|.+..+ ..||||+++... .....+..|+.+++.++| .+++++++++... .
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 357899999999999999999998754 469999986432 223345677887777754 4588888888765 4
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC---------
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL--------- 451 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--------- 451 (603)
..++|||++ +++|.+++...+. +++..+..++.||+.||.|||++. +|+||||||+|||++.++
T Consensus 206 ~~~iv~~~~-g~~l~~~l~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 206 HMCIVMPKY-GPCLLDWIMKHGP----FSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred eEEEEEecc-CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccccc
Confidence 678899987 6688888876533 899999999999999999999732 899999999999998765
Q ss_pred -------CeEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCc
Q 007455 452 -------EPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL 524 (603)
Q Consensus 452 -------~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~ 524 (603)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+........
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred ccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 499999998764322 223467899999999999999999999999999999999999999753211100
Q ss_pred cH---------hHHHHHHhhhCcchhhhcc------c------------CCCcCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007455 525 NV---------VGWMNTLLKENRLEDVIDK------R------------CADADMETVEAILEIAARCTDANPDDRPSMN 577 (603)
Q Consensus 525 ~~---------~~~~~~~~~~~~~~~~~~~------~------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ 577 (603)
.. ..|....... .....+.. . ...........+.+|+.+||+.||++|||++
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~ 433 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTE-EARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNAR 433 (467)
T ss_pred HHHHHHcCCCCHHHHhhccch-hHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHH
Confidence 00 0111100000 00000000 0 0000001134578999999999999999999
Q ss_pred HHHH
Q 007455 578 QVLQ 581 (603)
Q Consensus 578 evl~ 581 (603)
|+++
T Consensus 434 e~L~ 437 (467)
T PTZ00284 434 QMTT 437 (467)
T ss_pred HHhc
Confidence 9996
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=295.90 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=203.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.+.|+..+.||+|+||.||+|.+. ++..+++|++..... ..+.+.+|+++++.++|+|++++++++......++++||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 456777889999999999999987 567799999875544 456788999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 97 MDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999998754 2489999999999999999999998 89999999999999999999999999887654332
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...... ........ .... ..
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~------~~ 236 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITT-KGIP------PL 236 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-cCCC------CC
Confidence 1 122345788999999998888999999999999999999999998643211 11111000 0000 00
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......+..+.+++.+|++.+|.+||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111224567999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=299.90 Aligned_cols=266 Identities=22% Similarity=0.317 Sum_probs=196.4
Q ss_pred CCCCCCeeeecCCeEEEEEEECC---CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecC--CccE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND---CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLP--ATKL 383 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 383 (603)
+|++.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 46778899999999999999865 4679999997633 33345678899999999999999999999888 7899
Q ss_pred EEEEecCCCCccccccccCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC----CCCeEEeec
Q 007455 384 LIYDYLSMGSLDDFLHEHGEG-QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE----NLEPHVSDF 458 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~Df 458 (603)
+||||+++ ++.+++...... ...++...++.++.|++.||+|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 677666543322 22588999999999999999999998 8999999999999999 899999999
Q ss_pred ccccccCCCCc--ceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCc-------cHhH
Q 007455 459 GLAKLLVDEEA--HVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL-------NVVG 528 (603)
Q Consensus 459 G~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~-------~~~~ 528 (603)
|++........ .......++..|+|||.+.+. .++.++||||||+++|||++|+.||......... .+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 112334578899999987654 5789999999999999999999999754322100 0000
Q ss_pred HHHHH-----------hhhCcchhhhc-ccCCCcC-----------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 529 WMNTL-----------LKENRLEDVID-KRCADAD-----------METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 529 ~~~~~-----------~~~~~~~~~~~-~~~~~~~-----------~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..... ..........+ ......+ .....++.+++.+|++.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000000000 0000000 023456899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=294.28 Aligned_cols=264 Identities=22% Similarity=0.299 Sum_probs=194.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
+.+|.+.+.||+|+||.||+|... +++.|++|.+.... ......+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467889999999999999999876 46679999986443 2233467889999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+. +++.+++.... ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 57777665432 2267888889999999999999998 8999999999999999999999999998754332
Q ss_pred CcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHH----------HHHhhh
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWM----------NTLLKE 536 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~~ 536 (603)
.. ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.........-...|. ......
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 21 12234468899999998653 4788999999999999999999999753211000000000 000000
Q ss_pred CcchhhhcccC-CC------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 NRLEDVIDKRC-AD------ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ~~~~~~~~~~~-~~------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........... +. ........+.+++.+|+..||++|||++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00000000000 00 00112457889999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=291.78 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=203.5
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|++.+.||+|+||.||++.+.. +..+++|.+.... ......+.+|++++++++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47788999999999999998764 4579999986543 22344678899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++.........+++..++.++.|++.||+|||+. +++||||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999877444344589999999999999999999998 8999999999999999999999999999876543
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
......++..|+|||.+.+..++.++|+||+|+++|||++|+.||..... ...... . .....+
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~-~--------~~~~~~ 219 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM------QDLRYK-V--------QRGKYP 219 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH-H--------hcCCCC
Confidence 22234578899999999888899999999999999999999999864321 001000 0 111122
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+.++.+++.+|+..+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 233355678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=290.41 Aligned_cols=242 Identities=27% Similarity=0.358 Sum_probs=195.9
Q ss_pred eeecCCeEEEEEEECC-CCEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCc
Q 007455 319 VGSGGFGTVYRMVMND-CGTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 319 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
||.|+||.||+|.+.. +..+++|.+..... ...+.+.+|+++++.++||||+++++++.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999875 56799999865332 3346789999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeec
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 474 (603)
.+++..... ++...+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~----l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDRGL----FDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhcCC----CCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999976533 78899999999999999999998 89999999999999999999999999998765432 2233
Q ss_pred ccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHH
Q 007455 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554 (603)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (603)
..++..|++||.+.+..++.++|+||+|+++|||++|..||..... +........... ......+...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~--------~~~~~~~~~~ 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE----DPMEIYNDILKG--------NGKLEFPNYI 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC----CHHHHHHHHhcc--------CCCCCCCccc
Confidence 4678899999999888899999999999999999999999875421 111111111110 1111122233
Q ss_pred HHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 555 VEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 555 ~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
+.++.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 568999999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=296.01 Aligned_cols=256 Identities=25% Similarity=0.312 Sum_probs=201.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEC----CCCEEEEEEeCCCC----CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCcc
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN----DCGTFAVKRIDRSR----EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATK 382 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 382 (603)
+|++.+.||+|+||.||++... ++..+|||.+.... ....+.+.+|++++.++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677889999999999999853 44579999886432 22335678999999999 599999999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++||||+++|+|.+++.... .+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE----HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 99999999999999887543 378899999999999999999998 89999999999999999999999999987
Q ss_pred ccCCCCcceeecccccccccCccccccCC--CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGR--ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
..............|+..|+|||...+.. .+.++||||||+++|||++|..||...... ...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~~------ 225 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRIL------ 225 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHHH------
Confidence 76444333333455888999999987655 688999999999999999999998542111 11111111111
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
......+...+..+.+++.+||+.+|++|||+.++.+.|+..
T Consensus 226 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 226 ----KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred ----ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 111222333456789999999999999999999888877664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=293.90 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=195.6
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 313 LDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
|+..+.||+|++|.||+|.+. ++..||+|++.... ....+.+.+|+++++.++|||++++++++......+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999976 56779999886443 223356888999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
+ ++|.+++..... ..+++..++.++.|+++||+|||++ +++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 6 589998876542 2389999999999999999999998 899999999999999999999999999976543221
Q ss_pred ceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH-----------hhhC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL-----------LKEN 537 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~ 537 (603)
. .....++..|+|||++.+. .++.++||||||+++|||++|+.||...... .......... ....
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhch
Confidence 1 1223467899999987654 5688999999999999999999998643210 0001100000 0000
Q ss_pred cchhhhc----ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 RLEDVID----KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 ~~~~~~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+. ..........+..+.+++.+|++.+|++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 0000111223467899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=293.01 Aligned_cols=241 Identities=25% Similarity=0.345 Sum_probs=186.5
Q ss_pred eeeecCCeEEEEEEECC-CCEEEEEEeCCCCC---ChHHHHHHHHHHHh---hCCCCeeeecceeeecCCccEEEEEecC
Q 007455 318 VVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE---GSDQVFERELEILG---SIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 318 ~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
.||+|+||.||++.+.+ +..+|+|.+..... .....+.+|..+++ ..+||||+++++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999865 55799998864322 12233445544433 3479999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++...+. +++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~~----l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQHGV----FSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998876543 89999999999999999999998 89999999999999999999999999987653322
Q ss_pred eeecccccccccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQ-SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
.....|+..|+|||.+. +..++.++||||+|+++|||++|..||....... . ........ .....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~-~~~~~~~~---------~~~~~ 217 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---K-HEIDRMTL---------TVNVE 217 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC---H-HHHHHHhh---------cCCcC
Confidence 12345899999999886 4567899999999999999999999996532211 0 01111000 00111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
.+...+.++.+++.+||..+|++|| +++|+++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 2234556899999999999999999 5999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=294.41 Aligned_cols=244 Identities=28% Similarity=0.412 Sum_probs=193.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
+.|+..+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+++++.++||||+++++++...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999986 4567999988543322 2346889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+.+ ++.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 95 e~~~g-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCLG-SASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhCC-CHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99975 7777665432 2388999999999999999999998 899999999999999999999999999876533
Q ss_pred CCcceeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
. ....++..|+|||++. ...++.++||||||+++|||++|+.||..... ........
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~------~~~~~~~~--------- 227 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIA--------- 227 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH------HHHHHHHh---------
Confidence 2 2345788999999874 45678899999999999999999999864311 00000000
Q ss_pred cccCCC-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCAD-ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+. .....+..+.+++.+||+.+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 228 QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000111 12234567999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=293.48 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=196.4
Q ss_pred CCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecC--CccEEEEE
Q 007455 313 LDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLP--ATKLLIYD 387 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 387 (603)
|++.+.||+|+||.||+|.+.+ +..+|+|.+.... ......+.+|+++++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5677899999999999999875 4569999997653 33345688999999999999999999999888 78999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9985 8888876542 2389999999999999999999998 8999999999999999999999999999876554
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh---hCcch---
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK---ENRLE--- 540 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 540 (603)
.........++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .......... ...+.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCchhhccccc
Confidence 3222333456788999997754 457899999999999999999999987532110 0000000000 00000
Q ss_pred h-----------hhcccCCC-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 D-----------VIDKRCAD-ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ~-----------~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ........ .....+..+.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00000000 00112567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=286.77 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=202.0
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|++.+.||+|++|.||+|.+.. +..+++|.+..... .....+.+|++++++++|+|++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47788999999999999998874 45799999876543 3445789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~----~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKFG----PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 99999999987653 389999999999999999999998 89999999999999999999999999998765433
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.. .....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ....|. .. .....
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~--~~---------~~~~~ 217 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFR--IV---------QDDHP 217 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHH--Hh---------ccCCC
Confidence 22 2334578899999999887788999999999999999999999864321 000110 00 01111
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+..+.+++.+||..+|++|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 222334567999999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=291.45 Aligned_cols=246 Identities=23% Similarity=0.386 Sum_probs=196.1
Q ss_pred eeecCCeEEEEEEECC-CCEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCc
Q 007455 319 VGSGGFGTVYRMVMND-CGTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 319 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
||+|+||.||++.+.. +..+++|.+..... ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999885 66799999865433 3345688999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc-----
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA----- 469 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~----- 469 (603)
.+++...+ .+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~----~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENVG----SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 99997654 389999999999999999999998 899999999999999999999999999876433211
Q ss_pred --ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 470 --HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 470 --~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
.......++..|+|||.......+.++||||||+++||+++|..||..... ......... ... ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~-~~~------~~ 220 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP------EEIFQNILN-GKI------EW 220 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhc-CCc------CC
Confidence 122334577899999999888889999999999999999999999865321 111111111 000 00
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
+. ....+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 221 ~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 PE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred Cc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00 11125678999999999999999999666666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=286.20 Aligned_cols=250 Identities=32% Similarity=0.470 Sum_probs=203.8
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecC--CccEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLP--ATKLLIY 386 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 386 (603)
+|+..+.||+|++|.||+|.+. ++..+++|.+..... ...+.+.+|++++++++|+||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999987 556799998865543 3456789999999999999999999999888 8899999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++++|.+++.... .+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 9999999999998654 389999999999999999999998 899999999999999999999999999987655
Q ss_pred CCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 467 EEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 467 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.... ......++..|+|||...+...+.++||||||+++|+|++|..||.... .... ....... ..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~---~~~~~~~-----~~ 220 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMA---ALYKIGS-----SG 220 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHH---HHHhccc-----cC
Confidence 4321 1233557889999999988889999999999999999999999987542 0000 0000000 01
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+...+..+.+++.+|+..+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 112223344678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=293.19 Aligned_cols=264 Identities=23% Similarity=0.287 Sum_probs=197.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecC--CccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLP--ATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 384 (603)
.++|+..+.||+|+||.||+|.+.. +..+++|.++..... ....+.+|+.++++++||||+++++++... ...++
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4578888999999999999999874 556999998644322 234567899999999999999999998777 88999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++ +|.+++..... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~-~L~~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQ---PFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred EehhcCc-CHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 9999985 99888876432 489999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCcc----------HhHHHHHH
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLN----------VVGWMNTL 533 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~----------~~~~~~~~ 533 (603)
...... .....+++.|+|||.+.+. .++.++|+||+|+++|||++|+.||.......... ...|....
T Consensus 157 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 157 GSPLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred cCCccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 543221 2234578899999988654 46889999999999999999999987532110000 00010000
Q ss_pred h----hhCcchhhhcccCCC-cCHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 L----KENRLEDVIDKRCAD-ADME-TVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ~----~~~~~~~~~~~~~~~-~~~~-~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ............... .+.. .+..+.+++.+||+.+|++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000000000000 1111 3567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=301.85 Aligned_cols=247 Identities=27% Similarity=0.379 Sum_probs=206.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChH--HHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSD--QVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
...|.+...||+|.|+.|..|++.. +.+||||.++++..... ..+.+|+++|..++|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4578888999999999999999875 45799999987654433 44889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+.+|.+.+++.+++. +....+..++.|+.+|++|||++ .|||||||++|||++.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~~gr----~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR----MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHhccc----chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999998765 56688899999999999999999 899999999999999999999999999998863
Q ss_pred CCcceeecccccccccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
. ......+|++.|.|||++.+..| .+++|+||+|+++|.|+.|..||++.....-. ..++.
T Consensus 208 ~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr---------------~rvl~- 269 (596)
T KOG0586|consen 208 G--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR---------------PRVLR- 269 (596)
T ss_pred c--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc---------------chhee-
Confidence 3 34556789999999999998776 57899999999999999999999865322110 00111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+.-.+.+..+++++++..+|.+|++++++.+
T Consensus 270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred eeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 111122334457889999999999999999999985
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=292.11 Aligned_cols=244 Identities=25% Similarity=0.331 Sum_probs=192.5
Q ss_pred eeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCc
Q 007455 319 VGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 319 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
||+|+||+||+|.+. ++..+|+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999876 45679999886432 22234567899999999999999999999999999999999999999
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeec
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 474 (603)
.+++..... ..+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||.+....... ....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 999876542 3488999999999999999999998 89999999999999999999999999987654321 1233
Q ss_pred ccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHH
Q 007455 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554 (603)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (603)
..++..|+|||.+.+..++.++||||+|+++|+|++|+.||........ .. . +...........+...
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~-~---------~~~~~~~~~~~~~~~~ 221 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE--KE-E---------LKRRTLEMAVEYPDKF 221 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc--HH-H---------HHhccccccccCCccC
Confidence 4577899999999888899999999999999999999999865322100 00 0 0000011111122334
Q ss_pred HHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 555 VEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 555 ~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
+..+.+++.+||+.+|++|| ++.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 66799999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.86 Aligned_cols=268 Identities=21% Similarity=0.276 Sum_probs=188.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCE--EEEEEe--------------C---CCCCChHHHHHHHHHHHhhCCCCeee
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGT--FAVKRI--------------D---RSREGSDQVFERELEILGSIKHINLV 370 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~--vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~h~niv 370 (603)
.++|++.+.||+|+||+||++..+.... .+.|.+ . .........+++|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 5689999999999999999987643221 222211 0 01112234688999999999999999
Q ss_pred ecceeeecCCccEEEEEecCCCCccccccccCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC
Q 007455 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG-QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE 449 (603)
Q Consensus 371 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 449 (603)
++++++...+..|+|+|++.+ +|.+++...... ........+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 999999999999999999865 777766542211 11234566788999999999999998 8999999999999999
Q ss_pred CCCeEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccC-CccHhH
Q 007455 450 NLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKR-GLNVVG 528 (603)
Q Consensus 450 ~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~-~~~~~~ 528 (603)
++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..++....... ...+..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~ 382 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLK 382 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHH
Confidence 9999999999998775544333344679999999999998899999999999999999999886433211100 000100
Q ss_pred HHHHHh--hhC------cchhhhcccC-----CCc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 529 WMNTLL--KEN------RLEDVIDKRC-----ADA-----DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 529 ~~~~~~--~~~------~~~~~~~~~~-----~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...... .++ .+.+.++... ... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 383 ~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 383 IIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 000 0000000000 000 0012345778899999999999999999986
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=293.32 Aligned_cols=251 Identities=26% Similarity=0.336 Sum_probs=197.0
Q ss_pred CCCCCCeeeecCCeEEEEEEEC----CCCEEEEEEeCCCC----CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCcc
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN----DCGTFAVKRIDRSR----EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATK 382 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 382 (603)
+|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+++++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677899999999999999873 56679999986432 22335678899999999 599999999999998899
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++|+||+++++|.+++..... +++..+..++.|+++||.|||+. +++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999876433 78889999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCccccccC--CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSG--RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
..............|+..|+|||.+... .++.++||||||+++|+|++|+.||...... .....+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~------ 225 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRIL------ 225 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhh------
Confidence 7644333333345688899999998653 4678999999999999999999998642111 11111111111
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
...+..+......+.+++.+|++.+|++|| ++++++.
T Consensus 226 ----~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 226 ----KSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----ccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111122233456789999999999999997 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=292.07 Aligned_cols=257 Identities=18% Similarity=0.237 Sum_probs=181.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC---C-EEEEEEeCCCCCChH-----------HHHHHHHHHHhhCCCCeeeeccee
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC---G-TFAVKRIDRSREGSD-----------QVFERELEILGSIKHINLVNLRGY 375 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~---~-~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~~ 375 (603)
++|.+.++||+|+||.||+|.+.++ . .+|+|.......... .....+...+..+.|+|++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5788999999999999999998765 3 356664332221110 011233344566789999999987
Q ss_pred eecCC----ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC
Q 007455 376 CRLPA----TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL 451 (603)
Q Consensus 376 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 451 (603)
+.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+. +++||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK----CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc----cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence 65443 23567776644 5555554322 156778899999999999999998 899999999999999999
Q ss_pred CeEEeecccccccCCCCcc------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCcc
Q 007455 452 EPHVSDFGLAKLLVDEEAH------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLN 525 (603)
Q Consensus 452 ~~kl~DfG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~ 525 (603)
.++|+|||+++.+...... ......||+.|+|||+..+..++.++||||+||++|||++|+.||...... ..
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~--~~ 241 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN--GN 241 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc--hH
Confidence 9999999999876432211 112346999999999999999999999999999999999999999754211 11
Q ss_pred HhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007455 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583 (603)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 583 (603)
...-... +.......... .....+.++.+++..|+..+|++||+++++++.+
T Consensus 242 ~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKC----DFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHH----HHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1100000 00011000000 0112346799999999999999999999999876
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=291.33 Aligned_cols=264 Identities=22% Similarity=0.358 Sum_probs=196.8
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
+|+..+.||+|++|.||+|.+.. +..||+|.+..... .....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 47788999999999999999874 45699999865432 23456788999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++ +|.+++..... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 88888865432 23489999999999999999999998 899999999999999999999999999976533221
Q ss_pred ceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCc-cHhHH--------HHHHhhhCcc
Q 007455 470 HVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL-NVVGW--------MNTLLKENRL 539 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~-~~~~~--------~~~~~~~~~~ 539 (603)
......++..|++||.+.+. .++.++||||+|+++|||++|+.||......... ..... ..........
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 12234468899999988653 5688999999999999999999998753211000 00000 0000000000
Q ss_pred hhhhcc----cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 540 EDVIDK----RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 540 ~~~~~~----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+.. .........+..+.+++.+|++.+|.+||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 000001123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=293.68 Aligned_cols=243 Identities=22% Similarity=0.349 Sum_probs=195.6
Q ss_pred CeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCcc
Q 007455 317 DVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLD 395 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 395 (603)
.+||+|+||.||+|... ++..+|+|++..........+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999886 45679999886555555667899999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeecc
Q 007455 396 DFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475 (603)
Q Consensus 396 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~ 475 (603)
+++... .+++.....++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++....... ......
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 106 DIVTHT-----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred HHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 987542 278899999999999999999998 89999999999999999999999999987654322 122334
Q ss_pred cccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHH
Q 007455 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETV 555 (603)
Q Consensus 476 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 555 (603)
.|++.|+|||.+.+..++.++|+||+|+++|||++|..||...... ..... ... ....... .....+
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~------~~~~~-~~~-----~~~~~~~-~~~~~~ 243 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKM-IRD-----NLPPKLK-NLHKVS 243 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HHh-----hCCcccC-CcccCC
Confidence 5788999999998888899999999999999999999998643211 11110 000 0011111 112234
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 556 EAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 556 ~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+.+++.+||+.+|.+||++.++++
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 56889999999999999999999997
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=293.91 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=193.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCC-CCeeeecceeeecCCc-----
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIK-HINLVNLRGYCRLPAT----- 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 381 (603)
++|+..+.||+|+||.||+|.+.. +..||+|.+..... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 368888999999999999999874 56799998764332 22356888999999995 6999999999877665
Q ss_pred cEEEEEecCCCCccccccccCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-CCCeEEeecc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEG-QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-NLEPHVSDFG 459 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 459 (603)
.|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +++||||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 888888654332 34589999999999999999999998 8999999999999998 8899999999
Q ss_pred cccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh-C
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE-N 537 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~ 537 (603)
++..+..... ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||..... . ......... .
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~-~~~~~~~~~~~ 229 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-----L-QQLLHIFKLLG 229 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-----H-HHHHHHHHHhC
Confidence 9876533211 1122346788999998864 4578999999999999999999999864321 0 011100000 0
Q ss_pred -cchhhh------------cccC----CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 -RLEDVI------------DKRC----ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 -~~~~~~------------~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...... .... .......+.++.+++.+||..+|++||+++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000000 0000 0001124567899999999999999999999885
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=294.81 Aligned_cols=263 Identities=27% Similarity=0.347 Sum_probs=195.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCC-----
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPA----- 380 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 380 (603)
..++|++.+.||+|+||.||+|.+.. +..||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 45789999999999999999999874 5679999986432 233456788999999999999999999887654
Q ss_pred -----ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEE
Q 007455 381 -----TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455 (603)
Q Consensus 381 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 455 (603)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEe
Confidence 78999999987 6766665432 2389999999999999999999998 8999999999999999999999
Q ss_pred eecccccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 456 SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 456 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
+|||++...............++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ..........
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 9999998765433222223346778999998754 45688999999999999999999998743211 1000011100
Q ss_pred hhCc---chhh--------hc------ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 KENR---LEDV--------ID------KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 ~~~~---~~~~--------~~------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... .... .+ ..........+..+.+++.+||+.+|.+||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000 00 0000001123567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=292.85 Aligned_cols=255 Identities=28% Similarity=0.405 Sum_probs=192.8
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE-GSDQVFERELEILGSIK-HINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|+..+.||+|+||.||++.+.. +..+|+|.+..... .....+.+|+.++.++. |+||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45566789999999999999874 46799998865432 33456889999999996 99999999999999999999999
Q ss_pred cCCCCcccccccc-CCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 389 LSMGSLDDFLHEH-GEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 389 ~~~gsL~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
+.. ++.++.... ......+++..+..++.+++.||+|||+.. +++||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 875 655543221 111234889999999999999999999753 7999999999999999999999999999765432
Q ss_pred CcceeecccccccccCccccccC---CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSG---RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
.. .....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||.... .............. .
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~~--~--- 229 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGDP--P--- 229 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCCC--C---
Confidence 21 1233578899999998765 68899999999999999999999986431 11111111111000 0
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..........+.++.+++.+||+.+|++|||++++++
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001112235668999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.74 Aligned_cols=251 Identities=28% Similarity=0.382 Sum_probs=203.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
+-+++.+..||.|.||.||.|...++++ .|+|-+.-. .........+|+.++..++|||+|+++|+-.+.+..+|.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 4567778899999999999999988777 789977432 2333355789999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
|||++|+|.+.++.... .++.....+..|++.|++|||++ |||||||||.||+++.+|-+|.+|||.|.....
T Consensus 1314 EyC~~GsLa~ll~~gri----~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI----EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHhccCcHHHHHHhcch----hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999986433 55666667888999999999999 999999999999999999999999999987755
Q ss_pred CCc---ceeecccccccccCccccccC---CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 467 EEA---HVTTVVAGTFGYLAPEYLQSG---RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 467 ~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
... .......||+.|||||++.+. ....+.||||+|||+.||+||+.||..... .|.- +.
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aI-------My 1452 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAI-------MY 1452 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHH-------Hh
Confidence 421 122346799999999999653 345689999999999999999999853211 1211 11
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+.....++.|...+.+-.+++..|+..||++|-++.|+++
T Consensus 1453 ~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1453 HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 22233445566678889999999999999999999988876
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=276.08 Aligned_cols=207 Identities=27% Similarity=0.403 Sum_probs=172.5
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEECCC-----CEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeec-
Q 007455 307 IEKLEALDEEDVVGSGGFGTVYRMVMNDC-----GTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRL- 378 (603)
Q Consensus 307 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~- 378 (603)
.+....|+....||+|.||.||+|...++ ..+|+|+++... .+......+|+.+++.++|||++.+..++..
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 35567899999999999999999975432 258999997543 3344568899999999999999999999876
Q ss_pred CCccEEEEEecCCCCccccccccCCC-CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC----CCe
Q 007455 379 PATKLLIYDYLSMGSLDDFLHEHGEG-QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN----LEP 453 (603)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~----~~~ 453 (603)
+..+++++||.+. +|.+.++-+... ...++...+.+|+.||+.|+.|||++ =|+||||||.|||+..+ |.|
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence 7788999999998 998888754322 24588899999999999999999999 49999999999999887 899
Q ss_pred EEeecccccccCCCCcc--eeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCc
Q 007455 454 HVSDFGLAKLLVDEEAH--VTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDP 517 (603)
Q Consensus 454 kl~DfG~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~ 517 (603)
||+|||+++.+..+-.. .....+-|.+|.|||.+.+. .|+.+.||||.|||+.||+|-.+-|..
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999999988664322 23456689999999998765 588899999999999999997766544
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=292.27 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=201.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIK-HINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 385 (603)
++|.+.+.||+|+||.||+|... ++..+++|++.... ....+.+.+|+++++++. ||||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888899999999999999986 56679999886532 223456889999999998 99999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++++|.+++...+ .+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~----~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKYG----SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 99999999999998754 389999999999999999999998 89999999999999999999999999987664
Q ss_pred CCCc-------------------ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccH
Q 007455 466 DEEA-------------------HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNV 526 (603)
Q Consensus 466 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~ 526 (603)
.... .......++..|+|||...+..++.++||||+|++++++++|+.||.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------ 227 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE------ 227 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH------
Confidence 4321 122334578899999999888899999999999999999999999875321
Q ss_pred hHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 007455 527 VGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSM----NQVLQ 581 (603)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~----~evl~ 581 (603)
........ ......+...+..+.+++.+||+.+|.+||++ +++++
T Consensus 228 ~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 YLTFQKIL----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHH----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 00001110 01111223345679999999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=288.37 Aligned_cols=256 Identities=20% Similarity=0.262 Sum_probs=191.7
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCC-CCeeeecceeeecC--CccEEEEE
Q 007455 313 LDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE-GSDQVFERELEILGSIK-HINLVNLRGYCRLP--ATKLLIYD 387 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 387 (603)
|++.+.||+|+||.||+|.+. ++..+|+|.++.... .......+|+.++.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999976 456799998865422 22234567899999885 99999999999887 88999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++ +|.+.+.... ..+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||+++.....
T Consensus 81 ~~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMDM-NLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCCc-cHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 9975 8877776532 2389999999999999999999998 8999999999999999 99999999999876433
Q ss_pred CcceeecccccccccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh----------
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQ-SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE---------- 536 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------- 536 (603)
... ....++..|+|||.+. +..++.++||||+||++|||++|..||..... .+...+.......
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE---LDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH---HHHHHHHHHHcCCCCHHHHHhhc
Confidence 221 2245788999999764 45578899999999999999999999965321 1111111111100
Q ss_pred -Ccchhh-hccc----CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 -NRLEDV-IDKR----CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 -~~~~~~-~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...... +... ........+.++.+++.+||+.+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 0000 00011234678999999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=285.76 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=195.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-----CChHHHHHHHHHHHhhCCCCeeeecceeeecC--Ccc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-----EGSDQVFERELEILGSIKHINLVNLRGYCRLP--ATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 382 (603)
.+|++.+.||+|+||.||+|.+.. +..+++|.+.... ......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468889999999999999999864 5679999874321 12235688999999999999999999998664 457
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++++||+++++|.+++..... +++.....++.|++.||.|||++ +++||||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~----l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGA----LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999876433 78889999999999999999998 89999999999999999999999999997
Q ss_pred ccCCCCc--ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 463 LLVDEEA--HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 463 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
....... .......++..|+|||.+.+..++.++|+||||+++|||++|+.||..... . .-.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~-~~~~~~~------ 222 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----M-AAIFKIA------ 222 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----H-HHHHHHH------
Confidence 6532111 111234588899999999888889999999999999999999999864211 0 0000000
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+..+..+.....++.+++.+|+. +|..||++.+++.
T Consensus 223 --~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 --TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0011122344556789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=302.95 Aligned_cols=271 Identities=27% Similarity=0.358 Sum_probs=204.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecC------CccE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLP------ATKL 383 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 383 (603)
.+...+.||+|+||.||+|+++.+ +.||||.+.... ....+...+|++++++++|+|||+++++-... ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 345568899999999999997754 459999986543 33445678999999999999999999876543 3568
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC--CCCC--eEEeecc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD--ENLE--PHVSDFG 459 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~--~kl~DfG 459 (603)
+|||||.||||...+++- .+...+++.+.+.+..+++.||.|||++ +|+||||||.||++- .+|+ -||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 999999999999999863 3334599999999999999999999998 999999999999993 3343 7999999
Q ss_pred cccccCCCCcceeecccccccccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQ-SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
.|+.+.++. .....+||..|.+||... .+.|+..+|.|||||++|++.||..||.+........-+.|....-+...
T Consensus 170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 999987665 456788999999999998 47889999999999999999999999987543332222344333222222
Q ss_pred chhhhccc----------CCC---cCHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHhhccc
Q 007455 539 LEDVIDKR----------CAD---ADMETVEAILEIAARCTDANPDDRP--SMNQVLQLLEQEVM 588 (603)
Q Consensus 539 ~~~~~~~~----------~~~---~~~~~~~~l~~li~~cl~~~P~~RP--s~~evl~~L~~~~~ 588 (603)
..-..++. ++. ........+-..+..+|..+|++|- .+.+....+.++..
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 21111111 111 1122334566777888899999998 66666655555443
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=286.84 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=197.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCC-----CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRS-----REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+|.+.+.||+|+||.||++.+.... .+++|.++.. .......+.+|+.++++++||||+++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778899999999999999887543 3555555431 122334577899999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
+||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||++++ +.++|+|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998876444445589999999999999999999998 8999999999999975 569999999987664
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.... ......|++.|+|||...+..++.++|+||||+++|+|++|..||.... ........ ...
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~---------~~~ 220 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRI---------VEG 220 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHH---------HcC
Confidence 3322 2233457889999999988888899999999999999999999986421 11111111 111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+..+...+.++.+++.+||..+|++||++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 122233455678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=292.15 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=194.2
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.|+..+.||+|+||.||+|.+. ++..+|+|.+...... ....+.+|++++++++|||++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667788999999999999976 4557999988644222 23468889999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+.+ ++.+.+.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 106 ~~~g-~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCCC-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 9975 7777765432 2388999999999999999999998 8999999999999999999999999998754332
Q ss_pred CcceeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
....|++.|+|||.+. ++.++.++||||||+++|||++|+.||..... ...........
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~------- 240 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNE------- 240 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHhcc-------
Confidence 2345788999999873 45688899999999999999999999864211 00111111100
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~ 584 (603)
.........+..+.+++.+||+.+|.+||++.++++..-
T Consensus 241 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 241 -SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred -CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 001112234567999999999999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=301.53 Aligned_cols=260 Identities=23% Similarity=0.332 Sum_probs=193.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecC-----CccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLP-----ATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 383 (603)
++|++.+.||+|+||.||+|.+. .+..||+|++.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 84 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY 84 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence 57889999999999999999976 45679999986432 22345678899999999999999999987544 3478
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+|+||+.+ +|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 85 lv~e~~~~-~l~~~~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 85 IVQELMET-DLYKLIKTQ-----HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEehhccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999975 787776542 288999999999999999999999 899999999999999999999999999876
Q ss_pred cCCCCcc--eeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC---
Q 007455 464 LVDEEAH--VTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN--- 537 (603)
Q Consensus 464 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 537 (603)
....... ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...... .....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPSQE 232 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCCHH
Confidence 5432221 1123467889999998654 46889999999999999999999998643210 0011111100000
Q ss_pred cch--------hhhcc--cCCCc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 538 RLE--------DVIDK--RCADA-----DMETVEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 538 ~~~--------~~~~~--~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
... ..+.. ..... ....+.++.+++.+||+.+|++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 00000 00000 01234678999999999999999999999973
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=293.74 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=196.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCC--CCChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRS--REGSDQVFERELEILGSIK-HINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 386 (603)
-..|++.+.||+||.+.||++...+.+-||+|++... ....-..|..|+..|.+++ |.+||++++|-..++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 3568888999999999999999998888999887533 2223356899999999995 999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||=+. +|..++++.... ++...+..+..|++.++.++|++ ||||.||||.|+|+-. |.+||+|||.|..+..
T Consensus 440 E~Gd~-DL~kiL~k~~~~---~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 440 ECGDI-DLNKILKKKKSI---DPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred ecccc-cHHHHHHhccCC---CchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 98765 999999875432 33337788999999999999999 9999999999999865 6899999999998876
Q ss_pred CCcce-eecccccccccCccccccC-----------CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 467 EEAHV-TTVVAGTFGYLAPEYLQSG-----------RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 467 ~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
+.... ....+||+.||+||.+... ..+.++||||+|||||+|+.|+.||.... . .|.+
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n--~~aK--- 581 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----N--QIAK--- 581 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----H--HHHH---
Confidence 55443 3457899999999988432 24578999999999999999999986421 0 1211
Q ss_pred hhCcchhhhcccCC-CcC-HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 KENRLEDVIDKRCA-DAD-METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 ~~~~~~~~~~~~~~-~~~-~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+..+.++... +++ .....++.++++.||..||.+|||+.++++
T Consensus 582 ----l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 582 ----LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ----HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 2222222110 111 111234999999999999999999999997
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=293.38 Aligned_cols=261 Identities=25% Similarity=0.307 Sum_probs=194.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecC--CccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLP--ATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 384 (603)
.++|+..+.||+|+||.||+|.+.. +..||+|.++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4688999999999999999999874 56799998864332 2233467899999999999999999998654 45799
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+.+ +|.+++.... ..+++.++..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999975 8888876532 2389999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC--c-c-
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN--R-L- 539 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~-~- 539 (603)
..... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ....-........ . +
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI---EQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCChhhch
Confidence 54321 1222345778999998865 45789999999999999999999998643211 1100000000000 0 0
Q ss_pred -------hhhhc-ccCC-----CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 540 -------EDVID-KRCA-----DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 540 -------~~~~~-~~~~-----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..... ...+ ......+..+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 0000 000113567889999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=284.06 Aligned_cols=248 Identities=24% Similarity=0.308 Sum_probs=191.6
Q ss_pred HHHHHhhCCCCCCee--eecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCC
Q 007455 305 EIIEKLEALDEEDVV--GSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPA 380 (603)
Q Consensus 305 ~~~~~~~~~~~~~~i--g~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 380 (603)
+.....++|++.+.+ |+|+||.||++.... +..+|+|.+....... .|+.....+ +||||+++++++..++
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC
Confidence 344455677777776 999999999999864 4568888875432211 122222222 7999999999999999
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-CeEEeecc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-EPHVSDFG 459 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG 459 (603)
..++||||+++|+|.+++.... .+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 9999999999999999997653 389999999999999999999998 899999999999999998 99999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
+++..... ....++..|+|||++.+..++.++||||+|+++|||++|+.||...... ......+....
T Consensus 156 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~------ 223 (267)
T PHA03390 156 LCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ------ 223 (267)
T ss_pred cceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh------
Confidence 98765432 2235788999999998888999999999999999999999999743211 11111221111
Q ss_pred hhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 007455 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPS-MNQVLQ 581 (603)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~ 581 (603)
. .........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 224 ----~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ----Q-KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----c-ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 011112245567999999999999999996 688874
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=287.32 Aligned_cols=241 Identities=25% Similarity=0.369 Sum_probs=186.7
Q ss_pred eeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC---hHHHHHHHHH---HHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 318 VVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG---SDQVFERELE---ILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 318 ~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
.||+|+||.||+|.+.+ ++.||+|.+...... ....+..|.. .++...||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999865 567999988653221 1222344443 3445579999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++...+ .+++..+..++.|+++||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~~----~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQHG----VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 999999887543 389999999999999999999998 89999999999999999999999999987654322
Q ss_pred eeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
.....|+..|+|||.+.++ .++.++||||+|+++|||++|+.||.......... .... .......
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~---------~~~~~~~ 217 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRM---------TLTMAVE 217 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHH---------hhccCCC
Confidence 1234688999999998754 68899999999999999999999997542211100 0000 0000111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
.+...+.++.+++.+|+..+|.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2223456799999999999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=296.61 Aligned_cols=261 Identities=22% Similarity=0.280 Sum_probs=195.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecC------
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLP------ 379 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 379 (603)
..++|+..+.||+|+||.||+|.+. .+..||+|.+.... ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3578999999999999999999986 45679999886432 22334677899999999999999999988643
Q ss_pred CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
...++||||+.+ +|.+.+... ++...+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~------l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 346999999975 888777532 78888999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccC---------CccHhHHH
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKR---------GLNVVGWM 530 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~---------~~~~~~~~ 530 (603)
+++....... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... +.....+.
T Consensus 164 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 164 LARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred cceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9987543321 233457889999999998899999999999999999999999986432100 00000010
Q ss_pred HHH-------hhhC------cchhhhcccCCC-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 531 NTL-------LKEN------RLEDVIDKRCAD-----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 531 ~~~-------~~~~------~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... .... .+.+.+...... .....+..+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000 0000 000000000000 01234567899999999999999999999995
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=320.63 Aligned_cols=263 Identities=25% Similarity=0.403 Sum_probs=191.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecC------
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLP------ 379 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 379 (603)
+-..+|+..+.||+||||.||+++.+ ||+.||||++.... ......+.+|+.++++|+|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45677888899999999999999988 88899999996543 33345688999999999999999987532110
Q ss_pred --------------------------------------------------------------------------------
Q 007455 380 -------------------------------------------------------------------------------- 379 (603)
Q Consensus 380 -------------------------------------------------------------------------------- 379 (603)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHH
Q 007455 380 ---------------------------------ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426 (603)
Q Consensus 380 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 426 (603)
...||-||||+.-++.++++.+.-.. .....++++.+|+.||.|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHHH
Confidence 01255567776655555555433211 356789999999999999
Q ss_pred HHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC------C-----------CCcceeecccccccccCcccccc
Q 007455 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV------D-----------EEAHVTTVVAGTFGYLAPEYLQS 489 (603)
Q Consensus 427 LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~ 489 (603)
+|++ |+|||||||.||++|+++.|||+|||+++... + ......+..+||.-|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 89999999999999999999999999998721 0 01112345779999999999965
Q ss_pred C---CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC---cCHHHHHHHHHHHH
Q 007455 490 G---RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD---ADMETVEAILEIAA 563 (603)
Q Consensus 490 ~---~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~ 563 (603)
. .|+.|+|+||+|||++||+. ||...+.+ . . .+....+...+. ........-.++|+
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-----a------~---iL~~LR~g~iP~~~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMER-----A------S---ILTNLRKGSIPEPADFFDPEHPEEASLIR 852 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHH-----H------H---HHHhcccCCCCCCcccccccchHHHHHHH
Confidence 4 49999999999999999996 56544321 0 0 111111111222 23344455678999
Q ss_pred HcccCCCCCCCCHHHHHHHHhhcccCCCCcccc
Q 007455 564 RCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFY 596 (603)
Q Consensus 564 ~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~ 596 (603)
+|++.||.+||||.|+++ ....+|+..++.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~---s~llppe~~el~ 882 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN---SELLPPEESELL 882 (1351)
T ss_pred HHhcCCCccCCCHHHHhh---ccCCCccchHHH
Confidence 999999999999999987 555555444443
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=294.15 Aligned_cols=261 Identities=24% Similarity=0.338 Sum_probs=192.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCc----
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPAT---- 381 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 381 (603)
..++|+..+.||+|+||.||+|.... +..||+|.+.... ......+.+|++++++++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 35678999999999999999999874 5579999885432 2223456789999999999999999999866543
Q ss_pred ----cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEee
Q 007455 382 ----KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSD 457 (603)
Q Consensus 382 ----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 457 (603)
.++||||+.+ +|.+++.... ..+++.+++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence 4999999975 7887776532 2388999999999999999999998 899999999999999999999999
Q ss_pred cccccccCCCCcc---eeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH
Q 007455 458 FGLAKLLVDEEAH---VTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 458 fG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
||++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....... ........
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~---~~~~~~~~ 239 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH---QLTLISQL 239 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHH
Confidence 9999766433221 11234567889999988654 46889999999999999999999986532111 00000000
Q ss_pred hh--------h-------------CcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 LK--------E-------------NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ~~--------~-------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. . ............ .......+.+++.+||..+|++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLK--PYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcc--cccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00 0 000000000000 0012345789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=292.83 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=193.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|+..+.||+|++|.||+|.+. ++..||+|.+..... ...+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999987 456799998854332 223568899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-CCCeEEeecccccccCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-NLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~~~~~~~ 466 (603)
|+++ +|.+++..... ..+++..+..++.|++.||+|||++ +++||||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLDL-DLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cccc-cHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 9965 78777755332 2257888889999999999999998 8999999999999985 55799999999976543
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC---cc---
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN---RL--- 539 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~--- 539 (603)
... ......+++.|+|||.+.+ ..++.++||||+|+++|+|+||+.||....... ...... ...... .+
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~-~~~~~~~~~~~~~~ 231 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIF-RILGTPNEETWPGV 231 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHH-HHhCCCChhhcccc
Confidence 211 1223356889999998865 357889999999999999999999986432110 000000 000000 00
Q ss_pred ---hhhh--cccCCC-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 540 ---EDVI--DKRCAD-----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 540 ---~~~~--~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... ...... .....+.++.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000000 11123466899999999999999999999986
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=269.82 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=195.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCCC-ChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSRE-GSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++++....||.|+.|.|++++.+.++. .|||.+.+... ...+++...+.++..- +.|.||+.+|+|..+..+++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 344556789999999999999887554 89999976543 3446677778877665 48999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
.|.. .++.+++... .++++.-+-++...+.+||.||.+.+ +|+|||+||+|||+|+.|++|+||||.+.++.+.
T Consensus 172 lMs~-C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHH-HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9865 5666665432 23788888889999999999999886 9999999999999999999999999999887554
Q ss_pred CcceeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
.. .+..+|-+.|||||.+. ...|+-++||||||++++||.||..||..-.. . ++....+..++.
T Consensus 246 kA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--d---Fe~ltkvln~eP------ 312 (391)
T KOG0983|consen 246 KA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--D---FEVLTKVLNEEP------ 312 (391)
T ss_pred cc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--c---HHHHHHHHhcCC------
Confidence 33 34456889999999885 34678899999999999999999999975211 1 111222222111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+.++ .....+..+.+++..||.+|+.+||...++++
T Consensus 313 P~L~-~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 313 PLLP-GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCC-cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 1111 22236778999999999999999999999986
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=289.57 Aligned_cols=258 Identities=21% Similarity=0.283 Sum_probs=197.5
Q ss_pred CCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 313 LDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
|+..+.||+|++|.||+|... ++..+++|.+...... ....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 566789999999999999986 4556999988654332 4467889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++ ++.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 86 8888877632 2389999999999999999999998 89999999999999999999999999998765543
Q ss_pred ceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh---Ccchhhhc-
Q 007455 470 HVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE---NRLEDVID- 544 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~- 544 (603)
.......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...... ............ ..+....+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCchHhcccchhh
Confidence 112234577889999998766 7889999999999999999999998643210 000000000000 00000000
Q ss_pred -------------ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 -------------KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 -------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..........+.++.+++.+||+.+|.+||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000011234578999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=299.27 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=195.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeec----CCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRL----PATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 383 (603)
++|++.+.||+|+||.||+|.... +..||+|++..... .....+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 678889999999999999999874 56799999865422 234567889999999999999999998753 34578
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+|+||+. |+|.+++..... +++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQP----LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccCCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999996 589888865432 89999999999999999999998 899999999999999999999999999876
Q ss_pred cCCCCcc---eeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh-----
Q 007455 464 LVDEEAH---VTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL----- 534 (603)
Q Consensus 464 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~----- 534 (603)
....... ......|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~---~~~~~~~~~~g~~~~ 233 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV---HQLKLILSVLGSPSE 233 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH---HHHHHHHHHhCCChh
Confidence 5432211 1123468889999998755 46889999999999999999999999653211 0000000000
Q ss_pred ------hhCcchhhhcc--cCCCc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 ------KENRLEDVIDK--RCADA-----DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 ------~~~~~~~~~~~--~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.........+. ..... ....+.++.+++.+||+.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00001111100 00001 1224577999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=298.05 Aligned_cols=269 Identities=25% Similarity=0.358 Sum_probs=197.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC--CCChHHHHHHHHHHHhhC-CCCeeeecceeeecC--CccE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS--REGSDQVFERELEILGSI-KHINLVNLRGYCRLP--ATKL 383 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~~ 383 (603)
.++|++.+.||+|+||.||+|.+.. +..+|+|++... .......+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 4678888999999999999999874 456999988542 222334577899999999 999999999988654 3579
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+++ +|.+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEeccccc-CHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999985 998888653 378899999999999999999998 899999999999999999999999999986
Q ss_pred cCCCCc----ceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccH-hHHH-------
Q 007455 464 LVDEEA----HVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNV-VGWM------- 530 (603)
Q Consensus 464 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~-~~~~------- 530 (603)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 644322 12223458889999998754 4578899999999999999999999864321100000 0000
Q ss_pred HHHhhhCcchhhhc----cc---CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhhcc
Q 007455 531 NTLLKENRLEDVID----KR---CADADMETVEAILEIAARCTDANPDDRPSMNQVLQL--LEQEV 587 (603)
Q Consensus 531 ~~~~~~~~~~~~~~----~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~~~ 587 (603)
............++ .. ........+.++.+++.+||+.+|++|||+.++++. +++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 00000000000000 00 000111245679999999999999999999999963 54443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=295.61 Aligned_cols=265 Identities=24% Similarity=0.325 Sum_probs=202.0
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCC-----ccE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPA-----TKL 383 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 383 (603)
+|++.+.||+|+||.||+|...+ +..+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47788999999999999999875 5679999987643 334467899999999999999999999987775 789
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
++|||+.+ +|.+++.... .+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+..
T Consensus 81 lv~e~~~~-~l~~~l~~~~----~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ----PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchhh-hHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 99999985 8888887543 389999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCc--ceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh------
Q 007455 464 LVDEEA--HVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL------ 534 (603)
Q Consensus 464 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 534 (603)
...... .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||....... .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 229 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEE 229 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChh
Confidence 654431 122334578899999999877 78999999999999999999999986542110 000000000
Q ss_pred -----hhCcchhhhccc-------CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcc
Q 007455 535 -----KENRLEDVIDKR-------CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQEV 587 (603)
Q Consensus 535 -----~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~ 587 (603)
........+... ........+..+.+++.+||+.+|.+||+++++++ .+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 000000000000 00011123567899999999999999999999997 355433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=284.51 Aligned_cols=255 Identities=26% Similarity=0.351 Sum_probs=193.5
Q ss_pred CCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhC---CCCeeeecceeeecCCc-----
Q 007455 313 LDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSI---KHINLVNLRGYCRLPAT----- 381 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 381 (603)
|++.+.||+|+||.||+|.++. +..+|+|.+...... ....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5677899999999999999875 678999998643322 234566788777666 59999999999988776
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.+++|||+.+ +|.+++..... ..+++..++.++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||.+
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999985 89888876432 2389999999999999999999998 8999999999999999999999999998
Q ss_pred cccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc--
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL-- 539 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 539 (603)
..+..... .....++..|+|||.+.+..++.++|+||||+++|||++|..||...... ............
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~------~~~~~~~~~~~~~~ 226 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA------DQLDKIFDVIGLPS 226 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH------HHHHHHHHHcCCCC
Confidence 77643322 12234788899999998888999999999999999999999988653211 111111110000
Q ss_pred -----------hhhhcccCC----CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 540 -----------EDVIDKRCA----DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 540 -----------~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......... ......+..+.+++.+||+.||++||+++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000000000 011234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.34 Aligned_cols=263 Identities=22% Similarity=0.337 Sum_probs=196.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecC-----Ccc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLP-----ATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 382 (603)
.+|.+.+.||+|+||+||+|.+.. +..||||.+... .......+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 468888999999999999999864 457999998643 222345677899999999999999999987644 347
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++|+||+. ++|.+++..... +++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQT----LSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 99999997 588888875432 89999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh-------
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL------- 534 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~------- 534 (603)
...... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||...... ..........
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV---HQLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH---HHHHHHHHHhCCCChHH
Confidence 664432 12233457889999998754 46889999999999999999999998643210 0000000000
Q ss_pred ----hhCcchhhhc-------ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--Hhh
Q 007455 535 ----KENRLEDVID-------KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQL--LEQ 585 (603)
Q Consensus 535 ----~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~--L~~ 585 (603)
........+. ..........+.++.+++.+||+.+|++|||++|+++- ++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 0000000000 00000112345678999999999999999999999963 544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=288.70 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=193.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE-GSDQVFERELEILGSIK-HINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 386 (603)
.++|++.+.||+|+||.||+|.+++ +..||||.+..... .....+.+|+.++.+.. ||||+++++++......+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 4678889999999999999999986 56799999865432 23345667887777664 999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+.+ ++.+++.... ..+++..+..++.|+++|++|||+.. +++||||+|+||++++++.++|+|||++..+..
T Consensus 94 e~~~~-~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99865 7777665432 24889999999999999999999742 899999999999999999999999999876543
Q ss_pred CCcceeecccccccccCccccccCC----CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGR----ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... .............
T Consensus 168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~---- 236 (296)
T cd06618 168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-----EFEVLTKILQEEP---- 236 (296)
T ss_pred CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-----HHHHHHHHhcCCC----
Confidence 222 12234778899999987554 78899999999999999999999864211 0111111111110
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+ .....+.++.+++.+||..+|++||+++++++
T Consensus 237 --~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 237 --PSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred --CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 11124567999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=284.61 Aligned_cols=245 Identities=22% Similarity=0.310 Sum_probs=189.0
Q ss_pred CeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCCh---HHHHHHHHHHH-hhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGS---DQVFERELEIL-GSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+.. ++.||+|.+....... ...+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 568999999999999864 5679999886543221 12344455444 445899999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
++|.+++..... +++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTLGG----LPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999976433 78999999999999999999998 899999999999999999999999999875432
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....++..|+|||.+.+..++.++||||+|+++|||++|..||...... ....... ..... ......
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~-~~~~~-----~~~~~~ 217 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNIL-SRRIN-----WPEEVK 217 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHH-hcccC-----CCCccc
Confidence 12345788999999998888899999999999999999999998643211 1111110 00000 000111
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 552 METVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
...+.++.+++.+||+.+|++||++.++.+.+..
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 2345679999999999999999988766665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=284.88 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=195.5
Q ss_pred CCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEEEEec
Q 007455 313 LDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG-SDQVFERELEILGSIK-HINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
|++.+.||+|++|+||+|...+ ++.+++|++...... ......+|+..+++++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5677899999999999999875 456999988654332 2334567999999999 999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
+|+|.+++.... ...+++..+..++.|++.+|.|||++ +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 779998887643 23489999999999999999999998 899999999999999999999999999976543222
Q ss_pred ceeecccccccccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCC----------ccHhHHHHHHhhhCc
Q 007455 470 HVTTVVAGTFGYLAPEYLQ-SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG----------LNVVGWMNTLLKENR 538 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~----------~~~~~~~~~~~~~~~ 538 (603)
.....++..|+|||.+. ...++.++|+||||++++||++|+.||........ .....|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22345788999999874 44578999999999999999999999864321100 000011111111111
Q ss_pred chhhhcccCCC----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCAD----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+...... .....+..+.+++++||+.+|++|||++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 11111111000 00112467999999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=276.08 Aligned_cols=242 Identities=22% Similarity=0.277 Sum_probs=198.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChH---HHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSD---QVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
.+++|+..++||+|.||.|..++-+.+ +.||+|++++...-.. ..-..|-++|+..+||.+..+.-.|+..++.++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 467899999999999999999987754 4599999876543322 234568899999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||..||.|.-++.... .+++....-.-.+|+.||.|||++ +||.||+|.+|.|+|.||++||.|||+++.-
T Consensus 246 VMeyanGGeLf~HLsrer----~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER----VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhhhh----cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999998887643 388888888999999999999998 8999999999999999999999999999753
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
- .....+..++|||.|+|||++....|..++|.|.+||++|||++|+.||.... ...+ -+.|-
T Consensus 319 I-~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d---h~kL-------------FeLIl 381 (516)
T KOG0690|consen 319 I-KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD---HEKL-------------FELIL 381 (516)
T ss_pred c-cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc---hhHH-------------HHHHH
Confidence 2 23345678999999999999999999999999999999999999999997532 1111 11111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCC
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRP 574 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 574 (603)
-.-...+...+.+...|+..+|.+||.+|.
T Consensus 382 ~ed~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 382 MEDLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hhhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 111223455567889999999999999993
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=288.14 Aligned_cols=257 Identities=21% Similarity=0.270 Sum_probs=187.4
Q ss_pred CeeeecCCeEEEEEEECCCCEEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCc
Q 007455 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
+.+|.|+++.||++.. .+..||+|++... .....+.+.+|+++++.++|+||+++++++...+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3445555555555444 4578999998654 233446789999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc----
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH---- 470 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~---- 470 (603)
.+++..... ..+++.....++.|+++||+|||++ +|+||||||+||+++.++.++|+|||.+.........
T Consensus 87 ~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 87 EDLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999986432 2378889999999999999999999 8999999999999999999999999988655322111
Q ss_pred --eeecccccccccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHH----HhhhC-----
Q 007455 471 --VTTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT----LLKEN----- 537 (603)
Q Consensus 471 --~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~----- 537 (603)
......++..|+|||.+.. ..++.++||||+|+++|||++|+.||....... ........ .....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhh
Confidence 1123446778999999865 357889999999999999999999997432110 00000000 00000
Q ss_pred --cchh----h-----hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 --RLED----V-----IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 --~~~~----~-----~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... . ..............++.+++.+||+.+|++|||++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 0 000001122344567899999999999999999999996
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=289.87 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=189.2
Q ss_pred Ceeeec--CCeEEEEEEEC-CCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSG--GFGTVYRMVMN-DCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+| +||+||+|.+. .++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999986 5567999988654322 235688999999999999999999999999999999999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
+++.+++..... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999886532 2378899999999999999999998 89999999999999999999999998654332211100
Q ss_pred ------eecccccccccCccccccC--CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHH------------
Q 007455 472 ------TTVVAGTFGYLAPEYLQSG--RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN------------ 531 (603)
Q Consensus 472 ------~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~------------ 531 (603)
.....++..|+|||++.+. .++.++||||+|+++|||++|+.||....... .......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCcccccc
Confidence 0112345679999998763 46889999999999999999999986532100 0000000
Q ss_pred ----HH----------------hhhCcchhhhcccCC-CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 532 ----TL----------------LKENRLEDVIDKRCA-DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 532 ----~~----------------~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. ............... ......+..+.+++++||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 000000000000000 112345678999999999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=314.89 Aligned_cols=255 Identities=22% Similarity=0.319 Sum_probs=211.8
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCC---CCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCc
Q 007455 306 IIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDR---SREGSDQVFERELEILGSIKHINLVNLRGYCRLPAT 381 (603)
Q Consensus 306 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 381 (603)
+....++|.+.++||+|+||.|..++++.++. ||+|++.+ ........|..|-.+|..-+.+-|++++-.|.++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 33345789999999999999999999987665 89999865 334445678999999999999999999999999999
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
+|+|||||+||+|-.++.+... +++..+..++..|+-||.-+|+. |+|||||||+|||+|..|++||+|||.+
T Consensus 150 LYlVMdY~pGGDlltLlSk~~~----~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFDR----LPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred eEEEEecccCchHHHHHhhcCC----ChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 9999999999999999998763 88888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCccccc----c-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh-
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQ----S-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK- 535 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 535 (603)
-.+..++.-.....+|||.|++||++. + +.|+..+|.||+||++|||+.|..||+.+. +++.-..+..
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads------lveTY~KIm~h 296 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS------LVETYGKIMNH 296 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH------HHHHHHHHhch
Confidence 888877777778889999999999984 3 678899999999999999999999998642 2222222221
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPS---MNQVLQ 581 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs---~~evl~ 581 (603)
.+.+. .| .....+.+..+||++.+. +|+.|.. ++++..
T Consensus 297 k~~l~------FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 297 KESLS------FP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhhcC------CC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 11111 11 123467889999998886 7788877 888875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=311.71 Aligned_cols=260 Identities=30% Similarity=0.485 Sum_probs=206.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC----C----CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN----D----CGTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLP 379 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 379 (603)
.+++.+.+.+|+|.||.|++|... . ...||||.++..... ..+.+..|+++|..+ +|+||+.++|.|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 345566779999999999999743 1 235999998755433 456799999999998 599999999999999
Q ss_pred CccEEEEEecCCCCccccccccC---C---C----C--ccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHG---E---G----Q--QLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL 447 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~---~---~----~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 447 (603)
+..++|+||+..|+|.++++... . . . ..+...+.+.++.|||.|++||++. ++|||||.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEe
Confidence 99999999999999999998765 0 0 1 2388999999999999999999999 89999999999999
Q ss_pred CCCCCeEEeecccccccCCCCcceeecccc--cccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCc
Q 007455 448 DENLEPHVSDFGLAKLLVDEEAHVTTVVAG--TFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGL 524 (603)
Q Consensus 448 ~~~~~~kl~DfG~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~ 524 (603)
+++..+||+|||+++.....+........| ...|||||.+....++.|+|||||||++||++| |..||.... ...
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~--~~~ 529 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP--PTE 529 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--cHH
Confidence 999999999999999765554443333223 347999999999999999999999999999999 667775311 001
Q ss_pred cHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 525 NVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
++.. .++.+ .....|..+..+++++++.||+.+|++||++.++.+.++..
T Consensus 530 ~l~~----~l~~G--------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 530 ELLE----FLKEG--------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHH----HHhcC--------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1111 11111 11123445567899999999999999999999999999884
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=274.95 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=201.7
Q ss_pred CCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCCCC
Q 007455 316 EDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSMGS 393 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (603)
.+.||+|+|+.|-.++.- .+.+||||++.+....+..++.+|++++.+. .|+||++++++|.+++.+|+|||.|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 367999999999988754 5567999999888778888999999999998 49999999999999999999999999999
Q ss_pred ccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC---CeEEeecccccccCCC---
Q 007455 394 LDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL---EPHVSDFGLAKLLVDE--- 467 (603)
Q Consensus 394 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~~~~~~~~--- 467 (603)
|...+.++.- +++.++.++..+|+.||.+||.. ||.|||+||+|||-.... .+||+||.+..-....
T Consensus 163 lLshI~~~~~----F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQKRKH----FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHHHhhh----ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 9999987654 89999999999999999999999 899999999999996544 4899999887543211
Q ss_pred ---CcceeecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh---h
Q 007455 468 ---EAHVTTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK---E 536 (603)
Q Consensus 468 ---~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~ 536 (603)
........+|+..|||||+.. ...|+.+.|.||+|||+|-|++|.+||.+.-. .-.+|.+.... .
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg----~dCGWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG----ADCGWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC----CcCCccCCCccHHHH
Confidence 111223466888999999773 44688899999999999999999999975321 22233221111 1
Q ss_pred CcchhhhcccCCCcC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 NRLEDVIDKRCADAD----METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+.+-+.|+....+.| ..++.+..+++..++..++.+|.++.++++
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 112223333333333 245678899999999999999999999986
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=288.00 Aligned_cols=244 Identities=28% Similarity=0.421 Sum_probs=191.7
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.|+..+.||+|+||.||+|++.. +..+++|.+..... .....+.+|+++++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 36667889999999999999874 45699998854322 223467889999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+. |++.+.+.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 997 58877765432 2378899999999999999999998 8999999999999999999999999998765432
Q ss_pred CcceeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
....++..|+|||.+. ...++.++||||||+++|||++|+.||..... .........
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~--------- 228 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQ--------- 228 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH------HHHHHHHhh---------
Confidence 2345788999999874 35678899999999999999999999754211 011111100
Q ss_pred ccCCC-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 545 KRCAD-ADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 545 ~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
...+. .....+..+.+++.+||..+|++||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 01111 122345678999999999999999999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=291.06 Aligned_cols=259 Identities=23% Similarity=0.264 Sum_probs=192.4
Q ss_pred CCC-CCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCCh--------------HHHHHHHHHHHhhCCCCeeeeccee
Q 007455 312 ALD-EEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGS--------------DQVFERELEILGSIKHINLVNLRGY 375 (603)
Q Consensus 312 ~~~-~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~ 375 (603)
+|. +.+.||+|+||.||+|.+. .+..||+|++....... ...+.+|+++++.++|+||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 444 3567999999999999976 45679999885432221 1247789999999999999999999
Q ss_pred eecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEE
Q 007455 376 CRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455 (603)
Q Consensus 376 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 455 (603)
+...+..++||||+. |+|.+++..... +++.....++.|++.||+|||+. +++||||+|+||+++.++.++|
T Consensus 89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 89 YVEGDFINLVMDIMA-SDLKKVVDRKIR----LTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EecCCcEEEEEeccc-cCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence 999999999999997 589988865432 88999999999999999999998 8999999999999999999999
Q ss_pred eecccccccCCCC-------------cceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccccc
Q 007455 456 SDFGLAKLLVDEE-------------AHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVK 521 (603)
Q Consensus 456 ~DfG~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~ 521 (603)
+|||++....... ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999997654111 1111223467889999988654 4688999999999999999999998654211
Q ss_pred CCccHhHHHHHHhhhCc---chhh--------hcccCC----CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 522 RGLNVVGWMNTLLKENR---LEDV--------IDKRCA----DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 522 ~~~~~~~~~~~~~~~~~---~~~~--------~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.............. +... .....+ ......+.++.+++.+|++.+|++|||++|++.
T Consensus 241 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 ---DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred ---HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11111111000000 0000 000000 001123467889999999999999999999996
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.26 Aligned_cols=263 Identities=23% Similarity=0.324 Sum_probs=192.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCC------
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPA------ 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 380 (603)
..+|...+.||+|+||.||+|.+. .+..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 367888999999999999999976 45679999986532 222345789999999999999999999886543
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..++|+||+.. +|.++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMGH------PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999975 66655421 278899999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHh---------HHH
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVV---------GWM 530 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~---------~~~ 530 (603)
++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||............ .+.
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 8765322 123457888999998865 46888999999999999999999999753211000000 000
Q ss_pred HHHhhhCcchhhhc--ccCCC-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcc
Q 007455 531 NTLLKENRLEDVID--KRCAD-----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQEV 587 (603)
Q Consensus 531 ~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~ 587 (603)
.. ........... +..+. .....+..+.+++.+||+.||++||+++++++ .+++..
T Consensus 240 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 240 QK-LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HH-hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00 00000000000 00000 00123456889999999999999999999994 455544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=282.87 Aligned_cols=258 Identities=25% Similarity=0.350 Sum_probs=196.9
Q ss_pred CCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 313 LDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
|+..+.||+|+||.||+|...+ +..+++|.+.... ....+.+..|+.+++.++|+|++++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4567889999999999999875 6679999987643 333456788999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++ +|.+++.... ..+++..+..++.|+++||+|||++ +++||||+|+||++++++.++|+|||.++.......
T Consensus 81 ~~-~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 DM-DLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred Cc-CHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 85 9999998653 2389999999999999999999999 899999999999999999999999999977644322
Q ss_pred ceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC---------c-
Q 007455 470 HVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN---------R- 538 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~- 538 (603)
......++..|+|||.+.+. .++.++||||||+++||+++|+.||...... ............. .
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhccc
Confidence 12233456789999998766 7889999999999999999999998653210 0000000000000 0
Q ss_pred --chhhhccc----CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 --LEDVIDKR----CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 --~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........ ........+..+.+++.+||..+|++||++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 00000000 00001122567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=287.66 Aligned_cols=262 Identities=24% Similarity=0.296 Sum_probs=195.0
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeec-CCcc
Q 007455 307 IEKLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRL-PATK 382 (603)
Q Consensus 307 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 382 (603)
....++|+..+.||+|+||.||+|.+. .+..+|+|++.... ....+.+.+|+++++.++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345678999999999999999999977 55679999885432 2234568899999999999999999998865 4578
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++++||+. ++|.+++... .++......++.|+++||.|||+. +++||||+|+||++++++.++|+|||.+.
T Consensus 86 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELLG-TDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehhc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 89999985 5888877642 267888889999999999999998 89999999999999999999999999987
Q ss_pred ccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCC---------ccHhHHHHH
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG---------LNVVGWMNT 532 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~---------~~~~~~~~~ 532 (603)
..... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||........ ....+|...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54322 122346788999998765 5688999999999999999999999864321100 000111111
Q ss_pred HhhhCcchhhhcccC-CCcC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 533 LLKENRLEDVIDKRC-ADAD-----METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
............... ...+ ...+..+.+++.+|++.+|++|||+++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111110000000000 0001 123467999999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=284.95 Aligned_cols=243 Identities=28% Similarity=0.400 Sum_probs=190.2
Q ss_pred CCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 313 LDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
|...+.||+|+||.||+|++.. +..+++|++...... ....+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 5556789999999999999864 456999988643322 234578899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+.+ ++.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++|+|||++......
T Consensus 103 ~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~- 174 (313)
T cd06633 103 CLG-SASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA- 174 (313)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC-
Confidence 964 7777775432 2388999999999999999999998 8999999999999999999999999988643221
Q ss_pred cceeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 469 AHVTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
....|+..|+|||++. ...++.++||||||+++|||++|..||..... ........... .
T Consensus 175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~------~~~~~~~~~~~-~------ 237 (313)
T cd06633 175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQND-S------ 237 (313)
T ss_pred ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcC-C------
Confidence 2345788999999874 45678899999999999999999999864321 11111111100 0
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+..+.+++.+||+.+|.+||++.++++
T Consensus 238 -~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 238 -PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00011223456899999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=293.33 Aligned_cols=264 Identities=25% Similarity=0.316 Sum_probs=194.3
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecC--
Q 007455 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLP-- 379 (603)
Q Consensus 305 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-- 379 (603)
++.+..++|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 56667789999999999999999999875 455799999865422 2245678899999999999999999987543
Q ss_pred ----CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEE
Q 007455 380 ----ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455 (603)
Q Consensus 380 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 455 (603)
...+++++++ +++|.+++... .+++..+..++.|+++||+|||+. +++||||||+||++++++.++|
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence 3357788776 67998877643 288999999999999999999998 8999999999999999999999
Q ss_pred eecccccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCcc-HhH-----
Q 007455 456 SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLN-VVG----- 528 (603)
Q Consensus 456 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~-~~~----- 528 (603)
+|||+++..... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.......... ...
T Consensus 162 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (345)
T cd07877 162 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237 (345)
T ss_pred eccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999998764322 223457889999998865 467889999999999999999999986432110000 000
Q ss_pred --HHHHHhhhCcchhhhc--ccCCC-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 529 --WMNTLLKENRLEDVID--KRCAD-----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 529 --~~~~~~~~~~~~~~~~--~~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..............+. ...+. .....+.++.+++.+|++.+|.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 238 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000000000000 00000 00113456899999999999999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=276.55 Aligned_cols=236 Identities=29% Similarity=0.328 Sum_probs=191.6
Q ss_pred eeecCCeEEEEEEECC-CCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCc
Q 007455 319 VGSGGFGTVYRMVMND-CGTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 319 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
||+|+||.||++.+.+ +..+++|.+...... ....+.+|+.+++.++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6999999999999874 567999988654322 334688999999999999999999999999999999999999999
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeec
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 474 (603)
.+++.... .+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~----~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKEG----RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 99997653 288999999999999999999998 89999999999999999999999999987754432 12234
Q ss_pred ccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHH
Q 007455 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554 (603)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (603)
..++..|+|||...+...+.++|+||||+++||+++|..||..... ......... .....+...
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~~----------~~~~~~~~~ 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KEIYEKILK----------DPLRFPEFL 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc----------CCCCCCCCC
Confidence 5578899999999888889999999999999999999999864321 111111111 111122233
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHH
Q 007455 555 VEAILEIAARCTDANPDDRPSMNQ 578 (603)
Q Consensus 555 ~~~l~~li~~cl~~~P~~RPs~~e 578 (603)
+..+.+++.+||..+|++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 567899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=295.36 Aligned_cols=260 Identities=22% Similarity=0.295 Sum_probs=191.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecC----------
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLP---------- 379 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 379 (603)
.+|...+.||+|+||.||+|.+.. +..||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 578888999999999999999875 457999998766555667788999999999999999999876543
Q ss_pred ----CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-CCCeE
Q 007455 380 ----ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-NLEPH 454 (603)
Q Consensus 380 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~k 454 (603)
...++|+||+++ +|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++. ++.++
T Consensus 85 ~~~~~~~~lv~e~~~~-~L~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYMET-DLANVLEQG-----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeecccc-cHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 346899999984 888877542 278999999999999999999998 8999999999999985 55789
Q ss_pred EeecccccccCCCCcc--eeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHH
Q 007455 455 VSDFGLAKLLVDEEAH--VTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 455 l~DfG~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 531 (603)
++|||.++........ ......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ ......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~~~~~ 233 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQLILE 233 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHH
Confidence 9999999765332111 1122357889999997654 5678899999999999999999999964321100 000000
Q ss_pred HHh-----h----hCcchhhhc--ccCCCc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 532 TLL-----K----ENRLEDVID--KRCADA-----DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 532 ~~~-----~----~~~~~~~~~--~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... . ......... ...... ......++.+++.+||+.+|++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000 0 000000000 000000 1123467889999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=288.58 Aligned_cols=265 Identities=24% Similarity=0.282 Sum_probs=191.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCC------
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPA------ 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 380 (603)
+++|++.+.||+|+||.||+|.+.. +..+|+|++..... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5789999999999999999999874 56799998854322 22345788999999999999999999875443
Q ss_pred --ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 381 --TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 381 --~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
..++|+||+.+ ++.+.+.... ..+++..+..++.|+++||.|||+. +++||||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS---VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 35899999976 6766665422 2389999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCcc----------eeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccH-
Q 007455 459 GLAKLLVDEEAH----------VTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNV- 526 (603)
Q Consensus 459 G~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~- 526 (603)
|+++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765432211 1122356788999998764 3578899999999999999999999865321100000
Q ss_pred h---------HHHHHHhhhCcchhhhcccCCCc----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 527 V---------GWMNTLLKENRLEDVIDKRCADA----DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 527 ~---------~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. .|..................+.. .......+.+++.+|++.+|++|||+.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0 00000000000000000000000 0112256889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=288.74 Aligned_cols=267 Identities=23% Similarity=0.296 Sum_probs=196.5
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCC--
Q 007455 306 IIEKLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPA-- 380 (603)
Q Consensus 306 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 380 (603)
+....++|+..+.||+|+||.||+|.+. ++..||||++..... .....+.+|++++++++||||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3344578999999999999999999876 456799999864322 22346789999999999999999999886553
Q ss_pred ----ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEe
Q 007455 381 ----TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS 456 (603)
Q Consensus 381 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 456 (603)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKHE-----KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEe
Confidence 348999998 66898887642 288999999999999999999998 89999999999999999999999
Q ss_pred ecccccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCC---------ccH
Q 007455 457 DFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG---------LNV 526 (603)
Q Consensus 457 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~---------~~~ 526 (603)
|||++....... ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||........ ...
T Consensus 161 dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 161 DFGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred ecccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999997654321 23457889999998865 4578899999999999999999999874321000 000
Q ss_pred hHHHHHHhhhCcchhhhcc-------cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 007455 527 VGWMNTLLKENRLEDVIDK-------RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQE 586 (603)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~ 586 (603)
..|........ ....... ............+.+++.+|+..+|++|||+.++++ .++..
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 237 KEFVQKLQSED-AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred HHHHHhhcchh-HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 00111000000 0000000 000011123456889999999999999999999993 44443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=288.25 Aligned_cols=262 Identities=21% Similarity=0.255 Sum_probs=189.7
Q ss_pred CCCCCCeeeecCCeEEEEEEECC---CCEEEEEEeCCCC--CChHHHHHHHHHHHhhC-CCCeeeecceeeecC----Cc
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND---CGTFAVKRIDRSR--EGSDQVFERELEILGSI-KHINLVNLRGYCRLP----AT 381 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 381 (603)
+|++.+.||+|+||.||++.+.. +..||+|++.... ....+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46778899999999999999875 4569999886432 22345678899999999 599999999875322 45
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.++++||+. ++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 678888886 58988886543 388999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcc---eeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccC---------CccHhH
Q 007455 462 KLLVDEEAH---VTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKR---------GLNVVG 528 (603)
Q Consensus 462 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~---------~~~~~~ 528 (603)
+........ ......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||....... +.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 1223468899999998765 467899999999999999999999986532100 000000
Q ss_pred HHHHHhhhCcch--hhhccc----CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 529 WMNTLLKENRLE--DVIDKR----CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 529 ~~~~~~~~~~~~--~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+........... ...... ...........+.+++.+|++.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 100000000000 000000 00001112467999999999999999999999984
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=274.95 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=205.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCC------EEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeec-CC
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDCG------TFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRL-PA 380 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~------~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~ 380 (603)
...+++....+-+|.||.||.|.+.+.. .+.+|.++.... -.-..+..|.-.+..+.|||+.++.+++.+ .+
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~ 361 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYA 361 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccC
Confidence 3456777788999999999999776433 467777754322 233457788888889999999999998854 46
Q ss_pred ccEEEEEecCCCCccccccc----cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEe
Q 007455 381 TKLLIYDYLSMGSLDDFLHE----HGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS 456 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~----~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 456 (603)
..+++|.++.-|+|..++.. .....+.++..+...++.|++.|++|||.+ +|||.||.++|+++|+..++||+
T Consensus 362 ~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 362 TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEec
Confidence 67899999999999999983 223345688889999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCccee-ecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHh
Q 007455 457 DFGLAKLLVDEEAHVT-TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 457 DfG~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
|=.+++.+.+.+.+.. ........||+||.+....|+.++|||||||++|||+| |+.||....+ .++..+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---fEm~~y----- 510 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---FEMEHY----- 510 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---HHHHHH-----
Confidence 9999998877665433 22335678999999999999999999999999999999 8888754221 111111
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
..|......|..++.++..++..||...|++||+++|++.-|.+
T Consensus 511 -------lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 511 -------LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred -------HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 11222223466788899999999999999999999999998865
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=246.50 Aligned_cols=262 Identities=23% Similarity=0.340 Sum_probs=196.0
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCC--CCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDR--SREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+|+..++||+|.||+||+|+..++.+ ||+|++.. ..++......+|+-+++.++|.|||+++++...++..-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45566889999999999999887766 89998854 3445566789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+.. +|..+....... ++...+.+++.|+++||.++|++ .+.|||+||.|.+++.+|+.|++|||+++.++-+-
T Consensus 83 cdq-dlkkyfdslng~---~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGD---LDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHhcCCc---CCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 987 888887764322 88889999999999999999999 89999999999999999999999999999876542
Q ss_pred cceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCC-CcccccCCccHhHHHHHHhhhCcchhhh---
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPT-DPTFVKRGLNVVGWMNTLLKENRLEDVI--- 543 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 543 (603)
...+...-|.+|.+|.++.+. -|++..|+||.||++.|+.....|. .+....+....+-|.-....++.+..+-
T Consensus 156 -rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp 234 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP 234 (292)
T ss_pred -EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence 223445578999999998765 5788999999999999999866663 3221111111111111111111111110
Q ss_pred cc-cCCCcCH-----H----HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DK-RCADADM-----E----TVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~-~~~~~~~-----~----~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
|- ..+.++. + ....-.+++.+.+..+|.+|.++++.++
T Consensus 235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 00 0011111 1 1123578899999999999999999887
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=272.10 Aligned_cols=251 Identities=26% Similarity=0.357 Sum_probs=192.1
Q ss_pred CCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC-ChHHHHHHHHHHHhh-CCCCeeeecceeeecCCccEEEEEecC
Q 007455 314 DEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE-GSDQVFERELEILGS-IKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 314 ~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
+....||.|+||+|+|..++. ++..|||++..... .+.+++..|.+...+ -+.||||++||.+..++..++.||.|+
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd 146 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD 146 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence 335679999999999999875 45689999976554 455678888887554 479999999999999999999999997
Q ss_pred CCCccccccc-cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 391 MGSLDDFLHE-HGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 391 ~gsL~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
- ||+.+.+. .......+++.-.-+|..-...||.||.... .|||||+||+|||+|..|.+|+||||.+..+.+.
T Consensus 147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-- 221 (361)
T KOG1006|consen 147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-- 221 (361)
T ss_pred h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH--
Confidence 6 77665442 1122234778777888888899999999875 8999999999999999999999999999776432
Q ss_pred ceeecccccccccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 470 HVTTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
...+.-+|-..|||||.+.. ..|+-+|||||+|++|||+.||+.||.... ++.+....+.... +..
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gd-------pp~ 289 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGD-------PPI 289 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCC-------CCe
Confidence 22233457888999998853 348889999999999999999999986421 1222222222111 111
Q ss_pred CCc---CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 548 ADA---DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 548 ~~~---~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... ..+.+..+.+++.-|+.+|-.+||+..++++
T Consensus 290 l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 290 LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 111 2346678999999999999999999999886
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=266.09 Aligned_cols=247 Identities=23% Similarity=0.290 Sum_probs=194.6
Q ss_pred hCCCC-CCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecC----CccE
Q 007455 311 EALDE-EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLP----ATKL 383 (603)
Q Consensus 311 ~~~~~-~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~~~ 383 (603)
++|.+ -++||-|-.|.|-.+..+.++ .+|+|++... ....+|+++--.. .|||||+++++|.+. .-+.
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 34444 268999999999999988655 4999987432 2367888875544 699999999988543 4467
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC---CCCeEEeeccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE---NLEPHVSDFGL 460 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~ 460 (603)
+|||.|+||.|.+.++.++ .+.+++.++-.|+.||+.|+.|||+. +|.||||||+|+|.+. |..+||+|||+
T Consensus 136 iVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 9999999999999998865 35699999999999999999999999 8999999999999965 45699999999
Q ss_pred ccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
|+.-... ......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||....... +. ..+.
T Consensus 211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---is---------pgMk 276 (400)
T KOG0604|consen 211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---IS---------PGMK 276 (400)
T ss_pred ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CC---------hhHH
Confidence 9875432 22345668999999999999999999999999999999999999998654311 11 0111
Q ss_pred hhhcccCCCc----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 DVIDKRCADA----DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ~~~~~~~~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..|......+ ..+.++...++|+.+|..+|.+|.|+.+++.
T Consensus 277 ~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 277 RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1222222222 2355678999999999999999999999985
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=290.22 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=193.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCc----
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPAT---- 381 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 381 (603)
..++|+..+.||+|+||.||+|.+.. +..||+|++.... ......+.+|+.+++.++||||+++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 35678889999999999999999875 4579999886432 2233557789999999999999999998866554
Q ss_pred --cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 382 --KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 382 --~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ-----KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence 79999998 55998888752 389999999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh--
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE-- 536 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 536 (603)
++...... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... .........
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~------~~~~~i~~~~~ 233 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI------DQLKRIMNLVG 233 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHHhcC
Confidence 99865432 223457888999998764 36788999999999999999999998643211 111110000
Q ss_pred ------------Ccchhhhcc---cC-C---CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 ------------NRLEDVIDK---RC-A---DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ------------~~~~~~~~~---~~-~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......+.. .. . ......+.++.+++.+|++.+|++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000 00 0 000123567999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=276.06 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=199.4
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCCCCh---HHHHHHHHHHHhhC-CCCeeeecceeeecCCccE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGS---DQVFERELEILGSI-KHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 383 (603)
...+|....+||+|+||.|..|..+++.+ ||||++++...-. .+--+.|-++|+-. +-|.++++...|+.-+++|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 45689999999999999999999887665 9999997653222 22234566777665 5789999999999999999
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+.||+|--.++..+. +.+..+.-+|.+||-||-+||++ +|+.||||.+|||+|.+|++||+|||+++.
T Consensus 427 FVMEyvnGGDLMyhiQQ~Gk----FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQVGK----FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eEEEEecCchhhhHHHHhcc----cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence 99999999999988888766 77888999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
--- +...+..++||+.|+|||++....|+..+|.|||||+||||+.|.+||+++... .+-+.|
T Consensus 500 ni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----------------elF~aI 562 (683)
T KOG0696|consen 500 NIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----------------ELFQAI 562 (683)
T ss_pred ccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHH
Confidence 322 233456789999999999999999999999999999999999999999875321 111222
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCC
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRP 574 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 574 (603)
...-..++...+.+...+....+.+.|.+|.
T Consensus 563 ~ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 563 MEHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 2222345666778899999999999999993
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=306.12 Aligned_cols=146 Identities=27% Similarity=0.377 Sum_probs=129.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+++|.+.+.||+|+||.||+|.+. .++.||+|++...... ....+.+|+.++..++||||+++++++......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 467889999999999999999987 4567999998654322 235688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|||+.+++|.+++..... +++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~----l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999876432 78889999999999999999998 89999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=269.04 Aligned_cols=220 Identities=22% Similarity=0.220 Sum_probs=175.9
Q ss_pred cCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCccccccc
Q 007455 322 GGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHE 400 (603)
Q Consensus 322 G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 400 (603)
|.||.||++.+..+ ..+|+|++.... .+.+|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999998744 569999986543 233455555566799999999999999999999999999999999876
Q ss_pred cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeeccccccc
Q 007455 401 HGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480 (603)
Q Consensus 401 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~ 480 (603)
... +++..+..++.|++.||.|||+. +++||||||+||+++.++.++++|||.+...... .....++..
T Consensus 79 ~~~----l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 FLN----IPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred hcC----CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 433 88999999999999999999998 8999999999999999999999999987655332 122345678
Q ss_pred ccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHH
Q 007455 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILE 560 (603)
Q Consensus 481 y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 560 (603)
|+|||...+..++.++||||+|+++|||++|+.|+...... ...... ...+...+..+.+
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------------~~~~~~---~~~~~~~~~~~~~ 207 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------------INTHTT---LNIPEWVSEEARS 207 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------------cccccc---cCCcccCCHHHHH
Confidence 99999998888899999999999999999999886532100 000000 0112234567899
Q ss_pred HHHHcccCCCCCCCCHH
Q 007455 561 IAARCTDANPDDRPSMN 577 (603)
Q Consensus 561 li~~cl~~~P~~RPs~~ 577 (603)
++.+|++.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=286.52 Aligned_cols=239 Identities=23% Similarity=0.282 Sum_probs=192.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++.|.....+|.|+|+.|-.+.+..+ ...+||.+.+... ...+|+.++... .||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 67888888999999999999887754 4599999865522 234567665555 79999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE-CCCCCeEEeecccccccCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL-DENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll-~~~~~~kl~DfG~~~~~~~ 466 (603)
.+.|+-+.+.+...+. ....+..|+.+|+.++.|||++ |||||||||+|||+ ++.++++|+|||.++....
T Consensus 397 ~l~g~ell~ri~~~~~-----~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE-----FCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHhcch-----hHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999988887776442 2267778999999999999998 99999999999999 6889999999999987655
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
. ....+-|..|.|||+.....|++++|+||||++||+|++|+.||.....+ .. ....+.
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~e-i~~~i~----------- 527 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IE-IHTRIQ----------- 527 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HH-HHHhhc-----------
Confidence 4 22334577899999999999999999999999999999999998753211 00 000011
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+......+....+|+..||+.||.+||+++++..
T Consensus 528 ~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 MPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 11122566778999999999999999999999985
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-33 Score=272.41 Aligned_cols=256 Identities=26% Similarity=0.383 Sum_probs=197.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC-------hHHHHHHHHHHHhhCCCCeeeecceeeec-CCc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG-------SDQVFERELEILGSIKHINLVNLRGYCRL-PAT 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 381 (603)
++|-....||+|+|+.||+|.+-. .+.||||+-...... -.+...+|.++-+.++||.||++|+++.. .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 456667889999999999999764 455888865432211 12456799999999999999999999965 456
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC---CCCCeEEeec
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD---ENLEPHVSDF 458 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~Df 458 (603)
++-|.||++|.+|+-|++.+.. +++.++.+|+.||+.||.||.+. .++|||-||||.|||+- .-|.+||.||
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl----mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL----MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh----hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence 7889999999999999988654 89999999999999999999986 47899999999999994 4578999999
Q ss_pred ccccccCCCCcc------eeecccccccccCcccccc----CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhH
Q 007455 459 GLAKLLVDEEAH------VTTVVAGTFGYLAPEYLQS----GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVG 528 (603)
Q Consensus 459 G~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~ 528 (603)
|+++.+.++... .++...||.+|++||++.- ...+.|+||||+|||+|.++.|+.||.......
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ------ 691 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ------ 691 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH------
Confidence 999998764432 3456789999999998843 345789999999999999999999998654321
Q ss_pred HHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 529 WMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 529 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.++.++.+.....-.. ......+.+...+|++||.+--++|....++..
T Consensus 692 ---dILqeNTIlkAtEVqF-P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 ---DILQENTILKATEVQF-PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred ---HHHhhhchhcceeccC-CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1222222221111111 122344567899999999999999988877653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=293.80 Aligned_cols=263 Identities=18% Similarity=0.223 Sum_probs=172.2
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCC-----CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeeccee------ee
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDC-----GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY------CR 377 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~ 377 (603)
..++|++.+.||+|+||.||+|.+.++ ..||+|++...... +....| .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 357899999999999999999998764 67999987543211 111111 1222223333322221 23
Q ss_pred cCCccEEEEEecCCCCccccccccCCC----------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCC
Q 007455 378 LPATKLLIYDYLSMGSLDDFLHEHGEG----------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIK 441 (603)
Q Consensus 378 ~~~~~~lv~e~~~~gsL~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk 441 (603)
.....++||||+.+++|.+++...... ........+..++.|++.||+|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 556789999999999999988753210 00112334567999999999999998 89999999
Q ss_pred CCCeEECC-CCCeEEeecccccccCCCCcceeecccccccccCccccccC----------------------CCCcccch
Q 007455 442 SSNILLDE-NLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG----------------------RATEKSDV 498 (603)
Q Consensus 442 p~NIll~~-~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Dv 498 (603)
|+|||++. ++.+||+|||+++.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987654433334556789999999965322 23456799
Q ss_pred HhHHHHHHHHHhCCCCCCcccc-------cCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCC
Q 007455 499 YSFGVLLLELVTGKRPTDPTFV-------KRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPD 571 (603)
Q Consensus 499 ~slG~vl~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~ 571 (603)
||+||++|||+++..|++.... ....+...|......... .+ .... ............+|+.+||+.||+
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~-~~-~~~~-~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRAS-PD-LRRG-FEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccc-hh-hhhh-hhhccccchHHHHHHHHHccCCcc
Confidence 9999999999998777553210 111122223221111000 00 0000 000001123456899999999999
Q ss_pred CCCCHHHHHH
Q 007455 572 DRPSMNQVLQ 581 (603)
Q Consensus 572 ~RPs~~evl~ 581 (603)
+|||++|+++
T Consensus 440 kR~ta~e~L~ 449 (566)
T PLN03225 440 QRISAKAALA 449 (566)
T ss_pred cCCCHHHHhC
Confidence 9999999997
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=276.58 Aligned_cols=239 Identities=26% Similarity=0.407 Sum_probs=195.6
Q ss_pred CCeeeecCCeEEEEEEECC-CCEEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCC
Q 007455 316 EDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
.++||.|.||+||-|+++. |+.||||++.+. ....+.++.+|+.+|++++||.||.+.-.|+.++..++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 5889999999999999874 557999999653 233456789999999999999999999999999999999999976
Q ss_pred CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC---CCeEEeecccccccCCCCc
Q 007455 393 SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN---LEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 393 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~~~~~~~~~~ 469 (603)
+..+.+-....++ +++....-++.||+.||.|||.. +|+|+||||+|||+... .++||||||+|+..++..
T Consensus 648 DMLEMILSsEkgR--L~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGR--LPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hHHHHHHHhhccc--chHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 6666555433333 88888888999999999999998 89999999999999654 469999999999986543
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC--
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC-- 547 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 547 (603)
.....+||+.|+|||++....|...-|+||.||++|-=++|..||..+. .+.+.|++..
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE------------------dIndQIQNAaFM 782 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE------------------DINDQIQNAAFM 782 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc------------------chhHHhhccccc
Confidence 3456789999999999999999999999999999999999999996431 1112222111
Q ss_pred -C-CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007455 548 -A-DADMETVEAILEIAARCTDANPDDRPSMNQVL 580 (603)
Q Consensus 548 -~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 580 (603)
+ ....+++.+..++|...|+.+-.+|-|.+.-+
T Consensus 783 yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 783 YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 1 12345667889999999999999999988755
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=260.60 Aligned_cols=238 Identities=30% Similarity=0.421 Sum_probs=192.6
Q ss_pred CCeEEEEEEECC-CCEEEEEEeCCCCCCh-HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCccccccc
Q 007455 323 GFGTVYRMVMND-CGTFAVKRIDRSREGS-DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHE 400 (603)
Q Consensus 323 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 400 (603)
+||.||+|...+ +..+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 6779999987655444 57799999999999999999999999998999999999999999999876
Q ss_pred cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeeccccccc
Q 007455 401 HGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480 (603)
Q Consensus 401 ~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~ 480 (603)
... +++..++.++.++++++.|||+. +++|+||+|+||++++++.++++|||.+....... ......++..
T Consensus 81 ~~~----~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 RGR----LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred ccC----CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 443 78899999999999999999998 89999999999999999999999999998765432 2334557889
Q ss_pred ccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHH
Q 007455 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILE 560 (603)
Q Consensus 481 y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 560 (603)
|++||...+..++.++||||+|++++++++|..||.... ......... ...... ........+.++.+
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-----~~~~~~~~~-~~~~~~------~~~~~~~~~~~~~~ 219 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-----QLLELFKKI-GKPKPP------FPPPEWKISPEAKD 219 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----cHHHHHHHH-hccCCC------CccccccCCHHHHH
Confidence 999999988888999999999999999999999986521 111111111 100000 00000014567999
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 007455 561 IAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 561 li~~cl~~~P~~RPs~~evl~ 581 (603)
++.+|+..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=284.20 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=202.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeee-----cCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCR-----LPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~~~ 382 (603)
.+.|++.++||.|.+|.||+++..+++ ..|+|+..... ..+++++.|.++++.. .|||++.++|++. .++++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 567888999999999999999977555 47888776554 3455688999999988 6999999999985 35788
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++|||||.+||..|+++... +..+.|..+..|+..++.|+.+||.+ .++|||||-.|||++.++.||++|||.+.
T Consensus 97 WLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeee
Confidence 99999999999999999866 45589999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQS-----GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
.+.. .........||+.|||||++.. ..|+.++|+||+|++..||.-|.+|+-..++- +.++...
T Consensus 172 Qlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---------raLF~Ip 241 (953)
T KOG0587|consen 172 QLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---------RALFLIP 241 (953)
T ss_pred eeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---------hhhccCC
Confidence 7643 2334566789999999999853 34667899999999999999999997544321 1111110
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+-. .+.+ ..+..-..++.++|..|+.+|-++||++.++++
T Consensus 242 RNP---PPkL-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 RNP---PPKL-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCC---Cccc-cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 000 0000 124456678999999999999999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=256.20 Aligned_cols=248 Identities=21% Similarity=0.331 Sum_probs=201.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 384 (603)
+.+|++.++||+|+|+.|..+.+..+.. ||+|++++.- .......+.|-.+..+. +||.+|-+..+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 5789999999999999999999887765 8999886542 22334567788887776 79999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
|.||++||+|--.++.+.+ ++++.+.-+..+|.-||.|||++ ||+.||||.+|+|+|.+|++|+.|+|+++.-
T Consensus 329 vieyv~ggdlmfhmqrqrk----lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhhhhc----CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999888876554 89999999999999999999999 9999999999999999999999999999764
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCC-ccHhHHHHHHhhhCcchhhh
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG-LNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 543 (603)
-. ....++.++|||.|+|||++.+..|...+|.|++||+++||+.|+.||+....... ....++.-. ++
T Consensus 402 l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfq---------vi 471 (593)
T KOG0695|consen 402 LG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQ---------VI 471 (593)
T ss_pred CC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHH---------HH
Confidence 32 23456778999999999999999999999999999999999999999985432211 222222222 22
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCC
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRP 574 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP 574 (603)
-.+....+...+.....+++.-+.+||.+|.
T Consensus 472 lekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 472 LEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 2222223344445677788999999999994
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-33 Score=258.31 Aligned_cols=261 Identities=25% Similarity=0.395 Sum_probs=193.4
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeC--CCCCChHHHHHHHHHHHhhCCCCeeeecceeeec--------CC
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRID--RSREGSDQVFERELEILGSIKHINLVNLRGYCRL--------PA 380 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~~ 380 (603)
.|....+||+|.||.||+|+.++++. ||+|++. ....+......+|++++..++|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 34556789999999999999876554 7888763 3344555667899999999999999999998843 23
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..|+||.+++. +|.-++.... ..++..++.+++.++..||.|+|.. .|+|||+||.|+|++.+|.+||+|||+
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccc
Confidence 47999999988 8888887542 3388899999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCc---ceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh
Q 007455 461 AKLLVDEEA---HVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE 536 (603)
Q Consensus 461 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 536 (603)
++.+...+. ...+..+-|.+|.+||.+.+ ..|+++.|||+.||++.||+||.+-+...........++-.-..+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 987654321 12234556899999998865 46899999999999999999999877654322111111110000000
Q ss_pred --------Ccchh-------------hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 --------NRLED-------------VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 --------~~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
-.+.+ .+..+... .....+..+|+..++..||.+|+++++++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp--~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKP--YVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhccc--ccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00111 11111111 111246889999999999999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=279.05 Aligned_cols=261 Identities=22% Similarity=0.274 Sum_probs=181.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEE-----------------CCCCEEEEEEeCCCCCChHH--------------HHHHH
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVM-----------------NDCGTFAVKRIDRSREGSDQ--------------VFERE 357 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~--------------~~~~E 357 (603)
..++|++.++||+|+||.||+|.+ .+++.||||++........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999975 23346999998654332222 23457
Q ss_pred HHHHhhCCCCee-----eecceeeec--------CCccEEEEEecCCCCccccccccCC--------------------C
Q 007455 358 LEILGSIKHINL-----VNLRGYCRL--------PATKLLIYDYLSMGSLDDFLHEHGE--------------------G 404 (603)
Q Consensus 358 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~ 404 (603)
+.++.+++|.++ ++++++|.. .+..++||||+++|+|.++++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 677777643 3567999999999999998874211 0
Q ss_pred CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeecccccccccCc
Q 007455 405 QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484 (603)
Q Consensus 405 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aP 484 (603)
...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12246778899999999999999998 899999999999999999999999999976543222222223357899999
Q ss_pred cccccCCC----------------------CcccchHhHHHHHHHHHhCCC-CCCcccc------cCCccHhHHHHHHhh
Q 007455 485 EYLQSGRA----------------------TEKSDVYSFGVLLLELVTGKR-PTDPTFV------KRGLNVVGWMNTLLK 535 (603)
Q Consensus 485 E~~~~~~~----------------------~~~~Dv~slG~vl~elltg~~-p~~~~~~------~~~~~~~~~~~~~~~ 535 (603)
|.+..... ..+.||||+||++|||++|.. |+..... ........|... .
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--K 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--c
Confidence 98753221 124799999999999999886 6543211 001111112110 0
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANP---DDRPSMNQVLQ 581 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P---~~RPs~~evl~ 581 (603)
.... + . ...........+++.+++..+| .+|+|++|+++
T Consensus 458 ~~~~----~--~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQKY----D--F-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccCC----C--c-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000 0 0 0112345678999999999766 68999999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=286.57 Aligned_cols=246 Identities=27% Similarity=0.407 Sum_probs=189.6
Q ss_pred CCCCCeeeecCCeE-EEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecC
Q 007455 313 LDEEDVVGSGGFGT-VYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 313 ~~~~~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
|...+++|.|+-|+ ||+|...+ ++||||++-. +....+.+|+..++.- +||||||+++.-.+....||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~-R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEG-REVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCC-ceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 33456799999886 79999876 7999998743 3345678999999987 59999999999899999999999998
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC---C--CCeEEeecccccccC
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE---N--LEPHVSDFGLAKLLV 465 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~--~~~kl~DfG~~~~~~ 465 (603)
. +|.+++...............+.+..|++.||++||+- +||||||||.|||++. + .+++|+|||+++.+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 7 99999987522111122255678899999999999997 8999999999999975 3 469999999999886
Q ss_pred CCCcc--eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhC-CCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 466 DEEAH--VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTG-KRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 466 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
.+... ......||.+|+|||++.....+.++||||+||++|+.++| .+||+....++.. .......+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N-------Il~~~~~L~~- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN-------ILTGNYTLVH- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh-------hhcCccceee-
Confidence 55432 23557799999999999988888999999999999999996 8899764322110 0000111110
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+.. .... +..+||.+|+..+|..||++.+|+.
T Consensus 735 ----L~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 ----LEP-LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ----ecc-CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 001 1111 7899999999999999999999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=269.88 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=205.3
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++.+++....||-|+||.|=.+..+.... +|+|.+++. .....+.+..|-.+|...+.|.||++|-.|.+....|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 34566777889999999999888765443 888877653 33344567889999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
.||-|-||.|-..+++.+. ++...+.-++.-+.+|++|||++ +||.|||||+|.++|.+|-+||.|||+|+.+
T Consensus 498 LmEaClGGElWTiLrdRg~----Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki 570 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGS----FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKI 570 (732)
T ss_pred hHHhhcCchhhhhhhhcCC----cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHh
Confidence 9999999999999998765 88888888999999999999999 8999999999999999999999999999988
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
..+ .++..++||+.|.|||++.....+.++|.||+|+++|||++|.+||.+..+ +..+.. +++. ++
T Consensus 571 ~~g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-----mktYn~-ILkG------id 636 (732)
T KOG0614|consen 571 GSG--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-----MKTYNL-ILKG------ID 636 (732)
T ss_pred ccC--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-----HHHHHH-HHhh------hh
Confidence 554 457889999999999999999999999999999999999999999976432 111111 1110 00
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
....|..+.....++++++...+|.+|.. +.|+.+
T Consensus 637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 637 --KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred --hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 11234556677899999999999999965 556653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=237.82 Aligned_cols=202 Identities=28% Similarity=0.404 Sum_probs=166.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCC-ChHHHHHHHHHHHh-hCCCCeeeecceeeecCCccEEEEEe
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSRE-GSDQVFERELEILG-SIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~-~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.+...+.||+|+||.|=+.++..++ -.|+|.+...-. +..++..+|+.+.. ...+|.+|.+||...+....++.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3444678999999999888877544 589999975433 33456778888754 45799999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
|+- ||..+.++--..+..+++...-+||..+.+||.|||++- .++|||+||+|||++.+|++||||||.+..+.+.-
T Consensus 127 M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhh
Confidence 987 888877664445556899999999999999999999985 89999999999999999999999999998775432
Q ss_pred cceeecccccccccCccccc----cCCCCcccchHhHHHHHHHHHhCCCCCCcc
Q 007455 469 AHVTTVVAGTFGYLAPEYLQ----SGRATEKSDVYSFGVLLLELVTGKRPTDPT 518 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~slG~vl~elltg~~p~~~~ 518 (603)
..+...|-..|||||.+. ...|+-|+||||+|+++.||.+++.||+..
T Consensus 204 --Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 204 --AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred --HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 122245777899999884 347888999999999999999999998753
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=258.04 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=195.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhCC-C-C----eeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSIK-H-I----NLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~~~ 382 (603)
..+|.+...+|+|.||.|-.+.+... ..||+|+++.-.. -.+...-|+++++++. + | -+|++.++|...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 56889999999999999999998766 4599998864332 2344677999999994 2 2 478899999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-------------
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE------------- 449 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~------------- 449 (603)
++|+|.+.- |+.+++..+. -.+++..++..|+.|+++++++||+. +++|-||||+|||+.+
T Consensus 167 CivfellG~-S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 167 CIVFELLGL-STFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred EEEEeccCh-hHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence 999998844 9999998754 34588999999999999999999999 8999999999999931
Q ss_pred -------CCCeEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccC
Q 007455 450 -------NLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKR 522 (603)
Q Consensus 450 -------~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~ 522 (603)
+..++++|||.|+.-.+.. +..+.|..|.|||++.+-.+++++||||+||||.|+.||..-|..-...+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3458999999998754332 55678999999999999999999999999999999999998776422111
Q ss_pred CccHhHH--------------HHHHhhhCcc-----------hhhhcccCC-----CcCHHHHHHHHHHHHHcccCCCCC
Q 007455 523 GLNVVGW--------------MNTLLKENRL-----------EDVIDKRCA-----DADMETVEAILEIAARCTDANPDD 572 (603)
Q Consensus 523 ~~~~~~~--------------~~~~~~~~~~-----------~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~P~~ 572 (603)
...+.+- ..+.+..+++ ..+.+...+ .....+..++.+|+++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 0000000 0000110110 011110000 012244567999999999999999
Q ss_pred CCCHHHHHH
Q 007455 573 RPSMNQVLQ 581 (603)
Q Consensus 573 RPs~~evl~ 581 (603)
|+|+.|+++
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=264.86 Aligned_cols=202 Identities=25% Similarity=0.352 Sum_probs=171.5
Q ss_pred CCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 313 LDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
|..++.||-|+||.|.++...|+.. ||.|.+.+... ......+.|-.||...+.+-||++|-.|.+.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 5567889999999999999888765 89998865432 2223477899999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc----
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL---- 464 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~---- 464 (603)
++||++-.+|.+.+- +++.-+..++.++..|+++.|.. |+|||||||+|||||.+|++||.|||+++-+
T Consensus 711 IPGGDmMSLLIrmgI----FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGI----FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred cCCccHHHHHHHhcc----CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999887654 77888888899999999999999 9999999999999999999999999998543
Q ss_pred -----CCCCcc--------------------------------eeecccccccccCccccccCCCCcccchHhHHHHHHH
Q 007455 465 -----VDEEAH--------------------------------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLE 507 (603)
Q Consensus 465 -----~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~e 507 (603)
..++-. .....+||+.|+|||++....++..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 111000 0122469999999999998899999999999999999
Q ss_pred HHhCCCCCCccccc
Q 007455 508 LVTGKRPTDPTFVK 521 (603)
Q Consensus 508 lltg~~p~~~~~~~ 521 (603)
|+.|+.||......
T Consensus 864 m~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPG 877 (1034)
T ss_pred HhhCCCCccCCCCC
Confidence 99999999876543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-31 Score=244.02 Aligned_cols=261 Identities=24% Similarity=0.320 Sum_probs=194.2
Q ss_pred CCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecC-----CccEEE
Q 007455 314 DEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLP-----ATKLLI 385 (603)
Q Consensus 314 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 385 (603)
+..+.||.|+||.||.+++. +++.||.|++... ...+.+++.+|++++..++|.|++..++...-. .+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34577999999999999976 6777999998543 233567899999999999999999988876543 246788
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
+|.|.. +|...+-. .+.++-..+.-+..||++||.|||+. +|.||||||.|.|++.+...||||||+++.-.
T Consensus 136 TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 898876 77776654 34478888889999999999999999 89999999999999999999999999999876
Q ss_pred CCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHh---------HHHHHHhh
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVV---------GWMNTLLK 535 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~---------~~~~~~~~ 535 (603)
.++....+...-|..|.|||++.+. .|+.+.||||.||++.||+..+.-|....+....+++ +-++. -.
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~-AC 286 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY-AC 286 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH-Hh
Confidence 6555555556678899999999765 5899999999999999999988877654322111111 01111 11
Q ss_pred hCcchhhhcccCCC----------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007455 536 ENRLEDVIDKRCAD----------ADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583 (603)
Q Consensus 536 ~~~~~~~~~~~~~~----------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 583 (603)
++.-..++....+. .+.....+...+...++..||..|.+.++.+.-+
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11111111111111 1112234577888899999999999999988644
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=229.24 Aligned_cols=256 Identities=18% Similarity=0.306 Sum_probs=191.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CCeeeecceeeecC--CccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRGYCRLP--ATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv 385 (603)
.++|++.+++|+|-|+.||.|..- ++..++||.++... .+.+.+|+.+|+.+. ||||++++++..++ ....+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 467788889999999999999854 55679999986543 455899999999997 99999999999776 456799
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC-CCeEEeeccccccc
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN-LEPHVSDFGLAKLL 464 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~~~~ 464 (603)
+||+.+.+...+... ++...+...+.+++.||.|+|++ ||.|||+||.|+++|.. ...+|+|+|+|.++
T Consensus 114 FE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 999999777665543 77788899999999999999999 99999999999999975 46999999999998
Q ss_pred CCCCcceeecccccccccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhH------------HHH
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQ-SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVG------------WMN 531 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~------------~~~ 531 (603)
.+... .+....+..|.-||.+. -..|+..-|+|||||++..|+..+.||-.... ....++. +..
T Consensus 184 Hp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHH
Confidence 76543 23445677889999874 45688899999999999999999999843221 1111221 111
Q ss_pred HHhh--hCcchhhhcccCC---------CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 532 TLLK--ENRLEDVIDKRCA---------DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 532 ~~~~--~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...- ......++..... +...-...+..+++.+.|..|-.+|+|++|.+.
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1000 0011111100000 011123467899999999999999999999874
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=230.95 Aligned_cols=210 Identities=38% Similarity=0.601 Sum_probs=182.2
Q ss_pred eeecCCeEEEEEEECC-CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCccc
Q 007455 319 VGSGGFGTVYRMVMND-CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDD 396 (603)
Q Consensus 319 ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~ 396 (603)
||+|++|.||++...+ +..+++|++...... ....+.+|++.++.+.|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999875 677999998755433 34568999999999999999999999999999999999999999999
Q ss_pred cccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-CCCeEEeecccccccCCCCcceeecc
Q 007455 397 FLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-NLEPHVSDFGLAKLLVDEEAHVTTVV 475 (603)
Q Consensus 397 ~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~~~~~~~~~~~~~~~~ 475 (603)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987642 2378999999999999999999999 8999999999999999 89999999999987654321 12234
Q ss_pred cccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHH
Q 007455 476 AGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMET 554 (603)
Q Consensus 476 ~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 554 (603)
.+...|++||..... .++.++|+|++|++++++
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 477889999999877 788999999999999999
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 555 VEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 555 ~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 358889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=254.20 Aligned_cols=198 Identities=25% Similarity=0.354 Sum_probs=170.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChH--------HHHHHHHHHHhhCC---CCeeeecceee
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSD--------QVFERELEILGSIK---HINLVNLRGYC 376 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~--------~~~~~E~~~l~~l~---h~niv~l~~~~ 376 (603)
....|+..+.+|+|+||.|+.|+++.+. .|+||.+.+.+.-.+ ..+-.|+++|..++ |+||+|++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 4567888999999999999999988654 599998866432211 12457999999997 99999999999
Q ss_pred ecCCccEEEEEecC-CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEE
Q 007455 377 RLPATKLLIYDYLS-MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455 (603)
Q Consensus 377 ~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 455 (603)
++++.+|++||-.. +-+|.+++...+. +++..+..|+.|++.|+++||++ +|||||||-+||.++.+|-+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~----m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPR----MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCc----cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence 99999999999764 5589999987765 99999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCcceeecccccccccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCC
Q 007455 456 SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT-EKSDVYSFGVLLLELVTGKRPTD 516 (603)
Q Consensus 456 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~vl~elltg~~p~~ 516 (603)
+|||.+.....+ ....+.||..|.|||++.+..|- ..-|||++|+++|.++....||.
T Consensus 712 idfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999998775433 34567899999999999998875 45799999999999999888874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=235.51 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=191.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecC------Cc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLP------AT 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 381 (603)
.+|.....+|.|.- .|..|.+. .+++||+|++... .....++..+|...+..+.|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666777888887 56566654 4567999988543 233456789999999999999999999998543 35
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.|+|||+|.. +|...+.-. ++......+..|++.|++|||+. +|+||||||+||++..++.+||.|||++
T Consensus 96 ~y~v~e~m~~-nl~~vi~~e------lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILME------LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhhhh-HHHHHHHHh------cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence 6999999987 888887732 67888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh-----
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE----- 536 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 536 (603)
+..... ...+....|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+.. .+.+|.+.....
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-----~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-----HIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-----HHHHHHHHHHHhcCCCH
Confidence 864332 34455678899999999988889999999999999999999998775432 122222211100
Q ss_pred ---------------Ccc---hhhhcccCCC--------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 ---------------NRL---EDVIDKRCAD--------ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ---------------~~~---~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..- ...+....++ .+......+.+++.+||..+|++|.+++++++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000 0001111111 11223456889999999999999999999997
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=260.10 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=201.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
++|+....+|.|.||.||||++.... ..|+|.++.........++.|+-+++..+||||+.++|.+...+..++.|||+
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc 94 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC 94 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence 57888899999999999999987544 48999887766666667889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
.+|+|++.-+..+. +++.+...+.++..+|++|||++ +-+|||||-.||++++.|.+|++|||.+..+.. ..
T Consensus 95 gggslQdiy~~Tgp----lselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita-ti 166 (829)
T KOG0576|consen 95 GGGSLQDIYHVTGP----LSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA-TI 166 (829)
T ss_pred CCCcccceeeeccc----chhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh-hh
Confidence 99999998887665 88999999999999999999999 889999999999999999999999999876543 23
Q ss_pred ceeecccccccccCcccc---ccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 470 HVTTVVAGTFGYLAPEYL---QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.+...+.||+.|||||+. ..+.|.+++|||+.|+...|+---..|--..++.. +..+... .-+++.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr-------~l~LmTk----S~~qpp 235 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR-------ALFLMTK----SGFQPP 235 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH-------HHHHhhc----cCCCCC
Confidence 345668899999999987 35678899999999999999987777632221110 0000000 001111
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.......-.+.+-++++-++..+|++||+++.+++
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11123344567899999999999999999987763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=230.16 Aligned_cols=199 Identities=34% Similarity=0.481 Sum_probs=172.6
Q ss_pred CCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 313 LDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
|+..+.||+|++|.||++...+ +..+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999999886 667999999765544 56678999999999999999999999999899999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+++|.+++...... +++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGGK---LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcccC---CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 99999998764321 68899999999999999999998 8999999999999999999999999999877554311
Q ss_pred eeecccccccccCcccc-ccCCCCcccchHhHHHHHHHHHhCCCCCCc
Q 007455 471 VTTVVAGTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTGKRPTDP 517 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~vl~elltg~~p~~~ 517 (603)
......++..|++||.. ....++.++|+|+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334577889999998 666778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=224.03 Aligned_cols=253 Identities=18% Similarity=0.282 Sum_probs=188.3
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeeccee-eecCCccEEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGY-CRLPATKLLI 385 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv 385 (603)
-.+.|++.+.+|+|.||.+-.+.++.... +++|.+.+.. ...+.|.+|..---.| .|.||+.-|++ |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 35678899999999999999999987654 8888776554 4456799998875556 59999988875 5566777799
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC--CCCCeEEeecccccc
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD--ENLEPHVSDFGLAKL 463 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~~~~ 463 (603)
+||++.|+|.+-+...+ +.+....+++.|+++|+.|||+. .+||||||.+|||+- +..++|+||||.++.
T Consensus 101 qE~aP~gdL~snv~~~G-----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG-----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCccc-----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999999887644 67788899999999999999999 899999999999993 334899999999876
Q ss_pred cCCCCcceeecccccccccCccccccC-----CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSG-----RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
.+..- ...--+..|.+||..... ...+.+|||.||++++.++||+.||.... ........|..-.-...
T Consensus 173 ~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~- 246 (378)
T KOG1345|consen 173 VGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKN- 246 (378)
T ss_pred cCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccC-
Confidence 43211 112234568999977432 33567999999999999999999998432 23334444433211111
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
.+.+..-...++.+.++.++-+..+|++|-...++.++
T Consensus 247 ------~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 247 ------PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred ------ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 12233223445678899999999999999655555543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=232.98 Aligned_cols=132 Identities=23% Similarity=0.313 Sum_probs=110.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChHHHHHHHHHHHhhCC-----C---Ceeeecceeeec---
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIK-----H---INLVNLRGYCRL--- 378 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~--- 378 (603)
.+|.+.++||=|.|++||+|.+..+. .||+|+.+.. +.-.+....|+++|++++ | ..||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 47888999999999999999988655 4888877543 344456789999999984 3 379999999964
Q ss_pred -CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC
Q 007455 379 -PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD 448 (603)
Q Consensus 379 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 448 (603)
+.++++|+|++.. +|..++....-. .++...+.+|+.||+.||.|||..| +|||-||||+|||+.
T Consensus 157 NG~HVCMVfEvLGd-nLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGD-NLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhhhh-HHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4578999999955 898888875433 3899999999999999999999998 999999999999994
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-28 Score=240.54 Aligned_cols=262 Identities=24% Similarity=0.273 Sum_probs=198.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC------CCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIK------HINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~~~~ 383 (603)
..|.+....|+|-|++|.+|.+. .+.+||||++...... .+.=.+|+++|.+|. .-|+++++-.|...++++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLC 510 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLC 510 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeE
Confidence 46777888999999999999976 4557999999654332 233467999999995 348999999999999999
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-CeEEeeccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-EPHVSDFGLAK 462 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~ 462 (603)
+|+|-+.. +|.+.+++.+.. ..+....+..++.|+.-||..|... +|+|.||||.|||+++.. .+||||||.|.
T Consensus 511 lVFE~Lsl-NLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 511 LVFEPLSL-NLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred EEehhhhc-hHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcccc
Confidence 99998876 999999987653 3478889999999999999999987 999999999999998764 58999999998
Q ss_pred ccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhH--------------
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVG-------------- 528 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~-------------- 528 (603)
...+++. +...-+..|.|||++.+-.|+...|+||+||+||||.||+.-|.+........+..
T Consensus 586 ~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKg 662 (752)
T KOG0670|consen 586 FASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKG 662 (752)
T ss_pred ccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhc
Confidence 7765543 33345668999999999999999999999999999999998765422110000000
Q ss_pred -HHHHHhhh---------------------------Ccchhhh--cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007455 529 -WMNTLLKE---------------------------NRLEDVI--DKRCADADMETVEAILEIAARCTDANPDDRPSMNQ 578 (603)
Q Consensus 529 -~~~~~~~~---------------------------~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 578 (603)
+...++.. ..+...+ .+.+++.......++.+|+..|+..||++|.|..+
T Consensus 663 qF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nq 742 (752)
T KOG0670|consen 663 QFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQ 742 (752)
T ss_pred chhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHH
Confidence 00000000 0000000 01122233455678999999999999999999999
Q ss_pred HHH
Q 007455 579 VLQ 581 (603)
Q Consensus 579 vl~ 581 (603)
+|+
T Consensus 743 AL~ 745 (752)
T KOG0670|consen 743 ALK 745 (752)
T ss_pred Hhc
Confidence 885
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-27 Score=231.24 Aligned_cols=264 Identities=26% Similarity=0.339 Sum_probs=195.1
Q ss_pred HHHHhhCCCCCCeeeecCCeEEEEEEECC----CCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCC
Q 007455 306 IIEKLEALDEEDVVGSGGFGTVYRMVMND----CGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPA 380 (603)
Q Consensus 306 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 380 (603)
+....+.|...++||+|.|++||+|++.. ...||+|.+...+. ..++..|+++|..+ .+.||+++.+.+..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 33445678899999999999999998654 34699999866543 45589999999999 4999999999999999
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-CCCeEEeecc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-NLEPHVSDFG 459 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG 459 (603)
...+|+||++.....++... ++..++...+..+..||.++|.+ |||||||||+|+|.+. .++-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 99999999999888888775 67888999999999999999999 9999999999999975 4678999999
Q ss_pred cccccCCCC------------------c-------------------------ceeecccccccccCccccc-cCCCCcc
Q 007455 460 LAKLLVDEE------------------A-------------------------HVTTVVAGTFGYLAPEYLQ-SGRATEK 495 (603)
Q Consensus 460 ~~~~~~~~~------------------~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~ 495 (603)
++..+.... . .......||++|.|||++. ....+++
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 997321000 0 0112356999999999874 4567899
Q ss_pred cchHhHHHHHHHHHhCCCCCCcccccC-----CccHhHHHH--H---------Hhh-h------------Ccc-hhhhcc
Q 007455 496 SDVYSFGVLLLELVTGKRPTDPTFVKR-----GLNVVGWMN--T---------LLK-E------------NRL-EDVIDK 545 (603)
Q Consensus 496 ~Dv~slG~vl~elltg~~p~~~~~~~~-----~~~~~~~~~--~---------~~~-~------------~~~-~~~~~~ 545 (603)
+||||.||++..+++++.||-.....- ...+.+|.. + ... . ..+ .+.+.+
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 999999999999999999985321100 001111110 0 000 0 000 000000
Q ss_pred ------cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 ------RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+.....+..+++++.+|++.||.+|.|++|.++
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000112223457899999999999999999999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=262.82 Aligned_cols=195 Identities=17% Similarity=0.172 Sum_probs=138.2
Q ss_pred hCCC-Ceeeecceee-------ecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 007455 363 SIKH-INLVNLRGYC-------RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434 (603)
Q Consensus 363 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 434 (603)
.++| +||.+++++| .....++.++||+. ++|.+++... ...+++.+++.++.||++||.|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 3455 5788888877 22345677889875 4999999753 23489999999999999999999998 8
Q ss_pred eEEecCCCCCeEECC-------------------CCCeEEeecccccccCCCCc---------------ceeeccccccc
Q 007455 435 IIHRDIKSSNILLDE-------------------NLEPHVSDFGLAKLLVDEEA---------------HVTTVVAGTFG 480 (603)
Q Consensus 435 ivH~Dlkp~NIll~~-------------------~~~~kl~DfG~~~~~~~~~~---------------~~~~~~~gt~~ 480 (603)
|+||||||+|||++. ++.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999964 44566666666653211000 00112357889
Q ss_pred ccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHH
Q 007455 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILE 560 (603)
Q Consensus 481 y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 560 (603)
|+|||++.+..++.++|||||||++|||++|..|+.... ........ .. .+...........+
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~~-----~~----~~~~~~~~~~~~~~ 243 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLRH-----RV----LPPQILLNWPKEAS 243 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHHH-----hh----cChhhhhcCHHHHH
Confidence 999999998899999999999999999999888764311 01111000 00 01111112234668
Q ss_pred HHHHcccCCCCCCCCHHHHHH
Q 007455 561 IAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 561 li~~cl~~~P~~RPs~~evl~ 581 (603)
++.+||..+|.+||++.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=203.35 Aligned_cols=167 Identities=26% Similarity=0.287 Sum_probs=125.3
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.++++..+ ..+++.+++.++.|+++||+|||++ + ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 68888887643 2389999999999999999999998 4 999999999999999 99988654322
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ............... ........
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~---~~~~~~~~ 132 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-----LSAILEILLNGMPAD---DPRDRSNL 132 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-----hcHHHHHHHHHhccC---CccccccH
Confidence 2588999999999999999999999999999999999999864321 111111111110000 00000111
Q ss_pred HHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 552 METVE--AILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 552 ~~~~~--~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
..... ++.+++.+||..+|++||++.|+++.+...
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 22333 699999999999999999999999977653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=218.38 Aligned_cols=172 Identities=23% Similarity=0.213 Sum_probs=131.7
Q ss_pred CCChHHHHHHhhCCCCCCeeeecCCeEEEEEEECC--CCEEEEEEeCCCC-----CChHHHHHHHHHHHhhCCCCeeee-
Q 007455 300 PYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMND--CGTFAVKRIDRSR-----EGSDQVFERELEILGSIKHINLVN- 371 (603)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~- 371 (603)
|.|.........+|++.+.||+|+||+||+|.+.. +..+|||++.... ....+.+.+|++++++++|+|+++
T Consensus 7 ~~~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~ 86 (365)
T PRK09188 7 PLPGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ 86 (365)
T ss_pred CCcccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence 33444445556789999999999999999998763 4557999875321 122456899999999999999985
Q ss_pred cceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC-CCCCeEECCC
Q 007455 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDI-KSSNILLDEN 450 (603)
Q Consensus 372 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~ 450 (603)
+++ .+..|+||||++|++|... .. .. ...++.+++++|.|||++ +|+|||| ||+|||++.+
T Consensus 87 l~~----~~~~~LVmE~~~G~~L~~~-~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~ 148 (365)
T PRK09188 87 LLA----TGKDGLVRGWTEGVPLHLA-RP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPD 148 (365)
T ss_pred EEE----cCCcEEEEEccCCCCHHHh-Cc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCC
Confidence 443 2467999999999999632 11 11 146788999999999998 9999999 9999999999
Q ss_pred CCeEEeecccccccCCCCcce-------eecccccccccCcccccc
Q 007455 451 LEPHVSDFGLAKLLVDEEAHV-------TTVVAGTFGYLAPEYLQS 489 (603)
Q Consensus 451 ~~~kl~DfG~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 489 (603)
++++|+|||+++.+....... .....+++.|+|||.+..
T Consensus 149 ~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 149 GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999999998775432111 134568889999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.8e-23 Score=208.43 Aligned_cols=259 Identities=21% Similarity=0.288 Sum_probs=192.7
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCC--EEEEEEeCCCCCChHHHHHHHHHHHhhCCC----Ceeeecceee-ecCCccEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCG--TFAVKRIDRSREGSDQVFERELEILGSIKH----INLVNLRGYC-RLPATKLL 384 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~--~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 384 (603)
+|.+.+.||+|+||.||.+.+.... .+|+|............+..|..++..+.. +++.++++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7899999999999999999987754 688887765433333368889999998873 5888888888 46777899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC-----CCeEEeecc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN-----LEPHVSDFG 459 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-----~~~kl~DfG 459 (603)
||+.+ |.+|.++..... ...++..++..++.|++.+|+++|+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99977 559999887655 34489999999999999999999999 99999999999999865 359999999
Q ss_pred ccc--ccCCCCcc------e-eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHH
Q 007455 460 LAK--LLVDEEAH------V-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWM 530 (603)
Q Consensus 460 ~~~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~ 530 (603)
+++ .+...... . .....||.+|.+++...+...+.+.|+||++.++.|++.|..||........ ..-.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~ 249 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKF 249 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHH
Confidence 998 33222111 1 1335599999999999999999999999999999999999999854321110 1011
Q ss_pred HHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 531 NTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 531 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..... ...... .....+.++.++...+-..+..++|....+...+++..
T Consensus 250 ~~~~~----~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 250 EKDPR----KLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHhh----hhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 11000 000000 11122345666666666689999999999998876643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=189.43 Aligned_cols=260 Identities=18% Similarity=0.243 Sum_probs=195.1
Q ss_pred CCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEEEEec
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.|.++++||+|+||.++.|+.- ++..||||.-...++ .-++..|.+.++.|. .+.|...+-+..++.+-.+|+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 6788999999999999999853 667899996543332 235788999999884 789998888878888888999988
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-----CeEEeeccccccc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-----EPHVSDFGLAKLL 464 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-----~~kl~DfG~~~~~ 464 (603)
|-||+|+..-.+. .++..++..+|.|++.-++|+|++ .+|.|||||+|+||...+ .+.|+|||+|+.+
T Consensus 107 -GPSLEDLFD~CgR---~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR---RFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHHhcC---cccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 5599999886543 389999999999999999999999 899999999999997543 4899999999998
Q ss_pred CCCCcc------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 465 VDEEAH------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 465 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
.++... ......||.+||+-....+.+.+.+.|.-|+|-++++.+.|..||.+......-...+.+. +..
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIG----e~K 255 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIG----ETK 255 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhc----ccc
Confidence 776543 2345679999999999999999999999999999999999999998643211111111111 111
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
....+...+. ..+.++..-+.-.-+.+-.+-|..+-+...+.+...
T Consensus 256 r~T~i~~Lc~----g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 256 RSTPIEVLCE----GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred ccCCHHHHHh----cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 1111111122 234556666665666777788888877766655443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=194.34 Aligned_cols=250 Identities=22% Similarity=0.361 Sum_probs=189.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++++..+|.+...|..|+|++.+ ..+++|++... .....+.|..|.-.++-+.||||+.++|.|..+.+..++..|
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 345556778999999999999986 45666766432 223345689999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE-ecCCCCCeEECCCCCeEEe--ecccccccC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIH-RDIKSSNILLDENLEPHVS--DFGLAKLLV 465 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH-~Dlkp~NIll~~~~~~kl~--DfG~~~~~~ 465 (603)
|+.|+|...++.. .....+..++.+++.++|+|++|||+.. +++- --|.+..+++|++.+++|+ |--++...
T Consensus 269 mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsfqe- 343 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE- 343 (448)
T ss_pred ccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeeeec-
Confidence 9999999999864 3455788899999999999999999974 4443 4688999999999887764 32222111
Q ss_pred CCCcceeecccccccccCccccccCCCC---cccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRAT---EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
....-.+.||+||.++..+-+ .++|+|||++++|||.|...||....+-+.. +.-.
T Consensus 344 -------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--------------mkia 402 (448)
T KOG0195|consen 344 -------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--------------MKIA 402 (448)
T ss_pred -------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------------hhhh
Confidence 112235789999998765433 4789999999999999999999753221110 0111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
+.......+...+..+.+++.-|+..||.+||.++.++-.|+++.
T Consensus 403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 111112234456678999999999999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-21 Score=196.42 Aligned_cols=260 Identities=31% Similarity=0.426 Sum_probs=196.7
Q ss_pred CCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCC-eeeecceeeecCCccEEEEEe
Q 007455 313 LDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG---SDQVFERELEILGSIKHI-NLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 388 (603)
|...+.||.|+||.||++.+. ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999988 67899988654433 356799999999999988 799999999777778999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-CeEEeecccccccCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-EPHVSDFGLAKLLVDE 467 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~~~~~ 467 (603)
+.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776654321 2378899999999999999999999 899999999999999988 7999999999865543
Q ss_pred Ccc-----eeecccccccccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 468 EAH-----VTTVVAGTFGYLAPEYLQS---GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 468 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
... ......|+..|+|||.+.+ ..+....|+||+|++++++++|..|+...... ...............
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~ 232 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPT 232 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCC
Confidence 322 2356779999999999987 57888999999999999999999996543211 000011111111110
Q ss_pred hhhhcccCCC-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007455 540 EDVIDKRCAD-ADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582 (603)
Q Consensus 540 ~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~ 582 (603)
. ........ ........+.+++.+++..+|..|.+..+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 00000000 001223568899999999999999999887763
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-22 Score=234.69 Aligned_cols=172 Identities=39% Similarity=0.640 Sum_probs=124.4
Q ss_pred ChhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCccccceeecCCCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCC
Q 007455 26 LTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNS 105 (603)
Q Consensus 26 ~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~w~gv~C~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 105 (603)
.++|+.||++||+++.+|.+.+.+|+. ..+||.|.||+|+. .++|+.|+|++|++++.++..|..+++|+.|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~-~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCC-CCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 567999999999999888888899974 46789999999975 4689999999999999999899999999999999999
Q ss_pred CCCCCCCCcc-ccCCCceEEeccccCCCCCc----------------------cccccccccceecccCCccCCCCCCCC
Q 007455 106 LHGSIPNEIT-NCTELRALYLRANYLQGGIP----------------------ANIGNLLFLTILDLSSNSLKGAIPSSL 162 (603)
Q Consensus 106 l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p----------------------~~~~~l~~L~~L~l~~N~l~~~~p~~~ 162 (603)
+++.+|..+. .+++|++|+|++|++++.+| ..++++++|+.|+|++|.+.+.+|..+
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~ 184 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhh
Confidence 9888887654 67777777777776665444 445555555555555555555555555
Q ss_pred ccccccceeeccCCcCcccCC-CCccccccCcccccCC
Q 007455 163 GRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 163 ~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~~~~n 199 (603)
.++++|++|+|++|++++.+| .++.+.+|+.|++.+|
T Consensus 185 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 222 (968)
T PLN00113 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN 222 (968)
T ss_pred hhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCC
Confidence 555555555555555554433 2445555555555444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-23 Score=222.79 Aligned_cols=253 Identities=23% Similarity=0.248 Sum_probs=187.1
Q ss_pred CCCCeeeecCCeEEEEEEECCCC-EEEEEEeCC---CCCCh---HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 314 DEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDR---SREGS---DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 314 ~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~---~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
...+++|.|++|.|+.+...... .++.|.... ..... ...+..|+-+-..+.|+|++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45688999999988877654322 244443321 11111 122566778888899999998888777776666679
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++ +|..++..... +...++..++.|+..|+.|+|+. |+.|||+|++|++++.+|.+||+|||.+..+.-
T Consensus 401 E~~~~-Dlf~~~~~~~~----~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGK----LTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhcccc----cchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99999887533 78888999999999999999999 899999999999999999999999999877643
Q ss_pred CCc---ceeecccccccccCccccccCCCCc-ccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 467 EEA---HVTTVVAGTFGYLAPEYLQSGRATE-KSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 467 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
+.. .......|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||......+.... .........
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~-------~~~~~~~~~ 545 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK-------TNNYSDQRN 545 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh-------hhccccccc
Confidence 322 4556788999999999999988876 58999999999999999999875432211100 000000000
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+...........+.+...++.++++.+|.+|.|+++|++
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 011111123344567889999999999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=179.01 Aligned_cols=259 Identities=20% Similarity=0.263 Sum_probs=194.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE-CCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCC-CeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVM-NDCGTFAVKRIDRSREGSDQVFERELEILGSIKH-INLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 387 (603)
..+|.+.++||.|+||.+|.|.. .++.+||||.-...... .++..|.++++.+++ ..|..+..+..+...-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46788999999999999999985 46678999976544333 347889999999974 577778888888888899999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC---CCeEEeeccccccc
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN---LEPHVSDFGLAKLL 464 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~~~~~ 464 (603)
.+ |.||+++..-... .++..+++-++-|++.-++|+|.+ +++||||||+|+|..-+ ..+.++|||+|+.+
T Consensus 92 LL-GPsLEdLfnfC~R---~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSR---RFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred cc-CccHHHHHHHHhh---hhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhh
Confidence 88 5599998876433 388999999999999999999999 89999999999999643 46899999999988
Q ss_pred CCCCcce------eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 465 VDEEAHV------TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 465 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
.+..... .....||.+|.+-....+...+.+.|+-|+|.++.+.-.|..||.+.......... ..+.+..
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy----EkI~EkK 240 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY----EKISEKK 240 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH----HHHHHhh
Confidence 7644322 23466999999888777777888999999999999999999999764322111111 1112222
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
....+...+.+.| .++.-.+.-|-..--++-|...-+.+.++-
T Consensus 241 ~s~~ie~LC~G~P----~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 241 MSTPIEVLCKGFP----AEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred cCCCHHHHhCCCc----HHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 2223333344443 456667777777777788887777765543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=214.96 Aligned_cols=160 Identities=34% Similarity=0.578 Sum_probs=126.5
Q ss_pred CChhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCc-----cccceeecCC--C--CcEEEEEcCCCCcccccCCCccCCCC
Q 007455 25 ALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPC-----KWTGISCHTH--D--QRVRSINLPYMQLGGIISPSIGRLDK 95 (603)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c-----~w~gv~C~~~--~--~~l~~L~L~~n~l~~~~~~~~~~l~~ 95 (603)
....|..||+++|+.+.++.. .+|++ +|| .|.||.|... . ..|+.|+|++|+++|.+|+.++.|++
T Consensus 369 t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred cCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 355799999999999976643 48964 344 7999999532 1 25889999999999999999999999
Q ss_pred cceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccC
Q 007455 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLST 175 (603)
Q Consensus 96 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 175 (603)
|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|+.+++|++|+.|+|++|+++|.+|..+..+.
T Consensus 444 L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~--------- 514 (623)
T PLN03150 444 LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL--------- 514 (623)
T ss_pred CCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhcc---------
Confidence 99999999999989998899999999999999999999999899999999999999999888887765421
Q ss_pred CcCcccCCCCccccccCcccccCCcccCCCCCCCCC
Q 007455 176 NFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPC 211 (603)
Q Consensus 176 N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~~~~~~c 211 (603)
.++..+++.+|..+|+.|-...|
T Consensus 515 -------------~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 515 -------------LHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred -------------ccCceEEecCCccccCCCCCCCC
Confidence 12334556677777766544444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.7e-21 Score=180.20 Aligned_cols=140 Identities=14% Similarity=0.120 Sum_probs=108.7
Q ss_pred CCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC--h------------------------HHHHHHHHHHHhhCCCCee
Q 007455 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--S------------------------DQVFERELEILGSIKHINL 369 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni 369 (603)
.+.||+|+||.||+|.+.+++.||||+++..... . ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999888889999998654211 0 1123459999999988877
Q ss_pred eecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEecCCCCCeEEC
Q 007455 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYL-HHDCCPKIIHRDIKSSNILLD 448 (603)
Q Consensus 370 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~NIll~ 448 (603)
.....+.. ...++||||++++++........ .++......++.|++.+|.|+ |+. +|+||||||+||+++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~----~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA----PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC----CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 54443322 23489999999987765432222 378899999999999999999 677 899999999999998
Q ss_pred CCCCeEEeecccccccC
Q 007455 449 ENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 449 ~~~~~kl~DfG~~~~~~ 465 (603)
++.++|+|||++....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=184.45 Aligned_cols=177 Identities=15% Similarity=0.206 Sum_probs=135.4
Q ss_pred HHHHHH--hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHH---------HHHHHHHHhhCCCCeeeec
Q 007455 304 CEIIEK--LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQV---------FERELEILGSIKHINLVNL 372 (603)
Q Consensus 304 ~~~~~~--~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~l 372 (603)
.++... -.+|...+++|+|+||.||.+.. +++.+|+|.+.......+.. +++|++.+.++.|++|..+
T Consensus 22 ~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 22 KEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred HHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 344443 36888899999999999999766 56789999997554433332 6899999999999999999
Q ss_pred ceeeecC--------CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 007455 373 RGYCRLP--------ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSN 444 (603)
Q Consensus 373 ~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 444 (603)
.+++... +..++||||++|.+|.++.. ++. ....+++.++..+|.. +++|||++|+|
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~N 165 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGN 165 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHH
Confidence 8886533 35789999999999987632 222 2455889999999999 99999999999
Q ss_pred eEECCCCCeEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh
Q 007455 445 ILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT 510 (603)
Q Consensus 445 Ill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt 510 (603)
|+++.+| ++++|||........... ..+.....+..++|+|+||+++.....
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 9999998 999999988755322111 012334456678999999998876653
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=182.55 Aligned_cols=234 Identities=21% Similarity=0.291 Sum_probs=149.3
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCC---hHHHHHHHHHHHhhCCC----------Ceeeecceeee
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREG---SDQVFERELEILGSIKH----------INLVNLRGYCR 377 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 377 (603)
.+...+.||.|+++.||.+++.+++ ++|+|++...... ..+.+++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3445688999999999999999755 5999988433322 23456666655555332 22332222221
Q ss_pred ---------cCC--------ccEEEEEecCCCCccccccc---cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 007455 378 ---------LPA--------TKLLIYDYLSMGSLDDFLHE---HGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIH 437 (603)
Q Consensus 378 ---------~~~--------~~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH 437 (603)
... ..+++|+-+.+ +|.+++.. .......+....++.+..|+++.+++||+. |++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence 111 23567887755 88877543 222223355667788889999999999999 9999
Q ss_pred ecCCCCCeEECCCCCeEEeecccccccCCCCcceeecccccccccCcccccc--------CCCCcccchHhHHHHHHHHH
Q 007455 438 RDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS--------GRATEKSDVYSFGVLLLELV 509 (603)
Q Consensus 438 ~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~vl~ell 509 (603)
+||+|+|++++.+|.++|+||+.....+.. ... ...+..|.+||.... -.++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce---eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999877654321 111 334577999997643 24678899999999999999
Q ss_pred hCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCC
Q 007455 510 TGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDR 573 (603)
Q Consensus 510 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 573 (603)
+|..||+.......... ...... ..++.+.+||..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999986432211110 111222 667789999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.1e-20 Score=173.81 Aligned_cols=141 Identities=16% Similarity=0.125 Sum_probs=110.8
Q ss_pred CCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCCh--------------------------HHHHHHHHHHHhhCCCCee
Q 007455 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS--------------------------DQVFERELEILGSIKHINL 369 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni 369 (603)
.+.||+|+||.||+|.+.++..||||++....... ...+.+|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998878899999986542110 1224678999999999987
Q ss_pred eecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeEEC
Q 007455 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH-DCCPKIIHRDIKSSNILLD 448 (603)
Q Consensus 370 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~ 448 (603)
.....+... ..++||||++++++........ .++......++.|++.++.++|+ . +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 555444333 3489999999986544322211 26778899999999999999999 7 899999999999999
Q ss_pred CCCCeEEeecccccccCC
Q 007455 449 ENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 449 ~~~~~kl~DfG~~~~~~~ 466 (603)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-21 Score=208.19 Aligned_cols=254 Identities=21% Similarity=0.198 Sum_probs=185.2
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC-hH---HHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG-SD---QVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++...+.+|.+.|=+|.+|++++| .|+||++.+.... +- .+-.+|++ ...++|||.+++.-+-......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 567788999999999999999885 5999988554322 22 33344555 556789999999888777778899999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc--cC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL--LV 465 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~--~~ 465 (603)
|+.. +|.|.+..++- +...+..-|+.|++.||.-+|.. +|+|||||.+|||++.=.=+.|+||..-+. ++
T Consensus 102 yvkh-nLyDRlSTRPF----L~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPF----LVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccchH----HHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9987 99999987654 67777888999999999999999 999999999999999887899999986542 33
Q ss_pred CCCcceeeccc----ccccccCccccccC-----------CCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHH
Q 007455 466 DEEAHVTTVVA----GTFGYLAPEYLQSG-----------RATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGW 529 (603)
Q Consensus 466 ~~~~~~~~~~~----gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 529 (603)
+++......+. ...+|+|||.+... ..+++-||||+||++.||++ |++||...+. ..+
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL------~aY 247 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL------LAY 247 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH------HhH
Confidence 33333222222 23479999987431 14568899999999999999 5777764321 111
Q ss_pred HHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCC
Q 007455 530 MNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590 (603)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 590 (603)
-.. +....+..-+...+ ..++.++..|++.||++|.++++.++.-++.+++.
T Consensus 248 r~~---~~~~~e~~Le~Ied------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~FP~ 299 (1431)
T KOG1240|consen 248 RSG---NADDPEQLLEKIED------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVFPE 299 (1431)
T ss_pred hcc---CccCHHHHHHhCcC------ccHHHHHHHHHccCchhccCHHHHHHhhhccccHH
Confidence 000 00000000111111 25889999999999999999999999988877553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.5e-20 Score=168.59 Aligned_cols=187 Identities=18% Similarity=0.103 Sum_probs=138.0
Q ss_pred CCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCCh----HHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEEEEe
Q 007455 314 DEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS----DQVFERELEILGSIK-HINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 314 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.....|++|+||+||.+.. ++.+++.+.+....... ...+.+|+++|+++. |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3467899999999997766 55778777765443211 225889999999995 5788888886 346999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC-CCCCeEECCCCCeEEeecccccccCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDI-KSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
+.|.+|.+.... ....++.|++++|.++|++ ||+|||| ||+|||++.++.++|+|||++......
T Consensus 80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 999988654321 1135678899999999999 8999999 799999999999999999999865443
Q ss_pred Ccc----e--------eecccccccccCccccccC-CCC-cccchHhHHHHHHHHHhCCCCCCccc
Q 007455 468 EAH----V--------TTVVAGTFGYLAPEYLQSG-RAT-EKSDVYSFGVLLLELVTGKRPTDPTF 519 (603)
Q Consensus 468 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~slG~vl~elltg~~p~~~~~ 519 (603)
... . ......++.|++|+...-- ..+ ...+.++-|.-+|.++||+.+...+.
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 210 0 0112245667777644321 222 56799999999999999999876543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-20 Score=182.78 Aligned_cols=200 Identities=22% Similarity=0.263 Sum_probs=144.3
Q ss_pred CCCeeeecceeeec---------------------------CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHH
Q 007455 365 KHINLVNLRGYCRL---------------------------PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA 417 (603)
Q Consensus 365 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 417 (603)
+|||||++.+.|.+ +...|+||...+. +|.+++..+. .+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-----~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-----RSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-----CchHHHHHHH
Confidence 59999999887632 3456899988877 9999987654 4556677788
Q ss_pred HHHHHHHHHHHhCCCCCeEEecCCCCCeEE--CCCC--CeEEeecccccccCCCC-----cceeecccccccccCccccc
Q 007455 418 LGSARGLAYLHHDCCPKIIHRDIKSSNILL--DENL--EPHVSDFGLAKLLVDEE-----AHVTTVVAGTFGYLAPEYLQ 488 (603)
Q Consensus 418 ~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~--~~kl~DfG~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 488 (603)
.|+++|+.|||.+ ||.|||+|++|||+ |+|+ ...|+|||.+-...... ....-...|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 4443 47899999875322110 01112244777899999986
Q ss_pred cCCC------CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHH
Q 007455 489 SGRA------TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIA 562 (603)
Q Consensus 489 ~~~~------~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 562 (603)
...- -.|+|.|+.|.+.||+++...||.... +...+...+ -+..++..+...+..+.+++
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG-em~L~~r~Y-------------qe~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG-EMLLDTRTY-------------QESQLPALPSRVPPVARQLV 490 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc-hheechhhh-------------hhhhCCCCcccCChHHHHHH
Confidence 4321 358999999999999999999997521 111111111 11234445556677899999
Q ss_pred HHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 563 ARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 563 ~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
...++.||.+|++..-....|.=..
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~LsL 515 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLNLSL 515 (598)
T ss_pred HHHhcCCccccCCccHHHhHHHHHH
Confidence 9999999999999887766665433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.9e-21 Score=197.85 Aligned_cols=225 Identities=27% Similarity=0.297 Sum_probs=179.9
Q ss_pred eeeecCCeEEEEEEEC----CCCEEEEEEeCCCCCCh--HHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEEEEecC
Q 007455 318 VVGSGGFGTVYRMVMN----DCGTFAVKRIDRSREGS--DQVFERELEILGSIK-HINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 318 ~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|+|+||.|+.+.-- .+.-+|.|..++..... ......|..++...+ ||.++++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3699999999865422 22347888775432211 113556788888887 9999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|.|...+..... +.+.........++-+++++|+. +++|||+|++||+++.+|++++.|||+++..-+.+..
T Consensus 81 gg~lft~l~~~~~----f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVM----FDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccCCc----hHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999988876544 66777777888899999999999 8999999999999999999999999999876544332
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCc
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (603)
+||..|||||++. ....++|.||||++++||+||..||..+ +...|.......
T Consensus 154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il~~~~~~ 206 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRILKAELEM 206 (612)
T ss_pred -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHhhhccCC
Confidence 7999999999998 5678899999999999999999998651 112222333445
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCH
Q 007455 551 DMETVEAILEIAARCTDANPDDRPSM 576 (603)
Q Consensus 551 ~~~~~~~l~~li~~cl~~~P~~RPs~ 576 (603)
+.+....+.+++..++..+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 66777889999999999999999554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-19 Score=187.17 Aligned_cols=216 Identities=28% Similarity=0.397 Sum_probs=162.5
Q ss_pred HhhCCCCeeeecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC
Q 007455 361 LGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDI 440 (603)
Q Consensus 361 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 440 (603)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.... ..+++.....++.+++.||+|+|... -..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence 356889999999999999999999999999999999998732 34899999999999999999999972 3399999
Q ss_pred CCCCeEECCCCCeEEeecccccccCCC-CcceeecccccccccCccccccC-------CCCcccchHhHHHHHHHHHhCC
Q 007455 441 KSSNILLDENLEPHVSDFGLAKLLVDE-EAHVTTVVAGTFGYLAPEYLQSG-------RATEKSDVYSFGVLLLELVTGK 512 (603)
Q Consensus 441 kp~NIll~~~~~~kl~DfG~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~slG~vl~elltg~ 512 (603)
+++|+++|....+|+.|||+.....+. .........-..-|.|||.+.+. ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998776421 11111122234569999998653 1466799999999999999999
Q ss_pred CCCCcccccCCc-cHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 513 RPTDPTFVKRGL-NVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 513 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.||+........ +++.++.. .....+.+...... +..+++..++.+||..+|++||+++++-..++.+.
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred CccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 999864332221 22222111 01111111111111 44457999999999999999999999999887654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=167.91 Aligned_cols=137 Identities=20% Similarity=0.280 Sum_probs=107.5
Q ss_pred CCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhC-----CCCeeeecceeeecCC---ccE-
Q 007455 313 LDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSI-----KHINLVNLRGYCRLPA---TKL- 383 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~- 383 (603)
++..+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ .||||++++|++.++. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 45567899999999995 554455679988765445567799999999999 5799999999998764 333
Q ss_pred EEEEe--cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEecCCCCCeEECC----CCCeEEe
Q 007455 384 LIYDY--LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL-AYLHHDCCPKIIHRDIKSSNILLDE----NLEPHVS 456 (603)
Q Consensus 384 lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~NIll~~----~~~~kl~ 456 (603)
+|+|| ..+|+|.+++.... +++. ..++.+++.++ +|||++ +|+||||||+|||++. +++++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~-----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR-----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHccc-----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 55799999996531 4444 35577888777 999999 8999999999999974 3479999
Q ss_pred ecccc
Q 007455 457 DFGLA 461 (603)
Q Consensus 457 DfG~~ 461 (603)
||+-+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.2e-18 Score=189.22 Aligned_cols=194 Identities=20% Similarity=0.217 Sum_probs=154.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC---CCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIK---HINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 386 (603)
-+.|.+.+.||+|+||+||+|...+++.||+|+-+...... |.-=.+++.+|+ -+-|..+...+.-.+..++|+
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 46677888999999999999999998889999765543321 221223344444 233444555555677789999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-------CCCeEEeecc
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-------NLEPHVSDFG 459 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~~~~kl~DfG 459 (603)
||.+.|+|.+++...+ .+++.-.+.++.|+++.+++||.. +||||||||+|+||.. ...++|+|||
T Consensus 774 ey~~~Gtlld~~N~~~----~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 774 EYSPYGTLLDLINTNK----VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eccccccHHHhhccCC----CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999998443 399999999999999999999999 8999999999999942 3459999999
Q ss_pred cccccCC-CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCC
Q 007455 460 LAKLLVD-EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKR 513 (603)
Q Consensus 460 ~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~ 513 (603)
.+-.+.- .+........+|-.+-.+|...+..+++++|-|.++-+++-|+.|+.
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9865532 22335566778889999999999999999999999999999999885
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.9e-18 Score=163.99 Aligned_cols=142 Identities=13% Similarity=0.106 Sum_probs=109.9
Q ss_pred CCCCCCeeeecCCeEEEEEE--ECCCCEEEEEEeCCCCCC------------------------hHHHHHHHHHHHhhCC
Q 007455 312 ALDEEDVVGSGGFGTVYRMV--MNDCGTFAVKRIDRSREG------------------------SDQVFERELEILGSIK 365 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 365 (603)
-|.+.+.||+|+||.||+|. ..++..||+|.+...... ....+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46778999999999999998 457788999998643210 0123578999999997
Q ss_pred CCe--eeecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEecCCC
Q 007455 366 HIN--LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK-IIHRDIKS 442 (603)
Q Consensus 366 h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp 442 (603)
+.. +.+++++ ...++||||+++++|........ .....+...++.|++.++++||++ + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 532 3333432 24589999999998877653322 145566788999999999999999 8 99999999
Q ss_pred CCeEECCCCCeEEeecccccccC
Q 007455 443 SNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 443 ~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
+||+++ +++++|+|||.+....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999987543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8e-19 Score=178.20 Aligned_cols=174 Identities=26% Similarity=0.415 Sum_probs=130.3
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..|+.|+++..++|.+|+...... ...++...+.++.|++.|+.| + +.+|||+||.||+...+..+||+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 468999999999999999754332 236788889999999999999 4 799999999999999999999999999
Q ss_pred ccccCCCC-----cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh
Q 007455 461 AKLLVDEE-----AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535 (603)
Q Consensus 461 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (603)
........ ....+...||..||+||.+.+..|+.|+||||+|++++|+++ +|...+. .
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~e--------------r 465 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFE--------------R 465 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHH--------------H
Confidence 98765544 334456779999999999999999999999999999999997 2221110 1
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQ 578 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 578 (603)
...+.++-+...+........+=..|+.+++...|.+||++.+
T Consensus 466 ~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 466 IATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred HHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 1112222222222111111123457889999999999995444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=158.24 Aligned_cols=134 Identities=22% Similarity=0.303 Sum_probs=112.9
Q ss_pred CeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC--------hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--------SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+.||+|++|.||+|.+ .+..+++|+....... ....+.+|+.++..+.|+++.....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 4567889976543221 123577899999999999998888887778889999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
++|++|.+++.... . .+..++.+++.+|.++|+. +++|||++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886421 2 7788999999999999998 899999999999999 78999999998864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.4e-17 Score=153.35 Aligned_cols=138 Identities=16% Similarity=0.117 Sum_probs=108.6
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC----------------------hHHHHHHHHHHHhhCCCCe-
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG----------------------SDQVFERELEILGSIKHIN- 368 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~n- 368 (603)
.|.+.+.||+|+||.||++...+++.+|||++...... ....+.+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 36778999999999999999888889999987542210 1123677899999998774
Q ss_pred -eeecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE
Q 007455 369 -LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL 447 (603)
Q Consensus 369 -iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 447 (603)
+.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+. +++||||+|+||++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 333333 2456899999999998765431 23457888999999999998 89999999999999
Q ss_pred CCCCCeEEeecccccccCC
Q 007455 448 DENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 448 ~~~~~~kl~DfG~~~~~~~ 466 (603)
++++.++|+|||++.....
T Consensus 159 ~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCcEEEEECCccccCCC
Confidence 9999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.5e-18 Score=184.31 Aligned_cols=206 Identities=23% Similarity=0.373 Sum_probs=142.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCE-EEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.+|+.++.|..|+||.||.++++.+++ +|+| +.+... +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee-------------------
Confidence 578889999999999999999987664 7884 322111 1110 22222333333
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC--
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE-- 467 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~-- 467 (603)
|+-...++..+. ++.. ++.+++|+|+. +|+|||+||+|.+++.-|++|+.|||+++.....
T Consensus 136 --gDc~tllk~~g~----lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLKNIGP----LPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhcccCCC----Ccch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 455555554332 2222 26789999998 9999999999999999999999999998753210
Q ss_pred ------C------cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh
Q 007455 468 ------E------AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535 (603)
Q Consensus 468 ------~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (603)
. .......+||+.|+|||++....|...+|.|++|+++||.+.|..||.++.+.+ + +...+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---l---fg~vis 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---L---FGQVIS 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---H---Hhhhhh
Confidence 0 011244689999999999998899999999999999999999999998753211 1 111111
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCC
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDR 573 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R 573 (603)
.. ...++.....+.++++++.++|+.+|.+|
T Consensus 273 d~-------i~wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 273 DD-------IEWPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred hh-------ccccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 00 01111233445679999999999999999
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.9e-17 Score=153.85 Aligned_cols=130 Identities=20% Similarity=0.254 Sum_probs=106.2
Q ss_pred eeeecCCeEEEEEEECCCCEEEEEEeCCCCC-C-------hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 318 VVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE-G-------SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 318 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.||+|+||.||+|.+. +..+++|....... . ...++.+|++++..+.|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999854 47899998653221 1 1245778999999999887766666666677789999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+|++|.+++.... . .++.+++++|.++|+. +++|||++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998775421 0 7889999999999998 899999999999999 78999999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.5e-17 Score=175.53 Aligned_cols=136 Identities=18% Similarity=0.263 Sum_probs=110.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEE-eCCCCC-------ChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKR-IDRSRE-------GSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
..|...+.||+|+||+||+|.+.+.. +++|+ +.+... ...+++.+|+++++.++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 34566789999999999999887644 33343 222111 1124588999999999999999888887777788
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++||||+++++|.+++. ....++.+++++|.|||+. +++||||||+||++ +++.++|+|||+++
T Consensus 412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999999999988775 3467899999999999998 89999999999999 67799999999987
Q ss_pred c
Q 007455 463 L 463 (603)
Q Consensus 463 ~ 463 (603)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-17 Score=144.84 Aligned_cols=128 Identities=29% Similarity=0.433 Sum_probs=119.9
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
..+++.|.||+|+++- +|+.+..|.+|+.|++++|+|+ .+|..++.|++|+.|+++-|++. .+|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 3579999999999987 7778999999999999999998 99999999999999999999999 9999999999999999
Q ss_pred ccCCccC-CCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 149 LSSNSLK-GAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
|++|++. ..+|..|.-++.|+.|+|+.|.|.-.||+++.+.+|+-|.+..|
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdn 160 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDN 160 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccC
Confidence 9999997 47899999999999999999999999999999999999888887
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.1e-15 Score=135.92 Aligned_cols=135 Identities=21% Similarity=0.226 Sum_probs=114.2
Q ss_pred CCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCC--CeeeecceeeecCCccEEEEEecCCC
Q 007455 315 EEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKH--INLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 315 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++++++++....+..++++||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35679999999999999876 7899998765433 4568899999999976 58888888888778899999999998
Q ss_pred CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 393 SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 393 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
.+..+ +......++.+++++++++|.....+++|||++|+||++++++.++++|||.++.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 3456677889999999999996444799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=141.45 Aligned_cols=137 Identities=18% Similarity=0.183 Sum_probs=97.7
Q ss_pred CCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChH---HH---------------------HHHHHHHHhhCCCCe--e
Q 007455 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSD---QV---------------------FERELEILGSIKHIN--L 369 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---~~---------------------~~~E~~~l~~l~h~n--i 369 (603)
.+.||+|+||.||+|.+.+++.||||++........ .. ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999988788999998864322111 10 134555555554332 3
Q ss_pred eecceeeecCCccEEEEEecCCCCcccc-ccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeEE
Q 007455 370 VNLRGYCRLPATKLLIYDYLSMGSLDDF-LHEHGEGQQLLNWSARLKIALGSARGLAYLHH-DCCPKIIHRDIKSSNILL 447 (603)
Q Consensus 370 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll 447 (603)
.+.++. ...++||||++++++... +.... .. .+...++.+++.++.++|. . +++||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 333332 246899999999654321 21110 11 5577899999999999999 6 89999999999999
Q ss_pred CCCCCeEEeecccccccCC
Q 007455 448 DENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 448 ~~~~~~kl~DfG~~~~~~~ 466 (603)
+ ++.++++|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=9.8e-17 Score=174.37 Aligned_cols=254 Identities=26% Similarity=0.304 Sum_probs=189.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCE--EEEEEeCCCC--CChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGT--FAVKRIDRSR--EGSDQVFERELEILGSIK-HINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~--vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 385 (603)
..|...+.||+|+|+.|-......... +|+|.+.... ....+....|..+-..+. |+|++++++........+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 456677889999999998877654443 6666664432 223344555777777776 99999999999999999999
Q ss_pred EEecCCCCccccc-cccCCCCccCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEecCCCCCeEECCCC-CeEEeeccccc
Q 007455 386 YDYLSMGSLDDFL-HEHGEGQQLLNWSARLKIALGSARGLAYLH-HDCCPKIIHRDIKSSNILLDENL-EPHVSDFGLAK 462 (603)
Q Consensus 386 ~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~ 462 (603)
.+|..++++.+-+ ..... ..+...+-....|+..++.|+| .. ++.|||+||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~---~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDST---GTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCcccccccccccccCCcc---CCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999988 43321 2455667778899999999999 66 899999999999999999 99999999998
Q ss_pred ccCC--CCcceeecccc-cccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 463 LLVD--EEAHVTTVVAG-TFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 463 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
.+.. +.........| ++.|+|||...+. ......|+||.|+++.-+++|..|++...... .....|.... ..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~---~~ 249 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK---GR 249 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc---cc
Confidence 8766 33334455678 9999999999874 44567999999999999999999987654332 2222222111 00
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..............+++.+++..+|..|.+.+++..
T Consensus 250 -------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 -------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 001122233456788899999999999999988764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=9.3e-15 Score=141.98 Aligned_cols=136 Identities=19% Similarity=0.192 Sum_probs=104.6
Q ss_pred CCeee-ecCCeEEEEEEECCCCEEEEEEeCCCC-------------CChHHHHHHHHHHHhhCCCCee--eecceeeecC
Q 007455 316 EDVVG-SGGFGTVYRMVMNDCGTFAVKRIDRSR-------------EGSDQVFERELEILGSIKHINL--VNLRGYCRLP 379 (603)
Q Consensus 316 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 379 (603)
..+|| .|+.|+||.+... ++.+++|.+.... ......+.+|++++..+.|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999876 5788998774311 1223467899999999998875 6666664332
Q ss_pred Cc----cEEEEEecCC-CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeE
Q 007455 380 AT----KLLIYDYLSM-GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH 454 (603)
Q Consensus 380 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~k 454 (603)
.. .++|+|+++| .+|.+++.... ++.. .+.+++.++.+||+. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~~-----l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEAP-----LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcCC-----CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 22 2599999997 68988876421 3433 356889999999999 999999999999999999999
Q ss_pred Eeeccccccc
Q 007455 455 VSDFGLAKLL 464 (603)
Q Consensus 455 l~DfG~~~~~ 464 (603)
|+|||.+...
T Consensus 183 LIDfg~~~~~ 192 (239)
T PRK01723 183 LIDFDRGELR 192 (239)
T ss_pred EEECCCcccC
Confidence 9999988753
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.4e-16 Score=134.71 Aligned_cols=127 Identities=28% Similarity=0.402 Sum_probs=113.0
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCC-CCccccccccccceec
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG-GIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ 148 (603)
.+++.|++++|+|.. +|..++.|++|+.|+++-|++. .+|..|+.++.|+.|||++|+++. .+|..|..++.|+-|+
T Consensus 56 ~nlevln~~nnqie~-lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlraly 133 (264)
T KOG0617|consen 56 KNLEVLNLSNNQIEE-LPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALY 133 (264)
T ss_pred hhhhhhhcccchhhh-cChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHH
Confidence 467889999999977 7888999999999999999998 899999999999999999998874 5788899999999999
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
|+.|.+. .+|..++++++|+.|.+..|.+-..|.+++.+..|+.|.+.+|
T Consensus 134 l~dndfe-~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 134 LGDNDFE-ILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hcCCCcc-cCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHHHhcccc
Confidence 9999998 8888899999999999999999888888888888888888877
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.1e-13 Score=142.71 Aligned_cols=146 Identities=21% Similarity=0.251 Sum_probs=101.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCCh----------------------------------------
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS---------------------------------------- 350 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------- 350 (603)
..|+ .+.||.|++|.||+|+..+|+.||||+.+......
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 4444 36899999999999999999999999985431110
Q ss_pred HHHHHHHHHHHhhCC-----CCeeeecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHH-HH
Q 007455 351 DQVFERELEILGSIK-----HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSAR-GL 424 (603)
Q Consensus 351 ~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~L 424 (603)
+-.|.+|++.+.++. ++++.-..-+....+..++||||++|++|.++......+ . ....++..++. .+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~---~---~~~~ia~~~~~~~l 270 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG---L---DRKALAENLARSFL 270 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC---C---CHHHHHHHHHHHHH
Confidence 002344555555542 333322222223345679999999999999876532111 2 23456666665 46
Q ss_pred HHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 425 ~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
..+|.. |++|+|++|.||+++.+++++++|||++..+.+
T Consensus 271 ~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 271 NQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 788988 899999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.8e-14 Score=134.86 Aligned_cols=205 Identities=25% Similarity=0.341 Sum_probs=144.7
Q ss_pred HHHHhhCCCCeeeecceeeecC-----CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCC
Q 007455 358 LEILGSIKHINLVNLRGYCRLP-----ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432 (603)
Q Consensus 358 ~~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~ 432 (603)
+.-+-.+.|.|||+++.|+.+. .+..+++|||..|++..++++....+..+......+++.||..||.|||+ +.
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 3445566799999999988654 34678999999999999999877777778899999999999999999999 46
Q ss_pred CCeEEecCCCCCeEECCCCCeEEeecccccccC---CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHH
Q 007455 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV---DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELV 509 (603)
Q Consensus 433 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ell 509 (603)
|.++|+++..+-|++..+|-+||+----...-. ...........+-++|.+||.-.....+.++|||+||....||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 889999999999999999988875321111000 00001112233567899999887777788999999999999999
Q ss_pred hCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 510 TGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 510 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.|..-........ ..+......+.....+ .=..++.+|++..|..||+|++++.
T Consensus 277 ilEiq~tnseS~~-----------~~ee~ia~~i~~len~-------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKV-----------EVEENIANVIIGLENG-------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCccee-----------ehhhhhhhheeeccCc-------cccCcCcccccCCCCCCcchhhhhc
Confidence 8775321111000 0011111111110000 1234778999999999999999874
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.1e-14 Score=148.48 Aligned_cols=129 Identities=25% Similarity=0.273 Sum_probs=77.6
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
++++|+|+.|+++..-...+.+|+.|+.|+||+|.|...-++...-..+|++|+|++|+|+...+.+|..|..|++|+|+
T Consensus 270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs 349 (873)
T KOG4194|consen 270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS 349 (873)
T ss_pred ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence 46677777777776666666777777777777777776666666666777777777777775555556555566555555
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccCCC----CccccccCcccccCC
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD----FGALSAFGNKSFIGN 199 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~----~~~l~~l~~l~~~~n 199 (603)
+|+|+..-..+|..+++|+.|||++|.|+..+.+ |..|++|+.|.+.||
T Consensus 350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gN 402 (873)
T KOG4194|consen 350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGN 402 (873)
T ss_pred ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCc
Confidence 5555533334455555555555555555544443 344444444444444
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.42 E-value=9.2e-15 Score=143.03 Aligned_cols=124 Identities=30% Similarity=0.443 Sum_probs=100.2
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccc-cccccceecc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIG-NLLFLTILDL 149 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l 149 (603)
+++.||...|-++. +|+.++.+.+|+.|+|..|+|. .+| +|++++.|++|+++.|+|+ .+|.... +|++|..|||
T Consensus 184 ~L~~ld~~~N~L~t-lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 184 RLKHLDCNSNLLET-LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHHhcccchhhhhc-CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 45667776666644 7777888888888888888887 777 5888888888888888888 7777665 7888888888
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCc
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~ 200 (603)
..|+++ ..|+.+.-+++|.+||+++|.|++.|+.++++ .|+.|-+.||+
T Consensus 260 RdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~L~leGNP 308 (565)
T KOG0472|consen 260 RDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKFLALEGNP 308 (565)
T ss_pred cccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeeehhhcCCc
Confidence 888888 88888888888888888888888888888888 77777777764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.3e-13 Score=141.84 Aligned_cols=146 Identities=14% Similarity=0.162 Sum_probs=94.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC----------------------------------hHHH-
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG----------------------------------SDQV- 353 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~~- 353 (603)
...|+. +.||.|++|.||+|++++ |+.||||+.++.-.. ..+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 789999999999999987 889999998643110 0111
Q ss_pred -----HHHHHHHHhhCC----CCeeeecceeeec-CCccEEEEEecCCCCccccc--cccCCCCccCCHHHHHHHHHHHH
Q 007455 354 -----FERELEILGSIK----HINLVNLRGYCRL-PATKLLIYDYLSMGSLDDFL--HEHGEGQQLLNWSARLKIALGSA 421 (603)
Q Consensus 354 -----~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~i~ 421 (603)
+.+|+..+.+++ +.+.+.+-.++.+ .+..++||||++|+.+.+.- ...+.....+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 334444444432 3333333333322 45668999999999998742 2222111112222233333333
Q ss_pred HHHHHHHhCCCCCeEEecCCCCCeEECCCC----CeEEeecccccccCC
Q 007455 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENL----EPHVSDFGLAKLLVD 466 (603)
Q Consensus 422 ~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG~~~~~~~ 466 (603)
... |++|+|++|.||+++.++ +++++|||++..+.+
T Consensus 277 ------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 899999999999999988 999999999987754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.9e-13 Score=145.65 Aligned_cols=113 Identities=35% Similarity=0.594 Sum_probs=99.6
Q ss_pred CcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeecc
Q 007455 95 KLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLS 174 (603)
Q Consensus 95 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 174 (603)
.++.|+|++|.++|.+|..+..+++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 57899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCcccCCCCccccccCccc-ccCCcccCCCCCCCCCC
Q 007455 175 TNFFSGEIPDFGALSAFGNKS-FIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 175 ~N~l~~~~~~~~~l~~l~~l~-~~~n~~l~~~~~~~~c~ 212 (603)
+|+++|.+|. .+..+. -...+.+.+|+..|.++
T Consensus 499 ~N~l~g~iP~-----~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 499 GNSLSGRVPA-----ALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred CCcccccCCh-----HHhhccccCceEEecCCccccCCC
Confidence 9999999885 233221 12346788898877543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.4e-14 Score=143.43 Aligned_cols=127 Identities=29% Similarity=0.348 Sum_probs=81.5
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCC-------------------
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ------------------- 131 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~------------------- 131 (603)
+...|+||+|+|..++.+-|.+|+.|-.||||+|++. .+|+.+..|..|++|+|++|.+.
T Consensus 127 n~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms 205 (1255)
T KOG0444|consen 127 NSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMS 205 (1255)
T ss_pred CcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcc
Confidence 3455666666666655555666666666777777666 66666666666666666666543
Q ss_pred ------CCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 132 ------GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 132 ------~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
.-+|.++..|.+|..+|||.|++. .+|+.+.++++|+.|+|++|+|+..--..+.-.+|+.|+++.|
T Consensus 206 ~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrN 278 (1255)
T KOG0444|consen 206 NTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRN 278 (1255)
T ss_pred cccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccc
Confidence 235566667777777777777777 7777777777777777777777655443333445555555555
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8.7e-14 Score=136.12 Aligned_cols=143 Identities=23% Similarity=0.283 Sum_probs=126.8
Q ss_pred eeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEecc-ccCCC
Q 007455 63 ISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRA-NYLQG 132 (603)
Q Consensus 63 v~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~ 132 (603)
|+|++. +...+.|+|..|+|+.+.+.+|..+++|+.||||+|+|+.+-|++|.+|.+|..|-|.+ |+|+.
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 788643 35689999999999999999999999999999999999988999999999998887666 99996
Q ss_pred CCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCC-CCccccccCcccccCCcccCCC
Q 007455 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNKSFIGNLDLCGR 205 (603)
Q Consensus 133 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~~~~n~~l~~~ 205 (603)
..-..|.+|..|+.|.+.-|++.-...+.|..|++|..|.+..|.+..+.. .|..+.+++.+.+..|+..|.+
T Consensus 131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdC 204 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDC 204 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccccc
Confidence 666789999999999999999997777899999999999999999998776 4888889999998888766544
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.35 E-value=5.1e-14 Score=144.64 Aligned_cols=135 Identities=26% Similarity=0.389 Sum_probs=117.0
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCC-CCCcccccccccccee
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ-GGIPANIGNLLFLTIL 147 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L 147 (603)
..+++.|+||+|.|+. +.-..+...+|++|+||.|+++ .+|.++.+|++|+.|++.+|+++ .-+|..++.|.+|+.+
T Consensus 244 l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf 321 (1255)
T KOG0444|consen 244 LRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVF 321 (1255)
T ss_pred hhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHH
Confidence 4578889999999877 4455677788999999999998 89999999999999999999877 3488999999999999
Q ss_pred cccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCcccCCCC
Q 007455 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQ 206 (603)
Q Consensus 148 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~~ 206 (603)
..++|++. .+|+++.++..|+.|.|+.|++.+.|..+.-++.|+.|++..|+.|-=.|
T Consensus 322 ~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 322 HAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred Hhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeeccCCcCccCCC
Confidence 99999999 99999999999999999999999888888888899999999998765433
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.2e-12 Score=134.00 Aligned_cols=145 Identities=24% Similarity=0.288 Sum_probs=95.7
Q ss_pred CCCCccccceeecCC--------------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCC
Q 007455 54 EESPCKWTGISCHTH--------------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTE 119 (603)
Q Consensus 54 ~~~~c~w~gv~C~~~--------------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 119 (603)
.+|+|.-.-..|++. ++.++.|||++|+|+.+-+..|.++++|++++|.+|.++ .+|.......+
T Consensus 48 a~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sgh 126 (873)
T KOG4194|consen 48 ATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGH 126 (873)
T ss_pred CcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccc
Confidence 356676666778642 134678999999999988888999999999999999998 88875555556
Q ss_pred CceEEeccccCCCCCccccccccccceecccCCccC------------------------CCCCCCCccccccceeeccC
Q 007455 120 LRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLK------------------------GAIPSSLGRLTHLHYLNLST 175 (603)
Q Consensus 120 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~------------------------~~~p~~~~~l~~L~~l~l~~ 175 (603)
|+.|+|.+|.|+..-.+.+..++.|+.||||.|.|+ ..--..|..+.+|..|.|+.
T Consensus 127 l~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsr 206 (873)
T KOG4194|consen 127 LEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSR 206 (873)
T ss_pred eeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeeccc
Confidence 777777777777555555555555555555555555 33333444455555555555
Q ss_pred CcCcccCCC-CccccccCcccccCC
Q 007455 176 NFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 176 N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
|+|+.+|+. |..|+.|+.|++..|
T Consensus 207 NrittLp~r~Fk~L~~L~~LdLnrN 231 (873)
T KOG4194|consen 207 NRITTLPQRSFKRLPKLESLDLNRN 231 (873)
T ss_pred CcccccCHHHhhhcchhhhhhcccc
Confidence 555555443 444555555555555
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1e-11 Score=130.37 Aligned_cols=168 Identities=18% Similarity=0.259 Sum_probs=127.9
Q ss_pred ECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHH
Q 007455 332 MNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWS 411 (603)
Q Consensus 332 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~ 411 (603)
..+++++.|+..+...........+-++.++.++||||+++++.+...+..|+|+|.+. -|..+++.. ...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-------~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-------GKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-------HHH
Confidence 44667788888876655445567888999999999999999999999999999999885 466666653 345
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeecccccccccCccccccCC
Q 007455 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR 491 (603)
Q Consensus 412 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 491 (603)
...--+.||+.||.+||..+ +++|++|.-..|+++..|+.||++|.++........ ......---.|..|+.+....
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 56677889999999999876 899999999999999999999999998865433221 001111122466666543222
Q ss_pred CCcccchHhHHHHHHHHHhCCC
Q 007455 492 ATEKSDVYSFGVLLLELVTGKR 513 (603)
Q Consensus 492 ~~~~~Dv~slG~vl~elltg~~ 513 (603)
-..|.|-||++++|++.|..
T Consensus 182 --~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred --cchhhhhHHHHHHHHhCccc
Confidence 34699999999999999943
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=6e-12 Score=116.04 Aligned_cols=131 Identities=20% Similarity=0.138 Sum_probs=96.3
Q ss_pred CCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeee-ecceeeecCCccEEEEEecCCCCc
Q 007455 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLV-NLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
.+.|+.|.++.||++... ++.+++|....... ....+.+|+.+++.+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356899999999999876 57899998754332 223467899999988665544 344332 3446899999999888
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC--CPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
.+. . .. ....+.+++++|+.||+.. ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~-~--------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE-D--------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-c--------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 653 0 10 1235678999999999983 12369999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2e-12 Score=134.61 Aligned_cols=248 Identities=21% Similarity=0.240 Sum_probs=178.5
Q ss_pred hCCCCCCeeee--cCCeEEEEEEE--C-CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCC-CCeeeecceeeecCCcc
Q 007455 311 EALDEEDVVGS--GGFGTVYRMVM--N-DCGTFAVKRIDRSRE--GSDQVFERELEILGSIK-HINLVNLRGYCRLPATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~--G~~g~Vy~~~~--~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 382 (603)
..+.....+|. |.+|.||.+.. . +...+|+|+-+.... .....=.+|+..-.+++ |+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566788999 99999999987 3 445688887543322 22233356666666664 99999988889999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEecCCCCCeEECCC-CCeEEee
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSAR----GLAYLHHDCCPKIIHRDIKSSNILLDEN-LEPHVSD 457 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~D 457 (603)
++-+|++. .+|.++...... .++....+....+..+ ||.++|+. .++|-|+||.||+...+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 99999887 478777665332 2566777788888888 99999998 89999999999999999 8899999
Q ss_pred cccccccCCCCcce----eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH
Q 007455 458 FGLAKLLVDEEAHV----TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 458 fG~~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
||+...+.+..... .....|...|++||..++ .++..+|+|++|.++.+..+|..++.... ...|...
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~~~- 338 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK------NSSWSQL- 338 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC------CCCcccc-
Confidence 99998887654221 122357778999998874 67889999999999999999887654321 0112110
Q ss_pred hhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+-.. +.. ++......++...+..+++.+|..|++.+.+..
T Consensus 339 ----r~~~-ip~---e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 ----RQGY-IPL---EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ----cccc-Cch---hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0000 000 011112234555888999999999999988874
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.32 E-value=8.3e-13 Score=120.10 Aligned_cols=122 Identities=26% Similarity=0.311 Sum_probs=49.7
Q ss_pred CcEEEEEcCCCCcccccCCCcc-CCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcccc-cccccccee
Q 007455 70 QRVRSINLPYMQLGGIISPSIG-RLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTIL 147 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L 147 (603)
.+++.|+|++|+|+.+ +.++ .+++|+.|+|++|.|+ .+++ +..+++|++|+|++|+|+ .+++.+ ..+++|++|
T Consensus 19 ~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~~-l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L 93 (175)
T PF14580_consen 19 VKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLEG-LPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL 93 (175)
T ss_dssp -------------------S--TT-TT--EEE-TTS--S---TT-----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred cccccccccccccccc--cchhhhhcCCCEEECCCCCCc-cccC-ccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence 3678999999999875 3465 5889999999999998 6664 888999999999999999 565555 468999999
Q ss_pred cccCCccCCCCC-CCCccccccceeeccCCcCcccCC----CCccccccCcccc
Q 007455 148 DLSSNSLKGAIP-SSLGRLTHLHYLNLSTNFFSGEIP----DFGALSAFGNKSF 196 (603)
Q Consensus 148 ~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~~----~~~~l~~l~~l~~ 196 (603)
+|++|+|...-- ..+..+++|+.|+|.+|.++.... -+..+++|+.|+.
T Consensus 94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred ECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence 999999984211 356778899999999999986532 1455666666553
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.1e-13 Score=135.67 Aligned_cols=128 Identities=27% Similarity=0.354 Sum_probs=110.6
Q ss_pred EEEEEcCCCCcccc-----------------------cCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccc
Q 007455 72 VRSINLPYMQLGGI-----------------------ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN 128 (603)
Q Consensus 72 l~~L~L~~n~l~~~-----------------------~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 128 (603)
|+.++++.|+|..+ +|..+..+++|+.|+|++|-+. .+|..++.+..|++||||.|
T Consensus 390 Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~N 468 (565)
T KOG0472|consen 390 VTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFN 468 (565)
T ss_pred eEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccc
Confidence 78888888776542 3445677889999999999998 89999999999999999999
Q ss_pred cCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCcc
Q 007455 129 YLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLD 201 (603)
Q Consensus 129 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~ 201 (603)
+|. .+|..+..+..|+.+-.++|++....|..+.++.+|.+|||.+|.|..+||.++++.+++.|.+.||++
T Consensus 469 rFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 469 RFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred ccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEecCCcc
Confidence 998 899888888888888888899996666669999999999999999999999999999999999988843
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.5e-10 Score=107.62 Aligned_cols=137 Identities=13% Similarity=0.133 Sum_probs=98.2
Q ss_pred CCeeeecCCeEEEEEEECC-------CCEEEEEEeCCCC----------------------CChHHH----HHHHHHHHh
Q 007455 316 EDVVGSGGFGTVYRMVMND-------CGTFAVKRIDRSR----------------------EGSDQV----FERELEILG 362 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~----~~~E~~~l~ 362 (603)
...||.|--+.||.|...+ +..+|||..+... ....+. .++|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999998654 3689999763210 011222 348999999
Q ss_pred hCCC--CeeeecceeeecCCccEEEEEecCCCCccc-cccccCCCCccCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEe
Q 007455 363 SIKH--INLVNLRGYCRLPATKLLIYDYLSMGSLDD-FLHEHGEGQQLLNWSARLKIALGSARGLAYL-HHDCCPKIIHR 438 (603)
Q Consensus 363 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~ 438 (603)
++.. -++.+++++ ...++||||+.++.+.. .++.. .++..+...+..+++.++..+ |.. ++|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 9853 455566654 56789999998754422 22221 144455677889999999999 777 89999
Q ss_pred cCCCCCeEECCCCCeEEeecccccccC
Q 007455 439 DIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 439 Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
||++.||++++ +.+.|+|||.+....
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999974 689999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=9.5e-13 Score=141.56 Aligned_cols=128 Identities=27% Similarity=0.328 Sum_probs=110.7
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCC-ccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNE-ITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
..|+.|.|.+|.|+...-+.|.++.+|+.|+|++|+|. .+|.. +.++..|++|+||+|+|+ .+|+.+.++..|++|.
T Consensus 359 ~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ 436 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLR 436 (1081)
T ss_pred HHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHh
Confidence 46888999999999887788999999999999999998 77754 788999999999999999 8999999999999999
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccc-cccCcccccCCcc
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL-SAFGNKSFIGNLD 201 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l-~~l~~l~~~~n~~ 201 (603)
..+|+|. .+| .+.+++.|+.+|++.|+|+...-....- ++|+.|+++||.+
T Consensus 437 ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 437 AHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR 488 (1081)
T ss_pred hcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence 9999999 888 7899999999999999998543221112 6899999999974
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.3e-12 Score=126.27 Aligned_cols=55 Identities=22% Similarity=0.322 Sum_probs=39.9
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEecc-CCCCCCCC-CCccccCCCceEE
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQ-NSLHGSIP-NEITNCTELRALY 124 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p-~~~~~l~~L~~L~ 124 (603)
..+++.||||+|+|+.+-|.+|.+|.+|.+|-|.+ |+|+ .+| +.|.+|..|+.|.
T Consensus 90 l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 90 LHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLL 146 (498)
T ss_pred hhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHh
Confidence 46899999999999999999999998887765555 8877 333 3455444443333
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.18 E-value=2.9e-10 Score=109.68 Aligned_cols=142 Identities=22% Similarity=0.258 Sum_probs=108.3
Q ss_pred CeeeecCCeEEEEEEECCCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCC--eeeecceeeecC---CccEEEEEecC
Q 007455 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHI--NLVNLRGYCRLP---ATKLLIYDYLS 390 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~ 390 (603)
+.|+.|.++.||++...++..+++|....... .....+..|+++++.+.+. ++.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987767899998754332 1345688999999999753 456667666553 25689999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC--------------------------------------- 431 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--------------------------------------- 431 (603)
|+++.+.+.. ..++..+...++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988876542 12566777788888888888888531
Q ss_pred --------------CCCeEEecCCCCCeEECC--CCCeEEeecccccc
Q 007455 432 --------------CPKIIHRDIKSSNILLDE--NLEPHVSDFGLAKL 463 (603)
Q Consensus 432 --------------~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~~~~ 463 (603)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-11 Score=112.10 Aligned_cols=116 Identities=28% Similarity=0.320 Sum_probs=36.2
Q ss_pred cCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCcc-ccCCCceEEeccccCCCCCccccccccccceecccCCccC
Q 007455 77 LPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEIT-NCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLK 155 (603)
Q Consensus 77 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 155 (603)
|+.+.|..+ +.+.+..++++|+|++|+|+ .+. .++ .+.+|+.|||++|+|+ .++ .+..+++|++|++++|+|+
T Consensus 4 lt~~~i~~~--~~~~n~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~ 77 (175)
T PF14580_consen 4 LTANMIEQI--AQYNNPVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS 77 (175)
T ss_dssp ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred ccccccccc--cccccccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC
Confidence 444555442 23556678999999999998 565 466 5899999999999999 554 5889999999999999999
Q ss_pred CCCCCCC-ccccccceeeccCCcCcccCC--CCccccccCcccccCC
Q 007455 156 GAIPSSL-GRLTHLHYLNLSTNFFSGEIP--DFGALSAFGNKSFIGN 199 (603)
Q Consensus 156 ~~~p~~~-~~l~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~~~~n 199 (603)
.+++.+ ..+++|+.|++++|+|...-. .+..+++|+.|++.+|
T Consensus 78 -~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~N 123 (175)
T PF14580_consen 78 -SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGN 123 (175)
T ss_dssp -S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-
T ss_pred -ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCC
Confidence 565445 368999999999999985432 1344555555555544
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.6e-12 Score=120.57 Aligned_cols=123 Identities=26% Similarity=0.323 Sum_probs=99.7
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
.++.||||+|.|+. +.+++.-++.++.|+||+|.|. .+-. +..|++|+.||||+|.++ .+..+-..|.+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchhh-hhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 57889999999877 5677778889999999999998 5544 888999999999999998 666666778889999999
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccC--CCCccccccCcccccCC
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEI--PDFGALSAFGNKSFIGN 199 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~--~~~~~l~~l~~l~~~~n 199 (603)
.|.|. .+ .++.+|-+|..||+++|+|...- ..+++++.|+.+.+.+|
T Consensus 361 ~N~iE-~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~N 409 (490)
T KOG1259|consen 361 QNKIE-TL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGN 409 (490)
T ss_pred hhhHh-hh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCC
Confidence 99988 44 46888889999999999988543 24777777777776666
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.13 E-value=4e-11 Score=124.98 Aligned_cols=245 Identities=18% Similarity=0.186 Sum_probs=175.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC--CCCEEEEEEeCCCCCChHHH--HHHHHHHHhhC-CCCeeeecceeeecCCccE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMN--DCGTFAVKRIDRSREGSDQV--FERELEILGSI-KHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 383 (603)
.+.+|..+..||.|.|+.|++...+ ++..|++|.+.+.......+ -..|+.+...+ .|.++++.+..+......|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 4567888999999999999987754 45569999886654443322 34567666666 4899999888887778888
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC-CCeEEeeccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN-LEPHVSDFGLAK 462 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~~ 462 (603)
+=-||++++++...... .+.++....+++..|++.++.++|+. .++|+|++|+||++..+ +..+++|||.+.
T Consensus 343 ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 88999999988776632 22367778899999999999999988 89999999999999886 788999999886
Q ss_pred ccCCCCcceeeccccccccc--CccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 463 LLVDEEAHVTTVVAGTFGYL--APEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
.+.-. .....+.-+++ +|+......+-.+.|++|||..+.|..+|..-.... ..| .
T Consensus 416 ~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~--------~~~----------~ 473 (524)
T KOG0601|consen 416 RLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG--------VQS----------L 473 (524)
T ss_pred cccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccc--------ccc----------e
Confidence 42111 11122333444 445555667788999999999999999987532211 011 1
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L 583 (603)
.+....++..+... .++..+...+...++..||.+.++....
T Consensus 474 ~i~~~~~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 474 TIRSGDTPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred eeecccccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccc
Confidence 11111222222222 6677888889999999999998887644
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.11 E-value=6.9e-10 Score=99.39 Aligned_cols=131 Identities=24% Similarity=0.293 Sum_probs=100.5
Q ss_pred CeeeecCCeEEEEEEECCCCEEEEEEeCCC-CCCh-------HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRS-REGS-------DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
..+++|+-+.+|.+.+.+ .++++|.-.+. .... ..+-.+|++++++++--.|.-..=+..+++...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999997754 44666644222 1111 13456799999998766666556667788888999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
++|..|.+.+... ...++..+-.-+.-||.. +|+|+||.++||.+..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999988888754 245667777888999999 999999999999998864 99999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.4e-09 Score=96.85 Aligned_cols=143 Identities=19% Similarity=0.245 Sum_probs=105.2
Q ss_pred CCCeeeecCCeEEEEEEECCCCEEEEEEeCCC-CCC-------hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 315 EEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRS-REG-------SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 315 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
..+.|-+|+-+.|+++.+.+ +...||.-... ... ..++-.+|++.+.++.--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 45789999999999998875 55666644322 111 1245678999999887555555555666777788999
Q ss_pred EecCC-CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC---CeEEeeccccc
Q 007455 387 DYLSM-GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL---EPHVSDFGLAK 462 (603)
Q Consensus 387 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~~~ 462 (603)
||++| -++.+++....... ........++..|-+.+.-||.+ +++||||..+||++..++ .+.++|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~~~--~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE--SEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHccCc--ccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99987 47777777644321 22233367888999999999999 899999999999997655 35899999986
Q ss_pred c
Q 007455 463 L 463 (603)
Q Consensus 463 ~ 463 (603)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 4
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.5e-09 Score=108.12 Aligned_cols=170 Identities=21% Similarity=0.307 Sum_probs=128.4
Q ss_pred CeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeee----cCCccEEEEEecCC-CCcccc
Q 007455 324 FGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCR----LPATKLLIYDYLSM-GSLDDF 397 (603)
Q Consensus 324 ~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~~ 397 (603)
-.+.||+..+ +|..|+.|+++..+......-..-++.++++.|+|+|++.+++. .+....+||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 4578999865 77789999996554444433445688899999999999999886 33457899999875 366664
Q ss_pred ccccCC-----------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 398 LHEHGE-----------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 398 l~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
--.... .+...++...|.++.|+..||.++|+. |+..+-|.+++|+++.+.+++|+..|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 432221 223467889999999999999999999 899999999999999999999998887765543
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCC
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p 514 (603)
+.. |.+. --.+-|.=.||.+++.|.||..-
T Consensus 446 d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 320 1111 12467999999999999998654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=5.9e-11 Score=129.91 Aligned_cols=249 Identities=24% Similarity=0.247 Sum_probs=171.2
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCC---CCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDR---SREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
..+.+.+.+-+-+|+++.++.+.-...+ ..++|.... -.....+...++-.+.-..++|.+++....+.-....++
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3466677778889999999876644333 233332211 111111222233333333456777776666566677899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
+++|+.+++|...++..+. .+..........+.++++|||.. .+.|+|++|.|++...+++.++.|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~~~----~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSGC----LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCCC----cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999887653 34444555666778899999997 6899999999999999999999999833221
Q ss_pred CC------C------------------------CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCC
Q 007455 465 VD------E------------------------EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514 (603)
Q Consensus 465 ~~------~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p 514 (603)
.. . +........||+.|.+||...+......+|.|+.|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0 00112235689999999999999999999999999999999999999
Q ss_pred CCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007455 515 TDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMN 577 (603)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ 577 (603)
|......... ++... .+...+..+.+...+..+++...+..+|.+|-.+.
T Consensus 1035 ~na~tpq~~f-----------~ni~~--~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIF-----------ENILN--RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhh-----------hcccc--CCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9876443221 01011 11122334556667889999999999999997766
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=3.7e-10 Score=125.08 Aligned_cols=35 Identities=29% Similarity=0.238 Sum_probs=16.4
Q ss_pred ccceecccCCccCCCCCCCCccccccceeeccCCcCccc
Q 007455 143 FLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGE 181 (603)
Q Consensus 143 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 181 (603)
+|+.|+|++|+|+ .+|... ++|+.|++++|+|+++
T Consensus 383 ~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~LssI 417 (788)
T PRK15387 383 GLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLTSL 417 (788)
T ss_pred ccceEEecCCccc-CCCCcc---cCCCEEEccCCcCCCC
Confidence 4455555555555 333321 3444555555555543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.3e-09 Score=118.27 Aligned_cols=97 Identities=28% Similarity=0.454 Sum_probs=53.1
Q ss_pred EEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccC
Q 007455 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSS 151 (603)
Q Consensus 72 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 151 (603)
.+.|+|++++++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++
T Consensus 180 ~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 4667777777776 454443 46677777777776 5555443 46666666666666 4554332 2455555555
Q ss_pred CccCCCCCCCCccccccceeeccCCcCcc
Q 007455 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSG 180 (603)
Q Consensus 152 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~ 180 (603)
|+++ .+|..+. ++|+.|++++|+|+.
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~~ 276 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKISC 276 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccCc
Confidence 5554 4443332 244444444444443
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.5e-10 Score=123.77 Aligned_cols=116 Identities=21% Similarity=0.345 Sum_probs=82.8
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
..++.|+|++|+|+. +|..+. ++|++|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|
T Consensus 199 ~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~L 269 (754)
T PRK15370 199 EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDL 269 (754)
T ss_pred cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEEC
Confidence 468899999999986 555443 58899999999988 6776554 46888888888888 6776654 47888888
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|+|+ .+|..+. ++|+.|++++|+|++.++.+. .+|+.|++++|
T Consensus 270 s~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~lp--~sL~~L~Ls~N 314 (754)
T PRK15370 270 FHNKIS-CLPENLP--EELRYLSVYDNSIRTLPAHLP--SGITHLNVQSN 314 (754)
T ss_pred cCCccC-ccccccC--CCCcEEECCCCccccCcccch--hhHHHHHhcCC
Confidence 888888 5676554 478888888888877654332 24444554444
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.96 E-value=5e-11 Score=122.10 Aligned_cols=106 Identities=27% Similarity=0.469 Sum_probs=57.0
Q ss_pred EEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccC
Q 007455 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSS 151 (603)
Q Consensus 72 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 151 (603)
++.|-+++|+++. +|+.++.+..|..||.+.|+|. .+|..++++.+|+.|.+..|++. .+|+.+..| .|..||+|.
T Consensus 145 Lkvli~sNNkl~~-lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfSc 220 (722)
T KOG0532|consen 145 LKVLIVSNNKLTS-LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSC 220 (722)
T ss_pred ceeEEEecCcccc-CCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeeccc
Confidence 4455555555543 4444555555555555555554 45555555555555555555555 455555422 355555555
Q ss_pred CccCCCCCCCCccccccceeeccCCcCcccC
Q 007455 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEI 182 (603)
Q Consensus 152 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 182 (603)
|+++ .+|-.|.+|+.|++|-|.+|.|+..|
T Consensus 221 Nkis-~iPv~fr~m~~Lq~l~LenNPLqSPP 250 (722)
T KOG0532|consen 221 NKIS-YLPVDFRKMRHLQVLQLENNPLQSPP 250 (722)
T ss_pred Ccee-ecchhhhhhhhheeeeeccCCCCCCh
Confidence 5555 55555555555555555555555433
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.96 E-value=3.3e-10 Score=84.79 Aligned_cols=57 Identities=32% Similarity=0.420 Sum_probs=21.5
Q ss_pred EEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccc
Q 007455 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN 128 (603)
Q Consensus 72 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 128 (603)
+++|+|++|+|+.+.+..|..+++|++|+|++|+|+...|+.|.++++|++|+|++|
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N 59 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNN 59 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCC
Confidence 333333333333333333333333333333333333222333333333333333333
|
... |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.95 E-value=8.8e-10 Score=75.62 Aligned_cols=40 Identities=38% Similarity=0.964 Sum_probs=30.9
Q ss_pred hhhHHHHHHHHHhCC-CCCCCCCCCCCCC-CCCccccceeec
Q 007455 27 TEDGMTLLEIKSSLN-DSRNLLGNWQATE-ESPCKWTGISCH 66 (603)
Q Consensus 27 ~~~~~~l~~~k~~~~-~~~~~l~~w~~~~-~~~c~w~gv~C~ 66 (603)
++|++||++||+++. +|.+.+.+|+.++ .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999998 4778999998764 789999999995
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.95 E-value=6.2e-10 Score=83.31 Aligned_cols=61 Identities=36% Similarity=0.437 Sum_probs=56.0
Q ss_pred CCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCcc
Q 007455 94 DKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSL 154 (603)
Q Consensus 94 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 154 (603)
++|++|+|++|+|+...++.|.++++|++|+|++|+|+...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5799999999999955557899999999999999999977788999999999999999986
|
... |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.6e-11 Score=126.76 Aligned_cols=105 Identities=30% Similarity=0.544 Sum_probs=94.6
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+|.......+.+|..|+.|+||+|+++ .+|..+.+++.|++|...+|+|. .+| .+..++.|+.+|+
T Consensus 383 ~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDl 459 (1081)
T KOG0618|consen 383 KHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDL 459 (1081)
T ss_pred cceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEec
Confidence 47999999999999877778999999999999999999 99999999999999999999999 888 8999999999999
Q ss_pred cCCccCC-CCCCCCccccccceeeccCCcC
Q 007455 150 SSNSLKG-AIPSSLGRLTHLHYLNLSTNFF 178 (603)
Q Consensus 150 ~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l 178 (603)
|.|+|+- .+|..... ++|++|||++|.-
T Consensus 460 S~N~L~~~~l~~~~p~-p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 460 SCNNLSEVTLPEALPS-PNLKYLDLSGNTR 488 (1081)
T ss_pred ccchhhhhhhhhhCCC-cccceeeccCCcc
Confidence 9999984 34444433 8999999999983
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.94 E-value=6.4e-09 Score=96.31 Aligned_cols=126 Identities=20% Similarity=0.243 Sum_probs=81.7
Q ss_pred EEEEEEECCCCEEEEEEeCCC--------------CC--------C----hHHHHHHHHHHHhhCCCC--eeeecceeee
Q 007455 326 TVYRMVMNDCGTFAVKRIDRS--------------RE--------G----SDQVFERELEILGSIKHI--NLVNLRGYCR 377 (603)
Q Consensus 326 ~Vy~~~~~~~~~vavK~~~~~--------------~~--------~----~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 377 (603)
.||.|...++..+|+|..... .. . .....++|++.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999999899999977321 00 0 113467899999999755 456666442
Q ss_pred cCCccEEEEEecC--CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEecCCCCCeEECCCCCeE
Q 007455 378 LPATKLLIYDYLS--MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY-LHHDCCPKIIHRDIKSSNILLDENLEPH 454 (603)
Q Consensus 378 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlkp~NIll~~~~~~k 454 (603)
...+||||++ |..+..+.... ++......++.+++..+.. +|.. |++|||+.+.||+++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 4589999999 54454433321 1122345666777775555 4676 99999999999999988 999
Q ss_pred EeecccccccC
Q 007455 455 VSDFGLAKLLV 465 (603)
Q Consensus 455 l~DfG~~~~~~ 465 (603)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.3e-10 Score=110.17 Aligned_cols=104 Identities=24% Similarity=0.290 Sum_probs=86.6
Q ss_pred cCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccce
Q 007455 91 GRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHY 170 (603)
Q Consensus 91 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 170 (603)
.....|++||||+|.|+ .+.++..-+++++.|+||+|+|. .+.. +..|++|+.||||+|.++ .+...-.+|-+.+.
T Consensus 281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKt 356 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKT 356 (490)
T ss_pred chHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEee
Confidence 34567999999999999 88888888999999999999999 5544 889999999999999999 66666678889999
Q ss_pred eeccCCcCcccCCCCccccccCcccccCC
Q 007455 171 LNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 171 l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
|.|++|.|... .+++.+-+|.+|++.+|
T Consensus 357 L~La~N~iE~L-SGL~KLYSLvnLDl~~N 384 (490)
T KOG1259|consen 357 LKLAQNKIETL-SGLRKLYSLVNLDLSSN 384 (490)
T ss_pred eehhhhhHhhh-hhhHhhhhheecccccc
Confidence 99999999843 34556666666666665
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.86 E-value=5.4e-11 Score=121.90 Aligned_cols=119 Identities=30% Similarity=0.422 Sum_probs=68.0
Q ss_pred EEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCcc
Q 007455 75 INLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSL 154 (603)
Q Consensus 75 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 154 (603)
|.|..|.+.. +|+.+.+|..|++|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|+.++.+..|..||.+.|++
T Consensus 103 liLy~n~~r~-ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei 178 (722)
T KOG0532|consen 103 LILYHNCIRT-IPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI 178 (722)
T ss_pred HHHHhcccee-cchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhh
Confidence 3333344433 4455555666666666666665 5555555443 566666666665 5666666556666666666666
Q ss_pred CCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 155 KGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 155 ~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
. .+|..++.+.+|+.|++..|++...|+++..| .|..|+++.|
T Consensus 179 ~-slpsql~~l~slr~l~vrRn~l~~lp~El~~L-pLi~lDfScN 221 (722)
T KOG0532|consen 179 Q-SLPSQLGYLTSLRDLNVRRNHLEDLPEELCSL-PLIRLDFSCN 221 (722)
T ss_pred h-hchHHhhhHHHHHHHHHhhhhhhhCCHHHhCC-ceeeeecccC
Confidence 6 55556666666666666666666666554433 2455666665
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.9e-09 Score=124.46 Aligned_cols=129 Identities=19% Similarity=0.224 Sum_probs=93.5
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|+|++|..-..+|.. .++|+.|+|
T Consensus 778 ~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~L 853 (1153)
T PLN03210 778 PSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNL 853 (1153)
T ss_pred ccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeEC
Confidence 367778888877767777778888888888888765444777655 6788888888876544455543 357778888
Q ss_pred cCCccCCCCCCCCccccccceeeccC-CcCcccCCCCccccccCcccccCCcccC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLST-NFFSGEIPDFGALSAFGNKSFIGNLDLC 203 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~~~~~~l~~l~~l~~~~n~~l~ 203 (603)
++|.|+ .+|..+..+++|+.|+|++ |+++++++.+..+++|+.+++.+...|.
T Consensus 854 s~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~~L~ 907 (1153)
T PLN03210 854 SRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCGALT 907 (1153)
T ss_pred CCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCcccc
Confidence 888887 6777788888888888877 6677766667777777777777665443
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.9e-09 Score=118.08 Aligned_cols=74 Identities=24% Similarity=0.228 Sum_probs=59.5
Q ss_pred CCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCccccc
Q 007455 118 TELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFI 197 (603)
Q Consensus 118 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~ 197 (603)
++|+.|+|++|+|+ .+|.. .++|+.|++++|+|+ .+|... .+|+.|++++|+|+.+|..+..+.+|..++++
T Consensus 382 ~~L~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 382 SGLKELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLTRLPESLIHLSSETTVNLE 453 (788)
T ss_pred cccceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCcccccChHHhhccCCCeEECC
Confidence 46888899999988 46654 367999999999999 577643 57889999999999887778888888877776
Q ss_pred CC
Q 007455 198 GN 199 (603)
Q Consensus 198 ~n 199 (603)
+|
T Consensus 454 ~N 455 (788)
T PRK15387 454 GN 455 (788)
T ss_pred CC
Confidence 66
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.1e-08 Score=95.32 Aligned_cols=141 Identities=16% Similarity=0.144 Sum_probs=99.3
Q ss_pred CeeeecCCeEEEEEEECCCCEEEEEEeCCCCC-----------ChHHHHHHHHHHHhhCCCCee--eecceeeec-----
Q 007455 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE-----------GSDQVFERELEILGSIKHINL--VNLRGYCRL----- 378 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~----- 378 (603)
+.+-+.....|++... +|+.|.||....... .....+.+|...+.++...+| ++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4555555555777665 446799997633221 111247889999988854443 344555532
Q ss_pred CCccEEEEEecCCC-CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-------C
Q 007455 379 PATKLLIYDYLSMG-SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-------N 450 (603)
Q Consensus 379 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------~ 450 (603)
....++|+|++++. +|.+++..... ...+......++.+++..+.-||.. ||+|+|++++|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23468999999986 78888753211 1245566778999999999999999 9999999999999975 4
Q ss_pred CCeEEeecccccc
Q 007455 451 LEPHVSDFGLAKL 463 (603)
Q Consensus 451 ~~~kl~DfG~~~~ 463 (603)
+.+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6799999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=5.2e-08 Score=92.68 Aligned_cols=135 Identities=20% Similarity=0.148 Sum_probs=96.4
Q ss_pred CCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCC----------------------CChHHHHHHHHHHHhhCCCC--ee
Q 007455 314 DEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSR----------------------EGSDQVFERELEILGSIKHI--NL 369 (603)
Q Consensus 314 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~E~~~l~~l~h~--ni 369 (603)
.+++.||-|--+.||.|...++.++|||.-.... ..+....++|+++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 3568899999999999999999999999542110 01123468899999999655 67
Q ss_pred eecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC
Q 007455 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE 449 (603)
Q Consensus 370 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 449 (603)
.+.+++ +...+||||++|--|...-- +....-.++..|++-+..+-.. |+||+|+++-||++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~---------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~ 237 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL---------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE 237 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC---------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence 776653 46689999999966655331 1122233334444444444454 8999999999999999
Q ss_pred CCCeEEeeccccccc
Q 007455 450 NLEPHVSDFGLAKLL 464 (603)
Q Consensus 450 ~~~~kl~DfG~~~~~ 464 (603)
||.+.++||-.+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999876543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.6e-10 Score=114.11 Aligned_cols=131 Identities=22% Similarity=0.266 Sum_probs=93.2
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCC---cceEEeccCCCCC----CCCCCcccc-CCCceEEeccccCCCC----Ccc
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDK---LQRLALHQNSLHG----SIPNEITNC-TELRALYLRANYLQGG----IPA 136 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~ 136 (603)
..+++.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++.
T Consensus 80 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 80 GCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred cCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 457899999999888666666665555 9999999998873 233345566 8889999999998843 344
Q ss_pred ccccccccceecccCCccCCC----CCCCCccccccceeeccCCcCcccCC-----CCccccccCcccccCC
Q 007455 137 NIGNLLFLTILDLSSNSLKGA----IPSSLGRLTHLHYLNLSTNFFSGEIP-----DFGALSAFGNKSFIGN 199 (603)
Q Consensus 137 ~~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~~-----~~~~l~~l~~l~~~~n 199 (603)
.+..+++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++... .+..+++|+.|++++|
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n 231 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDN 231 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCC
Confidence 566677899999999988842 33345556689999999998874322 2445567777777776
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.4e-08 Score=118.65 Aligned_cols=126 Identities=21% Similarity=0.236 Sum_probs=85.9
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
+++.|++.++.++. +|..| .+.+|+.|+|++|+|. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|+
T Consensus 590 ~Lr~L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~ 665 (1153)
T PLN03210 590 KLRLLRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLS 665 (1153)
T ss_pred ccEEEEecCCCCCC-CCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEec
Confidence 46667777766654 45545 4577778888887776 6777777778888888877654446663 6777788888887
Q ss_pred CCccCCCCCCCCccccccceeeccCC-cCcccCCCCccccccCcccccCCcc
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTN-FFSGEIPDFGALSAFGNKSFIGNLD 201 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N-~l~~~~~~~~~l~~l~~l~~~~n~~ 201 (603)
+|.....+|..+.++++|+.|++++| .++..|..+ .+++|+.|++++|..
T Consensus 666 ~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 666 DCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSR 716 (1153)
T ss_pred CCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCC
Confidence 77655577777777888888888775 344443333 566777777766543
|
syringae 6; Provisional |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=5.1e-07 Score=90.36 Aligned_cols=258 Identities=13% Similarity=0.154 Sum_probs=154.7
Q ss_pred CCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeeccee------eec-CCccEEE
Q 007455 314 DEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGY------CRL-PATKLLI 385 (603)
Q Consensus 314 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~-~~~~~lv 385 (603)
.....||+|+-+.+|..- .-+..+.|+.+........ +.+..|... .||-+-.=+.+ ..+ .....+.
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 346789999999998532 1123456766554332222 223334443 56644331111 111 2225677
Q ss_pred EEecCCCC-ccccccc--cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 386 YDYLSMGS-LDDFLHE--HGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 386 ~e~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|..+.+.- ...+.+. ...+-...+|...++++..++.+.+.||.+ |.+-||+.++|+|+.+++.+.+.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 88776641 1111111 011112378999999999999999999999 89999999999999999999999855433
Q ss_pred ccCCCCcceeecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhC-CCCCCcccccC--CccHh-HHHHHH
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTG-KRPTDPTFVKR--GLNVV-GWMNTL 533 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg-~~p~~~~~~~~--~~~~~-~~~~~~ 533 (603)
.. .+.....-.+|...|.+||... +..-+...|.|.+|+++++++.| ++||.+..... ..... ...
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia--- 240 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA--- 240 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh---
Confidence 32 1222233456888999999764 23345678999999999999987 88987543211 11111 000
Q ss_pred hhhCcchhhhcc--cCC----CcCH-HHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHhhc
Q 007455 534 LKENRLEDVIDK--RCA----DADM-ETVEAILEIAARCTDA--NPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 534 ~~~~~~~~~~~~--~~~----~~~~-~~~~~l~~li~~cl~~--~P~~RPs~~evl~~L~~~ 586 (603)
.......-+. ... ..+. -.+..+..+..+|+.. .+.-|||++..+..|...
T Consensus 241 --~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 241 --HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred --cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 0111110010 011 1111 2235678888889864 467899999988776553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.72 E-value=5.3e-09 Score=110.33 Aligned_cols=123 Identities=29% Similarity=0.444 Sum_probs=64.3
Q ss_pred cEEEEEcCCCCcccccCCCccCCC-CcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLD-KLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++.|++.+|.++. +++....++ +|+.|++++|++. .+|..+..+++|+.|++++|+++ .+|...+.+++|+.|++
T Consensus 117 ~l~~L~l~~n~i~~-i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~l 193 (394)
T COG4886 117 NLTSLDLDNNNITD-IPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDL 193 (394)
T ss_pred ceeEEecCCccccc-Cccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheec
Confidence 35555555555555 333344442 5555566665555 55444555555566666666555 45544445555555555
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCccccc
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFI 197 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~ 197 (603)
++|+++ .+|.....+..|+.|.+++|++...+..+..+.++..+.+.
T Consensus 194 s~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~ 240 (394)
T COG4886 194 SGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELS 240 (394)
T ss_pred cCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccC
Confidence 555555 55544444444555555555443344444444444444433
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.7e-10 Score=94.47 Aligned_cols=139 Identities=20% Similarity=0.281 Sum_probs=104.0
Q ss_pred ecCCCCcEEEEEcCCCCcccccCCC---ccCCCCcceEEeccCCCCCCCCCCccc-cCCCceEEeccccCCCCCcccccc
Q 007455 65 CHTHDQRVRSINLPYMQLGGIISPS---IGRLDKLQRLALHQNSLHGSIPNEITN-CTELRALYLRANYLQGGIPANIGN 140 (603)
Q Consensus 65 C~~~~~~l~~L~L~~n~l~~~~~~~---~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p~~~~~ 140 (603)
|.+ ...+..++|+++.|-. +++. +.....|+..+|++|.+. ..|..|.. .+.++.|+|++|+|+ .+|..+..
T Consensus 23 ced-akE~h~ldLssc~lm~-i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aa 98 (177)
T KOG4579|consen 23 CED-AKELHFLDLSSCQLMY-IADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAA 98 (177)
T ss_pred hHH-HHHhhhcccccchhhH-HHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhh
Confidence 543 3456778999998854 4444 444566777899999998 77776655 458999999999999 89999999
Q ss_pred ccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCcccCCCCCCCCCCCC
Q 007455 141 LLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTS 214 (603)
Q Consensus 141 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~~~~~~c~~~ 214 (603)
++.|+.|+++.|.|. ..|..+..|.+|..|+..+|.+..++-++ -.-+..+-..+.++||...|+.-
T Consensus 99 m~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl------~~s~~~al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 99 MPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDL------FYSSLPALIKLGNEPLGDETKKK 165 (177)
T ss_pred hHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHH------hccccHHHHHhcCCcccccCccc
Confidence 999999999999999 88888888999999999999998665541 11111222344567887777653
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4.3e-09 Score=111.01 Aligned_cols=126 Identities=29% Similarity=0.396 Sum_probs=107.9
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
+++.|++++|++.. +|..+..+++|+.|++++|+++ .+|...+.++.|+.|++++|+++ .+|..+..+..|++|+++
T Consensus 141 nL~~L~l~~N~i~~-l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~ 217 (394)
T COG4886 141 NLKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS 217 (394)
T ss_pred hcccccccccchhh-hhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhc
Confidence 79999999999987 4467889999999999999999 88876779999999999999999 888877777789999999
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCc
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~ 200 (603)
+|++. ..+..+.++.++..|.+.+|++...+..++.+.+++.|++++|.
T Consensus 218 ~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~ 266 (394)
T COG4886 218 NNSII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQ 266 (394)
T ss_pred CCcce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccc
Confidence 99766 56677888888888889999888766567777778888888774
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.7e-10 Score=119.69 Aligned_cols=129 Identities=25% Similarity=0.324 Sum_probs=100.8
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcc-ccccccccceecc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPA-NIGNLLFLTILDL 149 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l 149 (603)
.+...+.+.|+|+- +..++.-++.|+.|||++|+++..- .+..|++|+.|||++|++. .+|. ....+. |+.|.|
T Consensus 165 ~L~~a~fsyN~L~~-mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~l 239 (1096)
T KOG1859|consen 165 KLATASFSYNRLVL-MDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNL 239 (1096)
T ss_pred hHhhhhcchhhHHh-HHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeeee
Confidence 57788888999876 5677888999999999999998433 6899999999999999999 5553 334454 999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCC--CCccccccCcccccCCcccCCCCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP--DFGALSAFGNKSFIGNLDLCGRQV 207 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~~~~n~~l~~~~~ 207 (603)
+||-++ .+ ..+.+|++|+.||+++|-|.+.-. .++.|..|..|.+.||+ +|-+||
T Consensus 240 rnN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNP-l~c~p~ 296 (1096)
T KOG1859|consen 240 RNNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNP-LCCAPW 296 (1096)
T ss_pred cccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCc-cccCHH
Confidence 999999 44 468899999999999999886432 25566777777777774 333444
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.9e-09 Score=110.27 Aligned_cols=130 Identities=22% Similarity=0.204 Sum_probs=94.6
Q ss_pred CcEEEEEcCCCCccc------ccCCCccCCCCcceEEeccCCCCCCCCCCccccCC---CceEEeccccCCC----CCcc
Q 007455 70 QRVRSINLPYMQLGG------IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTE---LRALYLRANYLQG----GIPA 136 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~ 136 (603)
++++.|+++++.+.+ .++..+..+++|+.|+|++|.+.+..+..+..+.+ |+.|+|++|++++ .+..
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 458889998888762 23456777889999999999998666666666666 9999999999883 2334
Q ss_pred ccccc-cccceecccCCccCCC----CCCCCccccccceeeccCCcCcccC-----CCCccccccCcccccCC
Q 007455 137 NIGNL-LFLTILDLSSNSLKGA----IPSSLGRLTHLHYLNLSTNFFSGEI-----PDFGALSAFGNKSFIGN 199 (603)
Q Consensus 137 ~~~~l-~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~-----~~~~~l~~l~~l~~~~n 199 (603)
.+..+ ++|+.|+|++|.+++. ++..+..+++|+.|++++|.+++.. ..+..+++|+.|++++|
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n 203 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNN 203 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCC
Confidence 55666 8899999999998843 3345666778999999999988421 12333457777777766
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.59 E-value=2.3e-07 Score=88.20 Aligned_cols=106 Identities=25% Similarity=0.281 Sum_probs=82.7
Q ss_pred HHHHHHHHHHHhhCCCCe--eeecceeeecC----CccEEEEEecCCC-CccccccccCCCCccCCHHHHHHHHHHHHHH
Q 007455 351 DQVFERELEILGSIKHIN--LVNLRGYCRLP----ATKLLIYDYLSMG-SLDDFLHEHGEGQQLLNWSARLKIALGSARG 423 (603)
Q Consensus 351 ~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~ 423 (603)
.....+|...+..+.... ..+++++.... ...++|+|++++. +|.+++..... .+......++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHH
Confidence 345788998888885433 44555555442 2348999999884 78888876332 4556678899999999
Q ss_pred HHHHHhCCCCCeEEecCCCCCeEECCCC---CeEEeecccccc
Q 007455 424 LAYLHHDCCPKIIHRDIKSSNILLDENL---EPHVSDFGLAKL 463 (603)
Q Consensus 424 L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~~~~ 463 (603)
+.-||.. ||+|+|+++.|||++.++ .+.++||+-++.
T Consensus 131 i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 999999999999999887 899999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.4e-08 Score=107.56 Aligned_cols=149 Identities=21% Similarity=0.368 Sum_probs=104.0
Q ss_pred HHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce--------eecccccccccCccccccC
Q 007455 419 GSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV--------TTVVAGTFGYLAPEYLQSG 490 (603)
Q Consensus 419 ~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~ 490 (603)
+++.|+.|+|... ++||++|.|++|.++..+..||+.|+.+.....+.... .........|.|||++...
T Consensus 107 ~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 4458999999984 99999999999999999999999999876543321111 1112234579999999988
Q ss_pred CCCcccchHhHHHHHHHHHhCCCC-CCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCC
Q 007455 491 RATEKSDVYSFGVLLLELVTGKRP-TDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDAN 569 (603)
Q Consensus 491 ~~~~~~Dv~slG~vl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 569 (603)
..+.++|+||+|+++|.+..|+.+ +..... ........ ...+-....+....+.++.+=+.+++..+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~---~~~~~~~~---------~~~~~~~~~~s~~~p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGG---LLSYSFSR---------NLLNAGAFGYSNNLPSELRESLKKLLNGD 252 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCC---cchhhhhh---------cccccccccccccCcHHHHHHHHHHhcCC
Confidence 889999999999999999955544 322110 00000000 00111112234566778999999999999
Q ss_pred CCCCCCHHHHHH
Q 007455 570 PDDRPSMNQVLQ 581 (603)
Q Consensus 570 P~~RPs~~evl~ 581 (603)
+.-||++.++..
T Consensus 253 ~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 253 SAVRPTLDLLLS 264 (700)
T ss_pred cccCcchhhhhc
Confidence 999998887764
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.3e-09 Score=88.22 Aligned_cols=113 Identities=22% Similarity=0.249 Sum_probs=93.8
Q ss_pred CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcccccccccccee
Q 007455 68 HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147 (603)
Q Consensus 68 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 147 (603)
....++.++|++|.+....+..-..++.++.|+|++|+|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|-.|
T Consensus 51 ~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 51 KGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred CCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence 3468999999999998854444445679999999999999 99999999999999999999999 899999999999999
Q ss_pred cccCCccCCCCCCCCccccccceeeccCCcCcccCC
Q 007455 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP 183 (603)
Q Consensus 148 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 183 (603)
+..+|.+. .+|..+.--..+-..++.+|.+.+.-+
T Consensus 129 ds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 129 DSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred cCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence 99999999 777665443445556667777776554
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.57 E-value=6.2e-07 Score=83.60 Aligned_cols=137 Identities=14% Similarity=0.143 Sum_probs=100.0
Q ss_pred eecCCeEEEEEEECCCCEEEEEEeCCCC------CChHHHHHHHHHHHhhCCCCe--eeecceeee-c--C--CccEEEE
Q 007455 320 GSGGFGTVYRMVMNDCGTFAVKRIDRSR------EGSDQVFERELEILGSIKHIN--LVNLRGYCR-L--P--ATKLLIY 386 (603)
Q Consensus 320 g~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~--~--~~~~lv~ 386 (603)
|+||.+.|++....+. .+.+|+-.... .-....|.+|+..+.++...+ +.++. ++. . + ...+||+
T Consensus 27 ~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEE
Confidence 6789999998776553 68888764211 223456999999999986332 44444 222 1 1 2357999
Q ss_pred EecCC-CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC--eEEeecccccc
Q 007455 387 DYLSM-GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE--PHVSDFGLAKL 463 (603)
Q Consensus 387 e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~~~~ 463 (603)
|-+++ -+|.+++..... ...+...+..+..++++.+.-||+. |+.|+|+.+.||+++.++. +.++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~--~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV--SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCc--CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97763 388888765322 1256677789999999999999999 9999999999999987677 99999986653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.9e-07 Score=95.76 Aligned_cols=148 Identities=19% Similarity=0.275 Sum_probs=96.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCC----------------------C----h--------HH---
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE----------------------G----S--------DQ--- 352 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~----~--------~~--- 352 (603)
..+|+. +-|+.++-|.||+|+..+|+.||||+.+..-. . . .+
T Consensus 125 F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 125 FSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 445543 78999999999999999999999998754310 0 0 01
Q ss_pred ---HHHHHHHHHhhCC-----CCeeeecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHH-
Q 007455 353 ---VFERELEILGSIK-----HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARG- 423 (603)
Q Consensus 353 ---~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~- 423 (603)
.+.+|+.-+.+++ .+++.=..=|....+...++|||++|-.+.+.......+ .+. ..++..++++
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g---~d~---k~ia~~~~~~f 277 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG---IDR---KELAELLVRAF 277 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC---CCH---HHHHHHHHHHH
Confidence 1334555555442 233322222223356678999999999998874322221 332 2333333332
Q ss_pred HHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 424 L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
+..+-.. |+.|.|..|.||+++.+|++.+.|||+...+.+.
T Consensus 278 ~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 278 LRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred HHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 2333334 8999999999999999999999999999876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.7e-06 Score=83.35 Aligned_cols=138 Identities=14% Similarity=0.183 Sum_probs=84.9
Q ss_pred CeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCe--eeecceeeecCCccEEEEEecCCCC-
Q 007455 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHIN--LVNLRGYCRLPATKLLIYDYLSMGS- 393 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs- 393 (603)
..||+|..+.||+. .++.+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999984 24567888765422 3345789999999886443 4567777777777889999999963
Q ss_pred ccccccc---------------------cCCCCccCCHHHHHH-HHH----------HHHH-HHHHHHhC-CCCCeEEec
Q 007455 394 LDDFLHE---------------------HGEGQQLLNWSARLK-IAL----------GSAR-GLAYLHHD-CCPKIIHRD 439 (603)
Q Consensus 394 L~~~l~~---------------------~~~~~~~l~~~~~~~-i~~----------~i~~-~L~~LH~~-~~~~ivH~D 439 (603)
+.+.+.. ..... ........ +.. .+.+ ...+|... ..+.++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 2211111 00000 11111000 000 0001 12222211 123578999
Q ss_pred CCCCCeEECCCCCeEEeeccccc
Q 007455 440 IKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 440 lkp~NIll~~~~~~kl~DfG~~~ 462 (603)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999988 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.3e-06 Score=79.04 Aligned_cols=149 Identities=17% Similarity=0.173 Sum_probs=95.5
Q ss_pred HHHHHhhCCCCCCeee---ecCCeEEEEEEECCCCEEEEEEeCCCCCCh-------------------H-----HHHHHH
Q 007455 305 EIIEKLEALDEEDVVG---SGGFGTVYRMVMNDCGTFAVKRIDRSREGS-------------------D-----QVFERE 357 (603)
Q Consensus 305 ~~~~~~~~~~~~~~ig---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~-----~~~~~E 357 (603)
.+........+.+..| .|--+.||+|...++..+|||+........ . ....+|
T Consensus 39 ~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kE 118 (268)
T COG1718 39 TLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKE 118 (268)
T ss_pred HHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHH
Confidence 3344445555555544 555668999998888899999885321111 1 123456
Q ss_pred HHHHhhCC--CCeeeecceeeecCCccEEEEEecCCC-CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 007455 358 LEILGSIK--HINLVNLRGYCRLPATKLLIYDYLSMG-SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434 (603)
Q Consensus 358 ~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ 434 (603)
+.-|.++. +-.+.+.+++. .-.+||||+... .-.-.|+..+ +.......+..++++.+.-|-..+ +
T Consensus 119 f~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~-----~e~~e~~~~~~~~v~~~~~l~~~a--~ 187 (268)
T COG1718 119 FRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVP-----LELEEAEGLYEDVVEYMRRLYKEA--G 187 (268)
T ss_pred HHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccCC-----cCchhHHHHHHHHHHHHHHHHHhc--C
Confidence 66666663 33444445443 237999999764 1122222221 222256667777888888777743 8
Q ss_pred eEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 435 ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
+||+||+.=|||+. ++.+.|+|||.+....
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 7899999999887554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=7.8e-08 Score=101.82 Aligned_cols=124 Identities=27% Similarity=0.328 Sum_probs=77.7
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
.+..++|..|.+.. +-..+..+++|+.|+|.+|+|. .+...+..+++|+.|+|++|+|+..- .+..++.|+.|+++
T Consensus 73 ~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~ 148 (414)
T KOG0531|consen 73 SLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLS 148 (414)
T ss_pred hHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhhheec
Confidence 45556666666655 2234666777777777777776 44433666777777777777777332 25566667777777
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCc
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNL 200 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~ 200 (603)
+|.|+ .+ ..+..+++|+.+++++|+++...+. ...+.+++.+.+.+|.
T Consensus 149 ~N~i~-~~-~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~ 197 (414)
T KOG0531|consen 149 GNLIS-DI-SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNS 197 (414)
T ss_pred cCcch-hc-cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCc
Confidence 77777 44 2455577777777777777755443 3455556666666653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.32 E-value=7.9e-08 Score=96.21 Aligned_cols=129 Identities=21% Similarity=0.181 Sum_probs=72.9
Q ss_pred CcEEEEEcCCCCcccccC--CCccCCCCcceEEeccCCCCCCCCCCc-cccCCCceEEeccccCCCC-Cccccccccccc
Q 007455 70 QRVRSINLPYMQLGGIIS--PSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGG-IPANIGNLLFLT 145 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~ 145 (603)
++++.||||.|-+....+ .....|++|+.|+|+.|++.-...... ..+++|+.|.|+.+.|+-. +-..+..+++|+
T Consensus 146 ~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~ 225 (505)
T KOG3207|consen 146 PNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLE 225 (505)
T ss_pred CcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHH
Confidence 467777777776654322 234557777777777777763332222 2366777777777777621 112233456677
Q ss_pred eecccCCccCCCCCCCCccccccceeeccCCcCcccC--CCCccccccCcccccC
Q 007455 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEI--PDFGALSAFGNKSFIG 198 (603)
Q Consensus 146 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~--~~~~~l~~l~~l~~~~ 198 (603)
.|+|..|...+.-.....-+..|+.|||++|++-..+ +-.+.|+.|..|+++.
T Consensus 226 ~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~ 280 (505)
T KOG3207|consen 226 VLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSS 280 (505)
T ss_pred HhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccc
Confidence 7777776433233334444566777777777666544 2344555555554444
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=8.3e-08 Score=100.63 Aligned_cols=181 Identities=20% Similarity=0.138 Sum_probs=135.4
Q ss_pred CeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCe-eeecceeeecCCccEEEEEecCCC-Cc
Q 007455 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHIN-LVNLRGYCRLPATKLLIYDYLSMG-SL 394 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~~~g-sL 394 (603)
.-.++|++++++|.+...++....+.+... ....-++++|.+++||| .++.++-+..+....++++++.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 456899999999998776666556655332 33456789999999999 777777777778888999999887 33
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeec
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~ 474 (603)
...... ....+...+...+...-.++++++|+. .-+|+| ||+..+ +..+..||+....+.+.. ....
T Consensus 323 ~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 323 ALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred cccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 222221 112245555666777778899999987 458998 776655 689999999887765443 3455
Q ss_pred ccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCC
Q 007455 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPT 515 (603)
Q Consensus 475 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~ 515 (603)
..+++.++|||+.....+..+.|+|+.|+-..++--|-.|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 67899999999999999999999999998777777777663
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.29 E-value=2e-07 Score=98.68 Aligned_cols=124 Identities=25% Similarity=0.296 Sum_probs=96.0
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
..+++.|+|.+|+|.++. ..+..+++|+.|+|++|.|+ .+.+ +..++.|+.|++++|.|+ .+. .+..+++|+.++
T Consensus 94 ~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~-~i~~-l~~l~~L~~L~l~~N~i~-~~~-~~~~l~~L~~l~ 168 (414)
T KOG0531|consen 94 LKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKIT-KLEG-LSTLTLLKELNLSGNLIS-DIS-GLESLKSLKLLD 168 (414)
T ss_pred ccceeeeeccccchhhcc-cchhhhhcchheeccccccc-cccc-hhhccchhhheeccCcch-hcc-CCccchhhhccc
Confidence 457999999999999854 33788999999999999999 4443 888899999999999999 444 466699999999
Q ss_pred ccCCccCCCCCCC-CccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 149 LSSNSLKGAIPSS-LGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~~p~~-~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
+++|.+. .+... +..+.+|+.+++.+|.+.... .+..+..+..+++..|
T Consensus 169 l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~~i~-~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 169 LSYNRIV-DIENDELSELISLEELDLGGNSIREIE-GLDLLKKLVLLSLLDN 218 (414)
T ss_pred CCcchhh-hhhhhhhhhccchHHHhccCCchhccc-chHHHHHHHHhhcccc
Confidence 9999999 44332 578899999999999998443 2333333333344444
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.25 E-value=6.1e-07 Score=61.58 Aligned_cols=36 Identities=31% Similarity=0.534 Sum_probs=19.6
Q ss_pred CcceEEeccCCCCCCCCCCccccCCCceEEeccccCC
Q 007455 95 KLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131 (603)
Q Consensus 95 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 131 (603)
+|++|+|++|+|+ .+|+.+.+|++|+.|+|++|+|+
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555666666665 45544555555555555555555
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.8e-07 Score=103.61 Aligned_cols=107 Identities=28% Similarity=0.321 Sum_probs=71.1
Q ss_pred CcEEEEEcCCCC--cccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcccccccccccee
Q 007455 70 QRVRSINLPYMQ--LGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147 (603)
Q Consensus 70 ~~l~~L~L~~n~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 147 (603)
+++++|-+..|. +..+..+.|..++.|+.|||++|.=-+.+|..+++|-+|++|+|++..++ .+|..+.+|..|.+|
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~L 623 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYL 623 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhee
Confidence 356667776665 44444444666777777777766555577777777777777777777777 677777777777777
Q ss_pred cccCCccCCCCCCCCccccccceeeccCCc
Q 007455 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNF 177 (603)
Q Consensus 148 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~ 177 (603)
++..+.-...+|.....|++|++|.+..-.
T Consensus 624 nl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 624 NLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred ccccccccccccchhhhcccccEEEeeccc
Confidence 777766554555555567777777765544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 603 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-64 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-64 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-45 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-45 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-40 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-39 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-38 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-29 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-27 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-25 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-25 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-25 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-25 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-25 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-25 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-25 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-25 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-25 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-25 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-25 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-25 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-25 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-24 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-24 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-24 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-24 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-24 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-24 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-24 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-23 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-22 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-22 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-22 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-22 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-22 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-22 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-22 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-22 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-22 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-22 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-22 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-22 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-22 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-22 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-22 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-22 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-22 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-22 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 6e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-21 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-21 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-20 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 8e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-19 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-19 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-19 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-19 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-19 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-19 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-19 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-19 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-19 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-19 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 7e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-18 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-17 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-17 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 9e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-14 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-14 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-14 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-14 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 8e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 8e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-13 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-13 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-13 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 7e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 9e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 9e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-10 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 7e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 7e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-09 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-09 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 8e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 9e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 8e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 9e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-07 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-07 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-06 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 386 bits (995), Expect = e-131
Identities = 123/275 (44%), Positives = 184/275 (66%), Gaps = 4/275 (1%)
Query: 314 DEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDR-SREGSDQVFERELEILGSIKHINLVNL 372
++++G GGFG VY+ + D AVKR+ +G + F+ E+E++ H NL+ L
Sbjct: 33 SNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
RG+C P +LL+Y Y++ GS+ L E E Q L+W R +IALGSARGLAYLH C
Sbjct: 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
PKIIHRD+K++NILLDE E V DFGLAKL+ ++ HVTT V GT G++APEYL +G++
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS 212
Query: 493 TEKSDVYSFGVLLLELVTGKRPTDPTFVK--RGLNVVGWMNTLLKENRLEDVIDKR-CAD 549
+EK+DV+ +GV+LLEL+TG+R D + + ++ W+ LLKE +LE ++D +
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGN 272
Query: 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
E VE ++++A CT ++P +RP M++V+++LE
Sbjct: 273 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-117
Identities = 106/274 (38%), Positives = 156/274 (56%), Gaps = 7/274 (2%)
Query: 314 DEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDR-SREGSDQVFERELEILGSIKHINLVNL 372
D + ++G G FG VY+ V+ D A+KR S +G ++ FE E+E L +H +LV+L
Sbjct: 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE-FETEIETLSFCRHPHLVSL 100
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
G+C +LIY Y+ G+L L+ ++W RL+I +G+ARGL YLH
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA- 159
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKL-LVDEEAHVTTVVAGTFGYLAPEYLQSGR 491
IIHRD+KS NILLDEN P ++DFG++K ++ H++TVV GT GY+ PEY GR
Sbjct: 160 --IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR 217
Query: 492 ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR-CADA 550
TEKSDVYSFGV+L E++ + + + +N+ W +LE ++D
Sbjct: 218 LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKI 277
Query: 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
E++ + A +C + +DRPSM VL LE
Sbjct: 278 RPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 341 bits (878), Expect = e-114
Identities = 106/279 (37%), Positives = 158/279 (56%), Gaps = 16/279 (5%)
Query: 318 VVGSGGFGTVYRMVMNDCGTFAVKRIDR-----SREGSDQVFERELEILGSIKHINLVNL 372
+G GGFG VY+ +N+ T AVK++ + E Q F++E++++ +H NLV L
Sbjct: 38 KMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELKQQ-FDQEIKVMAKCQHENLVEL 95
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
G+ L+Y Y+ GSL D L +G L+W R KIA G+A G+ +LH +
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHENH- 153
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTFGYLAPEYLQSGR 491
IHRDIKS+NILLDE +SDFGLA+ + +T+ + GT Y+APE L G
Sbjct: 154 --HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGE 210
Query: 492 ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR-LEDVIDKRCADA 550
T KSD+YSFGV+LLE++TG D + ++ + E + +ED IDK+ DA
Sbjct: 211 ITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLDIKEEIEDEEKTIEDYIDKKMNDA 268
Query: 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589
D +VEA+ +A++C + RP + +V QLL++ S
Sbjct: 269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 5e-85
Identities = 81/312 (25%), Positives = 128/312 (41%), Gaps = 33/312 (10%)
Query: 298 DMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERE 357
D+ + + L +V G FG V++ + + AVK ++ E E
Sbjct: 13 DLGTENLYF--QSMPLQLLEVKARGRFGCVWKAQLLNE-YVAVKIFP-IQDKQSWQNEYE 68
Query: 358 LEILGSIKHINLVNLRGYCRLPAT----KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR 413
+ L +KH N++ G + + LI + GSL DFL + +++W+
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNEL 123
Query: 414 LKIALGSARGLAYLHHDCC-------PKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-V 465
IA ARGLAYLH D P I HRDIKS N+LL NL ++DFGLA
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 466 DEEAHVTTVVAGTFGYLAPEYLQSG-----RATEKSDVYSFGVLLLELVTGKRPTDPTFV 520
+ A T GT Y+APE L+ A + D+Y+ G++L EL + D
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 521 KRGLNVVGWMNTLLKENRLEDVIDKRCAD-------ADMETVEAILEIAARCTDANPDDR 573
+ L + +++V+ + + + E C D + + R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 574 PSMNQVLQLLEQ 585
S V + + Q
Sbjct: 304 LSAGCVGERITQ 315
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 7e-72
Identities = 100/317 (31%), Positives = 155/317 (48%), Gaps = 27/317 (8%)
Query: 288 TSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSR 347
+T+ + F G M +I L+ ++ +G+G FGTV+R + AVK +
Sbjct: 16 PTTENLYFQGAMDGDDMDI--PWCDLNIKEKIGAGSFGTVHRAEWHGS-DVAVKILMEQD 72
Query: 348 EGSDQV--FERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQ 405
+++V F RE+ I+ ++H N+V G P ++ +YLS GSL LH+ G +
Sbjct: 73 FHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE 132
Query: 406 QLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465
QL + RL +A A+G+ YLH+ P I+HR++KS N+L+D+ V DFGL++L
Sbjct: 133 QL-DERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190
Query: 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLN 525
+ AGT ++APE L+ + EKSDVYSFGV+L EL T ++P LN
Sbjct: 191 STFLSSKS-AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG------NLN 243
Query: 526 VVGWMNTLLKEN-RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
+ + + RLE I + + I C P RPS ++ LL
Sbjct: 244 PAQVVAAVGFKCKRLE--IPRNLN-------PQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
Query: 585 QEVMSPCPSDFYESHSD 601
+ S P + SD
Sbjct: 295 PLIKSAVPP---PNRSD 308
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 1e-67
Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 35/289 (12%)
Query: 303 SCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-----AVKRIDRSREGSDQVFERE 357
S +I + ++ E+VVG G FG V + + A+K+I+ E + F E
Sbjct: 1 SLHMI-DYKEIEVEEVVGRGAFGVVCK------AKWRAKDVAIKQIESESE--RKAFIVE 51
Query: 358 LEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA 417
L L + H N+V L G C P L+ +Y GSL + LH E + +
Sbjct: 52 LRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWC 108
Query: 418 LGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE-PHVSDFGLAKLLVDEEAHVTTVVA 476
L ++G+AYLH +IHRD+K N+LL + DFG A + T
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNK 164
Query: 477 GTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE 536
G+ ++APE + +EK DV+S+G++L E++T ++P F + G M +
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNG 220
Query: 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
R + K + I + RC +P RPSM ++++++
Sbjct: 221 TRPP--LIKNLP-------KPIESLMTRCWSKDPSQRPSMEEIVKIMTH 260
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-67
Identities = 75/308 (24%), Positives = 140/308 (45%), Gaps = 44/308 (14%)
Query: 297 GDMPYPSCEIIE-KLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSD--- 351
G +P + ++ E +G GGFG V++ + + A+K + +
Sbjct: 4 GGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63
Query: 352 ----QVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQL 407
Q F+RE+ I+ ++ H N+V L G P ++ +++ G L L +
Sbjct: 64 IEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH---P 118
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH-----VSDFGLAK 462
+ WS +L++ L A G+ Y+ + P I+HRD++S NI L E V+DFGL++
Sbjct: 119 IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
Query: 463 LLVDEEAHVTTVVAGTFGYLAPEYL--QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFV 520
+ H + + G F ++APE + + TEK+D YSF ++L ++TG+ P D
Sbjct: 178 ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD---- 229
Query: 521 KRGLNV--VGWMNTLLKEN-RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMN 577
+ + ++N + +E R I + C + + C +P RP +
Sbjct: 230 --EYSYGKIKFINMIREEGLRPT--IPEDCP-------PRLRNVIELCWSGDPKKRPHFS 278
Query: 578 QVLQLLEQ 585
+++ L +
Sbjct: 279 YIVKELSE 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 217 bits (553), Expect = 1e-65
Identities = 72/330 (21%), Positives = 126/330 (38%), Gaps = 50/330 (15%)
Query: 298 DMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERE 357
+ + L+ L +++G G +G VY+ +++ AVK + Q F E
Sbjct: 2 EAAASEPSL--DLDNLKLLELIGRGRYGAVYKGSLDER-PVAVKVFS---FANRQNFINE 55
Query: 358 LEI--LGSIKHINLVNLRGYCR-----LPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNW 410
I + ++H N+ LL+ +Y GSL +L H +W
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDW 110
Query: 411 SARLKIALGSARGLAYLHHD------CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464
+ ++A RGLAYLH + P I HRD+ S N+L+ + +SDFGL+ L
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 465 -------VDEEAHVTTVVAGTFGYLAPEYLQS-------GRATEKSDVYSFGVLLLELVT 510
EE + GT Y+APE L+ A ++ D+Y+ G++ E+
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 511 GKRPTDPTFVKRGLNV-----VGW------MNTLLKENRLEDVIDKRCADADMETVEAIL 559
P + VG M L+ + + + V ++
Sbjct: 231 RCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW-KENSLAVRSLK 289
Query: 560 EIAARCTDANPDDRPSMNQVLQLLEQEVMS 589
E C D + + R + + + + +M
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 3e-65
Identities = 83/294 (28%), Positives = 131/294 (44%), Gaps = 39/294 (13%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRI--DRSREGSDQV--FERELEI 360
EI L E+++G GGFG VYR AVK D + S + +E ++
Sbjct: 3 EI--DFAELTLEEIIGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 361 LGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS 420
+KH N++ LRG C L+ ++ G L+ L + + A+
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQI 114
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH--------VSDFGLAKLLVDEEAHVT 472
ARG+ YLH + IIHRD+KSSNIL+ + +E ++DFGLA+
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---K 171
Query: 473 TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT 532
AG + ++APE +++ ++ SDV+S+GVLL EL+TG+ P G++ +
Sbjct: 172 MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR------GIDGLAVAYG 225
Query: 533 LLKEN-RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ L I C E ++ C + +P RPS +L L
Sbjct: 226 VAMNKLALP--IPSTCP-------EPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 3e-64
Identities = 80/302 (26%), Positives = 127/302 (42%), Gaps = 41/302 (13%)
Query: 301 YPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFERELE 359
P + L +V+G G FG ++ + G +K + R E + + F +E++
Sbjct: 2 MPHRIF--RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVK 59
Query: 360 ILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALG 419
++ ++H N++ G I +Y+ G+L + WS R+ A
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ---YPWSQRVSFAKD 116
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT------- 472
A G+AYLH IIHRD+ S N L+ EN V+DFGLA+L+VDE+
Sbjct: 117 IASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 473 ------TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPT---DPTFVKRG 523
V G ++APE + EK DV+SFG++L E++ P + G
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 524 LNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
LNV G++ + I RC D +P+ RPS ++ L
Sbjct: 234 LNVRGFL-------DRY---------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
Query: 584 EQ 585
E
Sbjct: 278 ET 279
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-62
Identities = 66/294 (22%), Positives = 117/294 (39%), Gaps = 45/294 (15%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-----AVKRIDRSREGSDQV--FERE 357
I + L+ + G +++ G + VK + + + F E
Sbjct: 6 GI--DFKQLNFLTKLNENHSGELWK------GRWQGNDIVVKVLKVRDWSTRKSRDFNEE 57
Query: 358 LEILGSIKHINLVNLRGYC-RLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK 415
L H N++ + G C PA LI ++ GSL + LHE +++ S +K
Sbjct: 58 CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVK 115
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
AL ARG+A+LH P I + S ++++DE++ +S +
Sbjct: 116 FALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGR 168
Query: 476 AGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT 532
++APE LQ +D++SF VLL ELVT + P F L+ +
Sbjct: 169 MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP----F--ADLSNMEIGMK 222
Query: 533 LLKEN-RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ E R I + + ++ C + +P RP + ++ +LE+
Sbjct: 223 VALEGLRPT--IPPGIS-------PHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 9e-62
Identities = 80/289 (27%), Positives = 136/289 (47%), Gaps = 29/289 (10%)
Query: 304 CEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQV--FERELEIL 361
EI + +GSG FGTVY+ + G AVK ++ + Q+ F+ E+ +L
Sbjct: 19 WEI--PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVL 74
Query: 362 GSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA 421
+H+N++ GY P ++ + SL LH + IA +A
Sbjct: 75 RKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTA 130
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD-EEAHVTTVVAGTFG 480
RG+ YLH IIHRD+KS+NI L E+ + DFGLA +H ++G+
Sbjct: 131 RGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 481 YLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRP-TDPTFVKRGLNVVGWMNTLLKE 536
++APE ++ S + +SDVY+FG++L EL+TG+ P ++ + + +VG +
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247
Query: 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+++ K + + A C D+RPS ++L +E+
Sbjct: 248 SKVRSNCPK-----------RMKRLMAECLKKKRDERPSFPRILAEIEE 285
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 5e-61
Identities = 66/299 (22%), Positives = 123/299 (41%), Gaps = 44/299 (14%)
Query: 304 CEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQV--FERELEIL 361
+I E L+ +++G G FG VY + G A++ ID R+ DQ+ F+RE+
Sbjct: 28 WDI--PFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAY 83
Query: 362 GSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA 421
+H N+V G C P +I +L + + +L+ + +IA
Sbjct: 84 RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI---VLDVNKTRQIAQEIV 140
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL----LVDEEAHVTTVVAG 477
+G+ YLH I+H+D+KS N+ D + ++DFGL + + G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 478 TFGYLAPEYLQSGRA---------TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNV-- 526
+LAPE ++ ++ SDV++ G + EL + P F +
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP----F--KTQPAEA 250
Query: 527 VGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ W + ++ + I +I C ++RP+ +++ +LE+
Sbjct: 251 IIWQ---MGTGMKPNLSQIGMG-------KEISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 4e-60
Identities = 70/316 (22%), Positives = 120/316 (37%), Gaps = 41/316 (12%)
Query: 298 DMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERE 357
+P I + + +G G +G V+ AVK + E + E E
Sbjct: 26 GLPLLVQRTI--AKQIQMVKQIGKGRYGEVWMGKWRGE-KVAVKVF-FTTEEASWFRETE 81
Query: 358 LEILGSIKHINLVNLRGYCRLPATK----LLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR 413
+ ++H N++ LI DY GSL D+L L+ +
Sbjct: 82 IYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSM 136
Query: 414 LKIALGSARGLAYLH-----HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468
LK+A S GL +LH P I HRD+KS NIL+ +N ++D GLA + +
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 469 AHV---TTVVAGTFGYLAPE------YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTF 519
V GT Y+ PE ++ +D+YSFG++L E+
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256
Query: 520 VKRGLNVVGWMNTLLKENRLEDVIDKRCAD----------ADMETVEAILEIAARCTDAN 569
+ + + + + + ED+ + C + E + + ++ C N
Sbjct: 257 EYQ----LPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312
Query: 570 PDDRPSMNQVLQLLEQ 585
P R + +V + L +
Sbjct: 313 PASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 5e-59
Identities = 75/307 (24%), Positives = 122/307 (39%), Gaps = 51/307 (16%)
Query: 313 LDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNL 372
+ + VG G +G V+R AVK SR+ E EL ++H N++
Sbjct: 10 ITLLECVGKGRYGEVWRGSWQGE-NVAVKIF-SSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 373 RGYCRLPATK----LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH 428
LI Y MGSL D+L L+ + L+I L A GLA+LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLSIASGLAHLH 122
Query: 429 HD-----CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV---TTVVAGTFG 480
+ P I HRD+KS NIL+ +N + ++D GLA + + GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 481 YLAPE------YLQSGRATEKSDVYSFGVLLLELVTGKR----------------PTDPT 518
Y+APE + + ++ D+++FG++L E+ P DP+
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 519 FVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQ 578
F V + + R I R T+ ++ ++ C NP R + +
Sbjct: 243 FEDMRKVVC------VDQQRPN--IPNRWFSD--PTLTSLAKLMKECWYQNPSARLTALR 292
Query: 579 VLQLLEQ 585
+ + L +
Sbjct: 293 IKKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-57
Identities = 74/313 (23%), Positives = 130/313 (41%), Gaps = 37/313 (11%)
Query: 299 MPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFEREL 358
+P I + + ++ +G G FG V+R AVK SRE E E+
Sbjct: 32 LPLLVQRTIART--IVLQESIGKGRFGEVWRGKWRGE-EVAVKIF-SSREERSWFREAEI 87
Query: 359 EILGSIKHINLVNLRGYC---RLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARL 414
++H N++ T+L L+ DY GSL D+L+ + + +
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMI 142
Query: 415 KIALGSARGLAYLHHD-----CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469
K+AL +A GLA+LH + P I HRD+KS NIL+ +N ++D GLA
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202
Query: 470 HVTTV---VAGTFGYLAPEYL------QSGRATEKSDVYSFGVLLLELVTGKRPTD--PT 518
+ GT Y+APE L + + +++D+Y+ G++ E+
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
Query: 519 FVKRGLNVVGWMNTLLKENRLEDVIDKRC------ADADMETVEAILEIAARCTDANPDD 572
+ ++V ++ E + V +++ E + + +I C AN
Sbjct: 263 YQLPYYDLVPSDPSV--EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 320
Query: 573 RPSMNQVLQLLEQ 585
R + ++ + L Q
Sbjct: 321 RLTALRIKKTLSQ 333
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 2e-51
Identities = 53/168 (31%), Positives = 77/168 (45%), Gaps = 6/168 (3%)
Query: 28 EDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCH--THDQRVRSINLPYMQLGG- 84
+D LL+IK L + L T+ W G+ C T RV +++L + L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 85 -IISPSIGRLDKLQRLALH-QNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLL 142
I S+ L L L + N+L G IP I T+L LY+ + G IP + +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 143 FLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALS 189
L LD S N+L G +P S+ L +L + N SG IPD +G+ S
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFS 173
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 41/133 (30%), Positives = 60/133 (45%), Gaps = 2/133 (1%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
S+ + +L G I P+ L L + L +N L G + + ++L N L
Sbjct: 176 FTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF 191
+ +G L LDL +N + G +P L +L LH LN+S N GEIP G L F
Sbjct: 235 FDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRF 293
Query: 192 GNKSFIGNLDLCG 204
++ N LCG
Sbjct: 294 DVSAYANNKCLCG 306
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 7e-45
Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 13/192 (6%)
Query: 17 TLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSIN 76
+ +S +L + L+ K L D NLL +W + + +PC + G++C +V SI+
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDK-NLLPDWSSNK-NPCTFDGVTCRD--DKVTSID 56
Query: 77 LPYMQL---GGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGG 133
L L +S S+ L L+ L L + ++GS+ L +L L N L G
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGP 115
Query: 134 IPA--NIGNLLFLTILDLSSNSLKGAIPSSLG-RLTHLHYLNLSTNFFSGEIPDFGALSA 190
+ ++G+ L L++SSN+L S G +L L L+LS N SG
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVV--GWVL 173
Query: 191 FGNKSFIGNLDL 202
+ +L +
Sbjct: 174 SDGCGELKHLAI 185
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-40
Identities = 51/143 (35%), Positives = 69/143 (48%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
N+ GG SP+ + L + N L G IP EI + L L L N +
Sbjct: 610 RNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDIS 669
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF 191
G IP +G+L L ILDLSSN L G IP ++ LT L ++LS N SG IP+ G F
Sbjct: 670 GSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETF 729
Query: 192 GNKSFIGNLDLCGRQVHKPCRTS 214
F+ N LCG + + ++
Sbjct: 730 PPAKFLNNPGLCGYPLPRCDPSN 752
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-33
Identities = 52/130 (40%), Positives = 67/130 (51%), Gaps = 5/130 (3%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
S++L + L G I S+G L KL+ L L N L G IP E+ L L L N L G
Sbjct: 421 VSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTG 480
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFG 192
IP+ + N L + LS+N L G IP +GRL +L L LS N FSG IP + G
Sbjct: 481 EIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP-----AELG 535
Query: 193 NKSFIGNLDL 202
+ + LDL
Sbjct: 536 DCRSLIWLDL 545
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-32
Identities = 47/116 (40%), Positives = 62/116 (53%), Gaps = 5/116 (4%)
Query: 81 QLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGN 140
L G I + + L+ L L N L G IP+ ++NCT L + L N L G IP IG
Sbjct: 453 MLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512
Query: 141 LLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSF 196
L L IL LS+NS G IP+ LG L +L+L+TN F+G IP +A +S
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP-----AAMFKQSG 563
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-31
Identities = 42/122 (34%), Positives = 62/122 (50%), Gaps = 5/122 (4%)
Query: 81 QLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGN 140
G I P++ +L L L N L G+IP+ + + ++LR L L N L+G IP +
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 141 LLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200
+ L L L N L G IPS L T+L++++LS N +GEIP + G + L
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW-----IGRLENLAIL 519
Query: 201 DL 202
L
Sbjct: 520 KL 521
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-31
Identities = 46/132 (34%), Positives = 68/132 (51%), Gaps = 7/132 (5%)
Query: 73 RSINLPYMQLGGIISPSIGR--LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYL 130
+++L G I P++ + + LQ L L N G IP ++NC+EL +L+L NYL
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 131 QGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
G IP+++G+L L L L N L+G IP L + L L L N +GEIP S
Sbjct: 431 SGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIP-----SG 485
Query: 191 FGNKSFIGNLDL 202
N + + + L
Sbjct: 486 LSNCTNLNWISL 497
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-29
Identities = 40/134 (29%), Positives = 61/134 (45%), Gaps = 9/134 (6%)
Query: 73 RSINLPYMQLGGIISP-SIGRLDKLQRLALHQNSLHGSIPNEITNCT-ELRALYLRANYL 130
S+ L G + ++ ++ L+ L L N G +P +TN + L L L +N
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 131 QGGIPANIGNLLF--LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
G I N+ L L L +N G IP +L + L L+LS N+ SG IP
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP----- 435
Query: 189 SAFGNKSFIGNLDL 202
S+ G+ S + +L L
Sbjct: 436 SSLGSLSKLRDLKL 449
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-29
Identities = 42/131 (32%), Positives = 59/131 (45%), Gaps = 7/131 (5%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ +++ +L G S +I +L+ L + N G IP L+ L L N G
Sbjct: 226 QHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTG 283
Query: 133 GIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF 191
IP + G LT LDLS N GA+P G + L L LS+N FSGE+P +
Sbjct: 284 EIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP----MDTL 339
Query: 192 GNKSFIGNLDL 202
+ LDL
Sbjct: 340 LKMRGLKVLDL 350
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-29
Identities = 37/143 (25%), Positives = 56/143 (39%), Gaps = 18/143 (12%)
Query: 73 RSINLPYMQLGGIISPSI---GRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
++L + G +L+ LA+ N + G + ++ C L L + +N
Sbjct: 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNN 211
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFG--- 186
GIP +G+ L LD+S N L G ++ T L LN+S+N F G IP
Sbjct: 212 FSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKS 270
Query: 187 --ALSAFGNK-------SFIGNL 200
LS NK G
Sbjct: 271 LQYLSLAENKFTGEIPDFLSGAC 293
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 28/124 (22%), Positives = 42/124 (33%), Gaps = 7/124 (5%)
Query: 81 QLGGIISPSIGRLDKLQRLALHQN--SLHGSIPNEITNCTELRALYLRANYLQGGIPANI 138
+ G I + N G ++ + + + G
Sbjct: 569 FIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTF 628
Query: 139 GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIG 198
N + LD+S N L G IP +G + +L LNL N SG IP G+ +
Sbjct: 629 DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP-----DEVGDLRGLN 683
Query: 199 NLDL 202
LDL
Sbjct: 684 ILDL 687
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-28
Identities = 32/122 (26%), Positives = 49/122 (40%), Gaps = 9/122 (7%)
Query: 81 QLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGN 140
L G I + L ++L N L G IP I L L L N G IPA +G+
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 141 LLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200
L LDL++N G IP+++ + + ++ NF +G+ + N
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVY-----IKNDGMKKEC 587
Query: 201 DL 202
Sbjct: 588 HG 589
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 31/124 (25%), Positives = 46/124 (37%), Gaps = 11/124 (8%)
Query: 81 QLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGN 140
+L G I IGRL+ L L L NS G+IP E+ +C L L L N G IPA +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560
Query: 141 LLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNF--FSGEIPDFGALSAFGNKSFIG 198
+++N + G + + + N F G S
Sbjct: 561 QS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS-----EQLNRLSTRN 611
Query: 199 NLDL 202
++
Sbjct: 612 PCNI 615
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-40
Identities = 80/307 (26%), Positives = 131/307 (42%), Gaps = 47/307 (15%)
Query: 309 KLEALDEEDVV-----GSGGFGTVYRMVMNDCGTF-----AVKRI-DRSREGSDQVFERE 357
L L E + GSG FGTVY+ + G A+K + + + +++ E
Sbjct: 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 358 LEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARL 414
++ S+ + ++ L G C L +T LI + G L D++ EH + Q LLNW
Sbjct: 68 AYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 122
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
+ A+G+ YL +HRD+ + N+L+ ++DFGLAKLL EE
Sbjct: 123 --CVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA- 176
Query: 475 VAGT---FGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWM 530
G ++A E + T +SDV+S+GV + EL+T G +P D G+
Sbjct: 177 -EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------GIPASEIS 229
Query: 531 NTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
+ L K RL + I +C + D RP +++ + M+
Sbjct: 230 SILEKGERLP---------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK--MAR 278
Query: 591 CPSDFYE 597
P +
Sbjct: 279 DPQRYLV 285
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 8e-40
Identities = 71/282 (25%), Positives = 109/282 (38%), Gaps = 41/282 (14%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQV----FERELEILGSIKHINLV 370
+ +G G FG V+ + T AVK RE F +E IL H N+V
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILKQYSHPNIV 175
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
L G C ++ + + G FL G L L++ +A G+ YL
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY--LAPEYLQ 488
CC IHRD+ + N L+ E +SDFG+++ D + + APE L
Sbjct: 233 CC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKWTAPEALN 288
Query: 489 SGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547
GR + +SDV+SFG+LL E + G P N + +
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYP-----------NLSN--------QQTREFVE 329
Query: 548 ADADME----TVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ +A+ + +C P RPS + + Q L+
Sbjct: 330 KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS 371
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 62/274 (22%), Positives = 109/274 (39%), Gaps = 32/274 (11%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQV--FERELEILGSIKHINLVNLR 373
+G G F TVY+ + + A + + + F+ E E+L ++H N+V
Sbjct: 32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91
Query: 374 GYCRLPATK---LLIY-DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429
+++ + ++ G+L +L + +GL +LH
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH- 146
Query: 430 DCCPKIIHRDIKSSNILLD-ENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
P IIHRD+K NI + + D GLA L + V+ GT ++APE +
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVI-GTPEFMAPEMYE 203
Query: 489 SGRATEKSDVYSFGVLLLELVTGKRP-TDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547
E DVY+FG+ +LE+ T + P ++ + V + +K + V
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---TSGVKPASFDKVAIPEV 259
Query: 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ I+E C N D+R S+ +L
Sbjct: 260 KE--------IIE---GCIRQNKDERYSIKDLLN 282
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-39
Identities = 82/309 (26%), Positives = 132/309 (42%), Gaps = 41/309 (13%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF-----AVKRIDRSREGSDQVFERELEILGSIKHINLV 370
+G G FG+V + G AVK++ S + F+RE++IL ++ +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 371 NLRGYCRLPATK--LLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALGSARGLA 425
RG P + L+ +YL G L DFL H +LL + + +G+
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQICKGME 141
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF--GYLA 483
YL C +HRD+ + NIL++ ++DFGLAKLL ++ + G + A
Sbjct: 142 YLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPT--FVKRGLNVVGWMN-----TLLK 535
PE L + +SDV+SFGV+L EL T + P+ F++ LL+
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258
Query: 536 EN-RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ--EVMSPCP 592
E RL A + E+ C +P DRPS + + L+ C
Sbjct: 259 EGQRLP---------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCE 309
Query: 593 SDFYESHSD 601
+ + +H +
Sbjct: 310 THAFTAHPE 318
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-38
Identities = 77/276 (27%), Positives = 118/276 (42%), Gaps = 31/276 (11%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFERELEILGSIKHINLVNLRG 374
+ +G G +G VY V AVK + + + F +E ++ IKH NLV L G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
C +I ++++ G+L D+L E Q ++ L +A + + YL
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKKNF-- 339
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATE 494
IHR++ + N L+ EN V+DFGL++L+ + + APE L + +
Sbjct: 340 -IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 495 KSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADME 553
KSDV++FGVLL E+ T G P G V + D ME
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYP-----------GIDL--------SQVYELLEKDYRME 439
Query: 554 ----TVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
E + E+ C NP DRPS ++ Q E
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-38
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 40/297 (13%)
Query: 311 EALDEEDVVGSGGFGTVYR----MVMNDCGTF-AVKRI-DRSREGSDQVFERELEILGSI 364
L +G G FG V ++ G AVK + S ++E+EIL ++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 365 KHINLVNLRGYCRLPATK--LLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALG 419
H N+V +G C LI ++L GSL ++L ++ +Q L + A+
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY------AVQ 134
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF 479
+G+ YL + +HRD+ + N+L++ + + DFGL K + ++ + T
Sbjct: 135 ICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
Query: 480 --GYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVV---GWMNT- 532
+ APE L + SDV+SFGV L EL+T + P + + T
Sbjct: 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251
Query: 533 ---LLKEN-RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
LKE RL + + ++ +C + P +R S +++ E
Sbjct: 252 LVNTLKEGKRLP---------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 87/292 (29%), Positives = 130/292 (44%), Gaps = 40/292 (13%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF-----AVKRIDRSREGSDQVFERELEILGSIKHINLV 370
+G G FG+V + AVK++ S E + FERE+EIL S++H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 371 NLRGYCRLPATK--LLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALGSARGLA 425
+G C + LI +YL GSL D+L +H E +LL +++++ +G+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGME 128
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF--GYLA 483
YL IHRD+ + NIL++ + DFGL K+L ++ G + A
Sbjct: 129 YLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVT----GKRPTDPTFVKRGLNVVGWMN-----TLL 534
PE L + + SDV+SFGV+L EL T K P G + G M LL
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
Query: 535 KEN-RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
K N RL + I I C + N + RPS + ++Q
Sbjct: 246 KNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 288
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 70/311 (22%), Positives = 133/311 (42%), Gaps = 65/311 (20%)
Query: 314 DEEDVVGSGGFGTVYRMV-MNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNL 372
E +++GSGGFG V++ D T+ +KR+ + E + ERE++ L + H+N+V+
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVHY 69
Query: 373 RGY---------------CRLPATKLLIY-DYLSMGSLDDFLHEHGEG----QQLLNWSA 412
G R L I ++ G+L+ ++ + L
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFE 129
Query: 413 RLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472
++ +G+ Y+H K+I+RD+K SNI L + + + DFGL L ++
Sbjct: 130 QI------TKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 473 TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP---TDPTFVKRGLNVVGW 529
+ GT Y++PE + S ++ D+Y+ G++L EL+ T F
Sbjct: 181 SK--GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD-------- 230
Query: 530 MNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589
L++ + D+ DK+ + + P+DRP+ +++L+ L +
Sbjct: 231 ----LRDGIISDIFDKKEKT-----------LLQKLLSKKPEDRPNTSEILRTLT---VW 272
Query: 590 PCPSDFYESHS 600
+ E H+
Sbjct: 273 KKSPEKNERHT 283
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 89/359 (24%), Positives = 144/359 (40%), Gaps = 46/359 (12%)
Query: 264 ICLLSKKERAVKRYTEVRKQVDQETSTKLITFHGDMPY-----PSCEIIEKLEALDEEDV 318
IC + + ++ + Q +T I P I + +V
Sbjct: 37 ICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEV 96
Query: 319 VGSGGFGTVYRMVMNDCG----TFAVKRIDRSREGSDQV-FERELEILGSIKHINLVNLR 373
+G G FG VY + D AVK ++R + + F E I+ H N+++L
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 374 GYCRLPATKLL-IYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALGSARGLAYLHH 429
G C L + Y+ G L +F+ + L+ L A+G+ +L
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI------GFGLQVAKGMKFLAS 210
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL-----AP 484
K +HRD+ + N +LDE V+DFGLA+ + D+E +V T L A
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD--SVHNKTGAKLPVKWMAL 265
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543
E LQ+ + T KSDV+SFGVLL EL+T G P +N LL+ RL
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNTFDITVYLLQGRRLLQPE 319
Query: 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHSDY 602
C D + E+ +C + RPS ++++ + + + ++ Y
Sbjct: 320 Y--CPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATY 369
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 56/289 (19%), Positives = 113/289 (39%), Gaps = 24/289 (8%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSD---QVFERELEILGSIKHINLVNL 372
+G G F VYR G A+K++ +E+++L + H N++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 373 RGYCRLPATKLLIY-DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC 431
+ +L I + G L + + ++L+ K + L ++H
Sbjct: 98 YASF-IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR 491
+++HRDIK +N+ + + D GL + + ++V GT Y++PE +
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENG 212
Query: 492 ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551
KSD++S G LL E+ + P F +N+ + + + + +
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQSP----FYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEE 266
Query: 552 METVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHS 600
+ ++ C + +P+ RP + V + + M C + E H
Sbjct: 267 LR------QLVNMCINPDPEKRPDVTYVYDV--AKRMHACTASSLEHHH 307
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 78/298 (26%), Positives = 127/298 (42%), Gaps = 41/298 (13%)
Query: 309 KLEALDEEDVV-----GSGGFGTVYRMVMNDCG-----TFAVKRI-DRSREGSDQVFERE 357
L L E + GSG FGTVY+ + G A+K + + + +++ E
Sbjct: 8 LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 67
Query: 358 LEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARL 414
++ S+ + ++ L G C L +T LI + G L D++ EH + Q LLNW
Sbjct: 68 AYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW---- 122
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
+ A+G+ YL +HRD+ + N+L+ ++DFGLAKLL EE
Sbjct: 123 --CVQIAKGMNYLEDRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 475 VAGT-FGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNT 532
++A E + T +SDV+S+GV + EL+T G +P D G+ +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD------GIPASEISSI 231
Query: 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
L K RL + I +C + D RP +++ + P
Sbjct: 232 LEKGERLP---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-38
Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 29/283 (10%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
E +G G FG V+ N A+K + + S + F +E +++ ++H LV L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 376 CRLPATK---LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
++ ++ +Y+S GSL DFL + L + +A A G+AY+
Sbjct: 248 V----SEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMNY 301
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
+HRD++++NIL+ ENL V+DFGLA+L+ D E + APE GR
Sbjct: 302 ---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 493 TEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551
T KSDV+SFG+LL EL T G+ P G+ ++ + + R+
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLDQVERGYRMP---------CP 403
Query: 552 METVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSD 594
E E++ ++ +C P++RP+ + LE S P
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 446
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 47/307 (15%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---RELEILGSI 364
K + ++ +G+G G V+++ G A K I E + REL++L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHEC 88
Query: 365 KHINLVNLRGYCRLPATKLLIY-DYLSMGSLDDFLHEHGE-GQQLLNWSARLKIALGSAR 422
+V G ++ I +++ GSLD L + G +Q+L K+++ +
Sbjct: 89 NSPYIVGFYG-AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIK 142
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
GL YL KI+HRD+K SNIL++ E + DFG++ L+D A+ + V GT Y+
Sbjct: 143 GLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYM 197
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRP----TDPTFVKRGLNVVGWMNTLLKENR 538
+PE LQ + +SD++S G+ L+E+ G+ P V
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 539 LEDVIDKRCADADMETVEAILEIA------------------------ARCTDANPDDRP 574
D AI E+ +C NP +R
Sbjct: 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317
Query: 575 SMNQVLQ 581
+ Q++
Sbjct: 318 DLKQLMV 324
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 88/292 (30%), Positives = 132/292 (45%), Gaps = 40/292 (13%)
Query: 316 EDVVGSGGFGTVYR-----MVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLV 370
+G G FG+V + N AVK++ S E + FERE+EIL S++H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 371 NLRGYCRLPATK--LLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALGSARGLA 425
+G C + LI +YL GSL D+L +H E +LL +++++ +G+
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQI------CKGME 159
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF--GYLA 483
YL IHRD+ + NIL++ + DFGL K+L ++ + G + A
Sbjct: 160 YLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVT----GKRPTDPTFVKRGLNVVGWMN-----TLL 534
PE L + + SDV+SFGV+L EL T K P G + G M LL
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
Query: 535 KEN-RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
K N RL + I I C + N + RPS + ++Q
Sbjct: 277 KNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ 319
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-37
Identities = 82/287 (28%), Positives = 131/287 (45%), Gaps = 37/287 (12%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
E +G G FG V+ N A+K + + S + F +E +++ ++H LV L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 376 CRLPATK---LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
++ ++ +Y+S GSL DFL + L + +A A G+AY+
Sbjct: 331 V----SEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERMNY 384
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
+HRD++++NIL+ ENL V+DFGLA+L+ D E + APE GR
Sbjct: 385 ---VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 493 TEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551
T KSDV+SFG+LL EL T G+ P G +N +V+D+
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYP-----------GMVN--------REVLDQVERGYR 482
Query: 552 ME----TVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSD 594
M E++ ++ +C P++RP+ + LE S P
Sbjct: 483 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 529
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-37
Identities = 75/315 (23%), Positives = 128/315 (40%), Gaps = 42/315 (13%)
Query: 292 LITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-----AVKRIDRS 346
+ P + L + +G G FG V + AVK + ++
Sbjct: 14 ALEVLFQGPGDPTVFHK--RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KA 70
Query: 347 REGSDQV--FERELEILGSIKHINLVNLRGYCRLPATK--LLIYDYLSMGSLDDFLHEHG 402
G +++E++IL ++ H +++ +G C L+ +Y+ +GSL D+L H
Sbjct: 71 DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS 130
Query: 403 EG-QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461
G QLL ++ ++ G+AYLH IHRD+ + N+LLD + + DFGLA
Sbjct: 131 IGLAQLLLFAQQI------CEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 181
Query: 462 KLLVDEEAHVTTVVAGTF--GYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPT 518
K + + + G + APE L+ + SDV+SFGV L EL+T P
Sbjct: 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241
Query: 519 FVKRGLNVV---GWMNT----LLKEN-RLEDVIDKRCADADMETVEAILEIAARCTDANP 570
L + LL+ RL +C + + C +
Sbjct: 242 TKFLELIGIAQGQMTVLRLTELLERGERLP--RPDKCPA-------EVYHLMKNCWETEA 292
Query: 571 DDRPSMNQVLQLLEQ 585
RP+ ++ +L+
Sbjct: 293 SFRPTFENLIPILKT 307
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 84/309 (27%), Positives = 132/309 (42%), Gaps = 41/309 (13%)
Query: 302 PSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRSREGSDQV-FER 356
I + +V+G G FG VY + D AVK ++R + + F
Sbjct: 16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT 75
Query: 357 ELEILGSIKHINLVNLRGYC-RLPATKLLIYDYLSMGSLDDFLHEHGEG---QQLLNWSA 412
E I+ H N+++L G C R + L++ Y+ G L +F+ + L+
Sbjct: 76 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI---- 131
Query: 413 RLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472
L A+G+ YL K +HRD+ + N +LDE V+DFGLA+ + D+E
Sbjct: 132 --GFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE--YY 184
Query: 473 TVVAGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNV 526
+V T L A E LQ+ + T KSDV+SFGVLL EL+T G P +N
Sbjct: 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY------PDVNT 238
Query: 527 VGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586
LL+ RL C D + E+ +C + RPS ++++ +
Sbjct: 239 FDITVYLLQGRRLLQPEY--CPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
Query: 587 VMSPCPSDF 595
+ +
Sbjct: 290 FSTFIGEHY 298
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 4e-37
Identities = 85/308 (27%), Positives = 133/308 (43%), Gaps = 42/308 (13%)
Query: 304 CEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRSREGSDQV-FEREL 358
I + + V+G G FG VY D A+K + R E F RE
Sbjct: 14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREG 73
Query: 359 EILGSIKHINLVNLRGYC-RLPATKLLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARL 414
++ + H N++ L G ++ Y+ G L F+ + L+
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI------ 127
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
L ARG+ YL K +HRD+ + N +LDE+ V+DFGLA+ ++D E +V
Sbjct: 128 SFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--YYSV 182
Query: 475 VAGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVG 528
L A E LQ+ R T KSDV+SFGVLL EL+T G P R ++
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY------RHIDPFD 236
Query: 529 WMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588
+ L + RL C D ++ ++ +C +A+P RP+ ++ +E +++
Sbjct: 237 LTHFLAQGRRLPQPEY--CPD-------SLYQVMQQCWEADPAVRPTFRVLVGEVE-QIV 286
Query: 589 SPCPSDFY 596
S D Y
Sbjct: 287 SALLGDHY 294
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 77/288 (26%), Positives = 128/288 (44%), Gaps = 40/288 (13%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF-----AVKRI-DRSREGSDQVFERELEILGSIKHINL 369
V+GSG FGTV++ V G +K I D+S S Q + +GS+ H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALGSARGLAY 426
V L G C ++ L+ YL +GSL D + +H Q LLNW + A+G+ Y
Sbjct: 78 VRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYY 130
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT---FGYLA 483
L +HR++ + N+LL + V+DFG+A LL ++ + + ++A
Sbjct: 131 LEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMA 185
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542
E + G+ T +SDV+S+GV + EL+T G P GL + + L K RL
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA------GLRLAEVPDLLEKGERLA-- 237
Query: 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
+ + +C + + RP+ ++ + P
Sbjct: 238 -------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-37
Identities = 80/292 (27%), Positives = 126/292 (43%), Gaps = 43/292 (14%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
E +G+G FG V+ N AVK + + S + F E ++ +++H LV L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 376 CRLPATK---LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
TK +I ++++ GSL DFL + + A G+A++
Sbjct: 252 V----TKEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY--LAPEYLQSG 490
IHRD++++NIL+ +L ++DFGLA+++ D E T F APE + G
Sbjct: 306 ---IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFG 360
Query: 491 RATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549
T KSDV+SFG+LL+E+VT G+ P G N +VI
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYP-----------GMSN--------PEVIRALERG 401
Query: 550 ADMETVE----AILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYE 597
M E + I RC P++RP+ + +L+ YE
Sbjct: 402 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD--FYTATESQYE 451
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 6e-37
Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 39/284 (13%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLR 373
+GSG FG V+ + A+K I REG S++ F E E++ + H LV L
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLY 69
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
G C A L+ +++ G L D+L L L + L G+AYL C
Sbjct: 70 GVCLEQAPICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACV- 125
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY--LAPEYLQSGR 491
IHRD+ + N L+ EN VSDFG+ + ++D++ T+ F +PE R
Sbjct: 126 --IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSR 181
Query: 492 ATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
+ KSDV+SFGVL+ E+ + GK P + N +V++
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYE-----------NRSN--------SEVVEDISTGF 222
Query: 551 DMET----VEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
+ + +I C P+DRP+ +++L+ L + S
Sbjct: 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG 266
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 139 bits (350), Expect = 2e-36
Identities = 40/355 (11%), Positives = 92/355 (25%), Gaps = 55/355 (15%)
Query: 266 LLSKKERAVKRYTEVRKQ----VDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGS 321
LL ++E + E + + + + + + + S + + L + +
Sbjct: 14 LLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDS-LLSQGERKLKLVEPLRV 72
Query: 322 GGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQV---FERELEILGSIKHINLVNLRGYCR 377
G V+ + + FA+K E S + + R R
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132
Query: 378 LPATK----------------------------LLIYDYLSMGSLDDFLHEHGEGQQLLN 409
L L+ + + L L +
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 410 WSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469
A + R A L ++H N+ + + + D +
Sbjct: 193 ILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW----KVG 245
Query: 470 HVTTVVAGTFGYLAPEYLQSGRA--TEKSDVYSFGVLLLELVTGKRP-TDPTFVKRGLNV 526
+ Y E+L + A T + + G+ + + P T +G
Sbjct: 246 TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS-- 303
Query: 527 VGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
W L+ + + C + + + R + + R + ++
Sbjct: 304 --WKRPSLRVPGTDSLAFGSCTPLP----DFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-36
Identities = 65/274 (23%), Positives = 110/274 (40%), Gaps = 27/274 (9%)
Query: 318 VVGSGGFGTVYRMV-MNDCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRG 374
+G+G +G ++ +D K +D E Q+ E+ +L +KH N+V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 375 -YCRLPATKLLIY-DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH--HD 430
T L I +Y G L + + + +Q L+ L++ L H D
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
++HRD+K +N+ LD + DFGLA++L + + T V GT Y++PE +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN--RLEDVIDKRCA 548
EKSD++S G LL EL P F + + + R+
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPP----F--TAFSQKELAGKIREGKFRRIPYRYSDELN 245
Query: 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582
+ I R + RPS+ ++L+
Sbjct: 246 E-----------IITRMLNLKDYHRPSVEEILEN 268
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-36
Identities = 82/288 (28%), Positives = 126/288 (43%), Gaps = 37/288 (12%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREG--SDQVFERELEILGSIKHINLVNL 372
+ +G G +G VY V AVK + +E + F +E ++ IKH NLV L
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQL 74
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
G C +I ++++ G+L D+L E +Q ++ L +A + + YL
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL-----APEYL 487
IHRD+ + N L+ EN V+DFGL++L+ + A APE L
Sbjct: 133 ---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----YTAHAGAKFPIKWTAPESL 184
Query: 488 QSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546
+ + KSDV++FGVLL E+ T G P G+++ L K+ R+E
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYP------GIDLSQVYELLEKDYRME------ 232
Query: 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSD 594
E + E+ C NP DRPS ++ Q E SD
Sbjct: 233 ---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 277
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 76/279 (27%), Positives = 122/279 (43%), Gaps = 39/279 (13%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLR 373
+GSG FG V AVK I +EG S+ F +E + + + H LV
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFY 69
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
G C ++ +Y+S G L ++L HG + L S L++ G+A+L
Sbjct: 70 GVCSKEYPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQF- 125
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY--LAPEYLQSGR 491
IHRD+ + N L+D +L VSDFG+ + ++D++ + V F APE +
Sbjct: 126 --IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFK 181
Query: 492 ATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
+ KSDV++FG+L+ E+ + GK P D + N +V+ K
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYD-----------LYTN--------SEVVLKVSQGH 222
Query: 551 DMETVE----AILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ I +I C P+ RP+ Q+L +E
Sbjct: 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEP 261
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 70/303 (23%), Positives = 116/303 (38%), Gaps = 42/303 (13%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG----TFAVK--RIDRSREGSDQVFERELEILGSIKHINL 369
++G G FG+V + AVK + D + F RE + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 370 VNLRGYC------RLPATKLLIYDYLSMGSLDDFL--HEHGEGQQLLNWSARLKIALGSA 421
L G ++I ++ G L FL GE L ++ + A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
G+ YL IHRD+ + N +L E++ V+DFGL++ + + + G
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR----QGCASK 200
Query: 482 L-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLK 535
L A E L T SDV++FGV + E++T G+ P G+ N L+
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY------AGIENAEIYNYLIG 254
Query: 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDF 595
NRL+ C + + ++ +C A+P RPS + LE +
Sbjct: 255 GNRLK--QPPECME-------EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305
Query: 596 YES 598
+
Sbjct: 306 SQD 308
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 72/289 (24%), Positives = 121/289 (41%), Gaps = 41/289 (14%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG----TFAVK--RIDRSREGSDQVFERELEILGSIKHINL 369
++G G FG+V + AVK ++D S + + F E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 370 VNLRGYC-----RLPATKLLIYDYLSMGSLDDFL--HEHGEGQQLLNWSARLKIALGSAR 422
+ L G C + ++I ++ G L +L G + + LK + A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
G+ YL + +HRD+ + N +L +++ V+DFGL+K + + + G +
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR----QGRIAKM 211
Query: 483 -----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKE 536
A E L T KSDV++FGV + E+ T G P G+ + LL
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY------PGVQNHEMYDYLLHG 265
Query: 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+RL+ D C D + EI C +P DRP+ + + LE+
Sbjct: 266 HRLKQPED--CLD-------ELYEIMYSCWRTDPLDRPTFSVLRLQLEK 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 7e-36
Identities = 66/294 (22%), Positives = 115/294 (39%), Gaps = 33/294 (11%)
Query: 316 EDVVGSGGFGTVYRMV-MNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRG 374
+G GGF V + ++D +A+KRI + + +RE ++ H N++ L
Sbjct: 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 375 YCRLPATK----LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
YC L+ + G+L + + + L L + LG RGL +H
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA--------GTFGYL 482
HRD+K +NILL + +P + D G + T Y
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 483 APEYLQSGR---ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539
APE E++DV+S G +L ++ G+ P + + G L +N+L
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----Y--DMVFQKGDSVALAVQNQL 264
Query: 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPS 593
R + A + + +++ + +P RP + +L LE + P P
Sbjct: 265 SIPQSPRHSSALWQLLNSMMTV-------DPHQRPHIPLLLSQLE-ALQPPAPG 310
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-36
Identities = 83/296 (28%), Positives = 129/296 (43%), Gaps = 47/296 (15%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLR 373
+ +G+G FG V+ N AVK + ++G S F E ++ ++H LV L
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 374 GYCRLPATK---LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
T+ +I +Y+ GSL DFL + L + L +A A G+A++
Sbjct: 75 AVV----TQEPIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER 128
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY--LAPEYLQ 488
IHRD++++NIL+ + L ++DFGLA+L+ D E T F APE +
Sbjct: 129 ---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPEAIN 183
Query: 489 SGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547
G T KSDV+SFG+LL E+VT G+ P G N +VI
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYP-----------GMTN--------PEVIQNLE 224
Query: 548 ADADMET----VEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESH 599
M E + ++ C P+DRP+ + + +LE Y+
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED--FFTATEGQYQPQ 278
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-35
Identities = 74/295 (25%), Positives = 121/295 (41%), Gaps = 44/295 (14%)
Query: 303 SCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEIL- 361
S I+ K+ +DV+G G GT+ M D AVKRI +RE+++L
Sbjct: 17 SVVIVGKIS-FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLR 72
Query: 362 GSIKHINLVNLRGYCRLPATKLLIYDYLSM----GSLDDFLHEHGEGQQLLNWSARLKIA 417
S +H N++ + + Y+++ +L +++ + L L+
Sbjct: 73 ESDEHPNVIRYFCTEKDRQ-----FQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQT 127
Query: 418 LGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-----NLEPHVSDFGLAKLLVDEEA--H 470
GLA+LH I+HRD+K NIL+ ++ +SDFGL K L
Sbjct: 128 T---SGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181
Query: 471 VTTVVAGTFGYLAPEYLQS---GRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNV 526
+ V GT G++APE L T D++S G + +++ G P + ++
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ---- 237
Query: 527 VGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
N LL L+ + E V A I + +P RPS VL+
Sbjct: 238 ---ANILLGACSLDCL-----HPEKHEDVIARELIE-KMIAMDPQKRPSAKHVLK 283
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 68/275 (24%), Positives = 115/275 (41%), Gaps = 38/275 (13%)
Query: 317 DVVGSGGFGTVYRMV-MNDCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLR 373
+G G FG + D + +K I+ SR + RE+ +L ++KH N+V R
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 374 GYCRLPATKLLIY-DYLSMGSLDDFLHEHGEG----QQLLNWSARLKIALGSARGLAYLH 428
L I DY G L ++ Q+L+W ++ L ++H
Sbjct: 90 ESF-EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI------CLALKHVH 142
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
KI+HRDIKS NI L ++ + DFG+A++L + GT YL+PE +
Sbjct: 143 D---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
Query: 489 SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN--RLEDVIDKR 546
+ KSD+++ G +L EL T K F ++ + ++ + +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA----F--EAGSMKNLVLKIISGSFPPVSLHYSYD 252
Query: 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ ++ NP DRPS+N +L+
Sbjct: 253 LRS-----------LVSQLFKRNPRDRPSVNSILE 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 5e-35
Identities = 61/293 (20%), Positives = 113/293 (38%), Gaps = 46/293 (15%)
Query: 314 DEEDVVGSGGFGTVYRMV-MNDCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVN 371
+ +G GGFG V+ D +A+KRI E + + RE++ L ++H +V
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 67
Query: 372 LRG-------YCRLPATKLLIYDYLSM-----GSLDDFLHEHGEGQQLLNWSARLKIALG 419
+L + +Y Y+ M +L D+++ + S L I L
Sbjct: 68 YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR-CTIEERERSVCLHIFLQ 126
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA--- 476
A + +LH ++HRD+K SNI + V DFGL + +E T +
Sbjct: 127 IAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 477 --------GTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVG 528
GT Y++PE + + K D++S G++L EL+ P +
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFSTQMERVRT- 236
Query: 529 WMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
T ++ + + ++ + +P +RP +++
Sbjct: 237 --LTDVRNLKFPPLFTQKYPCEY--------VMVQDMLSPSPMERPEAINIIE 279
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 63/316 (19%), Positives = 119/316 (37%), Gaps = 54/316 (17%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF---AVKRI-DRSREGSDQVFERELEI 360
+ + + +G G FG+V + V A+K + + + + RE +I
Sbjct: 5 FLKRDNLLI-ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQI 63
Query: 361 LGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS 420
+ + + +V L G C +L+ + G L FL E + S ++
Sbjct: 64 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQV 119
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF- 479
+ G+ YL +HRD+ + N+LL +SDFGL+K L ++++ T AG +
Sbjct: 120 SMGMKYLEEKNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176
Query: 480 -GYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKEN 537
+ APE + + + +SDV+S+GV + E ++ G++P
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-----------KMKGP----- 220
Query: 538 RLEDVIDK-----------RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586
+V+ C + + + C +DRP V Q +
Sbjct: 221 ---EVMAFIEQGKRMECPPECPP-------ELYALMSDCWIYKWEDRPDFLTVEQRMRA- 269
Query: 587 VMSPCPSDFYESHSDY 602
+ E H +
Sbjct: 270 -CYYSLASKVEGHHHH 284
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-35
Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 45/280 (16%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRG 374
+G G FG V AVK I + + Q F E ++ ++H NLV L G
Sbjct: 198 LQTIGKGEFGDVMLGDYRGN-KVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 375 YCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
L ++ +Y++ GSL D+L G +L LK +L + YL +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGNNF- 310
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT-FGY--LAPEYLQSG 490
+HRD+ + N+L+ E+ VSDFGL K ++ APE L+
Sbjct: 311 --VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 361
Query: 491 RATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549
+ + KSDV+SFG+LL E+ + G+ P +DV+ +
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPYP-----------RIPL--------KDVVPRVEKG 402
Query: 550 ADME----TVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
M+ A+ ++ C + RP+ Q+ + LE
Sbjct: 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 39/279 (13%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLR 373
+G+G FG V A+K I +EGS + F E +++ ++ H LV L
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLY 85
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
G C +I +Y++ G L ++L E L++ + YL
Sbjct: 86 GVCTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQF- 141
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY--LAPEYLQSGR 491
+HRD+ + N L+++ VSDFGL++ ++D+E T+ V F PE L +
Sbjct: 142 --LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSK 197
Query: 492 ATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
+ KSD+++FGVL+ E+ + GK P + + N + +
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYE-----------RFTN--------SETAEHIAQGL 238
Query: 551 DMETVE----AILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ + I C D+RP+ +L +
Sbjct: 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 277
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 61/284 (21%), Positives = 112/284 (39%), Gaps = 41/284 (14%)
Query: 315 EEDVVGSGGFGTVYRMVMNDCGTF---AVK--RIDRSREGSDQVFERELEILGSIKHINL 369
E+ +GSG FGTV + AVK + + + E ++ + + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 370 VNLRGYCRLPATK---LLIYDYLSMGSLDDFLHEHGE--GQQLLNWSARLKIALGSARGL 424
V + G C +L+ + +G L+ +L ++ + ++ + G+
Sbjct: 81 VRMIGIC----EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGM 130
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF--GYL 482
YL +HRD+ + N+LL +SDFGL+K L +E + G + +
Sbjct: 131 KYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 187
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541
APE + + + KSDV+SFGVL+ E + G++P G+ L K R+
Sbjct: 188 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR------GMKGSEVTAMLEKGERMG- 240
Query: 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ ++ C + ++RP V L
Sbjct: 241 --------CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-35
Identities = 75/298 (25%), Positives = 130/298 (43%), Gaps = 58/298 (19%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF-----AVKRIDRSREGSDQV----FERELEILGSIKH 366
+ V+G+G FG VY+ ++ A+K + + G + F E I+G H
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
N++ L G ++I +Y+ G+LD FL E +G+ + + + G A G+ Y
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGE--FSVLQLVGMLRGIAAGMKY 162
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY--LAP 484
L + +HRD+ + NIL++ NL VSDFGL+++L D+ T G AP
Sbjct: 163 LANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543
E + + T SDV+SFG+++ E++T G+RP N +V+
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-----------ELSN--------HEVM 260
Query: 544 DK-----------RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
C AI ++ +C RP ++ +L++ + +P
Sbjct: 261 KAINDGFRLPTPMDCPS-------AIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 7e-35
Identities = 71/307 (23%), Positives = 114/307 (37%), Gaps = 63/307 (20%)
Query: 304 CEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF----AVKRI---DRSREGSDQVFER 356
C I + L + +G G FG V R + AVK + S+ + F R
Sbjct: 13 CLI--GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 357 ELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG---QQLLNWSAR 413
E+ + S+ H NL+ L G L ++ + +GSL D L +H L ++ +
Sbjct: 71 EVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 414 LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT 473
+ A G+ YL IHRD+ + N+LL + DFGL + L + H
Sbjct: 130 V------AEGMGYLESKRF---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 474 VVAGTFGY--LAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWM 530
+ APE L++ + SD + FGV L E+ T G+ P G
Sbjct: 181 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----------GLN 229
Query: 531 NTLLKENRLEDVIDK------------RCADADMETVEAILEIAARCTDANPDDRPSMNQ 578
+ ++ K C I + +C P+DRP+
Sbjct: 230 GS--------QILHKIDKEGERLPRPEDCPQ-------DIYNVMVQCWAHKPEDRPTFVA 274
Query: 579 VLQLLEQ 585
+ L +
Sbjct: 275 LRDFLLE 281
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 76/279 (27%), Positives = 118/279 (42%), Gaps = 43/279 (15%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS-DQVFERELEILGSIKHINLVNLRG 374
+G G FG V AVK I + + Q F E ++ ++H NLV L G
Sbjct: 26 LQTIGKGEFGDVMLGDYRGN-KVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 375 YCRLPATKLLI-YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
L I +Y++ GSL D+L G + +L LK +L + YL +
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY--LAPEYLQSGR 491
+HRD+ + N+L+ E+ VSDFGL K + +T G APE L+ +
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLTK---EAS---STQDTGKLPVKWTAPEALREKK 190
Query: 492 ATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
+ KSDV+SFG+LL E+ + G+ P +DV+ +
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGRVPYP-----------RIPL--------KDVVPRVEKGY 231
Query: 551 DMETVE----AILEIAARCTDANPDDRPSMNQVLQLLEQ 585
M+ + A+ E+ C + RPS Q+ + LE
Sbjct: 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 86/317 (27%), Positives = 134/317 (42%), Gaps = 57/317 (17%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF---AVKRIDRSREGSDQV----FERELEILGSI-KHI 367
+DV+G G FG V + + G A+KR+ +E + + F ELE+L + H
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM---KEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR------------LK 415
N++NL G C L +Y G+L DFL + + ++ L
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
A ARG+ YL + IHRD+ + NIL+ EN ++DFGL++ +E +V
Sbjct: 147 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK-- 198
Query: 476 AGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGW 529
T G L A E L T SDV+S+GVLL E+V+ G P G+
Sbjct: 199 --TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY-C-----GMTCAEL 250
Query: 530 MNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589
L + RLE + + + ++ +C P +RPS Q+L L + +
Sbjct: 251 YEKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301
Query: 590 PCP---SDFYESHSDYC 603
+ YE +
Sbjct: 302 RKTYVNTTLYEKFTYAG 318
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 43/290 (14%)
Query: 316 EDVVGSGGFGTVY----RMVMNDCGTFAVKRIDRSREGSDQV----FERELEILGSIKHI 367
E ++GSG G V R+ A+K + + G + F E I+G H
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL---KAGYTERQRRDFLSEASIMGQFDHP 110
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYL 427
N++ L G +++ +Y+ GSLD FL H +GQ + + G G+ YL
Sbjct: 111 NIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH-DGQ--FTIMQLVGMLRGVGAGMRYL 167
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL--APE 485
+HRD+ + N+L+D NL VSDFGL+++L D+ T G APE
Sbjct: 168 SDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 486 YLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544
+ + SDV+SFGV++ E++ G+RP N DVI
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPYW-----------NMTN--------RDVIS 265
Query: 545 K----RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
A M A+ ++ C + RP +Q++ +L+ + SP
Sbjct: 266 SVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 43/290 (14%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF----AVKRIDRSREGSDQV----FERELEILGSIKHI 367
+ VVG+G FG V + A+K + + G + F E I+G H
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMGQFDHP 106
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYL 427
N++ L G +++ +Y+ GSLD FL +H + Q + + G A G+ YL
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQ--FTVIQLVGMLRGIASGMKYL 163
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL--APE 485
+HRD+ + NIL++ NL VSDFGL ++L D+ T G +PE
Sbjct: 164 SDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPE 220
Query: 486 YLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544
+ + T SDV+S+G++L E+++ G+RP N +DVI
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYW-----------EMSN--------QDVIK 261
Query: 545 K----RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
M+ A+ ++ C + ++RP Q++ +L++ + +P
Sbjct: 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 69/312 (22%), Positives = 113/312 (36%), Gaps = 81/312 (25%)
Query: 314 DEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNL 372
+E V+G G FG V + +A+K+I + E + E+ +L S+ H +V
Sbjct: 9 EEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI-LSEVMLLASLNHQYVVRY 67
Query: 373 RG----------YCRLPATKLLIY---DYLSMGSLDDFLHEHGEG----------QQLLN 409
K ++ +Y G+L D +H +Q+L
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILE 127
Query: 410 WSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL----- 464
L+Y+H IIHRD+K NI +DE+ + DFGLAK +
Sbjct: 128 -------------ALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171
Query: 465 ---------VDEEAHVTTVVAGTFGYLAPEYLQ-SGRATEKSDVYSFGVLLLELVTGKRP 514
++T+ + GT Y+A E L +G EK D+YS G++ E++
Sbjct: 172 ILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230
Query: 515 TDPTFVKRGLNVVGWMNTLLKEN-----RLEDVIDKRCADADMETVEAILEIAARCTDAN 569
G+ V + L + +D K I D +
Sbjct: 231 --------GMERVNILKKLRSVSIEFPPDFDDNKMKVEKK-----------IIRLLIDHD 271
Query: 570 PDDRPSMNQVLQ 581
P+ RP +L
Sbjct: 272 PNKRPGARTLLN 283
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 63/295 (21%), Positives = 101/295 (34%), Gaps = 37/295 (12%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRG 374
D++G G V+R G FA+K + V RE E+L + H N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 375 YCRLPATKL--LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHHDC 431
T+ LI ++ GSL L E L + + + + +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLREN- 131
Query: 432 CPKIIHRDIKSSNILLDENLEPH----VSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
I+HR+IK NI+ + ++DFG A+ L D+E V+ GT YL P+
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDMY 187
Query: 488 QSGRA--------TEKSDVYSFGVLLLELVTGKRPTDPTF-----------VKRGLNVVG 528
+ D++S GV TG P P + G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 529 WMNTLLKENRLEDVIDKRCADADM--ETVEAILEIAARCTDANPDDRPSMNQVLQ 581
EN D + + + A +A+ + +Q
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 57/224 (25%), Positives = 83/224 (37%), Gaps = 53/224 (23%)
Query: 316 EDVVGSGGFGTVY--------RMVMNDCGTFAVKRIDRSREGSDQV----FERELEILGS 363
+VG GG G VY R+V A+K + SD V +RE G
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIV-------ALK-LMSETLSSDPVFRTRMQREARTAGR 90
Query: 364 IKHINLVNLRGYCRLPATKLLIYD--------YLSM-----GSLDDFLHEHGEGQQLLNW 410
++ ++V I+D Y+ M L L G L
Sbjct: 91 LQEPHVVP-------------IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP----LAP 133
Query: 411 SARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470
+ I L H HRD+K NIL+ + ++ DFG+A DE+
Sbjct: 134 PRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190
Query: 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
GT Y+APE AT ++D+Y+ +L E +TG P
Sbjct: 191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 72/327 (22%), Positives = 117/327 (35%), Gaps = 76/327 (23%)
Query: 299 MPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF----AVKRI-DRSREGSDQV 353
M P I E + ++G G FG VY V + AVK + +
Sbjct: 2 MGGPQYGIAR--EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK 59
Query: 354 FERELEILGSIKHINLVNLRGYCRLPATK---LLIYDYLSMGSLDDFLHEHGEG---QQL 407
F E I+ ++ H ++V L G + +I + G L +L + L
Sbjct: 60 FMSEAVIMKNLDHPHIVKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTL 115
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467
+ + +L + +AYL C +HRDI NIL+ + DFGL++ + DE
Sbjct: 116 VLY------SLQICKAMAYLESINC---VHRDIAVRNILVASPECVKLGDFGLSRYIEDE 166
Query: 468 EAHVTTVVAGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVK 521
+ + L +PE + R T SDV+ F V + E+++ GK+P
Sbjct: 167 DY-----YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF----- 216
Query: 522 RGLNVVGWMNTLLKENRLEDVIDK-----------RCADADMETVEAILEIAARCTDANP 570
N +DVI C + + RC D +P
Sbjct: 217 ------WLEN--------KDVIGVLEKGDRLPKPDLCPP-------VLYTLMTRCWDYDP 255
Query: 571 DDRPSMNQVLQLLEQEVMSPCPSDFYE 597
DRP +++ L + D
Sbjct: 256 SDRPRFTELVCSLSD--VYQMEKDIAM 280
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 56/253 (22%), Positives = 100/253 (39%), Gaps = 38/253 (15%)
Query: 278 TEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCG- 336
++++ + + + + E E++ + + VG G FG V+RM G
Sbjct: 25 AKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGF 84
Query: 337 TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY-DYLSMGSLD 395
AVK++ + EL + +V L G + I+ + L GSL
Sbjct: 85 QCAVKKVR-----LEVFRVEELVACAGLSSPRIVPLYG-AVREGPWVNIFMELLEGGSLG 138
Query: 396 DFLHEHG---EGQ------QLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNIL 446
+ + G E + Q L GL YLH +I+H D+K+ N+L
Sbjct: 139 QLIKQMGCLPEDRALYYLGQAL-------------EGLEYLHTR---RILHGDVKADNVL 182
Query: 447 LDEN-LEPHVSDFGLAKLLVDEEAHVTTV----VAGTFGYLAPEYLQSGRATEKSDVYSF 501
L + + DFG A L + + + + GT ++APE + K D++S
Sbjct: 183 LSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSS 242
Query: 502 GVLLLELVTGKRP 514
++L ++ G P
Sbjct: 243 CCMMLHMLNGCHP 255
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 68/300 (22%), Positives = 122/300 (40%), Gaps = 66/300 (22%)
Query: 320 GSGGFGTVYRMVMNDCGTF------AVKRIDRSREGSDQV---FERELEILGSIKHINLV 370
G G FG V+ + AVK + ++ + F+RE E+L +++H ++V
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR------------LKIAL 418
G C +++++Y+ G L+ FL HG +L L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 419 GSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT 478
A G+ YL +HRD+ + N L+ NL + DFG+++ + + + G
Sbjct: 141 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR----VGG 193
Query: 479 FGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRP----TDP---TFVKRGLN 525
L PE + + T +SDV+SFGV+L E+ T GK+P ++ + +G
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG-- 251
Query: 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
LE + C + ++ C P R ++ ++ ++L
Sbjct: 252 -----------RVLE--RPRVCPK-------EVYDVMLGCWQREPQQRLNIKEIYKILHA 291
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 70/296 (23%), Positives = 118/296 (39%), Gaps = 65/296 (21%)
Query: 316 EDVVGSGGFGTVY--------RMVMNDCGTFAVKRIDRSREGSDQV----FERELEILGS 363
D +G GG TVY V A+K + FERE+
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKV-------AIK-AIFIPPREKEETLKRFEREVHNSSQ 67
Query: 364 IKHINLVNLRGYCRLPATKLLIYD--------YLSM-----GSLDDFLHEHGEGQQLLNW 410
+ H N+V+ + D YL M +L +++ HG L+
Sbjct: 68 LSHQNIVS-------------MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSV 110
Query: 411 SARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470
+ G+ + H +I+HRDIK NIL+D N + DFG+AK L +
Sbjct: 111 DTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167
Query: 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWM 530
T V GT Y +PE + E +D+YS G++L E++ G+ P F G V
Sbjct: 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----F--NGETAV--- 218
Query: 531 NTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRP-SMNQVLQLLEQ 585
+ +K ++D + D + +++ + R T+ + +R ++ ++ L
Sbjct: 219 SIAIK--HIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 72/303 (23%), Positives = 123/303 (40%), Gaps = 74/303 (24%)
Query: 316 EDVVGSGGFGTVY--------RMVMNDCGTFAVKRIDRSREGSDQV----FERELEILGS 363
+++G GG V+ R V AVK + R+ D F RE + +
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDV-------AVK-VLRADLARDPSFYLRFRREAQNAAA 68
Query: 364 IKHINLVNLRGYCRLPATKLLIYD------------YLSM-----GSLDDFLHEHGEGQQ 406
+ H +V +YD Y+ M +L D +H G
Sbjct: 69 LNHPAIVA-------------VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--- 112
Query: 407 LLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466
+ +++ + + L + H + IIHRD+K +NI++ V DFG+A+ + D
Sbjct: 113 -MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168
Query: 467 EEAHVTT--VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL 524
VT V GT YL+PE + +SDVYS G +L E++TG+ P F G
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----F--TGD 222
Query: 525 NVVGWMNTLLKENRLEDVIDKRCADADM-ETVEAILEIAARCTDANPDDRP-SMNQVLQL 582
+ V + + R ED I + ++A++ + NP++R + ++
Sbjct: 223 SPV---SVAYQHVR-EDPIPPSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRAD 275
Query: 583 LEQ 585
L +
Sbjct: 276 LVR 278
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 65/301 (21%), Positives = 121/301 (40%), Gaps = 30/301 (9%)
Query: 300 PYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF---AVKRI-DRSREGSDQVFE 355
+ + + +G G FG+V + V A+K + + + +
Sbjct: 326 KDKKLFLKRDNLLIADI-ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMM 384
Query: 356 RELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK 415
RE +I+ + + +V L G C +L+ + G L FL E + S +
Sbjct: 385 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAE 440
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
+ + G+ YL +HR++ + N+LL +SDFGL+K L ++++ T
Sbjct: 441 LLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 497
Query: 476 AGTFGY--LAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNT 532
AG + APE + + + +SDV+S+GV + E ++ G++P + K V M
Sbjct: 498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----YKKMKGPEV--MAF 551
Query: 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCP 592
+ + R+E E + + + C +DRP V Q + S
Sbjct: 552 IEQGKRME---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602
Query: 593 S 593
Sbjct: 603 K 603
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 63/303 (20%), Positives = 106/303 (34%), Gaps = 72/303 (23%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF----AVKRIDRSREGSDQV----FERELEILGSIKHI 367
+G G FG V++ + A+K + + F +E + H
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHP 76
Query: 368 NLVNLRGYCRLPATK---LLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALGSA 421
++V L G T+ +I + ++G L FL L+ + A +
Sbjct: 77 HIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILY------AYQLS 126
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTF-- 479
LAYL +HRDI + N+L+ N + DFGL++ + D G
Sbjct: 127 TALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--YYKASKGKLPI 181
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENR 538
++APE + R T SDV+ FGV + E++ G +P G N
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ-----------GVKN------- 223
Query: 539 LEDVIDK-----------RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587
DVI + C + + +C +P RP ++ L +
Sbjct: 224 -NDVIGRIENGERLPMPPNCPP-------TLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275
Query: 588 MSP 590
Sbjct: 276 EEE 278
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 42/301 (13%)
Query: 318 VVGSGGFGTVYRMVMNDCGTF------AVKRIDRSREGSDQV-FERELEILGSIKHINLV 370
+G G FG VY V A+K ++ + +++ F E ++ ++V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARL------KIALGSARGL 424
L G L+I + ++ G L +L A ++A A G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL-- 482
AYL+ + K +HRD+ + N ++ E+ + DFG+ + + + + + G G L
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLLPV 204
Query: 483 ---APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENR 538
+PE L+ G T SDV+SFGV+L E+ T ++P +GL+ + +++
Sbjct: 205 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY------QGLSNEQVLRFVMEGGL 258
Query: 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPS-DFYE 597
L+ C D + E+ C NP RPS +++ +++E+ FY
Sbjct: 259 LD--KPDNCPD-------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 309
Query: 598 S 598
S
Sbjct: 310 S 310
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-33
Identities = 63/299 (21%), Positives = 101/299 (33%), Gaps = 37/299 (12%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRG 374
D++G G V+R G FA+K + V RE E+L + H N+V L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFA 74
Query: 375 YCRLPATKL--LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHHDC 431
T+ LI ++ GSL L E L + + + + +L +
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG--MNHLREN- 131
Query: 432 CPKIIHRDIKSSNILLDENLEPH----VSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
I+HR+IK NI+ + ++DFG A+ L D+E V+ GT YL P+
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPDMY 187
Query: 488 QSGRA--------TEKSDVYSFGVLLLELVTGKRPTDPTF-----------VKRGLNVVG 528
+ D++S GV TG P P + G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 529 WMNTLLKENRLEDVIDKRCADADM--ETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
EN D + + + A +A+ + +Q
Sbjct: 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 37/216 (17%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
V+G G +G VY A+K I Q E+ + +KH N+V G
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLG- 86
Query: 376 CRLPATKLLIY-DYLSMGSLDDFL-HEHGEGQ-----------QLLNWSARLKIALGSAR 422
+ I+ + + GSL L + G + Q+L
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-------------E 133
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFG 480
GL YLH + +I+HRDIK N+L++ + SDFG +K L T GT
Sbjct: 134 GLKYLHDN---QIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFT-GTLQ 188
Query: 481 YLAPEYLQSGR--ATEKSDVYSFGVLLLELVTGKRP 514
Y+APE + G + +D++S G ++E+ TGK P
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-32
Identities = 66/214 (30%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQ-VFERELEILGSIKHINLVNL- 372
++ +G+GGFG V R + D G A+K+ + ++ + E++I+ + H N+V+
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 373 -----RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAY 426
LL +Y G L +L++ L R ++ + SA L Y
Sbjct: 79 EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRY 136
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPH---VSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
LH + +IIHRD+K NI+L + + D G AK L E V GT YLA
Sbjct: 137 LHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV--GTLQYLA 191
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDP 517
PE L+ + T D +SFG L E +TG RP P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 56/275 (20%), Positives = 90/275 (32%), Gaps = 37/275 (13%)
Query: 314 DEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE--RELEILGSI-KHINL 369
+G G +G V+++ + G +AVKR G E+ + +H
Sbjct: 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALGSARGLAY 426
V L L + L SL G Q+ + LA+
Sbjct: 120 VRLEQ-AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDT------LLALAH 172
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
LH ++H D+K +NI L + DFGL L A G Y+APE
Sbjct: 173 LHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPEL 227
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546
LQ +DV+S G+ +LE+ GW L++ L
Sbjct: 228 LQGS-YGTAADVFSLGLTILEVACNMELPH--------GGEGWQQ--LRQGYLPPEFTAG 276
Query: 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ + + + +P R + +L
Sbjct: 277 LSS-------ELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 68/288 (23%), Positives = 119/288 (41%), Gaps = 41/288 (14%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---RELEI-LGS 363
K + L+ +G G +G V +M G AVKRI + Q + +L+I + +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA--TVNSQEQKRLLMDLDISMRT 62
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARG 423
+ V G + + + SLD F + + Q + KIA+ +
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
L +LH +IHRD+K SN+L++ + + DFG++ LVD+ A G Y+A
Sbjct: 122 LEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMA 177
Query: 484 PE----YLQSGRATEKSDVYSFGVLLLELVTGKRP--TDPTFVKRGLNVVGWMNTLLKEN 537
PE L + KSD++S G+ ++EL + P + T ++ VV + L +
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237
Query: 538 R----LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ D + C N +RP+ +++Q
Sbjct: 238 KFSAEFVDFTSQ-------------------CLKKNSKERPTYPELMQ 266
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-32
Identities = 60/290 (20%), Positives = 108/290 (37%), Gaps = 46/290 (15%)
Query: 316 EDVVGSGGFGTVYR----MVMNDCGTFAVKRIDRSREGSDQV----FERELEILGSIKHI 367
+G G FG V++ N A+K + + F +E + H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHP 451
Query: 368 NLVNLRGYCRLPATK---LLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALGSA 421
++V L G T+ +I + ++G L FL L+ ++ +L +
Sbjct: 452 HIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL------S 501
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
LAYL +HRDI + N+L+ N + DFGL++ + D + + +
Sbjct: 502 TALAYLESKRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 558
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540
+APE + R T SDV+ FGV + E++ G +P G+ + + RL
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ------GVKNNDVIGRIENGERLP 612
Query: 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
+ + +C +P RP ++ L +
Sbjct: 613 ---------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 74/299 (24%), Positives = 124/299 (41%), Gaps = 51/299 (17%)
Query: 318 VVGSGGFGTVYRMVMNDCGTF------AVKRIDRSREGSDQV---FERELEILGSIKHIN 368
+G G FG V+ ++ AVK + +E S+ F+RE E+L ++H +
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTMLQHQH 104
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR-----------LKIA 417
+V G C L++++Y+ G L+ FL HG +LL L +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 418 LGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG 477
A G+ YL +HRD+ + N L+ + L + DFG+++ + + G
Sbjct: 165 SQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVG 217
Query: 478 TFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMN 531
L PE + + T +SDV+SFGV+L E+ T GK+P L+ ++
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW------YQLSNTEAID 271
Query: 532 TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
+ + LE + C + I C P R S+ V L+ +P
Sbjct: 272 CITQGRELE--RPRACPP-------EVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 69/294 (23%), Positives = 105/294 (35%), Gaps = 41/294 (13%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF------AVKRI-DRSREGSDQVFERELEILGSIKHIN 368
+G G FG VY ++ AVK + + E + F E I+ H N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEH---GEGQQLLNWSARLKIALGSARGLA 425
+V G + ++ + ++ G L FL E L L +A A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHV---SDFGLAKLLVDEEAHVTTVVAGTFGYL 482
YL + IHRDI + N LL V DFG+A+ + G L
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS----YYRKGGCAML 207
Query: 483 -----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKE 536
PE G T K+D +SFGVLL E+ + G P + + +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY------PSKSNQEVLEFVTSG 261
Query: 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
R++ + I +C P+DRP+ +L+ +E P
Sbjct: 262 GRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 8e-32
Identities = 69/313 (22%), Positives = 123/313 (39%), Gaps = 64/313 (20%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILG-S 363
+ ++ L ++ ++G G GTV AVKR+ + E+++L S
Sbjct: 11 QSLKNLVVSEK--ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC---DIALMEIKLLTES 65
Query: 364 IKHINLVNLRGYCRLPATKLLIYD-----YLSM----GSLDDFLHEHG---EGQQLLNWS 411
H N++ YC Y+++ +L D + E +L
Sbjct: 66 DDHPNVIRY--YC--------SETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEY 115
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH-------------VSDF 458
+ + A G+A+LH KIIHRD+K NIL+ + +SDF
Sbjct: 116 NPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172
Query: 459 GLAKLLVDEEAHVTTV---VAGTFGYLAPEYLQSG-------RATEKSDVYSFGVLLLEL 508
GL K L ++ T +GT G+ APE L+ R T D++S G + +
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
Query: 509 VTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDA 568
++ + P F + + + + ++ + D+ EA I ++ D
Sbjct: 233 LSKGKH--P-FGDKYSRESNIIRGIFSLDEMKCLHDRSLIA------EATDLI-SQMIDH 282
Query: 569 NPDDRPSMNQVLQ 581
+P RP+ +VL+
Sbjct: 283 DPLKRPTAMKVLR 295
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 69/295 (23%), Positives = 104/295 (35%), Gaps = 47/295 (15%)
Query: 318 VVGSGGFGTVYRMVMNDCGTF------AVKRIDRSREGSDQV----FERELEILGSIKHI 367
+G G FG VY ++ AVK + E + F E I+ H
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL---PEVCSEQDELDFLMEALIISKFNHQ 134
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEH---GEGQQLLNWSARLKIALGSARGL 424
N+V G + ++ + ++ G L FL E L L +A A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHV---SDFGLAKLLVDEEAHVTTVVAGTFGY 481
YL + IHRDI + N LL V DFG+A+ + G
Sbjct: 195 QYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG----YYRKGGCAM 247
Query: 482 L-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLK 535
L PE G T K+D +SFGVLL E+ + G P + + +
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY------PSKSNQEVLEFVTS 301
Query: 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
R++ + I +C P+DRP+ +L+ +E P
Sbjct: 302 GGRMD---------PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 52/292 (17%), Positives = 110/292 (37%), Gaps = 60/292 (20%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQV--FERELEILGSIKHINL--VNL 372
+GSGG V++++ +A+K ++ + + + E+ L ++ + + L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARG 423
Y ++ + L+ +L + + +L
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLE-------------A 139
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV--TTVVAGTFGY 481
+ +H I+H D+K +N L+ + + DFG+A + + V + V GT Y
Sbjct: 140 VHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNY 194
Query: 482 LAPEYLQS-----------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWM 530
+ PE ++ + + KSDV+S G +L + GK P +
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQ 240
Query: 531 NTLLKENRLEDVIDKRCADADMETVEAIL-EIAARCTDANPDDRPSMNQVLQ 581
+ + ++L +ID + E L ++ C +P R S+ ++L
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 81/316 (25%), Positives = 130/316 (41%), Gaps = 58/316 (18%)
Query: 320 GSGGFGTVYRMVMNDCGTF--------AVKRIDRSREGSDQV----FERELEILGSI-KH 366
G G FG V AVK + + + + E+E++ I KH
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML---KSDATEKDLSDLISEMEMMKMIGKH 134
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEH------------GEGQQLLNWSARL 414
N++NL G C +I +Y S G+L ++L ++ L+ +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
A ARG+ YL K IHRD+ + N+L+ E+ ++DFGLA+ + +
Sbjct: 195 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----YY 247
Query: 475 VAGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVG 528
T G L APE L T +SDV+SFGVLL E+ T G P P G+ V
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY-P-----GVPVEE 301
Query: 529 WMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ--E 586
L + +R++ C + + + C A P RP+ Q+++ L++
Sbjct: 302 LFKLLKEGHRMD--KPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352
Query: 587 VMSPCPSDFYESHSDY 602
+ S +Y H +
Sbjct: 353 LTSNQEMGYYHHHHHH 368
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 50/283 (17%), Positives = 110/283 (38%), Gaps = 42/283 (14%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQV--FERELEILGSIKHINL--VNL 372
+GSGG V++++ +A+K ++ + + + E+ L ++ + + L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
Y ++ + L+ +L + ++ R + +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV--TTVVAGTFGYLAPEYLQSG 490
I+H D+K +N L+ + + DFG+A + + V + V GT Y+ PE ++
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDM 184
Query: 491 RA-----------TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539
+ + KSDV+S G +L + GK P + + + ++L
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQISKL 230
Query: 540 EDVIDKRCADADMETV-EAILEIAARCTDANPDDRPSMNQVLQ 581
+ID + + + ++ C +P R S+ ++L
Sbjct: 231 HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---RELEI-LGS 363
E L + +G G +G+V +MV G AVKRI ++ + +L++ + S
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRS--TVDEKEQKQLLMDLDVVMRS 77
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARL------KIA 417
+V G + + +S S D F + KI
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLD-----DVIPEEILGKIT 131
Query: 418 LGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG 477
L + + L +L + KIIHRDIK SNILLD + + DFG++ LVD A G
Sbjct: 132 LATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--G 187
Query: 478 TFGYLAPEYLQSGRA----TEKSDVYSFGVLLLELVTGKRP 514
Y+APE + + +SDV+S G+ L EL TG+ P
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 79/347 (22%), Positives = 130/347 (37%), Gaps = 68/347 (19%)
Query: 275 KRYTEVRKQVDQETSTKLITFHG--DMPYPSC-EIIEKLEALDEEDVVGSGGFGTVYR-- 329
K +VR ++ + TF +PY E L +G+G FG V
Sbjct: 9 KPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEF--PRNNLQFGKTLGAGAFGKVVEAT 66
Query: 330 ----MVMNDCGTFAVKRIDRSREGSDQV----FERELEILGSI-KHINLVNLRGYCRLPA 380
+ AVK + + + EL+I+ + +H N+VNL G C
Sbjct: 67 AFGLGKEDAVLKVAVKML---KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123
Query: 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR----------LKIALGSARGLAYLHHD 430
L+I +Y G L +FL + A L + A+G+A+L
Sbjct: 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA-- 181
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL-----APE 485
IHRD+ + N+LL + DFGLA+ ++++ ++ L APE
Sbjct: 182 -SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI----VKGNARLPVKWMAPE 236
Query: 486 YLQSGRATEKSDVYSFGVLLLELVT-GKRP-----TDPTFVKRGLNVVGWMNTLLKE-NR 538
+ T +SDV+S+G+LL E+ + G P + F K L+K+ +
Sbjct: 237 SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK-----------LVKDGYQ 285
Query: 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ I I C P RP+ Q+ L++
Sbjct: 286 MA--QPAFAPK-------NIYSIMQACWALEPTHRPTFQQICSFLQE 323
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-31
Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 20/202 (9%)
Query: 320 GSGGFGTVYRMVMNDCG-TFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGY 375
G G FG VY A+K + ++ + G + RE+EI ++H N++ L GY
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 376 CRLPATKLLIY---DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
+Y +Y +G++ L + + I A L+Y H
Sbjct: 78 F---HDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITE-LANALSYCHSK-- 128
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
++IHRDIK N+LL E ++DFG + GT YL PE ++
Sbjct: 129 -RVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDLC--GTLDYLPPEMIEGRMH 184
Query: 493 TEKSDVYSFGVLLLELVTGKRP 514
EK D++S GVL E + GK P
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPP 206
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 6e-31
Identities = 53/298 (17%), Positives = 106/298 (35%), Gaps = 72/298 (24%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQV--FERELEILGSIKHINL--VNL 372
+GSGG V++++ +A+K ++ + + + E+ L ++ + + L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 373 RGYCRLPATKLLIYDYL--SMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSA 421
Y T IY + L+ +L + + +L
Sbjct: 122 YDYEI---TDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE------------ 166
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT-TVVAGTFG 480
+ +H I+H D+K +N L+ + + DFG+A + + V G
Sbjct: 167 -AVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 481 YLAPEYLQS-----------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGW 529
Y+ PE ++ + + KSDV+S G +L + GK P ++
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ--------QIINQ 273
Query: 530 MNTLLK------ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
++ L E D+ +K D + C +P R S+ ++L
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDLQD-----------VLKCCLKRDPKQRISIPELLA 320
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 46/308 (14%), Positives = 91/308 (29%), Gaps = 63/308 (20%)
Query: 313 LDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFER------ELEILGSIK 365
L V+G + G +F V + ++ L +L IK
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 366 H-------------INLVNLRGYCRLPATK-------------LLIYDYLSMGSLDDFLH 399
+ +LV ++ + L ++ + + L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 400 EHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459
H + L ARL++ L R LA LHH ++H ++ +I+LD+ ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFE 256
Query: 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA-----TEKSDVYSFGVLLLELVTGKRP 514
A L G+ T D ++ G+ + + P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 515 TDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADM-ETVEAILEIAARCTDANPDDR 573
+G + + + ++ + V A+LE +DR
Sbjct: 317 ----N--TDDAALGGSEWIFRSCK------------NIPQPVRALLE---GFLRYPKEDR 355
Query: 574 PSMNQVLQ 581
Q ++
Sbjct: 356 LLPLQAME 363
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 53/322 (16%), Positives = 114/322 (35%), Gaps = 80/322 (24%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF--------AVKRIDRSREGSDQVFERELEILGSIKHI 367
+ +G G F +++ V + G + +K +D++ + F ++ + H
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYL 427
+LV G C +L+ +++ GSLD +L ++ +N +L++A A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN---CINILWKLEVAKQLAAAMHFL 129
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPH--------VSDFGLAKLLVDEEAHVTTVVAGTF 479
+ IH ++ + NILL + +SD G++ ++ ++
Sbjct: 130 EENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------- 175
Query: 480 GY------LAPEYLQSGRA-TEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMN 531
+ PE +++ + +D +SFG L E+ + G +P +
Sbjct: 176 ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS-----------ALDS 224
Query: 532 TLLKENRLEDVIDKRCADADMETVEA-----------ILEIAARCTDANPDDRPSMNQVL 580
+ + E + + C D PD RPS ++
Sbjct: 225 --------QRKLQF---------YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAII 267
Query: 581 QLLEQEVMSPCPSDFYESHSDY 602
+ L H +
Sbjct: 268 RDLNSLFTPDLVPRGSHHHHHH 289
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 57/299 (19%), Positives = 108/299 (36%), Gaps = 57/299 (19%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTF------AVKRIDRSREG-SDQV---FERELEILGSIK 365
+ +G FG VY+ + A+K + ++ + F E + ++
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL---KDKAEGPLREEFRHEAMLRARLQ 70
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR------------ 413
H N+V L G +I+ Y S G L +FL + +
Sbjct: 71 HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 414 LKIALGSARGLAYL--HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471
+ + A G+ YL HH ++H+D+ + N+L+ + L +SD GL + + +
Sbjct: 131 VHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD--- 182
Query: 472 TTVVAGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLN 525
L APE + G+ + SD++S+GV+L E+ + G +P G +
Sbjct: 183 -YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY------CGYS 235
Query: 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
+ + L + + + C + P RP + L
Sbjct: 236 NQDVVEMIRNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 77/308 (25%), Positives = 129/308 (41%), Gaps = 57/308 (18%)
Query: 320 GSGGFGTVYRMVMNDCGTF--------AVKRIDRSREGSDQV----FERELEILGSI-KH 366
G G FG V AVK + ++ + + E+E++ I KH
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR------------L 414
N++NL G C +I +Y S G+L ++L ++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
ARG+ YL K IHRD+ + N+L+ EN ++DFGLA+ + + + +
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK--- 214
Query: 475 VAGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVG 528
T G L APE L T +SDV+SFGVL+ E+ T G P P G+ V
Sbjct: 215 -KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-P-----GIPVEE 267
Query: 529 WMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588
L + +R++ C + + + C A P RP+ Q+++ L+ ++
Sbjct: 268 LFKLLKEGHRMD--KPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD-RIL 317
Query: 589 SPCPSDFY 596
+ ++ Y
Sbjct: 318 TLTTNEEY 325
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 2e-30
Identities = 72/279 (25%), Positives = 114/279 (40%), Gaps = 53/279 (18%)
Query: 320 GSGGFGTVYRMVMNDCG-TFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGY 375
G G F VYR G A+K ID+ G Q + E++I +KH +++ L Y
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79
Query: 376 CRLPATKLLIY---DYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHHDC 431
+Y + G ++ +L + AR + + G+ YLH
Sbjct: 80 F---EDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARHFMHQI--ITGMLYLHSH- 131
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLA-KLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
I+HRD+ SN+LL N+ ++DFGLA +L + E H T GT Y++PE
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIATRS 187
Query: 491 RATEKSDVYSFGVLLLELVTGKRP-----TDPTF--VKRG-LNVVGWMNTLLKENRLEDV 542
+SDV+S G + L+ G+ P T V + +++ K D+
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK-----DL 242
Query: 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
I + +L NP DR S++ VL
Sbjct: 243 IHQ------------LL-------RRNPADRLSLSSVLD 262
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 60/294 (20%), Positives = 106/294 (36%), Gaps = 45/294 (15%)
Query: 316 EDVVGSGGFGTVYRMV-MNDCGTFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLR 373
V+ GGF VY + +A+KR+ + E ++ +E+ + + H N+V
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 374 GYCRLPA-------TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
+ + L+ L G L +FL + L + LKI + R + +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV-LKIFYQTCRAVQH 151
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA---------- 476
+H P IIHRD+K N+LL + DFG A + + +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 477 -GTFGYLAPEYLQSGR---ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNV-VGWMN 531
T Y PE + EK D+++ G +L L + P + R +N
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPP 270
Query: 532 TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ +I NP++R S+ +V+ L++
Sbjct: 271 HDTQYTVFHSLI-------------------RAMLQVNPEERLSIAEVVHQLQE 305
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 44/309 (14%), Positives = 90/309 (29%), Gaps = 72/309 (23%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFER------------------- 356
V+G + G +F V + ++
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 357 ---------ELEILGSIKHINLVNLRGYCRLPATK----LLIYDYLSMGSLDDFLHEHGE 403
+++ + ++ +R R L ++ + + L H
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 404 GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463
+ L ARL++ L R LA LHH ++H ++ +I+LD+ ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 254
Query: 464 LVDEEAHVTTVVAGTFGYLAPEYLQS-----------GRATEKSDVYSFGVLLLELVTGK 512
V + + G+ PE T D ++ G+++ +
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 513 RPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDD 572
P K + I + C + + V A+LE +D
Sbjct: 311 LP----ITKDA------------ALGGSEWIFRSCKNIP-QPVRALLE---GFLRYPKED 350
Query: 573 RPSMNQVLQ 581
R Q ++
Sbjct: 351 RLLPLQAME 359
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 60/294 (20%), Positives = 108/294 (36%), Gaps = 54/294 (18%)
Query: 314 DEEDVVGSGGFGTVYRMVMN--DCGTFAVKRIDRSREGSD--QVFERELEILGSI-KHIN 368
E + +GSG FG+V++ + D +A+KR + GS Q RE+ + +H +
Sbjct: 14 HELEKIGSGEFGSVFK-CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 369 LVNLRGYCRLPATKLLIY-DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYL 427
+V +LI +Y + GSL D + E+ + + L RGL Y+
Sbjct: 73 VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVS-------------------DFGLAKLLVDEE 468
H ++H DIK SNI + P+ + D G +
Sbjct: 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS-- 186
Query: 469 AHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVV 527
V G +LA E LQ K+D+++ + ++ + N
Sbjct: 187 ---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR--------NGD 235
Query: 528 GWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
W +++ RL + + E+ +P+ RPS +++
Sbjct: 236 QWHE--IRQGRLPRIPQVLSQEF--------TELLKVMIHPDPERRPSAMALVK 279
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 62/337 (18%), Positives = 115/337 (34%), Gaps = 89/337 (26%)
Query: 314 DEEDVVGSGGFGTVYRMV-MNDCGTFAVKRID-RSREGSDQVFERELEILGSIKHINLVN 371
+ +G GGFG V+ D +A+KRI +RE + + RE++ L ++H +V
Sbjct: 9 EPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 68
Query: 372 LRGYCRL-----------------------------------------PATKLLIYDYLS 390
P + L
Sbjct: 69 YFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQ 128
Query: 391 MGSLDDFLH---EHGEGQQLLNWSAR------------LKIALGSARGLAYLHHDCCPKI 435
S +L+ + + L +W R L I + A + +LH +
Sbjct: 129 PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GL 185
Query: 436 IHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA-----------GTFGYLAP 484
+HRD+K SNI + V DFGL + +E T + GT Y++P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544
E + + K D++S G++L EL+ T ++R + T ++ + +
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYSF----STQMERVRII-----TDVRNLKFPLLFT 296
Query: 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
++ + +P +RP +++
Sbjct: 297 QKYPQE--------HMMVQDMLSPSPTERPEATDIIE 325
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 76/322 (23%), Positives = 124/322 (38%), Gaps = 80/322 (24%)
Query: 320 GSGGFGTVYR------MVMNDCGTFAVKRIDRSREGSDQV----FERELEILGSI-KHIN 368
G+G FG V + + T AVK + + + EL++L + H+N
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKML---KPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR--------------L 414
+VNL G C + L+I +Y G L +FL + S L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
+ A+G+A+L IHRD+ + NILL + DFGLA+ + ++ +V
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV--- 202
Query: 475 VAGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRP-----TDP---TFV 520
L APE + + T +SDV+S+G+ L EL + G P D +
Sbjct: 203 -VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 521 KRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVL 580
K G R+ + + +I C DA+P RP+ Q++
Sbjct: 262 KEG-------------FRML--SPEHAPA-------EMYDIMKTCWDADPLKRPTFKQIV 299
Query: 581 QLLEQEVMSPCPSDFYESHSDY 602
QL+E +++
Sbjct: 300 QLIE---------KQISESTNH 312
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 69/239 (28%), Positives = 116/239 (48%), Gaps = 34/239 (14%)
Query: 285 DQETSTKL--ITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVK 341
D+E KL I GD P EK+ G G GTVY + G A++
Sbjct: 2 DEEILEKLRSIVSVGD-PKKKYTRFEKI---------GQGASGTVYTAMDVATGQEVAIR 51
Query: 342 RIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHE 400
+++ ++ ++ E+ ++ K+ N+VN L +L ++ +YL+ GSL D + E
Sbjct: 52 QMNLQQQPKKELIINEILVMRENKNPNIVNYLD-SYLVGDELWVVMEYLAGGSLTDVVTE 110
Query: 401 H--GEGQQLLNWSARLKIAL---GSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455
EGQ IA + L +LH + ++IHRDIKS NILL + +
Sbjct: 111 TCMDEGQ----------IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL 157
Query: 456 SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+DFG + E++ +T+V GT ++APE + K D++S G++ +E++ G+ P
Sbjct: 158 TDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 56/297 (18%)
Query: 320 GSGGFGTVYR-----MVMNDCGTF---AVKRIDRSREGSDQV----FERELEILGSI-KH 366
G G FG V + + AVK + ++ + + E+E++ I KH
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML---KDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR------------L 414
N++NL G C +I +Y S G+L ++L ++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
ARG+ YL K IHRD+ + N+L+ EN ++DFGLA+ + + + +
Sbjct: 207 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK--- 260
Query: 475 VAGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVG 528
T G L APE L T +SDV+SFGVL+ E+ T G P P G+ V
Sbjct: 261 -KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY-P-----GIPVEE 313
Query: 529 WMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
L + +R++ C + + + C A P RP+ Q+++ L++
Sbjct: 314 LFKLLKEGHRMD--KPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLDR 361
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 65/274 (23%), Positives = 107/274 (39%), Gaps = 44/274 (16%)
Query: 320 GSGGFGTVYRMVMNDCG-TFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGY 375
G GGF + + D FA K + +S + E+ I S+ H ++V G+
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 109
Query: 376 CRLPATKLLIY---DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
++ + SL + L AR G YLH +
Sbjct: 110 F---EDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEAR-YYLRQIVLGCQYLHRN-- 160
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTFGYLAPEYLQSGR 491
++IHRD+K N+ L+E+LE + DFGLA + D E GT Y+APE L
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKG 217
Query: 492 ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551
+ + DV+S G ++ L+ GK P + + + T R +
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGKPPFETSCL---------KETY-----------LRIKKNE 257
Query: 552 METVEAILEIA----ARCTDANPDDRPSMNQVLQ 581
+ I +A + +P RP++N++L
Sbjct: 258 YSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 53/294 (18%), Positives = 100/294 (34%), Gaps = 64/294 (21%)
Query: 316 EDVVGSGGFGTVY---------RMVMNDCGTFAVKRIDRSREGSDQ-VFERELEILGSIK 365
+ + GG G +Y R V +K + S + Q + E + L +
Sbjct: 85 KGCIAHGGLGWIYLALDRNVNGRPV-------VLKGLVHSGDAEAQAMAMAERQFLAEVV 137
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSM-----GSLDDFLHEHGEGQQLLNWSARLKIALGS 420
H ++V + + Y+ M SL + L + + L
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEI 191
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480
L+YLH +++ D+K NI+L E + + D G + + GT G
Sbjct: 192 LPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPG 242
Query: 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540
+ APE ++ T +D+Y+ G L L + +V
Sbjct: 243 FQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVD------------------- 282
Query: 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPS----MNQVLQLLEQEVMSP 590
+ + ++ +L R D +P R + M+ L + +EV++
Sbjct: 283 GLPEDDPVLKTYDSYGRLL---RRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQ 333
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 23/206 (11%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRID-RSREGSDQVFERELEILGSIKHINLVNLRG 374
+ +G G FG V++ + N A+K ID E + ++E+ +L + G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 375 YCRLPATKL-LIYDYLSMGSLDDFLHEHG--EGQQLLNWSARLKIAL---GSARGLAYLH 428
L TKL +I +YL GS D L E Q IA +GL YLH
Sbjct: 88 -SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ----------IATILREILKGLDYLH 136
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
+ K IHRDIK++N+LL E+ E ++DFG+A L D + T V GT ++APE ++
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIK 192
Query: 489 SGRATEKSDVYSFGVLLLELVTGKRP 514
K+D++S G+ +EL G+ P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEPP 218
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLR 373
+G G FG VY A+K + +S +EG + RE+EI ++H N++ +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 374 GYCRLPATKLLIY---DYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHH 429
Y + IY ++ G L L +HG + + + L A L Y H
Sbjct: 81 NYF---HDRKRIYLMLEFAPRGELYKELQKHG---RFDEQRSATFMEELADA--LHYCHE 132
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS 489
K+IHRDIK N+L+ E ++DFG + T GT YL PE ++
Sbjct: 133 R---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPPEMIEG 186
Query: 490 GRATEKSDVYSFGVLLLELVTGKRP 514
EK D++ GVL E + G P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 67/278 (24%), Positives = 111/278 (39%), Gaps = 52/278 (18%)
Query: 320 GSGGFGTVYRMVMNDCG-TFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGY 375
G GGF + + D FA K + +S + E+ I S+ H ++V G+
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83
Query: 376 CRLPATKLLIY---DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
++ + SL + L AR G YLH +
Sbjct: 84 F---EDNDFVFVVLELCRRRSLLELHKRRK---ALTEPEAR-YYLRQIVLGCQYLHRN-- 134
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTFGYLAPEYLQSGR 491
++IHRD+K N+ L+E+LE + DFGLA + D E GT Y+APE L
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKG 191
Query: 492 ATEKSDVYSFGVLLLELVTGKRP-----TDPTF--VKRG-LNVVGWMNTLLKENRLEDVI 543
+ + DV+S G ++ L+ GK P T+ +K+ ++ +N + +I
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAA-----SLI 246
Query: 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
K +L +P RP++N++L
Sbjct: 247 QK------------ML-------QTDPTARPTINELLN 265
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 34/239 (14%)
Query: 285 DQETSTKL--ITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVK 341
++ L + GD P + K+ G G G V G AVK
Sbjct: 27 HEQFKAALRMVVDQGD-PRLLLDSYVKI---------GEGSTGIVCLAREKHSGRQVAVK 76
Query: 342 RIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHE 400
+D ++ ++ E+ I+ +H N+V + L +L ++ ++L G+L D + +
Sbjct: 77 MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK-SYLVGEELWVLMEFLQGGALTDIVSQ 135
Query: 401 H--GEGQQLLNWSARLKIAL---GSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455
E Q IA + LAYLH +IHRDIKS +ILL + +
Sbjct: 136 VRLNEEQ----------IATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKL 182
Query: 456 SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
SDFG + + ++V GT ++APE + + D++S G++++E+V G+ P
Sbjct: 183 SDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 79/302 (26%), Positives = 124/302 (41%), Gaps = 61/302 (20%)
Query: 320 GSGGFGTVYR------MVMNDCGTFAVKRIDRSREGSDQV----FERELEILGSIKHINL 369
G G FG V + T AVK + +E + E +L + H ++
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKML---KENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR---------------- 413
+ L G C LLI +Y GSL FL E + S
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 414 ----LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469
+ A ++G+ YL K++HRD+ + NIL+ E + +SDFGL++ + +E++
Sbjct: 149 MGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 470 HVTTVVAGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRG 523
+V + G + A E L T +SDV+SFGVLL E+VT G P P G
Sbjct: 206 YV----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY-P-----G 255
Query: 524 LNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
+ N L +R+E C++ + + +C PD RP + + L
Sbjct: 256 IPPERLFNLLKTGHRME--RPDNCSE-------EMYRLMLQCWKQEPDKRPVFADISKDL 306
Query: 584 EQ 585
E+
Sbjct: 307 EK 308
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 48/219 (21%), Positives = 90/219 (41%), Gaps = 31/219 (14%)
Query: 320 GSGGFGTVYRMVMNDCGTFAVKRIDRSR-----------------EGSDQVFERELEILG 362
G F + + D +A+K+ ++S + F+ EL+I+
Sbjct: 40 NQGKFNKII-LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 363 SIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG-----EGQQLLNWSARLKIA 417
IK+ + G +IY+Y+ S+ F + + I
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-CII 157
Query: 418 LGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG 477
+Y+H++ I HRD+K SNIL+D+N +SDFG ++ +VD++ + G
Sbjct: 158 KSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS--RG 212
Query: 478 TFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRP 514
T+ ++ PE+ + K D++S G+ L + P
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 76/305 (24%), Positives = 117/305 (38%), Gaps = 54/305 (17%)
Query: 320 GSGGFGTVYRMVMNDCG------TFAVKRIDRSREGSDQV----FERELEILGSI-KHIN 368
G G FG V T AVK + +EG+ EL+IL I H+N
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKML---KEGATHSEHRALMSELKILIHIGHHLN 92
Query: 369 LVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSAR------------LK 415
+VNL G C P L +I ++ G+L +L + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
+ A+G+ +L K IHRD+ + NILL E + DFGLA+ + + +V
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV---- 205
Query: 476 AGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGW 529
L APE + T +SDV+SFGVLL E+ + G P P VK
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PG-VKIDEEF--- 260
Query: 530 MNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589
L + R+ + + C P RP+ +++++ L + +
Sbjct: 261 CRRLKEGTRMR--APDYTTP-------EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311
Query: 590 PCPSD 594
D
Sbjct: 312 NAQQD 316
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 20/216 (9%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---RELEIL-GS 363
++ L+ +GSG G V++M G AVK++ R G+ + + +L+++ S
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR--SGNKEENKRILMDLDVVLKS 80
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARG 423
+V G + + + + G + K+ + +
Sbjct: 81 HDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP----IPERILGKMTVAIVKA 136
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
L YL +IHRD+K SNILLDE + + DFG++ LVD++A + G Y+A
Sbjct: 137 LYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMA 192
Query: 484 PEYLQSGRATE-----KSDVYSFGVLLLELVTGKRP 514
PE + T+ ++DV+S G+ L+EL TG+ P
Sbjct: 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 71/302 (23%), Positives = 110/302 (36%), Gaps = 60/302 (19%)
Query: 320 GSGGFGTVYR------MVMNDCGTFAVKRIDRSREGSDQV----FERELEILGSI-KHIN 368
GSG FG V AVK + +E +D EL+++ + H N
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKML---KEKADSSEREALMSELKMMTQLGSHEN 110
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR--------------- 413
+VNL G C L LI++Y G L ++L E
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 414 ----LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469
L A A+G+ +L +HRD+ + N+L+ + DFGLA+ ++ +
Sbjct: 171 FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 470 HVTTVVAGTFGYL-----APEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRG 523
+V L APE L G T KSDV+S+G+LL E+ + G P P +
Sbjct: 228 YV----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY-PG-IPVD 281
Query: 524 LNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLL 583
N + +++ + I I C + RPS + L
Sbjct: 282 ANF---YKLIQNGFKMD--QPFYATE-------EIYIIMQSCWAFDSRKRPSFPNLTSFL 329
Query: 584 EQ 585
Sbjct: 330 GC 331
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 314 DEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNL 372
D + +G G +G+VY+ + + G A+K++ + + +E+ I+ ++V
Sbjct: 32 DVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE--IIKEISIMQQCDSPHVVKY 89
Query: 373 RGYCRLPATKL-LIYDYLSMGSLDDFLHEHG----EGQQLLNWSARLKIAL---GSARGL 424
G T L ++ +Y GS+ D + E + IA + +GL
Sbjct: 90 YG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE----------IATILQSTLKGL 138
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
YLH + IHRDIK+ NILL+ ++DFG+A L D A TV+ GT ++AP
Sbjct: 139 EYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAP 194
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
E +Q +D++S G+ +E+ GK P
Sbjct: 195 EVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 74/328 (22%), Positives = 133/328 (40%), Gaps = 67/328 (20%)
Query: 299 MPYPSCEIIEKLEALDEEDVV-----GSGGFGTVYRMVMNDCGTF------AVKRIDRSR 347
MP + LE ++ G G FG V++ + AVK + +
Sbjct: 31 MPLLLNPKLLSLE-YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML---K 86
Query: 348 EGSDQV----FERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEH-- 401
E + F+RE ++ + N+V L G C + L+++Y++ G L++FL
Sbjct: 87 EEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSP 146
Query: 402 ------------------GEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSS 443
G L+ + +L IA A G+AYL K +HRD+ +
Sbjct: 147 HTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATR 203
Query: 444 NILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL-----APEYLQSGRATEKSDV 498
N L+ EN+ ++DFGL++ + + + A + PE + R T +SDV
Sbjct: 204 NCLVGENMVVKIADFGLSRNIYSADYYK----ADGNDAIPIRWMPPESIFYNRYTTESDV 259
Query: 499 YSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEA 557
+++GV+L E+ + G +P G+ + + N L + C
Sbjct: 260 WAYGVVLWEIFSYGLQPY------YGMAHEEVIYYVRDGNILA--CPENCPL-------E 304
Query: 558 ILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ + C P DRPS + ++L++
Sbjct: 305 LYNLMRLCWSKLPADRPSFCSIHRILQR 332
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 68/206 (33%), Positives = 102/206 (49%), Gaps = 20/206 (9%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR-EGSDQVF--ERELEILGSIKHINLVNLR 373
+G G FG V + ND +A+K +++ + ++V +EL+I+ ++H LVNL
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 374 GYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHHDC 431
Y + ++ D L G L H + +L I L A L YL +
Sbjct: 82 -YSFQDEEDMFMVVDLLLGGDL--RYHLQQNVH-FKEETVKLFICELVMA--LDYLQNQ- 134
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR 491
+IIHRD+K NILLDE+ H++DF +A +L E T +AGT Y+APE S +
Sbjct: 135 --RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRK 190
Query: 492 ATEKS---DVYSFGVLLLELVTGKRP 514
S D +S GV EL+ G+RP
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-28
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 22/208 (10%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNL 372
+GSG +G V A+K I ++ S+ E+ +L + H N++ L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EGQQLLNWSARLKIALGSARGLAYLHH 429
+ L+ + G L D + E +A + + S + YLH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD-----AAVIIKQVLSG--VTYLHK 154
Query: 430 DCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
I+HRD+K N+LL +++ + DFGL+ + +++ + GT Y+APE
Sbjct: 155 H---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPEV 209
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRP 514
L+ + EK DV+S GV+L L+ G P
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 53/212 (25%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+G G FG VY+ + G A K I+ E + + E+EIL + H +V L G
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG- 83
Query: 376 CRLPATKL-LIYDYLSMGSLDDFLHEHG----EGQQLLNWSARLKIAL---GSARGLAYL 427
KL ++ ++ G++D + E E Q I + L +L
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ----------IQVVCRQMLEALNFL 133
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE-- 485
H +IIHRD+K+ N+L+ + ++DFG++ + + + GT ++APE
Sbjct: 134 HSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVV 189
Query: 486 ---YLQSGRATEKSDVYSFGVLLLELVTGKRP 514
++ K+D++S G+ L+E+ + P
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 64/230 (27%), Positives = 103/230 (44%), Gaps = 23/230 (10%)
Query: 298 DMPYP-SCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSD-QVF 354
+P+ + + E E V+GSG V A+KRI+ + +
Sbjct: 7 ALPWSINRDDYELQE------VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL 60
Query: 355 ERELEILGSIKHINLVNLRGYCRLPATKL-LIYDYLSMGSLDDFL-HEHGEGQQLLNWSA 412
+E++ + H N+V+ + +L L+ LS GS+ D + H +G+
Sbjct: 61 LKEIQAMSQCHHPNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD 119
Query: 413 RLKIAL---GSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469
IA GL YLH + IHRD+K+ NILL E+ ++DFG++ L
Sbjct: 120 ESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176
Query: 470 HVTTVVAGTF-G---YLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRP 514
V TF G ++APE ++ R K+D++SFG+ +EL TG P
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 32/203 (15%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRG 374
+V+GSG F V+ + G FA+K I +S D E E+ +L IKH N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARGLA 425
L+ +S G L D + E G E QQ+L+ +
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS-------------AVK 120
Query: 426 YLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
YLH + I+HRD+K N+L +EN + ++DFGL+K+ + + + GT GY+
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYV 174
Query: 483 APEYLQSGRATEKSDVYSFGVLL 505
APE L ++ D +S GV+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVIT 197
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVN 371
+ V+G G FG V G AVK I + + + + RE+++L + H N++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EGQQLLNWSARLKIALGSARGLAYLH 428
L + L+ + + G L D + E +AR+ + S + Y+H
Sbjct: 91 LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD-----AARIIRQVLSG--ITYMH 143
Query: 429 HDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
+ KI+HRD+K N+LL ++ + DFGL+ + + GT Y+APE
Sbjct: 144 KN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GTAYYIAPE 198
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRP 514
L G EK DV+S GV+L L++G P
Sbjct: 199 VLH-GTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 5e-27
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 32/212 (15%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRG 374
E+ +G G +G V V A K+I + F++E+EI+ S+ H N++ L
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARGLA 425
L+ + + G L + + E + +L+ +A
Sbjct: 74 TFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS-------------AVA 120
Query: 426 YLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
Y H + HRD+K N L + + DFGLA + T V GT Y+
Sbjct: 121 YCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYV 175
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+P+ L+ G + D +S GV++ L+ G P
Sbjct: 176 SPQVLE-GLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 60/293 (20%), Positives = 98/293 (33%), Gaps = 32/293 (10%)
Query: 320 GSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE--RELEILGSIKHINLVNLRGYC 376
G TV G + V+RI+ ++ V EL + H N+V R
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA-T 94
Query: 377 RLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKI 435
+ +L ++ +++ GS D + H A I G + L Y+HH
Sbjct: 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA--YILQGVLKALDYIHHM---GY 149
Query: 436 IHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV------VAGTFGYLAPEYLQS 489
+HR +K+S+IL+ + + ++S ++ V +L+PE LQ
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 490 GRA--TEKSDVYSFGVLLLELVTGKRP---TDPTFVKRGLNVVGWMNTLLKEN--RLEDV 542
KSD+YS G+ EL G P T + + L L D
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---------LLEKLNGTVPCLLDT 260
Query: 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDF 595
+ M ++ + RPS SP F
Sbjct: 261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 20/211 (9%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFERELEILGSI-KHINLVN--- 371
++VG+G +G VY+ G A+K +D ++ ++E+ +L H N+
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 372 --LRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH 428
++ +L L+ ++ GS+ D + W A I RGL++LH
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLH 146
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
K+IHRDIK N+LL EN E + DFG++ L T + GT ++APE +
Sbjct: 147 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 202
Query: 489 SGRATE-----KSDVYSFGVLLLELVTGKRP 514
+ KSD++S G+ +E+ G P
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 45/225 (20%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR-------------EGSDQVFERELEIL 361
+GSG +G V + A+K I +S+ E + E+ +L
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 362 GSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EGQ------QLLNWSA 412
S+ H N++ L L+ ++ G L + + E Q+L+
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS--- 157
Query: 413 RLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEA 469
G+ YLH I+HRDIK NILL + L + DFGL+ +
Sbjct: 158 ----------GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+ GT Y+APE L+ + EK DV+S GV++ L+ G P
Sbjct: 205 LRDRL--GTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-26
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 22/208 (10%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQV--FERELEILGSIKHINLVNL 372
++G G FG V + +AVK I+++ + RE+E+L + H N++ L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EGQQLLNWSARLKIALGSARGLAYLHH 429
++ ++ + + G L D + + E +AR+ + S + Y+H
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD-----AARIIKQVFSG--ITYMHK 139
Query: 430 DCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
I+HRD+K NILL +++ + + DFGL+ + GT Y+APE
Sbjct: 140 H---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEV 194
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRP 514
L+ G EK DV+S GV+L L++G P
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 2e-26
Identities = 37/244 (15%), Positives = 82/244 (33%), Gaps = 26/244 (10%)
Query: 294 TFHGDMPYPSCEIIEKLEALDEE----DVVGSGGFGTVY---RMVMNDCGT---FAVKRI 343
TF P+ + + + + ++G G F VY + +ND F +K
Sbjct: 44 TFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ 103
Query: 344 DRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGE 403
+ + + +E L + +L+ + S G+L + ++ +
Sbjct: 104 KPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKN 163
Query: 404 GQ-QLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH-------- 454
+++ + A+ + +H +IIH DIK N +L
Sbjct: 164 TPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSA 220
Query: 455 ---VSDFGLAK-LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT 510
+ D G + + + + + T T G+ E L + + D + + ++
Sbjct: 221 GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
Query: 511 GKRP 514
G
Sbjct: 281 GTYM 284
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 34/213 (15%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQV--FERELEILGSIKHINLVNLR 373
++G G FG V + +AVK I+++ + RE+E+L + H N++ L
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARGL 424
++ ++ + + G L D + + E +Q+ + G+
Sbjct: 88 EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS-------------GI 134
Query: 425 AYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
Y+H I+HRD+K NILL +++ + + DFGL+ + GT Y
Sbjct: 135 TYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYY 189
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+APE L+ G EK DV+S GV+L L++G P
Sbjct: 190 IAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 57/260 (21%), Positives = 102/260 (39%), Gaps = 33/260 (12%)
Query: 268 SKKERAVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTV 327
++ + V+ V D ++ + + + EE +G+G FG V
Sbjct: 116 DEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEE--LGTGAFGVV 173
Query: 328 YRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386
+R+ G FA K + E + +E++ + ++H LVNL ++IY
Sbjct: 174 HRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233
Query: 387 DYLSMGSL-DDFLHEHGE---------GQQLLNWSARLKIALGSARGLAYLHHDCCPKII 436
+++S G L + EH + +Q+ GL ++H + +
Sbjct: 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK-------------GLCHMHEN---NYV 277
Query: 437 HRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATE 494
H D+K NI+ + DFGL L + V GT + APE +
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 495 KSDVYSFGVLLLELVTGKRP 514
+D++S GVL L++G P
Sbjct: 336 YTDMWSVGVLSYILLSGLSP 355
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 51/207 (24%), Positives = 90/207 (43%), Gaps = 13/207 (6%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRID----RSREGSD-QVFERELEILGSIKHINLV 370
+V+G G F V R + + G FAVK +D S G + +RE I +KH ++V
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
L ++++++ L + + + + + + L Y H +
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 431 CCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
IIHRD+K +LL + + + FG+A L + V GT ++APE +
Sbjct: 150 ---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVV 205
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRP 514
+ + DV+ GV+L L++G P
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 56/212 (26%), Positives = 85/212 (40%), Gaps = 31/212 (14%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRG 374
+ +GSG FG V+R V G F K I+ + E+ I+ + H L+NL
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEG----------QQLLNWSARLKIALGSARGL 424
+LI ++LS G L D + +Q GL
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE-------------GL 162
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYL 482
++H I+H DIK NI+ + V DFGLA L +E + V T +
Sbjct: 163 KHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--IVKVTTATAEFA 217
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
APE + +D+++ GVL L++G P
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSD-QVFERELEILGSIKHINLVNLR 373
+ +GSG FG V+ + G +K I++ R + E E+E+L S+ H N++ +
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
++ + G L + + + L+ ++ LAY H
Sbjct: 87 EVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ--- 143
Query: 434 KIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
++H+D+K NIL + + DFGLA+L +E GT Y+APE +
Sbjct: 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAPEVFK-R 200
Query: 491 RATEKSDVYSFGVLLLELVTGKRP 514
T K D++S GV++ L+TG P
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 54/248 (21%), Positives = 89/248 (35%), Gaps = 52/248 (20%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR-----EGSDQVFERELEILGSIKHINL 369
+ +G G +G V + N A+K +++++ + + E+ ++ + H N+
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSAR------- 422
L L+ + G L D L+ + +K +
Sbjct: 91 ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150
Query: 423 -----------------------------GLAYLHHDCCPKIIHRDIKSSNILL--DENL 451
L YLH+ I HRDIK N L +++
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSF 207
Query: 452 EPHVSDFGLAKLLVD---EEAHVTTVVAGTFGYLAPEYLQSGRA--TEKSDVYSFGVLLL 506
E + DFGL+K E + T AGT ++APE L + K D +S GVLL
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 507 ELVTGKRP 514
L+ G P
Sbjct: 268 LLLMGAVP 275
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR-EGSD-QVFERELEILGSIKHINLVNLR 373
+ +G G F V R V G FA K I+ + D Q ERE I ++H N+V L
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 71
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARGL 424
+ + L++D ++ G L + + E QQ+L +
Sbjct: 72 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------------SI 118
Query: 425 AYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
AY H + I+HR++K N+LL + ++DFGLA + ++ AGT GY
Sbjct: 119 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGY 173
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
L+PE L+ ++ D+++ GV+L L+ G P
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-25
Identities = 32/183 (17%), Positives = 60/183 (32%), Gaps = 21/183 (11%)
Query: 25 ALTEDGMTLLEIKSSLN--------DSRNLLGNWQATEESPCKWT---GISCHTHDQRVR 73
+D + L EI +LN NW + W G+S +++ RV
Sbjct: 27 EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNK-ELDMWGAQPGVSLNSN-GRVT 84
Query: 74 SINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHG----SIPNEITNCTELRALYLRANY 129
++L G + +IG+L +L+ LAL + P I+ +
Sbjct: 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMH 144
Query: 130 LQGGIPANIGNLLF--LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FG 186
Q F L ++S+ + +I S + +N + +
Sbjct: 145 YQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVM 203
Query: 187 ALS 189
L+
Sbjct: 204 RLT 206
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-22
Identities = 27/133 (20%), Positives = 40/133 (30%), Gaps = 18/133 (13%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHG-------SIPNEITNCTELRALYL 125
SINL Q+ L + L N L N L ++ L
Sbjct: 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDL 495
Query: 126 RANYLQGGIPANI--GNLLFLTILDLSSNSLKGAIPSSLGRLTHL------HYLNLSTNF 177
R N L + + L +L +DLS NS P+ + L + + N
Sbjct: 496 RFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNR 553
Query: 178 FSGEIPD-FGALS 189
E P+
Sbjct: 554 TLREWPEGITLCP 566
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-21
Identities = 24/164 (14%), Positives = 44/164 (26%), Gaps = 8/164 (4%)
Query: 32 TLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIG 91
L + D L W A G + N G S+
Sbjct: 21 KLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANW--NFNKELDMWGAQPGVSLN 78
Query: 92 RLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGG----IPANIGNLLFLTIL 147
++ L+L G +P+ I TEL L L ++ + P I +
Sbjct: 79 SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138
Query: 148 DLSSNSLKGAIPSSLGRL--THLHYLNLSTNFFSGEIPDFGALS 189
+ R + L ++++ I ++
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT 182
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-21
Identities = 22/133 (16%), Positives = 50/133 (37%), Gaps = 12/133 (9%)
Query: 81 QLGGIISPSIGRLDKLQRLALHQNSLHGSIPN--EITNCTELRALYLRANYLQG------ 132
Q+ I + G ++++ L+ N L IPN + + + + A+ N +
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNF 422
Query: 133 -GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL--S 189
+ + ++ ++LS+N + + L +NL N + +
Sbjct: 423 DPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENE 482
Query: 190 AFGNKSFIGNLDL 202
F N + ++DL
Sbjct: 483 NFKNTYLLTSIDL 495
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-21
Identities = 27/146 (18%), Positives = 47/146 (32%), Gaps = 17/146 (11%)
Query: 73 RSINLPYMQLGGI-------ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYL 125
+I+ Y ++G + + P+ + + + L N + + + L ++ L
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464
Query: 126 RANYLQG-------GIPANIGNLLFLTILDLSSNSLKGAIPSSL--GRLTHLHYLNLSTN 176
N L N N LT +DL N L + L +L ++LS N
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYN 523
Query: 177 FFSGEIPDFGALSAFGNKSFIGNLDL 202
FS S D
Sbjct: 524 SFSKFPTQPLNSSTLKGFGIRNQRDA 549
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-20
Identities = 22/116 (18%), Positives = 45/116 (38%), Gaps = 3/116 (2%)
Query: 75 INLPYMQLGGIISPSIGRLDKLQRLALHQNSL-HGSIPNEITNCTELRALYLRANYLQGG 133
I+ ++ +K+Q + + N+L + + +L L N L+G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGK 345
Query: 134 IPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
+PA G+ + L L+L+ N + + G + L+ + N IP+
Sbjct: 346 LPA-FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAK 399
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 4e-19
Identities = 20/133 (15%), Positives = 42/133 (31%), Gaps = 9/133 (6%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
I + + S ++ RL KL++ + + E
Sbjct: 186 TQIGQLSNNITFV-SKAVMRLTKLRQFYMGNSPFVAENICEAWEN-----ENSEYAQQYK 239
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG---EIPDFGALS 189
NL LT +++ + +P+ L L + +N++ N D+ AL+
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA 299
Query: 190 AFGNKSFIGNLDL 202
I + +
Sbjct: 300 DAPVGEKIQIIYI 312
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-18
Identities = 17/111 (15%), Positives = 29/111 (26%), Gaps = 11/111 (9%)
Query: 82 LGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI--TNCTELRALYLRANYLQGGIPANIG 139
+ + L + L N L + ++ T L + L N P
Sbjct: 476 SLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPL 533
Query: 140 NLLFLTIL------DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
N L D N P + L L + +N + +
Sbjct: 534 NSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNE 583
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 23/120 (19%), Positives = 42/120 (35%), Gaps = 11/120 (9%)
Query: 73 RSINLPYMQLGGIISP-SIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLR----- 126
SI+L + +L + L L + L NS P + N + L+ +R
Sbjct: 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQRDA 549
Query: 127 -ANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDF 185
N P I LT L + SN ++ + + ++ L++ N +
Sbjct: 550 QGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 15/97 (15%), Positives = 28/97 (28%), Gaps = 9/97 (9%)
Query: 86 ISPSIGRLDKLQRLALHQ------NSLHGSIPNEITNCTELRALYLRANYLQGGIPANIG 139
L+ + N P IT C L L + +N ++ + I
Sbjct: 528 FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKIT 586
Query: 140 NLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+ ++LD+ N S + L +
Sbjct: 587 PNI--SVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-10
Identities = 13/65 (20%), Positives = 22/65 (33%), Gaps = 1/65 (1%)
Query: 138 IGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFI 197
+ + +T L L G +P ++G+LT L L L ++ FG
Sbjct: 77 LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFG-PKGISANMSD 135
Query: 198 GNLDL 202
Sbjct: 136 EQKQK 140
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 8/79 (10%), Positives = 23/79 (29%), Gaps = 3/79 (3%)
Query: 76 NLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIP 135
+ + I L +L + N + + +I + L ++ N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDL 604
Query: 136 ANIGNLLFLTILDLSSNSL 154
+ + + + L +
Sbjct: 605 SYVCPYIEAGMYMLFYDKT 623
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 33/213 (15%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR-EGSD-QVFERELEILGSIKHINLVNLR 373
+ +G G F V R V G FA K I+ + D Q ERE I ++H N+V L
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARGL 424
+ + L++D ++ G L + + E QQ+L +
Sbjct: 95 DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE-------------SI 141
Query: 425 AYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
AY H + I+HR++K N+LL + ++DFGLA + ++ AGT GY
Sbjct: 142 AYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDSEAWHGFAGTPGY 196
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
L+PE L+ ++ D+++ GV+L L+ G P
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR---------EGSDQVFERELEILGSIK-H 366
++G G V R + +AVK ID + + + +E++IL + H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIA 417
N++ L+ L++D + G L D+L E E + LL
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE-------- 135
Query: 418 LGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAG 477
+ LH I+HRD+K NILLD+++ ++DFG + L E G
Sbjct: 136 -----VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC--G 185
Query: 478 TFGYLAPEYLQSGRA------TEKSDVYSFGVLLLELVTGKRP 514
T YLAPE ++ ++ D++S GV++ L+ G P
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 44/211 (20%), Positives = 84/211 (39%), Gaps = 32/211 (15%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+ +G G FG V+R V T+ K + V ++E+ IL +H N+++L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLV-KKEISILNIARHRNILHLHES 69
Query: 376 CRLPATKLLIYDYLSMGSLDDFLHEHGEG----------QQLLNWSARLKIALGSARGLA 425
++I++++S + + ++ Q+ L
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE-------------ALQ 116
Query: 426 YLHHDCCPKIIHRDIKSSNILL--DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
+LH I H DI+ NI+ + + +FG A+ L + ++ Y A
Sbjct: 117 FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--NFRLLFTAPEYYA 171
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
PE Q + +D++S G L+ L++G P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 61/231 (26%), Positives = 95/231 (41%), Gaps = 34/231 (14%)
Query: 299 MPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR--EGSDQVFE 355
M +C + L EE +G G F V R V G +A I+ + Q E
Sbjct: 1 MATITCTRFTEEYQLFEE--LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE 58
Query: 356 RELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQ 406
RE I +KH N+V L LI+D ++ G L + + E QQ
Sbjct: 59 REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ 118
Query: 407 LLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKL 463
+L + + H ++HR++K N+LL + ++DFGLA
Sbjct: 119 ILE-------------AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162
Query: 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+ E+ GT GYL+PE L+ + D+++ GV+L L+ G P
Sbjct: 163 VEGEQQAWFGFA-GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 43/221 (19%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR--------EGSDQVFERELEILGSIKHIN 368
+GSG G V A++ I + + E E+EIL + H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALG 419
++ ++ + ++ + + G L D + + E Q+L
Sbjct: 202 IIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL---------- 250
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVA 476
+ YLH + IIHRD+K N+LL +E+ ++DFG +K+L E + +
Sbjct: 251 ---AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC 302
Query: 477 GTFGYLAPEYLQSGRA---TEKSDVYSFGVLLLELVTGKRP 514
GT YLAPE L S D +S GV+L ++G P
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 33/211 (15%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+G G VYR +A+K + ++ + ++ E+ +L + H N++ L+
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVD--KKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 376 CRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARGLAY 426
P L+ + ++ G L D + E G E +Q+L +AY
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE-------------AVAY 163
Query: 427 LHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
LH + I+HRD+K N+L + ++DFGL+K++ + T V GT GY A
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCA 218
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
PE L+ + D++S G++ L+ G P
Sbjct: 219 PEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 40/214 (18%)
Query: 320 GSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRL 378
GSG FG M AVK I+R + V +RE+ S++H N+V +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV-QREIINHRSLRHPNIVRFKEVI-- 85
Query: 379 PATKLLIY---DYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARGLAY 426
T + +Y S G L + + G E QQLL+ G++Y
Sbjct: 86 -LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-------------GVSY 131
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPH--VSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
H +I HRD+K N LLD + P + DFG +K V +TV GT Y+AP
Sbjct: 132 CHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAP 186
Query: 485 EYLQSGR--ATEKSDVYSFGVLLLELVTGKRPTD 516
E L + + +DV+S GV L ++ G P +
Sbjct: 187 EVL-LRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 43/222 (19%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR--------EGSDQVFERELEILGSIK-HI 367
V+G G V R V G FAVK ++ + E + RE IL + H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIAL 418
+++ L + L++D + G L D+L E E + LL
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE--------- 211
Query: 419 GSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGT 478
+++LH + I+HRD+K NILLD+N++ +SDFG + L E GT
Sbjct: 212 ----AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELC--GT 262
Query: 479 FGYLAPEYLQSGRA------TEKSDVYSFGVLLLELVTGKRP 514
GYLAPE L+ ++ D+++ GV+L L+ G P
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-24
Identities = 28/133 (21%), Positives = 47/133 (35%), Gaps = 4/133 (3%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
++++L + L + S S +LQ L L + + + + L L L N +Q
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF 191
L L L +L +G L L LN++ N F
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP----EYF 145
Query: 192 GNKSFIGNLDLCG 204
N + + +LDL
Sbjct: 146 SNLTNLEHLDLSS 158
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 32/135 (23%), Positives = 51/135 (37%), Gaps = 11/135 (8%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
++ L + + + L LQ+L + +L I + L+ L + N +Q
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 133 G-IPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHY----LNLSTNFFSGEIPDFGA 187
+P NL L LDLSSN ++ + L L + L+LS N + P
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP---- 194
Query: 188 LSAFGNKSFIGNLDL 202
AF L L
Sbjct: 195 -GAFKEIRLH-KLTL 207
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-21
Identities = 22/114 (19%), Positives = 38/114 (33%), Gaps = 1/114 (0%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSI-PNEITNCTELRALYLRANYLQ 131
+++ + + L L+ L + NS + P+ T L L L L+
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDF 185
P +L L +L++S N+ L L L+ S N
Sbjct: 484 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 29/161 (18%), Positives = 52/161 (32%), Gaps = 8/161 (4%)
Query: 45 NLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLG--GIISPSIGRLDKLQRLALH 102
L + + + K + ++L L G S S L+ L L
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 103 QNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSS 161
N + + + +L L + + L+ ++ +L L LD+S + A
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440
Query: 162 LGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
L+ L L ++ N F F + LDL
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFL----PDIFTELRNLTFLDL 477
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 25/113 (22%), Positives = 38/113 (33%), Gaps = 2/113 (1%)
Query: 73 RSINLPYMQLGGIISPSI-GRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
+ + P I L L L L Q L P + + L+ L + N
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF 507
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRL-THLHYLNLSTNFFSGEIP 183
L L +LD S N + + L + L +LNL+ N F+
Sbjct: 508 SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 8e-15
Identities = 21/139 (15%), Positives = 42/139 (30%), Gaps = 10/139 (7%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+ + ++L QL + + L LQ L + N+ L+ L N+
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529
Query: 130 LQGGIPANIGNLL-FLTILDLSSNSLKGAIPSS--LGRLTHLHYLNLSTNFFSGEIPDFG 186
+ + + L L+L+ N L + L + P
Sbjct: 530 IMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP--- 586
Query: 187 ALSAFGNKSFIGNLDL-CG 204
S + +L++ C
Sbjct: 587 --SDKQGMPVL-SLNITCQ 602
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 22/126 (17%), Positives = 35/126 (27%), Gaps = 10/126 (7%)
Query: 83 GGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRA----LYLRANYLQGGIPANI 138
+ L L+ L L N + ++ ++ L L N + I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGA 196
Query: 139 GNLLFLTILDLSSNSLKGAIPS-SLGRLTHLHYLNLSTNFFSGEI----PDFGALSAFGN 193
+ L L L +N + + L L L F E D AL N
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 194 KSFIGN 199
+
Sbjct: 257 LTIEEF 262
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 20/114 (17%), Positives = 34/114 (29%), Gaps = 11/114 (9%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNE-ITNCTELRALYLRANYLQGG------IPANI 138
I P + +L +L L N ++ I L L + + +
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 139 GNLLFLTILDLSSNSLK---GAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
L LTI + L I LT++ +L + + DF
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF 304
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 22/123 (17%), Positives = 36/123 (29%), Gaps = 14/123 (11%)
Query: 82 LGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNL 141
I L + +L ++ + + L L L
Sbjct: 270 YLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQ-----FPTL 322
Query: 142 LFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNF--FSGEIPDFGALSAFGNKSFIGN 199
++ L+ S KG S L L +L+LS N F G + + +
Sbjct: 323 KLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ-----SDFGTTSLKY 377
Query: 200 LDL 202
LDL
Sbjct: 378 LDL 380
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 31/215 (14%)
Query: 313 LDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVN 371
+ + +++G G FG V++ G A K I + + E+ ++ + H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG----------QQLLNWSARLKIALGSA 421
L +L+ +Y+ G L D + + +Q+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE------------ 198
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTF 479
G+ ++H I+H D+K NIL + DFGLA+ E V GT
Sbjct: 199 -GIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KLKVNFGTP 252
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+LAPE + + +D++S GV+ L++G P
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 51/215 (23%), Positives = 85/215 (39%), Gaps = 36/215 (16%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQV--FERELEILGSIKHI-NLVNLR 373
+G G F V + + G +A K + + R G D E+ +L K ++NL
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEG-----------QQLLNWSARLKIALGSAR 422
+ +LI +Y + G + +Q+L
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE------------- 142
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPH---VSDFGLAKLLVDEEAHVTTVVAGTF 479
G+ YLH + I+H D+K NILL + DFG+++ + A + GT
Sbjct: 143 GVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--GHACELREIMGTP 197
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
YLAPE L T +D+++ G++ L+T P
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 43/212 (20%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR--------EGSDQVFERELEILGSIKHIN 368
+GSG G V A+K I + + E E+EIL + H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALG 419
++ ++ + ++ + + G L D + + E Q+L
Sbjct: 77 IIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL---------- 125
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVA 476
+ YLH + IIHRD+K N+LL +E+ ++DFG +K+L E + +
Sbjct: 126 ---AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLC 177
Query: 477 GTFGYLAPEYLQSGRA---TEKSDVYSFGVLL 505
GT YLAPE L S D +S GV+L
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSD------QVFERELEILGSIKHIN 368
+ +GSG F V + G +A K I + R S + ERE+ IL I+H N
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALG 419
++ L +LI + +S G L DFL E E +Q+L+
Sbjct: 70 IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---------- 119
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH----VSDFGLAKLLVDEEAHVTTVV 475
G+ YLH +I H D+K NI+L + P+ + DFG+A + E + +
Sbjct: 120 ---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNI 171
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
GT ++APE + ++D++S GV+ L++G P
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRI--DRSREGSDQVFERELEILGSIKHINLVNLR 373
V+G+G FG V++ + + A+K++ D+ + REL+I+ +KH N+V+L+
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN------RELQIMRIVKHPNVVDLK 98
Query: 374 GYCRLPATKLL-IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA----------R 422
+ K ++ L + + + ++ + A+LK + R
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPETVY------RASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEP-HVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
LAY+H I HRDIK N+LLD + DFG AK+L+ E +V+ + + Y
Sbjct: 153 SLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYY 207
Query: 482 LAPE-YLQSGRATEKSDVYSFGVLLLELVTGK 512
APE + T D++S G ++ EL+ G+
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 35/213 (16%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTF-AVKRID---RSREGSDQVFERELEILGSIKHINLVNL 372
+G G FG VY A+K++ + Q +E+ L ++H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 373 RGYCRLPATKL-LIYDYLSMGSLDDFLHEHG----EGQQLLNWSARLKIAL---GSARGL 424
RG C L L+ +Y GS D L H E + IA G+ +GL
Sbjct: 120 RG-CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE----------IAAVTHGALQGL 167
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
AYLH +IHRD+K+ NILL E + DFG A ++ A + V GT ++AP
Sbjct: 168 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAP 219
Query: 485 E---YLQSGRATEKSDVYSFGVLLLELVTGKRP 514
E + G+ K DV+S G+ +EL K P
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 61/219 (27%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSD------QVFERELEILGSIKHIN 368
+ +GSG F V + G +A K I + R S + ERE+ IL I+H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALG 419
++ L +LI + ++ G L DFL E E +Q+LN
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN---------- 125
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH----VSDFGLAKLLVDEEAHVTTVV 475
G+ YLH +I H D+K NI+L + P + DFGLA + + + +
Sbjct: 126 ---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNI 177
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
GT ++APE + ++D++S GV+ L++G P
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 306 IIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSI 364
+ + ++ +G G F + V FAVK I + E + ++E+ L
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN---TQKEITALKLC 62
Query: 365 K-HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EGQQLLNWSARLKIALGS 420
+ H N+V L L+ + L+ G L + + + E + ++ + L S
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE-----ASYIMRKLVS 117
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAG 477
A ++++H ++HRD+K N+L ++NLE + DFG A+L + + T
Sbjct: 118 A--VSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-F 171
Query: 478 TFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
T Y APE L E D++S GV+L +++G+ P
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 59/219 (26%), Positives = 95/219 (43%), Gaps = 38/219 (17%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSD------QVFERELEILGSIKHIN 368
+ +GSG F V + G +A K I + + + + ERE+ IL + H N
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALG 419
++ L +LI + +S G L DFL + E +Q+L+
Sbjct: 77 VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD---------- 126
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH----VSDFGLAKLLVDEEAHVTTVV 475
G+ YLH KI H D+K NI+L + P + DFGLA + D +
Sbjct: 127 ---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNI 178
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
GT ++APE + ++D++S GV+ L++G P
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 5e-23
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 26/210 (12%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER---ELEILGSIKHINLVNLR 373
V+G GGFG V+ M G +A K++++ R + ++ E +IL + +V+L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 374 GYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWS---ARL---KIALGSARGLAY 426
Y T L L+ ++ G + H + + + A +I G L +
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSG----LEH 304
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
LH II+RD+K N+LLD+ + +V SD GLA L + GT G++AP
Sbjct: 305 LHQR---NIIYRDLKPENVLLDD--DGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAP 358
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
E L D ++ GV L E++ + P
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-23
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 38/218 (17%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSD------QVFERELEILGSIKHINL 369
+ +GSG F V + G +A K I + + + + ERE+ IL + H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGS 420
+ L +LI + +S G L DFL + E +Q+L+
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD----------- 126
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH----VSDFGLAKLLVDEEAHVTTVVA 476
G+ YLH KI H D+K NI+L + P + DFGLA + E+ +
Sbjct: 127 --GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIF 179
Query: 477 GTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
GT ++APE + ++D++S GV+ L++G P
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 53/197 (26%), Positives = 84/197 (42%), Gaps = 24/197 (12%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILG-SIKHINLVNLRGY 375
+G G + R + FAVK ID+S+ E+EIL +H N++ L+
Sbjct: 29 DIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKDV 84
Query: 376 CRLPATKLLIYDYLSMGSLDDFLHEHG---EGQQLLNWSARLKIALGSARGLAYLHHDCC 432
++ + + G L D + E + ++ + + + YLH
Sbjct: 85 YDDGKYVYVVTELMKGGELLDKILRQKFFSERE-----ASAVLFTITKT--VEYLHAQ-- 135
Query: 433 PKIIHRDIKSSNILL---DENLEP-HVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
++HRD+K SNIL N E + DFG AK L E + T T ++APE L+
Sbjct: 136 -GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLE 193
Query: 489 SGRATEKSDVYSFGVLL 505
D++S GVLL
Sbjct: 194 RQGYDAACDIWSLGVLL 210
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 66/286 (23%), Positives = 110/286 (38%), Gaps = 68/286 (23%)
Query: 320 GSGGFGTVYRMVMNDCGT-FAVKRIDRSR-------EGSDQVFERELEILGSIKHI--NL 369
GSGGFG+VY + A+K +++ R +V E+ +L + +
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV-PMEVVLLKKVSSGFSGV 110
Query: 370 VNLRGYCRLPATKLLIYDYLS-MGSLDDFLHEHG---EG------QQLLNWSARLKIALG 419
+ L + P + +LI + + L DF+ E G E Q+L
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE---------- 160
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDEN-LEPHVSDFGLAKLLVDEEAHVTTVVAGT 478
+ + H+ ++HRDIK NIL+D N E + DFG LL D GT
Sbjct: 161 ---AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGT 211
Query: 479 FGYLAPEYLQSGR-ATEKSDVYSFGVLLLELVTGKRP-TDPTFVKRG-LNVVGWMNTLLK 535
Y PE+++ R + V+S G+LL ++V G P + RG + +++ +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271
Query: 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+I C P DRP+ ++
Sbjct: 272 -----HLI-------------------RWCLALRPSDRPTFEEIQN 293
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 61/208 (29%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRS---REGSDQV--FERELEILGSIKHINLVN 371
++G G F TV +A+K +++ +E ++V RE +++ + H V
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKE--NKVPYVTRERDVMSRLDHPFFVK 94
Query: 372 LRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHH 429
L + KL Y G L + G R A + SA L YLH
Sbjct: 95 LYFTFQDD-EKLYFGLSYAKNGEL--LKYIRKIGS-FDETCTRFYTAEIVSA--LEYLHG 148
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTV-VAGTFGYLAPEY 486
IIHRD+K NILL+E++ H+ +DFG AK+L E GT Y++PE
Sbjct: 149 K---GIIHRDLKPENILLNEDM--HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 203
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRP 514
L A + SD+++ G ++ +LV G P
Sbjct: 204 LTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRI--DRSREGSDQVFERELEILGSIKHINLVNL 372
V+G+G FG VY+ + D G A+K++ D+ + REL+I+ + H N+V L
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDHCNIVRL 112
Query: 373 RGYCRLPATKLL-IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA---------- 421
R + K +Y L + + + ++ ++ +R K L
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVY------RVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEP-HVSDFGLAKLLVDEEAHVTTVVAGTFG 480
R LAY+H I HRDIK N+LLD + + DFG AK LV E +V+ + +
Sbjct: 167 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRY 221
Query: 481 YLAPEY-LQSGRATEKSDVYSFGVLLLELVTGK 512
Y APE + T DV+S G +L EL+ G+
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 3e-22
Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 25/208 (12%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---RELEILGSIKHINLVNLR 373
V+G GGFG V + G +A K++++ R + E +IL + +V+L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250
Query: 374 GYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWS-ARL---KIALGSARGLAYLH 428
Y L L+ ++ G L H + GQ + A +I G L LH
Sbjct: 251 -YAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAAEICCG----LEDLH 303
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
+ +I++RD+K NILLD+ H+ SD GLA + + + GT GY+APE
Sbjct: 304 RE---RIVYRDLKPENILLDD--HGHIRISDLGLAVHVPEGQ--TIKGRVGTVGYMAPEV 356
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRP 514
+++ R T D ++ G LL E++ G+ P
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 41/216 (18%)
Query: 320 GSGGFGTVYRMVMNDCG-TFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYC 376
G G +G V V AVK +D R + + + ++E+ I + H N+V G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI-KKEICINKMLNHENVVKFYGHR 74
Query: 377 RLPATKLLIY---DYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARGL 424
+ Y +Y S G L D + E QL+ G+
Sbjct: 75 ---REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------------GV 118
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD--EEAHVTTVVAGTFGYL 482
YLH I HRDIK N+LLDE +SDFGLA + E + + GT Y+
Sbjct: 119 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174
Query: 483 APEYLQSGR--ATEKSDVYSFGVLLLELVTGKRPTD 516
APE L R E DV+S G++L ++ G+ P D
Sbjct: 175 APELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-22
Identities = 33/132 (25%), Positives = 49/132 (37%), Gaps = 3/132 (2%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
S+++ + + + +L L+ L L N L CT L L+L +N +Q
Sbjct: 52 TSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQK 111
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFG 192
L LDLS N L + +L +L L LS N + L F
Sbjct: 112 IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSE--ELDIFA 169
Query: 193 NKSFIGNLDLCG 204
N S L+L
Sbjct: 170 NSSLK-KLELSS 180
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 7e-22
Identities = 29/131 (22%), Positives = 48/131 (36%), Gaps = 5/131 (3%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
+ +NL + QL + + + R +L L + N++ P L+ L L+ N L
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF 191
LT L L SNS++ + + +L L+LS N S
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG-----TQ 141
Query: 192 GNKSFIGNLDL 202
+ L L
Sbjct: 142 VQLENLQELLL 152
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-19
Identities = 28/132 (21%), Positives = 44/132 (33%), Gaps = 4/132 (3%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
++L + I + + L L L N L + L+ L L N +Q
Sbjct: 100 TELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA 159
Query: 133 GIPANIG--NLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
+ L L+LSSN +K P + L L L+ + + L
Sbjct: 160 LKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE--KLCL 217
Query: 191 FGNKSFIGNLDL 202
+ I NL L
Sbjct: 218 ELANTSIRNLSL 229
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-19
Identities = 25/132 (18%), Positives = 49/132 (37%), Gaps = 9/132 (6%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
++L Y L + + S L +L+ L N++ + + +R L L+ ++ +
Sbjct: 251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310
Query: 133 GIPAN---------IGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP 183
I L L L++ N + G + L +L YL+LS +F S
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 184 DFGALSAFGNKS 195
+ +
Sbjct: 371 TNETFVSLAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-18
Identities = 33/158 (20%), Positives = 51/158 (32%), Gaps = 14/158 (8%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLH--------GSIPNEITNCTELRALY 124
++L + I + L+KL+ L L N+L G + + L L
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 125 LRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
L +N +L L I+DL N+L S L LNL N +
Sbjct: 543 LESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEK- 601
Query: 185 FGALSAFGNK-SFIGNLDLCGRQVHKPCRTSMGFPAVL 221
FG + LD+ C + F +
Sbjct: 602 ----KVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWI 635
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-18
Identities = 31/136 (22%), Positives = 50/136 (36%), Gaps = 6/136 (4%)
Query: 73 RSINLPYMQLGGIISPS-IGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
++L ++G ++ L+ + + L N N L+ L LR L+
Sbjct: 408 EVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467
Query: 132 G--GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN---FFSGEIPDFG 186
P+ L LTILDLS+N++ L L L L+L N G
Sbjct: 468 NVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGG 527
Query: 187 ALSAFGNKSFIGNLDL 202
+ S + L+L
Sbjct: 528 PIYFLKGLSHLHILNL 543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 30/132 (22%), Positives = 50/132 (37%), Gaps = 6/132 (4%)
Query: 70 QRVRSINLPYMQLGGIISPSIG---RLDKLQRLALHQNSLHGSIPNEITNC--TELRALY 124
R+ + L +QLG ++ + ++ L+L + L + T L L
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 125 LRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
L N L + L L L N+++ SL L ++ YLNL +F I
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSIS- 313
Query: 185 FGALSAFGNKSF 196
+L + SF
Sbjct: 314 LASLPKIDDFSF 325
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-17
Identities = 24/130 (18%), Positives = 39/130 (30%), Gaps = 1/130 (0%)
Query: 76 NLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIP 135
L G + L L L L N + EL+ + L N L
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 136 ANIGNLLFLTILDLSSNSLKGAIPSSLGR-LTHLHYLNLSTNFFSGEIPDFGALSAFGNK 194
+ N + L L+L N + G +L L++ N F + N+
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINE 637
Query: 195 SFIGNLDLCG 204
+ +L
Sbjct: 638 THTNIPELSS 647
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 30/165 (18%), Positives = 53/165 (32%), Gaps = 12/165 (7%)
Query: 45 NLLGNWQATEESPCKWTGISCHT--HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALH 102
NL ++ S I + + + +N+ + GI S L L+ L+L
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 103 QNSLHGSIPNEIT----NCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAI 158
+ T + L L L N + L L +LDL N + +
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 159 P-SSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
L ++ + LS N + + +F + L L
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRN-----SFALVPSLQRLML 461
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 17/100 (17%), Positives = 27/100 (27%), Gaps = 1/100 (1%)
Query: 95 KLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPAN-IGNLLFLTILDLSSNS 153
L L L +N + + + L L L N + + L + + LS N
Sbjct: 382 PLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNK 441
Query: 154 LKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGN 193
+S + L L L N
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 25/122 (20%), Positives = 43/122 (35%), Gaps = 6/122 (4%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+ +NL I L +L+ + L N+L+ + N L++L L+ N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNL 595
Query: 130 LQGGIPANIGNLL-FLTILDLSSNSLKGAIPSSLG-----RLTHLHYLNLSTNFFSGEIP 183
+ G LT LD+ N S TH + LS+++ P
Sbjct: 596 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPP 655
Query: 184 DF 185
+
Sbjct: 656 HY 657
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 14/59 (23%), Positives = 23/59 (38%), Gaps = 8/59 (13%)
Query: 144 LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
+ D S L +P L T++ LNL+ N + F S + +LD+
Sbjct: 6 HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPA-----ANFTRYSQLTSLDV 56
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 6e-22
Identities = 69/211 (32%), Positives = 100/211 (47%), Gaps = 30/211 (14%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR-EGSDQVF----ERE-LEILGSIKHINLV 370
++G GGFG VY D G +A+K +D+ R + ER L ++ + +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 371 NLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARL---KIALGSARGLAY 426
+ Y KL I D ++ G L H G R +I LG L +
Sbjct: 256 CMS-YAFHTPDKLSFILDLMNGGDL--HYHLSQHGV-FSEADMRFYAAEIILG----LEH 307
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
+H+ +++RD+K +NILLDE HV SD GLA ++ H V GT GY+AP
Sbjct: 308 MHNR---FVVYRDLKPANILLDE--HGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAP 359
Query: 485 EYLQSGRATEKS-DVYSFGVLLLELVTGKRP 514
E LQ G A + S D +S G +L +L+ G P
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 55/234 (23%)
Query: 320 GSGGFGTVYRMVMNDCGT-FAVKRIDRSR--------------------------EGSDQ 352
G G +G V + T +A+K + + + G +
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 353 VFERELEILGSIKHINLVNLRGYCRL-PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWS 411
+E+ IL + H N+V L L + +Y + E ++
Sbjct: 82 QVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLY----------MVFELVNQGPVMEVP 129
Query: 412 ARLKIALGSAR--------GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463
++ AR G+ YLH+ KIIHRDIK SN+L+ E+ ++DFG++
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRAT---EKSDVYSFGVLLLELVTGKRP 514
+A ++ GT ++APE L R + DV++ GV L V G+ P
Sbjct: 187 FKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 33/211 (15%)
Query: 320 GSGGFGTVYRMVMNDCGT-FAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYC 376
G G F V G A+K ID+++ S Q RE+ I+ + H N+V L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 377 RLPATKLLIYDYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARGLAYL 427
T LI +Y S G + D+L HG E +Q+++ + Y
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-------------AVQYC 130
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
H I+HRD+K+ N+LLD ++ ++DFG + G Y APE
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC--GAPPYAAPELF 185
Query: 488 QSGRATE--KSDVYSFGVLLLELVTGKRPTD 516
Q G+ + + DV+S GV+L LV+G P D
Sbjct: 186 Q-GKKYDGPEVDVWSLGVILYTLVSGSLPFD 215
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 9e-22
Identities = 55/217 (25%), Positives = 90/217 (41%), Gaps = 35/217 (16%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRI-----DRSREGSDQVFERELEILGSIKHINL 369
E + G G FGTV G + A+K++ R+RE + ++ L + H N+
Sbjct: 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE------LQIMQDLAVLHHPNI 81
Query: 370 VNLRGYCRLPATKLL--IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA------ 421
V L+ Y + IY + M + D LH + R ++A
Sbjct: 82 VQLQSYFYTLGERDRRDIYLNVVMEYVPDTLH------RCCRNYYRRQVAPPPILIKVFL 135
Query: 422 ----RGLAYLHHDCCPKIIHRDIKSSNILLD-ENLEPHVSDFGLAKLLVDEEAHVTTVVA 476
R + LH + HRDIK N+L++ + + DFG AK L E +V +
Sbjct: 136 FQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC- 193
Query: 477 GTFGYLAPEY-LQSGRATEKSDVYSFGVLLLELVTGK 512
+ Y APE + T D++S G + E++ G+
Sbjct: 194 -SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 65/288 (22%), Positives = 102/288 (35%), Gaps = 70/288 (24%)
Query: 320 GSGGFGTVYRMVMNDCGT-FAVKRIDRSR-------EGSDQVFERELEIL----GSIKHI 367
G GGFGTV+ A+K I R+R S E+ +L H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC-PLEVALLWKVGAGGGHP 98
Query: 368 NLVNLRGYCRLPATKLLIYDY-LSMGSLDDFLHEHG---EG------QQLLNWSARLKIA 417
++ L + +L+ + L L D++ E G EG Q++
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-------- 150
Query: 418 LGSARGLAYLHHDCCPKIIHRDIKSSNILLD-ENLEPHVSDFGLAKLLVDEEAHVTTVVA 476
+ + H ++HRDIK NIL+D + DFG LL DE
Sbjct: 151 -----AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---D 199
Query: 477 GTFGYLAPEYLQSGR-ATEKSDVYSFGVLLLELVTGKRP-TDPTFVKRG-LNVVGWMNTL 533
GT Y PE++ + + V+S G+LL ++V G P + L+ ++
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHVSPD 259
Query: 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+I RC P RPS+ ++L
Sbjct: 260 CC-----ALI-------------------RRCLAPKPSSRPSLEEILL 283
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 41/216 (18%)
Query: 320 GSGGFGTVYRMVMNDCGT-FAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYC 376
G G +G V V AVK +D R + + + ++E+ I + H N+V G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI-KKEICINKMLNHENVVKFYGHR 74
Query: 377 RLPATKLLIY---DYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARGL 424
+ Y +Y S G L D + E QL+ G+
Sbjct: 75 ---REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-------------GV 118
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD--EEAHVTTVVAGTFGYL 482
YLH I HRDIK N+LLDE +SDFGLA + E + + GT Y+
Sbjct: 119 VYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174
Query: 483 APEYLQSGR--ATEKSDVYSFGVLLLELVTGKRPTD 516
APE L R E DV+S G++L ++ G+ P D
Sbjct: 175 APELL-KRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-21
Identities = 22/128 (17%), Positives = 43/128 (33%), Gaps = 13/128 (10%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
N Y + S L L + L+ +P+ + + EL++L + N
Sbjct: 470 EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS 529
Query: 133 ---------GIPANIGNLLFLTILDLSSNSLKGAIPSS--LGRLTHLHYLNLSTNFFSGE 181
+ + + I + N+L+ P+S L ++ L L+ N
Sbjct: 530 AAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVR-H 587
Query: 182 IPDFGALS 189
+ FG
Sbjct: 588 LEAFGTNV 595
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 7e-19
Identities = 20/147 (13%), Positives = 41/147 (27%), Gaps = 22/147 (14%)
Query: 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSL-------HGSIPNEITNCTELRAL 123
++ L Y ++ + + + L N + N L +
Sbjct: 674 NASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTI 733
Query: 124 YLRANYLQGGIPANI--GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNL------ST 175
LR N L + + L +L+ +D+S N P+ + L +
Sbjct: 734 DLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEG 791
Query: 176 NFFSGEIPDFGALSAFGNKSFIGNLDL 202
N + P + L +
Sbjct: 792 NRILRQWPT-----GITTCPSLIQLQI 813
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-18
Identities = 25/138 (18%), Positives = 41/138 (29%), Gaps = 15/138 (10%)
Query: 75 INLPYMQLGGI------ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN 128
I+L Q+G + IS +I RL KLQ + + +
Sbjct: 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNI-----AVDWEDANSDYA 477
Query: 129 YLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
+ NL LT ++L + +P L L L LN++ N
Sbjct: 478 KQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADW 537
Query: 189 S----AFGNKSFIGNLDL 202
+ I +
Sbjct: 538 TRLADDEDTGPKIQIFYM 555
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-17
Identities = 25/135 (18%), Positives = 50/135 (37%), Gaps = 12/135 (8%)
Query: 73 RSINLPYMQLGGIISP-SIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLR----- 126
+I+L + +L + L L + + N S P + N ++L+A +R
Sbjct: 731 TTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDA 789
Query: 127 -ANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN-FFSGEIPD 184
N + P I L L + SN ++ + L L+ L+++ N S ++
Sbjct: 790 EGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTS 846
Query: 185 FGALSAFGNKSFIGN 199
G + +
Sbjct: 847 VCPYIEAGMYVLLYD 861
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 7e-16
Identities = 22/160 (13%), Positives = 51/160 (31%), Gaps = 3/160 (1%)
Query: 32 TLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRV-RSINLPYMQLGGIISPSI 90
L E + D + L W+A + ++ + + + + N G +
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDL 319
Query: 91 GRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150
++ L+L G +P+ I TEL+ L + L + +
Sbjct: 320 DNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEER 379
Query: 151 SNSLKGAIPS-SLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
+ ++ L L+ +L + + P+ +
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAIN-RNPEMKPIK 418
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 22/129 (17%), Positives = 43/129 (33%), Gaps = 15/129 (11%)
Query: 86 ISPSIGR-LDKLQRLALHQNSLHGSIPN--EITNCTELRALYLRANYLQGGIPANIG--- 139
I D+++ L N L IPN + + ++ N + NI
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSM 667
Query: 140 ---NLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD---FGALSAFGN 193
+ + + LS N ++ + + + LS N + IP+ + N
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKN 726
Query: 194 KSFIGNLDL 202
+ +DL
Sbjct: 727 TYLLTTIDL 735
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 24/120 (20%), Positives = 43/120 (35%), Gaps = 11/120 (9%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNE--ITNCTELRALYLRANYLQGGIPANIGNLLF 143
++ K+Q + N+L P + +L L N ++ + A G +
Sbjct: 540 LADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEA-FGTNVK 596
Query: 144 LTILDLSSNSLKGAIPSSLGR-LTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
LT L L N ++ IP + L S N IP+ + +G++D
Sbjct: 597 LTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNA---KSVYVMGSVDF 651
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 71/209 (33%), Positives = 103/209 (49%), Gaps = 26/209 (12%)
Query: 318 VVGSGGFGTVY---RMVMNDCGT-FAVKRIDR----SREGSDQVFERELEILGSIKHINL 369
V+G G FG V+ ++ +D +A+K + + R+ ER+ IL + H +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERD--ILVEVNHPFI 88
Query: 370 VNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYL 427
V L Y KL LI D+L G L F E + +A L A L +L
Sbjct: 89 VKLH-YAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEED-VKFYLAELALA--LDHL 142
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
H II+RD+K NILLDE E H+ +DFGL+K +D E + GT Y+APE
Sbjct: 143 HSL---GIIYRDLKPENILLDE--EGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPE 196
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+ T+ +D +SFGVL+ E++TG P
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 4e-21
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 23/210 (10%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR-EGSDQV--FERELEILGSIKHINLVNLR 373
V+G G FG V + + + FA+K +++ + F E ++L + + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 374 GYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHHDC 431
Y L L+ DY G L +L AR +A + A + +H
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDL--LTLLSKFEDRLPEEMARFYLAEMVIA--IDSVHQL- 194
Query: 432 CPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS 489
+HRDIK NIL+D N H+ +DFG L+++ ++V GT Y++PE LQ+
Sbjct: 195 --HYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 250
Query: 490 GRATEKS-----DVYSFGVLLLELVTGKRP 514
+ D +S GV + E++ G+ P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 318 VVGSGGFGTVY---RMVMNDCGT-FAVKRIDRSR--EGSDQVF----ERELEILGSIKHI 367
V+G GG+G V+ ++ + G FA+K + ++ + ER IL +KH
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN--ILEEVKHP 81
Query: 368 NLVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLA 425
+V+L Y KL LI +YLS G L F+ EG + + A +A + A L
Sbjct: 82 FIVDLI-YAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMEDT-ACFYLAEISMA--LG 135
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
+LH II+RD+K NI+L+ + HV +DFGL K + + T GT Y+A
Sbjct: 136 HLHQK---GIIYRDLKPENIMLNH--QGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMA 189
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
PE L D +S G L+ +++TG P
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 6e-21
Identities = 41/281 (14%), Positives = 73/281 (25%), Gaps = 65/281 (23%)
Query: 316 EDVVGSGGFGTVY--------RMVMNDCGTFAVKRIDRSREGSDQV---FERELEILGSI 364
G + R V A+ +D D V L I
Sbjct: 36 LIFHGGVPPLQFWQALDTALDRQV-------ALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
+ + A L++ +++ GSL + + ++ A
Sbjct: 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAA 142
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
H + S + VS G L +
Sbjct: 143 DAAHRA---GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATMPD 178
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544
A + D+ G L L+ + P V+ GL + + I+
Sbjct: 179 -------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIE 224
Query: 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
D D+ I +AAR + R + +L L++Q
Sbjct: 225 PADIDRDIP--FQISAVAARSVQGDGGIRSAS-TLLNLMQQ 262
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-21
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 40/215 (18%)
Query: 320 GSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---RELEILGSIKHINLVNLRGY 375
G G FG V G AVK ++R + S V RE++ L +H +++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY-- 77
Query: 376 CRLPATKLLIY---DYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARG 423
++ +T + +Y+S G L D++ +HG E QQ+L+
Sbjct: 78 -QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-------------A 123
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
+ Y H ++HRD+K N+LLD ++ ++DFGL+ ++ D E T+ G+ Y A
Sbjct: 124 VDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAA 178
Query: 484 PEYLQSGRATE--KSDVYSFGVLLLELVTGKRPTD 516
PE + SGR + D++S GV+L L+ G P D
Sbjct: 179 PEVI-SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-21
Identities = 64/292 (21%), Positives = 113/292 (38%), Gaps = 40/292 (13%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLR 373
EDV+G G V + +AVK I++ RE+E+L + H N++ L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHG---EGQQLLNWSARLKIALGSARGLAYLHHD 430
+ L+++ + GS+ +H+ E + ++ + + SA L +LH+
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE-----ASVVVQDVASA--LDFLHN- 129
Query: 431 CCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLL------VDEEAHVTTVVAGTFGY 481
I HRD+K NIL ++ + DF L + G+ Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 482 LAPEYLQSGRATEKS-----DVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE 536
+APE +++ D++S GV+L L++G P FV R + GW
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP----FVGRCGSDCGWDRGEACP 243
Query: 537 NRLEDVIDK-RCADADMETVE--AILEIA----ARCTDANPDDRPSMNQVLQ 581
+ + + + + I A ++ + R S QVLQ
Sbjct: 244 ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-21
Identities = 55/213 (25%), Positives = 87/213 (40%), Gaps = 27/213 (12%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDR----SREGSDQVFERELEILGSIKHINLVNL 372
V+G G F V + M G +A+K +++ R E E ++L + + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE-ERDVLVNGDRRWITQL 126
Query: 373 RGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHHD 430
+ L L+ +Y G L G+++ AR +A + A + +H
Sbjct: 127 H-FAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARFYLAEIVMA--IDSVHRL 181
Query: 431 CCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
+HRDIK NILLD H+ +DFG L + + V GT YL+PE LQ
Sbjct: 182 ---GYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 489 SGRATEKSDVY-------SFGVLLLELVTGKRP 514
+ + Y + GV E+ G+ P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 32/219 (14%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR----EGSDQVFERELEILGSIKHINLV 370
D++G G +G V ++ ++ AVK + + + + ++E+++L ++H N++
Sbjct: 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVI 69
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG--QQLLNWSARLKIALGSAR------ 422
L K +Y + M E+ Q++L+ + + A
Sbjct: 70 QLVDVLY-NEEKQKMY--MVM--------EYCVCGMQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 423 --GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE-EAHVTTVVAGTF 479
GL YLH I+H+DIK N+LL +S G+A+ L G+
Sbjct: 119 IDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 480 GYLAPEYLQSGRATE--KSDVYSFGVLLLELVTGKRPTD 516
+ PE K D++S GV L + TG P +
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-20
Identities = 45/219 (20%), Positives = 81/219 (36%), Gaps = 44/219 (20%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLR 373
+ V+G G G V G A+K + S + +E++ ++V +
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCIL 88
Query: 374 GYC----RLPATKLLIYDYLSMGSLDDFLHEHGEG-----------QQLLNWSARLKIAL 418
L+I + + G L + E G+ + +
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT--------- 139
Query: 419 GSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVV 475
+ +LH I HRD+K N+L +++ ++DFG AK + T
Sbjct: 140 ----AIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC 190
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
T Y+APE L + + D++S GV++ L+ G P
Sbjct: 191 -YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 69/214 (32%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 318 VVGSGGFGTVY---RMVMNDCGT-FAVK-----RIDRSREGSDQVF-ERELEILGSIKHI 367
V+G+G +G V+ ++ +D G +A+K I + + ++ ER+ +L I+
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ--VLEHIRQS 118
Query: 368 N-LVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGL 424
LV L Y TKL LI DY++ G L F H + + ++ + + A L
Sbjct: 119 PFLVTLH-YAFQTETKLHLILDYINGGEL--FTHLSQRERFTEHE-VQIYVGEIVLA--L 172
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYL 482
+LH II+RDIK NILLD HV +DFGL+K V +E GT Y+
Sbjct: 173 EHLHKL---GIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 483 APEYLQSGRA--TEKSDVYSFGVLLLELVTGKRP 514
AP+ ++ G + + D +S GVL+ EL+TG P
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 1e-19
Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 38/221 (17%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRI--DRSREGSDQVFERELEILGSI 364
EKLE + E G +GTV++ + A+KR+ D EG RE+ +L +
Sbjct: 5 EKLEKIGE------GTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL 58
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG----------QQLLNWSARL 414
KH N+V L L++++ L + QLL
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL------ 111
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
+GL + H ++HRD+K N+L++ N E +++FGLA+ +
Sbjct: 112 -------KGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
Query: 475 VAGTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTGKRP 514
V T Y P+ L + + D++S G + EL RP
Sbjct: 162 VV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 62/231 (26%), Positives = 101/231 (43%), Gaps = 39/231 (16%)
Query: 298 DMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE- 355
+ +EK E L +VG G +G V + D G A+K+ S + D++ +
Sbjct: 15 GTENLYFQSMEKYENLG---LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD--DKMVKK 69
Query: 356 ---RELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG-------- 404
RE+++L ++H NLVNL C+ L+++++ ++ D L G
Sbjct: 70 IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQK 128
Query: 405 --QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462
Q++ G+ + H IIHRDIK NIL+ ++ + DFG A+
Sbjct: 129 YLFQII-------------NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFAR 172
Query: 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKS-DVYSFGVLLLELVTGK 512
L VA T Y APE L K+ DV++ G L+ E+ G+
Sbjct: 173 TLAAPGEVYDDEVA-TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 49/230 (21%), Positives = 85/230 (36%), Gaps = 45/230 (19%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGS 363
II+ + + V+G G G V ++ FA+K + RE+E+
Sbjct: 58 AIIDDYKVTSQ--VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWR 110
Query: 364 I-KHINLVNLRGYC----RLPATKLLIYDYLSMGSLDDFLHEHGEG-----------QQL 407
+ ++V + L++ + L G L + + G+ + +
Sbjct: 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 170
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLL 464
+ YLH I HRD+K N+L N ++DFG AK
Sbjct: 171 GE-------------AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214
Query: 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+ T T Y+APE L + + D++S GV++ L+ G P
Sbjct: 215 TSHNSLTTPC--YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 58/218 (26%), Positives = 82/218 (37%), Gaps = 40/218 (18%)
Query: 320 GSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE--------RELEILGSIKHINLV 370
GSG FG V+ V + VK I + + D E E+ IL ++H N++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 371 NLRGYCRLPATKLLIY----DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS------ 420
+ + + S L F+ H RL L S
Sbjct: 93 KVLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHP----------RLDEPLASYIFRQL 139
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFG 480
+ YL IIHRDIK NI++ E+ + DFG A L + T GT
Sbjct: 140 VSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC--GTIE 194
Query: 481 YLAPEYLQSGRATE--KSDVYSFGVLLLELVTGKRPTD 516
Y APE L G + +++S GV L LV + P
Sbjct: 195 YCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 3e-19
Identities = 58/225 (25%), Positives = 96/225 (42%), Gaps = 51/225 (22%)
Query: 319 VGSGGFGTVYRMVMNDCGT---FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
VG G +G VY+ D +A+K+I+ G RE+ +L +KH N+++L+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSACREIALLRELKHPNVISLQKV 86
Query: 376 CRLPATKL--LIYDYLSMGSLDDFLHEHGEG------------------QQLLNWSARLK 415
A + L++DY L + H Q+L+
Sbjct: 87 FLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILD------ 139
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH----VSDFGLAKLL---VDEE 468
G+ YLH + ++HRD+K +NIL+ ++D G A+L +
Sbjct: 140 -------GIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 469 AHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGK 512
A + VV TF Y APE L R T+ D+++ G + EL+T +
Sbjct: 190 ADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 4e-19
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER--------ELEILGSIKHIN 368
++G G FG V + G +A+K + + + + + E +L + +H
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKK-----EVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 369 LVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAY 426
L L+ Y +L + +Y + G L F H E AR A + SA L Y
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGEL--FFHLSRERV-FSEDRARFYGAEIVSA--LDY 263
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
LH + +++RD+K N++LD+ + H+ +DFGL K + + A GT YLAP
Sbjct: 264 LHSEK--NVVYRDLKLENLMLDK--DGHIKITDFGLCKEGIKDGA-TMKTFCGTPEYLAP 318
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
E L+ D + GV++ E++ G+ P
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 4e-19
Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 40/215 (18%)
Query: 320 GSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---RELEILGSIKHINLVNLRGY 375
G G FG V G AVK ++R + S V RE++ L +H +++ L Y
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL--Y 82
Query: 376 CRLPATKLLIY---DYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARG 423
++ +T I+ +Y+S G L D++ ++G E QQ+L+ G
Sbjct: 83 -QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-------------G 128
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
+ Y H ++HRD+K N+LLD ++ ++DFGL+ ++ D E T+ G+ Y A
Sbjct: 129 VDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC--GSPNYAA 183
Query: 484 PEYLQSGRATE--KSDVYSFGVLLLELVTGKRPTD 516
PE + SGR + D++S GV+L L+ G P D
Sbjct: 184 PEVI-SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 5e-19
Identities = 52/239 (21%), Positives = 89/239 (37%), Gaps = 53/239 (22%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRI--DRSREGSDQVFERELEILGSIKHINLVNL 372
+G+G FG V + + G FA+K++ D + REL+I+ + H+N++ L
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK------NRELDIMKVLDHVNIIKL 65
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG---------------------------Q 405
Y + +G
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125
Query: 406 QLLNWSARLKIALGSA----------RGLAYLHHDCCPKIIHRDIKSSNILLD-ENLEPH 454
++L R ++ R + ++H I HRDIK N+L++ ++
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLK 182
Query: 455 VSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE-YLQSGRATEKSDVYSFGVLLLELVTGK 512
+ DFG AK L+ E V + + Y APE L + T D++S G + EL+ GK
Sbjct: 183 LCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 63/240 (26%), Positives = 104/240 (43%), Gaps = 45/240 (18%)
Query: 298 DMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRI--DRSREGSDQVF 354
+ P C+ + K E L + +G G FG V++ G A+K++ + +EG
Sbjct: 7 SVECPFCDEVSKYEKLAK---IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA 63
Query: 355 ERELEILGSIKHINLVNLRGYCRLPATKL--------LIYDYLS---MGSLDDFLHEHGE 403
RE++IL +KH N+VNL CR A+ L++D+ G L + L +
Sbjct: 64 LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL 123
Query: 404 GQ------QLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSD 457
+ LL GL Y+H + KI+HRD+K++N+L+ + ++D
Sbjct: 124 SEIKRVMQMLL-------------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167
Query: 458 FGLAKL----LVDEEAHVTTVVAGTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTGK 512
FGLA+ + T V T Y PE L D++ G ++ E+ T
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 50/231 (21%), Positives = 91/231 (39%), Gaps = 39/231 (16%)
Query: 300 PYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRI--DRSREGSDQVFER 356
PS I++ + + +G G +G VY+ + A+KRI + EG R
Sbjct: 26 AAPSATSIDRYRRITK---LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR 82
Query: 357 ELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGE---------GQQL 407
E+ +L ++H N++ L+ LI++Y L ++ ++ + QL
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH-----VSDFGLAK 462
+ G+ + H + +HRD+K N+LL + + DFGLA+
Sbjct: 142 I-------------NGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
Query: 463 LLVDEEAHVTTVVAGTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTGK 512
T + T Y PE L S + D++S + E++
Sbjct: 186 AFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 38/229 (16%)
Query: 298 DMPYPSC-EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRI--DRSREGSDQVF 354
++ + E +KLE + E G +G VY+ + A+KRI D EG
Sbjct: 13 NLYFQGLMEKYQKLEKVGE------GTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA 66
Query: 355 ERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG---------- 404
RE+ +L + H N+V+L L+++++ L L E+ G
Sbjct: 67 IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYL 125
Query: 405 QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464
QLL RG+A+ H +I+HRD+K N+L++ + ++DFGLA+
Sbjct: 126 YQLL-------------RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF 169
Query: 465 VDEEAHVTTVVAGTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTGK 512
T V T Y AP+ L S + + D++S G + E++TGK
Sbjct: 170 GIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 38/219 (17%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRI--DRSREGSDQVFERELEILGSI 364
EK+ +G G +G V++ D G A+K+ ++ RE+ +L +
Sbjct: 6 EKIG------KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL 59
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG----------QQLLNWSARL 414
KH NLVNL R L+++Y ++ L + G Q L
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTL------ 112
Query: 415 KIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTV 474
+ + + H IHRD+K NIL+ ++ + DFG A+LL +
Sbjct: 113 -------QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162
Query: 475 VAGTFGYLAPEYLQSGRATEKS-DVYSFGVLLLELVTGK 512
VA T Y +PE L DV++ G + EL++G
Sbjct: 163 VA-TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 54/209 (25%), Positives = 86/209 (41%), Gaps = 24/209 (11%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR-EGSDQV--FERELEILGSIKHINLVNLR 373
V+G G FG V + +A+K + + F E +I+ +V L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 374 GYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHHDC 431
Y L ++ +Y+ G D ++ + AR A + A L +H
Sbjct: 136 -YAFQDDRYLYMVMEYMPGG---DLVN-LMSNYDVPEKWARFYTAEVVLA--LDAIHSM- 187
Query: 432 CPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS 489
IHRD+K N+LLD++ H+ +DFG + E GT Y++PE L+S
Sbjct: 188 --GFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 490 ----GRATEKSDVYSFGVLLLELVTGKRP 514
G + D +S GV L E++ G P
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 48/207 (23%), Positives = 81/207 (39%), Gaps = 37/207 (17%)
Query: 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE 449
S+ +++ + L + + A+G+ +L K IHRD+ + NILL E
Sbjct: 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 228
Query: 450 NLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL-----APEYLQSGRATEKSDVYSFGVL 504
+ DFGLA+ + + +V L APE + T +SDV+SFGVL
Sbjct: 229 KNVVKICDFGLARDIYKDPDYV----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284
Query: 505 LLELVT-GKRP-----TDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAI 558
L E+ + G P D F +R L + R+ +
Sbjct: 285 LWEIFSLGASPYPGVKIDEEFCRR----------LKEGTRMRA--PDYTTP-------EM 325
Query: 559 LEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ C P RP+ +++++ L
Sbjct: 326 YQTMLDCWHGEPSQRPTFSELVEHLGN 352
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR-EGSDQV----FERELEILG 362
+L+ D +G+G FG V + + G +A+K +D+ + Q+ E+ IL
Sbjct: 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKR--ILQ 96
Query: 363 SIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSA 421
++ LV L + + ++ +Y++ G + F H G+ AR A +
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGR-FSEPHARFYAAQIVLT 153
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTF 479
YLH +I+RD+K N+L+D+ + ++ +DFG AK T + GT
Sbjct: 154 --FEYLHSL---DLIYRDLKPENLLIDQ--QGYIQVTDFGFAK----RVKGRTWTLCGTP 202
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
LAPE + S + D ++ GVL+ E+ G P
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 30/210 (14%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER--------ELEILGSIKHIN 368
++G G FG V + G +A+K + + + + + E +L + +H
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRK-----EVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 369 LVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAY 426
L L+ Y +L + +Y + G L F H E AR A + SA L Y
Sbjct: 67 LTALK-YAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEER-ARFYGAEIVSA--LEY 120
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
LH +++RDIK N++LD+ + H+ +DFGL K + + A GT YLAP
Sbjct: 121 LHSR---DVVYRDIKLENLMLDK--DGHIKITDFGLCKEGISDGA-TMKTFCGTPEYLAP 174
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
E L+ D + GV++ E++ G+ P
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 27/104 (25%), Positives = 38/104 (36%), Gaps = 2/104 (1%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147
SI L L+ L + + L ++ I + +L L LR P G L L
Sbjct: 200 ASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRL 258
Query: 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSA 190
L S +P + RLT L L+L +P L A
Sbjct: 259 ILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 25/114 (21%), Positives = 39/114 (34%), Gaps = 13/114 (11%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT 145
RL LQ + + L +P+ + L L L N L+ +PA+I +L L
Sbjct: 96 FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLR 153
Query: 146 ILDLSSNSLKGAIPSSLGR---------LTHLHYLNLSTNFFSGEIPD-FGALS 189
L + + +P L L +L L L +P L
Sbjct: 154 ELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQ 206
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 22/95 (23%), Positives = 39/95 (41%), Gaps = 2/95 (2%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLR-ANYLQGGIPANIGNLLFL 144
+ P+I L KL+ L L + + P L+ L L+ + L +P +I L L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQL 279
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
LDL +PS + +L + + + +
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 25/112 (22%), Positives = 47/112 (41%), Gaps = 12/112 (10%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNC---------TELRALYLRANYLQGGIPANI 138
SI L++L+ L++ +P + + L++L L ++ +PA+I
Sbjct: 144 ASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS-LPASI 202
Query: 139 GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALS 189
NL L L + ++ L A+ ++ L L L+L P FG +
Sbjct: 203 ANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 14/104 (13%), Positives = 30/104 (28%), Gaps = 10/104 (9%)
Query: 89 SIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNL--LFLTI 146
+ + + ++ N + L+ + +
Sbjct: 31 VLSQWQRHYNADRNRWHSAWRQANS----NNPQIETRTGRALKA-TADLLEDATQPGRVA 85
Query: 147 LDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALS 189
L+L S L P RL+HL ++ + E+PD +
Sbjct: 86 LELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFA 127
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 19/80 (23%), Positives = 32/80 (40%), Gaps = 5/80 (6%)
Query: 88 PSIGRLDKLQRLAL-HQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTI 146
P G L+RL L ++L ++P +I T+L L LR +P+ I L I
Sbjct: 247 PIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCI 305
Query: 147 LDLSSNSLKGAI---PSSLG 163
+ + + P +
Sbjct: 306 ILVPPHLQAQLDQHRPVARP 325
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.7 bits (208), Expect = 5e-18
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 37/218 (16%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRI--DRSREGSDQVFERELEILGSIK 365
LE + E G +G VY+ N TFA+K+I ++ EG RE+ IL +K
Sbjct: 5 HGLEKIGE------GTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK 58
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG----------QQLLNWSARLK 415
H N+V L +L++++L L L G QLL
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL------- 110
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
G+AY H +++HRD+K N+L++ E ++DFGLA+ T +
Sbjct: 111 ------NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEI 161
Query: 476 AGTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTGK 512
T Y AP+ L S + + D++S G + E+V G
Sbjct: 162 V-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 320 GSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---RELEILGSIKHINLVNLRGY 375
G G FG V A+K I R + RE+ L ++H +++ L Y
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL--Y 75
Query: 376 CRLPATKLLIY---DYLSMGSLDDFLHEHG---EG------QQLLNWSARLKIALGSARG 423
+ T I +Y G L D++ E E QQ++
Sbjct: 76 -DVITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEGRRFFQQIIC-------------A 120
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
+ Y H KI+HRD+K N+LLD+NL ++DFGL+ ++ D T+ G+ Y A
Sbjct: 121 IEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAA 175
Query: 484 PEYLQSGRATE--KSDVYSFGVLLLELVTGKRPTD 516
PE + +G+ + DV+S G++L ++ G+ P D
Sbjct: 176 PEVI-NGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 31/211 (14%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER--------ELEILG-SIKHI 367
V+G G FG V +AVK + + + ++ E +L ++KH
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQK-----KAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 368 NLVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLA 425
LV L + A KL + DY++ G L F H E L AR A + SA L
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPR-ARFYAAEIASA--LG 153
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
YLH I++RD+K NILLD + H+ +DFGL K ++ + +T GT YLA
Sbjct: 154 YLHSL---NIVYRDLKPENILLDS--QGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLA 207
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
PE L D + G +L E++ G P
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 1e-17
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTF-AVKRID-RSREGSDQVFERELEILGSIKHINLVNLRG 374
D +G G + TVY+ A+K I EG+ RE+ +L +KH N+V L
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEG----------QQLLNWSARLKIALGSARGL 424
+ L+++YL L +L + G QLL RGL
Sbjct: 68 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL-------------RGL 113
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
AY H K++HRD+K N+L++E E ++DFGLA+ V T Y P
Sbjct: 114 AYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPP 169
Query: 485 EYL-QSGRATEKSDVYSFGVLLLELVTGK 512
+ L S + + D++ G + E+ TG+
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR-EGSDQV----FERELEILGSIKHINLVN 371
+G+G FG V+ + G +A+K + + QV ER +L + H ++
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL--MLSIVTHPFIIR 70
Query: 372 LRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHH 429
+ G + ++ +I DY+ G L F + N A+ A + A L YLH
Sbjct: 71 MWGTFQDA-QQIFMIMDYIEGGEL--FSLLRKSQR-FPNPVAKFYAAEVCLA--LEYLHS 124
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
II+RD+K NILLD+ H+ +DFG AK VT + GT Y+APE +
Sbjct: 125 K---DIIYRDLKPENILLDK--NGHIKITDFGFAK----YVPDVTYTLCGTPDYIAPEVV 175
Query: 488 QS---GRATEKSDVYSFGVLLLELVTGKRP 514
+ ++ D +SFG+L+ E++ G P
Sbjct: 176 STKPYNKSI---DWWSFGILIYEMLAGYTP 202
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-17
Identities = 21/122 (17%), Positives = 38/122 (31%), Gaps = 3/122 (2%)
Query: 81 QLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGN 140
Q+ I + +L L L N L ++ L+ L+ + + N
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHN 127
Query: 141 LLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200
L L L SN + L L+ N +S+ + + +L
Sbjct: 128 QKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK--EDMSSLQQATNL-SL 184
Query: 201 DL 202
+L
Sbjct: 185 NL 186
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 21/113 (18%), Positives = 33/113 (29%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
+ + L I + + RL L L L + ++ + + L L L AN L
Sbjct: 35 TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLI 94
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
+ L L + L L L L +N S
Sbjct: 95 FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP 147
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 30/136 (22%), Positives = 46/136 (33%), Gaps = 9/136 (6%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+S+NL Y + + + + +L+ L L L N L+ L L + L
Sbjct: 379 QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAI---PSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
L L L+L N +SL L L L LS S
Sbjct: 439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH---- 494
Query: 189 SAFGNKSFIGNLDLCG 204
AF + + ++DL
Sbjct: 495 -AFTSLKMMNHVDLSH 509
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 7e-16
Identities = 27/135 (20%), Positives = 47/135 (34%), Gaps = 7/135 (5%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDK--LQRLALHQNSLHGSIPNEITNCTELRALYLRA 127
Q + M I L + ++ + L ++ N + L+ L L A
Sbjct: 228 QSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTA 287
Query: 128 NYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGA 187
+L +P+ + L L L LS+N + S L +L++ N E+
Sbjct: 288 THLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT--- 343
Query: 188 LSAFGNKSFIGNLDL 202
N + LDL
Sbjct: 344 -GCLENLENLRELDL 357
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 4e-15
Identities = 32/133 (24%), Positives = 47/133 (35%), Gaps = 9/133 (6%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSI---PNEITNCTELRALYLRANY 129
+ +NL + L L LQ L L N N + L L L
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
L +L + +DLS N L + +L L + YLNL++N S +P S
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILP-----S 541
Query: 190 AFGNKSFIGNLDL 202
S ++L
Sbjct: 542 LLPILSQQRTINL 554
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 25/129 (19%), Positives = 47/129 (36%), Gaps = 2/129 (1%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
++ L L + ++ L+ L Q + + N L +LYL +N++
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLH--YLNLSTNFFSGEIPDFGALSA 190
L +LD +N++ + L LNL+ N +G P +
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAV 203
Query: 191 FGNKSFIGN 199
F + +F G
Sbjct: 204 FQSLNFGGT 212
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 25/133 (18%), Positives = 45/133 (33%), Gaps = 7/133 (5%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSI-PNEITNCTELRALYLRANYLQ 131
+ + L + + S L L++ N+ + + N LR L L + ++
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 132 --GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
+ NL L L+LS N + L L+L+ + S
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQ----S 419
Query: 190 AFGNKSFIGNLDL 202
F N + L+L
Sbjct: 420 PFQNLHLLKVLNL 432
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 22/97 (22%), Positives = 39/97 (40%), Gaps = 1/97 (1%)
Query: 84 GIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLF 143
+ S+ L +L+ L L L + T+ + + L N L + +L
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525
Query: 144 LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG 180
+ L+L+SN + +PS L L+ +NL N
Sbjct: 526 IY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 19/118 (16%), Positives = 35/118 (29%), Gaps = 3/118 (2%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+ + S+ L + I P +KL+ L N++H ++++ + L L N
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG 188
Query: 130 LQ-GGIPANIGNLLFLTILDLSSNSLKGAIPSSLG--RLTHLHYLNLSTNFFSGEIPD 184
GI + L+ I L + L P
Sbjct: 189 NDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA 246
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 24/119 (20%), Positives = 38/119 (31%), Gaps = 5/119 (4%)
Query: 71 RVRSINLPYMQLGGIISPSIG--RLDKLQRLALHQNSLHGSIPNEITNCTE--LRALYLR 126
+S+N Q +I + + L P E + ++ L+
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 127 ANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDF 185
+Y L LDL++ L +PS L L+ L L LS N F
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQIS 320
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 17/84 (20%), Positives = 35/84 (41%), Gaps = 1/84 (1%)
Query: 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYL 130
R+ + L + L I + L + + L N L S +++ + L L +N++
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHI 535
Query: 131 QGGIPANIGNLLFLTILDLSSNSL 154
+P+ + L ++L N L
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPL 559
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 50/230 (21%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRI--DRSREGSDQVFE---RELEIL 361
E + + G +GTVY+ G F A+K + G + RE+ +L
Sbjct: 12 EPVAEIGV------GAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 362 GSIK---HINLVNLR----GYCRLPATKL-LIYDYLSMGSLDDFLHEHGEG--------- 404
++ H N+V L K+ L+++++ L +L +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 405 --QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462
+Q L RGL +LH + I+HRD+K NIL+ ++DFGLA+
Sbjct: 125 LMRQFL-------------RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR 168
Query: 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGK 512
+ + A VV T Y APE L D++S G + E+ K
Sbjct: 169 IYSYQMALTPVVV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 27/115 (23%), Positives = 44/115 (38%), Gaps = 1/115 (0%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
++I+L + L + S S +LQ L L + + L L L N +Q
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG-EIPDF 185
P + L L L L +G+L L LN++ NF ++P +
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAY 148
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 5e-17
Identities = 25/131 (19%), Positives = 41/131 (31%), Gaps = 6/131 (4%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+++ Y L L L + NS + + + N T L L L L+
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLE 486
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF 191
L L +L++S N+L S +L L L+ S N
Sbjct: 487 QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL-----Q 541
Query: 192 GNKSFIGNLDL 202
+ +L
Sbjct: 542 HFPKSLAFFNL 552
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 31/137 (22%), Positives = 47/137 (34%), Gaps = 11/137 (8%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
++ L + S L L+ L + L I L+ L + N++
Sbjct: 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 133 -GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLH----YLNLSTNFFSGEIPDFGA 187
+PA NL L +DLS N ++ + L L L++S N I D
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQD--- 198
Query: 188 LSAFGNKSFIGNLDLCG 204
AF L L G
Sbjct: 199 -QAFQGIKLH-ELTLRG 213
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 19/98 (19%), Positives = 32/98 (32%)
Query: 82 LGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNL 141
+S L L L + L L+ L + N L ++ L
Sbjct: 461 KDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQL 520
Query: 142 LFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
L+ LD S N ++ + L + NL+ N +
Sbjct: 521 YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 29/136 (21%), Positives = 49/136 (36%), Gaps = 8/136 (5%)
Query: 70 QRVRSINLPYMQLGGII--SPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRA 127
+ ++L L S S + L+ L L N + EL+ L +
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQH 408
Query: 128 NYLQGGIPAN-IGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFG 186
+ L+ + +L L LD+S + K LT L+ L ++ N F
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS-- 466
Query: 187 ALSAFGNKSFIGNLDL 202
+ F N + + LDL
Sbjct: 467 --NVFANTTNLTFLDL 480
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 33/151 (21%), Positives = 48/151 (31%), Gaps = 33/151 (21%)
Query: 81 QLGGIISPSIGRLDKLQRLALHQNSLHG-SIPNEITNCTELRALYLRANYLQG------- 132
+L + S IG+L L++L + N +H +P +N T L + L NY+Q
Sbjct: 115 KLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQ 174
Query: 133 --------------------GIPANIGNLLFLTILDLSSNSLKGAIPSSLGR-LTHLHYL 171
I + L L L N I + + L LH
Sbjct: 175 FLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVH 234
Query: 172 NLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
L F E L F G D+
Sbjct: 235 RLILGEFKDERN----LEIFEPSIMEGLCDV 261
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 17/85 (20%), Positives = 30/85 (35%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+ ++L QL I L +LQ L + N+L + L L N
Sbjct: 473 TNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNR 532
Query: 130 LQGGIPANIGNLLFLTILDLSSNSL 154
++ L +L++NS+
Sbjct: 533 IETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 6e-09
Identities = 30/122 (24%), Positives = 51/122 (41%), Gaps = 9/122 (7%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
V +++L + + + + + K Q L++ + L P + L++L L N
Sbjct: 285 ANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLK-QFPTL--DLPFLKSLTLTMN- 338
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRL--THLHYLNLSTNFFSGEIPDFGA 187
+G I L L+ LDLS N+L + S L L +L+LS N +F
Sbjct: 339 -KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMG 397
Query: 188 LS 189
L
Sbjct: 398 LE 399
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 15/109 (13%), Positives = 29/109 (26%), Gaps = 10/109 (9%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNE-ITNCTELRALYLRANYLQGGIPANIGNL--- 141
I + KL L L N +I + N L L + I
Sbjct: 196 IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIM 255
Query: 142 -----LFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDF 185
+ + L+ + L ++ ++L+ + D
Sbjct: 256 EGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLEDV 303
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 13/108 (12%), Positives = 26/108 (24%), Gaps = 10/108 (9%)
Query: 81 QLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRAL--------YLRANYLQG 132
I+ + L L L EI + + L L
Sbjct: 216 NSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFS 275
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG 180
L ++ + L+ S+K + + L++
Sbjct: 276 DDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ 321
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 50/222 (22%), Positives = 81/222 (36%), Gaps = 44/222 (19%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSD--QVFE---------RELEILGSIK 365
+ SG +G V V ++ A+KR+ + + RE+ +L
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLH----------EHGEGQ----QLLNWS 411
H N++ LR + YL + L Q +L
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL--- 144
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471
GL LH ++HRD+ NILL +N + + DF LA+ +A+
Sbjct: 145 ----------LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR-EDTADANK 190
Query: 472 TTVVAGTFGYLAPEY-LQSGRATEKSDVYSFGVLLLELVTGK 512
T V Y APE +Q T+ D++S G ++ E+ K
Sbjct: 191 THYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 57/211 (27%), Positives = 88/211 (41%), Gaps = 31/211 (14%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER--------ELEILGSI-KHI 367
V+G G FG V +AVK + + D V + E +L K
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKK-----DVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 368 NLVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLA 425
L L C +L + +Y++ G L H G+ A A + L
Sbjct: 82 FLTQLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPH-AVFYAAEIAIG--LF 135
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
+L II+RD+K N++LD E H+ +DFG+ K + + T GT Y+A
Sbjct: 136 FLQSK---GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGV-TTKTFCGTPDYIA 189
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
PE + + D ++FGVLL E++ G+ P
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER---ELEILGSI-KHINLVNL 372
V+G G + V + + +A+K + + D+ + E + H LV L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 373 RGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHHD 430
C ++L + +Y++ G L H + + AR A + A L YLH
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEH-ARFYSAEISLA--LNYLHER 129
Query: 431 CCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
II+RD+K N+LLD E H+ +D+G+ K + T+ GT Y+APE L+
Sbjct: 130 ---GIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPEILR 183
Query: 489 SGRATEKSDVYSFGVLLLELVTGKRP 514
D ++ GVL+ E++ G+ P
Sbjct: 184 GEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 53/217 (24%), Positives = 84/217 (38%), Gaps = 47/217 (21%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE---------RELEILGSIKHI 367
+GSG G V A+K++ R F+ REL ++ + H
Sbjct: 32 PIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELVLMKCVNHK 84
Query: 368 NLVNLRGYCRLPATKLLIYD-YLSMGSLDDFLH-------EHGEGQ----QLLNWSARLK 415
N++ L + D Y+ M +D L +H Q+L
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQML------- 137
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
G+ +LH IIHRD+K SNI++ + + DFGLA+ +T V
Sbjct: 138 ------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYV 187
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGK 512
T Y APE + E D++S G ++ E++ G
Sbjct: 188 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 45/233 (19%)
Query: 303 SCEIIEKLEALDEEDVVGSGGFGTVYR-MVMNDCGTF-AVKRI--DRSREGSDQVFEREL 358
C ++ E + E +G G +G V++ + + G F A+KR+ EG RE+
Sbjct: 6 LCRADQQYECVAE---IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 62
Query: 359 EILGSIK---HINLVNLR----GYCRLPATKL-LIYDYLSMGSLDDFLHEHGEG------ 404
+L ++ H N+V L TKL L+++++ L +L + E
Sbjct: 63 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121
Query: 405 -----QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459
QLL RGL +LH +++HRD+K NIL+ + + ++DFG
Sbjct: 122 IKDMMFQLL-------------RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 165
Query: 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGK 512
LA++ + A + VV T Y APE L D++S G + E+ K
Sbjct: 166 LARIYSFQMALTSVVV--TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 62/211 (29%), Positives = 90/211 (42%), Gaps = 31/211 (14%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER--------ELEILGSI-KHI 367
V+G G FG V + + G +AVK + + D + + E IL H
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKK-----DVILQDDDVECTMTEKRILSLARNHP 84
Query: 368 NLVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLA 425
L L C +L + ++++ G L H + AR A + SA L
Sbjct: 85 FLTQLF-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEAR-ARFYAAEIISA--LM 138
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
+LH II+RD+K N+LLD E H +DFG+ K + T GT Y+A
Sbjct: 139 FLHDK---GIIYRDLKLDNVLLDH--EGHCKLADFGMCKEGICNGV-TTATFCGTPDYIA 192
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
PE LQ D ++ GVLL E++ G P
Sbjct: 193 PEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER--------ELEILG-SIKHI 367
++G G FG V+ FA+K + + D V E +L + +H
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKK-----DVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 368 NLVNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARL---KIALGSARG 423
L ++ L + +YL+ G L H + L+ A +I LG
Sbjct: 79 FLTHMF-CTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSR-ATFYAAEIILG---- 130
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGY 481
L +LH I++RD+K NILLD+ + H+ +DFG+ K + +A T GT Y
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDK--DGHIKIADFGMCKENMLGDA-KTNTFCGTPDY 184
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+APE L + D +SFGVLL E++ G+ P
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFER---ELEILGSI-KHINLVNL 372
V+G G + V + + +A++ + + D+ + E + H LV L
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 373 RGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA-LGSARGLAYLHHD 430
C ++L + +Y++ G L H + + AR A + A L YLH
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEH-ARFYSAEISLA--LNYLHER 172
Query: 431 CCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
II+RD+K N+LLD E H+ +D+G+ K + T+ GT Y+APE L+
Sbjct: 173 ---GIIYRDLKLDNVLLDS--EGHIKLTDYGMCKEGLRPGD-TTSTFCGTPNYIAPEILR 226
Query: 489 SGRATEKSDVYSFGVLLLELVTGKRP 514
D ++ GVL+ E++ G+ P
Sbjct: 227 GEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 56/217 (25%), Positives = 85/217 (39%), Gaps = 47/217 (21%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---------RELEILGSIKHI 367
+GSG G V A+K++ R F+ REL ++ + H
Sbjct: 69 PIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELVLMKCVNHK 121
Query: 368 NLVNLRGYCRLPATKLLIYD-YLSMGSLDDFLH-------EHGEGQ----QLLNWSARLK 415
N+++L T D YL M +D L +H Q+L
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML------- 174
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
G+ +LH IIHRD+K SNI++ + + DFGLA+ +T V
Sbjct: 175 ------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMTPYV 224
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGK 512
T Y APE + E D++S G ++ E+V K
Sbjct: 225 V-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 3e-16
Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 23/207 (11%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKR------IDRSREGSDQVFERELEILGSIKHINLV 370
V+G G FG V +AVK I V +R L + K L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL--PGKPPFLT 405
Query: 371 NLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429
L C +L + +Y++ G L H G+ A A A GL +L
Sbjct: 406 QLH-SCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPH-AVFYAA-EIAIGLFFLQS 460
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
II+RD+K N++LD E H+ +DFG+ K + + T GT Y+APE +
Sbjct: 461 K---GIIYRDLKLDNVMLDS--EGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEII 514
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRP 514
+ D ++FGVLL E++ G+ P
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRIDR--SREGSDQVFERELEILGSI 364
++LE L G + TVY+ + G + A+K + + S EG+ RE+ ++ +
Sbjct: 8 KQLEKLGN------GTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIREISLMKEL 60
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARL--KIALGSAR 422
KH N+V L L+++++ L ++ G L +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
GLA+ H + KI+HRD+K N+L+++ + + DFGLA+ ++ V T Y
Sbjct: 120 GLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYR 175
Query: 483 APEYL-QSGRATEKSDVYSFGVLLLELVTGK 512
AP+ L S + D++S G +L E++TGK
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRI-----DRSREGSDQVFERELEIL 361
EKL+ L E G F TVY+ + A+K+I +++G ++ RE+++L
Sbjct: 13 EKLDFLGE------GQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL 66
Query: 362 GSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEG----------QQLLNWS 411
+ H N++ L + L++D++ L+ + ++ L
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTL--- 122
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471
+GL YLH I+HRD+K +N+LLDEN ++DFGLAK
Sbjct: 123 ----------QGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169
Query: 472 TTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGK 512
T V T Y APE L R D+++ G +L EL+
Sbjct: 170 THQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 31/209 (14%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE---------RELEILGSIKHI 367
VGSG +G+V G AVK++ R F+ REL +L +KH
Sbjct: 36 PVGSGAYGSVCAAFDTKTGLRVAVKKLSR-------PFQSIIHAKRTYRELRLLKHMKHE 88
Query: 368 NLVNLRGYCRLPATKLLIYD-YLSMGSLDDFLHEHGEGQQLLNWSARLKI--ALGSARGL 424
N++ L + D YL + L+ + Q+L + + I L RGL
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL---RGL 145
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
Y+H IIHRD+K SN+ ++E+ E + DFGLA+ DE +T VA T Y AP
Sbjct: 146 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE---MTGYVA-TRWYRAP 198
Query: 485 E-YLQSGRATEKSDVYSFGVLLLELVTGK 512
E L + D++S G ++ EL+TG+
Sbjct: 199 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 31/211 (14%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---------RELEILGSIKHI 367
+G G +G V N A+K+I FE RE++IL +H
Sbjct: 34 YIGEGAYGMVCSAYDNLNKVRVAIKKIS--------PFEHQTYCQRTLREIKILLRFRHE 85
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKI--ALGSARGLA 425
N++ + R P + + Y+ ++ L++ + Q L N + L RGL
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL---RGLK 142
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV---TTVVAGTFGYL 482
Y+H ++HRD+K SN+LL+ + + DFGLA++ + H T VA T Y
Sbjct: 143 YIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYR 198
Query: 483 APEY-LQSGRATEKSDVYSFGVLLLELVTGK 512
APE L S T+ D++S G +L E+++ +
Sbjct: 199 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 44/222 (19%)
Query: 318 VVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE---------RELEILGSIKHI 367
+G GG G V+ V NDC A+K+I V RE++I+ + H
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKI---------VLTDPQSVKHALREIKIIRRLDHD 68
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDF----------LHEHGEGQQLLNWSARLKI- 416
N+V + P+ L D S+ L+ L E LL ARL +
Sbjct: 69 NIVKVFEILG-PSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 417 -ALGSARGLAYLHHDCCPKIIHRDIKSSNILLD-ENLEPHVSDFGLAKLLVDEEAHV--- 471
L RGL Y+H ++HRD+K +N+ ++ E+L + DFGLA+++ +H
Sbjct: 128 QLL---RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL 181
Query: 472 TTVVAGTFGYLAPE-YLQSGRATEKSDVYSFGVLLLELVTGK 512
+ + T Y +P L T+ D+++ G + E++TGK
Sbjct: 182 SEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 56/221 (25%)
Query: 318 VVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFE---------RELEILGSIKHI 367
VGSG +G+V + G A+K++ R F+ REL +L ++H
Sbjct: 31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELLLLKHMQHE 83
Query: 368 NLVNLRGYCRLPATKLLIYD--YLSMGSLDDFLH---------EHGEGQ----QLLNWSA 412
N++ L PA+ L + YL M + L E Q Q+L
Sbjct: 84 NVIGLL-DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKI--QYLVYQML---- 136
Query: 413 RLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472
+GL Y+H ++HRD+K N+ ++E+ E + DFGLA+ +A +T
Sbjct: 137 ---------KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH---ADAEMT 181
Query: 473 TVVAGTFGYLAPE-YLQSGRATEKSDVYSFGVLLLELVTGK 512
V T Y APE L + D++S G ++ E++TGK
Sbjct: 182 GYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 4e-15
Identities = 27/129 (20%), Positives = 54/129 (41%), Gaps = 8/129 (6%)
Query: 61 TGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTEL 120
T + + + + + ++ I I L L+ L L+ N + P ++N +L
Sbjct: 35 TDVVTQEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKL 90
Query: 121 RALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG 180
LY+ N + + + NL L L L+ +++ P L LT ++ LNL N
Sbjct: 91 TNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS 146
Query: 181 EIPDFGALS 189
++ ++
Sbjct: 147 DLSPLSNMT 155
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 29/117 (24%), Positives = 53/117 (45%), Gaps = 7/117 (5%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
S+ + ++ + + L +L L + N + S N + + T+L+ L + +N +
Sbjct: 224 NSLKIGNNKITDL--SPLANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD 279
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
+ + NL L L L++N L +G LT+L L LS N + I +LS
Sbjct: 280 --ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRPLASLS 333
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 8/117 (6%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
R + L + I + L K+ L L N S + ++N T L L + + ++
Sbjct: 113 RELYLNEDNISDI--SPLANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKD 169
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
+ I NL L L L+ N ++ P L LT LHY N + I ++
Sbjct: 170 -VT-PIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITPVANMT 221
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 25/117 (21%), Positives = 45/117 (38%), Gaps = 9/117 (7%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ + ++ + I L L L+L+ N + P + + T L N +
Sbjct: 158 NYLTVTESKVKDV--TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD 213
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
P + N+ L L + +N + P L L+ L +L + TN S I L+
Sbjct: 214 ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-INAVKDLT 265
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 26/104 (25%), Positives = 44/104 (42%), Gaps = 6/104 (5%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ + Q+ I ++ L KL+ L + N + I + N ++L +L+L N L
Sbjct: 246 TWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQIS-DISV-LNNLSQLNSLFLNNNQLGN 301
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
IG L LT L LS N + P L L+ + + +
Sbjct: 302 EDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 19/83 (22%), Positives = 35/83 (42%), Gaps = 4/83 (4%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ +N+ Q+ I + L +L L L+ N L I T L L+L N++
Sbjct: 268 KMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
Query: 133 GIPANIGNLLFLTILDLSSNSLK 155
P + +L + D ++ +K
Sbjct: 326 IRP--LASLSKMDSADFANQVIK 346
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 33/210 (15%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE---------RELEILGSIKHI 367
VGSG +G V V G A+K++ R F+ REL +L ++H
Sbjct: 32 PVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELRLLKHMRHE 84
Query: 368 NLVNLRGYCRLPATKLLIYD--YLSMGSLDDFLHEHGEGQQLLNWSARLKI--ALGSARG 423
N++ L P L + YL M + L + + ++L + + L +G
Sbjct: 85 NVIGLLDVFT-PDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML---KG 140
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
L Y+H IIHRD+K N+ ++E+ E + DFGLA+ E +T V T Y A
Sbjct: 141 LRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVV-TRWYRA 193
Query: 484 PEY-LQSGRATEKSDVYSFGVLLLELVTGK 512
PE L R T+ D++S G ++ E++TGK
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 7e-15
Identities = 57/234 (24%), Positives = 93/234 (39%), Gaps = 68/234 (29%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE---------RELEILGSIKH 366
++G G +G V G A+K+I+ F+ RE++IL KH
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIE--------PFDKPLFALRTLREIKILKHFKH 68
Query: 367 INLVNLRGYCRLPATKL-----LIYDY--------LSMGSLDD-----FLHEHGEGQQLL 408
N++ + R + + +I + +S L D F++ Q L
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY------QTL 122
Query: 409 NWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468
R + LH +IHRD+K SN+L++ N + V DFGLA+++ +
Sbjct: 123 -------------RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 469 AHVTTVVAGTFG---------YLAPEY-LQSGRATEKSDVYSFGVLLLELVTGK 512
A + G Y APE L S + + DV+S G +L EL +
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 50/263 (19%), Positives = 112/263 (42%), Gaps = 64/263 (24%)
Query: 275 KRYTEV-----RKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYR 329
+ YT+V R+ D E+ + + Y +++ K +G G + V+
Sbjct: 9 RVYTDVNTHRPREYWDYESHV--VEWGNQDDY---QLVRK---------LGRGKYSEVFE 54
Query: 330 MVMNDCGTF-AVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRGYCRLPATK--LLI 385
+ VK + ++ + +RE++IL +++ N++ L + P ++ L+
Sbjct: 55 AINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111
Query: 386 YDYLS-------MGSLDD-----FLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
+++++ +L D +++ ++L + L Y H
Sbjct: 112 FEHVNNTDFKQLYQTLTDYDIRFYMY------EIL-------------KALDYCH---SM 149
Query: 434 KIIHRDIKSSNILLD-ENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
I+HRD+K N+++D E+ + + D+GLA+ + + V + + PE L +
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA--SRYFKGPELLVDYQM 207
Query: 493 TEKS-DVYSFGVLLLELVTGKRP 514
+ S D++S G +L ++ K P
Sbjct: 208 YDYSLDMWSLGCMLASMIFRKEP 230
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 4e-14
Identities = 21/107 (19%), Positives = 40/107 (37%), Gaps = 7/107 (6%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
R + + L ++ ++ L L N L ++ T+L L L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L ++ +L L LDL++N + L + L+ + N
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANN 109
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 28/143 (19%), Positives = 50/143 (34%), Gaps = 10/143 (6%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHG-SIPNEITNCTELRALYLRAN 128
Q ++I L ++ + G ++Q L L N + + + L L L+ N
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 129 YLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
++ + + L LDLSSN L + + +++L N I
Sbjct: 180 FIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEK---- 231
Query: 189 SAFGNKSFIGNLDLCGRQVHKPC 211
A + + DL G H
Sbjct: 232 -ALRFSQNLEHFDLRGNGFHCGT 253
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 21/96 (21%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
++ + + +SL ++ + + ++ L L N L A++ L +L+LSSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
L L L+ L L+L+ N+ E+ ++
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPSI 101
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 5e-11
Identities = 21/81 (25%), Positives = 33/81 (40%), Gaps = 1/81 (1%)
Query: 109 SIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHL 168
+I N + + + L+ + + + + LDLS N L + L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 169 HYLNLSTNFFSGEIPDFGALS 189
LNLS+N E D +LS
Sbjct: 61 ELLNLSSNVLY-ETLDLESLS 80
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 16/113 (14%), Positives = 35/113 (30%), Gaps = 18/113 (15%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147
+ L L+ L L+ N + E+ + L+ N + + + G +
Sbjct: 74 LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSCSRGQ--GKKNI 125
Query: 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200
L++N + G + + YL+L N + +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNE----------IDTVNFAELAASS 168
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 21/108 (19%), Positives = 35/108 (32%), Gaps = 5/108 (4%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+ +NL Y + + KL+ L L N L + E + + + LR N
Sbjct: 169 DTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNK 225
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLK-GAIPSSLGRLTHLHYLNLSTN 176
L I + L DL N G + + + + T
Sbjct: 226 LVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 8/105 (7%), Positives = 16/105 (15%), Gaps = 4/105 (3%)
Query: 76 NLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG--- 132
+ + + + L+ QG
Sbjct: 266 TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET 325
Query: 133 -GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+ N +D + I R L
Sbjct: 326 ERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 22/108 (20%), Positives = 46/108 (42%), Gaps = 5/108 (4%)
Query: 70 QRVRSINLPYMQLGGIISPS-IGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN 128
RV+ ++L ++ + D L+ L L N ++ + ++ +L+ L L +N
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSN 201
Query: 129 YLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L + + +T + L +N L I +L +L + +L N
Sbjct: 202 KLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 22/114 (19%), Positives = 42/114 (36%), Gaps = 8/114 (7%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
R + + L ++ ++ L L N L ++ T+L L L +N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP 183
L ++ +L L LDL++N + L + L+ + N S +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-RVS 115
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 21/96 (21%), Positives = 43/96 (44%), Gaps = 3/96 (3%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
++ + + +SL ++ + + ++ L L N L A++ L +L+LSSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
L L L+ L L+L+ N+ E+ ++
Sbjct: 69 VLYE--TLDLESLSTLRTLDLNNNYVQ-ELLVGPSI 101
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 21/81 (25%), Positives = 33/81 (40%), Gaps = 1/81 (1%)
Query: 109 SIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHL 168
+I N + + + L+ + + + + LDLS N L + L T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 169 HYLNLSTNFFSGEIPDFGALS 189
LNLS+N E D +LS
Sbjct: 61 ELLNLSSNVLY-ETLDLESLS 80
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 16/113 (14%), Positives = 35/113 (30%), Gaps = 18/113 (15%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147
+ L L+ L L+ N + E+ + L+ N + + + G +
Sbjct: 74 LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR-VSCSRGQGK--KNI 125
Query: 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200
L++N + G + + YL+L N + +
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNE----------IDTVNFAELAASS 168
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 16/102 (15%), Positives = 32/102 (31%), Gaps = 5/102 (4%)
Query: 89 SIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148
+ ++ L N++ + + +YL N + + G + LD
Sbjct: 94 ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150
Query: 149 LSSNSLKG-AIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
L N + L +LNL NF ++ +
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVVFA 191
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 12/99 (12%), Positives = 27/99 (27%), Gaps = 3/99 (3%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT 145
+ P + ++L N L I + L LR N
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH-CGTLRDFFSKNQR 263
Query: 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
+ ++ ++K + + L + ++P
Sbjct: 264 VQTVAKQTVKK-LTGQNEEECTVPTLGHYGAYCCEDLPA 301
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 74.1 bits (181), Expect = 7e-14
Identities = 78/502 (15%), Positives = 159/502 (31%), Gaps = 179/502 (35%)
Query: 167 HLHYLNLSTN---FFSGEI-PDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFP-AVL 221
H H+++ T + +I F +F+ N D C+ P ++L
Sbjct: 3 HHHHMDFETGEHQYQYKDILSVF-------EDAFVDNFD---------CKDVQDMPKSIL 46
Query: 222 PHASSDE-VAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLWICLLSKKERAVKRYTEV 280
D + S L+ LLSK+E V+++ E
Sbjct: 47 SKEEIDHIIMSKDAVSGTL---------------------RLFWTLLSKQEEMVQKFVEE 85
Query: 281 RKQVD------------QETSTKLITF-------HGD----MPY--PSCEIIEKL-EAL- 313
+++ ++ S + + D Y + KL +AL
Sbjct: 86 VLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL 145
Query: 314 ---DEEDVV--GSGGFG-TVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHI 367
++V+ G G G T + ++ C ++ V+ + ++F +
Sbjct: 146 ELRPAKNVLIDGVLGSGKTW--VALDVCLSYKVQ-----CKMDFKIF-----------WL 187
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHE-HGEGQQLLNWSARLKIALGSARG-LA 425
NL C P T L + L L++ + S+ +K+ + S + L
Sbjct: 188 NL----KNCNSPETVLEM--------LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 426 YLHHDCCPKIIHRDIKSSNILLDE--NLEPHVSDFGL-AKLLVDEEAHVTT--------V 474
L + + ++ ++L N + + F L K+L +TT +
Sbjct: 236 RL-------LKSKPYENCLLVLLNVQNAK-AWNAFNLSCKIL------LTTRFKQVTDFL 281
Query: 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTD-PTFVKRG----LNVVG- 528
A T +++ ++ ++ LL RP D P V L+++
Sbjct: 282 SAATTTHISLDHHSMTLTPDEVKS------LLLKYLDCRPQDLPREVLTTNPRRLSIIAE 335
Query: 529 --------WMNTL-LKENRLEDVIDKRCADADMETVE--------AILEIAARCTDANPD 571
W N + ++L +I+ + +E E ++ P
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIES-SLNV-LEPAEYRKMFDRLSVF----------PP 383
Query: 572 DRPSMNQVLQLL-----EQEVM 588
+L L+ + +VM
Sbjct: 384 SAHIPTILLSLIWFDVIKSDVM 405
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 3e-05
Identities = 68/485 (14%), Positives = 139/485 (28%), Gaps = 162/485 (33%)
Query: 37 KSSLNDSRNLLGNWQATEESPCK--WTGIS-CHTHDQRVRSINLPYMQL------GGIIS 87
K+ + + ++ +++ + K W + C++ + + + Q+ S
Sbjct: 163 KTWV--ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHS 220
Query: 88 PSI--------GRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLR------------A 127
+I L +L + ++N L + + N A L
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278
Query: 128 NYLQGGIPANI------GNL-------LFLTILDLSSNSL----KGAIP---SSLGRLTH 167
++L +I L L L LD L P S +
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIR 338
Query: 168 LHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFPAVLPHASSD 227
L N+ + + L+ +S + L+ ++ + +V P
Sbjct: 339 -DGLATWDNW---KHVNCDKLTTI-IESSLNVLE---PAEYRKMFDRL---SVFP----P 383
Query: 228 EVAVPTKRSSHYMKGVLIGAMSTMGLALVVLLAFLW-----------ICLLSKK---ERA 273
+PT LL+ +W + L K E+
Sbjct: 384 SAHIPTI-----------------------LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQ 420
Query: 274 VKRYT--------EVRKQVDQETSTKLITFHGDMPYPSCEIIEK---LEALDEEDVVGSG 322
K T E++ +++ E + H I++ + D +D++
Sbjct: 421 PKESTISIPSIYLELKVKLENEYA-----LHR-------SIVDHYNIPKTFDSDDLIPPY 468
Query: 323 GFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFER---ELEILGS-IKHIN---------- 368
Y + +K I+ +F + L I+H +
Sbjct: 469 LDQYFYSHIG-----HHLKNIEHPER--MTLFRMVFLDFRFLEQKIRHDSTAWNASGSIL 521
Query: 369 --LVNLRGYCRL-----PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA 421
L L+ Y P + L+ L DFL + E ++ L+IAL +
Sbjct: 522 NTLQQLKFYKPYICDNDPKYERLVNAIL------DFLPKIEENLICSKYTDLLRIALMAE 575
Query: 422 RGLAY 426
+
Sbjct: 576 DEAIF 580
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-13
Identities = 30/131 (22%), Positives = 49/131 (37%), Gaps = 4/131 (3%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
++++L + L + S S +LQ L L + + + + L L L N +Q
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF 191
L L L +L +G L L LN++ N I F F
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL----IQSFKLPEYF 145
Query: 192 GNKSFIGNLDL 202
N + + +LDL
Sbjct: 146 SNLTNLEHLDL 156
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 30/125 (24%), Positives = 50/125 (40%), Gaps = 3/125 (2%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+++ + + L L+ L + NS + +I T L L L L+
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 132 GGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
+ +L L +L+++SN LK RLT L + L TN + P LS
Sbjct: 484 Q-LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 542
Query: 191 FGNKS 195
+ NK+
Sbjct: 543 WLNKN 547
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 5e-13
Identities = 26/136 (19%), Positives = 46/136 (33%), Gaps = 6/136 (4%)
Query: 59 KWTGISCHTHDQRVRSINLPYMQLG--GIISPSIGRLDKLQRLALHQNSLHGSIPNEITN 116
K + ++L L G S S L+ L L N + ++ +
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLG 394
Query: 117 CTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLST 175
+L L + + L+ ++ +L L LD+S + A L+ L L ++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 176 NFFSGEIPD--FGALS 189
N F F L
Sbjct: 455 NSFQENFLPDIFTELR 470
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 28/117 (23%), Positives = 47/117 (40%), Gaps = 6/117 (5%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ- 131
++ L + + + L LQ+L + +L I + L+ L + N +Q
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHY----LNLSTNFFSGEIPD 184
+P NL L LDLSSN ++ + L L + L+LS N + I
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 18/114 (15%), Positives = 35/114 (30%), Gaps = 7/114 (6%)
Query: 73 RSINLPYMQLGGI-ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRA----LYLRA 127
+ +N+ + + + L L+ L L N + ++ ++ L L
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 128 NYLQGGIPANIGNLLFLTILDLSSNSLKGAIPS-SLGRLTHLHYLNLSTNFFSG 180
N + I + L L L +N + + L L L F
Sbjct: 187 NPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 17/68 (25%), Positives = 29/68 (42%), Gaps = 2/68 (2%)
Query: 109 SIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHL 168
IP+ + + L L N L+ + + L +LDLS ++ + L+HL
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 169 HYLNLSTN 176
L L+ N
Sbjct: 79 STLILTGN 86
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 30/122 (24%), Positives = 41/122 (33%), Gaps = 9/122 (7%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
V S +L + + + Q L L P L+ L +N
Sbjct: 282 TNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFG-QFPTL--KLKSLKRLTFTSNK 336
Query: 130 LQGGIPANIGNLLFLTILDLSSNSL--KGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGA 187
+ + +L L LDLS N L KG S T L YL+LS N +F
Sbjct: 337 GGN-AFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG 394
Query: 188 LS 189
L
Sbjct: 395 LE 396
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 51/241 (21%), Positives = 90/241 (37%), Gaps = 63/241 (26%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFERELEILGS 363
++ KL G G F TV+ T A+K + R + + E E+++L
Sbjct: 22 ILVRKL---------GWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQR 71
Query: 364 IKHI-----------NLVNLRG--YCRLPATK--LLIYDYLSMGSLDDFLHEHGE----- 403
+ +++ L + P +++++ L +L + ++
Sbjct: 72 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKKYEHRGIPL 130
Query: 404 ------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH--- 454
+QLL GL Y+H C IIH DIK N+L++ P
Sbjct: 131 IYVKQISKQLL-------------LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 175
Query: 455 ---VSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTG 511
++D G A + H T + Y +PE L +D++S L+ EL+TG
Sbjct: 176 QIKIADLGNA---CWYDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITG 231
Query: 512 K 512
Sbjct: 232 D 232
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 31/131 (23%), Positives = 53/131 (40%), Gaps = 15/131 (11%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
V ++ + + I + L+ L ++ N L P + N T+L + + N +
Sbjct: 48 VTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA 103
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF 191
+ NL LT L L +N + P L LT+L+ L LS+N S +SA
Sbjct: 104 D--ITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-------ISAL 152
Query: 192 GNKSFIGNLDL 202
+ + L
Sbjct: 153 SGLTSLQQLSF 163
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 3e-13
Identities = 30/116 (25%), Positives = 50/116 (43%), Gaps = 9/116 (7%)
Query: 76 NLPYMQLGGIIS--PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGG 133
+L + G ++ + L L+RL + N + S + + T L +L N +
Sbjct: 157 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDI 214
Query: 134 IPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
P +G L L L L+ N LK +L LT+L L+L+ N S + L+
Sbjct: 215 TP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLT 265
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 31/117 (26%), Positives = 45/117 (38%), Gaps = 9/117 (7%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
++L Q+ + + L KL L L N + P + T L L L N L+
Sbjct: 246 TDLDLANNQISNL--APLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED 301
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
+ I NL LT L L N++ P + LT L L N S + L+
Sbjct: 302 --ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD-VSSLANLT 353
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 18/102 (17%), Positives = 40/102 (39%), Gaps = 7/102 (6%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147
+ L + + L + ++ ++ T+ ++ L ++ + L LT +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
+ S+N L P L LT L + ++ N + I L+
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-ITPLANLT 112
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 25/102 (24%), Positives = 38/102 (37%), Gaps = 8/102 (7%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147
+ L L L L N + P + N T L L L +N + + + L L L
Sbjct: 106 TPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQL 161
Query: 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
+ L LT L L++S+N S +I L+
Sbjct: 162 SFGNQVTD---LKPLANLTTLERLDISSNKVS-DISVLAKLT 199
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 25/130 (19%), Positives = 45/130 (34%), Gaps = 13/130 (10%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ L + + I + L KLQRL + N + S + + N T + L N +
Sbjct: 312 TYLTLYFNNISDI--SPVSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISD 367
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFG 192
P + NL +T L L+ + A + ++ N N I +
Sbjct: 368 LTP--LANLTRITQLGLNDQAWTNAPVNYKANVS---IPNTVKNVTGALIA----PATIS 418
Query: 193 NKSFIGNLDL 202
+ D+
Sbjct: 419 DGGSYTEPDI 428
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 17/111 (15%), Positives = 37/111 (33%), Gaps = 5/111 (4%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
++ + Q+ + + L ++ +L L+ + + N N + + L
Sbjct: 356 NWLSAGHNQISDL--TPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI- 412
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP 183
PA I + T D++ N + + T FSG +
Sbjct: 413 -APATISDGGSYTEPDITWNLPSY-TNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 27/117 (23%), Positives = 47/117 (40%), Gaps = 13/117 (11%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ + QL + P + L+ + + NSL +P+ + L + N L+
Sbjct: 134 EYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLEE 187
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
+P + NL FLT + +NSLK +P L + N E+P+ L
Sbjct: 188 -LP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLES---IVAGNNILE-ELPELQNLP 237
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 9e-13
Identities = 27/136 (19%), Positives = 43/136 (31%), Gaps = 25/136 (18%)
Query: 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN 128
D++ + L + L + L+ L NSL +P + L
Sbjct: 70 DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 129 YLQGGIPA---------------NIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNL 173
L P + N FL I+D+ +NSLK +P L +
Sbjct: 125 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSLEF---IAA 180
Query: 174 STNFFSGEIPDFGALS 189
N E+P+ L
Sbjct: 181 GNNQLE-ELPELQNLP 195
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 19/122 (15%), Positives = 29/122 (23%), Gaps = 18/122 (14%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITN-------------CTELRALYLRANYLQG 132
+ + + + P + L L L
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS 85
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFG 192
+P +L L S NSL +P L L N + S P L
Sbjct: 86 -LPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 140
Query: 193 NK 194
N+
Sbjct: 141 NQ 142
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 29/140 (20%), Positives = 44/140 (31%), Gaps = 25/140 (17%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHG------------------SIPNEI 114
I QL + P + L L + NSL E+
Sbjct: 176 EFIAAGNNQLEEL--PELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPEL 233
Query: 115 TNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLS 174
N L +Y N L+ +P +L L++ N L +P LT L
Sbjct: 234 QNLPFLTTIYADNNLLKT-LPDLPPSL---EALNVRDNYLT-DLPELPQSLTFLDVSENI 288
Query: 175 TNFFSGEIPDFGALSAFGNK 194
+ S P+ L+A N+
Sbjct: 289 FSGLSELPPNLYYLNASSNE 308
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 1e-09
Identities = 28/111 (25%), Positives = 44/111 (39%), Gaps = 21/111 (18%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147
P + L L + N L ++P+ + L AL +R NYL +P +L FL +
Sbjct: 231 PELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLT-DLPELPQSLTFLDVS 285
Query: 148 DLSSNSLKGAIPSSLGRL--------------THLHYLNLSTNFFSGEIPD 184
+ + L +P +L L L LN+S N E+P
Sbjct: 286 ENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA 334
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 22/92 (23%), Positives = 31/92 (33%), Gaps = 13/92 (14%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
L L N + S+ + + L L + N L +PA L L S N
Sbjct: 296 PPNLYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLIE-LPALPPRL---ERLIASFN 347
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
L +P L L++ N E PD
Sbjct: 348 HLA-EVPELPQNLK---QLHVEYNPLR-EFPD 374
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-07
Identities = 18/96 (18%), Positives = 32/96 (33%), Gaps = 22/96 (22%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLF--------- 143
+L+RL N L +P N L+ L++ N L+ P ++
Sbjct: 336 PPRLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAE 390
Query: 144 -------LTILDLSSNSLKGAIPSSLGRLTHLHYLN 172
L L + +N L+ P + L +
Sbjct: 391 VPELPQNLKQLHVETNPLR-EFPDIPESVEDLRMNS 425
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-04
Identities = 14/103 (13%), Positives = 30/103 (29%), Gaps = 21/103 (20%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRA----------------LYLRANYLQGGIPA 136
L++L + N L P+ + +LR L++ N L+ P
Sbjct: 356 PQNLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLRE-FPD 413
Query: 137 NIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
++ L ++S + + L +
Sbjct: 414 IPESV---EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 50/257 (19%), Positives = 85/257 (33%), Gaps = 80/257 (31%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE---------RELEILGSIKH 366
++G G +G VY + A+K+++R +FE RE+ IL +K
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREITILNRLKS 84
Query: 367 INLVNLRGYCRLPATKL-----LIYDYL---------SMGSLDD-----FLHEHGEGQQL 407
++ L ++ + + L + L+ L
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILY------NL 138
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467
L G ++H IIHRD+K +N LL+++ V DFGLA+ + E
Sbjct: 139 L-------------LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182
Query: 468 EAHVTTVVAGTFG---------------------YLAPEY-LQSGRATEKSDVYSFGVLL 505
+ Y APE L T+ D++S G +
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 506 LELVTGKRPTDPTFVKR 522
EL+ + R
Sbjct: 243 AELLNMLQSHINDPTNR 259
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 45/230 (19%), Positives = 78/230 (33%), Gaps = 66/230 (28%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGS 363
II+ + + +G G G V ++ FA+K + RE+E+
Sbjct: 14 AIIDDYKVTSQV--LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWR 66
Query: 364 I-KHINLVNLRG-YCRLPATKLLIY---DYLSMGSLDDFLHEHGEG-----------QQL 407
+ ++V + Y L A + + + L G L + + G+ + +
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 126
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLL 464
+ YLH I HRD+K N+L N ++DFG AK
Sbjct: 127 GE-------------AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170
Query: 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
E Y + D++S GV++ L+ G P
Sbjct: 171 TGE------------KY-----------DKSCDMWSLGVIMYILLCGYPP 197
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 3e-12
Identities = 21/114 (18%), Positives = 38/114 (33%), Gaps = 13/114 (11%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSS 151
+ L + ++ L ++P+ + + L + N L +PA L L++S
Sbjct: 38 LNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LPALPPEL---RTLEVSG 90
Query: 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNK-----SFIGNL 200
N L ++P L L + L FGN+ L
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGL 143
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 25/113 (22%), Positives = 36/113 (31%), Gaps = 14/113 (12%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
LQ L++ N L S+P + L L+ N L +P L L +S N
Sbjct: 140 PPGLQELSVSDNQL-ASLPALPSE---LCKLWAYNNQLTS-LPMLPSGL---QELSVSDN 191
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNK-----SFIGNL 200
L ++P+ L L N L GN+ L
Sbjct: 192 QLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSEL 243
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 25/133 (18%), Positives = 41/133 (30%), Gaps = 18/133 (13%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
R++ + QL + L +L + L P + L L++ N L
Sbjct: 84 RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSG---LCKLWIFGNQLT- 134
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFG 192
+P L L +S N L ++P+ L L N LS
Sbjct: 135 SLPVLPPG---LQELSVSDNQLA-SLPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSD 190
Query: 193 NK-----SFIGNL 200
N+ + L
Sbjct: 191 NQLASLPTLPSEL 203
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 24/133 (18%), Positives = 43/133 (32%), Gaps = 18/133 (13%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ +++ QL + +L +L + N L S+P + L+ L + N L
Sbjct: 144 QELSVSDNQLASL-PALPS---ELCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQLAS 195
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFG 192
+P L L +N L ++P+ L L + L G
Sbjct: 196 -LPTLPSEL---YKLWAYNNRLT-SLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSG 250
Query: 193 NK-----SFIGNL 200
N+ L
Sbjct: 251 NRLTSLPMLPSGL 263
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 18/92 (19%), Positives = 33/92 (35%), Gaps = 5/92 (5%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
+L+ L + N L S+P + L + N L +P ++ +L T ++L N
Sbjct: 240 PSELKELMVSGNRL-TSLPMLPSGLLSL---SVYRNQLTR-LPESLIHLSSETTVNLEGN 294
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
L +L +T + F
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGAS 326
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 14/101 (13%), Positives = 31/101 (30%), Gaps = 6/101 (5%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
L L++++N L +P + + + + L N L + +T S
Sbjct: 260 PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE---ITSAPGYSG 315
Query: 153 SL--KGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF 191
+ +S R T +L + + +
Sbjct: 316 PIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRW 356
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 52/263 (19%), Positives = 87/263 (33%), Gaps = 87/263 (33%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE---------RELEILGSIKH 366
++G+G +G V A+K+I R VFE RE+ IL + H
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNH 111
Query: 367 INLVNLRGYCRLPATKL-----LIYDYL---------SMGSLDD-----FLHEHGEGQQL 407
++V + + ++ + + L + L+ L
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY------NL 165
Query: 408 LNWSARLKIALGSARGLAYLH-HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466
L G+ Y+H I+HRD+K +N L++++ V DFGLA+ +
Sbjct: 166 L-------------VGVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208
Query: 467 EEAHVTTVVAGTFG--------------------------YLAPE-YLQSGRATEKSDVY 499
E + + Y APE L TE DV+
Sbjct: 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW 268
Query: 500 SFGVLLLELVTGKRPTDPTFVKR 522
S G + EL+ + R
Sbjct: 269 SIGCIFAELLNMIKENVAYHADR 291
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 26/119 (21%), Positives = 40/119 (33%), Gaps = 8/119 (6%)
Query: 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNC----TELRALY 124
++ +++ + L L L N G C L+ L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 125 LRANYLQ---GGIPANIGNLLFLTILDLSSNSLKGAIPSSL-GRLTHLHYLNLSTNFFS 179
LR ++ G A + L LDLS NSL+ A + + L+ LNLS
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 37/147 (25%), Positives = 54/147 (36%), Gaps = 16/147 (10%)
Query: 38 SSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQ 97
S+L+ S N + + C Q + N G+ S +LQ
Sbjct: 176 STLDLSDNPELGERGLISALCP----LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ 231
Query: 98 RLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ---GGIPANIGNLLFLTILDLSSNS 153
L L NSL + ++L +L L L+ G+PA L++LDLS N
Sbjct: 232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAK------LSVLDLSYNR 285
Query: 154 LKGAIPSSLGRLTHLHYLNLSTNFFSG 180
L PS L + L+L N F
Sbjct: 286 LDR-NPSPDE-LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 26/127 (20%), Positives = 43/127 (33%), Gaps = 9/127 (7%)
Query: 71 RVRSINLPYMQLGGIISPSIGRLD---KLQRLALHQNSLHGSIPNEITNCT--ELRALYL 125
++ + + ++ I R+ LQ L L + G+ P + T +L L L
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 126 RANYLQGG--IPANIGNLLF--LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGE 181
R A + L L +L ++ + L L+LS N GE
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 182 IPDFGAL 188
AL
Sbjct: 189 RGLISAL 195
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 3e-08
Identities = 17/96 (17%), Positives = 27/96 (28%), Gaps = 7/96 (7%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGI-------PANIGNLLFLTILD 148
L+ L++ Q ++ L L L N G P L L + +
Sbjct: 151 LKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRN 210
Query: 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
+ G + L L+LS N
Sbjct: 211 AGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 7e-08
Identities = 27/104 (25%), Positives = 36/104 (34%), Gaps = 8/104 (7%)
Query: 91 GRLDKLQRLALHQN---SLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLF-LTI 146
+ LQ LAL + G +L+ L L N L+ A + L
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257
Query: 147 LDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
L+LS LK +P L L L+LS N P L
Sbjct: 258 LNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNPSPDELPQ 297
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 16/109 (14%), Positives = 38/109 (34%), Gaps = 3/109 (2%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ + + P++ L L L + ++ SI +I ++ ++ L N
Sbjct: 91 ERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT 150
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGE 181
I + L L L++ + + + L+ L + G+
Sbjct: 151 DIM-PLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 24/118 (20%), Positives = 48/118 (40%), Gaps = 7/118 (5%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
+ I L + + + I ++ L ++ P I+ + L L + +
Sbjct: 46 LTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVT 101
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
N+ L LT+LD+S ++ +I + + L ++ ++LS N G I D L
Sbjct: 102 SDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYN---GAITDIMPLK 156
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 4e-06
Identities = 15/103 (14%), Positives = 27/103 (26%), Gaps = 21/103 (20%)
Query: 93 LDKLQRLALHQNSLHGSIP-------------NEIT------NCTELRALYLRANYLQGG 133
L Q+S +T ++ L + +
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIEYAHNIKDLTINNIHATN- 80
Query: 134 IPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
I L L L + + +L LT L L++S +
Sbjct: 81 -YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS 122
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 31/154 (20%), Positives = 53/154 (34%), Gaps = 9/154 (5%)
Query: 24 LALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLG 83
L ++ + +++ R + S VR ++L + L
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDL---RSKFLLENSVLKMEYADVRVLHLAHKDLT 454
Query: 84 GIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLF 143
+ + +L + L L N L ++P + L L N L+ + + NL
Sbjct: 455 VL--CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPR 509
Query: 144 LTILDLSSNSLKG-AIPSSLGRLTHLHYLNLSTN 176
L L L +N L+ A L L LNL N
Sbjct: 510 LQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 8e-08
Identities = 31/165 (18%), Positives = 54/165 (32%), Gaps = 15/165 (9%)
Query: 34 LEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISP--SIG 91
E S Q+ ES + + + I L L ++ ++
Sbjct: 348 DEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMR-ALDPLLYEKETLQ 406
Query: 92 RLDKLQRL--------ALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLF 143
L+ + ++ ++R L+L L + ++ LL
Sbjct: 407 YFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLL 464
Query: 144 LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
+T LDLS N L+ A+P +L L L L S N + L
Sbjct: 465 VTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDGVANL 507
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 29/133 (21%), Positives = 52/133 (39%), Gaps = 10/133 (7%)
Query: 76 NLPYMQLGG--IISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQG 132
L Y+++ + + L L L N + +I E ++L L L N ++
Sbjct: 173 KLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRM 231
Query: 133 GIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP--DFGALS 189
I L L L L +N L +P+ L L L + L TN + ++ DF +
Sbjct: 232 -IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVG 288
Query: 190 AFGNKSFIGNLDL 202
+++ + L
Sbjct: 289 FGVKRAYYNGISL 301
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 25/112 (22%), Positives = 49/112 (43%), Gaps = 11/112 (9%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
++L + ++ I + R KL RL L N + I N + LR L+L N L
Sbjct: 196 NELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS 254
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSS-------LGRLTHLHYLNLSTN 176
+PA + +L L ++ L +N++ + + + + + ++L N
Sbjct: 255 -RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNN 304
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 21/94 (22%), Positives = 34/94 (36%), Gaps = 7/94 (7%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ-GGIPANIGNLLFLTILDLS 150
L L +H N + +P + + + + + N L+ G + L L L +S
Sbjct: 122 PSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRIS 180
Query: 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
L IP L L+ L+L N I
Sbjct: 181 EAKLT-GIPKDL--PETLNELHLDHNKIQ-AIEL 210
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 20/113 (17%), Positives = 41/113 (36%), Gaps = 11/113 (9%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ L + Q+ I + S+ L L+ L L N L +P + + L+ +YL N +
Sbjct: 220 YRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK 278
Query: 133 GIPANI-------GNLLFLTILDLSSNSLKGAI--PSSLGRLTHLHYLNLSTN 176
+ N + + L +N + P++ +T +
Sbjct: 279 -VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 21/108 (19%), Positives = 40/108 (37%), Gaps = 9/108 (8%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYL 130
++L + + L L L L N + I + + +L+ LY+ N+L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHL 114
Query: 131 QGGIPANIGNLLF--LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
IP N L L L + N ++ L +++ + + N
Sbjct: 115 VE-IPPN----LPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGN 157
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 18/82 (21%), Positives = 32/82 (39%), Gaps = 5/82 (6%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPAN-IGNLLFLTILDLSSNSL 154
L+ + L ++P EI+ + L L+ N + + + L L L L +N +
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKI 90
Query: 155 KGAIPSSLGRLTHLHYLNLSTN 176
+ L L L +S N
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKN 112
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 7e-11
Identities = 27/99 (27%), Positives = 38/99 (38%), Gaps = 4/99 (4%)
Query: 81 QLGGIISPSI-GRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI 138
L + S+ L L L + N I + L L + N Q +I
Sbjct: 112 NLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
Query: 139 -GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L LT LDLS L+ P++ L+ L LN+S N
Sbjct: 171 FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 18/93 (19%), Positives = 35/93 (37%), Gaps = 2/93 (2%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSS 151
L+ L L N + ++ + +L L + + L+ ++ +L L LD+S
Sbjct: 77 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135
Query: 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
+ A L+ L L ++ N F
Sbjct: 136 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 21/106 (19%), Positives = 38/106 (35%), Gaps = 3/106 (2%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+++ + + L L+ L + NS + +I T L L L L+
Sbjct: 129 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 188
Query: 132 GGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+ +L L +L++S N+ L L L+ S N
Sbjct: 189 Q-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 18/95 (18%), Positives = 37/95 (38%), Gaps = 4/95 (4%)
Query: 85 IISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLL 142
+S + L++L+ L ++L + + L L + + + I L
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLS 150
Query: 143 FLTILDLSSNSLKGAIPS-SLGRLTHLHYLNLSTN 176
L +L ++ NS + L +L +L+LS
Sbjct: 151 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 30/119 (25%), Positives = 47/119 (39%), Gaps = 9/119 (7%)
Query: 61 TGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLH--GSIPNEITNCT 118
TGI + L +L + +L +L +L+L N L G T
Sbjct: 24 TGIPSSA-----TRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 119 ELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSL-GRLTHLHYLNLSTN 176
L+ L L N + + +N L L LD ++LK S+ L +L YL++S
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 24/100 (24%), Positives = 37/100 (37%), Gaps = 4/100 (4%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ-GGIPANI-GNLLFLTILDLSSNS 153
RL L N L T+L L L +N L G + L LDLS N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 154 LKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGN 193
+ + S+ L L +L+ + ++ +F + N
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRN 127
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 21/89 (23%), Positives = 31/89 (34%), Gaps = 7/89 (7%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEITNC-TELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
L L L L Q L + N + L+ L + N + L L +LD
Sbjct: 173 ELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFS-LDTFPYKCLNSLQVLDY 230
Query: 150 SSNSLKGAIPSSL--GRLTHLHYLNLSTN 176
S N + + L +LNL+ N
Sbjct: 231 SLNHIM-TSKKQELQHFPSSLAFLNLTQN 258
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 58/243 (23%), Positives = 94/243 (38%), Gaps = 76/243 (31%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE---------RELEILGSIK- 365
+G G +G V++ + G AVK+I F+ RE+ IL +
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-------AFQNSTDAQRTFREIMILTELSG 67
Query: 366 HINLVNLRGYCRLPATK--LLIYDY--------LSMGSLDD-----FLHEHGEGQQLLNW 410
H N+VNL R + L++DY + L+ ++ QL+
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVY------QLI-- 119
Query: 411 SARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470
+ + YLH ++HRD+K SNILL+ V+DFGL++ V+
Sbjct: 120 -----------KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 471 VTTVVAGTFG--------------------YLAPEY-LQSGRATEKSDVYSFGVLLLELV 509
+ Y APE L S + T+ D++S G +L E++
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 510 TGK 512
GK
Sbjct: 226 CGK 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.0 bits (152), Expect = 7e-11
Identities = 36/217 (16%), Positives = 60/217 (27%), Gaps = 54/217 (24%)
Query: 288 TSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRI---- 343
+ + F +P + EK+ G G FG V++ + D A+K I
Sbjct: 6 SQKGPVPFSHCLPTEKLQRCEKI---------GEGVFGEVFQ-TIADHTPVAIKIIAIEG 55
Query: 344 DRSREGSDQVFERE-------------LEILGSIKHINLVNLRGY--CRLPATKLLIYDY 388
GS Q E L + + L + LL+ +
Sbjct: 56 PDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAW 115
Query: 389 LSM----GSLDDFLHEHGEGQ-------------------QLLNWSARLKIALGSARGLA 425
GS +D + Q +L + + I LA
Sbjct: 116 DHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLA 175
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462
+ HRD+ N+LL + + K
Sbjct: 176 VAEASL--RFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 24/115 (20%), Positives = 43/115 (37%), Gaps = 3/115 (2%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHG-SIPNEITNCTELRALYLRANYLQ 131
++L L + S G L L+ L L N + + N T L+ L +
Sbjct: 77 EHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETF 136
Query: 132 GGIPAN-IGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDF 185
I L L L++ + SL+ SL + +H+L L + + + +
Sbjct: 137 SEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEI 190
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 28/108 (25%), Positives = 46/108 (42%), Gaps = 6/108 (5%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSL 154
++ L L N + ++ C L+ L L+++ + I + +L L LDLS N L
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHL 86
Query: 155 KGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
S G L+ L YLNL N + + F N + + L +
Sbjct: 87 SSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTS---LFPNLTNLQTLRI 130
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 27/133 (20%), Positives = 46/133 (34%), Gaps = 9/133 (6%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNE-ITNCTELRALYLRANYLQ 131
+ + L ++ I + L L+ L L N L S+ + + L+ L L N Q
Sbjct: 53 QVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQ 111
Query: 132 G-GIPANIGNLLFLTILDLSSNSLKGAIP-SSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
G+ + NL L L + + I LT L+ L +
Sbjct: 112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQS----Q 166
Query: 190 AFGNKSFIGNLDL 202
+ + I +L L
Sbjct: 167 SLKSIRDIHHLTL 179
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 28/134 (20%), Positives = 55/134 (41%), Gaps = 9/134 (6%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYL 130
++S++L + ++ I + LQ L L + ++ +I + + L L L N+L
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHL 86
Query: 131 QGGIPAN-IGNLLFLTILDLSSNSLKG-AIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
+ ++ G L L L+L N + + S LT+L L + EI
Sbjct: 87 S-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRR---- 141
Query: 189 SAFGNKSFIGNLDL 202
F + + L++
Sbjct: 142 IDFAGLTSLNELEI 155
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 27/124 (21%), Positives = 46/124 (37%), Gaps = 7/124 (5%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYL 130
+R +++P L +S L+K++R+ + + + +P + L L L N +
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLM 346
Query: 131 QGGIPAN---IGNLLFLTILDLSSNSLK--GAIPSSLGRLTHLHYLNLSTNFFSGEIPDF 185
N G L L LS N L+ L L +L L++S N F
Sbjct: 347 VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSC 406
Query: 186 GALS 189
Sbjct: 407 QWPE 410
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 19/106 (17%), Positives = 35/106 (33%), Gaps = 2/106 (1%)
Query: 73 RSINLPYMQLGGIISPS-IGRLDKLQRLALHQNSLHGSIPNE-ITNCTELRALYLRANYL 130
+ +NL + S L LQ L + I T L L ++A L
Sbjct: 101 KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160
Query: 131 QGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+ ++ ++ + L L + + L+ + YL L
Sbjct: 161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 21/95 (22%), Positives = 35/95 (36%), Gaps = 6/95 (6%)
Query: 87 SPSIGRLDKLQRLALHQNSLH--GSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144
S G LQ L L QN L + L +L + N +P + +
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP-MPDSCQWPEKM 412
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
L+LSS ++ + + + L L++S N
Sbjct: 413 RFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 23/117 (19%), Positives = 40/117 (34%), Gaps = 14/117 (11%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT 145
+ S +K++ L L + + I L L + N L + L
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIR-VVKTCIP--QTLEVLDVSNNNLD-SFSLFLPR---LQ 454
Query: 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
L +S N LK +P + L + +S N +PD F + + + L
Sbjct: 455 ELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLK-SVPD----GIFDRLTSLQKIWL 504
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 23/86 (26%), Positives = 35/86 (40%), Gaps = 6/86 (6%)
Query: 91 GRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150
L+ L + N+L S + L+ LY+ N L+ +P L ++ +S
Sbjct: 428 CIPQTLEVLDVSNNNL-DSFSLFLPR---LQELYISRNKLKT-LPDA-SLFPVLLVMKIS 481
Query: 151 SNSLKGAIPSSLGRLTHLHYLNLSTN 176
N LK RLT L + L TN
Sbjct: 482 RNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 26/109 (23%), Positives = 43/109 (39%), Gaps = 8/109 (7%)
Query: 94 DKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNS 153
D S SIP+ +T +++L L N + ++ L +L L S+
Sbjct: 5 DASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61
Query: 154 LKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
+ + L L +L+LS N S + S FG S + L+L
Sbjct: 62 INTIEGDAFYSLGSLEHLDLSDNHLS-SLSS----SWFGPLSSLKYLNL 105
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 28/188 (14%), Positives = 54/188 (28%), Gaps = 22/188 (11%)
Query: 35 EIKSSLNDSRNLLGNWQATEESPCKWTGISCHTH--DQRVRSINLPYMQLGGIISPSIGR 92
E L ++L + + E D+ + + + S
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 93 LDKLQRLALHQNSLH---------GSIPNEITN---------CTELRALYLRANYLQGGI 134
L KL R L + + G ++ +R L++ YL +
Sbjct: 243 LLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302
Query: 135 PANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNK 194
L + + + ++ + S L L +L+LS N E + G
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY--LKNSACKGAW 360
Query: 195 SFIGNLDL 202
+ L L
Sbjct: 361 PSLQTLVL 368
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 14/96 (14%), Positives = 25/96 (26%)
Query: 81 QLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGN 140
I L L L + SL + + ++ L L + +
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194
Query: 141 LLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L + L+L +L S L +
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAF 230
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 15/107 (14%), Positives = 31/107 (28%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ + + L S S+ + + L LH + + + +R L LR L
Sbjct: 151 NELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLAR 210
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
+ + + + + S L L L +
Sbjct: 211 FQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE 257
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 26/110 (23%), Positives = 44/110 (40%), Gaps = 5/110 (4%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+ ++L Y +L I+ ++ +L+RL + N L ++ L+ L L N+
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 312
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
L + N L L L NS+ + L L L LS N +
Sbjct: 313 LLH-VERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 24/135 (17%), Positives = 49/135 (36%), Gaps = 9/135 (6%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRAN 128
+ + + + + + +++ L L+ + I ++ LY+ N
Sbjct: 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFN 109
Query: 129 YLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGA 187
++ +P ++ N+ LT+L L N L L L++S N I D
Sbjct: 110 AIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIED--- 164
Query: 188 LSAFGNKSFIGNLDL 202
F + + NL L
Sbjct: 165 -DTFQATTSLQNLQL 178
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 30/122 (24%), Positives = 54/122 (44%), Gaps = 6/122 (4%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRAN 128
++V +NL +Q+ I + + +Q+L + N++ +P + N L L L N
Sbjct: 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN 133
Query: 129 YLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGA 187
L +P I N LT L +S+N+L+ + T L L LS+N + +
Sbjct: 134 DLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD-LSL 190
Query: 188 LS 189
+
Sbjct: 191 IP 192
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 17/132 (12%), Positives = 42/132 (31%), Gaps = 9/132 (6%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+++ L+ + + +++ +P + + ++ L L ++
Sbjct: 30 YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE 88
Query: 132 GGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
I + L + N+++ P + L L L N S +P
Sbjct: 89 E-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPR----GI 142
Query: 191 FGNKSFIGNLDL 202
F N + L +
Sbjct: 143 FHNTPKLTTLSM 154
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 28/98 (28%), Positives = 41/98 (41%), Gaps = 8/98 (8%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLS 150
+ L L L +N L S+P I N +L L + N L+ I + L L LS
Sbjct: 122 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLS 179
Query: 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
SN L + L + L + N+S N S + A+
Sbjct: 180 SNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPIAV 213
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 23/107 (21%), Positives = 41/107 (38%), Gaps = 10/107 (9%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+ N+ Y L ++ ++ L NS++ + + EL L L+ N
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNN 243
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L + N L +DLS N L+ + ++ L L +S N
Sbjct: 244 LTD-TAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 288
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 20/114 (17%), Positives = 37/114 (32%), Gaps = 15/114 (13%)
Query: 89 SIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148
+ + L + N L + + + L N + + + + LTIL
Sbjct: 187 DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 238
Query: 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
L N+L + L L ++LS N +I F + L +
Sbjct: 239 LQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMY----HPFVKMQRLERLYI 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 26/110 (23%), Positives = 44/110 (40%), Gaps = 5/110 (4%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+ ++L Y +L I+ ++ +L+RL + N L ++ L+ L L N+
Sbjct: 248 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNH 306
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
L + N L L L NS+ + S L L LS N +
Sbjct: 307 LLH-VERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 24/132 (18%), Positives = 49/132 (37%), Gaps = 9/132 (6%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+ + + + + + +++ L L+ + I ++ LY+ N ++
Sbjct: 48 KIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR 106
Query: 132 GGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
+P ++ N+ LT+L L N L L L++S N I D
Sbjct: 107 Y-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIED----DT 160
Query: 191 FGNKSFIGNLDL 202
F + + NL L
Sbjct: 161 FQATTSLQNLQL 172
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 30/122 (24%), Positives = 54/122 (44%), Gaps = 6/122 (4%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRAN 128
++V +NL +Q+ I + + +Q+L + N++ +P + N L L L N
Sbjct: 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERN 127
Query: 129 YLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGA 187
L +P I N LT L +S+N+L+ + T L L LS+N + +
Sbjct: 128 DLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD-LSL 184
Query: 188 LS 189
+
Sbjct: 185 IP 186
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 17/132 (12%), Positives = 42/132 (31%), Gaps = 9/132 (6%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+++ L+ + + +++ +P + + ++ L L ++
Sbjct: 24 YDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE 82
Query: 132 GGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
I + L + N+++ P + L L L N S +P
Sbjct: 83 -EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPR----GI 136
Query: 191 FGNKSFIGNLDL 202
F N + L +
Sbjct: 137 FHNTPKLTTLSM 148
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 23/107 (21%), Positives = 41/107 (38%), Gaps = 10/107 (9%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+ N+ Y L ++ ++ L NS++ + + EL L L+ N
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNN 237
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L + N L +DLS N L+ + ++ L L +S N
Sbjct: 238 LTD-TAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNN 282
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 28/99 (28%), Positives = 41/99 (41%), Gaps = 8/99 (8%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLS 150
+ L L L +N L S+P I N +L L + N L+ I + L L LS
Sbjct: 116 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLS 173
Query: 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
SN L + L + L + N+S N S + A+
Sbjct: 174 SNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAIPIAVE 208
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 12/110 (10%), Positives = 35/110 (31%), Gaps = 7/110 (6%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSL 154
+ + + E + + + + ++ +PA + + + +L+L+ +
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQI 81
Query: 155 KGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
+ + + L + N +P F N + L L
Sbjct: 82 EEIDTYAFAYAHTIQKLYMGFNAIR-YLPP----HVFQNVPLLTVLVLER 126
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 13/103 (12%), Positives = 30/103 (29%), Gaps = 5/103 (4%)
Query: 100 ALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIP 159
+ + I + + +++ L I+ +++++
Sbjct: 3 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 62
Query: 160 SSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
+ L + LNL+ EI AF I L +
Sbjct: 63 ALLDSFRQVELLNLNDLQIE-EIDT----YAFAYAHTIQKLYM 100
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 23/113 (20%), Positives = 38/113 (33%), Gaps = 5/113 (4%)
Query: 76 NLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIP 135
N + ++ L N L ++ + TEL L L+ N L+ +
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364
Query: 136 ANIG---NLLFLTILDLSSNSLKGAIPSSL-GRLTHLHYLNLSTNFFSGEIPD 184
+ L LD+S NS+ L LN+S+N + I
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 24/118 (20%), Positives = 41/118 (34%), Gaps = 7/118 (5%)
Query: 63 ISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI---TNCTE 119
+ C + ++ L + + G L +L+ L L N L + T
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKS 375
Query: 120 LRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L+ L + N + L L++SSN L I L + L+L +N
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSN 431
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 27/107 (25%), Positives = 42/107 (39%), Gaps = 6/107 (5%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYL 130
+N+ + + + I L KL+ L + N + + + EL L L N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKL 81
Query: 131 QGGIPANIGNLLFLTILDLSSNSLKG-AIPSSLGRLTHLHYLNLSTN 176
I + L LDLS N+ I G ++ L +L LST
Sbjct: 82 V-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTT 125
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 24/87 (27%), Positives = 38/87 (43%), Gaps = 3/87 (3%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSS 151
L L + N L +I + ++ L L +N ++ IP + L L L+++S
Sbjct: 397 WTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKS-IPKQVVKLEALQELNVAS 453
Query: 152 NSLKGAIPSSLGRLTHLHYLNLSTNFF 178
N LK RLT L + L TN +
Sbjct: 454 NQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 20/76 (26%), Positives = 35/76 (46%), Gaps = 3/76 (3%)
Query: 101 LHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPS 160
+N L +P +++ + L + NY+ ++I +L L IL +S N ++ S
Sbjct: 7 RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63
Query: 161 SLGRLTHLHYLNLSTN 176
L YL+LS N
Sbjct: 64 VFKFNQELEYLDLSHN 79
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 17/96 (17%), Positives = 29/96 (30%), Gaps = 4/96 (4%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSS 151
+ + + + L N L + N G+L L L L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 152 NSLKGAIPSSLG---RLTHLHYLNLSTNFFSGEIPD 184
N LK + ++ L L++S N S +
Sbjct: 358 NQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 18/93 (19%), Positives = 34/93 (36%), Gaps = 5/93 (5%)
Query: 89 SIGRLDKLQRLALHQNSLHGSIP--NEITNCTELRALYLRANYLQGGIPANIGNLLFLTI 146
S L+ L L N+ ++P E N ++L+ L L +L+ I +L +
Sbjct: 85 SCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKV 143
Query: 147 LDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
L + + L + +L F +
Sbjct: 144 LLVLGETYG--EKEDPEGLQDFNTESLHIVFPT 174
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 28/109 (25%), Positives = 41/109 (37%), Gaps = 5/109 (4%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYL 130
V ++L + + S RL LQ L + Q + I N + L L L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 131 QGGIPANI-GNLLFLTILDLSSNSLKGAI--PSSLGRLTHLHYLNLSTN 176
+ L L +L L+ +L GA+ + LT L L L N
Sbjct: 92 L-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 29/87 (33%), Positives = 39/87 (44%), Gaps = 4/87 (4%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
L L +L L QN L GSI + + N +L L L N+++ + L L L L
Sbjct: 321 GLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLPNLKELAL 378
Query: 150 SSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+N LK RLT L + L TN
Sbjct: 379 DTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 29/87 (33%), Positives = 42/87 (48%), Gaps = 6/87 (6%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLS 150
L++L L QN ++ I + T L L L N+L I + + NL L +LDLS
Sbjct: 298 FTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLS 355
Query: 151 SNSLKGAIPS-SLGRLTHLHYLNLSTN 176
N ++ A+ S L +L L L TN
Sbjct: 356 YNHIR-ALGDQSFLGLPNLKELALDTN 381
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 23/117 (19%), Positives = 43/117 (36%), Gaps = 6/117 (5%)
Query: 64 SCHTHDQRVRSINLPYMQLGGIISPSIGRLD--KLQRLALHQNSLHGSIPNEI-TNCTEL 120
S + + + + + L+ ++ L ++ + ++ + ++ T+L
Sbjct: 243 SLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDL 301
Query: 121 RALYLRANYLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L L N + I N L L L+LS N L L L L+LS N
Sbjct: 302 EQLTLAQNEINK-IDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYN 357
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 5e-06
Identities = 21/116 (18%), Positives = 38/116 (32%), Gaps = 15/116 (12%)
Query: 76 NLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI---TNCTELRALYLRANY--- 129
++ LG + + + L L N S+ T++++L L +Y
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253
Query: 130 --LQGGIPANIGNLLF-------LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+ N F + DLS + + + S T L L L+ N
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN 309
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 5/90 (5%)
Query: 92 RLDKLQRLALHQNSLHGS-IPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILD 148
L L+ L L Q +L G+ + T L L LR N ++ PA+ N+ +LD
Sbjct: 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160
Query: 149 LSSNSLKGAIPSSLGRLT--HLHYLNLSTN 176
L+ N +K L H L LS+
Sbjct: 161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSI 190
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 26/121 (21%), Positives = 37/121 (30%), Gaps = 15/121 (12%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI---TNCTELRALYLRANYLQ--------GGIPANIGN 140
+ + L L N + SI E L L + LQ N
Sbjct: 152 NMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 141 LLFLTILDLSSNSLKGAIPS---SLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFI 197
+T LDLS N K ++ T + L LS ++ G N +F
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFK 270
Query: 198 G 198
G
Sbjct: 271 G 271
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 5e-05
Identities = 26/165 (15%), Positives = 54/165 (32%), Gaps = 20/165 (12%)
Query: 38 SSLNDSRNLLGNWQATEESPCKWTGISCHT--HDQRVRSINLPYMQLGGIISPSI---GR 92
+ + L + + + C + + +++L ++
Sbjct: 178 QGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIA 237
Query: 93 LDKLQRLALHQN-----SLHGSIPNEITNCT-------ELRALYLRANYLQGGIPANI-G 139
K+Q L L + S + + N T ++ L + + + ++
Sbjct: 238 GTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFS 296
Query: 140 NLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
+ L L L+ N + ++ LTHL LNLS NF I
Sbjct: 297 HFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDS 340
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 24/85 (28%), Positives = 37/85 (43%), Gaps = 4/85 (4%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYL 130
+ +NL LG I S LDKL+ L L N + ++ ++ L+ L L N L
Sbjct: 325 LLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQL 383
Query: 131 QGGIPANI-GNLLFLTILDLSSNSL 154
+ +P I L L + L +N
Sbjct: 384 K-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 30/124 (24%), Positives = 51/124 (41%), Gaps = 7/124 (5%)
Query: 63 ISCHTHDQRVRSINLPYMQLGGI-ISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTEL 120
++ + I+L +L + I + R+ LQ L L+QN ++ + L
Sbjct: 394 VTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSL 453
Query: 121 RALYLRANYLQGGIPANIGNLLF-----LTILDLSSNSLKGAIPSSLGRLTHLHYLNLST 175
L+L N LQ + +F L +L L+ N L P LT L L+L++
Sbjct: 454 EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513
Query: 176 NFFS 179
N +
Sbjct: 514 NRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 31/111 (27%), Positives = 43/111 (38%), Gaps = 4/111 (3%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSS 151
L+ +RL L N + + +L+ L L + Y I NL L ILDL S
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
+ + P + L HL L L S + G F N + LDL
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDG---YFRNLKALTRLDL 130
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 24/108 (22%), Positives = 40/108 (37%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
VR ++L + + + S L L+ L L N ++ L+ L L N L
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
+N L + +DL N + + L L L+L N +
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 29/139 (20%), Positives = 51/139 (36%), Gaps = 8/139 (5%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSI--PNEITNCTELRALYLRANYL 130
R ++L ++ + + L L L L+ L ++ N L L L N +
Sbjct: 76 RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQI 135
Query: 131 QG-GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLT--HLHYLNLSTNFFSGEIPD--F 185
+ + + G L L +D SSN + L L L + +L+ N +
Sbjct: 136 RSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG 195
Query: 186 GALSAFGNKSFIGNLDLCG 204
++ F N LD+ G
Sbjct: 196 KCMNPFRNMVL-EILDVSG 213
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 24/110 (21%), Positives = 45/110 (40%), Gaps = 5/110 (4%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+ ++ +NL Y ++ I + LD LQ L L N L + ++ + L+ N+
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNH 349
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
+ L L LDL N+L +++ + + + LS N
Sbjct: 350 IAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 6e-07
Identities = 43/219 (19%), Positives = 73/219 (33%), Gaps = 20/219 (9%)
Query: 76 NLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGI 134
L + L LQ L L+ N L+ S+P + ++ T LR L L +N L
Sbjct: 462 MLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT--- 517
Query: 135 PANIGNLLF---LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF 191
+ + L ILD+S N L P L L+++ N F E LS F
Sbjct: 518 --VLSHNDLPANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICECE----LSTF 568
Query: 192 GNKSFIGNLDLCGRQVHKPCRT---SMGFPAVLPHASSDEVAVPTKRSSHYMKGVLIGAM 248
N N+ + G C G + K + V +
Sbjct: 569 INWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTL 628
Query: 249 STMGLALVVLLAFLWICLLSKKERAVKRYTEVRKQVDQE 287
+ + ++ + F C + K + + + + +
Sbjct: 629 TLFLMTILTVTKFRGFCFICYKTAQRLVFKDHPQGTEPD 667
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 32/155 (20%), Positives = 45/155 (29%), Gaps = 27/155 (17%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN- 128
+V I+L + I + L+KLQ L L N+L I + ++L N
Sbjct: 338 PKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNK 392
Query: 129 --------------YLQGGIPANIGNLLF------LTILDLSSNSLKGAIPSSL-GRLTH 167
+L N+ L F L IL L+ N
Sbjct: 393 LVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPS 452
Query: 168 LHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
L L L N F S + L L
Sbjct: 453 LEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 9e-05
Identities = 18/69 (26%), Positives = 25/69 (36%), Gaps = 7/69 (10%)
Query: 134 IPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGN 193
+P + L LS N ++ SS L L L L + + I AF N
Sbjct: 19 VPQVLNTT---ERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK----EAFRN 71
Query: 194 KSFIGNLDL 202
+ LDL
Sbjct: 72 LPNLRILDL 80
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 26/150 (17%), Positives = 43/150 (28%), Gaps = 25/150 (16%)
Query: 73 RSINLPYMQLGGIISPSIGRLDK------LQRLALHQNSLHGSIPNEITNC--------- 117
+L L +S G+ L+ L + N I +N
Sbjct: 177 SFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSL 236
Query: 118 ---TELRALYLRANYLQGGIPANIGNL--LFLTILDLSSNSLKGAIPSSLGRLTHLHYLN 172
+ + ++ L + LDLS + L L LN
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296
Query: 173 LSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
L+ N + +I D AF + L+L
Sbjct: 297 LAYNKIN-KIAD----EAFYGLDNLQVLNL 321
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 19/91 (20%), Positives = 31/91 (34%), Gaps = 10/91 (10%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT----ILD 148
L+ L++ N L +P + L AL + N L+ +PA
Sbjct: 159 PTSLEVLSVRNNQL-TFLPELPES---LEALDVSTNLLES-LPAVPVRNHHSEETEIFFR 213
Query: 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
N + IP ++ L + L N S
Sbjct: 214 CRENRIT-HIPENILSLDPTCTIILEDNPLS 243
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 23/111 (20%), Positives = 46/111 (41%), Gaps = 16/111 (14%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147
+++ L L++ +L S+P+ + ++ L + N L +P + L L
Sbjct: 53 LKECLINQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPAS---LEYL 105
Query: 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGA----LSAFGNK 194
D N L +P L H L++ N + +P+ A ++A N+
Sbjct: 106 DACDNRLS-TLPELPASLKH---LDVDNNQLT-MLPELPALLEYINADNNQ 151
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 18/116 (15%), Positives = 38/116 (32%), Gaps = 17/116 (14%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
++ + + L + L+ L N L ++P + L + N
Sbjct: 80 PQITVLEITQNALI-SLPELPA---SLEYLDACDNRLS-TLPELPASLKHL---DVDNNQ 131
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDF 185
L +P L ++ +N L +P L L++ N + +P+
Sbjct: 132 LTM-LPELPALL---EYINADNNQLT-MLPELPTSLEV---LSVRNNQLT-FLPEL 178
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 22/96 (22%), Positives = 32/96 (33%), Gaps = 6/96 (6%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELR----ALYLRANYLQGGIPANIGNLLFLTILD 148
+ L+ L + N L S+P R N + IP NI +L +
Sbjct: 179 PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTII 236
Query: 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
L N L I SL + T + +FS
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ 272
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 5e-10
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 38/214 (17%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT---FAVKRIDRSREGSDQVFERELEILGSIKHI------ 367
V+G G FG V + D A+K + R+ + + E+ IL ++
Sbjct: 103 KVIGKGSFGQVVKAY--DHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTM 159
Query: 368 NLVNLRGY-------CRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS 420
N++++ C + ++ LSM +L + + ++ Q + K A
Sbjct: 160 NVIHMLENFTFRNHIC-------MTFELLSM-NLYELIKKNKF--QGFSLPLVRKFAHSI 209
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH--VSDFGLAKLLVDEEAHVTTVVAGT 478
+ L LH +IIH D+K NILL + V DFG + E V T +
Sbjct: 210 LQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYTYIQSR 263
Query: 479 FGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGK 512
F Y APE + R D++S G +L EL+TG
Sbjct: 264 F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 31/113 (27%), Positives = 46/113 (40%), Gaps = 11/113 (9%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLF 143
+ L L L + N L S+P EL+ LYL+ N L+ +P +
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPK 149
Query: 144 LTILDLSSNSLKGAIPSSL-GRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKS 195
L L L++N+L +P+ L L +L L L N IP FG+
Sbjct: 150 LEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPK----GFFGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 24/81 (29%), Positives = 34/81 (41%), Gaps = 3/81 (3%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLK 155
L L +N L+ + T L L L L + + G L L LDLS N L+
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ 90
Query: 156 GAIPSSLGRLTHLHYLNLSTN 176
++P L L L++S N
Sbjct: 91 -SLPLLGQTLPALTVLDVSFN 110
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 27/105 (25%), Positives = 40/105 (38%), Gaps = 5/105 (4%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
++L L ++ +L +L L + L + L L L N LQ
Sbjct: 34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQ-VDGTLPVLGTLDLSHNQLQS 91
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSL-GRLTHLHYLNLSTN 176
+P L LT+LD+S N L ++P L L L L N
Sbjct: 92 -LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGN 134
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 17/62 (27%), Positives = 24/62 (38%), Gaps = 3/62 (4%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150
KL++L+L N+L +P + L L L+ N L IP L L
Sbjct: 146 PTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLH 203
Query: 151 SN 152
N
Sbjct: 204 GN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 22/95 (23%), Positives = 30/95 (31%), Gaps = 16/95 (16%)
Query: 115 TNCTELRALYLRANYLQ---GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYL 171
+ + L +P + TIL LS N L ++L T L L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLPKD------TTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 172 NLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQ 206
NL + L G +G LDL Q
Sbjct: 61 NLDRAELT-------KLQVDGTLPVLGTLDLSHNQ 88
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 29/112 (25%), Positives = 42/112 (37%), Gaps = 9/112 (8%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLS 150
L LQ L L N+L ++P++ + L L+L N + +P L L L L
Sbjct: 128 LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLH 185
Query: 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
N + P + L L L L N S +P A + L L
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPT----EALAPLRALQYLRL 232
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 30/113 (26%), Positives = 46/113 (40%), Gaps = 10/113 (8%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLS 150
L L++L L N+ S+ L L+L LQ + + L L L L
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQ 137
Query: 151 SNSLKGAIPS-SLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
N+L+ A+P + L +L +L L N S +P+ AF + L L
Sbjct: 138 DNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPE----RAFRGLHSLDRLLL 184
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 24/86 (27%), Positives = 35/86 (40%), Gaps = 4/86 (4%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLS 150
L +L L L + L + + L+ LYL+ N LQ +P + +L LT L L
Sbjct: 104 LGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLH 161
Query: 151 SNSLKGAIPSSLGRLTHLHYLNLSTN 176
N + + L L L L N
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQN 187
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 27/106 (25%), Positives = 41/106 (38%), Gaps = 4/106 (3%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+ + L L + + L L L LH N + S+P L L L N +
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA 190
Query: 132 GGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+ + +L L L L +N+L +L L L YL L+ N
Sbjct: 191 H-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 32/135 (23%), Positives = 42/135 (31%), Gaps = 13/135 (9%)
Query: 61 TGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTE 119
GI + + I L ++ + + S L L LH N L I T
Sbjct: 28 VGIPAAS-----QRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLAL 81
Query: 120 LRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSLKGAIPS-SLGRLTHLHYLNLSTNF 177
L L L N + L L L L L+ + L L YL L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 178 FSGEIPD--FGALSA 190
+PD F L
Sbjct: 141 LQ-ALPDDTFRDLGN 154
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 22/84 (26%), Positives = 32/84 (38%), Gaps = 4/84 (4%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+ L ++ + + L L RL LHQN + + + L LYL AN L
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS 214
Query: 132 GGIPANI-GNLLFLTILDLSSNSL 154
+P L L L L+ N
Sbjct: 215 -ALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 23/95 (24%), Positives = 36/95 (37%), Gaps = 8/95 (8%)
Query: 109 SIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTH 167
++P I + ++L N + +PA LTIL L SN L ++ L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 168 LHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
L L+LS N + + F + L L
Sbjct: 82 LEQLDLSDNAQLRSVDP----ATFHGLGRLHTLHL 112
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 73/391 (18%), Positives = 114/391 (29%), Gaps = 137/391 (35%)
Query: 297 GDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFE 355
GD+ +I KL G G F TV+ F A+K + +S E +
Sbjct: 32 GDLFNGRYHVIRKL---------GWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL 81
Query: 356 RELEILGSIKHINLVNL-RGYCRLPATKLLIYDYLSMGSLDDFLHE--HGE--------- 403
E+ +L S+++ + + R LDDF +G
Sbjct: 82 DEIRLLKSVRNSDPNDPNREMVVQL--------------LDDFKISGVNGTHICMVFEVL 127
Query: 404 GQQLLNWSARLK-----------IALGSARGLAYLHHDCCPKIIHRDIKSSNILL----- 447
G LL W + I +GL YLH C +IIH DIK NILL
Sbjct: 128 GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQ 185
Query: 448 --------------------------------------------DENLEPHVSDFGLAKL 463
E L+ ++D G A
Sbjct: 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA-- 243
Query: 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPT----- 518
H T + T Y + E L +D++S + EL TG +P
Sbjct: 244 -CWVHKHFTEDI-QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
Query: 519 --------------------FVKRGLNVVGWMN--------TLLKENRLEDVIDKRCADA 550
+ G + T LK L +V+ ++ +
Sbjct: 302 TRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY-EW 360
Query: 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
E + + P+ R + + L+
Sbjct: 361 SQEEAAGFTDFLLPMLELIPEKRATAAECLR 391
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 28/133 (21%), Positives = 49/133 (36%), Gaps = 7/133 (5%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+ L L I + ++ L L L L +++ +I + L+ L +
Sbjct: 155 EQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEISHWPYL 213
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF 191
+ N L LT L ++ +L ++ L +L +LNLS N S I S
Sbjct: 214 DTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEG----SML 268
Query: 192 GNKSFIGNLDLCG 204
+ + L G
Sbjct: 269 HELLRLQEIQLVG 281
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 30/121 (24%), Positives = 49/121 (40%), Gaps = 6/121 (4%)
Query: 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANY 129
R ++L ++ + L+ L L++N + ++ N LR L LR+N
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNR 91
Query: 130 LQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
L+ IP + L LT LD+S N + + L +L L + N I A
Sbjct: 92 LKL-IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISH-RAF 148
Query: 189 S 189
S
Sbjct: 149 S 149
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 28/135 (20%), Positives = 55/135 (40%), Gaps = 9/135 (6%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNE-ITNCTELRALYLRAN 128
R++ + + + ++P+ L L++ +L ++P + + LR L L N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYN 258
Query: 129 YLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGA 187
+ I ++ LL L + L L P + L +L LN+S N + + +
Sbjct: 259 PIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEE--- 313
Query: 188 LSAFGNKSFIGNLDL 202
S F + + L L
Sbjct: 314 -SVFHSVGNLETLIL 327
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 22/114 (19%), Positives = 46/114 (40%), Gaps = 4/114 (3%)
Query: 68 HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLR 126
+ + S+++ + L + ++ L L+ L L N + +I + L+ + L
Sbjct: 222 YGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLV 280
Query: 127 ANYLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
L + L +L +L++S N L S + +L L L +N +
Sbjct: 281 GGQLAV-VEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 27/132 (20%), Positives = 54/132 (40%), Gaps = 9/132 (6%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+S+ + L I + L+ L++L L + +L SIP E ++ L L LR +
Sbjct: 131 KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
Query: 132 GGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
I L L +L++S + + +L L+++ + +P A
Sbjct: 190 -AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY----LA 243
Query: 191 FGNKSFIGNLDL 202
+ ++ L+L
Sbjct: 244 VRHLVYLRFLNL 255
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 7e-08
Identities = 23/114 (20%), Positives = 41/114 (35%), Gaps = 9/114 (7%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLS 150
L L +L + +N + + + + + L++L + N L I L L L L
Sbjct: 103 LSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLE 160
Query: 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
+L +L L L L L + I D +F + L++
Sbjct: 161 KCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRD----YSFKRLYRLKVLEISH 209
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 24/94 (25%), Positives = 37/94 (39%), Gaps = 7/94 (7%)
Query: 109 SIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHL 168
++P I TE R L L N ++ + L L+L+ N + P + L +L
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 169 HYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
L L +N IP F S + LD+
Sbjct: 83 RTLGLRSNRLK-LIPL----GVFTGLSNLTKLDI 111
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 21/139 (15%), Positives = 42/139 (30%), Gaps = 16/139 (11%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
+ + L S+ + + L LH + + + L LR L
Sbjct: 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLD 235
Query: 132 G--------GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP 183
G ++ + ++ SL + L +++ L L S N +P
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VP 293
Query: 184 DFGALSAFGNKSFIGNLDL 202
D F + + + L
Sbjct: 294 D----GIFDRLTSLQKIWL 308
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 5/108 (4%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSL 154
++ L L N + +++ C L+AL L +N + I + +L L LDLS N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYL 112
Query: 155 KGAIPSSL-GRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLD 201
+ SS L+ L +LNL N + + + S + +
Sbjct: 113 S-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGN 158
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 20/122 (16%), Positives = 38/122 (31%), Gaps = 8/122 (6%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
L KLQ L + I + T L L + A+ LQ ++ ++ L L
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQS-YEPKSLKSIQNVSHLIL 205
Query: 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG----EIPDFGALSAFGNKSFIGNLDLCGR 205
+ + + + L L E+ G ++ K N+ +
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELST-GETNSLIKKFTFRNVKITDE 264
Query: 206 QV 207
+
Sbjct: 265 SL 266
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 22/118 (18%), Positives = 40/118 (33%), Gaps = 9/118 (7%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
L L+ L L N L ++ + + L L L N + ++ +L L IL +
Sbjct: 98 SLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156
Query: 150 SSNSLKGAIPS-SLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQ 206
+ I LT L L + + + + + +L L +Q
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEP----KSLKSIQNVSHLILHMKQ 209
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 27/96 (28%), Positives = 40/96 (41%), Gaps = 5/96 (5%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
R LQ L L N ++ +I + ++ L L L NYL + ++ L LT L+L
Sbjct: 74 RCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNL 131
Query: 150 SSNSLKGAIPSSL-GRLTHLHYLNLSTNFFSGEIPD 184
N K +SL LT L L + +I
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR 167
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 19/93 (20%), Positives = 30/93 (32%), Gaps = 9/93 (9%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI--------TNCTELRALYLRANYLQGGIPANIGNLLF 143
++ L L L +E+ R + + L + + +
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISG 278
Query: 144 LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L L+ S N LK RLT L + L TN
Sbjct: 279 LLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 13/109 (11%), Positives = 30/109 (27%), Gaps = 12/109 (11%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
L L+ L + + L S + + + L L + + L+L
Sbjct: 172 GLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVECLEL 229
Query: 150 SSNSLKG----AIPS----SLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
L + + SL + + ++ + +S
Sbjct: 230 RDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISG 278
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 22/111 (19%), Positives = 49/111 (44%), Gaps = 9/111 (8%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
++L ++ + + S+ L+ L +L L NS+ ++ N N LR L+L N L
Sbjct: 195 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV 253
Query: 132 GGIPANIGNLLFLTILDLSSNSLKG------AIPSSLGRLTHLHYLNLSTN 176
+P + + ++ ++ L +N++ P + ++L +N
Sbjct: 254 -KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 303
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 23/108 (21%), Positives = 36/108 (33%), Gaps = 9/108 (8%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYL 130
++L ++ I L L L L N + I +L LYL N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQL 112
Query: 131 QGGIPANIGNLLF--LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+ +P + L L + N + S L + + L TN
Sbjct: 113 KE-LPEK----MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTN 155
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 7e-07
Identities = 18/87 (20%), Positives = 35/87 (40%), Gaps = 7/87 (8%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ-GGIPANI-GNLLFLTILDL 149
LQ L +H+N + + + ++ + L N L+ GI + L+ + +
Sbjct: 120 PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178
Query: 150 SSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+ ++ IP L L L+L N
Sbjct: 179 ADTNIT-TIPQGL--PPSLTELHLDGN 202
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 26/111 (23%), Positives = 44/111 (39%), Gaps = 11/111 (9%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSS 151
+ KL + + ++ +IP + L L+L N + + A L L L LS
Sbjct: 170 MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK-VDAASLKGLNNLAKLGLSF 225
Query: 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
NS+ SL HL L+L+ N ++P + +I + L
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVP-----GGLADHKYIQVVYL 270
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 20/82 (24%), Positives = 31/82 (37%), Gaps = 5/82 (6%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSL 154
L+ + L +P ++ + L L+ N + I NL L L L +N +
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITE-IKDGDFKNLKNLHTLILINNKI 88
Query: 155 KGAIPSSLGRLTHLHYLNLSTN 176
P + L L L LS N
Sbjct: 89 SKISPGAFAPLVKLERLYLSKN 110
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 48/214 (22%), Positives = 85/214 (39%), Gaps = 36/214 (16%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT---FAVKRIDRSREGSDQVFERELEILGSIKHI------ 367
++G G FG V + D A+K I ++++ + E+ +L +
Sbjct: 60 SLIGKGSFGQVVKAY--DRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEMKY 116
Query: 368 NLVNLRGY-------CRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS 420
+V+L+ + C L+++ LS +L D L + ++ + K A
Sbjct: 117 YIVHLKRHFMFRNHLC-------LVFEMLSY-NLYDLLRNTNF--RGVSLNLTRKFAQQM 166
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH--VSDFGLAKLLVDEEAHVTTVVAGT 478
L +L IIH D+K NILL + DFG + + +
Sbjct: 167 CTALLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQSR 222
Query: 479 FGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGK 512
F Y +PE L D++S G +L+E+ TG+
Sbjct: 223 F-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 30/117 (25%), Positives = 46/117 (39%), Gaps = 6/117 (5%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
RL L L L N L+ I +E LR L L +N+L + + +L L +L L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLL 119
Query: 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQ 206
+N + ++ + L L LS N S P + + LDL +
Sbjct: 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPV-ELIKDGNKLPKLMLLDLSSNK 174
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 23/93 (24%), Positives = 39/93 (41%), Gaps = 9/93 (9%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLS 150
+ L+ L L N LH ++ + ++ L L L N++ + N ++ L L LS
Sbjct: 87 VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLS 144
Query: 151 SNSLKGAIP----SSLGRLTHLHYLNLSTNFFS 179
N + P +L L L+LS+N
Sbjct: 145 QNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 6e-07
Identities = 25/91 (27%), Positives = 38/91 (41%), Gaps = 7/91 (7%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRAN---YLQGGIPANIGNLLFLTIL 147
L L+ L L+ N + + + +L+ LYL N + + L L +L
Sbjct: 110 DLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLL 168
Query: 148 DLSSNSLKGAIPSSLGRLTHL--HYLNLSTN 176
DLSSN LK + L +L + L L N
Sbjct: 169 DLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 30/112 (26%), Positives = 41/112 (36%), Gaps = 10/112 (8%)
Query: 96 LQRLALHQNSLHGSIPNEIT--NCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSN 152
L L N+L + E T T L +L L N+L I + + L LDLSSN
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSN 98
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
L L L L L N + +AF + + + L L
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNNHIV-VVDR----NAFEDMAQLQKLYLSQ 145
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 29/121 (23%), Positives = 50/121 (41%), Gaps = 12/121 (9%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ L +L I + L L L L +N + + + + + +L++L L N +
Sbjct: 68 TKLFLNGNKLTDI--KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGISD 123
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFG 192
I + +L L L L +N + + L RLT L L+L N +I D L+
Sbjct: 124 -IN-GLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDN----QISDIVPLAGLT 175
Query: 193 N 193
Sbjct: 176 K 176
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 20/108 (18%), Positives = 38/108 (35%), Gaps = 11/108 (10%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT 145
I P + + L + S+ ++ + + + ++ + I L +T
Sbjct: 14 IFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVT 68
Query: 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGN 193
L L+ N L L L +L +L L N +I D +L
Sbjct: 69 KLFLNGNKLTDI--KPLTNLKNLGWLFLDEN----KIKDLSSLKDLKK 110
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 45.5 bits (107), Expect = 4e-05
Identities = 21/91 (23%), Positives = 37/91 (40%), Gaps = 5/91 (5%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT 145
I+ + RL KL L+L N + I + T+L+ LYL N++ + L L
Sbjct: 146 ITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS--DLRALAGLKNLD 200
Query: 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+L+L S + L + + +
Sbjct: 201 VLELFSQECLNKPINHQSNLVVPNTVKNTDG 231
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 6e-09
Identities = 26/110 (23%), Positives = 39/110 (35%), Gaps = 8/110 (7%)
Query: 73 RSINLPYMQLGGIISPSI-GRLDKLQRLALHQNSLHGSIPNEI-TNCTELRA----LYLR 126
+ +N+ + + P L L+ L L N + SI ++ L L
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLS 185
Query: 127 ANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
N + I + L L L +N LK RLT L + L TN
Sbjct: 186 LNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 30/150 (20%), Positives = 49/150 (32%), Gaps = 18/150 (12%)
Query: 54 EESPCKWTGISCHTHDQRVRSI--NLP---------YMQLGGIISPSIGRLDKLQRLALH 102
E I+ + I NLP + L + S S +LQ L L
Sbjct: 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 103 QNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSLKGAIPS 160
+ + +I + + + L L L N +Q + L L L +L ++ +
Sbjct: 61 RCEIQ-TIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA-SLEN 117
Query: 161 SL-GRLTHLHYLNLSTNFFSGEIPDFGALS 189
G L L LN++ N S
Sbjct: 118 FPIGHLKTLKELNVAHNLIQ-SFKLPEYFS 146
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 31/103 (30%), Positives = 50/103 (48%), Gaps = 5/103 (4%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
+ + L L N L GS+ + +++ L L N + IP ++ +L L L+++SN
Sbjct: 427 AESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASN 483
Query: 153 SLKGAIP-SSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNK 194
LK ++P RLT L Y+ L N + P LS + NK
Sbjct: 484 QLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINK 525
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 31/120 (25%), Positives = 53/120 (44%), Gaps = 9/120 (7%)
Query: 91 GRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
+ + L+L QNS+ +I+ +ELR L L N ++ + ++ L LD+
Sbjct: 49 DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDV 107
Query: 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHK 209
S N L+ I + L +L+LS N F +P FGN + + L L + +
Sbjct: 108 SHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCK---EFGNLTKLTFLGLSAAKFRQ 160
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 26/112 (23%), Positives = 39/112 (34%), Gaps = 3/112 (2%)
Query: 76 NLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ--GG 133
L I L QN S+ + L+ L L+ N L+
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK 394
Query: 134 IPANIGNLLFLTILDLSSNSL-KGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
+ N+ L LD+S NSL A + + LNLS+N +G +
Sbjct: 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 28/148 (18%), Positives = 49/148 (33%), Gaps = 35/148 (23%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSL----------------------HGSI 110
+N + L +LQ L L +N L S+
Sbjct: 356 TFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL 415
Query: 111 PNEITNC-----TELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRL 165
+ + + L L +N L G + + + +LDL +N + +IP + L
Sbjct: 416 NSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKV--KVLDLHNNRIM-SIPKDVTHL 472
Query: 166 THLHYLNLSTNFFSGEIPDFGALSAFGN 193
L LN+++N +PD F
Sbjct: 473 QALQELNVASNQLK-SVPD----GVFDR 495
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 30/128 (23%), Positives = 50/128 (39%), Gaps = 9/128 (7%)
Query: 76 NLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIP--NEITNCTELRALYLRANYLQGG 133
++ + +L I S + L+ L L N +P E N T+L L L A +
Sbjct: 106 DVSHNRLQNI---SCCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQL 161
Query: 134 IPANIGNL-LFLTILDLSSNSLKGAIPSSLGRL-THLHYLNLSTNFFSGEIPDFGALSAF 191
+ +L L +LDL S +KG SL T + +L N + +++A
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLF-SVQVNMSVNAL 220
Query: 192 GNKSFIGN 199
G+
Sbjct: 221 GHLQLSNI 228
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 13/84 (15%), Positives = 22/84 (26%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
L L + S + E+ L + + T L+ + N
Sbjct: 304 LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTN 176
++ L L L L N
Sbjct: 364 VFTDSVFQGCSTLKRLQTLILQRN 387
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 31/101 (30%), Positives = 45/101 (44%), Gaps = 6/101 (5%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLS 150
L L L L N L +IPN ++L+ L+LR N ++ IP+ + L LDL
Sbjct: 111 LANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLG 168
Query: 151 S-NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
L + L++L YLNL+ EIP+ L
Sbjct: 169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIK 208
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 30/106 (28%), Positives = 45/106 (42%), Gaps = 6/106 (5%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQ 131
R +NL L I P++ L KL L L N L +I L+ L++ + +Q
Sbjct: 188 RYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ 244
Query: 132 GGIPAN-IGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
I N NL L ++L+ N+L L HL ++L N
Sbjct: 245 -VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 25/111 (22%), Positives = 43/111 (38%), Gaps = 9/111 (8%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSS 151
L L+ L L +L IP +T +L L L N+L I L+ L L +
Sbjct: 184 LSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWMIQ 240
Query: 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
+ ++ ++ L L +NL+ N + +P F + + L
Sbjct: 241 SQIQVIERNAFDNLQSLVEINLAHNNLT-LLPH----DLFTPLHHLERIHL 286
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 32/118 (27%), Positives = 45/118 (38%), Gaps = 9/118 (7%)
Query: 61 TGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTE 119
GIS +T R +NL Q+ I S L L+ L L +N + +I
Sbjct: 60 DGISTNT-----RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLAN 113
Query: 120 LRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L L L N L IP L L L L +N ++ + R+ L L+L
Sbjct: 114 LNTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL 170
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 28/108 (25%), Positives = 39/108 (36%), Gaps = 7/108 (6%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSL 154
+ L LH+N + N + L L L N+++ I L L L+L N L
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNRL 124
Query: 155 KGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
+ L+ L L L N IP AF + LDL
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPS----YAFNRIPSLRRLDL 167
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 20/86 (23%), Positives = 33/86 (38%), Gaps = 4/86 (4%)
Query: 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNE-ITNCTELRALYLRANY 129
++ ++L L I S L LQ+L + Q+ + I N L + L N
Sbjct: 208 KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNN 266
Query: 130 LQGGIPANI-GNLLFLTILDLSSNSL 154
L +P ++ L L + L N
Sbjct: 267 LT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 31/88 (35%), Positives = 44/88 (50%), Gaps = 6/88 (6%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
RL KL+ L L+ N L ++P I L L++ N LQ +P + L+ L L L
Sbjct: 59 RLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRL 116
Query: 150 SSNSLKGAIPSSL-GRLTHLHYLNLSTN 176
N LK ++P + LT L YL+L N
Sbjct: 117 DRNQLK-SLPPRVFDSLTKLTYLSLGYN 143
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 28/87 (32%), Positives = 36/87 (41%), Gaps = 4/87 (4%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
L KL L+L N L S+P + T L+ L L N L+ +P L L L L
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKL 188
Query: 150 SSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+N LK + L L L L N
Sbjct: 189 DNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 28/83 (33%), Positives = 39/83 (46%), Gaps = 4/83 (4%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSL 154
++L L N L T+LR LYL N LQ +PA I L L L ++ N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 155 KGAIPSSL-GRLTHLHYLNLSTN 176
+ A+P + +L +L L L N
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRN 119
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 29/101 (28%), Positives = 43/101 (42%), Gaps = 6/101 (5%)
Query: 93 LDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLS 150
L L L L N L IP+ ++LR L+LR N ++ IP+ + L LDL
Sbjct: 122 LASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLG 179
Query: 151 S-NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
L+ + L +L YLNL ++P+ L
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVG 219
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 24/111 (21%), Positives = 41/111 (36%), Gaps = 9/111 (8%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPAN-IGNLLFLTILDLSS 151
L L+ L L ++ +P +T L L + N+ I L L L + +
Sbjct: 195 LFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPE-IRPGSFHGLSSLKKLWVMN 251
Query: 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
+ + ++ L L LNL+ N S +P F ++ L L
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLS-SLPH----DLFTPLRYLVELHL 297
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 23/105 (21%), Positives = 42/105 (40%), Gaps = 4/105 (3%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+ +NL + + P++ L L+ L + N P + L+ L++ + +
Sbjct: 199 KYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256
Query: 133 GIPAN-IGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
I N L L L+L+ N+L L +L L+L N
Sbjct: 257 -IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 27/110 (24%), Positives = 42/110 (38%), Gaps = 4/110 (3%)
Query: 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRA 127
R +NL + I + + L L+ L L +NS+ I L L L
Sbjct: 74 PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFD 132
Query: 128 NYLQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
N+L IP+ L L L L +N ++ + R+ L L+L
Sbjct: 133 NWLTV-IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGEL 181
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 26/108 (24%), Positives = 38/108 (35%), Gaps = 7/108 (6%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSL 154
+ L L +N++ + + L L L N ++ I L L L+L N L
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ-IEVGAFNGLASLNTLELFDNWL 135
Query: 155 KGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
+ L+ L L L N IP AF + LDL
Sbjct: 136 TVIPSGAFEYLSKLRELWLRNNPIE-SIPS----YAFNRVPSLMRLDL 178
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 17/86 (19%), Positives = 29/86 (33%), Gaps = 4/86 (4%)
Query: 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNE-ITNCTELRALYLRANY 129
+ + + I S L L++L + + + I L L L N
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNN 277
Query: 130 LQGGIPANI-GNLLFLTILDLSSNSL 154
L +P ++ L +L L L N
Sbjct: 278 LS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-08
Identities = 18/112 (16%), Positives = 35/112 (31%), Gaps = 7/112 (6%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
+ + L L + I N + A+ N ++ L L L +++N
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 74
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
+ L L L L+ N + + G L + + L +
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNS----LVELGDLDPLASLKSLTYLCILR 122
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 26/128 (20%), Positives = 48/128 (37%), Gaps = 6/128 (4%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYL 130
+ I L + I + KL+R+ L N + + + L +L L N +
Sbjct: 34 ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 131 QGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
+P ++ L L +L L++N + + L +L+ L+L N I G S
Sbjct: 93 TE-LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAK-GTFS 149
Query: 190 AFGNKSFI 197
+
Sbjct: 150 PLRAIQTM 157
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 20/87 (22%), Positives = 36/87 (41%), Gaps = 4/87 (4%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
L L L L+ N + +P + L+ L L AN + + + +L L +L L
Sbjct: 78 GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSL 135
Query: 150 SSNSLKGAIPSSLGRLTHLHYLNLSTN 176
N L+ + L + ++L+ N
Sbjct: 136 YDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 22/107 (20%), Positives = 43/107 (40%), Gaps = 11/107 (10%)
Query: 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129
+ S++ + + I +L L +L N++ ++ ++ T L L +N
Sbjct: 42 ATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNK 96
Query: 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L + + L LT L+ +N L + + L YLN + N
Sbjct: 97 LTN-LD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARN 137
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 25/96 (26%), Positives = 37/96 (38%), Gaps = 8/96 (8%)
Query: 84 GIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLF 143
+ S +L L L H +S+ + I T L L +N + + +
Sbjct: 32 ATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TLD--LSQNTN 86
Query: 144 LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
LT L SN L + + LT L YLN TN +
Sbjct: 87 LTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT 119
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 7e-07
Identities = 19/104 (18%), Positives = 39/104 (37%), Gaps = 12/104 (11%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132
+++ + ++ + + + L RL N++ + + +L L +N L
Sbjct: 173 TTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTE 226
Query: 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
++ L LT D S N L + S L+ L L+
Sbjct: 227 ---IDVTPLTQLTYFDCSVNPLT-ELDVST--LSKLTTLHCIQT 264
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 8/92 (8%)
Query: 85 IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144
+ + + L L +N+L I +++ T+L L + + ++ L
Sbjct: 118 LTKLDVSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDC--HLNKKITKLDVTPQTQL 172
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
T LD S N + + + L+ LN TN
Sbjct: 173 TTLDCSFNKITE---LDVSQNKLLNRLNCDTN 201
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 23/106 (21%), Positives = 37/106 (34%), Gaps = 10/106 (9%)
Query: 76 NLPYMQLGG--IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGG 133
NL Y+ + + + L KL L N L + ++ L L N L
Sbjct: 86 NLTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT-- 140
Query: 134 IPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
++ + LT LD N + + T L L+ S N +
Sbjct: 141 -EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 16/123 (13%), Positives = 38/123 (30%), Gaps = 8/123 (6%)
Query: 85 IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144
I + +L L + + ++ +L LYL L + + + L
Sbjct: 288 IKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELTE-LD--VSHNTKL 341
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
L + ++ S+G++ L+ + + ++ LD G
Sbjct: 342 KSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQFG 399
Query: 205 RQV 207
+
Sbjct: 400 NPM 402
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 18/92 (19%), Positives = 33/92 (35%), Gaps = 8/92 (8%)
Query: 85 IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144
+ + L KL L Q L I +T+ T+L + ++ + L
Sbjct: 245 LTELDVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQA--EGCRKIKELDVTHNTQL 299
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+LD + + + L + L YL L+
Sbjct: 300 YLLDCQAAGIT-ELD--LSQNPKLVYLYLNNT 328
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 12/95 (12%), Positives = 28/95 (29%), Gaps = 8/95 (8%)
Query: 85 IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144
+ + L +L N L + ++ ++L L+ L I + + L
Sbjct: 224 LTEIDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE-ID--LTHNTQL 277
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFS 179
+ + T L+ L+ +
Sbjct: 278 IYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT 310
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 7e-05
Identities = 21/92 (22%), Positives = 28/92 (30%), Gaps = 9/92 (9%)
Query: 85 IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144
I + + +L L N L I +T T+L N L + + L L
Sbjct: 203 ITKLDLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSKL 256
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
T L L I L T L Y
Sbjct: 257 TTLHCIQTDLL-EID--LTHNTQLIYFQAEGC 285
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 28/108 (25%), Positives = 47/108 (43%), Gaps = 11/108 (10%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT 145
I P + L L L L +N + + + + + +L++L L N + I + +L L
Sbjct: 83 IKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISD-IN-GLVHLPQLE 137
Query: 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGN 193
L L +N + + L RLT L L+L N +I D L+
Sbjct: 138 SLYLGNNKIT--DITVLSRLTKLDTLSLEDN----QISDIVPLAGLTK 179
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 17/91 (18%), Positives = 33/91 (36%), Gaps = 7/91 (7%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT 145
I + + L + S+ ++ + + + ++ + I L +T
Sbjct: 17 IFS-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVT 71
Query: 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L L+ N L I L L +L +L L N
Sbjct: 72 KLFLNGNKLT-DI-KPLANLKNLGWLFLDEN 100
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 21/91 (23%), Positives = 38/91 (41%), Gaps = 5/91 (5%)
Query: 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT 145
I+ + RL KL L+L N + I + T+L+ LYL N++ + + L L
Sbjct: 149 ITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLD 203
Query: 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+L+L S + L + + +
Sbjct: 204 VLELFSQECLNKPINHQSNLVVPNTVKNTDG 234
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 30/106 (28%), Positives = 48/106 (45%), Gaps = 5/106 (4%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNC-TELRALYLRANYLQ 131
+ + L Q+ + L L+ L L N L ++P + + T+L L L N L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 132 GGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+P+ + L+ L L + N L +P + RLTHL +L L N
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN 145
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150
L +L L L N L +P+ + L+ L++ N L +P I L LT L L
Sbjct: 86 SLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALD 143
Query: 151 SNSLKGAIPSSLGRLTHLHYLNLSTN 176
N LK + RL+ L + L N
Sbjct: 144 QNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 23/108 (21%), Positives = 44/108 (40%), Gaps = 4/108 (3%)
Query: 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANY 129
++R IN ++ I + + + L N L ++ +++ L+ L LR+N
Sbjct: 58 QLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNR 116
Query: 130 LQGGIPANI-GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+ + + L + +L L N + P + L L LNL N
Sbjct: 117 ITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 18/88 (20%), Positives = 37/88 (42%), Gaps = 6/88 (6%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
+L +L+++ N + I + + + L +N L+ + + L L L L
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLML 112
Query: 150 SSNSLKGAIPS-SLGRLTHLHYLNLSTN 176
SN + + + S L+ + L+L N
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDN 139
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 17/83 (20%), Positives = 28/83 (33%), Gaps = 5/83 (6%)
Query: 97 QRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSL 154
L L+ N I +LR + N + I + + L+SN L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRL 93
Query: 155 KGAIPSSL-GRLTHLHYLNLSTN 176
+ + + L L L L +N
Sbjct: 94 E-NVQHKMFKGLESLKTLMLRSN 115
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 6/107 (5%)
Query: 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNC-TELRALYLRANYLQ 131
++L L + + L L +L L N L S+PN + N T L L L N LQ
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 132 GGIPANI-GNLLFLTILDLSSNSLKGAIPSSL-GRLTHLHYLNLSTN 176
+P + L L L L++N L+ ++P + +LT L L L N
Sbjct: 90 S-LPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN 134
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 29/91 (31%), Positives = 41/91 (45%), Gaps = 12/91 (13%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEITNC-TELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
+L L L L N L S+PN + + T+L+ L L N LQ +P + L L L L
Sbjct: 74 KLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRL 131
Query: 150 SSNSLKGAIPS----SLGRLTHLHYLNLSTN 176
N LK ++P L L ++ L N
Sbjct: 132 YQNQLK-SVPDGVFDRLTSLQYIW---LHDN 158
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 32/88 (36%), Positives = 49/88 (55%), Gaps = 6/88 (6%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
L +L L L N L S+P + + T+L LYL N L+ +P+ + L L L L
Sbjct: 81 DLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRL 138
Query: 150 SSNSLKGAIPSSL-GRLTHLHYLNLSTN 176
++N L+ +IP+ +LT+L L+LSTN
Sbjct: 139 NTNQLQ-SIPAGAFDKLTNLQTLSLSTN 165
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 24/82 (29%), Positives = 35/82 (42%), Gaps = 4/82 (4%)
Query: 97 QRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLL-FLTILDLSSNSLK 155
++L L L T+L L L N LQ + A + + L L L L++N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 156 GAIPSSL-GRLTHLHYLNLSTN 176
++P + LT L L L N
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGN 117
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 4e-06
Identities = 30/87 (34%), Positives = 41/87 (47%), Gaps = 4/87 (4%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
L +L +L L N L S+P+ + T+L+ L L N LQ IPA L L L L
Sbjct: 105 HLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSL 162
Query: 150 SSNSLKGAIPSSLGRLTHLHYLNLSTN 176
S+N L+ + RL L + L N
Sbjct: 163 STNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 21/102 (20%), Positives = 38/102 (37%), Gaps = 7/102 (6%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147
+I L ++ L L + + + + L+ LYL N + I + L L L
Sbjct: 101 SAIAGLQSIKTLDLTSTQIT-DVTP-LAGLSNLQVLYLDLNQITN-IS-PLAGLTNLQYL 156
Query: 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189
+ + + + L L+ L L N S +I +L
Sbjct: 157 SIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DISPLASLP 195
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 17/96 (17%), Positives = 34/96 (35%), Gaps = 7/96 (7%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152
L ++A ++++ ++ + + L + I + L L L+L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDN 73
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188
+ + L LT + L LS N + L
Sbjct: 74 QITD--LAPLKNLTKITELELSGNPLK-NVSAIAGL 106
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 15/89 (16%), Positives = 32/89 (35%), Gaps = 4/89 (4%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147
+ L KL L N + I + + L ++L+ N + P + N L I+
Sbjct: 167 TPLANLSKLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIV 222
Query: 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L++ ++ L + + +
Sbjct: 223 TLTNQTITNQPVFYNNNLVVPNVVKGPSG 251
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 3e-07
Identities = 30/128 (23%), Positives = 46/128 (35%), Gaps = 9/128 (7%)
Query: 80 MQLGGIISPSIG--RLDKLQRLALHQNSLH-GSIPNEITNCTELRALYLRANYLQGGIPA 136
M + I + ++ L L + G I L L L L +
Sbjct: 8 MDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVS 65
Query: 137 NIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSF 196
N+ L L L+LS N + G + +L +L +LNLS N + D L
Sbjct: 66 NLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNK----LKDISTLEPLKKLEC 121
Query: 197 IGNLDLCG 204
+ +LDL
Sbjct: 122 LKSLDLFN 129
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 32/88 (36%), Positives = 46/88 (52%), Gaps = 6/88 (6%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEITNC-TELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
+L L+ L L +N L S+P+ + + T L L L N LQ +P + L LT LDL
Sbjct: 107 KLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLTELDL 164
Query: 150 SSNSLKGAIPSSL-GRLTHLHYLNLSTN 176
S N L+ ++P + +LT L L L N
Sbjct: 165 SYNQLQ-SLPEGVFDKLTQLKDLRLYQN 191
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 32/88 (36%), Positives = 48/88 (54%), Gaps = 6/88 (6%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEITNC-TELRALYLRANYLQGGIPANIGNLLF-LTILDL 149
L L L L N L S+PN + + T L+ L L N LQ +P + + L LT L+L
Sbjct: 83 ELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNL 140
Query: 150 SSNSLKGAIPSSL-GRLTHLHYLNLSTN 176
+ N L+ ++P + +LT+L L+LS N
Sbjct: 141 AHNQLQ-SLPKGVFDKLTNLTELDLSYN 167
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 33/92 (35%), Positives = 43/92 (46%), Gaps = 8/92 (8%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIP--NEITNCTELRALYLRANYLQGGIPANIGNLLF-L 144
I L ++ LAL N LH I E+TN L L L N LQ +P + + L L
Sbjct: 57 QGIQYLPNVRYLALGGNKLH-DISALKELTN---LTYLILTGNQLQ-SLPNGVFDKLTNL 111
Query: 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L L N L+ +LT+L YLNL+ N
Sbjct: 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHN 143
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 28/91 (30%), Positives = 37/91 (40%), Gaps = 12/91 (13%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
+L L L L N L S+P + T L L L N LQ +P + L L L L
Sbjct: 131 KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRL 188
Query: 150 SSNSLKGAIPS----SLGRLTHLHYLNLSTN 176
N LK ++P L L ++ L N
Sbjct: 189 YQNQLK-SVPDGVFDRLTSLQYIW---LHDN 215
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 64/345 (18%), Positives = 108/345 (31%), Gaps = 110/345 (31%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTF-AVKRIDRSREGSDQVFERELEILGSIKHI-----NLV 370
+G G FG V D + AVK + R+ + + + E +IL I++ N+V
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVV-RNIKKYTRSAKIEADILKKIQNDDINNNNIV 99
Query: 371 NLRGY-------CRLPATKLLIYDYLSMGSLDDFLHEHGE-----------GQQLLNWSA 412
G C LI++ L SL + + + ++L
Sbjct: 100 KYHGKFMYYDHMC-------LIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEIL---- 147
Query: 413 RLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS---------------- 456
+ L YL + H D+K NILLD+
Sbjct: 148 ---------KALNYLR-KM--SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195
Query: 457 ---------DFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLE 507
DFG A + + +++ Y APE + + SD++SFG +L E
Sbjct: 196 TKSTGIKLIDFGCA---TFKSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAE 251
Query: 508 LVTG-------------------------------KRPTDPTFVKRGLNVVGWMNTLLKE 536
L TG + +V + + W
Sbjct: 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSI 311
Query: 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
N ++ V K + E + +P RPS ++L+
Sbjct: 312 NSIKHV-KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 52/244 (21%), Positives = 80/244 (32%), Gaps = 80/244 (32%)
Query: 317 DVVGSGGFGTVYRMVMNDCG--TFAVKRI---DRSREGSDQVFERELEILGSIKHI---- 367
+G G FG V + + G A+K I + RE + E+ +L IK
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKEN 80
Query: 368 --NLVNLRGY-------CRLPATKLLIYDYLSMGSLDDFLHEHGE-----------GQQL 407
V + + C + ++ L + +FL E+ QL
Sbjct: 81 KFLCVLMSDWFNFHGHMC-------IAFELLGK-NTFEFLKENNFQPYPLPHVRHMAYQL 132
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPH------------- 454
L +LH ++ H D+K NIL +
Sbjct: 133 C-------------HALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 455 ------VSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLEL 508
V+DFG A + H TT+VA Y PE + + DV+S G +L E
Sbjct: 177 KNTSIRVADFGSA---TFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEY 232
Query: 509 VTGK 512
G
Sbjct: 233 YRGF 236
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 36/178 (20%), Positives = 60/178 (33%), Gaps = 34/178 (19%)
Query: 319 VGSGGFGTVYRMVMNDCGTFAVKR---IDRSREGSDQVFE--RELEILGSIKHINLVNLR 373
+G GGFG +Y MN + + + +F + + + I
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 374 G-----------YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR-------LK 415
L Y ++ M L Q++ +A+ L+
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDL------QKIYEANAKRFSRKTVLQ 156
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHV 471
++L L Y+H +H DIK+SN+LL+ V D+GLA E H
Sbjct: 157 LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 23/82 (28%), Positives = 32/82 (39%), Gaps = 5/82 (6%)
Query: 97 QRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSLK 155
L L N +P E++N L + L N + + N+ L L LS N L+
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST-LSNQSFSNMTQLLTLILSYNRLR 91
Query: 156 GAIPSSL-GRLTHLHYLNLSTN 176
IP L L L+L N
Sbjct: 92 -CIPPRTFDGLKSLRLLSLHGN 112
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 5e-05
Identities = 24/91 (26%), Positives = 38/91 (41%), Gaps = 12/91 (13%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
L + L N + ++ N+ +N T+L L L N L+ IP L L +L L
Sbjct: 52 NYKHLTLIDLSNNRI-STLSNQSFSNMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSL 109
Query: 150 SSNSLKGAIP----SSLGRLTHLHYLNLSTN 176
N + +P + L L+HL + N
Sbjct: 110 HGNDIS-VVPEGAFNDLSALSHLA---IGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 1e-04
Identities = 23/69 (33%), Positives = 32/69 (46%), Gaps = 5/69 (7%)
Query: 109 SIPNEI-TNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTH 167
+P I + TEL YL N +P + N LT++DLS+N + S +T
Sbjct: 24 VLPKGIPRDVTEL---YLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQ 79
Query: 168 LHYLNLSTN 176
L L LS N
Sbjct: 80 LLTLILSYN 88
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 34/173 (19%), Positives = 62/173 (35%), Gaps = 27/173 (15%)
Query: 319 VGSGGFGTVY---RMVMNDCGTFAVKRIDRSREGSDQV---FEREL---EILGSIKHINL 369
+GSGGFG +Y + V +++ G F + + + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 370 VNLRG-----YCRLPATKLLIYDYLSM----GSLDDFLHEHGEGQQLLNWSARLKIALGS 420
++ G L K Y ++ M L ++G S L++ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT----FKKSTVLQLGIRM 160
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHV 471
L Y+H + +H DIK++N+LL V +D+GL+ H
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-06
Identities = 28/114 (24%), Positives = 42/114 (36%), Gaps = 7/114 (6%)
Query: 92 RLDKLQRLALHQNSL-HGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150
++ L L + G + EL L L I AN+ L L L+LS
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-I-ANLPKLNKLKKLELS 72
Query: 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
N + G + + +L +LNLS N I D + + +LDL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNK----IKDLSTIEPLKKLENLKSLDLFN 122
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 19/117 (16%), Positives = 42/117 (35%), Gaps = 5/117 (4%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYL 130
+++ L L I S + L + R+ + + + + N +++ + +R
Sbjct: 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92
Query: 131 QGGIPANI-GNLLFLTILDLSSNSLKGAIP--SSLGRLTHLHYLNLSTNFFSGEIPD 184
I + L L L + + LK P + + L ++ N + IP
Sbjct: 93 LTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 24/81 (29%), Positives = 34/81 (41%), Gaps = 5/81 (6%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI--GNLLFLTILDLSSNS 153
L L+ N S+ N T+L A+YL N I + G ++LD+S S
Sbjct: 158 TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216
Query: 154 LKGAIPS-SLGRLTHLHYLNL 173
+ A+PS L L L N
Sbjct: 217 VT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 25/115 (21%), Positives = 38/115 (33%), Gaps = 11/115 (9%)
Query: 93 LDKLQRLALHQNSLHGSIPNE--ITNCTELRALYLRANYLQGGIPANIGNLL--FLTILD 148
L L+ L + L P+ + + L + N IP N L L
Sbjct: 104 LPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLK 162
Query: 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF-GNKSFIGNLDL 202
L +N ++ T L + L+ N + I AF G S LD+
Sbjct: 163 LYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDK----DAFGGVYSGPSLLDV 212
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 22/117 (18%), Positives = 43/117 (36%), Gaps = 6/117 (5%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYL-RANY 129
+ +L I + L+++ + QN + I ++ +N +L + + +AN
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 130 LQGGIPANI-GNLLFLTILDLSSNSLKGAIPS-SLGRLTHLHYLNLSTNFFSGEIPD 184
L I NL L L +S+ +K +P L++ N I
Sbjct: 92 LL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 23/98 (23%), Positives = 37/98 (37%), Gaps = 7/98 (7%)
Query: 95 KLQRLALHQNSLHGSIPNEITNCTELRALYLRA-NYLQGGIPANI-GNLLFLTILDLSSN 152
+ L L++N + I N N T+L L L N L+ +P ++ ILD+S
Sbjct: 155 ESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEE-LPNDVFHGASGPVILDISRT 212
Query: 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
+ L L L + ++P L A
Sbjct: 213 RIHSLPSYGLENLKKLRARSTYNLK---KLPTLEKLVA 247
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 21/111 (18%), Positives = 38/111 (34%), Gaps = 7/111 (6%)
Query: 96 LQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLS-SNS 153
L L + +L + + N + I A++ NL L + + +N+
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 154 LKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
L P + L +L YL +S +PD + LD+
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDV----HKIHSLQKVLLDIQD 137
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 51/217 (23%), Positives = 83/217 (38%), Gaps = 40/217 (18%)
Query: 319 VGSGGFGTVYR-MVMNDCGTFAVKRIDRSREGSDQVFE-RELEILGSIKHINLVNLRGYC 376
+GSG FG +Y + A+K + + ++E + IL I N+R +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGI--PNVRWFG 72
Query: 377 RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR-------LKIALGSARGLAYLHH 429
+L+ D L SL+D L N+ +R L +A + ++H
Sbjct: 73 VEGDYNVLVMDLLGP-SLED----------LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 430 DCCPKIIHRDIKSSNILLDENLEPH---VSDFGLAKLLVDEEAHV------TTVVAGTFG 480
+HRDIK N L+ + + DFGLAK D H + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 481 YL---APEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
Y ++ R + D+ S G +L+ + G P
Sbjct: 179 YASVNTHLGIEQSR---RDDLESLGYVLMYFLRGSLP 212
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (111), Expect = 8e-06
Identities = 13/74 (17%), Positives = 27/74 (36%), Gaps = 7/74 (9%)
Query: 115 TNCTELRALYLRANYLQGGIPANIGNLLF---LTILDLSSNSLKG----AIPSSLGRLTH 167
L+ L + Q + L +D+S+ L + + ++ H
Sbjct: 249 DRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKH 308
Query: 168 LHYLNLSTNFFSGE 181
L ++N+ N+ S E
Sbjct: 309 LKFINMKYNYLSDE 322
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 23/124 (18%), Positives = 42/124 (33%), Gaps = 25/124 (20%)
Query: 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131
NL + + S L +Q +++ S+ + T L+ L+L N +
Sbjct: 21 AVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS 76
Query: 132 GGIPANIGNLLFLTILDLSSNSLKGAIP-------------------SSLGRLTHLHYLN 172
+ + +L L L ++ N LK SL L +L L+
Sbjct: 77 D-LS-PLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLEILS 134
Query: 173 LSTN 176
+ N
Sbjct: 135 IRNN 138
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 36/167 (21%), Positives = 62/167 (37%), Gaps = 32/167 (19%)
Query: 319 VGSGGFGTVYR-MVMNDCGTFAVKRIDRSREGSDQVFE-RELEILGSIKHINLVNLRGYC 376
+G G FG ++ + + A+K R + E R ++L I N+ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGI--PNVYYFG 75
Query: 377 RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR-------LKIALGSARGLAYLHH 429
+ +L+ D L SL+D LL+ R A + +H
Sbjct: 76 QEGLHNVLVIDLLGP-SLED----------LLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 430 DCCPKIIHRDIKSSNILL------DENLEPHVSDFGLAKLLVDEEAH 470
+++RDIK N L+ + N+ +V DFG+ K D
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVKFYRDPVTK 167
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 51/250 (20%), Positives = 85/250 (34%), Gaps = 92/250 (36%)
Query: 317 DVVGSGGFGTVYRMV--MNDCGTFAVKRI---DRSREGSDQVFERELEILGSIKHI---- 367
D +G G FG V + AVK + DR E + E+++L +
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNS 75
Query: 368 --NLVNLRGY-------CRLPATKLLIYDYLSMGSLDDFLHEHGE-----------GQQL 407
V + + C ++++ L + S DF+ E+G Q+
Sbjct: 76 TFRCVQMLEWFEHHGHIC-------IVFELLGL-STYDFIKENGFLPFRLDHIRKMAYQI 127
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS----------- 456
+ + +LH K+ H D+K NIL ++
Sbjct: 128 C-------------KSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 457 --------DFGLAKLLVDEEAHVTTVVAGTFGYLAPE------YLQSGRATEKSDVYSFG 502
DFG A ++ H +T+V+ Y APE + Q DV+S G
Sbjct: 172 INPDIKVVDFGSA---TYDDEHHSTLVSTRH-YRAPEVILALGWSQP------CDVWSIG 221
Query: 503 VLLLELVTGK 512
+L+E G
Sbjct: 222 CILIEYYLGF 231
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 37/165 (22%), Positives = 62/165 (37%), Gaps = 28/165 (16%)
Query: 319 VGSGGFGTVYR-MVMNDCGTFAVKRIDRSREGSDQVFE-RELEILGSIKHINLVNLRGYC 376
+GSG FG +Y + A+K + E + +++ I +R
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGI--PTIRWCG 74
Query: 377 RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR-------LKIALGSARGLAYLHH 429
+++ + L SL+D L N+ +R L +A + Y+H
Sbjct: 75 AEGDYNVMVMELLGP-SLED----------LFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 430 DCCPKIIHRDIKSSNILLDENLEPH---VSDFGLAKLLVDEEAHV 471
IHRD+K N L+ + + + DFGLAK D H
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 25/87 (28%), Positives = 38/87 (43%), Gaps = 4/87 (4%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
RL L +L L +N L I + ++ L L N ++ I + L L L+L
Sbjct: 52 RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNL 109
Query: 150 SSNSLKGAIPSSLGRLTHLHYLNLSTN 176
N + +P S L L LNL++N
Sbjct: 110 YDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 23/83 (27%), Positives = 31/83 (37%), Gaps = 5/83 (6%)
Query: 97 QRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSL 154
L L+ N L + + L L L+ N L G I N + L L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI 90
Query: 155 KGAIPSSL-GRLTHLHYLNLSTN 176
K I + + L L LNL N
Sbjct: 91 K-EISNKMFLGLHQLKTLNLYDN 112
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 31/177 (17%), Positives = 56/177 (31%), Gaps = 32/177 (18%)
Query: 319 VGSGGFGTVY---------RMVMNDCGTFAVK--RIDRSREGSDQVFERELEILGSIKHI 367
G +Y F++K D F+R + L K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 368 NLVNLRG-------YCRLPATKLLIYDYLSM----GSLDDFLHEHGEGQQLLNWSARLKI 416
L + + K Y +L + SL L + +L+ + L++
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDK---YRFLVLPSLGRSLQSALDV--SPKHVLSERSVLQV 164
Query: 417 ALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHV 471
A L +LH + +H ++ + NI +D + V + +G A HV
Sbjct: 165 ACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 28/82 (34%), Positives = 38/82 (46%), Gaps = 4/82 (4%)
Query: 97 QRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI-GNLLFLTILDLSSNSLK 155
RL L N L T+L L L N +Q +P + L LTIL L N L+
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTKLTILYLHENKLQ 89
Query: 156 GAIPSSL-GRLTHLHYLNLSTN 176
++P+ + +LT L L L TN
Sbjct: 90 -SLPNGVFDKLTQLKELALDTN 110
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 31/87 (35%), Positives = 44/87 (50%), Gaps = 4/87 (4%)
Query: 92 RLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANI-GNLLFLTILDL 149
+L +L +L+L QN + S+P+ + T+L LYL N LQ +P + L L L L
Sbjct: 50 KLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELAL 107
Query: 150 SSNSLKGAIPSSLGRLTHLHYLNLSTN 176
+N LK RLT L + L TN
Sbjct: 108 DTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 37/166 (22%), Positives = 57/166 (34%), Gaps = 30/166 (18%)
Query: 319 VGSGGFGTVYRMV-MNDCGTFAVKRIDRSREGSDQVFE-RELEILGSIKHINLVNLRGYC 376
+G G FG + + A+K E R + LGS I + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGI--PQVYYFG 74
Query: 377 RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR-------LKIALGSARGLAYLHH 429
++ + L SL+D L + R L IA+ + Y+H
Sbjct: 75 PCGKYNAMVLELLGP-SLED----------LFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 430 DCCPKIIHRDIKSSNILLDENLEP-----HVSDFGLAKLLVDEEAH 470
I+RD+K N L+ H+ DF LAK +D E
Sbjct: 124 KNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 23/89 (25%), Positives = 40/89 (44%), Gaps = 6/89 (6%)
Query: 90 IGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149
+ ++ L+ L+L +N + I N L L++ N + + I L+ L +L +
Sbjct: 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYM 122
Query: 150 SSNSLK--GAIPSSLGRLTHLHYLNLSTN 176
S+N + G I L L L L L+ N
Sbjct: 123 SNNKITNWGEI-DKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 20/93 (21%), Positives = 30/93 (32%), Gaps = 15/93 (16%)
Query: 93 LDKLQRLALHQNSLHGSIPNEITN-------CTELRALYLRANYLQGGIP--ANIGNLLF 143
+ + LHG I I + L L N I +++ +
Sbjct: 17 RKSVVATEAEKVELHGMI-PPIEKMDATLSTLKACKHLALSTN----NIEKISSLSGMEN 71
Query: 144 LTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L IL L N +K I + L L +S N
Sbjct: 72 LRILSLGRNLIK-KIENLDAVADTLEELWISYN 103
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 14/77 (18%), Positives = 23/77 (29%), Gaps = 1/77 (1%)
Query: 104 NSLHGSIPNEITNCTELRALYLRANYLQGGIPAN-IGNLLFLTILDLSSNSLKGAIPSSL 162
+ + L LY+ + + L L L + + L+ P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 163 GRLTHLHYLNLSTNFFS 179
L LNLS N
Sbjct: 77 HFTPRLSRLNLSFNALE 93
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 24/128 (18%), Positives = 42/128 (32%), Gaps = 24/128 (18%)
Query: 96 LQRLALHQNSLHG----SIPNEITNCTELRALYLRANYLQG-GIPANIGNLL----FLTI 146
L+ + +N L + L + + N ++ GI + L L +
Sbjct: 161 LRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKV 220
Query: 147 LDLSSNSL--KGA--IPSSLGRLTHLHYLNLSTNFFSGEIPDFGA------LSAFGNKSF 196
LDL N+ G+ + +L +L L L+ + GA S N
Sbjct: 221 LDLQDNTFTHLGSSALAIALKSWPNLRELGLNDC----LLSARGAAAVVDAFSKLENIG- 275
Query: 197 IGNLDLCG 204
+ L L
Sbjct: 276 LQTLRLQY 283
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 603 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.88 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.87 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.87 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.86 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.84 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.84 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.82 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.78 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.77 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.76 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.76 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.76 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.75 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.74 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.74 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.74 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.73 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.73 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.73 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.73 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.72 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.71 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.7 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.7 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.69 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.69 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.69 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.69 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.68 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.68 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.68 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.67 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.67 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.67 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.67 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.67 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.66 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.66 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.66 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.65 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.65 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.65 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.64 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.64 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.64 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.64 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.63 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.63 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.63 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.63 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.62 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.62 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.62 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.62 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.62 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.61 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.61 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.61 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.61 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.61 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.6 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.6 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.59 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.58 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.58 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.58 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.58 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.57 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.57 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.56 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.56 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.56 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.56 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.56 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.56 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.56 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.55 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.55 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.54 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.54 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.54 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.54 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.54 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.53 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.53 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.53 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.53 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.52 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.52 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.51 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.51 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.51 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.5 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.5 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.49 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.49 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.47 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.47 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.46 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.45 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.44 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.42 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.4 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.39 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.39 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.38 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.38 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.37 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.37 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.32 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.29 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.28 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.27 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.26 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.22 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.22 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.21 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.21 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.19 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.14 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.12 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.0 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 98.91 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.86 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.82 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 98.7 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.68 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.66 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 98.66 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.56 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.53 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.42 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 98.36 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.31 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.24 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 98.22 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.2 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.18 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.09 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.05 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.76 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.67 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.59 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.57 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.51 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.38 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.27 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.23 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.19 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.15 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.08 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.06 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.05 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.04 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 96.96 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.92 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.88 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 96.87 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.82 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.75 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.48 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.85 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 92.09 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.06 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 89.98 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 89.64 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 83.53 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 82.54 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.39 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=438.73 Aligned_cols=259 Identities=25% Similarity=0.431 Sum_probs=214.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|.+.+.||+|+||+||+|.+.+ +..||||+++.......+.|.+|++++++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 467778999999999999998752 45699999987665566789999999999999999999999999999999
Q ss_pred EEEecCCCCccccccccC---------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEE
Q 007455 385 IYDYLSMGSLDDFLHEHG---------EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 455 (603)
||||+++|+|.++++..+ .....+++.+++.++.||++||+|||++ +|+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEE
Confidence 999999999999997643 2234599999999999999999999998 8999999999999999999999
Q ss_pred eecccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHH
Q 007455 456 SDFGLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 456 ~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
+|||+|+......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||..... .+.....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~~i 243 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN------NEVIECI 243 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHH
Confidence 9999998765443322 234569999999999999999999999999999999999 8999975321 1111111
Q ss_pred hhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.. ......+...+.++.+|+.+||+.||++|||++|+.+.|+++.
T Consensus 244 ~~---------~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 244 TQ---------GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Hc---------CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 1112234456678999999999999999999999999998865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=440.05 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=209.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|.+.++||+|+||+||+|.+.+ +..||||+++.......+.|.+|+++|++++|||||+++|+|.+++..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 456677899999999999998753 45699999987665566789999999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCC-----------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCe
Q 007455 385 IYDYLSMGSLDDFLHEHGEG-----------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEP 453 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~ 453 (603)
||||+++|+|.++++..... ...++|.+++.++.|+++||+|||++ +||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 99999999999999865421 23589999999999999999999998 89999999999999999999
Q ss_pred EEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHH
Q 007455 454 HVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 454 kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 531 (603)
||+|||+++.....+. .......||+.|||||++.+..++.++|||||||++|||+| |+.||..... .....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~------~~~~~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN------TEAID 271 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH------HHHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH------HHHHH
Confidence 9999999987654332 23345679999999999999999999999999999999999 8999875321 11111
Q ss_pred HHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 532 TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
.+... .....+...+.++.+|+.+||+.||++||||+||++.|+.+...
T Consensus 272 ~i~~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 272 CITQG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHcC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 11111 11223345567899999999999999999999999999987643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-54 Score=431.85 Aligned_cols=258 Identities=21% Similarity=0.357 Sum_probs=210.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
.++++.+.||+|+||+||+|.+. ++..||||+++.... ...+.|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34566789999999999999874 345699999965433 34567999999999999999999999999999999
Q ss_pred EEEEecCCCCccccccccCCC------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC
Q 007455 384 LIYDYLSMGSLDDFLHEHGEG------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL 451 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 451 (603)
+||||+++|+|.+++...... ...+++.+++.++.|||+||+|||++ +||||||||+|||+++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 999999999999999654321 23589999999999999999999998 899999999999999999
Q ss_pred CeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHH
Q 007455 452 EPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGW 529 (603)
Q Consensus 452 ~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 529 (603)
++||+|||+++.....+. .......||++|||||++.++.++.++|||||||++|||+| |+.||..... ...
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------~~~ 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------QDV 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------HHH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------HHH
Confidence 999999999987644332 22345679999999999999999999999999999999999 8999865321 111
Q ss_pred HHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 530 MNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
...+.. ......+...+.++.+|+.+||+.||++||||+||++.|+..
T Consensus 257 ~~~i~~---------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRN---------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHc---------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111111 111223445667899999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-53 Score=424.51 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=203.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.+++++.+.||+|+||+||+|.+++ .||||+++..... ..+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3577888999999999999998764 6999998754333 33579999999999999999999998864 57899999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++.... ..+++.++..++.||++||+|||++ +||||||||+|||+++++.+||+|||+|+.....
T Consensus 112 y~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred cCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 999999999997543 2389999999999999999999998 8999999999999999999999999999876543
Q ss_pred C-cceeecccccccccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 468 E-AHVTTVVAGTFGYLAPEYLQS---GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 468 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
. ........||+.|||||++.+ +.|+.++|||||||++|||+||+.||..... ............ .
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~------~~~~~~~~~~~~----~ 255 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN------RDQIIFMVGRGY----A 255 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHTTC----C
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhcCC----C
Confidence 2 223445679999999999864 4589999999999999999999999964321 111111111111 1
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.+.....+...+.++.+|+.+||+.||++||||+||++.|+.+.
T Consensus 256 ~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 256 SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 11222233455678999999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=430.61 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=204.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
+++|++.+.||+|+||+||+|++.. ++.||||++...... ..+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 4689999999999999999999874 567999999754333 3457899999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||++||+|.+++...+. ..+++.+++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 103 Ey~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999976432 3378999999999999999999999 899999999999999999999999999987643
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......+.. ..
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~------~~~~~~~i~~---------~~ 241 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS------MKNLVLKIIS---------GS 241 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHH---------TC
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC------HHHHHHHHHc---------CC
Confidence 21 22345679999999999999999999999999999999999999997532 1122222221 11
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22233345678999999999999999999999985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-53 Score=426.93 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=209.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
+.|+..+.||+|+||+||+|.+.. +..||||++........+.+.+|+++|++++|||||++++++.+++..|+||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 457888999999999999999875 5679999997665555667899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
+||+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.+|++||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~-----~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT-----RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp TTEEHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 999999998753 289999999999999999999999 899999999999999999999999999987754332
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ........... ... ..
T Consensus 226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~------~~~-~~ 291 (346)
T 4fih_A 226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNL------PPR-LK 291 (346)
T ss_dssp -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSS------CCC-CS
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCC------CCC-CC
Confidence 34457899999999999999999999999999999999999999975321 11111111110 001 11
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+.++.+|+.+||+.||++|||++|+++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22345678999999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-53 Score=421.91 Aligned_cols=247 Identities=23% Similarity=0.341 Sum_probs=208.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||+||+|++.. ++.||||++.+. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 578999999999999999999875 557999999643 2334567899999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||++||+|.+++...+. +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999987644 89999999999999999999999 899999999999999999999999999998754
Q ss_pred CC-cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 467 EE-AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 467 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. .......+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+...
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~--------- 249 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKL--------- 249 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT---------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC---------
Confidence 33 2334567899999999999999999999999999999999999999975321 1111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVL 580 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 580 (603)
....+...+.++.+|+.+||+.||++|||++|++
T Consensus 250 -~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 250 -EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1122334567899999999999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=420.36 Aligned_cols=252 Identities=23% Similarity=0.279 Sum_probs=205.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.+.|+..++||+|+||.||+|++.. +..||||+++.... ..+|+.++++++|||||++++++.+++..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 3567778899999999999999875 56799999965432 24799999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-CeEEeecccccccCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-EPHVSDFGLAKLLVDE 467 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~~~~~ 467 (603)
++||+|.++++..+. +++..+..++.||+.||+|||++ +||||||||+|||++.+| ++||+|||+|+.+...
T Consensus 132 ~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQMGC----LPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999987544 99999999999999999999999 899999999999999988 6999999999887543
Q ss_pred Ccc----eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 468 EAH----VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 468 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||....... +. ..+.....
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~---~~i~~~~~----- 273 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LC---LKIASEPP----- 273 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CH---HHHHHSCC-----
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HH---HHHHcCCC-----
Confidence 322 1234579999999999999999999999999999999999999997643221 11 11111110
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
.....+...+.++.+++.+||+.||++|||++|+++.|...
T Consensus 274 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 274 --PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp --GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 01112334567899999999999999999999999887654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=408.01 Aligned_cols=246 Identities=22% Similarity=0.364 Sum_probs=192.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||+||+|.+. .++.||||++.+.. ....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999986 45679999996542 23346789999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+ +|+|.+++...+. +++.++..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+...
T Consensus 92 mEy~-~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDK----MSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EECC-CEEHHHHHHHSCS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EeCC-CCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 9999 5799999987543 99999999999999999999999 89999999999999999999999999998764
Q ss_pred CCCcceeecccccccccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
+.. ......||+.|||||++.+..+ +.++||||+||++|||+||+.||.... ..........
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~------~~~~~~~i~~--------- 226 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES------IPVLFKNISN--------- 226 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH---------
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC------HHHHHHHHHc---------
Confidence 432 2345679999999999988776 579999999999999999999997532 1111111111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+...+.++.+|+.+||+.||++|||++|+++
T Consensus 227 -~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 227 -GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111223345577999999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=427.91 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=209.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
+.|+..+.||+|+||.||+|.+.. +..||||++........+.+.+|+.+|++++|||||++++++.+++..|+||||+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 568889999999999999999875 5679999997666666677999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
+||+|.++++... +++.++..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+.....
T Consensus 231 ~gG~L~~~i~~~~-----l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 231 EGGALTDIVTHTR-----MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp TTEEHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCcHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999987532 89999999999999999999999 899999999999999999999999999987754332
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+.... .... .
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~~------~~~~-~ 368 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP------LKAMKMIRDNL------PPRL-K 368 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSC------CCCC-S
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCC------CCCC-c
Confidence 34456899999999999999999999999999999999999999965321 11111111110 0111 1
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+.++.+|+.+||..||++|||++|+++
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 22344568999999999999999999999986
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-52 Score=424.68 Aligned_cols=272 Identities=27% Similarity=0.415 Sum_probs=216.8
Q ss_pred CCChHHHHHHhhCCCCCCeeeecCCeEEEEEEECCC------CEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCC-Ceeee
Q 007455 300 PYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDC------GTFAVKRIDRSREG-SDQVFERELEILGSIKH-INLVN 371 (603)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-~niv~ 371 (603)
++...++....++|++.+.||+|+||+||+|.+.+. +.||||++...... ..+.|.+|+++|.+++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 333333333457899999999999999999997643 35999999765433 34569999999999965 89999
Q ss_pred cceeeecC-CccEEEEEecCCCCccccccccCC------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 007455 372 LRGYCRLP-ATKLLIYDYLSMGSLDDFLHEHGE------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHR 438 (603)
Q Consensus 372 l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~ 438 (603)
++|+|.++ +..++||||+++|+|.++++.... ....+++.++..++.|||+||+|||++ +||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence 99998764 568999999999999999976432 124489999999999999999999999 89999
Q ss_pred cCCCCCeEECCCCCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCC
Q 007455 439 DIKSSNILLDENLEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTD 516 (603)
Q Consensus 439 Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~ 516 (603)
||||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987654433 33445679999999999999999999999999999999998 899996
Q ss_pred cccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 517 PTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
..... ..+...+..+ .....+...+.++.+++.+||+.||++|||++|+++.|+++..
T Consensus 290 ~~~~~------~~~~~~i~~g--------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 290 GVKID------EEFCRRLKEG--------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp TCCCS------HHHHHHHHHT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHH------HHHHHHHHcC--------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 53211 1111111111 1112233456789999999999999999999999999987653
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=409.06 Aligned_cols=246 Identities=26% Similarity=0.409 Sum_probs=195.5
Q ss_pred CCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeec----CCccEEEE
Q 007455 314 DEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRL----PATKLLIY 386 (603)
Q Consensus 314 ~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 386 (603)
.+.++||+|+||+||+|.+.. +..||+|++..... ...+.|.+|++++++++|||||++++++.. +...|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 445689999999999999875 45799999965432 234568999999999999999999999865 34579999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-CCCeEEeecccccccC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-NLEPHVSDFGLAKLLV 465 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~~~~~~ 465 (603)
||+++|+|.+++...+. +++..+..++.||+.||+|||+++ ++|+||||||+|||++. ++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999987543 899999999999999999999981 23999999999999984 7999999999998643
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. .....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.... .......... ......
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~-----~~~~~~~~i~-~~~~~~---- 249 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVT-SGVKPA---- 249 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHT-TTCCCG----
T ss_pred CC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----cHHHHHHHHH-cCCCCC----
Confidence 32 2345689999999999875 69999999999999999999999996421 1111111111 111100
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 250 ---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111223457899999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=412.69 Aligned_cols=267 Identities=25% Similarity=0.320 Sum_probs=201.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCC----ccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPA----TKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 386 (603)
++|.+.+.||+|+||+||+|.++ ++.||||++.... .....++.|+..+.+++|||||++++++.+++ ..|+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 35667789999999999999985 5789999996432 22223455666677899999999999997654 479999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD-----CCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
||+++|+|.++++... +++..+.+++.|+++||+|||++ ..++|+||||||+|||++.++++||+|||++
T Consensus 81 Ey~~~gsL~~~l~~~~-----l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred cCCCCCcHHHHHHhCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999998643 89999999999999999999986 2458999999999999999999999999999
Q ss_pred cccCCCCcc---eeecccccccccCccccccC------CCCcccchHhHHHHHHHHHhCCCCCCcccccCC--------c
Q 007455 462 KLLVDEEAH---VTTVVAGTFGYLAPEYLQSG------RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG--------L 524 (603)
Q Consensus 462 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~--------~ 524 (603)
+........ ......||+.|||||++.+. .++.++|||||||++|||+||+.|+........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 876544322 12345799999999998754 467799999999999999999887754321100 0
Q ss_pred cHhHHHHHHhhhCcchhhhcccCCC--cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 525 NVVGWMNTLLKENRLEDVIDKRCAD--ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
............... ++..+. ...+.+..+.+|+.+||+.||++||||+||++.|+++..
T Consensus 236 ~~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 111112222211111 112221 123556789999999999999999999999999988653
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=412.48 Aligned_cols=247 Identities=27% Similarity=0.315 Sum_probs=197.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC----CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN----DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|++.+.||+|+||+||+|++. .++.||||+++.... .....+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57899999999999999999873 245799999965321 223358899999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||++||+|.+++.+.+. +++.++..++.|++.||+|||++ +|+||||||+|||++.+|++||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVM----FTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999987554 89999999999999999999999 8999999999999999999999999999865
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
..... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||..... .........
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~--------- 240 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR------KETMTMILK--------- 240 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH---------
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH------HHHHHHHHc---------
Confidence 44322 23456799999999999999999999999999999999999999975321 111111111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSM-----NQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 581 (603)
.....+...+.++.+|+.+||+.||++|||+ +|+++
T Consensus 241 -~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 241 -AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -CCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1112233456789999999999999999984 67764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=399.76 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=189.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCC-------
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPA------- 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 380 (603)
..+|++.+.||+|+||+||+|.+. ++..||||+++..... ..+.+.+|++++++++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 356888999999999999999987 4567999999654332 3457899999999999999999999986544
Q ss_pred -----ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEE
Q 007455 381 -----TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455 (603)
Q Consensus 381 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 455 (603)
..|+||||+++|+|.+++..... ....++..++.++.||++||+|||++ +|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 36899999999999999986543 22356777899999999999999999 8999999999999999999999
Q ss_pred eecccccccCCCCcc-----------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCc
Q 007455 456 SDFGLAKLLVDEEAH-----------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL 524 (603)
Q Consensus 456 ~DfG~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~ 524 (603)
+|||+|+........ .....+||+.|||||++.+..|+.++||||+||++|||++ ||.....
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---- 232 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---- 232 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----
Confidence 999999877543221 1234579999999999999999999999999999999996 7653210
Q ss_pred cHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 525 NVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....... ......+......+....+|+.+||+.||++|||+.|+++
T Consensus 233 -~~~~~~~---------~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 233 -RVRTLTD---------VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -HHHHHHH---------HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHH---------HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000010 1111111112233456788999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=386.78 Aligned_cols=299 Identities=41% Similarity=0.757 Sum_probs=250.0
Q ss_pred CCChHHHHHHhhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeec
Q 007455 300 PYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRL 378 (603)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 378 (603)
.++..++....++|+..+.||+|+||.||+|.+.++..||||++...... ....+.+|+++++.++||||+++++++..
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 98 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMT 98 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEec
Confidence 36777888889999999999999999999999888888999998654322 23368999999999999999999999999
Q ss_pred CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 379 PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
++..++||||+++|+|.+++.........+++..+..++.|++.||+|||+++.++|+||||||+||+++.++.+||+||
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Df 178 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDF 178 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccC
Confidence 99999999999999999999887666667999999999999999999999986668999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccc--cCCccHhHHHHHHhhh
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFV--KRGLNVVGWMNTLLKE 536 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~ 536 (603)
|+++..............||+.|+|||++.+..++.++||||+|+++|||++|+.||+.... ........|.......
T Consensus 179 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 3uim_A 179 GLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258 (326)
T ss_dssp SSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred ccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence 99988765555555566799999999999888899999999999999999999999974322 2234455666555555
Q ss_pred CcchhhhcccCC-CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCCCcccccc
Q 007455 537 NRLEDVIDKRCA-DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYES 598 (603)
Q Consensus 537 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~~~ 598 (603)
.......+.... ......+..+.+++.+||+.+|++|||++|+++.|++.......++|...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 321 (326)
T 3uim_A 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERWEEWQKE 321 (326)
T ss_dssp CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSCC-----
T ss_pred hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhhhhhhHH
Confidence 555555444433 35677888999999999999999999999999999998888777776543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=381.41 Aligned_cols=283 Identities=38% Similarity=0.659 Sum_probs=241.4
Q ss_pred ChHHHHHHhhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCc
Q 007455 302 PSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPAT 381 (603)
Q Consensus 302 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 381 (603)
+..++...+++|+..+.||+|+||.||+|.+.++..||||++........+.+.+|+++++.++||||+++++++...+.
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 33344556789999999999999999999988888999999877666667789999999999999999999999999999
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.++||||+++|+|.+++.........+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999987654445689999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCC-cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 462 KLLVDEE-AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 462 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
+...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.............|.........+.
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 8654322 222334568999999999988899999999999999999999999998766555566667766655555555
Q ss_pred hhhcccCCC-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 541 DVIDKRCAD-ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 541 ~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..+++.... .....+..+.+++.+||+.||++|||++|+++.|+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 555544332 45678889999999999999999999999999998765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=393.83 Aligned_cols=260 Identities=24% Similarity=0.331 Sum_probs=198.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeec------CCc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRL------PAT 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 381 (603)
++|++.+.||+|+||+||+|.+.. ++.||||+++..... ..+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 468889999999999999999874 567999999755433 23568899999999999999999998754 357
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.|+||||++ |+|.+++...+. +++..+..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~~----l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQP----LTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 589999876543 99999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCC---cceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 462 KLLVDEE---AHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 462 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
+.+.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.... .....+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~---~~l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV---HQLQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH---HHHHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH---HHHHHHHHhcCCC
Confidence 8764322 2233457899999999998765 4689999999999999999999999754211 1110000000000
Q ss_pred -----------cchhhhccc--CCCcC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 -----------RLEDVIDKR--CADAD-----METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 -----------~~~~~~~~~--~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+... ....+ ...+.++.+|+.+||..||++|||++|+++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000 00000 123467899999999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=383.43 Aligned_cols=196 Identities=28% Similarity=0.383 Sum_probs=168.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC----CCCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN----DCGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 384 (603)
.+.|++.+.||+|+||+||+|+++ .+..||+|++.... ...++.+|+++++.+ +||||+++++++.+.++.|+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 367999999999999999999864 23469999986543 345688999999998 69999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC-CCeEEeecccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN-LEPHVSDFGLAKL 463 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~~~ 463 (603)
||||+++|+|.++++. +++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 98 vmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 98 AMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999852 88999999999999999999999 89999999999999876 7999999999986
Q ss_pred cCCCCc---------------------------ceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCC
Q 007455 464 LVDEEA---------------------------HVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPT 515 (603)
Q Consensus 464 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~ 515 (603)
..+... ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 543221 112345799999999998765 5899999999999999999999999
Q ss_pred Cc
Q 007455 516 DP 517 (603)
Q Consensus 516 ~~ 517 (603)
..
T Consensus 248 ~~ 249 (361)
T 4f9c_A 248 YK 249 (361)
T ss_dssp SC
T ss_pred CC
Confidence 54
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=402.51 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=202.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHH---HHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFE---RELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
+++|++.++||+|+||.||+|++.. +..||||++.+.. ......+. +++.+++.++|||||+++++|.+++..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 5779999999999999999999875 4569999995421 12222333 346677788999999999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|+||||++||+|.+++...+. +++..+..++.||+.||+|||++ +||||||||+|||++.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~----l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999987654 89999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
.+.... ....+||+.|||||++.. ..|+.++|+||+||++|||++|+.||....... .........
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~~i~------- 407 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDRMTL------- 407 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHHHHH-------
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHhhc-------
Confidence 765432 345689999999999964 579999999999999999999999997543221 111111111
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
......+...+.++.+|+.+||+.||++|++ ++|+++
T Consensus 408 ---~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 408 ---TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ---HCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ---CCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111233345678999999999999999998 788874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=402.10 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=208.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+++|++.+.||+|+||.||+|.++. +..||+|.+........+.+.+|+.+|+.++|||||++++++.+++..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 4689999999999999999999875 557999999766555567789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC--CCeEEeecccccccCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN--LEPHVSDFGLAKLLVD 466 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~~~~~~~ 466 (603)
++||+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+..
T Consensus 236 ~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999999886532 2389999999999999999999999 89999999999999854 8999999999998754
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ........... .. +.
T Consensus 310 ~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~------~~~~~~i~~~~-~~--~~-- 376 (573)
T 3uto_A 310 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCD-WN--MD-- 376 (573)
T ss_dssp TS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTC-CC--CC--
T ss_pred CC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHhCC-CC--CC--
Confidence 43 23456799999999999999999999999999999999999999975421 11111111110 00 00
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.......+.++.+|+.+||+.||++|||++|+++
T Consensus 377 -~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 377 -DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111234567899999999999999999999986
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=356.38 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=209.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++|++.+.||+|+||+||+|.+. .+..||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 468999999999999999999975 4567999999766666677899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++.... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTETC-----MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhcC-----CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999997642 88999999999999999999999 89999999999999999999999999998765433
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
. ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ............ ...
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~~~-------~~~ 236 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGT-------PEL 236 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCS-------CCC
T ss_pred c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-------CCC
Confidence 2 23445799999999999999999999999999999999999999965321 111111111110 001
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+..+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 122344567999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=360.16 Aligned_cols=259 Identities=28% Similarity=0.473 Sum_probs=210.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++|.+.+.||+|+||.||+|.+.. +..||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 3578888999999999999999874 567999998766555667899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++..... .+++.+++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCCT---TSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999986432 389999999999999999999999 89999999999999999999999999998764432
Q ss_pred cce-------------eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh
Q 007455 469 AHV-------------TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535 (603)
Q Consensus 469 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (603)
... .....||+.|+|||++.+..++.++||||||+++|||++|..|+.............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~------- 235 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN------- 235 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-------
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-------
Confidence 211 114569999999999999999999999999999999999999986543221110000
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.....+.. .+...+..+.+++.+||+.||++|||++|+++.|++..
T Consensus 236 ---~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~ 281 (310)
T 3s95_A 236 ---VRGFLDRY---CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR 281 (310)
T ss_dssp ---HHHHHHHT---CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---hhcccccc---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00111111 11223356899999999999999999999999988754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=359.05 Aligned_cols=261 Identities=32% Similarity=0.473 Sum_probs=203.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCCh--HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
..+|++.+.||+|+||+||+|.+. +..||||++....... .+.+.+|++++++++||||+++++++......++|||
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 467888999999999999999874 5789999987554332 3568899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK--IIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|+++|+|.+++..... ...+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 115 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp CCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred cCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999986432 23488999999999999999999998 7 9999999999999999999999999997643
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ ..
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~------~~~~~~~~--------~~ 255 (309)
T 3p86_A 191 STF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA------QVVAAVGF--------KC 255 (309)
T ss_dssp ------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHHH--------SC
T ss_pred ccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh--------cC
Confidence 322 2234456999999999999999999999999999999999999999753211 11111100 11
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCC
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 590 (603)
.....+...+.++.+++.+||+.+|++|||++|+++.|+......
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 111223345567999999999999999999999999999866443
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=349.71 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=213.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|++++++++||||+++++++......++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 357888999999999999999999888899999975443 3466899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++.... ..+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 86 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 86 SNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp TTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 9999999997643 2389999999999999999999999 899999999999999999999999999987765544
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .......... ...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~---------~~~ 224 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN------SEVVLKVSQG---------HRL 224 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTT---------CCC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh------HHHHHHHHcC---------CCC
Confidence 44444556778999999998889999999999999999999 9999865321 1111111111 111
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..+...+..+.+++.+||+.+|++|||++|+++.|++..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 122234567999999999999999999999999998865
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=362.25 Aligned_cols=247 Identities=26% Similarity=0.370 Sum_probs=206.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
..+|++.+.||+|+||.||+|.+. .+..||||++...... ..+.+.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 467889999999999999999985 5667999999654322 3456889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++...+. +++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~~~----l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGR----MKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999976543 89999999999999999999999 899999999999999999999999999987654
Q ss_pred CCcceeecccccccccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRAT-EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. ......||+.|+|||++.+..++ .++||||+||++|||++|+.||..... .........
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~---------- 228 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL------KELRERVLR---------- 228 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH----------
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHh----------
Confidence 32 23456799999999999887765 789999999999999999999975321 111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+...+.++.+++.+||..||.+|||++|+++
T Consensus 229 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 229 GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp CCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111222334567999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=347.18 Aligned_cols=280 Identities=38% Similarity=0.602 Sum_probs=229.9
Q ss_pred CCChHHHHHHhhCCCCC------CeeeecCCeEEEEEEECCCCEEEEEEeCCCC----CChHHHHHHHHHHHhhCCCCee
Q 007455 300 PYPSCEIIEKLEALDEE------DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSR----EGSDQVFERELEILGSIKHINL 369 (603)
Q Consensus 300 ~~~~~~~~~~~~~~~~~------~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~ni 369 (603)
.+...++...+++|+.. +.||+|+||.||+|.+. +..||||++.... ....+.+.+|+.++++++||||
T Consensus 14 ~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 92 (307)
T 2nru_A 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL 92 (307)
T ss_dssp ECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS-SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB
T ss_pred cccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC-CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe
Confidence 36677888888888877 89999999999999874 5789999986532 2335678999999999999999
Q ss_pred eecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC
Q 007455 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE 449 (603)
Q Consensus 370 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 449 (603)
+++++++...+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||++ +++||||||+||+++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 93 VELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp CCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEEecCCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999875432 23489999999999999999999998 8999999999999999
Q ss_pred CCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhH
Q 007455 450 NLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVG 528 (603)
Q Consensus 450 ~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~ 528 (603)
++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|..||...... .....
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~ 245 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP--QLLLD 245 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS--SBTTH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch--HHHHH
Confidence 999999999999876543222 2334568999999998875 5789999999999999999999999764322 12222
Q ss_pred HHHHHhh-hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 529 WMNTLLK-ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 529 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
+...... ...+...++......+...+..+.+++.+||+.+|.+|||++++++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 3222222 2234455566666667788899999999999999999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.07 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=212.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 57888899999999999999998888899999975543 34679999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++.... ..+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 89 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 999999997543 2389999999999999999999999 8999999999999999999999999999876543333
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .......... ....
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~------~~~~~~~~~~---------~~~~ 227 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTG---------FRLY 227 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT---------CCCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHHhcC---------ccCC
Confidence 3334557788999999998899999999999999999999 9999865321 1111111111 1111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.+...+..+.+++.+||+.+|++|||++|+++.|+++.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 22334567999999999999999999999999998754
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=360.72 Aligned_cols=261 Identities=27% Similarity=0.414 Sum_probs=209.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC----CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND----CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
++|++.+.||+|+||.||+|.+.. +..||||+++.... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 567888999999999999999863 33599999975433 2345689999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 129 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 99999999999997542 2389999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCcc--eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 466 DEEAH--VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 466 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||..... .........
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~------~~~~~~~~~------- 269 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN------RDVISSVEE------- 269 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHHT-------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHc-------
Confidence 43222 2223446778999999998899999999999999999999 9999865321 111111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCCC
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCP 592 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 592 (603)
......+...+..+.+++.+||..||++|||++|+++.|+.+...++.
T Consensus 270 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 270 --GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp --TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred --CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 111122334567899999999999999999999999999987755443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=353.50 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=206.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||+|.+. .+..||+|.+...... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 56888999999999999999986 4567999998544332 2356889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++...+. +++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~g~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp ECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred eCCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999987543 89999999999999999999999 899999999999999999999999999987755
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
..........||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... ........... .....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~-~~~~~--- 233 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS-VPNVT--- 233 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC-CCCHH---
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc-CCCcc---
Confidence 444444556799999999999998999999999999999999999999975321 11111111111 00000
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhcccCC
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRP-SMNQVLQLLEQEVMSP 590 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~~ 590 (603)
.......+..+.+++.+||+.||++|| +++++.+.|++.....
T Consensus 234 -~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 234 -TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 011223456799999999999999998 9999999999865443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=364.52 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=210.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC--------CCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN--------DCGTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLP 379 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 379 (603)
.++|++.+.||+|+||.||+|.+. .+..||||+++..... ..+.+.+|+++++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367888999999999999999863 2235999998754332 335689999999999 899999999999999
Q ss_pred CccEEEEEecCCCCccccccccCCC------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHGEG------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL 447 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 447 (603)
+..|+||||+++|+|.+++...... ...+++..++.++.|+++||+|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 9999999999999999999865321 23478999999999999999999999 89999999999999
Q ss_pred CCCCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCcc
Q 007455 448 DENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLN 525 (603)
Q Consensus 448 ~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~ 525 (603)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... .
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~---~ 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE---E 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H
Confidence 99999999999999876543321 2233457789999999998899999999999999999999 99998653211 1
Q ss_pred HhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
....... ......+...+.++.+++.+||+.+|++|||++|+++.|+++.
T Consensus 314 ---~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 314 ---LFKLLKE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp ---HHHHHHT---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111111 1111223345568999999999999999999999999998854
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=352.05 Aligned_cols=259 Identities=23% Similarity=0.354 Sum_probs=212.2
Q ss_pred CChHHHHHHhhC----------CCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCee
Q 007455 301 YPSCEIIEKLEA----------LDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINL 369 (603)
Q Consensus 301 ~~~~~~~~~~~~----------~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 369 (603)
++..++..+++. |+..+.||+|+||.||+|.+. +++.||||++........+.+.+|+.++++++||||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 104 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence 555566665543 566679999999999999987 567899999977666667779999999999999999
Q ss_pred eecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC
Q 007455 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE 449 (603)
Q Consensus 370 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~ 449 (603)
+++++++...+..++||||+++|+|.+++... .+++..+..++.|+++||.|||+. +|+||||||+||+++.
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 99999999999999999999999999998753 289999999999999999999998 8999999999999999
Q ss_pred CCCeEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHH
Q 007455 450 NLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGW 529 (603)
Q Consensus 450 ~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~ 529 (603)
++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~------~~~ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP------VQA 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHH
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHH
Confidence 99999999999987654322 23445799999999999988999999999999999999999999965321 111
Q ss_pred HHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 530 MNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........ .+.. ......+.++.+++.+||+.||++|||++|+++
T Consensus 250 ~~~~~~~~------~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 250 MKRLRDSP------PPKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHHHSS------CCCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHhcCC------CCCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111110 0000 112234567999999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=356.10 Aligned_cols=248 Identities=21% Similarity=0.282 Sum_probs=205.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+.. +..||+|++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4678889999999999999999874 567999998643 223445688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+++...
T Consensus 84 ~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999876543 89999999999999999999999 89999999999999999999999999998643
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .........
T Consensus 157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~---------- 219 (337)
T 1o6l_A 157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELILM---------- 219 (337)
T ss_dssp CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH----------
T ss_pred cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH------HHHHHHHHc----------
Confidence 322 223456799999999999998999999999999999999999999965321 111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
.....+...+.++.+++.+||+.||++|| +++|+++
T Consensus 220 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 220 EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 11112334556899999999999999999 8999975
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=349.46 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=209.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.++|++.+.||+|+||.||+|.+.++..||+|++..... ..+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 467888899999999999999999888899999975543 3466899999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 102 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp TTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 9999999997632 2389999999999999999999999 899999999999999999999999999987654333
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||..... .......... ...
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~------~~~~~~~~~~---------~~~ 240 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQG---------LRL 240 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH------HHHHHHHHTT---------CCC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh------hHHHHHHhcc---------cCC
Confidence 33334456788999999998899999999999999999998 9999865321 1111111111 111
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..+...+..+.+++.+||+.+|++|||++|+++.|+++.
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 122233567999999999999999999999999998754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=363.28 Aligned_cols=259 Identities=26% Similarity=0.441 Sum_probs=198.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC----CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN----DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
..+|++.+.||+|+||.||+|.+. .+..||||.++.... ...+.+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357899999999999999999875 345699999975432 234568999999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999997643 2389999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcce--eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 465 VDEEAHV--TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 465 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
....... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ..........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~------~~~~~~i~~~----- 266 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN------QDVIKAVDEG----- 266 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH------HHHHHHHHTT-----
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC-----
Confidence 5432221 122335678999999998999999999999999999998 9999864321 1111111110
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
.....+...+.++.+++.+||+.+|++||+++|+++.|+++...
T Consensus 267 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 ----YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ----EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11112334557799999999999999999999999999886543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=373.64 Aligned_cols=258 Identities=28% Similarity=0.445 Sum_probs=211.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.++|++.+.||+|+||.||+|.++++..||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 45778889999999999999999988889999997644 34667999999999999999999999986 66789999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 265 ~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 265 AKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp TTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999997542 12378899999999999999999999 899999999999999999999999999987654322
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......+++.|+|||++....++.++||||||+++|||++ |+.||..... ........... ..
T Consensus 340 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~~~---------~~ 404 (454)
T 1qcf_A 340 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN------PEVIRALERGY---------RM 404 (454)
T ss_dssp HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHHTC---------CC
T ss_pred eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCC---------CC
Confidence 22233446788999999998899999999999999999999 9999864321 11111111111 11
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
..+...+.++.+++.+||+.||++|||++++++.|++....
T Consensus 405 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 405 PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 12334567899999999999999999999999999986543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=355.16 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=204.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC------hHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG------SDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.+.|++.+.||+|+||.||+|.+.. +..||+|.+...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3578889999999999999999874 567999998654322 346789999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC----CeEEeec
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL----EPHVSDF 458 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 458 (603)
++||||+++|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSC----CBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999976433 89999999999999999999999 899999999999998877 7999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
|++....... ......||+.|+|||++.+..++.++||||+|+++|+|++|..||..... ...........
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~------~~~~~~i~~~~- 234 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITAVS- 234 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTC-
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcC-
Confidence 9998765432 23445699999999999988999999999999999999999999975321 11111111100
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. ++. ......+.++.+++.+||..||++|||++|+++
T Consensus 235 ~~--~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 YD--FDE---EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CC--CCH---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CC--CCc---hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 000 001123467899999999999999999999985
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=364.22 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=207.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|.+.+.||+|+||.||+|.+. ++..||||.++..... ....+.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888899999999999999997 5667999998654322 22458899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++...+ ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 193 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred cCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999998643 2388999999999999999999999 8999999999999999999999999999865432
Q ss_pred Cccee-ecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 468 EAHVT-TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 468 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
..... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .........
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~-------- 331 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ-------QTREFVEKG-------- 331 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH-------HHHHHHHTT--------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcC--------
Confidence 21111 12235678999999998899999999999999999998 99998653211 111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.....+...+.++.+++.+||+.||++|||++++++.|+++.
T Consensus 332 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 332 GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 011123344567999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=357.10 Aligned_cols=266 Identities=30% Similarity=0.378 Sum_probs=206.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCc----cEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPAT----KLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv 385 (603)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ......++|+.++++++||||+++++++..... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467889999999999999999987 4789999986432 233456779999999999999999999987543 5999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD-------CCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
|||+++|+|.++++... +++..++.++.|+++||+|||+. ..++|+||||||+|||++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHhcC-----CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 99999999999997642 89999999999999999999986 1237999999999999999999999999
Q ss_pred ccccccCCCCcc-eeecccccccccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccH------
Q 007455 459 GLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQS-----GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNV------ 526 (603)
Q Consensus 459 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~------ 526 (603)
|+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...........
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999876543322 2334579999999999876 3456689999999999999999999976432221111
Q ss_pred ----hHHHHHHhhhCcchhhhcccCCC--cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 527 ----VGWMNTLLKENRLEDVIDKRCAD--ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 527 ----~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..+...... .... +.... .....+.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 256 ~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 256 HPSLEDMQEVVVH-KKKR----PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp SCCHHHHHHHHTT-SCCC----CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCchhhhhhhhhc-ccCC----CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111111111 1100 11111 12345677999999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=370.44 Aligned_cols=260 Identities=31% Similarity=0.464 Sum_probs=206.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||.||+|.++++..||||+++... ...+.+.+|++++++++||||+++++++.. +..++||||++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~ 261 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 261 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhc
Confidence 5677889999999999999999988889999997644 345679999999999999999999999876 67899999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 262 ~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 262 KGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp TCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 999999997532 12388999999999999999999999 8999999999999999999999999999876544333
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ........... ...
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~------~~~~~~i~~~~---------~~~ 401 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGY---------RMP 401 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTTC---------CCC
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCC---------CCC
Confidence 3334457789999999998899999999999999999999 8999864321 11111111111 111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCCC
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCP 592 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 592 (603)
.+...+..+.+++.+||+.+|++|||++++++.|++......+
T Consensus 402 ~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 402 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 2334567899999999999999999999999999987644433
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=349.54 Aligned_cols=267 Identities=29% Similarity=0.423 Sum_probs=205.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-----CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecC--CccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-----DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLP--ATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 383 (603)
++|++.+.||+|+||+||+|.+. .+..||||++........+.+.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 57888999999999999999842 4557999999766555557799999999999999999999998543 5589
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGG---GCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEeCCCCCHHHHHHhccc---ccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 99999999999999986532 389999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcc--eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccccc-----CCccHhHHHHHHhhh
Q 007455 464 LVDEEAH--VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVK-----RGLNVVGWMNTLLKE 536 (603)
Q Consensus 464 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~ 536 (603)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... ...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~---- 239 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF---- 239 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH----
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH----
Confidence 6543221 223345777899999999899999999999999999999999998653210 00000000000
Q ss_pred CcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 537 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..............+...+.++.+++.+||+.+|++|||++|+++.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~ 290 (295)
T 3ugc_A 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290 (295)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 000001111112233455678999999999999999999999999998754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=342.80 Aligned_cols=255 Identities=28% Similarity=0.436 Sum_probs=211.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 57888899999999999999998888899999976543 34678999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+++|.+++.... ..+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 87 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 87 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 999999997643 2388999999999999999999999 8999999999999999999999999999876443222
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......++..|+|||++.+..++.++||||+|+++|||++ |+.||..... .......... ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~i~~~---------~~~~ 225 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVEDISTG---------FRLY 225 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT---------CCCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH------HHHHHHHhcC---------CcCC
Confidence 2233457788999999998889999999999999999999 8999865321 1111111111 0111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.+...+..+.+++.+||+.+|++|||++|+++.|+++.
T Consensus 226 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 226 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 22234567999999999999999999999999998754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=346.28 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=195.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC----CEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC----GTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
.++|++.+.||+|+||.||+|.+..+ ..||+|.+...... ..+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 35788899999999999999998642 35899988654322 3456889999999999999999999984 567899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccccc
Confidence 999999999999997643 2389999999999999999999999 8999999999999999999999999999877
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
............+++.|+|||.+.+..++.++||||||+++|||++ |..||...... .. .......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~---~~~i~~~------- 233 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DV---IGRIENG------- 233 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GH---HHHHHTT-------
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HH---HHHHHcC-------
Confidence 5544333344557789999999998899999999999999999997 89998753211 11 1111111
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.....+...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 234 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 234 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111223345577999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=355.27 Aligned_cols=261 Identities=25% Similarity=0.427 Sum_probs=211.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.++|++.+.||+|+||.||+|.+.+ +..||||.++..... ..+.+.+|+.++++++||||+++++++...+..
T Consensus 46 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 46 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 4688899999999999999999863 256999998754332 345689999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCCC--------------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEG--------------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKS 442 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 442 (603)
++||||+++|+|.+++...... ...+++.+++.++.|+++||.|||++ +|+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCc
Confidence 9999999999999999864321 14589999999999999999999999 899999999
Q ss_pred CCeEECCCCCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccc
Q 007455 443 SNILLDENLEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFV 520 (603)
Q Consensus 443 ~NIll~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~ 520 (603)
+||+++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.....
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 999999999999999999986643322 12234567889999999998899999999999999999999 9999864321
Q ss_pred cCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 521 KRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
........ +......+...+.++.+++.+||+.+|++|||++++++.|+++..
T Consensus 283 ------~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 283 ------EEVIYYVR---------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp ------HHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ------HHHHHHHh---------CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 11111111 111122233455679999999999999999999999999998654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=354.10 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=203.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
..+|.+.+.||+|+||.||+|.+. .+..||+|++... .......+.+|+.+++.++||||+++++++..++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 367888999999999999999985 4567999998542 122335689999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+ +|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKR----MTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 6799988876543 89999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
.... .....||+.|+|||++.+..+ +.++||||+|+++|+|++|+.||....... +...+.
T Consensus 160 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~----------------~~~~i~ 221 (336)
T 3h4j_B 160 DGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN----------------LFKKVN 221 (336)
T ss_dssp TSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT----------------CBCCCC
T ss_pred CCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH----------------HHHHHH
Confidence 4332 234569999999999987776 689999999999999999999997543211 111111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......+...+.++.+++.+||+.||.+|||++|+++
T Consensus 222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1112233345577999999999999999999999986
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=351.55 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=196.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC----EEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc-
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLPATK- 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~- 382 (603)
.++|++.+.||+|+||.||+|.+..++ .||||.+... .....+.+.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 357889999999999999999977544 6999998654 233456789999999999999999999999877665
Q ss_pred -----EEEEEecCCCCccccccccCC--CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEE
Q 007455 383 -----LLIYDYLSMGSLDDFLHEHGE--GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455 (603)
Q Consensus 383 -----~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 455 (603)
++||||+++|+|.+++..... ....+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEE
Confidence 999999999999999875432 222489999999999999999999999 8999999999999999999999
Q ss_pred eecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHH
Q 007455 456 SDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 456 ~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . .....
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~---~~~~~ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---E---IYNYL 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---G---HHHHH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---H---HHHHH
Confidence 999999876443321 2233456788999999999899999999999999999999 89998753211 1 11111
Q ss_pred hhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
.. ......+...+.++.+++.+||+.||++|||+.++++.|++....
T Consensus 253 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 IG---------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hc---------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11 111222334557899999999999999999999999999986643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=350.75 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=202.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||.||+|.+. .+..||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999987 556799999864432 233568899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++..... +++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 86 ~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBTTTB----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999976533 89999999999999999999998 8999999999999999999999999999866433
Q ss_pred Cc-ceeecccccccccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 468 EA-HVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 468 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. .......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||....... .....| .....
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~~~----~~~~~------- 226 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----KEKKT------- 226 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS-HHHHHH----HTTCT-------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHH----hcccc-------
Confidence 22 22334679999999999987665 778999999999999999999997532110 111111 11000
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+..+.+++.+||+.||++|||++|+++
T Consensus 227 -~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00111234567889999999999999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=359.15 Aligned_cols=260 Identities=29% Similarity=0.413 Sum_probs=211.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC--------CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND--------CGTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLP 379 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 379 (603)
.++|.+.+.||+|+||.||+|.+.. +..||||++...... ..+.+.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 3578888999999999999998632 235999999755332 235688999999999 899999999999999
Q ss_pred CccEEEEEecCCCCccccccccCCC------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHGEG------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL 447 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 447 (603)
+..++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 9999999999999999999875421 23489999999999999999999999 89999999999999
Q ss_pred CCCCCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCcc
Q 007455 448 DENLEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLN 525 (603)
Q Consensus 448 ~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~ 525 (603)
+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~------ 298 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 298 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------
Confidence 9999999999999987654332 22334557889999999999999999999999999999999 999986432
Q ss_pred HhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
........... .....+...+.++.+++.+||+.+|++|||++|+++.|+++.
T Consensus 299 ~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 299 VEELFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp HHHHHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111111111 111122344567999999999999999999999999998865
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=371.95 Aligned_cols=259 Identities=29% Similarity=0.441 Sum_probs=213.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++|++.+.||+|+||.||+|.+.+ +..||||.++.... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 3567888999999999999999986 55799999875443 456799999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 298 ~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 298 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred cCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 999999999986432 3488999999999999999999999 89999999999999999999999999998765443
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
........+++.|+|||++.+..++.++||||||+++|||++ |..||...... .+. ....... .
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~---~~~---~~~~~~~---------~ 437 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVY---ELLEKDY---------R 437 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHH---HHHHTTC---------C
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH---HHH---HHHHcCC---------C
Confidence 333334456789999999998899999999999999999999 88998653211 111 1111110 1
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
...+...+.++.+|+.+||+.+|++|||++++++.|+++...
T Consensus 438 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 438 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 112334557899999999999999999999999999987543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=344.39 Aligned_cols=259 Identities=26% Similarity=0.391 Sum_probs=200.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhh--CCCCeeeecceeeec----CCccE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGS--IKHINLVNLRGYCRL----PATKL 383 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~ 383 (603)
.++|++.+.||+|+||.||+|.+. +..||||++... ....+.+|.+++.. ++||||+++++++.. ....+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEEC-CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 357889999999999999999984 578999998543 34456667777666 799999999998654 34578
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEecCCCCCeEECCCCCeEE
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH--------HDCCPKIIHRDIKSSNILLDENLEPHV 455 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~~kl 455 (603)
+||||+++|+|.++++.. .+++..++.++.|++.||+||| +. +|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 999999999999999643 3899999999999999999999 66 8999999999999999999999
Q ss_pred eecccccccCCCCcce---eecccccccccCccccccC------CCCcccchHhHHHHHHHHHhC----------CCCCC
Q 007455 456 SDFGLAKLLVDEEAHV---TTVVAGTFGYLAPEYLQSG------RATEKSDVYSFGVLLLELVTG----------KRPTD 516 (603)
Q Consensus 456 ~DfG~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~vl~elltg----------~~p~~ 516 (603)
+|||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998765443322 2234799999999999876 455799999999999999999 77775
Q ss_pred cccccCCccHhHHHHHHhhhCcchhhhcccCCC--cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 517 PTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD--ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 517 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
....... ... ............ ...+. .....+.++.+++.+||+.||++|||++|+++.|+++
T Consensus 235 ~~~~~~~-~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDP-SFE-DMRKVVCVDQQR----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSC-CHH-HHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCc-chh-hhhHHHhccCCC----CCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 4322111 111 111111111111 11111 1235678899999999999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=358.71 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=200.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC---CCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS---REGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 383 (603)
..++|++.+.||+|+||.||+|.+.. +..||||++... .....+.+.+|..+++.+ +||||+++++++...+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 35789999999999999999999875 567999998643 223345678999999988 6999999999999999999
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999987543 89999999999999999999999 899999999999999999999999999985
Q ss_pred cCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||..... .........
T Consensus 174 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-------- 238 (353)
T 3txo_A 174 GICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE------DDLFEAILN-------- 238 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH--------
T ss_pred cccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH------HHHHHHHHc--------
Confidence 4322 2234456799999999999988899999999999999999999999975421 111111111
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSM------NQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~ 581 (603)
.....+...+.++.+++.+||+.+|++||++ +|+++
T Consensus 239 --~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 --DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred --CCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1112233355679999999999999999998 77764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=358.57 Aligned_cols=255 Identities=20% Similarity=0.315 Sum_probs=204.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCC---hHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREG---SDQVFERELEILGSI-KHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 384 (603)
.++|++.++||+|+||.||+|.+..++ .||+|++++.... ..+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 568899999999999999999988655 5999999654322 224578899999887 89999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999987543 89999999999999999999999 8999999999999999999999999999863
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCC--ccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG--LNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 542 (603)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||........ .....+.....
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i-------- 274 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------- 274 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--------
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--------
Confidence 3222 234556799999999999999999999999999999999999999964321111 11111111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSM------NQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~ 581 (603)
.......+...+.++.+++.+||+.||++||++ +|+++
T Consensus 275 -~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 275 -LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp -HHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred -hccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 111122333456789999999999999999995 56664
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=354.08 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=204.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC-----CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS-----REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
+.|++.+.||+|+||.||+|.+.. +..||||++... .....+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 568889999999999999999874 567999998532 22245678999999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC---eEEeecccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE---PHVSDFGLA 461 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~~ 461 (603)
||||+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999988876543344589999999999999999999999 8999999999999987655 999999999
Q ss_pred cccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
+....... ......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .......... ...
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i~~~~-~~~ 251 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGIIKGK-YKM 251 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHHHHTC-CCC
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHHHcCC-CCC
Confidence 87654322 23345699999999999988999999999999999999999999975311 1111111110 000
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. +......+.++.+++.+||..||++|||+.|+++
T Consensus 252 --~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 252 --N---PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp --C---HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --C---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 0000123467999999999999999999999985
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.50 Aligned_cols=249 Identities=23% Similarity=0.324 Sum_probs=204.1
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC---CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCcc
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR---EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATK 382 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 382 (603)
...++|++.+.||+|+||.||+|.++.+ ..||+|+++... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3567899999999999999999999754 569999986532 23345678899999877 899999999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|+||||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999986543 89999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .........
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~------- 232 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRM------- 232 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-------
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHh-------
Confidence 643322 223456799999999999998999999999999999999999999975321 111111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMN-QVL 580 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl 580 (603)
.....+...+.++.+++.+||..||++||++. |++
T Consensus 233 ---~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 233 ---DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ---CCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 11122333456799999999999999999997 665
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.17 Aligned_cols=250 Identities=21% Similarity=0.290 Sum_probs=204.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
++|++.+.||+|+||.||+|.+..+ ..+|+|.+... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 83 (321)
T 1tki_A 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeC
Confidence 5788899999999999999998864 45999988643 234456889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC--CCCeEEeecccccccCCC
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE--NLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~~~~~~~~ 467 (603)
++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 84 ~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 84 SGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 9999999997543 2389999999999999999999999 8999999999999987 789999999999877543
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
. ......||+.|+|||++.+..++.++||||+|+++|||++|..||..... .............. ..
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~~~~~---~~-- 224 (321)
T 1tki_A 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYTF---DE-- 224 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCC---CH--
T ss_pred C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHcCCCCC---Ch--
Confidence 3 23445689999999999988889999999999999999999999975321 11111111111000 00
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......+.++.+++.+||..||++|||+.|+++
T Consensus 225 -~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 225 -EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 000123467999999999999999999999997
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=347.91 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=204.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467888999999999999999987 4567999998643 123345678999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.+|.+||+|||+++...
T Consensus 85 ~e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp ECCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred EeCCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 999999999999987543 89999999999999999999998 89999999999999999999999999998754
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. .....||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ..........
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~--------- 218 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNA--------- 218 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHC---------
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC---------
Confidence 32 2345799999999999998999999999999999999999999965321 1111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
....+...+.++.+++.+||..||++|| +++|+++
T Consensus 219 -~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 219 -ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 1112233456799999999999999999 8999984
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=348.19 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=210.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+..... ...+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 467888899999999999999873 235699999875432 2335688999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCC--------------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 007455 383 LLIYDYLSMGSLDDFLHEHGE--------------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKS 442 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 442 (603)
++||||+++|+|.+++..... ....+++..++.++.|+++||+|||++ +++||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999986543 123488999999999999999999999 899999999
Q ss_pred CCeEECCCCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccc
Q 007455 443 SNILLDENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFV 520 (603)
Q Consensus 443 ~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~ 520 (603)
+||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876544332 2233457788999999998889999999999999999999 9999865322
Q ss_pred cCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 521 KRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
. .. ... .... .....+...+.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 259 ~---~~---~~~-~~~~--------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 259 E---RL---FNL-LKTG--------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp G---GH---HHH-HHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---HH---HHH-hhcC--------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1 11 111 1111 111223345578999999999999999999999999998764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=347.48 Aligned_cols=261 Identities=23% Similarity=0.315 Sum_probs=201.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||+||+|.+.+++.||+|++..... .....+.+|++++++++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 467888999999999999999998888999999965432 234678899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9986 8888776543 2389999999999999999999999 8999999999999999999999999999876533
Q ss_pred CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc---hh--
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL---ED-- 541 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~-- 541 (603)
.. ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .....+......... ..
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD---DQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT---THHHHHHHHHCCCCTTTSGGGT
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHHCCCChHHhhhhh
Confidence 22 2334568999999999876 56899999999999999999999999754321 111111111111000 00
Q ss_pred ----hhcccC---CC-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 542 ----VIDKRC---AD-----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 542 ----~~~~~~---~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...... .. .....+.++.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 00 01123467899999999999999999999986
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=340.65 Aligned_cols=256 Identities=30% Similarity=0.449 Sum_probs=210.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.++|++.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|++++++++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 367888999999999999999998878899999975443 4567899999999999999999999886 45689999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++........
T Consensus 90 ~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 9999999997532 12389999999999999999999999 899999999999999999999999999987765443
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .......... ...
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~---------~~~ 229 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN------PEVIQNLERG---------YRM 229 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHHHHTT---------CCC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH------HHHHHHHhcc---------cCC
Confidence 33334557788999999988889999999999999999999 8999864321 1111111111 011
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..+...+.++.+++.+||+.+|++|||++++++.|++..
T Consensus 230 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 122344568999999999999999999999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=351.41 Aligned_cols=255 Identities=25% Similarity=0.427 Sum_probs=201.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-----EEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|+..+.||+|+||+||+|.+..++ +||+|.+.... ....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 57888899999999999999976443 26888875432 334567999999999999999999999998754 789
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
|+||+.+|+|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 94 v~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 9999999999999986432 389999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ... ......
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~----~~~~~~----- 235 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS----SILEKG----- 235 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH----HHHHTT-----
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHH----HHHHcC-----
Confidence 544322 2233456889999999999999999999999999999999 99999753211 111 111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.....+...+.++.+++.+||+.+|++|||++|+++.|+.+.
T Consensus 236 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 236 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ---CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111123345567999999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=340.18 Aligned_cols=253 Identities=30% Similarity=0.485 Sum_probs=195.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCC----ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE----GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+. +..+|||++..... ...+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999986 57899999865432 2235688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC--------CCCeEEee
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE--------NLEPHVSD 457 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--------~~~~kl~D 457 (603)
|||+++++|.+++... .+++..++.++.|+++||+|||+++..+++||||||+||+++. ++.+||+|
T Consensus 85 ~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EECCTTEEHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEcCCCCCHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999999998643 3899999999999999999999982222999999999999986 67899999
Q ss_pred cccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 458 FGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 458 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
||+++...... .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... ....... ..
T Consensus 160 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~-~~ 229 (271)
T 3dtc_A 160 FGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL------AVAYGVA-MN 229 (271)
T ss_dssp CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH------HHHHHHH-TS
T ss_pred CCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHhhh-cC
Confidence 99998654332 22456899999999999889999999999999999999999999653210 0111111 11
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
......+...+..+.+++.+||+.+|++|||++|+++.|++
T Consensus 230 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 230 -------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 11112233455679999999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=343.57 Aligned_cols=270 Identities=24% Similarity=0.302 Sum_probs=212.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCC--ccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPA--TKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 386 (603)
++|.+.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 467888999999999999999885 5679999996533 233566889999999999999999999987665 679999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE----CCCCCeEEeeccccc
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL----DENLEPHVSDFGLAK 462 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~~~ 462 (603)
||+++|+|.+++..... ...+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999986533 22389999999999999999999999 89999999999999 788889999999998
Q ss_pred ccCCCCcceeecccccccccCccccc--------cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQ--------SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||....... .....+....
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~ 240 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR--RNKEVMYKII 240 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG--GCHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc--hhHHHHHHHh
Confidence 7654432 23456899999999886 5678899999999999999999999996432211 1111222222
Q ss_pred hhCc---chhh-------h--cccC---CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 535 KENR---LEDV-------I--DKRC---ADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 535 ~~~~---~~~~-------~--~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
.... +... + .... .......+..+.+++.+||+.||++|||++|+++-..+.+.
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 1111 0000 0 0001 12345777889999999999999999999999998887664
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=350.12 Aligned_cols=251 Identities=22% Similarity=0.355 Sum_probs=199.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCc------
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPAT------ 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 381 (603)
.++|++.+.||+|+||.||+|.+. ++..||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467889999999999999999987 56789999996543 3345679999999999999999999998865432
Q ss_pred ---------------------------------------------------cEEEEEecCCCCccccccccCCCCccCCH
Q 007455 382 ---------------------------------------------------KLLIYDYLSMGSLDDFLHEHGEGQQLLNW 410 (603)
Q Consensus 382 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~ 410 (603)
.++||||+++|+|.+++..... ....++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS-LEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS-GGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC-ccchhh
Confidence 7899999999999999987543 233677
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc-----------ceeecccccc
Q 007455 411 SARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA-----------HVTTVVAGTF 479 (603)
Q Consensus 411 ~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~-----------~~~~~~~gt~ 479 (603)
..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999999 899999999999999999999999999987755421 1223456999
Q ss_pred cccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHH
Q 007455 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAIL 559 (603)
Q Consensus 480 ~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 559 (603)
.|+|||++.+..++.++||||+|+++|||++|..|+.... .... .......+......+.++.
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~~~~---------~~~~~~~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------RIIT---------DVRNLKFPLLFTQKYPQEH 303 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------HHHH---------HHHTTCCCHHHHHHCHHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------HHHH---------HhhccCCCcccccCChhHH
Confidence 9999999998899999999999999999999877742110 0000 0011111112234446789
Q ss_pred HHHHHcccCCCCCCCCHHHHHH
Q 007455 560 EIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 560 ~li~~cl~~~P~~RPs~~evl~ 581 (603)
+++.+||+.||++|||++|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999986
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=363.01 Aligned_cols=251 Identities=29% Similarity=0.443 Sum_probs=205.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCC-ccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPA-TKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 388 (603)
.++|++.+.||+|+||.||+|.+. +..||||+++... ..+.+.+|++++++++||||+++++++.... ..++||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 467888899999999999999987 4689999997543 4467999999999999999999999987665 78999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++...+. ..+++..++.++.|+++||+|||++ +++||||||+|||++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 999999999987532 3378999999999999999999999 8999999999999999999999999999854322
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... .. ....... ..
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~---~~~i~~~---------~~ 404 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DV---VPRVEKG---------YK 404 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---TH---HHHHHTT---------CC
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHHHcC---------CC
Confidence 122357889999999999999999999999999999998 99998653211 11 1111111 11
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
...+...+.++.+++.+||+.||++|||++++++.|+++.
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1223345678999999999999999999999999998764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=359.13 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=207.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
++|++.+.||+|+||.||+|.+. .+..||||++.... ......+.+|+.++++++||||+++++++......+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 57888999999999999999954 23469999986543 233456889999999999999999999999999999
Q ss_pred EEEEecCCCCccccccccCC---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC---CeEEee
Q 007455 384 LIYDYLSMGSLDDFLHEHGE---GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL---EPHVSD 457 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~D 457 (603)
+||||+++|+|.+++..... ....+++..++.++.|+++||+|||++ +|+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999986542 223489999999999999999999999 899999999999999655 499999
Q ss_pred cccccccCCCC-cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhh
Q 007455 458 FGLAKLLVDEE-AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLK 535 (603)
Q Consensus 458 fG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 535 (603)
||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |..||..... .........
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~------~~~~~~i~~ 301 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVTS 301 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHHT
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHc
Confidence 99997653221 122334567899999999998899999999999999999998 9999865321 111111111
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
. .....+...+..+.+++.+||+.+|++|||++++++.|+...
T Consensus 302 ~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 302 G---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C---------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 1 111223344567999999999999999999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=346.55 Aligned_cols=249 Identities=27% Similarity=0.339 Sum_probs=203.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC------hHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG------SDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
+.|++.+.||+|+||.||+|.+.. +..||+|.+...... ..+.+.+|+.++++++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 568889999999999999999874 567999998654321 3567899999999999999999999999999999
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC----CeEEeecc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL----EPHVSDFG 459 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG 459 (603)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKE----SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTTSS----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhcC----CcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 9999999999999997643 389999999999999999999998 899999999999999887 79999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC-c
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN-R 538 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 538 (603)
+++....... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ........... .
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~~~ 235 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVNYE 235 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHTCCC
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHHhcCCC
Confidence 9987654322 2345699999999999988999999999999999999999999965321 11111111100 0
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... ......+..+.+++.+||..||++|||++|+++
T Consensus 236 ~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 FED-------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CCH-------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred cCc-------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 001123457899999999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=342.14 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=196.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--------------------------hHHHHHHHHHHHh
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--------------------------SDQVFERELEILG 362 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 362 (603)
.++|++.+.||+|+||.||+|.+.. +..||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4678899999999999999999875 456999998643211 1245889999999
Q ss_pred hCCCCeeeecceeeec--CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC
Q 007455 363 SIKHINLVNLRGYCRL--PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDI 440 (603)
Q Consensus 363 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 440 (603)
+++||||+++++++.. ....++||||+++++|.+++... .+++..+..++.|+++||+|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999986 56789999999999999876532 389999999999999999999999 8999999
Q ss_pred CCCCeEECCCCCeEEeecccccccCCCCcceeecccccccccCccccccCC---CCcccchHhHHHHHHHHHhCCCCCCc
Q 007455 441 KSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR---ATEKSDVYSFGVLLLELVTGKRPTDP 517 (603)
Q Consensus 441 kp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~vl~elltg~~p~~~ 517 (603)
||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 234457999999999997655 37789999999999999999999965
Q ss_pred ccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 518 TFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. ...+.... ...... . ......+.++.+++.+||+.||++|||++|+++
T Consensus 243 ~~------~~~~~~~~-~~~~~~------~-~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ER------IMCLHSKI-KSQALE------F-PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SS------HHHHHHHH-HHCCCC------C-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cc------HHHHHHHH-hcccCC------C-CCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 32 11111111 111110 0 011234467999999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.92 Aligned_cols=252 Identities=23% Similarity=0.274 Sum_probs=203.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.++|++.+.||+|+||.||+|.+.. +..+|+|++...... ..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 4678999999999999999999874 456999998654432 3356889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC---CCCCeEEeecccccc
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD---ENLEPHVSDFGLAKL 463 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~~~~ 463 (603)
||+++|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 90 E~~~gg~L~~~i~~~~~----~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHHCSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999886543 89999999999999999999999 899999999999998 467899999999987
Q ss_pred cCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
...... ......||+.|+|||++.+..++.++||||+||++|+|++|..||..... ........ .....
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~------~~~~~~i~-~~~~~--- 231 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ------HRLYQQIK-AGAYD--- 231 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHH-HTCCC---
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH-hCCCC---
Confidence 654332 23346799999999999988999999999999999999999999965321 11111111 11100
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. .......+.++.+++.+||+.||++|||++|+++
T Consensus 232 -~~-~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 232 -FP-SPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -CC-TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CC-ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00 0011234567999999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=357.74 Aligned_cols=268 Identities=27% Similarity=0.425 Sum_probs=211.3
Q ss_pred hHHHHHHhhCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecce
Q 007455 303 SCEIIEKLEALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRG 374 (603)
Q Consensus 303 ~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~ 374 (603)
...+....++|++.+.||+|+||.||+|.+. .++.||||++...... ..+.+.+|++++.++ +||||+++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 3344445678999999999999999999843 2346999999754332 335689999999999 7999999999
Q ss_pred eeecCCc-cEEEEEecCCCCccccccccCCC-------------------------------------------------
Q 007455 375 YCRLPAT-KLLIYDYLSMGSLDDFLHEHGEG------------------------------------------------- 404 (603)
Q Consensus 375 ~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------- 404 (603)
++...+. .++||||+++|+|.+++......
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 9887654 89999999999999999765321
Q ss_pred -------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc-c
Q 007455 405 -------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA-H 470 (603)
Q Consensus 405 -------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~-~ 470 (603)
...+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....... .
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 12288999999999999999999999 899999999999999999999999999987644322 2
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......||+.|+|||++.+..++.++||||||+++|||++ |+.||...... .......... ....
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~~~--------~~~~ 316 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEG--------TRMR 316 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS------HHHHHHHHHT--------CCCC
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh------HHHHHHHHcC--------CCCC
Confidence 3344668899999999998999999999999999999998 99998653211 0111111111 1111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.+...+.++.+++.+||+.+|++|||++|+++.|++..
T Consensus 317 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 317 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 22334567999999999999999999999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=347.54 Aligned_cols=253 Identities=21% Similarity=0.390 Sum_probs=204.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC--------EEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG--------TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~--------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
++|.+.+.||+|+||.||+|.+..++ .||+|.+........+.+.+|+.++++++||||+++++++..++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 57888899999999999999876533 5999999776666677899999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC--------eE
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE--------PH 454 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--------~k 454 (603)
++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++. +|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceee
Confidence 99999999999999998643 2388999999999999999999999 8999999999999998887 99
Q ss_pred EeecccccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH
Q 007455 455 VSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 455 l~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
|+|||++...... ....|++.|+|||++.+ ..++.++||||+|+++|||++|..|+..... ........
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-----~~~~~~~~ 231 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-----SQRKLQFY 231 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----HHHHHHHH
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-----hHHHHHHh
Confidence 9999998765332 23457889999999987 6789999999999999999996655432211 11111111
Q ss_pred hhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCC
Q 007455 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590 (603)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 590 (603)
... ...+...+.++.+++.+||+.||++|||++|+++.|+++..+.
T Consensus 232 ~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 232 EDR-----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp HTT-----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred hcc-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 000 0111122346889999999999999999999999999876443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=364.42 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=206.4
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
..++|++.++||+|+||+||+|.+.+++ .||+|++.+.. ......+.+|+.++..++||||+++++++.+.+..|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 3578999999999999999999998654 59999985421 1122347899999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 152 V~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp EECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 999999999999998632 2389999999999999999999999 8999999999999999999999999999877
Q ss_pred CCCCcceeecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
............||+.|+|||++. ...++.++||||+||++|||++|+.||..... ...........
T Consensus 226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~~~-- 297 (437)
T 4aw2_A 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHK-- 297 (437)
T ss_dssp CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHH--
T ss_pred ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh------hHHHHhhhhcc--
Confidence 655554455578999999999986 45789999999999999999999999975321 11111111100
Q ss_pred hhhhcccCCCcCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007455 540 EDVIDKRCADADMETVEAILEIAARCTDANPDD--RPSMNQVLQ 581 (603)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~ 581 (603)
.....+......+.++.+|+.+||..+|++ ||+++|+++
T Consensus 298 ---~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 298 ---ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ---HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ---ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 000111111234567999999999888888 999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=355.59 Aligned_cols=250 Identities=27% Similarity=0.397 Sum_probs=204.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+..+ ..||+|++... .....+.+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46788999999999999999998754 56999998542 223346688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+.+|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHHTTCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999986433 89999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQS---GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... .......
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---~~~~~~~---------- 231 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS---SKEIVHT---------- 231 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC---HHHHHHH----------
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc---HHHHHHH----------
Confidence 432 2345679999999999863 458899999999999999999999997532211 1111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPS-MNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~ 581 (603)
+.......+...+.++.+++.+||+.+|++||+ ++++++
T Consensus 232 ~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 232 FETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 111122233445678999999999999999998 777764
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=339.93 Aligned_cols=260 Identities=17% Similarity=0.214 Sum_probs=207.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||.||+|.+. ++..||||++..... ...+.+|+.+++.+ +|+|++++++++......++||||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 87 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 87 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence 46888999999999999999975 455799998864432 23478899999999 799999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC-----eEEeecccccc
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE-----PHVSDFGLAKL 463 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG~~~~ 463 (603)
+ +++|.+++...+. .+++..++.++.|+++||+|||++ +|+||||||+||+++.++. +||+|||+++.
T Consensus 88 ~-~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 88 L-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9 8999999986432 389999999999999999999998 8999999999999988776 99999999987
Q ss_pred cCCCCcc------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 464 LVDEEAH------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 464 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543321 2344669999999999999899999999999999999999999997643211111111111111111
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.... .....+.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 241 ~~~~--------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~ 282 (298)
T 1csn_A 241 PLRE--------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 282 (298)
T ss_dssp CHHH--------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cHHH--------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence 1111 11123467999999999999999999999999998755
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=346.86 Aligned_cols=259 Identities=15% Similarity=0.194 Sum_probs=205.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||.||+|.+. ++..||||.+..... ...+.+|+++++++ +||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 46888999999999999999985 455699999865432 23488999999999 999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC-----eEEeecccccc
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE-----PHVSDFGLAKL 463 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-----~kl~DfG~~~~ 463 (603)
+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 87 L-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred C-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9 899999998642 2389999999999999999999999 8999999999999999887 99999999987
Q ss_pred cCCCCcc------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 464 LVDEEAH------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 464 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 6543321 1245679999999999999999999999999999999999999997642211111111111100000
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
... . .....+ ++.+++..||+.+|.+||+++++.+.|++..
T Consensus 240 ~~~----~----~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 240 PIE----V----LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp CHH----H----HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CHH----H----HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000 0 001123 7999999999999999999999999988654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=351.59 Aligned_cols=245 Identities=22% Similarity=0.300 Sum_probs=205.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+.. +..||+|++.... ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 4678899999999999999999874 5679999985432 23345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++...+. +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EcCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999987543 89999999999999999999999 89999999999999999999999999998764
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. .....||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ..........
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~~--------- 253 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIVSG--------- 253 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHC---------
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH------HHHHHHHHcC---------
Confidence 33 2345799999999999988999999999999999999999999975321 1111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
....+...+.++.+++.+||+.||++||+ ++|+++
T Consensus 254 -~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 254 -KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11123345577999999999999999998 888875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=342.32 Aligned_cols=257 Identities=30% Similarity=0.447 Sum_probs=213.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++|++.+.||+|+||.||+|.+.+ +..||+|.+.... ...+.+.+|++++++++||||+++++++......++||||
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 90 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 90 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEc
Confidence 4678888999999999999999986 4569999986543 3456789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++..... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 91 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred CCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999986432 3489999999999999999999999 89999999999999999999999999998876555
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
........+++.|+|||.+.+..++.++||||+|+++|+|++ |..||...... .. ....... ..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~---~~~~~~~---------~~ 230 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QV---YELLEKD---------YR 230 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GH---HHHHHTT---------CC
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HH---HHHHhcc---------CC
Confidence 444555667889999999998899999999999999999999 89998653211 11 1111111 11
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
...+...+..+.+++.+||..||++|||++|+++.|++..
T Consensus 231 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 231 MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 1223344567999999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=351.76 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=203.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.++|++.+.||+|+||.||+|.+.. +..||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4678999999999999999999874 567999999654332 2356889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC---CeEEeecccccc
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL---EPHVSDFGLAKL 463 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~~~~ 463 (603)
||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~~~----~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE----FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTCS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 9999999999887643 389999999999999999999999 899999999999998654 599999999987
Q ss_pred cCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........ ......
T Consensus 181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~-~~~~~~-- 249 (362)
T 2bdw_A 181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIK-AGAYDY-- 249 (362)
T ss_dssp CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HTCCCC--
T ss_pred ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-hCCCCC--
Confidence 654322 2345799999999999988999999999999999999999999965321 11111111 111000
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+.++.+++.+||..||++|||+.|+++
T Consensus 250 ---~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 ---PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ---CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00011234567999999999999999999999985
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=342.63 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=199.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||.||+|.+..+..||+|++..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57888999999999999999998788999999965432 2246688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++ +|.+++..... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 986 89888875422 388999999999999999999999 89999999999999999999999999998764322
Q ss_pred cceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC---cchhh--
Q 007455 469 AHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN---RLEDV-- 542 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 542 (603)
. ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... ............. .+...
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA---DQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHHCCCChhhchhhhc
Confidence 2 2234568999999999865 45899999999999999999999999753211 0100010100000 00000
Q ss_pred ---hcccCC--------CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 ---IDKRCA--------DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ---~~~~~~--------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.++... ......+.++.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 011234567899999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=347.36 Aligned_cols=248 Identities=26% Similarity=0.343 Sum_probs=195.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEE----CCCCEEEEEEeCCCC----CChHHHHHHHHHHHhhCCCCeeeecceeeecCCc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVM----NDCGTFAVKRIDRSR----EGSDQVFERELEILGSIKHINLVNLRGYCRLPAT 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 381 (603)
.++|++.+.||+|+||.||+|.+ ..+..||+|+++... ......+.+|+.+++.++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46788999999999999999998 366789999997542 2233457889999999999999999999999999
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.++||||+++|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREGI----FMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhCCC----CCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999986543 88999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
+...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ..........
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~~----- 236 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR------KKTIDKILKC----- 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHT-----
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhC-----
Confidence 7643322 223446799999999999988899999999999999999999999975321 1111111111
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
....+...+.++.+++.+||+.+|++|| +++|+++
T Consensus 237 -----~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 237 -----KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred -----CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 1112233456799999999999999999 7888875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=349.58 Aligned_cols=255 Identities=21% Similarity=0.319 Sum_probs=203.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCC---hHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREG---SDQVFERELEILGSI-KHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 384 (603)
.++|++.+.||+|+||.||+|.+..+ +.||+|++...... ..+.+.+|..++.++ +||||+++++++...+..|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 46788899999999999999998754 46999999754322 234578999999988 89999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 88 v~e~~~gg~L~~~l~~~~~----l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp EECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EEeCCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999986543 89999999999999999999999 8999999999999999999999999999864
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCc--cHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL--NVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 542 (603)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......... ............
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~------ 233 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE------ 233 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH------
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc------
Confidence 3222 2234567999999999999989999999999999999999999999653211100 111111111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSM------NQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~------~evl~ 581 (603)
.....+...+.++.+++.+||+.||++||++ +|+++
T Consensus 234 ---~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 234 ---KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 1112233455679999999999999999995 67663
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=353.69 Aligned_cols=252 Identities=24% Similarity=0.323 Sum_probs=206.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.+.|++.+.||+|+||.||+|.+.. +..+|+|.+..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 4678999999999999999999874 557999998765544556789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC--CCCeEEeecccccccCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE--NLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~~~~~~~ 466 (603)
+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 130 ~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999987543 2389999999999999999999999 8999999999999974 47799999999987754
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........... .. .
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~------~~~~~~i~~~~-~~--~--- 269 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCD-WE--F--- 269 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCC-CC--C---
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-CC--C---
Confidence 432 2345699999999999988999999999999999999999999975321 11111111110 00 0
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+.++.+++.+||..||++|||++|+++
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 01112234567999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=348.57 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=205.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEE-----CCCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecC--Ccc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVM-----NDCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLP--ATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 382 (603)
+.|++.+.||+|+||.||+|.+ ..+..||+|++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 245679999997543 23346789999999999999999999999876 668
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++||||+++|+|.+++..... .+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN---KINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999965432 389999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCcc--eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccccc--------CCccHhHHHHH
Q 007455 463 LLVDEEAH--VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVK--------RGLNVVGWMNT 532 (603)
Q Consensus 463 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~--------~~~~~~~~~~~ 532 (603)
........ ......||..|+|||++.+..++.++||||+|+++|||++|..|+...... ...........
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 77554332 223456888899999999888999999999999999999999986432110 00000000000
Q ss_pred HhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
. .........+...+.++.+++.+||+.||++|||++|+++.|+++
T Consensus 255 ~--------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 255 T--------LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp H--------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred H--------HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 0 011111122334567899999999999999999999999999874
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=349.57 Aligned_cols=265 Identities=28% Similarity=0.441 Sum_probs=209.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSR-EGSDQVFERELEILGSI-KHINLVNLRGYCRLPAT 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 381 (603)
.++|++.+.||+|+||.||+|.+. .+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 468889999999999999999972 23469999997542 23346789999999999 89999999999999999
Q ss_pred cEEEEEecCCCCccccccccCCC-------------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEG-------------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKS 442 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 442 (603)
.++||||+++|+|.+++...... ...+++..++.++.|++.||+|||++ +|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 99999999999999999765321 13478999999999999999999999 899999999
Q ss_pred CCeEECCCCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccc
Q 007455 443 SNILLDENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFV 520 (603)
Q Consensus 443 ~NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~ 520 (603)
+||+++.++.+||+|||++......... ......||+.|+|||++.+..++.++||||||+++|||+| |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 9999999999999999999876543322 2334557889999999988899999999999999999998 9999865321
Q ss_pred cCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCC
Q 007455 521 KRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPC 591 (603)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 591 (603)
. .......... .....+...+.++.+++.+||+.||.+|||++|+++.|+.......
T Consensus 281 ~------~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 281 D------ANFYKLIQNG--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp S------HHHHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred H------HHHHHHHhcC--------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 1 0111111111 0111223345679999999999999999999999999998765443
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=350.20 Aligned_cols=275 Identities=19% Similarity=0.245 Sum_probs=207.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC----CCEEEEEEeCCCCCCh-----------HHHHHHHHHHHhhCCCCeeeeccee
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND----CGTFAVKRIDRSREGS-----------DQVFERELEILGSIKHINLVNLRGY 375 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~~ 375 (603)
++|.+.+.||+|+||.||+|.+.. +..+|+|++....... ...+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 568889999999999999999874 4569999986543221 1236678889999999999999999
Q ss_pred eec----CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC
Q 007455 376 CRL----PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL 451 (603)
Q Consensus 376 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 451 (603)
+.. ....++||||+ +++|.+++...+ .+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCC
Confidence 887 67889999999 899999998754 389999999999999999999999 899999999999998887
Q ss_pred --CeEEeecccccccCCCCcc------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCC
Q 007455 452 --EPHVSDFGLAKLLVDEEAH------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG 523 (603)
Q Consensus 452 --~~kl~DfG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~ 523 (603)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-- 266 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD-- 266 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC--
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc--
Confidence 9999999999876433211 113456899999999999888999999999999999999999999642111
Q ss_pred ccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCCCcccccc
Q 007455 524 LNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYES 598 (603)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~~~ 598 (603)
.............. ....+....+ ....+.++.+++.+||+.+|++|||++++++.|++...+..+.+|...
T Consensus 267 ~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d~~~~ 338 (345)
T 2v62_A 267 PVAVQTAKTNLLDE-LPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLDFSTK 338 (345)
T ss_dssp HHHHHHHHHHHHHT-TTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCCCCCT
T ss_pred cHHHHHHHHhhccc-ccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCCcccC
Confidence 11111111111111 1111111111 113446799999999999999999999999999998887777776654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=372.75 Aligned_cols=258 Identities=31% Similarity=0.461 Sum_probs=211.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.++|++.+.||+|+||.||+|.+.++..||||+++.... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 457888899999999999999999888899999976543 45679999999999999999999999876 6789999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++.... ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 344 ~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 344 SKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp TTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred cCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999997532 12388999999999999999999999 899999999999999999999999999987654322
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.......++..|+|||++....++.++||||||+++|||++ |+.||..... ........... ..
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~------~~~~~~i~~~~---------~~ 483 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN------REVLDQVERGY---------RM 483 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH------HHHHHHHHTTC---------CC
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCC---------CC
Confidence 22233446788999999998899999999999999999999 8999864321 11111111111 11
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
..+...+.++.+|+.+||+.+|++|||++++++.|++....
T Consensus 484 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 12234556799999999999999999999999999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=350.11 Aligned_cols=249 Identities=22% Similarity=0.319 Sum_probs=204.5
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCC---CCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRS---REGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 383 (603)
..++|++.+.||+|+||.||+|.+..+ ..||+|++... .....+.+.+|..++..+ +||||+++++++...+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 457899999999999999999999864 45999998643 223345688999999988 7999999999999999999
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+++|+|.+++...+. +++..++.++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999986543 89999999999999999999999 899999999999999999999999999986
Q ss_pred cCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
..... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... .........
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~-------- 235 (353)
T 2i0e_A 171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIME-------- 235 (353)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH--------
T ss_pred cccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH------HHHHHHHHh--------
Confidence 43222 223456799999999999988999999999999999999999999975321 111111111
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
.....+...+.++.+++.+||..||++||+ ++|+++
T Consensus 236 --~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 236 --HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred --CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 111223345578999999999999999995 577764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=339.76 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=203.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC----EEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
.++|.+.+.||+|+||.||+|.+.+.. .||+|.+..... ...+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 467888999999999999999865322 499999875432 234678999999999999999999999865 45789
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++++|.+++..... .+++..++.++.|+++||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKN---SLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHHTT---TCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhccc---cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 9999999999999976432 388999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
............+++.|+|||++.+..++.++||||||+++|||++ |+.||...... ... ......
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~---~~~~~~------- 230 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVI---GVLEKG------- 230 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHH---HHHHHT-------
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHH---HHHhcC-------
Confidence 5544333444567889999999998899999999999999999998 99998643211 111 111111
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.....+...+..+.+++.+||+.+|++|||++|+++.|++..
T Consensus 231 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 231 --DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 111122234567999999999999999999999999998753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=352.75 Aligned_cols=266 Identities=28% Similarity=0.444 Sum_probs=198.8
Q ss_pred CCCCCCeeeecCCeEEEEEEECC--CC--EEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeec-CCccEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND--CG--TFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRL-PATKLLI 385 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv 385 (603)
.|++.+.||+|+||.||+|.+.+ +. .+|+|.+..... ...+.+.+|+.++++++||||+++++++.. ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 35567899999999999998743 22 489998865433 344678999999999999999999998754 5678999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++..... .+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999976432 378899999999999999999999 89999999999999999999999999998664
Q ss_pred CCCcc---eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 466 DEEAH---VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 466 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |..||..... ..... .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~---~~~~~---~~~~~----- 312 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITV---YLLQG----- 312 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS---SCHHH---HHHTT-----
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH---HHHHH---HHHcC-----
Confidence 43221 1233457789999999999999999999999999999999 5666654321 11111 11111
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCCCcccccc
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYES 598 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~~~ 598 (603)
.....+...+..+.+++.+||+.+|++|||++|+++.|+++......+.|...
T Consensus 313 ----~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~~~~ 365 (373)
T 3c1x_A 313 ----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHV 365 (373)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCBCCC
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccceeec
Confidence 11112234456799999999999999999999999999987755555544433
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=361.82 Aligned_cols=253 Identities=21% Similarity=0.293 Sum_probs=205.2
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
..++|++.+.||+|+||.||+|.+.. +..||+|++.+. .....+.+.+|+.+++.++||||+++++++.++...|+
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 45789999999999999999999875 456999998542 11222347899999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++.... +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 147 V~E~~~gg~L~~~l~~~~-----~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~ 218 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSNYD-----VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218 (410)
T ss_dssp EECCCTTEEHHHHHHHCC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeCCCCCcHHHHHHcCC-----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEee
Confidence 999999999999987532 88999999999999999999999 8999999999999999999999999999877
Q ss_pred CCCCcceeecccccccccCccccccCC----CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGR----ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
............||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ......+.....
T Consensus 219 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~-- 290 (410)
T 3v8s_A 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKN-- 290 (410)
T ss_dssp CTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHHH--
T ss_pred ccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh------hhHHHHHHhccc--
Confidence 655444445678999999999997655 78899999999999999999999975321 111111111100
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDD--RPSMNQVLQ 581 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~--RPs~~evl~ 581 (603)
....+ .....+.++.+|+.+||..+|.+ ||+++|+++
T Consensus 291 ---~~~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 291 ---SLTFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ---HCCCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ---cccCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 00011 11134567999999999999988 999999996
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=334.56 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=204.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecC--CccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLP--ATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+. +..+|||++...... ..+.+.+|+.++++++||||+++++++... ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467888999999999999999986 578999999765432 345689999999999999999999999877 778999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK--IIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
|||+++|+|.+++..... ..+++..++.++.|++.||+|||++ + ++||||||+||+++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 999999999999986432 3489999999999999999999998 7 99999999999999999999999998765
Q ss_pred cCCCCcceeecccccccccCccccccCCCCc---ccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATE---KSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||..... ..........
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~---- 226 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALE---- 226 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHS----
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhc----
Confidence 332 2245899999999998665544 79999999999999999999964321 1111111111
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
...+..+...+.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 227 ----GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp ----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111223345567999999999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=349.58 Aligned_cols=256 Identities=27% Similarity=0.428 Sum_probs=202.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-----EEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|++.+.||+|+||.||+|.+..++ .||+|.+.... ......+.+|+.++++++||||+++++++. ....++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56788899999999999999986544 27888875432 223345778999999999999999999886 466899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 999999999999997642 2388899999999999999999999 8999999999999999999999999999877
Q ss_pred CCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
...... ......|+..|+|||++.+..++.++||||||+++|||++ |+.||...... ... .. ....
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~---~~-~~~~----- 233 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVP---DL-LEKG----- 233 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHH---HH-HHTT-----
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHH---HH-HHcC-----
Confidence 544322 2344567889999999998899999999999999999999 99999753211 111 11 1111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
.....+...+.++.+++.+||+.+|++|||++|+++.|+++..
T Consensus 234 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 ---ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111122234568899999999999999999999999988653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=338.92 Aligned_cols=258 Identities=29% Similarity=0.456 Sum_probs=201.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC----EEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceee-ecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYC-RLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 384 (603)
.+|++.+.||+|+||.||+|.+.++. .+|+|.+...... ..+.+.+|+.++++++||||+++++++ ..++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 45777899999999999999975432 4899988754332 345688999999999999999999986 45567899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997533 2378999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCc---ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCC-CCCcccccCCccHhHHHHHHhhhCcch
Q 007455 465 VDEEA---HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKR-PTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 465 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
..... .......+|+.|+|||.+.+..++.++||||+|+++|||++|.. ||..... ... ......
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~---~~~~~~----- 247 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDI---TVYLLQ----- 247 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TTH---HHHHHT-----
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HHH---HHHHhc-----
Confidence 54322 12234557789999999998899999999999999999999554 5443211 111 111111
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
......+...+..+.+++.+||+.+|++|||++|+++.|+++...
T Consensus 248 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 248 ----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111112233456799999999999999999999999999986543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=335.27 Aligned_cols=246 Identities=22% Similarity=0.271 Sum_probs=204.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++|++.+.||+|+||.||+|.+..++ .+|+|++........+.+.+|++++++++||||+++++++......++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457888999999999999999987644 6999999776556677899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE---CCCCCeEEeecccccccC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~~~~ 465 (603)
+++++|.+++..... +++..++.++.|++.||+|||++ +++||||||+||++ +.++.++|+|||++....
T Consensus 88 ~~~~~L~~~~~~~~~----~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHKRV----FRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999998876543 89999999999999999999999 89999999999999 788999999999998765
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.... .....||+.|+|||.+.+ .++.++||||+|+++|||++|+.||..... ......... .
T Consensus 161 ~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~-~-------- 222 (277)
T 3f3z_A 161 PGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD------SEVMLKIRE-G-------- 222 (277)
T ss_dssp TTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-C--------
T ss_pred Cccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHh-C--------
Confidence 4332 234568999999999875 489999999999999999999999965321 111111111 1
Q ss_pred cCCCcCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADM----ETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+. ..+..+.+++.+||+.||++|||+.|+++
T Consensus 223 -~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 -TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp -CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 23567999999999999999999999985
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=339.30 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=196.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||.||+|.+.+ .+|+|+++..... ..+.+.+|++++++++||||+++++++ .....++||||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~ 100 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 100 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEEC
T ss_pred cceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEe
Confidence 578899999999999999998754 6999999755433 235689999999999999999999965 55678999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 101 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 101 CEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred cCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccccccc
Confidence 99999999986543 2389999999999999999999999 89999999999999999999999999997654321
Q ss_pred -cceeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 469 -AHVTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 469 -~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
........||+.|+|||.+. +..++.++||||+|+++|||++|+.||..... . ............ .
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~-~~~~~~~~~~~~----~ 244 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-----R-DQIIEMVGRGSL----S 244 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----H-HHHHHHHHHTSC----C
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-----H-HHHHHHhccccc----C
Confidence 22233456899999999986 56788899999999999999999999965321 1 111111111111 1
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..........+.++.+++.+||+.+|++|||++|+++.|+++.
T Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 1112223345578999999999999999999999999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=342.20 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=200.2
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG---SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
..++|++.+.||+|+||.||+|.+.. +..||+|.+...... ..+.+.+|+.++++++||||+++++++...+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 46789999999999999999999874 556999998654322 23568899999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++++|.+++..... +++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EEECCCCEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEEecCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999986543 89999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
............|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...........
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~----- 252 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP----- 252 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC-----
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC-----
Confidence 554333344566899999999999889999999999999999999999999753211 11111111100
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhcccCC
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRP-SMNQVLQLLEQEVMSP 590 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~~ 590 (603)
.....+...+.++.+++.+||+.||++|| +++++++.|++.....
T Consensus 253 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 253 -RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 00011223445799999999999999999 9999999999865443
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=337.59 Aligned_cols=258 Identities=21% Similarity=0.346 Sum_probs=199.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|++.+.||+|+||+||+|.+.. +..||+|++..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 578889999999999999999875 56799999965432 334678899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++ ++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9987 5555554422 2389999999999999999999999 8999999999999999999999999999876433
Q ss_pred CcceeecccccccccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh---hC---cch
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGR-ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK---EN---RLE 540 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~ 540 (603)
.. ......||+.|+|||++.+.. ++.++||||+|+++|||++|+.||.... ........... .. .+.
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~-----~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----SHHHHHHHHHHHHCCCCTTTCT
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC-----CHHHHHHHHHHHhCCCChhhhh
Confidence 22 234456899999999987665 7999999999999999999998864321 11111111111 00 000
Q ss_pred hhh-------------cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 DVI-------------DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ~~~-------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... ...........+.++.+++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 00001112234567899999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=343.24 Aligned_cols=265 Identities=24% Similarity=0.329 Sum_probs=207.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeee----cCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCR----LPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv 385 (603)
++|++.+.||+|+||.||+|.+. ++..||||++........+.+.+|+++++.++||||+++++++. .....++|
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 57888999999999999999985 56679999986655555677899999999999999999999986 33467899
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++.........+++..++.++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999987444445589999999999999999999999 89999999999999999999999999987653
Q ss_pred CCCcc--------eeecccccccccCccccccCC---CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 466 DEEAH--------VTTVVAGTFGYLAPEYLQSGR---ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 466 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
..... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||........ .... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~~ 260 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----AV 260 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----HH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----Hh
Confidence 21110 012245789999999987543 68899999999999999999999864221111 1100 00
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCC
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPC 591 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 591 (603)
.. ..........+.++.+++.+||+.||.+|||++++++.|+.+..++.
T Consensus 261 ~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~ 309 (317)
T 2buj_A 261 QN--------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP 309 (317)
T ss_dssp HC--------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred hc--------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence 00 00011122345679999999999999999999999999998764443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=347.19 Aligned_cols=261 Identities=28% Similarity=0.421 Sum_probs=210.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC--------CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhC-CCCeeeecceeeecC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN--------DCGTFAVKRIDRSRE-GSDQVFERELEILGSI-KHINLVNLRGYCRLP 379 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 379 (603)
.++|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 367888999999999999999974 345699999875432 2345688999999999 899999999999999
Q ss_pred CccEEEEEecCCCCccccccccCCC------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHGEG------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL 447 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 447 (603)
+..++||||+++|+|.+++...... ...+++..++.++.|+++||.|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 9999999999999999999865421 23488999999999999999999999 89999999999999
Q ss_pred CCCCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCcc
Q 007455 448 DENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLN 525 (603)
Q Consensus 448 ~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~ 525 (603)
+.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------ 264 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 264 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC------
Confidence 99999999999999876543322 2233457789999999988889999999999999999999 999986432
Q ss_pred HhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
........... .....+...+.++.+++.+||+.+|.+|||++|+++.|+++..
T Consensus 265 ~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 265 VEELFKLLKEG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11111111111 1111223445679999999999999999999999999998654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=336.50 Aligned_cols=265 Identities=24% Similarity=0.384 Sum_probs=212.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+..++ .||+|.+... .......+.+|+++++.++||||+++++++...+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467888999999999999999987544 6999998543 223346789999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++..... +++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGR----FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999987543 89999999999999999999998 89999999999999999999999999987654
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
... .....|++.|+|||++.+..++.++||||+|+++|||++|+.||..... .........
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~---------- 226 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH------TETHRRIVN---------- 226 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHT----------
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH------hHHHHHHhc----------
Confidence 322 2345689999999999988899999999999999999999999975321 111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcccCCCCcccccccC
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQEVMSPCPSDFYESHS 600 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~~~~~~~~~~~~~~ 600 (603)
.....+...+.++.+++.+||+.+|.+|||++|+++ .+.+......|+.+...++
T Consensus 227 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~~~~~~~ 283 (284)
T 2vgo_A 227 VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQSTQS 283 (284)
T ss_dssp TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCCC-----
T ss_pred cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCccccCCC
Confidence 011122334567999999999999999999999996 6666555555555555443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=336.41 Aligned_cols=252 Identities=27% Similarity=0.521 Sum_probs=201.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChH-------HHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSD-------QVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
++|++.+.||+|+||.||+|.+. ++..||+|++........ +.+.+|++++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 57888899999999999999986 556799999865432221 56899999999999999999999986554
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCCeEECCCCC-----eEE
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK--IIHRDIKSSNILLDENLE-----PHV 455 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~-----~kl 455 (603)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ + ++||||||+||+++.++. +||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 79999999999998886543 2489999999999999999999998 7 999999999999988876 999
Q ss_pred eecccccccCCCCcceeecccccccccCcccc--ccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH
Q 007455 456 SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL--QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 456 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
+|||+++.... ......||+.|+|||++ ....++.++||||+|+++|||++|+.||..... ....+....
T Consensus 171 ~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~ 242 (287)
T 4f0f_A 171 ADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY----GKIKFINMI 242 (287)
T ss_dssp CCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC----CHHHHHHHH
T ss_pred CCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc----cHHHHHHHH
Confidence 99999975433 23445689999999998 345578899999999999999999999975321 111111111
Q ss_pred hhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
.. .. .....+...+.++.+++.+||+.||++|||++|+++.|+++
T Consensus 243 ~~-~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 RE-EG-------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HH-SC-------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hc-cC-------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 11 11112334456899999999999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=342.99 Aligned_cols=261 Identities=29% Similarity=0.470 Sum_probs=210.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecCCc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLPAT 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 381 (603)
.++|++.+.||+|+||.||+|.+. .+..||+|.+...... ..+.+.+|+.+++++ +||||+++++++..++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 357888999999999999999862 3346999999755432 346789999999999 89999999999999999
Q ss_pred cEEEEEecCCCCccccccccCCC--------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEG--------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL 447 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 447 (603)
.++||||+++|+|.+++...... ...+++..++.++.|+++||.|||++ +++||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 99999999999999999865421 23489999999999999999999999 89999999999999
Q ss_pred CCCCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCcc
Q 007455 448 DENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLN 525 (603)
Q Consensus 448 ~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~ 525 (603)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---- 254 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---- 254 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS----
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch----
Confidence 99999999999999876554332 2234557889999999988899999999999999999999 99998653211
Q ss_pred HhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
........... ....+...+.++.+++.+||+.||.+|||++|+++.|++..
T Consensus 255 --~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 255 --SKFYKMIKEGF--------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp --HHHHHHHHHTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --hHHHHHhccCC--------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 01111111110 01112334567999999999999999999999999998865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=340.96 Aligned_cols=254 Identities=28% Similarity=0.458 Sum_probs=197.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 56788899999999999999986 478999998643 34567899999999999999999999886 45899999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC-eEEeecccccccCCCCc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE-PHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~-~kl~DfG~~~~~~~~~~ 469 (603)
+|+|.+++..... ...+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 9999999986532 233788999999999999999999932228999999999999998887 799999999765332
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ............ ..+.
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~---------~~~~ 224 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG----PAFRIMWAVHNG---------TRPP 224 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS----SHHHHHHHHHTT---------CCCC
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc----cHHHHHHHHhcC---------CCCC
Confidence 2234589999999999988999999999999999999999999964311 111111111110 1111
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.....+..+.+++.+||+.+|++|||++|+++.|++..
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 22234567999999999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=350.64 Aligned_cols=271 Identities=28% Similarity=0.402 Sum_probs=209.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEE-----CCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeee--cCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVM-----NDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCR--LPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 383 (603)
++|++.+.||+|+||.||+|.+ ..+..||||++........+.+.+|++++++++||||+++++++. .....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999984 245569999997765555667999999999999999999999886 445688
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+++|+|.+++..... .+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 103 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEeecCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccccee
Confidence 99999999999999976432 389999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcc--eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 464 LVDEEAH--VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 464 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .....+...........+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF-LRMMGCERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHCC----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh-hhhcccccccccHHHHHH
Confidence 6543322 2233457888999999998889999999999999999999999986432100 000000000000000011
Q ss_pred hh-cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 542 VI-DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 542 ~~-~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
.+ .......+...+.++.+++.+||+.||++|||++|+++.|+....
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11 111122334556789999999999999999999999999998653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=344.56 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=200.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-----EEEEEEeCCC-CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRS-REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|++.+.||+|+||.||+|.+..++ +|++|.+... .....+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57888999999999999999986443 3688877543 3345677999999999999999999999998754 789
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
|+||+.+|+|.+++..... .+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 94 v~~~~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHKD---NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EECCCSSCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEecCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 9999999999999986432 389999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ... ...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~---~~~-~~~------ 234 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EI---SSI-LEK------ 234 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GH---HHH-HHT------
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HH---HHH-HHc------
Confidence 543222 2233456788999999999999999999999999999999 99999754221 11 111 111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
......+...+.++.+++.+||+.||++|||++|+++.|+++...
T Consensus 235 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 235 --GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp --TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred --CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 111122334556799999999999999999999999999987643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=360.28 Aligned_cols=251 Identities=23% Similarity=0.402 Sum_probs=206.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
..+|.+.+.||+|+||.||+|.+. .+..||||++.... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888999999999999999987 56679999986432 22345689999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++...+. +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 95 ~E~~~gg~L~~~l~~~~~----l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGR----LDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTSSSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999976443 89999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
... ......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||..... .........
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~------~~~~~~i~~--------- 230 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV------PTLFKKICD--------- 230 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS------HHHHHHHHT---------
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH------HHHHHHHhc---------
Confidence 433 2334579999999999987765 6899999999999999999999975321 111111111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQ 585 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~ 585 (603)
.....+...+.++.+++.+||+.||++|||++|+++ .+.+
T Consensus 231 -~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 231 -GIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp -TCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred -CCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 111122334567999999999999999999999996 4544
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=337.56 Aligned_cols=246 Identities=28% Similarity=0.449 Sum_probs=201.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+++|++.+.||+|+||.||+|.+..++ .||+|++.... ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 567889999999999999999987654 69999985422 22345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++..... +++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999986543 89999999999999999999998 89999999999999999999999999986543
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
... .....|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ........ .
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~----------~ 221 (279)
T 3fdn_A 161 SSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRIS----------R 221 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHH----------H
T ss_pred ccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH------HHHHHHHH----------h
Confidence 322 2345689999999999988999999999999999999999999975321 11111111 1
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+...+..+.+++.+||+.+|++|||++|+++
T Consensus 222 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 222 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111122334567899999999999999999999996
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=351.58 Aligned_cols=266 Identities=18% Similarity=0.246 Sum_probs=203.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC------CEEEEEEeCCCCCChH-----------HHHHHHHHHHhhCCCCeeeec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC------GTFAVKRIDRSREGSD-----------QVFERELEILGSIKHINLVNL 372 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l 372 (603)
.++|++.+.||+|+||.||+|.+..+ ..||||++........ ..+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 35788899999999999999998764 4699999865432111 123345666777889999999
Q ss_pred ceeeecC----CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC
Q 007455 373 RGYCRLP----ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD 448 (603)
Q Consensus 373 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 448 (603)
++++... ...++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEe
Confidence 9998764 4479999999 999999998642 2389999999999999999999999 899999999999999
Q ss_pred --CCCCeEEeecccccccCCCCcce------eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccc
Q 007455 449 --ENLEPHVSDFGLAKLLVDEEAHV------TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFV 520 (603)
Q Consensus 449 --~~~~~kl~DfG~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~ 520 (603)
.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765432211 1334599999999999998999999999999999999999999975321
Q ss_pred cCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 521 KRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
. .....+..... ...+...++..... ...+.++.+++..||+.+|++||+++++++.|++..
T Consensus 267 ~--~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~ 328 (364)
T 3op5_A 267 D--PKYVRDSKIRY-RENIASLMDKCFPA--ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL 328 (364)
T ss_dssp C--HHHHHHHHHHH-HHCHHHHHHHHSCT--TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred C--HHHHHHHHHHh-hhhHHHHHHHhccc--ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence 1 11121222111 11233333322211 123467999999999999999999999999988754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=346.66 Aligned_cols=262 Identities=23% Similarity=0.257 Sum_probs=202.1
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC-----CCChHHHHHHHHHHHhhCCCCeeeecceeeec
Q 007455 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS-----REGSDQVFERELEILGSIKHINLVNLRGYCRL 378 (603)
Q Consensus 305 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 378 (603)
++.+..++|++.+.||+|+||.||+|.+.. +..||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 455667889999999999999999999864 456999988543 23445679999999999999999999999999
Q ss_pred CCccEEEEEecCCCCccccccccCCC------------------------------------CccCCHHHHHHHHHHHHH
Q 007455 379 PATKLLIYDYLSMGSLDDFLHEHGEG------------------------------------QQLLNWSARLKIALGSAR 422 (603)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~ 422 (603)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998631110 112457778899999999
Q ss_pred HHHHHHhCCCCCeEEecCCCCCeEECCCC--CeEEeecccccccCCCCc---ceeecccccccccCcccccc--CCCCcc
Q 007455 423 GLAYLHHDCCPKIIHRDIKSSNILLDENL--EPHVSDFGLAKLLVDEEA---HVTTVVAGTFGYLAPEYLQS--GRATEK 495 (603)
Q Consensus 423 ~L~~LH~~~~~~ivH~Dlkp~NIll~~~~--~~kl~DfG~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~ 495 (603)
||+|||+. +|+||||||+||+++.++ .+||+|||+++.+..... .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 899999999999998776 899999999986643221 12345669999999999865 678899
Q ss_pred cchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC
Q 007455 496 SDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPS 575 (603)
Q Consensus 496 ~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs 575 (603)
+||||||+++|||++|+.||..... .............. ........+.++.+++.+||+.+|++|||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND------ADTISQVLNKKLCF------ENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCCCT------TSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh------HHHHHHHHhccccc------CCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 9999999999999999999965321 11111111111000 00011124567999999999999999999
Q ss_pred HHHHHH
Q 007455 576 MNQVLQ 581 (603)
Q Consensus 576 ~~evl~ 581 (603)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999987
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=362.83 Aligned_cols=248 Identities=20% Similarity=0.274 Sum_probs=195.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+.. +..||||++... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 4678899999999999999999874 557999998642 223334578899999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH-DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
|||+++|+|.+++..... +++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERV----FSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999976543 8999999999999999999998 6 8999999999999999999999999999864
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .........
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~------~~~~~~i~~--------- 363 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------EKLFELILM--------- 363 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH---------
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH------HHHHHHHHh---------
Confidence 3322 223446799999999999999999999999999999999999999965321 111111111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
.....+...+.++.+++.+||+.||++|| +++|+++
T Consensus 364 -~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 364 -EEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 11112334456799999999999999999 9999985
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=344.46 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=200.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-----EEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|+..+.||+|+||.||+|.+..+. .||+|.+...... ....+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 45667789999999999999876432 4999999754332 34568899999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 124 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp EEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 999999999999997642 2389999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCcc--eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 465 VDEEAH--VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 465 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ..........
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~~~~~~----- 266 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN------HEVMKAINDG----- 266 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT-----
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH------HHHHHHHHCC-----
Confidence 543221 1223346788999999998899999999999999999999 9999864321 1111111111
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
.....+...+..+.+++.+||+.+|++||+++++++.|++...
T Consensus 267 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 267 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111233455679999999999999999999999999987653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=338.05 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=206.3
Q ss_pred hCCCCCC-eeeecCCeEEEEEEEC---CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEED-VVGSGGFGTVYRMVMN---DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
++|.+.+ .||+|+||.||+|.+. .+..||+|.++.... ...+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 8999999999999864 445699999976533 2346689999999999999999999999 45678999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++++|.+++.... ..+++..++.++.|+++||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 99999999999987532 2389999999999999999999999 89999999999999999999999999998775
Q ss_pred CCCcce--eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 466 DEEAHV--TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 466 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
...... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... . .........
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~---~~~~~i~~~------ 229 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---P---EVMAFIEQG------ 229 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---H---HHHHHHHTT------
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---H---HHHHHHhcC------
Confidence 443322 223446789999999988889999999999999999998 9999865321 1 111111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
.....+...+.++.+++.+||+.+|++||++.++++.|++....
T Consensus 230 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 230 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11122334567899999999999999999999999999886533
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=347.14 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=188.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.+.|++.+.||+|+||.||+|.+.+ +..||||++.... ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 129 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEe
Confidence 3568888999999999999999985 4579999987543 345688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC---CCCeEEeecccccccC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE---NLEPHVSDFGLAKLLV 465 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~~~~~~ 465 (603)
+++|+|.+++..... +++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||+++...
T Consensus 130 ~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 130 VTGGELFDRIVEKGY----YSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCSCBHHHHHTTCSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred CCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999876433 89999999999999999999999 8999999999999975 8899999999998664
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ......... ....
T Consensus 203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~i~~-~~~~----- 269 (349)
T 2w4o_A 203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-----QFMFRRILN-CEYY----- 269 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-----HHHHHHHHT-TCCC-----
T ss_pred ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-----HHHHHHHHh-CCCc-----
Confidence 322 223456899999999999889999999999999999999999998643211 001111111 1000
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.........+.++.+++.+||+.||++|||+.|+++
T Consensus 270 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111234567999999999999999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=342.46 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=189.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||.||+|.+.. +..||+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4678999999999999999999874 5679999986543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCccccccccC--CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 388 YLSMGSLDDFLHEHG--EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|++ |+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 49999887542 2223488999999999999999999999 89999999999999999999999999998764
Q ss_pred CCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh---Ccchh
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE---NRLED 541 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 541 (603)
.... ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .....+...... ..+..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE---EQLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCChhHhhh
Confidence 3322 2234568999999999876 46899999999999999999999999754211 111111111000 00000
Q ss_pred h---------hcccCC---------CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 542 V---------IDKRCA---------DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 542 ~---------~~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. +..... ......+.++.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 000000 001123467999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=344.00 Aligned_cols=266 Identities=26% Similarity=0.440 Sum_probs=205.7
Q ss_pred CCCCCeeeecCCeEEEEEEEC-----CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecC--CccEE
Q 007455 313 LDEEDVVGSGGFGTVYRMVMN-----DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLP--ATKLL 384 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 384 (603)
|++.+.||+|+||.||++.+. .+..||||++..... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999988653 445699999976533 2345689999999999999999999999874 56789
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++.... +++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~~~-----~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGSC-----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhCC-----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 999999999999997643 89999999999999999999999 8999999999999999999999999999877
Q ss_pred CCCCcc--eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAH--VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
...... ......++..|+|||++.+..++.++||||+|+++|||++|+.||....... .....+.........+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccchhHHHHHHH
Confidence 554322 2234557888999999998889999999999999999999999986432100 0000000000000011111
Q ss_pred hccc-CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 543 IDKR-CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 543 ~~~~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
+... ....+...+.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~ 309 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111 12233455678999999999999999999999999998753
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=339.82 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=195.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCCh---HHHHHHHHHHHhhCCCCeeeecceeeecCCcc----
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGS---DQVFERELEILGSIKHINLVNLRGYCRLPATK---- 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 382 (603)
++|++.+.||+|+||.||+|.+. ++..||||++....... ...+.+|+.++++++||||+++++++......
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 57888999999999999999985 45569999997653332 34688999999999999999999998766554
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++||||+++|+|.+++...+. +++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 999999999999999986543 89999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCc--ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 463 LLVDEEA--HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 463 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCCC
Confidence 7654322 122345689999999999988999999999999999999999999975321 11111111111110
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHH-HHHhh
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVL-QLLEQ 585 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl-~~L~~ 585 (603)
.. ......+.++.+++.+||+.||++||++.+++ +.+..
T Consensus 239 ~~------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 278 (311)
T 3ork_A 239 PS------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 278 (311)
T ss_dssp HH------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cc------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence 00 00112456799999999999999999766555 45554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=340.41 Aligned_cols=262 Identities=23% Similarity=0.286 Sum_probs=197.8
Q ss_pred hCCCCC-CeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEE-DVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 387 (603)
+.|++. +.||+|+||.||+|.+. ++..||||++..........+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 456664 78999999999999976 5567999999776656667899999999985 79999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC---eEEeeccccccc
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE---PHVSDFGLAKLL 464 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~~~~~ 464 (603)
|+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHKRRH----FNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999987543 89999999999999999999999 8999999999999998776 999999998765
Q ss_pred CCCCc------ceeecccccccccCcccccc-----CCCCcccchHhHHHHHHHHHhCCCCCCcccccCC-ccHhHHHHH
Q 007455 465 VDEEA------HVTTVVAGTFGYLAPEYLQS-----GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG-LNVVGWMNT 532 (603)
Q Consensus 465 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~-~~~~~~~~~ 532 (603)
..... .......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||........ .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11223458999999999864 5678999999999999999999999976432110 000000000
Q ss_pred HhhhCcchhhhcccCCCcCH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 533 LLKENRLEDVIDKRCADADM----ETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ...+.+.+.......+. ..+.++.+++.+||+.||++|||++|+++
T Consensus 245 -~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 -C-QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp -H-HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -H-HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0 00000111111111111 23467999999999999999999999987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.77 Aligned_cols=252 Identities=27% Similarity=0.343 Sum_probs=193.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++|++.+.||+|+||.||+|.+. .+..||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467899999999999999999987 456799999965443 345688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC--eEEeecccccccCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE--PHVSDFGLAKLLVD 466 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~~~~~~~ 466 (603)
+++|+|.+++...+. +++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~~~----~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICNAGR----FSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999976543 89999999999999999999998 8999999999999987765 99999999975432
Q ss_pred CCcceeecccccccccCccccccCCCCcc-cchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEK-SDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. ......||+.|+|||++.+..++.+ +||||+|+++|||++|+.||....... ............. .
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~-~------ 239 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVK-Y------ 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTC-C------
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCC-C------
Confidence 22 2234569999999999988777655 899999999999999999997543211 1111111111110 0
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+ .....+.++.+|+.+||..+|++|||++|+++
T Consensus 240 ~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 240 SIP-DDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp CCC-TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCC-CcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 001 11123467899999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=355.90 Aligned_cols=255 Identities=22% Similarity=0.279 Sum_probs=204.1
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
..++|++.+.||+|+||.||+|.++ .++.||+|++.+.. ....+.+.+|..++..++||||+++++++.+.+..|+
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 138 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYL 138 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 3578999999999999999999987 45679999986421 1122347889999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++...+. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+++..
T Consensus 139 VmE~~~gg~L~~~l~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~ 212 (412)
T 2vd5_A 139 VMEYYVGGDLLTLLSKFGE---RIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212 (412)
T ss_dssp EECCCCSCBHHHHHHHHSS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCCcHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheec
Confidence 9999999999999986432 389999999999999999999998 8999999999999999999999999999877
Q ss_pred CCCCcceeecccccccccCccccc-------cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQ-------SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
............||+.|+|||++. ...++.++|||||||++|||++|+.||..... ...........
T Consensus 213 ~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~ 286 (412)
T 2vd5_A 213 RADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST------AETYGKIVHYK 286 (412)
T ss_dssp CTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTHH
T ss_pred cCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH------HHHHHHHHhcc
Confidence 655444444568999999999987 35689999999999999999999999975321 11111111100
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDR---PSMNQVLQ 581 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---Ps~~evl~ 581 (603)
. ....+..+...+.++.+++.+||. +|++| |+++|+++
T Consensus 287 ---~--~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 287 ---E--HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp ---H--HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred ---c--CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 0 001111122345689999999999 99998 69999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=349.64 Aligned_cols=247 Identities=22% Similarity=0.288 Sum_probs=196.6
Q ss_pred CCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCC
Q 007455 315 EEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGS 393 (603)
Q Consensus 315 ~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (603)
..+.||+|+||.||+|.+. ++..||+|++........+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 3568999999999999986 456799999976655556779999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE--CCCCCeEEeecccccccCCCCcce
Q 007455 394 LDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL--DENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 394 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|.+++.... ..+++..++.++.|+++||+|||+. +|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 173 L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 173 LFDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred HHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 999887532 2389999999999999999999999 89999999999999 6678899999999987654332
Q ss_pred eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcC
Q 007455 472 TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551 (603)
Q Consensus 472 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 551 (603)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........... .. ......
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~------~~~~~~i~~~~-~~-----~~~~~~ 312 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND------AETLNNILACR-WD-----LEDEEF 312 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTC-CC-----SCSGGG
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhcc-CC-----CChhhh
Confidence 2345699999999999988999999999999999999999999975321 11111111111 00 000011
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 552 METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 552 ~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+.++.+++.+||+.||++|||++|+++
T Consensus 313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 313 QDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 234567999999999999999999999996
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=344.30 Aligned_cols=248 Identities=22% Similarity=0.333 Sum_probs=179.7
Q ss_pred CCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEEEEecCCCC
Q 007455 316 EDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRGYCRLPATKLLIYDYLSMGS 393 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (603)
.+.||+|+||.||+|.+.. +..||||++... ....+.+|+.++..+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 4789999999999999874 567999998542 3456889999999997 9999999999999999999999999999
Q ss_pred ccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC---CeEEeecccccccCCCCcc
Q 007455 394 LDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL---EPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 394 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~DfG~~~~~~~~~~~ 470 (603)
|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 93 LFERIKKKKH----FSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp HHHHHHHCSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 9999987543 89999999999999999999999 899999999999998765 799999999986644322
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCC-ccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG-LNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||........ .......... ...... ...
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~~------~~~ 237 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDFS------FEG 237 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCCC------CCS
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCCC------CCc
Confidence 23345689999999999998999999999999999999999999975432111 1111111111 111100 000
Q ss_pred -cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 550 -ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 550 -~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+.++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 01224567999999999999999999999884
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.99 Aligned_cols=258 Identities=29% Similarity=0.436 Sum_probs=203.6
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCC----EEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCcc-EEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATK-LLI 385 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv 385 (603)
.|...+.||+|+||.||+|.+.++. .+|+|.+...... ..+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4455688999999999999864332 5999998754432 345688999999999999999999999776665 999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 99999999999997632 2378999999999999999999999 89999999999999999999999999998664
Q ss_pred CCCc---ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 466 DEEA---HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 466 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
.... .......+++.|+|||.+.+..++.++||||+|+++|||++|+.|+..... .... .......
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~~---~~~~~~~------ 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFDL---THFLAQG------ 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGGH---HHHHHTT------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHHH---HHHhhcC------
Confidence 4321 122345678899999999998999999999999999999997666533211 1111 1111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
.....+...+..+.+++.+||+.+|.+|||++++++.|+++...
T Consensus 245 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 245 ---RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11112333456799999999999999999999999999986543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=339.39 Aligned_cols=251 Identities=25% Similarity=0.326 Sum_probs=204.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC------hHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG------SDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.+.|++.+.||+|+||.||+|.+.. +..||+|.+...... ..+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3568889999999999999999874 567999998654322 356799999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC----CeEEeec
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL----EPHVSDF 458 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~Df 458 (603)
++||||+++++|.+++..... +++..++.++.|++.||+|||++ +++||||||+||+++.++ .+||+||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKES----LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSC----EEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999976433 88999999999999999999999 899999999999999888 7999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
|++........ .....||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ...........
T Consensus 164 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~~~~- 234 (321)
T 2a2a_A 164 GLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANITSVS- 234 (321)
T ss_dssp TTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHTTC-
T ss_pred ccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcc-
Confidence 99987654322 2345689999999999988999999999999999999999999965321 11111111100
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. ... ......+..+.+++.+||+.||++|||++|+++
T Consensus 235 ~~--~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 YD--FDE---EFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CC--CCH---HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred cc--cCh---hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000 000123467899999999999999999999986
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=348.41 Aligned_cols=265 Identities=23% Similarity=0.304 Sum_probs=202.1
Q ss_pred hhCCCCCCeeeec--CCeEEEEEEEC-CCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSG--GFGTVYRMVMN-DCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
.++|++.+.||+| +||.||+|.+. ++..||||++...... ..+.+.+|+.+++.++||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4678999999999 99999999987 4567999999654322 23568889999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.+...
T Consensus 104 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 9999999999999986532 2389999999999999999999999 8999999999999999999999999998654
Q ss_pred CCCCc------ceeecccccccccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh-
Q 007455 465 VDEEA------HVTTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK- 535 (603)
Q Consensus 465 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 535 (603)
..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ...........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCc
Confidence 32211 11223468899999999987 578999999999999999999999997532111 00000000000
Q ss_pred ---------------------hCcchhhh----------cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 536 ---------------------ENRLEDVI----------DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 536 ---------------------~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........ .......+...+.++.+|+.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00000000 00000122334567999999999999999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=351.88 Aligned_cols=245 Identities=24% Similarity=0.297 Sum_probs=193.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC---ChHHHHHHHHHH-HhhCCCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE---GSDQVFERELEI-LGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
.++|++.+.||+|+||.||+|.++. +..||+|++..... .....+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 4678889999999999999999875 45699999965432 223446677776 567899999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.+|++||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERC----FLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999986543 88999999999999999999999 8999999999999999999999999999864
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..........
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-------- 254 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK-------- 254 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHS--------
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc--------
Confidence 3322 223456799999999999998999999999999999999999999975321 1111111111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQ 578 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~e 578 (603)
....+...+.++.+++.+||+.||++||++.+
T Consensus 255 --~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 255 --PLQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp --CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred --ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 11122234567999999999999999999853
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=342.81 Aligned_cols=262 Identities=23% Similarity=0.375 Sum_probs=210.7
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCc
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPAT 381 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 381 (603)
..++|++.+.||+|+||.||+|.+.+ +..||+|.+...... ....+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 45788999999999999999998752 456999998654332 33468899999999999999999999999999
Q ss_pred cEEEEEecCCCCccccccccCC------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEE
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGE------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 455 (603)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEE
Confidence 9999999999999999976321 113368999999999999999999999 8999999999999999999999
Q ss_pred eecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHH
Q 007455 456 SDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 456 ~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
+|||+++........ ......+|+.|+|||++.+..++.++||||+|+++|||++ |..||.... ........
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~~~~~~~~ 253 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS------NEQVLRFV 253 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC------HHHHHHHH
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC------HHHHHHHH
Confidence 999999866443221 1223456889999999998899999999999999999999 888886432 11111111
Q ss_pred hhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
.. ......+...+..+.+++.+||+.+|++|||+.|+++.|++...
T Consensus 254 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 ME---------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred Hc---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11 11122233455679999999999999999999999999988653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=333.79 Aligned_cols=250 Identities=27% Similarity=0.405 Sum_probs=184.6
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL 88 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence 4578899999999999999999985 56689999985432 2234668999999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++++|.+++.... ..+++..++.++.|+++||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 999999999999987642 2389999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
..... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......... .....
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~ 226 (278)
T 3cok_A 163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVL 226 (278)
T ss_dssp C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCS
T ss_pred cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhh
Confidence 43322 223456899999999999888999999999999999999999999754221100 00000
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ....+...+.++.+++.+||+.||++|||++++++
T Consensus 227 ~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 A-DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp S-CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred c-ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0 01122334567999999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=338.06 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=205.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeee--cCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCR--LPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 384 (603)
.++|++.+.||+|+||.||+|.+. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467888999999999999999987 4567999998654322 3456889999999999999999999874 4567899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEecCCCCCeEECCCCCeEEeecc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK-----IIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
||||+++|+|.+++.........+++..++.++.|++.||+|||+. + ++||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999987554445589999999999999999999998 6 9999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
+++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ....... ...
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i-~~~-- 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKI-REG-- 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHT--
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH------HHHHHHH-hhc--
Confidence 9987644322 12335689999999999988899999999999999999999999875321 1111111 111
Q ss_pred hhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.....+...+.++.+++.+||+.+|++|||++|+++.+..
T Consensus 232 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 232 ------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ------ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1112233455679999999999999999999999986644
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.48 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=192.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCCh--HHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGS--DQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|+..++||+|+||+||+|.+. ++..||||++....... ......|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57899999999999999999987 56789999986544332 23455566665555 8999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 569988887653 2389999999999999999999998 899999999999999999999999999987644
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
.. ......||+.|+|||++.+ .++.++||||||+++|||++|..|+.... .|. ..........
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~~--~~~~~~~~~~---- 272 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GWQ--QLRQGYLPPE---- 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HHH--HHTTTCCCHH----
T ss_pred CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHH--HHhccCCCcc----
Confidence 32 2334569999999999876 78999999999999999999977764321 010 0111111100
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+...+.++.+++.+||+.||++|||++|+++
T Consensus 273 ---~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 ---FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11123467999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-41 Score=342.98 Aligned_cols=259 Identities=29% Similarity=0.457 Sum_probs=205.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC-E--EEEEEeCCCC-CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG-T--FAVKRIDRSR-EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 384 (603)
.++|++.+.||+|+||.||+|.+..++ . +|+|.+.... ....+.+.+|+++++++ +||||+++++++...+..++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 468899999999999999999987544 3 5999886432 23345689999999999 89999999999999999999
Q ss_pred EEEecCCCCccccccccC------------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC
Q 007455 385 IYDYLSMGSLDDFLHEHG------------EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE 452 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 452 (603)
||||+++|+|.+++.... .....+++..++.++.|+++||.|||++ +|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCe
Confidence 999999999999998653 2234589999999999999999999999 8999999999999999999
Q ss_pred eEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHH
Q 007455 453 PHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 453 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~ 531 (603)
+||+|||+++...... ......+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... .....
T Consensus 181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~------~~~~~ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYE 252 (327)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHH
T ss_pred EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH------HHHHH
Confidence 9999999987432211 1223446789999999988889999999999999999998 9999865321 11111
Q ss_pred HHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 532 TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
.... ......+...+.++.+++.+||..+|++|||++|+++.|+++..
T Consensus 253 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 253 KLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp HGGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Hhhc---------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111 11112233445679999999999999999999999999887553
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.76 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=197.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCCh--HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.++|++.+.||+|+||.||+|.+.. +..||+|++....... .+.+.+|++++++++||||+++++++...+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3578889999999999999999875 5679999986554332 356789999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++++|.+++..... +++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~----~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRG----VPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHHTSSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHhhhcC----CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 99999999988775433 89999999999999999999999 899999999999999999999999999987653
Q ss_pred CCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH-----------h
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL-----------L 534 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~ 534 (603)
... ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||....... ........ .
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 155 PSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD---QLYLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHH
T ss_pred ccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhccccccccccc
Confidence 322 2234568999999999875 567999999999999999999999997542211 11111110 0
Q ss_pred hhCcchhhhc-ccCCC------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 KENRLEDVID-KRCAD------ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 ~~~~~~~~~~-~~~~~------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.......... +.... .....+.++.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 00000 00134567899999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=335.46 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=202.5
Q ss_pred hCCCCCC-eeeecCCeEEEEEEEC---CCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEED-VVGSGGFGTVYRMVMN---DCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~-~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
++|.+.+ .||+|+||.||+|.+. .+..||||.+...... ..+.+.+|+++++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 4667777 8999999999999653 2356999999754322 246789999999999999999999999 5677899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++++|.+++..... +++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 95 v~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEECCTTEEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHhCcC----CCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999987543 89999999999999999999999 8999999999999999999999999999877
Q ss_pred CCCCccee--ecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 465 VDEEAHVT--TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 465 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
........ ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ..... ....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~-~~~~---- 236 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAM-LEKG---- 236 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHH-HHTT----
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHH-HHcC----
Confidence 55433222 22346788999999988889999999999999999999 99998753211 11111 1111
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.....+...+..+.+++.+||+.||++|||+.++++.|++..
T Consensus 237 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 237 ----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111223345678999999999999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=338.87 Aligned_cols=262 Identities=19% Similarity=0.336 Sum_probs=200.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
..+|++.+.||+|+||.||+|.+. ++..||+|++..... .....+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 467889999999999999999985 567899999975332 2345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++.........+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999976443344589999999999999999999999 89999999999999999999999999998664
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............ ....
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~-~~~~----- 256 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK----MNLYSLCKKIEQ-CDYP----- 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCHHHHHHHHHT-TCSC-----
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc----hhHHHHHHHhhc-ccCC-----
Confidence 4322 2234568999999999998899999999999999999999999986432 111122111111 1100
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.......+.++.+++.+||+.||++|||++++++.|+++.
T Consensus 257 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 257 --PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp --CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0011234567999999999999999999999999999865
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=345.64 Aligned_cols=249 Identities=19% Similarity=0.355 Sum_probs=194.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCC--CeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIKH--INLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~ 386 (603)
+.|++.+.||+|+||.||+|.+.++..||||++...... ..+.+.+|+.++.+++| |||+++++++......++||
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 468888999999999999999988888999998654333 23568899999999986 99999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
| +.+|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++ ++.+||+|||+++....
T Consensus 89 e-~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp C-CCSEEHHHHHHHSCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred e-CCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 9 567799999987543 89999999999999999999999 899999999999997 57899999999987654
Q ss_pred CCcc-eeecccccccccCcccccc-----------CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 467 EEAH-VTTVVAGTFGYLAPEYLQS-----------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 467 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.... ..........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----SHHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh-----hHHHHHHHHh
Confidence 3322 2335679999999999864 678889999999999999999999996421 1111111111
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... .....+...+.++.+++.+||+.||++|||++|+++
T Consensus 235 ~~~--------~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 235 DPN--------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp CTT--------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cCC--------cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 110 011122223457899999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=331.95 Aligned_cols=250 Identities=26% Similarity=0.338 Sum_probs=203.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|++.+.||+|+||.||+|.+.. +..||+|++...... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 578889999999999999999875 567999998654332 23568899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC---eEEeeccccccc
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE---PHVSDFGLAKLL 464 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~DfG~~~~~ 464 (603)
|+++|+|.+++..... +++..+..++.|++.||.|||+. +++||||||+||+++.++. +||+|||++...
T Consensus 86 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 86 LVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999998876543 89999999999999999999999 8999999999999987665 999999999776
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
..... .....||+.|+|||++.+..++.++||||+|+++|+|++|+.||..... ....... .......
T Consensus 159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~-~~~~~~~--- 226 (284)
T 3kk8_A 159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQI-KAGAYDY--- 226 (284)
T ss_dssp CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HHTCCCC---
T ss_pred ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch------hHHHHHH-HhccccC---
Confidence 54332 2345689999999999998999999999999999999999999865321 1111111 1111000
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+.++.+++.+||+.||++|||++|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 --PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00111234567999999999999999999999987
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=331.17 Aligned_cols=261 Identities=19% Similarity=0.214 Sum_probs=201.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceee-ecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYC-RLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||.||+|.+. .+..||||++...... ..+.+|+++++.++|++++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence 468999999999999999999985 4556999987543322 2478899999999988877776655 56677899999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE---CCCCCeEEeeccccccc
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLL 464 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~~~ 464 (603)
|+ +++|.+++..... .+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 86 LL-GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred cc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 99 8899999875322 389999999999999999999999 89999999999999 78899999999999876
Q ss_pred CCCCcc------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 465 VDEEAH------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 465 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 544321 22345789999999999998999999999999999999999999976433222222211111110110
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.. . .....+.++.+++.+||+.+|++|||++++++.|++..
T Consensus 239 ~~----~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 239 IE----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp HH----H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred hh----h----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 00 0 01123467999999999999999999999999988754
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=335.19 Aligned_cols=253 Identities=25% Similarity=0.326 Sum_probs=198.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|.+.+.||+|+||.||+|.+.. +..+|+|++.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 3578889999999999999999864 5679999986543 3345679999999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE---CCCCCeEEeeccccccc
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLL 464 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~~~ 464 (603)
|+++|+|.+++.........+++..++.++.|+++||+|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999865433334489999999999999999999999 89999999999999 45678999999999876
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
.... ......||+.|+|||.+. ..++.++||||+|+++|||++|+.||..... ...........
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~------~~~~~~~~~~~------- 241 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL------EEVQQKATYKE------- 241 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCC-------
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH------HHHHhhhccCC-------
Confidence 4432 233456899999999886 4688999999999999999999999975321 11111111000
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..........+.++.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000111113467889999999999999999999985
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=362.39 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=207.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+. .+..||+|++... .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888899999999999999987 4567999998543 223345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||++||+|.+++...+. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+++...
T Consensus 263 mEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecc
Confidence 999999999999876432 3389999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........ +..
T Consensus 338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~--~~~~i~~~----------i~~ 403 (576)
T 2acx_A 338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI--KREEVERL----------VKE 403 (576)
T ss_dssp TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC--CHHHHHHH----------HHH
T ss_pred cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch--hHHHHHHH----------hhc
Confidence 4332 334579999999999998889999999999999999999999997643211 11111111 111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
.....+...+.++.+++.+||+.||++|| +++|+++
T Consensus 404 ~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 404 VPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 11122334557899999999999999999 7899884
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=343.13 Aligned_cols=242 Identities=23% Similarity=0.324 Sum_probs=201.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--------hHHHHHHHHHHHhhCCCCeeeecceeeecC
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--------SDQVFERELEILGSIKHINLVNLRGYCRLP 379 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 379 (603)
..++|++.+.||+|+||.||+|.+.. +..||||.+...... ....+.+|+.++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 35789999999999999999999865 456999998654321 223477899999999999999999999999
Q ss_pred CccEEEEEecCCC-CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 380 ATKLLIYDYLSMG-SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 380 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
+..++||||+.+| +|.+++..... +++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~----l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPR----LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999777 99999886543 89999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
|+++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99987654432 234568999999999987776 78999999999999999999998642110
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. .. ....+...+.++.+++.+||+.||++|||++|+++
T Consensus 237 -~----~~-~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 237 -V----EA-AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp -T----TT-CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -H----hh-ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 01112224567999999999999999999999997
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=349.41 Aligned_cols=253 Identities=26% Similarity=0.335 Sum_probs=204.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC----CCCEEEEEEeCCCC----CChHHHHHHHHHHHhhC-CCCeeeecceeeecCC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN----DCGTFAVKRIDRSR----EGSDQVFERELEILGSI-KHINLVNLRGYCRLPA 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 380 (603)
.++|++.+.||+|+||.||+|.+. .+..||||+++... ....+.+.+|+++++++ +||||+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 468899999999999999999983 56789999986432 22334577899999999 6999999999999999
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..++||||+++|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999986543 89999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
++..............||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...........
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~--- 280 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILK--- 280 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHH---
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhc---
Confidence 98765444444455679999999999975 347889999999999999999999997542211 11112111111
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
..+..+...+..+.+++.+||..||++|| +++|+++
T Consensus 281 -------~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 281 -------SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------cCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 11223334556789999999999999999 9999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=335.12 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=200.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999987 56789999987543 23445688999999999 899999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC---------------
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN--------------- 450 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--------------- 450 (603)
|||+++|+|.+++.........+++..++.++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999987543334489999999999999999999999 89999999999999844
Q ss_pred ----CCeEEeecccccccCCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCcc
Q 007455 451 ----LEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLN 525 (603)
Q Consensus 451 ----~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~ 525 (603)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||||+++|||++|..++....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~------ 235 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------ 235 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH------
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh------
Confidence 479999999998765432 23489999999999765 56689999999999999999998764321
Q ss_pred HhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+ . .......+..+...+.++.+++.+||+.||++|||++|+++
T Consensus 236 --~~-~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 236 --QW-H---------EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --HH-H---------HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HH-H---------HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 01 0 11111122223344567999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=337.51 Aligned_cols=260 Identities=25% Similarity=0.401 Sum_probs=196.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC----CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCc--
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND----CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPAT-- 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 381 (603)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+...... ..+.+.+|+.++++++||||+++++++.....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4678888999999999999998653 226999998654333 23568899999999999999999999977653
Q ss_pred ---cEEEEEecCCCCccccccccC--CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEe
Q 007455 382 ---KLLIYDYLSMGSLDDFLHEHG--EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS 456 (603)
Q Consensus 382 ---~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 456 (603)
.++||||+++|+|.+++.... .....+++..++.++.|+++||.|||++ +|+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEe
Confidence 499999999999999985432 2234589999999999999999999998 89999999999999999999999
Q ss_pred ecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHh
Q 007455 457 DFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 457 DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . ......
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~---~~~~~~ 263 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---E---MYDYLL 263 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---G---HHHHHH
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---H---HHHHHH
Confidence 9999987644322 12233457789999999998899999999999999999999 88888653211 1 111111
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.. .....+...+.++.+++.+||..+|++|||++++++.|+++.
T Consensus 264 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~ 307 (313)
T 3brb_A 264 HG---------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL 307 (313)
T ss_dssp TT---------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cC---------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11 111222344567999999999999999999999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=340.94 Aligned_cols=263 Identities=28% Similarity=0.437 Sum_probs=209.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecC
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLP 379 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 379 (603)
...++|++.+.||+|+||.||+|.+. .+..||||.+...... ..+.+.+|+.++.++ +||||+++++++...
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 103 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 103 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC
Confidence 34578999999999999999999852 3356999999765432 335688999999999 799999999998765
Q ss_pred C-ccEEEEEecCCCCccccccccCCC------------CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeE
Q 007455 380 A-TKLLIYDYLSMGSLDDFLHEHGEG------------QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNIL 446 (603)
Q Consensus 380 ~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIl 446 (603)
+ ..++||||+++|+|.+++...... ...+++..++.++.|+++||.|||++ +|+||||||+||+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil 180 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 180 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEE
Confidence 4 489999999999999999875432 12378999999999999999999999 8999999999999
Q ss_pred ECCCCCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCc
Q 007455 447 LDENLEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGL 524 (603)
Q Consensus 447 l~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~ 524 (603)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--- 257 (316)
T 2xir_A 181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--- 257 (316)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS---
T ss_pred ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh---
Confidence 99999999999999987654332 22334567889999999998899999999999999999998 99998653211
Q ss_pred cHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 525 NVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.......... .....+...+.++.+++.+||+.+|++|||++|+++.|+++.
T Consensus 258 ---~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 258 ---EEFCRRLKEG--------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp ---HHHHHHHHHT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---HHHHHHhccC--------ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0111111111 011122234567999999999999999999999999998765
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=330.42 Aligned_cols=260 Identities=19% Similarity=0.222 Sum_probs=204.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceee-ecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYC-RLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||.||+|.+. ++..||||++...... ..+.+|+.+++.++|++++..+.++ ......++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEe
Confidence 57888999999999999999985 5567999988654332 3588999999999988877666655 566777999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE---CCCCCeEEeecccccccC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~~~~ 465 (603)
+ +++|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 87 ~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 87 L-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred c-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 9 889999997532 2389999999999999999999999 89999999999999 478899999999998765
Q ss_pred CCCcc------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 466 DEEAH------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 466 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 54321 124457999999999999989999999999999999999999999764332222222111111111100
Q ss_pred hhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
. . .....+.++.+++.+||+.||++|||++++++.|++..
T Consensus 240 ~----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 240 E----V----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp H----H----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred H----H----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 0 0 01123467999999999999999999999999998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=329.11 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=204.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 467889999999999999999987 55679999986433 3345678999999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++++|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 86 YCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp CCTTEEGGGGSBTTT----BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ecCCCcHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 999999999997643 389999999999999999999998 8999999999999999999999999999865432
Q ss_pred Cc-ceeecccccccccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 468 EA-HVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 468 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. .......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||....... .....| .....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~----~~~~~------- 226 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDW----KEKKT------- 226 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS-HHHHHH----HTTCT-------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH-HHHHHh----hhccc-------
Confidence 21 12334568999999999987665 778999999999999999999997532110 111111 11000
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+..+.+++.+||+.||++|||++|+++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00111234567899999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=360.17 Aligned_cols=256 Identities=23% Similarity=0.305 Sum_probs=208.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|...+.||+|+||.||+|.+.. ++.||+|++.... ......+.+|++++++++||||+++++++...+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 3678888999999999999999874 5679999985432 22345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||++||+|.+++.........+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999987654445699999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ............
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~--~~~~~~~~~i~~---------- 407 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK--VENKELKQRVLE---------- 407 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC--CCHHHHHHHHHH----------
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccc--hhHHHHHHHHhh----------
Confidence 4332 233457999999999999989999999999999999999999999764211 111111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSM-----NQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 581 (603)
.....+...+.++.+++.+||+.||++||++ +++++
T Consensus 408 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 408 QAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 1112233456789999999999999999965 67763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=367.36 Aligned_cols=248 Identities=23% Similarity=0.379 Sum_probs=197.8
Q ss_pred eeeecCCeEEEEEEEC---CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCCCC
Q 007455 318 VVGSGGFGTVYRMVMN---DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGS 393 (603)
Q Consensus 318 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (603)
.||+|+||.||+|.+. ++..||||+++... ....+.+.+|++++++++||||+++++++.. +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 33459999997643 3345779999999999999999999999976 56899999999999
Q ss_pred ccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCccee-
Q 007455 394 LDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT- 472 (603)
Q Consensus 394 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~- 472 (603)
|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..........
T Consensus 422 L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 999997542 3489999999999999999999999 899999999999999999999999999987654332221
Q ss_pred -ecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCc
Q 007455 473 -TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550 (603)
Q Consensus 473 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (603)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..+ ....... .....
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~---~~~i~~~---------~~~~~ 560 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEV---MAFIEQG---------KRMEC 560 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHH---HHHHHTT---------CCCCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHH---HHHHHcC---------CCCCC
Confidence 22335689999999998999999999999999999998 9999875321 111 1111111 11122
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 551 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
+...+.++.+++.+||..+|++||+++++++.|++..
T Consensus 561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 3345678999999999999999999999999998753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=352.04 Aligned_cols=255 Identities=21% Similarity=0.274 Sum_probs=192.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCC------
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPA------ 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 380 (603)
.++|++.+.||+|+||.||+|.+.. ++.||||++.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4678899999999999999999875 4569999996542 223456889999999999999999999996553
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..|+||||+++ +|.+.+... +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~~------l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQME------LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTSC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhhc------CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 46999999987 465555431 88999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH-------
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL------- 533 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~------- 533 (603)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..+....
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-----~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 211 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-----DQWNKVIEQLGTPC 283 (464)
T ss_dssp C-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHHHCSCC
T ss_pred eeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCC
Confidence 98764332 234467999999999999999999999999999999999999999753211 1111100
Q ss_pred --------------hhhC------cchhhhcccCCC----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 --------------LKEN------RLEDVIDKRCAD----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 --------------~~~~------~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... .+...+...... .....+.++.+|+.+||..||++|||++|+++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 000000000000 01122567999999999999999999999996
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.83 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=200.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||.||+|.+.. +..||+|.+...... ..+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4678899999999999999999875 456999999665433 35688888887 79999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC-C---CeEEeecccccc
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN-L---EPHVSDFGLAKL 463 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~---~~kl~DfG~~~~ 463 (603)
|+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||+.++ + .+||+|||+++.
T Consensus 97 ~~~gg~L~~~i~~~~~----~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILRQKF----FSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHTCTT----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999876543 89999999999999999999999 89999999999998543 3 499999999987
Q ss_pred cCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ........... .....
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~---~~~~~~~~~i~-~~~~~--- 241 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD---DTPEEILARIG-SGKFS--- 241 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT---SCHHHHHHHHH-HCCCC---
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc---CCHHHHHHHHc-cCCcc---
Confidence 654332 23445789999999999887889999999999999999999999975321 11111111111 11110
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.........+.++.+++.+||..||++|||+.|+++
T Consensus 242 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 --LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 001112345567999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=344.72 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=209.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC------CEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecCCc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC------GTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLPAT 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 381 (603)
.++|++.+.||+|+||.||+|.+... ..||+|.+...... ..+.+.+|+.+++++ +||||+++++++...+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 46788899999999999999998643 26999999755432 345689999999999 89999999999999999
Q ss_pred cEEEEEecCCCCccccccccCC----------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGE----------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL 451 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 451 (603)
.++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCC
Confidence 9999999999999999875421 123478999999999999999999999 899999999999999999
Q ss_pred CeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHH
Q 007455 452 EPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGW 529 (603)
Q Consensus 452 ~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~ 529 (603)
.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... ..
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------~~ 275 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN------SK 275 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS------HH
T ss_pred eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh------HH
Confidence 9999999999866443322 2234557889999999988899999999999999999999 88898653211 01
Q ss_pred HHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 530 MNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 530 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
......... ....+...+..+.+++.+||+.+|.+|||++|+++.|++..
T Consensus 276 ~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 FYKLVKDGY--------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp HHHHHHHTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHhcCC--------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 111111110 01112233567999999999999999999999999998754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=333.72 Aligned_cols=251 Identities=29% Similarity=0.435 Sum_probs=198.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecC-CccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLP-ATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~ 388 (603)
.++|++.+.||+|+||.||+|.+. +..||||.+.... ..+.+.+|++++++++||||+++++++... +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467889999999999999999886 5789999986543 446689999999999999999999987554 578999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++.... ...+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999997642 22378899999999999999999999 89999999999999999999999999987654321
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... ........ ...
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~---------~~~ 232 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPRVEK---------GYK 232 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG------GHHHHHTT---------TCC
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHhc---------CCC
Confidence 22357889999999998899999999999999999998 99998653211 11111111 111
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
...+...+..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 1223345578999999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.88 Aligned_cols=249 Identities=19% Similarity=0.351 Sum_probs=195.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCC--CCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIK--HINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~ 386 (603)
+.|++.+.||+|+||.||+|.+.++..||||++...... ..+.+.+|+.++++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458889999999999999999988888999998654332 3456899999999996 599999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
| +.+++|.+++..... +++..+..++.||+.||.|||++ +|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 136 E-~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHCSS----CCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 567899999987543 88999999999999999999999 899999999999996 57999999999987654
Q ss_pred CCcc-eeecccccccccCcccccc-----------CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 467 EEAH-VTTVVAGTFGYLAPEYLQS-----------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 467 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ..........
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-----NQISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CHHHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh-----HHHHHHHHHh
Confidence 3322 2344679999999999864 368889999999999999999999996431 1111111111
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... ....+...+.++.+++.+||+.||++|||++|+++
T Consensus 282 ~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 282 DPNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp CTTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Cccc--------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1110 01112222457899999999999999999999985
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=338.72 Aligned_cols=266 Identities=29% Similarity=0.428 Sum_probs=208.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEE-----CCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCC--ccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVM-----NDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPA--TKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~ 383 (603)
++|++.+.||+|+||.||+|.+ ..+..||||++........+.+.+|++++++++||||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 5678889999999999999984 245679999998766556678999999999999999999999886654 689
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+++|+|.+++..... .+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 121 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEECCCTTCBHHHHHHHSTT---SSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEECCCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 99999999999999986532 389999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCcce--eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCccccc-----CCccHhHHHHHHhhh
Q 007455 464 LVDEEAHV--TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVK-----RGLNVVGWMNTLLKE 536 (603)
Q Consensus 464 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~ 536 (603)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..|+...... .......+...
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~---- 270 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF---- 270 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH----
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH----
Confidence 75443321 12345677899999998888999999999999999999999987642100 00000000000
Q ss_pred Ccchhhhcc-cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 537 NRLEDVIDK-RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 537 ~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.+.+.+.. .....+...+.++.+++.+||+.+|++|||++|+++.|+++.
T Consensus 271 -~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 271 -HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp -HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00111111 111223345678999999999999999999999999998754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.65 Aligned_cols=267 Identities=27% Similarity=0.380 Sum_probs=201.8
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhC--CCCeeeecceeeecC----Cc
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSI--KHINLVNLRGYCRLP----AT 381 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~ 381 (603)
...++|++.+.||+|+||.||+|.+. +..||||++... ....+.+|.+++... +||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34578999999999999999999987 578999998543 233455566665554 899999999999877 67
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEecCCCCCeEECCCCCeEEe
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC-----CPKIIHRDIKSSNILLDENLEPHVS 456 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~NIll~~~~~~kl~ 456 (603)
.++||||+++|+|.++++.. .+++..++.++.|++.||+|||++. .++|+||||||+||+++.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 89999999999999999754 2899999999999999999999861 2379999999999999999999999
Q ss_pred ecccccccCCCCcce---eecccccccccCccccccCCCCcc------cchHhHHHHHHHHHhC----------CCCCCc
Q 007455 457 DFGLAKLLVDEEAHV---TTVVAGTFGYLAPEYLQSGRATEK------SDVYSFGVLLLELVTG----------KRPTDP 517 (603)
Q Consensus 457 DfG~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~slG~vl~elltg----------~~p~~~ 517 (603)
|||+++......... .....||+.|+|||++.+...+.+ +||||||+++|||++| ..||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999997764433221 124569999999999987766655 9999999999999999 555543
Q ss_pred ccccCCccHhHHHHHHhhhCcchhhhcccCCC--cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 518 TFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD--ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
..... ... ............. ...+. .....+.++.+++.+||+.||++|||++|+++.|+++...
T Consensus 265 ~~~~~-~~~-~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 265 LVPSD-PSY-EDMREIVCIKKLR----PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp TSCSS-CCH-HHHHHHHTTSCCC----CCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred hcCCC-Cch-hhhHHHHhhhccC----ccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 22111 111 1111111111111 11111 1236778899999999999999999999999999986643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=327.85 Aligned_cols=250 Identities=26% Similarity=0.358 Sum_probs=200.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC------ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE------GSDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
++|++.+.||+|+||.||+|.+. .+..||+|.+..... ...+.+.+|+.++++++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999987 466799999864322 13567999999999999999999999999999999
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC----CeEEeecc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL----EPHVSDFG 459 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG 459 (603)
+||||+++++|.+++..... +++..++.++.|++.||.|||+. +++||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKES----LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999976433 89999999999999999999999 899999999999998877 89999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
++........ .....|++.|+|||++.+..++.++||||||+++|||++|+.||..... ........... .
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~-~ 228 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK------QETLTNISAVN-Y 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTC-C
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch------HHHHHHhHhcc-c
Confidence 9987644322 2345689999999999988999999999999999999999999875321 11111111100 0
Q ss_pred hhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. .. .......+..+.+++.+||..||++|||++|+++
T Consensus 229 ~--~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 D--FD---EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp C--CC---HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--Cc---chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0 00 0001123457899999999999999999999996
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=334.95 Aligned_cols=253 Identities=24% Similarity=0.381 Sum_probs=206.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|.+.+.||+|+||.||+|.+.++ ..+|+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 35788899999999999999998854 5689998864422 2345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++++|.+++..... +++..++.++.|+++||+|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999998876543 89999999999999999999999 89999999999999999999999999998764
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.... ......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...... ........
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~---------- 229 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKK---------- 229 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT----------
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhh----------
Confidence 3322 223456899999999999888999999999999999999999999753211 11111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQE 586 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~ 586 (603)
.....+...+..+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 230 NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred ccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 011122234467899999999999999999999997 45443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=340.31 Aligned_cols=198 Identities=26% Similarity=0.301 Sum_probs=172.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-----CCeeeecceeeecCCccE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIK-----HINLVNLRGYCRLPATKL 383 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~ 383 (603)
.++|.+.+.||+|+||.||+|.+. ++..||||++... ......+..|+.+++.+. ||||+++++++...+..+
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 468899999999999999999986 4567999998643 233456788999999986 999999999999999999
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC--------------
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-------------- 449 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-------------- 449 (603)
+||||+ +++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 113 lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred EEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccc
Confidence 999999 8899999987543 2388999999999999999999999 8999999999999975
Q ss_pred -----------CCCeEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcc
Q 007455 450 -----------NLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPT 518 (603)
Q Consensus 450 -----------~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~ 518 (603)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 789999999999865432 23456899999999999999999999999999999999999999753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=330.21 Aligned_cols=247 Identities=23% Similarity=0.386 Sum_probs=195.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357888999999999999999987 5678999998543 223345788999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++++|.+++..... +++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGR----VEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999976543 89999999999999999999999 89999999999999999999999999998764
Q ss_pred CCCcceeecccccccccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
... ......|++.|+|||.+.+..+ +.++||||+|+++|||++|+.||..... ....... ..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~-~~-------- 225 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV------PTLFKKI-RG-------- 225 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHH-HH--------
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH------HHHHHHh-hc--------
Confidence 432 2234568999999999987665 6899999999999999999999865321 1111111 11
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+...+..+.+++.+||+.||++|||++|+++
T Consensus 226 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 226 -GVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 111122234567999999999999999999999997
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=346.59 Aligned_cols=251 Identities=22% Similarity=0.283 Sum_probs=190.9
Q ss_pred hhCCCCC-CeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHh-hCCCCeeeecceeeec----CCcc
Q 007455 310 LEALDEE-DVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILG-SIKHINLVNLRGYCRL----PATK 382 (603)
Q Consensus 310 ~~~~~~~-~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~ 382 (603)
.++|.+. +.||+|+||+||+|.+.. +..||||++.. ...+.+|+.++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456655 689999999999999875 45699999853 235778888875 4589999999998865 5668
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC---CCCeEEeecc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE---NLEPHVSDFG 459 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 459 (603)
|+||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 99999999999999998643 23489999999999999999999998 8999999999999998 7899999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCc-cHhHHHHHHhhhCc
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL-NVVGWMNTLLKENR 538 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 538 (603)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... .+....
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~----~i~~~~ 283 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT----RIRMGQ 283 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH----HHHHTC
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH----HHHcCc
Confidence 998654322 234466899999999999999999999999999999999999999764322111 1111 111111
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... . .......+.++.+|+.+||+.||++|||++|+++
T Consensus 284 ~~~----~-~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 284 YEF----P-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp CCC----C-TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccC----C-CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000 0 0011234567999999999999999999999997
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=346.39 Aligned_cols=271 Identities=24% Similarity=0.291 Sum_probs=211.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCC--ccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPA--TKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 386 (603)
++|.+.+.||+|+||.||+|.+.. +..||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 467888999999999999999875 5679999996533 233466889999999999999999999998765 679999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE----CCCCCeEEeeccccc
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL----DENLEPHVSDFGLAK 462 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~DfG~~~ 462 (603)
||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999986533 22389999999999999999999999 89999999999999 777889999999998
Q ss_pred ccCCCCcceeecccccccccCcccccc--------CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQS--------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ....+....
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKII 240 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHH
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHh
Confidence 7654322 234568999999999864 5677899999999999999999999965322111 111222222
Q ss_pred hhCcch---hh-------h--c---ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 535 KENRLE---DV-------I--D---KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 535 ~~~~~~---~~-------~--~---~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
...... .. + . +............+.+++.+||+.||++||+++|+++.++++...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 211100 00 0 0 001123466778899999999999999999999999998876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=341.73 Aligned_cols=272 Identities=25% Similarity=0.379 Sum_probs=198.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHH--HhhCCCCeeeecceeee-----cCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEI--LGSIKHINLVNLRGYCR-----LPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~-----~~~~~ 382 (603)
.++|++.+.||+|+||.||+|.+. +..||||++.... ...+..|.++ +..++||||+++++.+. .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEEC-CeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 468889999999999999999874 5789999986432 2334444444 55689999999997543 23356
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEecCCCCCeEECCCCCeEEe
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC------CPKIIHRDIKSSNILLDENLEPHVS 456 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------~~~ivH~Dlkp~NIll~~~~~~kl~ 456 (603)
++||||+++|+|.+++.... .++..++.++.|+++||+|||+.. .++|+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhcc-----cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 89999999999999997643 588999999999999999999872 2379999999999999999999999
Q ss_pred ecccccccCCCCc-------ceeecccccccccCcccccc-------CCCCcccchHhHHHHHHHHHhCCCCCCcccccC
Q 007455 457 DFGLAKLLVDEEA-------HVTTVVAGTFGYLAPEYLQS-------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKR 522 (603)
Q Consensus 457 DfG~~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~ 522 (603)
|||+++.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987654221 12234569999999999976 456678999999999999999988765432211
Q ss_pred Ccc-----------HhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCC
Q 007455 523 GLN-----------VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPC 591 (603)
Q Consensus 523 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 591 (603)
... .................+..... .....+.++.+++.+||+.||++|||++|+++.|+++.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWK-ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCC-CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccc-cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence 110 00111111111111111111111 123466789999999999999999999999999998664433
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=335.13 Aligned_cols=264 Identities=26% Similarity=0.368 Sum_probs=207.6
Q ss_pred HHHhhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhh--CCCCeeeecceeeecCC----
Q 007455 307 IEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGS--IKHINLVNLRGYCRLPA---- 380 (603)
Q Consensus 307 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---- 380 (603)
....++|++.+.||+|+||.||+|.+. ++.||||.+... ....+.+|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 344578999999999999999999985 578999998543 34567889999887 78999999999998776
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEecCCCCCeEECCCCC
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH--------HDCCPKIIHRDIKSSNILLDENLE 452 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--------~~~~~~ivH~Dlkp~NIll~~~~~ 452 (603)
..++||||+++|+|.+++... .+++..++.++.|++.||.||| +. +|+||||||+||+++.++.
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred eeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 789999999999999999764 2899999999999999999999 66 8999999999999999999
Q ss_pred eEEeecccccccCCCCcc---eeecccccccccCccccccC------CCCcccchHhHHHHHHHHHhC----------CC
Q 007455 453 PHVSDFGLAKLLVDEEAH---VTTVVAGTFGYLAPEYLQSG------RATEKSDVYSFGVLLLELVTG----------KR 513 (603)
Q Consensus 453 ~kl~DfG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~slG~vl~elltg----------~~ 513 (603)
+||+|||++......... ......||+.|+|||++.+. .++.++||||||+++|||++| ..
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876544322 12345689999999998765 233689999999999999999 66
Q ss_pred CCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC--cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 514 PTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD--ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 514 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
||...... ......+..... ..... ...+. .....+..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 266 p~~~~~~~-~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 266 PYYDLVPS-DPSVEEMRKVVC-EQKLR----PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTTTSCS-SCCHHHHHHHHT-TSCCC----CCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccccCcC-cccHHHHHHHHH-HHHhC----CCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 77543221 112222222211 11111 11111 123567789999999999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=347.29 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=190.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--------ChHHHHHHHHHHHhhCCCCeeeecceeeecC
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--------GSDQVFERELEILGSIKHINLVNLRGYCRLP 379 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 379 (603)
..++|.+.+.||+|+||.||+|.+.. +..||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 35789999999999999999999875 45799999864321 112247899999999999999999999854
Q ss_pred CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC---CeEEe
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL---EPHVS 456 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~~kl~ 456 (603)
+..++||||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKR----LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEe
Confidence 557999999999999998876543 89999999999999999999999 899999999999997544 59999
Q ss_pred ecccccccCCCCcceeecccccccccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH
Q 007455 457 DFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS---GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 457 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
|||+++...... ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... ......
T Consensus 285 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~---- 356 (419)
T 3i6u_A 285 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQ---- 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS--CCHHHH----
T ss_pred ecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch--HHHHHH----
Confidence 999998765432 2344679999999999853 56788999999999999999999999753211 111111
Q ss_pred hhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........ .+......+..+.+++.+||+.||++|||++|+++
T Consensus 357 i~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 357 ITSGKYNF-----IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHTTCCCC-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCC-----CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 11110000 00001123467999999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.23 Aligned_cols=261 Identities=24% Similarity=0.305 Sum_probs=198.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-----CChHHHHHHHHHHHhhCC---CCeeeecceeeecCC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-----EGSDQVFERELEILGSIK---HINLVNLRGYCRLPA 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 380 (603)
.++|++.+.||+|+||+||+|.+. .+..||+|++.... ......+.+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 468999999999999999999975 45679999985322 222345778888877775 999999999997765
Q ss_pred -----ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEE
Q 007455 381 -----TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455 (603)
Q Consensus 381 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 455 (603)
..++||||+.+ +|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||
T Consensus 88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQ-DLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp SSSEEEEEEEEECCCC-BHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEE
T ss_pred CCCceeEEEEehhhhc-CHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence 47899999985 99999887543 2389999999999999999999999 8999999999999999999999
Q ss_pred eecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh
Q 007455 456 SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535 (603)
Q Consensus 456 ~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (603)
+|||+++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... .....+.....
T Consensus 162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA---DQLGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH---HHHHHHHHHHC
T ss_pred eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhC
Confidence 9999998764332 234567899999999999889999999999999999999999999753211 11111111110
Q ss_pred hC---cchh-------hhcccCCC----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 536 EN---RLED-------VIDKRCAD----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 536 ~~---~~~~-------~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. .+.. .+....+. .....+.++.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 0000 00000000 01134467899999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=335.22 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=202.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 357888999999999999999987 5667999999765554556789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE---CCCCCeEEeecccccccC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~~~~ 465 (603)
+++++|.+++...+. +++..+..++.|++.||.|||+. +++||||||+||++ +.++.++|+|||++....
T Consensus 88 ~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILERGV----YTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999876543 89999999999999999999999 89999999999999 788899999999997643
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. ......|++.|+|||++.+..++.++||||+|+++|||++|+.||..... ........ .....
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~i~-~~~~~----- 225 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE------SKLFEKIK-EGYYE----- 225 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH-HCCCC-----
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cCCCC-----
Confidence 32 12335689999999999988999999999999999999999999865321 11111111 11100
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.........+.++.+++.+||..||++|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 FESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 001112234567999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=340.65 Aligned_cols=245 Identities=29% Similarity=0.422 Sum_probs=198.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCCh---HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGS---DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
+.|+..+.||+|+||.||+|.+. ++..||||++....... .+.+.+|++++++++||||+++++++..++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45778899999999999999985 45569999996543332 246889999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+. |+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9998 58888776432 2389999999999999999999999 899999999999999999999999999987643
Q ss_pred CCcceeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
. ....||+.|+|||++. ...++.++||||||+++|||++|+.||.... .............
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~------~~~~~~~~~~~~~----- 270 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------AMSALYHIAQNES----- 270 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC------HHHHHHHHHHSCC-----
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHhcCC-----
Confidence 2 2356899999999884 5678999999999999999999999986432 1111111111110
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+..+.+++.+||+.+|++|||++++++
T Consensus 271 ---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 00112234567899999999999999999999986
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=341.40 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=206.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCC---ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSRE---GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|.+.+.||+|+||.||+|.+.++ ..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35788889999999999999998764 5689998864422 2345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++++|.+++..... +++..++.++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~~~~----l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRRKA----LTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999998876433 89999999999999999999999 89999999999999999999999999998764
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......... .
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~-~-------- 256 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL------KETYLRIKK-N-------- 256 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHH-T--------
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH------HHHHHHHhc-C--------
Confidence 3322 22345689999999999988899999999999999999999999975321 111111111 1
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQE 586 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~ 586 (603)
....+...+..+.+++.+||+.||++|||++|+++ .+.+.
T Consensus 257 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 257 -EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 01112234467899999999999999999999996 45443
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=366.45 Aligned_cols=247 Identities=23% Similarity=0.386 Sum_probs=197.1
Q ss_pred CeeeecCCeEEEEEEEC---CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMN---DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
+.||+|+||.||+|.+. .+..||||+++.... ...+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999764 234699999975432 234679999999999999999999999864 568899999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc-
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH- 470 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~- 470 (603)
|+|.+++..... +++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhCCC----CCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999976543 89999999999999999999999 8999999999999999999999999999876543321
Q ss_pred -eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 471 -VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 471 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ..... +... ...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~-i~~~--------~~~ 591 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAM-LEKG--------ERM 591 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHH-HHTT--------CCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH-HHcC--------CCC
Confidence 2233446789999999999999999999999999999998 99999653211 11111 1111 111
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
..+...+.++.+++.+||+.||++|||++++++.|++.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22334567899999999999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=332.47 Aligned_cols=247 Identities=27% Similarity=0.428 Sum_probs=204.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+.|+..+.||+|+||.||+|.+. .+..||+|.+.... ....+.+.+|+.+++.++||||+++++++......++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56788899999999999999986 45679999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEPG-----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 9999999998753 389999999999999999999999 89999999999999999999999999998765432
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
. ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ....... ... ...
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~--------~~~ 237 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP------MKVLFLI-PKN--------NPP 237 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHH-HHS--------CCC
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH------HHHHHHh-hcC--------CCC
Confidence 2 22345689999999999988999999999999999999999999864321 1111111 111 111
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+..+.+++.+||+.+|++|||++|+++
T Consensus 238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 122234567999999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=347.92 Aligned_cols=243 Identities=18% Similarity=0.201 Sum_probs=189.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC---CCChHHHHHHHH---HHHhhCCCCeeeecc-------ee
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS---REGSDQVFEREL---EILGSIKHINLVNLR-------GY 375 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 375 (603)
.++|++.+.||+|+||.||+|.+. ++..||||++... .....+.+.+|+ +.+++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 357888899999999999999975 5678999999633 333456789999 455566899999998 55
Q ss_pred eecCC-----------------ccEEEEEecCCCCccccccccCC---CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 007455 376 CRLPA-----------------TKLLIYDYLSMGSLDDFLHEHGE---GQQLLNWSARLKIALGSARGLAYLHHDCCPKI 435 (603)
Q Consensus 376 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i 435 (603)
+..++ ..|+||||+ +|+|.+++..... ....+++..++.++.|++.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 55443 278999999 5799999986422 122344688889999999999999999 89
Q ss_pred EEecCCCCCeEECCCCCeEEeecccccccCCCCcceeecccccccccCccccccC-----------CCCcccchHhHHHH
Q 007455 436 IHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG-----------RATEKSDVYSFGVL 504 (603)
Q Consensus 436 vH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~slG~v 504 (603)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986332 2344567 999999999877 89999999999999
Q ss_pred HHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 505 LLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 505 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+|||++|+.||........ ... +.... ...+.++.+++.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~~---------------~~~-~~~~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG---------------SEW-IFRSC----KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------CC---------------SGG-GGSSC----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCcccccccc---------------hhh-hhhhc----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999965322111 111 11111 123467999999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=329.28 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=199.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
++|....+||+|+||.||+|.+.. +..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 345556699999999999999864 4579999997665555677999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-CCCeEEeecccccccCCCC
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-NLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-~~~~kl~DfG~~~~~~~~~ 468 (603)
++++|.+++..... ...+++..+..++.|++.||.|||++ +++||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 99999999986432 23367889999999999999999999 8999999999999987 8999999999998764432
Q ss_pred cceeecccccccccCccccccCC--CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGR--ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
. ......|++.|+|||++.+.. ++.++||||||+++|||++|+.||..... ... ...... ....
T Consensus 178 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~-~~~~~~---------~~~~ 243 (295)
T 2clq_A 178 P-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE---PQA-AMFKVG---------MFKV 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS---HHH-HHHHHH---------HHCC
T ss_pred C-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc---hhH-HHHhhc---------cccc
Confidence 1 223456899999999987643 78999999999999999999999864211 000 000000 0011
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+..+...+.++.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11223345567999999999999999999999985
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=345.60 Aligned_cols=261 Identities=27% Similarity=0.391 Sum_probs=188.8
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCC-CCeeeecceeeecCC--cc
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIK-HINLVNLRGYCRLPA--TK 382 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 382 (603)
..++|++.+.||+|+||.||+|.+.. +..||||++..... .....+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 35789999999999999999999874 56799999865432 23456789999999997 999999999997544 67
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|+||||+++ +|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~~-~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYMET-DLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCSE-EHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccCc-CHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 999999985 899888753 288999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCC--------------------CcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCccccc
Q 007455 463 LLVDE--------------------EAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVK 521 (603)
Q Consensus 463 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~ 521 (603)
.+... .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65331 1112234579999999999876 67899999999999999999999999753211
Q ss_pred CCccHhHHHHHHhhhCcchhh-----------h----------cccCCC-------------cCHHHHHHHHHHHHHccc
Q 007455 522 RGLNVVGWMNTLLKENRLEDV-----------I----------DKRCAD-------------ADMETVEAILEIAARCTD 567 (603)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~-----------~----------~~~~~~-------------~~~~~~~~l~~li~~cl~ 567 (603)
. ...-+............ + ...... .....+.++.+|+.+||.
T Consensus 238 ~---~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 N---QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp H---HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred H---HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 0 00000000000000000 0 000000 001234578999999999
Q ss_pred CCCCCCCCHHHHHH
Q 007455 568 ANPDDRPSMNQVLQ 581 (603)
Q Consensus 568 ~~P~~RPs~~evl~ 581 (603)
.||++|||++|+++
T Consensus 315 ~dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 315 FNPNKRISANDALK 328 (388)
T ss_dssp SSGGGSCCHHHHTT
T ss_pred cCcccCCCHHHHhC
Confidence 99999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=343.30 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=193.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCCh-HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGS-DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|.+.+.||+|+||.||+|.+. ++..||+|++....... ...+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999987 55679999986443221 12356799999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++ +|.+++...+. .+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LDK-DLKQYLDDCGN---IINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CSE-EHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred ccc-CHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 985 89888876432 388999999999999999999999 89999999999999999999999999998654332
Q ss_pred cceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC---cchhhhc
Q 007455 469 AHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN---RLEDVID 544 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 544 (603)
. ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .....+....... .+.....
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHhchhhhc
Confidence 2 2234568999999999876 56899999999999999999999999754211 1111111111100 0000000
Q ss_pred c------cCC--------CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 K------RCA--------DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~------~~~--------~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ..+ ......+.++.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 000 011123467899999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=337.80 Aligned_cols=260 Identities=25% Similarity=0.361 Sum_probs=204.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.++|++.+.||+|+||.||+|.+. .+..||||.+.... ......+.+|+.++++++||||+++++++......
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 367889999999999999999843 34579999986443 23345688999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCCC---CccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC---CCeEEe
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEG---QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN---LEPHVS 456 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~ 456 (603)
++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +++||||||+||+++.+ ..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 9999999999999999875421 23488999999999999999999999 89999999999999844 469999
Q ss_pred ecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHh
Q 007455 457 DFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 457 DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
|||+++....... .......|++.|+|||++.+..++.++||||||+++|||++ |+.||..... ........
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~------~~~~~~~~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN------QEVLEFVT 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH------HHHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH------HHHHHHHh
Confidence 9999976543222 22234567889999999988899999999999999999998 8899864321 11111111
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.. .....+...+..+.+++.+||+.+|++|||++|+++.|+...
T Consensus 260 ~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 SG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 11 111222344567999999999999999999999999988754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=339.11 Aligned_cols=258 Identities=20% Similarity=0.296 Sum_probs=192.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
..++|++.+.||+|+||+||+|.+.. +..||||++...... ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 46789999999999999999999874 456999998654322 234578999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC-----CCCCeEEeeccc
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD-----ENLEPHVSDFGL 460 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-----~~~~~kl~DfG~ 460 (603)
|||+++ +|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++ .++.+||+|||+
T Consensus 112 ~e~~~~-~L~~~~~~~~~----~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPD----VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EECCSE-EHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EecCCC-CHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 999985 99999987544 89999999999999999999999 899999999999994 455699999999
Q ss_pred ccccCCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh---
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE--- 536 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--- 536 (603)
++....... ......||+.|+|||++.+. .++.++||||+|+++|||++|+.||...... .........
T Consensus 184 a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~ 256 (329)
T 3gbz_A 184 ARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI------DQLFKIFEVLGL 256 (329)
T ss_dssp HHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCC
T ss_pred ccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH------HHHHHHHHHhCC
Confidence 987643322 23345689999999998764 4899999999999999999999999753211 111111100
Q ss_pred ---Ccchhhh-----cccCC---Cc------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 537 ---NRLEDVI-----DKRCA---DA------DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 537 ---~~~~~~~-----~~~~~---~~------~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+.... ....+ .. ....+.++.+|+.+||+.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 00000 00 0113467899999999999999999999986
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=333.32 Aligned_cols=254 Identities=18% Similarity=0.285 Sum_probs=198.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CCeeeecceeeec--CCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRGYCRL--PATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 386 (603)
++|++.+.||+|+||.||+|.+. ++..||||++... ..+.+.+|+.++++++ ||||+++++++.. ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 57888999999999999999975 5567999998643 3467899999999997 9999999999987 56789999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-CeEEeecccccccC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-EPHVSDFGLAKLLV 465 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~~~ 465 (603)
||+++++|.+++.. ++...+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 99999999998853 78899999999999999999999 899999999999999777 89999999998765
Q ss_pred CCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
.... .....|+..|+|||++.+ ..++.++||||+|+++|||++|+.||...... .................+.++
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~--~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN--YDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH--HHHHHHHHHHHCHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch--HHHHHHHHHhcCCchhhhHHH
Confidence 4332 234568999999999876 67899999999999999999999998543211 000000000000000000000
Q ss_pred cc-----------------------C-CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KR-----------------------C-ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~-----------------------~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. . .......+.++.+++.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 0 0011224678999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=342.14 Aligned_cols=261 Identities=15% Similarity=0.203 Sum_probs=202.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC---------CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeee----------
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND---------CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVN---------- 371 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------- 371 (603)
++|++.+.||+|+||.||+|.+.. +..||+|.+... +.+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578889999999999999999875 567999998644 34889999999999999998
Q ss_pred -----cceeeec-CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCe
Q 007455 372 -----LRGYCRL-PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNI 445 (603)
Q Consensus 372 -----l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NI 445 (603)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NI 190 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENI 190 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHE
Confidence 5566655 67789999999 899999998652 23489999999999999999999999 899999999999
Q ss_pred EECCCC--CeEEeecccccccCCCCcc------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCc
Q 007455 446 LLDENL--EPHVSDFGLAKLLVDEEAH------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDP 517 (603)
Q Consensus 446 ll~~~~--~~kl~DfG~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~ 517 (603)
+++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876543221 12345799999999999988999999999999999999999999975
Q ss_pred ccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 518 TFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 518 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..... .......... ... ......... .....+.++.+++.+||+.||++|||++++++.|+++.
T Consensus 271 ~~~~~-~~~~~~~~~~-~~~-~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 335 (352)
T 2jii_A 271 CLPNT-EDIMKQKQKF-VDK-PGPFVGPCG--HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALL 335 (352)
T ss_dssp GTTCH-HHHHHHHHHH-HHS-CCCEECTTS--CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCcCH-HHHHHHHHhc-cCC-hhhhhhhcc--ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHH
Confidence 42110 1111111111 100 000000000 00123467999999999999999999999999988765
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=330.91 Aligned_cols=252 Identities=25% Similarity=0.447 Sum_probs=203.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeec----------
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRL---------- 378 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 378 (603)
..+|++.+.||+|+||.||+|.+. ++..||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 357888999999999999999987 56789999986543 247789999999999999999998754
Q ss_pred ------CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC
Q 007455 379 ------PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE 452 (603)
Q Consensus 379 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 452 (603)
....++||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 3457899999999999999976422 2389999999999999999999999 8999999999999999999
Q ss_pred eEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHH
Q 007455 453 PHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT 532 (603)
Q Consensus 453 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 532 (603)
+||+|||++........ .....|++.|+|||.+.+..++.++||||||+++|||++|..|+.... .+...
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~ 230 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTD 230 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHH
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHH
Confidence 99999999987654322 234468999999999998889999999999999999999998863210 11111
Q ss_pred HhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCCC
Q 007455 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCP 592 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 592 (603)
. .. .. .+...+..+.+++.+||+.||++|||+.|+++.|+.....++.
T Consensus 231 ~-~~--------~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 231 L-RD--------GI---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp H-HT--------TC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred h-hc--------cc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence 1 11 11 1122345688999999999999999999999999987655544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=338.78 Aligned_cols=257 Identities=23% Similarity=0.355 Sum_probs=202.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCCh-----------------HHHHHHHHHHHhhCCCCeeeec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS-----------------DQVFERELEILGSIKHINLVNL 372 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 372 (603)
.++|++.+.||+|+||.||+|.+ ++..||+|.+....... .+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788999999999999999999 77889999985432111 1679999999999999999999
Q ss_pred ceeeecCCccEEEEEecCCCCcccc------ccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCe
Q 007455 373 RGYCRLPATKLLIYDYLSMGSLDDF------LHEHGEGQQLLNWSARLKIALGSARGLAYLHH-DCCPKIIHRDIKSSNI 445 (603)
Q Consensus 373 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NI 445 (603)
++++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||.|||+ . +++||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999999 5442 13448999999999999999999999 7 899999999999
Q ss_pred EECCCCCeEEeecccccccCCCCcceeecccccccccCccccccC-CCCc-ccchHhHHHHHHHHHhCCCCCCcccccCC
Q 007455 446 LLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG-RATE-KSDVYSFGVLLLELVTGKRPTDPTFVKRG 523 (603)
Q Consensus 446 ll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~slG~vl~elltg~~p~~~~~~~~~ 523 (603)
+++.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||+|+++|||++|+.||......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-- 258 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-- 258 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence 9999999999999999876443 33456689999999999876 5666 999999999999999999999753210
Q ss_pred ccHhHHHHHHhhhCcchhhhc----------ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 524 LNVVGWMNTLLKENRLEDVID----------KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 524 ~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......... ........ ..........+.++.+++.+||+.||++|||++|+++
T Consensus 259 ---~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 259 ---VELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---HHHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111111 11000000 0000001334568999999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=340.66 Aligned_cols=252 Identities=15% Similarity=0.166 Sum_probs=203.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEE------ECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC---CCeeeecceeeecCC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMV------MNDCGTFAVKRIDRSREGSDQVFERELEILGSIK---HINLVNLRGYCRLPA 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 380 (603)
.++|.+.+.||+|+||.||+|. ...+..||||++... ....+.+|++++..++ |+||+++++++...+
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 3578888999999999999994 334567999998653 3456788888888886 999999999999999
Q ss_pred ccEEEEEecCCCCccccccccCC-CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC----------
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGE-GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE---------- 449 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---------- 449 (603)
..++||||+++|+|.+++..... ....+++..++.++.|+++||+|||++ +|+||||||+|||++.
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC-----
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccc
Confidence 99999999999999999975322 234499999999999999999999998 8999999999999998
Q ss_pred -CCCeEEeecccccccCC-CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHh
Q 007455 450 -NLEPHVSDFGLAKLLVD-EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVV 527 (603)
Q Consensus 450 -~~~~kl~DfG~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~ 527 (603)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 89999999999976542 22333455679999999999999899999999999999999999999986432110
Q ss_pred HHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHhhcc
Q 007455 528 GWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDR-PSMNQVLQLLEQEV 587 (603)
Q Consensus 528 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-Ps~~evl~~L~~~~ 587 (603)
.. +....... .....+.+++..|++.+|.+| |+++++.+.|++..
T Consensus 293 ---------~~----~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 ---------CK----PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ---------EE----ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ---------ee----echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 00 01111111 124567889999999999999 78888888887644
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=332.88 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=197.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC--CC--EEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND--CG--TFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~--~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
++|++.+.||+|+||.||+|.+.. +. .||+|+++... ....+.+.+|++++++++||||+++++++..+. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 578889999999999999998642 22 48999886542 233467899999999999999999999997754 89
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+|+||+++|+|.+++.... ..+++..+..++.|+++||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 97 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999997642 2388999999999999999999999 899999999999999999999999999987
Q ss_pred cCCCCcce--eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 464 LVDEEAHV--TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 464 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
........ .....+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ...........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~--- 241 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEG--- 241 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSC---
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH------HHHHHHHHccC---
Confidence 75443321 223457788999999988889999999999999999999 9999865321 11111111111
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCCCc
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPS 593 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 593 (603)
.....+...+.++.+++.+||..+|++|||++++++.|++........
T Consensus 242 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 289 (291)
T 1u46_A 242 -----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDMRA 289 (291)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred -----CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccchhh
Confidence 011122345577999999999999999999999999999876544433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=346.56 Aligned_cols=198 Identities=24% Similarity=0.343 Sum_probs=166.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecC-----Ccc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLP-----ATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 382 (603)
++|++.+.||+|+||.||+|.+..++ .||||++...... ..+.+.+|++++++++||||+++++++... ...
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 57888999999999999999987654 5999999754333 345788999999999999999999998766 568
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|+||||+++ +|.+++.... .+++..+..++.||++||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~lv~e~~~~-~L~~~~~~~~----~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 106 YIVLEIADS-DLKKLFKTPI----FLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEECCSE-EHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecCCc-CHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 999999875 9999987643 389999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCc---------------------ceeecccccccccCcccc-ccCCCCcccchHhHHHHHHHHHhCCCCCC
Q 007455 463 LLVDEEA---------------------HVTTVVAGTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTGKRPTD 516 (603)
Q Consensus 463 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~vl~elltg~~p~~ 516 (603)
....... .......||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 7654321 122456799999999986 56679999999999999999999766654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=353.10 Aligned_cols=193 Identities=24% Similarity=0.341 Sum_probs=153.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeec-----CCcc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRL-----PATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~ 382 (603)
++|++.+.||+|+||.||+|.+. .+..||||++...... ..+.+.+|++++++++||||+++++++.. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57899999999999999999987 4567999999654333 34568899999999999999999999843 3568
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|+||||+. |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~lv~e~~~-~~L~~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTPV----YLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCCS-EEHHHHHHSSC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEeccc-cchhhhcccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 99999985 58999887643 389999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCc--------------------------ceeecccccccccCcccc-ccCCCCcccchHhHHHHHHHHHhC
Q 007455 463 LLVDEEA--------------------------HVTTVVAGTFGYLAPEYL-QSGRATEKSDVYSFGVLLLELVTG 511 (603)
Q Consensus 463 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~slG~vl~elltg 511 (603)
....... .......||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7643211 122345689999999976 566799999999999999999994
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=367.48 Aligned_cols=249 Identities=22% Similarity=0.321 Sum_probs=206.2
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCC---CCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRS---REGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 383 (603)
..++|++.++||+|+||.||+|.+..+ ..||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 467899999999999999999998754 46999998643 223345678899999987 7999999999999999999
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+++|+|.+++...+. +++..+..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~~~----~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999987543 89999999999999999999999 899999999999999999999999999986
Q ss_pred cCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+..
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~-------- 556 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIME-------- 556 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHS--------
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHh--------
Confidence 43322 234556799999999999999999999999999999999999999975321 111111111
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSM-----NQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~-----~evl~ 581 (603)
.....+...+.++.+|+.+||+.||++||++ +|+++
T Consensus 557 --~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 557 --HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --SCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --CCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1122334456789999999999999999997 77763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=335.07 Aligned_cols=253 Identities=28% Similarity=0.424 Sum_probs=202.7
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC--------hHHHHHHHHHHHhhC-CCCeeeecceeee
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG--------SDQVFERELEILGSI-KHINLVNLRGYCR 377 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 377 (603)
...++|++.+.||+|+||.||+|.+. ++..||||++...... ..+.+.+|+.+++++ +||||+++++++.
T Consensus 91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 170 (365)
T 2y7j_A 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE 170 (365)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence 34567999999999999999999987 5678999998654321 134578999999999 7999999999999
Q ss_pred cCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEee
Q 007455 378 LPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSD 457 (603)
Q Consensus 378 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 457 (603)
.....++||||+++++|.+++..... +++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|
T Consensus 171 ~~~~~~lv~e~~~g~~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 171 SSSFMFLVFDLMRKGELFDYLTEKVA----LSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp BSSEEEEEECCCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred eCCEEEEEEEeCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEe
Confidence 99999999999999999999976433 89999999999999999999998 899999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCcccccc------CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHH
Q 007455 458 FGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 458 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 531 (603)
||++........ .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .....
T Consensus 244 fG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~------~~~~~ 315 (365)
T 2y7j_A 244 FGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ------ILMLR 315 (365)
T ss_dssp CTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH
T ss_pred cCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH------HHHHH
Confidence 999987654332 234679999999998863 3578899999999999999999999965321 11111
Q ss_pred HHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 532 TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... ...... .+. ....+..+.+++.+||+.||++|||++|+++
T Consensus 316 ~i~~-~~~~~~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 316 MIME-GQYQFS-SPE----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHH-TCCCCC-HHH----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHh-CCCCCC-Ccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111 100000 000 0122456899999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=339.82 Aligned_cols=262 Identities=24% Similarity=0.384 Sum_probs=202.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||.||+|.+. .+..||+|++..... ...+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 57888999999999999999987 456799999865432 2345689999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++..... +++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~~~----~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999987543 899999999999999999999842 7999999999999999999999999999765322
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhH--------------------
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVG-------------------- 528 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~-------------------- 528 (603)
......||+.|+|||++.+..++.++||||+|+++|||++|+.||.............
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1234568999999999999899999999999999999999999997532110000000
Q ss_pred ---HHHHHhhhCcc----hhhhcccCCC-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 529 ---WMNTLLKENRL----EDVIDKRCAD-ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 529 ---~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
+.......... ........+. .....+.++.+++.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000000000 0000111111 11234567999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=345.93 Aligned_cols=262 Identities=20% Similarity=0.265 Sum_probs=204.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCC-CeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKH-INLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||.||+|.+. .+..||||++...... ..+.+|+++++.+.| +++..+..++...+..++||||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~ 84 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDL 84 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEEC
Confidence 57899999999999999999985 4567999987654332 247899999999987 4555666666778888999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE---CCCCCeEEeecccccccC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~~~~ 465 (603)
+ +++|.+++..... .+++..++.++.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 85 ~-g~sL~~ll~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 85 L-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred C-CCCHHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 9 8899999975332 389999999999999999999999 89999999999999 588999999999998775
Q ss_pred CCCcc------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 466 DEEAH------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 466 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 54321 123567999999999999999999999999999999999999999764322111111111111111111
Q ss_pred hhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
.. ... ..+.++.+++..||+.+|++||+++++++.|++....
T Consensus 238 ~~----l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 238 EA----LCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HH----HHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HH----Hhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 11 111 2245799999999999999999999999999886543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.12 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=192.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCC------c
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPA------T 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 381 (603)
++|+..+.||+|+||.||+|.+. .+..||||++...... ..+.+.+|+++++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 57888899999999999999986 4567999999654332 2456889999999999999999999997653 4
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.|+||||+ +++|.+++... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecC-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 59999999 77999998763 288999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh-C-c
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE-N-R 538 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~-~ 538 (603)
+..... .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ......... . .
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL------DQLKEIMKVTGTP 245 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCC
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHhcCCC
Confidence 875432 234568999999999876 67899999999999999999999999754211 111111000 0 0
Q ss_pred c------------hhhh-------cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 L------------EDVI-------DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~------------~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ...+ ...........+..+.+|+.+||..||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 0000 00001111234567999999999999999999999997
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=328.26 Aligned_cols=254 Identities=20% Similarity=0.317 Sum_probs=199.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC----CChHHHHHHHHHHHhhCCCCeeeecceeee--cCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR----EGSDQVFERELEILGSIKHINLVNLRGYCR--LPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 382 (603)
.++|.+.+.||+|+||.||+|.+.. +..+|+|.+.... ......+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4689999999999999999999864 5579999986432 234567899999999999999999999984 45678
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
++||||++++ |.+++..... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999986 7777765432 3489999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCC-cceeecccccccccCccccccCC--CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 463 LLVDEE-AHVTTVVAGTFGYLAPEYLQSGR--ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 463 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
...... ........|++.|+|||++.+.. ++.++||||+|+++|||++|+.||.... .......... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~i~~-~-- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN------IYKLFENIGK-G-- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHH-C--
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch------HHHHHHHHhc-C--
Confidence 764322 22234456899999999987643 3779999999999999999999997532 1111111111 1
Q ss_pred hhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 007455 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQ 585 (603)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~ 585 (603)
....+...+..+.+++.+||..||++|||++|+++ .+.+
T Consensus 229 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 229 -------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp -------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred -------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 11122234567899999999999999999999996 4544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.80 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=195.9
Q ss_pred HHhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC-----hHHHHHHHHHHHhhCCCCeeeecceeeecCCc
Q 007455 308 EKLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG-----SDQVFERELEILGSIKHINLVNLRGYCRLPAT 381 (603)
Q Consensus 308 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 381 (603)
...++|++.+.||+|+||.||+|.+.. +..||||++...... ..+.+.+|+++++.++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 446789999999999999999999874 567999998643221 12457899999999999999999999999999
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.++||||+++ +|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred eEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 9999999987 8888887543 2378889999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh---C
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE---N 537 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 537 (603)
+....... ......||+.|+|||++.+. .++.++||||+|+++|||++|..||..... .......... .
T Consensus 160 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~------~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 160 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD------LDQLTRIFETLGTP 232 (346)
T ss_dssp STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHHHCCC
T ss_pred eeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHHHcCCC
Confidence 87654322 23345689999999998654 578999999999999999999999865321 1111111110 0
Q ss_pred ---cchhh------hc-ccCCCcC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 ---RLEDV------ID-KRCADAD-----METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 ---~~~~~------~~-~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+... +. ...+..+ ...+.++.+++.+||..||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000 00 0000011 233467999999999999999999999997
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=353.76 Aligned_cols=250 Identities=24% Similarity=0.346 Sum_probs=203.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+. .+..||||++.... ......+.+|+.++++++||||+++++++...+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 357888999999999999999987 55679999985432 33456799999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE---CCCCCeEEeeccccc
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL---DENLEPHVSDFGLAK 462 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~~~ 462 (603)
|||+.+|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 105 ~e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC----CBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999998876543 89999999999999999999999 89999999999999 567899999999998
Q ss_pred ccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
.+..... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......... .....
T Consensus 178 ~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~-~~~~~- 246 (484)
T 3nyv_A 178 HFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE------YDILKKVEK-GKYTF- 246 (484)
T ss_dssp HBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCCCC-
T ss_pred Ecccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHc-CCCCC-
Confidence 7654332 234569999999999876 689999999999999999999999975321 111111111 11000
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. .......+.++.+++.+||+.+|++|||++|+++
T Consensus 247 ---~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ---E-LPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ---C-SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---C-CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 0111234567999999999999999999999995
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=334.62 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=198.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCCh--HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.++|++.+.||+|+||.||+|.+.. +..||+|++....... .+.+.+|+.++++++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 5688999999999999999999875 5679999986544332 355789999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++++|.++...... +++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 104 e~~~~~~l~~~~~~~~~----~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNG----LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHSTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999999887665433 89999999999999999999999 899999999999999999999999999986644
Q ss_pred CCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHH----------HHHhh
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWM----------NTLLK 535 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~----------~~~~~ 535 (603)
... ......||+.|+|||++.+. .++.++||||+|+++|||++|+.||....... ...... .....
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID--QLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHHHHHH
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCChhhhhHhh
Confidence 322 22345689999999998765 68899999999999999999999997542110 000000 00000
Q ss_pred hCc-chhhhcccCCC------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 536 ENR-LEDVIDKRCAD------ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 536 ~~~-~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... ......+.... .....+..+.+++.+||+.||++|||++|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 00000000000 01134567999999999999999999999986
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=332.34 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=199.2
Q ss_pred hhCCCCC-CeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEE
Q 007455 310 LEALDEE-DVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIK-HINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~-~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 384 (603)
.+.|.+. +.||+|+||.||+|.+.. +..||+|++..... .....+.+|+.++..+. ||||+++++++...+..++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 3456665 889999999999999874 56799999865432 23567899999999995 6999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC---CCCeEEeecccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE---NLEPHVSDFGLA 461 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~~ 461 (603)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a 181 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181 (327)
T ss_dssp EEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGC
T ss_pred EEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccc
Confidence 999999999999986532 23489999999999999999999999 8999999999999998 789999999999
Q ss_pred cccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
+....... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ..........
T Consensus 182 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~---- 249 (327)
T 3lm5_A 182 RKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ------ETYLNISQVN---- 249 (327)
T ss_dssp EEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC----
T ss_pred cccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHHHhcc----
Confidence 87644322 23456999999999999899999999999999999999999999653211 1111111000
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...........+..+.+++.+||+.||++|||++|+++
T Consensus 250 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 250 --VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp --CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00011112234567999999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.43 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=201.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.++|++.+.||+|+||+||+|.+. .+..||||++... .......+.+|++++++++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 467899999999999999999987 4567999998532 2334567899999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC---CCCCeEEeecccccc
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD---ENLEPHVSDFGLAKL 463 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~~~~ 463 (603)
||+.+|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~~~----~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999998876543 89999999999999999999999 899999999999995 456799999999987
Q ss_pred cCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
..... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||..... ......... .....
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~-~~~~~-- 241 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVET-GKYAF-- 241 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-TCCCS--
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-CCCCC--
Confidence 64432 2334569999999999875 589999999999999999999999965321 111111111 11000
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. .......+.++.+++.+||+.+|++|||+.|+++
T Consensus 242 --~-~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 242 --D-LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp --C-SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --C-CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0011234567999999999999999999999997
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=351.61 Aligned_cols=250 Identities=24% Similarity=0.306 Sum_probs=199.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCC-------------ChHHHHHHHHHHHhhCCCCeeeeccee
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSRE-------------GSDQVFERELEILGSIKHINLVNLRGY 375 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 375 (603)
.++|.+.+.||+|+||+||+|.+..+ ..||+|++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 46788899999999999999998754 5799999865321 234678999999999999999999999
Q ss_pred eecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC---C
Q 007455 376 CRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL---E 452 (603)
Q Consensus 376 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~---~ 452 (603)
+.+....++||||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||+++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRHK----FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999876543 89999999999999999999999 899999999999998876 6
Q ss_pred eEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHH
Q 007455 453 PHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT 532 (603)
Q Consensus 453 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 532 (603)
+||+|||+++...... ......||+.|+|||++. +.++.++||||+|+++|+|++|+.||..... ......
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~ 258 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND------QDIIKK 258 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHH
Confidence 9999999998765432 234456999999999987 4689999999999999999999999975321 111111
Q ss_pred HhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... ....... ......+.++.+++.+||..||.+|||++|+++
T Consensus 259 i~~-~~~~~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEK-GKYYFDF-----NDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHH-CCCCCCH-----HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHc-CCCCCCc-----cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 111 1100000 000123467999999999999999999999985
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=351.88 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=197.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.+.|++.+.||+|+||+||+|.+.. +..||+|++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3568889999999999999999874 4579999986543 333567899999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC---CCeEEeecccccc
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN---LEPHVSDFGLAKL 463 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~~~~ 463 (603)
||+++|+|.+++..... +++..+..++.|++.||.|||++ +|+||||||+|||++.. +.+||+|||+++.
T Consensus 116 e~~~~g~L~~~~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMK----FNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ecCCCCcHHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999998876543 89999999999999999999999 89999999999999764 4599999999987
Q ss_pred cCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
..... ......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... .......... ....
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~------~~~~~~i~~~-~~~~-- 256 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD------QEILRKVEKG-KYTF-- 256 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT-CCCC--
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-CCCC--
Confidence 65432 234456999999999986 4689999999999999999999999975321 1111111111 1000
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. .......+..+.+++.+||+.+|++|||++|+++
T Consensus 257 ~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 D---SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp C---SGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C---chhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 0 0011134467999999999999999999999985
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=323.39 Aligned_cols=246 Identities=26% Similarity=0.403 Sum_probs=195.6
Q ss_pred CCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeec----CCccEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRL----PATKLL 384 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 384 (603)
.|.+.+.||+|+||.||+|.+..+ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 466678899999999999998754 4699998865432 234568899999999999999999998865 355799
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCCeEEC-CCCCeEEeecccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK--IIHRDIKSSNILLD-ENLEPHVSDFGLA 461 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~-~~~~~kl~DfG~~ 461 (603)
||||+++|+|.+++..... +++..++.++.|++.||.|||+. + ++||||||+||+++ .++.+||+|||++
T Consensus 107 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp EEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EEEecCCCCHHHHHHHccC----CCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 9999999999999986543 89999999999999999999998 6 99999999999998 7899999999999
Q ss_pred cccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
....... .....||+.|+|||++.+ .++.++||||+|+++|+|++|+.||.... .............. ..
T Consensus 180 ~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~-~~ 249 (290)
T 1t4h_A 180 TLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTSGVK-PA 249 (290)
T ss_dssp GGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTTTCC-CG
T ss_pred ccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC-----cHHHHHHHHhccCC-cc
Confidence 7654332 234568999999998874 58999999999999999999999996432 11111111111111 00
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+.++.+++.+||+.||++|||++|+++
T Consensus 250 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 -------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011222357999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=337.36 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=186.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CCeeeecceeee--------cCC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRGYCR--------LPA 380 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~~~ 380 (603)
.+|++.+.||+|+||.||+|.+. .+..||||++........+.+.+|+.++.++. ||||+++++++. ...
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 46888899999999999999986 45679999986655555667899999999996 999999999984 334
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCCeEECCCCCeEEeec
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK--IIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
..++||||+. |+|.+++..... ...+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred eEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecC
Confidence 4789999997 599998875322 22389999999999999999999998 7 999999999999999999999999
Q ss_pred ccccccCCCCcc-----------eeecccccccccCcccc---ccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCc
Q 007455 459 GLAKLLVDEEAH-----------VTTVVAGTFGYLAPEYL---QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL 524 (603)
Q Consensus 459 G~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~ 524 (603)
|+++........ ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 999876543221 11234589999999998 56678899999999999999999999986432110
Q ss_pred cHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 525 NVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
... ... . .......+..+.+++.+||+.||++|||++|+++.|+...
T Consensus 261 ----~~~-----~~~----~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 261 ----IVN-----GKY----S---IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp --------------C----C---CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----hhc-----Ccc----c---CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 000 000 0 0011122245889999999999999999999999998754
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.47 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=197.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeec--------
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRL-------- 378 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 378 (603)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+++++.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 478999999999999999999985 55679999985443 2234568899999999999999999999876
Q ss_pred CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 379 PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
.+..++||||+++ +|.+.+..... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 3467999999986 77776665322 389999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCC---cceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 459 GLAKLLVDEE---AHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 459 G~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
|+++.+.... ........||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... .....+....
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~ 245 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLC 245 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 9998764322 122344568999999998875 45799999999999999999999999754211 1111111111
Q ss_pred hhC---cchhh--------hcccCC-CcCH-------HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 KEN---RLEDV--------IDKRCA-DADM-------ETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 ~~~---~~~~~--------~~~~~~-~~~~-------~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... ..... +..... .... ..+..+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000 00000 000000 0000 11356889999999999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=329.84 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=195.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCC--------ChHHHHHHHHHHHhhCCCCeeeecceeeecCC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSRE--------GSDQVFERELEILGSIKHINLVNLRGYCRLPA 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 380 (603)
.++|.+.+.||+|+||.||+|.+..+ ..||||.+..... .....+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 35788999999999999999998754 5699999864321 12234789999999999999999999987654
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC---eEEee
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE---PHVSD 457 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D 457 (603)
.++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK----RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 899999999999999887643 389999999999999999999999 8999999999999987665 99999
Q ss_pred cccccccCCCCcceeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 458 FGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 458 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||...... .......
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~---- 232 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ--VSLKDQI---- 232 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS--SCHHHHH----
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH--HHHHHHH----
Confidence 99998764332 223456899999999873 467889999999999999999999999753221 1111111
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...... ..+......+.++.+++.+||..||++|||++|+++
T Consensus 233 ~~~~~~-----~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKYN-----FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCCC-----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCccc-----cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111100 000001123467999999999999999999999984
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=328.64 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=198.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.+.|++.+.||+|+||.||+|.+.. +..+|+|.+........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 3678889999999999999999875 567999999776666667899999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++++|.+++..... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 98 CPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CTTEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred CCCCcHHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999998875322 389999999999999999999999 8999999999999999999999999987543211
Q ss_pred cceeecccccccccCcccc-----ccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 469 AHVTTVVAGTFGYLAPEYL-----QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
........|++.|+|||++ ....++.++||||||+++|||++|+.||..... ............
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~----- 239 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDP----- 239 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-----
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCC-----
Confidence 1112334689999999988 356788999999999999999999999875321 111111111110
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+...+.++.+++.+||+.||++|||++|+++
T Consensus 240 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 --PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp --CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred --cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 001112334567999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=362.06 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=203.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC----CEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC----GTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
.++|++.+.||+|+||.||+|.+..+ ..||+|.+...... ..+.+.+|+.++++++||||+++++++. .+..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 46788889999999999999998532 35899988654332 3367899999999999999999999985 467899
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+++|+|.+++.... ..+++..++.++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 468 v~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp EEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred EEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 999999999999998643 2389999999999999999999999 8999999999999999999999999999877
Q ss_pred CCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 465 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
............+++.|+|||++.+..++.++||||||+++|||++ |..||..... ..........
T Consensus 542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~------~~~~~~i~~~------- 608 (656)
T 2j0j_A 542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN------NDVIGRIENG------- 608 (656)
T ss_dssp CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHHT-------
T ss_pred CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHcC-------
Confidence 5544333444557789999999998899999999999999999997 8999865321 1111111111
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.....+...+..+.+++.+||..||++|||++|+++.|+++.
T Consensus 609 --~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 609 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111223345578999999999999999999999999998754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=328.38 Aligned_cols=250 Identities=25% Similarity=0.384 Sum_probs=199.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.+.|++.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+|+.++++++||||+++++++...+..++||||
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 4678889999999999999999875 5679999986543 345689999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 106 ~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 106 CGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999987432 2389999999999999999999999 89999999999999999999999999998765432
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...... ..... ...
T Consensus 180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~------~~~ 245 (314)
T 3com_A 180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMI-PTNPP------PTF 245 (314)
T ss_dssp S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHH-HHSCC------CCC
T ss_pred c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHH-hcCCC------ccc
Confidence 2 223456899999999999888999999999999999999999998653210 000000 00100 000
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+..+.+++.+||..||.+|||++++++
T Consensus 246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 112234567999999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.87 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=190.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCC------
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPA------ 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 380 (603)
.++|++.+.||+|+||.||+|.+.. +..||||++...... ..+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3578889999999999999999874 456999998654322 3356889999999999999999999997665
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..++||||+++ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 67999999986 78777753 278999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH-------
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL------- 533 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~------- 533 (603)
++...... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||...... ..+....
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~~ 246 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI-----DQWNKVIEQLGTPC 246 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHC-CCCCC
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCC
Confidence 98654322 233456899999999999889999999999999999999999999753211 1111000
Q ss_pred --------------hhhC------cchhhhcccCCC----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 --------------LKEN------RLEDVIDKRCAD----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 --------------~~~~------~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... .+...+...... .....+.++.+|+.+||..||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000 000000000000 11233678999999999999999999999996
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.66 Aligned_cols=265 Identities=21% Similarity=0.279 Sum_probs=195.5
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCCh-----------HHHHHHHHHHHhhCCCCeeeecc
Q 007455 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS-----------DQVFERELEILGSIKHINLVNLR 373 (603)
Q Consensus 305 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~ 373 (603)
++....++|.+.+.||+|+||.||+|.+.++..||||++....... .+.+.+|++++++++||||++++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 95 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLR 95 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCS
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcccee
Confidence 4555678999999999999999999999888899999985432211 26789999999999999999999
Q ss_pred eeeec-----CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC
Q 007455 374 GYCRL-----PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD 448 (603)
Q Consensus 374 ~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 448 (603)
+++.. ....++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 96 DIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA 168 (362)
T ss_dssp EEEEECCTTTCCEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred eeEEeccCCCcceEEEEEccCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence 99844 3357999999984 8888877532 2489999999999999999999999 899999999999999
Q ss_pred CCCCeEEeecccccccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHh
Q 007455 449 ENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVV 527 (603)
Q Consensus 449 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~ 527 (603)
.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... ...
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~ 243 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY---NQL 243 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHH
T ss_pred CCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH---HHH
Confidence 99999999999997543322 2234568999999999876 67899999999999999999999999753211 011
Q ss_pred HHHHHHhhhCc-----------chhhhcccCCC--------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 528 GWMNTLLKENR-----------LEDVIDKRCAD--------ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 528 ~~~~~~~~~~~-----------~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........... ..+.+...... .....+..+.+++.+||+.||++|||++|+++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 00100000000 00001000000 11223467899999999999999999999996
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=331.71 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=185.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||.||+|.+. ++..||||.+.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 468899999999999999999975 45679999886432 2334568899999999999999999999999999999999
Q ss_pred ecCCCCccccccccC----CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 388 YLSMGSLDDFLHEHG----EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
|+++|+|.+++.... .....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 999999999987421 1123489999999999999999999999 899999999999999999999999999876
Q ss_pred cCCCCc----ceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 464 LVDEEA----HVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 464 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
...... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ..........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~ 244 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQNDP 244 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHTSSC
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhccCC
Confidence 643221 11234568999999999865 568899999999999999999999997532111 1111111110
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
................+.++.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000000000111233467899999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=327.33 Aligned_cols=254 Identities=24% Similarity=0.341 Sum_probs=187.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCCh--HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.++|++.+.||+|+||.||+|.+. +++.||+|++....... .+.+.++...++.++||||+++++++..++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467888999999999999999986 45569999996543222 223445555688889999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++ +|.+++.........+++..++.++.|++.||+|||++. +++||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 99985 888877653333345899999999999999999999963 799999999999999999999999999987644
Q ss_pred CCcceeecccccccccCcccc----ccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 467 EEAHVTTVVAGTFGYLAPEYL----QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
... .....||+.|+|||++ .+..++.++||||+|+++|||++|+.||.... ... ...........
T Consensus 163 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~-~~~~~~~~~~~---- 231 (290)
T 3fme_A 163 DVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG----TPF-QQLKQVVEEPS---- 231 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS----CHH-HHHHHHHHSCC----
T ss_pred ccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC----chH-HHHHHHhccCC----
Confidence 322 2334689999999996 55678899999999999999999999996421 111 11111111110
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+.++.+++.+||+.+|++|||++|+++
T Consensus 232 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 ----PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11112234567999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=332.85 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=198.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecC-----CccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLP-----ATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 383 (603)
.+|++.+.||+|+||.||+|.+..+ ..||||++...... ..+.+.+|++++++++||||+++++++... ...+
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 106 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 106 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEE
Confidence 4788899999999999999998754 46999999754332 236688999999999999999999998654 3679
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+.+ +|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 107 iv~e~~~~-~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 107 IVQDLMET-DLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEECCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEcccCc-CHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999985 999988753 289999999999999999999999 899999999999999999999999999987
Q ss_pred cCCCCcce--eecccccccccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 464 LVDEEAHV--TTVVAGTFGYLAPEYLQ-SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 464 ~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
........ .....||+.|+|||++. +..++.++||||+|+++|||++|+.||...... .....+..........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 254 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPSQE 254 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG---GHHHHHHHHHCSCCHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHHHhCCCCHH
Confidence 65432221 23457999999999865 445899999999999999999999999754321 1111111110000000
Q ss_pred -----------hhh----cccCCC---cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 -----------DVI----DKRCAD---ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 -----------~~~----~~~~~~---~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... ...... .....+.++.+++.+||+.||++|||++|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000 01123467899999999999999999999996
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=333.74 Aligned_cols=266 Identities=24% Similarity=0.396 Sum_probs=198.5
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||.||+|.+.+ .+|+|+++.... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 4678899999999999999999865 599998864322 223457889999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++++|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+||+++ ++.+||+|||+++.....
T Consensus 110 ~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 110 LCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp CCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred cccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999997643 2388999999999999999999999 899999999999998 679999999998765321
Q ss_pred C----cceeecccccccccCcccccc---------CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 468 E----AHVTTVVAGTFGYLAPEYLQS---------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 468 ~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
. ........|++.|+|||++.+ ..++.++||||||+++|||++|+.||..... ........
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~ 256 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA------EAIIWQMG 256 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH------HHHHHHHH
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHhc
Confidence 1 112233458999999999864 3578899999999999999999999875321 11111111
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC----CCCcccccc
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS----PCPSDFYES 598 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~----~~~~~~~~~ 598 (603)
. .. .... .....+.++.+++.+||..+|++|||++++++.|+++... +.+..||.+
T Consensus 257 ~-~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~~ 316 (319)
T 2y4i_B 257 T-GM-----KPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316 (319)
T ss_dssp T-TC-----CCCC--CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----------------
T ss_pred c-CC-----CCCC--CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcccccc
Confidence 1 10 0000 1112345689999999999999999999999999986533 444455543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=340.63 Aligned_cols=197 Identities=24% Similarity=0.314 Sum_probs=170.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhC------CCCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSI------KHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~~ 383 (603)
.+|++.+.||+|+||.||+|.+..+ ..||||++.... .....+.+|+++++.+ .|+||+++++++......+
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 175 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHIC 175 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEE
Confidence 5688899999999999999998764 569999986532 2345678888888877 5779999999999999999
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC--eEEeecccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE--PHVSDFGLA 461 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~~ 461 (603)
+||||+. ++|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 176 lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 176 MTFELLS-MNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEECCCC-CBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEeccC-CCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 9999997 599998886542 2389999999999999999999999 8999999999999999987 999999999
Q ss_pred cccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcc
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPT 518 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~ 518 (603)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 765332 23456899999999999989999999999999999999999999754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=324.76 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=202.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC---------ChHHHHHHHHHHHhhCC-CCeeeecceeeec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE---------GSDQVFERELEILGSIK-HINLVNLRGYCRL 378 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 378 (603)
.++|++.+.||+|+||.||+|.+.. +..||||.+..... ...+.+.+|+++++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4688899999999999999999875 45699999865431 11345789999999995 9999999999999
Q ss_pred CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 379 PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
....++||||+++++|.+++..... +++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999986533 89999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccc------cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHH
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ------SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT 532 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~ 532 (603)
|++........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||..... ......
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~ 240 (298)
T 1phk_A 169 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLMLRM 240 (298)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHH
T ss_pred cchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH------HHHHHH
Confidence 99987654322 23456899999999885 45678899999999999999999999864321 111111
Q ss_pred HhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 533 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..... .. .........+..+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~-~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGN-YQ-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTC-CC-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCC-cc-----cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111 00 000111234567999999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=339.80 Aligned_cols=255 Identities=25% Similarity=0.341 Sum_probs=180.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecC------Cc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLP------AT 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 381 (603)
++|++.+.||+|+||.||+|.+.. +..||||++...... ..+.+.+|+++++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 578889999999999999999875 456999998654332 345688999999999999999999998654 56
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.++|+||+ +++|.+++... .+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CEEEEECC-CEECC-----C-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEEEeccc-CCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 79999999 67999988752 389999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc--
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR-- 538 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 538 (603)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+........
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLVGTPGAE 252 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCSCCHH
T ss_pred cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHH
Confidence 865432 234568999999999876 67899999999999999999999999753211 11111111000000
Q ss_pred ---------chhhhcc--cCCCcC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 ---------LEDVIDK--RCADAD-----METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ---------~~~~~~~--~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+.. ..+... ...+..+.+|+.+||..||++|||++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 0000000 000000 123467899999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=338.68 Aligned_cols=260 Identities=21% Similarity=0.286 Sum_probs=194.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecC--------
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLP-------- 379 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 379 (603)
..++|++.+.||+|+||.||+|.+. .+..||||++...... ..+|+++++.++||||+++++++...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 4568899999999999999999986 4567999998654332 34799999999999999999998443
Q ss_pred ------------------------------CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHh
Q 007455 380 ------------------------------ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429 (603)
Q Consensus 380 ------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~ 429 (603)
...++||||+++ +|.+.+.........+++..+..++.|+++||+|||+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp -----------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 337899999995 8887776533333458999999999999999999999
Q ss_pred CCCCCeEEecCCCCCeEEC-CCCCeEEeecccccccCCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHH
Q 007455 430 DCCPKIIHRDIKSSNILLD-ENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLE 507 (603)
Q Consensus 430 ~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~e 507 (603)
. +|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+||++||
T Consensus 160 ~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 160 L---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp T---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred C---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 8 899999999999997 688999999999987654332 2345689999999998764 48999999999999999
Q ss_pred HHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh----------hcccCCC------cCHHHHHHHHHHHHHcccCCCC
Q 007455 508 LVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV----------IDKRCAD------ADMETVEAILEIAARCTDANPD 571 (603)
Q Consensus 508 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~------~~~~~~~~l~~li~~cl~~~P~ 571 (603)
|++|+.||....... .+.... ........... .-+.... .+...+.++.+|+.+||..||+
T Consensus 235 ll~g~~pf~~~~~~~--~~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 235 LILGKPLFSGETSID--QLVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHSSCSSCCSSHHH--HHHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHhCCCCCCCCChHH--HHHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999997542110 000000 00000000000 0000000 1223456799999999999999
Q ss_pred CCCCHHHHHH
Q 007455 572 DRPSMNQVLQ 581 (603)
Q Consensus 572 ~RPs~~evl~ 581 (603)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999984
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=335.19 Aligned_cols=261 Identities=21% Similarity=0.253 Sum_probs=199.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhCC--------CCeeeecceeee----
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSIK--------HINLVNLRGYCR---- 377 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---- 377 (603)
++|++.+.||+|+||.||+|.+..+ ..||||++... ....+.+.+|+++++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 6789999999999999999998754 46999998643 233456889999999985 788999999987
Q ss_pred cCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC------
Q 007455 378 LPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL------ 451 (603)
Q Consensus 378 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~------ 451 (603)
.....++||||+. ++|.+++..... ..+++..++.++.|++.||+|||+++ +|+||||||+|||++.++
T Consensus 116 ~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 116 NGTHICMVFEVLG-HHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TEEEEEEEECCCC-CBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCceEEEEEeccC-ccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 5567899999994 566666654321 33899999999999999999999964 799999999999999775
Q ss_pred -------------------------------------------CeEEeecccccccCCCCcceeecccccccccCccccc
Q 007455 452 -------------------------------------------EPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488 (603)
Q Consensus 452 -------------------------------------------~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 488 (603)
.+||+|||+++..... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999876432 23356899999999999
Q ss_pred cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh---h--------Ccch-hhhc------------
Q 007455 489 SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK---E--------NRLE-DVID------------ 544 (603)
Q Consensus 489 ~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~--------~~~~-~~~~------------ 544 (603)
+..++.++|||||||++|||++|+.||.................... . .... ..+.
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 88999999999999999999999999976432221111111111100 0 0000 0000
Q ss_pred --------ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 --------KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 --------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......+...+..+.+|+.+||+.||++|||++|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0011234567788999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=338.91 Aligned_cols=252 Identities=12% Similarity=0.075 Sum_probs=180.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC---hHHHHHHHHHHHhhC--CCCeeeecc-------eeee
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG---SDQVFERELEILGSI--KHINLVNLR-------GYCR 377 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~ 377 (603)
.+|...+.||+|+||.||+|.+. ++..||||++...... ..+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888899999999999999987 4556999999765432 234577885544444 699988754 4443
Q ss_pred cC-----------------CccEEEEEecCCCCccccccccCCCCccCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 007455 378 LP-----------------ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR------LKIALGSARGLAYLHHDCCPK 434 (603)
Q Consensus 378 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~~~ 434 (603)
.+ ...++||||++ |+|.+++..... .+++..+ ..++.|+++||+|||++ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF---VYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc---ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 32 23799999999 799999986422 2444555 78889999999999999 8
Q ss_pred eEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeecccccccccCcccccc--CCCCcccchHhHHHHHHHHHhCC
Q 007455 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGK 512 (603)
Q Consensus 435 ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~ 512 (603)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999865422 224557799999999987 67899999999999999999999
Q ss_pred CCCCcccccCCccHhHHHHHHhhhCcchhhhcccC-CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 513 RPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC-ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 513 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.||.......... | ............. .......+..+.+++.+||+.||++|||++|+++
T Consensus 291 ~Pf~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS---W-----KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC---C-----CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc---h-----hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9997653211000 0 0000000000000 0111234568999999999999999999999974
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=342.13 Aligned_cols=258 Identities=24% Similarity=0.325 Sum_probs=193.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCc------cEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPAT------KLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~l 384 (603)
.+|++.+.||+|+||.||+|.+..++.+|+|++...... ..+|+++++.++||||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 468889999999999999999988888999988654322 2469999999999999999999855433 789
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC-CCCCeEEeecccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD-ENLEPHVSDFGLAKL 463 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~~~~ 463 (603)
||||++++. .+.+.........+++..+..++.|+++||+|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 116 v~e~~~~~l-~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPETV-YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSEEH-HHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCccH-HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 999998844 333332212233489999999999999999999999 899999999999999 789999999999987
Q ss_pred cCCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch--
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE-- 540 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 540 (603)
...... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .+..... ........
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~-~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIK-VLGTPSREQI 266 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH-HHCCCCHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH-HhCCCCHHHH
Confidence 644332 2345689999999998654 58999999999999999999999997542110 0111110 00000000
Q ss_pred -----hhhcccCC---C------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 -----DVIDKRCA---D------ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 -----~~~~~~~~---~------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.......+ . .+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 00000000 0 11124568999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.09 Aligned_cols=264 Identities=22% Similarity=0.294 Sum_probs=194.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeee------------
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCR------------ 377 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~------------ 377 (603)
++|.+.+.||+|+||.||+|.+.. ++.||+|++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 568888999999999999999986 5579999987665555677899999999999999999998873
Q ss_pred --cCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC-CCCCeE
Q 007455 378 --LPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD-ENLEPH 454 (603)
Q Consensus 378 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~k 454 (603)
.....++||||++ |+|.+++... .+++..++.++.|++.||+|||++ +|+||||||+||+++ +++.+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQG-----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhcC-----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 3467799999998 5999988642 288999999999999999999999 899999999999997 567999
Q ss_pred EeecccccccCCCCc--ceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHH
Q 007455 455 VSDFGLAKLLVDEEA--HVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 455 l~DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 531 (603)
|+|||+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~ 235 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL------EQMQ 235 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH------HHHH
Confidence 999999987643221 12234557899999998865 67899999999999999999999999754211 1111
Q ss_pred HHhhhCc-------------chhhhcccC--CC-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcccC
Q 007455 532 TLLKENR-------------LEDVIDKRC--AD-----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQEVMS 589 (603)
Q Consensus 532 ~~~~~~~-------------~~~~~~~~~--~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~~~ 589 (603)
....... ....+.... +. .....+.++.+++.+||+.||++|||++|+++ .+.....+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 1111000 000000000 00 11234567999999999999999999999986 56554433
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=335.67 Aligned_cols=269 Identities=19% Similarity=0.226 Sum_probs=190.4
Q ss_pred HHHHHHhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCc-
Q 007455 304 CEIIEKLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPAT- 381 (603)
Q Consensus 304 ~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~- 381 (603)
.......++|++.+.||+|+||.||+|.+. ++..||||++...... .....+|++.++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 355677899999999999999999999986 4567999988554322 2346778888999999999999999865443
Q ss_pred ------cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEecCCCCCeEECC-CCC
Q 007455 382 ------KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH--HDCCPKIIHRDIKSSNILLDE-NLE 452 (603)
Q Consensus 382 ------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH--~~~~~~ivH~Dlkp~NIll~~-~~~ 452 (603)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999987 555444432223344889999999999999999999 77 8999999999999997 899
Q ss_pred eEEeecccccccCCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHH
Q 007455 453 PHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 453 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 531 (603)
+||+|||+++....... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||....... .......
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~~~~~ 246 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG--QLHEIVR 246 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH--HHHHHHH
Confidence 99999999987654332 2345689999999998654 48999999999999999999999997542110 0001110
Q ss_pred -----------HHhhhCcchhhh-------cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 532 -----------TLLKENRLEDVI-------DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 532 -----------~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
............ ...........+.++.+|+.+||+.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000 00011112235678999999999999999999999996
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.19 Aligned_cols=264 Identities=22% Similarity=0.330 Sum_probs=180.9
Q ss_pred CCCC-CCeeeecCCeEEEEEEEC---CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeee--cCCccEEE
Q 007455 312 ALDE-EDVVGSGGFGTVYRMVMN---DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCR--LPATKLLI 385 (603)
Q Consensus 312 ~~~~-~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv 385 (603)
.|++ +++||+|+||.||+|.+. .+..||||++.... ....+.+|+.++++++||||+++++++. .....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3444 568999999999999976 34569999986543 2346889999999999999999999995 46778999
Q ss_pred EEecCCCCccccccccC-----CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE----CCCCCeEEe
Q 007455 386 YDYLSMGSLDDFLHEHG-----EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL----DENLEPHVS 456 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll----~~~~~~kl~ 456 (603)
|||+.+ +|.+++.... .....+++..++.++.|++.||+|||++ +|+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999986 8887775322 1122489999999999999999999999 89999999999999 677899999
Q ss_pred ecccccccCCCCc--ceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccC---CccHhHHH
Q 007455 457 DFGLAKLLVDEEA--HVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKR---GLNVVGWM 530 (603)
Q Consensus 457 DfG~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~---~~~~~~~~ 530 (603)
|||+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... ........
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987654321 223446789999999998764 58999999999999999999999997543210 00000011
Q ss_pred HHHhh---h---Ccchhh------------h-cccCCCc---------CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 531 NTLLK---E---NRLEDV------------I-DKRCADA---------DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 531 ~~~~~---~---~~~~~~------------~-~~~~~~~---------~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+.. . ..+... + ....... ....+..+.+|+.+||+.||++|||++|+++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11100 0 000000 0 0000000 0011356889999999999999999999997
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=326.83 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=194.7
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeec------CC
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRL------PA 380 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~~ 380 (603)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... .....+.+|+.+++++ +||||+++++++.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 3567889999999999999999986 55679999986543 3346789999999999 79999999999976 46
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 7899999999999999998643 23488999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (603)
+........ ......|++.|+|||++. +..++.++||||||+++|||++|+.||...... ...... .
T Consensus 176 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~ 247 (326)
T 2x7f_A 176 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLI-P 247 (326)
T ss_dssp TC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHH-H
T ss_pred ceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHh-h
Confidence 986543221 223456899999999986 567889999999999999999999998643211 000111 1
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..... .......+..+.+++.+||..||++|||++|+++
T Consensus 248 ~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAP-------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCC-------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCccc-------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11000 0011233467999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=327.96 Aligned_cols=257 Identities=22% Similarity=0.325 Sum_probs=200.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEE-C-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCe------eeecceeeecCCcc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVM-N-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHIN------LVNLRGYCRLPATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~ 382 (603)
++|++.+.||+|+||.||+|.+ . ++..||||++.... ...+.+.+|+++++.++|++ ++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 5788899999999999999997 3 45679999986432 33456889999999997765 99999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-------------
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE------------- 449 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~------------- 449 (603)
++||||+ +++|.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+||+++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcccc
Confidence 9999999 7899999976532 3488999999999999999999999 8999999999999987
Q ss_pred ------CCCeEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCC
Q 007455 450 ------NLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG 523 (603)
Q Consensus 450 ------~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~ 523 (603)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 241 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE- 241 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence 678999999999865432 234568999999999998899999999999999999999999997532111
Q ss_pred ccHhHHHHHHhhh--------Ccchhh-----------------hc------ccCCCcCHHHHHHHHHHHHHcccCCCCC
Q 007455 524 LNVVGWMNTLLKE--------NRLEDV-----------------ID------KRCADADMETVEAILEIAARCTDANPDD 572 (603)
Q Consensus 524 ~~~~~~~~~~~~~--------~~~~~~-----------------~~------~~~~~~~~~~~~~l~~li~~cl~~~P~~ 572 (603)
........... ...... +. ..........+.++.+++.+||+.||++
T Consensus 242 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 242 --HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp --HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred --HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 11111111000 000000 00 0001123355678999999999999999
Q ss_pred CCCHHHHHH
Q 007455 573 RPSMNQVLQ 581 (603)
Q Consensus 573 RPs~~evl~ 581 (603)
|||++|+++
T Consensus 320 Rpt~~ell~ 328 (339)
T 1z57_A 320 RITLREALK 328 (339)
T ss_dssp SCCHHHHTT
T ss_pred ccCHHHHhc
Confidence 999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=343.37 Aligned_cols=258 Identities=26% Similarity=0.314 Sum_probs=192.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecC----C--ccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLP----A--TKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----~--~~~ 383 (603)
.+|+..+.||+|+||.||+|.+.. +..||||++...... ..+|+++++.++||||+++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh----HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 367888999999999999999974 667999998654322 34799999999999999999988532 1 256
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC-CCeEEeeccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN-LEPHVSDFGLAK 462 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG~~~ 462 (603)
+||||+++ ++.+.+.........+++..+..++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999987 66666654322334589999999999999999999998 89999999999999965 568999999998
Q ss_pred ccCCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc---
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR--- 538 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 538 (603)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+...... .....
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~-lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKV-LGTPTREQ 280 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHH-HCSCCHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHH-hCCCCHHH
Confidence 7644332 2345689999999998664 78999999999999999999999997542110 11111110 00000
Q ss_pred -------chhhhcccCCC------cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 -------LEDVIDKRCAD------ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 -------~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+.... .+...+.++.+|+.+||..||++|||+.|+++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00000000000 11223567999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=329.27 Aligned_cols=254 Identities=21% Similarity=0.297 Sum_probs=193.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCCh--HHHHHHHHHHHhhCCCCeeeecceeeecCCcc-----
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLRGYCRLPATK----- 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----- 382 (603)
++|...+.||+|+||.||+|.+.. +..||||++....... .+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 578888999999999999999875 4569999997643332 45688999999999999999999999877655
Q ss_pred -EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 383 -LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 383 -~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
++||||+.+ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 122 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 122 FYLVMPFMQT-DLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CEEEEECCCE-EHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred EEEEEccccc-cHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 999999984 88877743 289999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc--
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR-- 538 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 538 (603)
+..... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... ..............
T Consensus 192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGVPGTE 264 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCHH
T ss_pred cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCcHH
Confidence 865432 234568999999999876 67899999999999999999999999753211 00000000000000
Q ss_pred ---------chhhhc---ccCC----CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 ---------LEDVID---KRCA----DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ---------~~~~~~---~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+. .... ......+..+.+|+.+||+.||++|||++|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000000 0000 011123567999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.06 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=190.9
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeec----------
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRL---------- 378 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 378 (603)
.++|++.+.||+|+||.||+|.+. ++..||||.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457888999999999999999986 5667999998542 2234568899999999999999999998754
Q ss_pred ---CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEE
Q 007455 379 ---PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455 (603)
Q Consensus 379 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl 455 (603)
....++||||+++|+|.+++.... ..+++..++.++.|+++||+|||++ +++||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 346789999999999999998643 2378889999999999999999999 8999999999999999999999
Q ss_pred eecccccccCCCC-------------cceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCccccc
Q 007455 456 SDFGLAKLLVDEE-------------AHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVK 521 (603)
Q Consensus 456 ~DfG~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~ 521 (603)
+|||++....... ........|++.|+|||++.+. .++.++||||+|+++|||++ ||....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-- 232 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-- 232 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--
Confidence 9999998664321 1122345689999999998754 68999999999999999998 543211
Q ss_pred CCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 522 RGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........... .. .......+...+..+.+++.+||+.||.+|||++|+++
T Consensus 233 ---~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 233 ---ERVNILKKLRS-VS-----IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp ---HHHHHHHHHHS-TT-----CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---hHHHHHHhccc-cc-----cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 11111111111 00 00011223344567899999999999999999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=319.08 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=201.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
..++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|++++++++||||+++++++...+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4578999999999999999999987 56679999985432 33456789999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC---CCeEEeeccccc
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN---LEPHVSDFGLAK 462 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~---~~~kl~DfG~~~ 462 (603)
+||+++++|.+++..... +++..++.++.|++.||.|||+. +++||||||+||+++.+ +.+||+|||++.
T Consensus 100 ~e~~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 100 GELYTGGELFDEIIKRKR----FSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp ECCCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEccCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999998876543 89999999999999999999999 89999999999999764 469999999998
Q ss_pred ccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
....... .....|++.|+|||.+.+ .++.++||||+|+++|+|++|+.||..... ......... .....
T Consensus 173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~~- 241 (287)
T 2wei_A 173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE------YDILKRVET-GKYAF- 241 (287)
T ss_dssp TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHH-CCCCC-
T ss_pred eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH------HHHHHHHHc-CCCCC-
Confidence 7644322 233458899999999875 488999999999999999999999865321 111111111 11000
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. ......+.++.+++.+||+.+|++|||++|+++
T Consensus 242 ---~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 ---DL-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp ---CS-GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---Cc-hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00 001233567999999999999999999999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=324.24 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=193.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCCh--HHHHHHHHHHHhhCCCCeeeecceeeecCCc------
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLRGYCRLPAT------ 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 381 (603)
++|...+.||+|+||.||+|.+.. +..||||++....... .+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 567888999999999999999875 5569999997643332 3568899999999999999999999987654
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.++||||+.+ +|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 104 ~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQT-DLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCSE-EGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEeccccC-CHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 4999999984 88887753 288999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhh---C
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE---N 537 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~ 537 (603)
+..... .....||+.|+|||++.+ ..++.++||||+|+++|||++|+.||...... ......... .
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~i~~~~~~~ 243 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL------DQLTQILKVTGVP 243 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH------HHHHHHHHHHCBC
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhCCC
Confidence 865332 234568999999999876 67899999999999999999999999753211 111111100 0
Q ss_pred c-----------chhhh-------cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 R-----------LEDVI-------DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 ~-----------~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ....+ ...........+.++.+++.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 00000 00111112244678999999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=323.95 Aligned_cols=261 Identities=23% Similarity=0.323 Sum_probs=198.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC--CCCEEEEEEeCCCC--CChHHHHHHHHHHHhhC---CCCeeeecceeee-----
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN--DCGTFAVKRIDRSR--EGSDQVFERELEILGSI---KHINLVNLRGYCR----- 377 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----- 377 (603)
.++|++.+.||+|+||.||+|.+. ++..||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 468899999999999999999984 45679999885432 12223466788777766 8999999999987
Q ss_pred cCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEee
Q 007455 378 LPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSD 457 (603)
Q Consensus 378 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~D 457 (603)
.....++||||++ |+|.+++..... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 90 RETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred CCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEec
Confidence 5567899999998 599999876533 2388999999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 458 FGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 458 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .............
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCC
Confidence 99998664322 223456899999999999889999999999999999999999999753211 1111111110000
Q ss_pred ---cch-------hhhc----ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 ---RLE-------DVID----KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 ---~~~-------~~~~----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+. ..+. ..........+..+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000 0000 0000112234567899999999999999999999995
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=323.55 Aligned_cols=250 Identities=19% Similarity=0.339 Sum_probs=194.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCC--CCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG--SDQVFERELEILGSIK--HINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 385 (603)
.++|++.+.||+|+||.||+|.+.++..||||++...... ....+.+|++++.+++ |+||+++++++......++|
T Consensus 27 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 27 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 4578889999999999999999988889999998654332 3456889999999997 59999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|| +.+++|.+++..... +++..+..++.|+++||.|||++ +++||||||+||++++ +.+||+|||+++...
T Consensus 107 ~e-~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKKS----IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ 177 (313)
T ss_dssp EC-CCSEEHHHHHHHCSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred Ee-cCCCcHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeecccccccc
Confidence 99 567799999986543 88999999999999999999999 8999999999999965 899999999998765
Q ss_pred CCCcc-eeecccccccccCcccccc-----------CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH
Q 007455 466 DEEAH-VTTVVAGTFGYLAPEYLQS-----------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 466 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
..... ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||..... ........
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~~~~~~~~ 252 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAI 252 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHH
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-----HHHHHHHH
Confidence 43221 2234568999999999865 4678899999999999999999999864311 11111111
Q ss_pred hhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..... ....+...+.++.+++.+||+.||++|||++|+++
T Consensus 253 ~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 253 IDPNH--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HCTTS--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred Hhccc--------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 11110 01112223467999999999999999999999996
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=330.33 Aligned_cols=259 Identities=21% Similarity=0.297 Sum_probs=195.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecC-----CccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLP-----ATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 383 (603)
++|++.+.||+|+||.||+|.+.. +..||||++...... ....+.+|++++++++||||+++++++... ...+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 90 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVY 90 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEE
Confidence 578889999999999999999874 456999999654322 345678999999999999999999987654 6789
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+.+ +|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 91 lv~e~~~~-~L~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 91 IIQELMQT-DLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEECCCSE-EHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEeccCc-cHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999984 899888753 289999999999999999999999 899999999999999999999999999987
Q ss_pred cCCCCcc---------eeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH
Q 007455 464 LVDEEAH---------VTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 464 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
....... ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||....... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~ 238 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QLLLIFGI 238 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHH
Confidence 6532211 1123468999999998754 678999999999999999999999997542110 00000000
Q ss_pred hhhCc------------chhhhcc--cCCC-----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 LKENR------------LEDVIDK--RCAD-----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ~~~~~------------~~~~~~~--~~~~-----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..... ..+.+.. ..+. .....+.++.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 0000000 0000 01134567899999999999999999999997
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.31 Aligned_cols=260 Identities=19% Similarity=0.266 Sum_probs=197.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-----------CCeeeecceeeec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIK-----------HINLVNLRGYCRL 378 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~ 378 (603)
.+|.+.+.||+|+||.||+|.+. ++..||||++.... .....+.+|+.+++++. ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 57889999999999999999986 45569999986432 23456889999999886 8999999999876
Q ss_pred CC----ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC------
Q 007455 379 PA----TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD------ 448 (603)
Q Consensus 379 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~------ 448 (603)
.+ ..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++. +|+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 54 678999999 8899999986433 23889999999999999999999963 799999999999994
Q ss_pred CCCCeEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhH
Q 007455 449 ENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVG 528 (603)
Q Consensus 449 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~ 528 (603)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4457999999999876432 233468999999999998899999999999999999999999997543211111111
Q ss_pred HHHHHhh-----------hCcc----------------------hhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC
Q 007455 529 WMNTLLK-----------ENRL----------------------EDVIDKRCADADMETVEAILEIAARCTDANPDDRPS 575 (603)
Q Consensus 529 ~~~~~~~-----------~~~~----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs 575 (603)
....... .... .... ......+...+.++.+|+.+||+.||++|||
T Consensus 249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL-TEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH-HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhh-hhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1111100 0000 0000 0111234567788999999999999999999
Q ss_pred HHHHHH
Q 007455 576 MNQVLQ 581 (603)
Q Consensus 576 ~~evl~ 581 (603)
++|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999997
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=323.63 Aligned_cols=240 Identities=26% Similarity=0.376 Sum_probs=191.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC------hHHHHHHHHHHHhhC----CCCeeeecceeeec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG------SDQVFERELEILGSI----KHINLVNLRGYCRL 378 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~~~~ 378 (603)
.++|++.+.||+|+||.||+|.+. ++..||||.+...... ....+.+|+.++.++ +||||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 467999999999999999999976 4567999998654322 122356799999988 89999999999999
Q ss_pred CCccEEEEEe-cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC-CCCCeEEe
Q 007455 379 PATKLLIYDY-LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD-ENLEPHVS 456 (603)
Q Consensus 379 ~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~ 456 (603)
.+..++|+|| +.+++|.+++..... +++..++.++.|+++||+|||++ +++||||||+||+++ .++.+||+
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~~~----~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEKGP----LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEEC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEE
Confidence 9999999999 789999999987543 89999999999999999999999 899999999999999 88999999
Q ss_pred ecccccccCCCCcceeecccccccccCccccccCCCC-cccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh
Q 007455 457 DFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT-EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535 (603)
Q Consensus 457 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 535 (603)
|||+++...... .....|+..|+|||++.+..+. .++||||+|+++|||++|+.||..... ...
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------~~~ 247 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------ILE 247 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHH
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------Hhh
Confidence 999998765432 2345689999999998776664 589999999999999999999864210 000
Q ss_pred hCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 536 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
. ....+...+.++.+++.+||+.+|++|||++|+++
T Consensus 248 -~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 248 -A---------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp -T---------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -h---------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01122234567899999999999999999999997
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=327.20 Aligned_cols=200 Identities=24% Similarity=0.289 Sum_probs=168.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CC-----eeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGSDQVFERELEILGSIK-HI-----NLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~ 382 (603)
.++|++.+.||+|+||.||+|.+..+ ..||||++.... .....+.+|+.+++.++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 46889999999999999999998754 469999986432 23456778999988885 44 499999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC--CCCCeEEeeccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD--ENLEPHVSDFGL 460 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~ 460 (603)
++||||+++ +|.+++..... ..+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 132 ~lv~e~~~~-~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 132 CLVFEMLSY-NLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEECCCC-BHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEecCCC-CHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 999999975 99999986532 2389999999999999999999952 12899999999999995 477899999999
Q ss_pred ccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcc
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPT 518 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~ 518 (603)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9876432 23456899999999999989999999999999999999999999754
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=326.06 Aligned_cols=240 Identities=25% Similarity=0.394 Sum_probs=197.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC------hHHHHHHHHHHHhhCC--CCeeeecceeeecCC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG------SDQVFERELEILGSIK--HINLVNLRGYCRLPA 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 380 (603)
.++|++.+.||+|+||.||+|.+.. +..||||.+...... ....+.+|+.++++++ |+||+++++++..++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~ 121 (320)
T 3a99_A 42 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121 (320)
T ss_dssp TTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred cCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCC
Confidence 4678899999999999999999864 456999998654221 1234678999999996 599999999999999
Q ss_pred ccEEEEEecCC-CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC-CCCCeEEeec
Q 007455 381 TKLLIYDYLSM-GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD-ENLEPHVSDF 458 (603)
Q Consensus 381 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~Df 458 (603)
..++|+|++.+ ++|.+++..... +++..++.++.|+++||+|||+. +|+||||||+||+++ +++.+||+||
T Consensus 122 ~~~lv~e~~~~~~~L~~~l~~~~~----l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 122 SFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCC
T ss_pred cEEEEEEcCCCCccHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 99999999986 899999886543 89999999999999999999998 899999999999999 7889999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
|+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... .....
T Consensus 195 g~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------------~~~~~ 259 (320)
T 3a99_A 195 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------------IIRGQ 259 (320)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------HHHCC
T ss_pred cccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh------------hhccc
Confidence 9998765432 234568999999999877665 6789999999999999999999864310 00000
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+...+.++.+++.+||+.||++|||++|+++
T Consensus 260 ----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111233467999999999999999999999987
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=322.81 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=198.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC--CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCe------eeecceeeecCCcc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC--GTFAVKRIDRSREGSDQVFERELEILGSIKHIN------LVNLRGYCRLPATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~~ 382 (603)
++|++.+.||+|+||.||+|.+... ..||+|++.... ...+.+.+|+.+++.++|++ ++++++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 5788999999999999999998643 469999986432 33456889999999998776 89999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE---------------
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL--------------- 447 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll--------------- 447 (603)
++||||+ ++++.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 9999999 5577777765432 3489999999999999999999998 89999999999999
Q ss_pred ----CCCCCeEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCC
Q 007455 448 ----DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG 523 (603)
Q Consensus 448 ----~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~ 523 (603)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||......
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-- 245 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR-- 245 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 56789999999999865432 23456899999999999889999999999999999999999999753211
Q ss_pred ccHhHHHHHHhhhC--------cchhh-----------------hcc------cCCCcCHHHHHHHHHHHHHcccCCCCC
Q 007455 524 LNVVGWMNTLLKEN--------RLEDV-----------------IDK------RCADADMETVEAILEIAARCTDANPDD 572 (603)
Q Consensus 524 ~~~~~~~~~~~~~~--------~~~~~-----------------~~~------~~~~~~~~~~~~l~~li~~cl~~~P~~ 572 (603)
.....+....... ..... ... .........+.++.+|+.+||+.||++
T Consensus 246 -~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 324 (355)
T 2eu9_A 246 -EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324 (355)
T ss_dssp -HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred -HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence 1111111111000 00000 000 000122344668999999999999999
Q ss_pred CCCHHHHHH
Q 007455 573 RPSMNQVLQ 581 (603)
Q Consensus 573 RPs~~evl~ 581 (603)
|||++|+++
T Consensus 325 Rpt~~e~l~ 333 (355)
T 2eu9_A 325 RITLAEALL 333 (355)
T ss_dssp SCCHHHHTT
T ss_pred CcCHHHHhc
Confidence 999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=322.60 Aligned_cols=258 Identities=20% Similarity=0.238 Sum_probs=175.6
Q ss_pred hhCCCCC-CeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeec----CCccE
Q 007455 310 LEALDEE-DVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRL----PATKL 383 (603)
Q Consensus 310 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 383 (603)
.++|.+. ++||+|+||.||+|.+. ++..||||++... .....+....++.+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4677774 46999999999999988 4567999998542 2222333344667799999999999875 44579
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC---CCCeEEeeccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE---NLEPHVSDFGL 460 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~ 460 (603)
+||||+++|+|.+++..... ..+++..++.++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 99999999999999986532 3489999999999999999999999 8999999999999986 44599999999
Q ss_pred ccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
++...... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||.......... ...........
T Consensus 178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~- 250 (336)
T 3fhr_A 178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQY- 250 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcccc-
Confidence 98654322 234568999999999988889999999999999999999999996543211000 00000000000
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcc
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQEV 587 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~ 587 (603)
. .........+.++.+++.+||+.||++|||++|+++ .+.+..
T Consensus 251 ---~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 251 ---G-FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ---C-CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ---c-cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 0 000111234567999999999999999999999997 555543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=334.65 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=185.7
Q ss_pred CCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEecCCC
Q 007455 314 DEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 314 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
...++||+|+||+||.+...+++.||||++... ..+.+.+|+++++++ +||||+++++++...+..++||||+. |
T Consensus 18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 345789999999998777777889999998543 235578999999876 89999999999999999999999996 5
Q ss_pred CccccccccCCCCcc---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC-------------CCeEEe
Q 007455 393 SLDDFLHEHGEGQQL---LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN-------------LEPHVS 456 (603)
Q Consensus 393 sL~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-------------~~~kl~ 456 (603)
+|.+++......... .++..++.++.|++.||+|||++ +|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999865432211 13334678999999999999999 89999999999999754 479999
Q ss_pred ecccccccCCCCcc---eeecccccccccCcccccc-------CCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCcc
Q 007455 457 DFGLAKLLVDEEAH---VTTVVAGTFGYLAPEYLQS-------GRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLN 525 (603)
Q Consensus 457 DfG~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~ 525 (603)
|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~---- 246 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR---- 246 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH----
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh----
Confidence 99999877543322 1234579999999999865 568899999999999999999 89998643211
Q ss_pred HhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 526 VVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 526 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. ...... .. ............+.++.+++.+||+.||++|||+.|+++
T Consensus 247 ~~----~i~~~~-~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ES----NIIRGI-FS--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HH----HHHHTC-CC--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH----HHhcCC-CC--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 00 111100 00 000011123466788999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=321.25 Aligned_cols=252 Identities=29% Similarity=0.402 Sum_probs=176.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC-hHHHHHHHHH-HHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG-SDQVFERELE-ILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|+..+.||+|+||.||+|.+. ++..||||++...... ....+.+|+. +++.++||||+++++++..++..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67888999999999999999987 4556999999654322 2344556666 6777899999999999999999999999
Q ss_pred ecCCCCccccccccC-CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 388 YLSMGSLDDFLHEHG-EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
|+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +++||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9986 8877776311 11234899999999999999999999962 699999999999999999999999999987644
Q ss_pred CCcceeecccccccccCcccc----ccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 467 EEAHVTTVVAGTFGYLAPEYL----QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||....... ......
T Consensus 179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------------~~~~~~ 242 (327)
T 3aln_A 179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--------------DQLTQV 242 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------CCC
T ss_pred ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--------------HHHHHH
Confidence 322 2334689999999998 45678899999999999999999999986532100 000111
Q ss_pred hcccCC----CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 543 IDKRCA----DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 543 ~~~~~~----~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+ ......+..+.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111100 011234567999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=332.03 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=185.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.+|+..++||+|+||+||.....+++.||||++...... .+.+|+++++.+ +||||+++++++.+....|+||||+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 357778899999999976655667789999999653322 257899999999 7999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-----CCCeEEeeccccccc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-----NLEPHVSDFGLAKLL 464 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfG~~~~~ 464 (603)
.+ +|.+++...... .....++.++.|+++||+|||++ +|+||||||+|||++. ...+||+|||+++..
T Consensus 101 ~g-~L~~~l~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 101 AA-TLQEYVEQKDFA---HLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp SE-EHHHHHHSSSCC---CCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CHHHHHHhcCCC---ccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 75 999998765422 33445678999999999999999 8999999999999953 235889999999876
Q ss_pred CCCCc--ceeecccccccccCccccc---cCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 465 VDEEA--HVTTVVAGTFGYLAPEYLQ---SGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 465 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
..... .......||+.|+|||++. ...++.++||||+||++|||++ |..||...... ..........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~-------~~~~~~~~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR-------QANILLGACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH-------HHHHHTTCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH-------HHHHHhccCC
Confidence 54321 2234467999999999997 4567789999999999999999 88888542110 1111111110
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.............+.+++.+||+.||++|||++|+++
T Consensus 247 ------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 ------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0111122345567889999999999999999999983
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=311.97 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=178.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCCh--HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGS--DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.++|+..+.||+|+||.||+|.+. ++..||||++....... .+.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999987 56689999996543322 233445556788889999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+ ++.+..+..... ..+++..+..++.|+++||.|||+.. +++||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 445554444321 23899999999999999999999831 799999999999999999999999999976644
Q ss_pred CCcceeecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
... .....|++.|+|||++. ...++.++||||||+++|||++|+.||..... .............
T Consensus 178 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~--- 247 (318)
T 2dyl_A 178 DKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-----DFEVLTKVLQEEP--- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHHHSCC---
T ss_pred Ccc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-----cHHHHHHHhccCC---
Confidence 322 23456899999999984 45678899999999999999999999864211 1111111111110
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+ .....+.++.+++.+||+.||.+|||++|+++
T Consensus 248 ---~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ---PLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ---CCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ---CCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0011 11124467999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.61 Aligned_cols=260 Identities=26% Similarity=0.358 Sum_probs=196.9
Q ss_pred HhhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeec------CC
Q 007455 309 KLEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRL------PA 380 (603)
Q Consensus 309 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 380 (603)
..++|++.+.||+|+||.||+|.+.. +..||||++..... ...+.+.+|++++++++||||+++++++.. .+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 35789999999999999999999864 56799998865422 234568899999999999999999998755 67
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC---eEEee
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE---PHVSD 457 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~---~kl~D 457 (603)
..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+. +|+||||||+||+++.++. +||+|
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred eEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcc
Confidence 78999999999999999987543 23488889999999999999999998 8999999999999997765 99999
Q ss_pred cccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh--
Q 007455 458 FGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK-- 535 (603)
Q Consensus 458 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 535 (603)
||++........ .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... ...|......
T Consensus 168 FG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~ 240 (676)
T 3qa8_A 168 LGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKS 240 (676)
T ss_dssp CCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC---
T ss_pred cccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhccc
Confidence 999987654332 2445789999999999999999999999999999999999999975311 1111100000
Q ss_pred ------hCcchhh--hccc---CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 007455 536 ------ENRLEDV--IDKR---CADADMETVEAILEIAARCTDANPDDRPSMNQV 579 (603)
Q Consensus 536 ------~~~~~~~--~~~~---~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev 579 (603)
....... +... ........+..+.+++.+||..||++|||++|+
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 0000000 0000 111334567889999999999999999999773
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=305.94 Aligned_cols=231 Identities=15% Similarity=0.092 Sum_probs=183.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCCh---HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGS---DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||.||+|.+.. ++.||||++....... .+.+.+|+.++.+++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 468889999999999999999975 5679999997654332 256899999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++++|.++++.. ....++..++.|++.||+|||++ +|+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-------
Confidence 999999999998642 34557889999999999999999 89999999999999999999998544
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
|++ .++.++||||||+++|||++|+.||........... ....+...
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~ 221 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQ 221 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSC
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccC
Confidence 333 367899999999999999999999976432211100 00000000
Q ss_pred CC---CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccCCC
Q 007455 547 CA---DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPC 591 (603)
Q Consensus 547 ~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 591 (603)
.. ......+.++.+++.+||+.||++| |++|+++.|++......
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 00 0112345679999999999999999 99999999998664433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=339.86 Aligned_cols=237 Identities=20% Similarity=0.320 Sum_probs=190.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC--CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCc-----c
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN--DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPAT-----K 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 382 (603)
++|++.+.||+|+||.||+|.+. +++.||||++..... .....+.+|++++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 57888999999999999999986 467799998865432 234568899999999999999999999987665 6
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|+||||+++++|.+++.. .+++.+++.++.|++.||.|||++ +|+||||||+|||++.+ .+||+|||+++
T Consensus 160 ~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccch
Confidence 999999999999987754 389999999999999999999999 89999999999999986 89999999998
Q ss_pred ccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
..... ....||+.|+|||++.+. ++.++||||||+++|||++|..||.........
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------ 285 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------ 285 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------
T ss_pred hcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc------------------
Confidence 76443 345699999999998765 488999999999999999999887643211100
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHhh
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPS-MNQVLQLLEQ 585 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-~~evl~~L~~ 585 (603)
........+..+.+++.+||+.||++||+ ++++.+.|.+
T Consensus 286 ----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 286 ----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp ----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00011123357899999999999999995 6666665554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.23 Aligned_cols=233 Identities=21% Similarity=0.299 Sum_probs=181.1
Q ss_pred hhCCCCC-CeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHH-hhCCCCeeeecceeeec----CCcc
Q 007455 310 LEALDEE-DVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEIL-GSIKHINLVNLRGYCRL----PATK 382 (603)
Q Consensus 310 ~~~~~~~-~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 382 (603)
.++|.+. +.||+|+||.||+|.+. .+..||+|.+.. ...+.+|+.++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3566666 77999999999999986 456799999853 24577899888 55689999999999876 6678
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC---CCCeEEeecc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE---NLEPHVSDFG 459 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 459 (603)
++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 999999999999999987532 3489999999999999999999999 8999999999999998 7889999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
++.... +..++.++||||+|+++|||++|+.||........ ....
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------------~~~~ 210 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPGM 210 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCS
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------------hHHH
Confidence 986532 13467899999999999999999999965321100 0000
Q ss_pred hhhhcccCCCcC----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhcc
Q 007455 540 EDVIDKRCADAD----METVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQEV 587 (603)
Q Consensus 540 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~~ 587 (603)
...+.......+ ...+.++.+++.+||+.||++|||++|+++ .+.+..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 011111111111 124567999999999999999999999997 455443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-36 Score=318.31 Aligned_cols=241 Identities=17% Similarity=0.171 Sum_probs=178.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC---hHHHHHHHHHHHhhCCC-Ceeeec---------cee-
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG---SDQVFERELEILGSIKH-INLVNL---------RGY- 375 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h-~niv~l---------~~~- 375 (603)
.+|...+.||+|+||.||+|.+. .+..||||++...... ..+.+.+|+.+++.+.| +|.... ...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 45677889999999999999976 4567999998743322 24678999999999977 221111 111
Q ss_pred -----------eec-----CCccEEEEEecCCCCcccccccc---CCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 007455 376 -----------CRL-----PATKLLIYDYLSMGSLDDFLHEH---GEGQQLLNWSARLKIALGSARGLAYLHHDCCPKII 436 (603)
Q Consensus 376 -----------~~~-----~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv 436 (603)
+.. ....+++|+++ +++|.++++.. ......+++..++.++.|+++||+|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111 12345666655 56999888521 22234478889999999999999999999 899
Q ss_pred EecCCCCCeEECCCCCeEEeecccccccCCCCcceeecccccccccCcccc----------ccCCCCcccchHhHHHHHH
Q 007455 437 HRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL----------QSGRATEKSDVYSFGVLLL 506 (603)
Q Consensus 437 H~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~slG~vl~ 506 (603)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999998865332 344567 999999999 5556788999999999999
Q ss_pred HHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007455 507 ELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVL 580 (603)
Q Consensus 507 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl 580 (603)
||++|+.||........ ....+. ... ..+.++.+++.+||+.||++|||+.|++
T Consensus 309 elltg~~Pf~~~~~~~~---------------~~~~~~-~~~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGG---------------SEWIFR-SCK----NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHSSCCCCTTGGGSC---------------SGGGGS-SCC----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHCCCCCCCcchhhh---------------HHHHHh-hcc----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999999975432111 111111 111 2346799999999999999999977764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.20 Aligned_cols=240 Identities=17% Similarity=0.178 Sum_probs=182.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCC--------ChHHHHHHHHHHHhhCC----------------
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE--------GSDQVFERELEILGSIK---------------- 365 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------------- 365 (603)
.++|++.+.||+|+||.||+|++ .+..||||++..... ...+.+.+|+.+++.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788899999999999999998 457899999965422 22367899999999886
Q ss_pred ----------CCeeeecceeeec-------------CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHH
Q 007455 366 ----------HINLVNLRGYCRL-------------PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSAR 422 (603)
Q Consensus 366 ----------h~niv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~ 422 (603)
||||+++++++.. .+..++||||+++|++.+.+.. ..+++..+..++.|++.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 4555555555544 6789999999999987776643 23799999999999999
Q ss_pred HHHHHH-hCCCCCeEEecCCCCCeEECCCC--------------------CeEEeecccccccCCCCcceeecccccccc
Q 007455 423 GLAYLH-HDCCPKIIHRDIKSSNILLDENL--------------------EPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481 (603)
Q Consensus 423 ~L~~LH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y 481 (603)
||+||| ++ +|+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 899999999999999887 8999999999876432 24699999
Q ss_pred cCccccccCCCCcccchHhHHHH-HHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh-hhcc-cCCCcCHHHHHHH
Q 007455 482 LAPEYLQSGRATEKSDVYSFGVL-LLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED-VIDK-RCADADMETVEAI 558 (603)
Q Consensus 482 ~aPE~~~~~~~~~~~Dv~slG~v-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~l 558 (603)
+|||++.+.. +.++||||+|++ .+++++|..||... .|.......- ... .... .........+.++
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDKM-LKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHHH-HHTCCCSSCCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHhh-hhhhccCcccchhhhhhcCHHH
Confidence 9999998765 889999998777 77899999987421 1211111100 000 0000 0111234567889
Q ss_pred HHHHHHcccCCCCCCCCHHHHH
Q 007455 559 LEIAARCTDANPDDRPSMNQVL 580 (603)
Q Consensus 559 ~~li~~cl~~~P~~RPs~~evl 580 (603)
.+|+.+||+.| |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999966 999988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-29 Score=276.69 Aligned_cols=184 Identities=16% Similarity=0.093 Sum_probs=128.2
Q ss_pred eeecCCeEEEEEEEC-CCCEEEEEEeCCCCC----------ChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEEEE
Q 007455 319 VGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE----------GSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 319 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 386 (603)
.+.|+.|.+..++.. -+..+++|.+..... ...++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 455666655554432 345699999864321 1224689999999999 6999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||++|++|.+++...+. ++.. +|+.||+.||+|+|++ |||||||||+|||++++|++||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~~~~----l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE----IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTTCC----CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhCCC----CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999987543 5543 5889999999999999 999999999999999999999999999987654
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCC
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p 514 (603)
... .....+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 322 2345679999999999975 567789999999998887765544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=3.5e-27 Score=239.26 Aligned_cols=173 Identities=32% Similarity=0.556 Sum_probs=159.4
Q ss_pred CChhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCcc--ccceeecCCC--CcEEEEEcCCCCccc--ccCCCccCCCCcce
Q 007455 25 ALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCK--WTGISCHTHD--QRVRSINLPYMQLGG--IISPSIGRLDKLQR 98 (603)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~--w~gv~C~~~~--~~l~~L~L~~n~l~~--~~~~~~~~l~~L~~ 98 (603)
|.++|+.||++||+++.||. .+.+|+. +.+||. |.||+|+... ++|+.|+|++|++++ .+|+.|.++++|++
T Consensus 3 c~~~~~~aL~~~k~~~~~~~-~l~~W~~-~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~ 80 (313)
T 1ogq_A 3 CNPQDKQALLQIKKDLGNPT-TLSSWLP-TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCT-TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHhcCCcc-cccCCCC-CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCe
Confidence 56789999999999998887 7899975 457888 9999998654 799999999999999 89999999999999
Q ss_pred EEecc-CCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCc
Q 007455 99 LALHQ-NSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNF 177 (603)
Q Consensus 99 L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~ 177 (603)
|+|++ |.+.+.+|..|.++++|++|+|++|++++.+|..|.++++|++|+|++|++++.+|..+.++++|++|++++|+
T Consensus 81 L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 99995 99999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCC-CCcccc-ccCcccccCC
Q 007455 178 FSGEIP-DFGALS-AFGNKSFIGN 199 (603)
Q Consensus 178 l~~~~~-~~~~l~-~l~~l~~~~n 199 (603)
+++.+| .+..+. +|+.|++++|
T Consensus 161 l~~~~p~~l~~l~~~L~~L~L~~N 184 (313)
T 1ogq_A 161 ISGAIPDSYGSFSKLFTSMTISRN 184 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSS
T ss_pred ccCcCCHHHhhhhhcCcEEECcCC
Confidence 997666 477777 8888888887
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-27 Score=254.06 Aligned_cols=184 Identities=19% Similarity=0.201 Sum_probs=146.5
Q ss_pred CCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCCh--------HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 314 DEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGS--------DQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 314 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
...+.||+|+||.||+|.. .+..+++|+........ .+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3467899999999999954 45788999875432211 23478999999999999999877777788889999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++++|.+++.. +..++.|+++||+|||++ +|+||||||+|||++. ++||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999875 458999999999999999 8999999999999999 99999999999875
Q ss_pred CCCcce------eecccccccccCcccccc--CCCCcccchHhHHHHHHHHHhCCCCC
Q 007455 466 DEEAHV------TTVVAGTFGYLAPEYLQS--GRATEKSDVYSFGVLLLELVTGKRPT 515 (603)
Q Consensus 466 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~vl~elltg~~p~ 515 (603)
...... .....||+.|+|||++.. ..|+..+|+|+..+-..+-+.++.+|
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 532221 235679999999999976 56788899999999988888877765
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=5.3e-24 Score=242.18 Aligned_cols=172 Identities=28% Similarity=0.392 Sum_probs=124.3
Q ss_pred ccCChhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCccccceeecCCCCcEEEEEcCCCCcccc---cCCCccCCCCcceE
Q 007455 23 CLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGI---ISPSIGRLDKLQRL 99 (603)
Q Consensus 23 ~~~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c~w~gv~C~~~~~~l~~L~L~~n~l~~~---~~~~~~~l~~L~~L 99 (603)
..+.++|+.||++||+++.||. .+++|+ .+.+||+|.||+|+ .++|+.|+|+++++.|. +|+++.+|++|+.+
T Consensus 7 ~~~~~~~~~all~~k~~~~~~~-~l~~W~-~~~~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 7 SQSLYREIHQLISFKDVLPDKN-LLPDWS-SNKNPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp -CCHHHHHHHHHHHHTTCSCTT-SSTTCC-TTSCGGGSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred ccCCHHHHHHHHHHHhhCCCcc-cccCCC-CCCCCcCCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 3346779999999999999998 899997 35689999999998 58999999999999997 77666666666666
Q ss_pred EeccCCCCCCCCCCccccCCCceEEeccccCCCCCcc--ccccccccceecccCCccCCCCCCCC-ccccccceeeccCC
Q 007455 100 ALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPA--NIGNLLFLTILDLSSNSLKGAIPSSL-GRLTHLHYLNLSTN 176 (603)
Q Consensus 100 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~l~l~~N 176 (603)
+++.|.+. .+|..|+++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|++++|
T Consensus 83 ~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 83 FLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp ECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred CCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 66666665 4556666677777777777777666666 66667777777777776666666554 56666666666666
Q ss_pred cCcccCCC----CccccccCcccccCC
Q 007455 177 FFSGEIPD----FGALSAFGNKSFIGN 199 (603)
Q Consensus 177 ~l~~~~~~----~~~l~~l~~l~~~~n 199 (603)
++++.++. +..+++|+.|++++|
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n 188 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGN 188 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSS
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCC
Confidence 66655542 344555555555554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.8e-23 Score=205.83 Aligned_cols=146 Identities=14% Similarity=0.100 Sum_probs=117.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCC------------------ChHHHHHHHHHHHhhCCCCeeee
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE------------------GSDQVFERELEILGSIKHINLVN 371 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~ 371 (603)
...|.+.+.||+|+||.||+|.+.++..||+|.+..... .....+.+|++++++++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 345556699999999999999996677899999864321 12456889999999999 5 67
Q ss_pred cceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC
Q 007455 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL 451 (603)
Q Consensus 372 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 451 (603)
+.+++.. +..++||||+++|+|.+ +.. .....++.|++.||.|||+. +|+||||||+|||++ ++
T Consensus 166 v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~ 229 (282)
T 1zar_A 166 VPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EE 229 (282)
T ss_dssp SCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TT
T ss_pred cCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CC
Confidence 7776544 56799999999999998 432 12346999999999999998 899999999999999 99
Q ss_pred CeEEeecccccccCCCCcceeecccccccccCccccc
Q 007455 452 EPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488 (603)
Q Consensus 452 ~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 488 (603)
.+||+|||+++. +..++|||++.
T Consensus 230 ~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 230 GIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp EEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred cEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 999999999863 34467888775
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.88 E-value=7.7e-24 Score=240.25 Aligned_cols=167 Identities=23% Similarity=0.314 Sum_probs=145.8
Q ss_pred hhhHHHHHHHHHhCCCCCCCCCCCCCCC----CCC--ccc------------cceeecCCCCcEEEEEcCCCCcccccCC
Q 007455 27 TEDGMTLLEIKSSLNDSRNLLGNWQATE----ESP--CKW------------TGISCHTHDQRVRSINLPYMQLGGIISP 88 (603)
Q Consensus 27 ~~~~~~l~~~k~~~~~~~~~l~~w~~~~----~~~--c~w------------~gv~C~~~~~~l~~L~L~~n~l~~~~~~ 88 (603)
.+|+.||++||+++.+| +|+.++ .+| |.| .||+|+. .++|+.|+|++|+|+|.+|+
T Consensus 268 ~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 268 IKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp HHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEEECG
T ss_pred hHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCcCch
Confidence 46999999999999877 786554 355 999 9999986 57999999999999999999
Q ss_pred CccCCCCcceEEe-ccCCCCCC----------------------------------------------------------
Q 007455 89 SIGRLDKLQRLAL-HQNSLHGS---------------------------------------------------------- 109 (603)
Q Consensus 89 ~~~~l~~L~~L~L-~~N~l~~~---------------------------------------------------------- 109 (603)
+|++|++|+.|+| ++|.++|.
T Consensus 342 ~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~ 421 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421 (876)
T ss_dssp GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCC
T ss_pred HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccccccc
Confidence 9999999999999 77765443
Q ss_pred ------------------CCCCccccCCCceEEeccccCCC-----------------CCccccc--cccccceecccCC
Q 007455 110 ------------------IPNEITNCTELRALYLRANYLQG-----------------GIPANIG--NLLFLTILDLSSN 152 (603)
Q Consensus 110 ------------------~p~~~~~l~~L~~L~L~~N~l~~-----------------~~p~~~~--~l~~L~~L~l~~N 152 (603)
+|..|+++++|+.|+|++|+|+| .+|+.++ ++++|+.|+|++|
T Consensus 422 ~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 422 RISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESC
T ss_pred ccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCC
Confidence 78889999999999999999997 3899987 9999999999999
Q ss_pred ccCCCCCCCCccccccceeeccCCc-Ccc-cCC-CCcccc-------ccCcccccCC
Q 007455 153 SLKGAIPSSLGRLTHLHYLNLSTNF-FSG-EIP-DFGALS-------AFGNKSFIGN 199 (603)
Q Consensus 153 ~l~~~~p~~~~~l~~L~~l~l~~N~-l~~-~~~-~~~~l~-------~l~~l~~~~n 199 (603)
++.+.+|..|.++++|+.|+|++|+ |++ .+| .++.+. +|+.|++++|
T Consensus 502 ~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N 558 (876)
T 4ecn_A 502 PNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYN 558 (876)
T ss_dssp TTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSS
T ss_pred CCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCC
Confidence 9999999999999999999999998 987 444 455555 7888877776
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.8e-23 Score=211.86 Aligned_cols=174 Identities=19% Similarity=0.235 Sum_probs=151.3
Q ss_pred ccCChhhHHHHHHHHHhC-CCCCCCCCCCC---CCCCCCccccceeec--------CCCCcEEEEEcCCCCcccccCCCc
Q 007455 23 CLALTEDGMTLLEIKSSL-NDSRNLLGNWQ---ATEESPCKWTGISCH--------THDQRVRSINLPYMQLGGIISPSI 90 (603)
Q Consensus 23 ~~~~~~~~~~l~~~k~~~-~~~~~~l~~w~---~~~~~~c~w~gv~C~--------~~~~~l~~L~L~~n~l~~~~~~~~ 90 (603)
+.+..+|+.||++||..+ .|+.+.+++|. ....++|.|.|+.|. ....+|+.|+|++|+++. +|+.+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~~-lp~~l 100 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQ-FPDQA 100 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCSS-CCSCG
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCchh-cChhh
Confidence 335667999999999998 57777788994 345678999999994 234689999999999984 78889
Q ss_pred cCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCcc------
Q 007455 91 GRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGR------ 164 (603)
Q Consensus 91 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~------ 164 (603)
+++++|++|+|++|.|+ .+|..|+++++|++|+|++|+|+ .+|..+.++++|+.|+|++|++.+.+|..+..
T Consensus 101 ~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~ 178 (328)
T 4fcg_A 101 FRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178 (328)
T ss_dssp GGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCC
T ss_pred hhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhh
Confidence 99999999999999999 89999999999999999999999 88999999999999999999988899988765
Q ss_pred ---ccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 165 ---LTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 165 ---l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
+++|+.|++++|+|+..+..+..+++|+.|++++|
T Consensus 179 ~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L~~N 216 (328)
T 4fcg_A 179 HQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNS 216 (328)
T ss_dssp EEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEEESS
T ss_pred hccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEccCC
Confidence 89999999999999977667888888888888887
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.1e-23 Score=228.24 Aligned_cols=170 Identities=24% Similarity=0.335 Sum_probs=149.7
Q ss_pred hhhHHHHHHHHHhCCCCCCC--------CCCCCCCCCCCccc---cceeecCCCCcEEEEEcCCCCcccccCCCccCCCC
Q 007455 27 TEDGMTLLEIKSSLNDSRNL--------LGNWQATEESPCKW---TGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDK 95 (603)
Q Consensus 27 ~~~~~~l~~~k~~~~~~~~~--------l~~w~~~~~~~c~w---~gv~C~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~ 95 (603)
..|+.||.+|++++.++... ..+|+. +.+||.| .||+|+.. ++|+.|+|++|+++|.+|++|++|++
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~-~~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~~l~~L~~ 106 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNF-NKELDMWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPDAIGQLTE 106 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCC-SSCGGGTTCCTTEEECTT-CCEEEEECTTSCCEEEECGGGGGCTT
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCC-CCCcccccCCCCeEEcCC-CCEEEEEecCcccCCcCChHHhcCcc
Confidence 35999999999999766432 347985 4788999 99999764 79999999999999999999999999
Q ss_pred cceEEeccCC----------------------------------------------------------------------
Q 007455 96 LQRLALHQNS---------------------------------------------------------------------- 105 (603)
Q Consensus 96 L~~L~L~~N~---------------------------------------------------------------------- 105 (603)
|++|+|++|.
T Consensus 107 L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l 186 (636)
T 4eco_A 107 LEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDT 186 (636)
T ss_dssp CCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTT
T ss_pred ceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhh
Confidence 9999999984
Q ss_pred --------CCCCCCCCccccCCCceEEeccccCCCC-----------------Cccccc--cccccceecccCCccCCCC
Q 007455 106 --------LHGSIPNEITNCTELRALYLRANYLQGG-----------------IPANIG--NLLFLTILDLSSNSLKGAI 158 (603)
Q Consensus 106 --------l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~--~l~~L~~L~l~~N~l~~~~ 158 (603)
|+| +|..|+++++|++|+|++|+|+|. +|+.++ ++++|++|+|++|++.+.+
T Consensus 187 ~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~ 265 (636)
T 4eco_A 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265 (636)
T ss_dssp TTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSC
T ss_pred hhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccC
Confidence 444 888899999999999999999985 999999 9999999999999999999
Q ss_pred CCCCccccccceeeccCCc-Ccc-c-CCCCccc------cccCcccccCC
Q 007455 159 PSSLGRLTHLHYLNLSTNF-FSG-E-IPDFGAL------SAFGNKSFIGN 199 (603)
Q Consensus 159 p~~~~~l~~L~~l~l~~N~-l~~-~-~~~~~~l------~~l~~l~~~~n 199 (603)
|..|.++++|+.|++++|+ +++ . |..++.+ ++|+.|++++|
T Consensus 266 p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n 315 (636)
T 4eco_A 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYN 315 (636)
T ss_dssp CTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSS
T ss_pred hHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCC
Confidence 9999999999999999998 997 4 4456665 78888888877
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.86 E-value=8.2e-22 Score=190.21 Aligned_cols=152 Identities=25% Similarity=0.309 Sum_probs=133.4
Q ss_pred CCCCccccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEE
Q 007455 54 EESPCKWTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALY 124 (603)
Q Consensus 54 ~~~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 124 (603)
..+.|+|++|.|++. ..+++.|+|++|+|+++.|..|..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 15 ~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 94 (229)
T 3e6j_A 15 SQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD 94 (229)
T ss_dssp TTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEE
Confidence 457899999999752 25799999999999999999999999999999999999855556789999999999
Q ss_pred eccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccC
Q 007455 125 LRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLC 203 (603)
Q Consensus 125 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~ 203 (603)
|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.++. +..+++|+.|++.
T Consensus 95 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~------ 167 (229)
T 3e6j_A 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLF------ 167 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECT------
T ss_pred CCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEee------
Confidence 9999999777777899999999999999999 8899999999999999999999988875 6677777766555
Q ss_pred CCCCCCCCC
Q 007455 204 GRQVHKPCR 212 (603)
Q Consensus 204 ~~~~~~~c~ 212 (603)
+||+.|+|+
T Consensus 168 ~N~~~c~c~ 176 (229)
T 3e6j_A 168 GNPWDCECR 176 (229)
T ss_dssp TSCBCTTBG
T ss_pred CCCccCCcc
Confidence 557777774
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-21 Score=187.41 Aligned_cols=152 Identities=20% Similarity=0.271 Sum_probs=134.0
Q ss_pred CCCccccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEe
Q 007455 55 ESPCKWTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYL 125 (603)
Q Consensus 55 ~~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 125 (603)
.|.|.|..|.|.+. ..+++.|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 8 ~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~L 87 (220)
T 2v9t_B 8 ACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVL 87 (220)
T ss_dssp TSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEEC
T ss_pred CCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEEC
Confidence 35589999999752 247999999999999988889999999999999999999888999999999999999
Q ss_pred ccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccCC
Q 007455 126 RANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLCG 204 (603)
Q Consensus 126 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~ 204 (603)
++|+|++..+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++.+++ |..+++|+.+++.+|
T Consensus 88 s~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N----- 162 (220)
T 2v9t_B 88 YGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN----- 162 (220)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS-----
T ss_pred CCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC-----
Confidence 99999966666689999999999999999988899999999999999999999999885 777778877766655
Q ss_pred CCCCCCCC
Q 007455 205 RQVHKPCR 212 (603)
Q Consensus 205 ~~~~~~c~ 212 (603)
||.|+|.
T Consensus 163 -~~~c~c~ 169 (220)
T 2v9t_B 163 -PFICDCH 169 (220)
T ss_dssp -CEECSGG
T ss_pred -CcCCCCc
Confidence 6666664
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.4e-21 Score=180.29 Aligned_cols=147 Identities=22% Similarity=0.228 Sum_probs=129.8
Q ss_pred CCCccccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEe
Q 007455 55 ESPCKWTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYL 125 (603)
Q Consensus 55 ~~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 125 (603)
.|.|.|.+|.|... ..++++|+|++|+++++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|
T Consensus 4 ~C~C~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 83 (208)
T 2o6s_A 4 RCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNL 83 (208)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEECCCEEEecCCCccCCCCCCCCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEEC
Confidence 45689999999753 247999999999999988888999999999999999999666667899999999999
Q ss_pred ccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcc
Q 007455 126 RANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLD 201 (603)
Q Consensus 126 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~ 201 (603)
++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|++++|+|++.++. +..+++|+.|++.+|..
T Consensus 84 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 160 (208)
T 2o6s_A 84 STNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW 160 (208)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred CCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCe
Confidence 99999977777789999999999999999977777789999999999999999998876 77888888888877743
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-21 Score=183.54 Aligned_cols=152 Identities=18% Similarity=0.267 Sum_probs=132.5
Q ss_pred CCCccccceeecCC---------CCcEEEEEcCCCCcccccC-CCccCCCCcceEEeccCCCCCCCCCCccccCCCceEE
Q 007455 55 ESPCKWTGISCHTH---------DQRVRSINLPYMQLGGIIS-PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALY 124 (603)
Q Consensus 55 ~~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 124 (603)
.|.|.|..+.|++. ...++.|+|++|+|+++.+ ..|..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 8 ~C~C~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~ 87 (220)
T 2v70_A 8 KCRCEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEIL 87 (220)
T ss_dssp TCEEETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred CCEECCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEE
Confidence 35588999999643 2367899999999999865 4589999999999999999977777899999999999
Q ss_pred eccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccC
Q 007455 125 LRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLC 203 (603)
Q Consensus 125 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~ 203 (603)
|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++.+|. |..+++|+.|++++|
T Consensus 88 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N---- 163 (220)
T 2v70_A 88 LTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN---- 163 (220)
T ss_dssp CCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSC----
T ss_pred CCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCc----
Confidence 999999988888899999999999999999988899999999999999999999999664 777788877766555
Q ss_pred CCCCCCCCC
Q 007455 204 GRQVHKPCR 212 (603)
Q Consensus 204 ~~~~~~~c~ 212 (603)
||.|+|.
T Consensus 164 --~l~c~c~ 170 (220)
T 2v70_A 164 --PFNCNCY 170 (220)
T ss_dssp --CEECSGG
T ss_pred --CCcCCCc
Confidence 6666664
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.1e-20 Score=184.92 Aligned_cols=130 Identities=27% Similarity=0.259 Sum_probs=116.6
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+++++.+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 46889999999999988888999999999999999999878888999999999999999999777788899999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
++|+|++..+..|..+++|+.|+|++|+|++.++. |..+++|+.|++++|
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 165 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTN 165 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCC
Confidence 99999976666788999999999999999988884 888889998888887
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.82 E-value=7.1e-20 Score=181.33 Aligned_cols=130 Identities=26% Similarity=0.322 Sum_probs=109.5
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+++++.+..|.++++|++|+|++|+|+...+..|.++++|++|+|++|++++..+..|..+++|+.|+|
T Consensus 37 ~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 116 (270)
T 2o6q_A 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRL 116 (270)
T ss_dssp TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEEC
T ss_pred CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEEC
Confidence 36889999999999887778999999999999999998555555788999999999999999766677788889999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
++|++++..+..|..+++|+.|+|++|+|++.++. |..+++|+.|++++|
T Consensus 117 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 167 (270)
T 2o6q_A 117 DRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNN 167 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCC
Confidence 99998877777788888888888888888887765 677788888888777
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.4e-20 Score=192.83 Aligned_cols=157 Identities=22% Similarity=0.208 Sum_probs=138.0
Q ss_pred CCccccceeecCC---------CCcEEEEEcCCCCcccccCCCcc-CCCCcceEEeccCCCCCCCCCCccccCCCceEEe
Q 007455 56 SPCKWTGISCHTH---------DQRVRSINLPYMQLGGIISPSIG-RLDKLQRLALHQNSLHGSIPNEITNCTELRALYL 125 (603)
Q Consensus 56 ~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 125 (603)
|.|.+..|.|.+. ...++.|+|++|+|+++.+..+. ++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 16 C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L 95 (361)
T 2xot_A 16 CLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL 95 (361)
T ss_dssp CEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred CEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence 4478888999642 24588999999999998888888 9999999999999999777788999999999999
Q ss_pred ccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCC----ccccccCcccccCC--
Q 007455 126 RANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDF----GALSAFGNKSFIGN-- 199 (603)
Q Consensus 126 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~----~~l~~l~~l~~~~n-- 199 (603)
++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++.+ ..+++|+.|++++|
T Consensus 96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCC
T ss_pred CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCC
Confidence 999999777778999999999999999999888899999999999999999999987763 56888999988877
Q ss_pred ------------------cccCCCCCCCCCC
Q 007455 200 ------------------LDLCGRQVHKPCR 212 (603)
Q Consensus 200 ------------------~~l~~~~~~~~c~ 212 (603)
+++.+|||.|+|.
T Consensus 176 ~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~ 206 (361)
T 2xot_A 176 KKLPLTDLQKLPAWVKNGLYLHNNPLECDCK 206 (361)
T ss_dssp CCCCHHHHHHSCHHHHTTEECCSSCEECCHH
T ss_pred CccCHHHhhhccHhhcceEEecCCCccCCcC
Confidence 4678999999884
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.4e-19 Score=177.78 Aligned_cols=136 Identities=19% Similarity=0.172 Sum_probs=103.8
Q ss_pred CCCCCeeeecCCeEEEEEEE-CCCCE--EEEEEeCCCCCC------------------------hHHHHHHHHHHHhhCC
Q 007455 313 LDEEDVVGSGGFGTVYRMVM-NDCGT--FAVKRIDRSREG------------------------SDQVFERELEILGSIK 365 (603)
Q Consensus 313 ~~~~~~ig~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 365 (603)
|.+.+.||+|+||.||+|.+ .++.. ||||+++..... ....+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999998 56778 999987543111 0135889999999998
Q ss_pred CCee--eecceeeecCCccEEEEEecCC-C----CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEE
Q 007455 366 HINL--VNLRGYCRLPATKLLIYDYLSM-G----SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH-HDCCPKIIH 437 (603)
Q Consensus 366 h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH-~~~~~~ivH 437 (603)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8864 333332 367899999953 4 44443322 123456789999999999999 87 8999
Q ss_pred ecCCCCCeEECCCCCeEEeeccccccc
Q 007455 438 RDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 438 ~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999764
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.78 E-value=1.6e-19 Score=169.08 Aligned_cols=128 Identities=28% Similarity=0.382 Sum_probs=78.9
Q ss_pred CCCccccceeecCC---------CCcEEEEEcCCCCcccccCC-CccCCCCcceEEeccCCCCCCCCCCccccCCCceEE
Q 007455 55 ESPCKWTGISCHTH---------DQRVRSINLPYMQLGGIISP-SIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALY 124 (603)
Q Consensus 55 ~~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 124 (603)
.|.|.|+.+.|++. ..+++.|+|++|+|+++.+. .|..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 5 ~C~C~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 84 (192)
T 1w8a_A 5 MCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp TSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCEECCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEE
Confidence 34577877777532 12556666666666665443 356666666666666666655566666666666666
Q ss_pred eccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccC
Q 007455 125 LRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEI 182 (603)
Q Consensus 125 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 182 (603)
|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++++..
T Consensus 85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 6666666555555666666666666666666655666666666666666666666543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=2.5e-19 Score=203.61 Aligned_cols=141 Identities=38% Similarity=0.585 Sum_probs=133.6
Q ss_pred EEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCC
Q 007455 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152 (603)
Q Consensus 73 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 152 (603)
..++++.|.++|.+|..+..+++|+.|||++|+++|.+|..|+++++|+.|+|++|+|+|.+|..|+++++|+.|||++|
T Consensus 611 ~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N 690 (768)
T 3rgz_A 611 NPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSN 690 (768)
T ss_dssp CCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSS
T ss_pred cccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCC
Confidence 34567778999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCcccCCCCCCCCCCCC
Q 007455 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTS 214 (603)
Q Consensus 153 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~~~~~~c~~~ 214 (603)
+++|.+|..+.++++|+.|++++|+|+|.+|..+.+.++....+.+|+.+||.|+. +|+..
T Consensus 691 ~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~-~C~~~ 751 (768)
T 3rgz_A 691 KLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP-RCDPS 751 (768)
T ss_dssp CCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC-CCCSC
T ss_pred cccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc-CCCCC
Confidence 99999999999999999999999999999999888899999999999999999987 78653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=172.77 Aligned_cols=139 Identities=25% Similarity=0.226 Sum_probs=86.6
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+|+++.+. ..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|.++++|+.|+|
T Consensus 55 ~~L~~L~L~~n~l~~~~~~--~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L 131 (290)
T 1p9a_G 55 TRLTQLNLDRAELTKLQVD--GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL 131 (290)
T ss_dssp TTCCEEECTTSCCCEEECC--SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCcccCC--CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEEC
Confidence 3455555555555543221 45555666666666665 56666666667777777777776555566666777777777
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC-----------------cccCCCCCCCCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN-----------------LDLCGRQVHKPC 211 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n-----------------~~l~~~~~~~~c 211 (603)
++|+|++..+..|..+++|+.|+|++|+|++.++. |..+++|+.|++++| +++.+|||.|+|
T Consensus 132 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcC
Confidence 77777655555566667777777777777766654 455666666666665 245666777776
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.2e-18 Score=167.42 Aligned_cols=136 Identities=27% Similarity=0.320 Sum_probs=121.2
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
..++++|+|++|+|+++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 58 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 137 (251)
T 3m19_A 58 LTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELR 137 (251)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEE
Confidence 46899999999999999888999999999999999999977778899999999999999999977777789999999999
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccCCCCCCCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVHKP 210 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~~~ 210 (603)
|++|+|++..+..|..+++|+.|+|++|+|++.++. +..+++|+.|++.+| ++.|.
T Consensus 138 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N------~~~c~ 194 (251)
T 3m19_A 138 LNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN------QFDCS 194 (251)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSC------CBCTT
T ss_pred CcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCC------ceeCC
Confidence 999999977777899999999999999999998874 777778877766655 56655
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.76 E-value=3.8e-18 Score=169.03 Aligned_cols=131 Identities=26% Similarity=0.224 Sum_probs=93.6
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
..++++|+|++|+++++.+..|.++++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 84 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 163 (272)
T 3rfs_A 84 LTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELD 163 (272)
T ss_dssp CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEE
Confidence 35677777777777776666677777777777777777755555677777777777777777766666667777777777
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
|++|++++..+..+..+++|+.|++++|++++.++. +..+++|+.|++.+|
T Consensus 164 l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 215 (272)
T 3rfs_A 164 LSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCC
Confidence 777777766666667777777777777777776665 566666666665555
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.75 E-value=4.6e-19 Score=179.39 Aligned_cols=138 Identities=30% Similarity=0.452 Sum_probs=107.6
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
+++.|+|++|++++.+|..+..++ |++|+|++|++++..|..|..+++|+.|+|++|++++.+|. +..+++|++|+|+
T Consensus 175 ~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls 252 (313)
T 1ogq_A 175 LFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252 (313)
T ss_dssp TCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC
T ss_pred cCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc
Confidence 455566666666555555555555 66666666666666666677777788888888887755554 7778888999999
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCcccCCCCCCCCC
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPC 211 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~~~~~~c 211 (603)
+|+|++.+|..+..+++|+.|+|++|+|++.+|....+++|+.+++.+|..+|+.|+. .|
T Consensus 253 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred CCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC-CC
Confidence 9999888999999999999999999999988888888999999999999999988775 45
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.75 E-value=3e-18 Score=158.18 Aligned_cols=129 Identities=27% Similarity=0.354 Sum_probs=68.6
Q ss_pred CCCccccceeecCCC---------CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEe
Q 007455 55 ESPCKWTGISCHTHD---------QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYL 125 (603)
Q Consensus 55 ~~~c~w~gv~C~~~~---------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 125 (603)
.|.|+|.+|.|.+.. .+++.|+|++|+++++.+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 4 ~C~C~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 83 (177)
T 2o6r_A 4 RCSCSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYL 83 (177)
T ss_dssp TCEEETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEeCCCEEEecCCCCccCCCCCCCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEEC
Confidence 355889999886421 24555555555555544444555555555555555555333334455555555555
Q ss_pred ccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCC
Q 007455 126 RANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP 183 (603)
Q Consensus 126 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 183 (603)
++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|++++|++++.++
T Consensus 84 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 84 HENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 5555554444444555555555555555553333334455555555555555554443
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.74 E-value=9.5e-18 Score=161.64 Aligned_cols=132 Identities=23% Similarity=0.269 Sum_probs=116.3
Q ss_pred ccceeecCCCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccc
Q 007455 60 WTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIG 139 (603)
Q Consensus 60 w~gv~C~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 139 (603)
|..-.|+. +.++.++++++. +|..+. ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.
T Consensus 14 ~~~~~Cs~-----~~v~c~~~~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~ 85 (229)
T 3e6j_A 14 PSQCSCSG-----TTVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFD 85 (229)
T ss_dssp CTTCEEET-----TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CCCCEEeC-----CEeEccCCCcCc-cCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcc
Confidence 44456854 569999999987 555554 8999999999999988899999999999999999999966667789
Q ss_pred cccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 140 NLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 140 ~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
.+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+.++..+..+++|+.|++++|
T Consensus 86 ~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~L~~N 145 (229)
T 3e6j_A 86 SLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRGIERLTHLTHLALDQN 145 (229)
T ss_dssp TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTTGGGCTTCSEEECCSS
T ss_pred cCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCcccccCcccccCCCCCEEECCCC
Confidence 999999999999999977777789999999999999999988888999999999999888
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.74 E-value=8.4e-18 Score=166.55 Aligned_cols=129 Identities=27% Similarity=0.274 Sum_probs=117.9
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
..++++|+|++|++++. +.+..+++|++|+|++|.|++..|..|.++++|++|+|++|++++..+..|..+++|+.|+
T Consensus 62 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 139 (272)
T 3rfs_A 62 LPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN 139 (272)
T ss_dssp CTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence 46799999999999984 4799999999999999999977777789999999999999999987788899999999999
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
|++|++++..+..+..+++|+.|++++|+|++.++. +..+++|+.|++++|
T Consensus 140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (272)
T 3rfs_A 140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQN 191 (272)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCC
Confidence 999999977777789999999999999999998876 688899999998887
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.74 E-value=4.9e-18 Score=162.55 Aligned_cols=125 Identities=22% Similarity=0.212 Sum_probs=111.8
Q ss_pred EEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCC
Q 007455 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152 (603)
Q Consensus 73 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 152 (603)
+.+++++++++. +|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 14 ~~v~c~~~~l~~-iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLTE-IPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCSS-CCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcCc-CCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 468999999988 555554 79999999999999777778999999999999999999888999999999999999999
Q ss_pred ccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCc
Q 007455 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNL 200 (603)
Q Consensus 153 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~ 200 (603)
+|++..+..|..+++|+.|+|++|+|++.++. |..+++|+.|++++|.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 139 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNK 139 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCc
Confidence 99966666688999999999999999999775 8888999999988883
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=4.7e-18 Score=188.89 Aligned_cols=138 Identities=20% Similarity=0.219 Sum_probs=123.3
Q ss_pred ceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCC
Q 007455 62 GISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG 132 (603)
Q Consensus 62 gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 132 (603)
.|.|.+. +..+++|||++|+|+++.+.+|.++++|++|+|++|+|++..|++|.+|++|++|+|++|+|++
T Consensus 35 ~~~c~~~~l~~vP~~lp~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~ 114 (635)
T 4g8a_A 35 TYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS 114 (635)
T ss_dssp EEECTTSCCSSCCSSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCE
T ss_pred EEECCCCCcCccCCCCCcCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCC
Confidence 4778642 2579999999999999888999999999999999999997777889999999999999999997
Q ss_pred CCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccC-C-CCccccccCcccccCC
Q 007455 133 GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEI-P-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 133 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~-~-~~~~l~~l~~l~~~~n 199 (603)
..+..|.+|++|++|+|++|+|++..+..|+++++|+.|+|++|+|++.. | .+..+++|+.|++++|
T Consensus 115 l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N 183 (635)
T 4g8a_A 115 LALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 183 (635)
T ss_dssp ECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred CCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCc
Confidence 77778999999999999999999777778999999999999999998753 3 4778899999998887
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=6.3e-18 Score=158.19 Aligned_cols=131 Identities=23% Similarity=0.253 Sum_probs=113.8
Q ss_pred EEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCC-CccccCCCceEEeccccCCCCCccccccccccceecccC
Q 007455 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPN-EITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSS 151 (603)
Q Consensus 73 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 151 (603)
+.|++++|+|+. +|..+.. +|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|+.|+|++
T Consensus 11 ~~l~~s~~~l~~-ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcCc-CccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 689999999976 6666654 999999999999965554 489999999999999999998899999999999999999
Q ss_pred CccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccCCCCCCCCCC
Q 007455 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 152 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
|+|++..|..|.++++|+.|+|++|+|++.+|. +..+++|+.|++++| +|.|+|+
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N------~l~c~c~ 143 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN------PFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTC------CBCCSGG
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCC------CccCcCc
Confidence 999988888899999999999999999998774 777788887766655 6666664
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1e-17 Score=156.71 Aligned_cols=129 Identities=24% Similarity=0.269 Sum_probs=110.1
Q ss_pred EEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCc
Q 007455 74 SINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNS 153 (603)
Q Consensus 74 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 153 (603)
.+++++|+|+. +|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+
T Consensus 14 ~l~~~~~~l~~-ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~ 89 (193)
T 2wfh_A 14 VVRCSNKGLKV-LPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89 (193)
T ss_dssp EEECTTSCCSS-CCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEcCCCCCCc-CCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence 46667778876 555553 68999999999998 888899999999999999999998888889999999999999999
Q ss_pred cCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccCCCCCCCCCC
Q 007455 154 LKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 154 l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
|++..|..|..+++|+.|+|++|+|++.++. |..+++|+.+++.+| ||.|+|.
T Consensus 90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N------~~~C~c~ 143 (193)
T 2wfh_A 90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN------PLYCDCN 143 (193)
T ss_dssp CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSS------CEECSGG
T ss_pred cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCC------CeecCCc
Confidence 9988888899999999999999999988875 777777777765554 6666664
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.73 E-value=1.5e-17 Score=166.18 Aligned_cols=140 Identities=23% Similarity=0.176 Sum_probs=127.2
Q ss_pred CCCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccce
Q 007455 67 THDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTI 146 (603)
Q Consensus 67 ~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 146 (603)
....+++.|+|++|+|+. +|..+..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.
T Consensus 74 ~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 152 (290)
T 1p9a_G 74 GTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEK 152 (290)
T ss_dssp SCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE
T ss_pred CCCCcCCEEECCCCcCCc-CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCE
Confidence 345689999999999986 7788999999999999999999777788999999999999999999777778899999999
Q ss_pred ecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCcccCCCCC
Q 007455 147 LDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQV 207 (603)
Q Consensus 147 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~~~ 207 (603)
|+|++|+|++..+..|.++++|+.|+|++|+|+.+++.+..+.+|+.+.+.+|++.|++.+
T Consensus 153 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~~ 213 (290)
T 1p9a_G 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (290)
T ss_dssp EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred EECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCcc
Confidence 9999999996666677889999999999999999888888888999999999999998864
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=8e-18 Score=167.88 Aligned_cols=130 Identities=24% Similarity=0.201 Sum_probs=95.1
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCC-CCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNS-LHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
.++++|+|++|.++++.+..|..+++|++|+|++|. ++...|..|..+++|++|+|++|++++..|..|.++++|++|+
T Consensus 56 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 135 (285)
T 1ozn_A 56 RNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLY 135 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEE
Confidence 467777777777777777777777777777777776 6645466777777777777777777766677777777777777
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
|++|++++..+..|.++++|+.|++++|+|++.++. +..+++|+.|++++|
T Consensus 136 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 187 (285)
T 1ozn_A 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187 (285)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCC
Confidence 777777755555677777777777777777776664 666677777777666
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.72 E-value=2.5e-17 Score=162.94 Aligned_cols=130 Identities=23% Similarity=0.229 Sum_probs=96.4
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|+++.+.+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..|..|..+++|+.|+|
T Consensus 61 ~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L 140 (270)
T 2o6q_A 61 TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140 (270)
T ss_dssp TTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEEC
Confidence 56788888888887766666777888888888888887555556777788888888888887666666777777888888
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
++|+|++..+..|..+++|+.|++++|++++.++. |..+++|+.|++++|
T Consensus 141 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 191 (270)
T 2o6q_A 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191 (270)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCC
Confidence 88877755555577777777777777777777664 666777777776665
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.5e-17 Score=159.17 Aligned_cols=124 Identities=19% Similarity=0.147 Sum_probs=110.2
Q ss_pred EEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCC-CCccccCCCceEEeccccCCCCCccccccccccceecccC
Q 007455 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIP-NEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSS 151 (603)
Q Consensus 73 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 151 (603)
+.|++++|+++. +|..+. ..+++|+|++|+|++..| ..|..+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 389999999988 566554 467899999999996655 4589999999999999999987788999999999999999
Q ss_pred CccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 152 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
|+|++..|..|..+++|+.|+|++|+|++.+|. |..+++|+.|++++|
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 139 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDN 139 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTS
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCC
Confidence 999988888899999999999999999999765 888999999998887
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.5e-17 Score=154.16 Aligned_cols=126 Identities=21% Similarity=0.265 Sum_probs=113.0
Q ss_pred CCCccccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEe
Q 007455 55 ESPCKWTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYL 125 (603)
Q Consensus 55 ~~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 125 (603)
.|.|.|..|.|++. ..+++.|+|++|+|+. +|..|.++++|+.|+|++|+|++..|..|.++++|++|+|
T Consensus 7 ~C~C~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~~-ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~L 85 (193)
T 2wfh_A 7 ECTCLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLIL 85 (193)
T ss_dssp TCEEETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCCS-CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCEeCCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCch-hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEEC
Confidence 35578888999642 2479999999999985 6689999999999999999999877888999999999999
Q ss_pred ccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCccc
Q 007455 126 RANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGE 181 (603)
Q Consensus 126 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 181 (603)
++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+...
T Consensus 86 s~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 86 SYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 99999988888999999999999999999966666799999999999999999864
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.5e-17 Score=152.03 Aligned_cols=129 Identities=24% Similarity=0.209 Sum_probs=117.0
Q ss_pred CcEEEEEcCCCCcc-cccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 70 QRVRSINLPYMQLG-GIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
.+++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 57999999999998 67888899999999999999999955 6799999999999999999987898888899999999
Q ss_pred ccCCccCCCC-CCCCccccccceeeccCCcCcccCC----CCccccccCcccccCCc
Q 007455 149 LSSNSLKGAI-PSSLGRLTHLHYLNLSTNFFSGEIP----DFGALSAFGNKSFIGNL 200 (603)
Q Consensus 149 l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~~----~~~~l~~l~~l~~~~n~ 200 (603)
|++|+|++.. +..+..+++|+.|++++|++++.++ .+..+++|+.|++.+|.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~ 158 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDRE 158 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETT
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCC
Confidence 9999999532 2789999999999999999999888 58888999999988874
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.9e-17 Score=165.21 Aligned_cols=130 Identities=23% Similarity=0.232 Sum_probs=101.9
Q ss_pred CcEEEEEcCCCC-cccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 70 QRVRSINLPYMQ-LGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
.++++|+|++|. ++.+.+..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|+
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 159 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEE
Confidence 568888888886 7776677788888888888888888876677788888888888888888866666678888888888
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCC-CCccccccCcccccCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~~~~n 199 (603)
|++|++++..+..+..+++|+.|++++|++++.+| .+..+++|+.|++++|
T Consensus 160 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 211 (285)
T 1ozn_A 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211 (285)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCC
Confidence 88888885555567788888888888888887755 4777777777777776
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.9e-17 Score=163.00 Aligned_cols=123 Identities=20% Similarity=0.249 Sum_probs=81.3
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|+++++.+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|++++..+..+..+++|++|+|
T Consensus 52 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 131 (276)
T 2z62_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (276)
T ss_dssp TTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred cCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEEC
Confidence 46777777777777666666777777777777777776555566777777777777777777555556667777777777
Q ss_pred cCCccCCC-CCCCCccccccceeeccCCcCcccCCC-CccccccC
Q 007455 150 SSNSLKGA-IPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFG 192 (603)
Q Consensus 150 ~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~ 192 (603)
++|++++. +|..+.++++|+.|++++|++++.++. +..+.+++
T Consensus 132 ~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 176 (276)
T 2z62_A 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176 (276)
T ss_dssp CSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCT
T ss_pred cCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhcc
Confidence 77777642 466666777777777777777665542 44444444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.69 E-value=1.4e-17 Score=149.04 Aligned_cols=126 Identities=21% Similarity=0.211 Sum_probs=114.2
Q ss_pred CcEEEEEcCCCCcc-cccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 70 QRVRSINLPYMQLG-GIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
.+++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..+..+++|++|+|++|++++.+|..+..+++|+.|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 57999999999998 77888999999999999999999955 6799999999999999999987999888999999999
Q ss_pred ccCCccCCC-CCCCCccccccceeeccCCcCcccCC----CCccccccCccccc
Q 007455 149 LSSNSLKGA-IPSSLGRLTHLHYLNLSTNFFSGEIP----DFGALSAFGNKSFI 197 (603)
Q Consensus 149 l~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~~~~~----~~~~l~~l~~l~~~ 197 (603)
+++|++++. .+..+..+++|+.|++++|++++.++ .+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 999999963 34789999999999999999999887 47788888888775
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=2.1e-17 Score=176.23 Aligned_cols=144 Identities=25% Similarity=0.276 Sum_probs=127.9
Q ss_pred Cccccc--eeecCCC--------CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCC-CCCccccCCCceEEe
Q 007455 57 PCKWTG--ISCHTHD--------QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSI-PNEITNCTELRALYL 125 (603)
Q Consensus 57 ~c~w~g--v~C~~~~--------~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L 125 (603)
.|.|.+ |.|+... .++++|+|++|.++++.|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|
T Consensus 7 ~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~L 86 (455)
T 3v47_A 7 ECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKL 86 (455)
T ss_dssp CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEEC
T ss_pred eeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeC
Confidence 466555 8886532 57999999999999999999999999999999999998666 567999999999999
Q ss_pred ccccCCCCCccccccccccceecccCCccCCCCCCC--CccccccceeeccCCcCcccCCC--CccccccCcccccCCc
Q 007455 126 RANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSS--LGRLTHLHYLNLSTNFFSGEIPD--FGALSAFGNKSFIGNL 200 (603)
Q Consensus 126 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~l~l~~N~l~~~~~~--~~~l~~l~~l~~~~n~ 200 (603)
++|++++..|..|.++++|++|+|++|++++.+|.. +.++++|+.|+|++|++++.+|. +..+++|+.|++++|.
T Consensus 87 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 87 DYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp TTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 999999888999999999999999999999855544 99999999999999999999775 7889999999998873
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=4.3e-17 Score=173.85 Aligned_cols=137 Identities=24% Similarity=0.259 Sum_probs=124.9
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|++++.+|..+..+++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 354 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDL 354 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEEC
T ss_pred cCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEEC
Confidence 47999999999999999999999999999999999999888889999999999999999999888999999999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccCCCCCCCCCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
++|++++..|..|..+++|+.|++++|+|++.++. +..+++|+.|++++| |+.|+|+
T Consensus 355 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N------~l~~~~~ 412 (455)
T 3v47_A 355 SYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN------PWDCSCP 412 (455)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS------CBCCCTT
T ss_pred CCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCC------CcccCCC
Confidence 99999988899999999999999999999998875 577788877766655 6666664
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=6.5e-17 Score=160.45 Aligned_cols=130 Identities=20% Similarity=0.196 Sum_probs=119.5
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|+++++.+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|+.|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 46999999999999988889999999999999999999777778999999999999999999888889999999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCccc--CCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGE--IPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~--~~~~~~l~~l~~l~~~~n 199 (603)
++|++++..+..+.++++|+.|++++|++++. +..+..+++|+.|++++|
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N 159 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCC
Confidence 99999977777899999999999999999984 445888999999998887
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.69 E-value=2.2e-17 Score=166.51 Aligned_cols=129 Identities=19% Similarity=0.274 Sum_probs=65.1
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCC-CCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIP-NEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
.++++|+|++|++++ +|..+..+++|++|+|++|++++..+ ..+..+++|++|+|++|++++..|..+..+++|++|+
T Consensus 78 ~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 156 (306)
T 2z66_A 78 TSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 156 (306)
T ss_dssp SCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEE
T ss_pred cccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEE
Confidence 345555555555554 33345555555555555555553222 2455555555555555555544444555555555555
Q ss_pred ccCCccCC-CCCCCCccccccceeeccCCcCcccCC-CCccccccCcccccCC
Q 007455 149 LSSNSLKG-AIPSSLGRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~~~~n 199 (603)
|++|.+++ .+|..+..+++|+.|++++|++++.+| .+..+++|+.|++++|
T Consensus 157 l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N 209 (306)
T 2z66_A 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 209 (306)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTS
T ss_pred CCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCC
Confidence 55555543 344455555555555555555555433 2444445555544444
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.68 E-value=5.4e-17 Score=172.97 Aligned_cols=140 Identities=19% Similarity=0.174 Sum_probs=122.6
Q ss_pred ccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccC
Q 007455 60 WTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYL 130 (603)
Q Consensus 60 w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 130 (603)
|..|.|.+. ..+++.|+|++|+|+++.+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|
T Consensus 56 ~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp SCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CcEEEECCCCcCccCCCCCCCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 567888642 25799999999999999999999999999999999999988889999999999999999999
Q ss_pred CCCCccccccccccceecccCCccCCCCCCCCccccccceeeccC-CcCcccCCC-CccccccCcccccCC
Q 007455 131 QGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLST-NFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 131 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
++..+..|..+++|++|+|++|+|++..+..|.++++|+.|++++ |.++..++. |..+++|+.|++++|
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n 206 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTS
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCC
Confidence 977777799999999999999999976667899999999999998 556555553 778888888888877
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.68 E-value=6.1e-17 Score=179.19 Aligned_cols=145 Identities=22% Similarity=0.250 Sum_probs=128.2
Q ss_pred CCCccc----cceeecC---------CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCc
Q 007455 55 ESPCKW----TGISCHT---------HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELR 121 (603)
Q Consensus 55 ~~~c~w----~gv~C~~---------~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 121 (603)
.+||.| ..|.|.+ ...++++|+|++|+++++.+..|.++++|++|+|++|+|++..|..|.++++|+
T Consensus 4 ~~~c~~~~~~~~~~c~~~~l~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~ 83 (606)
T 3vq2_A 4 LNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLS 83 (606)
T ss_dssp --CCEEEETTTEEECTTSCCSSCCTTSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCC
T ss_pred CCCceecCCCCceEccCCCcccCCCCCCCCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcC
Confidence 356655 3477854 235799999999999999888999999999999999999988888999999999
Q ss_pred eEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcc--cCCCCccccccCcccccCC
Q 007455 122 ALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG--EIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 122 ~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~~~~~~l~~l~~l~~~~n 199 (603)
+|+|++|++++..|..|.++++|++|+|++|++++..|..++++++|++|++++|++++ .|..++.+++|+.|++++|
T Consensus 84 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n 163 (606)
T 3vq2_A 84 NLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYN 163 (606)
T ss_dssp EEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSS
T ss_pred EeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCC
Confidence 99999999998889999999999999999999997777889999999999999999986 3455889999999999887
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.68 E-value=4e-17 Score=166.58 Aligned_cols=141 Identities=11% Similarity=0.054 Sum_probs=99.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCC--------------ChHHHHHHHHHHHhhCCCCeeeecceeee
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSRE--------------GSDQVFERELEILGSIKHINLVNLRGYCR 377 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 377 (603)
-|.+.+.||+|+||.||+|.+.+|+.||||+++.... ........+.+++....|+|+.+++....
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3788899999999999999999999999998753210 01112222333333333444444332211
Q ss_pred ------cCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC
Q 007455 378 ------LPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL 451 (603)
Q Consensus 378 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~ 451 (603)
.....++||||++|++|.++... .....++.|++.+|.|||+. +||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEE
T ss_pred CCCeeeeccCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCC
Confidence 11234799999999888765432 12356789999999999998 899999999999998876
Q ss_pred C----------eEEeecccccccC
Q 007455 452 E----------PHVSDFGLAKLLV 465 (603)
Q Consensus 452 ~----------~kl~DfG~~~~~~ 465 (603)
. +.|+||+.+....
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEETT
T ss_pred CcccccccccceEEEEeCCcccCC
Confidence 3 8999999876543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=7.2e-17 Score=173.23 Aligned_cols=141 Identities=21% Similarity=0.229 Sum_probs=127.5
Q ss_pred cccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEecccc
Q 007455 59 KWTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129 (603)
Q Consensus 59 ~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 129 (603)
.|..|.|.+. ..+++.|+|++|+|+++.+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 3678999642 2478999999999999989999999999999999999998889999999999999999999
Q ss_pred CCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCC-CCccccccCcccccCC
Q 007455 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 130 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~~~~n 199 (603)
|++..+..|.++++|+.|+|++|++++..|..|.++++|+.|++++|++++..+ .|..+++|+.|++++|
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 162 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKC 162 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCC
Confidence 996666678999999999999999998888999999999999999999998876 4888899999988887
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=5.8e-17 Score=166.91 Aligned_cols=143 Identities=24% Similarity=0.331 Sum_probs=124.2
Q ss_pred CCCccccceeecCC-----------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceE
Q 007455 55 ESPCKWTGISCHTH-----------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRAL 123 (603)
Q Consensus 55 ~~~c~w~gv~C~~~-----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 123 (603)
.++|.|.|+ |+.. ..++++|+|++|+++++.+..|.++++|++|+|++|+|++..|..|.++++|++|
T Consensus 27 ~~~C~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 27 SLSCDRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp CCEECTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCCeE-eeCCCCCcccccccccccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 466889887 5421 2479999999999999888899999999999999999998778889999999999
Q ss_pred EeccccCCCCCccccccccccceecccCCccCCCCCC--CCccccccceeeccCC-cCcccCC-CCccccccCcccccCC
Q 007455 124 YLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPS--SLGRLTHLHYLNLSTN-FFSGEIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 124 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N-~l~~~~~-~~~~l~~l~~l~~~~n 199 (603)
+|++|+|++..+..|.++++|++|+|++|+++ .+|. .+.++++|+.|++++| .+++.++ .+..+++|+.|++++|
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence 99999999655555999999999999999999 5554 7999999999999999 5777765 4888899999988887
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=5.1e-17 Score=177.56 Aligned_cols=142 Identities=22% Similarity=0.290 Sum_probs=125.9
Q ss_pred CccccceeecCC-----------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEe
Q 007455 57 PCKWTGISCHTH-----------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYL 125 (603)
Q Consensus 57 ~c~w~gv~C~~~-----------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 125 (603)
.|.|.|+ |+.. ..++++|+|++|+++++.|..|.++++|++|+|++|+|++..|..|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 5899988 7532 247999999999999999999999999999999999999888889999999999999
Q ss_pred ccccCCCCCccccccccccceecccCCccCC-CCCCCCccccccceeeccCCc-CcccCC-CCccccccCcccccCC
Q 007455 126 RANYLQGGIPANIGNLLFLTILDLSSNSLKG-AIPSSLGRLTHLHYLNLSTNF-FSGEIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 126 ~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~-l~~~~~-~~~~l~~l~~l~~~~n 199 (603)
++|++++..|..|+++++|++|+|++|++++ ..|..+.++++|+.|++++|+ +...++ .+..+++|+.|++++|
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n 158 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKAL 158 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCC
Confidence 9999998777789999999999999999996 457789999999999999998 454543 5888889999988877
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.67 E-value=5.4e-17 Score=165.22 Aligned_cols=130 Identities=22% Similarity=0.349 Sum_probs=118.6
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcccccc---------
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGN--------- 140 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~--------- 140 (603)
.++++|+|++|+++ .+|..++++++|++|+|++|+|+ .+|..|.++++|++|+|++|++.+.+|..+..
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~ 181 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEE
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhcc
Confidence 57999999999999 68889999999999999999999 88999999999999999999988899988765
Q ss_pred ccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCccc
Q 007455 141 LLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202 (603)
Q Consensus 141 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~l 202 (603)
+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|++++.++.+..+++|+.|++++|...
T Consensus 182 l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~ 242 (328)
T 4fcg_A 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL 242 (328)
T ss_dssp STTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTC
T ss_pred CCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcch
Confidence 999999999999999 8898999999999999999999998888889999999999887443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.67 E-value=9.5e-17 Score=170.46 Aligned_cols=142 Identities=25% Similarity=0.281 Sum_probs=90.5
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCC-------------------------ccccCCCceE
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNE-------------------------ITNCTELRAL 123 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-------------------------~~~l~~L~~L 123 (603)
..++++|+|++|+|+++.+..|..+++|++|+|++|+|++..+.. |.++++|++|
T Consensus 111 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L 190 (440)
T 3zyj_A 111 LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190 (440)
T ss_dssp CSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEE
T ss_pred CccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCee
Confidence 356788888888887766667777777777777777776433323 4445555555
Q ss_pred EeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC---
Q 007455 124 YLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN--- 199 (603)
Q Consensus 124 ~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n--- 199 (603)
+|++|+|+ .+| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.++. |..+++|+.|++++|
T Consensus 191 ~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 268 (440)
T 3zyj_A 191 NLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268 (440)
T ss_dssp ECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCC
T ss_pred cCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCC
Confidence 55555555 344 255566666666666666655566666666666666666666666553 556666666666655
Q ss_pred ---------------cccCCCCCCCCCC
Q 007455 200 ---------------LDLCGRQVHKPCR 212 (603)
Q Consensus 200 ---------------~~l~~~~~~~~c~ 212 (603)
+++.+|||.|+|.
T Consensus 269 ~~~~~~~~~l~~L~~L~L~~Np~~CdC~ 296 (440)
T 3zyj_A 269 LLPHDLFTPLHHLERIHLHHNPWNCNCD 296 (440)
T ss_dssp CCCTTTTSSCTTCCEEECCSSCEECSST
T ss_pred ccChhHhccccCCCEEEcCCCCccCCCC
Confidence 3566777777774
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=2.9e-16 Score=144.76 Aligned_cols=132 Identities=25% Similarity=0.238 Sum_probs=112.4
Q ss_pred EEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccC
Q 007455 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSS 151 (603)
Q Consensus 72 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 151 (603)
.+.+++++|+++.+ |..+ .++|+.|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCccC-CCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 46899999999884 4444 37999999999999976667789999999999999999977777789999999999999
Q ss_pred CccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccCCCCCCCCCC
Q 007455 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 152 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
|+|++..+..+.++++|+.|++++|+|++.++. +..+++|+.|++.+| ++.|.|+
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N------~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN------PWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS------CBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCC------CeeccCc
Confidence 999977777789999999999999999988886 567888888777665 5666553
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.7e-17 Score=169.93 Aligned_cols=130 Identities=17% Similarity=0.207 Sum_probs=114.0
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|++++|.++.+.+..|..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..|.++++|++|+|
T Consensus 45 ~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 124 (390)
T 3o6n_A 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124 (390)
T ss_dssp CCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEEC
Confidence 56889999999998876666888999999999999999777778999999999999999999888888999999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
++|+++...+..|.++++|+.|++++|++++.++. +..+++|+.|++++|
T Consensus 125 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n 175 (390)
T 3o6n_A 125 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 175 (390)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSS
T ss_pred CCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCC
Confidence 99999944444568999999999999999988775 888889999988887
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.66 E-value=8.8e-17 Score=155.90 Aligned_cols=142 Identities=18% Similarity=0.278 Sum_probs=122.5
Q ss_pred CCccc-cce--eecC------CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCC-CCCCCCCCccccCCCceEEe
Q 007455 56 SPCKW-TGI--SCHT------HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNS-LHGSIPNEITNCTELRALYL 125 (603)
Q Consensus 56 ~~c~w-~gv--~C~~------~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L 125 (603)
|.|.+ .++ .|.+ ...+++.|+|++|+++++.+..|.++++|++|+|++|+ +++..+..|.++++|++|+|
T Consensus 8 C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l 87 (239)
T 2xwt_C 8 CECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87 (239)
T ss_dssp CSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEE
T ss_pred CeeCCCCcceeEccCccccCCCCCcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEEC
Confidence 44644 554 4964 23579999999999999888899999999999999997 88555668999999999999
Q ss_pred cc-ccCCCCCccccccccccceecccCCccCCCCCCCCccccccc---eeeccCC-cCcccCCC-CccccccC-cccccC
Q 007455 126 RA-NYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLH---YLNLSTN-FFSGEIPD-FGALSAFG-NKSFIG 198 (603)
Q Consensus 126 ~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~---~l~l~~N-~l~~~~~~-~~~l~~l~-~l~~~~ 198 (603)
++ |+|++..+..|.++++|+.|+|++|++++ +|. +..+++|+ .|++++| ++++.++. |..+++|+ .+++++
T Consensus 88 ~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~ 165 (239)
T 2xwt_C 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYN 165 (239)
T ss_dssp EEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCS
T ss_pred CCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCC
Confidence 99 99997777889999999999999999995 776 88888888 9999999 99988875 88888898 888887
Q ss_pred C
Q 007455 199 N 199 (603)
Q Consensus 199 n 199 (603)
|
T Consensus 166 n 166 (239)
T 2xwt_C 166 N 166 (239)
T ss_dssp C
T ss_pred C
Confidence 7
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.66 E-value=4.8e-17 Score=167.97 Aligned_cols=139 Identities=22% Similarity=0.143 Sum_probs=121.4
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
..+|+.|+|++|+|+++.+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+
T Consensus 63 l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~ 142 (361)
T 2xot_A 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLY 142 (361)
T ss_dssp CTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred ccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEE
Confidence 46899999999999998888999999999999999999977777899999999999999999988899999999999999
Q ss_pred ccCCccCCCCCCCC---ccccccceeeccCCcCcccCCC-Cccccc--cCcccccCCcccCCCCC
Q 007455 149 LSSNSLKGAIPSSL---GRLTHLHYLNLSTNFFSGEIPD-FGALSA--FGNKSFIGNLDLCGRQV 207 (603)
Q Consensus 149 l~~N~l~~~~p~~~---~~l~~L~~l~l~~N~l~~~~~~-~~~l~~--l~~l~~~~n~~l~~~~~ 207 (603)
|++|+|++..+..| ..+++|+.|+|++|+|++.++. +..++. ++.|++.+|+..|++.+
T Consensus 143 L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l 207 (361)
T 2xot_A 143 LSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDCKL 207 (361)
T ss_dssp CCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCHHH
T ss_pred CCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCcCc
Confidence 99999995433334 5799999999999999987753 556665 47899999999998763
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-16 Score=160.97 Aligned_cols=131 Identities=21% Similarity=0.243 Sum_probs=96.8
Q ss_pred CCcEEEEEcCCCCcccccC-CCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCC-CCccccccccccce
Q 007455 69 DQRVRSINLPYMQLGGIIS-PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG-GIPANIGNLLFLTI 146 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~ 146 (603)
..++++|+|++|++++..+ ..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++ .+|..+..+++|+.
T Consensus 100 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 179 (306)
T 2z66_A 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179 (306)
T ss_dssp CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE
Confidence 3567778888887777554 567777778888888877777777777777777888887777775 46777777777777
Q ss_pred ecccCCccCCCCCCCCccccccceeeccCCcCcccCC-CCccccccCcccccCC
Q 007455 147 LDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 147 L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~~~~n 199 (603)
|+|++|++++..|..+..+++|+.|++++|++++.++ .+..+++|+.|++++|
T Consensus 180 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 233 (306)
T 2z66_A 180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233 (306)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTS
T ss_pred EECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCC
Confidence 7777777776667777777777777777777777665 3666677777776666
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.65 E-value=8.3e-17 Score=180.83 Aligned_cols=169 Identities=25% Similarity=0.284 Sum_probs=112.6
Q ss_pred hhhHHHHHHHHHhCCCCCC-CCCCCCCCCCCCccccceeecCCCCcE------------------EEEEcCCCCccc---
Q 007455 27 TEDGMTLLEIKSSLNDSRN-LLGNWQATEESPCKWTGISCHTHDQRV------------------RSINLPYMQLGG--- 84 (603)
Q Consensus 27 ~~~~~~l~~~k~~~~~~~~-~l~~w~~~~~~~c~w~gv~C~~~~~~l------------------~~L~L~~n~l~~--- 84 (603)
+.++.+|+++......+.. .-.+|.......+.|.++.++. +++ ..++|+.|.|.+
T Consensus 131 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~~ 208 (727)
T 4b8c_D 131 DCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDDD 208 (727)
T ss_dssp -CCCHHHHHHHHHHHHHHTTC-----------------------------------------------------------
T ss_pred ccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcchhhHhhcCccCcccccCccc
Confidence 4588999999887743222 2345654444456788877643 233 334444554443
Q ss_pred ------ccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCC
Q 007455 85 ------IISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAI 158 (603)
Q Consensus 85 ------~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 158 (603)
..+..+..+++|+.|+|++|.|. .+|..+.++++|++|+|++|+|+ .+|..|.+|++|+.|+|++|+|+ .+
T Consensus 209 ~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~l 285 (727)
T 4b8c_D 209 IENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SL 285 (727)
T ss_dssp -------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SC
T ss_pred cccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-cc
Confidence 23667888999999999999998 88888889999999999999999 89999999999999999999999 88
Q ss_pred CCCCccccccceeeccCCcCcccCCCCccccccCcccccCCc
Q 007455 159 PSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200 (603)
Q Consensus 159 p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~ 200 (603)
|..|++|++|+.|+|++|.|+.+|..|+.+++|+.|++++|.
T Consensus 286 p~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~L~~N~ 327 (727)
T 4b8c_D 286 PAELGSCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNP 327 (727)
T ss_dssp CSSGGGGTTCSEEECCSSCCCCCCSSTTSCTTCCCEECTTSC
T ss_pred ChhhcCCCCCCEEECCCCCCCccChhhhcCCCccEEeCCCCc
Confidence 999999999999999999999888789999999999999883
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.65 E-value=1.2e-16 Score=176.51 Aligned_cols=130 Identities=17% Similarity=0.207 Sum_probs=105.6
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|++++|.++.+.+..|.++++|++|+|++|.|++..|..|..+++|++|+|++|.|++..|..|+++++|+.|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 35678888888888866666788888888888888888777778888888888888888888777777888888888888
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
++|.|++..+..|.++++|+.|+|++|.|++.+|. |..+++|+.|++++|
T Consensus 131 ~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 181 (597)
T 3oja_B 131 ERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSN 181 (597)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTS
T ss_pred eCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCC
Confidence 88888855555568888888888888888888774 777888888888777
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.1e-15 Score=144.82 Aligned_cols=124 Identities=26% Similarity=0.264 Sum_probs=109.4
Q ss_pred EEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCC
Q 007455 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152 (603)
Q Consensus 73 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 152 (603)
+.++.++++++.+ |..+ .++|++|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccCC-CCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 5788999999874 4444 469999999999999766677899999999999999999766677899999999999999
Q ss_pred ccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 153 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
++++..+..|.++++|+.|++++|+|++.++. +..+++|+.|++++|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 134 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQN 134 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCC
Confidence 99977667789999999999999999998886 788999999999887
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.7e-16 Score=173.89 Aligned_cols=130 Identities=22% Similarity=0.218 Sum_probs=85.0
Q ss_pred CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCC--CCCCccccCCCceEEeccccCCCCCcc-cccccccc
Q 007455 68 HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGS--IPNEITNCTELRALYLRANYLQGGIPA-NIGNLLFL 144 (603)
Q Consensus 68 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L 144 (603)
...++++|+|++|++++.+|..+.++++|++|+|++|+|++. +|..|.++++|++|+|++|++++.+|. .+..+++|
T Consensus 351 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L 430 (562)
T 3a79_B 351 SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESI 430 (562)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTC
T ss_pred CCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccC
Confidence 345788888888888887777888888888888888888742 235577788888888888888764554 35566666
Q ss_pred ceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 145 ~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
+.|+|++|++++.+|..+. ++|+.|++++|+|+.+++.+..+++|+.|++++|
T Consensus 431 ~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N 483 (562)
T 3a79_B 431 LVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASN 483 (562)
T ss_dssp CEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSS
T ss_pred CEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCC
Confidence 6666666666555544433 4555555555555555444445555555555544
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1e-16 Score=174.05 Aligned_cols=130 Identities=21% Similarity=0.191 Sum_probs=93.7
Q ss_pred CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCC--CCCCCccccCCCceEEeccccCCCCCccc-ccccccc
Q 007455 68 HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHG--SIPNEITNCTELRALYLRANYLQGGIPAN-IGNLLFL 144 (603)
Q Consensus 68 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L 144 (603)
...++++|+|++|++++.+|..+..+++|++|+|++|+|++ .+|..+..+++|++|+|++|++++.+|.. +..+++|
T Consensus 322 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L 401 (520)
T 2z7x_B 322 KISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401 (520)
T ss_dssp SCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTC
T ss_pred hCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccC
Confidence 34578888888888888888888888888888888888875 45566788888888888888888656654 6667777
Q ss_pred ceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 145 ~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
+.|+|++|++++.+|..+. ++|+.|++++|+|+.+++.+..+++|+.|++++|
T Consensus 402 ~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~~ip~~~~~l~~L~~L~L~~N 454 (520)
T 2z7x_B 402 LSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIKSIPKQVVKLEALQELNVASN 454 (520)
T ss_dssp CEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSS
T ss_pred CEEECcCCCCCcchhhhhc--ccCCEEECCCCcccccchhhhcCCCCCEEECCCC
Confidence 7777777777666555443 5666666666666655555556666666666555
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.64 E-value=2.8e-16 Score=173.82 Aligned_cols=140 Identities=18% Similarity=0.111 Sum_probs=126.9
Q ss_pred ccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccC
Q 007455 60 WTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYL 130 (603)
Q Consensus 60 w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 130 (603)
+..|.|.+. ...++.|+|++|.|+++.|..|.++++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 455788542 35799999999999999999999999999999999999988899999999999999999999
Q ss_pred CCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccC-CCCccccccCcccccCC
Q 007455 131 QGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEI-PDFGALSAFGNKSFIGN 199 (603)
Q Consensus 131 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~-~~~~~l~~l~~l~~~~n 199 (603)
++..|..|.++++|++|+|++|++++..|..+.++++|++|++++|++++.. |.+..+++|+.|++++|
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 163 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNN 163 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSS
T ss_pred cccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccC
Confidence 9888999999999999999999999776888999999999999999999853 66666899999998887
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=1.6e-16 Score=175.78 Aligned_cols=129 Identities=19% Similarity=0.185 Sum_probs=62.6
Q ss_pred cEEEEEcCCCCcccccC-CCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCC-CCccccccccccceec
Q 007455 71 RVRSINLPYMQLGGIIS-PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG-GIPANIGNLLFLTILD 148 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~ 148 (603)
+++.|+|++|++++..+ ..+..+++|++|+|++|.+++..|..+.++++|++|+|++|++++ .+|..|..+++|+.|+
T Consensus 400 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 479 (606)
T 3vq2_A 400 ELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLD 479 (606)
T ss_dssp TCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEE
T ss_pred CCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEE
Confidence 45555555555555444 344455555555555555554444445555555555555555543 2444444555555555
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCC-CCccccccCcccccCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~~~~n 199 (603)
|++|++++..|..+.++++|+.|++++|++++.+| .+..+++|+.|++++|
T Consensus 480 Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N 531 (606)
T 3vq2_A 480 LSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531 (606)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTS
T ss_pred CCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCC
Confidence 55555544444444445555555555555544433 2444444444444433
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=5.4e-16 Score=164.65 Aligned_cols=136 Identities=23% Similarity=0.255 Sum_probs=119.4
Q ss_pred CcEEEEEcCCCCcccccC-------------------------CCccCCCCcceEEeccCCCCCCCCCCccccCCCceEE
Q 007455 70 QRVRSINLPYMQLGGIIS-------------------------PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALY 124 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~-------------------------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 124 (603)
.+++.|+|++|+|+++.+ ..|.++++|++|+|++|+|+ .+|. +..+++|+.|+
T Consensus 136 ~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~ 213 (440)
T 3zyj_A 136 SKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELD 213 (440)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCCC-CTTCSSCCEEE
T ss_pred ccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cccc-cCCCcccCEEE
Confidence 467777777776665433 34667888888899999998 7775 89999999999
Q ss_pred eccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccC
Q 007455 125 LRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLC 203 (603)
Q Consensus 125 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~ 203 (603)
|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++.+++ |..+++|+.|++.+|++.|
T Consensus 214 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp CTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred CCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccC
Confidence 999999988899999999999999999999988899999999999999999999998876 7889999999999999999
Q ss_pred CCCC
Q 007455 204 GRQV 207 (603)
Q Consensus 204 ~~~~ 207 (603)
++.+
T Consensus 294 dC~l 297 (440)
T 3zyj_A 294 NCDI 297 (440)
T ss_dssp SSTT
T ss_pred CCCc
Confidence 8864
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.63 E-value=4.6e-16 Score=174.62 Aligned_cols=144 Identities=21% Similarity=0.167 Sum_probs=125.7
Q ss_pred CCccccceeecC---------CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEec
Q 007455 56 SPCKWTGISCHT---------HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLR 126 (603)
Q Consensus 56 ~~c~w~gv~C~~---------~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 126 (603)
|.|.++.|.|.. ...++++|+|++|+++++.+..|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus 2 C~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 81 (680)
T 1ziw_A 2 CTVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQ 81 (680)
T ss_dssp --CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECC
T ss_pred ceeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECC
Confidence 345566677753 23579999999999999888889999999999999999998889999999999999999
Q ss_pred cccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 127 ANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 127 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
+|+|++..+..|.++++|++|+|++|++++..|..|.++++|++|++++|.+++.++. +..+++|+.|++++|
T Consensus 82 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n 155 (680)
T 1ziw_A 82 HNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNN 155 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSS
T ss_pred CCccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCC
Confidence 9999965555799999999999999999977778899999999999999999988775 788899999998887
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.63 E-value=2.1e-16 Score=169.76 Aligned_cols=30 Identities=13% Similarity=0.039 Sum_probs=25.5
Q ss_pred HHHHHHHHHHHhhCCCCeeeecceeeecCC
Q 007455 351 DQVFERELEILGSIKHINLVNLRGYCRLPA 380 (603)
Q Consensus 351 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 380 (603)
.+.|..|++.+.+++|+|+|+++|||....
T Consensus 323 ~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~ 352 (487)
T 3oja_A 323 SETERLECERENQARQREIDALKEQYRTVI 352 (487)
T ss_dssp --CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred HHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence 456999999999999999999999997643
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.62 E-value=7.2e-16 Score=141.06 Aligned_cols=113 Identities=24% Similarity=0.202 Sum_probs=98.3
Q ss_pred EEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCC
Q 007455 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152 (603)
Q Consensus 73 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 152 (603)
+.|++++|+|+. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 356777888887 565553 89999999999999888999999999999999999999777777899999999999999
Q ss_pred ccCCCCCCCCccccccceeeccCCcCcccCCCCccc
Q 007455 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGAL 188 (603)
Q Consensus 153 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l 188 (603)
+|++..+..|.++++|+.|+|++|+++...+++..+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~~l~~l 124 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWDCACSDILYL 124 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBCTTBGGGHHH
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCCCCchhHHHH
Confidence 999777778999999999999999999887654333
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=6.1e-16 Score=177.58 Aligned_cols=131 Identities=23% Similarity=0.262 Sum_probs=71.3
Q ss_pred cEEEEEcCCCCcccccCC-CccCCCCcceEEeccCCCC-----CCCCCCccccCCCceEEeccccCCCCCcccccccccc
Q 007455 71 RVRSINLPYMQLGGIISP-SIGRLDKLQRLALHQNSLH-----GSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 144 (603)
+++.|+|++|++++..+. .+..+++|+.|+|++|.++ +..|..|.++++|+.|+|++|+|++..|..|.++++|
T Consensus 427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 506 (844)
T 3j0a_A 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTAL 506 (844)
T ss_dssp TCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSC
T ss_pred ccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhh
Confidence 455555555555543322 2344555555555555554 2333445556666666666666665555556666666
Q ss_pred ceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCcccCCC
Q 007455 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGR 205 (603)
Q Consensus 145 ~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~ 205 (603)
+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|+. +.+|..+++++|++.|++
T Consensus 507 ~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c 563 (844)
T 3j0a_A 507 RGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICEC 563 (844)
T ss_dssp SEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSS
T ss_pred heeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccccc
Confidence 6666666666644444443 56666666666666665542 335555555555444433
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.62 E-value=9.3e-16 Score=163.40 Aligned_cols=135 Identities=21% Similarity=0.216 Sum_probs=85.4
Q ss_pred CcEEEEEcCCCCcccccCCCccCC-------------------------CCcceEEeccCCCCCCCCCCccccCCCceEE
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRL-------------------------DKLQRLALHQNSLHGSIPNEITNCTELRALY 124 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l-------------------------~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 124 (603)
.++++|+|++|+|+++.+..|.++ ++|++|+|++|+|+ .+|. +..+++|+.|+
T Consensus 147 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~-~~~l~~L~~L~ 224 (452)
T 3zyi_A 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELE 224 (452)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-cccc-ccccccccEEE
Confidence 578899999988887665555544 45555555555555 3332 55556666666
Q ss_pred eccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccC
Q 007455 125 LRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLC 203 (603)
Q Consensus 125 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~ 203 (603)
|++|+|++..|..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++.+++ +..+++|+.|++ .
T Consensus 225 Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L------~ 298 (452)
T 3zyi_A 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHL------H 298 (452)
T ss_dssp CTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEEC------C
T ss_pred CcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEc------c
Confidence 666666655566666666666666666666666666666666777777777777666554 445555555544 4
Q ss_pred CCCCCCCCC
Q 007455 204 GRQVHKPCR 212 (603)
Q Consensus 204 ~~~~~~~c~ 212 (603)
+|||.|+|.
T Consensus 299 ~Np~~CdC~ 307 (452)
T 3zyi_A 299 HNPWNCDCD 307 (452)
T ss_dssp SSCEECSTT
T ss_pred CCCcCCCCC
Confidence 556677774
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=5.3e-16 Score=178.15 Aligned_cols=140 Identities=24% Similarity=0.256 Sum_probs=125.7
Q ss_pred ccccceeecCCCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCC-CCCccccCCCceEEeccccCCCCCcc
Q 007455 58 CKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSI-PNEITNCTELRALYLRANYLQGGIPA 136 (603)
Q Consensus 58 c~w~gv~C~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~ 136 (603)
|.|..|.+ ...+++.|+|++|.|+++.+..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|++|+|++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 46777776 4578999999999999999999999999999999999766666 78899999999999999999988899
Q ss_pred ccccccccceecccCCccCCCCCCC--CccccccceeeccCCcCcccCC--CCccccccCcccccCC
Q 007455 137 NIGNLLFLTILDLSSNSLKGAIPSS--LGRLTHLHYLNLSTNFFSGEIP--DFGALSAFGNKSFIGN 199 (603)
Q Consensus 137 ~~~~l~~L~~L~l~~N~l~~~~p~~--~~~l~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~~~~n 199 (603)
.|.++++|++|+|++|.+++.+|.. |.++++|+.|+|++|.+++.++ .|+.+++|+.|++++|
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N 158 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSN 158 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESS
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCC
Confidence 9999999999999999999877665 9999999999999999998765 4888999999998887
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.62 E-value=4.4e-16 Score=172.97 Aligned_cols=137 Identities=18% Similarity=0.205 Sum_probs=120.0
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCC-CCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLH-GSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
.+++.++++.|.+.+..+..+..+++|+.|+|++|++. +..|..|..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 57889999999999999999999999999999999854 45788899999999999999999988899999999999999
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCC-Cccc-cccCcccccCCcccCCCCCCCCCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGAL-SAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l-~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
|++|+|++..|..|.++++|+.|+|++|+|++.+|+ +..+ ++|+.|+++ +|||.|+|.
T Consensus 525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~------~Np~~C~C~ 584 (635)
T 4g8a_A 525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT------QNDFACTCE 584 (635)
T ss_dssp CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECT------TCCBCCSGG
T ss_pred CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEee------CCCCcccCC
Confidence 999999988888899999999999999999999885 5555 456665554 557777774
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=6.4e-16 Score=170.97 Aligned_cols=130 Identities=22% Similarity=0.202 Sum_probs=83.3
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCC-ccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNE-ITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
.+++.|+|++|++++..|..|..+++|+.|+|++|++++..|.. +..+++|+.|+|++|++++..|..+..+++|++|+
T Consensus 376 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 455 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455 (606)
T ss_dssp TTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEE
Confidence 46777777777777766767777777777777777776555433 66667777777777776666666666666666666
Q ss_pred ccCCccCCC---CCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 149 LSSNSLKGA---IPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~---~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
|++|++++. .+..+..+++|+.|++++|++++.+|. |..+++|+.|++++|
T Consensus 456 L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 510 (606)
T 3t6q_A 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510 (606)
T ss_dssp CTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCC
Confidence 666666541 224456666666666666666665443 555556666655555
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.61 E-value=1.3e-15 Score=155.41 Aligned_cols=140 Identities=17% Similarity=0.277 Sum_probs=120.9
Q ss_pred CCccccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEec
Q 007455 56 SPCKWTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLR 126 (603)
Q Consensus 56 ~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 126 (603)
|.|.|+.+.|.+. ..+++.|+|++|+++++.+..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 31 c~c~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 31 CHCHLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp CEEETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred CcccCCEEECCCCCccccCCCCCCCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 3478999999642 2479999999999999888899999999999999999998789999999999999999
Q ss_pred cccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcc--cCC-CCccccccCcccccCC
Q 007455 127 ANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG--EIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 127 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~~-~~~~l~~l~~l~~~~n 199 (603)
+|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|.++. ..+ .+..+ +|+.|++++|
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n 182 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEA 182 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCC
Confidence 99999 7777665 899999999999996666679999999999999999974 444 35555 7888888777
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.61 E-value=9.6e-16 Score=140.75 Aligned_cols=114 Identities=26% Similarity=0.305 Sum_probs=99.4
Q ss_pred EEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCC
Q 007455 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152 (603)
Q Consensus 73 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 152 (603)
+.+++++|+|+. +|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~~-iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLAS-VPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCCc-cCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 578999999976 666664 89999999999999888999999999999999999999766666899999999999999
Q ss_pred ccCCCCCCCCccccccceeeccCCcCcccCCCCcccc
Q 007455 153 SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALS 189 (603)
Q Consensus 153 ~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~ 189 (603)
+|++..+..|..+++|+.|+|++|++...++++..+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~~~~~l~ 128 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWDCECRDIMYLR 128 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBCTTBGGGHHHH
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcccccccHHHHH
Confidence 9996666669999999999999999998776554443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.61 E-value=4.3e-16 Score=143.50 Aligned_cols=126 Identities=19% Similarity=0.153 Sum_probs=108.9
Q ss_pred CcEEEEEcCCCCcccccCCCccCCC-CcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLD-KLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
.+++.|+|++|+++.+ + .+..+. +|++|+|++|.|++. ..|..+++|++|+|++|+|++..|..+..+++|+.|+
T Consensus 19 ~~L~~L~l~~n~l~~i-~-~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIPVI-E-NLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCCSC-C-CGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCchh-H-HhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 4799999999999975 4 466665 999999999999954 5799999999999999999965455569999999999
Q ss_pred ccCCccCCCCCC--CCccccccceeeccCCcCcccCCC----CccccccCcccccCCc
Q 007455 149 LSSNSLKGAIPS--SLGRLTHLHYLNLSTNFFSGEIPD----FGALSAFGNKSFIGNL 200 (603)
Q Consensus 149 l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~~~----~~~l~~l~~l~~~~n~ 200 (603)
|++|+|+ .+|. .+..+++|+.|++++|+++..++. +..+++|+.|++++|.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~ 151 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVK 151 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECC
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCC
Confidence 9999997 6776 789999999999999999977664 7888999999888873
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.8e-15 Score=169.85 Aligned_cols=142 Identities=20% Similarity=0.206 Sum_probs=101.4
Q ss_pred EEEEEcCCCCcc--cccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCC--------ccccccc
Q 007455 72 VRSINLPYMQLG--GIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGI--------PANIGNL 141 (603)
Q Consensus 72 l~~L~L~~n~l~--~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--------p~~~~~l 141 (603)
++.|+|++|.++ +.+|..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|++++.. +..|.++
T Consensus 456 L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l 535 (680)
T 1ziw_A 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL 535 (680)
T ss_dssp CCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTC
T ss_pred cccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCC
Confidence 444444444443 345666777777888888888887666666777888888888888777431 1236777
Q ss_pred cccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC-------------------cc
Q 007455 142 LFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN-------------------LD 201 (603)
Q Consensus 142 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n-------------------~~ 201 (603)
++|+.|+|++|+++...+..|.++++|+.|+|++|+|+++++. |..+++|+.|++++| ++
T Consensus 536 ~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~ 615 (680)
T 1ziw_A 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELD 615 (680)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEE
T ss_pred CCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEE
Confidence 8888888888888843344678888888888888888887776 567788888877776 35
Q ss_pred cCCCCCCCCCCC
Q 007455 202 LCGRQVHKPCRT 213 (603)
Q Consensus 202 l~~~~~~~~c~~ 213 (603)
+.+|||.|+|+.
T Consensus 616 l~~N~~~c~c~~ 627 (680)
T 1ziw_A 616 MRFNPFDCTCES 627 (680)
T ss_dssp CTTCCCCBCCCC
T ss_pred ccCCCcccCCcc
Confidence 788999999964
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=1e-15 Score=156.00 Aligned_cols=141 Identities=18% Similarity=0.278 Sum_probs=123.2
Q ss_pred CCccccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEec
Q 007455 56 SPCKWTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLR 126 (603)
Q Consensus 56 ~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 126 (603)
|.|.|+.+.|.+. ...++.|+|++|+++++.+..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 29 c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 29 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4478999999642 2578999999999999888899999999999999999998779999999999999999
Q ss_pred cccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcc--cCC-CCccccccCcccccCC
Q 007455 127 ANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG--EIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 127 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~--~~~-~~~~l~~l~~l~~~~n 199 (603)
+|+|+ .+|..+. ++|+.|++++|++++..+..+.++++|+.|++++|+++. ..+ .+..+++|+.|++++|
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n 181 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSS
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCC
Confidence 99999 7777665 799999999999997777778999999999999999974 333 4778888888888877
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.60 E-value=6.3e-16 Score=145.17 Aligned_cols=124 Identities=17% Similarity=0.221 Sum_probs=69.0
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
++++|+|++|.++.. +.+..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++|+.|+|+
T Consensus 67 ~L~~L~l~~n~~~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~ 144 (197)
T 4ezg_A 67 NIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144 (197)
T ss_dssp TCSEEEEESCCCSCC--GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECC
T ss_pred CCCEEEccCCCCCcc--hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEcc
Confidence 455556655544332 245555566666666666654455555556666666666666655555555556666666666
Q ss_pred CCc-cCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 151 SNS-LKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 151 ~N~-l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
+|. ++ .+| .+..+++|+.|++++|++++.+ .+..+++|+.|++.+|
T Consensus 145 ~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~-~l~~l~~L~~L~l~~N 191 (197)
T 4ezg_A 145 YNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR-GIEDFPKLNQLYAFSQ 191 (197)
T ss_dssp SCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT-TGGGCSSCCEEEECBC
T ss_pred CCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH-HhccCCCCCEEEeeCc
Confidence 665 33 443 4555556666666666655533 4555555555555554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.59 E-value=5.8e-16 Score=172.03 Aligned_cols=130 Identities=18% Similarity=0.278 Sum_probs=121.2
Q ss_pred CCcEEEEEcCCCCcccc-----------------cCCCcc--CCCCcceEEeccCCCCCCCCCCccccCCCceEEecccc
Q 007455 69 DQRVRSINLPYMQLGGI-----------------ISPSIG--RLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~-----------------~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 129 (603)
..++++|+|++|.+++. +|+.++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+
T Consensus 205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~ 284 (636)
T 4eco_A 205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNR 284 (636)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCT
T ss_pred ccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCC
Confidence 46899999999999996 899999 99999999999999999999999999999999999998
Q ss_pred -CCC-CCccccccc------cccceecccCCccCCCCCC--CCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 130 -LQG-GIPANIGNL------LFLTILDLSSNSLKGAIPS--SLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 130 -l~~-~~p~~~~~l------~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++| .+|..++.+ ++|+.|+|++|+++ .+|. .+.++++|+.|++++|+++|.+|.+..+++|+.|++++|
T Consensus 285 ~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip~~~~l~~L~~L~L~~N 363 (636)
T 4eco_A 285 GISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYN 363 (636)
T ss_dssp TSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECCCCEEEEEESEEECCSS
T ss_pred CCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchhhhCCCCCCCEEECCCC
Confidence 998 899999887 99999999999999 8998 899999999999999999977778888999999988887
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.58 E-value=1.9e-15 Score=164.74 Aligned_cols=120 Identities=24% Similarity=0.242 Sum_probs=107.7
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
.++.|+|++|+|++ +|. |+.+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .|++|++|+.|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 48899999999998 565 999999999999999999 899999999999999999999995 77 89999999999999
Q ss_pred CCccCCCC-CCCCccccccceeeccCCcCcccCCCCcc----ccccCccc
Q 007455 151 SNSLKGAI-PSSLGRLTHLHYLNLSTNFFSGEIPDFGA----LSAFGNKS 195 (603)
Q Consensus 151 ~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~~~~~~----l~~l~~l~ 195 (603)
+|+|++.. |..+.++++|+.|+|++|+|++.++.+.. +++|+.|+
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEE
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccC
Confidence 99999776 99999999999999999999999886433 45565553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=3.1e-15 Score=164.08 Aligned_cols=130 Identities=20% Similarity=0.196 Sum_probs=116.9
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+++++.+.+|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|++
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 57999999999999988889999999999999999999777788999999999999999999777889999999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCccc--CCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGE--IPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~--~~~~~~l~~l~~l~~~~n 199 (603)
++|++++..+..++++++|++|++++|.+++. |..+..+++|+.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n 159 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTS
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCC
Confidence 99999966555799999999999999999973 445888999999998887
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.1e-15 Score=143.53 Aligned_cols=125 Identities=17% Similarity=0.246 Sum_probs=112.4
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+++. +| .+..+++|++|+|++|.++ .+ ..+..+++|++|+|++|++++..|..+..+++|+.|+|
T Consensus 44 ~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~L 119 (197)
T 4ezg_A 44 NSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119 (197)
T ss_dssp HTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEEC
T ss_pred CCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEe
Confidence 469999999999986 45 6999999999999999886 44 46999999999999999999888999999999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCc-CcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNF-FSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~-l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|++++..|..+.++++|+.|++++|+ ++.. +.+..+++|+.|++++|
T Consensus 120 s~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~~l~~l~~L~~L~l~~n 169 (197)
T 4ezg_A 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFD 169 (197)
T ss_dssp CSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-GGGGGCSSCCEEECTTB
T ss_pred cCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-HhhcCCCCCCEEECCCC
Confidence 9999998788889999999999999998 6655 47888999999998887
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.58 E-value=1.9e-15 Score=165.76 Aligned_cols=129 Identities=19% Similarity=0.274 Sum_probs=59.8
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCC-CCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIP-NEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
.+++.|+|++|.+++..+. +..+++|++|+|++|.+++..| ..+.++++|++|+|++|++++..|..+.++++|+.|+
T Consensus 373 ~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 451 (570)
T 2z63_A 373 TSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451 (570)
T ss_dssp SCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEE
T ss_pred CccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEE
Confidence 3455566666555553332 4445555555555555443333 2344444444444444444444444444444444444
Q ss_pred ccCCccC-CCCCCCCccccccceeeccCCcCcccCC-CCccccccCcccccCC
Q 007455 149 LSSNSLK-GAIPSSLGRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~-~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~~~~n 199 (603)
|++|+++ +.+|..+..+++|+.|++++|++++.+| .+..+++|+.|++++|
T Consensus 452 l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 504 (570)
T 2z63_A 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASN 504 (570)
T ss_dssp CTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCC
Confidence 4444443 2344444444444444444444444432 2344444444444443
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=2.6e-15 Score=151.61 Aligned_cols=128 Identities=18% Similarity=0.157 Sum_probs=100.0
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCC--C--CCCccccCCCceEEeccccCCCCCcc----cccc
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGS--I--PNEITNCTELRALYLRANYLQGGIPA----NIGN 140 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~ 140 (603)
..++++|+|++|++++..+..|..+++|++|+|++|++.+. + +..+..+++|++|+|++|+|+ .+|. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhc
Confidence 35788888888888888888888888888888888887642 2 233467888888888888887 4444 2567
Q ss_pred ccccceecccCCccCCCCCCCCccc---cccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 141 LLFLTILDLSSNSLKGAIPSSLGRL---THLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 141 l~~L~~L~l~~N~l~~~~p~~~~~l---~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
+++|++|+|++|+|++..|..+..+ ++|+.|+|++|+|+.+|..+. ++|+.|++++|
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N 282 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSN 282 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSC
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCC
Confidence 7889999999999987778777776 689999999999987666553 67888888777
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-15 Score=154.28 Aligned_cols=129 Identities=16% Similarity=0.120 Sum_probs=76.3
Q ss_pred CcEEEEEcCCCCcccccCCCccCC-----CCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCC--Ccccc--cc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRL-----DKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGG--IPANI--GN 140 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~--~~ 140 (603)
.++++|+|++|++++. |..++.+ ++|++|+|++|+|++..|..|.++++|++|+|++|++.+. +|..+ ..
T Consensus 121 ~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~ 199 (312)
T 1wwl_A 121 PDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199 (312)
T ss_dssp CCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTS
T ss_pred CCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhcc
Confidence 4567777777777665 5555555 6677777777777655556666677777777777766543 23333 55
Q ss_pred ccccceecccCCccCC--CCC-CCCccccccceeeccCCcCcccCC--CCccccccCcccccCC
Q 007455 141 LLFLTILDLSSNSLKG--AIP-SSLGRLTHLHYLNLSTNFFSGEIP--DFGALSAFGNKSFIGN 199 (603)
Q Consensus 141 l~~L~~L~l~~N~l~~--~~p-~~~~~l~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~~~~n 199 (603)
+++|++|+|++|+|++ .++ ..+.++++|+.|++++|+|++.+| .+..+++|+.|++++|
T Consensus 200 l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N 263 (312)
T 1wwl_A 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263 (312)
T ss_dssp CTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTS
T ss_pred CCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCC
Confidence 6666666666666652 111 122345566666666666665542 2444555666655555
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.2e-15 Score=152.66 Aligned_cols=125 Identities=15% Similarity=0.094 Sum_probs=78.7
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccc-cccccceec
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIG-NLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~ 148 (603)
.+++.|+|++|++++..+.. +++|++|+|++|++++..|..+..+++|++|+|++|++++..|..+. .+++|+.|+
T Consensus 99 ~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 175 (317)
T 3o53_A 99 PSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175 (317)
T ss_dssp TTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred CCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence 45666666666666654432 45667777777777655555666667777777777777655555553 566677777
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
|++|+|++. |. ...+++|+.|+|++|+|++.++.+..+++|+.|++++|
T Consensus 176 L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N 224 (317)
T 3o53_A 176 LQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNN 224 (317)
T ss_dssp CTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTS
T ss_pred CCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCC
Confidence 777776633 32 23466667777777777666666666666666666665
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=2.4e-15 Score=161.41 Aligned_cols=132 Identities=16% Similarity=0.102 Sum_probs=120.0
Q ss_pred CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcccccccccccee
Q 007455 68 HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147 (603)
Q Consensus 68 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 147 (603)
...++++|+|++|.++++.|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|.++++|+.|
T Consensus 54 ~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 133 (477)
T 2id5_A 54 SFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133 (477)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEE
Confidence 34689999999999999999999999999999999999996555678999999999999999998889999999999999
Q ss_pred cccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 148 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
+|++|++++..|..|.++++|+.|++++|++++.++. +..+++|+.|++.+|
T Consensus 134 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n 186 (477)
T 2id5_A 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186 (477)
T ss_dssp EECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESC
T ss_pred ECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCC
Confidence 9999999988888999999999999999999987764 777888888888877
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=9.7e-16 Score=164.50 Aligned_cols=123 Identities=16% Similarity=0.109 Sum_probs=76.5
Q ss_pred EEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccc-cccccceeccc
Q 007455 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIG-NLLFLTILDLS 150 (603)
Q Consensus 72 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~l~ 150 (603)
++.|+|++|.|++..+. .+++|+.|+|++|.|++..|..|+++++|+.|+|++|+|++..|..+. .+++|+.|+|+
T Consensus 101 L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls 177 (487)
T 3oja_A 101 IETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177 (487)
T ss_dssp CCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECT
T ss_pred cCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecC
Confidence 33444444444443332 245666777777777666666666677777777777777766666665 56777777777
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
+|.|++. |. +..+++|+.|+|++|+|++.++.+..+++|+.|++++|
T Consensus 178 ~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N 224 (487)
T 3oja_A 178 YNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNN 224 (487)
T ss_dssp TSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTS
T ss_pred CCccccc-cc-cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCC
Confidence 7777644 22 33466777777777777776666666666666666665
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.56 E-value=8.1e-15 Score=134.01 Aligned_cols=109 Identities=27% Similarity=0.315 Sum_probs=95.6
Q ss_pred CcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeecc
Q 007455 95 KLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLS 174 (603)
Q Consensus 95 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 174 (603)
..+.|++++|+|+ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3578999999998 7887764 899999999999998889999999999999999999997777778999999999999
Q ss_pred CCcCcccCCC-CccccccCcccccCCcccCCCCCCCCCC
Q 007455 175 TNFFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 175 ~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
+|+|++.+++ |..+++|+.|++++| ||.|.|.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N------~~~c~c~ 119 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNN------PWDCACS 119 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSS------CBCTTBG
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCC------CCCCCch
Confidence 9999999886 778888887766665 6667664
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=8.5e-15 Score=152.79 Aligned_cols=128 Identities=23% Similarity=0.201 Sum_probs=115.7
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|+++++.+..|..+++|++|+|++|++++..|..|.++++|++|+|++|+|+...+..|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 57899999999999988889999999999999999999888888999999999999999999544445799999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|++++..|..+.++++|+.|++++|++++.+ +..+++|+.+++++|
T Consensus 149 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--~~~l~~L~~L~l~~n 196 (390)
T 3o6n_A 149 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYN 196 (390)
T ss_dssp CSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--GGGCTTCSEEECCSS
T ss_pred CCCccCccChhhccCCCCCCEEECCCCcCCccc--cccccccceeecccc
Confidence 999999888888999999999999999999763 567788888888776
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.56 E-value=7.2e-15 Score=162.12 Aligned_cols=128 Identities=23% Similarity=0.201 Sum_probs=116.8
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+|+.|+|++|.|+++.+..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|+|++..+..|.++++|+.|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 57899999999999998889999999999999999999888888999999999999999999665666799999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|.+++..|..|.++++|+.|++++|.|++.+ ++.+++|..|++++|
T Consensus 155 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n 202 (597)
T 3oja_B 155 SNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYN 202 (597)
T ss_dssp CSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSS
T ss_pred eCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccC
Confidence 999999888889999999999999999999874 466778888877776
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.56 E-value=4.3e-15 Score=162.81 Aligned_cols=135 Identities=21% Similarity=0.284 Sum_probs=116.9
Q ss_pred CCcEEEEEcCCCCcccc--cCCCccCCCCcceEEeccCCCCCCCCC-CccccCCCceEEeccccCCCCCccccccccccc
Q 007455 69 DQRVRSINLPYMQLGGI--ISPSIGRLDKLQRLALHQNSLHGSIPN-EITNCTELRALYLRANYLQGGIPANIGNLLFLT 145 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~--~~~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 145 (603)
..+++.|+|++|+++++ +|..+.++++|++|+|++|++++.+|. .+..+++|+.|+|++|+|++.+|..+. ++|+
T Consensus 376 l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~ 453 (562)
T 3a79_B 376 LKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVK 453 (562)
T ss_dssp CSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCS
T ss_pred cCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCC
Confidence 35899999999999984 356799999999999999999975765 488999999999999999987777664 7999
Q ss_pred eecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccCCCCCCCCCC
Q 007455 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 146 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
.|+|++|+|+ .+|..+..+++|+.|+|++|+|+++++. +..+++|+.+++++| ||.|+|+
T Consensus 454 ~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N------~~~c~c~ 514 (562)
T 3a79_B 454 VLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN------PWDCTCP 514 (562)
T ss_dssp EEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSC------CBCCCHH
T ss_pred EEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCC------CcCCCcc
Confidence 9999999999 8888888999999999999999988877 777888887766655 6667774
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.55 E-value=3.7e-15 Score=144.37 Aligned_cols=130 Identities=16% Similarity=0.116 Sum_probs=111.7
Q ss_pred CCcEEEEEcCCCC-cccccCCCccCCCCcceEEecc-CCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccc-
Q 007455 69 DQRVRSINLPYMQ-LGGIISPSIGRLDKLQRLALHQ-NSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT- 145 (603)
Q Consensus 69 ~~~l~~L~L~~n~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~- 145 (603)
..+++.|+|++|+ ++++.+..|.++++|++|+|++ |+|++..+..|.++++|++|+|++|++++ +|. |..+++|+
T Consensus 54 l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~ 131 (239)
T 2xwt_C 54 LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDI 131 (239)
T ss_dssp CTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCS
T ss_pred CCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-ccccccccc
Confidence 4689999999997 8888778899999999999998 99996666789999999999999999995 776 88888888
Q ss_pred --eecccCC-ccCCCCCCCCccccccc-eeeccCCcCcccCCCCccccccCcccccCCc
Q 007455 146 --ILDLSSN-SLKGAIPSSLGRLTHLH-YLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200 (603)
Q Consensus 146 --~L~l~~N-~l~~~~p~~~~~l~~L~-~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~ 200 (603)
.|++++| ++++..+..|.++++|+ .|++++|+++.+++......+|+.|++++|.
T Consensus 132 L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 132 FFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp EEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCT
T ss_pred ccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCC
Confidence 9999999 99966667799999999 9999999999777654344788888888884
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.55 E-value=2.3e-15 Score=170.93 Aligned_cols=130 Identities=18% Similarity=0.239 Sum_probs=118.9
Q ss_pred CCcEEEEEcCCCCccc-----------------ccCCCcc--CCCCcceEEeccCCCCCCCCCCccccCCCceEEecccc
Q 007455 69 DQRVRSINLPYMQLGG-----------------IISPSIG--RLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANY 129 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~-----------------~~~~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 129 (603)
..+++.|+|++|+|++ .+|+.++ ++++|++|+|++|++.+.+|..|.++++|+.|+|++|+
T Consensus 447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~ 526 (876)
T 4ecn_A 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526 (876)
T ss_dssp CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCT
T ss_pred CCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCC
Confidence 4689999999999999 4888888 99999999999999999999999999999999999998
Q ss_pred -CCC-CCcccccccc-------ccceecccCCccCCCCCC--CCccccccceeeccCCcCcccCCCCccccccCcccccC
Q 007455 130 -LQG-GIPANIGNLL-------FLTILDLSSNSLKGAIPS--SLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIG 198 (603)
Q Consensus 130 -l~~-~~p~~~~~l~-------~L~~L~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~ 198 (603)
|+| .+|..+++++ +|+.|+|++|+++ .+|. .+.++++|+.|+|++|+|+. +|.++.+++|+.|++++
T Consensus 527 ~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~-lp~~~~L~~L~~L~Ls~ 604 (876)
T 4ecn_A 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRH-LEAFGTNVKLTDLKLDY 604 (876)
T ss_dssp TSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCCB-CCCCCTTSEESEEECCS
T ss_pred CcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCccc-chhhcCCCcceEEECcC
Confidence 998 8998888877 9999999999999 8998 89999999999999999994 44888899999998888
Q ss_pred Cc
Q 007455 199 NL 200 (603)
Q Consensus 199 n~ 200 (603)
|.
T Consensus 605 N~ 606 (876)
T 4ecn_A 605 NQ 606 (876)
T ss_dssp SC
T ss_pred Cc
Confidence 73
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.1e-15 Score=153.89 Aligned_cols=131 Identities=17% Similarity=0.159 Sum_probs=115.6
Q ss_pred CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcc--ccccccccc
Q 007455 68 HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPA--NIGNLLFLT 145 (603)
Q Consensus 68 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~ 145 (603)
...+++.|+|++|+++++.+..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+++ .+|. .+..+++|+
T Consensus 74 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~ 152 (353)
T 2z80_A 74 RCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQ 152 (353)
T ss_dssp TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCC
T ss_pred cCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCc
Confidence 3468999999999999988899999999999999999999544445899999999999999999 4554 789999999
Q ss_pred eecccCC-ccCCCCCCCCccccccceeeccCCcCcccCC-CCccccccCcccccCC
Q 007455 146 ILDLSSN-SLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNKSFIGN 199 (603)
Q Consensus 146 ~L~l~~N-~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~~~~n 199 (603)
.|++++| .+++..|..+.++++|+.|++++|++++.+| .+..+++|+.|++++|
T Consensus 153 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n 208 (353)
T 2z80_A 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMK 208 (353)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECS
T ss_pred EEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCC
Confidence 9999999 4776667889999999999999999999865 4888888988888876
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.54 E-value=3.7e-15 Score=161.69 Aligned_cols=135 Identities=24% Similarity=0.281 Sum_probs=117.7
Q ss_pred CCcEEEEEcCCCCccc--ccCCCccCCCCcceEEeccCCCCCCCCCC-ccccCCCceEEeccccCCCCCccccccccccc
Q 007455 69 DQRVRSINLPYMQLGG--IISPSIGRLDKLQRLALHQNSLHGSIPNE-ITNCTELRALYLRANYLQGGIPANIGNLLFLT 145 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 145 (603)
..+++.|+|++|++++ .+|..+..+++|++|+|++|++++.+|.. +..+++|+.|+|++|++++.+|..+. ++|+
T Consensus 347 l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~ 424 (520)
T 2z7x_B 347 LTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIK 424 (520)
T ss_dssp CSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCC
T ss_pred CCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCC
Confidence 4579999999999997 45678999999999999999999767764 88999999999999999988887765 7999
Q ss_pred eecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccCCCCCCCCCC
Q 007455 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 146 ~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
.|+|++|+|+ .+|..+..+++|+.|++++|+|++.++. +..+++|+.+++++| |+.|+|+
T Consensus 425 ~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N------~~~c~c~ 485 (520)
T 2z7x_B 425 VLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN------PWDCSCP 485 (520)
T ss_dssp EEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS------CBCCCHH
T ss_pred EEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCC------CCcccCC
Confidence 9999999999 8998888999999999999999988776 777778877766655 6666664
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.54 E-value=8e-16 Score=155.46 Aligned_cols=128 Identities=18% Similarity=0.158 Sum_probs=66.1
Q ss_pred cEEEEEcCCCCcccccCCCc--cCCCCcceEEeccCCCCCCCCCCcccc-----CCCceEEeccccCCCCCccccccccc
Q 007455 71 RVRSINLPYMQLGGIISPSI--GRLDKLQRLALHQNSLHGSIPNEITNC-----TELRALYLRANYLQGGIPANIGNLLF 143 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~ 143 (603)
++++|+|++|++++.+|..+ ..+++|++|+|++|+|++. |..+..+ ++|++|+|++|+|++..|..|.++++
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~ 174 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSS
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCC
Confidence 45555555555555555544 5555555555555555533 5545544 55555555555555544455555555
Q ss_pred cceecccCCccCCC--CCCCC--ccccccceeeccCCcCcccCC---C-CccccccCcccccCC
Q 007455 144 LTILDLSSNSLKGA--IPSSL--GRLTHLHYLNLSTNFFSGEIP---D-FGALSAFGNKSFIGN 199 (603)
Q Consensus 144 L~~L~l~~N~l~~~--~p~~~--~~l~~L~~l~l~~N~l~~~~~---~-~~~l~~l~~l~~~~n 199 (603)
|++|+|++|++.+. +|..+ .++++|+.|++++|+|++.+. . +..+++|+.|++++|
T Consensus 175 L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N 238 (312)
T 1wwl_A 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238 (312)
T ss_dssp CCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTS
T ss_pred CCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCC
Confidence 55555555555433 12222 455555555555555553221 1 223345555555554
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.54 E-value=1.7e-14 Score=132.38 Aligned_cols=107 Identities=24% Similarity=0.326 Sum_probs=94.2
Q ss_pred ceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCC
Q 007455 97 QRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176 (603)
Q Consensus 97 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 176 (603)
+.+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 68999999997 8888775 89999999999999888999999999999999999999766666899999999999999
Q ss_pred cCcccCCC-CccccccCcccccCCcccCCCCCCCCCC
Q 007455 177 FFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 177 ~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
+|+++++. |..+++|+.|++.+| +|.|.|.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N------~~~c~~~ 122 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNN------PWDCECR 122 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSS------CBCTTBG
T ss_pred ccceeCHHHhccccCCCEEEeCCC------Ccccccc
Confidence 99999886 788888888776655 6666664
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.54 E-value=7.8e-15 Score=150.53 Aligned_cols=112 Identities=22% Similarity=0.213 Sum_probs=96.3
Q ss_pred CccccceeecCCCCcEEEEEcCCCCcccccCCCccCCCCcceEEecc-CCCCCCCCCCccccCCCceEEeccccCCCCCc
Q 007455 57 PCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQ-NSLHGSIPNEITNCTELRALYLRANYLQGGIP 135 (603)
Q Consensus 57 ~c~w~gv~C~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 135 (603)
.|.|.+|.|.+ +|+|++ +|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|
T Consensus 7 ~C~~~~v~~~~-----------~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 73 (347)
T 2ifg_A 7 PHGSSGLRCTR-----------DGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (347)
T ss_dssp CSSSSCEECCS-----------SCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred cccCCEEEcCC-----------CCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH
Confidence 58888777753 226777 666 99999999999996 99997777889999999999999999999889
Q ss_pred cccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccC
Q 007455 136 ANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEI 182 (603)
Q Consensus 136 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~ 182 (603)
..|.+|++|+.|+|++|+|++..+..|..++ |+.|+|++|+|....
T Consensus 74 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c 119 (347)
T 2ifg_A 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSC 119 (347)
T ss_dssp TGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCG
T ss_pred HHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCC
Confidence 9999999999999999999966555666665 999999999998654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.53 E-value=1.3e-14 Score=147.80 Aligned_cols=124 Identities=19% Similarity=0.220 Sum_probs=54.5
Q ss_pred EEEEEcCCCCcccccCCCccCCCCcceEEeccCCCC--CCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLH--GSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 72 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
+++|+|++|+++++.+..|..+++|+.|+|++|.++ +..|..+..+ +|+.|+|++|+++ .+|..+. ++|+.|+|
T Consensus 125 L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l 200 (332)
T 2ft3_A 125 LVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNELHL 200 (332)
T ss_dssp CCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCS-SCCSSSC--SSCSCCBC
T ss_pred CCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCC-ccCcccc--CCCCEEEC
Confidence 444444444444433334555555555555555553 1333333333 2222222222222 1221111 34455555
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
++|++++..|..+.++++|+.|++++|++++.++. +..+++|+.|++++|
T Consensus 201 ~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 251 (332)
T 2ft3_A 201 DHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNN 251 (332)
T ss_dssp CSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSS
T ss_pred CCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCC
Confidence 55555544444555555555555555555554442 444445555544444
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2.5e-14 Score=145.62 Aligned_cols=129 Identities=19% Similarity=0.160 Sum_probs=74.8
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCC--CCCCCccccC---------------------CCceEEecc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHG--SIPNEITNCT---------------------ELRALYLRA 127 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~---------------------~L~~L~L~~ 127 (603)
+++.|+|++|+++++.+..|.++++|++|+|++|.++. ..+..+.+++ +|+.|+|++
T Consensus 122 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~ 201 (330)
T 1xku_A 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDG 201 (330)
T ss_dssp TCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTT
T ss_pred cccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECCC
Confidence 45666666666655544445555555555555555532 3344444444 455555555
Q ss_pred ccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 128 NYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 128 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|+|+..+..+..+++|+.|++++|
T Consensus 202 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N 273 (330)
T 1xku_A 202 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN 273 (330)
T ss_dssp SCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCC
Confidence 555555555666666666666666666655555666666666666666666655555666666666666655
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.53 E-value=3.4e-15 Score=151.18 Aligned_cols=127 Identities=20% Similarity=0.177 Sum_probs=83.7
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCc-cccCCCceEEeccccCCCCCccccccccccceec
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEI-TNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
.+++.|+|++|++++..+..+..+++|++|+|++|.|++..|..+ ..+++|++|+|++|+|++. |. ...+++|++|+
T Consensus 120 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~ 197 (317)
T 3o53_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLD 197 (317)
T ss_dssp SSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEE
Confidence 456777777777777666667777777777777777775555555 3567777777777777633 32 23467777777
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
|++|+|+ .+|..+..+++|+.|++++|+|++.++.+..+++|+.|++++|
T Consensus 198 Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~~l~~~~~~l~~L~~L~l~~N 247 (317)
T 3o53_A 198 LSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGN 247 (317)
T ss_dssp CCSSCCC-EECGGGGGGTTCSEEECTTSCCCEECTTCCCCTTCCEEECTTC
T ss_pred CCCCcCC-cchhhhcccCcccEEECcCCcccchhhHhhcCCCCCEEEccCC
Confidence 7777777 3444566777777777777777766666666666666665555
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.53 E-value=1.4e-14 Score=144.77 Aligned_cols=121 Identities=26% Similarity=0.355 Sum_probs=97.1
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|++++..+ +..+++|++|+|++|+++ .+|. +..+++|+.|+|++|+|++ + +.+..+++|+.|+|
T Consensus 68 ~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~-~~~~-l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 68 PNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (291)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CGGG-GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred CCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC-CChh-hccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEEc
Confidence 578888888888888554 888888888888888887 4444 8888888888888888884 3 46788888888888
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|++++. ..+..+++|+.|++++|+|++.++ +..+++|+.|++++|
T Consensus 142 ~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N 188 (291)
T 1h6t_A 142 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN 188 (291)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred cCCcCCcc--hhhccCCCCCEEEccCCccccchh-hcCCCccCEEECCCC
Confidence 88888844 568888888888888888887766 777788888887777
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=1.3e-14 Score=158.54 Aligned_cols=133 Identities=20% Similarity=0.250 Sum_probs=75.5
Q ss_pred CcEEEEEcCCCCcccccC--CCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcccc---------
Q 007455 70 QRVRSINLPYMQLGGIIS--PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANI--------- 138 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~--~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~--------- 138 (603)
++++.|+|++|++++..+ ..+..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|..+
T Consensus 361 ~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~L 438 (549)
T 2z81_A 361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQTLEVLDV 438 (549)
T ss_dssp TTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTSCTTCSEEEC
T ss_pred ccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchhcCCceEEEC
Confidence 455566666666555322 33556666666666666666 56666666666666666666665 233221
Q ss_pred ---------ccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccCCCCCC
Q 007455 139 ---------GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVH 208 (603)
Q Consensus 139 ---------~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~ 208 (603)
..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|+|++.+|+ +..+++|+.+++++ |||.
T Consensus 439 s~N~l~~~~~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~------N~~~ 510 (549)
T 2z81_A 439 SNNNLDSFSLFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT------NPWD 510 (549)
T ss_dssp CSSCCSCCCCCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCS------SCBC
T ss_pred CCCChhhhcccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecC------CCcc
Confidence 24555666666666665 4554 34566666666666666666554 45555555554444 4555
Q ss_pred CCCC
Q 007455 209 KPCR 212 (603)
Q Consensus 209 ~~c~ 212 (603)
|+|+
T Consensus 511 ~~~~ 514 (549)
T 2z81_A 511 CSCP 514 (549)
T ss_dssp CCHH
T ss_pred CCCc
Confidence 6664
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.52 E-value=8.3e-15 Score=147.83 Aligned_cols=128 Identities=21% Similarity=0.215 Sum_probs=108.0
Q ss_pred CCCcEEEEEcCCCCcccc---cC-CCccCCCCcceEEeccCCCCCCCCC----CccccCCCceEEeccccCCCCCccccc
Q 007455 68 HDQRVRSINLPYMQLGGI---IS-PSIGRLDKLQRLALHQNSLHGSIPN----EITNCTELRALYLRANYLQGGIPANIG 139 (603)
Q Consensus 68 ~~~~l~~L~L~~n~l~~~---~~-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p~~~~ 139 (603)
...++++|+|++|++.+. .+ ..+..+++|++|+|++|+|+ .+|. .+.++++|++|+|++|+|++..|..+.
T Consensus 167 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~ 245 (310)
T 4glp_A 167 AFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAP 245 (310)
T ss_dssp CCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCS
T ss_pred cCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHH
Confidence 346899999999998763 22 33478999999999999997 5554 257889999999999999988898888
Q ss_pred cc---cccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCc
Q 007455 140 NL---LFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200 (603)
Q Consensus 140 ~l---~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~ 200 (603)
.+ ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++.+ .+..+++|+.|++++|.
T Consensus 246 ~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~-~~~~l~~L~~L~L~~N~ 305 (310)
T 4glp_A 246 RCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAP-QPDELPEVDNLTLDGNP 305 (310)
T ss_dssp SCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCC-CTTSCCCCSCEECSSTT
T ss_pred hccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCc-hhhhCCCccEEECcCCC
Confidence 87 69999999999999 7888775 89999999999999874 46778888888888774
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.51 E-value=9.2e-15 Score=133.36 Aligned_cols=113 Identities=21% Similarity=0.207 Sum_probs=100.7
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCC-ccccccccccceec
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGI-PANIGNLLFLTILD 148 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 148 (603)
.+++.|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|+.|+|++|+|++.. +..+..+++|+.|+
T Consensus 49 ~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~ 126 (168)
T 2ell_A 49 VNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLD 126 (168)
T ss_dssp GGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEE
T ss_pred CCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEEE
Confidence 5799999999999986 78999999999999999999778888888999999999999999532 27899999999999
Q ss_pred ccCCccCCCCC---CCCccccccceeeccCCcCcccCCC
Q 007455 149 LSSNSLKGAIP---SSLGRLTHLHYLNLSTNFFSGEIPD 184 (603)
Q Consensus 149 l~~N~l~~~~p---~~~~~l~~L~~l~l~~N~l~~~~~~ 184 (603)
|++|.+++..+ ..+..+++|+.|++++|.++..+.+
T Consensus 127 l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~ 165 (168)
T 2ell_A 127 LFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPDS 165 (168)
T ss_dssp CCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCSS
T ss_pred eeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcccc
Confidence 99999995444 3789999999999999999877653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.51 E-value=2.4e-14 Score=140.73 Aligned_cols=121 Identities=26% Similarity=0.376 Sum_probs=93.6
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+|+++.+ +..+++|++|+|++|+|+ .+|. +.. ++|+.|+|++|+|++ ++ .+..+++|+.|+|
T Consensus 63 ~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~-~l~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L 135 (263)
T 1xeu_A 63 TNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NLNG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI 135 (263)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCS-CCTT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred CCCCEEECCCCccCCChh--hccCCCCCEEECCCCccC-CcCc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence 568888888888887554 888888888888888887 4554 333 888888888888884 44 5788888888888
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCc
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~ 200 (603)
++|+|++ +| .+..+++|+.|++++|+|++. +.+..+++|+.|++++|.
T Consensus 136 s~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~ 183 (263)
T 1xeu_A 136 RNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQK 183 (263)
T ss_dssp TTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEE
T ss_pred CCCcCCC-Ch-HHccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCc
Confidence 8888884 44 578888888888888888877 567777888888777774
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.51 E-value=8.7e-15 Score=158.81 Aligned_cols=132 Identities=21% Similarity=0.310 Sum_probs=100.5
Q ss_pred CCCCCCCCCCCc-----cccce-eecCCCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCC
Q 007455 47 LGNWQATEESPC-----KWTGI-SCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTEL 120 (603)
Q Consensus 47 l~~w~~~~~~~c-----~w~gv-~C~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 120 (603)
+.+|.. +..|| .|.|+ .|.. .+++.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|
T Consensus 33 l~~W~~-~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L 102 (571)
T 3cvr_A 33 WDKWEK-QALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASL 102 (571)
T ss_dssp HHHHHT-TCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTC
T ss_pred HHHHhc-cCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCC
Confidence 456753 34577 79999 7864 479999999999988 666553 78999999999988 777 457888
Q ss_pred ceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 121 RALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 121 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
+.|+|++|+|++ +|. +.+ +|+.|+|++|+|++ +|. .+++|+.|+|++|+|+++++ .+++|+.|++++|
T Consensus 103 ~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N 170 (571)
T 3cvr_A 103 EYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE---LPTSLEVLSVRNN 170 (571)
T ss_dssp CEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC---CCTTCCEEECCSS
T ss_pred CEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC---cCCCcCEEECCCC
Confidence 888888888885 776 655 88888888888885 665 56788888888888887554 4567777777776
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.50 E-value=3.4e-14 Score=143.17 Aligned_cols=121 Identities=23% Similarity=0.361 Sum_probs=88.9
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+++++.+ +..+++|++|+|++|+|+ .+| .+..+++|+.|+|++|++++ +|. +..+++|+.|+|
T Consensus 63 ~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 63 NNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYL 136 (308)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCC-Cch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEEC
Confidence 467888888888877544 777888888888888877 344 47778888888888888874 443 777788888888
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|++++..+ +..+++|+.|++++|++++.++ +..+++|+.|++++|
T Consensus 137 ~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~l~~n 183 (308)
T 1h6u_A 137 DLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDN 183 (308)
T ss_dssp CSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred CCCccCcCcc--ccCCCCccEEEccCCcCCCChh-hcCCCCCCEEECCCC
Confidence 8888774433 7777778888888888776655 667777777777766
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.50 E-value=3.7e-14 Score=142.91 Aligned_cols=123 Identities=20% Similarity=0.330 Sum_probs=104.7
Q ss_pred CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcccccccccccee
Q 007455 68 HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147 (603)
Q Consensus 68 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 147 (603)
...+++.|+|++|++++. +.+..+++|++|+|++|+|++ +|. +..+++|+.|+|++|++++ ++. +..+++|+.|
T Consensus 83 ~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L 156 (308)
T 1h6u_A 83 NLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYL 156 (308)
T ss_dssp TCCSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEE
T ss_pred cCCCCCEEEccCCcCCCc--hhhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEE
Confidence 346899999999999885 368899999999999999984 554 8999999999999999995 443 8899999999
Q ss_pred cccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 148 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
+|++|++++. +. +..+++|+.|++++|++++.++ +..+++|+.|++++|
T Consensus 157 ~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N 205 (308)
T 1h6u_A 157 SIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNN 205 (308)
T ss_dssp ECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTS
T ss_pred EccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCC
Confidence 9999999954 43 8899999999999999998765 778888888888887
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.49 E-value=1.9e-14 Score=161.67 Aligned_cols=113 Identities=32% Similarity=0.475 Sum_probs=106.1
Q ss_pred CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcccccccccccee
Q 007455 68 HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147 (603)
Q Consensus 68 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 147 (603)
....++.|+|++|++.. +|..+..+++|++|+|++|.|+ .+|..|.+|++|++|+|++|+|+ .+|..|.+|++|+.|
T Consensus 222 ~l~~L~~L~Ls~n~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L 298 (727)
T 4b8c_D 222 DDQLWHALDLSNLQIFN-ISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYF 298 (727)
T ss_dssp CCCCCCEEECTTSCCSC-CCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEE
T ss_pred cCCCCcEEECCCCCCCC-CChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEE
Confidence 44679999999999985 7777889999999999999999 99999999999999999999999 889999999999999
Q ss_pred cccCCccCCCCCCCCccccccceeeccCCcCcccCCC
Q 007455 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184 (603)
Q Consensus 148 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~ 184 (603)
+|++|.|+ .+|..|.+|++|+.|+|++|+|++.+|.
T Consensus 299 ~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~ 334 (727)
T 4b8c_D 299 YFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLK 334 (727)
T ss_dssp ECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHH
T ss_pred ECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChH
Confidence 99999998 8899999999999999999999998875
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.49 E-value=4.2e-14 Score=141.19 Aligned_cols=124 Identities=25% Similarity=0.336 Sum_probs=109.7
Q ss_pred CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcccccccccccee
Q 007455 68 HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147 (603)
Q Consensus 68 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 147 (603)
...+++.|+|++|.+++. + .+..+++|++|+|++|+|++ ++ .+..+++|+.|+|++|++++. ..+..+++|+.|
T Consensus 88 ~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~L~~n~i~~-~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L 161 (291)
T 1h6t_A 88 NLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL 161 (291)
T ss_dssp TCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCC-CG-GGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred cCCCCCEEECCCCcCCCC-h-hhccCCCCCEEECCCCcCCC-Ch-hhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEE
Confidence 346899999999999884 3 49999999999999999984 44 599999999999999999954 679999999999
Q ss_pred cccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCc
Q 007455 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200 (603)
Q Consensus 148 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~ 200 (603)
+|++|++++..| +..+++|+.|++++|+|++.+ .+..+++|+.|++++|.
T Consensus 162 ~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~l~-~l~~l~~L~~L~l~~n~ 211 (291)
T 1h6t_A 162 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELFSQE 211 (291)
T ss_dssp ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEEEEE
T ss_pred EccCCccccchh--hcCCCccCEEECCCCcCCCCh-hhccCCCCCEEECcCCc
Confidence 999999996554 999999999999999999864 58888999999998884
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.47 E-value=6.2e-14 Score=137.76 Aligned_cols=120 Identities=23% Similarity=0.305 Sum_probs=105.0
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+++.+ + .+..+++|++|+|++|+|++ +|. +.++++|+.|+|++|+|++ +|... . ++|+.|+|
T Consensus 41 ~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~~L~L 113 (263)
T 1xeu_A 41 SGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLSRLFL 113 (263)
T ss_dssp TTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCCEEEC
T ss_pred CcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEEECCCCccCC-cCccc-c-CcccEEEc
Confidence 5799999999999874 4 79999999999999999994 555 9999999999999999995 55433 3 99999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|+|++ ++ .+.++++|+.|++++|+|++.+ .+..+++|+.|++++|
T Consensus 114 ~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~-~l~~l~~L~~L~L~~N 160 (263)
T 1xeu_A 114 DNNELRD-TD-SLIHLKNLEILSIRNNKLKSIV-MLGFLSKLEVLDLHGN 160 (263)
T ss_dssp CSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCG-GGGGCTTCCEEECTTS
T ss_pred cCCccCC-Ch-hhcCcccccEEECCCCcCCCCh-HHccCCCCCEEECCCC
Confidence 9999995 44 5999999999999999999874 6888899999988887
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.47 E-value=7.4e-14 Score=153.10 Aligned_cols=121 Identities=26% Similarity=0.351 Sum_probs=85.7
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+|+.|+|++|+|+++.+ +..+++|+.|+|++|+|+ .+| .+..+++|+.|+|++|+|++ + +.+..|++|+.|+|
T Consensus 65 ~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 65 PNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCC-CCT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCC-CCh-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 567778888887777554 777777777777777776 344 47777777777777777774 3 34677777777777
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|+|++. ..+..+++|+.|+|++|+|++.+| +..+++|+.|++++|
T Consensus 139 s~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N 185 (605)
T 1m9s_A 139 GNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKN 185 (605)
T ss_dssp CSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSS
T ss_pred CCCccCCc--hhhcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCC
Confidence 77777743 456777777777777777777666 666677777776666
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.47 E-value=2.3e-14 Score=127.92 Aligned_cols=106 Identities=22% Similarity=0.206 Sum_probs=97.0
Q ss_pred CCCCcceEEeccCCCC-CCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccce
Q 007455 92 RLDKLQRLALHQNSLH-GSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHY 170 (603)
Q Consensus 92 ~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 170 (603)
..++|+.|+|++|.++ +.+|..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++.+|..+.++++|+.
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~ 92 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH 92 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence 3578999999999998 78999899999999999999999965 78999999999999999999778888888999999
Q ss_pred eeccCCcCcccC--CCCccccccCcccccCC
Q 007455 171 LNLSTNFFSGEI--PDFGALSAFGNKSFIGN 199 (603)
Q Consensus 171 l~l~~N~l~~~~--~~~~~l~~l~~l~~~~n 199 (603)
|++++|++++.+ ..+..+++|+.|++++|
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N 123 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTC
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCC
Confidence 999999999864 56888999999999888
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=4.4e-16 Score=146.36 Aligned_cols=124 Identities=24% Similarity=0.317 Sum_probs=88.5
Q ss_pred cEEEEEcCCCCcccccCC------CccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcccccccccc
Q 007455 71 RVRSINLPYMQLGGIISP------SIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL 144 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 144 (603)
+++.++|+.+.+++..|. .+..+++|++|+|++|+|++ +| .+.++++|+.|+|++|+|+ .+|..+..+++|
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L 95 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL 95 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHC
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcC
Confidence 456666666666666555 67777778888888887774 66 6777778888888888777 677777777778
Q ss_pred ceecccCCccCCCCCCCCccccccceeeccCCcCcccCC--CCccccccCcccccCC
Q 007455 145 TILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP--DFGALSAFGNKSFIGN 199 (603)
Q Consensus 145 ~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~~~~n 199 (603)
+.|+|++|++++ +| .+..+++|+.|++++|+|++.++ .+..+++|+.|++++|
T Consensus 96 ~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N 150 (198)
T 1ds9_A 96 EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150 (198)
T ss_dssp SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSC
T ss_pred CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCC
Confidence 888888887774 44 57777778888888887776543 3566666766666665
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.46 E-value=4.1e-14 Score=145.02 Aligned_cols=122 Identities=25% Similarity=0.373 Sum_probs=55.2
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
+++.|+|++|++++..+ +..+++|++|+|++|.+++ ++ .+..+++|+.|+|++|++++ + +.+..+++|+.|+|+
T Consensus 222 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~ 295 (347)
T 4fmz_A 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-IN-AVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLN 295 (347)
T ss_dssp TCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECC
T ss_pred cCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-Ch-hHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECc
Confidence 34444444444444322 4444444444444444442 22 24444444444444444442 2 234444444444444
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
+|++++..|..+.++++|+.|++++|++++.+| +..+++|+.+++++|
T Consensus 296 ~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N 343 (347)
T 4fmz_A 296 NNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQ 343 (347)
T ss_dssp SSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC
T ss_pred CCcCCCcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhh
Confidence 444444444444444444455555544444443 444444444444443
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.45 E-value=8.4e-14 Score=142.98 Aligned_cols=144 Identities=17% Similarity=0.122 Sum_probs=111.3
Q ss_pred CCccccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCC-CCccccCCCce-EE
Q 007455 56 SPCKWTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIP-NEITNCTELRA-LY 124 (603)
Q Consensus 56 ~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~ 124 (603)
|-|+|..|.|++. ..++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| ..|.++++|+. ++
T Consensus 7 C~C~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~ 86 (350)
T 4ay9_X 7 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 86 (350)
T ss_dssp SEEETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEE
T ss_pred cEeeCCEEEecCCCCCccCcCcCCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhc
Confidence 4588999999642 2478999999999998777889999999999999999876666 46888988775 67
Q ss_pred eccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccC-CcCcccCCC-Ccccc-ccCcccccCC
Q 007455 125 LRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLST-NFFSGEIPD-FGALS-AFGNKSFIGN 199 (603)
Q Consensus 125 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~-N~l~~~~~~-~~~l~-~l~~l~~~~n 199 (603)
+++|+|++..|..|..+++|+.|++++|+|++..+..+....++..|++.+ |+++.+++. |..+. .++.|++++|
T Consensus 87 ~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N 164 (350)
T 4ay9_X 87 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKN 164 (350)
T ss_dssp EEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSS
T ss_pred ccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccc
Confidence 778999977788899999999999999999966666666777777777754 567666553 44333 3445555554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1e-13 Score=151.90 Aligned_cols=123 Identities=24% Similarity=0.337 Sum_probs=110.5
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
..+|+.|+|++|.|+++ +.+..+++|+.|+|++|+|++ +| .+..|++|+.|+|++|+|++. ..+..|++|+.|+
T Consensus 86 l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~ 159 (605)
T 1m9s_A 86 LKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-IN-GLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLS 159 (605)
T ss_dssp CTTCCEEECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-CG-GGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEE
T ss_pred CCCCCEEECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-Cc-cccCCCccCEEECCCCccCCc--hhhcccCCCCEEE
Confidence 46899999999999884 379999999999999999994 54 599999999999999999964 6799999999999
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCc
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNL 200 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~ 200 (603)
|++|+|++..| +..+++|+.|+|++|+|++. +.+..+++|+.|++++|.
T Consensus 160 Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 160 LEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQE 208 (605)
T ss_dssp CCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEE
T ss_pred CcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCc
Confidence 99999997666 99999999999999999986 568889999999999884
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.42 E-value=5.8e-14 Score=129.09 Aligned_cols=108 Identities=15% Similarity=0.173 Sum_probs=95.9
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcc--cccccccccee
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPA--NIGNLLFLTIL 147 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L 147 (603)
++++.|+|++|+|+++ +.|..+++|++|+|++|+|++..|..|..+++|++|+|++|+|+ .+|. .+..+++|+.|
T Consensus 42 ~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L 118 (176)
T 1a9n_A 42 DQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYL 118 (176)
T ss_dssp TCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEE
T ss_pred CCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEE
Confidence 3799999999999996 68999999999999999999544444599999999999999997 6776 89999999999
Q ss_pred cccCCccCCCCCCC----CccccccceeeccCCcCccc
Q 007455 148 DLSSNSLKGAIPSS----LGRLTHLHYLNLSTNFFSGE 181 (603)
Q Consensus 148 ~l~~N~l~~~~p~~----~~~l~~L~~l~l~~N~l~~~ 181 (603)
++++|.++ .+|.. +..+++|+.|++++|.+...
T Consensus 119 ~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~~ 155 (176)
T 1a9n_A 119 CILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKER 155 (176)
T ss_dssp ECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred EecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence 99999999 67774 89999999999999987643
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.40 E-value=3.2e-13 Score=138.39 Aligned_cols=108 Identities=20% Similarity=0.208 Sum_probs=91.8
Q ss_pred ceEEeccC-CCCCCCCCCccccCCCceEEecc-ccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeecc
Q 007455 97 QRLALHQN-SLHGSIPNEITNCTELRALYLRA-NYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLS 174 (603)
Q Consensus 97 ~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~ 174 (603)
..+++++| +|+ .+|. |..+++|+.|+|++ |+|++..|..|.+|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 46799998 998 7998 99999999999996 99998888899999999999999999999888899999999999999
Q ss_pred CCcCcccCCCCccccccCcccccCCcccCCCCCCCCCC
Q 007455 175 TNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 175 ~N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
+|+|+++++.+.....|+.|++. +|+|.|+|.
T Consensus 89 ~N~l~~~~~~~~~~~~L~~l~l~------~N~~~c~c~ 120 (347)
T 2ifg_A 89 FNALESLSWKTVQGLSLQELVLS------GNPLHCSCA 120 (347)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECC------SSCCCCCGG
T ss_pred CCccceeCHHHcccCCceEEEee------CCCccCCCc
Confidence 99999998864332236665555 456666664
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.39 E-value=3.7e-13 Score=143.82 Aligned_cols=121 Identities=28% Similarity=0.320 Sum_probs=77.4
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|.+++..+ +..+++|+.|+|++|.+++ +|. +..+++|+.|+|++|++++..| +..+++|+.|+|
T Consensus 243 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L 316 (466)
T 1o6v_A 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTL 316 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEEC
T ss_pred CCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCc-ccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEEC
Confidence 467777777777766544 6667777777777777763 333 6666777777777777764333 566666777777
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|++++..| +..+++|+.|++++|++++. +.+..+++|+.|++++|
T Consensus 317 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n 363 (466)
T 1o6v_A 317 YFNNISDISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHN 363 (466)
T ss_dssp CSSCCSCCGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSS
T ss_pred cCCcCCCchh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCC
Confidence 7776665544 56666666666666666654 34555666666666555
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=4.4e-14 Score=153.94 Aligned_cols=116 Identities=21% Similarity=0.219 Sum_probs=100.2
Q ss_pred EEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCc
Q 007455 74 SINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNS 153 (603)
Q Consensus 74 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 153 (603)
.+.+++|.++.+.+ ..|+.|+|++|+|+ .+|. |+.+++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+
T Consensus 427 ~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~ 497 (567)
T 1dce_A 427 SKFLLENSVLKMEY------ADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNA 497 (567)
T ss_dssp HHHHHHHHHHHHHH------TTCSEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSC
T ss_pred hhhhhcccccccCc------cCceEEEecCCCCC-CCcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCC
Confidence 33344455555332 25899999999999 5787 999999999999999999 899999999999999999999
Q ss_pred cCCCCCCCCccccccceeeccCCcCccc--CCCCccccccCcccccCCc
Q 007455 154 LKGAIPSSLGRLTHLHYLNLSTNFFSGE--IPDFGALSAFGNKSFIGNL 200 (603)
Q Consensus 154 l~~~~p~~~~~l~~L~~l~l~~N~l~~~--~~~~~~l~~l~~l~~~~n~ 200 (603)
|++ +| .++++++|+.|+|++|+|++. |..++.+++|+.|++++|.
T Consensus 498 l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~ 544 (567)
T 1dce_A 498 LEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNS 544 (567)
T ss_dssp CCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred CCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCc
Confidence 995 77 899999999999999999999 4568999999999988883
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.38 E-value=3.1e-15 Score=140.56 Aligned_cols=121 Identities=21% Similarity=0.292 Sum_probs=105.6
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|++++ +| .+..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +| .+..+++|+.|+|
T Consensus 48 ~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l 122 (198)
T 1ds9_A 48 KACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEE
T ss_pred CCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEEC
Confidence 579999999999999 56 8999999999999999999 889888889999999999999995 66 6899999999999
Q ss_pred cCCccCCCCC-CCCccccccceeeccCCcCcccCCC-----------CccccccCccc
Q 007455 150 SSNSLKGAIP-SSLGRLTHLHYLNLSTNFFSGEIPD-----------FGALSAFGNKS 195 (603)
Q Consensus 150 ~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~~~~~~-----------~~~l~~l~~l~ 195 (603)
++|++++..+ ..+..+++|+.|++++|++++.+|. +..+++|+.|+
T Consensus 123 ~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld 180 (198)
T 1ds9_A 123 SNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp SEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC
T ss_pred CCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC
Confidence 9999994322 4688999999999999999988765 56666776654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.38 E-value=5.5e-13 Score=144.68 Aligned_cols=112 Identities=20% Similarity=0.180 Sum_probs=78.3
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
..+++.|+|++|+|++ +|. +.. +|++|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+
T Consensus 99 l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~ 166 (571)
T 3cvr_A 99 PASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLS 166 (571)
T ss_dssp CTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred cCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEE
Confidence 3578888888888887 555 554 88888888888874 665 57788888888888874 665 567778888
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCCCcccccc-------CcccccCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAF-------GNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l-------~~l~~~~n 199 (603)
|++|+|++ +|. |. ++|+.|+|++|+|+.+++ +.. +| +.|++++|
T Consensus 167 Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N 217 (571)
T 3cvr_A 167 VRNNQLTF-LPE-LP--ESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCREN 217 (571)
T ss_dssp CCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCCC-CC----------CCEEEECCSS
T ss_pred CCCCCCCC-cch-hh--CCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCC
Confidence 88888774 666 54 777777777777775555 433 45 55555555
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.37 E-value=6.1e-13 Score=142.13 Aligned_cols=122 Identities=29% Similarity=0.379 Sum_probs=103.9
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceec
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 148 (603)
..+++.|+|++|++++. +.+..+++|+.|+|++|.+++..| +..+++|+.|+|++|++++. |. +..+++|+.|+
T Consensus 220 l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~ 293 (466)
T 1o6v_A 220 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI-SP-LAGLTALTNLE 293 (466)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEE
T ss_pred cCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcc-cc-ccCCCccCeEE
Confidence 45799999999999875 468889999999999999985544 88899999999999999954 43 88899999999
Q ss_pred ccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 149 LSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 149 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
|++|++++..| +..+++|+.|++++|++++.++ +..+++|+.|++++|
T Consensus 294 L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~n 341 (466)
T 1o6v_A 294 LNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFYNN 341 (466)
T ss_dssp CCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG-GGGCTTCCEEECCSS
T ss_pred cCCCcccCchh--hcCCCCCCEEECcCCcCCCchh-hccCccCCEeECCCC
Confidence 99999996544 8889999999999999998877 778888998888887
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.3e-12 Score=138.92 Aligned_cols=117 Identities=21% Similarity=0.266 Sum_probs=79.1
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|+++++ | .+..+++|++|+|++|+|++ +| ++.+++|++|+|++|+|++ +| ++++++|++|+|
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L 113 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC 113 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence 3577777777777764 3 56777777777777777764 34 6677777777777777774 33 667777777777
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|++++ +| +.++++|+.|++++|+|++. +++.+++|+.|++++|
T Consensus 114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l--~l~~l~~L~~L~l~~n 158 (457)
T 3bz5_A 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEI--DVSHNTQLTELDCHLN 158 (457)
T ss_dssp CSSCCSC-CC--CTTCTTCCEEECTTSCCSCC--CCTTCTTCCEEECTTC
T ss_pred CCCcCCe-ec--CCCCCcCCEEECCCCcccee--ccccCCcCCEEECCCC
Confidence 7777774 43 66777777777777777764 2556666666666666
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=3.3e-12 Score=125.31 Aligned_cols=148 Identities=16% Similarity=0.115 Sum_probs=114.6
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccE
Q 007455 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRGYCRLPATKL 383 (603)
Q Consensus 305 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 383 (603)
.+...+..|+....++.|+.+.||++... ++.+++|............+.+|+++++.+. +..+.++++++...+..|
T Consensus 8 ~l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 34456678888888898999999999865 5789999886432222345889999999884 677888999998888899
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC-------------------------------- 431 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------- 431 (603)
+||||++|.+|.+.... ......++.+++++|..||+..
T Consensus 87 lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred EEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence 99999999998775321 1123467889999999999810
Q ss_pred ------------------------CCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 432 ------------------------CPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 432 ------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
.+.++|||++|.||++++++.+.|+||+.+.
T Consensus 158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876556799999764
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.32 E-value=4.4e-13 Score=147.21 Aligned_cols=135 Identities=20% Similarity=0.205 Sum_probs=82.3
Q ss_pred CCCCCCCCCCCCccccceee------cCCCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCC
Q 007455 46 LLGNWQATEESPCKWTGISC------HTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTE 119 (603)
Q Consensus 46 ~l~~w~~~~~~~c~w~gv~C------~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 119 (603)
..++|.. +.+||.|+|..| .....+++.|++++|+|+. +|..+. ++|++|+|++|+|+ .+|. .+++
T Consensus 11 ~w~~W~~-~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~~-lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~ 82 (622)
T 3g06_A 11 VWSAWRR-AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPA---LPPE 82 (622)
T ss_dssp HHHHHHH-TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCSC-CCSCCC--TTCSEEEECSCCCS-CCCC---CCTT
T ss_pred HHHHHHh-cCCcchhccccccCcccccccCCCCcEEEecCCCcCc-cChhhC--CCCcEEEecCCCCC-CCCC---cCCC
Confidence 3456753 345788866421 1111347777888887774 555554 67777777777777 5665 4577
Q ss_pred CceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 120 LRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 120 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
|++|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|+.|++++|+|+++++. +++|+.|++++|
T Consensus 83 L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L~~N~l~~lp~~---l~~L~~L~Ls~N 151 (622)
T 3g06_A 83 LRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWIFGNQLTSLPVL---PPGLQELSVSDN 151 (622)
T ss_dssp CCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSS
T ss_pred CCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEECCCCCCCcCCCC---CCCCCEEECcCC
Confidence 777777777777 4554 5567777777777776 3444 345566666666666654443 245555555554
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.31 E-value=2.9e-12 Score=131.12 Aligned_cols=122 Identities=26% Similarity=0.373 Sum_probs=78.4
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|+++++.+ +..+++|++|+|++|.++ .+| .+.++++|++|+|++|++++ +|. +..+++|+.|++
T Consensus 66 ~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~-~~~-~~~~l~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L~l 139 (347)
T 4fmz_A 66 TNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DIS-ALQNLTNLRELYLNEDNISD-ISP-LANLTKMYSLNL 139 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECTTSCCCC-CGG-GTTCTTCCEEEC
T ss_pred CCccEEEccCCccccchh--hhcCCcCCEEEccCCccc-Cch-HHcCCCcCCEEECcCCcccC-chh-hccCCceeEEEC
Confidence 456777777777766433 666777777777777776 344 46677777777777777763 333 666777777777
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|...+.++ .+..+++|+.|++++|.+++.++ +..+++|+.|++++|
T Consensus 140 ~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~-~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 140 GANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP-IANLTDLYSLSLNYN 187 (347)
T ss_dssp TTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG-GGGCTTCSEEECTTS
T ss_pred CCCCCccccc-chhhCCCCcEEEecCCCcCCchh-hccCCCCCEEEccCC
Confidence 7775543333 36667777777777777665544 566666666666655
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.29 E-value=5.4e-12 Score=134.13 Aligned_cols=117 Identities=20% Similarity=0.191 Sum_probs=80.6
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|+++++ | ++.+++|++|+|++|+|++ +| ++++++|++|+|++|++++ +| +..+++|+.|++
T Consensus 64 ~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l 134 (457)
T 3bz5_A 64 TGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNC 134 (457)
T ss_dssp TTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEEC
Confidence 5678888888888774 3 7777888888888888874 34 7777888888888888875 44 777777788888
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|++++ ++ +.++++|+.|++++|+..+.+ .+..+++|+.|++++|
T Consensus 135 ~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n 180 (457)
T 3bz5_A 135 ARNTLTE-ID--VSHNTQLTELDCHLNKKITKL-DVTPQTQLTTLDCSFN 180 (457)
T ss_dssp TTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC-CCTTCTTCCEEECCSS
T ss_pred CCCccce-ec--cccCCcCCEEECCCCCccccc-ccccCCcCCEEECCCC
Confidence 8777775 33 566666666666666444333 3455556666655555
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.28 E-value=4.8e-14 Score=143.82 Aligned_cols=108 Identities=21% Similarity=0.226 Sum_probs=47.9
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCC-CCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGS-IPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
+++.|+|++|.+++..+. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|++++..|..+..+++|++|+|
T Consensus 71 ~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L 149 (336)
T 2ast_B 71 GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL 149 (336)
T ss_dssp TCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred cceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence 344444444444443322 33344444444444444432 3444444444444444444444444444444444444444
Q ss_pred cCC-ccCC-CCCCCCccccccceeeccCC-cCc
Q 007455 150 SSN-SLKG-AIPSSLGRLTHLHYLNLSTN-FFS 179 (603)
Q Consensus 150 ~~N-~l~~-~~p~~~~~l~~L~~l~l~~N-~l~ 179 (603)
++| .+++ .++..+.++++|+.|++++| .++
T Consensus 150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~ 182 (336)
T 2ast_B 150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT 182 (336)
T ss_dssp TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC
T ss_pred CCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcC
Confidence 444 3332 13333444444444444444 444
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.27 E-value=1.3e-11 Score=131.08 Aligned_cols=115 Identities=21% Similarity=0.224 Sum_probs=69.3
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+++++ +.. .++|++|+|++|++++ +| .|+++++|++|+|++|++++ +|..+ ++|++|++
T Consensus 111 ~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L 180 (454)
T 1jl5_A 111 QSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAA 180 (454)
T ss_dssp TTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEEC
T ss_pred CCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEEC
Confidence 3455555555555542 111 1567777777777763 66 47777777777777777773 55433 36777777
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|++++ +| .+.++++|+.|++++|++++.+... .+|+.|++++|
T Consensus 181 ~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~n 225 (454)
T 1jl5_A 181 GNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLPDLP---LSLESIVAGNN 225 (454)
T ss_dssp CSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCCCC---TTCCEEECCSS
T ss_pred cCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCCCCc---CcccEEECcCC
Confidence 7777764 55 4666777777777777766644321 35555555555
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.26 E-value=9.5e-12 Score=136.57 Aligned_cols=54 Identities=24% Similarity=0.161 Sum_probs=25.2
Q ss_pred cccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 142 LFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 142 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+.+|+.+..+++|+.|++++|
T Consensus 241 ~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N 294 (622)
T 3g06_A 241 SELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGN 294 (622)
T ss_dssp TTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSC
T ss_pred CcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCC
Confidence 34444444444444 3333 234455555555555544444444555555544444
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.22 E-value=2.1e-13 Score=142.02 Aligned_cols=130 Identities=20% Similarity=0.260 Sum_probs=69.5
Q ss_pred CcEEEEEcCCCCccc----ccCCCccCC---------CCcceEEeccCCCC-CCCC---CCccccCCCceEEeccccCC-
Q 007455 70 QRVRSINLPYMQLGG----IISPSIGRL---------DKLQRLALHQNSLH-GSIP---NEITNCTELRALYLRANYLQ- 131 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~----~~~~~~~~l---------~~L~~L~L~~N~l~-~~~p---~~~~~l~~L~~L~L~~N~l~- 131 (603)
.++++|+|++|++++ .++..+..+ ++|++|+|++|+|+ +.+| ..+..+++|+.|+|++|+|+
T Consensus 122 ~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~ 201 (386)
T 2ca6_A 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRP 201 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCH
T ss_pred CCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCH
Confidence 456666666666642 233444444 56666666666665 2333 23445566666666666655
Q ss_pred -C---CCccccccccccceecccCCccC----CCCCCCCccccccceeeccCCcCccc-----CCCC--ccccccCcccc
Q 007455 132 -G---GIPANIGNLLFLTILDLSSNSLK----GAIPSSLGRLTHLHYLNLSTNFFSGE-----IPDF--GALSAFGNKSF 196 (603)
Q Consensus 132 -~---~~p~~~~~l~~L~~L~l~~N~l~----~~~p~~~~~l~~L~~l~l~~N~l~~~-----~~~~--~~l~~l~~l~~ 196 (603)
| ..|..+..+++|+.|+|++|.|+ +.+|..+..+++|+.|+|++|+|++. +..+ +.+++|+.|++
T Consensus 202 ~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L 281 (386)
T 2ca6_A 202 EGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRL 281 (386)
T ss_dssp HHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEEC
T ss_pred hHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEEC
Confidence 1 23335556666666666666663 34555555666666666666666543 1112 22455555555
Q ss_pred cCC
Q 007455 197 IGN 199 (603)
Q Consensus 197 ~~n 199 (603)
++|
T Consensus 282 ~~n 284 (386)
T 2ca6_A 282 QYN 284 (386)
T ss_dssp CSS
T ss_pred cCC
Confidence 554
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.22 E-value=2.8e-13 Score=138.05 Aligned_cols=133 Identities=17% Similarity=0.165 Sum_probs=97.0
Q ss_pred CcEEEEEcCCCCcccc-cCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccc-cCCC-CCccccccccccce
Q 007455 70 QRVRSINLPYMQLGGI-ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN-YLQG-GIPANIGNLLFLTI 146 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~-~~p~~~~~l~~L~~ 146 (603)
.++++|+|++|.+++. ++..+..+++|++|+|++|.+++..|..+..+++|++|+|++| .+++ .++..+.++++|++
T Consensus 93 ~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~ 172 (336)
T 2ast_B 93 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 172 (336)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCE
Confidence 5688888888888765 6667778888888888888887777777888888888888888 6765 26666777888888
Q ss_pred ecccCC-ccCCC-CCCCCcccc-ccceeeccCC--cCc--ccCCCCccccccCcccccCCccc
Q 007455 147 LDLSSN-SLKGA-IPSSLGRLT-HLHYLNLSTN--FFS--GEIPDFGALSAFGNKSFIGNLDL 202 (603)
Q Consensus 147 L~l~~N-~l~~~-~p~~~~~l~-~L~~l~l~~N--~l~--~~~~~~~~l~~l~~l~~~~n~~l 202 (603)
|+|++| .+++. ++..+..++ +|+.|++++| .++ +.+..+..+++|+.|++++|..+
T Consensus 173 L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l 235 (336)
T 2ast_B 173 LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 235 (336)
T ss_dssp EECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTC
T ss_pred EcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcC
Confidence 888888 77743 456677777 7888888887 343 22333556677777777776433
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.21 E-value=3.1e-11 Score=128.19 Aligned_cols=115 Identities=23% Similarity=0.315 Sum_probs=95.2
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|.+++ +|.. +++|++|+|++|+++ .+|.. .++|++|+|++|++++ +| .|.++++|++|++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l 160 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDV 160 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEEC
Confidence 578999999999988 5543 478999999999998 45532 2689999999999995 77 5999999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|++++ +|..+ ++|+.|++++|++++. |+++.+++|+.|++++|
T Consensus 161 ~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l-~~~~~l~~L~~L~l~~N 205 (454)
T 1jl5_A 161 DNNSLKK-LPDLP---PSLEFIAAGNNQLEEL-PELQNLPFLTAIYADNN 205 (454)
T ss_dssp CSSCCSC-CCCCC---TTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSS
T ss_pred CCCcCcc-cCCCc---ccccEEECcCCcCCcC-ccccCCCCCCEEECCCC
Confidence 9999994 66644 5899999999999985 47888999999988887
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.21 E-value=5.4e-13 Score=137.59 Aligned_cols=130 Identities=22% Similarity=0.283 Sum_probs=83.8
Q ss_pred CcEEEEEcCCCCcccccC----CCccCCC-CcceEEeccCCCCCCCCCCcccc-----CCCceEEeccccCCCCCccccc
Q 007455 70 QRVRSINLPYMQLGGIIS----PSIGRLD-KLQRLALHQNSLHGSIPNEITNC-----TELRALYLRANYLQGGIPANIG 139 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~ 139 (603)
.++++|+|++|.+++..+ ..|..++ +|++|+|++|+|++..+..+..+ ++|++|+|++|+|++..+..+.
T Consensus 22 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~ 101 (362)
T 3goz_A 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELV 101 (362)
T ss_dssp TTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHH
T ss_pred CCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHH
Confidence 347777777777777555 5566676 77777777777776666666664 7777777777777766665444
Q ss_pred cc-----cccceecccCCccCCCCCCCCcc-----ccccceeeccCCcCcccCCC-----Ccccc-ccCcccccCC
Q 007455 140 NL-----LFLTILDLSSNSLKGAIPSSLGR-----LTHLHYLNLSTNFFSGEIPD-----FGALS-AFGNKSFIGN 199 (603)
Q Consensus 140 ~l-----~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~~~~~~-----~~~l~-~l~~l~~~~n 199 (603)
.. ++|+.|+|++|+|++..+..+.. .++|+.|+|++|+|+..... +..+. +|+.|++++|
T Consensus 102 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n 177 (362)
T 3goz_A 102 KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGN 177 (362)
T ss_dssp HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTS
T ss_pred HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCC
Confidence 43 67777777777777544433332 24777777777777743221 22222 5666666655
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.19 E-value=4.2e-13 Score=139.72 Aligned_cols=130 Identities=18% Similarity=0.275 Sum_probs=63.7
Q ss_pred CcEEEEEcCCCCccc----ccCCCccCCCCcceEEeccCCCCCCCCCCc----ccc---------CCCceEEeccccCC-
Q 007455 70 QRVRSINLPYMQLGG----IISPSIGRLDKLQRLALHQNSLHGSIPNEI----TNC---------TELRALYLRANYLQ- 131 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l---------~~L~~L~L~~N~l~- 131 (603)
.++++|+|++|.+++ .++..+..+++|++|+|++|.|++..+..+ ..+ ++|++|+|++|+|+
T Consensus 94 ~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~ 173 (386)
T 2ca6_A 94 PKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLEN 173 (386)
T ss_dssp TTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTG
T ss_pred CcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCc
Confidence 345555555555554 344445555555555555555542222222 222 55555555555554
Q ss_pred CCCc---cccccccccceecccCCccC--C---CCCCCCccccccceeeccCCcCc----c-cCCCCccccccCcccccC
Q 007455 132 GGIP---ANIGNLLFLTILDLSSNSLK--G---AIPSSLGRLTHLHYLNLSTNFFS----G-EIPDFGALSAFGNKSFIG 198 (603)
Q Consensus 132 ~~~p---~~~~~l~~L~~L~l~~N~l~--~---~~p~~~~~l~~L~~l~l~~N~l~----~-~~~~~~~l~~l~~l~~~~ 198 (603)
+.+| ..+..+++|+.|+|++|+|+ | ..|..+..+++|+.|+|++|.|+ + .+..+..+++|+.|++++
T Consensus 174 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~ 253 (386)
T 2ca6_A 174 GSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLND 253 (386)
T ss_dssp GGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTT
T ss_pred HHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCC
Confidence 2233 24445555555555555555 1 23334555555666666665553 1 222244445555555554
Q ss_pred C
Q 007455 199 N 199 (603)
Q Consensus 199 n 199 (603)
|
T Consensus 254 n 254 (386)
T 2ca6_A 254 C 254 (386)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.15 E-value=2.3e-12 Score=132.86 Aligned_cols=126 Identities=20% Similarity=0.168 Sum_probs=105.8
Q ss_pred EEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCC----CCccccC-CCceEEeccccCCCCCccccccc-----cc
Q 007455 74 SINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIP----NEITNCT-ELRALYLRANYLQGGIPANIGNL-----LF 143 (603)
Q Consensus 74 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~ 143 (603)
.+.|++|++++.+|..+...++|++|+|++|.|++..+ ..|..++ +|++|+|++|+|++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46899999999988877777889999999999996655 6788888 99999999999998888888886 99
Q ss_pred cceecccCCccCCCCCCCCccc-----cccceeeccCCcCcccCCC-----Ccc-ccccCcccccCC
Q 007455 144 LTILDLSSNSLKGAIPSSLGRL-----THLHYLNLSTNFFSGEIPD-----FGA-LSAFGNKSFIGN 199 (603)
Q Consensus 144 L~~L~l~~N~l~~~~p~~~~~l-----~~L~~l~l~~N~l~~~~~~-----~~~-l~~l~~l~~~~n 199 (603)
|++|+|++|++++..+..+... ++|+.|+|++|+|++..+. +.. ..+|+.|++++|
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N 148 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGN 148 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTS
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCC
Confidence 9999999999997766655444 8999999999999977653 222 257888888877
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.14 E-value=4.1e-11 Score=117.12 Aligned_cols=137 Identities=14% Similarity=0.030 Sum_probs=99.1
Q ss_pred CCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCe--eeecceeeecCCccEEEEEec
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHIN--LVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~ 389 (603)
.+....+.+.|..+.||++...++..+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34433333456669999998777778999987543 2234788999999886444 556888888777889999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC-------------------------------------- 431 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------------- 431 (603)
+|.++. ... .+ ...++.++++.|..||+..
T Consensus 98 ~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 98 PGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp SSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred CCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 998884 211 11 1256677788888888742
Q ss_pred -----------------CCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 432 -----------------CPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 432 -----------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
...++|||++|.||++++++.+.|+|||.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776667999998753
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.12 E-value=8.1e-11 Score=120.61 Aligned_cols=130 Identities=22% Similarity=0.122 Sum_probs=92.9
Q ss_pred CCcEEEEEcCCCCcccccC-CCccCCCCcce-EEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccc-------
Q 007455 69 DQRVRSINLPYMQLGGIIS-PSIGRLDKLQR-LALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIG------- 139 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~-~~~~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~------- 139 (603)
..+|++|+|++|++.+.+| ..|.++++|.+ +++++|+|+...|+.|..+++|++|++++|+|++..+..+.
T Consensus 53 l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~ 132 (350)
T 4ay9_X 53 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVL 132 (350)
T ss_dssp CTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEE
T ss_pred CCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhh
Confidence 4689999999999876555 56888888765 66778999877788899999999999999998854443322
Q ss_pred ------------------cc-cccceecccCCccCCCCCCCCccccccceeecc-CCcCcccCCC-CccccccCcccccC
Q 007455 140 ------------------NL-LFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLS-TNFFSGEIPD-FGALSAFGNKSFIG 198 (603)
Q Consensus 140 ------------------~l-~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~-~N~l~~~~~~-~~~l~~l~~l~~~~ 198 (603)
.+ ..|+.|+|++|+|+ .+|.......+|+.|+++ +|.++.++++ |..+++|+.|++++
T Consensus 133 l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~ 211 (350)
T 4ay9_X 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 211 (350)
T ss_dssp EEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTT
T ss_pred hhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCC
Confidence 22 24566777777777 555555556677777775 4566665554 56777777777777
Q ss_pred C
Q 007455 199 N 199 (603)
Q Consensus 199 n 199 (603)
|
T Consensus 212 N 212 (350)
T 4ay9_X 212 T 212 (350)
T ss_dssp S
T ss_pred C
Confidence 6
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=3.6e-10 Score=116.20 Aligned_cols=141 Identities=18% Similarity=0.271 Sum_probs=105.9
Q ss_pred CCeeeecCCeEEEEEEECCCCEEEEEEeC--CCC-CChHHHHHHHHHHHhhCC--CCeeeecceeeecC---CccEEEEE
Q 007455 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRID--RSR-EGSDQVFERELEILGSIK--HINLVNLRGYCRLP---ATKLLIYD 387 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~e 387 (603)
.+.|+.|.++.||+....+ +.+++|+.. ... ......+.+|+.+++.+. +..+.++++++.+. +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999988765 688888765 322 122346889999999997 45578888888766 45799999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC------------------------------------ 431 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------ 431 (603)
|++|..+.+... ..++..++..++.++++.|..||+..
T Consensus 122 ~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999988854221 11677888899999999999999831
Q ss_pred -------------------CCCeEEecCCCCCeEECCCCC--eEEeecccccc
Q 007455 432 -------------------CPKIIHRDIKSSNILLDENLE--PHVSDFGLAKL 463 (603)
Q Consensus 432 -------------------~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~~~~ 463 (603)
.+.++|||+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999998764 68999998864
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.00 E-value=3.4e-12 Score=135.96 Aligned_cols=130 Identities=18% Similarity=0.109 Sum_probs=78.8
Q ss_pred CcEEEEEcCCCCccccc-----CCCccCCCCcceEEeccCCCCCC----CCCCccccCCCceEEeccccCCCCCcccccc
Q 007455 70 QRVRSINLPYMQLGGII-----SPSIGRLDKLQRLALHQNSLHGS----IPNEITNCTELRALYLRANYLQGGIPANIGN 140 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~-----~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 140 (603)
.+++.|+|++|.+++.. +..+..+++|++|+|++|+|+.. ++..+.++++|+.|+|++|++++..+..+..
T Consensus 227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~ 306 (461)
T 1z7x_W 227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE 306 (461)
T ss_dssp TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence 46777888877776532 22223467777777777777642 5556666777777777777776443433433
Q ss_pred c-----cccceecccCCccCCC----CCCCCccccccceeeccCCcCcccCCC-Ccc-----ccccCcccccCC
Q 007455 141 L-----LFLTILDLSSNSLKGA----IPSSLGRLTHLHYLNLSTNFFSGEIPD-FGA-----LSAFGNKSFIGN 199 (603)
Q Consensus 141 l-----~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~-----l~~l~~l~~~~n 199 (603)
. ++|+.|+|++|.+++. ++..+..+++|+.|++++|++++..+. +.. .++|+.|++++|
T Consensus 307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n 380 (461)
T 1z7x_W 307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380 (461)
T ss_dssp HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCC
Confidence 2 5677777777777643 344555667777777777776654221 111 345666666555
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.99 E-value=1.3e-11 Score=120.02 Aligned_cols=124 Identities=19% Similarity=0.153 Sum_probs=84.8
Q ss_pred CccccceeecCCCCcEEEEEcCC---CCcccccC------------------------CCccCCCCcce--EEeccCCCC
Q 007455 57 PCKWTGISCHTHDQRVRSINLPY---MQLGGIIS------------------------PSIGRLDKLQR--LALHQNSLH 107 (603)
Q Consensus 57 ~c~w~gv~C~~~~~~l~~L~L~~---n~l~~~~~------------------------~~~~~l~~L~~--L~L~~N~l~ 107 (603)
.|+|.|+.|+....+|..+...+ ..+.+.++ ..|...+.|.. ++++.|+..
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~ 156 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRS 156 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHH
T ss_pred HHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHHH
Confidence 48999999987666776666544 12222221 11333344444 667777543
Q ss_pred CCCCCC----ccccCCCceEEeccccCCC--CCccccccccccceecccCCccCCCCCCCCcccc--ccceeeccCCcCc
Q 007455 108 GSIPNE----ITNCTELRALYLRANYLQG--GIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLT--HLHYLNLSTNFFS 179 (603)
Q Consensus 108 ~~~p~~----~~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~--~L~~l~l~~N~l~ 179 (603)
.++.. ..++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..++ +|+.|+|++|.++
T Consensus 157 -~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~ 233 (267)
T 3rw6_A 157 -CMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLC 233 (267)
T ss_dssp -HHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTG
T ss_pred -HHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCc
Confidence 33322 2457899999999999997 4557778899999999999999954 3455555 8999999999998
Q ss_pred ccCC
Q 007455 180 GEIP 183 (603)
Q Consensus 180 ~~~~ 183 (603)
+..|
T Consensus 234 ~~~~ 237 (267)
T 3rw6_A 234 DTFR 237 (267)
T ss_dssp GGCS
T ss_pred cccC
Confidence 7665
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.97 E-value=3.5e-10 Score=113.40 Aligned_cols=185 Identities=21% Similarity=0.214 Sum_probs=120.2
Q ss_pred CCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CCe--eeecceeeecCC---ccEEEEEec
Q 007455 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIK-HIN--LVNLRGYCRLPA---TKLLIYDYL 389 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~ 389 (603)
.+.++.|....||+.. +.+++|..... .....+.+|+++++.+. +.. +.+++....... ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4678999999999863 56888875432 23466899999998883 333 334444433332 348899999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD--------------------------------------- 430 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------- 430 (603)
+|.++.+.... .++..++..++.++++.+..||+.
T Consensus 99 ~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99888653321 166777788888888888888861
Q ss_pred ----------------CCCCeEEecCCCCCeEECC--CCCeEEeecccccccCCCCcceeec--------------cccc
Q 007455 431 ----------------CCPKIIHRDIKSSNILLDE--NLEPHVSDFGLAKLLVDEEAHVTTV--------------VAGT 478 (603)
Q Consensus 431 ----------------~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~~~~~~~~~~~~~~~--------------~~gt 478 (603)
..+.++|+|++|.||++++ ++.+.|+||+.+..-... ...... ....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHH
Confidence 1135899999999999998 456789999988653211 100000 0000
Q ss_pred ccccC-ccccccCCCCcccchHhHHHHHHHHHhCCCCC
Q 007455 479 FGYLA-PEYLQSGRATEKSDVYSFGVLLLELVTGKRPT 515 (603)
Q Consensus 479 ~~y~a-PE~~~~~~~~~~~Dv~slG~vl~elltg~~p~ 515 (603)
.+... |+... +.....+.|++|.++|.+.+|..+|
T Consensus 252 Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 252 YKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred cCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 01111 22111 1112368999999999999998775
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=98.91 E-value=1.7e-11 Score=130.62 Aligned_cols=129 Identities=19% Similarity=0.184 Sum_probs=73.2
Q ss_pred cEEEEEcCCCCccc----ccCCCccCCCCcceEEeccCCCCCCCCCCcc-----ccCCCceEEeccccCCCC----Cccc
Q 007455 71 RVRSINLPYMQLGG----IISPSIGRLDKLQRLALHQNSLHGSIPNEIT-----NCTELRALYLRANYLQGG----IPAN 137 (603)
Q Consensus 71 ~l~~L~L~~n~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~----~p~~ 137 (603)
++++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+. ..++|++|+|++|++++. ++..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 46667777776663 4456666666777777777666533222222 234566777777666642 2444
Q ss_pred cccccccceecccCCccCCCCCCCCcc-----ccccceeeccCCcCccc-----CCCCccccccCcccccCC
Q 007455 138 IGNLLFLTILDLSSNSLKGAIPSSLGR-----LTHLHYLNLSTNFFSGE-----IPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 138 ~~~l~~L~~L~l~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~~~-----~~~~~~l~~l~~l~~~~n 199 (603)
+..+++|+.|+|++|.+++..+..+.. +++|+.|++++|.+++. +..+..+++|+.|++++|
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n 237 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSN 237 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSS
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCC
Confidence 555666777777777665433222321 34666777777766652 222444556666666655
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.86 E-value=1.8e-09 Score=109.43 Aligned_cols=59 Identities=14% Similarity=0.120 Sum_probs=34.2
Q ss_pred ccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccC-cccccCCc
Q 007455 141 LLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFG-NKSFIGNL 200 (603)
Q Consensus 141 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~-~l~~~~n~ 200 (603)
+++|+.|+|++|+++...+.+|.++++|+.|+|.+| ++.+.+. |..+.+|+ .+.+.+++
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~~l 285 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPASV 285 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECTTC
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcccc
Confidence 456666666666666444445666666666666665 5544443 55556665 55555543
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.82 E-value=4.5e-11 Score=123.22 Aligned_cols=130 Identities=18% Similarity=0.159 Sum_probs=90.3
Q ss_pred CcEEEEEcCCCCcccccCCCc-cCCCCcceEEeccCCCCCCCCCCc-----cccCCCceEEeccccCCC----CCccccc
Q 007455 70 QRVRSINLPYMQLGGIISPSI-GRLDKLQRLALHQNSLHGSIPNEI-----TNCTELRALYLRANYLQG----GIPANIG 139 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~-~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~ 139 (603)
.+++.|+|++|.|+..-...+ ..+++|+.|+|++|.|+..-...+ ...++|+.|+|++|+|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 478889999888865433222 346788899999998864332333 235789999999998873 2445556
Q ss_pred cccccceecccCCccCCC----CCCCCccccccceeeccCCcCcccCC-----CCccccccCcccccCC
Q 007455 140 NLLFLTILDLSSNSLKGA----IPSSLGRLTHLHYLNLSTNFFSGEIP-----DFGALSAFGNKSFIGN 199 (603)
Q Consensus 140 ~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~~~-----~~~~l~~l~~l~~~~n 199 (603)
.+++|++|+|++|.|++. ++..+...++|+.|+|++|.|+.... .+...++|+.|++++|
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N 249 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFN 249 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTS
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCC
Confidence 788899999999988742 34556677889999999998875321 1334467777777776
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.70 E-value=5.8e-10 Score=114.91 Aligned_cols=111 Identities=21% Similarity=0.225 Sum_probs=88.7
Q ss_pred cEEEEEcCCCCcccccCCCc-----cCCCCcceEEeccCCCCC----CCCCCccccCCCceEEeccccCCCC----Cccc
Q 007455 71 RVRSINLPYMQLGGIISPSI-----GRLDKLQRLALHQNSLHG----SIPNEITNCTELRALYLRANYLQGG----IPAN 137 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~ 137 (603)
+++.|+|++|+|+......+ ...++|++|+|++|.|+. .++..+..+++|++|+|++|+|++. ++..
T Consensus 127 ~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~ 206 (372)
T 3un9_A 127 RARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQ 206 (372)
T ss_dssp TEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHH
T ss_pred hccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHH
Confidence 69999999999986544443 246889999999999974 2445557789999999999999842 3566
Q ss_pred cccccccceecccCCccCCC----CCCCCccccccceeeccCCcCccc
Q 007455 138 IGNLLFLTILDLSSNSLKGA----IPSSLGRLTHLHYLNLSTNFFSGE 181 (603)
Q Consensus 138 ~~~l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~~ 181 (603)
+...++|+.|+|++|.|++. ++..+...++|+.|+|++|.|+..
T Consensus 207 L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~ 254 (372)
T 3un9_A 207 LDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSE 254 (372)
T ss_dssp GGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHH
T ss_pred HhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHH
Confidence 77888999999999999853 334455678999999999999854
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.68 E-value=2.1e-09 Score=104.36 Aligned_cols=80 Identities=24% Similarity=0.283 Sum_probs=65.9
Q ss_pred cCCCCcceEEeccCCCCC--CCCCCccccCCCceEEeccccCCCCCcccccccc--ccceecccCCccCCCCCC------
Q 007455 91 GRLDKLQRLALHQNSLHG--SIPNEITNCTELRALYLRANYLQGGIPANIGNLL--FLTILDLSSNSLKGAIPS------ 160 (603)
Q Consensus 91 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~------ 160 (603)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 468899999999999997 4556678999999999999999954 4456666 999999999999987763
Q ss_pred -CCccccccceee
Q 007455 161 -SLGRLTHLHYLN 172 (603)
Q Consensus 161 -~~~~l~~L~~l~ 172 (603)
.+..+++|+.||
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 366778888776
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=98.66 E-value=2.2e-08 Score=101.40 Aligned_cols=100 Identities=15% Similarity=0.049 Sum_probs=58.2
Q ss_pred CCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccc-eecccCCccCCCCCCCCcccccccee
Q 007455 93 LDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLT-ILDLSSNSLKGAIPSSLGRLTHLHYL 171 (603)
Q Consensus 93 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~~~l~~L~~l 171 (603)
+++|+.|+|++|+++..-+.+|.++++|+.|+|++| ++..-+..|.+|++|+ .|+|.+ +++..-+.+|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 456666666666666333345666666666666665 5544445566666666 666666 4553444566666666666
Q ss_pred eccCCcCcccCCC-CccccccCcc
Q 007455 172 NLSTNFFSGEIPD-FGALSAFGNK 194 (603)
Q Consensus 172 ~l~~N~l~~~~~~-~~~l~~l~~l 194 (603)
++++|+++.+.+. |..+++|+.+
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEE
T ss_pred EeCCCccCccchhhhcCCcchhhh
Confidence 6666666655543 5555555544
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.53 E-value=9.7e-09 Score=112.80 Aligned_cols=104 Identities=10% Similarity=0.089 Sum_probs=63.4
Q ss_pred cEEEEEcCCCC-ccc-ccCCCccCCCCcceEEeccCCCCCC----CCCCccccCCCceEEeccccCCC----CCcccccc
Q 007455 71 RVRSINLPYMQ-LGG-IISPSIGRLDKLQRLALHQNSLHGS----IPNEITNCTELRALYLRANYLQG----GIPANIGN 140 (603)
Q Consensus 71 ~l~~L~L~~n~-l~~-~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~ 140 (603)
++++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++ .++..+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 37777777765 211 1122233567777777777777644 23334566777777777777762 33444556
Q ss_pred ccccceecccCCccCCCCCCCCccccccceeeccC
Q 007455 141 LLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLST 175 (603)
Q Consensus 141 l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~ 175 (603)
+++|+.|+|++|.+.+ +|..+.++++|+.|++++
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 7777777777777763 445556666666666653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.50 E-value=3.9e-09 Score=97.42 Aligned_cols=111 Identities=14% Similarity=0.206 Sum_probs=80.6
Q ss_pred CCcEEEEEcCCC-Ccccc----cCCCccCCCCcceEEeccCCCCCC----CCCCccccCCCceEEeccccCCCC----Cc
Q 007455 69 DQRVRSINLPYM-QLGGI----ISPSIGRLDKLQRLALHQNSLHGS----IPNEITNCTELRALYLRANYLQGG----IP 135 (603)
Q Consensus 69 ~~~l~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p 135 (603)
...+++|+|++| .|... +...+...++|++|+|++|.|... +...+...++|++|+|++|.|+.. +.
T Consensus 35 ~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~ 114 (185)
T 1io0_A 35 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 114 (185)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence 357889999998 88642 344566678899999999988632 333455567899999999988843 45
Q ss_pred cccccccccceecc--cCCccCCC----CCCCCccccccceeeccCCcCc
Q 007455 136 ANIGNLLFLTILDL--SSNSLKGA----IPSSLGRLTHLHYLNLSTNFFS 179 (603)
Q Consensus 136 ~~~~~l~~L~~L~l--~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~ 179 (603)
..+...++|++|+| ++|.|... +...+...++|+.|+|++|.+.
T Consensus 115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 56677788899999 77888743 3334555678888888888875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=9.6e-07 Score=88.25 Aligned_cols=136 Identities=17% Similarity=0.184 Sum_probs=92.4
Q ss_pred CCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCC---eeeecceeee-cCCccEEEEEecCC
Q 007455 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHI---NLVNLRGYCR-LPATKLLIYDYLSM 391 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 391 (603)
.+.++.|....||+. ++.+++|.-.. ......+.+|+++++.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888999999988 46788887422 22345689999999999642 3556666664 44567899999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD----------------------------------------- 430 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------------- 430 (603)
.++.+..-. .++..+...++.++++.|..||+.
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 888653111 033344444555555555555432
Q ss_pred ----------------CCCCeEEecCCCCCeEECC---CCCe-EEeecccccc
Q 007455 431 ----------------CCPKIIHRDIKSSNILLDE---NLEP-HVSDFGLAKL 463 (603)
Q Consensus 431 ----------------~~~~ivH~Dlkp~NIll~~---~~~~-kl~DfG~~~~ 463 (603)
..+.++|+|+++.||+++. ++.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 4554 7999998764
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=98.36 E-value=4.5e-08 Score=107.43 Aligned_cols=129 Identities=10% Similarity=-0.025 Sum_probs=84.9
Q ss_pred CcEEEEEcCCCCcccc----cCCCccCCCCcceEEeccCCCCC----CCCCCccccCCCceEEeccccCCCCCccccccc
Q 007455 70 QRVRSINLPYMQLGGI----ISPSIGRLDKLQRLALHQNSLHG----SIPNEITNCTELRALYLRANYLQGGIPANIGNL 141 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 141 (603)
+++++|+|++|.+++. ++..+..+++|++|+|++|.+++ .++..+.++++|+.|+|++|.+. .+|..+.++
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~-~l~~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGG-GGHHHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHH-HHHHHHhhh
Confidence 5789999999987665 33345667889999999998873 33444567888999999998888 477778888
Q ss_pred cccceecccCCccC---CCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 142 LFLTILDLSSNSLK---GAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 142 ~~L~~L~l~~N~l~---~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|+.|+++++... +..+..+..+++|+.|+++++.....+..+..+++|+.|++++|
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~l~~~~~~~~~L~~L~Ls~~ 303 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYA 303 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTTTGGGGGGGGGGCCEEEETTC
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccchhHHHHHHhhcCCCcEEecCCC
Confidence 88888888753322 22334455555566666555544433333444555555555554
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.36 E-value=7.2e-09 Score=95.59 Aligned_cols=116 Identities=10% Similarity=0.086 Sum_probs=86.8
Q ss_pred cccCCCccCCCCcceEEeccC-CCCCC----CCCCccccCCCceEEeccccCCCC----CccccccccccceecccCCcc
Q 007455 84 GIISPSIGRLDKLQRLALHQN-SLHGS----IPNEITNCTELRALYLRANYLQGG----IPANIGNLLFLTILDLSSNSL 154 (603)
Q Consensus 84 ~~~~~~~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l 154 (603)
..+...+...++|++|+|++| .|... +...+...++|++|+|++|+|... +...+...++|++|+|++|.|
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 344556777899999999999 88632 344566778999999999999842 344566678999999999999
Q ss_pred CCC----CCCCCccccccceeec--cCCcCcccCC-----CCccccccCcccccCC
Q 007455 155 KGA----IPSSLGRLTHLHYLNL--STNFFSGEIP-----DFGALSAFGNKSFIGN 199 (603)
Q Consensus 155 ~~~----~p~~~~~l~~L~~l~l--~~N~l~~~~~-----~~~~l~~l~~l~~~~n 199 (603)
+.. +...+...++|+.|+| ++|.|+..-. .+...++|+.|++++|
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n 161 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 161 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCC
Confidence 853 4567788889999999 8899985321 1333456777777665
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=9.7e-07 Score=86.45 Aligned_cols=136 Identities=19% Similarity=0.174 Sum_probs=96.0
Q ss_pred CeeeecCCe-EEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccEEEEEecCCCC
Q 007455 317 DVVGSGGFG-TVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRGYCRLPATKLLIYDYLSMGS 393 (603)
Q Consensus 317 ~~ig~G~~g-~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (603)
+.+..|..| .||+..... +..+++|+-.. .....+.+|+..++.+. +--+.++++++.+++..++|||+++|.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345666666 689887654 45688887542 23456889999998884 3346678888888899999999999988
Q ss_pred ccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 007455 394 LDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC------------------------------------------ 431 (603)
Q Consensus 394 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~------------------------------------------ 431 (603)
+.+...... .....++.++++.|..||+..
T Consensus 107 ~~~~~~~~~--------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 107 AFQVLEEYP--------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp HHHHHHHCG--------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccCCH--------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 766543321 122345556666666666420
Q ss_pred -------------CCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 432 -------------CPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 432 -------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
.+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877677999997753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=9.2e-07 Score=90.45 Aligned_cols=80 Identities=10% Similarity=0.078 Sum_probs=55.5
Q ss_pred Cee-eecCCeEEEEEEEC-------CCCEEEEEEeCCCC---CChHHHHHHHHHHHhhCC-C--CeeeecceeeecC---
Q 007455 317 DVV-GSGGFGTVYRMVMN-------DCGTFAVKRIDRSR---EGSDQVFERELEILGSIK-H--INLVNLRGYCRLP--- 379 (603)
Q Consensus 317 ~~i-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--- 379 (603)
+.| +.|..+.+|+.... +++.+++|...... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999988764 24578888764322 111234788999998885 3 2466777776554
Q ss_pred CccEEEEEecCCCCccc
Q 007455 380 ATKLLIYDYLSMGSLDD 396 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~ 396 (603)
+..++||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999988765
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.24 E-value=3e-08 Score=108.91 Aligned_cols=63 Identities=19% Similarity=0.236 Sum_probs=27.0
Q ss_pred ccCCCceEEeccccCCCCCcccccc-ccccceecccCCccCCCCCCCC-ccccccceeeccCCcCc
Q 007455 116 NCTELRALYLRANYLQGGIPANIGN-LLFLTILDLSSNSLKGAIPSSL-GRLTHLHYLNLSTNFFS 179 (603)
Q Consensus 116 ~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~-~~l~~L~~l~l~~N~l~ 179 (603)
.+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|+|++|.++
T Consensus 430 ~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~ 494 (594)
T 2p1m_B 430 HCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFG 494 (594)
T ss_dssp HCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCC
T ss_pred hCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCc
Confidence 344444444433 333322233332 4445555555555443222222 33455555555555553
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=98.22 E-value=3.1e-08 Score=108.73 Aligned_cols=83 Identities=17% Similarity=0.194 Sum_probs=40.4
Q ss_pred cEEEEEcCCCCcccccCCCcc-CCCCcceEEeccC-CCCCC-CCCCccccCCCceEEeccccCCCCCccccc----cccc
Q 007455 71 RVRSINLPYMQLGGIISPSIG-RLDKLQRLALHQN-SLHGS-IPNEITNCTELRALYLRANYLQGGIPANIG----NLLF 143 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~ 143 (603)
++++|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+. .+++
T Consensus 106 ~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~ 185 (594)
T 2p1m_B 106 WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTS 185 (594)
T ss_dssp TCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCC
T ss_pred CCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCc
Confidence 455555555555544444443 3555555555555 33311 222233455555555555555543333332 3445
Q ss_pred cceecccCCc
Q 007455 144 LTILDLSSNS 153 (603)
Q Consensus 144 L~~L~l~~N~ 153 (603)
|+.|+|++|.
T Consensus 186 L~~L~l~~~~ 195 (594)
T 2p1m_B 186 LVSLNISCLA 195 (594)
T ss_dssp CCEEECTTCC
T ss_pred CcEEEecccC
Confidence 5555555554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.20 E-value=1.9e-06 Score=89.38 Aligned_cols=126 Identities=12% Similarity=0.086 Sum_probs=78.3
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.+.|.++ ++.+-..+|.++++|+.|+|..| ++..-..+|.+ .+|+.+.| .|.++..-+..|.+|++|+.+++
T Consensus 203 ~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l 278 (401)
T 4fdw_A 203 AGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTT 278 (401)
T ss_dssp CCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEE
T ss_pred cccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEe
Confidence 35777788744 77777777888888888888764 44233445555 56777777 34455344556666777777777
Q ss_pred cCCccC-----CCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCc
Q 007455 150 SSNSLK-----GAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNL 200 (603)
Q Consensus 150 ~~N~l~-----~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~ 200 (603)
.+|.+. ...+..|.++++|+.++|. |.++.+... |..+.+|+.+.+..|+
T Consensus 279 ~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~l 334 (401)
T 4fdw_A 279 YGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPANV 334 (401)
T ss_dssp ESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTTC
T ss_pred CCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECccc
Confidence 666554 2334566666677777766 335544433 5556666666665554
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.18 E-value=3.2e-06 Score=87.73 Aligned_cols=123 Identities=11% Similarity=0.109 Sum_probs=77.0
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
+|+.+.|.+ .++.+-+.+|.++++|+.++|++|+++..-...|. .++|+.+.|.+| ++..-...|.++++|+.++|.
T Consensus 158 ~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~ 234 (401)
T 4fdw_A 158 TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIP 234 (401)
T ss_dssp CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECC
T ss_pred CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecC
Confidence 477788875 67777777888888888888888888733333444 577888887744 554555667777777777777
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN 199 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n 199 (603)
+| ++..-..+|.+ .+|+.+.+ .|.++.+... |..+.+|+.+.+.+|
T Consensus 235 ~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~ 281 (401)
T 4fdw_A 235 EN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGS 281 (401)
T ss_dssp TT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESS
T ss_pred CC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCc
Confidence 64 34233334444 55666666 3334444332 555555555555554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.09 E-value=2.8e-07 Score=94.09 Aligned_cols=128 Identities=13% Similarity=0.113 Sum_probs=82.7
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCcc--ccCCCceEEecc--ccCCCC-----Ccccc-
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEIT--NCTELRALYLRA--NYLQGG-----IPANI- 138 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~-----~p~~~- 138 (603)
.++|+.|+|++|.-.. +++ + .+++|+.|+|..|.+....-..+. .+++|+.|+|+. |...+. +...+
T Consensus 171 ~P~L~~L~L~g~~~l~-l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~ 247 (362)
T 2ra8_A 171 MPLLNNLKIKGTNNLS-IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247 (362)
T ss_dssp CTTCCEEEEECCBTCB-CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSC
T ss_pred CCCCcEEEEeCCCCce-ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHh
Confidence 3689999998873112 333 4 378999999988887632222333 688899998863 222111 11222
Q ss_pred -ccccccceecccCCccCCCCCCCCc---cccccceeeccCCcCccc-----CCCCccccccCcccccCC
Q 007455 139 -GNLLFLTILDLSSNSLKGAIPSSLG---RLTHLHYLNLSTNFFSGE-----IPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 139 -~~l~~L~~L~l~~N~l~~~~p~~~~---~l~~L~~l~l~~N~l~~~-----~~~~~~l~~l~~l~~~~n 199 (603)
..+++|+.|+|++|.+.+..+..+. .+++|+.|+|+.|.|+.. ...+..+++|+.|+++.|
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n 317 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYN 317 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSB
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCC
Confidence 2478999999999888743332232 478899999999988863 223355677888877766
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.06 E-value=3.7e-07 Score=93.17 Aligned_cols=127 Identities=14% Similarity=0.132 Sum_probs=84.2
Q ss_pred CcEEEEEcCCCCcc---------cccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccc-
Q 007455 70 QRVRSINLPYMQLG---------GIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIG- 139 (603)
Q Consensus 70 ~~l~~L~L~~n~l~---------~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~- 139 (603)
++|+.|.+.++... +.++..+..+++|+.|+|++|.-. .++. + .+++|+.|+|..|.++......+.
T Consensus 139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~ 215 (362)
T 2ra8_A 139 AHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILG 215 (362)
T ss_dssp TTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHH
T ss_pred chhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHH
Confidence 57888888765432 123344567899999999988411 3444 4 388999999999887743333444
Q ss_pred -cccccceecccC--CccCCC-----CCCCC--ccccccceeeccCCcCcccCCC----CccccccCcccccCC
Q 007455 140 -NLLFLTILDLSS--NSLKGA-----IPSSL--GRLTHLHYLNLSTNFFSGEIPD----FGALSAFGNKSFIGN 199 (603)
Q Consensus 140 -~l~~L~~L~l~~--N~l~~~-----~p~~~--~~l~~L~~l~l~~N~l~~~~~~----~~~l~~l~~l~~~~n 199 (603)
.+++|+.|+|+. |...+. +...+ ..+++|+.|+|.+|.++..... ...+++|+.|+++.|
T Consensus 216 ~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n 289 (362)
T 2ra8_A 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAG 289 (362)
T ss_dssp SBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSS
T ss_pred ccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCC
Confidence 689999999863 332211 11122 3578999999999998743221 234678899988876
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.05 E-value=1.2e-05 Score=81.34 Aligned_cols=141 Identities=19% Similarity=0.298 Sum_probs=80.8
Q ss_pred CeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCC--Ceeeecce------eeecCCccEEEEEe
Q 007455 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKH--INLVNLRG------YCRLPATKLLIYDY 388 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 388 (603)
+.|+.|..+.||+....+ +.+++|..... ...+..|+.+++.+.. -.+.+++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~-~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDS-GAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETT-EEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCC-CCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 346667789999998765 46999988652 2345556666665531 12333332 12345667899999
Q ss_pred cCCCCccc--------------cccccC-----CCC-----ccCCHHHH-------------------------------
Q 007455 389 LSMGSLDD--------------FLHEHG-----EGQ-----QLLNWSAR------------------------------- 413 (603)
Q Consensus 389 ~~~gsL~~--------------~l~~~~-----~~~-----~~l~~~~~------------------------------- 413 (603)
++|.++.. .++... ... ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 011100 000 01122211
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 414 LKIALGSARGLAYLHH----------DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 414 ~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
..+...+.+++.+|+. ...+.++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111223345666653 123479999999999999888899999999775
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.93 E-value=2.2e-05 Score=81.37 Aligned_cols=75 Identities=11% Similarity=-0.007 Sum_probs=49.1
Q ss_pred CCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC-------ChHHHHHHHHHHHhhCCC--Ce-eeecceeeecCCccEE
Q 007455 316 EDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE-------GSDQVFERELEILGSIKH--IN-LVNLRGYCRLPATKLL 384 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 384 (603)
.+.||.|.++.||++... +++.++||....... ....++..|+++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357899999999999764 457899997643211 123456789999887742 33 3345443 4456789
Q ss_pred EEEecCCC
Q 007455 385 IYDYLSMG 392 (603)
Q Consensus 385 v~e~~~~g 392 (603)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.90 E-value=4e-05 Score=76.35 Aligned_cols=139 Identities=18% Similarity=0.219 Sum_probs=91.7
Q ss_pred CCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC---CCeeeecceeeecCCccEEEEEecCCC
Q 007455 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIK---HINLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
.+.|+.|....+|+... +++.+++|..... ....+.+|++.|+.+. ...+.+++++....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 35789999999999876 4578999976432 3556889999998884 356788888888778899999999998
Q ss_pred Ccccc-----------ccccCC-C-----------------CccCCHHHHH---HHHH----------------HHHHH-
Q 007455 393 SLDDF-----------LHEHGE-G-----------------QQLLNWSARL---KIAL----------------GSARG- 423 (603)
Q Consensus 393 sL~~~-----------l~~~~~-~-----------------~~~l~~~~~~---~i~~----------------~i~~~- 423 (603)
.+..- ++.... . ...-+|.... ++.. .+...
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 76321 111111 0 0012344321 1111 11111
Q ss_pred HHHHHh-CCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 424 LAYLHH-DCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 424 L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223322 2346899999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00014 Score=71.72 Aligned_cols=76 Identities=16% Similarity=0.195 Sum_probs=56.1
Q ss_pred CCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCC---eeeecceeeecCCccEEEEEecCCC
Q 007455 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHI---NLVNLRGYCRLPATKLLIYDYLSMG 392 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lv~e~~~~g 392 (603)
.+.+|.|..+.||+....+|+.|++|+-..........+.+|++.|+.+.-. -+.+++++ +..++||||++++
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEeeccc
Confidence 4678999999999999999999999986554444455688999999988422 23344443 2358899999887
Q ss_pred Ccc
Q 007455 393 SLD 395 (603)
Q Consensus 393 sL~ 395 (603)
...
T Consensus 96 ~~~ 98 (288)
T 3f7w_A 96 PPT 98 (288)
T ss_dssp CCC
T ss_pred CCC
Confidence 543
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.67 E-value=5.8e-06 Score=74.37 Aligned_cols=82 Identities=15% Similarity=0.156 Sum_probs=33.0
Q ss_pred CcceEEeccCCCCCCCCCCccccCCCceEEecccc-CCCCCccccccc----cccceecccCCc-cCCCCCCCCcccccc
Q 007455 95 KLQRLALHQNSLHGSIPNEITNCTELRALYLRANY-LQGGIPANIGNL----LFLTILDLSSNS-LKGAIPSSLGRLTHL 168 (603)
Q Consensus 95 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~p~~~~~l~~L 168 (603)
+|+.|||+++.|+..--..+..+++|+.|+|+++. |+..--..+..+ ++|++|+|++|. |+..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 34444444444432212223444444455554442 332111222221 245555555543 442111234445555
Q ss_pred ceeeccCC
Q 007455 169 HYLNLSTN 176 (603)
Q Consensus 169 ~~l~l~~N 176 (603)
+.|+++++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 55555554
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.59 E-value=9.6e-06 Score=72.96 Aligned_cols=86 Identities=10% Similarity=0.082 Sum_probs=65.7
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCC-CCCCCCCCcccc----CCCceEEecccc-CCCCCccccccccc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNS-LHGSIPNEITNC----TELRALYLRANY-LQGGIPANIGNLLF 143 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~p~~~~~l~~ 143 (603)
-+|+.|||+++.++..--..+.++++|+.|+|++|. |+..--..+..+ ++|++|+|++|. |+..--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 479999999999876544567889999999999985 653222224443 479999999984 87544456788999
Q ss_pred cceecccCCc-cC
Q 007455 144 LTILDLSSNS-LK 155 (603)
Q Consensus 144 L~~L~l~~N~-l~ 155 (603)
|+.|+|+++. ++
T Consensus 141 L~~L~L~~c~~It 153 (176)
T 3e4g_A 141 LKYLFLSDLPGVK 153 (176)
T ss_dssp CCEEEEESCTTCC
T ss_pred CCEEECCCCCCCC
Confidence 9999999986 44
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00018 Score=75.10 Aligned_cols=78 Identities=12% Similarity=0.117 Sum_probs=48.0
Q ss_pred CCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcceeecc-cccccccCccccccC---CCCcccchHhHHHHHHHH
Q 007455 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV-AGTFGYLAPEYLQSG---RATEKSDVYSFGVLLLEL 508 (603)
Q Consensus 433 ~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~~Dv~slG~vl~el 508 (603)
+.++|||++|.||+++.++ +.++||+.+..-... ....... .-...|.+|+..... ......++......+|+.
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~-~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG-FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH-HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH-HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 4799999999999999876 999999988753211 0000000 011346666654311 112235566788888888
Q ss_pred HhCC
Q 007455 509 VTGK 512 (603)
Q Consensus 509 ltg~ 512 (603)
+++.
T Consensus 310 y~~~ 313 (420)
T 2pyw_A 310 FNKR 313 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7753
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00031 Score=70.22 Aligned_cols=158 Identities=12% Similarity=0.087 Sum_probs=87.7
Q ss_pred ChHHHHHHhhCCCCC-----CeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCe--eeecce
Q 007455 302 PSCEIIEKLEALDEE-----DVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHIN--LVNLRG 374 (603)
Q Consensus 302 ~~~~~~~~~~~~~~~-----~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~ 374 (603)
+..++......|... +.|+.|....+|+....++ .+++|...... ....+..|+.+++.+.... +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 344555555666553 3466788899999987654 78899876521 2234667888887774222 333332
Q ss_pred e------eecCCccEEEEEecCCCCcccc--------------cccc----CCCC----ccCCHHHHHH-----------
Q 007455 375 Y------CRLPATKLLIYDYLSMGSLDDF--------------LHEH----GEGQ----QLLNWSARLK----------- 415 (603)
Q Consensus 375 ~------~~~~~~~~lv~e~~~~gsL~~~--------------l~~~----~~~~----~~l~~~~~~~----------- 415 (603)
. ....+..+++++|++|..+... ++.. .... ....|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1223556899999998765321 1110 0000 0011222110
Q ss_pred -HHHHHHHHHHHHHhC----CCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 416 -IALGSARGLAYLHHD----CCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 416 -i~~~i~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
+...+.+.++.++.. ...+++|+|+.+.||++++++.+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011134445555532 12479999999999999987656899999775
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00066 Score=67.23 Aligned_cols=72 Identities=14% Similarity=0.124 Sum_probs=45.1
Q ss_pred CCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCee-eecceeeecCCccEEEEEec-CCCC
Q 007455 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINL-VNLRGYCRLPATKLLIYDYL-SMGS 393 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs 393 (603)
.+.|+.|....+|+. +.+++|......... ....+|+.+++.+....+ .+++++ .++.-++++||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 568888775432111 113568877777643223 344443 344567899999 6655
Q ss_pred cc
Q 007455 394 LD 395 (603)
Q Consensus 394 L~ 395 (603)
+.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00095 Score=68.39 Aligned_cols=127 Identities=15% Similarity=0.157 Sum_probs=90.9
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
.++.+.+..+ +..+...+|.+..+|+.+.+..+ ++..-..+|.++.+|+.+.+..+ ++..-...|.++++|+.+.+.
T Consensus 218 ~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~ 294 (379)
T 4h09_A 218 NLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMD 294 (379)
T ss_dssp SCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEEC
T ss_pred ccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccccccc
Confidence 3555555433 45555567778888888888766 55344567888888888888655 553445678888999999998
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccCC-CCccccccCcccccCCcc
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNKSFIGNLD 201 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~~~~n~~ 201 (603)
+|.++..-..+|.++.+|+.+.|.++ ++.+.. .|..+.+|+.+.+..++.
T Consensus 295 ~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~v~ 345 (379)
T 4h09_A 295 NSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKSIT 345 (379)
T ss_dssp CTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTTCC
T ss_pred ccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCccC
Confidence 88888555678888899999998755 665544 377778888888877654
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00039 Score=59.43 Aligned_cols=56 Identities=20% Similarity=0.167 Sum_probs=36.3
Q ss_pred EEEcCCCCcc-cccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCC
Q 007455 74 SINLPYMQLG-GIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQ 131 (603)
Q Consensus 74 ~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 131 (603)
.++.++++|+ ..+|..+. ++|+.|+|++|+|+..-++.|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5666777776 23554332 36777788888877444455677777777777777664
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0036 Score=62.58 Aligned_cols=157 Identities=13% Similarity=0.094 Sum_probs=88.7
Q ss_pred hHHHHHHhhCCCC-----CCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCC--eeeeccee
Q 007455 303 SCEIIEKLEALDE-----EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHI--NLVNLRGY 375 (603)
Q Consensus 303 ~~~~~~~~~~~~~-----~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~ 375 (603)
...+......|.+ ...++ |....||+....+++.+++|...... .....+..|..+++.+... .+++++..
T Consensus 13 ~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~ 90 (328)
T 1zyl_A 13 PDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF 90 (328)
T ss_dssp HHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB
T ss_pred HHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec
Confidence 3445455444433 23466 88889999887776679999875332 2345677888888877422 24444443
Q ss_pred -----eecCCccEEEEEecCCCCcccc--------------ccc----cCC-CCccCCHHHH----HHH-----------
Q 007455 376 -----CRLPATKLLIYDYLSMGSLDDF--------------LHE----HGE-GQQLLNWSAR----LKI----------- 416 (603)
Q Consensus 376 -----~~~~~~~~lv~e~~~~gsL~~~--------------l~~----~~~-~~~~l~~~~~----~~i----------- 416 (603)
....+..+++|+|++|..+... ++. ... .....++... ..+
T Consensus 91 ~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 170 (328)
T 1zyl_A 91 NGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGL 170 (328)
T ss_dssp TTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTT
T ss_pred CCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHH
Confidence 1224455789999998654310 000 000 0111222111 000
Q ss_pred ----HHHHHHHHHHHHhC----CCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 417 ----ALGSARGLAYLHHD----CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 417 ----~~~i~~~L~~LH~~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
...+.+.+..+... ....++|||+++.||+++ + .+.|+||+.+..
T Consensus 171 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 171 KAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 01111223333221 224689999999999999 4 899999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00051 Score=71.70 Aligned_cols=73 Identities=11% Similarity=0.114 Sum_probs=49.5
Q ss_pred CeeeecCCeEEEEEEECC--------CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCee-eecceeeecCCccEEEEE
Q 007455 317 DVVGSGGFGTVYRMVMND--------CGTFAVKRIDRSREGSDQVFERELEILGSIKHINL-VNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 387 (603)
+.|+.|....+|++...+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+.+ .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 467888899999998753 467889877432 222446689999888853333 455665432 38999
Q ss_pred ecCCCCcc
Q 007455 388 YLSMGSLD 395 (603)
Q Consensus 388 ~~~~gsL~ 395 (603)
|++|.++.
T Consensus 153 ~l~G~~l~ 160 (429)
T 1nw1_A 153 YIPSRPLS 160 (429)
T ss_dssp CCCEEECC
T ss_pred EeCCcccC
Confidence 99875553
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.19 E-value=1.6e-05 Score=72.97 Aligned_cols=83 Identities=11% Similarity=0.217 Sum_probs=42.9
Q ss_pred CcEEEEEcCCC-Cccc----ccCCCccCCCCcceEEeccCCCCC----CCCCCccccCCCceEEeccccCCCC----Ccc
Q 007455 70 QRVRSINLPYM-QLGG----IISPSIGRLDKLQRLALHQNSLHG----SIPNEITNCTELRALYLRANYLQGG----IPA 136 (603)
Q Consensus 70 ~~l~~L~L~~n-~l~~----~~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 136 (603)
..++.|+|++| +|.. .+.+++..=+.|+.|+|++|+|.. .+...+..-+.|+.|+|++|+|+.. +-+
T Consensus 41 ~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~ 120 (197)
T 1pgv_A 41 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 120 (197)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHH
Confidence 45667777664 5542 133344445666677777766652 1222233445666666666666521 112
Q ss_pred ccccccccceecccCC
Q 007455 137 NIGNLLFLTILDLSSN 152 (603)
Q Consensus 137 ~~~~l~~L~~L~l~~N 152 (603)
.+..-+.|++|+|++|
T Consensus 121 aL~~N~tL~~L~L~n~ 136 (197)
T 1pgv_A 121 STLVTQSIVEFKADNQ 136 (197)
T ss_dssp HTTTTCCCSEEECCCC
T ss_pred HHhhCCceeEEECCCC
Confidence 2333344666666544
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.001 Score=68.69 Aligned_cols=125 Identities=14% Similarity=0.132 Sum_probs=63.1
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+|+.+.|.+ .++.+-..+|.++++|+.++|.+| ++..-..+|.++++|+.+.+..+- ...-...|.++..+.....
T Consensus 71 ~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l-~~i~~~aF~~~~~~~~~~~ 147 (394)
T 4fs7_A 71 RKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLML-KSIGVEAFKGCDFKEITIP 147 (394)
T ss_dssp TTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTC-CEECTTTTTTCCCSEEECC
T ss_pred CCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCce-eeecceeeecccccccccC
Confidence 4677777764 366666677777778888777654 442334557777777776665442 2122223333322222222
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCC-CCccccccCcccccCCc
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP-DFGALSAFGNKSFIGNL 200 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~-~~~~l~~l~~l~~~~n~ 200 (603)
.+... .-..+|.++++|+.+.+.++..+ +.. .|..+.+|+.+.+..|+
T Consensus 148 ~~~~~--i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~~ 196 (394)
T 4fs7_A 148 EGVTV--IGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRNL 196 (394)
T ss_dssp TTCCE--ECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTTC
T ss_pred ccccc--cchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCCc
Confidence 11111 11234555555655555544322 222 24445555555555544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0017 Score=65.19 Aligned_cols=142 Identities=13% Similarity=0.085 Sum_probs=72.0
Q ss_pred CeeeecCCeE-EEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCC--CeeeecceeeecCCccEEEEEecCCCC
Q 007455 317 DVVGSGGFGT-VYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKH--INLVNLRGYCRLPATKLLIYDYLSMGS 393 (603)
Q Consensus 317 ~~ig~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gs 393 (603)
+.|+.|.... +|+....+++.+++|....... ..+..|+.+++.+.. -.+.+++.+.. ..-+++||++.+.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 3455555444 6677654467787776543221 224567777776642 23445555532 23378999998766
Q ss_pred ccccccccCC----------------------CCccCCHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 007455 394 LDDFLHEHGE----------------------GQQLLNWSARL-------K-------------IALGSARGLAYLHH-- 429 (603)
Q Consensus 394 L~~~l~~~~~----------------------~~~~l~~~~~~-------~-------------i~~~i~~~L~~LH~-- 429 (603)
+.+++..... ....++..... . ....+...+..+..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6543321100 00001111000 0 00111122222211
Q ss_pred -CCCCCeEEecCCCCCeEECCC----CCeEEeecccccc
Q 007455 430 -DCCPKIIHRDIKSSNILLDEN----LEPHVSDFGLAKL 463 (603)
Q Consensus 430 -~~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~~~~ 463 (603)
...+.++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123479999999999999875 6799999998865
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00076 Score=69.62 Aligned_cols=116 Identities=10% Similarity=0.199 Sum_probs=87.8
Q ss_pred cccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCC
Q 007455 82 LGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSS 161 (603)
Q Consensus 82 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 161 (603)
++.+-..+|.+.++|+.+.+.++..+ .-..+|.++++|+.+.+. +.++..-...|.++.+|+.++|..| ++..-..+
T Consensus 253 v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a 329 (394)
T 4gt6_A 253 VARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDA 329 (394)
T ss_dssp EEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTT
T ss_pred ceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhH
Confidence 44444567888899999999876654 556778899999999996 4566455667889999999999865 55355678
Q ss_pred CccccccceeeccCCcCcccCCC-CccccccCcccccCCcc
Q 007455 162 LGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLD 201 (603)
Q Consensus 162 ~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~ 201 (603)
|.++++|+.+.+.++ ++.+... |..+.+|+.+.+.+|..
T Consensus 330 F~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~ 369 (394)
T 4gt6_A 330 FAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRS 369 (394)
T ss_dssp TTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHH
T ss_pred hhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCcee
Confidence 999999999999755 6655443 78888898888888753
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.06 E-value=0.00047 Score=71.16 Aligned_cols=124 Identities=12% Similarity=0.112 Sum_probs=86.9
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
..++.+.+.++- ..+-..+|.+.++|+.+.+. +.++..-..+|.++++|+.++|..| ++..-...|.+|++|+.+.|
T Consensus 265 ~~L~~i~lp~~~-~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~i 341 (394)
T 4gt6_A 265 AYLASVKMPDSV-VSIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAI 341 (394)
T ss_dssp SSCCEEECCTTC-CEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEE
T ss_pred ccccEEeccccc-ceecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEE
Confidence 356677776543 34556788999999999996 5566345567999999999999865 66455678999999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
..+ ++..-..+|.++++|+.+++.+|.... ..+....+|+.+.+..|
T Consensus 342 p~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~--~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 342 PSS-VTKIPESAFSNCTALNNIEYSGSRSQW--NAISTDSGLQNLPVAPG 388 (394)
T ss_dssp CTT-CCBCCGGGGTTCTTCCEEEESSCHHHH--HTCBCCCCC--------
T ss_pred Ccc-cCEEhHhHhhCCCCCCEEEECCceeeh--hhhhccCCCCEEEeCCC
Confidence 765 663445689999999999999886542 23444556666655443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0017 Score=66.30 Aligned_cols=142 Identities=14% Similarity=0.073 Sum_probs=80.9
Q ss_pred CeeeecCCeEEEEEEECC--------CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCe-eeecceeeecCCccEEEEE
Q 007455 317 DVVGSGGFGTVYRMVMND--------CGTFAVKRIDRSREGSDQVFERELEILGSIKHIN-LVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 387 (603)
+.|..|-...+|+....+ ++.+++|+.... ......+.+|.++++.+.-.. ..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 567778888999988642 467888875332 223445678999998884222 3455665543 38999
Q ss_pred ecCCCCcccc-cc----------------ccC-CCCccCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 007455 388 YLSMGSLDDF-LH----------------EHG-EGQQLLN--WSARLKIALGSAR-------------------GLAYL- 427 (603)
Q Consensus 388 ~~~~gsL~~~-l~----------------~~~-~~~~~l~--~~~~~~i~~~i~~-------------------~L~~L- 427 (603)
|++|.+|..- +. ... ....... +.+..++..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 11 000 0011122 3333334433211 12232
Q ss_pred ---HhC-CCCCeEEecCCCCCeEECCC----CCeEEeecccccc
Q 007455 428 ---HHD-CCPKIIHRDIKSSNILLDEN----LEPHVSDFGLAKL 463 (603)
Q Consensus 428 ---H~~-~~~~ivH~Dlkp~NIll~~~----~~~kl~DfG~~~~ 463 (603)
... ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 222 12368999999999999876 7899999998764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00089 Score=57.16 Aligned_cols=57 Identities=21% Similarity=0.274 Sum_probs=47.7
Q ss_pred ceEEeccCCCC-CCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccC
Q 007455 97 QRLALHQNSLH-GSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLK 155 (603)
Q Consensus 97 ~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 155 (603)
..++.++++++ ..+|..+. ++|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 37899999996 46776544 47999999999999666677899999999999999875
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0015 Score=67.35 Aligned_cols=85 Identities=14% Similarity=0.094 Sum_probs=49.3
Q ss_pred CccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCC-Ccccccc
Q 007455 113 EITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAF 191 (603)
Q Consensus 113 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l 191 (603)
.|..+.+|+.+.+.++ ++..-...|.++++|+.++|.++ ++..-..+|.++++|+.+++..| ++.+... |..+.+|
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 368 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINL 368 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence 3555666666666544 44233455666777777777543 54333456666777777777655 5544332 6666666
Q ss_pred CcccccCCc
Q 007455 192 GNKSFIGNL 200 (603)
Q Consensus 192 ~~l~~~~n~ 200 (603)
+.+.+..++
T Consensus 369 ~~i~lp~~~ 377 (394)
T 4fs7_A 369 KKVELPKRL 377 (394)
T ss_dssp CEEEEEGGG
T ss_pred CEEEECCCC
Confidence 666665554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0039 Score=62.81 Aligned_cols=67 Identities=12% Similarity=0.119 Sum_probs=43.0
Q ss_pred ecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC---CCeeeeccee------eecCCccEEEEEecCC
Q 007455 321 SGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIK---HINLVNLRGY------CRLPATKLLIYDYLSM 391 (603)
Q Consensus 321 ~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~~ 391 (603)
.|....||+....++ .+++|+...... .+|+.+++.+. -|++.+++.. ....+..+++|+|++|
T Consensus 33 ~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G 105 (339)
T 3i1a_A 33 ADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHA 105 (339)
T ss_dssp SCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCC
T ss_pred CccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCC
Confidence 333679999987775 899998755432 34566665553 2224454432 2334667899999998
Q ss_pred CCc
Q 007455 392 GSL 394 (603)
Q Consensus 392 gsL 394 (603)
..+
T Consensus 106 ~~~ 108 (339)
T 3i1a_A 106 PNG 108 (339)
T ss_dssp CBT
T ss_pred CcC
Confidence 766
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0033 Score=65.95 Aligned_cols=74 Identities=11% Similarity=0.100 Sum_probs=47.4
Q ss_pred CeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCee-eecceeeecCCccEEEEEecCCCCc
Q 007455 317 DVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINL-VNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
+.|+.|-...+|+....+ ++.+++|+......... ...+|..+++.+...++ .++++.+. + ..|+||++|.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 568889899999998875 46788887643221111 12578888888864444 45666652 2 359999998665
Q ss_pred c
Q 007455 395 D 395 (603)
Q Consensus 395 ~ 395 (603)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0014 Score=67.03 Aligned_cols=108 Identities=13% Similarity=0.121 Sum_probs=87.0
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
..++.+.+..+ ++.+-..+|.+..+|+.+.+..+ +...-...|.++++|+.+.+.+|.++..-...|.++.+|+.+.|
T Consensus 240 ~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 240 KALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp SSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEc
Confidence 46788888765 77777788999999999999765 55344567999999999999999998556678999999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCccc
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGE 181 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~ 181 (603)
..+ ++..-..+|.++++|+.+.+..| ++.+
T Consensus 318 p~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I 347 (379)
T 4h09_A 318 PTA-LKTIQVYAFKNCKALSTISYPKS-ITLI 347 (379)
T ss_dssp CTT-CCEECTTTTTTCTTCCCCCCCTT-CCEE
T ss_pred Ccc-ccEEHHHHhhCCCCCCEEEECCc-cCEE
Confidence 865 66345568999999999998655 5433
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0033 Score=57.90 Aligned_cols=102 Identities=15% Similarity=0.092 Sum_probs=66.2
Q ss_pred CccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCccee
Q 007455 393 SLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT 472 (603)
Q Consensus 393 sL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~~ 472 (603)
||.+.++..+ +++++.++|.++.|.+.+|.-.-.... . ..+=+.|..|++..+|.|...+ +.+.
T Consensus 34 SL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc----------
Confidence 7888887654 459999999999999999877632110 1 1223346889999999988764 1110
Q ss_pred ecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCC
Q 007455 473 TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514 (603)
Q Consensus 473 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p 514 (603)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1123467888764 3456788999999999999975555
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0026 Score=64.87 Aligned_cols=73 Identities=11% Similarity=0.066 Sum_probs=43.0
Q ss_pred CeeeecCCeEEEEEEECC---------CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCe-eeecceeeecCCccEEEE
Q 007455 317 DVVGSGGFGTVYRMVMND---------CGTFAVKRIDRSREGSDQVFERELEILGSIKHIN-LVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 386 (603)
+.|+.|....+|+....+ ++.+++|........ ......|.++++.+...+ ..++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 457788888999998764 257888876432211 112367888888775333 33555443 237899
Q ss_pred EecCCCCc
Q 007455 387 DYLSMGSL 394 (603)
Q Consensus 387 e~~~~gsL 394 (603)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99998654
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.48 E-value=0.00034 Score=64.01 Aligned_cols=89 Identities=13% Similarity=0.105 Sum_probs=64.1
Q ss_pred CccCCCCcceEEeccC-CCCC----CCCCCccccCCCceEEeccccCCC----CCccccccccccceecccCCccCCC--
Q 007455 89 SIGRLDKLQRLALHQN-SLHG----SIPNEITNCTELRALYLRANYLQG----GIPANIGNLLFLTILDLSSNSLKGA-- 157 (603)
Q Consensus 89 ~~~~l~~L~~L~L~~N-~l~~----~~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~-- 157 (603)
.+.+-+.|++|+|++| +|.. .+-+.+..-+.|+.|+|++|+|.. .+.+.+..-+.|+.|+|++|.|...
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3455678999999986 7752 133445566889999999999983 2344455667899999999999842
Q ss_pred --CCCCCccccccceeeccCCc
Q 007455 158 --IPSSLGRLTHLHYLNLSTNF 177 (603)
Q Consensus 158 --~p~~~~~l~~L~~l~l~~N~ 177 (603)
+-+++..-+.|+.|+|++|.
T Consensus 116 ~ala~aL~~N~tL~~L~L~n~~ 137 (197)
T 1pgv_A 116 ARLLRSTLVTQSIVEFKADNQR 137 (197)
T ss_dssp HHHHHHTTTTCCCSEEECCCCS
T ss_pred HHHHHHHhhCCceeEEECCCCc
Confidence 23345556779999998763
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.85 E-value=0.13 Score=53.10 Aligned_cols=74 Identities=12% Similarity=0.098 Sum_probs=47.3
Q ss_pred CeeeecCCeEEEEEEECC--------CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCe-eeecceeeecCCccEEEEE
Q 007455 317 DVVGSGGFGTVYRMVMND--------CGTFAVKRIDRSREGSDQVFERELEILGSIKHIN-LVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 387 (603)
+.+..|-...+|+....+ ++.+++|+........ -...+|..+++.+...+ ..++++.+ .-+.|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-YDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-CCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-cCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence 467778889999998763 4678888754322111 12357888888774222 33445433 2378999
Q ss_pred ecCCCCcc
Q 007455 388 YLSMGSLD 395 (603)
Q Consensus 388 ~~~~gsL~ 395 (603)
|++|.+|.
T Consensus 151 fI~G~~l~ 158 (424)
T 3mes_A 151 FIDGEPLT 158 (424)
T ss_dssp CCCSEECC
T ss_pred EeCCccCC
Confidence 99997653
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=92.09 E-value=0.18 Score=32.08 Aligned_cols=29 Identities=17% Similarity=0.208 Sum_probs=16.3
Q ss_pred cccccchhhhhHhHHHHHHHHHHHHHHhh
Q 007455 238 HYMKGVLIGAMSTMGLALVVLLAFLWICL 266 (603)
Q Consensus 238 ~~~~~~vi~~~~~~~~~~~~~~~~~~~~~ 266 (603)
..+.+.+.|+++++.+.+++++++.++++
T Consensus 7 ~ls~GaIAGiVvG~v~gv~li~~l~~~~~ 35 (38)
T 2k1k_A 7 GLTGGEIVAVIFGLLLGAALLLGILVFRS 35 (38)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCceeeeehHHHHHHHHHHHHHHHHe
Confidence 34556677777766555554444444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.06 E-value=0.19 Score=51.58 Aligned_cols=30 Identities=30% Similarity=0.434 Sum_probs=25.3
Q ss_pred CeEEecCCCCCeEE------CCCCCeEEeecccccc
Q 007455 434 KIIHRDIKSSNILL------DENLEPHVSDFGLAKL 463 (603)
Q Consensus 434 ~ivH~Dlkp~NIll------~~~~~~kl~DfG~~~~ 463 (603)
.++|+|+.+.||++ +++..+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998864
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.98 E-value=0.38 Score=31.59 Aligned_cols=27 Identities=11% Similarity=0.042 Sum_probs=11.4
Q ss_pred hhhhhHhHHHHHHHHHHHHHHhhhhcc
Q 007455 244 LIGAMSTMGLALVVLLAFLWICLLSKK 270 (603)
Q Consensus 244 vi~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (603)
+++.++++.+++++++...|+++++|+
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 444444444433333333344444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.64 E-value=0.48 Score=31.16 Aligned_cols=27 Identities=15% Similarity=0.116 Sum_probs=10.8
Q ss_pred hhhhhHhHHHHHHHHHHHHHHhhhhcc
Q 007455 244 LIGAMSTMGLALVVLLAFLWICLLSKK 270 (603)
Q Consensus 244 vi~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (603)
+++.++++.+++++++..+|+++++|+
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 444444433333333333344443333
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=83.53 E-value=1.5 Score=40.08 Aligned_cols=117 Identities=12% Similarity=0.128 Sum_probs=76.8
Q ss_pred CCCeeeecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCC
Q 007455 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSN 444 (603)
Q Consensus 365 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N 444 (603)
.||+.+.. .+-...+.+.+.|+.-+ +..++-.-. ..+...+++++..|+....++++. +|--+.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence 57877755 44555555555555433 333332211 178899999999999877666554 788899999
Q ss_pred eEECCCCCeEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCc
Q 007455 445 ILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDP 517 (603)
Q Consensus 445 Ill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~ 517 (603)
|+++.++.+++.=.|+-..+ +|. ..+...=.-.+=+++..+++++..|+.
T Consensus 110 L~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999877754332 221 111122233566788899999988764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=82.54 E-value=1.5 Score=28.73 Aligned_cols=7 Identities=29% Similarity=0.434 Sum_probs=3.6
Q ss_pred hhhhhHh
Q 007455 244 LIGAMST 250 (603)
Q Consensus 244 vi~~~~~ 250 (603)
+++.+++
T Consensus 14 Ia~~vVG 20 (44)
T 2jwa_A 14 IISAVVG 20 (44)
T ss_dssp HHHHHHH
T ss_pred hHHHHHH
Confidence 4555554
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.39 E-value=2.4 Score=38.90 Aligned_cols=116 Identities=13% Similarity=0.107 Sum_probs=74.1
Q ss_pred CCCeeeecceeeecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEecCCCC
Q 007455 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLA-YLHHDCCPKIIHRDIKSS 443 (603)
Q Consensus 365 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlkp~ 443 (603)
.||++ -..+-.+++.+.+.|+.-+++.=...++. ++...+++++..++.... +++. -+|=-+.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 57777 33344566666666665433222222222 788899999999887666 5544 478889999
Q ss_pred CeEECCCCCeEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCc
Q 007455 444 NILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDP 517 (603)
Q Consensus 444 NIll~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~ 517 (603)
||++|.++.+++.-.|+-..+ +|.-+ +..-=.-.+=+++..++.++..|+.
T Consensus 114 NL~f~~~~~p~i~hRGi~~~l------------------pP~e~-----~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKESL------------------PPDEW-----DDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp GEEECTTCCEEESCCEETTTB------------------SSCSC-----CHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred eEEEeCCCcEEEEEcCCcccC------------------CCCCC-----CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999999877754332 22211 1111123566788888888887753
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 603 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-71 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-67 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-60 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-57 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-51 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-44 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 6e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-33 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.001 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-08 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.003 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 7e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (586), Expect = 1e-71
Identities = 78/276 (28%), Positives = 132/276 (47%), Gaps = 25/276 (9%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQV--FERELEILGSIKHINLVNLR 373
+GSG FGTVY+ + G AVK ++ + Q+ F+ E+ +L +H+N++
Sbjct: 13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
GY P ++ + SL LH + + IA +A+G+ YLH
Sbjct: 71 GYSTAP-QLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLH---AK 123
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQ---S 489
IIHRD+KS+NI L E+L + DFGLA + H ++G+ ++APE ++
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 490 GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549
+ +SDVY+FG++L EL+TG+ P +N + ++ L + K ++
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDLSKVRSN 237
Query: 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+A+ + A C D+RP Q+L +E
Sbjct: 238 CP----KAMKRLMAECLKKKRDERPLFPQILASIEL 269
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 2e-67
Identities = 78/274 (28%), Positives = 124/274 (45%), Gaps = 21/274 (7%)
Query: 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLV 370
E L + +G+G FG V+ N AVK + + D F E ++ ++H LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLV 71
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
L +I +Y+ GSL DFL + L + L +A A G+A++
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEER 128
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
IHRD++++NIL+ + L ++DFGLA+L+ D E + APE + G
Sbjct: 129 N---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
T KSDV+SFG+LL E+VT R P G+ + L + R+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYP-----GMTNPEVIQNLERGYRMVR--------- 231
Query: 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
E + ++ C P+DRP+ + + +LE
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (547), Expect = 7e-66
Identities = 81/283 (28%), Positives = 129/283 (45%), Gaps = 21/283 (7%)
Query: 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLV 370
E+L E +G G FG V+ N A+K + + F +E +++ ++H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLV 75
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
L ++ +Y+S GSL D GE + L + +A A G+AY+
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE-- 130
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
+HRD++++NIL+ ENL V+DFGLA+L+ D E + APE G
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
R T KSDV+SFG+LL EL T R P G+ ++ + + R+
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYP-----GMVNREVLDQVERGYRMP---------C 235
Query: 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPS 593
E E++ ++ +C P++RP+ + LE S P
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 8e-64
Identities = 69/294 (23%), Positives = 117/294 (39%), Gaps = 31/294 (10%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
++ +G G FG V+R AVK SRE E E+ ++H N++
Sbjct: 8 QESIGKGRFGEVWRGKWRG-EEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 376 CRLPATKL----LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC 431
L+ DY GSL D+L+ + + +K+AL +A GLA+LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEI 120
Query: 432 C-----PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV---TTVVAGTFGYLA 483
P I HRD+KS NIL+ +N ++D GLA + GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 484 PEYLQS------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKR----GLNVVGWMNTL 533
PE L + +++D+Y+ G++ E+ + L
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 534 LKENRLEDVIDKRCAD--ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+++ E + + E + + +I C AN R + ++ + L Q
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 9e-64
Identities = 67/273 (24%), Positives = 116/273 (42%), Gaps = 21/273 (7%)
Query: 313 LDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNL 372
L +GSG FG V+ + A+K I + F E E++ + H LV L
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQL 65
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
G C A L+++++ G L D+L + L L + L G+ +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGM---AYLEE 119
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
+IHRD+ + N L+ EN VSDFG+ + ++D++ +T + +PE R
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 493 TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADM 552
+ KSDV+SFGVL+ E+ + + + + + RL
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYE-----NRSNSEVVEDISTGFRLYK---------PR 225
Query: 553 ETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ +I C P+DRP+ +++L+ L +
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-62
Identities = 84/321 (26%), Positives = 139/321 (43%), Gaps = 39/321 (12%)
Query: 294 TFHGDMPYPSCEIIEKLEA---------LDEEDVVGSGGFGTVYRMVMNDCGT----FAV 340
T H D+ + E+++ ++ + +V+G G FG VY + D AV
Sbjct: 1 TVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAV 60
Query: 341 KRIDR-SREGSDQVFERELEILGSIKHINLVNLRGYC-RLPATKLLIYDYLSMGSLDDFL 398
K ++R + G F E I+ H N+++L G C R + L++ Y+ G L +F+
Sbjct: 61 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120
Query: 399 HEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458
+ L A+G+ K +HRD+ + N +LDE V+DF
Sbjct: 121 RNET---HNPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADF 174
Query: 459 GLAKLLVDEEA---HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPT 515
GLA+ + D+E H T ++A E LQ+ + T KSDV+SFGVLL EL+T P
Sbjct: 175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234
Query: 516 DPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPS 575
P +N LL+ RL + + E+ +C + RPS
Sbjct: 235 YP-----DVNTFDITVYLLQGRRLLQ---------PEYCPDPLYEVMLKCWHPKAEMRPS 280
Query: 576 MNQVLQLLEQEVMSPCPSDFY 596
++++ + + S + Y
Sbjct: 281 FSELVSRIS-AIFSTFIGEHY 300
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 3e-62
Identities = 66/303 (21%), Positives = 122/303 (40%), Gaps = 39/303 (12%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRS-REGSDQVFERELEILGSIKH 366
K + ++ +G+G G V+++ G A K I + REL++L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
+V G + +++ GSLD L + G + K+++ +GL Y
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTY 119
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
L KI+HRD+K SNIL++ E + DFG++ L+D + GT Y++PE
Sbjct: 120 LREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPER 174
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRP-----------------------TDPTFVKRG 523
LQ + +SD++S G+ L+E+ G+ P T P G
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 524 LNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAA-----RCTDANPDDRPSMNQ 578
+ + + +++D + + + + +C NP +R + Q
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 579 VLQ 581
++
Sbjct: 295 LMV 297
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 5e-62
Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 23/280 (8%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR--EGSDQVFERELEILGSIK 365
+ E + +G+G +G ++ G K +D E Q+ E+ +L +K
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK 61
Query: 366 HINLVNLRGYCRLPATKLL--IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARG 423
H N+V L + +Y G L + + + +Q L+ L++
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 424 LAYLH--HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
L H D ++HRD+K +N+ LD + DFGLA++L + + GT Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFVGTPYY 180
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541
++PE + EKSD++S G LL EL P + + +
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREGKFRR- 233
Query: 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
I R +D + EI R + RPS+ ++L+
Sbjct: 234 -IPYRYSD-------ELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (519), Expect = 9e-62
Identities = 79/290 (27%), Positives = 128/290 (44%), Gaps = 22/290 (7%)
Query: 298 DMPYPSCEIIE-KLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFE 355
D P+ + E + + + +G G +G VY V AVK + ++ F
Sbjct: 3 DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FL 61
Query: 356 RELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK 415
+E ++ IKH NLV L G C +I ++++ G+L D+L E + ++ L
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLY 119
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
+A + + YL IHRD+ + N L+ EN V+DFGL++L+ +
Sbjct: 120 MATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535
+ APE L + + KSDV++FGVLL E+ T P G+++ L K
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP-----GIDLSQVYELLEK 231
Query: 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ R+E E + E+ C NP DRPS ++ Q E
Sbjct: 232 DYRME---------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 1e-61
Identities = 60/273 (21%), Positives = 109/273 (39%), Gaps = 21/273 (7%)
Query: 313 LDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNL 372
L +G+G FG V A+K I D+ F E +++ ++ H LV L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNLSHEKLVQL 64
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
G C +I +Y++ G L ++L E + L++ + YL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
+ +HRD+ + N L+++ VSDFGL++ ++D+E + + PE L +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 493 TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADM 552
+ KSD+++FGVL+ E+ + + + + RL
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYE-----RFTNSETAEHIAQGLRLYR---------PH 224
Query: 553 ETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
E + I C D+RP+ +L +
Sbjct: 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 2e-60
Identities = 71/290 (24%), Positives = 130/290 (44%), Gaps = 29/290 (10%)
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRSR-EGSDQVFERELEILGSI 364
+ + E V+G+G FG V + G A+K + E + F E I+G
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF 84
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
H N+++L G ++I +++ GSLD FL ++ + + G A G+
Sbjct: 85 DHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF---TVIQLVGMLRGIAAGM 141
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVA----GTFG 480
YL +HRD+ + NIL++ NL VSDFGL++ L D+ + T A
Sbjct: 142 KYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 481 YLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540
+ APE +Q + T SDV+S+G+++ E+++ + +N + ++ RL
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW-----DMTNQDVINAIEQDYRLP 253
Query: 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
M+ A+ ++ C + + RP Q++ L++ + +P
Sbjct: 254 P---------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 3e-60
Identities = 70/300 (23%), Positives = 130/300 (43%), Gaps = 31/300 (10%)
Query: 311 EALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRSR-EGSDQVFERELEILGSI 364
+ + V+G+G FG VY+ ++ A+K + E F E I+G
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 365 KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
H N++ L G ++I +Y+ G+LD FL E + + + G A G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGM 123
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA--HVTTVVAGTFGYL 482
+ +HRD+ + NIL++ NL VSDFGL+++L D+ + T+ +
Sbjct: 124 ---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542
APE + + T SDV+SFG+++ E++T L ++ +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGER--------------PYWELSNHEVMKAI 226
Query: 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSDFYESHSDY 602
D M+ AI ++ +C RP ++ +L++ + +P D ++ +D+
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP---DSLKTLADF 283
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-60
Identities = 73/277 (26%), Positives = 119/277 (42%), Gaps = 27/277 (9%)
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINL 369
++ L +G G FG V AVK I + + Q F E ++ ++H NL
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCIKN--DATAQAFLAEASVMTQLRHSNL 62
Query: 370 VNLRGYCRLPATKL-LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH 428
V L G L ++ +Y++ GSL D+L G + +L LK +L + YL
Sbjct: 63 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
+HRD+ + N+L+ E+ VSDFGL K + + APE L+
Sbjct: 121 G---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALR 173
Query: 489 SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548
+ + KSDV+SFG+LL E+ + R P + + + + K +++ C
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPYP-----RIPLKDVVPRVEKGYKMD--APDGCP 226
Query: 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
A+ E+ C + RPS Q+ + LE
Sbjct: 227 -------PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 6e-60
Identities = 64/274 (23%), Positives = 106/274 (38%), Gaps = 30/274 (10%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNL 372
+ +G G F TVY+ + + A + + + Q F+ E E+L ++H N+V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 373 RGYCRLPATK----LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH 428
+L+ + ++ G+L +L + +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLH 129
Query: 429 HDCCPKIIHRDIKSSNILL-DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
P IIHRD+K NI + + D GLA L A V GT ++APE
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMY 185
Query: 488 QSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547
+ + E DVY+FG+ +LE+ T + P + + DK
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVA 238
Query: 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ + EI C N D+R S+ +L
Sbjct: 239 -------IPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-59
Identities = 66/289 (22%), Positives = 123/289 (42%), Gaps = 30/289 (10%)
Query: 305 EIIEKLEALDEEDVV-GSGGFGTVYRMVMNDCGT---FAVKRIDRSREGSD-QVFERELE 359
++ K + L D+ G G FG+V + V A+K + + E +D + RE +
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 360 ILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALG 419
I+ + + +V L G C+ +L+ + G L FL E + S ++
Sbjct: 62 IMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQ 117
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT--TVVAG 477
+ G+ YL +HRD+ + N+LL +SDFGL+K L ++++ T +
Sbjct: 118 VSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 478 TFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKE 536
+ APE + + + +SDV+S+GV + E ++ G++P + M + +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK------KMKGPEVMAFIEQG 228
Query: 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
R+E E + + + C +DRP V Q +
Sbjct: 229 KRME---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 7e-59
Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 39/295 (13%)
Query: 316 EDVVGSGGFGTVYR------MVMNDCGTFAVKRIDRS-REGSDQVFERELEILGSIK-HI 367
+G+G FG V + + T AVK + S + EL++L + H+
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG--------------EGQQLLNWSAR 413
N+VNL G C + L+I +Y G L +FL + + L+
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 414 LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH-VT 472
L + A+G+A+L IHRD+ + NILL + DFGLA+ + ++ + V
Sbjct: 148 LSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 473 TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT 532
++APE + + T +SDV+S+G+ L EL + P G+ V
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-----GMPVDSKFYK 259
Query: 533 LLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587
++KE + + + +I C DA+P RP+ Q++QL+E+++
Sbjct: 260 MIKEG-FRMLSPEHAP-------AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-58
Identities = 61/279 (21%), Positives = 111/279 (39%), Gaps = 31/279 (11%)
Query: 315 EEDVVGSGGFGTVYRMVMNDCGT---FAVKRIDRSREGSDQV--FERELEILGSIKHINL 369
E+ +GSG FGTV + AVK + E ++ + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429
V + G C + +L+ + +G L+ +L ++ + +++ + G+ YL
Sbjct: 71 VRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLE- 124
Query: 430 DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT--VVAGTFGYLAPEYL 487
+HRD+ + N+LL +SDFGL+K L +E + + APE +
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 488 QSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546
+ + KSDV+SFGVL+ E + G++P G+ L K R+
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYR------GMKGSEVTAMLEKGERMG--CPAG 234
Query: 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
C + ++ C + ++RP V L
Sbjct: 235 CP-------REMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 2e-58
Identities = 69/283 (24%), Positives = 117/283 (41%), Gaps = 35/283 (12%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGS 363
EII +L G G FG VY+ + A K ID E + + E++IL S
Sbjct: 15 EIIGEL---------GDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILAS 65
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARG 423
H N+V L ++ ++ + G++D + E L S + +
Sbjct: 66 CDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTESQIQVVCKQTLDA 122
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLA 483
L YLH KIIHRD+K+ NIL + + ++DFG++ + + GT ++A
Sbjct: 123 LNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMA 178
Query: 484 PEYLQSGRA-----TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538
PE + + K+DV+S G+ L+E+ + P LN + + + K
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH------ELNPMRVLLKIAKSEP 232
Query: 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
R + + +C + N D R + +Q+LQ
Sbjct: 233 PTLAQPSRWSS-------NFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 5e-58
Identities = 67/301 (22%), Positives = 121/301 (40%), Gaps = 45/301 (14%)
Query: 313 LDEEDVVGSGGFGTVYR------MVMNDCGTFAVKRIDRSREGSDQV-FERELEILGSIK 365
++ +G G FG V++ + AVK + Q F+RE ++
Sbjct: 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGE--------------------GQ 405
+ N+V L G C + L+++Y++ G L++FL G
Sbjct: 75 NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134
Query: 406 QLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465
L+ + +L IA A G+AYL K +HRD+ + N L+ EN+ ++DFGL++ +
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 466 DEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL 524
+ A ++ PE + R T +SDV+++GV+L E+ +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ---------- 241
Query: 525 NVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
+ E + V D + + C P DRPS + ++L+
Sbjct: 242 ----PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 585 Q 585
+
Sbjct: 298 R 298
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 6e-58
Identities = 68/277 (24%), Positives = 110/277 (39%), Gaps = 32/277 (11%)
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV---FERELEILGSIK 365
LE + +G G FG VY A+K + +++ V RE+EI ++
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 366 HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLA 425
H N++ L GY LI +Y +G++ L + + + A L+
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALS 120
Query: 426 YLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
Y H ++IHRDIK N+LL E ++DFG + + GT YL PE
Sbjct: 121 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPE 174
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN-RLEDVID 544
++ EK D++S GVL E + GK P + + + D +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYKRISRVEFTFPDFVT 228
Query: 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ D + +R NP RP + +VL+
Sbjct: 229 EGARD-----------LISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-57
Identities = 84/319 (26%), Positives = 132/319 (41%), Gaps = 39/319 (12%)
Query: 302 PSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT---FAVKRIDRSREGSDQV-FERE 357
P+ + + +DV+G G FG V + + G A+KR+ D F E
Sbjct: 1 PTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE 60
Query: 358 LEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEH------------GEG 404
LE+L + H N++NL G C L +Y G+L DFL +
Sbjct: 61 LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 120
Query: 405 QQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464
L+ L A ARG+ YL + IHRD+ + NIL+ EN ++DFGL++
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG- 176
Query: 465 VDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL 524
E T+ ++A E L T SDV+S+GVLL E+V+ G+
Sbjct: 177 -QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GM 230
Query: 525 NVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
L + RLE ++ + + ++ +C P +RPS Q+L L
Sbjct: 231 TCAELYEKLPQGYRLEKPLN---------CDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
Query: 585 ---QEVMSPCPSDFYESHS 600
+E + + YE +
Sbjct: 282 RMLEERKTYVNTTLYEKFT 300
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 2e-56
Identities = 66/271 (24%), Positives = 105/271 (38%), Gaps = 33/271 (12%)
Query: 318 VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV---FERELEILGSIKHINLVNLR 373
+G G FG VY A+K++ S + S++ +E+ L ++H N + R
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
G T L+ +Y + D L + G+ +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHKKP----LQEVEIAAVTHGALQGLAYLHS---H 134
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQS---G 490
+IHRD+K+ NILL E + DFG A ++ GT ++APE + + G
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEG 189
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
+ K DV+S G+ +EL K P L + +N + +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------AQNESPALQSGHWS-- 240
Query: 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
E C P DRP+ +L+
Sbjct: 241 -----EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 4e-56
Identities = 67/288 (23%), Positives = 130/288 (45%), Gaps = 33/288 (11%)
Query: 305 EIIEKLEAL----DEED------VVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV 353
EI+EKL ++ D + +G G GTVY + G A+++++ ++ ++
Sbjct: 4 EILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL 63
Query: 354 FERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSAR 413
E+ ++ K+ N+VN + ++ +YL+ GSL D + E +
Sbjct: 64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQI 118
Query: 414 LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT 473
+ + L +LH + ++IHRDIKS NILL + ++DFG + E++ +T
Sbjct: 119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175
Query: 474 VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533
+V GT ++APE + K D++S G++ +E++ G+ P N + + +
Sbjct: 176 MV-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL------NENPLRALYLI 228
Query: 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
E ++ + + RC D + + R S ++LQ
Sbjct: 229 ATNGTPELQNPEKLS-------AIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-56
Identities = 74/304 (24%), Positives = 118/304 (38%), Gaps = 44/304 (14%)
Query: 311 EALDEEDVVGSGGFGTVYRMVMNDCG------TFAVKRID-RSREGSDQVFERELEILGS 363
E L+ V+GSG FG V AVK + ++ + EL+++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 364 I-KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG-------------------E 403
+ H N+VNL G C L LI++Y G L ++L E
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 404 GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463
+L + L A A+G+ +L +HRD+ + N+L+ + DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 464 LVDEEAHVT-TVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKR 522
++ + +V ++APE L G T KSDV+S+G+LL E+ + P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP----- 268
Query: 523 GLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQL 582
G+ V L++ D E I I C + RPS +
Sbjct: 269 GIPVDANFYKLIQNGFKMDQ--------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
Query: 583 LEQE 586
L +
Sbjct: 321 LGCQ 324
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-56
Identities = 68/269 (25%), Positives = 108/269 (40%), Gaps = 24/269 (8%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRG 374
+G G +G V V AVK +D R + ++E+ I + H N+V G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
+ R + L +Y S G L D + + + G+ YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVYLHG---IG 123
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTFGYLAPEYLQSGR-A 492
I HRDIK N+LLDE +SDFGLA + + + + GT Y+APE L+
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 493 TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADM 552
E DV+S G++L ++ G+ P D + + KE + K+
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWD------QPSDSCQEYSDWKEKKTYLNPWKKID---- 233
Query: 553 ETVEAILEIAARCTDANPDDRPSMNQVLQ 581
A L + + NP R ++ + +
Sbjct: 234 ---SAPLALLHKILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 7e-54
Identities = 73/290 (25%), Positives = 118/290 (40%), Gaps = 38/290 (13%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRSREGSDQV---FERE 357
++EKL G G FG V R + + AVK + + F RE
Sbjct: 11 RLLEKL---------GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 61
Query: 358 LEILGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIA 417
+ + S+ H NL+ L G P K+ + + +GSL D L +H Q + A
Sbjct: 62 VNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTLSRYA 117
Query: 418 LGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH--VTTVV 475
+ A G+ YL + IHRD+ + N+LL + DFGL + L + H +
Sbjct: 118 VQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK 535
F + APE L++ + SD + FGV L E+ T + GLN ++ + K
Sbjct: 175 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----GLNGSQILHKIDK 229
Query: 536 ENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
E + + + I + +C P+DRP+ + L +
Sbjct: 230 EGERLPRPE--------DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 3e-53
Identities = 70/291 (24%), Positives = 123/291 (42%), Gaps = 28/291 (9%)
Query: 307 IEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-----FAVKRIDRS-REGSDQVFERELEI 360
I K + V+GSG FGTVY+ + G A+K + + +++ E +
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 64
Query: 361 LGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGS 420
+ S+ + ++ L G C L +T LI + G L D++ EH + L +
Sbjct: 65 MASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQI 120
Query: 421 ARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL-VDEEAHVTTVVAGTF 479
A+G+ YL +++HRD+ + N+L+ ++DFGLAKLL +E+ +
Sbjct: 121 AKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 480 GYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539
++A E + T +SDV+S+GV + EL+T G+ + L K RL
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-----GIPASEISSILEKGERL 232
Query: 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSP 590
+ I +C + D RP +++ + P
Sbjct: 233 PQ---------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 5e-53
Identities = 58/275 (21%), Positives = 108/275 (39%), Gaps = 26/275 (9%)
Query: 316 EDVVGSGGFGTVYRMVM----NDCGTFAVKRIDR-SREGSDQVFERELEILGSIKHINLV 370
+G G FG V++ + N A+K + + + F +E + H ++V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
L G +I + ++G L FL + L+ ++ + A + LAYL
Sbjct: 72 KLIGVIT-ENPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLES- 126
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
+ +HRDI + N+L+ N + DFGL++ + D + + ++APE +
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
R T SDV+ FGV + E++ G+ + + RL + C
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQ-----GVKNNDVIGRIENGERLP--MPPNCP-- 235
Query: 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ + +C +P RP ++ L
Sbjct: 236 -----PTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 3e-52
Identities = 66/307 (21%), Positives = 126/307 (41%), Gaps = 32/307 (10%)
Query: 309 KLEALDEEDVVGSGGFGTVYRMV------MNDCGTFAVKRIDRSREGSDQV-FERELEIL 361
E + +G G FG VY V A+K ++ + +++ F E ++
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77
Query: 362 GSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQ------QLLNWSARLK 415
++V L G L+I + ++ G L +L + S ++
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA-HVTTV 474
+A A G+AYL+ K +HRD+ + N ++ E+ + DFG+ + + + +
Sbjct: 138 MAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 475 VAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534
+++PE L+ G T SDV+SFGV+L E+ T GL+ + ++
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-----GLSNEQVLRFVM 249
Query: 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMSPCPSD 594
+ L D + + E+ C NP RPS +++ +++E M P +
Sbjct: 250 EGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE-MEPGFRE 299
Query: 595 FYESHSD 601
+S+
Sbjct: 300 VSFYYSE 306
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (455), Expect = 1e-51
Identities = 57/269 (21%), Positives = 113/269 (42%), Gaps = 23/269 (8%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRG 374
+ +G+G FG V+R+ G FA K + E + +E++ + ++H LVNL
Sbjct: 31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 90
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
++IY+++S G L + + + ++ ++ +GL ++H +
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMHENN--- 144
Query: 435 IIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
+H D+K NI+ + DFGL L +++ T GT + APE +
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPV 202
Query: 493 TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADM 552
+D++S GVL L++G P L V + + ++ +
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI---------- 252
Query: 553 ETVEAILEIAARCTDANPDDRPSMNQVLQ 581
E + + A+P+ R +++Q L+
Sbjct: 253 --SEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-51
Identities = 75/309 (24%), Positives = 122/309 (39%), Gaps = 38/309 (12%)
Query: 299 MPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCG------TFAVKRIDR-SREGSD 351
+PY + + + L +G G FG V T AVK + +
Sbjct: 1 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH 60
Query: 352 QVFERELEILGSIKH-INLVNLRGYCRLPATKLLI-YDYLSMGSLDDFLHEHGE------ 403
+ EL+IL I H +N+VNL G C P L++ ++ G+L +L
Sbjct: 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120
Query: 404 ------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSD 457
+ L + + A+G+ +L K IHRD+ + NILL E + D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICD 177
Query: 458 FGLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTD 516
FGLA+ + + +V ++APE + T +SDV+SFGVLL E+ +
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237
Query: 517 PTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSM 576
P G+ + LKE D T + + C P RP+
Sbjct: 238 P-----GVKIDEEFCRRLKEGTRMRAPDY--------TTPEMYQTMLDCWHGEPSQRPTF 284
Query: 577 NQVLQLLEQ 585
+++++ L
Sbjct: 285 SELVEHLGN 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (446), Expect = 2e-50
Identities = 62/268 (23%), Positives = 101/268 (37%), Gaps = 23/268 (8%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGY 375
+ +GSG FG V+R V G F K I+ + E+ I+ + H L+NL
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 376 CRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKI 435
+LI ++LS G L D + ++ + + + GL ++H I
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDYK---MSEAEVINYMRQACEGLKHMHE---HSI 148
Query: 436 IHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
+H DIK NI+ + V DFGLA L +E T T + APE +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVG 206
Query: 494 EKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADME 553
+D+++ GVL L++G P L V + E+ V
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV----------- 255
Query: 554 TVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ P R +++ L+
Sbjct: 256 -SPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-50
Identities = 77/311 (24%), Positives = 129/311 (41%), Gaps = 41/311 (13%)
Query: 298 DMPYPSCEIIEKLEALDEEDVVGSGGFGTVY--------RMVMNDCGTFAVKRIDRSR-E 348
++P + + + L +G G FG V + N AVK + E
Sbjct: 1 ELPEDPRWELPR-DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE 59
Query: 349 GSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHG----- 402
E+E++ I KH N++NL G C +I +Y S G+L ++L
Sbjct: 60 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLE 119
Query: 403 -------EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHV 455
++ L+ + A ARG+ YL K IHRD+ + N+L+ E+ +
Sbjct: 120 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKI 176
Query: 456 SDFGLAKLLVDEEAHVTT-VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP 514
+DFGLA+ + + + T ++APE L T +SDV+SFGVLL E+ T
Sbjct: 177 ADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236
Query: 515 TDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRP 574
P G+ V L + +R++ + + C A P RP
Sbjct: 237 PYP-----GVPVEELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRP 282
Query: 575 SMNQVLQLLEQ 585
+ Q+++ L++
Sbjct: 283 TFKQLVEDLDR 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (431), Expect = 5e-49
Identities = 56/275 (20%), Positives = 103/275 (37%), Gaps = 30/275 (10%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV---FERELEILGSIKHINLVN 371
++G G F TV +A+K +++ + RE +++ + H V
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 372 LRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC 431
L + Y G L ++ + G + + A ++ L +
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYT---AEIVSALEYLH 125
Query: 432 CPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE-EAHVTTVVAGTFGYLAPEYLQSG 490
IIHRD+K NILL+E++ ++DFG AK+L E + GT Y++PE L
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN-RLEDVIDKRCAD 549
A + SD+++ G ++ +LV G P F R N ++K + + D
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPP----F--RAGNEYLIFQKIIKLEYDFPEKFFPKARD 239
Query: 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLE 584
+ + + R ++
Sbjct: 240 -----------LVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 5e-47
Identities = 52/280 (18%), Positives = 106/280 (37%), Gaps = 27/280 (9%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGS 363
E+ EK ++ +G G FG V+R V T+ K + + ++E+ IL
Sbjct: 2 ELYEKYMIAED---LGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNI 57
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARG 423
+H N+++L ++I++++S + + ++ LN +
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE---LNEREIVSYVHQVCEA 114
Query: 424 LAYLHHDCCPKIIHRDIKSSNILLDENLEPHV--SDFGLAKLLVDEEAHVTTVVAGTFGY 481
L +LH I H DI+ NI+ + +FG A+ L + ++ Y
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEY 169
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541
APE Q + +D++S G L+ L++G P ++ + + E ++
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ ++ R R + ++ LQ
Sbjct: 230 I------------SIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 2e-46
Identities = 68/271 (25%), Positives = 108/271 (39%), Gaps = 26/271 (9%)
Query: 316 EDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLR 373
DV+G+G F V A+K I + EG + E E+ +L IKH N+V L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
LI +S G L D + E G ++ + YLH
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQVLDAVKYLHDLG-- 127
Query: 434 KIIHRDIKSSNILL---DENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
I+HRD+K N+L DE+ + +SDFGL+K+ + V + GT GY+APE L
Sbjct: 128 -IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQK 184
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550
++ D +S GV+ L+ G P + + +D+
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI-------- 236
Query: 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
++ + + +P+ R + Q LQ
Sbjct: 237 ----SDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (408), Expect = 6e-46
Identities = 62/281 (22%), Positives = 114/281 (40%), Gaps = 30/281 (10%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV---FERELEILGSIKHINLVN 371
+++G GG V+ AVK + F RE + ++ H +V
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 372 LRGYCRLPATKL----LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYL 427
+ ++ +Y+ +L D +H G + +++ + + L +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFS 127
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV--TTVVAGTFGYLAPE 485
H IIHRD+K +NI++ V DFG+A+ + D V T V GT YL+PE
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545
+ +SDVYS G +L E++TG+ P G + V ++E+ +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVREDPIPPSARH 238
Query: 546 RCADADMETVEAILEIAARCTDANPDDRP-SMNQVLQLLEQ 585
AD++ + + NP++R + ++ L +
Sbjct: 239 EGLSADLD------AVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 159 bits (402), Expect = 5e-45
Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 38/283 (13%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSD---------QVFERELEILGSIK 365
++++G G V R + +AVK ID + GS + +E++IL +
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 366 -HINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGL 424
H N++ L+ L++D + G L D+L E L+ KI +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVI 123
Query: 425 AYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAP 484
LH I+HRD+K NILLD+++ ++DFG + L + V GT YLAP
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAP 178
Query: 485 EYLQSGRA------TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538
E ++ ++ D++S GV++ L+ G P L ++ N
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238
Query: 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+D + + ++ +R P R + + L
Sbjct: 239 WDDY------------SDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 9e-45
Identities = 67/299 (22%), Positives = 116/299 (38%), Gaps = 28/299 (9%)
Query: 303 SCEIIEKLEALDEEDVVGSGGFGTVY--RMVMNDCGTFAVKRI--DRSREGSDQVFEREL 358
C ++ E + E +G G +G V+ R + N A+KR+ EG RE+
Sbjct: 2 LCRADQQYECVAE---IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREV 58
Query: 359 EI---LGSIKHINLVNLRGYCRLPATKLLIYDYLSMGSL--DDFLHEHGEGQQLLNWSAR 413
+ L + +H N+V L C + T L + D + + +
Sbjct: 59 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 118
Query: 414 LKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTT 473
+ RGL +LH +++HRD+K NIL+ + + ++DFGLA++ + A +
Sbjct: 119 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 175
Query: 474 VVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP----TDPTFVKRGLNVVGW 529
V T Y APE L D++S G + E+ K +D + + L+V+G
Sbjct: 176 V--VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233
Query: 530 -------MNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ L + + E ++ +C NP R S L
Sbjct: 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-44
Identities = 60/271 (22%), Positives = 108/271 (39%), Gaps = 31/271 (11%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSD---QVFERELEILG-SIKHINLV 370
++G G FG V+ FA+K + + D + E +L + +H L
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 371 NLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD 430
++ + + +YL+ G L + + + S A GL +L
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFL--- 119
Query: 431 CCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSG 490
I++RD+K NILLD++ ++DFG+ K + +A T GT Y+APE L
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQ 178
Query: 491 RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN-RLEDVIDKRCAD 549
+ D +SFGVLL E++ G+ P G + +++ +N ++K D
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFH------GQDEEELFHSIRMDNPFYPRWLEKEAKD 232
Query: 550 ADMETVEAILEIAARCTDANPDDRPSMNQVL 580
+ + P+ R + +
Sbjct: 233 -----------LLVKLFVREPEKRLGVRGDI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 6e-44
Identities = 53/280 (18%), Positives = 90/280 (32%), Gaps = 26/280 (9%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRG 374
+GSG FG +Y G A+K + E +I ++ +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
+C ++ L SL+D + + + L +A + Y+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHS---KN 123
Query: 435 IIHRDIKSSNIL---LDENLEPHVSDFGLAKLLVDEEAHV------TTVVAGTFGYLAPE 485
IHRD+K N L + ++ DFGLAK D H + GT Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545
+ + D+ S G +L+ G + + E ++ I+
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGS----LPWQGLKAATKRQKYERISEKKMSTPIEV 239
Query: 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
C E C DD+P + + QL
Sbjct: 240 LCKGYPSE----FATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 3e-43
Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 32/290 (11%)
Query: 314 DEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINLVNL 372
+ V+G+G FG VY+ + D G A+K++ + + REL+I+ + H N+V L
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRL 78
Query: 373 RGYCRLPATK------LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
R + K L+ DY+ H + +Q L R LAY
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPH-VSDFGLAKLLVDEEAHVTTVVAGTFGYLAP- 484
+H I HRDIK N+LLD + + DFG AK LV E +V+ + + Y AP
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRAPE 192
Query: 485 EYLQSGRATEKSDVYSFGVLLLELVTGKRP----TDPTFVKRGLNVVG--------WMNT 532
+ T DV+S G +L EL+ G+ + + + V+G MN
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252
Query: 533 LLKENRLEDVIDKRCADADMETV-EAILEIAARCTDANPDDRPSMNQVLQ 581
E + + + + +R + P R + +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 156 bits (395), Expect = 4e-43
Identities = 66/271 (24%), Positives = 106/271 (39%), Gaps = 31/271 (11%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV------FERELEILGSIKHIN 368
++G GGFG VY D G +A+K +D+ R Q L ++ +
Sbjct: 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68
Query: 369 LVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLH 428
+V + P I D ++ G L L +HG + + + A GL ++H
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILGLEHMH 124
Query: 429 HDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQ 488
+ +++RD+K +NILLDE+ +SD GLA ++ H + GT GY+APE LQ
Sbjct: 125 N---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQ 178
Query: 489 SGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547
G A +D +S G +L +L+ G P K + T L D
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSFSPEL 236
Query: 548 ADADMETVEAILEIAARCTDANPDDRPSMNQ 578
+ + + R
Sbjct: 237 RS-----------LLEGLLQRDVNRRLGCLG 256
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 153 bits (386), Expect = 1e-42
Identities = 61/292 (20%), Positives = 112/292 (38%), Gaps = 31/292 (10%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRI--DRSREGSDQVFERELEILG 362
+EK+ G G +G VY+ N TFA+K+I ++ EG RE+ IL
Sbjct: 5 HGLEKI---------GEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILK 55
Query: 363 SIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSAR 422
+KH N+V L +L++++L G L L
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----LESVTAKSFLLQLLN 111
Query: 423 GLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYL 482
G+AY H +++HRD+K N+L++ E ++DFGLA+ T + +
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRA 168
Query: 483 APEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542
+ S + + D++S G + E+V G L + + +V
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 543 IDKRCADADMETVEAI-------------LEIAARCTDANPDDRPSMNQVLQ 581
+ D + E + +++ ++ +P+ R + Q L+
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 24/285 (8%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT-FAVKRIDR-SREGSDQVFERELEILGSIKHINLVNLRG 374
+G G +G V N A+K+I + Q RE++IL +H N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
R P + + YL + L++ + Q L + RGL Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHL-SNDHICYFLYQILRGLKYIHS---AN 129
Query: 435 IIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVT--TVVAGTFGYLAPEYLQSGRA 492
++HRD+K SN+LL+ + + DFGLA++ + H T T Y APE + + +
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 493 -TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADAD 551
T+ D++S G +L E+++ + LN + + + L +I+ + +
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 552 METV---------------EAILEIAARCTDANPDDRPSMNQVLQ 581
+ L++ + NP R + Q L
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 54/285 (18%), Positives = 103/285 (36%), Gaps = 31/285 (10%)
Query: 306 IIEKLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSI 364
II+ + + V+G G G V ++ FA+K + + RE+E+
Sbjct: 9 IIDDYKVTSQ--VLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRA 61
Query: 365 -KHINLVNLRGYCRLPATK----LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALG 419
+ ++V + L++ + L G L + + G+ Q +I
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKS 119
Query: 420 SARGLAYLHHDCCPKIIHRDIKSSNILLDENLEP---HVSDFGLAKLLVDEEAHVTTVVA 476
+ YLH I HRD+K N+L ++DFG AK + T
Sbjct: 120 IGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY- 175
Query: 477 GTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKE 536
T Y+APE L + + D++S GV++ L+ G P + + +
Sbjct: 176 -TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY------SNHGLAISPGMKTR 228
Query: 537 NRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
R+ +++ E + + P R ++ + +
Sbjct: 229 IRMGQYEFPNPEWSEVS--EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 2e-42
Identities = 54/288 (18%), Positives = 99/288 (34%), Gaps = 22/288 (7%)
Query: 310 LEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRI--DRSREGSDQVFERELEILGSIKH 366
+E + + +G G +G VY+ G A+K+I D EG RE+ +L + H
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
N+V L L++++L G + +GLA+
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG---IPLPLIKSYLFQLLQGLAF 117
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEY 486
H ++HRD+K N+L++ ++DFGLA+ T V +
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 487 LQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVV-------------GWMNTL 533
L + D++S G + E+VT + L + G +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ + + E + ++ +P+ R S L
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 3e-42
Identities = 43/282 (15%), Positives = 83/282 (29%), Gaps = 28/282 (9%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRG 374
+G G FG ++ A+K R + E + +
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVY 67
Query: 375 YCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPK 434
Y ++ L SL+D L G + + A + +H
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 435 IIHRDIKSSNILLDENLEPH-----VSDFGLAKLLVDEEAHV------TTVVAGTFGYLA 483
+++RDIK N L+ + V DFG+ K D ++GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 484 PEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543
+ + D+ + G + + + G P + E + +
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI----GEKKQSTPL 237
Query: 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585
+ CA E + + D P + + L +
Sbjct: 238 RELCAGFPEE----FYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 6e-42
Identities = 63/276 (22%), Positives = 109/276 (39%), Gaps = 32/276 (11%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV------FERELEILGSIKHINL 369
+ +GSG F V + G +A K I + R S + ERE+ IL I+H N+
Sbjct: 16 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 370 VNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH 429
+ L +LI + ++ G L DFL E L + G+ ++
Sbjct: 76 ITLHEVYENKTDVILILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGV---YY 128
Query: 430 DCCPKIIHRDIKSSNILLDENLEP----HVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
+I H D+K NI+L + P + DFGLA + + + + GT ++APE
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPE 186
Query: 486 YLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545
+ ++D++S GV+ L++G P + L V +N ++ +
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT--- 243
Query: 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ R +P R ++ LQ
Sbjct: 244 ---------SALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 150 bits (380), Expect = 2e-41
Identities = 59/267 (22%), Positives = 104/267 (38%), Gaps = 33/267 (12%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV---FERELEILGSIKHINLVNL 372
+G+G FG V+ + G +A+K + + + E +L + H ++ +
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
G + +I DY+ G L L + + ++ L L +
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL-------ALEYLHS 122
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
II+RD+K NILLD+N ++DFG AK + D T + GT Y+APE + +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIAPEVVSTKPY 178
Query: 493 TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN-RLEDVIDKRCADAD 551
+ D +SFG+L+ E++ G P N + +L R ++ D
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTP------FYDSNTMKTYEKILNAELRFPPFFNEDVKD-- 230
Query: 552 METVEAILEIAARCTDANPDDRPSMNQ 578
+ +R + R Q
Sbjct: 231 ---------LLSRLITRDLSQRLGNLQ 248
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 2e-41
Identities = 70/293 (23%), Positives = 116/293 (39%), Gaps = 33/293 (11%)
Query: 308 EKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRS-----REGSDQVFERELEIL 361
EKL+ +G G F TVY+ + A+K+I ++G ++ RE+++L
Sbjct: 1 EKLD------FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL 54
Query: 362 GSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA 421
+ H N++ L + L++D++ +L S L +
Sbjct: 55 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL----VLTPSHIKAYMLMTL 110
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
+GL YLH I+HRD+K +N+LLDEN ++DFGLAK T T Y
Sbjct: 111 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVVTRWY 166
Query: 482 LAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRP----TDPTFVKRGLNVVGW------- 529
APE L R D+++ G +L EL+ +D + R +G
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 226
Query: 530 -MNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
M +L + + +L++ NP R + Q L+
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-39
Identities = 64/314 (20%), Positives = 120/314 (38%), Gaps = 41/314 (13%)
Query: 299 MPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRI--DRSREGSDQVFE 355
+ P C+ + K E L + +G G FG V++ G A+K++ + +EG
Sbjct: 1 VECPFCDEVSKYEKLAK---IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL 57
Query: 356 RELEILGSIKHINLVNLRGYCRLPATK--------LLIYDYLSMGSLDDFLHEHGEGQQL 407
RE++IL +KH N+VNL CR A+ L++D+ + +
Sbjct: 58 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTL- 116
Query: 408 LNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467
+ R+ L L L++ KI+HRD+K++N+L+ + ++DFGLA+
Sbjct: 117 -SEIKRVMQML-----LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 170
Query: 468 EA---HVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRG 523
+ + T T Y PE L R D++ G ++ E+ T +
Sbjct: 171 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ 230
Query: 524 LNVVGWMNTLLKENRLEDVIDKRCAD----------------ADMETVEAILEIAARCTD 567
L ++ + + +V + + L++ +
Sbjct: 231 LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 290
Query: 568 ANPDDRPSMNQVLQ 581
+P R + L
Sbjct: 291 LDPAQRIDSDDALN 304
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-39
Identities = 61/294 (20%), Positives = 105/294 (35%), Gaps = 33/294 (11%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRI--DRSREGSDQVFERELEIL 361
E +EK+ G G +GTV++ + A+KR+ D EG RE+ +L
Sbjct: 5 EKLEKI---------GEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLL 55
Query: 362 GSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA 421
+KH N+V L L++++ F +G +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG-------DLDPEIVKSFLF 108
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
+ L L ++HRD+K N+L++ N E +++FGLA+ + V +
Sbjct: 109 QLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP-----TDPTFVKRGLNVVGWMN--TLL 534
+ + D++S G + EL RP +KR ++G
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 535 KENRLEDVIDKRCADADMETVEAILEIAA-------RCTDANPDDRPSMNQVLQ 581
+L D A V + ++ A NP R S + LQ
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 6e-39
Identities = 57/277 (20%), Positives = 97/277 (35%), Gaps = 42/277 (15%)
Query: 316 EDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV------FERELEILGSIK--H 366
++GSGGFG+VY + A+K +++ R E+ +L +
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
++ L + P + +LI + + L + +
Sbjct: 69 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRH 125
Query: 427 LHHDCCPKIIHRDIKSSNILLDEN-LEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPE 485
++HRDIK NIL+D N E + DFG LL D V T GT Y PE
Sbjct: 126 C---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPE 179
Query: 486 YLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544
+++ R + V+S G+LL ++V G P + + + +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE-----------HDEEIIRGQVFFRQRVS 228
Query: 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
C + C P DRP+ ++
Sbjct: 229 SECQH-----------LIRWCLALRPSDRPTFEEIQN 254
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 55/283 (19%), Positives = 100/283 (35%), Gaps = 24/283 (8%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV--FERELEILGSIKHINLVNLR 373
VGSG +G V V G A+K++ R + REL +L ++H N++ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83
Query: 374 GYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCP 433
T D+ + + L + +GL Y+H
Sbjct: 84 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGII 143
Query: 434 KIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRAT 493
HRD+K N+ ++E+ E + DFGLA+ ++ +T V + L R T
Sbjct: 144 ---HRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMRYT 197
Query: 494 EKSDVYSFGVLLLELVTGKRP---------------TDPTFVKRGLNVVGWMNTLLKENR 538
+ D++S G ++ E++TGK T + +
Sbjct: 198 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 257
Query: 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
L ++ K A + + + + + R + + L
Sbjct: 258 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 9e-37
Identities = 53/267 (19%), Positives = 98/267 (36%), Gaps = 30/267 (11%)
Query: 317 DVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV---FERELEILGSIKHINLVNL 372
++G G FG V + G +A+K + + + E +L + +H L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 373 RGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
+ + + +Y + G L L ++ A ++ L +
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYG---AEIVSALEYLHS 123
Query: 433 PKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA 492
+++RDIK N++LD++ ++DFGL K + + A + T GT YLAPE L+
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDY 182
Query: 493 TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN-RLEDVIDKRCADAD 551
D + GV++ E++ G+ P + +L E R +
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLP------FYNQDHERLFELILMEEIRFPRTLSPEAKS-- 234
Query: 552 METVEAILEIAARCTDANPDDRPSMNQ 578
+ A +P R
Sbjct: 235 ---------LLAGLLKKDPKQRLGGGP 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 6e-36
Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 16/246 (6%)
Query: 273 AVKRYTEVRKQVDQETSTKLITFHGDMPYPSCEIIEKLEALDEEDVVGSGGFGTVYRMVM 332
A + ++ V + + F PS +L+ D +G+G FG V +
Sbjct: 4 AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTA-QLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 333 NDCGT-FAVKRIDRSREGSDQV---FERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388
+ G +A+K +D+ + + E IL ++ LV L + + ++ +Y
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD 448
++ G + L G + A YLH +I+RD+K N+L+D
Sbjct: 123 VAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLID 175
Query: 449 ENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLEL 508
+ V+DFG AK T + GT LAPE + S + D ++ GVL+ E+
Sbjct: 176 QQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231
Query: 509 VTGKRP 514
G P
Sbjct: 232 AAGYPP 237
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 63/295 (21%), Positives = 108/295 (36%), Gaps = 27/295 (9%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQV--FERELEIL 361
E+ E+ + L VGSG +G+V G AVK++ R + REL +L
Sbjct: 15 EVPERYQNLS---PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 362 GSIKHINLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSA 421
+KH N++ L + D + L + Q L +
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 422 RGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGY 481
RGL Y+H HRD+K SN+ ++E+ E + DFGLA+ + +T VA +
Sbjct: 132 RGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYR 185
Query: 482 LAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP---------------TDPTFVKRGLNV 526
L + D++S G ++ EL+TG+ T L
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 527 VGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
+ + L + A+ + +++ + + D R + Q L
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-33
Identities = 66/273 (24%), Positives = 109/273 (39%), Gaps = 30/273 (10%)
Query: 317 DVVGSGGFGTVYR---MVMNDCGT-FAVKRIDRSREGSD----QVFERELEILGSIKHI- 367
V+G+G +G V+ + +D G +A+K + ++ + E ++L I+
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 368 NLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYL 427
LV L + LI DY++ G L L + ++ ++ + + L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVG----EIVLAL 142
Query: 428 HHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYL 487
H II+RDIK NILLD N ++DFGL+K V +E GT Y+AP+ +
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 488 QSGRA--TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545
+ G + + D +S GVL+ EL+TG P K + L E +
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-SRRILKSEPPYPQEMSA 261
Query: 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQ 578
D + R +P R
Sbjct: 262 LAKD-----------LIQRLLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 122 bits (307), Expect = 2e-31
Identities = 44/293 (15%), Positives = 104/293 (35%), Gaps = 43/293 (14%)
Query: 317 DVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRG 374
+G G + V+ + VK + ++ + +RE++IL +++ N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLAD 97
Query: 375 YCRLPATKL--LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCC 432
+ P ++ L++++++ L + L Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHS--- 147
Query: 433 PKIIHRDIKSSNILLD-ENLEPHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGR 491
I+HRD+K N+++D E+ + + D+GLA+ + + V + + PE L +
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQ 205
Query: 492 A-TEKSDVYSFGVLLLELVTGKRPTDPT----------------------FVKRGLNVVG 528
D++S G +L ++ K P K + +
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 529 WMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581
N +L + + ++ L+ + + R + + ++
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (300), Expect = 2e-30
Identities = 61/333 (18%), Positives = 113/333 (33%), Gaps = 57/333 (17%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQV--FERELEIL 361
++++ + L +GSG G V A+K++ R + REL ++
Sbjct: 14 TVLKRYQNLK---PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 362 GSIKHINLVNLRGYCRLPATK------LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLK 415
+ H N+++L T L+ + + E +
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSY 123
Query: 416 IALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHVTTVV 475
+ G+ +LH IHRD+K SNI++ + + DFGLA+ + + T
Sbjct: 124 LLYQMLCGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPY 178
Query: 476 AGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRP---------------TDPTFV 520
T Y APE + E D++S G ++ E+V K T
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238
Query: 521 KRGLNVVGWMNTLLKENR-----------LEDVIDKRCADADMETVEAILEIAARCTDAN 569
+ + ENR D + ++ + ++ ++ +
Sbjct: 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVID 298
Query: 570 PDDRPSMNQVLQ-------LLEQEVMSPCPSDF 595
P R S++ LQ EV +P P +
Sbjct: 299 PAKRISVDDALQHPYINVWYDPAEVEAPPPQIY 331
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (277), Expect = 3e-27
Identities = 63/351 (17%), Positives = 110/351 (31%), Gaps = 67/351 (19%)
Query: 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGT-FAVKRIDRSREGSDQVFERELEILGS 363
++ KL G G F TV+ T A+K + + ++ E E+++L
Sbjct: 16 ILVRKL---------GWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQR 65
Query: 364 IKHINLVNLRGYCRLPATKLLIYDYLSMGSL------------DDFLHEHGEGQQLLNWS 411
+ + KLL + + + + +
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 412 ARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEP-HVSDFGLAKL-LVDEEA 469
+I+ GL Y+H C IIH DIK N+L++ P ++ +A L
Sbjct: 126 YVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 183
Query: 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGW 529
T T Y +PE L +D++S L+ EL+TG +P
Sbjct: 184 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243
Query: 530 MNTL---------------------------------LKENRLEDVIDKRCADADMETVE 556
+ + LK LEDV+ ++ + E E
Sbjct: 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKE 303
Query: 557 AILEIAARCTDANPDDRPSMNQVLQ------LLEQEVMSPCPSDFYESHSD 601
+ + +P R ++ L E + + Y S SD
Sbjct: 304 IS-DFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSD 353
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 74.4 bits (182), Expect = 5e-16
Identities = 25/163 (15%), Positives = 48/163 (29%), Gaps = 21/163 (12%)
Query: 317 DVVGSGGFGTVYRMVMNDCGTFAVKRIDRS----------REGSDQVFERELEILGSIKH 366
++G G V+ G VK R+ D F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 367 INLVNLRGYCRLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAY 426
L L+G +Y + L + + + + + +A
Sbjct: 66 RALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 427 LHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469
+H I+H D+ N+L+ E + DF + + +E
Sbjct: 119 FYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW 157
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 76.3 bits (186), Expect = 9e-16
Identities = 50/162 (30%), Positives = 72/162 (44%), Gaps = 5/162 (3%)
Query: 28 EDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCH--THDQRVRSINLPYMQLGGI 85
+D LL+IK L + L T+ W G+ C T RV +++L + L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 86 --ISPSIGRLDKLQRLALHQN-SLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLL 142
I S+ L L L + +L G IP I T+L LY+ + G IP + +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 143 FLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
L LD S N+L G +P S+ L +L + N SG IPD
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPD 167
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.1 bits (175), Expect = 2e-14
Identities = 25/64 (39%), Positives = 33/64 (51%), Gaps = 1/64 (1%)
Query: 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQV 207
DL +N + G +P L +L LH LN+S N GEIP G L F ++ N LCG +
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309
Query: 208 HKPC 211
C
Sbjct: 310 -PAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.6 bits (140), Expect = 5e-10
Identities = 19/60 (31%), Positives = 26/60 (43%), Gaps = 1/60 (1%)
Query: 124 YLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP 183
LR N + G +P + L FL L++S N+L G IP G L + N P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.5 bits (132), Expect = 6e-09
Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 1/59 (1%)
Query: 101 LHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIP 159
L N ++G++P +T L +L + N L G IP GNL + ++N P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.6 bits (127), Expect = 3e-08
Identities = 14/78 (17%), Positives = 27/78 (34%), Gaps = 1/78 (1%)
Query: 58 CKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNC 117
+ + + ++L ++ G + + +L L L + N+L G IP + N
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNL 290
Query: 118 TELRALYLRANYLQGGIP 135
N G P
Sbjct: 291 QRFDVSAYANNKCLCGSP 308
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.1 bits (165), Expect = 7e-13
Identities = 26/150 (17%), Positives = 54/150 (36%), Gaps = 26/150 (17%)
Query: 47 LGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIIS------------------- 87
L N + + + + ++ + ++ + L Q+ I
Sbjct: 240 LTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED 299
Query: 88 -PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTI 146
I L L L L+ N++ P +++ T+L+ L+ N + +++ NL +
Sbjct: 300 ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW 355
Query: 147 LDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176
L N + P L LT + L L+
Sbjct: 356 LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 1e-12
Identities = 34/165 (20%), Positives = 56/165 (33%), Gaps = 33/165 (20%)
Query: 58 CKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIP------ 111
+ I + ++L Q+ + + L KL L L N + P
Sbjct: 229 NQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTA 286
Query: 112 --------------NEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGA 157
+ I+N L L L N + P + +L L L ++N +
Sbjct: 287 LTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD- 343
Query: 158 IPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDL 202
SSL LT++++L+ N S P N + I L L
Sbjct: 344 -VSSLANLTNINWLSAGHNQISDLTP-------LANLTRITQLGL 380
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 15/75 (20%), Positives = 25/75 (33%), Gaps = 7/75 (9%)
Query: 112 NEI---TNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHL 168
N+I T E L + + +L +T L +K + L +L
Sbjct: 13 NQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNL 68
Query: 169 HYLNLSTNFFSGEIP 183
+N S N + P
Sbjct: 69 TQINFSNNQLTDITP 83
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 24/128 (18%), Positives = 34/128 (26%), Gaps = 15/128 (11%)
Query: 58 CKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNC 117
C + C D + + + P LD L N + + N
Sbjct: 10 CHLRVVQCS--DLGLEKVPKD-------LPPDTALLD------LQNNKITEIKDGDFKNL 54
Query: 118 TELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNF 177
L L L N + P L+ L L LS N LK L L
Sbjct: 55 KNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
Query: 178 FSGEIPDF 185
+ +
Sbjct: 115 VRKSVFNG 122
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 43.9 bits (102), Expect = 3e-05
Identities = 28/181 (15%), Positives = 66/181 (36%), Gaps = 8/181 (4%)
Query: 2 KMHELVLILTVIFAATLFSSCCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWT 61
++ +T + + + + E G L+ N + + + T
Sbjct: 104 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163
Query: 62 GISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELR 121
I + ++L ++ + + S+ L+ L +L L NS+ + N LR
Sbjct: 164 TIPQGLPPS-LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLR 222
Query: 122 ALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKG------AIPSSLGRLTHLHYLNLST 175
L+L N L +P + + ++ ++ L +N++ P + ++L +
Sbjct: 223 ELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFS 281
Query: 176 N 176
N
Sbjct: 282 N 282
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 23/109 (21%), Positives = 37/109 (33%), Gaps = 5/109 (4%)
Query: 79 YMQLGGIISPSIGRLDKLQRLALHQNSLH--GSIPNEITNCTELRALYLRANYLQGGIPA 136
++ + L+++ + L N L G +L + + + IP
Sbjct: 109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ 167
Query: 137 NIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDF 185
G LT L L N + +SL L +L L LS N S
Sbjct: 168 --GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 214
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.5 bits (124), Expect = 7e-08
Identities = 19/125 (15%), Positives = 33/125 (26%), Gaps = 10/125 (8%)
Query: 48 GNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLH 107
+ + + + + I L+ L + N L
Sbjct: 238 DLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI 297
Query: 108 GSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTH 167
+P L L N+L +P NL L + N L+ P +
Sbjct: 298 -ELPALPPR---LERLIASFNHLAE-VPELPQNL---KQLHVEYNPLRE-FPDIPESVED 348
Query: 168 LHYLN 172
L +N
Sbjct: 349 L-RMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 3e-06
Identities = 25/148 (16%), Positives = 40/148 (27%), Gaps = 9/148 (6%)
Query: 38 SSLNDSRNLLGNWQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQ 97
L + + P ++ + + + L +L
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELP 263
Query: 98 RLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGA 157
+ N+ I + L L + N L +PA L L S N L
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-E 318
Query: 158 IPSSLGRLTHLHYLNLSTNFFSGEIPDF 185
+P L LH + N E PD
Sbjct: 319 VPELPQNLKQLH---VEYNPLR-EFPDI 342
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.1 bits (123), Expect = 7e-08
Identities = 27/126 (21%), Positives = 42/126 (33%)
Query: 58 CKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNC 117
+ G ++ + L L + + L L L LH N +
Sbjct: 117 LQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGL 176
Query: 118 TELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNF 177
L L L N + P +L L L L +N+L +L L L YL L+ N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
Query: 178 FSGEIP 183
+ +
Sbjct: 237 WVCDCR 242
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.5 bits (111), Expect = 2e-06
Identities = 30/148 (20%), Positives = 44/148 (29%), Gaps = 5/148 (3%)
Query: 65 CHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALY 124
R+ +++L L + L LQ L L N+L + + L L+
Sbjct: 100 TFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159
Query: 125 LRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
L N + L L L L N + P + L L L L N S +
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219
Query: 185 FGALSAFGNKSFIGNLDLCGRQVHKPCR 212
+ L L CR
Sbjct: 220 A-----LAPLRALQYLRLNDNPWVCDCR 242
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 25/161 (15%), Positives = 50/161 (31%), Gaps = 6/161 (3%)
Query: 22 CCLALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPCKWTGISCHTHD--QRVRSINLPY 79
AL + +++ +D+ LGN + + + + + L
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 80 MQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIG 139
++ + + L +L L L N+L + L+ L L N
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARP 245
Query: 140 NLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSG 180
+L SS+ + ++P L L+ N G
Sbjct: 246 LWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 3e-06
Identities = 16/62 (25%), Positives = 24/62 (38%), Gaps = 3/62 (4%)
Query: 113 EITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLN 172
E++ + L +P ++ TIL LS N L ++L T L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPKDT--TILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 173 LS 174
L
Sbjct: 62 LD 63
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 6e-05
Identities = 27/129 (20%), Positives = 43/129 (33%), Gaps = 1/129 (0%)
Query: 50 WQATEESPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGS 109
+ + +++ + +L + ++ L +LQ L L N L
Sbjct: 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTL 139
Query: 110 IPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLH 169
P +T +L L L N L + L L L L NSL IP L
Sbjct: 140 PPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLP 198
Query: 170 YLNLSTNFF 178
+ L N +
Sbjct: 199 FAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 11/65 (16%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 89 SIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILD 148
+ ++ + + +L ++P ++ + L+L N L A + LT L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 149 LSSNS 153
L
Sbjct: 62 LDRAE 66
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 4e-06
Identities = 16/102 (15%), Positives = 29/102 (28%), Gaps = 5/102 (4%)
Query: 119 ELRALYLRANYLQ-GGIPANIGNLLFLTILDLSSNSLKG----AIPSSLGRLTHLHYLNL 173
++++L ++ L + L ++ L L I S+L L LNL
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 174 STNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSM 215
+N I L L + +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVL 104
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 20/79 (25%), Positives = 30/79 (37%), Gaps = 9/79 (11%)
Query: 116 NCTELRALYLRANYLQGGIPANIGNLLF----LTILDLSSNSLKGAIPSSLGR-----LT 166
+ LR L+L + +++ L L LDLS+N L A L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 167 HLHYLNLSTNFFSGEIPDF 185
L L L ++S E+ D
Sbjct: 427 LLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 3e-04
Identities = 16/91 (17%), Positives = 32/91 (35%), Gaps = 10/91 (10%)
Query: 72 VRSINLPYMQLGGI-ISPSIGRLDKLQRLALHQNSLHG----SIPNEITNCTELRALYLR 126
++S+++ +L + + L + Q + L L I + + L L LR
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 127 ANYLQGGIPANIGNLLF-----LTILDLSSN 152
+N L + L + L L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 15/80 (18%), Positives = 22/80 (27%), Gaps = 9/80 (11%)
Query: 95 KLQRLALHQNSLHG----SIPNEITNCTELRALYLRANYLQGGIPANIGNLLF-----LT 145
L+ L L + S+ + LR L L N L + + L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 146 ILDLSSNSLKGAIPSSLGRL 165
L L + L L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 12/68 (17%), Positives = 21/68 (30%), Gaps = 4/68 (5%)
Query: 144 LTILDLSSNSLKG----AIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199
L +L L+ + ++ ++L L L+LS N S +
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 200 LDLCGRQV 207
L L
Sbjct: 431 LVLYDIYW 438
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.3 bits (103), Expect = 1e-05
Identities = 14/73 (19%), Positives = 28/73 (38%), Gaps = 4/73 (5%)
Query: 102 HQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSS 161
+ S + N ++L L N + P + +L L + L +N + P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212
Query: 162 LGRLTHLHYLNLS 174
L ++L + L+
Sbjct: 213 LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 4e-04
Identities = 15/95 (15%), Positives = 27/95 (28%), Gaps = 4/95 (4%)
Query: 56 SPCKWTGISCHTHDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEIT 115
+ L + L KL L N + P +
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192
Query: 116 NCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150
+ L ++L+ N + P + N L I+ L+
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 5e-05
Identities = 23/117 (19%), Positives = 33/117 (28%), Gaps = 26/117 (22%)
Query: 97 QRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFL------------ 144
+ L L L ++ + + L L N L+ P + L L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 145 ----------TILDLSSNSLKG-AIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSA 190
L L +N L+ A L L LNL N E L+
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.003
Identities = 26/125 (20%), Positives = 40/125 (32%), Gaps = 29/125 (23%)
Query: 121 RALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLH----------- 169
R L+L L + ++ LL +T LDLS N L+ P +L L L
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 170 -----------YLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCRTSMGFP 218
L L N A+ + + L+L G + +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQ----QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 113
Query: 219 AVLPH 223
+LP
Sbjct: 114 EMLPS 118
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 7e-05
Identities = 24/99 (24%), Positives = 37/99 (37%), Gaps = 3/99 (3%)
Query: 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQG--GIPANIGNLLFLT 145
P + + L ++S+ ++ N EL +L L N L + + + L
Sbjct: 36 PDLVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94
Query: 146 ILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD 184
IL+LS N LK + L L L N S D
Sbjct: 95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 9e-05
Identities = 21/111 (18%), Positives = 37/111 (33%), Gaps = 11/111 (9%)
Query: 102 HQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLF------LTILDLSSNSLK 155
+ ++ + + LR L L L A + + L L L N ++
Sbjct: 227 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286
Query: 156 GAIPSSL-----GRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLD 201
+L ++ L +L L+ N FS E + + G LD
Sbjct: 287 LDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELD 337
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 15/88 (17%), Positives = 36/88 (40%), Gaps = 3/88 (3%)
Query: 97 QRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKG 156
Q L L +LH + + + + A +++ + + + + +DLS++ ++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEH-FSPFRVQHMDLSNSVIEV 60
Query: 157 -AIPSSLGRLTHLHYLNLSTNFFSGEIP 183
+ L + + L L+L S I
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIV 88
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (89), Expect = 5e-04
Identities = 20/137 (14%), Positives = 40/137 (29%), Gaps = 7/137 (5%)
Query: 87 SPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTI 146
+ + + L L + I N + A+ N ++ L L
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKT 67
Query: 147 LDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQ 206
L +++N + L L L L+ N + + G L + + L +
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNS----LVELGDLDPLASLKSLTYLCILRNP 123
Query: 207 VHKPCRTSMGFPAVLPH 223
V + +P
Sbjct: 124 VTNKKHYRLYVIYKVPQ 140
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 8e-04
Identities = 12/78 (15%), Positives = 19/78 (24%)
Query: 97 QRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKG 156
L L++N + N L+ ILD+S +
Sbjct: 156 VILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215
Query: 157 AIPSSLGRLTHLHYLNLS 174
L L L +
Sbjct: 216 LPSYGLENLKKLRARSTY 233
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 36.7 bits (83), Expect = 0.004
Identities = 38/159 (23%), Positives = 58/159 (36%), Gaps = 14/159 (8%)
Query: 58 CKWTGISCHTHDQRVRSI------NLPYMQLGG------IISPSIGRLDKLQRLALHQNS 105
C+ T + C + ++ I + + L GRL L +L L +N
Sbjct: 8 CEGTTVDCT--GRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 106 LHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRL 165
L G PN + ++ L L N ++ L L L+L N + +P S L
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 166 THLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCG 204
L LNL++N F+ KS G CG
Sbjct: 126 NSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCG 164
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 603 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.71 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.69 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.67 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.63 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.62 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.62 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.58 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.57 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.42 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.4 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.38 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.35 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.34 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.32 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.31 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.31 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.3 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.28 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.26 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.19 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.15 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.13 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.88 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 98.84 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.61 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 98.58 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.44 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.4 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.37 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 98.28 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.19 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.09 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.09 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 97.91 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.71 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.7 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.31 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.16 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.09 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.52 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.48 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.31 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=410.61 Aligned_cols=256 Identities=27% Similarity=0.418 Sum_probs=200.8
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||+||+|.+.+++.||||++.... ...+.|.+|++++++++||||++++|++..++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4677889999999999999999988889999997544 345679999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++.... ..+++..++.++.|+++||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 999999987543 3388999999999999999999998 8999999999999999999999999999877655444
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCCc
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCADA 550 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 550 (603)
......||+.|+|||++.+..++.++|||||||++|||+|++.|+.... ............. ....
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~~~~~i~~~~---------~~~~ 223 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSEVVEDISTGF---------RLYK 223 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHHHHHHHHHTC---------CCCC
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHhcC---------CCCC
Confidence 4455678999999999999999999999999999999999655543221 1111111111111 1112
Q ss_pred CHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 551 DMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 551 ~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
+...+.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 2344567999999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=407.99 Aligned_cols=255 Identities=30% Similarity=0.451 Sum_probs=210.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.++|++.+.||+|+||+||+|.++++..||||+++.... ..+.|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 357888899999999999999999888899999976543 45679999999999999999999998754 5679999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++.... ...+++..++.++.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 90 ~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 90 ENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp TTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcc
Confidence 9999999876532 23389999999999999999999998 899999999999999999999999999998766554
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
.......||+.|+|||++.++.++.++|||||||++|||+||+.|+.... ............ ....
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-----~~~~~~~~i~~~---------~~~~ 230 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEVIQNLERG---------YRMV 230 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTT---------CCCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhc---------CCCC
Confidence 44555678999999999998899999999999999999999776654321 111111111111 1112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.+...+.++.+|+.+||+.+|++||||+|+++.|++
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 233455689999999999999999999999999986
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=404.70 Aligned_cols=246 Identities=28% Similarity=0.445 Sum_probs=207.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+++|++.+.||+|+||+||+|.+.. +..||+|++.+. .....+.+.+|++++++++||||+++++++.+++..|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 4678899999999999999999975 557999998542 233456789999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++...+. +++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 85 mEy~~~g~L~~~l~~~~~----l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EeecCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecC
Confidence 999999999999987544 89999999999999999999999 89999999999999999999999999998764
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .........
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~---------- 218 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISR---------- 218 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHT----------
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHc----------
Confidence 432 3456799999999999999999999999999999999999999975321 111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+...+.++.+++.+||+.||++|||++|+++
T Consensus 219 ~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 219 VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 111223345578999999999999999999999986
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=406.00 Aligned_cols=260 Identities=28% Similarity=0.450 Sum_probs=204.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||+||+|++++ .||||+++... ....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 3678999999999999999998654 69999986542 3345679999999999999999999998754 56899999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++..... .+++..+..++.|+++||+|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 y~~~g~L~~~l~~~~~---~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CCCEEEHHHHHHTSCC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred cCCCCCHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 9999999999975432 389999999999999999999998 8999999999999999999999999999876543
Q ss_pred Cc-ceeecccccccccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 468 EA-HVTTVVAGTFGYLAPEYLQS---GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 468 ~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
.. .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ............
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~------~~~~~~~~~~~~---- 227 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR------DQIIFMVGRGYL---- 227 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHHTSC----
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCC----
Confidence 22 23345679999999999864 35789999999999999999999999753211 111111111111
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
.+.....+...+.++.+++.+||+.||++|||++|+++.|+.+..
T Consensus 228 ~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 228 SPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp CCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111122233456789999999999999999999999999987653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=398.81 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=214.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLS 390 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 390 (603)
++|++.+.||+|+||+||+|+++++..||||+++.... ..+.|.+|+.++++++||||++++|++.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57899999999999999999998877899999976544 45679999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcc
Q 007455 391 MGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAH 470 (603)
Q Consensus 391 ~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~ 470 (603)
+|+|.+++..... .+++..+.+++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~~~---~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSGGG---CCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhcccc---CCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999998765432 388999999999999999999998 8999999999999999999999999999877665554
Q ss_pred eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 471 VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 471 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......||+.|+|||++.+..++.++||||||+++|||+| |+.||..... .......... ....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~------~~~~~~i~~~---------~~~~ 221 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN------SETAEHIAQG---------LRLY 221 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH------HHHHHHHHTT---------CCCC
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH------HHHHHHHHhC---------CCCC
Confidence 4555679999999999999999999999999999999998 7889865321 1111111111 1112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.+...+.++.+++.+||+.||++|||++|+++.|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 233455789999999999999999999999998865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-51 Score=405.17 Aligned_cols=249 Identities=22% Similarity=0.373 Sum_probs=209.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
++|++.+.||+|+||+||+|.+. ++..||||++........+.+.+|++++++++|||||++++++.+++..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46999999999999999999986 45679999997666566678999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999987653 289999999999999999999999 899999999999999999999999999987754332
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............. ...
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~~~~~~~~-------~~~ 237 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP------LRALYLIATNGTP-------ELQ 237 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHHCSC-------CCS
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH------HHHHHHHHhCCCC-------CCC
Confidence 23456799999999999999999999999999999999999999965321 1111111111110 011
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+...+.++.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22345578999999999999999999999985
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=403.95 Aligned_cols=252 Identities=27% Similarity=0.358 Sum_probs=203.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||+||+|.+.. +..||||++.... ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 3578899999999999999999874 5679999986543 2234568999999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++..... +++.++..++.|+++||+|||++ +|+||||||+|||+++++++||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~~~~----l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBTTTB----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred ccCCCcHHHHHhcCCC----CCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 9999999999976443 89999999999999999999999 8999999999999999999999999999876543
Q ss_pred Cc-ceeecccccccccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 468 EA-HVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 468 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... . ..+ ........
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~--~--~~~-~~~~~~~~------- 224 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--C--QEY-SDWKEKKT------- 224 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT--S--HHH-HHHHTTCT-------
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH--H--HHH-HHHhcCCC-------
Confidence 32 22345679999999999987776 57899999999999999999999653211 1 111 11111000
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+.++.+|+.+||+.||++|||++|+++
T Consensus 225 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01112234567899999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.7e-51 Score=410.34 Aligned_cols=258 Identities=26% Similarity=0.451 Sum_probs=199.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC----EEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+.|++.++||+|+||+||+|.+..++ .||||++...... ..+.|.+|++++++++|||||+++|++..++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45666789999999999999986433 4889988654333 345799999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++..... .+++.+++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~~~~---~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG---QFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeeccccC---CCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998876432 389999999999999999999998 89999999999999999999999999998765
Q ss_pred CCCcce----eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 466 DEEAHV----TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 466 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
...... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||..... ..........
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~------~~~~~~i~~~---- 249 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN------QDVINAIEQD---- 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTT----
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH------HHHHHHHHcC----
Confidence 433221 122457899999999999999999999999999999998 8999864321 1111111111
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
.....+...+.++.+|+.+||+.||++|||++|+++.|+++...
T Consensus 250 -----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 250 -----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -----CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 11223345567899999999999999999999999999887644
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-51 Score=407.05 Aligned_cols=259 Identities=29% Similarity=0.439 Sum_probs=215.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++|++.+.||+|+||+||+|.+.+ +..||||+++.... ..+++.+|++++++++|||||++++++.+++..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 4578888999999999999999875 45699999875543 456799999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++..... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 95 MTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 999999999876432 3489999999999999999999998 89999999999999999999999999999876655
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
........|++.|+|||++.+..++.++|||||||++|||++|+.|+.... ....... ..... ...
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-----~~~~~~~-~i~~~--------~~~ 235 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYE-LLEKD--------YRM 235 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHHH-HHHTT--------CCC
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-----hHHHHHH-HHhcC--------CCC
Confidence 555555668999999999999999999999999999999999887764321 1111111 11111 111
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhccc
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVM 588 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 588 (603)
..+...+.++.+|+.+||+.||++|||++|+++.|+.+..
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2233456789999999999999999999999999987643
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=406.24 Aligned_cols=255 Identities=23% Similarity=0.361 Sum_probs=196.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeec--CCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRL--PATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 385 (603)
++|++.+.||+|+||+||+|++.. +..||||.+...... ..+.+.+|++++++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 678899999999999999999875 567999999765433 23568899999999999999999999864 4567999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC--CPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
|||+++|+|.+++.........+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765444455999999999999999999999862 12499999999999999999999999999987
Q ss_pred cCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhh
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVI 543 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 543 (603)
...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....... ..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~------~~~~~~i-~~------- 228 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ------KELAGKI-RE------- 228 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHH-HH-------
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH------HHHHHHH-Hc-------
Confidence 754322 23456799999999999999999999999999999999999999975321 1111111 11
Q ss_pred cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 544 DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 544 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
......+...+.++.+|+.+||+.||++|||++|+++
T Consensus 229 -~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 -GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1112233345678999999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=401.98 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=205.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
+.|++.+.||+|+||+||+|.+.. +..||||++........+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 457888999999999999999875 4569999997766666677999999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++++||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999876532 2389999999999999999999999 89999999999999999999999999997653321
Q ss_pred ceeecccccccccCccccc-----cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 470 HVTTVVAGTFGYLAPEYLQ-----SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
.......||+.|+|||++. ...++.++||||+||++|||+||+.||...... . ..........
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~---~~~~i~~~~~------ 232 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---R---VLLKIAKSEP------ 232 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---G---HHHHHHHSCC------
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---H---HHHHHHcCCC------
Confidence 1223467999999999983 456789999999999999999999999754221 1 1111111110
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+...+.++.+|+.+||+.||++|||++|+++
T Consensus 233 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 233 -PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011122345678999999999999999999999976
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=398.73 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=205.2
Q ss_pred hCCCCCCe-eeecCCeEEEEEEECC---CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDV-VGSGGFGTVYRMVMND---CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~-ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
++|.+.+. ||+|+||+||+|.++. +..||||+++..... ..+.|.+|++++++++|||||+++|++.. +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45556664 9999999999998753 235999999765433 34679999999999999999999999865 568999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++.... ..+++..+..++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 mE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccc
Confidence 99999999999876532 2389999999999999999999998 89999999999999999999999999998876
Q ss_pred CCCcce--eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 466 DEEAHV--TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 466 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||..... ..+ .... ..+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~---~~~i-~~~----- 228 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEV---MAFI-EQG----- 228 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHH---HHHH-HTT-----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHH---HHHH-HcC-----
Confidence 543322 234568899999999998999999999999999999998 8999875321 111 1111 111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
..+..+...+.++.+|+.+||+.+|++|||+.++++.|+..
T Consensus 229 ---~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 229 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11223345567899999999999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-50 Score=398.63 Aligned_cols=259 Identities=26% Similarity=0.439 Sum_probs=202.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-----EEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
+.|+..++||+|+||.||+|.++.+. .||||++...... ....|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 45677889999999999999976532 5999999654333 33468999999999999999999999999999999
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
||||+.+|++.+++..... .+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~~~~---~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG---EFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT---CSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhcccc---cccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999988775432 389999999999999999999998 8999999999999999999999999999876
Q ss_pred CCCCcc--eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAH--VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
...... ......||+.|+|||++.++.++.++|||||||++|||++|+.|+.... ..........
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-----~~~~~~~~i~-------- 227 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNHEVMKAIN-------- 227 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHHHHH--------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-----CHHHHHHHHh--------
Confidence 543222 2334568999999999999999999999999999999999777654321 1111111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
+...+..+...+.++.+|+.+||+.+|++||||+||++.|+++...
T Consensus 228 -~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 228 -DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp -TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred -ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111223344567899999999999999999999999999887644
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=398.13 Aligned_cols=257 Identities=30% Similarity=0.453 Sum_probs=205.2
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.++|++.+.||+|+||.||+|+++++.+||||+++... ...+.|.+|+.++++++|||||++++++. .+..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEec
Confidence 36788999999999999999999998899999997554 34567999999999999999999999985 46789999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++..... ..+++.+++.++.||++||+|||++ +|+||||||+|||+|.++++||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCc
Confidence 99999998876422 2389999999999999999999999 899999999999999999999999999987755444
Q ss_pred ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCCC
Q 007455 470 HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCAD 549 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 549 (603)
.......||+.|+|||++..+.++.++||||||+++|||++|+.|+.... ............ ....
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-----~~~~~~~~i~~~---------~~~~ 234 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNREVLDQVERG---------YRMP 234 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHTT---------CCCC
T ss_pred eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-----CHHHHHHHHHhc---------CCCC
Confidence 44445678999999999999999999999999999999999877764321 111111111111 1112
Q ss_pred cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 550 ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 550 ~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.+...+.++.+++.+||+.||++|||+++|+++|++..
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 33345678999999999999999999999999998854
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=402.02 Aligned_cols=248 Identities=23% Similarity=0.343 Sum_probs=204.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 386 (603)
++|++.+.||+|+||+||+|.+. ++..||||++... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57899999999999999999986 4567999998642 2334467899999999999999999999999999999999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~ 466 (603)
||+++|+|.+++...+. +++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGS----FDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhccCC----CCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999887654 89999999999999999999999 899999999999999999999999999987754
Q ss_pred CCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 467 EEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 467 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .........
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~---------- 224 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------YLIFQKIIK---------- 224 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHT----------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH------HHHHHHHHc----------
Confidence 332 233456799999999999999999999999999999999999999975321 111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+...+.++.+|+.+||+.||++|||++|+++
T Consensus 225 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 225 LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp TCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 111223345678999999999999999999998743
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=394.23 Aligned_cols=246 Identities=24% Similarity=0.384 Sum_probs=198.2
Q ss_pred CeeeecCCeEEEEEEECCC---CEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEecCC
Q 007455 317 DVVGSGGFGTVYRMVMNDC---GTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYLSM 391 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 391 (603)
++||+|+||+||+|.+.++ +.||||+++.... ...+.+.+|++++++++|||||++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 4699999999999987532 3599999965432 234579999999999999999999999865 567899999999
Q ss_pred CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCcce
Q 007455 392 GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEAHV 471 (603)
Q Consensus 392 gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~~~ 471 (603)
|+|.+++..... +++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~~----l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQNRH----VKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHCTT----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhccC----CCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999986543 89999999999999999999998 89999999999999999999999999998765443322
Q ss_pred --eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccCC
Q 007455 472 --TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRCA 548 (603)
Q Consensus 472 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 548 (603)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||..... ...... +... ...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~------~~~~~~-i~~~--------~~~ 229 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG------SEVTAM-LEKG--------ERM 229 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH------HHHHHH-HHTT--------CCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH------HHHHHH-HHcC--------CCC
Confidence 234568999999999999999999999999999999998 8999865321 111111 1111 112
Q ss_pred CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 549 DADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 549 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
..+...+.++.+|+.+||+.||++|||+++|++.|+.
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 2334456789999999999999999999999998876
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-50 Score=405.20 Aligned_cols=267 Identities=24% Similarity=0.375 Sum_probs=205.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.++|++.+.||+|+||+||+|.+..+ ..||+|+++... ......+.+|+.++++++|||||+++++|.++++.|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 36788999999999999999998754 569999986543 3345678999999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+++|+|.+++.+.+. +++..+..++.|++.||.|||+.. +|+||||||+|||++.++++||+|||+|+...+.
T Consensus 85 y~~gg~L~~~l~~~~~----l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcCC----CCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999987543 899999999999999999999732 7999999999999999999999999999876432
Q ss_pred CcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCc-----cHh----------HHHHH
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGL-----NVV----------GWMNT 532 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~-----~~~----------~~~~~ 532 (603)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+....... ... .+...
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 223467999999999999999999999999999999999999999753211000 000 00000
Q ss_pred Hh--------hhCcchhh----hcccCCC-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 007455 533 LL--------KENRLEDV----IDKRCAD-ADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQ 585 (603)
Q Consensus 533 ~~--------~~~~~~~~----~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~ 585 (603)
.. ......+. .....+. .....+.++.+++.+||+.||++|||++|+++ .+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 00 00000000 0000000 11123467999999999999999999999987 4443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-49 Score=390.57 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=194.8
Q ss_pred CCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeec----CCccEEEE
Q 007455 314 DEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRL----PATKLLIY 386 (603)
Q Consensus 314 ~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 386 (603)
++.++||+|+||+||+|.+.. +..||+|++..... ...+.+.+|++++++++|||||++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 445689999999999999875 45799999865432 234568999999999999999999999864 34578999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC-CCCCeEEeecccccccC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD-ENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~-~~~~~kl~DfG~~~~~~ 465 (603)
||+++|+|.+++..... +++..+..++.||++||+|||++. ++|+||||||+|||++ +++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~~~~----~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcccc----ccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999987543 899999999999999999999981 1399999999999996 57899999999998643
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.... ........... .....
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-----~~~~~~~~i~~-~~~~~---- 232 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-----NAAQIYRRVTS-GVKPA---- 232 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-----SHHHHHHHHTT-TCCCG----
T ss_pred CC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-----cHHHHHHHHHc-CCCCc----
Confidence 32 2345679999999999875 69999999999999999999999996421 11111111111 11000
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
..+...+.++.+++.+||+.||++|||++|+++
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111223457899999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=400.64 Aligned_cols=258 Identities=29% Similarity=0.472 Sum_probs=207.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC------EEEEEEeCCCC-CChHHHHHHHHHHHhhC-CCCeeeecceeeecCCcc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG------TFAVKRIDRSR-EGSDQVFERELEILGSI-KHINLVNLRGYCRLPATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~------~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 382 (603)
++|++.+.||+|+||+||+|++.... .||+|.+.... ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 57888999999999999999975432 58999986532 33445789999999998 899999999999999999
Q ss_pred EEEEEecCCCCccccccccCC-------------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCC
Q 007455 383 LLIYDYLSMGSLDDFLHEHGE-------------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSS 443 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~ 443 (603)
++||||+++|+|.++++.... ....+++..++.++.|+++||+|||++ +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999976432 123489999999999999999999998 8999999999
Q ss_pred CeEECCCCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCccccc
Q 007455 444 NILLDENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVK 521 (603)
Q Consensus 444 NIll~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~ 521 (603)
|||++.++.+||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999876554332 2334668999999999999999999999999999999998 89998653211
Q ss_pred CCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 522 RGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 522 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
.. ........ .....+...+.++.+|+.+||+.||++|||++||++.|..
T Consensus 274 --~~----~~~~~~~~--------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 274 --AN----FYKLIQNG--------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp --HH----HHHHHHTT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --HH----HHHHHhcC--------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 01 11111111 0112233456789999999999999999999999999853
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-49 Score=397.72 Aligned_cols=250 Identities=28% Similarity=0.374 Sum_probs=189.7
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+.|++.+.||+|+||+||+|.+.. ++.||||++.... ......+.+|++++++++|||||++++++.+++..|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 468889999999999999999875 5679999986543 23345688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC---CCCCeEEeecccccccC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD---ENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~---~~~~~kl~DfG~~~~~~ 465 (603)
++||+|.+++...+. +++..+..++.|++.||+|||++ +|+||||||+||+++ +++.+||+|||+++...
T Consensus 89 ~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 89 VSGGELFDRIVEKGF----YTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCSCBHHHHHHTCSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred cCCCcHHHhhhcccC----CCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999976543 99999999999999999999999 899999999999994 57899999999998764
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .......... ..
T Consensus 162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~-~~----- 227 (307)
T d1a06a_ 162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAE-YE----- 227 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTC-CC-----
T ss_pred CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccC-CC-----
Confidence 432 234467999999999999999999999999999999999999999753211 1111111111 00
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.........+.++.+|+.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 001112244567999999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-48 Score=398.54 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=208.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
+++|++.+.||+|+||.||+|.+.. +..||||++........+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5689999999999999999999875 456999999776655667799999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC--CCCeEEeecccccccCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE--NLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~--~~~~kl~DfG~~~~~~~ 466 (603)
+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||+++.+..
T Consensus 105 ~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999999986432 2389999999999999999999999 8999999999999964 67899999999988754
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............ . .
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~-~--~--- 244 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND------DETLRNVKSCDW-N--M--- 244 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCC-C--S---
T ss_pred ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCC-C--C---
Confidence 433 3456799999999999999999999999999999999999999975321 111111111110 0 0
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+.++.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111234567999999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-49 Score=395.52 Aligned_cols=244 Identities=27% Similarity=0.377 Sum_probs=199.9
Q ss_pred CCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCCCCCh---HHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRSREGS---DQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
.|+..+.||+|+||+||+|++..+ ..||||++....... .+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488889999999999999998754 459999997654333 2468899999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+.+|+|..++.... .+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~~----~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 999999987665543 389999999999999999999999 8999999999999999999999999999865432
Q ss_pred CcceeecccccccccCcccccc---CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQS---GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
....||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... ............
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~------~~~~~~i~~~~~------ 231 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES------ 231 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC------
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCC------
Confidence 34569999999999853 4588999999999999999999999864321 111111111110
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+...+.++.+|+.+||+.||++|||++|+++
T Consensus 232 --~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 --PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 00112234568999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=388.68 Aligned_cols=255 Identities=22% Similarity=0.363 Sum_probs=196.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC----CEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC----GTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
++|++.+.||+|+||.||+|.+..+ ..||||.++..... ..+.+.+|++++++++||||+++++++. .+..++|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence 5788899999999999999987643 24889988654333 3456899999999999999999999985 4678999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++.... ..+++..++.++.||++||+|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 86 ~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheecc
Confidence 99999999999876543 2389999999999999999999999 89999999999999999999999999998776
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVID 544 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 544 (603)
...........||+.|+|||++.+..++.++|||||||++|||++ |..||...... .+. .....
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~---~~i~~--------- 224 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVI---GRIEN--------- 224 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHH---HHHHT---------
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH---HHH---HHHHc---------
Confidence 555445556678999999999999999999999999999999998 88888654221 111 11111
Q ss_pred ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 545 KRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 545 ~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
......+...+.++.+|+.+||+.||++|||++||++.|+.+.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 225 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1111233445678999999999999999999999999888653
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-48 Score=397.57 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=208.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.+.|++.+.||+|+||.||+|.+. .+..||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457899999999999999999986 4567999999766555566789999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC--CCCCeEEeecccccccCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD--ENLEPHVSDFGLAKLLVD 466 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~--~~~~~kl~DfG~~~~~~~ 466 (603)
+++|+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+++.+..
T Consensus 108 ~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999998776543 2389999999999999999999998 899999999999998 578999999999988765
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
... .....||+.|+|||++.+..++.++||||+||++|||+||+.||..... ........... .. .
T Consensus 182 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~-~~-----~ 247 (352)
T d1koba_ 182 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD------LETLQNVKRCD-WE-----F 247 (352)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH------HHHHHHHHHCC-CC-----C
T ss_pred CCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCC-CC-----C
Confidence 432 3446699999999999999999999999999999999999999975321 11111111111 00 0
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
........+.++.+|+.+||+.||++|||++|+++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01122345567999999999999999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=394.75 Aligned_cols=248 Identities=21% Similarity=0.287 Sum_probs=208.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+++|++.+.||+|+||.||+|++. .+..||||++.+. .....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 467999999999999999999986 4567999999643 233456788999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~~~~----~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eeccCCCchhhhhhcccC----CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccc
Confidence 999999999999987654 89999999999999999999999 89999999999999999999999999998764
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........ .
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~------~~~~~~i~----------~ 219 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH------ERLFELIL----------M 219 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH----------H
T ss_pred cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH------HHHHHHHh----------c
Confidence 4322 33456799999999999999999999999999999999999999975421 11111111 1
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
.....+...+.++.+|+.+||+.||++||+ ++|+++
T Consensus 220 ~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 220 EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 112233445678999999999999999995 888875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=384.79 Aligned_cols=249 Identities=27% Similarity=0.331 Sum_probs=204.5
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCC------CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSR------EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
+.|++.+.||+|+||+||+|.+. ++..||||++.+.. ....+.+.+|++++++++|||||++++++.+++..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56899999999999999999986 45679999985432 123467999999999999999999999999999999
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC----CeEEeecc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL----EPHVSDFG 459 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~----~~kl~DfG 459 (603)
+||||+++|+|.+++...+. +++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+|++|||
T Consensus 90 iv~E~~~gg~L~~~i~~~~~----l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKES----LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhccccc----cchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999987543 89999999999999999999999 899999999999998876 49999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC-c
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN-R 538 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 538 (603)
+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........... .
T Consensus 163 ~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 163 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------QETLANVSAVNYE 234 (293)
T ss_dssp TCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHTTCCC
T ss_pred hhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH------HHHHHHHHhcCCC
Confidence 9987654332 3445689999999999998999999999999999999999999975321 11111111110 0
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... .+...+.++.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 FEDE-------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CCHH-------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCch-------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 11123467899999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-48 Score=390.81 Aligned_cols=260 Identities=25% Similarity=0.424 Sum_probs=209.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCCC-hHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSREG-SDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.++|++.+.||+|+||+||+|++++ +..||||+++..... ..++|.+|++++++++||||+++++++...+..
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 4578999999999999999998753 346999998754333 345799999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccCC--------------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 007455 383 LLIYDYLSMGSLDDFLHEHGE--------------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKS 442 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 442 (603)
++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ ++|||||||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp 168 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLAT 168 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcc
Confidence 999999999999999865321 123488999999999999999999998 899999999
Q ss_pred CCeEECCCCCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCC-CCCcccc
Q 007455 443 SNILLDENLEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKR-PTDPTFV 520 (603)
Q Consensus 443 ~NIll~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~-p~~~~~~ 520 (603)
+|||+|.++.+||+|||+++....... .......|++.|+|||.+.+..++.++|||||||++|||++|.. ||....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~- 247 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA- 247 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-
T ss_pred cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC-
Confidence 999999999999999999987644332 23345678899999999999999999999999999999999964 565321
Q ss_pred cCCccHhHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 521 KRGLNVVGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 521 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
..+...... +...+..+...+.++.+|+.+||+.+|++||||.||+++|+++.
T Consensus 248 -----~~e~~~~v~---------~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 248 -----HEEVIYYVR---------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -----HHHHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -----HHHHHHHHH---------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111111111 11122233445568999999999999999999999999999863
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=382.15 Aligned_cols=251 Identities=30% Similarity=0.437 Sum_probs=198.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeec-CCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRL-PATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 388 (603)
.++|++.+.||+|+||.||+|.++ +..||||+++.. ...+.+.+|++++++++||||++++|++.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 356788899999999999999996 468999999654 344679999999999999999999999855 4668999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+++|+|.+++.... ...+++..+++++.||+.||.|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 99999999997642 23489999999999999999999998 8999999999999999999999999999865432
Q ss_pred cceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhhhcccC
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKRC 547 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 547 (603)
.....++..|+|||++.+..++.++||||||+++|||+| |+.||..... ..+..+ ... ...
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~---i~~---------~~~ 218 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPR---VEK---------GYK 218 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHH---HTT---------TCC
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH---HHHHHH---HHc---------CCC
Confidence 233457889999999998999999999999999999998 6777654321 111111 111 111
Q ss_pred CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 548 ADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 548 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
+..+...+.++.+++.+||+.||++||||.|+++.|+++.
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 2233345568999999999999999999999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.3e-48 Score=388.43 Aligned_cols=245 Identities=25% Similarity=0.351 Sum_probs=205.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+++|++.+.||+|+||+||+|+++. +..||||+++.. .....+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 4678999999999999999999864 567999998642 233456789999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||++||+|..++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+++...
T Consensus 83 mE~~~gg~l~~~~~~~~~----~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQR----FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp ECCCCSCBHHHHHHHTSS----CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eeecCCcccccccccccc----ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEec
Confidence 999999999999887554 78889999999999999999999 89999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. .....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ..........
T Consensus 156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~~~--------- 216 (316)
T d1fota_ 156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------MKTYEKILNA--------- 216 (316)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHC---------
T ss_pred cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH------HHHHHHHHcC---------
Confidence 43 2346799999999999999999999999999999999999999975321 1111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
....+...+.++.+++.+||..||.+|+ |++|+++
T Consensus 217 -~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 217 -ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1122334456799999999999999996 8999985
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=389.64 Aligned_cols=255 Identities=26% Similarity=0.418 Sum_probs=202.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCC-----EEEEEEeCCC-CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCG-----TFAVKRIDRS-REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~-----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 384 (603)
.+|++.++||+|+||+||+|.+..++ +||+|+++.. .....+.+.+|++++++++|||||+++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46888999999999999999986543 4899988643 334567799999999999999999999999864 5678
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
++||+.+|+|.+++.... ..+++..++.++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999887643 2389999999999999999999998 8999999999999999999999999999887
Q ss_pred CCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcchhh
Q 007455 465 VDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLEDV 542 (603)
Q Consensus 465 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 542 (603)
...... ......||+.|+|||++.++.++.++|||||||++|||+| |..||+..... .+. ......
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~---~~i~~~------ 229 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EIS---SILEKG------ 229 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHH---HHHHHT------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHH---HHHHcC------
Confidence 554333 2334568999999999999999999999999999999999 78887643211 111 111111
Q ss_pred hcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 543 IDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 543 ~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.....+...+.++.+|+.+||+.||++|||++|+++.|+.+.
T Consensus 230 ---~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 230 ---ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp ---CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 111223345678999999999999999999999999887653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-47 Score=381.76 Aligned_cols=254 Identities=29% Similarity=0.457 Sum_probs=202.8
Q ss_pred CCeeeecCCeEEEEEEECCCC----EEEEEEeCCCC-CChHHHHHHHHHHHhhCCCCeeeecceeeec-CCccEEEEEec
Q 007455 316 EDVVGSGGFGTVYRMVMNDCG----TFAVKRIDRSR-EGSDQVFERELEILGSIKHINLVNLRGYCRL-PATKLLIYDYL 389 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 389 (603)
.++||+|+||+||+|.+.++. .||||+++... ....++|.+|++++++++||||++++|++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 468999999999999986432 48999997543 3334679999999999999999999999865 56789999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
++|+|.+++..... ..++..+++++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~~~~---~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTTC---CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhccccc---cchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999876433 377889999999999999999998 899999999999999999999999999987654332
Q ss_pred c---eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhccc
Q 007455 470 H---VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDKR 546 (603)
Q Consensus 470 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 546 (603)
. ......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .. +........
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~---~~~~i~~g~--------- 251 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FD---ITVYLLQGR--------- 251 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTC---------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HH---HHHHHHcCC---------
Confidence 2 223356899999999999999999999999999999999998887653211 11 111111111
Q ss_pred CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcccC
Q 007455 547 CADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEVMS 589 (603)
Q Consensus 547 ~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 589 (603)
.+..+...+.++.+|+.+||+.||++||||+||++.|+++.-.
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1122234456799999999999999999999999999987643
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=384.76 Aligned_cols=258 Identities=29% Similarity=0.447 Sum_probs=205.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC---EEEEEEeCCC-CCChHHHHHHHHHHHhhC-CCCeeeecceeeecCCccEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG---TFAVKRIDRS-REGSDQVFERELEILGSI-KHINLVNLRGYCRLPATKLL 384 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 384 (603)
.++|++.+.||+|+||+||+|++++++ .||||++... .....+.+.+|+++++++ +|||||++++++.+++..++
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 368888999999999999999987654 3788887543 233445699999999998 79999999999999999999
Q ss_pred EEEecCCCCccccccccC------------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC
Q 007455 385 IYDYLSMGSLDDFLHEHG------------EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE 452 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~ 452 (603)
||||+++|+|.++++... .....+++..+..++.||++||.|+|++ +|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence 999999999999997642 2234589999999999999999999999 8999999999999999999
Q ss_pred eEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCC-CCCcccccCCccHhHHHH
Q 007455 453 PHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKR-PTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 453 ~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~-p~~~~~~~~~~~~~~~~~ 531 (603)
+||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ......
T Consensus 166 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~------~~~~~~ 237 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT------CAELYE 237 (309)
T ss_dssp EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC------HHHHHH
T ss_pred eEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC------HHHHHH
Confidence 9999999997654322 1234568999999999999999999999999999999999775 554321 111111
Q ss_pred HHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 532 TLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 532 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
.... ...+..+...+.++.+|+.+||+.||++||||+|+++.|+++.
T Consensus 238 ~i~~---------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 238 KLPQ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp HGGG---------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHh---------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1111 1112233445678999999999999999999999999988765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-47 Score=390.19 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=206.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC---CCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEE
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS---REGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 385 (603)
+++|++.+.||+|+||.||+|.++ ++..||||++... .....+.+.+|+++++.++||||+++++++......++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 468999999999999999999986 4567999998542 223345688999999999999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+.+|+|.+++...+. +++..+..++.||+.||.|||++ +||||||||+|||++.+|.+||+|||+++...
T Consensus 120 ~e~~~~g~l~~~l~~~~~----l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EECCTTCBHHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cccccccchhhhHhhcCC----CCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999999987654 89999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.. .....||+.|+|||++.+..++.++||||+||++|||+||+.||.... ..........
T Consensus 193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~------~~~~~~~i~~---------- 252 (350)
T d1rdqe_ 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ------PIQIYEKIVS---------- 252 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS------HHHHHHHHHH----------
T ss_pred cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC------HHHHHHHHhc----------
Confidence 43 234679999999999999999999999999999999999999997532 1111111111
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCC-----CCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDR-----PSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~R-----Ps~~evl~ 581 (603)
.....+...+.++.+++.+||..||.+| ||++|+++
T Consensus 253 ~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 253 GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1112233456789999999999999999 48999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=379.24 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=196.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC----CEEEEEEeCCCC---CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC----GTFAVKRIDRSR---EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKL 383 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~----~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 383 (603)
++|++.+.||+|+||.||+|.+... ..||||++.... ....+.|.+|++++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5688889999999999999986432 258999886542 2234578999999999999999999999965 4678
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
+||||+++|++.+++..... .+++..++.++.|+++||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~~---~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG---GSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcccC---CCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998876432 389999999999999999999998 899999999999999999999999999998
Q ss_pred cCCCCcce--eecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 464 LVDEEAHV--TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 464 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
........ .....|+..|+|||++.+..++.++||||||+++|||+| |+.||..... ...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~------~~~~~~i~~~~--- 231 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG------SQILHKIDKEG--- 231 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHHHHTSC---
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH------HHHHHHHHhCC---
Confidence 75543322 233557889999999999999999999999999999998 8999864321 11111111111
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQ 585 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~ 585 (603)
..+..+...+.++.+++.+||+.||++||||+||++.|++
T Consensus 232 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 232 -----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1112233445679999999999999999999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.4e-46 Score=372.93 Aligned_cols=257 Identities=23% Similarity=0.360 Sum_probs=200.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCCh---HHHHHHHHHHHhhCCCCeeeecceeeecCCc----c
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGS---DQVFERELEILGSIKHINLVNLRGYCRLPAT----K 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~ 382 (603)
++|++.+.||+|+||+||+|.+.. ++.||||+++...... ...+.+|+++++.++||||+++++++...+. .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 568899999999999999999864 5569999997644332 3468999999999999999999999876543 7
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|+||||++||+|.+++...+. +++.++..++.|+++||+|||++ +|+||||||+|||++.++..+++|||.+.
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~----l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEECCCCCEehhhhcccCC----CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 899999999999998877544 89999999999999999999998 89999999999999999999999999987
Q ss_pred ccCCCCc--ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch
Q 007455 463 LLVDEEA--HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE 540 (603)
Q Consensus 463 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 540 (603)
....... .......||+.|+|||++.+..++.++||||+||++|||+||+.||..... ..............
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC
Confidence 6543222 233456799999999999998999999999999999999999999975321 11122222221111
Q ss_pred hhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhc
Q 007455 541 DVIDKRCADADMETVEAILEIAARCTDANPDDRP-SMNQVLQLLEQE 586 (603)
Q Consensus 541 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-s~~evl~~L~~~ 586 (603)
.. ......+.++.+++.+||+.||++|| |++++++.|.+.
T Consensus 234 ~~------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 234 PS------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp GG------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred Cc------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 00 01123456799999999999999998 899999988764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=381.38 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=204.6
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCCC-EEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDCG-TFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
.++|++.+.||+|+||+||+|.+..++ .||||.++... .....+.+|+++++.++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467899999999999999999998544 69999997543 3345688999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC--CCeEEeecccccccCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN--LEPHVSDFGLAKLLVD 466 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~--~~~kl~DfG~~~~~~~ 466 (603)
++||+|.+++...+ ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999997643 2389999999999999999999998 89999999999999854 4799999999987644
Q ss_pred CCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC-cchhhhcc
Q 007455 467 EEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN-RLEDVIDK 545 (603)
Q Consensus 467 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 545 (603)
.. ......+|+.|+|||...+..++.++||||+||++|||++|+.||..... ........... .....
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~------~~~~~~i~~~~~~~~~~--- 225 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN------QQIIENIMNAEYTFDEE--- 225 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHHTCCCCCHH---
T ss_pred CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCCCCChh---
Confidence 33 23445689999999999999999999999999999999999999975421 11111111111 00000
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.....+.++.+|+.+||..||++|||++|+++
T Consensus 226 ----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 ----AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00123467899999999999999999999987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=386.41 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=202.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC-CEEEEEEeCCC---CCChHHHHHHHHHHHh-hCCCCeeeecceeeecCCccEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC-GTFAVKRIDRS---REGSDQVFERELEILG-SIKHINLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 385 (603)
++|++.+.||+|+||+||+|.+..+ +.||||++++. .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 6788999999999999999999754 45999999643 2233345667777665 68999999999999999999999
Q ss_pred EEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccC
Q 007455 386 YDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLV 465 (603)
Q Consensus 386 ~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~ 465 (603)
|||+++|+|.+++..... +++.++..++.||+.||+|||++ +|+||||||+|||++.++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~~~----~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK----FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhccCC----CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999987554 88999999999999999999999 89999999999999999999999999998665
Q ss_pred CCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchhhhcc
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLEDVIDK 545 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 545 (603)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...... . .
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i-~---------~ 217 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSI-R---------M 217 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH-H---------H
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHH-H---------c
Confidence 4332 234467999999999999999999999999999999999999999753211 111111 1 1
Q ss_pred cCCCcCHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 007455 546 RCADADMETVEAILEIAARCTDANPDDRPSMN-QVL 580 (603)
Q Consensus 546 ~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-evl 580 (603)
..+..+...+.++.+|+.+||+.||++|||+. |++
T Consensus 218 ~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 218 DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 11223334567799999999999999999995 675
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-47 Score=383.05 Aligned_cols=261 Identities=27% Similarity=0.407 Sum_probs=197.4
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECCC------CEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecC-C
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMNDC------GTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLP-A 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~~------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 380 (603)
.++|++.+.||+|+||.||+|.+... +.||||+++..... ..+.+.+|..++.++ +|+||+++++++..+ .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 36789999999999999999997532 36999998654332 345678888888877 689999999988654 4
Q ss_pred ccEEEEEecCCCCccccccccCC------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGE------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD 448 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 448 (603)
..++||||+++|+|.++++.... ....+++.+++.++.||++||+|||++ +|+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeEC
Confidence 68999999999999999975432 123488999999999999999999998 899999999999999
Q ss_pred CCCCeEEeecccccccCCCCcc-eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCC-CCCCcccccCCccH
Q 007455 449 ENLEPHVSDFGLAKLLVDEEAH-VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGK-RPTDPTFVKRGLNV 526 (603)
Q Consensus 449 ~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~-~p~~~~~~~~~~~~ 526 (603)
.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+||. .||.....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~------ 242 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------ 242 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC------
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH------
Confidence 9999999999999876543332 234467999999999999999999999999999999999975 46643211
Q ss_pred hHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 527 VGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
........... ..+..+...+.++.+++.+||+.||++|||++|+++.|+++.
T Consensus 243 ~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 243 DEEFCRRLKEG--------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp SHHHHHHHHHT--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcC--------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11111111111 111223344567999999999999999999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5e-47 Score=374.54 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=203.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC---------hHHHHHHHHHHHhhCC-CCeeeecceeeecC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG---------SDQVFERELEILGSIK-HINLVNLRGYCRLP 379 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 379 (603)
++|++.+.||+|+||+||+|++. +++.||||++...... ..+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57889999999999999999986 4557999998654322 1235889999999997 99999999999999
Q ss_pred CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecc
Q 007455 380 ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFG 459 (603)
Q Consensus 380 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG 459 (603)
+..|+||||+++|+|.+++...+. +++.++..++.||++||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~----l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVT----LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999986543 89999999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCcceeecccccccccCcccccc------CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHH
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQS------GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTL 533 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~ 533 (603)
+++....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...... .-....
T Consensus 156 ~a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~i 227 (277)
T d1phka_ 156 FSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMI 227 (277)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred heeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHHH
Confidence 9988755332 344679999999998853 34678999999999999999999999754211 111111
Q ss_pred hhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 LKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... ... .........++++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~-~~~-----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSG-NYQ-----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHT-CCC-----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhC-CCC-----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 111 110 000112245578999999999999999999999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.2e-47 Score=388.49 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=200.3
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC---CChHHHHHH---HHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR---EGSDQVFER---ELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
+++|++.+.||+|+||.||+|++.. +..||||++.... ......+.+ |+++++.++|||||++++++.+++..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 4678999999999999999999875 5679999985321 112233344 46777788899999999999999999
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
|+||||+++|+|.+++..... +++..+..++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~----~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGV----FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEecCCCcHHHHHHhccc----ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceee
Confidence 999999999999999987544 88999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcchh
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLED 541 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 541 (603)
...... .....||+.|+|||++.. ..++.++||||+||++|||+||+.||....... .... . .
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~-~---------~ 219 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEI-D---------R 219 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC---HHHH-H---------H
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH---HHHH-H---------H
Confidence 765432 344579999999999864 568999999999999999999999997542211 1110 0 0
Q ss_pred hhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007455 542 VIDKRCADADMETVEAILEIAARCTDANPDDRPS-----MNQVLQ 581 (603)
Q Consensus 542 ~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs-----~~evl~ 581 (603)
.........+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 220 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred hcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111111223345677999999999999999999 788874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=379.55 Aligned_cols=258 Identities=30% Similarity=0.434 Sum_probs=204.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCC--------CEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecCC
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDC--------GTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLPA 380 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 380 (603)
++|++.+.||+|+||.||+|+.... ..||||+++..... ....+.+|+..+.++ +|||||+++++|.+++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 5788889999999999999986533 25999999765432 336688899999888 7999999999999999
Q ss_pred ccEEEEEecCCCCccccccccCC------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEEC
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGE------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLD 448 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~ 448 (603)
..++||||+++|+|.+++..... ....+++.+++.++.|+++||+|||++ +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 99999999999999999976532 234589999999999999999999999 899999999999999
Q ss_pred CCCCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHh-CCCCCCcccccCCccH
Q 007455 449 ENLEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVT-GKRPTDPTFVKRGLNV 526 (603)
Q Consensus 449 ~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~ellt-g~~p~~~~~~~~~~~~ 526 (603)
.++.+||+|||+++....... .......|++.|+|||.+.++.++.++||||||+++|||++ |..||...... .
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~- 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---E- 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H-
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---H-
Confidence 999999999999987654332 23345668999999999999999999999999999999998 67777543211 1
Q ss_pred hHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 527 VGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
+...+... ..+..+...+.++.+|+.+||+.||++|||++||++.|+++
T Consensus 246 ---~~~~i~~~--------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 246 ---LFKLLKEG--------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHHTT--------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHcC--------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11111111 11222334556799999999999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-47 Score=379.35 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=211.0
Q ss_pred hhCCCCCCeeeecCCeEEEEEEECC------CCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCCcc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMND------CGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPATK 382 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 382 (603)
.++|++.+.||+|+||+||+|.++. +..||||+++.... .....+.+|+.++++++||||+++++++..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 4678889999999999999998752 34699999975432 2334689999999999999999999999999999
Q ss_pred EEEEEecCCCCccccccccC------CCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEe
Q 007455 383 LLIYDYLSMGSLDDFLHEHG------EGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS 456 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 456 (603)
++||||+++|+|.+++.... .....+++..+.+++.|+++||.|||++ +|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 99999999999999987532 1223478999999999999999999998 89999999999999999999999
Q ss_pred ecccccccCCCCcce-eecccccccccCccccccCCCCcccchHhHHHHHHHHHhCC-CCCCcccccCCccHhHHHHHHh
Q 007455 457 DFGLAKLLVDEEAHV-TTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGK-RPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 457 DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .||... ....+.....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~------~~~~~~~~i~ 249 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL------SNEQVLRFVM 249 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS------CHHHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC------CHHHHHHHHH
Confidence 999998765433322 23346899999999999999999999999999999999986 555432 2222222222
Q ss_pred hhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 535 KENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 535 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
. ......+...+..+.+++.+||+.+|++|||++||++.|++..
T Consensus 250 ~---------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 250 E---------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp T---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred h---------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 1 1222233445578999999999999999999999999998864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=376.44 Aligned_cols=266 Identities=26% Similarity=0.319 Sum_probs=199.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecCC----ccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLPA----TKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 386 (603)
++|.+.+.||+|+||.||+|+++ +..||||+++... ......+.|+..+..++||||+++++++...+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 35667789999999999999975 5789999986432 12222344555566789999999999997654 578999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHD-----CCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
||+++|+|.+++++.. +++..+++++.|++.||+|+|+. ..++|+||||||+|||++.++.+||+|||++
T Consensus 81 Ey~~~g~L~~~l~~~~-----l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp ECCTTCBHHHHHHHCC-----BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred ecccCCCHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999998642 89999999999999999999973 1248999999999999999999999999999
Q ss_pred cccCCCCcc---eeecccccccccCccccccCC------CCcccchHhHHHHHHHHHhCCCCCCcccccCC--------c
Q 007455 462 KLLVDEEAH---VTTVVAGTFGYLAPEYLQSGR------ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG--------L 524 (603)
Q Consensus 462 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~--------~ 524 (603)
+........ ......||+.|+|||++.+.. ++.++|||||||++|||+||..|+........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 877554322 223467999999999987542 56789999999999999999988754221110 1
Q ss_pred cHhHHHHHHhhhCcchhhhcccCCC--cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 525 NVVGWMNTLLKENRLEDVIDKRCAD--ADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 525 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
............... ++..+. ........+.+++.+||+.||++|||+.||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred chHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 111222222222221 111111 12345567999999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=378.50 Aligned_cols=262 Identities=28% Similarity=0.445 Sum_probs=209.7
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC------CCCEEEEEEeCCCCCC-hHHHHHHHHHHHhhC-CCCeeeecceeeecCCc
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN------DCGTFAVKRIDRSREG-SDQVFERELEILGSI-KHINLVNLRGYCRLPAT 381 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 381 (603)
.++|++.++||+|+||.||+|++. .+..||||+++..... ....+.+|+.+++++ +|||||++++++.++..
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367888999999999999999863 2336999999765433 345688999999999 69999999999999999
Q ss_pred cEEEEEecCCCCccccccccCC--------------CCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEE
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGE--------------GQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILL 447 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll 447 (603)
.++||||+++|+|.++++.... ....+++..+..++.||++||+|||++ +++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccccc
Confidence 9999999999999999876432 233589999999999999999999999 89999999999999
Q ss_pred CCCCCeEEeecccccccCCCCc-ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccH
Q 007455 448 DENLEPHVSDFGLAKLLVDEEA-HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNV 526 (603)
Q Consensus 448 ~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~ 526 (603)
+.++.+|++|||.++....... .......||+.|+|||++.++.++.++||||||+++|||+|++.|+..... ...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~--~~~- 255 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--VDS- 255 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--SSH-
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCC--HHH-
Confidence 9999999999999988765433 333456799999999999999999999999999999999995555432211 111
Q ss_pred hHHHHHHhhhCcchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhcc
Q 007455 527 VGWMNTLLKENRLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQEV 587 (603)
Q Consensus 527 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~~ 587 (603)
-.......+ ..+..+...+.++.+|+.+||+.||++||||+|++++|++..
T Consensus 256 --~~~~~i~~~--------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 256 --KFYKMIKEG--------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp --HHHHHHHHT--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHHhcC--------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 111111111 111122334567999999999999999999999999998753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=377.89 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=197.5
Q ss_pred hhCCCCCC-eeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhC-CCCeeeecceeeec----CCcc
Q 007455 310 LEALDEED-VVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSI-KHINLVNLRGYCRL----PATK 382 (603)
Q Consensus 310 ~~~~~~~~-~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~ 382 (603)
.++|.+.+ +||+|+||+||+|.+.. +..||||+++. ...+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46787764 69999999999999864 56799999853 24578899987655 89999999999865 4568
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC---CCCeEEeecc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE---NLEPHVSDFG 459 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG 459 (603)
|+||||++||+|.+++...+. ..+++.++..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 999999999999999986432 3489999999999999999999999 8999999999999986 4579999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
+++....... .....||+.|+|||++.+..++.++||||+||++|||+||+.||........ ............
T Consensus 160 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~- 233 (335)
T d2ozaa1 160 FAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQ- 233 (335)
T ss_dssp TCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS-
T ss_pred eeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCC-
Confidence 9987654432 3456799999999999999999999999999999999999999965422110 000000000000
Q ss_pred hhhhcccCCC-cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 540 EDVIDKRCAD-ADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 540 ~~~~~~~~~~-~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
...+. .....+.++.+|+.+||+.||++|||++|+++
T Consensus 234 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 -----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp -----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00111 11245678999999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-46 Score=371.53 Aligned_cols=259 Identities=25% Similarity=0.282 Sum_probs=195.6
Q ss_pred CCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC-----hHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEec
Q 007455 316 EDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG-----SDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDYL 389 (603)
Q Consensus 316 ~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 389 (603)
.++||+|+||+||+|.+.. ++.||||+++..... ..+.+.+|+.++++++|||||++++++..++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 4789999999999999864 567999998644322 1246889999999999999999999999999999999999
Q ss_pred CCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCCc
Q 007455 390 SMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEEA 469 (603)
Q Consensus 390 ~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~~ 469 (603)
.++++..+..... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCCS----SCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhccc----CCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 9988776665433 388889999999999999999999 899999999999999999999999999987654432
Q ss_pred ceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc---chhhh--
Q 007455 470 HVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR---LEDVI-- 543 (603)
Q Consensus 470 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-- 543 (603)
......||+.|+|||++.. ..++.++||||+||++|||++|..||...... +....+........ +....
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~~l~~i~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQLTRIFETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---HHHHHHHHhcCCCChhhccchhcc
Confidence 2334579999999998864 45799999999999999999999998653211 11111111110000 00000
Q ss_pred -----cccCCCcC-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 007455 544 -----DKRCADAD-----METVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQ 585 (603)
Q Consensus 544 -----~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~ 585 (603)
....+..+ ...+.++.+|+.+||+.||++|||++|+++ .+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00001111 123467999999999999999999999986 4544
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=369.76 Aligned_cols=239 Identities=26% Similarity=0.411 Sum_probs=195.6
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCCC------hHHHHHHHHHHHhhCC--CCeeeecceeeecCCc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSREG------SDQVFERELEILGSIK--HINLVNLRGYCRLPAT 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 381 (603)
++|++.+.||+|+||+||+|++. ++..||||++...... ...++.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 46888999999999999999987 4567999998643211 1234678999999986 8999999999999999
Q ss_pred cEEEEEecCC-CCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCC-CCeEEeecc
Q 007455 382 KLLIYDYLSM-GSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDEN-LEPHVSDFG 459 (603)
Q Consensus 382 ~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~-~~~kl~DfG 459 (603)
.++||||+.+ +++.+++..... +++..+..++.|+++||+|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~----l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCS----CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhccCC----CCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 577777766443 89999999999999999999999 89999999999999854 789999999
Q ss_pred cccccCCCCcceeecccccccccCccccccCCC-CcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 460 LAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRA-TEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 460 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
+++..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .....
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~-- 219 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG-- 219 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC--
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhc--
Confidence 99875433 2345679999999999987765 567899999999999999999996531 01110
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....+...+.++.+++.+||+.||++|||++|+++
T Consensus 220 --------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 --------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01112234567999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-46 Score=370.85 Aligned_cols=267 Identities=22% Similarity=0.314 Sum_probs=199.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC--ChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE--GSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|++.+.||+|+||+||+|.+. .+..||||+++.... ...+++.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 68899999999999999999986 456799999965432 234678999999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
|+.++.+ +++.... ...+++..+..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~~-~~~~~~~--~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLK-KFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHH-HHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchh-hhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9987544 4443322 22389999999999999999999999 8999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh--hCcchhh--
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGR-ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK--ENRLEDV-- 542 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-- 542 (603)
.. ......||+.|+|||.+.... ++.++||||+||++|||++|+.||....... ........... +......
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGG
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhcccccc
Confidence 22 233456999999999876655 5789999999999999999999997532110 00000000000 0000000
Q ss_pred -------hcccCCC----cCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 007455 543 -------IDKRCAD----ADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQE 586 (603)
Q Consensus 543 -------~~~~~~~----~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~ 586 (603)
....... .....+.++.+|+.+||+.||++|||++|+++ .+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 0000000 01123467899999999999999999999997 35543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9.4e-46 Score=368.84 Aligned_cols=261 Identities=24% Similarity=0.319 Sum_probs=199.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.++||+|+||+||+|.++++..||||++.... ....+.+.+|+.++++++||||+++++++..++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6788999999999999999999988899999996543 22346799999999999999999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCCC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDEE 468 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~~ 468 (603)
+.++.+..+....+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~~~~~~~~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhcC----CcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 99877777665443 399999999999999999999998 89999999999999999999999999998765432
Q ss_pred cceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh--hCcch-----
Q 007455 469 AHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK--ENRLE----- 540 (603)
Q Consensus 469 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~----- 540 (603)
. ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||........ .......... .....
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhhh
Confidence 2 23345689999999998654 568999999999999999999999975321100 0000000000 00000
Q ss_pred ----hhhcccC----CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 ----DVIDKRC----ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ----~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
....... .......+..+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 0011223467899999999999999999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-45 Score=367.06 Aligned_cols=260 Identities=22% Similarity=0.314 Sum_probs=194.3
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCC-EEEEEEeCCCC--CChHHHHHHHHHHHhhC---CCCeeeecceeeec-----
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCG-TFAVKRIDRSR--EGSDQVFERELEILGSI---KHINLVNLRGYCRL----- 378 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~-~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 378 (603)
++|++.+.||+|+||+||+|.+. .++ .||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 68899999999999999999985 334 58999985432 22233466788877665 79999999999853
Q ss_pred CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 379 PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
....+++|||++++++........ ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecch
Confidence 346789999999977655444322 2388999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC-
Q 007455 459 GLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN- 537 (603)
Q Consensus 459 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 537 (603)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ...-+.......
T Consensus 161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCC
T ss_pred hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhhCCCc
Confidence 9987654332 2345679999999999999999999999999999999999999997542111 100000000000
Q ss_pred --cc-------hhhhccc----CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 538 --RL-------EDVIDKR----CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 538 --~~-------~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.+ ....... ........+..+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0000000 00112234567899999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=357.92 Aligned_cols=262 Identities=22% Similarity=0.308 Sum_probs=194.1
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCC--CCChHHHHHHHHHHHhhCCCCeeeecceeeec--------
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRS--REGSDQVFERELEILGSIKHINLVNLRGYCRL-------- 378 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 378 (603)
.++|++.+.||+|+||+||+|++. ++..||||++... ......++.+|++++++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 478999999999999999999986 5667999998543 23345678999999999999999999998855
Q ss_pred CCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeec
Q 007455 379 PATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDF 458 (603)
Q Consensus 379 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~Df 458 (603)
....++||||+.++.+........ .++...+..++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~----~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhccc----ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 345789999999877765544332 388899999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCc---ceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHh
Q 007455 459 GLAKLLVDEEA---HVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLL 534 (603)
Q Consensus 459 G~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 534 (603)
|+++....... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ....-.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~---~~~~~i~~~~ 238 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ---HQLALISQLC 238 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH---HHHHHHHHhc
Confidence 99987654322 122335699999999998754 6889999999999999999999999753211 1111111111
Q ss_pred hh---Cc--------chhhhccc-CCCcC-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 535 KE---NR--------LEDVIDKR-CADAD-------METVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 535 ~~---~~--------~~~~~~~~-~~~~~-------~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. .. ....+... ..... .....++.+|+.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 00 00000000 00000 112346789999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=361.96 Aligned_cols=253 Identities=26% Similarity=0.346 Sum_probs=204.8
Q ss_pred hhCCCCCCeeeecCCeEEEEEEEC----CCCEEEEEEeCCCC----CChHHHHHHHHHHHhhCCC-CeeeecceeeecCC
Q 007455 310 LEALDEEDVVGSGGFGTVYRMVMN----DCGTFAVKRIDRSR----EGSDQVFERELEILGSIKH-INLVNLRGYCRLPA 380 (603)
Q Consensus 310 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~ 380 (603)
+++|++.+.||+|+||+||+|.+. .+..||||.++... ....+.+.+|++++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 477999999999999999999863 35679999986432 2234568899999999976 89999999999999
Q ss_pred ccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccc
Q 007455 381 TKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGL 460 (603)
Q Consensus 381 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 460 (603)
..+++|||+.+|+|.+++..... ++...+..++.|++.||+|+|+. +|+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~----~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceeeeeecccccHHHHHHHhccc----ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999987654 78889999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCcceeecccccccccCccccccC--CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc
Q 007455 461 AKLLVDEEAHVTTVVAGTFGYLAPEYLQSG--RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR 538 (603)
Q Consensus 461 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 538 (603)
++.+............|++.|+|||.+.+. .++.++||||+||++|||++|+.||......... ........
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~---- 249 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRIL---- 249 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHH----
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcc----
Confidence 987765555445567799999999998654 4678999999999999999999999765322211 11111110
Q ss_pred chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007455 539 LEDVIDKRCADADMETVEAILEIAARCTDANPDDRP-----SMNQVLQ 581 (603)
Q Consensus 539 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP-----s~~evl~ 581 (603)
......+...+.++.+++.+||+.||++|| |++|+++
T Consensus 250 ------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 ------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 011122334567899999999999999999 5889885
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.4e-43 Score=347.62 Aligned_cols=259 Identities=17% Similarity=0.225 Sum_probs=203.0
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCC-CeeeecceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKH-INLVNLRGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||+||+|++.. ++.||||++..... ...+.+|++.++.+.| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 468889999999999999999875 45699998854432 2347889999999975 8999999999999999999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC-----CCCeEEeecccccc
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE-----NLEPHVSDFGLAKL 463 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~-----~~~~kl~DfG~~~~ 463 (603)
+ +++|.+++...+. .++...+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~~~~---~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR---KFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHhhcc---chhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 5799998876432 389999999999999999999999 8999999999999974 57899999999988
Q ss_pred cCCCCc------ceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhC
Q 007455 464 LVDEEA------HVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKEN 537 (603)
Q Consensus 464 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 537 (603)
+..... .......||+.|+|||++.+..++.++||||||+++|||+||+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 754322 12334679999999999999999999999999999999999999997543221111111111111111
Q ss_pred cchhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 538 RLEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 538 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
...+ ..+ ..++++.+++..|+..+|++||+++.+.+.|+++
T Consensus 236 ~~~~----l~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 236 PLRE----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp CHHH----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred ChHH----hcC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1111 111 2345799999999999999999999988877654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-43 Score=349.88 Aligned_cols=259 Identities=19% Similarity=0.202 Sum_probs=195.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeec-ceeeecCCccEEEEEe
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNL-RGYCRLPATKLLIYDY 388 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~ 388 (603)
++|++.+.||+|+||.||+|.+.. +..||||++...... ..+.+|+++++.++|+|++.. .+++...+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 368889999999999999999865 457999988654332 347889999999987765554 5556777888999999
Q ss_pred cCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECC---CCCeEEeecccccccC
Q 007455 389 LSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDE---NLEPHVSDFGLAKLLV 465 (603)
Q Consensus 389 ~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~---~~~~kl~DfG~~~~~~ 465 (603)
+.+ ++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. +..++|+|||+|+.+.
T Consensus 85 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 LGP-SLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCC-BHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred cCC-chhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 955 6666655432 2389999999999999999999999 8999999999999864 4579999999998875
Q ss_pred CCCcc------eeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcc
Q 007455 466 DEEAH------VTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRL 539 (603)
Q Consensus 466 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 539 (603)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 43321 234467999999999999999999999999999999999999999764322211111110000000000
Q ss_pred hhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhc
Q 007455 540 EDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQLLEQE 586 (603)
Q Consensus 540 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~~L~~~ 586 (603)
. ......+.++.+++.+||+.+|++||+++++.+.|++.
T Consensus 238 ~--------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 238 E--------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp H--------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred h--------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 0 01112346799999999999999999999998888764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-43 Score=359.54 Aligned_cols=260 Identities=23% Similarity=0.322 Sum_probs=194.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEEC-CCCEEEEEEeCCCCC-ChHHHHHHHHHHHhhCCCCeeeecceeeecCC----ccEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMN-DCGTFAVKRIDRSRE-GSDQVFERELEILGSIKHINLVNLRGYCRLPA----TKLL 384 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 384 (603)
++|++.+.||+|+||+||+|.++ .+..||||++..... ...+.+.+|+.+|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 46888999999999999999986 556799999975433 23457889999999999999999999986653 2356
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLL 464 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~ 464 (603)
+++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 66778899999999754 289999999999999999999999 8999999999999999999999999999876
Q ss_pred CCCCcc--eeecccccccccCccccc-cCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCcch-
Q 007455 465 VDEEAH--VTTVVAGTFGYLAPEYLQ-SGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENRLE- 540 (603)
Q Consensus 465 ~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 540 (603)
...... ......||+.|+|||++. +..++.++||||+||++|||++|+.||....... ...............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QLNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH---HHHHHhhhccCCChhh
Confidence 443222 234466999999999984 4567889999999999999999999997542110 000000000000000
Q ss_pred ----------hhh--cccCCCc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 ----------DVI--DKRCADA-----DMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ----------~~~--~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
... .+..... ....+.++.+|+.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 0000000 1122356899999999999999999999996
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-43 Score=358.10 Aligned_cols=261 Identities=23% Similarity=0.324 Sum_probs=192.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecCC------c
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLPA------T 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 381 (603)
++|++.+.||+|+||+||+|.+.. +..||||+++..... ..+.+.+|+++|++++|||||+++++|...+ +
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 578889999999999999999875 567999999754332 2356889999999999999999999997654 4
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.|+||||+ +++|..+.+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE-----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-cccHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccce
Confidence 69999999 45777766542 289999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHH-------H
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNT-------L 533 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-------~ 533 (603)
+..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ +...... .
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LKEIMKVTGTPPAEF 242 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HHHHHhccCCCcHHH
Confidence 876433 234669999999999865 4568999999999999999999999975421100 0000000 0
Q ss_pred hhhCc----------chhhhcccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhhc
Q 007455 534 LKENR----------LEDVIDKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQE 586 (603)
Q Consensus 534 ~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~~ 586 (603)
..... ..+.............+.++.+|+.+||..||++|||++|+++ .+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 00000 0000000001111233467889999999999999999999997 35443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=360.05 Aligned_cols=259 Identities=26% Similarity=0.293 Sum_probs=190.7
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCeeeecceeeecC------CccEE
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIKHINLVNLRGYCRLP------ATKLL 384 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 384 (603)
+|+..++||+|+||+||+|++.. ++.||||++...... ..+|++++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 57778899999999999999975 567999999654432 34799999999999999999998543 34689
Q ss_pred EEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-CeEEeecccccc
Q 007455 385 IYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-EPHVSDFGLAKL 463 (603)
Q Consensus 385 v~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~ 463 (603)
||||++++.+..+.. .......+++.++..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999998764443332 222233489999999999999999999998 899999999999999875 899999999987
Q ss_pred cCCCCcceeecccccccccCcccccc-CCCCcccchHhHHHHHHHHHhCCCCCCcccccCCcc---------HhHHHHHH
Q 007455 464 LVDEEAHVTTVVAGTFGYLAPEYLQS-GRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLN---------VVGWMNTL 533 (603)
Q Consensus 464 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~---------~~~~~~~~ 533 (603)
...... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......... ...+....
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 654432 234568999999998764 568999999999999999999999997532111000 00000000
Q ss_pred hhhCcchhhhccc-----CCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 LKENRLEDVIDKR-----CADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. ......+... ........+.++.+|+.+||+.||++|||++|+++
T Consensus 251 ~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 251 NP-NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp CC----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cc-chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0000000000 00011234567999999999999999999999995
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=347.29 Aligned_cols=258 Identities=22% Similarity=0.340 Sum_probs=202.4
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCC--CChHHHHHHHHHHHhhCCCCeeeecceeeecCCccEEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSR--EGSDQVFERELEILGSIKHINLVNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 387 (603)
++|++.+.||+|+||+||+|++.. ++.||||+++... .....++.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 578999999999999999999874 4569999986443 3345678999999999999999999999999999999999
Q ss_pred ecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccccccCCC
Q 007455 388 YLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAKLLVDE 467 (603)
Q Consensus 388 ~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~~~~~ 467 (603)
++.++++..++...+. +++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCNGD----LDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTTTC----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccccc----cchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999999888776543 88999999999999999999998 8999999999999999999999999999876543
Q ss_pred CcceeecccccccccCccccccCC-CCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhh---hC---cch
Q 007455 468 EAHVTTVVAGTFGYLAPEYLQSGR-ATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLK---EN---RLE 540 (603)
Q Consensus 468 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~---~~~ 540 (603)
.. ......+++.|+|||.+.... ++.++||||+||++|||++|+.||.... +.......... .. ...
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN-----DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS-----SHHHHHHHHHHHHCCCCTTTCT
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC-----CHHHHHHHHHhhcCCCChhhhh
Confidence 32 233345778999999887654 6899999999999999999999974321 11111111111 00 000
Q ss_pred hh---h----------cccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 541 DV---I----------DKRCADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 541 ~~---~----------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.. . ...........+..+.+|+.+||+.||.+|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 0 00011112234567899999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-42 Score=350.19 Aligned_cols=256 Identities=17% Similarity=0.288 Sum_probs=194.9
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CCeeeecceeeecC--CccEEEE
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRGYCRLP--ATKLLIY 386 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 386 (603)
++|++.++||+|+||+||+|++.. +..||||+++.. ..+++.+|+++|+++. ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 578999999999999999999875 456999998643 3467899999999995 99999999998743 5689999
Q ss_pred EecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCC-CeEEeecccccccC
Q 007455 387 DYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENL-EPHVSDFGLAKLLV 465 (603)
Q Consensus 387 e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~~~~~~ 465 (603)
||+.+|+|..+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999987643 289999999999999999999999 899999999999998765 59999999998765
Q ss_pred CCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCC--ccH---------hHHHHHH
Q 007455 466 DEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRG--LNV---------VGWMNTL 533 (603)
Q Consensus 466 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~--~~~---------~~~~~~~ 533 (603)
.... .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........ ... ..|....
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 4332 3455689999999998765 479999999999999999999999865321100 000 0000000
Q ss_pred hhhC--cchhhhcc--------cCC-CcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 534 LKEN--RLEDVIDK--------RCA-DADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 534 ~~~~--~~~~~~~~--------~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
.... ........ ... ......+.++.+|+.+||..||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00000000 000 011234567899999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-41 Score=348.13 Aligned_cols=259 Identities=20% Similarity=0.239 Sum_probs=188.1
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeec------CCc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRL------PAT 381 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 381 (603)
++|++.++||+|+||+||+|.+.. +..||||++...... ...++.+|+.++++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 578899999999999999999875 566999999755433 23468899999999999999999999864 357
Q ss_pred cEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeecccc
Q 007455 382 KLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLA 461 (603)
Q Consensus 382 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~ 461 (603)
.|+||||+.++.+... .. .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.++++|||++
T Consensus 97 ~~iv~Ey~~~~l~~~~-~~------~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI-QM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSEEHHHHH-TS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccchHHHHhh-hc------CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 7999999987655443 22 288999999999999999999999 8999999999999999999999999998
Q ss_pred cccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCcc----------------
Q 007455 462 KLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLN---------------- 525 (603)
Q Consensus 462 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~---------------- 525 (603)
+...... ......+|+.|+|||++.+..++.++||||+||++|||++|+.||..........
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 8664432 2344568999999999999999999999999999999999999996432100000
Q ss_pred HhHHHHHHhhhC------cchhhhcccC----CCcCHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007455 526 VVGWMNTLLKEN------RLEDVIDKRC----ADADMETVEAILEIAARCTDANPDDRPSMNQVLQ 581 (603)
Q Consensus 526 ~~~~~~~~~~~~------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~P~~RPs~~evl~ 581 (603)
............ .....+.... .......+.++.+|+++||..||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000000000 0000111111 1112345678999999999999999999999985
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=346.96 Aligned_cols=260 Identities=25% Similarity=0.319 Sum_probs=194.2
Q ss_pred hCCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCC--hHHHHHHHHHHHhhCCCCeeeecceeeecC-----Ccc
Q 007455 311 EALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREG--SDQVFERELEILGSIKHINLVNLRGYCRLP-----ATK 382 (603)
Q Consensus 311 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 382 (603)
++|++.+.||+|+||+||+|.+.. +..||||++...... ..+++.+|++++++++||||+++++++... ...
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 578899999999999999999874 556999999765433 235688999999999999999999998643 344
Q ss_pred EEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 383 LLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 383 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
+++++|+.+|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++.
T Consensus 98 ~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhc
Confidence 6778888999999998653 289999999999999999999999 89999999999999999999999999997
Q ss_pred ccCCCCcceeecccccccccCccccccC-CCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHHHHhhhCc---
Q 007455 463 LLVDEEAHVTTVVAGTFGYLAPEYLQSG-RATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMNTLLKENR--- 538 (603)
Q Consensus 463 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 538 (603)
..... .....|++.|+|||...+. .++.++||||+||++|+|++|+.||....... ....+........
T Consensus 170 ~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~---~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 170 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGAEL 242 (348)
T ss_dssp CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCHHH
T ss_pred ccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChHH
Confidence 65332 2345689999999987655 46889999999999999999999997532110 0000000000000
Q ss_pred --------chhhhc--ccCCCc-----CHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHhh
Q 007455 539 --------LEDVID--KRCADA-----DMETVEAILEIAARCTDANPDDRPSMNQVLQ--LLEQ 585 (603)
Q Consensus 539 --------~~~~~~--~~~~~~-----~~~~~~~l~~li~~cl~~~P~~RPs~~evl~--~L~~ 585 (603)
...... ...+.. ....+.++.+|+.+||+.||++|||++|+++ .+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~ 306 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred hhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence 000000 000000 1123467899999999999999999999997 4544
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.5e-37 Score=314.12 Aligned_cols=262 Identities=18% Similarity=0.203 Sum_probs=188.0
Q ss_pred CCCCCCeeeecCCeEEEEEEECC-CCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-----------CCeeeecceeeecC
Q 007455 312 ALDEEDVVGSGGFGTVYRMVMND-CGTFAVKRIDRSREGSDQVFERELEILGSIK-----------HINLVNLRGYCRLP 379 (603)
Q Consensus 312 ~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~~ 379 (603)
+|++.++||+|+||+||+|++.. +..||||+++... ...+.+.+|+++++.++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 48889999999999999999864 5669999996543 23456788999988875 47899999887543
Q ss_pred --CccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCC-----
Q 007455 380 --ATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLE----- 452 (603)
Q Consensus 380 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~----- 452 (603)
...++++++...+......... .....+++..+..++.|++.||+|||+.. +|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc--CcccccCChhHeeeeccCcccccc
Confidence 4556677776655443333222 22334788999999999999999999832 8999999999999987654
Q ss_pred -eEEeecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHHHHHHhCCCCCCcccccCCccHhHHHH
Q 007455 453 -PHVSDFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLLLELVTGKRPTDPTFVKRGLNVVGWMN 531 (603)
Q Consensus 453 -~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl~elltg~~p~~~~~~~~~~~~~~~~~ 531 (603)
++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||.+..............
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 999999999865432 244669999999999998899999999999999999999999997643221111111111
Q ss_pred HHh-----------hhCc-chhhhc--------------------ccCCCcCHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 007455 532 TLL-----------KENR-LEDVID--------------------KRCADADMETVEAILEIAARCTDANPDDRPSMNQV 579 (603)
Q Consensus 532 ~~~-----------~~~~-~~~~~~--------------------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ev 579 (603)
... .... .....+ ..........+.++.+|+.+||..||.+|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 000 0000 000000 00112345667889999999999999999999999
Q ss_pred HH
Q 007455 580 LQ 581 (603)
Q Consensus 580 l~ 581 (603)
++
T Consensus 326 L~ 327 (362)
T d1q8ya_ 326 VN 327 (362)
T ss_dssp HT
T ss_pred hc
Confidence 87
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=8.2e-30 Score=256.40 Aligned_cols=184 Identities=35% Similarity=0.591 Sum_probs=158.4
Q ss_pred CChhhHHHHHHHHHhCCCCCCCCCCCCCCCCCCc--cccceeecCCC--CcEEEEEcCCCCccc--ccCCCccCCCCcce
Q 007455 25 ALTEDGMTLLEIKSSLNDSRNLLGNWQATEESPC--KWTGISCHTHD--QRVRSINLPYMQLGG--IISPSIGRLDKLQR 98 (603)
Q Consensus 25 ~~~~~~~~l~~~k~~~~~~~~~l~~w~~~~~~~c--~w~gv~C~~~~--~~l~~L~L~~n~l~~--~~~~~~~~l~~L~~ 98 (603)
|.++|++||++||+++.+|. .+++|..+ .||| .|.||+|+... .+|+.|+|++|+++| .+|+++++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 57899999999999999886 68999754 5788 59999998643 489999999999998 47899999999999
Q ss_pred EEecc-CCCCCCCCCCccccCCCceEEeccccCCCCCc------------------------------------------
Q 007455 99 LALHQ-NSLHGSIPNEITNCTELRALYLRANYLQGGIP------------------------------------------ 135 (603)
Q Consensus 99 L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------------------------------------ 135 (603)
|+|++ |+++|.+|..|++|++|++|+|++|+|++..|
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~ 160 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeeccccc
Confidence 99997 89999999999999999999999998753221
Q ss_pred -----------------------------------------------------------------------------ccc
Q 007455 136 -----------------------------------------------------------------------------ANI 138 (603)
Q Consensus 136 -----------------------------------------------------------------------------~~~ 138 (603)
..+
T Consensus 161 l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~ 240 (313)
T d1ogqa_ 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240 (313)
T ss_dssp CEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 113
Q ss_pred ccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCcccCCCCCCCCC
Q 007455 139 GNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPC 211 (603)
Q Consensus 139 ~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~~~~~~c 211 (603)
..+++|+.|+|++|+|+|.+|..|+++++|+.|+|++|+|+|.+|.++.+++|+.+++.+|..+||.|+. .|
T Consensus 241 ~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp-~c 312 (313)
T d1ogqa_ 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp CCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS-CC
T ss_pred ccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccCCCCC-CC
Confidence 4456778889999999999999999999999999999999998888888999999999999989998764 44
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.1e-23 Score=193.13 Aligned_cols=168 Identities=14% Similarity=0.145 Sum_probs=119.3
Q ss_pred CCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCC------------------hHHHHHHHHHHHhhCCCCeeeecceee
Q 007455 315 EEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREG------------------SDQVFERELEILGSIKHINLVNLRGYC 376 (603)
Q Consensus 315 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~niv~l~~~~ 376 (603)
+.++||+|+||+||+|.+.++++||||+++..... ......+|+..+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 46889999999999999988889999987532110 012345788899999999998877653
Q ss_pred ecCCccEEEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCCeEECCCCCeEEe
Q 007455 377 RLPATKLLIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDCCPKIIHRDIKSSNILLDENLEPHVS 456 (603)
Q Consensus 377 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~NIll~~~~~~kl~ 456 (603)
..+++|||++++.+.+ ++......++.|++++++|||++ +|+||||||+|||++++ .++|+
T Consensus 84 ----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEEC
T ss_pred ----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEE
Confidence 2479999999865543 23334567899999999999999 89999999999999975 48999
Q ss_pred ecccccccCCCCcceeecccccccccCccccccCCCCcccchHhHHHHH
Q 007455 457 DFGLAKLLVDEEAHVTTVVAGTFGYLAPEYLQSGRATEKSDVYSFGVLL 505 (603)
Q Consensus 457 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~vl 505 (603)
|||.|.....+....... .+... -.+.+ ...|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~~l~--rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILE--RDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHH--HHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHH--HHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 999997764332211000 00000 01111 35678899999975433
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=1.3e-19 Score=167.51 Aligned_cols=129 Identities=27% Similarity=0.370 Sum_probs=99.3
Q ss_pred CCCccccceeecCC---------CCcEEEEEcCCCCcccc-cCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEE
Q 007455 55 ESPCKWTGISCHTH---------DQRVRSINLPYMQLGGI-ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALY 124 (603)
Q Consensus 55 ~~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 124 (603)
.|-|+|..|.|++. ..++++|+|++|+|++. .+..|.++++|+.|+|++|++.+..+..|..+++|++|+
T Consensus 5 ~C~C~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~ 84 (192)
T d1w8aa_ 5 MCHCEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp TSEEETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCEEcCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceee
Confidence 35578998999642 24678888888888764 355677888888888888888877777788888888888
Q ss_pred eccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCC
Q 007455 125 LRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP 183 (603)
Q Consensus 125 L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 183 (603)
|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.....
T Consensus 85 Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~ 143 (192)
T d1w8aa_ 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred eccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence 88888886667778888888888888888886667778888888888888888775543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.71 E-value=1.3e-17 Score=153.68 Aligned_cols=131 Identities=23% Similarity=0.241 Sum_probs=113.6
Q ss_pred EEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCC-CCCccccCCCceEEeccccCCCCCccccccccccceecccC
Q 007455 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSI-PNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSS 151 (603)
Q Consensus 73 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 151 (603)
+.++.++++|+. +|..+. +++++|+|++|+|++.+ +..|.++++|+.|+|++|++++..+..|..+++|++|+|++
T Consensus 11 ~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence 478999999997 566554 68999999999998645 56689999999999999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccCCCCCCCCCC
Q 007455 152 NSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 152 N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
|+|++..|..|.++++|+.|+|++|+|++++++ |..+++|+.+++.+| |+.|+|.
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N------~~~~~~~ 143 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN------PFNCNCH 143 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTC------CBCCSGG
T ss_pred ccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccc------ccccccc
Confidence 999977788899999999999999999999886 777788877766555 6666663
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=3.8e-17 Score=158.82 Aligned_cols=140 Identities=24% Similarity=0.213 Sum_probs=79.4
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+|+++.+.+|.++++|++|+|++|+|+ .+|. +..+++|+.|+|++|+++ ..+..+.++++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccc-ccccccccccccccccc
Confidence 35777777777777766667777777777777777776 4443 456666666666666665 33333433333333333
Q ss_pred cCCc------------------------cCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCC-----
Q 007455 150 SSNS------------------------LKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGN----- 199 (603)
Q Consensus 150 ~~N~------------------------l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n----- 199 (603)
++|. +++..+..+..+++|+.|++++|+|++.+++ |..+++|+.|++++|
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~l 187 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTI 187 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCC
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCccc
Confidence 3332 2222222333444555555555555554443 444555555555544
Q ss_pred ------------cccCCCCCCCCCC
Q 007455 200 ------------LDLCGRQVHKPCR 212 (603)
Q Consensus 200 ------------~~l~~~~~~~~c~ 212 (603)
+++.||||.|+|.
T Consensus 188 p~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 188 PKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred ChhHCCCCCCCEEEecCCCCCCCcc
Confidence 3566778888884
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=1.2e-16 Score=155.17 Aligned_cols=137 Identities=23% Similarity=0.193 Sum_probs=102.5
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|++++ .+..+..+++|+.|+|++|.+.+..+..+..+.+|+.|++++|.+++..+..+..+++|+.|++
T Consensus 77 ~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l 155 (266)
T d1p9ag_ 77 PVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (266)
T ss_dssp TTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccccccccccccccc-cccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccc
Confidence 345555555555544 2344555555555555555555444444555666666666666677555666778999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCCcccCCCCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQV 207 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~~~ 207 (603)
++|+|++..+..|..+++|++|+|++|+|+.+|+++..+.+|+.|++++|++.|++.+
T Consensus 156 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 156 ANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEI 213 (266)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGG
T ss_pred ccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcch
Confidence 9999998888889999999999999999998888888999999999999999998754
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.63 E-value=4e-16 Score=154.70 Aligned_cols=143 Identities=23% Similarity=0.285 Sum_probs=108.3
Q ss_pred CCccccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEec
Q 007455 56 SPCKWTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLR 126 (603)
Q Consensus 56 ~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 126 (603)
|-|.|++|.|++. ...+++|+|++|+|+.+.+.+|.++++|++|++++|.+....|..|.++++|+.|+|+
T Consensus 8 c~c~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 8 CQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp CEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEecCCEEEecCCCCCccCCCCCCCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4488999999752 3579999999999999777789999999999999999997778889999999999999
Q ss_pred cccCCCCCc-----------------------------------------------------------------------
Q 007455 127 ANYLQGGIP----------------------------------------------------------------------- 135 (603)
Q Consensus 127 ~N~l~~~~p----------------------------------------------------------------------- 135 (603)
+|+|+ .+|
T Consensus 88 ~n~l~-~l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~ 166 (305)
T d1xkua_ 88 KNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 166 (305)
T ss_dssp SSCCS-BCCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCC
T ss_pred CCccC-cCccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccC
Confidence 99876 222
Q ss_pred ----------------------cccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCc
Q 007455 136 ----------------------ANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGN 193 (603)
Q Consensus 136 ----------------------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~ 193 (603)
..|.+++.++.|++++|.+++..+..+.++++|+.|+|++|+|+.+++++..+++|+.
T Consensus 167 ~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~ 246 (305)
T d1xkua_ 167 QGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQV 246 (305)
T ss_dssp SSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCE
T ss_pred cccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecccccccccccccccccCCCE
Confidence 1233344455555666666655555666667777777777777766666777777777
Q ss_pred ccccCC
Q 007455 194 KSFIGN 199 (603)
Q Consensus 194 l~~~~n 199 (603)
|++++|
T Consensus 247 L~Ls~N 252 (305)
T d1xkua_ 247 VYLHNN 252 (305)
T ss_dssp EECCSS
T ss_pred EECCCC
Confidence 777666
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.62 E-value=3.7e-16 Score=132.49 Aligned_cols=105 Identities=26% Similarity=0.291 Sum_probs=91.7
Q ss_pred EEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCC
Q 007455 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSN 152 (603)
Q Consensus 73 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 152 (603)
+.|+|++|+|+.. + .+..+++|++|+|++|+|+ .+|+.|+.+++|+.|+|++|+|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~~l-~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTVL-C-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSSC-C-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCCC-c-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 3699999999864 4 4899999999999999998 78888999999999999999999 565 5899999999999999
Q ss_pred ccCCCC-CCCCccccccceeeccCCcCcccC
Q 007455 153 SLKGAI-PSSLGRLTHLHYLNLSTNFFSGEI 182 (603)
Q Consensus 153 ~l~~~~-p~~~~~l~~L~~l~l~~N~l~~~~ 182 (603)
+|++.. ...+..+++|+.|++++|+++...
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~ 106 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 106 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCc
Confidence 999432 246889999999999999998654
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=2.7e-16 Score=154.31 Aligned_cols=137 Identities=22% Similarity=0.220 Sum_probs=114.0
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|++..+.+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|++
T Consensus 105 ~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l 184 (284)
T d1ozna_ 105 GRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184 (284)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred ccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhh
Confidence 57888999999988877778888889999999999998666677888889999999999998777888888999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCC-CccccccCcccccCCcccCCCCCCCCCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
++|++++..|..|..+++|+.|++++|++++.++. |..+.+|+.+++ .+|||.|+|.
T Consensus 185 ~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l------~~N~l~C~C~ 242 (284)
T d1ozna_ 185 HQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL------NDNPWVCDCR 242 (284)
T ss_dssp CSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEEC------CSSCEECSGG
T ss_pred hhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEe------cCCCCCCCcc
Confidence 99999888888899999999999999999887764 666666766555 4557777774
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=2.2e-15 Score=147.64 Aligned_cols=121 Identities=25% Similarity=0.237 Sum_probs=94.0
Q ss_pred CCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCC
Q 007455 80 MQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIP 159 (603)
Q Consensus 80 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 159 (603)
|.++.+.+..|.++++|++|+|++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 34444445667778888888888888876666667778888888888888886666778888888888888888887777
Q ss_pred CCCccccccceeeccCCcCcccCCC-CccccccCcccccCCc
Q 007455 160 SSLGRLTHLHYLNLSTNFFSGEIPD-FGALSAFGNKSFIGNL 200 (603)
Q Consensus 160 ~~~~~l~~L~~l~l~~N~l~~~~~~-~~~l~~l~~l~~~~n~ 200 (603)
..|.++++|+.+++++|++++.+|. |..+++++.|++++|.
T Consensus 171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 212 (284)
T d1ozna_ 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred hhhccccccchhhhhhccccccChhHhhhhhhcccccccccc
Confidence 7888888888888888888887664 7777788888777763
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=8e-16 Score=137.02 Aligned_cols=122 Identities=20% Similarity=0.159 Sum_probs=101.4
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|+|++|+|+.+ +..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+|+...+..+..+++|+.|+|
T Consensus 18 ~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 4789999999999885 566678999999999999998 665 4899999999999999999555555678999999999
Q ss_pred cCCccCCCCC--CCCccccccceeeccCCcCcccCC----CCccccccCccc
Q 007455 150 SSNSLKGAIP--SSLGRLTHLHYLNLSTNFFSGEIP----DFGALSAFGNKS 195 (603)
Q Consensus 150 ~~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~~~~~----~~~~l~~l~~l~ 195 (603)
++|+|+ .++ ..+..+++|+.|++++|+++..+. .+..+++|+.|+
T Consensus 95 ~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 95 TNNSLV-ELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cccccc-ccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 999998 444 368889999999999999987653 155566666655
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.52 E-value=1.2e-14 Score=123.03 Aligned_cols=99 Identities=21% Similarity=0.272 Sum_probs=87.2
Q ss_pred ceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCC
Q 007455 97 QRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTN 176 (603)
Q Consensus 97 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N 176 (603)
+.|+|++|+|+ .+|. +..+++|++|+|++|+|+ .+|+.|+.+++|+.|++++|+|+ .+| .+.++++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCcc-cccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 57999999998 7775 999999999999999999 78889999999999999999999 555 5999999999999999
Q ss_pred cCcccCC--CCccccccCcccccCCc
Q 007455 177 FFSGEIP--DFGALSAFGNKSFIGNL 200 (603)
Q Consensus 177 ~l~~~~~--~~~~l~~l~~l~~~~n~ 200 (603)
+|+..+. .+..+++|+.+++.+|.
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~ 101 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNS 101 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCc
Confidence 9997764 36777788888877773
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=2e-14 Score=127.77 Aligned_cols=110 Identities=15% Similarity=0.073 Sum_probs=92.6
Q ss_pred CCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccc
Q 007455 88 PSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTH 167 (603)
Q Consensus 88 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~ 167 (603)
+.+.+..+|++|+|++|+|+ .+|+.+..+++|+.|+|++|+|+ .++ .|..+++|++|++++|++++..+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccc
Confidence 34678889999999999998 77877788999999999999999 554 5899999999999999999544445678999
Q ss_pred cceeeccCCcCcccCC--CCccccccCcccccCCc
Q 007455 168 LHYLNLSTNFFSGEIP--DFGALSAFGNKSFIGNL 200 (603)
Q Consensus 168 L~~l~l~~N~l~~~~~--~~~~l~~l~~l~~~~n~ 200 (603)
|+.|++++|+|+.... .+..+++|+.+++.+|+
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~ 123 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNP 123 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSG
T ss_pred cccceeccccccccccccccccccccchhhcCCCc
Confidence 9999999999987643 46677788888877773
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=9.9e-14 Score=122.36 Aligned_cols=100 Identities=20% Similarity=0.093 Sum_probs=78.9
Q ss_pred CCCCcccccCCCccCCCCcceEEeccC-CCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCC
Q 007455 78 PYMQLGGIISPSIGRLDKLQRLALHQN-SLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKG 156 (603)
Q Consensus 78 ~~n~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 156 (603)
+++++.. .|..+..+++|++|+|++| .|+..-++.|.++++|+.|+|++|+|+...|..|..+++|++|+|++|+|+
T Consensus 16 ~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~- 93 (156)
T d2ifga3 16 TRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE- 93 (156)
T ss_dssp CSSCCCT-TTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS-
T ss_pred cCCCCcc-CcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCc-
Confidence 3444544 4667888899999999766 487555567899999999999999999777888999999999999999999
Q ss_pred CCCCCCccccccceeeccCCcCc
Q 007455 157 AIPSSLGRLTHLHYLNLSTNFFS 179 (603)
Q Consensus 157 ~~p~~~~~l~~L~~l~l~~N~l~ 179 (603)
.+|.......+|+.|+|++|.+.
T Consensus 94 ~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 94 SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp CCCSTTTCSCCCCEEECCSSCCC
T ss_pred ccChhhhccccccccccCCCccc
Confidence 55555555557888898888886
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=1.9e-13 Score=120.58 Aligned_cols=112 Identities=20% Similarity=0.171 Sum_probs=87.7
Q ss_pred CCcceEEeccCCCCCCCCCCccccCCCceEEeccc-cCCCCCccccccccccceecccCCccCCCCCCCCccccccceee
Q 007455 94 DKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN-YLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLN 172 (603)
Q Consensus 94 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~ 172 (603)
...+.++++++++. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+...|.+|..+++|+.|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 44567888888887 77888888999999999766 58866667789999999999999999976678899999999999
Q ss_pred ccCCcCcccCCCCccccccCcccccCCcccCCCCCCCCCC
Q 007455 173 LSTNFFSGEIPDFGALSAFGNKSFIGNLDLCGRQVHKPCR 212 (603)
Q Consensus 173 l~~N~l~~~~~~~~~l~~l~~l~~~~n~~l~~~~~~~~c~ 212 (603)
|++|+|+.++++.....+|.. +++.+|||.|+|.
T Consensus 87 Ls~N~l~~l~~~~~~~~~l~~------L~L~~Np~~C~C~ 120 (156)
T d2ifga3 87 LSFNALESLSWKTVQGLSLQE------LVLSGNPLHCSCA 120 (156)
T ss_dssp CCSSCCSCCCSTTTCSCCCCE------EECCSSCCCCCGG
T ss_pred ccCCCCcccChhhhccccccc------cccCCCcccCCch
Confidence 999999988776433334444 4555667777773
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.40 E-value=2.3e-13 Score=125.52 Aligned_cols=121 Identities=30% Similarity=0.391 Sum_probs=94.7
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|++++..+ +.++++|++|++++|.+. .+|. +.++++|+.|++++|.+.. + ..+..+++|+.|++
T Consensus 62 ~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~-~-~~~~~l~~L~~L~l 135 (199)
T d2omxa2 62 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP-LANLTNLTGLTLFNNQITD-I-DPLKNLTNLNRLEL 135 (199)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEEC
T ss_pred CCcCcCccccccccCccc--ccCCcccccccccccccc-cccc-ccccccccccccccccccc-c-cccchhhhhHHhhh
Confidence 578888888888887543 788888888888888887 5553 7888888888888888873 3 34778888888888
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|++. .++ .+..+++|+.|++.+|++++.+ .+..+++|+.|++++|
T Consensus 136 ~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l~-~l~~l~~L~~L~ls~N 182 (199)
T d2omxa2 136 SSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDLK-PLANLTTLERLDISSN 182 (199)
T ss_dssp CSSCCC-CCG-GGTTCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSS
T ss_pred hhhhhc-ccc-cccccccccccccccccccCCc-cccCCCCCCEEECCCC
Confidence 888887 443 5778888888888888888754 4777888888888777
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.38 E-value=4.9e-13 Score=131.98 Aligned_cols=110 Identities=19% Similarity=0.212 Sum_probs=100.2
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.+++++|+++.+ |..+ +++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+.++++|++|+|
T Consensus 150 ~~L~~l~l~~n~l~~l-~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L 226 (305)
T d1xkua_ 150 KKLSYIRIADTNITTI-PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHL 226 (305)
T ss_dssp TTCCEEECCSSCCCSC-CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEEC
T ss_pred cccCccccccCCcccc-Cccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeec
Confidence 4689999999999874 4433 689999999999999888999999999999999999999888999999999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIP 183 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~ 183 (603)
++|+|+ .+|.+|.++++|+.|+|++|+|+.+..
T Consensus 227 ~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~ 259 (305)
T d1xkua_ 227 NNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGS 259 (305)
T ss_dssp CSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCT
T ss_pred cccccc-ccccccccccCCCEEECCCCccCccCh
Confidence 999999 788999999999999999999998755
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.35 E-value=7.3e-13 Score=123.13 Aligned_cols=121 Identities=26% Similarity=0.342 Sum_probs=95.2
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|+|+++. .++.+++|++|+|++|+|+ .+| .+..+++|+.|++++|.+. .++ .+..+++|+.+++
T Consensus 68 ~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 68 PNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYL 141 (210)
T ss_dssp TTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEEC
T ss_pred CCCCEEeCCCccccCcc--ccccCcccccccccccccc-ccc-ccccccccccccccccccc-ccc-ccccccccccccc
Confidence 57888888888888754 3678888888888888887 566 4888888888888888887 343 5778888888888
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|.+++ . ..+.++++|+.+++++|++++.+ .+..+++|+.|++++|
T Consensus 142 ~~n~l~~-~-~~~~~l~~L~~l~l~~n~l~~i~-~l~~l~~L~~L~Ls~N 188 (210)
T d1h6ta2 142 GNNKITD-I-TVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKN 188 (210)
T ss_dssp CSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCCEEECCSS
T ss_pred ccccccc-c-ccccccccccccccccccccccc-cccCCCCCCEEECCCC
Confidence 8888873 2 34777888889999999888754 4777888888888776
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.34 E-value=2.6e-13 Score=134.52 Aligned_cols=109 Identities=28% Similarity=0.374 Sum_probs=98.3
Q ss_pred EEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccC
Q 007455 72 VRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSS 151 (603)
Q Consensus 72 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~ 151 (603)
...++++++.+.+.+|..+..+++|+.|++++|.+++.+| .+..+++|+.|+|++|+|+|.+|+.|++|++|++|+|++
T Consensus 199 ~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~ 277 (313)
T d1ogqa_ 199 LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcC
Confidence 3468888888888888888999999999999999997665 589999999999999999999999999999999999999
Q ss_pred CccCCCCCCCCccccccceeeccCCc-CcccC
Q 007455 152 NSLKGAIPSSLGRLTHLHYLNLSTNF-FSGEI 182 (603)
Q Consensus 152 N~l~~~~p~~~~~l~~L~~l~l~~N~-l~~~~ 182 (603)
|+|+|.+|. ++++++|+.+++++|+ +.|.|
T Consensus 278 N~l~g~iP~-~~~L~~L~~l~l~~N~~l~g~p 308 (313)
T d1ogqa_ 278 NNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308 (313)
T ss_dssp SEEEEECCC-STTGGGSCGGGTCSSSEEESTT
T ss_pred CcccccCCC-cccCCCCCHHHhCCCccccCCC
Confidence 999999985 6899999999999997 66653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.32 E-value=1.6e-12 Score=119.79 Aligned_cols=121 Identities=26% Similarity=0.382 Sum_probs=104.3
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.+++.|++++|+++.+ +.+..+++|++|+|++|+|++ +++ +.++++|+.|++++|.+. .++ .+.++++|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred cCCCEEECCCCCCCCc--cccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-ccccccccccccc
Confidence 4689999999999874 358899999999999999994 444 999999999999999998 555 4889999999999
Q ss_pred cCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 150 SSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 150 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
++|.+... ..+..+++|+.|++++|+++.. +.+..+++++.|++.+|
T Consensus 114 ~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~-~~l~~~~~L~~L~l~~n 160 (199)
T d2omxa2 114 FNNQITDI--DPLKNLTNLNRLELSSNTISDI-SALSGLTSLQQLNFSSN 160 (199)
T ss_dssp CSSCCCCC--GGGTTCTTCSEEECCSSCCCCC-GGGTTCTTCSEEECCSS
T ss_pred cccccccc--cccchhhhhHHhhhhhhhhccc-ccccccccccccccccc
Confidence 99999843 3488899999999999999864 45778888888888877
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.31 E-value=9.2e-15 Score=134.69 Aligned_cols=108 Identities=23% Similarity=0.325 Sum_probs=64.4
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDL 149 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 149 (603)
.++++|+|++|+|+.+ + .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+ .++ .+..+++|+.|+|
T Consensus 48 ~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~L 122 (198)
T d1m9la_ 48 KACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKLVNLRVLYM 122 (198)
T ss_dssp TTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHHHHSSEEEE
T ss_pred cccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-ccccccccccccc
Confidence 3566666666666653 2 3666666666666666665 55544444556666666666666 232 3566666666666
Q ss_pred cCCccCCCCC--CCCccccccceeeccCCcCcccCC
Q 007455 150 SSNSLKGAIP--SSLGRLTHLHYLNLSTNFFSGEIP 183 (603)
Q Consensus 150 ~~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~~~~~ 183 (603)
++|+|+ .++ ..+..+++|+.|++++|+++..++
T Consensus 123 ~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 123 SNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp SEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccchhc-cccccccccCCCccceeecCCCccccCcc
Confidence 666666 222 245566666666666666655444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.31 E-value=1.8e-12 Score=120.38 Aligned_cols=122 Identities=25% Similarity=0.338 Sum_probs=105.0
Q ss_pred CCCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCcccccccccccee
Q 007455 68 HDQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTIL 147 (603)
Q Consensus 68 ~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 147 (603)
...+++.|+|++|+|+++ + .+..+++|+.|++++|.+. .++ .+..+++|+.+++++|.+++ +..+..+++|+.+
T Consensus 88 ~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l 161 (210)
T d1h6ta2 88 NLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTL 161 (210)
T ss_dssp TCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCC-CCG-GGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEE
T ss_pred cCcccccccccccccccc-c-ccccccccccccccccccc-ccc-cccccccccccccccccccc--ccccccccccccc
Confidence 346899999999999884 3 5889999999999999997 554 58999999999999999984 3457889999999
Q ss_pred cccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccC
Q 007455 148 DLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIG 198 (603)
Q Consensus 148 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~ 198 (603)
++++|++++ ++ .+.++++|+.|+|++|+|+.+ +.+..+++|+.|++++
T Consensus 162 ~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 162 SLEDNQISD-IV-PLAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFS 209 (210)
T ss_dssp ECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEEEEE
T ss_pred ccccccccc-cc-cccCCCCCCEEECCCCCCCCC-hhhcCCCCCCEEEccC
Confidence 999999995 43 388999999999999999975 4688888999888764
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.30 E-value=1.5e-12 Score=132.48 Aligned_cols=123 Identities=23% Similarity=0.327 Sum_probs=74.3
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCC--------------------CCccccCCCceEEecccc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIP--------------------NEITNCTELRALYLRANY 129 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p--------------------~~~~~l~~L~~L~L~~N~ 129 (603)
.+++.|++++|.+++..+ +..+++|++|++++|.+++..+ ..+..+++|+.|+|++|+
T Consensus 241 ~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~ 318 (384)
T d2omza2 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNN 318 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSC
T ss_pred cccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCCC
Confidence 467778888887777543 6667777777777777763221 124445556666666666
Q ss_pred CCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 130 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
|++. + .+..+++|+.|+|++|+|+ .++ .+.++++|++|++++|+|++.+| +..+++|+.|++++|
T Consensus 319 l~~l-~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 319 ISDI-S-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSCC-G-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCC-c-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 6632 2 2556666666666666665 333 45666666666666666665544 555566666666555
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.28 E-value=2.7e-14 Score=131.45 Aligned_cols=110 Identities=23% Similarity=0.288 Sum_probs=94.6
Q ss_pred cCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccc
Q 007455 86 ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRL 165 (603)
Q Consensus 86 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l 165 (603)
++.++..|++|++|+|++|+|+ .++ .+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|+ .++ .+.++
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-ccccc
Confidence 4567889999999999999998 666 4999999999999999999 77877777889999999999999 443 58899
Q ss_pred cccceeeccCCcCcccCC--CCccccccCcccccCCc
Q 007455 166 THLHYLNLSTNFFSGEIP--DFGALSAFGNKSFIGNL 200 (603)
Q Consensus 166 ~~L~~l~l~~N~l~~~~~--~~~~l~~l~~l~~~~n~ 200 (603)
++|+.|++++|+|+.... .+..+++|+.|++++|+
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~ 151 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNP 151 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCc
Confidence 999999999999987642 46778888888888874
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=5.8e-12 Score=119.63 Aligned_cols=100 Identities=20% Similarity=0.274 Sum_probs=67.6
Q ss_pred CCccccceeecCC---------CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCC-CCccccCCCceEEe
Q 007455 56 SPCKWTGISCHTH---------DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIP-NEITNCTELRALYL 125 (603)
Q Consensus 56 ~~c~w~gv~C~~~---------~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L 125 (603)
|-|....|.|.+. ..++++|+|++|.|+.+.+..|.++++|++|+|++|.+...+| ..|.+++++++|++
T Consensus 6 C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 6 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp EEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 3467788899632 2479999999999998777789999999999999998875443 34555666555554
Q ss_pred c-cccCCCCCccccccccccceecccCCccC
Q 007455 126 R-ANYLQGGIPANIGNLLFLTILDLSSNSLK 155 (603)
Q Consensus 126 ~-~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 155 (603)
. .|++....+..|.++++|+.|++++|++.
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred cccccccccccccccccccccccccchhhhc
Confidence 4 24454444444555555555555555443
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.19 E-value=1.9e-11 Score=114.80 Aligned_cols=124 Identities=19% Similarity=0.268 Sum_probs=91.5
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCc-------------
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIP------------- 135 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------- 135 (603)
.++|+.|+|++|.++++.+ +..+++|++|++++|.++ .++ .+.++++|+.|++++|++.+..+
T Consensus 62 l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~ 137 (227)
T d1h6ua2 62 LNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLD 137 (227)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECC
T ss_pred CCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccccccccccccccccchhccccchhhhhch
Confidence 3578888888888887544 788888888888888887 555 37788888888888887663221
Q ss_pred -------cccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 136 -------ANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 136 -------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
..+.++++|+.|++++|.+++.. .+.++++|+.|+|++|++++++ .+..+++|+.|++++|
T Consensus 138 ~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~-~l~~l~~L~~L~Ls~N 205 (227)
T d1h6ua2 138 LNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDIS-PLASLPNLIEVHLKNN 205 (227)
T ss_dssp SSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECTTS
T ss_pred hhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCCh-hhcCCCCCCEEECcCC
Confidence 23566777888888888877433 3777888888888888887653 4677777877777776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.15 E-value=2.3e-11 Score=123.51 Aligned_cols=124 Identities=27% Similarity=0.259 Sum_probs=89.1
Q ss_pred CCcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCc-------------
Q 007455 69 DQRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIP------------- 135 (603)
Q Consensus 69 ~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p------------- 135 (603)
..+++.|++++|+++.. +.+..+++|+.|++++|.+++. +. +..+++|+.|++++|++++..+
T Consensus 218 ~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~-~~-~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~ 293 (384)
T d2omza2 218 LTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNL-AP-LSGLTKLTELKLGANQISNISPLAGLTALTNLELN 293 (384)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECC
T ss_pred cCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCC-Cc-ccccccCCEeeccCcccCCCCcccccccccccccc
Confidence 35788899999988773 3578889999999999999854 33 8888999999999998884322
Q ss_pred -------cccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcccccCC
Q 007455 136 -------ANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFIGN 199 (603)
Q Consensus 136 -------~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~~n 199 (603)
..+..+++|+.|++++|++++.. .+..+++|+.|++++|+|++++ .+..+++|+.|++++|
T Consensus 294 ~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~l~-~l~~l~~L~~L~l~~N 361 (384)
T d2omza2 294 ENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGHN 361 (384)
T ss_dssp SSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSS
T ss_pred ccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCCCh-hHcCCCCCCEEECCCC
Confidence 22455566677777777776432 2666777777777777776543 4666677777776665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.13 E-value=3.2e-11 Score=113.27 Aligned_cols=121 Identities=20% Similarity=0.271 Sum_probs=90.0
Q ss_pred CcEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCC--------------------CCCCccccCCCceEEecccc
Q 007455 70 QRVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGS--------------------IPNEITNCTELRALYLRANY 129 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~--------------------~p~~~~~l~~L~~L~L~~N~ 129 (603)
.+++.|++++|.++.+ +.+.++++|+.|++++|.+.+. ....+.++++|+.|++++|+
T Consensus 85 ~~l~~l~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~ 162 (227)
T d1h6ua2 85 TKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQ 162 (227)
T ss_dssp CSCCEEECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSC
T ss_pred cccccccccccccccc--ccccccccccccccccccccccchhccccchhhhhchhhhhchhhhhccccccccccccccc
Confidence 4566666666666542 2355566666666666554421 11236778899999999999
Q ss_pred CCCCCccccccccccceecccCCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCccccc
Q 007455 130 LQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNKSFI 197 (603)
Q Consensus 130 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l~~~ 197 (603)
+++ .+ .+.++++|+.|+|++|++++ ++ .+.++++|++|+|++|+|+++++ +..+++|+.|+++
T Consensus 163 ~~~-~~-~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~-l~~l~~L~~L~ls 225 (227)
T d1h6ua2 163 VSD-LT-PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP-LANTSNLFIVTLT 225 (227)
T ss_dssp CCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG-GTTCTTCCEEEEE
T ss_pred ccc-ch-hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc-cccCCCCCEEEee
Confidence 984 33 38899999999999999994 54 38999999999999999998764 7888888888875
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.88 E-value=2.5e-09 Score=106.48 Aligned_cols=101 Identities=21% Similarity=0.289 Sum_probs=84.2
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceeccc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLS 150 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 150 (603)
+++.|||++++|+. +|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .+++. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 58899999999987 5653 578999999999999 888754 57999999999999 55532 1469999999
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccCCCC
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDF 185 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~ 185 (603)
+|.++ .+|. ++.+++|+.|++++|.++..+...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~ 139 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLP 139 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCC
T ss_pred ccccc-cccc-hhhhccceeecccccccccccccc
Confidence 99999 6775 688999999999999998776643
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=2.5e-09 Score=100.90 Aligned_cols=118 Identities=15% Similarity=0.134 Sum_probs=93.6
Q ss_pred EEEEcCCCCcccccCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCC-ccccccccccceeccc-
Q 007455 73 RSINLPYMQLGGIISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGI-PANIGNLLFLTILDLS- 150 (603)
Q Consensus 73 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~- 150 (603)
+.++.++++++. +|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...+ +..|.+++++++|++.
T Consensus 11 ~~i~c~~~~l~~-iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVTE-IPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCSS-CCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCCC-cCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 367888889985 665553 58999999999998444557999999999999999998654 4568899999999986
Q ss_pred CCccCCCCCCCCccccccceeeccCCcCcccCCCCccccccCcc
Q 007455 151 SNSLKGAIPSSLGRLTHLHYLNLSTNFFSGEIPDFGALSAFGNK 194 (603)
Q Consensus 151 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~~~~~~~~~l~~l~~l 194 (603)
.|++....+..|.++++|+.|++++|.++..++ +..+.+++.+
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~-~~~~~~l~~l 130 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPD-VHKIHSLQKV 130 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCC-CTTTCBSSCE
T ss_pred cccccccccccccccccccccccchhhhccccc-cccccccccc
Confidence 477887778889999999999999999986544 3333444333
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=4.6e-10 Score=99.03 Aligned_cols=68 Identities=29% Similarity=0.208 Sum_probs=33.3
Q ss_pred ccccCCCceEEeccccCCCC--CccccccccccceecccCCccCCCCCC-CCccccccceeeccCCcCcccC
Q 007455 114 ITNCTELRALYLRANYLQGG--IPANIGNLLFLTILDLSSNSLKGAIPS-SLGRLTHLHYLNLSTNFFSGEI 182 (603)
Q Consensus 114 ~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~l~l~~N~l~~~~ 182 (603)
+..+++|++|+|++|+|+.. ++..+..+++|+.|+|++|.|+ .+++ .+....+|+.|++++|+++...
T Consensus 61 ~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 61 EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp HHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred HHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc-cchhhhhhhccccceeecCCCCcCcCc
Confidence 34455555555555555532 1233445555555566665555 2222 1222234555666666555443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=98.58 E-value=5.1e-08 Score=96.66 Aligned_cols=94 Identities=26% Similarity=0.257 Sum_probs=77.7
Q ss_pred CCcceEEeccCCCCCCCCCCccccCCCceEEeccccCCCCCccccccccccceecccCCccCCCCCCCCccccccceeec
Q 007455 94 DKLQRLALHQNSLHGSIPNEITNCTELRALYLRANYLQGGIPANIGNLLFLTILDLSSNSLKGAIPSSLGRLTHLHYLNL 173 (603)
Q Consensus 94 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~l~l 173 (603)
.+|+.|||++|.|+ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++. +. +.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-lp--~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-LP--PLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-CC--TTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-hc--cccccccc
Confidence 47899999999998 78864 578999999999999 788754 57899999999998 5553 21 46999999
Q ss_pred cCCcCcccCCCCccccccCcccccCCc
Q 007455 174 STNFFSGEIPDFGALSAFGNKSFIGNL 200 (603)
Q Consensus 174 ~~N~l~~~~~~~~~l~~l~~l~~~~n~ 200 (603)
++|+++..+ .++.+.+|+.+++.+|.
T Consensus 106 ~~n~l~~lp-~~~~l~~L~~L~l~~~~ 131 (353)
T d1jl5a_ 106 SNNQLEKLP-ELQNSSFLKIIDVDNNS 131 (353)
T ss_dssp CSSCCSSCC-CCTTCTTCCEEECCSSC
T ss_pred ccccccccc-chhhhccceeecccccc
Confidence 999999765 57788899999887763
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=2.6e-07 Score=87.73 Aligned_cols=149 Identities=16% Similarity=0.120 Sum_probs=101.1
Q ss_pred HHHHHhhCCCCCCeeeecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCC-CCeeeecceeeecCCccE
Q 007455 305 EIIEKLEALDEEDVVGSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIK-HINLVNLRGYCRLPATKL 383 (603)
Q Consensus 305 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 383 (603)
++......|...+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++++...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 5555566776655544455578998764 45678899886554444445788998888774 333567778888888899
Q ss_pred EEEEecCCCCccccccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 007455 384 LIYDYLSMGSLDDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHHDC-------------------------------- 431 (603)
Q Consensus 384 lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-------------------------------- 431 (603)
+||++++|.++.+..... . ....++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEeccccccccccccc------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999998775543221 1 12234455556666666421
Q ss_pred ------------------------CCCeEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 432 ------------------------CPKIIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 432 ------------------------~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
.+.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999876667999997753
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=7.5e-09 Score=100.14 Aligned_cols=33 Identities=21% Similarity=0.384 Sum_probs=17.6
Q ss_pred cEEEEEcCCCCcccccCCCccCCCCcceEEecc
Q 007455 71 RVRSINLPYMQLGGIISPSIGRLDKLQRLALHQ 103 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 103 (603)
++++|+|+++.+++.....++.+++|++|+|++
T Consensus 72 ~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 72 KLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 455555555555544444455555555555555
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=4.9e-09 Score=108.16 Aligned_cols=110 Identities=24% Similarity=0.302 Sum_probs=85.6
Q ss_pred cEEEEEcCCCCccccc-CCCccCCCCcceEEeccCCCCC----CCCCCccccCCCceEEeccccCCCC----Cccccc-c
Q 007455 71 RVRSINLPYMQLGGII-SPSIGRLDKLQRLALHQNSLHG----SIPNEITNCTELRALYLRANYLQGG----IPANIG-N 140 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~-~ 140 (603)
+|+.||++.|++++.. ..-+..+++|++|+|++|.|+. .++..+..+++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 6999999999998642 3446678999999999999872 3345567889999999999998631 222222 2
Q ss_pred ccccceecccCCccCCC----CCCCCccccccceeeccCCcCcc
Q 007455 141 LLFLTILDLSSNSLKGA----IPSSLGRLTHLHYLNLSTNFFSG 180 (603)
Q Consensus 141 l~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~~ 180 (603)
..+|+.|+|++|++++. ++..+..+++|+.|++++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35799999999999743 45567888999999999999874
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.37 E-value=3.5e-08 Score=86.60 Aligned_cols=90 Identities=22% Similarity=0.171 Sum_probs=67.3
Q ss_pred cCCCccCCCCcceEEeccCCCCCCC--CCCccccCCCceEEeccccCCCCCcc-ccccccccceecccCCccCCCCCCC-
Q 007455 86 ISPSIGRLDKLQRLALHQNSLHGSI--PNEITNCTELRALYLRANYLQGGIPA-NIGNLLFLTILDLSSNSLKGAIPSS- 161 (603)
Q Consensus 86 ~~~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~- 161 (603)
++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|+|+. +++ .+....+|+.|++++|.+++.....
T Consensus 57 l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~-l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~ 135 (162)
T d1koha1 57 LRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS-ERELDKIKGLKLEELWLDGNSLSDTFRDQS 135 (162)
T ss_dssp HHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC-GGGHHHHTTCCCSSCCCTTSTTSSSSSSHH
T ss_pred hHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc-chhhhhhhccccceeecCCCCcCcCcccch
Confidence 3444567899999999999998432 3446789999999999999994 443 3445567999999999998655432
Q ss_pred ------CccccccceeeccCCcC
Q 007455 162 ------LGRLTHLHYLNLSTNFF 178 (603)
Q Consensus 162 ------~~~l~~L~~l~l~~N~l 178 (603)
+..+|+|+.|| ++++
T Consensus 136 ~y~~~i~~~~P~L~~LD--g~~v 156 (162)
T d1koha1 136 TYISAIRERFPKLLRLD--GHEL 156 (162)
T ss_dssp HHHHHHHTTSTTCCEET--TEEC
T ss_pred hHHHHHHHHCCCCCEEC--cCCC
Confidence 45678888776 5554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.28 E-value=1.1e-08 Score=98.81 Aligned_cols=83 Identities=22% Similarity=0.189 Sum_probs=66.4
Q ss_pred CcEEEEEcCCCCcccc-cCCCccCCCCcceEEeccCCCCCCCCCCccccCCCceEEeccc-cCCCC-Cccccccccccce
Q 007455 70 QRVRSINLPYMQLGGI-ISPSIGRLDKLQRLALHQNSLHGSIPNEITNCTELRALYLRAN-YLQGG-IPANIGNLLFLTI 146 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~ 146 (603)
.++++|||+++.++.. +...+.++++|++|+|++|.+++..+..+..+++|+.|+|+++ .++.. +...+.++++|++
T Consensus 46 ~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~ 125 (284)
T d2astb2 46 FRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE 125 (284)
T ss_dssp BCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCE
T ss_pred CCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccc
Confidence 4799999999988754 3445778999999999999998777778889999999999994 66521 2233457889999
Q ss_pred ecccCC
Q 007455 147 LDLSSN 152 (603)
Q Consensus 147 L~l~~N 152 (603)
|+++++
T Consensus 126 L~ls~c 131 (284)
T d2astb2 126 LNLSWC 131 (284)
T ss_dssp EECCCC
T ss_pred cccccc
Confidence 999885
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.19 E-value=2.1e-08 Score=99.81 Aligned_cols=109 Identities=19% Similarity=0.188 Sum_probs=54.6
Q ss_pred cEEEEEcCCCCcccc----cCCCccCCCCcceEEeccCCCCCC-----CCCCccccCCCceEEeccccCCCC----Cccc
Q 007455 71 RVRSINLPYMQLGGI----ISPSIGRLDKLQRLALHQNSLHGS-----IPNEITNCTELRALYLRANYLQGG----IPAN 137 (603)
Q Consensus 71 ~l~~L~L~~n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~ 137 (603)
.++.|++++|.++.. +...+...+.|++|+|++|+|+.. +...+..+++|+.|+|++|.++.. +...
T Consensus 159 ~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~ 238 (344)
T d2ca6a1 159 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 238 (344)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHH
T ss_pred ccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccccccccc
Confidence 344555555544321 122233455666666666665421 223345556666666666665421 2334
Q ss_pred cccccccceecccCCccCCCCC----CCCcc--ccccceeeccCCcCc
Q 007455 138 IGNLLFLTILDLSSNSLKGAIP----SSLGR--LTHLHYLNLSTNFFS 179 (603)
Q Consensus 138 ~~~l~~L~~L~l~~N~l~~~~p----~~~~~--l~~L~~l~l~~N~l~ 179 (603)
+..+++|++|+|++|.|++.-. ..+.. .+.|+.|++++|+|+
T Consensus 239 l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred ccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 5556666666666666653211 11111 234666666666655
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.09 E-value=6.2e-06 Score=77.39 Aligned_cols=130 Identities=14% Similarity=0.026 Sum_probs=85.9
Q ss_pred eeeecCC-eEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCC--CeeeecceeeecCCccEEEEEecCCCCc
Q 007455 318 VVGSGGF-GTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKH--INLVNLRGYCRLPATKLLIYDYLSMGSL 394 (603)
Q Consensus 318 ~ig~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL 394 (603)
.+..|.. +.||+....++..+++|....... ..+.+|+..++.+.. -.+.+++++..+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3455554 678999888777788997654332 236778888887743 2356677887888888999999998766
Q ss_pred cccccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 007455 395 DDFLHEHGEGQQLLNWSARLKIALGSARGLAYLHH--------------------------------------------- 429 (603)
Q Consensus 395 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~--------------------------------------------- 429 (603)
.+... .. ...+.++++.|.-||+
T Consensus 94 ~~~~~---------~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSHL---------AP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSCC---------CH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccccc---------cH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 44211 11 1112233333333332
Q ss_pred ------C----CCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 430 ------D----CCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 430 ------~----~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
. ..+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 11247999999999999987667899999765
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.09 E-value=9.2e-08 Score=94.96 Aligned_cols=113 Identities=19% Similarity=0.261 Sum_probs=86.1
Q ss_pred CcEEEEEcCCCCccc-----ccCCCccCCCCcceEEeccCCCCCC----CCCCccccCCCceEEeccccCCCCCcc----
Q 007455 70 QRVRSINLPYMQLGG-----IISPSIGRLDKLQRLALHQNSLHGS----IPNEITNCTELRALYLRANYLQGGIPA---- 136 (603)
Q Consensus 70 ~~l~~L~L~~n~l~~-----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~---- 136 (603)
..++.|+|++|+++. .+...+...++|+.|+|++|.|+.. +...+..+++|++|+|++|.|++.-..
T Consensus 186 ~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~ 265 (344)
T d2ca6a1 186 RLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVD 265 (344)
T ss_dssp TTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHH
T ss_pred hhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHH
Confidence 469999999999874 2456688899999999999998632 345577889999999999999854222
Q ss_pred cccc--ccccceecccCCccCCC----CCCCCc-cccccceeeccCCcCcccC
Q 007455 137 NIGN--LLFLTILDLSSNSLKGA----IPSSLG-RLTHLHYLNLSTNFFSGEI 182 (603)
Q Consensus 137 ~~~~--l~~L~~L~l~~N~l~~~----~p~~~~-~l~~L~~l~l~~N~l~~~~ 182 (603)
.+.. .+.|++|+|++|+|+.. +...+. ++++|+.|+|++|++....
T Consensus 266 ~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~~ 318 (344)
T d2ca6a1 266 AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 318 (344)
T ss_dssp HHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCcc
Confidence 2332 35799999999998742 223332 5678999999999997543
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.91 E-value=1.6e-07 Score=96.37 Aligned_cols=106 Identities=17% Similarity=0.178 Sum_probs=79.5
Q ss_pred CCcceEEeccCCCCCCC-CCCccccCCCceEEeccccCCC----CCccccccccccceecccCCccCCC----CCCCCcc
Q 007455 94 DKLQRLALHQNSLHGSI-PNEITNCTELRALYLRANYLQG----GIPANIGNLLFLTILDLSSNSLKGA----IPSSLGR 164 (603)
Q Consensus 94 ~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~p~~~~~ 164 (603)
.+|+.||++.|+|++.. ..-+..+++|+.|+|++|.|+. .+...+..+++|++|||++|+|+.. +...+..
T Consensus 2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 37899999999998421 3336778999999999999883 3455677899999999999998631 2223322
Q ss_pred -ccccceeeccCCcCcccC-----CCCccccccCcccccCC
Q 007455 165 -LTHLHYLNLSTNFFSGEI-----PDFGALSAFGNKSFIGN 199 (603)
Q Consensus 165 -l~~L~~l~l~~N~l~~~~-----~~~~~l~~l~~l~~~~n 199 (603)
..+|+.|+|++|+++... ..+..+++|+.|++++|
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N 122 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSS
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccc
Confidence 357999999999998542 12556778888888877
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.71 E-value=1.5e-06 Score=76.24 Aligned_cols=86 Identities=10% Similarity=0.200 Sum_probs=46.0
Q ss_pred CcEEEEEcCCC-Ccccc----cCCCccCCCCcceEEeccCCCCC----CCCCCccccCCCceEEeccccCCCC----Ccc
Q 007455 70 QRVRSINLPYM-QLGGI----ISPSIGRLDKLQRLALHQNSLHG----SIPNEITNCTELRALYLRANYLQGG----IPA 136 (603)
Q Consensus 70 ~~l~~L~L~~n-~l~~~----~~~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 136 (603)
++++.|+|+++ .++.. +...+...++|++|+|++|.+.. .+...+...+.|+.|+|++|.|+.. +-.
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 45777777653 34421 22345555667777777776652 1222234456666666666666531 112
Q ss_pred ccccccccceecccCCccC
Q 007455 137 NIGNLLFLTILDLSSNSLK 155 (603)
Q Consensus 137 ~~~~l~~L~~L~l~~N~l~ 155 (603)
.+...++|++|+|++|.+.
T Consensus 95 aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HTTTTCCCSEEECCCCSSC
T ss_pred HHHhCCcCCEEECCCCcCC
Confidence 3444455666666666544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.70 E-value=5.9e-05 Score=75.43 Aligned_cols=76 Identities=12% Similarity=0.032 Sum_probs=48.3
Q ss_pred CeeeecCCeEEEEEEECC-CCEEEEEEeCCC-------CCChHHHHHHHHHHHhhCC-C--CeeeecceeeecCCccEEE
Q 007455 317 DVVGSGGFGTVYRMVMND-CGTFAVKRIDRS-------REGSDQVFERELEILGSIK-H--INLVNLRGYCRLPATKLLI 385 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 385 (603)
+.||.|....||++...+ ++.++||.-... ......+...|++.++.+. + ..+.+++. .+++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEE
Confidence 468999999999998765 457889865321 1112234567888887663 2 33445544 355677899
Q ss_pred EEecCCCCc
Q 007455 386 YDYLSMGSL 394 (603)
Q Consensus 386 ~e~~~~gsL 394 (603)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999987543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.31 E-value=1.6e-05 Score=69.34 Aligned_cols=90 Identities=13% Similarity=0.100 Sum_probs=66.7
Q ss_pred cCCCCcceEEeccC-CCCCC----CCCCccccCCCceEEeccccCCC----CCccccccccccceecccCCccCCC----
Q 007455 91 GRLDKLQRLALHQN-SLHGS----IPNEITNCTELRALYLRANYLQG----GIPANIGNLLFLTILDLSSNSLKGA---- 157 (603)
Q Consensus 91 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~---- 157 (603)
.+-++|++|+|+++ .++.. +-..+...+.|+.|+|++|.+.. .+.+.+...+.|+.|+|++|.|+..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34588999999974 56521 22346677889999999999873 2334556678999999999999842
Q ss_pred CCCCCccccccceeeccCCcCcc
Q 007455 158 IPSSLGRLTHLHYLNLSTNFFSG 180 (603)
Q Consensus 158 ~p~~~~~l~~L~~l~l~~N~l~~ 180 (603)
+-.++...++|+.|++++|.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~ 114 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSV 114 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCC
T ss_pred HHHHHHhCCcCCEEECCCCcCCC
Confidence 22356677889999999998764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.16 E-value=9.2e-06 Score=70.91 Aligned_cols=110 Identities=15% Similarity=0.211 Sum_probs=67.2
Q ss_pred CCcEEEEEcCC-CCcccc----cCCCccCCCCcceEEeccCCCCCC----CCCCccccCCCceEEeccccCCCC----Cc
Q 007455 69 DQRVRSINLPY-MQLGGI----ISPSIGRLDKLQRLALHQNSLHGS----IPNEITNCTELRALYLRANYLQGG----IP 135 (603)
Q Consensus 69 ~~~l~~L~L~~-n~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p 135 (603)
.+.++.|+|++ +.++.. +..++...++|++|+|++|.++.. +-..+...++|+.|++++|.++.. +-
T Consensus 16 ~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~ 95 (166)
T d1io0a_ 16 DPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV 95 (166)
T ss_dssp CTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred CCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence 35788888887 456432 334455677888888888887632 222345567788888888877632 22
Q ss_pred ccccccccccee--cccCCccCC----CCCCCCccccccceeeccCCcC
Q 007455 136 ANIGNLLFLTIL--DLSSNSLKG----AIPSSLGRLTHLHYLNLSTNFF 178 (603)
Q Consensus 136 ~~~~~l~~L~~L--~l~~N~l~~----~~p~~~~~l~~L~~l~l~~N~l 178 (603)
..+...++|+.+ ++++|.+.. .+...+...++|+.|+++.|+.
T Consensus 96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 445566677654 445566653 2333455667777777765543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.09 E-value=0.00068 Score=65.54 Aligned_cols=137 Identities=12% Similarity=0.076 Sum_probs=79.3
Q ss_pred CeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCee--eecce-----eeecCCccEEEEEecCCCCccc
Q 007455 324 FGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINL--VNLRG-----YCRLPATKLLIYDYLSMGSLDD 396 (603)
Q Consensus 324 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~~ 396 (603)
--.||++...+|..|++|.... ...+.+++..|...+..|....+ +.... .+...+..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp-~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRP-ERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECT-TTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCC-CCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 3589999999988899997654 34456778899999888853322 22211 2234556788999998754422
Q ss_pred ccc----c--------------c-CCCCccCCHH-------------------HHHHHHHHHHHHHHHHHh----CCCCC
Q 007455 397 FLH----E--------------H-GEGQQLLNWS-------------------ARLKIALGSARGLAYLHH----DCCPK 434 (603)
Q Consensus 397 ~l~----~--------------~-~~~~~~l~~~-------------------~~~~i~~~i~~~L~~LH~----~~~~~ 434 (603)
.-. . . .......++. ....+...+.+.++.+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 100 0 0 0011111111 011111122223333322 22347
Q ss_pred eEEecCCCCCeEECCCCCeEEeecccccc
Q 007455 435 IIHRDIKSSNILLDENLEPHVSDFGLAKL 463 (603)
Q Consensus 435 ivH~Dlkp~NIll~~~~~~kl~DfG~~~~ 463 (603)
++|+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999753 46899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.52 E-value=0.0038 Score=61.83 Aligned_cols=73 Identities=11% Similarity=0.122 Sum_probs=48.7
Q ss_pred CeeeecCCeEEEEEEECCC--------CEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCee-eecceeeecCCccEEEEE
Q 007455 317 DVVGSGGFGTVYRMVMNDC--------GTFAVKRIDRSREGSDQVFERELEILGSIKHINL-VNLRGYCRLPATKLLIYD 387 (603)
Q Consensus 317 ~~ig~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 387 (603)
+.|+.|-.-.+|++...++ ..|.++.... . .......+|..+++.+.-.++ .++++++.+ ..|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-c-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5688899999999987643 3466665542 2 223346689999888853343 466666642 68999
Q ss_pred ecCCCCcc
Q 007455 388 YLSMGSLD 395 (603)
Q Consensus 388 ~~~~gsL~ 395 (603)
|++|.++.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99886554
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.48 E-value=0.0064 Score=58.00 Aligned_cols=158 Identities=13% Similarity=0.057 Sum_probs=83.6
Q ss_pred ChHHHHHHhhCCCCCCee-----eecCCeEEEEEEECCCCEEEEEEeCCCCCChHHHHHHHHHHHhhCCCCee--eecce
Q 007455 302 PSCEIIEKLEALDEEDVV-----GSGGFGTVYRMVMNDCGTFAVKRIDRSREGSDQVFERELEILGSIKHINL--VNLRG 374 (603)
Q Consensus 302 ~~~~~~~~~~~~~~~~~i-----g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~ 374 (603)
+..++..-..+|.+++.. ..|---+.|+....+ +.+++|+..... ..+.+..|++++..+...++ .....
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-CcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 345677777888876554 356667889988776 468999875432 22346667778777753322 11111
Q ss_pred ------eeecCCccEEEEEecCCCCcccccccc------------------C-CCCccCC------------------HH
Q 007455 375 ------YCRLPATKLLIYDYLSMGSLDDFLHEH------------------G-EGQQLLN------------------WS 411 (603)
Q Consensus 375 ------~~~~~~~~~lv~e~~~~gsL~~~l~~~------------------~-~~~~~l~------------------~~ 411 (603)
+.........++.++.+......-... . ....... ..
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 112234456677777665443211100 0 0000000 00
Q ss_pred HHHHHHHHHHHHHHHHHh-CCCCCeEEecCCCCCeEECCCCCeEEeeccccc
Q 007455 412 ARLKIALGSARGLAYLHH-DCCPKIIHRDIKSSNILLDENLEPHVSDFGLAK 462 (603)
Q Consensus 412 ~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~NIll~~~~~~kl~DfG~~~ 462 (603)
.....+......+...+. ....++||+|+.++||+++++...-|.||+.+.
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011111122222222221 122379999999999999988777899999875
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.31 E-value=3.5e-05 Score=67.04 Aligned_cols=91 Identities=13% Similarity=0.129 Sum_probs=65.0
Q ss_pred CccCCCCcceEEecc-CCCCCC----CCCCccccCCCceEEeccccCCCC----CccccccccccceecccCCccCCC--
Q 007455 89 SIGRLDKLQRLALHQ-NSLHGS----IPNEITNCTELRALYLRANYLQGG----IPANIGNLLFLTILDLSSNSLKGA-- 157 (603)
Q Consensus 89 ~~~~l~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~-- 157 (603)
...+.++|++|+|++ |.|+.. +-..+...++|+.|+|++|.++.. +-..+...++|+.|++++|.+...
T Consensus 12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~ 91 (166)
T d1io0a_ 12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 91 (166)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhH
Confidence 345668999999998 556521 233356788999999999998743 223456678999999999998742
Q ss_pred --CCCCCccccccceeec--cCCcCc
Q 007455 158 --IPSSLGRLTHLHYLNL--STNFFS 179 (603)
Q Consensus 158 --~p~~~~~l~~L~~l~l--~~N~l~ 179 (603)
+-..+...++|+.++| ++|.+.
T Consensus 92 ~~l~~~l~~~~~L~~l~L~l~~n~i~ 117 (166)
T d1io0a_ 92 LALVEALQSNTSLIELRIDNQSQPLG 117 (166)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred HHHHHHHHhCccccEEeeccCCCcCc
Confidence 2346677788887555 567775
|